Psyllid ID: psy11098
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 380 | 2.2.26 [Sep-21-2011] | |||||||
| P97924 | 2959 | Kalirin OS=Rattus norvegi | yes | N/A | 0.847 | 0.108 | 0.325 | 6e-40 | |
| A2CG49 | 2964 | Kalirin OS=Mus musculus G | yes | N/A | 0.847 | 0.108 | 0.325 | 7e-40 | |
| O60229 | 2985 | Kalirin OS=Homo sapiens G | yes | N/A | 0.847 | 0.107 | 0.323 | 8e-40 | |
| O75962 | 3097 | Triple functional domain | no | N/A | 0.723 | 0.088 | 0.344 | 2e-38 | |
| Q1LUA6 | 3028 | Triple functional domain | no | N/A | 0.723 | 0.090 | 0.336 | 3e-38 | |
| Q0KL02 | 3102 | Triple functional domain | no | N/A | 0.723 | 0.088 | 0.338 | 7e-38 | |
| O43293 | 454 | Death-associated protein | no | N/A | 0.663 | 0.555 | 0.361 | 2e-37 | |
| O54784 | 448 | Death-associated protein | no | N/A | 0.663 | 0.562 | 0.353 | 1e-35 | |
| O88764 | 448 | Death-associated protein | no | N/A | 0.663 | 0.562 | 0.353 | 2e-35 | |
| O44997 | 1425 | Death-associated protein | yes | N/A | 0.731 | 0.195 | 0.325 | 2e-33 |
| >sp|P97924|KALRN_RAT Kalirin OS=Rattus norvegicus GN=Kalrn PE=1 SV=3 | Back alignment and function desciption |
|---|
Score = 165 bits (417), Expect = 6e-40, Method: Compositional matrix adjust.
Identities = 118/362 (32%), Positives = 185/362 (51%), Gaps = 40/362 (11%)
Query: 45 SGVWSDARWVISPHNGTIQVDDLAPGHTYTFCINNEYKVLYTVPFE-------------- 90
S VW + V S + + ++DL+PG Y F ++ ++P E
Sbjct: 2585 SQVWQQS--VASTLDTYLVIEDLSPGCPYQFRVSASNPWGISLPSEPSEFVHLPEYDAAA 2642
Query: 91 ----TRWQQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAE 146
W+ E F+ Y EL +G GRF V+K + T + VA+K + ++ + ++ E
Sbjct: 2643 DGATISWK-ENFDSAYTELNEIGRGRFSIVKKCIHKATRKDVAVKFVSKKMKKKEQAAHE 2701
Query: 147 YNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIR 206
LL L H P + L + P + ++++L+ L+ +L + E + IR
Sbjct: 2702 AALLQHLQH---PQYVTLHDTYESPTSYILILELMDDGRLLDYLMNHDELMEEKVAFYIR 2758
Query: 207 QLHSALHCLHSQQIAHKDIRPENILMNGAV----LKLIDLGSSVSVSTV-----VLPDLE 257
+ AL LH+ ++AH DI+PEN+L++ + +KLIDL +V +S +L + E
Sbjct: 2759 DIMEALQYLHNCRVAHLDIKPENLLIDLRIPVPRVKLIDLEDAVQISGHFHIHHLLGNPE 2818
Query: 258 FASPEMLTS-PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQ 316
FA+PE++ P + G TD+WS+GVL Y++LSGVSPFLDES+EET ++ D+SFP E
Sbjct: 2819 FAAPEVIQGIPVSLG--TDIWSIGVLTYVMLSGVSPFLDESKEETCINVCRVDFSFPHEY 2876
Query: 317 CGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASCSE----FDTERLLPFSARRK 372
+S AR+ I +L +RPTA LQ W + S DT RL F RRK
Sbjct: 2877 FCGVSNAARDFINVILQEDFRRRPTAATCLQHPWLQPHNGSYSKIPLDTSRLACFIERRK 2936
Query: 373 QK 374
+
Sbjct: 2937 HQ 2938
|
Promotes the exchange of GDP by GTP. Activates specific Rho GTPase family members, thereby inducing various signaling mechanisms that regulate neuronal shape, growth, and plasticity, through their effects on the actin cytoskeleton. Induces lamellipodia independent of its GEF activity. Isoforms 1 and 7 are necessary for neuronal development and axonal outgrowth. Isoform 6 is required for dendritic spine formation. Rattus norvegicus (taxid: 10116) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|A2CG49|KALRN_MOUSE Kalirin OS=Mus musculus GN=Kalrn PE=1 SV=1 | Back alignment and function description |
|---|
Score = 164 bits (416), Expect = 7e-40, Method: Compositional matrix adjust.
Identities = 118/362 (32%), Positives = 185/362 (51%), Gaps = 40/362 (11%)
Query: 45 SGVWSDARWVISPHNGTIQVDDLAPGHTYTFCINNEYKVLYTVPFE-------------- 90
S VW + V S + + ++DL+PG Y F ++ ++P E
Sbjct: 2584 SQVWQQS--VASTLDTYLVIEDLSPGCPYQFRVSASNPWGISLPSEPSEFVRLPEYDAAA 2641
Query: 91 ----TRWQQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAE 146
W+ E F+ Y EL +G GRF V+K + T + VA+K + ++ + ++ E
Sbjct: 2642 DGATISWK-ENFDSAYTELNEIGRGRFSIVKKCIHKATRKDVAVKFVSKKMKKKEQAAHE 2700
Query: 147 YNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIR 206
LL L H P + L + P + ++++L+ L+ +L + E + IR
Sbjct: 2701 AALLQHLQH---PQYVTLHDTYESPTSYILILELMDDGRLLDYLMNHDELMEEKVAFYIR 2757
Query: 207 QLHSALHCLHSQQIAHKDIRPENILMNGAV----LKLIDLGSSVSVSTV-----VLPDLE 257
+ AL LH+ ++AH DI+PEN+L++ + +KLIDL +V +S +L + E
Sbjct: 2758 DIMEALQYLHNCRVAHLDIKPENLLIDLRIPVPRVKLIDLEDAVQISGHFHIHHLLGNPE 2817
Query: 258 FASPEMLTS-PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQ 316
FA+PE++ P + G TD+WS+GVL Y++LSGVSPFLDES+EET ++ D+SFP E
Sbjct: 2818 FAAPEVIQGIPVSLG--TDIWSIGVLTYVMLSGVSPFLDESKEETCINVCRVDFSFPHEY 2875
Query: 317 CGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASCSE----FDTERLLPFSARRK 372
+S AR+ I +L +RPTA LQ W + S DT RL F RRK
Sbjct: 2876 FCGVSNAARDFINVILQEDFRRRPTAATCLQHPWLQPHNGSYSKIPLDTSRLACFIERRK 2935
Query: 373 QK 374
+
Sbjct: 2936 HQ 2937
|
Promotes the exchange of GDP by GTP. Activates specific Rho GTPase family members, thereby inducing various signaling mechanisms that regulate neuronal shape, growth, and plasticity, through their effects on the actin cytoskeleton. Induces lamellipodia independent of its GEF activity. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O60229|KALRN_HUMAN Kalirin OS=Homo sapiens GN=KALRN PE=1 SV=2 | Back alignment and function description |
|---|
Score = 164 bits (416), Expect = 8e-40, Method: Compositional matrix adjust.
Identities = 117/362 (32%), Positives = 185/362 (51%), Gaps = 40/362 (11%)
Query: 45 SGVWSDARWVISPHNGTIQVDDLAPGHTYTFCINNEYKVLYTVPFE-------------- 90
S +W + V S + + ++DL+PG Y F ++ ++P E
Sbjct: 2611 SQIWQQS--VASTLDTYLVIEDLSPGCPYQFRVSASNPWGISLPSEPSEFVRLPEYDAAA 2668
Query: 91 ----TRWQQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAE 146
W+ E F+ Y EL +G GRF V+K + T + VA+K + ++ + ++ E
Sbjct: 2669 DGATISWK-ENFDSAYTELNEIGRGRFSIVKKCIHKATRKDVAVKFVSKKMKKKEQAAHE 2727
Query: 147 YNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIR 206
LL L H P + L + P + ++++L+ L+ +L + E + IR
Sbjct: 2728 AALLQHLQH---PQYITLHDTYESPTSYILILELMDDGRLLDYLMNHDELMEEKVAFYIR 2784
Query: 207 QLHSALHCLHSQQIAHKDIRPENILMNGAV----LKLIDLGSSVSVSTV-----VLPDLE 257
+ AL LH+ ++AH DI+PEN+L++ + +KLIDL +V +S +L + E
Sbjct: 2785 DIMEALQYLHNCRVAHLDIKPENLLIDLRIPVPRVKLIDLEDAVQISGHFHIHHLLGNPE 2844
Query: 258 FASPEMLTS-PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQ 316
FA+PE++ P + G TD+WS+GVL Y++LSGVSPFLDES+EET ++ D+SFP E
Sbjct: 2845 FAAPEVIQGIPVSLG--TDIWSIGVLTYVMLSGVSPFLDESKEETCINVCRVDFSFPHEY 2902
Query: 317 CGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASCSE----FDTERLLPFSARRK 372
+S AR+ I +L +RPTA LQ W + S DT RL F RRK
Sbjct: 2903 FCGVSNAARDFINVILQEDFRRRPTAATCLQHPWLQPHNGSYSKIPLDTSRLACFIERRK 2962
Query: 373 QK 374
+
Sbjct: 2963 HQ 2964
|
Promotes the exchange of GDP by GTP. Activates specific Rho GTPase family members, thereby inducing various signaling mechanisms that regulate neuronal shape, growth, and plasticity, through their effects on the actin cytoskeleton. Induces lamellipodia independent of its GEF activity. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O75962|TRIO_HUMAN Triple functional domain protein OS=Homo sapiens GN=TRIO PE=1 SV=2 | Back alignment and function description |
|---|
Score = 159 bits (403), Expect = 2e-38, Method: Compositional matrix adjust.
Identities = 101/293 (34%), Positives = 160/293 (54%), Gaps = 18/293 (6%)
Query: 95 QEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLM 154
++ F+ Y E+ LG GRF V+K +GT + VA K + ++ + E +L +L
Sbjct: 2789 KDNFDSFYSEVAELGRGRFSVVKKCDQKGTKRAVATKFVNKKLMKRDQVTHELGILQSLQ 2848
Query: 155 HAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHC 214
H P + L + P + +V+++ L+ + R ++TE I + ++ A+
Sbjct: 2849 H---PLLVGLLDTFETPTSYILVLEMADQGRLLDCVVRWGSLTEGKIRAHLGEVLEAVRY 2905
Query: 215 LHSQQIAHKDIRPENILMNGAV----LKLIDLGSSVSVSTV-----VLPDLEFASPEM-L 264
LH+ +IAH D++PENIL++ ++ +KL D G +V ++T +L + EFA+PE+ L
Sbjct: 2906 LHNCRIAHLDLKPENILVDESLAKPTIKLADFGDAVQLNTTYYIHQLLGNPEFAAPEIIL 2965
Query: 265 TSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPA 324
+P + ++D WS+GVL Y+LLSGVSPFLD+S EET +I D+SFP + +S A
Sbjct: 2966 GNPVSL--TSDTWSVGVLTYVLLSGVSPFLDDSVEETCLNICRLDFSFPDDYFKGVSQKA 3023
Query: 325 RELIGQLLNTHADKRPTAGQLLQVAWFAEA---SCSEFDTERLLPFSARRKQK 374
+E + LL KRP+A LQ W S DT RL F RRK +
Sbjct: 3024 KEFVCFLLQEDPAKRPSAALALQEQWLQAGNGRSTGVLDTSRLTSFIERRKHQ 3076
|
Promotes the exchange of GDP by GTP. Together with leukocyte antigen-related (LAR) protein, it could play a role in coordinating cell-matrix and cytoskeletal rearrangements necessary for cell migration and cell growth. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q1LUA6|TRIO_DANRE Triple functional domain protein OS=Danio rerio GN=trio PE=3 SV=1 | Back alignment and function description |
|---|
Score = 159 bits (403), Expect = 3e-38, Method: Compositional matrix adjust.
Identities = 99/294 (33%), Positives = 158/294 (53%), Gaps = 19/294 (6%)
Query: 95 QEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLM 154
++ FE Y E+ LG GRF V++ RG+ + VA+K + ++ + E+++L L
Sbjct: 2719 KDNFESFYTEVAELGRGRFSVVKRCDQRGSKRTVAVKFVNKKLMKRDQVTHEFSVLQRLQ 2778
Query: 155 HAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHC 214
H H+ L FE + + +V+++ L+ ++ +TE + +R + AL
Sbjct: 2779 HPHLVRLLDTFETS---SSYALVLEMSDQGRLLDYIVSWGNLTEEKVAFYLRDILEALQY 2835
Query: 215 LHSQQIAHKDIRPENILMNGA----VLKLIDLGSSVSVSTV-----VLPDLEFASPEM-L 264
LH+ +I H D++PEN+++ + ++KL D G +V +++ +L EFA+PE+ L
Sbjct: 2836 LHNCRIVHLDLKPENLVVEQSPSQPLVKLTDFGDAVQLNSTPYVHPLLGSPEFAAPELVL 2895
Query: 265 TSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPA 324
P + S+D+WSLGVL Y++LSG SPFLDES EET +I D+SFP + +S A
Sbjct: 2896 GDPVSL--SSDLWSLGVLTYVMLSGASPFLDESVEETCLNICRLDFSFPDDYFQGVSQAA 2953
Query: 325 RELIGQLLNTHADKRPTAGQLLQVAWF----AEASCSEFDTERLLPFSARRKQK 374
R+ + LL KRP A LQ W S DT RL+ F RRK +
Sbjct: 2954 RDFMCLLLRMEPSKRPPATSCLQEPWLRAGGGRRSAECIDTSRLISFIDRRKHQ 3007
|
Promotes the exchange of GDP by GTP. Together with leukocyte antigen-related (LAR) protein, it could play a role in coordinating cell-matrix and cytoskeletal rearrangements necessary for cell migration and cell growth. Danio rerio (taxid: 7955) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0KL02|TRIO_MOUSE Triple functional domain protein OS=Mus musculus GN=Trio PE=1 SV=3 | Back alignment and function description |
|---|
Score = 158 bits (399), Expect = 7e-38, Method: Compositional matrix adjust.
Identities = 100/295 (33%), Positives = 160/295 (54%), Gaps = 20/295 (6%)
Query: 95 QEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLM 154
++ F+ Y E+ LG GRF V+K +GT + VA K + ++ + E +L L
Sbjct: 2792 KDNFDAFYSEVAELGRGRFAVVKKCDQKGTKRAVATKFVNKKLMKRDQVTHELGILQNLQ 2851
Query: 155 HAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHC 214
H P ++L + P + +V+++ L+ + R ++TE + + ++ A+
Sbjct: 2852 H---PLLVSLLDTFETPTSYVLVLEMADQGRLLDCVVRWGSLTEGKVRAHLGEVLEAVRY 2908
Query: 215 LHSQQIAHKDIRPENILMNGAV----LKLIDLGSSVSVSTV-----VLPDLEFASPEM-L 264
LH+ +IAH D++PENIL++ ++ +KL D G +V ++T +L + EFA+PE+ L
Sbjct: 2909 LHNCRIAHLDLKPENILVDQSLAKPTIKLADFGDAVQLNTTYYIHQLLGNPEFAAPEIIL 2968
Query: 265 TSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPA 324
+P + + D WS+GVL Y+LLSGVSPFLD+S EET +I D+SFP + +S A
Sbjct: 2969 GNPVSL--TADTWSVGVLTYVLLSGVSPFLDDSVEETCLNICRLDFSFPEDYFQGVSQKA 3026
Query: 325 RELIGQLLNTHADKRPTAGQLLQVAWFAEASCSE-----FDTERLLPFSARRKQK 374
+E + LL KRP+A LQ W + S DT RL F RRK +
Sbjct: 3027 KEFVCFLLQEDPAKRPSAALALQEQWLQAGNGSGKGTGVLDTSRLTSFIERRKHQ 3081
|
Promotes the exchange of GDP by GTP. Together with leukocyte antigen-related (LAR) protein, it could play a role in coordinating cell-matrix and cytoskeletal rearrangements necessary for cell migration and cell growth. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O43293|DAPK3_HUMAN Death-associated protein kinase 3 OS=Homo sapiens GN=DAPK3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 156 bits (395), Expect = 2e-37, Method: Compositional matrix adjust.
Identities = 100/277 (36%), Positives = 151/277 (54%), Gaps = 25/277 (9%)
Query: 93 WQQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER--------QPQQITR 144
++QE E YE E LG+G+F VRK R +GTG+ A K I + R ++I R
Sbjct: 4 FRQEDVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIER 63
Query: 145 AEYNLLSTLMHAHIPTALALFENAPVPGTDTI-VMQLVHGESLIQHLCRQSTITESYICC 203
E N+L + H +I T +FEN TD + +++LV G L L + ++TE
Sbjct: 64 -EVNILREIRHPNIITLHDIFENK----TDVVLILELVSGGELFDFLAEKESLTEDEATQ 118
Query: 204 IIRQLHSALHCLHSQQIAHKDIRPENI-LMNGAV----LKLIDLGSSVSVSTV-----VL 253
++Q+ +H LHS++IAH D++PENI L++ V +KLID G + + +
Sbjct: 119 FLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF 178
Query: 254 PDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFP 313
EF +PE++ G DMWS+GV+ YILLSG SPFL E+++ET +IS +Y F
Sbjct: 179 GTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFD 237
Query: 314 PEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAW 350
E + S A++ I +LL +R T Q L+ +W
Sbjct: 238 EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSW 274
|
Isoform 2 can phosphorylate myosin, PPP1R12A and MYL12B. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O54784|DAPK3_MOUSE Death-associated protein kinase 3 OS=Mus musculus GN=Dapk3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 150 bits (379), Expect = 1e-35, Method: Compositional matrix adjust.
Identities = 98/277 (35%), Positives = 148/277 (53%), Gaps = 25/277 (9%)
Query: 93 WQQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP--------QQITR 144
++QE E YE E LG+G+F VRK + +GTG A K I + R P ++I R
Sbjct: 4 FRQEDVEDHYEMGEELGSGQFAIVRKCQQKGTGMEYAAKFIKKRRLPSSRRGVSREEIER 63
Query: 145 AEYNLLSTLMHAHIPTALALFENAPVPGTDTI-VMQLVHGESLIQHLCRQSTITESYICC 203
E ++L + H +I T +FEN TD + +++LV G L L + ++TE
Sbjct: 64 -EVSILREIRHPNIITLHDVFENK----TDVVLILELVSGGELFDFLAEKESLTEDEATQ 118
Query: 204 IIRQLHSALHCLHSQQIAHKDIRPENILM-----NGAVLKLIDLG-----SSVSVSTVVL 253
++Q+ +H LHS++IAH D++PENI++ +KLID G + S +
Sbjct: 119 FLKQILDGVHYLHSKRIAHFDLKPENIMLLDKHAASPRIKLIDFGIAHRIEAGSEFKNIF 178
Query: 254 PDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFP 313
EF +PE++ G DMWS+GV+ YILLSG SPFL E+++ET +IS +Y F
Sbjct: 179 GTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFD 237
Query: 314 PEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAW 350
E S A++ I +LL +R T Q L+ +W
Sbjct: 238 EEYFSSTSELAKDFIRRLLVKDPKRRMTIAQSLEHSW 274
|
Serine/threonine kinase which is involved in the regulation of apoptosis, autophagy, transcription, actin cytoskeleton reorganization, cell motility, smooth muscle contraction, and mitosis, particularly cytokinesis. Regulates both type I apoptotic and type II autophagic cell deaths signal, depending on the cellular setting. The former is caspase-dependent, while the latter is caspase-independent and is characterized by the accumulation of autophagic vesicles. Regulates myosin phosphorylation in both smooth muscle and non-muscle cells. In smooth muscle, regulates myosin either directly by phosphorylating MYL12B and MYL9 or through inhibition of smooth muscle myosin phosphatase (SMPP1M) via phosphorylation of PPP1R12A, and the inhibition of SMPP1M functions to enhance muscle responsiveness to Ca(2+) and promote a contractile state. Enhances transcription from AR-responsive promoters in a hormone- and kinase-dependent manner. Phosphorylates STAT3 and enhances its transcriptional activity. Positively regulates the canonical Wnt/beta-catenin signaling through interaction with NLK and TCF7L2. Can disrupt the NLK-TCF7L2 complex thereby influencing the phosphorylation of TCF7L2 by NLK. Phosphorylates histone H3 on 'Thr-11' at centromeres during mitosis. Involved in the formation of promyelocytic leukemia protein nuclear body (PML-NB), one of many subnuclear domains in the eukaryotic cell nucleus, and which is involved in oncogenesis and viral infection. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O88764|DAPK3_RAT Death-associated protein kinase 3 OS=Rattus norvegicus GN=Dapk3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 150 bits (379), Expect = 2e-35, Method: Compositional matrix adjust.
Identities = 98/277 (35%), Positives = 148/277 (53%), Gaps = 25/277 (9%)
Query: 93 WQQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP--------QQITR 144
++QE E YE E LG+G+F VRK + +GTG A K I + R P ++I R
Sbjct: 4 FRQEDVEDHYEMGEELGSGQFAIVRKCQQKGTGMEYAAKFIKKRRLPSSRRGVSREEIER 63
Query: 145 AEYNLLSTLMHAHIPTALALFENAPVPGTDTI-VMQLVHGESLIQHLCRQSTITESYICC 203
E ++L + H +I T +FEN TD + +++LV G L L + ++TE
Sbjct: 64 -EVSILREIRHPNIITLHDVFENK----TDVVLILELVSGGELFDFLAEKESLTEDEATQ 118
Query: 204 IIRQLHSALHCLHSQQIAHKDIRPENILM-----NGAVLKLIDLG-----SSVSVSTVVL 253
++Q+ +H LHS++IAH D++PENI++ +KLID G + S +
Sbjct: 119 FLKQILDGVHYLHSKRIAHFDLKPENIMLLDKHAASPRIKLIDFGIAHRIEAGSEFKNIF 178
Query: 254 PDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFP 313
EF +PE++ G DMWS+GV+ YILLSG SPFL E+++ET +IS +Y F
Sbjct: 179 GTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFD 237
Query: 314 PEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAW 350
E S A++ I +LL +R T Q L+ +W
Sbjct: 238 EEYFSSTSELAKDFIRRLLVKDPKRRMTIAQSLEHSW 274
|
Serine/threonine kinase which is involved in the regulation of apoptosis, autophagy, transcription, actin cytoskeleton reorganization, cell motility, smooth muscle contraction, and mitosis, particularly cytokinesis. Regulates both type I apoptotic and type II autophagic cell deaths signal, depending on the cellular setting. The former is caspase-dependent, while the latter is caspase-independent and is characterized by the accumulation of autophagic vesicles. Regulates myosin phosphorylation in both smooth muscle and non-muscle cells. In smooth muscle, regulates myosin either directly by phosphorylating MYL12B and MYL9 or through inhibition of smooth muscle myosin phosphatase (SMPP1M) via phosphorylation of PPP1R12A, and the inhibition of SMPP1M functions to enhance muscle responsiveness to Ca(2+) and promote a contractile state. Enhances transcription from AR-responsive promoters in a hormone- and kinase-dependent manner. Phosphorylates STAT3 and enhances its transcriptional activity. Positively regulates the canonical Wnt/beta-catenin signaling through interaction with NLK and TCF7L2. Can disrupt the NLK-TCF7L2 complex thereby influencing the phosphorylation of TCF7L2 by NLK. Phosphorylates histone H3 on 'Thr-11' at centromeres during mitosis. Involved in the formation of promyelocytic leukemia protein nuclear body (PML-NB), one of many subnuclear domains in the eukaryotic cell nucleus, and which is involved in oncogenesis and viral infection. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O44997|DAPK_CAEEL Death-associated protein kinase dapk-1 OS=Caenorhabditis elegans GN=dapk-1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 143 bits (360), Expect = 2e-33, Method: Compositional matrix adjust.
Identities = 97/298 (32%), Positives = 149/298 (50%), Gaps = 20/298 (6%)
Query: 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP--------QQITRAEYNL 149
FE YE LG+G+F VR+ RDR TG+ A K I + R Q I R L
Sbjct: 24 FEDVYEIETELGSGQFAVVRRVRDRKTGEKYAAKFIKKRRYATSRRGVTRQNIEREVRVL 83
Query: 150 LSTLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLH 209
++++ A++E A IV++LV G L H+C + + E I+Q+
Sbjct: 84 QKIRGNSNVVELHAVYETA---SDVIIVLELVSGGELFDHVCAKECLDEVEAAAFIKQIL 140
Query: 210 SALHCLHSQQIAHKDIRPENILM---NGAVLKLIDLGSSVSVS-TVVLPDL----EFASP 261
A+ LHS I H DI+PEN+++ + +K+ID G S + V+ D+ EF +P
Sbjct: 141 LAVRHLHSLHIVHLDIKPENVMLKQRGDSQIKIIDFGLSREIEPGAVVKDMVGTPEFVAP 200
Query: 262 EMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHIS 321
E++ A + P+TDMW++GV+ YILLSG SPFL ++ +ET ++I+ Y F + S
Sbjct: 201 EVVNYEALS-PATDMWAVGVVTYILLSGGSPFLGDNRDETFSNITRVRYHFSDRYFKNTS 259
Query: 322 VPARELIGQLLNTHADKRPTAGQLLQVAWFAEASCSEFDTERLLPFSARRKQKFKEIQ 379
A++ I +L D+R T + LQ W + D + + Q FK Q
Sbjct: 260 KHAKDFIYRLFVRDVDQRATVEECLQHPWIRGPEGNAIDIRKASCITISHIQSFKTRQ 317
|
Negative regulator of barrier repair and innate immune responses to wounding. Appears to act downstream from or in parallel to muscarinic signaling in the regulation of autophagy. Caenorhabditis elegans (taxid: 6239) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 380 | ||||||
| 345483533 | 3031 | PREDICTED: kalirin-like [Nasonia vitripe | 0.823 | 0.103 | 0.446 | 6e-65 | |
| 270003788 | 584 | hypothetical protein TcasGA2_TC003064 [T | 0.936 | 0.609 | 0.414 | 4e-64 | |
| 189235151 | 1387 | PREDICTED: similar to AGAP006107-PB [Tri | 0.884 | 0.242 | 0.427 | 4e-64 | |
| 242007893 | 709 | serine/threonine-protein kinase, putativ | 0.736 | 0.394 | 0.473 | 8e-64 | |
| 307204441 | 3432 | Triple functional domain protein [Harpeg | 0.884 | 0.097 | 0.430 | 9e-64 | |
| 332029109 | 1559 | Triple functional domain protein [Acromy | 0.760 | 0.185 | 0.459 | 3e-62 | |
| 322786731 | 1051 | hypothetical protein SINV_04039 [Solenop | 0.755 | 0.273 | 0.472 | 1e-60 | |
| 307169364 | 1506 | Kalirin [Camponotus floridanus] | 0.755 | 0.190 | 0.462 | 1e-59 | |
| 350396743 | 3149 | PREDICTED: triple functional domain prot | 0.747 | 0.090 | 0.458 | 2e-59 | |
| 340715586 | 3145 | PREDICTED: triple functional domain prot | 0.747 | 0.090 | 0.453 | 8e-59 |
| >gi|345483533|ref|XP_001599496.2| PREDICTED: kalirin-like [Nasonia vitripennis] | Back alignment and taxonomy information |
|---|
Score = 254 bits (648), Expect = 6e-65, Method: Compositional matrix adjust.
Identities = 147/329 (44%), Positives = 202/329 (61%), Gaps = 16/329 (4%)
Query: 66 DLAPGHTYTFCI------NNEYKVLYTVPFE--TRWQQEQFEHRYEELERLGNGRFCTVR 117
DL PG +Y+F + + + +P T W+ EQF RY EL+ +G GRF VR
Sbjct: 2698 DLLPGASYSFRVVGKNGSHTSASPIVNLPLGDGTAWEAEQFVARYLELDEIGKGRFAIVR 2757
Query: 118 KARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIV 177
+ARDRGTGQ VALKQ PR++Q + +TRAEY+LL++ H +I A ALFENAP G DTI+
Sbjct: 2758 RARDRGTGQEVALKQTPRQKQSRSLTRAEYDLLASTHHGNIVRAFALFENAPQLGVDTII 2817
Query: 178 MQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILM--NGA 235
++LV G +L +L ++S TES QL SAL LH + AH D++PEN+L+ +
Sbjct: 2818 LELVRGPTLFCYLSKKSEYTESMASKFANQLLSALQWLHHRDKAHLDLKPENVLVDQDTG 2877
Query: 236 VLKLIDLGSSVS--VSTVVLP-DLEFASPE-MLTSPATAGPSTDMWSLGVLLYILLSGVS 291
++KLIDLG +V V VV P DLEFA+PE +L P G TDMW+ GV +Y+LLSG+S
Sbjct: 2878 IVKLIDLGEAVRGPVEEVVPPADLEFAAPESVLGRP--VGTYTDMWAAGVFIYVLLSGLS 2935
Query: 292 PFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWF 351
PFLD+S EET +I D+ FP E IS A++L+G+LL ++ R TA L WF
Sbjct: 2936 PFLDDSVEETTTNILKCDFCFPDEYFVMISNEAKDLLGRLLCLRSEDRATAEVSLASPWF 2995
Query: 352 AEASCSEFDTERLLPFSARRKQKFKEIQD 380
+ + + R+ F+ RR K +D
Sbjct: 2996 KVSKGATIPSTRMAAFTERRAHCSKSHRD 3024
|
Source: Nasonia vitripennis Species: Nasonia vitripennis Genus: Nasonia Family: Pteromalidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|270003788|gb|EFA00236.1| hypothetical protein TcasGA2_TC003064 [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
Score = 251 bits (641), Expect = 4e-64, Method: Compositional matrix adjust.
Identities = 162/391 (41%), Positives = 222/391 (56%), Gaps = 35/391 (8%)
Query: 7 DFNPATQ-PVINVHPLSESSVELALLTENLSS--IRLCDHESGVWSDARWVISPHNGTI- 62
D PA Q P I V LS SSV L +E I C +G W +SP+N +
Sbjct: 179 DPYPALQEPQIQV--LSCSSVLLEWESEFYHQFWIEYCQLGTGEW------LSPNNNRVI 230
Query: 63 -----QVDDLAPGHTYTF---CINNEY----KVLYTVPF--ETRWQQEQFEHRYEELERL 108
V++L PG TY+F + N+ V T+P +WQQEQF++RY ELE +
Sbjct: 231 NSQRYTVENLIPGETYSFRIIAVQNKLVSLPSVAITLPVADNLKWQQEQFKNRYLELEEI 290
Query: 109 GNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENA 168
GRF VR+A+DRGT VALKQ+ R RQ +T+AEY LL+ + H ++ A+ALF+NA
Sbjct: 291 SRGRFSIVRRAKDRGTNLEVALKQVTRRRQSHHVTQAEYGLLAGMQHVNVIRAMALFDNA 350
Query: 169 PVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPE 228
P PG DTIV++LV G L +LC + TE+ + RQL SAL LH + I+H DI+PE
Sbjct: 351 PQPGIDTIVLELVRGPLLFTYLCEKEEYTEATVKTYSRQLMSALLWLHQKDISHLDIKPE 410
Query: 229 NILMN----GAVLKLIDLGSSVSVS-TVVLPD--LEFASPEMLTSPATAGPSTDMWSLGV 281
N++++ +LKL+D G SV+ S +V+LP LEFASPE++ G TD W+ GV
Sbjct: 411 NVMVDLSGSSPLLKLVDFGDSVNTSKSVILPPACLEFASPELVLG-QPVGKHTDCWAAGV 469
Query: 282 LLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPT 341
LY+LLSGVSPFLD+S EET A+I D+ FP + IS A+ L+ LL +R
Sbjct: 470 FLYVLLSGVSPFLDDSMEETTANILKCDFCFPDDYFAEISPEAKSLVNNLLVLVPSQRIN 529
Query: 342 AGQLLQVAWF-AEASCSEFDTERLLPFSARR 371
+ L+ W + + +L F RR
Sbjct: 530 MEECLKSTWMTTDQKTVVIPSSKLKTFMLRR 560
|
Source: Tribolium castaneum Species: Tribolium castaneum Genus: Tribolium Family: Tenebrionidae Order: Coleoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|189235151|ref|XP_968430.2| PREDICTED: similar to AGAP006107-PB [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
Score = 251 bits (641), Expect = 4e-64, Method: Compositional matrix adjust.
Identities = 158/370 (42%), Positives = 215/370 (58%), Gaps = 34/370 (9%)
Query: 7 DFNPATQ-PVINVHPLSESSVELALLTENLSS--IRLCDHESGVWSDARWVISPHNGTI- 62
D PA Q P I V LS SSV L +E I C +G W +SP+N +
Sbjct: 982 DPYPALQEPQIQV--LSCSSVLLEWESEFYHQFWIEYCQLGTGEW------LSPNNNRVI 1033
Query: 63 -----QVDDLAPGHTYTF---CINNEY----KVLYTVPF--ETRWQQEQFEHRYEELERL 108
V++L PG TY+F + N+ V T+P +WQQEQF++RY ELE +
Sbjct: 1034 NSQRYTVENLIPGETYSFRIIAVQNKLVSLPSVAITLPVADNLKWQQEQFKNRYLELEEI 1093
Query: 109 GNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENA 168
GRF VR+A+DRGT VALKQ+ R RQ +T+AEY LL+ + H ++ A+ALF+NA
Sbjct: 1094 SRGRFSIVRRAKDRGTNLEVALKQVTRRRQSHHVTQAEYGLLAGMQHVNVIRAMALFDNA 1153
Query: 169 PVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPE 228
P PG DTIV++LV G L +LC + TE+ + RQL SAL LH + I+H DI+PE
Sbjct: 1154 PQPGIDTIVLELVRGPLLFTYLCEKEEYTEATVKTYSRQLMSALLWLHQKDISHLDIKPE 1213
Query: 229 NILMN----GAVLKLIDLGSSVSVS-TVVLPD--LEFASPEMLTSPATAGPSTDMWSLGV 281
N++++ +LKL+D G SV+ S +V+LP LEFASPE++ G TD W+ GV
Sbjct: 1214 NVMVDLSGSSPLLKLVDFGDSVNTSKSVILPPACLEFASPELVLG-QPVGKHTDCWAAGV 1272
Query: 282 LLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPT 341
LY+LLSGVSPFLD+S EET A+I D+ FP + IS A+ L+ LL +R
Sbjct: 1273 FLYVLLSGVSPFLDDSMEETTANILKCDFCFPDDYFAEISPEAKSLVNNLLVLVPSQRIN 1332
Query: 342 AGQLLQVAWF 351
+ L+ W
Sbjct: 1333 MEECLKSTWM 1342
|
Source: Tribolium castaneum Species: Tribolium castaneum Genus: Tribolium Family: Tenebrionidae Order: Coleoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|242007893|ref|XP_002424752.1| serine/threonine-protein kinase, putative [Pediculus humanus corporis] gi|212508255|gb|EEB12014.1| serine/threonine-protein kinase, putative [Pediculus humanus corporis] | Back alignment and taxonomy information |
|---|
Score = 250 bits (639), Expect = 8e-64, Method: Compositional matrix adjust.
Identities = 141/298 (47%), Positives = 179/298 (60%), Gaps = 18/298 (6%)
Query: 90 ETRWQQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNL 149
+T W+ EQF RYEELE LG GR V+ ARDR TG +VA+KQI R+ Q ++TRAEY L
Sbjct: 401 DTNWEAEQFRKRYEELEELGKGRMSVVKAARDRSTGHVVAVKQINRKYQSPEVTRAEYEL 460
Query: 150 LSTLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLH 209
L+TL H+H+P ALALF NAP P TD+I+M+L ESL +CR +E + +RQL
Sbjct: 461 LATLRHSHLPQALALFTNAPNPNTDSIIMELAK-ESLFDFVCRHDEYSEKTVRRALRQLL 519
Query: 210 SALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSV---SVSTVVLP--DLEFASPEM 263
SAL CLH + H D+RPENIL++G +KL+DLG V SV VLP LEFA+PEM
Sbjct: 520 SALACLHLHGVMHLDVRPENILVDGNGEIKLVDLGEGVRRNSVPGSVLPPVSLEFAAPEM 579
Query: 264 LTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVP 323
+ +A +DMWS GV YI LSGVSPFLDE+ EET +HI D+ + E ++S
Sbjct: 580 VLG-KSATSQSDMWSAGVFFYIFLSGVSPFLDETIEETTSHILQCDFFYAYEHFSNVSDE 638
Query: 324 ARELIGQLLNTHADKRPTAGQLLQVAWFAEASCSEF----------DTERLLPFSARR 371
A+ L+ LL +R A L WF S F TE+L F RR
Sbjct: 639 AKSLVSALLQLAPQQRLNAAACLLDPWFQSVSKKIFFFLCETGNVWKTEKLKRFMERR 696
|
Source: Pediculus humanus corporis Species: Pediculus humanus Genus: Pediculus Family: Pediculidae Order: Phthiraptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|307204441|gb|EFN83148.1| Triple functional domain protein [Harpegnathos saltator] | Back alignment and taxonomy information |
|---|
Score = 250 bits (638), Expect = 9e-64, Method: Compositional matrix adjust.
Identities = 154/358 (43%), Positives = 206/358 (57%), Gaps = 22/358 (6%)
Query: 18 VHPLSESSVELALLTENLSSIRLCDHESGVWSDARWV--ISPHNGTIQVDDLAPGHTYTF 75
V L S VE+ + S C E + +WV + N V D+ P +Y+F
Sbjct: 2637 VRVLGSSRVEIDWEKREIGSAS-CSIECRILPSQQWVSVLKQANEPPSVLDMPPDASYSF 2695
Query: 76 CINNEYKVLYTVPFE------------TRWQQEQFEHRYEELERLGNGRFCTVRKARDRG 123
+ + + T P W+ +QF RY EL+ LGNGRF TVR+A+DRG
Sbjct: 2696 RVVGDGGRM-TSPSNVVTLSRLDADSGAEWEAKQFIGRYLELDELGNGRFGTVRRAKDRG 2754
Query: 124 TGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHG 183
TGQ VALKQ PR +Q + +TRAEY+LL+ H +I A ALFENAP PG DTIV++LV G
Sbjct: 2755 TGQEVALKQTPRHKQSRSLTRAEYDLLAAAHHTNIVRAFALFENAPRPGVDTIVLELVKG 2814
Query: 184 ESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGA--VLKLID 241
+L +L + TE+ QL SALH LH + AH D++PENIL++ V+K+ID
Sbjct: 2815 PTLFAYLSEKMEYTEATAARYTGQLLSALHWLHCRDRAHLDVKPENILVDQETDVVKVID 2874
Query: 242 LGSSVS--VSTVVLP-DLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESE 298
LG +V V VV P DLEFA+PE + T GP TDMW++GV +Y+LLSG+SPFLD+S
Sbjct: 2875 LGEAVRAPVDEVVPPADLEFAAPESVLGRPT-GPYTDMWAIGVFIYVLLSGLSPFLDDSI 2933
Query: 299 EETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASC 356
EET A+I D+ FP E IS A+ L+ +LL H++ R A L W A+
Sbjct: 2934 EETTANILKCDFCFPDEYFETISSDAKNLLKRLLCLHSEDRINAELCLASTWLKRATA 2991
|
Source: Harpegnathos saltator Species: Harpegnathos saltator Genus: Harpegnathos Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|332029109|gb|EGI69122.1| Triple functional domain protein [Acromyrmex echinatior] | Back alignment and taxonomy information |
|---|
Score = 245 bits (626), Expect = 3e-62, Method: Compositional matrix adjust.
Identities = 136/296 (45%), Positives = 189/296 (63%), Gaps = 7/296 (2%)
Query: 91 TRWQQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLL 150
T W+ +QF RY EL+ LGNGRF TVR+ARD+GTGQ VALKQI R +Q + +TRAEY++L
Sbjct: 1259 TEWEAKQFISRYLELDELGNGRFGTVRRARDKGTGQEVALKQISRHKQSRLLTRAEYDVL 1318
Query: 151 STLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHS 210
++ HA+I A ALFENAP G DTIV++LV G +L +L +++ +E+ QL S
Sbjct: 1319 ASTHHANIVRAFALFENAPRSGVDTIVLELVRGPTLFAYLSKKTEYSEAMATRYTCQLLS 1378
Query: 211 ALHCLHSQQIAHKDIRPENILMNGAV--LKLIDLGSSVS--VSTVVLP--DLEFASPEML 264
ALH LH + AH DI+PEN+L++ +K+IDLG +V + +V P DLEFA+PE +
Sbjct: 1379 ALHWLHCRSRAHLDIKPENVLIDRETDQVKVIDLGEAVKAPIDEIVPPPADLEFAAPESV 1438
Query: 265 TSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPA 324
T+ TDMW++GV +Y+LLSG+SPFLD+S EET A+I D+ FP E IS A
Sbjct: 1439 LGRPTSS-YTDMWAVGVFIYVLLSGLSPFLDDSVEETTANILKCDFCFPDEYFKIISSDA 1497
Query: 325 RELIGQLLNTHADKRPTAGQLLQVAWFAEASCSEFDTERLLPFSARRKQKFKEIQD 380
+EL+ ++L + R A L W ++ + + R+ F RR FK QD
Sbjct: 1498 KELLRRMLCLRGEDRMNAETCLGSPWLKISTGATIPSTRMAAFIERRAHCFKLRQD 1553
|
Source: Acromyrmex echinatior Species: Acromyrmex echinatior Genus: Acromyrmex Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|322786731|gb|EFZ13098.1| hypothetical protein SINV_04039 [Solenopsis invicta] | Back alignment and taxonomy information |
|---|
Score = 239 bits (611), Expect = 1e-60, Method: Compositional matrix adjust.
Identities = 139/294 (47%), Positives = 187/294 (63%), Gaps = 7/294 (2%)
Query: 93 WQQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLST 152
W+ +QF RY EL+ LGNGRF TVR+ARD+GTGQ VALKQI R +Q + +TRAEY++L++
Sbjct: 752 WEAKQFVGRYLELDELGNGRFSTVRRARDKGTGQEVALKQISRHKQSRLLTRAEYDVLAS 811
Query: 153 LMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSAL 212
HA+I A ALFENAP PG DTIV++LV G +L +L + TE+ QL SAL
Sbjct: 812 THHANIVRAFALFENAPRPGLDTIVLELVRGPTLFAYLGEKMEYTEATATRYTCQLLSAL 871
Query: 213 HCLHSQQIAHKDIRPENILMNGAV--LKLIDLGSSVS--VSTVVLP--DLEFASPEMLTS 266
LH + AH D++PENIL++ +K+IDLG +V + +V P DLEFA+PE +
Sbjct: 872 RWLHCRSRAHLDVKPENILVDHETDQVKIIDLGEAVRAPIDEIVPPPADLEFAAPESVLG 931
Query: 267 PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARE 326
T GP TDMW++GV +Y+LLSG+SPFLD+S EET A+I D+ FP E IS A+E
Sbjct: 932 RPT-GPCTDMWAVGVFIYVLLSGLSPFLDDSVEETTANILKCDFCFPDEYFEMISSDAKE 990
Query: 327 LIGQLLNTHADKRPTAGQLLQVAWFAEASCSEFDTERLLPFSARRKQKFKEIQD 380
L+ +LL + R TA L W ++ + + R+ F RR K QD
Sbjct: 991 LLRRLLCLRGEDRVTAEICLGSPWLKISTGATIPSTRMAAFIERRAHCLKLRQD 1044
|
Source: Solenopsis invicta Species: Solenopsis invicta Genus: Solenopsis Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|307169364|gb|EFN62085.1| Kalirin [Camponotus floridanus] | Back alignment and taxonomy information |
|---|
Score = 236 bits (602), Expect = 1e-59, Method: Compositional matrix adjust.
Identities = 136/294 (46%), Positives = 185/294 (62%), Gaps = 7/294 (2%)
Query: 93 WQQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLST 152
W+ +QF RY EL+ LGNGRF VR+ARD+GTGQ VALKQIPR +Q + +TRAEY++L++
Sbjct: 1207 WESKQFVGRYLELDELGNGRFGVVRRARDKGTGQEVALKQIPRHKQSRLLTRAEYDVLAS 1266
Query: 153 LMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSAL 212
H +I A ALFENAP PG DTIV++LV G +L +L ++ TE+ QL SAL
Sbjct: 1267 THHVNIIRAFALFENAPRPGIDTIVLELVKGPTLFVYLSEKTEYTEAVATRYTGQLLSAL 1326
Query: 213 HCLHSQQIAHKDIRPENILMNGAV--LKLIDLGSSVS--VSTVVLP--DLEFASPEMLTS 266
LH + H D++PEN+L++ +K+IDLG +V + VV P DLEFA+PE +
Sbjct: 1327 GWLHCRSRMHLDVKPENVLVDQETDQVKVIDLGEAVRTPIDEVVPPPADLEFAAPESVLG 1386
Query: 267 PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARE 326
T GP TDMW++GV +Y+LLSG+SPFLD+S EET A+I D+ FP E IS A+E
Sbjct: 1387 RPT-GPYTDMWAVGVFIYVLLSGLSPFLDDSVEETTANILKCDFCFPDEYFEMISSDAKE 1445
Query: 327 LIGQLLNTHADKRPTAGQLLQVAWFAEASCSEFDTERLLPFSARRKQKFKEIQD 380
L+ +LL + R A L W ++ + + R+ F RR K QD
Sbjct: 1446 LLRRLLRLRGEDRANAEFCLGSPWLKISTGATILSTRMAAFIERRAHCLKLRQD 1499
|
Source: Camponotus floridanus Species: Camponotus floridanus Genus: Camponotus Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|350396743|ref|XP_003484649.1| PREDICTED: triple functional domain protein-like [Bombus impatiens] | Back alignment and taxonomy information |
|---|
Score = 235 bits (600), Expect = 2e-59, Method: Compositional matrix adjust.
Identities = 134/292 (45%), Positives = 179/292 (61%), Gaps = 8/292 (2%)
Query: 96 EQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMH 155
EQF ++Y ELE LG GRF V AR++G + VALKQI R +QP +TRAEY+LL ++ H
Sbjct: 2852 EQFTNKYIELEELGTGRFARVCCAREKGFDREVALKQISRSKQPLSLTRAEYDLLRSIRH 2911
Query: 156 AHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCL 215
+I A ALFE+ P P DTIV++LV G +L +L Q TES + QL SAL L
Sbjct: 2912 DNIVRAFALFEDTPQPDIDTIVLELVRGSTLFAYLGEQVEYTESTVAKYTGQLLSALQWL 2971
Query: 216 HSQQIAHKDIRPENILMNG--AVLKLIDLGS---SVSVSTVVLP--DLEFASPEMLTSPA 268
HS++ AH D++PENIL++ ++KLID G +V + VV P DLEFA+PE +
Sbjct: 2972 HSRKQAHLDLKPENILVDSETGIVKLIDFGEAIRAVPLDQVVPPPVDLEFAAPESVLGKP 3031
Query: 269 TAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELI 328
T G TDMW+ GV LY+LLSG+SPFLD+S EET A+I D+ FP E IS + L+
Sbjct: 3032 T-GSYTDMWAAGVFLYVLLSGLSPFLDDSIEETTANILKCDFCFPDEYFNEISTDVKNLL 3090
Query: 329 GQLLNTHADKRPTAGQLLQVAWFAEASCSEFDTERLLPFSARRKQKFKEIQD 380
LL H + R TA +L WF + + + R++ F RR + K QD
Sbjct: 3091 ETLLRLHGEDRATAQLILSSPWFKISIGATIPSSRMVAFIERRAHRSKSHQD 3142
|
Source: Bombus impatiens Species: Bombus impatiens Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|340715586|ref|XP_003396292.1| PREDICTED: triple functional domain protein-like [Bombus terrestris] | Back alignment and taxonomy information |
|---|
Score = 233 bits (595), Expect = 8e-59, Method: Compositional matrix adjust.
Identities = 132/291 (45%), Positives = 179/291 (61%), Gaps = 7/291 (2%)
Query: 96 EQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMH 155
EQF ++Y ELE LG GRF V AR++G + VALKQI R +QP +TRAEY+LL ++ H
Sbjct: 2849 EQFTNKYIELEELGTGRFARVCCAREKGFDREVALKQISRSKQPLSLTRAEYDLLRSIRH 2908
Query: 156 AHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCL 215
+I A ALFE+ P P DTIV++LV G +L +L Q TES + QL SAL L
Sbjct: 2909 DNIVRAFALFEDTPQPDIDTIVLELVRGSTLFAYLGEQVEYTESTVAKYTGQLLSALQWL 2968
Query: 216 HSQQIAHKDIRPENILMNG--AVLKLIDLGSSV-SVSTVVLP---DLEFASPEMLTSPAT 269
HS++ AH D++PENIL++ ++KLID G ++ +V +P DLEFA+PE + T
Sbjct: 2969 HSRKQAHLDLKPENILVDSDTGIVKLIDFGEAIRAVPLDQVPPPVDLEFAAPESVLGKPT 3028
Query: 270 AGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIG 329
G TDMW+ GV LY+LLSG+SPFLD+S EET A+I D+ FP E IS + L+
Sbjct: 3029 -GSYTDMWAAGVFLYVLLSGLSPFLDDSIEETTANILKCDFCFPDEYFNEISTDVKNLLE 3087
Query: 330 QLLNTHADKRPTAGQLLQVAWFAEASCSEFDTERLLPFSARRKQKFKEIQD 380
LL H + R TA +L WF + + + R++ F RR + K QD
Sbjct: 3088 TLLRLHGEDRATAQLILSSPWFKISIGATIPSSRMVAFIERRAHRSKSHQD 3138
|
Source: Bombus terrestris Species: Bombus terrestris Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 380 | ||||||
| UNIPROTKB|C9JQ37 | 1289 | KALRN "Kalirin" [Homo sapiens | 0.723 | 0.213 | 0.356 | 2.4e-38 | |
| UNIPROTKB|F1NPK0 | 2952 | KALRN "Uncharacterized protein | 0.728 | 0.093 | 0.350 | 5.8e-38 | |
| UNIPROTKB|F1PUI1 | 2201 | KALRN "Uncharacterized protein | 0.723 | 0.124 | 0.356 | 1.5e-37 | |
| UNIPROTKB|H7BXZ5 | 2955 | KALRN "Kalirin" [Homo sapiens | 0.723 | 0.093 | 0.356 | 2.5e-37 | |
| MGI|MGI:2685385 | 2964 | Kalrn "kalirin, RhoGEF kinase" | 0.723 | 0.092 | 0.356 | 2.5e-37 | |
| UNIPROTKB|O60229 | 2985 | KALRN "Kalirin" [Homo sapiens | 0.723 | 0.092 | 0.356 | 2.5e-37 | |
| UNIPROTKB|J3QSW6 | 2986 | KALRN "Kalirin" [Homo sapiens | 0.723 | 0.092 | 0.356 | 2.5e-37 | |
| UNIPROTKB|F1MXJ6 | 2941 | KALRN "Uncharacterized protein | 0.723 | 0.093 | 0.356 | 3.1e-37 | |
| UNIPROTKB|F1PPJ4 | 2945 | KALRN "Uncharacterized protein | 0.723 | 0.093 | 0.356 | 3.1e-37 | |
| ZFIN|ZDB-GENE-060503-334 | 3087 | si:dkey-158b13.2 "si:dkey-158b | 0.723 | 0.089 | 0.340 | 3.1e-36 |
| UNIPROTKB|C9JQ37 KALRN "Kalirin" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 408 (148.7 bits), Expect = 2.4e-38, Sum P(2) = 2.4e-38
Identities = 106/297 (35%), Positives = 160/297 (53%)
Query: 93 WQQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLST 152
W+ E F+ Y EL +G GRF V+K + T + VA+K + ++ + ++ E LL
Sbjct: 979 WK-ENFDSAYTELNEIGRGRFSIVKKCIHKATRKDVAVKFVSKKMKKKEQAAHEAALLQH 1037
Query: 153 LMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSAL 212
L H P + L + P + ++++L+ L+ +L + E + IR + AL
Sbjct: 1038 LQH---PQYITLHDTYESPTSYILILELMDDGRLLDYLMNHDELMEEKVAFYIRDIMEAL 1094
Query: 213 HCLHSQQIAHKDIRPENILMNGAV----LKLIDLGXXXXXXXXX-----LPDLEFASPEM 263
LH+ ++AH DI+PEN+L++ + +KLIDL L + EFA+PE+
Sbjct: 1095 QYLHNCRVAHLDIKPENLLIDLRIPVPRVKLIDLEDAVQISGHFHIHHLLGNPEFAAPEV 1154
Query: 264 LTS-PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQ-CGHIS 321
+ P + G TD+WS+GVL Y++LSGVSPFLDES+EET ++ D+SFP E CG +S
Sbjct: 1155 IQGIPVSLG--TDIWSIGVLTYVMLSGVSPFLDESKEETCINVCRVDFSFPHEYFCG-VS 1211
Query: 322 VPARELIGQLLNTHADKRPTAGQLLQVAWFA--EASCSEF--DTERLLPFSARRKQK 374
AR+ I +L +RPTA LQ W S S+ DT RL F RRK +
Sbjct: 1212 NAARDFINVILQEDFRRRPTAATCLQHPWLQPHNGSYSKIPLDTSRLACFIERRKHQ 1268
|
|
| UNIPROTKB|F1NPK0 KALRN "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 413 (150.4 bits), Expect = 5.8e-38, Sum P(2) = 5.8e-38
Identities = 104/297 (35%), Positives = 160/297 (53%)
Query: 93 WQQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLST 152
W+ E F+ Y EL +G GRF V+K + T + VA+K I ++ + ++ E LL
Sbjct: 2642 WK-ENFDLAYAELHEIGRGRFSIVKKCVHKATRKDVAVKFISKKMKKKEQAAHEAALLQH 2700
Query: 153 LMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSAL 212
L H P + + + P + +V++L+ L+ +L + E + IR AL
Sbjct: 2701 LQH---PQYITIHDTYESPTSYILVLELMDDGRLLDYLMNHDELMEEKVAFYIRDTMEAL 2757
Query: 213 HCLHSQQIAHKDIRPENILMNGAV----LKLIDLGXXXXXXXXX-----LPDLEFASPEM 263
LH+ ++AH DI+PEN+L++ + +K+IDL L + EFA+PE+
Sbjct: 2758 QYLHNCRVAHLDIKPENLLIDLRIPVPRVKIIDLEDAVQITGHYHVHHLLGNPEFAAPEV 2817
Query: 264 LTS-PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISV 322
+ P + STD+WS+GVL Y++LSGVSPFLDES+EET ++ D+SFPPE +S
Sbjct: 2818 IQGLPVSL--STDIWSIGVLTYVMLSGVSPFLDESKEETCINVCRVDFSFPPEYFSDVSH 2875
Query: 323 PARELIGQLLNTHADKRPTAGQLLQVAWFA--EASCSEF--DTERLLPFSARRKQKF 375
AR+ I +L + +RPTA LQ W S S+ DT RL F RR+ ++
Sbjct: 2876 AARDFINVILQEDSRRRPTAATCLQHPWLQPHNGSYSKIPLDTSRLASFIERRRHQY 2932
|
|
| UNIPROTKB|F1PUI1 KALRN "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 408 (148.7 bits), Expect = 1.5e-37, Sum P(2) = 1.5e-37
Identities = 106/297 (35%), Positives = 160/297 (53%)
Query: 93 WQQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLST 152
W+ E F+ Y EL +G GRF V+K + T + VA+K + ++ + ++ E LL
Sbjct: 1891 WK-ENFDSAYTELNEIGRGRFSIVKKCIHKATRKDVAVKFVSKKMKKKEQAAHEAALLQH 1949
Query: 153 LMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSAL 212
L H P + L + P + ++++L+ L+ +L + E + IR + AL
Sbjct: 1950 LQH---PQYITLHDTYESPTSYILILELMDDGRLLDYLMNHDELMEEKVAFYIRDIMEAL 2006
Query: 213 HCLHSQQIAHKDIRPENILMNGAV----LKLIDLGXXXXXXXXX-----LPDLEFASPEM 263
LH+ ++AH DI+PEN+L++ + +KLIDL L + EFA+PE+
Sbjct: 2007 QYLHNCRVAHLDIKPENLLIDLRIPVPRVKLIDLEDAVQISGHFHIHHLLGNPEFAAPEV 2066
Query: 264 LTS-PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQ-CGHIS 321
+ P + G TD+WS+GVL Y++LSGVSPFLDES+EET ++ D+SFP E CG +S
Sbjct: 2067 IQGIPVSLG--TDIWSIGVLTYVMLSGVSPFLDESKEETCINVCRVDFSFPHEYFCG-VS 2123
Query: 322 VPARELIGQLLNTHADKRPTAGQLLQVAWFA--EASCSEF--DTERLLPFSARRKQK 374
AR+ I +L +RPTA LQ W S S+ DT RL F RRK +
Sbjct: 2124 NAARDFINVILQEDFRRRPTAATCLQHPWLQPHNGSYSKIPLDTSRLACFIERRKHQ 2180
|
|
| UNIPROTKB|H7BXZ5 KALRN "Kalirin" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 408 (148.7 bits), Expect = 2.5e-37, Sum P(2) = 2.5e-37
Identities = 106/297 (35%), Positives = 160/297 (53%)
Query: 93 WQQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLST 152
W+ E F+ Y EL +G GRF V+K + T + VA+K + ++ + ++ E LL
Sbjct: 2645 WK-ENFDSAYTELNEIGRGRFSIVKKCIHKATRKDVAVKFVSKKMKKKEQAAHEAALLQH 2703
Query: 153 LMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSAL 212
L H P + L + P + ++++L+ L+ +L + E + IR + AL
Sbjct: 2704 LQH---PQYITLHDTYESPTSYILILELMDDGRLLDYLMNHDELMEEKVAFYIRDIMEAL 2760
Query: 213 HCLHSQQIAHKDIRPENILMNGAV----LKLIDLGXXXXXXXXX-----LPDLEFASPEM 263
LH+ ++AH DI+PEN+L++ + +KLIDL L + EFA+PE+
Sbjct: 2761 QYLHNCRVAHLDIKPENLLIDLRIPVPRVKLIDLEDAVQISGHFHIHHLLGNPEFAAPEV 2820
Query: 264 LTS-PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQ-CGHIS 321
+ P + G TD+WS+GVL Y++LSGVSPFLDES+EET ++ D+SFP E CG +S
Sbjct: 2821 IQGIPVSLG--TDIWSIGVLTYVMLSGVSPFLDESKEETCINVCRVDFSFPHEYFCG-VS 2877
Query: 322 VPARELIGQLLNTHADKRPTAGQLLQVAWFA--EASCSEF--DTERLLPFSARRKQK 374
AR+ I +L +RPTA LQ W S S+ DT RL F RRK +
Sbjct: 2878 NAARDFINVILQEDFRRRPTAATCLQHPWLQPHNGSYSKIPLDTSRLACFIERRKHQ 2934
|
|
| MGI|MGI:2685385 Kalrn "kalirin, RhoGEF kinase" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 407 (148.3 bits), Expect = 2.5e-37, Sum P(2) = 2.5e-37
Identities = 106/297 (35%), Positives = 160/297 (53%)
Query: 93 WQQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLST 152
W+ E F+ Y EL +G GRF V+K + T + VA+K + ++ + ++ E LL
Sbjct: 2648 WK-ENFDSAYTELNEIGRGRFSIVKKCIHKATRKDVAVKFVSKKMKKKEQAAHEAALLQH 2706
Query: 153 LMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSAL 212
L H P + L + P + ++++L+ L+ +L + E + IR + AL
Sbjct: 2707 LQH---PQYVTLHDTYESPTSYILILELMDDGRLLDYLMNHDELMEEKVAFYIRDIMEAL 2763
Query: 213 HCLHSQQIAHKDIRPENILMNGAV----LKLIDLGXXXXXXXXX-----LPDLEFASPEM 263
LH+ ++AH DI+PEN+L++ + +KLIDL L + EFA+PE+
Sbjct: 2764 QYLHNCRVAHLDIKPENLLIDLRIPVPRVKLIDLEDAVQISGHFHIHHLLGNPEFAAPEV 2823
Query: 264 LTS-PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQ-CGHIS 321
+ P + G TD+WS+GVL Y++LSGVSPFLDES+EET ++ D+SFP E CG +S
Sbjct: 2824 IQGIPVSLG--TDIWSIGVLTYVMLSGVSPFLDESKEETCINVCRVDFSFPHEYFCG-VS 2880
Query: 322 VPARELIGQLLNTHADKRPTAGQLLQVAWFA--EASCSEF--DTERLLPFSARRKQK 374
AR+ I +L +RPTA LQ W S S+ DT RL F RRK +
Sbjct: 2881 NAARDFINVILQEDFRRRPTAATCLQHPWLQPHNGSYSKIPLDTSRLACFIERRKHQ 2937
|
|
| UNIPROTKB|O60229 KALRN "Kalirin" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 408 (148.7 bits), Expect = 2.5e-37, Sum P(2) = 2.5e-37
Identities = 106/297 (35%), Positives = 160/297 (53%)
Query: 93 WQQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLST 152
W+ E F+ Y EL +G GRF V+K + T + VA+K + ++ + ++ E LL
Sbjct: 2675 WK-ENFDSAYTELNEIGRGRFSIVKKCIHKATRKDVAVKFVSKKMKKKEQAAHEAALLQH 2733
Query: 153 LMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSAL 212
L H P + L + P + ++++L+ L+ +L + E + IR + AL
Sbjct: 2734 LQH---PQYITLHDTYESPTSYILILELMDDGRLLDYLMNHDELMEEKVAFYIRDIMEAL 2790
Query: 213 HCLHSQQIAHKDIRPENILMNGAV----LKLIDLGXXXXXXXXX-----LPDLEFASPEM 263
LH+ ++AH DI+PEN+L++ + +KLIDL L + EFA+PE+
Sbjct: 2791 QYLHNCRVAHLDIKPENLLIDLRIPVPRVKLIDLEDAVQISGHFHIHHLLGNPEFAAPEV 2850
Query: 264 LTS-PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQ-CGHIS 321
+ P + G TD+WS+GVL Y++LSGVSPFLDES+EET ++ D+SFP E CG +S
Sbjct: 2851 IQGIPVSLG--TDIWSIGVLTYVMLSGVSPFLDESKEETCINVCRVDFSFPHEYFCG-VS 2907
Query: 322 VPARELIGQLLNTHADKRPTAGQLLQVAWFA--EASCSEF--DTERLLPFSARRKQK 374
AR+ I +L +RPTA LQ W S S+ DT RL F RRK +
Sbjct: 2908 NAARDFINVILQEDFRRRPTAATCLQHPWLQPHNGSYSKIPLDTSRLACFIERRKHQ 2964
|
|
| UNIPROTKB|J3QSW6 KALRN "Kalirin" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 408 (148.7 bits), Expect = 2.5e-37, Sum P(2) = 2.5e-37
Identities = 106/297 (35%), Positives = 160/297 (53%)
Query: 93 WQQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLST 152
W+ E F+ Y EL +G GRF V+K + T + VA+K + ++ + ++ E LL
Sbjct: 2676 WK-ENFDSAYTELNEIGRGRFSIVKKCIHKATRKDVAVKFVSKKMKKKEQAAHEAALLQH 2734
Query: 153 LMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSAL 212
L H P + L + P + ++++L+ L+ +L + E + IR + AL
Sbjct: 2735 LQH---PQYITLHDTYESPTSYILILELMDDGRLLDYLMNHDELMEEKVAFYIRDIMEAL 2791
Query: 213 HCLHSQQIAHKDIRPENILMNGAV----LKLIDLGXXXXXXXXX-----LPDLEFASPEM 263
LH+ ++AH DI+PEN+L++ + +KLIDL L + EFA+PE+
Sbjct: 2792 QYLHNCRVAHLDIKPENLLIDLRIPVPRVKLIDLEDAVQISGHFHIHHLLGNPEFAAPEV 2851
Query: 264 LTS-PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQ-CGHIS 321
+ P + G TD+WS+GVL Y++LSGVSPFLDES+EET ++ D+SFP E CG +S
Sbjct: 2852 IQGIPVSLG--TDIWSIGVLTYVMLSGVSPFLDESKEETCINVCRVDFSFPHEYFCG-VS 2908
Query: 322 VPARELIGQLLNTHADKRPTAGQLLQVAWFA--EASCSEF--DTERLLPFSARRKQK 374
AR+ I +L +RPTA LQ W S S+ DT RL F RRK +
Sbjct: 2909 NAARDFINVILQEDFRRRPTAATCLQHPWLQPHNGSYSKIPLDTSRLACFIERRKHQ 2965
|
|
| UNIPROTKB|F1MXJ6 KALRN "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 408 (148.7 bits), Expect = 3.1e-37, Sum P(2) = 3.1e-37
Identities = 106/297 (35%), Positives = 160/297 (53%)
Query: 93 WQQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLST 152
W+ E F+ Y EL +G GRF V+K + T + VA+K + ++ + ++ E LL
Sbjct: 2631 WK-ENFDSAYTELNEIGRGRFSIVKKCIHKATRKDVAVKFVSKKMKKKEQAAHEAALLQH 2689
Query: 153 LMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSAL 212
L H P + L + P + ++++L+ L+ +L + E + IR + AL
Sbjct: 2690 LQH---PQYITLHDTYESPTSYILILELMDDGRLLDYLMNHDELMEEKVAFYIRDIMEAL 2746
Query: 213 HCLHSQQIAHKDIRPENILMNGAV----LKLIDLGXXXXXXXXX-----LPDLEFASPEM 263
LH+ ++AH DI+PEN+L++ + +KLIDL L + EFA+PE+
Sbjct: 2747 QYLHNCRVAHLDIKPENLLIDLRIPVPRVKLIDLEDAVQISGHFHIHHLLGNPEFAAPEV 2806
Query: 264 LTS-PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQ-CGHIS 321
+ P + G TD+WS+GVL Y++LSGVSPFLDES+EET ++ D+SFP E CG +S
Sbjct: 2807 IQGIPVSLG--TDIWSIGVLTYVMLSGVSPFLDESKEETCINVCRVDFSFPHEYFCG-VS 2863
Query: 322 VPARELIGQLLNTHADKRPTAGQLLQVAWFA--EASCSEF--DTERLLPFSARRKQK 374
AR+ I +L +RPTA LQ W S S+ DT RL F RRK +
Sbjct: 2864 NAARDFINVILQEDFRRRPTAATCLQHPWLQPHNGSYSKIPLDTSRLACFIERRKHQ 2920
|
|
| UNIPROTKB|F1PPJ4 KALRN "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 408 (148.7 bits), Expect = 3.1e-37, Sum P(2) = 3.1e-37
Identities = 106/297 (35%), Positives = 160/297 (53%)
Query: 93 WQQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLST 152
W+ E F+ Y EL +G GRF V+K + T + VA+K + ++ + ++ E LL
Sbjct: 2635 WK-ENFDSAYTELNEIGRGRFSIVKKCIHKATRKDVAVKFVSKKMKKKEQAAHEAALLQH 2693
Query: 153 LMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSAL 212
L H P + L + P + ++++L+ L+ +L + E + IR + AL
Sbjct: 2694 LQH---PQYITLHDTYESPTSYILILELMDDGRLLDYLMNHDELMEEKVAFYIRDIMEAL 2750
Query: 213 HCLHSQQIAHKDIRPENILMNGAV----LKLIDLGXXXXXXXXX-----LPDLEFASPEM 263
LH+ ++AH DI+PEN+L++ + +KLIDL L + EFA+PE+
Sbjct: 2751 QYLHNCRVAHLDIKPENLLIDLRIPVPRVKLIDLEDAVQISGHFHIHHLLGNPEFAAPEV 2810
Query: 264 LTS-PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQ-CGHIS 321
+ P + G TD+WS+GVL Y++LSGVSPFLDES+EET ++ D+SFP E CG +S
Sbjct: 2811 IQGIPVSLG--TDIWSIGVLTYVMLSGVSPFLDESKEETCINVCRVDFSFPHEYFCG-VS 2867
Query: 322 VPARELIGQLLNTHADKRPTAGQLLQVAWFA--EASCSEF--DTERLLPFSARRKQK 374
AR+ I +L +RPTA LQ W S S+ DT RL F RRK +
Sbjct: 2868 NAARDFINVILQEDFRRRPTAATCLQHPWLQPHNGSYSKIPLDTSRLACFIERRKHQ 2924
|
|
| ZFIN|ZDB-GENE-060503-334 si:dkey-158b13.2 "si:dkey-158b13.2" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 397 (144.8 bits), Expect = 3.1e-36, Sum P(2) = 3.1e-36
Identities = 101/297 (34%), Positives = 156/297 (52%)
Query: 93 WQQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQ-QITRAEYNLLS 151
W+ + FE Y E+ LG GRF V++ RG+ + VA+K + ++ + Q+T E+++L
Sbjct: 2777 WK-DNFESFYTEVAELGRGRFSVVKRCDQRGSKRTVAVKFVNKKLMKRDQVTH-EFSVLQ 2834
Query: 152 TLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSA 211
L H H+ L FE + + +V+++ L+ ++ +TE + +R + A
Sbjct: 2835 RLQHPHLVRLLDTFETS---SSYALVLEMSDQGRLLDYIVSWGNLTEEKVAFYLRDILEA 2891
Query: 212 LHCLHSQQIAHKDIRPENILMNGA----VLKLIDLGXXXXXXXX-----XLPDLEFASPE 262
L LH+ +I H D++PEN+++ + ++KL D G L EFA+PE
Sbjct: 2892 LQYLHNCRIVHLDLKPENLVVEQSPSQPLVKLTDFGDAVQLNSTPYVHPLLGSPEFAAPE 2951
Query: 263 M-LTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHIS 321
+ L P + S+D+WSLGVL Y++LSG SPFLDES EET +I D+SFP + +S
Sbjct: 2952 LVLGDPVSL--SSDLWSLGVLTYVMLSGASPFLDESVEETCLNICRLDFSFPDDYFQGVS 3009
Query: 322 VPARELIGQLLNTHADKRPTAGQLLQVAWF----AEASCSEFDTERLLPFSARRKQK 374
AR+ + LL KRP A LQ W S DT RL+ F RRK +
Sbjct: 3010 QAARDFMCLLLRMEPSKRPPATSCLQEPWLRAGGGRRSAECIDTSRLISFIDRRKHQ 3066
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 380 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-61 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-50 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-43 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-38 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-36 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-34 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-34 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-34 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-32 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-31 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-31 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-30 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-29 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 9e-29 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-27 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-26 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-25 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-25 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-25 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-25 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-25 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-25 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-25 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-25 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-25 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-24 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-24 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-24 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 8e-24 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-23 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-23 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-23 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-23 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-23 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-23 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-23 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-22 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-22 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-22 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-21 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-21 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-21 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-20 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 8e-20 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-19 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-19 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 6e-19 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-18 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-18 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-18 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-18 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-18 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-18 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-18 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-18 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-18 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-18 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-17 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-17 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-17 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-17 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-17 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-17 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-17 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-17 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-17 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 7e-17 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 9e-17 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-16 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-16 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-16 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-16 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-16 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-16 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-16 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-16 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-16 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-16 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-16 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-16 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-16 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-16 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 7e-16 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-15 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-15 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-15 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-15 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-15 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-15 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-15 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-15 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 6e-15 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-15 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 7e-15 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-14 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-14 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-14 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-14 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-14 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-14 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-13 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-13 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-13 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-13 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-13 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-13 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 9e-13 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 9e-13 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-12 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-12 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-12 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-12 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-12 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-12 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-12 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-12 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 6e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-12 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 7e-12 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 7e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 9e-12 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 9e-12 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-11 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-11 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-11 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 7e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-11 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 8e-11 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 8e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-10 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-10 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-10 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-10 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-09 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-09 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-09 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-09 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-09 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-09 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 6e-09 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 8e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-08 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-08 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-08 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-08 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-08 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-08 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-08 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-08 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-08 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 9e-08 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-07 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-07 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 5e-07 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 7e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-06 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-06 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 1e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 1e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-06 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-06 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 2e-06 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-06 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-06 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 5e-06 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-06 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-06 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-05 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 3e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 5e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 6e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 6e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 9e-05 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-04 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-04 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-04 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-04 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-04 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 2e-04 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-04 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-04 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-04 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-04 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-04 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 5e-04 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 7e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-04 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-04 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 0.001 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 0.001 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 0.001 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 0.001 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 0.002 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 0.003 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 197 bits (503), Expect = 3e-61
Identities = 86/258 (33%), Positives = 130/258 (50%), Gaps = 12/258 (4%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRA--EYNLLSTLMHAHIP 159
YE LE+LG G F V ARD+ TG+LVA+K I +++ + R E +L L H +I
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 160 TALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQ 219
+FE+ +VM+ G L L ++ ++E +RQ+ SAL LHS+
Sbjct: 61 RLYDVFED---EDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG 117
Query: 220 IAHKDIRPENILMNG-AVLKLIDLGSSVSVSTVVLPD-----LEFASPEMLTSPATAGPS 273
I H+D++PENIL++ +KL D G + + E+ +PE+L G +
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGK-GYGKA 176
Query: 274 TDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLN 333
D+WSLGV+LY LL+G PF + + P IS A++LI +LL
Sbjct: 177 VDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLV 236
Query: 334 THADKRPTAGQLLQVAWF 351
+KR TA + LQ +F
Sbjct: 237 KDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 2e-50
Identities = 89/263 (33%), Positives = 132/263 (50%), Gaps = 16/263 (6%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP---QQITRAEYNLLSTLMHAHI 158
YE L +LG+G F TV KA+ +GTG++VA+K + + + Q R E +L L H +I
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 159 PTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQ 218
+ FE+ +VM+ G L +L R ++E I Q+ L LHS
Sbjct: 61 VRLIDAFED---KDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN 117
Query: 219 QIAHKDIRPENILMNGA-VLKLIDLGSSV------SVSTVVLPDLEFASPEMLTSPATAG 271
I H+D++PENIL++ V+K+ D G + S T + + +PE+L G
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 272 PSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISV---ADYSFPPEQCGHISVPARELI 328
P D+WSLGV+LY LL+G PF E+ + I F + S A++LI
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLI 237
Query: 329 GQLLNTHADKRPTAGQLLQVAWF 351
+ LN KRPTA ++LQ WF
Sbjct: 238 KKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 3e-43
Identities = 71/251 (28%), Positives = 110/251 (43%), Gaps = 49/251 (19%)
Query: 108 LGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRA--EYNLLSTLMHAHIPTALALF 165
LG G F TV ARD+ TG+ VA+K I +E + E +L L H +I +F
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 166 ENAPVPGTDTIVMQLVHGESLIQHLCRQS-TITESYICCIIRQLHSALHCLHSQQIAHKD 224
E+ +VM+ G SL L ++E I I+ Q+ L LHS I H+D
Sbjct: 61 EDENHLY---LVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRD 117
Query: 225 IRPENILMNGA--VLKLIDLGSSVSVSTVVLPD------LEFASPEMLTSPATAGPSTDM 276
++PENIL++ +KL D G S +++ + +PE+L +D+
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDI 177
Query: 277 WSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHA 336
WSLGV+LY L E ++LI ++L
Sbjct: 178 WSLGVILY--------ELPE---------------------------LKDLIRKMLQKDP 202
Query: 337 DKRPTAGQLLQ 347
+KRP+A ++L+
Sbjct: 203 EKRPSAKEILE 213
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 2e-38
Identities = 80/260 (30%), Positives = 119/260 (45%), Gaps = 35/260 (13%)
Query: 108 LGNGRFCTVRKARDRGTGQLVALKQIP----RERQPQQITRAEYNLLSTLMHAHIPTALA 163
LG G F V R + TG+L A+K + +R+ + T E N+LS + H I
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 164 LFENAPVPGTDT---IVMQLVHGESLIQHLCRQSTITES----YICCIIRQLHSALHCLH 216
F+ T+ +V++ G L HL ++ +E Y I+ AL LH
Sbjct: 61 AFQ------TEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIV----LALEYLH 110
Query: 217 SQQIAHKDIRPENILMN--GAVLKLIDLGSS-VSVSTVVLPD-----LEFASPEMLTSPA 268
S I ++D++PENIL++ G +KL D G + S + E+ +PE+L
Sbjct: 111 SLGIIYRDLKPENILLDADGH-IKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLG-K 168
Query: 269 TAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELI 328
G + D WSLGVLLY +L+G PF E +E I FP +S AR+LI
Sbjct: 169 GYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPE----FLSPEARDLI 224
Query: 329 GQLLNTHADKRPTAGQLLQV 348
LL KR +G ++
Sbjct: 225 SGLLQKDPTKRLGSGGAEEI 244
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 4e-36
Identities = 79/266 (29%), Positives = 121/266 (45%), Gaps = 31/266 (11%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRA---EYNLLSTLMHAH 157
+YE ++++G G F V R + G+L LK+I ++ E +L L H +
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 158 IPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQ----STITESYICCIIRQLHSALH 213
I + +E+ G IVM+ G L Q + +Q E I QL AL
Sbjct: 61 I---IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALK 117
Query: 214 CLHSQQIAHKDIRPENI-LMNGAVLKLIDLGSSVSVSTVVLPDLEFA----------SPE 262
LHS++I H+DI+P+NI L + ++KL D G +S V+ ++ A SPE
Sbjct: 118 YLHSRKILHRDIKPQNIFLTSNGLVKLGDFG----ISKVLSSTVDLAKTVVGTPYYLSPE 173
Query: 263 MLTS-PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHIS 321
+ + P +D+WSLG +LY L + PF E+ E I Y P S
Sbjct: 174 LCQNKPYNY--KSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPS---QYS 228
Query: 322 VPARELIGQLLNTHADKRPTAGQLLQ 347
R L+ LL ++RP+ Q+LQ
Sbjct: 229 SELRNLVSSLLQKDPEERPSIAQILQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 1e-34
Identities = 75/258 (29%), Positives = 121/258 (46%), Gaps = 21/258 (8%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP--QQITRAEYNLLSTLMHAHIP 159
+E LE++G G F V KAR + TG+ VA+K I E + ++I E +L H +I
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIIN-EIQILKKCKHPNI- 59
Query: 160 TALALFENAPVPGTDTIVMQLVHGESL---IQHLCRQSTITESYICCIIRQLHSALHCLH 216
+ + + IVM+ G SL ++ + T+TES I + ++L L LH
Sbjct: 60 --VKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQ--TLTESQIAYVCKELLKGLEYLH 115
Query: 217 SQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVSTVVLPD-----LEFASPEMLTSPATA 270
S I H+DI+ NIL+ +KLID G S +S + + +PE++
Sbjct: 116 SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPY- 174
Query: 271 GPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGH-ISVPARELIG 329
D+WSLG+ L G P+ + +A +A P + S ++ +
Sbjct: 175 DYKADIWSLGITAIELAEGKPPYSE--LPPMKALFKIATNGPPGLRNPEKWSDEFKDFLK 232
Query: 330 QLLNTHADKRPTAGQLLQ 347
+ L + +KRPTA QLL+
Sbjct: 233 KCLQKNPEKRPTAEQLLK 250
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 131 bits (328), Expect = 1e-34
Identities = 92/300 (30%), Positives = 137/300 (45%), Gaps = 39/300 (13%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQI----TRAEYNLLSTLMHA- 156
Y L +LG G F V ARDR +LVALK + ++ + + E +L++L H
Sbjct: 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 157 HIPTALALFENAPVPGTDTIVMQLVHGESLIQHLC---RQSTITESYICCIIRQLHSALH 213
+I F++ G+ +VM+ V G SL L R+ ++ES I+ Q+ SAL
Sbjct: 59 NIVKLYDFFQD---EGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALE 115
Query: 214 CLHSQQIAHKDIRPENILM--NGAVLKLIDLGSSVSVS------------TVVLPDLEFA 259
LHS+ I H+DI+PENIL+ +G V+KLID G + + + + +
Sbjct: 116 YLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 260 SPEML--TSPATAGPSTDMWSLGVLLYILLSGVSPFLDES----EEETRAHISVADYSFP 313
+PE+L S A A S+D+WSLG+ LY LL+G+ PF E +T I
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235
Query: 314 PEQC-----GHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASCSEFDTERLLPFS 368
IS A +L+ +LL R ++ L A E D LL
Sbjct: 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPD 295
|
Length = 384 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 3e-34
Identities = 73/290 (25%), Positives = 135/290 (46%), Gaps = 52/290 (17%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALK-----QIPRERQPQQITRAEYNLLSTL-MH 155
++ + +G G F TV A+++ T + A+K Q+ +E++ + + E +L+ L H
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKI-EKEVLTRLNGH 61
Query: 156 AHIPTALALFENAPVPGTDTI--VMQLV-HGESLIQHLCRQSTITESYICCIIRQLHSAL 212
I F++ + + V++ +GE L+Q++ + ++ E ++ AL
Sbjct: 62 PGIIKLYYTFQDE-----ENLYFVLEYAPNGE-LLQYIRKYGSLDEKCTRFYAAEILLAL 115
Query: 213 HCLHSQQIAHKDIRPENILMNGAV-LKLIDLGSSVSVSTVVLPDL--------------- 256
LHS+ I H+D++PENIL++ + +K+ D G++ + P+
Sbjct: 116 EYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175
Query: 257 -----------EFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHI 305
E+ SPE+L AG S+D+W+LG ++Y +L+G PF +E T I
Sbjct: 176 RRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKI 234
Query: 306 SVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAG----QLLQVAWF 351
+YSFPP + A++LI +LL R +L +F
Sbjct: 235 LKLEYSFPP----NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 2e-32
Identities = 82/272 (30%), Positives = 120/272 (44%), Gaps = 28/272 (10%)
Query: 103 EELER---LGNGRFCTVRKARDRGTGQLVALKQIP---RERQPQQITRAEYNLLSTLMHA 156
+LER LG G V K R + TG++ ALK+I E +Q+ R L TL
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRE----LKTLRSC 56
Query: 157 HIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLH 216
P + + G +IV++ + G SL L + I E + I RQ+ L LH
Sbjct: 57 ESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLH 116
Query: 217 SQ-QIAHKDIRPENILMN--GAVLKLIDLGSSVSVSTVVLPDLEFA------SPEMLTSP 267
++ I H+DI+P N+L+N G V K+ D G S + + F SPE +
Sbjct: 117 TKRHIIHRDIKPSNLLINSKGEV-KIADFGISKVLENTLDQCNTFVGTVTYMSPERI-QG 174
Query: 268 ATAGPSTDMWSLGVLLYILLSGVSPFLDESE----EETRAHISVADYSFPPEQCGHISVP 323
+ + D+WSLG+ L G PFL + E +A S P E+ S
Sbjct: 175 ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEF---SPE 231
Query: 324 ARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355
R+ I L KRP+A +LLQ + +A
Sbjct: 232 FRDFISACLQKDPKKRPSAAELLQHPFIKKAD 263
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 3e-31
Identities = 82/282 (29%), Positives = 126/282 (44%), Gaps = 58/282 (20%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQI------PRERQPQQITRAEYNLLSTLMH 155
YE LE +G G F TVRK R + G+++ K+I +E+ QQ+ +E N+L L H
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEK--QQLV-SEVNILRELKH 58
Query: 156 AHI---------PTALALFENAPVPGTDTIVMQLVHG---ESLIQHLCRQ--STITESYI 201
+I + L+ IVM+ G LIQ C++ I E +I
Sbjct: 59 PNIVRYYDRIIDRSNQTLY----------IVMEYCEGGDLAQLIQK-CKKERKYIEEEFI 107
Query: 202 CCIIRQLHSALHCLH-----SQQIAHKDIRPENILMNGA-VLKLIDLGSSVSVSTVVLPD 255
I+ QL AL+ H + H+D++P NI ++ +KL D G + + D
Sbjct: 108 WRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH----D 163
Query: 256 LEFA----------SPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHI 305
FA SPE L + +D+WSLG L+Y L + PF ++ + + I
Sbjct: 164 SSFAKTYVGTPYYMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI 222
Query: 306 SVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQ 347
+ P + S E+I +LN DKRP+ +LLQ
Sbjct: 223 KEGKFRRIPYR---YSSELNEVIKSMLNVDPDKRPSTEELLQ 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 4e-31
Identities = 73/257 (28%), Positives = 117/257 (45%), Gaps = 19/257 (7%)
Query: 106 ERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQ---ITRAEYNLLSTLMHAHIPTAL 162
+ +G G F V K + TG VA+KQI E+ ++ E +LL L H +I +
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 163 ALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAH 222
E + + I+++ SL Q + + ES + + Q+ L LH Q + H
Sbjct: 66 GSIETS---DSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIH 122
Query: 223 KDIRPENILMNGA-VLKLIDLGSSVSVSTVVLPDLEFA------SPEMLT-SPATAGPST 274
+DI+ NIL V+KL D G + ++ V D +PE++ S A+ ++
Sbjct: 123 RDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGAST--AS 180
Query: 275 DMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNT 334
D+WSLG + LL+G P+ D + I D+ PE IS ++ + Q
Sbjct: 181 DIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPE---GISPELKDFLMQCFQK 237
Query: 335 HADKRPTAGQLLQVAWF 351
+ RPTA QLL+ W
Sbjct: 238 DPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 6e-30
Identities = 87/288 (30%), Positives = 128/288 (44%), Gaps = 43/288 (14%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQI-PRERQP--QQITRAEYNLLSTLMHAHI 158
Y++L ++G G + V KARD+ TG++VA+K+I R + E LL L H +I
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 159 PTALALFENAPVPGTDTIVMQLVHG--ESLIQHLCRQSTITESYICCIIRQLHSALHCLH 216
L +F G +V + + LI+ RQ + ES I + QL L H
Sbjct: 61 IKLLDVF---RHKGDLYLVFEFMDTDLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCH 115
Query: 217 SQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVSTVVLPDLEFAS------PEMLTSPAT 269
S I H+D++PEN+L+N VLKL D G + S + V P + PE+L
Sbjct: 116 SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKG 175
Query: 270 AGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHI----------------SVADY--- 310
D+WS+G + LLS F +SE + I S+A
Sbjct: 176 YSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF 235
Query: 311 SFP-------PEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWF 351
SFP P+ + S A +L+ Q+L+ KR TA Q L +F
Sbjct: 236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-29
Identities = 75/263 (28%), Positives = 118/263 (44%), Gaps = 25/263 (9%)
Query: 106 ERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRA---EYNLLSTLMHAHIPTAL 162
E LG G F +V A D+ TG+L+A+K + ++ A E +LS+L H +I
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 163 ALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAH 222
E T I ++ V G SL L + + E I RQ+ L LHS I H
Sbjct: 66 G-SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVH 124
Query: 223 KDIRPENILMNGA-VLKLIDLGSSVSVSTVVLPDLE--------FASPEMLTSPATAGPS 273
+DI+ NIL++ V+KL D G + + + + + +PE++ G +
Sbjct: 125 RDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE-YGRA 183
Query: 274 TDMWSLGVLLYILLSGVSPFLDESEEETRA----HISVADYSFP-PEQCGHISVPARELI 328
D+WSLG + + +G P+ SE I + PE H+S A++ +
Sbjct: 184 ADIWSLGCTVIEMATGKPPW---SELGNPMAALYKIGSSGEPPEIPE---HLSEEAKDFL 237
Query: 329 GQLLNTHADKRPTAGQLLQVAWF 351
+ L KRPTA +LLQ +
Sbjct: 238 RKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 9e-29
Identities = 71/274 (25%), Positives = 123/274 (44%), Gaps = 40/274 (14%)
Query: 108 LGNGRFCTVRKARDRGTGQLVALKQIPR-----ERQPQQITRAEYNLLSTLMHAHIPTAL 162
+ G + V A+ + TG + A+K I + + Q Q+ E ++LS ++
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQV-LTERDILSQAQSPYVVKLY 59
Query: 163 ALFENAPVPGTDT--IVMQLVHG---ESLIQHLCRQSTITESYICCIIRQLHSALHCLHS 217
F+ G +VM+ + G SL++++ ++ E I ++ AL LHS
Sbjct: 60 YSFQ-----GKKNLYLVMEYLPGGDLASLLENV---GSLDEDVARIYIAEIVLALEYLHS 111
Query: 218 QQIAHKDIRPENILMNGA-VLKLIDLG-SSVSV--STVVLPD-----------LEFASPE 262
I H+D++P+NIL++ LKL D G S V + + L D ++ +PE
Sbjct: 112 NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171
Query: 263 MLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISV 322
++ + D WSLG +LY L G+ PF E+ EE +I +P + +S
Sbjct: 172 VILGQGH-SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWP--EDVEVSD 228
Query: 323 PARELIGQLLNTHADKRPTAG---QLLQVAWFAE 353
A +LI +LL +KR A ++ +F
Sbjct: 229 EAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG 262
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 6e-27
Identities = 73/291 (25%), Positives = 121/291 (41%), Gaps = 44/291 (15%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALK---QIPRERQPQQITRAEYNLLSTLMHAH 157
+YE L +G G + V K R++ TG++VA+K + + ++ E +L L H +
Sbjct: 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHEN 61
Query: 158 IPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQST-ITESYICCIIRQLHSALHCLH 216
I + L E G +V + V +L++ L + + I QL A+ H
Sbjct: 62 I---VNLKEAFRRKGRLYLVFEYVE-RTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCH 117
Query: 217 SQQIAHKDIRPENILMNGA-VLKLIDLGSSVSVSTVVLPDLE-------FASPEMLTSPA 268
S I H+DI+PENIL++ + VLKL D G + ++ L + +PE+L
Sbjct: 118 SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDT 177
Query: 269 TAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQC----------- 317
G D+W++G ++ LL G F +S+ + I PP
Sbjct: 178 NYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237
Query: 318 -----------------GHISVPARELIGQLLNTHADKRPTAGQLLQVAWF 351
G +S PA + + L +R T +LLQ +F
Sbjct: 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-26
Identities = 75/261 (28%), Positives = 126/261 (48%), Gaps = 27/261 (10%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTA 161
Y+ LE++G G V KA DR TG+ VA+K++ +Q +++ E ++ H +I
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDY 80
Query: 162 LALFENAPVPGTDTIVMQLVHGESL----IQHLCRQSTITESYICCIIRQLHSALHCLHS 217
+ V +VM+ + G SL Q+ + E I + R++ L LHS
Sbjct: 81 YDSYL---VGDELWVVMEYMDGGSLTDIITQN---FVRMNEPQIAYVCREVLQGLEYLHS 134
Query: 218 QQIAHKDIRPENIL--MNGAVLKLIDLGSSVSVS-------TVV-LPDLEFASPEMLTSP 267
Q + H+DI+ +NIL +G+V KL D G + ++ +VV P + +PE++
Sbjct: 135 QNVIHRDIKSDNILLSKDGSV-KLADFGFAAQLTKEKSKRNSVVGTP--YWMAPEVIKRK 191
Query: 268 ATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVP-ARE 326
GP D+WSLG++ + G P+L E RA + PP + P ++
Sbjct: 192 DY-GPKVDIWSLGIMCIEMAEGEPPYLREPPL--RALFLITTKGIPPLKNPEKWSPEFKD 248
Query: 327 LIGQLLNTHADKRPTAGQLLQ 347
+ + L +KRP+A +LLQ
Sbjct: 249 FLNKCLVKDPEKRPSAEELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-25
Identities = 75/248 (30%), Positives = 123/248 (49%), Gaps = 22/248 (8%)
Query: 109 GNGRFCTVRKARDRGTGQLVALK-----QIPRERQPQQITRAEYNLLSTLMHAHIPTALA 163
G G+ VRK TG++ A+K I R ++ T+AE N+L + H I +
Sbjct: 8 GYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIY 67
Query: 164 LFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHK 223
F+ G ++++ + G L HL R+ E C + ++ AL LH Q I ++
Sbjct: 68 AFQTG---GKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYR 124
Query: 224 DIRPENILMN--GAVLKLIDLG------SSVSVSTVVLPDLEFASPEMLTSPATAGPSTD 275
D++PENIL++ G V KL D G +V+ +E+ +PE+L + G + D
Sbjct: 125 DLKPENILLDAQGHV-KLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMR-SGHGKAVD 182
Query: 276 MWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNTH 335
WSLG L+Y +L+G PF E+ ++T I + PP +++ AR+L+ +LL +
Sbjct: 183 WWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPP----YLTPEARDLLKKLLKRN 238
Query: 336 ADKRPTAG 343
R AG
Sbjct: 239 PSSRLGAG 246
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-25
Identities = 91/293 (31%), Positives = 130/293 (44%), Gaps = 49/293 (16%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIP--RERQ--PQQITRAEYNLLSTLMHAH 157
YE++ ++G G + V KAR++ TG+LVALK+I E++ P R E LL L H +
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR-EIKLLQKLRHPN 59
Query: 158 IPTALALFENAPVPGTDTIVMQLVHGE----SLIQHLCRQSTITESYICCIIRQLHSALH 213
I + L E G +I M + + L+ + TES I C ++QL L
Sbjct: 60 I---VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDS--PEVKFTESQIKCYMKQLLEGLQ 114
Query: 214 CLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVSTVVLPD-------LEFASPEMLT 265
LHS I H+DI+ NIL+N VLKL D G + + D L + PE+L
Sbjct: 115 YLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLL 174
Query: 266 SPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHI-----SVADYSFP------- 313
GP DMWS+G +L L G F +E E I S D ++P
Sbjct: 175 GATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW 234
Query: 314 -----PEQ----------CGHISVPARELIGQLLNTHADKRPTAGQLLQVAWF 351
P++ I A +L+ +LL KR +A Q LQ +F
Sbjct: 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-25
Identities = 76/259 (29%), Positives = 118/259 (45%), Gaps = 21/259 (8%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE---RQPQQITRAEYNLLSTLMHAH 157
+YE++ +G G F V R + +LV +KQIP E + + + E +L L H
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSH-- 58
Query: 158 IPTALALFENAPVPGTDTIVMQLVHG---ESLIQHLCRQSTITESYICCIIRQLHSALHC 214
P + +EN IVM+ G IQ C S + E I Q+ ALH
Sbjct: 59 -PNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCN-SLLDEDTILHFFVQILLALHH 116
Query: 215 LHSQQIAHKDIRPENILMN--GAVLKLIDLG-----SSVSVSTVVLPDLEFASPEMLTSP 267
+H++ I H+D++ +NIL++ V+K+ D G SS S + V+ + SPE+
Sbjct: 117 VHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGK 176
Query: 268 ATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAREL 327
S D+W+LG +LY L S F E+ + + +F P S R+L
Sbjct: 177 PYNQKS-DIWALGCVLYELASLKRAF--EAANLPALVLKIMSGTFAPIS-DRYSPDLRQL 232
Query: 328 IGQLLNTHADKRPTAGQLL 346
I +LN KRP Q++
Sbjct: 233 ILSMLNLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 74/260 (28%), Positives = 118/260 (45%), Gaps = 22/260 (8%)
Query: 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQIT--RAEYNLLSTLMHAH 157
+ LE +G G F V KA D+ T Q+VA+K I E +I + E LS +
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60
Query: 158 IPTALALFENAPVPGTDT-IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLH 216
I F + G+ I+M+ G S + L + + E+YI I+R++ L LH
Sbjct: 61 ITKYYGSF----LKGSKLWIIMEYCGGGSCL-DLLKPGKLDETYIAFILREVLLGLEYLH 115
Query: 217 SQQIAHKDIRPENILM--NGAVLKLIDLGSSVSVSTVVLPDLEFA------SPEMLTSPA 268
+ H+DI+ NIL+ G V KL D G S +++ + F +PE++
Sbjct: 116 EEGKIHRDIKAANILLSEEGDV-KLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSG 174
Query: 269 TAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGH-ISVPAREL 327
+ D+WSLG+ L G P D R + + + PP G+ S P ++
Sbjct: 175 YDEKA-DIWSLGITAIELAKGEPPLSD--LHPMRV-LFLIPKNNPPSLEGNKFSKPFKDF 230
Query: 328 IGQLLNTHADKRPTAGQLLQ 347
+ LN +RP+A +LL+
Sbjct: 231 VSLCLNKDPKERPSAKELLK 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-25
Identities = 85/269 (31%), Positives = 128/269 (47%), Gaps = 31/269 (11%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQI-------PRERQPQQITRAEYNLLSTLM 154
++ +++G G+F V KA G++VALK++ + RQ E +LL L
Sbjct: 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQD---CLKEIDLLKQLD 60
Query: 155 HAHIPTALALF-ENAPVPGTDTIVMQLVHG---ESLIQHLCRQ-STITESYICCIIRQLH 209
H ++ LA F EN + IV++L +I+H +Q I E I QL
Sbjct: 61 HPNVIKYLASFIENNEL----NIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC 116
Query: 210 SALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLG-----SSVSV---STVVLPDLEFAS 260
SAL +HS++I H+DI+P N+ + V+KL DLG SS + S V P + S
Sbjct: 117 SALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTP--YYMS 174
Query: 261 PEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHI 320
PE + S D+WSLG LLY + + SPF + + +PP H
Sbjct: 175 PERIHENGYNFKS-DIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHY 233
Query: 321 SVPARELIGQLLNTHADKRPTAGQLLQVA 349
S R+L+ + +N +KRP +LQVA
Sbjct: 234 SEELRDLVSRCINPDPEKRPDISYVLQVA 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-25
Identities = 74/254 (29%), Positives = 118/254 (46%), Gaps = 32/254 (12%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALK-----QIPRERQPQQITRAEYNLLSTLMHA 156
+E ++ LG G F V R +G+G+ ALK +I + +Q + + E +L ++ H
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHV-LNEKRILQSIRHP 61
Query: 157 HIPTALALFENAPVPGTDT----IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSAL 212
+ F+ D +VM+ V G L HL + E Q+ AL
Sbjct: 62 FLVNLYGSFQ-------DDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLAL 114
Query: 213 HCLHSQQIAHKDIRPENIL--MNGAVLKLIDLGSSVSVS--TVVL---PDLEFASPEMLT 265
LHS I ++D++PEN+L +G +K+ D G + V T L P E+ +PE++
Sbjct: 115 EYLHSLDIVYRDLKPENLLLDSDGY-IKITDFGFAKRVKGRTYTLCGTP--EYLAPEIIL 171
Query: 266 SPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAR 325
S G + D W+LG+L+Y +L+G PF D++ + I FP S A+
Sbjct: 172 SKGY-GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPS----FFSPDAK 226
Query: 326 ELIGQLLNTHADKR 339
+LI LL KR
Sbjct: 227 DLIRNLLQVDLTKR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 4e-25
Identities = 87/301 (28%), Positives = 133/301 (44%), Gaps = 60/301 (19%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQI---PRERQPQQITRA---EYNLLSTLM 154
RYE+ ++LG G + V KARD+ TG++VA+K+I R+ I E LL L
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 155 HAHIPTALALFENAPVPGTDT---IVMQLVHG--ESLIQHLCRQSTITESYICCIIRQLH 209
H +I L +F G + +V + + E +I+ + +T + I +
Sbjct: 61 HPNIIGLLDVF------GHKSNINLVFEFMETDLEKVIKD--KSIVLTPADIKSYMLMTL 112
Query: 210 SALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVSTVVLPDLEFAS-------- 260
L LHS I H+D++P N+L+ VLKL D G + S + P+ +
Sbjct: 113 RGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGS---PNRKMTHQVVTRWYR 169
Query: 261 -PEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLD-ESEEETRAHI------------- 305
PE+L G DMWS+G + LL V PFL +S+ + I
Sbjct: 170 APELLFGARHYGVGVDMWSVGCIFAELLLRV-PFLPGDSDIDQLGKIFEALGTPTEENWP 228
Query: 306 ---SVADY----SFPPEQCGHISVPAR-----ELIGQLLNTHADKRPTAGQLLQVAWFAE 353
S+ DY FPP I PA +L+ +LL + +KR TA Q L+ +F+
Sbjct: 229 GVTSLPDYVEFKPFPPTPLKQI-FPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSN 287
Query: 354 A 354
Sbjct: 288 D 288
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-25
Identities = 69/257 (26%), Positives = 111/257 (43%), Gaps = 33/257 (12%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPR----ERQPQQITRAEYNLLSTLMHAH 157
+E L +G G F V + R T ++ A+K + + E+ + E +L L H
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 158 IPTALALFENAPVPGTDT-IVMQLVHGESLIQHLCRQSTITES----YICCIIRQLHSAL 212
+ F++ + +V+ L+ G L HL ++ +E +IC I+ AL
Sbjct: 62 LVNLWYSFQD----EENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIV----LAL 113
Query: 213 HCLHSQQIAHKDIRPENILMN--GAVLKLIDLGSSVSVSTVVLPD-----LEFASPEMLT 265
LHS+ I H+DI+P+NIL++ G V + D + V+ L + +PE+L
Sbjct: 114 EYLHSKGIIHRDIKPDNILLDEQGHV-HITDFNIATKVTPDTLTTSTSGTPGYMAPEVLC 172
Query: 266 SPATAGPSTDMWSLGVLLYILLSGVSPF---LDESEEETRAHISVADYSFPPEQCGHISV 322
+ D WSLGV Y L G P+ ++ RA AD +P S
Sbjct: 173 R-QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATW----ST 227
Query: 323 PARELIGQLLNTHADKR 339
A + I +LL KR
Sbjct: 228 EAIDAINKLLERDPQKR 244
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 7e-25
Identities = 78/290 (26%), Positives = 128/290 (44%), Gaps = 44/290 (15%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ----PQQITRAEYNLLSTLMHA 156
RY+ L R+G G V KA+DR TG+ VALK++ R P Q R E L H
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALR-EIKALQACQHP 59
Query: 157 HIPTALALFENAPVPGTDTIVMQLVHGESLIQHLC-RQSTITESYICCIIRQLHSALHCL 215
++ L +F P +VM+ + L + L + + E+ + +R L + +
Sbjct: 60 YVVKLLDVF---PHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYM 115
Query: 216 HSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVS--TVVLPDLEFAS-----PEMLTSP 267
H+ I H+D++P N+L++ VLK+ D G + S L + A+ PE+L
Sbjct: 116 HANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA 175
Query: 268 ATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHI----------------SVADYS 311
P D+W++G + LL+G F E++ E A + S+ DY+
Sbjct: 176 RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN 235
Query: 312 ---FPPEQCGHIS--VP-----ARELIGQLLNTHADKRPTAGQLLQVAWF 351
FP + + P A +L+ LL KR +A + L+ +F
Sbjct: 236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-24
Identities = 71/259 (27%), Positives = 118/259 (45%), Gaps = 14/259 (5%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQIT--RAEYNLLSTLMHAHIP 159
Y+ LE +G G + V + + TG++VALK I + ++ + E LLS L + P
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 160 TALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQ 219
+ + I+M+ G S ++ L + I E YI IIR++ AL +H
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGS-VRTLMKAGPIAEKYISVIIREVLVALKYIHKVG 121
Query: 220 IAHKDIRPENIL--MNGAVLKLIDLGSSVSVSTVVLPDLEFA------SPEMLTSPATAG 271
+ H+DI+ NIL G V KL D G + ++ F +PE++T
Sbjct: 122 VIHRDIKAANILVTNTGNV-KLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYD 180
Query: 272 PSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQL 331
D+WSLG+ +Y + +G P+ D + RA + + P + S RE +
Sbjct: 181 TKADIWSLGITIYEMATGNPPYSD--VDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAAC 238
Query: 332 LNTHADKRPTAGQLLQVAW 350
L+ +R +A +LL+ W
Sbjct: 239 LDEEPKERLSAEELLKSKW 257
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 5e-24
Identities = 81/268 (30%), Positives = 121/268 (45%), Gaps = 22/268 (8%)
Query: 97 QFEHRYEELER---LGNGRFCTVRKARDRGTGQLVALKQIP-RERQPQQITRAEYNLLST 152
++E+ Y+E LG G + V ARD T +A+K+IP R+ + Q E L S
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61
Query: 153 LMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQS----TITESYICCIIRQL 208
L H +I L G I M+ V G SL L R E I +Q+
Sbjct: 62 LKHRNIVQYLGSDS---ENGFFKIFMEQVPGGSL-SALLRSKWGPLKDNEQTIIFYTKQI 117
Query: 209 HSALHCLHSQQIAHKDIRPENILMN--GAVLKLIDLGSSVSVSTV------VLPDLEFAS 260
L LH QI H+DI+ +N+L+N V+K+ D G+S ++ + L++ +
Sbjct: 118 LEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMA 177
Query: 261 PEML-TSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGH 319
PE++ P G D+WSLG + + +G PF+ E E A V + PE
Sbjct: 178 PEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFI-ELGEPQAAMFKVGMFKIHPEIPES 236
Query: 320 ISVPARELIGQLLNTHADKRPTAGQLLQ 347
+S A+ I + DKR +A LLQ
Sbjct: 237 LSAEAKNFILRCFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 6e-24
Identities = 77/294 (26%), Positives = 128/294 (43%), Gaps = 56/294 (19%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALK----------QIPRERQPQQITRAEYNLLS 151
Y+ L ++G G F V KA+ R TG+ A+K Q+ R+ Q + R
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSP---- 56
Query: 152 TLMHAHIPTAL-ALFENAPVPGTDTIVMQLVHGE--SLIQHLCRQSTITESYICCIIRQL 208
H +I + LF+ G +V +L+ LI+ R+ + E + + QL
Sbjct: 57 ---HPNILRLIEVLFD--RKTGRLALVFELMDMNLYELIKG--RKRPLPEKRVKSYMYQL 109
Query: 209 HSALHCLHSQQIAHKDIRPENILMNGAVLKLIDLGSSVSVSTVVLPDLEFAS------PE 262
+L +H I H+DI+PENIL+ +LKL D GS + + P E+ S PE
Sbjct: 110 LKSLDHMHRNGIFHRDIKPENILIKDDILKLADFGSCRGIYS-KPPYTEYISTRWYRAPE 168
Query: 263 MLTSPATAGPSTDMWSLGVLLYILLSGVSPF--LDESEEETRAH---------------- 304
L + GP D+W++G + + +LS F +E ++ + H
Sbjct: 169 CLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRK 228
Query: 305 ISVADYSFPPEQ-------CGHISVPARELIGQLLNTHADKRPTAGQLLQVAWF 351
+Y+FP ++ + S +L+ +LL D+R TA Q L+ +F
Sbjct: 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 8e-24
Identities = 80/300 (26%), Positives = 126/300 (42%), Gaps = 62/300 (20%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE---RQPQ-QITRAEYNLLSTLMHA 156
+E ++ +G G F V RD+ TGQ+ A+K + + ++ Q RAE ++L+
Sbjct: 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSP 61
Query: 157 HIPTALALFENAPVPGTDT----IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSAL 212
I F+ D +VM+ + G L+ L R+ E I +L AL
Sbjct: 62 WIVKLYYSFQ-------DEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLAL 114
Query: 213 HCLHSQQIAHKDIRPENILMN--GAVLKLIDLGSSVSV---------------------- 248
+H H+DI+P+NIL++ G + KL D G +
Sbjct: 115 DSVHKLGFIHRDIKPDNILIDADGHI-KLADFGLCKKMNKAKDREYYLNDSHNLLFRDNV 173
Query: 249 ---------------STVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPF 293
STV PD + +PE+L G D WSLGV+LY +L G PF
Sbjct: 174 LVRRRDHKQRRVRANSTVGTPD--YIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPF 230
Query: 294 LDESEEETRAHISVADYS--FPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWF 351
++ +ET I S FPP+ +S A +LI +LL D+ + ++ +F
Sbjct: 231 YSDTLQETYNKIINWKESLRFPPDP--PVSPEAIDLICRLLCDPEDRLGSFEEIKSHPFF 288
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 1e-23
Identities = 69/251 (27%), Positives = 114/251 (45%), Gaps = 32/251 (12%)
Query: 111 GRFCTVRKARDRGTGQLVALK-----QIPRERQPQQITRAEYNLLSTLMHAHIPTALALF 165
G+ VRK G+L A+K I ++ + + TR E +L + P + L
Sbjct: 14 GKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRC--PFLVTLH 71
Query: 166 ENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDI 225
+++ V+G L HL ++ TES + I ++ AL LH I ++DI
Sbjct: 72 YAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDI 131
Query: 226 RPENILMNG-AVLKLIDLGSSVSVSTVVLPD-----------LEFASPEMLTSPATA-GP 272
+ ENIL++ + L D G +S L + +E+ +PE++ +
Sbjct: 132 KLENILLDSEGHVVLTDFG----LSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDK 187
Query: 273 STDMWSLGVLLYILLSGVSPFLDESEEETRAHIS----VADYSFPPEQCGHISVPARELI 328
+ D WSLGVL + LL+G SPF + E+ +++ IS + FP +S AR+ I
Sbjct: 188 AVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKT----MSAEARDFI 243
Query: 329 GQLLNTHADKR 339
+LL KR
Sbjct: 244 QKLLEKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 2e-23
Identities = 77/261 (29%), Positives = 133/261 (50%), Gaps = 22/261 (8%)
Query: 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHI 158
+ +Y E++G G TV A D TGQ VA+KQ+ ++QP++ N + +
Sbjct: 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKK--ELIINEILVMRENKN 75
Query: 159 PTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQ 218
P + ++ V +VM+ + G SL + ++ + E I + R+ AL LHS
Sbjct: 76 PNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALDFLHSN 134
Query: 219 QIAHKDIRPENIL--MNGAVLKLIDLGSSVSVS------TVVLPDLEFASPEMLTSPATA 270
Q+ H+DI+ +NIL M+G+V KL D G ++ + ++ + +PE++T A
Sbjct: 135 QVIHRDIKSDNILLGMDGSV-KLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY- 192
Query: 271 GPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFP----PEQCGHISVPARE 326
GP D+WSLG++ ++ G P+L+E+ RA +A P PE+ +S R+
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNEN--PLRALYLIATNGTPELQNPER---LSAVFRD 247
Query: 327 LIGQLLNTHADKRPTAGQLLQ 347
+ + L D+R +A +LLQ
Sbjct: 248 FLNRCLEMDVDRRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 2e-23
Identities = 68/273 (24%), Positives = 118/273 (43%), Gaps = 43/273 (15%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRA----EYNLLSTLMHA 156
++ L++LG G + +V K + Q ALK++ Q+ R E +L+++ H
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQK-EREDAVNEIRILASVNHP 59
Query: 157 HIPTALALFENAPVPGTD-TIVMQLVHGESLIQHLCRQST----ITESYICCIIRQLHSA 211
+I + ++ A + G IVM+ L + + ++ I E I I QL
Sbjct: 60 NIIS----YKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115
Query: 212 LHCLHSQQIAHKDIRPENIL-MNGAVLKLIDLGSSVSVSTVVLPDLE--------FASPE 262
L LH Q+I H+D++ NIL + ++K+ DLG +S V+ ++ + +PE
Sbjct: 116 LQALHEQKILHRDLKSANILLVANDLVKIGDLG----ISKVLKKNMAKTQIGTPHYMAPE 171
Query: 263 MLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISV 322
+ + S D+WSLG LLY + + PF S ++ R + Y PP +
Sbjct: 172 VWKGRPYSYKS-DIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKY--PP-------I 221
Query: 323 PAR------ELIGQLLNTHADKRPTAGQLLQVA 349
P I +L RP ++L
Sbjct: 222 PPIYSQDLQNFIRSMLQVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (245), Expect = 3e-23
Identities = 80/288 (27%), Positives = 134/288 (46%), Gaps = 44/288 (15%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRA---EYNLLSTLMHAHI 158
YE+LE+LG G + V KARD+ TG++VALK+I + + + I E +LL L H +I
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60
Query: 159 PTALALFENAPVPGTDTIVMQLVHGESLIQHLC-RQSTITESYICCIIRQLHSALHCLHS 217
+ L + +V + L ++L R ++ + I I+ QL L HS
Sbjct: 61 ---VKLLDVIHTERKLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS 116
Query: 218 QQIAHKDIRPENILMNGA-VLKLIDLGSSVSVS--------TVVLPDLEFASPEMLTSPA 268
+I H+D++P+NIL+N VLKL D G + + VV L + +PE+L
Sbjct: 117 HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVT--LWYRAPEILLGSK 174
Query: 269 TAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHI----------------SVADYS- 311
+ D+WS+G + +++G F +SE + I + DY
Sbjct: 175 HYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234
Query: 312 -FP--PEQCGHISVP-----ARELIGQLLNTHADKRPTAGQLLQVAWF 351
FP P + +P +L+ ++L + KR +A + L+ +F
Sbjct: 235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 3e-23
Identities = 77/267 (28%), Positives = 123/267 (46%), Gaps = 26/267 (9%)
Query: 84 LYTVPFETRWQQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALK-----QIPRERQ 138
++T P + W+ FE E LG G F VR A+ +GTG+ A+K +I + +Q
Sbjct: 6 MFTKPDTSSWKLSDFEMG----ETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQ 61
Query: 139 PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITE 198
Q + E ++L L H I + F++ +++ V G L HL +
Sbjct: 62 VQHVA-QEKSILMELSHPFIVNMMCSFQDE---NRVYFLLEFVVGGELFTHLRKAGRFPN 117
Query: 199 SYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVS--TVVL-- 253
+L A LHS+ I ++D++PEN+L++ +K+ D G + V T L
Sbjct: 118 DVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLCG 177
Query: 254 -PDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSF 312
P E+ +PE++ S G + D W++GVLLY ++G PF D++ I F
Sbjct: 178 TP--EYLAPEVIQSKG-HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKF 234
Query: 313 PPEQCGHISVPARELIGQLLNTHADKR 339
P AR+L+ LL T KR
Sbjct: 235 P----NWFDGRARDLVKGLLQTDHTKR 257
|
Length = 329 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 97.9 bits (243), Expect = 4e-23
Identities = 76/261 (29%), Positives = 134/261 (51%), Gaps = 22/261 (8%)
Query: 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHI 158
+ +Y E++G G TV A D TGQ VA++Q+ ++QP++ N + +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK--ELIINEILVMRENKN 76
Query: 159 PTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQ 218
P + ++ V +VM+ + G SL + ++ + E I + R+ AL LHS
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 219 QIAHKDIRPENIL--MNGAVLKLIDLGSSVSVS------TVVLPDLEFASPEMLTSPATA 270
Q+ H+DI+ +NIL M+G+V KL D G ++ + ++ + +PE++T A
Sbjct: 136 QVIHRDIKSDNILLGMDGSV-KLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY- 193
Query: 271 GPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFP----PEQCGHISVPARE 326
GP D+WSLG++ ++ G P+L+E+ RA +A P PE+ +S R+
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNEN--PLRALYLIATNGTPELQNPEK---LSAIFRD 248
Query: 327 LIGQLLNTHADKRPTAGQLLQ 347
+ + L+ +KR +A +LLQ
Sbjct: 249 FLNRCLDMDVEKRGSAKELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 5e-23
Identities = 75/257 (29%), Positives = 114/257 (44%), Gaps = 26/257 (10%)
Query: 108 LGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITR------AEYNLLSTLMHAHIPTA 161
LG G F V D TG+ +A+KQ+P + + + E LL L H I
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 162 LALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIA 221
+ T +I M+ + G S+ L +TE+ RQ+ + LHS I
Sbjct: 70 YGCLRD---DETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIV 126
Query: 222 HKDIRPENIL--MNGAVLKLIDLGSSVSVSTV---------VLPDLEFASPEMLTSPATA 270
H+DI+ NIL G V KL D G+S + T+ V + SPE++ S
Sbjct: 127 HRDIKGANILRDSAGNV-KLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI-SGEGY 184
Query: 271 GPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHI-SVADYSFPPEQCGHISVPARELIG 329
G D+WS+G + +L+ P+ +E E A I +A P+ H+S AR +
Sbjct: 185 GRKADVWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLR 241
Query: 330 QLLNTHADKRPTAGQLL 346
+ +A KRP+A +LL
Sbjct: 242 RTFVENAKKRPSAEELL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 3e-22
Identities = 79/260 (30%), Positives = 135/260 (51%), Gaps = 24/260 (9%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQ-QITRAEYNLLSTLMHAHIP 159
+Y E++G G TV A D TGQ VA+KQ+ ++QP+ ++ E ++ H +I
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIV 79
Query: 160 TALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQ 219
L ++ V +VM+ + G SL + ++ + E I + R+ AL LHS Q
Sbjct: 80 NYL---DSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 135
Query: 220 IAHKDIRPENIL--MNGAVLKLIDLGSSVSVS------TVVLPDLEFASPEMLTSPATAG 271
+ H+DI+ +NIL M+G+V KL D G ++ + ++ + +PE++T A G
Sbjct: 136 VIHRDIKSDNILLGMDGSV-KLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY-G 193
Query: 272 PSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFP----PEQCGHISVPAREL 327
P D+WSLG++ ++ G P+L+E+ RA +A P PE+ +S R+
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYLNEN--PLRALYLIATNGTPELQNPEK---LSAIFRDF 248
Query: 328 IGQLLNTHADKRPTAGQLLQ 347
+ + L +KR +A +LLQ
Sbjct: 249 LNRCLEMDVEKRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 94.8 bits (235), Expect = 5e-22
Identities = 75/258 (29%), Positives = 131/258 (50%), Gaps = 16/258 (6%)
Query: 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHI 158
+ +Y E++G G TV A D TGQ VA+KQI ++QP++ N + +
Sbjct: 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKK--ELIINEILVMKELKN 75
Query: 159 PTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQ 218
P + ++ V +VM+ + G SL + ++ + E+ I + R+ AL LH+
Sbjct: 76 PNIVNFLDSFLVGDELFVVMEYLAGGSLTD-VVTETCMDEAQIAAVCRECLQALEFLHAN 134
Query: 219 QIAHKDIRPENIL--MNGAVLKLIDLGSSVSVS------TVVLPDLEFASPEMLTSPATA 270
Q+ H+DI+ +N+L M+G+V KL D G ++ + ++ + +PE++T A
Sbjct: 135 QVIHRDIKSDNVLLGMDGSV-KLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY- 192
Query: 271 GPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPA-RELIG 329
GP D+WSLG++ ++ G P+L+E+ RA +A P Q P R+ +
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNEN--PLRALYLIATNGTPELQNPEKLSPIFRDFLN 250
Query: 330 QLLNTHADKRPTAGQLLQ 347
+ L +KR +A +LLQ
Sbjct: 251 RCLEMDVEKRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.2 bits (235), Expect = 6e-22
Identities = 85/291 (29%), Positives = 136/291 (46%), Gaps = 45/291 (15%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQI--PRERQ--PQQITRAEYNLLSTLMHAH 157
YEEL +G G + TV KARD TG+ VALK++ P + P R E LL L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR-EIALLKQLESFE 59
Query: 158 IPTALALFENAPVPGTD-----TIVMQLVHGESLIQHL--CRQSTITESYICCIIRQLHS 210
P + L + P TD T+V + V + L +L C + + I ++RQL
Sbjct: 60 HPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLR 118
Query: 211 ALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSS------VSVSTVVLPDLEFASPEM 263
+ LHS +I H+D++P+NIL+ +K+ D G + +++++VV+ L + +PE+
Sbjct: 119 GVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV-TLWYRAPEV 177
Query: 264 LTSPATAGPSTDMWSLGVLLYILLSGVSPF--------LDE--------SEEETRAHISV 307
L ++ DMWS+G + L F LD+ SEEE ++S+
Sbjct: 178 LLQ-SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSL 236
Query: 308 ADYSFPP-------EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWF 351
SFP I +L+ ++L + KR +A + LQ +F
Sbjct: 237 PRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 1e-21
Identities = 69/252 (27%), Positives = 118/252 (46%), Gaps = 26/252 (10%)
Query: 108 LGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRA----EYNLLSTLMHAHIPTALA 163
+G G F V+ R++ TG + A+K + + Q T + E ++LS IP
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQY 68
Query: 164 LFENAPVPGTDTIVMQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAH 222
F++ +VM+ G L+ L R + E + +L A+H +H H
Sbjct: 69 AFQDK---DNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVH 125
Query: 223 KDIRPENILMN-GAVLKLIDLGSS--VSVSTVVLPDL-----EFASPEMLT-----SPAT 269
+DI+PEN+L++ +KL D GS+ ++ + +V L ++ +PE+LT T
Sbjct: 126 RDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGT 185
Query: 270 AGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHI-SVADY-SFPPEQCGHISVPAREL 327
G D WSLGV+ Y ++ G SPF + + +T +I + + FP + +S +L
Sbjct: 186 YGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDP--KVSSDFLDL 243
Query: 328 IGQLLNTHADKR 339
I LL +R
Sbjct: 244 IQSLL-CGQKER 254
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 3e-21
Identities = 76/280 (27%), Positives = 114/280 (40%), Gaps = 50/280 (17%)
Query: 92 RWQQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRA------ 145
RW++ + LG+G F +V + + G A+K++ Q A
Sbjct: 1 RWRKGEL---------LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQ 51
Query: 146 EYNLLSTLMHAHIPTALALFENAPVPGTDT------IVMQLVHGESLIQHLCRQSTITES 199
E LLS L H +I L GT+ I ++LV G SL + L + + E
Sbjct: 52 EIALLSKLQHPNIVQYL---------GTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEP 102
Query: 200 YICCIIRQLHSALHCLHSQQIAHKDIRPENILM--NGAVLKLIDLGSSVSVSTVVLPDLE 257
I RQ+ L LH + H+DI+ NIL+ NG V KL D G + V
Sbjct: 103 VIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVV-KLADFGMAKQVVE-----FS 156
Query: 258 FAS----------PEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISV 307
FA PE++ G + D+WSLG + + +G P+ E A +
Sbjct: 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQ--LEGVAAVFKI 214
Query: 308 ADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQ 347
P H+S A++ I + L RPTA +LL+
Sbjct: 215 GRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 6e-21
Identities = 76/281 (27%), Positives = 124/281 (44%), Gaps = 40/281 (14%)
Query: 92 RWQQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRA---EYN 148
RWQ+ +G G F V A + TG+L+A+K+I + + + E
Sbjct: 1 RWQRGNK---------IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMK 51
Query: 149 LLSTLMHAHIPTALAL-FENAPVPGTDTIVMQLVHGESLIQHLCRQSTIT-ESYICCIIR 206
+L L H ++ + V I M+ G +L + L I E I
Sbjct: 52 VLELLKHPNLVKYYGVEVHREKV----YIFMEYCSGGTLEE-LLEHGRILDEHVIRVYTL 106
Query: 207 QLHSALHCLHSQQIAHKDIRPENILM--NGAVLKLIDLGSSVSV---STVVLPDLE---- 257
QL L LHS I H+DI+P NI + NG V+KL D G +V + +T + +++
Sbjct: 107 QLLEGLAYLHSHGIVHRDIKPANIFLDHNG-VIKLGDFGCAVKLKNNTTTMGEEVQSLAG 165
Query: 258 ---FASPEMLTSPATAGP--STDMWSLGVLLYILLSGVSPFLDESEEETRAHI--SVADY 310
+ +PE++T G + D+WSLG ++ + +G P+ SE + I V
Sbjct: 166 TPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPW---SELDNEFQIMFHVGAG 222
Query: 311 SFPP-EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAW 350
PP +S ++ + + L + KRPTA +LLQ +
Sbjct: 223 HKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 2e-20
Identities = 77/284 (27%), Positives = 123/284 (43%), Gaps = 52/284 (18%)
Query: 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPR----ERQPQQITRAEYNLLSTLMH 155
+++++ LG G V R +GTG+L ALK + + +R + E +L+TL H
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 156 AHIPTALALFENAPVPGTDT---IVMQLVHGESLIQHLCRQST--ITESYICCIIRQLHS 210
+PT A F+ T+T +VM G L + L RQ ++E ++
Sbjct: 61 PFLPTLYASFQ------TETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLL 114
Query: 211 ALHCLHSQQIAHKDIRPENILMNGA---VLKLIDLGSSVSVST-VVLPDLEFASP----- 261
AL LH I ++D++PENIL++ + +L DL V V L S
Sbjct: 115 ALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVN 174
Query: 262 ----EMLTSPATA----------------------GPSTDMWSLGVLLYILLSGVSPFLD 295
E + + G + D W+LG+LLY +L G +PF
Sbjct: 175 SIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKG 234
Query: 296 ESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHADKR 339
+ +ET ++I + +FP +S AR+LI +LL KR
Sbjct: 235 SNRDETFSNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKR 276
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 8e-20
Identities = 71/242 (29%), Positives = 114/242 (47%), Gaps = 22/242 (9%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQ--IP---RERQPQQITRAEYNLLSTLMHA 156
E ++ +G G F V RDR + ALK IP R +Q Q + E +L + H
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHV-HNEKRVLKEVSH- 60
Query: 157 HIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLH 216
P + LF ++M+ V G L +L + S ++ AL LH
Sbjct: 61 --PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLH 118
Query: 217 SQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVS--TVVL---PDLEFASPEMLTSPATA 270
S++I ++D++PENIL++ +KL D G + + T L P E+ +PE++ S
Sbjct: 119 SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCGTP--EYLAPEVIQSKG-H 175
Query: 271 GPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQ 330
+ D W+LG+L+Y +L G PF D++ I FP H+ + A++LI +
Sbjct: 176 NKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR----HLDLYAKDLIKK 231
Query: 331 LL 332
LL
Sbjct: 232 LL 233
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 1e-19
Identities = 77/295 (26%), Positives = 132/295 (44%), Gaps = 53/295 (17%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIP--RERQPQQIT--RAEYNLLSTLMHAH 157
YE+L R+ G + V +ARD+ TG++VALK++ +E++ IT R E N+L L H +
Sbjct: 7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLKLQHPN 65
Query: 158 IPTALALFENAPVPGTDT----IVMQLVHGE--SLIQHLCRQSTITESYICCIIRQLHSA 211
I T V G++ +VM+ V + SL++ + + +E + C++ QL S
Sbjct: 66 IVTV-----KEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSE--VKCLMLQLLSG 118
Query: 212 LHCLHSQQIAHKDIRPENILMNGA-VLKLIDLG------SSVSVSTVVLPDLEFASPEML 264
+ LH I H+D++ N+L+N +LK+ D G S + T ++ L + +PE+L
Sbjct: 119 VAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELL 178
Query: 265 TSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHI------------------S 306
+ DMWS+G + LL+ F +SE + I
Sbjct: 179 LGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238
Query: 307 VADYSFPPEQCG----------HISVPARELIGQLLNTHADKRPTAGQLLQVAWF 351
A + +S +L+ +LL KR +A L+ +F
Sbjct: 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 5e-19
Identities = 72/264 (27%), Positives = 118/264 (44%), Gaps = 28/264 (10%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYN---LLSTLMHAH 157
RYE ++++G G F + A+ + + +K+I + P + A LL+ + H +
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 158 IPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTI--TESYICCIIRQLHSALHCL 215
I T A F+ G IVM+ G L++ + RQ + +E I Q+ L +
Sbjct: 61 IVTFFASFQEN---GRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHI 117
Query: 216 HSQQIAHKDIRPENILM--NGAVLKLIDLGSSVSVSTVVLPDLEFA----------SPEM 263
H ++I H+DI+ +NI + NG V KL D G ++ + +E A SPE+
Sbjct: 118 HDRKILHRDIKSQNIFLSKNGMVAKLGDFG----IARQLNDSMELAYTCVGTPYYLSPEI 173
Query: 264 LTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVP 323
+ TD+WSLG +LY L + PF E + + + F P + S
Sbjct: 174 CQNRPYNN-KTDIWSLGCVLYELCTLKHPF--EGNNLHQLVLKICQGYFAPIS-PNFSRD 229
Query: 324 ARELIGQLLNTHADKRPTAGQLLQ 347
R LI QL RP+ +L+
Sbjct: 230 LRSLISQLFKVSPRDRPSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 6e-19
Identities = 66/243 (27%), Positives = 107/243 (44%), Gaps = 19/243 (7%)
Query: 108 LGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLL----STLMHAHIPTALA 163
+G G F V + R R T ++ ALK I R+ ++R+E + L + P +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTI---RKAHIVSRSEVTHTLAERTVLAQVNCPFIVP 57
Query: 164 LFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHK 223
L + P +V+ ++G L HL R+ S +L AL LH + ++
Sbjct: 58 LKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYR 117
Query: 224 DIRPENILMNGA-VLKLIDLG------SSVSVSTVVLPDLEFASPEMLTSPATAGPSTDM 276
D++PENIL++ + L D G + E+ +PE+L + D
Sbjct: 118 DLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYT-KAVDW 176
Query: 277 WSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHA 336
W+LGVLLY +L+G+ PF DE+ E I FP A++L+ LL+
Sbjct: 177 WTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFP----DGFDRDAKDLLIGLLSRDP 232
Query: 337 DKR 339
+R
Sbjct: 233 TRR 235
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 7e-19
Identities = 70/262 (26%), Positives = 117/262 (44%), Gaps = 30/262 (11%)
Query: 108 LGNGRFCTVRKARDRGTGQLVALKQI----------PRERQPQQITRAEYNLLSTLMHAH 157
+G+G F +V + +G+L+A+KQ+ R+R E LL L H +
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 158 IPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHS 217
I L +A I ++ V G S+ L E+ + +RQ+ L+ LH+
Sbjct: 68 IVQYLGSSLDA---DHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124
Query: 218 QQIAHKDIRPENILM-NGAVLKLIDLGSSVSVSTVVL--------PDLE----FASPEML 264
+ I H+DI+ NIL+ N +K+ D G S + L P L+ + +PE++
Sbjct: 125 RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVV 184
Query: 265 TSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPA 324
+ D+WSLG L+ +L+G PF D ++ + I P +IS A
Sbjct: 185 KQTSYT-RKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPS---NISSEA 240
Query: 325 RELIGQLLNTHADKRPTAGQLL 346
+ + + +KRPTA +LL
Sbjct: 241 IDFLEKTFEIDHNKRPTAAELL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 1e-18
Identities = 77/271 (28%), Positives = 108/271 (39%), Gaps = 29/271 (10%)
Query: 103 EELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP---QQITRAEYNLLSTLMHAHIP 159
EL RLG G +V K R + TG + ALK I + P +QI R E + + +I
Sbjct: 4 VELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILR-ELEINKSCKSPYIV 62
Query: 160 TALALFENAPVPGTDTIVMQLVHGESL----IQHLCRQSTITESYICCIIRQLHSALHCL 215
F + + I M+ G SL + R I E + I + L L
Sbjct: 63 KYYGAFLD-ESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL 121
Query: 216 HSQQIAHKDIRPENILMN--GAVLKLIDLGSSVSVSTVVLPDLEFASPEMLTSPA--TAG 271
HS++I H+DI+P NIL+ G V KL D G VS V F +P
Sbjct: 122 HSRKIIHRDIKPSNILLTRKGQV-KLCDFG--VSGELVNSLAGTFTGTSFYMAPERIQGK 178
Query: 272 PST---DMWSLGVLLYILLSGVSPFLDESEEETRAHISVADY---SFPPE--QCGHISV- 322
P + D+WSLG+ L + PF E E I + Y PE +
Sbjct: 179 PYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL-GPIELLSYIVNMPNPELKDEPGNGIK 237
Query: 323 ---PARELIGQLLNTHADKRPTAGQLLQVAW 350
++ I Q L +RPT +L+ W
Sbjct: 238 WSEEFKDFIKQCLEKDPTRRPTPWDMLEHPW 268
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 1e-18
Identities = 69/263 (26%), Positives = 120/263 (45%), Gaps = 26/263 (9%)
Query: 106 ERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQ-------QITRAEYNLLSTLMHAHI 158
++LG G F + +ARD TG L+A+KQ+ R + R E L++ L H HI
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 159 PTAL-ALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHS 217
L A E++ + ++ + G S+ L + E+ I QL L LH
Sbjct: 66 IRMLGATCEDSHF----NLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHE 121
Query: 218 QQIAHKDIRPENILMN--GAVLKLIDLGSSVSVSTVV----------LPDLEFASPEMLT 265
QI H+D++ N+L++ G L++ D G++ ++ L + F +PE+L
Sbjct: 122 NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR 181
Query: 266 SPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHI-SVADYSFPPEQCGHISVPA 324
G S D+WS+G ++ + + P+ E A I +A + P H+S
Sbjct: 182 G-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGL 240
Query: 325 RELIGQLLNTHADKRPTAGQLLQ 347
R++ + L + RP + +LL+
Sbjct: 241 RDVTLRCLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 2e-18
Identities = 73/272 (26%), Positives = 114/272 (41%), Gaps = 38/272 (13%)
Query: 103 EELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQ---QITRAEYNLLSTLMHAHIP 159
E L LG G V K R TG+++A+K I E QI R L L + P
Sbjct: 4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRE----LDILHKCNSP 59
Query: 160 TAL----ALFENAPVPGTDTIVMQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHC 214
+ A + N G +I M+ + G SL + L Q I E + I + L
Sbjct: 60 YIVGFYGAFYNN----GDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTY 115
Query: 215 LHSQ-QIAHKDIRPENILMN--GAVLKLIDLGSSVSVSTVVLPDL--------EFASPEM 263
LH + +I H+D++P NIL+N G + KL D G VS ++ L + +PE
Sbjct: 116 LHEKHKIIHRDVKPSNILVNSRGQI-KLCDFG----VSGQLVNSLAKTFVGTSSYMAPER 170
Query: 264 LTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSF---PPEQCGHI 320
+ +D+WSLG+ L L +G P+ E++ + Y PP
Sbjct: 171 I-QGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQYIVNEPPPRLPSGK 228
Query: 321 -SVPARELIGQLLNTHADKRPTAGQLLQVAWF 351
S ++ + L +RP+ +LL+ +
Sbjct: 229 FSPDFQDFVNLCLIKDPRERPSYKELLEHPFI 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 3e-18
Identities = 74/263 (28%), Positives = 122/263 (46%), Gaps = 28/263 (10%)
Query: 102 YEELERLGNGRFCTV---RKARDRGTGQLVALK-----QIPRERQPQQITRAEYNLLSTL 153
+E L+ LG G + V RK TG+L A+K + ++ + + TR E N+L +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 154 MHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALH 213
+ P + L +++ V G + HL ++ +E + ++ AL
Sbjct: 62 RQS--PFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALE 119
Query: 214 CLHSQQIAHKDIRPENILMN--GAVLKLIDLGSSVSVST-------VVLPDLEFASPEML 264
LH I ++DI+ ENIL++ G V+ L D G S + +E+ +PE++
Sbjct: 120 HLHKLGIVYRDIKLENILLDSEGHVV-LTDFGLSKEFLSEEKERTYSFCGTIEYMAPEII 178
Query: 265 TSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHIS----VADYSFPPEQCGHI 320
G + D WSLG+L++ LL+G SPF E E T++ +S D FP I
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPS----FI 234
Query: 321 SVPARELIGQLLNTHADKRPTAG 343
A++L+ +LL KR AG
Sbjct: 235 GPEAQDLLHKLLRKDPKKRLGAG 257
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 3e-18
Identities = 72/258 (27%), Positives = 119/258 (46%), Gaps = 17/258 (6%)
Query: 102 YEELERLGNGRFCTV---RKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHI 158
+E L+ LG G + V RK +G+L A+K + + Q+ E+ + HI
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 159 PTALALFENAPVPGTDT---IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCL 215
+ L TDT +++ ++G L HL ++ E + ++ AL L
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHL 121
Query: 216 HSQQIAHKDIRPENILM--NGAVLKLIDLGSS-------VSVSTVVLPDLEFASPEMLTS 266
H I ++DI+ ENIL+ NG V+ L D G S V + +E+ +P+++
Sbjct: 122 HKLGIIYRDIKLENILLDSNGHVV-LTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRG 180
Query: 267 PATA-GPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAR 325
+ D WS+GVL+Y LL+G SPF + E+ ++A IS P +S A+
Sbjct: 181 GDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAK 240
Query: 326 ELIGQLLNTHADKRPTAG 343
++I +LL KR G
Sbjct: 241 DIIQRLLMKDPKKRLGCG 258
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 3e-18
Identities = 61/245 (24%), Positives = 107/245 (43%), Gaps = 27/245 (11%)
Query: 107 RLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLS----TLMHAHIPTAL 162
+L +G+F V + + T +L K I + +N + LM + P +
Sbjct: 23 KLIDGKFGKVSVLKHKPTQKLFVQKIIKAK---------NFNAIEPMVHQLMKDN-PNFI 72
Query: 163 ALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAH 222
L+ + ++M + L L ++ ++E+ + IIRQL AL+ LH I H
Sbjct: 73 KLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIH 132
Query: 223 KDIRPENILMNGAV--LKLIDLGSSVSVSTVVLPD--LEFASPEMLTSPATAGPSTDMWS 278
DI+ EN+L + A + L D G + T D L++ SPE + S D W+
Sbjct: 133 NDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGTLDYFSPEKIKG-HNYDVSFDWWA 191
Query: 279 LGVLLYILLSGVSPFLDESEEETRAHISVAD----YSFPPEQCGHISVPARELIGQLLNT 334
+GVL Y LL+G PF ++ +EE + + ++S A + + +L
Sbjct: 192 VGVLTYELLTGKHPFKEDEDEE----LDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKY 247
Query: 335 HADKR 339
+ + R
Sbjct: 248 NINYR 252
|
Length = 267 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 4e-18
Identities = 76/276 (27%), Positives = 124/276 (44%), Gaps = 34/276 (12%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLM-HAHIP 159
+E +E +G G + V KAR + TGQLVA+K + ++ + EYN+L H +I
Sbjct: 7 IFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIA 66
Query: 160 TALALFENAPVPGTDT---IVMQLVHGES---LIQHLCRQ-STITESYICCIIRQLHSAL 212
T F PG D +VM+L G S L++ L ++ + E +I I+R+ L
Sbjct: 67 TFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGL 126
Query: 213 HCLHSQQIAHKDIRPENILM--NGAVLKLIDLGSSVSVSTVVLPDLEFA------SPEML 264
LH ++ H+DI+ +NIL+ N V KL+D G S + + + F +PE++
Sbjct: 127 AYLHENKVIHRDIKGQNILLTKNAEV-KLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVI 185
Query: 265 TSPATAGPS----TDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHI 320
S +D+WSLG+ L G P D H A + P +
Sbjct: 186 ACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM-------HPMRALFKIPRNPPPTL 238
Query: 321 SVPAR------ELIGQLLNTHADKRPTAGQLLQVAW 350
P + I + L + ++RP +LL+ +
Sbjct: 239 KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 4e-18
Identities = 81/279 (29%), Positives = 122/279 (43%), Gaps = 35/279 (12%)
Query: 102 YEELER---LGNGRFCTVRKARDRGTGQLVALKQI---PRERQPQQITRAEYNLLSTLMH 155
ELER +G+G TV K R TG+L ALK I + +QI R E +L + H
Sbjct: 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICR-EIEILRDVNH 131
Query: 156 AHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCL 215
++ +F++ G ++++ + G SL E ++ + RQ+ S + L
Sbjct: 132 PNVVKCHDMFDHN---GEIQVLLEFMDGGSLEGTHIAD----EQFLADVARQILSGIAYL 184
Query: 216 HSQQIAHKDIRPENILMNGAV-LKLIDLGSS-----------VSVSTVVLPDLEFASPEM 263
H + I H+DI+P N+L+N A +K+ D G S SV T+ + SPE
Sbjct: 185 HRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIA-----YMSPER 239
Query: 264 ----LTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGH 319
L A G + D+WSLGV + G PF + + + + S PPE
Sbjct: 240 INTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPAT 299
Query: 320 ISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASCSE 358
S R I L KR +A QLLQ + A +
Sbjct: 300 ASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPGQ 338
|
Length = 353 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 4e-18
Identities = 69/261 (26%), Positives = 108/261 (41%), Gaps = 25/261 (9%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQI------PRERQPQQITRAEYNLLSTLM 154
Y + LG G F R LV K++ +ER+ E +LS L
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDAL---NEIVILSLLQ 57
Query: 155 HAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQST--ITESYICCIIRQLHSAL 212
H +I F + T I M+ +G +L + RQ E + + Q+ SA+
Sbjct: 58 HPNIIAYYNHFMDD---NTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAV 114
Query: 213 HCLHSQQIAHKDIRPENILMNGA-VLKLID------LGSSVSVSTVVLPDLEFASPEMLT 265
+H I H+DI+ NI + A ++KL D LGS S++ V+ + SPE+
Sbjct: 115 SYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPEL-C 173
Query: 266 SPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAR 325
+D+W+LG +LY LL+ F + I +Y+ S
Sbjct: 174 QGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSV---YSSELI 230
Query: 326 ELIGQLLNTHADKRPTAGQLL 346
L+ LL +KRPTA ++L
Sbjct: 231 SLVHSLLQQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 4e-18
Identities = 78/293 (26%), Positives = 129/293 (44%), Gaps = 45/293 (15%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQI--PRERQPQQITRA-EYNLLSTLMHAHI 158
+E+L R+G G + V +ARD +G++VALK++ ER I+ E LL L H +I
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68
Query: 159 PTALALFENAPVPGTDTI--VMQLVHGE--SLIQHLCRQSTITESYICCIIRQLHSALHC 214
+ L E D+I VM+ + SL+ ++ + +ES + C++ QL L
Sbjct: 69 ---VELKEVVVGKHLDSIFLVMEYCEQDLASLLDNM--PTPFSESQVKCLMLQLLRGLQY 123
Query: 215 LHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVSTVVLP------DLEFASPEMLTSP 267
LH I H+D++ N+L+ LK+ D G + + P L + +PE+L
Sbjct: 124 LHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGC 183
Query: 268 ATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHI-------------------SVA 308
T + DMW++G +L LL+ +SE E I V
Sbjct: 184 TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVG 243
Query: 309 DYSFPPE-------QCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEA 354
++ P + + +S L+ LL KR TA + L+ ++F E
Sbjct: 244 KFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK 296
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 5e-18
Identities = 72/252 (28%), Positives = 108/252 (42%), Gaps = 46/252 (18%)
Query: 108 LGNGRFCTVRKARDRGTGQLVALKQIPRE-----RQPQQITRAEYNLLSTLMHAHIPTAL 162
LG G F V + + + ALK + + Q + I +E +L H I
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHI-FSEKEILEECNHPFIVKLY 59
Query: 163 ALFENAPVPGTDT----IVMQLVHGESLIQHLCRQSTITES----YICCIIRQLHSALHC 214
F+ D ++M+ G L L + E YI C++ A
Sbjct: 60 RTFK-------DKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVV----LAFEY 108
Query: 215 LHSQQIAHKDIRPENILM--NGAVLKLIDLGSSVSVS------TVV-LPDLEFASPEMLT 265
LH++ I ++D++PEN+L+ NG V KL+D G + + T P E+ +PE++
Sbjct: 109 LHNRGIIYRDLKPENLLLDSNGYV-KLVDFGFAKKLKSGQKTWTFCGTP--EYVAPEIIL 165
Query: 266 SPATAGPSTDMWSLGVLLYILLSGVSPF--LDESEEETRAHI--SVADYSFPPEQCGHIS 321
+ S D WSLG+LLY LL+G PF DE E I FP +I
Sbjct: 166 NKGY-DFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPN----YID 220
Query: 322 VPARELIGQLLN 333
A++LI QLL
Sbjct: 221 KAAKDLIKQLLR 232
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 1e-17
Identities = 72/260 (27%), Positives = 121/260 (46%), Gaps = 21/260 (8%)
Query: 106 ERLGNGRFCTVRKARDRGTGQLVALKQIP----RERQPQQITRAEYNLLSTLMHAHIPTA 161
+++G G+F V +A + VALK++ + + +Q E +LL L H ++
Sbjct: 8 KKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKY 67
Query: 162 LALF-ENAPVPGTDTIVMQLVHGESL---IQHLCRQST-ITESYICCIIRQLHSALHCLH 216
L F E+ + IV++L L I++ +Q I E + QL SA+ +H
Sbjct: 68 LDSFIEDNEL----NIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 217 SQQIAHKDIRPENILMNGA-VLKLIDLG------SSVSVSTVVLPDLEFASPEMLTSPAT 269
S+++ H+DI+P N+ + V+KL DLG S + + ++ + SPE +
Sbjct: 124 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY 183
Query: 270 AGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIG 329
S D+WSLG LLY + + SPF + + +PP H S REL+
Sbjct: 184 NFKS-DIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVS 242
Query: 330 QLLNTHADKRPTAGQLLQVA 349
+ D+RP G + Q+A
Sbjct: 243 MCIYPDPDQRPDIGYVHQIA 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 1e-17
Identities = 68/262 (25%), Positives = 117/262 (44%), Gaps = 25/262 (9%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQI------PRERQPQQITRAEYNLLSTLM 154
+Y +++++G G F + + G+ +K+I P+ER+ +R E +LS +
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREE---SRKEVAVLSNMK 57
Query: 155 HAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTI--TESYICCIIRQLHSAL 212
H +I FE G IVM G L + + Q + E I Q+ AL
Sbjct: 58 HPNIVQYQESFEEN---GNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLAL 114
Query: 213 HCLHSQQIAHKDIRPENI-LMNGAVLKLIDLG------SSVSVSTVVLPDLEFASPEMLT 265
+H ++I H+DI+ +NI L +KL D G S+V ++ + + SPE+
Sbjct: 115 KHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICE 174
Query: 266 SPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAR 325
+ S D+W+LG +LY + + F E+ + + S+PP H S R
Sbjct: 175 NRPYNNKS-DIWALGCVLYEMCTLKHAF--EAGNMKNLVLKIIRGSYPPVSS-HYSYDLR 230
Query: 326 ELIGQLLNTHADKRPTAGQLLQ 347
L+ QL + RP+ +L+
Sbjct: 231 NLVSQLFKRNPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 1e-17
Identities = 75/305 (24%), Positives = 127/305 (41%), Gaps = 55/305 (18%)
Query: 97 QFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHA 156
RY+ +E +G+G + V A D +G+ VA+K+IP + + L L H
Sbjct: 2 DVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF 61
Query: 157 HIPTALALFENAPVPGTDTI----VMQLVHGESLIQHL--CRQSTITESYICCIIRQLHS 210
+A+ + PG D VM L+ ES + H+ Q +TE +I + QL
Sbjct: 62 KHDNIIAIRDILRPPGADFKDVYVVMDLM--ESDLHHIIHSDQ-PLTEEHIRYFLYQLLR 118
Query: 211 ALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVS----------TVVLPDLEFA 259
L +HS + H+D++P N+L+N L++ D G + +S T + +
Sbjct: 119 GLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYR 178
Query: 260 SPEMLTSPATAGPSTDMWSLG-----------------------VLLYILLSGVSPFLDE 296
+PE+L S + DMWS+G ++L +L S L+
Sbjct: 179 APELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR 238
Query: 297 -SEEETRAHISVADYSFPPEQC-------GHISVPARELIGQLLNTHADKRPTAGQLLQV 348
+ R +I + P +Q S A +L+ Q+L ++R T Q LQ
Sbjct: 239 IGSDRVRKYIQ----NLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294
Query: 349 AWFAE 353
+ A+
Sbjct: 295 PFLAQ 299
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 71/257 (27%), Positives = 117/257 (45%), Gaps = 46/257 (17%)
Query: 108 LGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLS--------TLMH 155
LG G F V A +GT +L A+K + ++ + T E +L+ T +H
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62
Query: 156 AHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITES----YICCIIRQLHSA 211
+ T LF VM+ V+G L+ H+ R E Y I+
Sbjct: 63 SCFQTKDRLF----------FVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIV----LG 108
Query: 212 LHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSS-------VSVSTVV-LPDLEFASPE 262
L LH + I ++D++ +N+L++ +K+ D G V+ ST PD + +PE
Sbjct: 109 LQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPD--YIAPE 166
Query: 263 MLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISV 322
+L+ GP+ D W+LGVLLY +L+G SPF + E+E I + +P +S
Sbjct: 167 ILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPR----WLSK 221
Query: 323 PARELIGQLLNTHADKR 339
A+ ++ L + +KR
Sbjct: 222 EAKSILKSFLTKNPEKR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 2e-17
Identities = 67/259 (25%), Positives = 118/259 (45%), Gaps = 21/259 (8%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQI---PRERQPQQITRAEYNLLSTLMHAHI 158
+E L ++G G F V K + ++ A+KQI R+ ++ E +L+ L ++I
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 159 PTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQ--STITESYICCIIRQLHSALHCLH 216
+ +E+ G IVM+ L + L Q + E + Q+ L LH
Sbjct: 62 ---IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH 118
Query: 217 SQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVST------VVLPDLEFASPEMLT-SPA 268
S++I H+DI+ N+ ++ +K+ DLG + +S ++ + SPE+ P
Sbjct: 119 SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPY 178
Query: 269 TAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELI 328
+D+W+LGV+LY +G PF ++ + + + FPP + S +LI
Sbjct: 179 NE--KSDVWALGVVLYECCTGKHPF--DANNQGALILKIIRGVFPPVSQMY-SQQLAQLI 233
Query: 329 GQLLNTHADKRPTAGQLLQ 347
Q L +RP QLL+
Sbjct: 234 DQCLTKDYRQRPDTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 3e-17
Identities = 64/206 (31%), Positives = 103/206 (50%), Gaps = 18/206 (8%)
Query: 108 LGNGRFCTVRKARDRGTGQLVALKQIPRERQPQ----QITRAEYNLLSTLMHAHIPTALA 163
LG G F V AR + +G+L A+K + ++ Q + T E +LS L H P
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILS-LARNH-PFLTQ 60
Query: 164 LFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHK 223
L+ P VM+ V+G L+ H+ + E+ ++ SAL LH + I ++
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120
Query: 224 DIRPENILMN-GAVLKLIDLG-------SSVSVSTVV-LPDLEFASPEMLTSPATAGPST 274
D++ +N+L++ KL D G + + ST PD + +PE+L GPS
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPD--YIAPEILQE-MLYGPSV 177
Query: 275 DMWSLGVLLYILLSGVSPFLDESEEE 300
D W++GVLLY +L G +PF E+E++
Sbjct: 178 DWWAMGVLLYEMLCGHAPFEAENEDD 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 4e-17
Identities = 63/244 (25%), Positives = 107/244 (43%), Gaps = 16/244 (6%)
Query: 108 LGNGRFCTVRKARDRGTGQLVALKQIPRER--QPQQI--TRAEYNLLSTLMHAHIPTALA 163
+G G F V + R + T ++ A+K + ++ +++ T E N+L + P +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 164 LFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHK 223
L + +V + G L HL ++ +E I +L AL LH I ++
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 224 DIRPENILM--NGAVLKLIDLGSSVS------VSTVVLPDLEFASPEMLTSPATAGPSTD 275
D++PENIL+ G + L D G S + + E+ +PE+L D
Sbjct: 121 DLKPENILLDATGHI-ALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVD 179
Query: 276 MWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNTH 335
WSLGVL++ + G SPF E ++ +I+ FP +S R+ + LLN +
Sbjct: 180 FWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPK---NVLSDEGRQFVKGLLNRN 236
Query: 336 ADKR 339
R
Sbjct: 237 PQHR 240
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 5e-17
Identities = 74/258 (28%), Positives = 116/258 (44%), Gaps = 17/258 (6%)
Query: 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQI--TRAEYNLLSTLMHA 156
E + +LER+G G F V K D T ++VA+K I E +I + E +LS
Sbjct: 3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 157 HIPTALALFENAPVPGTDT-IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCL 215
+I + + GT I+M+ + G S + L + + E+YI I+R++ L L
Sbjct: 63 YITRYYGSY----LKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYL 117
Query: 216 HSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVSTVVLPDLEFASPEMLTSPATAGPS- 273
HS++ H+DI+ N+L++ +KL D G + ++ + F +P S
Sbjct: 118 HSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA 177
Query: 274 ----TDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIG 329
D+WSLG+ L G P D R + S PP G S P +E +
Sbjct: 178 YDFKADIWSLGITAIELAKGEPPNSD--LHPMRVLFLIPKNS-PPTLEGQYSKPFKEFVE 234
Query: 330 QLLNTHADKRPTAGQLLQ 347
LN RPTA +LL+
Sbjct: 235 ACLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 5e-17
Identities = 73/261 (27%), Positives = 118/261 (45%), Gaps = 23/261 (8%)
Query: 106 ERLGNGRFCTVRKARDRGTGQLVALKQIP----RERQPQQITRAEYNLLSTLMHAHIPTA 161
+++G G+F V +A G VALK++ + + + E +LL L H ++
Sbjct: 8 KKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 67
Query: 162 LALF--ENAPVPGTDTIVMQLVHGESL---IQHLCRQST-ITESYICCIIRQLHSALHCL 215
A F +N IV++L L I+H +Q I E + QL SAL +
Sbjct: 68 YASFIEDNEL-----NIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 216 HSQQIAHKDIRPENILMNG-AVLKLIDLG------SSVSVSTVVLPDLEFASPEMLTSPA 268
HS+++ H+DI+P N+ + V+KL DLG S + + ++ + SPE +
Sbjct: 123 HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG 182
Query: 269 TAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELI 328
S D+WSLG LLY + + SPF + + +PP H S R+L+
Sbjct: 183 YNFKS-DIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLV 241
Query: 329 GQLLNTHADKRPTAGQLLQVA 349
+N +KRP + VA
Sbjct: 242 NMCINPDPEKRPDITYVYDVA 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 6e-17
Identities = 73/264 (27%), Positives = 119/264 (45%), Gaps = 28/264 (10%)
Query: 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHI 158
E ++ LE+LG G + +V KA + TGQ+VA+K +P E Q+I + E ++L +I
Sbjct: 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIK-EISILKQCDSPYI 60
Query: 159 PTALALFENAPVPGTDTIVMQLVHGESLIQHL-CRQSTITESYICCIIRQLHSALHCLHS 217
+ + + IVM+ S+ + T+TE I I+ Q L LHS
Sbjct: 61 ---VKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS 117
Query: 218 QQIAHKDIRPENILMN-GAVLKLIDLGSS-------VSVSTVVLPDLEFASPEMLTSPAT 269
+ H+DI+ NIL+N KL D G S +TV+ + +PE++
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPF-WMAPEVI-QEIG 175
Query: 270 AGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAR---- 325
D+WSLG+ + G P+ D H A + P + +S P +
Sbjct: 176 YNNKADIWSLGITAIEMAEGKPPYSD-------IHPMRAIFMIPNKPPPTLSDPEKWSPE 228
Query: 326 --ELIGQLLNTHADKRPTAGQLLQ 347
+ + + L ++RP+A QLLQ
Sbjct: 229 FNDFVKKCLVKDPEERPSAIQLLQ 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 7e-17
Identities = 55/235 (23%), Positives = 99/235 (42%), Gaps = 41/235 (17%)
Query: 101 RYEELER-LGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRA-------------- 145
RY + LG G + V KA D TG++VA+K++ +T+
Sbjct: 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTL 68
Query: 146 -EYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCI 204
E +++ + H +I + ++ +VM ++ + L + + R+ +TES + CI
Sbjct: 69 RELKIMNEIKHENIMGLVDVYVEG---DFINLVMDIMASD-LKKVVDRKIRLTESQVKCI 124
Query: 205 IRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLG-SSVSVSTVVLPD------- 255
+ Q+ + L+ LH H+D+ P NI +N + K+ D G +
Sbjct: 125 LLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 256 ------------LEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESE 298
L + +PE+L + DMWS+G + LL+G F E+E
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239
|
Length = 335 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 79.4 bits (195), Expect = 9e-17
Identities = 72/263 (27%), Positives = 118/263 (44%), Gaps = 19/263 (7%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMH-AHIPT 160
+E +E +GNG + V K R TGQL A+K + ++ + E N+L H +I T
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 161 ALALFENAPVPGTDT---IVMQLVHGESLIQHL--CRQSTITESYICCIIRQLHSALHCL 215
F PG D +VM+ S+ + + +T+ E +I I R++ L L
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 127
Query: 216 HSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVSTVVLPDLEF------ASPEMLT--- 265
H ++ H+DI+ +N+L+ A +KL+D G S + V F +PE++
Sbjct: 128 HQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDE 187
Query: 266 SP-ATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPA 324
+P AT +D+WSLG+ + G P D RA + P + S
Sbjct: 188 NPDATYDFKSDLWSLGITAIEMAEGAPPLCD--MHPMRALFLIPRNPAPRLKSKKWSKKF 245
Query: 325 RELIGQLLNTHADKRPTAGQLLQ 347
+ I L + +RPT QL++
Sbjct: 246 QSFIESCLVKNHSQRPTTEQLMK 268
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 1e-16
Identities = 67/260 (25%), Positives = 123/260 (47%), Gaps = 22/260 (8%)
Query: 107 RLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFE 166
++G G V A D+ TG+ VA+K++ + + QQ +N + + P + ++
Sbjct: 26 KIGEGSTGIVCIATDKSTGRQVAVKKM--DLRKQQRRELLFNEVVIMRDYQHPNIVEMYS 83
Query: 167 NAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIR 226
+ V +VM+ + G +L + + + E I + + AL LH+Q + H+DI+
Sbjct: 84 SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIK 142
Query: 227 PENILM--NGAVLKLIDLG--SSVSV------STVVLPDLEFASPEMLTSPATAGPSTDM 276
++IL+ +G V KL D G + VS S V P + +PE++ S G D+
Sbjct: 143 SDSILLTSDGRV-KLSDFGFCAQVSKEVPRRKSLVGTP--YWMAPEVI-SRLPYGTEVDI 198
Query: 277 WSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPA--RELIGQLLNT 334
WSLG+++ ++ G P+ +E + I + PP+ V R + ++L
Sbjct: 199 WSLGIMVIEMVDGEPPYFNEPPLQAMKRIRD---NLPPKLKNLHKVSPRLRSFLDRMLVR 255
Query: 335 HADKRPTAGQLLQVAWFAEA 354
+R TA +LL + A+A
Sbjct: 256 DPAQRATAAELLNHPFLAKA 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 1e-16
Identities = 77/304 (25%), Positives = 123/304 (40%), Gaps = 73/304 (24%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQI----PRERQPQQITRAEYNLLSTLMHA 156
+YE+LE++G G + TV KA++R T ++VALK++ E P R E LL L H
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHK 59
Query: 157 HIPTALALFENAPVPGTDTIVMQLVHGES---LIQHLCRQS----------TITESYICC 203
+I + L++ ++H + L+ C Q I +
Sbjct: 60 NI---VRLYD-------------VLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKS 103
Query: 204 IIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLG---------SSVSVSTVVL 253
+ QL L HS + H+D++P+N+L+N LKL D G S V
Sbjct: 104 FMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVT- 162
Query: 254 PDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESE--------------- 298
L + P++L S DMWS G + L + P ++
Sbjct: 163 --LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP 220
Query: 299 -EETRAHIS-VADY----SFPPEQCGHISVP-----ARELIGQLLNTHADKRPTAGQLLQ 347
EE+ +S + DY +P VP R+L+ LL + +R +A + LQ
Sbjct: 221 TEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280
Query: 348 VAWF 351
+F
Sbjct: 281 HPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-16
Identities = 70/250 (28%), Positives = 117/250 (46%), Gaps = 23/250 (9%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPR----ERQPQQITRAEYNLLSTLMHAH 157
+E ++ +G G F V + + T ++ A+K + + +R R E N+L
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62
Query: 158 IPTALALFENAPVPGTDTIVMQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLH 216
I T F++ +VM G L+ L + + + E I ++ A+H +H
Sbjct: 63 ITTLHYAFQDE---NYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH 119
Query: 217 SQQIAHKDIRPENIL--MNGAVLKLIDLGSSVSV-------STVVLPDLEFASPEMLTSP 267
H+DI+P+N+L MNG + +L D GS + + S+V + ++ SPE+L +
Sbjct: 120 QLHYVHRDIKPDNVLLDMNGHI-RLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAM 178
Query: 268 ATA----GPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFP-PEQCGHISV 322
GP D WSLGV +Y +L G +PF ES ET I + F P +S
Sbjct: 179 EDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSE 238
Query: 323 PARELIGQLL 332
A++LI +L+
Sbjct: 239 EAKDLIQRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-16
Identities = 67/248 (27%), Positives = 112/248 (45%), Gaps = 22/248 (8%)
Query: 105 LERLGNGRFCTVRKARDRGTGQLVALKQIPRER--QPQQIT--RAEYNLLSTLMHAHIPT 160
L+ + G F +V A+ R TG A+K + + Q+T +AE ++ ++ P
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIM--MIQGESPY 58
Query: 161 ALALFENAPVPGTDTIVMQLVHG---ESLIQHLCRQSTITESYICCIIRQLHSALHCLHS 217
L+ + +VM+ ++G SLI+ L + E + I ++ + LH
Sbjct: 59 VAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTL---GGLPEDWAKQYIAEVVLGVEDLHQ 115
Query: 218 QQIAHKDIRPENILM-NGAVLKLIDLGSS----VSVSTVVLPDLEFASPEMLTS-PATAG 271
+ I H+DI+PEN+L+ LKL D G S + V PD + +PE +
Sbjct: 116 RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPD--YLAPETILGVGDDK- 172
Query: 272 PSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQL 331
+D WSLG +++ L G PF E+ + +I ++P E S A +LI +L
Sbjct: 173 -MSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRL 231
Query: 332 LNTHADKR 339
L KR
Sbjct: 232 LCMDPAKR 239
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 2e-16
Identities = 75/307 (24%), Positives = 123/307 (40%), Gaps = 65/307 (21%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQ--QITR-AEYNLLSTLMHAH 157
+YE+L ++G G F V KAR + T Q+VALK++ E + + IT E +L L H +
Sbjct: 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHEN 72
Query: 158 IPTALALFENAPVP-----GTDTIVMQLVHGE--SLIQHLCRQSTITESYICCIIRQLHS 210
+ + + P G+ +V + + L+ + + T S I +++ L +
Sbjct: 73 VVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSN--KNVKFTLSEIKKVMKMLLN 130
Query: 211 ALHCLHSQQIAHKDIRPENILM--NGAVLKLIDLGSSVSVSTVVLPD----------LEF 258
L+ +H +I H+D++ NIL+ +G +LKL D G + + S L +
Sbjct: 131 GLYYIHRNKILHRDMKAANILITKDG-ILKLADFGLARAFSLSKNSKPNRYTNRVVTLWY 189
Query: 259 ASPEMLTSPATAGPSTDMWSLGVLL------YILLSGVSPFLDESEEETRAHISVADYSF 312
PE+L GP DMW G ++ ++ G +E+ IS S
Sbjct: 190 RPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQG------NTEQHQLTLISQLCGSI 243
Query: 313 PPE-----------------QCGHISVPAR-----------ELIGQLLNTHADKRPTAGQ 344
PE Q V R +LI +LL KR A
Sbjct: 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADT 303
Query: 345 LLQVAWF 351
L +F
Sbjct: 304 ALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-16
Identities = 68/267 (25%), Positives = 117/267 (43%), Gaps = 30/267 (11%)
Query: 106 ERLGNGRFCTVRKARDRGTGQLVALKQ--IPR---ERQPQQIT------RAEYNLLSTLM 154
E +G G + V A + TG+++A+KQ +P R + R+E L L
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 155 HAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHC 214
H +I L FE +I ++ V G S+ L E + Q+ L
Sbjct: 67 HLNIVQYLG-FETTEE--YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAY 123
Query: 215 LHSQQIAHKDIRPENILMN-GAVLKLIDLGSS-------VSVSTVVLPDLEF-ASPEMLT 265
LHS+ I H+D++ +N+L++ + K+ D G S + + + F +PE++
Sbjct: 124 LHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIH 183
Query: 266 SPATA-GPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYS----FPPEQCGHI 320
S + D+WSLG ++ + +G P+ D EE A + + PP+ ++
Sbjct: 184 SYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD--EEAIAAMFKLGNKRSAPPIPPDVSMNL 241
Query: 321 SVPARELIGQLLNTHADKRPTAGQLLQ 347
S A + + + D RPTA +LLQ
Sbjct: 242 SPVALDFLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 2e-16
Identities = 72/283 (25%), Positives = 115/283 (40%), Gaps = 51/283 (18%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQI--TRAEYNLLSTLMHAHIP 159
YE +E +G G V A + VA+K+I E+ + R E +S H ++
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVV 62
Query: 160 TALALFENAPVPGTDT-IVMQLVHGESL---IQHLCRQSTITESYICCIIRQLHSALHCL 215
F V G + +VM + G SL ++ + + E+ I +++++ L L
Sbjct: 63 KYYTSF----VVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118
Query: 216 HSQQIAHKDIRPENILM--NGAVLKLIDLGSSVSVS-----------TVVLPDLEFASPE 262
HS H+DI+ NIL+ +G+V K+ D G S S++ T V A PE
Sbjct: 119 HSNGQIHRDIKAGNILLGEDGSV-KIADFGVSASLADGGDRTRKVRKTFVGTPCWMA-PE 176
Query: 263 MLTSPATAGPSTDMWSLGVLLYILLSGVSPFL--------------DESEEETRAHISVA 308
++ D+WS G+ L +G +P+ D ET A
Sbjct: 177 VMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKY 236
Query: 309 DYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWF 351
SF R++I L KRPTA +LL+ +F
Sbjct: 237 SKSF------------RKMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 3e-16
Identities = 67/275 (24%), Positives = 125/275 (45%), Gaps = 24/275 (8%)
Query: 108 LGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLSTLMHAHIPTALA 163
LG G F V R++ +G+ A+K + +E + T E +L H + +
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 164 LFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHK 223
F+ VM+ V+G L HL R+ +E ++ SAL LHS +I ++
Sbjct: 63 SFQTK---DRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYR 119
Query: 224 DIRPENILMN-GAVLKLIDLG------SSVSVSTVVLPDLEFASPEMLTSPATAGPSTDM 276
D++ EN++++ +K+ D G + + E+ +PE+L G + D
Sbjct: 120 DLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLED-NDYGRAVDW 178
Query: 277 WSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHA 336
W LGV++Y ++ G PF ++ E+ I + D FP +S A+ L+ LL
Sbjct: 179 WGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRT----LSADAKSLLSGLLIKDP 234
Query: 337 DKRPTAG-----QLLQVAWFAEASCSEFDTERLLP 366
+KR G ++++ ++F + + ++L+P
Sbjct: 235 NKRLGGGPDDAKEIMRHSFFTGVNWQDVYDKKLVP 269
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 3e-16
Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 39/213 (18%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQ-IPRERQPQ--QITRAEYNLLSTLMHAH 157
+YE+L ++G G + V K R+R TGQ+VA+K+ + E P +I E +L L H +
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPN 61
Query: 158 IPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITE----------SYICCIIRQ 207
+ + +F + +H L+ C + + E I II Q
Sbjct: 62 LVNLIEVFRRK----------RKLH---LVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQ 108
Query: 208 LHSALHCLHSQQIAHKDIRPENILMNGA-VLKLIDLGSSVSVSTVVLPDLEFA------- 259
A++ H H+D++PENIL+ +KL D G + ++ P ++
Sbjct: 109 TLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTG---PGDDYTDYVATRW 165
Query: 260 --SPEMLTSPATAGPSTDMWSLGVLLYILLSGV 290
+PE+L GP D+W++G + LL+G
Sbjct: 166 YRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 3e-16
Identities = 80/292 (27%), Positives = 126/292 (43%), Gaps = 50/292 (17%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIP---RERQPQQITRAEYNLLSTLM-HA 156
+YE L++LG G + V KA DR T ++VALK+I R Q T E L L H
Sbjct: 8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHP 67
Query: 157 HIPTALALF--ENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHC 214
+I L + EN D I + + E+ + + R + + + + I+ QL AL
Sbjct: 68 NIVKLLNVIKAEN----DKD-IYLVFEYMETDLHAVIRANILEDVHKRYIMYQLLKALKY 122
Query: 215 LHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVST----VVLPDLE-------FASPE 262
+HS + H+D++P NIL+N +KL D G + S+S P L + +PE
Sbjct: 123 IHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPE 182
Query: 263 MLTSPATAGPSTDMWSLGVLLYILLSGVSPF-----LDE-----------SEEETRA--- 303
+L DMWS+G +L +L G F L++ S E+ +
Sbjct: 183 ILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKS 242
Query: 304 --------HISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQ 347
+ E S A +L+ +LL + +KR TA + L+
Sbjct: 243 PFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE 294
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 3e-16
Identities = 69/259 (26%), Positives = 115/259 (44%), Gaps = 29/259 (11%)
Query: 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLL----STLMH 155
++ ++ +G G F V+ R + + Q+ A+K + + + I R++ + H
Sbjct: 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKF---EMIKRSDSAFFWEERDIMAH 99
Query: 156 AHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCL 215
A+ + L +VM+ + G L+ +L I E + ++ AL +
Sbjct: 100 ANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLV-NLMSNYDIPEKWARFYTAEVVLALDAI 158
Query: 216 HSQQIAHKDIRPENILM--NGAVLKLIDLGSS--------VSVSTVV-LPDLEFASPEML 264
HS H+D++P+N+L+ +G LKL D G+ V T V PD + SPE+L
Sbjct: 159 HSMGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMDANGMVRCDTAVGTPD--YISPEVL 215
Query: 265 TSP---ATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYS--FPPEQCGH 319
S G D WS+GV LY +L G +PF +S T + I S FP +
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDI--E 273
Query: 320 ISVPARELIGQLLNTHADK 338
IS A++LI L +
Sbjct: 274 ISKQAKDLICAFLTDREVR 292
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 4e-16
Identities = 71/257 (27%), Positives = 114/257 (44%), Gaps = 23/257 (8%)
Query: 108 LGNGRFCTVRKARDRGTGQLVALKQI------PRERQPQQITRAEYNLLSTLMHAHIPTA 161
LG G F V D TG+ +A+KQ+ P + E LL L+H I
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 162 LALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIA 221
+ P+ T +I M+ + G S+ L +TE+ RQ+ + LHS I
Sbjct: 70 YGCLRD-PMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIV 128
Query: 222 HKDIRPENILMNGA-VLKLIDLGSSVSVSTVVLPDL---------EFASPEMLTSPATAG 271
H+DI+ NIL + +KL D G+S + T+ L + SPE+++ G
Sbjct: 129 HRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGY-G 187
Query: 272 PSTDMWSLGVLLYILLSGVSPFLDESEEETRAHI-SVADYSFPPEQCGHISVPARELIGQ 330
D+WS+G + +L+ P+ +E E A I +A P H+S R+ + +
Sbjct: 188 RKADIWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKR 244
Query: 331 LLNTHADKRPTAGQLLQ 347
+ A RP+A +LL+
Sbjct: 245 IF-VEAKLRPSADELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 4e-16
Identities = 79/272 (29%), Positives = 123/272 (45%), Gaps = 43/272 (15%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQ-QITRAEYNLLSTLMHAHIPT 160
+E + LG+G F V KA+++ TG L A K I + + + + E +L+T H +I
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVK 73
Query: 161 ALALF----------ENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHS 210
L F E P D I+++L G +TE I I RQ+
Sbjct: 74 LLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRG------------LTEPQIQVICRQMLE 121
Query: 211 ALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLG-SSVSVSTVVLPDLEFASP------- 261
AL LHS +I H+D++ N+L+ +KL D G S+ +V T+ D +P
Sbjct: 122 ALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEV 181
Query: 262 ----EMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPP--E 315
M +P D+WSLG+ L I ++ + P E R + +A S PP
Sbjct: 182 VMCETMKDTPYDY--KADIWSLGITL-IEMAQIEPPHHEL-NPMRVLLKIAK-SEPPTLS 236
Query: 316 QCGHISVPARELIGQLLNTHADKRPTAGQLLQ 347
Q S+ R+ + L+ H + RP+A QLL+
Sbjct: 237 QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 4e-16
Identities = 71/266 (26%), Positives = 110/266 (41%), Gaps = 34/266 (12%)
Query: 106 ERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEY-------NLLSTLMHAHI 158
E LG G + TV GQL+A+KQ+ + EY +LL +L H +I
Sbjct: 6 EVLGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 159 PTALA--LFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLH 216
L L +N T +I M+ V G S+ L R + E C +Q+ + LH
Sbjct: 65 VQYLGTCLDDN-----TISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLH 119
Query: 217 SQQIAHKDIRPENI-LMNGAVLKLIDLGSSVSVSTVVLPDLEFASPEMLTS----PATAG 271
+ + H+DI+ N+ LM ++KLID G + ++ V L ML S P
Sbjct: 120 NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV---GLHGTHSNMLKSMHGTPYWMA 176
Query: 272 PS----------TDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHIS 321
P +D+WS+G ++ + +G P +I A P S
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG-AHRGLMPRLPDSFS 235
Query: 322 VPARELIGQLLNTHADKRPTAGQLLQ 347
A + + L +RP+A QLL+
Sbjct: 236 AAAIDFVTSCLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 6e-16
Identities = 67/255 (26%), Positives = 112/255 (43%), Gaps = 11/255 (4%)
Query: 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHI 158
E + +LE++G G F V K D T ++VA+K I E +I + + + L
Sbjct: 3 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEI-TVLSQCDS 61
Query: 159 PTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQ 218
P + + I+M+ + G S + L + E+ I I+R++ L LHS+
Sbjct: 62 PYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSE 120
Query: 219 QIAHKDIRPENILMN-GAVLKLIDLGSSVSVSTVVLPDLEFASPEMLTSPATAGPS---- 273
+ H+DI+ N+L++ +KL D G + ++ + F +P S
Sbjct: 121 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 180
Query: 274 -TDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLL 332
D+WSLG+ L G P SE + + + PP G+ S P +E + L
Sbjct: 181 KADIWSLGITAIELAKGEPP---HSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACL 237
Query: 333 NTHADKRPTAGQLLQ 347
N RPTA +LL+
Sbjct: 238 NKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 6e-16
Identities = 76/257 (29%), Positives = 113/257 (43%), Gaps = 23/257 (8%)
Query: 108 LGNGRFCTVRKARDRGTGQLVALKQI------PRERQPQQITRAEYNLLSTLMHAHIPTA 161
LG G F V D TG+ +A KQ+ P + E LL L H I
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 162 LALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIA 221
+ T TI M+ + G S+ L +TES RQ+ + LHS I
Sbjct: 70 YGCLRDR-AEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIV 128
Query: 222 HKDIRPENILMNGA-VLKLIDLGSSVSVSTVVLPDL---------EFASPEMLTSPATAG 271
H+DI+ NIL + A +KL D G+S + T+ + + SPE+++ G
Sbjct: 129 HRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGY-G 187
Query: 272 PSTDMWSLGVLLYILLSGVSPFLDESEEETRAHI-SVADYSFPPEQCGHISVPARELIGQ 330
D+WSLG + +L+ P+ +E E A I +A P+ HIS AR+ +G
Sbjct: 188 RKADVWSLGCTVVEMLTEKPPW---AEYEAMAAIFKIATQPTNPQLPSHISEHARDFLGC 244
Query: 331 LLNTHADKRPTAGQLLQ 347
+ A RP+A +LL+
Sbjct: 245 IF-VEARHRPSAEELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 6e-16
Identities = 75/309 (24%), Positives = 126/309 (40%), Gaps = 71/309 (22%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP----QQITRAEYNLLSTLMHA 156
RYE L+ +G+G + V A D+ TG+ VA+K+I ++I R E LL L H
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR-EIKLLRHLRHE 59
Query: 157 HIPTALALFENAPVPGTDT-----IVMQLVHG--ESLIQHLCRQSTITESYICCIIRQLH 209
+I + L + P + IV +L+ +I+ +T+ +I + Q+
Sbjct: 60 NI---IGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKS---PQPLTDDHIQYFLYQIL 113
Query: 210 SALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVSTVVLPDLEFAS-------- 260
L LHS + H+D++P NIL+N LK+ D G ++ V PD +
Sbjct: 114 RGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFG----LARGVDPDEDEKGFLTEYVVT 169
Query: 261 -----PEMLTSPATAGPSTDMWSLGVLL------YILLSGVSP----------------- 292
PE+L S + + D+WS+G + L G
Sbjct: 170 RWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEE 229
Query: 293 -FLDESEEETRAHISVADYSFPPEQCGHIS--VP-----ARELIGQLLNTHADKRPTAGQ 344
+ E+ R ++ S P + +S P A +L+ ++L KR TA +
Sbjct: 230 DLKFITSEKARNYLK----SLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADE 285
Query: 345 LLQVAWFAE 353
L + A+
Sbjct: 286 ALAHPYLAQ 294
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 7e-16
Identities = 69/258 (26%), Positives = 111/258 (43%), Gaps = 20/258 (7%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQI--PRERQPQQITRAEYNLLSTLMHAHI 158
+Y L +G G F + + Q A+K+I P+ + +R E LL+ + H
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKH--- 57
Query: 159 PTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQ--STITESYICCIIRQLHSALHCLH 216
P +A E+ G IVM+ G L+Q + Q E I Q+ + +H
Sbjct: 58 PNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH 117
Query: 217 SQQIAHKDIRPENILM--NGAVLKLIDLGSS------VSVSTVVLPDLEFASPEMLTSPA 268
+++ H+DI+ +NI + NG V KL D GS+ + + + + PE+ +
Sbjct: 118 EKRVLHRDIKSKNIFLTQNGKV-KLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMP 176
Query: 269 TAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELI 328
S D+WSLG +LY L + PF S + + Y P H S R LI
Sbjct: 177 YNNKS-DIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPS---HYSYELRSLI 232
Query: 329 GQLLNTHADKRPTAGQLL 346
Q+ + RP+A +L
Sbjct: 233 KQMFKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 1e-15
Identities = 67/210 (31%), Positives = 102/210 (48%), Gaps = 30/210 (14%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQI---PRERQPQQITRAEYNLLSTLMHAHI 158
Y++L++LG G + TV K R + TGQLVALK+I E P R E +LL L HA+I
Sbjct: 7 YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANI 65
Query: 159 PTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHS 217
T L + T T+V + + + L Q++ ++ + + QL L H
Sbjct: 66 VT---LHDIIHTKKTLTLVFEYLDTD-LKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQ 121
Query: 218 QQIAHKDIRPENILMNGA-VLKLIDLG----SSVSVST-----VVL----PDLEFASPEM 263
+++ H+D++P+N+L++ LKL D G SV T V L PD+ S E
Sbjct: 122 RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEY 181
Query: 264 LTSPATAGPSTDMWSLGVLLYILLSGVSPF 293
T S DMW +G + Y + +G F
Sbjct: 182 ST-------SLDMWGVGCIFYEMATGRPLF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 1e-15
Identities = 79/263 (30%), Positives = 117/263 (44%), Gaps = 23/263 (8%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQ-QITRAEYNLLSTLMHAHIP 159
YE ++R+G+G + V KARD TG+LVA+K I E +I + E ++L H +I
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI- 62
Query: 160 TALALFENAPVPGTDTIVMQLVHGESL--IQHLCRQSTITESYICCIIRQLHSALHCLHS 217
+A F + IVM+ G SL I + R ++E I + R+ L LH
Sbjct: 63 --VAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHE 119
Query: 218 QQIAHKDIRPENILMN--GAVLKLIDLGSSVSVSTVVLPDLEF------ASPEMLTSPAT 269
H+DI+ NIL+ G V KL D G S ++ + F +PE+
Sbjct: 120 TGKIHRDIKGANILLTEDGDV-KLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERK 178
Query: 270 AGPST--DMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPP---EQCGHISVPA 324
G D+W+LG+ L P D RA ++ +FPP + S
Sbjct: 179 GGYDGKCDIWALGITAIELAELQPPMFD--LHPMRALFLISKSNFPPPKLKDKEKWSPVF 236
Query: 325 RELIGQLLNTHADKRPTAGQLLQ 347
+ I + L KRPTA +LLQ
Sbjct: 237 HDFIKKCLTKDPKKRPTATKLLQ 259
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-15
Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 19/212 (8%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLM-HAHIPT 160
+E +E +GNG + V K R TGQL A+K + ++ + E N+L H +I T
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77
Query: 161 ALALFENAPVPGTDT---IVMQLVHGESLIQHLCRQS---TITESYICCIIRQLHSALHC 214
F PG D +VM+ G + L + + + E +I I R++ L
Sbjct: 78 YYGAFIKKSPPGHDDQLWLVMEFC-GAGSVTDLVKNTKGNALKEDWIAYICREILRGLAH 136
Query: 215 LHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVSTVVLPDLEF------ASPEMLT-- 265
LH+ ++ H+DI+ +N+L+ A +KL+D G S + V F +PE++
Sbjct: 137 LHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACD 196
Query: 266 -SP-ATAGPSTDMWSLGVLLYILLSGVSPFLD 295
+P AT +D+WSLG+ + G P D
Sbjct: 197 ENPDATYDYRSDIWSLGITAIEMAEGAPPLCD 228
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 1e-15
Identities = 75/260 (28%), Positives = 118/260 (45%), Gaps = 21/260 (8%)
Query: 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQI--TRAEYNLLSTLMHA 156
E + +LER+G G F V K D T Q+VA+K I E +I + E +LS
Sbjct: 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 157 HIPTALALFENAPVPGTDT-IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCL 215
++ + + + GT I+M+ + G S + L R E I +++++ L L
Sbjct: 63 YVTK----YYGSYLKGTKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEILKGLDYL 117
Query: 216 HSQQIAHKDIRPENILMN--GAVLKLIDLGSSVSVSTVVLPDLEFA------SPEMLTSP 267
HS++ H+DI+ N+L++ G V KL D G + ++ + F +PE++
Sbjct: 118 HSEKKIHRDIKAANVLLSEQGDV-KLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQS 176
Query: 268 ATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAREL 327
A + D+WSLG+ L G P D I + PP G S P +E
Sbjct: 177 AYDSKA-DIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN---PPTLTGEFSKPFKEF 232
Query: 328 IGQLLNTHADKRPTAGQLLQ 347
I LN RPTA +LL+
Sbjct: 233 IDACLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 72/262 (27%), Positives = 120/262 (45%), Gaps = 47/262 (17%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPR----ERQPQQITRAEYNLLS------ 151
+E L+ +G G F V + + TGQ+ A+K + + +R R E ++L
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRW 62
Query: 152 -TLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCR-QSTITESYICCIIRQLH 209
T +H L+ +VM G L+ L + + + E + ++
Sbjct: 63 ITNLHYAFQDENNLY----------LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMV 112
Query: 210 SALHCLHSQQIAHKDIRPENILMN----------GAVLKLIDLG---SSVSVSTVVLPDL 256
A+ +H H+DI+P+N+L++ G+ L+L+ G S+V+V T PD
Sbjct: 113 LAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGT---PD- 168
Query: 257 EFASPEMLTS----PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVAD--Y 310
+ SPE+L + GP D WSLGV +Y +L G +PF ES ET I +
Sbjct: 169 -YISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHF 227
Query: 311 SFPPEQCGHISVPARELIGQLL 332
FPP+ +S A++LI +L+
Sbjct: 228 QFPPDVTD-VSEEAKDLIRRLI 248
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (187), Expect = 2e-15
Identities = 78/294 (26%), Positives = 134/294 (45%), Gaps = 55/294 (18%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTL-----MHA 156
Y+ +++LG+G F +V AR++ TG+LVA+K++ ++ + E L + ++
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE----ECMNLREVKSLRKLNE 56
Query: 157 HIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQ---STITESYICCIIRQLHSALH 213
H P + L E V + + G +L Q L + +ES I II Q+ L
Sbjct: 57 H-PNIVKLKEVFRENDELYFVFEYMEG-NLYQ-LMKDRKGKPFSESVIRSIIYQILQGLA 113
Query: 214 CLHSQQIAHKDIRPENILMNGA-VLKLIDLGSSVSVSTVVLPDLEFAS------PEMLTS 266
+H H+D++PEN+L++G V+K+ D G + + + P ++ S PE+L
Sbjct: 114 HIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRS-RPPYTDYVSTRWYRAPEILLR 172
Query: 267 PATAGPSTDMWSLGVL---LYI---LLSGVSPFLDE-----------SEEETRAHISVA- 308
+ D+W+LG + LY L G S +D+ ++++ +A
Sbjct: 173 STSYSSPVDIWALGCIMAELYTLRPLFPGSSE-IDQLYKICSVLGTPTKQDWPEGYKLAS 231
Query: 309 --DYSFPPEQCGHIS----VP-----ARELIGQLLNTHADKRPTAGQLLQVAWF 351
+ FP Q S +P A +LI +L KRPTA Q LQ +F
Sbjct: 232 KLGFRFP--QFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 3e-15
Identities = 76/271 (28%), Positives = 121/271 (44%), Gaps = 37/271 (13%)
Query: 108 LGNGRFCTVRKARDRGTGQLVALK--QIPRERQPQQITRAEYNLLSTLMHAHIPTALALF 165
LG+G F V KA+ + TG A K QI E + + E ++LS H +I + L+
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFM-VEIDILSECKHPNI---VGLY 68
Query: 166 ENAPVPGTDTIVMQLVHG---ESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAH 222
E I+++ G +S++ L R +TE I + RQ+ AL+ LHS ++ H
Sbjct: 69 EAYFYENKLWILIEFCDGGALDSIMLELER--GLTEPQIRYVCRQMLEALNFLHSHKVIH 126
Query: 223 KDIRPENILM--NGAVLKLIDLGSSVSVSTVVLPDLE----------FASPE-MLTSPAT 269
+D++ NIL+ +G V KL D G VS L+ + +PE +
Sbjct: 127 RDLKAGNILLTLDGDV-KLADFG----VSAKNKSTLQKRDTFIGTPYWMAPEVVACETFK 181
Query: 270 AGP---STDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPP--EQCGHISVPA 324
P D+WSLG+ L L P + + R + + S PP +Q S
Sbjct: 182 DNPYDYKADIWSLGITLIELAQMEPPHHELN--PMRVLLKILK-SEPPTLDQPSKWSSSF 238
Query: 325 RELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355
+ + L D RPTA +LL+ + ++ S
Sbjct: 239 NDFLKSCLVKDPDDRPTAAELLKHPFVSDQS 269
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 4e-15
Identities = 71/233 (30%), Positives = 103/233 (44%), Gaps = 21/233 (9%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALK----QIPRERQPQQITRAEYNLLSTLMHA 156
+YE + +G G + TV KARD +G VALK Q + P R E LL L
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVR-EVALLKRLEAF 59
Query: 157 HIPTALALFENAPVPGTD-----TIVMQLVHGESLIQHLCRQST--ITESYICCIIRQLH 209
P + L + TD T+V + V + L +L + + I ++RQ
Sbjct: 60 DHPNIVRLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFL 118
Query: 210 SALHCLHSQQIAHKDIRPENILM-NGAVLKLIDLGSSVSVS-----TVVLPDLEFASPEM 263
L LH+ I H+D++PENIL+ +G +KL D G + S T V+ L + +PE+
Sbjct: 119 RGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEV 178
Query: 264 LTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQ 316
L A P DMWS+G + + F SE + I PPE
Sbjct: 179 LLQSTYATP-VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI-FDLIGLPPED 229
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 4e-15
Identities = 59/223 (26%), Positives = 100/223 (44%), Gaps = 20/223 (8%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQI---TRAEYNLLSTLMHA-H 157
YE+LE++G G + V KARD+ TG+LVALK+ E + I E +LL L + +
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIY 62
Query: 158 IPTALALF---ENAPVPGTDTIVMQLVHGE--SLIQHLCRQST--ITESYICCIIRQLHS 210
I L + E P +V + + + + R + I + QL
Sbjct: 63 IVRLLDVEHVEEKNGKPSL-YLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLK 121
Query: 211 ALHCLHSQQIAHKDIRPENILMN--GAVLKLIDLGSSVSVSTVV------LPDLEFASPE 262
+ H + H+D++P+N+L++ +LK+ DLG + S V + L + +PE
Sbjct: 122 GVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPE 181
Query: 263 MLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHI 305
+L D+WS+G + + F +SE + HI
Sbjct: 182 VLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHI 224
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 4e-15
Identities = 64/270 (23%), Positives = 105/270 (38%), Gaps = 44/270 (16%)
Query: 105 LERLGNGRFCTVRKAR----DRGTGQLVALKQIPRERQPQQIT--RAEYNLLSTLMHAHI 158
++LG G F V K G VA+K + + QQI E ++ L H +I
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 159 PTALALF----ENAPVPGTDTIVMQLVHGESLIQHL--CRQSTITESYICCIIRQLHSAL 212
+ L E P+ IVM+ + G L+ +L R ++ S + Q+ +
Sbjct: 64 ---VKLLGVCTEEEPL----MIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGM 116
Query: 213 HCLHSQQIAHKDIRPENILMN-GAVLKLIDLG-----SSVSVSTVVLPDLEFA--SPEML 264
L S+ H+D+ N L+ V+K+ D G V L +PE L
Sbjct: 117 EYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESL 176
Query: 265 T----SPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGH 319
+ +D+WS GVLL+ + + G P+ S E ++ P C
Sbjct: 177 KEGKFTSK-----SDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNC-- 229
Query: 320 ISVPA--RELIGQLLNTHADKRPTAGQLLQ 347
P +L+ Q + RPT +L++
Sbjct: 230 ---PPELYKLMLQCWAEDPEDRPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 6e-15
Identities = 70/251 (27%), Positives = 115/251 (45%), Gaps = 25/251 (9%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPR----ERQPQQITRAEYNLLSTLMHAH 157
+E L+ +G G F V + + ++ A+K + + +R R E ++L +
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 158 IPTALALFENAPVPGTDTIVMQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLH 216
I T F++ +VM G L+ L + + + E + ++ A+ +H
Sbjct: 63 ITTLHYAFQD---ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH 119
Query: 217 SQQIAHKDIRPENILMN----------GAVLKLIDLGSSVSVSTVVLPDLEFASPEMLTS 266
H+DI+P+NILM+ G+ LKL++ G+ S V PD + SPE+L +
Sbjct: 120 QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPD--YISPEILQA 177
Query: 267 ----PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFP-PEQCGHIS 321
GP D WSLGV +Y +L G +PF ES ET I F P Q +S
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVS 237
Query: 322 VPARELIGQLL 332
A++LI +L+
Sbjct: 238 EDAKDLIRRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 7e-15
Identities = 79/345 (22%), Positives = 141/345 (40%), Gaps = 64/345 (18%)
Query: 89 FETRWQQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYN 148
+T W+ RY+ L +G+G + V A D TG+ VA+K++ R Q + Y
Sbjct: 7 NKTVWE---VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR 63
Query: 149 LLSTLMHAHIPTALALFENAPVPGTDT-------IVMQLVHGESLIQHLCRQSTITESYI 201
L L H + L + P + +V L+ G L ++ + +++ +I
Sbjct: 64 ELRLLKHMDHENVIGLL-DVFTPASSLEDFQDVYLVTHLM-GADL-NNIVKCQKLSDDHI 120
Query: 202 CCIIRQLHSALHCLHSQQIAHKDIRPENILMNGAV-LKLIDLGSSVSVS---TVVLPDLE 257
++ Q+ L +HS I H+D++P NI +N LK++D G + T +
Sbjct: 121 QFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATRW 180
Query: 258 FASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPF-----LDE---------------- 296
+ +PE++ + + D+WS+G ++ LL+G + F +D+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL 240
Query: 297 ---SEEETRAHISVADYSFPPEQ--------CGHISVPARELIGQLLNTHADKRPTAGQL 345
S E R +I S P G + A +L+ ++L DKR TA +
Sbjct: 241 QKISSESARNYIQ----SLPQMPKKDFKEVFSGA-NPLAIDLLEKMLVLDPDKRITAAEA 295
Query: 346 LQVAWFA-------EASCSEFD---TERLLPFSARRKQKFKEIQD 380
L + A E +D R L ++ +KEI +
Sbjct: 296 LAHPYLAEYHDPEDEPVAPPYDQSFESRDLTVDEWKELVYKEIMN 340
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 7e-15
Identities = 72/285 (25%), Positives = 122/285 (42%), Gaps = 28/285 (9%)
Query: 103 EELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNL----LSTLMHAHI 158
E L+ LG G + +V K R TG +A+K+I E + +++N L L A
Sbjct: 4 EVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-----LDESKFNQIIMELDILHKAVS 58
Query: 159 PTALALFENAPVPGTDTIVMQLVHG---ESLIQHLCRQSTITESYICCIIRQLHSALHCL 215
P + + + G + M+ + + L I E + I + L L
Sbjct: 59 PYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118
Query: 216 HSQ-QIAHKDIRPENILMNG-AVLKLIDLGSS----VSVSTVVLPDLEFASPEMLTS--- 266
+ I H+D++P N+L+NG +KL D G S S++ + + +PE + S
Sbjct: 119 KEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGP 178
Query: 267 --PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPA 324
T +D+WSLG+ + + G P+ E+ A +S PP S A
Sbjct: 179 NQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDA 238
Query: 325 RELIGQLLNTHADKRPTAGQLLQVAWF-----AEASCSEFDTERL 364
++ + + LN ++RPT QLL+ W A+ +E+ T L
Sbjct: 239 QDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNADVDMAEWVTGAL 283
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-14
Identities = 67/229 (29%), Positives = 109/229 (47%), Gaps = 17/229 (7%)
Query: 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQI---TRAEYNLLSTLMHA 156
+++E L +G G + V K R + T ++VA+K+ + +++ T E +L TL
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 157 HIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQST-ITESYICCIIRQLHSALHCL 215
+I + L E G +V + V +++++ L + + I QL A+H
Sbjct: 61 NI---VELKEAFRRRGKLYLVFEYVE-KNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWC 116
Query: 216 HSQQIAHKDIRPENILMNGA-VLKLIDLGSSVSVS-------TVVLPDLEFASPEMLTSP 267
H I H+DI+PEN+L++ VLKL D G + ++S T + + SPE+L
Sbjct: 117 HKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLG- 175
Query: 268 ATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQ 316
A G + DMWS+G +L L G F ESE + I P EQ
Sbjct: 176 APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQ 224
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 1e-14
Identities = 71/255 (27%), Positives = 113/255 (44%), Gaps = 27/255 (10%)
Query: 105 LERLGNGRFCTV---RKARDRGTGQLVALKQIP------RERQPQQITRAEYNLLSTLMH 155
L+ LG G F V RK GQL A+K + R+R T+ E ++L+ + H
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVR---TKMERDILAEVNH 57
Query: 156 AHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCL 215
I F+ G +++ + G L L ++ TE + + +L AL L
Sbjct: 58 PFIVKLHYAFQT---EGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 114
Query: 216 HSQQIAHKDIRPENILMNGA-VLKLIDLGSS------VSVSTVVLPDLEFASPEMLTSPA 268
HS I ++D++PENIL++ +KL D G S + +E+ +PE++
Sbjct: 115 HSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRG 174
Query: 269 TAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELI 328
S D WS GVL++ +L+G PF + +ET I A P +S A+ L+
Sbjct: 175 HT-QSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQ----FLSPEAQSLL 229
Query: 329 GQLLNTHADKRPTAG 343
L + R AG
Sbjct: 230 RALFKRNPANRLGAG 244
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-14
Identities = 76/294 (25%), Positives = 136/294 (46%), Gaps = 55/294 (18%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQI---PRERQPQQITRAEYNLLSTLMHAHI 158
+++LE+LG G + TV K R+R TG++VALK+I E P R E +L+ L H +I
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR-EISLMKELKHENI 60
Query: 159 PTALALFENAPVPGTDTIVMQLVHGESLIQHLCR-------QSTITESYICCIIRQLHSA 211
+ L + V T+ +M LV E + + L + + + + + QL
Sbjct: 61 ---VRLHD---VIHTENKLM-LVF-EYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKG 112
Query: 212 LHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSS----VSVST----VVLPDLEFASPE 262
+ H ++ H+D++P+N+L+N LKL D G + + V+T VV L + +P+
Sbjct: 113 IAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAPD 170
Query: 263 MLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHI-----SVADYSFP---- 313
+L T S D+WS+G ++ +++G F + E+ I + + ++P
Sbjct: 171 VLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ 230
Query: 314 -PE------QCGHISVP---------ARELIGQLLNTHADKRPTAGQLLQVAWF 351
PE + + +L+ +LL + + R +A LQ WF
Sbjct: 231 LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 2e-14
Identities = 63/203 (31%), Positives = 100/203 (49%), Gaps = 16/203 (7%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQI---PRERQPQQITRAEYNLLSTLMHAHI 158
YE+LE+LG G + TV K + + G+LVALK I E P R E +LL L HA+I
Sbjct: 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANI 65
Query: 159 PTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHS 217
+ L + T T+V + VH + L Q++ + + + + QL L +H
Sbjct: 66 ---VLLHDIIHTKETLTLVFEYVHTD-LCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ 121
Query: 218 QQIAHKDIRPENILM-NGAVLKLIDLG----SSVSVSTVV--LPDLEFASPEMLTSPATA 270
+ I H+D++P+N+L+ + LKL D G SV T + L + P++L
Sbjct: 122 RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEY 181
Query: 271 GPSTDMWSLGVLLYILLSGVSPF 293
DMW +G + ++ GV+ F
Sbjct: 182 STCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 2e-14
Identities = 85/296 (28%), Positives = 134/296 (45%), Gaps = 59/296 (19%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQI----PRERQPQQITRAEYNLLSTLMHAH 157
++++E++G G + V KAR++ TG++VALK+I E P R E +LL L H +
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 60
Query: 158 IPTALALFENAPVPGTDTIVMQLVHGESLIQHL------CRQSTITESYICCIIRQLHSA 211
I L + + LV E L Q L S I I + QL
Sbjct: 61 IVKLLDVIHTEN-------KLYLVF-EFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQG 112
Query: 212 LHCLHSQQIAHKDIRPENILMN--GAVLKLIDLGSS----VSVST----VVLPDLEFASP 261
L HS ++ H+D++P+N+L+N GA+ KL D G + V V T VV L + +P
Sbjct: 113 LAFCHSHRVLHRDLKPQNLLINTEGAI-KLADFGLARAFGVPVRTYTHEVV--TLWYRAP 169
Query: 262 EMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHI---------------- 305
E+L + D+WSLG + +++ + F +SE + I
Sbjct: 170 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 229
Query: 306 SVADY--SFP---PEQCGHISVP-----ARELIGQLLNTHADKRPTAGQLLQVAWF 351
S+ DY SFP + + VP R+L+ Q+L+ +KR +A L +F
Sbjct: 230 SLPDYKPSFPKWARQDFSKV-VPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 2e-14
Identities = 61/269 (22%), Positives = 106/269 (39%), Gaps = 43/269 (15%)
Query: 105 LERLGNGRFCTVRKAR----DRGTGQLVALKQIPRERQPQQIT--RAEYNLLSTLMHAHI 158
++LG G F V K + VA+K + + QQI E ++ L H ++
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 159 PTALALF----ENAPVPGTDTIVMQLVHGESLIQHL-CRQSTITESYICCIIRQLHSALH 213
+ L E P+ IVM+ + G L+ +L + ++ S + Q+ +
Sbjct: 64 ---VKLLGVCTEEEPL----YIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGME 116
Query: 214 CLHSQQIAHKDIRPENILM-NGAVLKLIDLGSSVSVSTVVLPDLEFA-------SPEMLT 265
L S+ H+D+ N L+ V+K+ D G S + +PE L
Sbjct: 117 YLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLK 176
Query: 266 ----SPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHI 320
+ +D+WS GVLL+ + + G P+ S EE ++ P C
Sbjct: 177 EGKFTSK-----SDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNC--- 228
Query: 321 SVPA--RELIGQLLNTHADKRPTAGQLLQ 347
P +L+ Q + RPT +L++
Sbjct: 229 --PPELYDLMLQCWAEDPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 3e-14
Identities = 67/226 (29%), Positives = 107/226 (47%), Gaps = 17/226 (7%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRA--EYNLLSTLMHAHIP 159
Y +L++LG G + TV K R + T LVALK+I E + A E +LL L HA+I
Sbjct: 8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 67
Query: 160 TALALFENAPVPGTDTIVMQLVHGESLIQHL--CRQSTITESYICCIIRQLHSALHCLHS 217
T L + + T+V + + + L Q+L C S I + + QL L+ H
Sbjct: 68 T---LHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNS-INMHNVKLFLFQLLRGLNYCHR 122
Query: 218 QQIAHKDIRPENILMNG-AVLKLIDLG--SSVSVSTVVLPD----LEFASPEMLTSPATA 270
+++ H+D++P+N+L+N LKL D G + S+ T + L + P++L
Sbjct: 123 RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDY 182
Query: 271 GPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQ 316
DMW +G + Y + +G P S E + H P E+
Sbjct: 183 STQIDMWGVGCIFYEMSTG-RPLFPGSTVEEQLHFIFRILGTPTEE 227
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 3e-14
Identities = 69/277 (24%), Positives = 121/277 (43%), Gaps = 28/277 (10%)
Query: 108 LGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLSTLMHAHIPTALA 163
LG G F V R++ TG+ A+K + +E + T E +L H +
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 164 LFENAPVPGTDTI--VMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIA 221
F+ D + VM+ +G L HL R+ TE ++ SAL LHS+ +
Sbjct: 63 AFQT-----HDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV 117
Query: 222 HKDIRPENILM-NGAVLKLIDLG------SSVSVSTVVLPDLEFASPEMLTSPATAGPST 274
++DI+ EN+++ +K+ D G S + E+ +PE+L G +
Sbjct: 118 YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-NDYGRAV 176
Query: 275 DMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNT 334
D W LGV++Y ++ G PF ++ E I + + FP +S A+ L+ LL
Sbjct: 177 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----LSPEAKSLLAGLLKK 232
Query: 335 HADKRPTAG-----QLLQVAWFAEASCSEFDTERLLP 366
+R G ++++ +F + + ++LLP
Sbjct: 233 DPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLP 269
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 4e-14
Identities = 79/286 (27%), Positives = 129/286 (45%), Gaps = 40/286 (13%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRA--EYNLLSTLMHAHIP 159
Y +LE+LG G + TV K R + T LVALK+I E + A E +LL L HA+I
Sbjct: 8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 67
Query: 160 TALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESY-ICCIIRQLHSALHCLHSQ 218
T L + + T+V + + + L Q++ I + + + Q+ L H +
Sbjct: 68 T---LHDIVHTDKSLTLVFEYLD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR 123
Query: 219 QIAHKDIRPENILMN-GAVLKLIDLG--SSVSVSTVVLPD----LEFASPEMLTSPATAG 271
++ H+D++P+N+L+N LKL D G + SV T + L + P++L +
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYS 183
Query: 272 PSTDMWSLGVLLYILLSGVSPF---------------LDESEEETRAHISVAD----YSF 312
DMW +G + + + SG F L EET IS D Y+F
Sbjct: 184 TQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNF 243
Query: 313 P---PE----QCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWF 351
P P+ + EL+ + L + KR +A + ++ A+F
Sbjct: 244 PKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 6e-14
Identities = 75/251 (29%), Positives = 112/251 (44%), Gaps = 26/251 (10%)
Query: 108 LGNGRFCTVRKARDRGTGQLVALK----QIPRERQPQQITRAEYN-LLSTLMHAHIPTAL 162
+G G F V A+ + G+ A+K + +++ Q+ AE N LL + H P +
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKH---PFLV 59
Query: 163 ALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAH 222
L + V+ V+G L HL R+ + E ++ SAL LHS I +
Sbjct: 60 GLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIY 119
Query: 223 KDIRPENILMN--GAVLKLIDLG-------SSVSVSTVV-LPDLEFASPEMLTSPATAGP 272
+D++PENIL++ G V+ L D G S + ST P E+ +PE+L
Sbjct: 120 RDLKPENILLDSQGHVV-LTDFGLCKEGIEHSKTTSTFCGTP--EYLAPEVLRK-QPYDR 175
Query: 273 STDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLL 332
+ D W LG +LY +L G+ PF E +I P +ISV AR L+ LL
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKP----NISVSARHLLEGLL 231
Query: 333 NTHADKRPTAG 343
KR A
Sbjct: 232 QKDRTKRLGAK 242
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 63/250 (25%), Positives = 109/250 (43%), Gaps = 23/250 (9%)
Query: 108 LGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLSTLMHAHIPTALA 163
LG G F V R++ TG+ A+K + +E + T E +L H +
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62
Query: 164 LFENAPVPGTDTI--VMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIA 221
F+ D + VM+ +G L HL R+ +E ++ SAL LHS +
Sbjct: 63 SFQT-----HDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVV 117
Query: 222 HKDIRPENILMN-GAVLKLIDLG------SSVSVSTVVLPDLEFASPEMLTSPATAGPST 274
++D++ EN++++ +K+ D G S + E+ +PE+L G +
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-NDYGRAV 176
Query: 275 DMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNT 334
D W LGV++Y ++ G PF ++ E+ I + + FP +S A+ L+ LL
Sbjct: 177 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT----LSPEAKSLLAGLLKK 232
Query: 335 HADKRPTAGQ 344
+R G
Sbjct: 233 DPKQRLGGGP 242
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-13
Identities = 77/272 (28%), Positives = 120/272 (44%), Gaps = 28/272 (10%)
Query: 92 RWQQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER-QPQQITRAEYNLL 150
R QE FE ++R+G+G + V KAR+ TG+L A+K I E + + + E ++
Sbjct: 5 RNPQEDFEL----IQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMM 60
Query: 151 STLMHAHIPTALALFENAPVPGTDTIVMQLVHGESL--IQHLCRQSTITESYICCIIRQL 208
H++I +A F + I M+ G SL I H+ ++ES I + R+
Sbjct: 61 KDCKHSNI---VAYFGSYLRRDKLWICMEFCGGGSLQDIYHV--TGPLSESQIAYVSRET 115
Query: 209 HSALHCLHSQQIAHKDIRPENILM--NGAVLKLIDLGSSVSVSTVVLPDLEFASPEMLTS 266
L+ LHS+ H+DI+ NIL+ NG V KL D G S ++ + F +
Sbjct: 116 LQGLYYLHSKGKMHRDIKGANILLTDNGHV-KLADFGVSAQITATIAKRKSFIGTPYWMA 174
Query: 267 PATAGPS--------TDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSF-PPEQC 317
P A D+W++G+ L P D RA + +F PP+
Sbjct: 175 PEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFD--LHPMRALFLMTKSNFQPPKLK 232
Query: 318 GHI--SVPARELIGQLLNTHADKRPTAGQLLQ 347
+ S + L + KRPTA +LLQ
Sbjct: 233 DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-13
Identities = 62/202 (30%), Positives = 97/202 (48%), Gaps = 21/202 (10%)
Query: 100 HRYEELERLGNGRFCTVRKARD-RGTGQLVALK----QIPRERQPQQITRAEYNLLSTLM 154
+YE + +G G + V KARD + G+ VALK Q E P R E +L L
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLE 59
Query: 155 HAHIPTALALFENAPVPGTD-----TIVMQLVHGESLIQHLCR--QSTITESYICCIIRQ 207
P + LF+ V TD T+V + V + L +L + + + I ++ Q
Sbjct: 60 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQ 118
Query: 208 LHSALHCLHSQQIAHKDIRPENILM-NGAVLKLIDLG-----SSVSVSTVVLPDLEFASP 261
L L LHS ++ H+D++P+NIL+ + +KL D G S T V+ L + +P
Sbjct: 119 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 178
Query: 262 EMLTSPATAGPSTDMWSLGVLL 283
E+L + A P D+WS+G +
Sbjct: 179 EVLLQSSYATP-VDLWSVGCIF 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-13
Identities = 62/202 (30%), Positives = 98/202 (48%), Gaps = 14/202 (6%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRA--EYNLLSTLMHAHIP 159
Y +L++LG G + TV K R + T LVALK+I E + A E +LL L HA+I
Sbjct: 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIV 66
Query: 160 TALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESY-ICCIIRQLHSALHCLHSQ 218
T L + T+V + + + L Q+L + + + + QL L H +
Sbjct: 67 T---LHDIIHTERCLTLVFEYLDSD-LKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR 122
Query: 219 QIAHKDIRPENILMNG-AVLKLIDLG--SSVSVSTVVLPD----LEFASPEMLTSPATAG 271
+I H+D++P+N+L+N LKL D G + SV T + L + P++L
Sbjct: 123 KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYS 182
Query: 272 PSTDMWSLGVLLYILLSGVSPF 293
DMW +G +LY + +G F
Sbjct: 183 TPIDMWGVGCILYEMATGRPMF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 74/288 (25%), Positives = 124/288 (43%), Gaps = 53/288 (18%)
Query: 108 LGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLS--------TLMH 155
LG G F V A +GT Q A+K + ++ + T E +LS T ++
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 156 AHIPTALALFENAPVPGTDTIVMQLVHGESLIQHL--CRQ-----STITESYICCIIRQL 208
T LF VM+ ++G L+ H+ C + +T + I C
Sbjct: 63 CTFQTKENLF----------FVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIIC----- 107
Query: 209 HSALHCLHSQQIAHKDIRPENILMN-GAVLKLID--------LGSSVSVSTVVLPDLEFA 259
L LHS+ I ++D++ +NIL++ +K+ D LG + + + PD +
Sbjct: 108 --GLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPD--YI 163
Query: 260 SPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGH 319
+PE+L S D WS GVLLY +L G SPF EEE I + + +P
Sbjct: 164 APEILLG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPR----W 218
Query: 320 ISVPARELIGQLLNTHADKR-PTAGQLLQVAWFAEASCSEFDTERLLP 366
++ A++++ +L ++R G + Q +F E S + + P
Sbjct: 219 LTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDWSALEEREIEP 266
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 3e-13
Identities = 70/297 (23%), Positives = 121/297 (40%), Gaps = 58/297 (19%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQI---PRERQPQQITRAEYNLLSTLMHAH 157
+YE L +G G + V K + + TGQ+VA+K+ ++ ++I E +L L H +
Sbjct: 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHEN 61
Query: 158 IPTALALFENAPVPGTDTIVMQLVHGESL--IQHLCR--QSTITESYICCIIRQLHSALH 213
+ + +F +V + V L ++ + Y+ I+R +
Sbjct: 62 LVNLIEVFRRKK---RLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILR----GIE 114
Query: 214 CLHSQQIAHKDIRPENILMN-GAVLKLIDLG------SSVSVSTVVLPDLEFASPEMLTS 266
HS I H+DI+PENIL++ V+KL D G + V T + + +PE+L
Sbjct: 115 FCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVG 174
Query: 267 PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISV------------------- 307
G + D+W++G L+ +L+G F +S+ + HI
Sbjct: 175 DTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF 234
Query: 308 -------------ADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWF 351
+ FP +S +L Q L D RP++ QLL +F
Sbjct: 235 AGMRLPEVKEIEPLEKRFP-----KLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 4e-13
Identities = 70/294 (23%), Positives = 124/294 (42%), Gaps = 64/294 (21%)
Query: 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPR----ERQPQQITRAEYNLLSTLMH 155
+E ++ +G G F VR + + TG + A+K++ + E++ RAE ++L+
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILA---E 57
Query: 156 AHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCL 215
A P + L+ + ++M+ + G ++ L ++ T TE I + A+ +
Sbjct: 58 ADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSI 117
Query: 216 HSQQIAHKDIRPENILM--NGAVLKLIDLGSSVSV------------------------- 248
H H+DI+P+N+L+ G + KL D G +
Sbjct: 118 HKLGYIHRDIKPDNLLLDAKGHI-KLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFIS 176
Query: 249 ---------------------STVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILL 287
STV PD + +PE+ D WSLGV++Y +L
Sbjct: 177 KPMSSKRKAETWKRNRRALAYSTVGTPD--YIAPEVFL-QTGYNKECDWWSLGVIMYEML 233
Query: 288 SGVSPFLDESEEET-RAHISVADY-SFPPEQCGHISVPARELIGQLLNTHADKR 339
G PF ++ +ET R I+ + FP E +S A++LI +L A++R
Sbjct: 234 VGYPPFCSDNPQETYRKIINWKETLQFPDEV--PLSPEAKDLIKRLC-CEAERR 284
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 4e-13
Identities = 64/258 (24%), Positives = 129/258 (50%), Gaps = 18/258 (6%)
Query: 107 RLGNGRFCTVRKARDRGTGQLVALKQIP-RERQPQQITRAEYNLLSTLMHAHIPTALALF 165
++G G V A + +G+LVA+K++ R++Q +++ E ++ H ++ + ++
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV---VEMY 83
Query: 166 ENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDI 225
+ V +VM+ + G +L + + + E I + + AL LH+Q + H+DI
Sbjct: 84 NSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDI 142
Query: 226 RPENILM-NGAVLKLIDLGSSVSVSTVV------LPDLEFASPEMLTSPATAGPSTDMWS 278
+ ++IL+ + +KL D G VS V + + +PE++ S GP D+WS
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELI-SRLPYGPEVDIWS 201
Query: 279 LGVLLYILLSGVSPFLDESEEETRAHISVADYSFPP--EQCGHISVPARELIGQLLNTHA 336
LG+++ ++ G P+ +E +A + D + PP + +S + + +LL
Sbjct: 202 LGIMVIEMVDGEPPYFNEP--PLKAMKMIRD-NLPPKLKNLHKVSPSLKGFLDRLLVRDP 258
Query: 337 DKRPTAGQLLQVAWFAEA 354
+R TA +LL+ + A+A
Sbjct: 259 AQRATAAELLKHPFLAKA 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 4e-13
Identities = 57/198 (28%), Positives = 94/198 (47%), Gaps = 16/198 (8%)
Query: 108 LGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLSTLMHAHIPTALA 163
+G G F V A+ + G+ A+K + ++ R+ Q+ AE N+L L + P +
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVL--LKNVKHPFLVG 60
Query: 164 LFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHK 223
L + V+ V+G L HL R+ + E ++ SAL LHS I ++
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120
Query: 224 DIRPENILMN--GAVLKLIDLG------SSVSVSTVVLPDLEFASPEMLTSPATAGPSTD 275
D++PENIL++ G V+ L D G + +T E+ +PE++ + D
Sbjct: 121 DLKPENILLDSQGHVV-LTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN-TVD 178
Query: 276 MWSLGVLLYILLSGVSPF 293
W LG +LY +L G+ PF
Sbjct: 179 WWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 5e-13
Identities = 69/257 (26%), Positives = 113/257 (43%), Gaps = 23/257 (8%)
Query: 108 LGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITR------AEYNLLSTLMHAHIPTA 161
LG G F V D TG+ +A+KQ+P + Q+ ++ E LL L H I
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 162 LALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIA 221
+ P +I ++ + G S+ L +TE+ RQ+ + LHS I
Sbjct: 70 YGCLRD-PEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIV 128
Query: 222 HKDIRPENILMNGA-VLKLIDLGSSVSVSTVVLPDL---------EFASPEMLTSPATAG 271
H+DI+ NIL + A +KL D G+S + T+ + + SPE+++ G
Sbjct: 129 HRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGY-G 187
Query: 272 PSTDMWSLGVLLYILLSGVSPFLDESEEETRAHI-SVADYSFPPEQCGHISVPARELIGQ 330
D+WS+ + +L+ P+ +E E A I +A P +S R+ + Q
Sbjct: 188 RKADVWSVACTVVEMLTEKPPW---AEYEAMAAIFKIATQPTKPMLPDGVSDACRDFLKQ 244
Query: 331 LLNTHADKRPTAGQLLQ 347
+ +RPTA LL+
Sbjct: 245 IF-VEEKRRPTAEFLLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 6e-13
Identities = 69/255 (27%), Positives = 112/255 (43%), Gaps = 31/255 (12%)
Query: 108 LGNGRFCTVRKARDRGTGQLVALKQIPR----ERQPQQITRAEYNLLSTLMHAHIPTALA 163
LG G F V A + TG+L A+K + + R + E + T P +
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 164 LFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITES----YICCIIRQLHSALHCLHSQQ 219
LF VM+ G L+ H+ +E Y C++ L LH +
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVL----GLQYLHENK 121
Query: 220 IAHKDIRPENILMN--GAVLKLID-------LGSSVSVSTVV-LPDLEFASPEMLTSPAT 269
I ++D++ +N+L++ G V K+ D +G ST P EF +PE+LT +
Sbjct: 122 IVYRDLKLDNLLLDTEGFV-KIADFGLCKEGMGFGDRTSTFCGTP--EFLAPEVLTE-TS 177
Query: 270 AGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIG 329
+ D W LGVL+Y +L G SPF + EEE I + +P +S A ++
Sbjct: 178 YTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYP----RFLSREAISIMR 233
Query: 330 QLLNTHADKRPTAGQ 344
+LL + ++R +G+
Sbjct: 234 RLLRRNPERRLGSGE 248
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 9e-13
Identities = 76/303 (25%), Positives = 132/303 (43%), Gaps = 73/303 (24%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ----PQQITRAEYNLLSTLMHAH 157
Y+++E++G G + V KARD+ TG++VALK+I E + P R E +LL L H +
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR-EISLLKELNHPN 59
Query: 158 IPTALALFENAPVPGTDTIVMQLVHGES------------LIQHL--CRQSTITESYICC 203
I + L + +VH E+ L +++ + + I
Sbjct: 60 I---VRLLD-------------VVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKS 103
Query: 204 IIRQLHSALHCLHSQQIAHKDIRPENILMNGA-VLKLIDLG----SSVSVST----VVLP 254
+ QL + HS ++ H+D++P+N+L++ LKL D G V V T VV
Sbjct: 104 YLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV-- 161
Query: 255 DLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESE---------------E 299
L + +PE+L D+WS+G + +++ F +SE E
Sbjct: 162 TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDE 221
Query: 300 ETRAHIS-VADY--SFP---PEQCGHISVP-----ARELIGQLLNTHADKRPTAGQLLQV 348
+ ++ + DY +FP + + VP +L+ ++L KR +A LQ
Sbjct: 222 DVWPGVTSLPDYKPTFPKWARQDLSKV-VPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280
Query: 349 AWF 351
+F
Sbjct: 281 PYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (165), Expect = 9e-13
Identities = 65/278 (23%), Positives = 116/278 (41%), Gaps = 55/278 (19%)
Query: 106 ERLGNGRFCTVRKAR---DRGTGQLVALKQIPRERQPQQIT--RAEYNLLSTLMHAHIPT 160
++LG G F V K + G VA+K + + ++ E ++ L H ++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNV-- 58
Query: 161 ALALF----ENAPVPGTDTIVMQLVHGESLIQHL--CRQ-------STITESYICCIIRQ 207
+ L E P+ +V++ + G L+ +L R ST++ + Q
Sbjct: 59 -VRLLGVCTEEEPL----YLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQ 113
Query: 208 LHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSV---------STVVLPDLE 257
+ + L S++ H+D+ N L+ V+K+ D G S V + LP +
Sbjct: 114 IAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLP-IR 172
Query: 258 FASPEMLT----SPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSF 312
+ +PE L + + D+WS GVLL+ + + G +P+ S EE ++ Y
Sbjct: 173 WMAPESLKDGIFTSKS-----DVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR-KGYRL 226
Query: 313 P-PEQCGHISVPAR--ELIGQLLNTHADKRPTAGQLLQ 347
P PE C P EL+ + RPT +L++
Sbjct: 227 PKPEYC-----PDELYELMLSCWQLDPEDRPTFSELVE 259
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 66/267 (24%), Positives = 130/267 (48%), Gaps = 20/267 (7%)
Query: 103 EELERLGNGRFCTVRKARDRGTGQLVALKQIP-RERQPQQITRAEYNLLSTLMHAHIPTA 161
E ++G G V AR++ +G+ VA+K + R++Q +++ E ++ H ++
Sbjct: 24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNV--- 80
Query: 162 LALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIA 221
+ ++++ V ++M+ + G +L + Q+ + E I + + AL LHSQ +
Sbjct: 81 VEMYKSYLVGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVI 139
Query: 222 HKDIRPENIL--MNGAVLKLIDLGSSVSVSTVVLPDLE-------FASPEMLTSPATAGP 272
H+DI+ ++IL ++G V KL D G +S V P + + +PE++ S G
Sbjct: 140 HRDIKSDSILLTLDGRV-KLSDFGFCAQISKDV-PKRKSLVGTPYWMAPEVI-SRTPYGT 196
Query: 273 STDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPA-RELIGQL 331
D+WSLG+++ ++ G P+ S+ +A + D P + H P R+ + ++
Sbjct: 197 EVDIWSLGIMVIEMVDGEPPYF--SDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERM 254
Query: 332 LNTHADKRPTAGQLLQVAWFAEASCSE 358
L +R TA +LL + + E
Sbjct: 255 LTREPQERATAQELLDHPFLLQTGLPE 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 78/325 (24%), Positives = 127/325 (39%), Gaps = 67/325 (20%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRA--EYNLLSTLMHAHI 158
RY +L LG G V A D + VA+K+I PQ + A E ++ L H +I
Sbjct: 6 RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVL-TDPQSVKHALREIKIIRRLDHDNI 64
Query: 159 PTALALFENAPVPGTDT--------------IVMQLVHGESLIQHLCRQSTITESYICCI 204
+ ++E G+D IV + + E+ + ++ Q ++E +
Sbjct: 65 ---VKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM--ETDLANVLEQGPLSEEHARLF 119
Query: 205 IRQLHSALHCLHSQQIAHKDIRPENILMNGA--VLKLIDLGSSVSVSTVVLPDLE----- 257
+ QL L +HS + H+D++P N+ +N VLK+ D G ++ +V P
Sbjct: 120 MYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFG----LARIVDPHYSHKGYL 175
Query: 258 --------FASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESE----------- 298
+ SP +L SP + DMW+ G + +L+G F E
Sbjct: 176 SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV 235
Query: 299 ----EETRAHISVADYSFPPEQCGHISVPAREL-----------IGQLLNTHADKRPTAG 343
EE R + SF G P R+L + Q+L + R TA
Sbjct: 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAE 295
Query: 344 QLLQVAWFAEASCSEFDTERLLPFS 368
+ L + + SC + L PF
Sbjct: 296 EALMHPYMSCYSCPFDEPVSLHPFH 320
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 1e-12
Identities = 76/308 (24%), Positives = 117/308 (37%), Gaps = 62/308 (20%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQI--PRERQPQQIT--RAEYNLLSTLMHA 156
YE L +LG G F V KAR TG++VALK+I E+ IT R E +L L H
Sbjct: 9 DYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKLKH- 66
Query: 157 HIPTALALFENAPVPGTDT------IVMQLVHGES-LIQHLCRQS-TITESYICCIIRQL 208
P + L + A + + M + + L L S +TES I C + QL
Sbjct: 67 --PNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQL 124
Query: 209 HSALHCLHSQQIAHKDIRPENILM-NGAVLKLIDLG----------SSVSVSTVVLPDLE 257
++ LH I H+DI+ NIL+ N +LK+ D G +
Sbjct: 125 LEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYT 184
Query: 258 -------FASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHI----- 305
+ PE+L + D+W +G + + + P L + + H+
Sbjct: 185 NLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR-RPILQGKSDIDQLHLIFKLC 243
Query: 306 --------SVADY--------SFPP------EQCGHISVPARELIGQLLNTHADKRPTAG 343
SF E+ G + +L+ +LL+ KR TA
Sbjct: 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTAS 303
Query: 344 QLLQVAWF 351
L+ +F
Sbjct: 304 DALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 20/209 (9%)
Query: 105 LERLGNGRFCTVRKARDRGTGQLVALKQIPRE-----RQPQQITRAEYNLLSTLMHAHIP 159
L ++G G + V A+ + TG++VALK++ + + + + E ++L+T +
Sbjct: 6 LTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLT-ERDILTTTKSEWLV 64
Query: 160 TALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQ 219
L F++ + M+ V G L ++E + + ++ A+ LH
Sbjct: 65 KLLYAFQD---DEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG 121
Query: 220 IAHKDIRPENILMN--GAVLKLIDLGSSVSV-----STVVLPDLEFASPEMLTSPATAGP 272
H+D++PEN L++ G + KL D G S + S V PD + +PE+L
Sbjct: 122 YIHRDLKPENFLIDASGHI-KLTDFGLSKGIVTYANSVVGSPD--YMAPEVLRGKGY-DF 177
Query: 273 STDMWSLGVLLYILLSGVSPFLDESEEET 301
+ D WSLG +LY L G PF + ET
Sbjct: 178 TVDYWSLGCMLYEFLCGFPPFSGSTPNET 206
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 2e-12
Identities = 58/193 (30%), Positives = 99/193 (51%), Gaps = 19/193 (9%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ----PQQITRAEYNLLSTLMHAH 157
Y ++E++G G + V K R++ TGQ+VA+K+I E + P R E +LL L H +
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR-EISLLKELQHPN 60
Query: 158 IPTALALF--ENAPVPGTDTIVMQLV-HGESLIQHLCRQSTITESYICCIIRQLHSALHC 214
I + E+ + + M L + +SL + + + +SY+ I L L C
Sbjct: 61 IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQI---LQGILFC 117
Query: 215 LHSQQIAHKDIRPENILM-NGAVLKLIDLGSS------VSVSTVVLPDLEFASPEMLTSP 267
HS+++ H+D++P+N+L+ N V+KL D G + V V T + L + +PE+L
Sbjct: 118 -HSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGS 176
Query: 268 ATAGPSTDMWSLG 280
D+WS+G
Sbjct: 177 PRYSTPVDIWSIG 189
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-12
Identities = 78/309 (25%), Positives = 135/309 (43%), Gaps = 76/309 (24%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ----PQQITRAEYNLLSTLMHA 156
+YE++E++G G + V KARDR T + +ALK+I E++ P R E +LL + H
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR-EISLLKEMQHG 61
Query: 157 HIPTALALFENAPVPGTDTIVMQLVHGE------------SLIQHL------CRQSTITE 198
+I + +VH E L +H+ + + +
Sbjct: 62 NI----------------VRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIK 105
Query: 199 SYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGA--VLKLIDLGSS------VSVST 250
+Y+ I+R + +C HS ++ H+D++P+N+L++ LKL D G + V T
Sbjct: 106 TYLYQILRGI---AYC-HSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161
Query: 251 VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESE------------ 298
+ L + +PE+L D+WS+G + +++ F +SE
Sbjct: 162 HEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILG 221
Query: 299 ---EETRAHI-SVADY--SFP--PEQCGHISVPARE-----LIGQLLNTHADKRPTAGQL 345
EET + S+ DY +FP P + VP E L+ ++L KR TA
Sbjct: 222 TPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAA 281
Query: 346 LQVAWFAEA 354
L+ +F +
Sbjct: 282 LEHEYFKDL 290
|
Length = 294 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-12
Identities = 62/246 (25%), Positives = 111/246 (45%), Gaps = 20/246 (8%)
Query: 108 LGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQITRAEYNLLSTLMHAHIPTALA 163
LG G F V + + TG++ A K++ ++R + +Q+ E +L + + +LA
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILE-KVSSRFIVSLA 59
Query: 164 L-FENAPVPGTDTIVMQLVHGESLIQHLCR--QSTITESYICCIIRQLHSALHCLHSQQI 220
FE +VM L++G L H+ + E+ Q+ L LH ++I
Sbjct: 60 YAFET---KDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRI 116
Query: 221 AHKDIRPENILMN--GAVLKLIDLGSSVSVSTVVLPDLE-----FASPEMLTSPATAGPS 273
++D++PEN+L++ G V ++ DLG +V + + +PE+L S
Sbjct: 117 VYRDLKPENVLLDDHGNV-RISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDF-S 174
Query: 274 TDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLN 333
D ++LG LY +++G SPF E+ + + E S A++L LL
Sbjct: 175 VDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQ 234
Query: 334 THADKR 339
+KR
Sbjct: 235 KDPEKR 240
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 2e-12
Identities = 67/260 (25%), Positives = 115/260 (44%), Gaps = 38/260 (14%)
Query: 105 LERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQ----QITRAEYNLLS--------T 152
L LG G F V A +GT +L A+K + ++ Q + T E +L+ T
Sbjct: 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLT 64
Query: 153 LMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSAL 212
+H+ T L+ VM+ V+G L+ + + E + ++ L
Sbjct: 65 QLHSCFQTMDRLY----------FVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGL 114
Query: 213 HCLHSQQIAHKDIRPENILMNG-AVLKLIDLG-------SSVSVSTVV-LPDLEFASPEM 263
LHS+ I ++D++ +N++++ +K+ D G V+ T PD + +PE+
Sbjct: 115 FFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPD--YIAPEI 172
Query: 264 LTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVP 323
+ G S D W+ GVLLY +L+G +PF E E+E I + ++P +S
Sbjct: 173 IAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS----MSKE 227
Query: 324 ARELIGQLLNTHADKRPTAG 343
A + L+ H KR G
Sbjct: 228 AVAICKGLMTKHPGKRLGCG 247
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 3e-12
Identities = 73/264 (27%), Positives = 114/264 (43%), Gaps = 25/264 (9%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTG---QLVALKQIP-RERQPQQITRA--EYNLLSTLM 154
RY +RLG G F TV +D+ +L LK+IP E P + +A E LLS L
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 155 HAHIPTALALF-ENAPVPGTDTIVMQLVHGESLIQHL--CRQS--TITESYICCIIRQLH 209
H I A F E I+ + G L L + + T++E+ +C QL
Sbjct: 61 HPAIVKFHASFLERDAF----CIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLL 116
Query: 210 SALHCLHSQQIAHKDIRPENILMNGAVLKLIDLG------SSVSVSTVVLPDLEFASPEM 263
+H +H ++I H+D++ +NI + +LK+ D G S ++T + SPE
Sbjct: 117 LGVHYMHQRRILHRDLKAKNIFLKNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEA 176
Query: 264 LTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVP 323
L S D+WSLG +LY + F ++ I PE S
Sbjct: 177 LKHQGYDSKS-DIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPET---YSRQ 232
Query: 324 ARELIGQLLNTHADKRPTAGQLLQ 347
++ +LN RP+A ++L+
Sbjct: 233 LNSIMQSMLNKDPSLRPSAAEILR 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 77/318 (24%), Positives = 139/318 (43%), Gaps = 50/318 (15%)
Query: 73 YTFCINNEYKVLYTVPFETRWQQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQ 132
TF K ++ VP RY+ L +G+G + +V A D TG VA+K+
Sbjct: 1 PTFYRQELNKTIWEVP-----------ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKK 49
Query: 133 IPRERQP---QQITRAEYNLLSTLMHAHIPTALALFENAPV--PGTDTIVMQLVHGESLI 187
+ R Q + T E LL + H ++ L +F A D ++ + G L
Sbjct: 50 LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL- 108
Query: 188 QHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSV 246
++ + +T+ ++ +I Q+ L +HS I H+D++P N+ +N LK++D G +
Sbjct: 109 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 168
Query: 247 SVS---TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPF-----LDE-- 296
T + + +PE++ + + D+WS+G ++ LL+G + F +D+
Sbjct: 169 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 228
Query: 297 -----------------SEEETRAHISVADYSFPPEQCGHISVPAR----ELIGQLLNTH 335
S E R +I P ++ + A +L+ ++L
Sbjct: 229 LILRLVGTPGAELLKKISSESARNYIQSLTQ-MPKMNFANVFIGANPLAVDLLEKMLVLD 287
Query: 336 ADKRPTAGQLLQVAWFAE 353
+DKR TA Q L A+FA+
Sbjct: 288 SDKRITAAQALAHAYFAQ 305
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 3e-12
Identities = 75/299 (25%), Positives = 118/299 (39%), Gaps = 56/299 (18%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQI--PRERQPQQITRA-EYNLLSTLMHAHI 158
++ + ++G G + V KARD+ TG+LVALK++ E++ IT E +L L H +I
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68
Query: 159 PTALALFENAPVP-------GTDTIVMQLV-HG-----ESLIQHLCRQSTITESYICCII 205
+ + G +V + + H ES + H +E +I +
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHF------SEDHIKSFM 122
Query: 206 RQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLG-------SSVSVSTVVLPDLE 257
+QL L+ H + H+DI+ NIL+N +KL D G T + L
Sbjct: 123 KQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLW 182
Query: 258 FASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHIS-VADYSFPP-- 314
+ PE+L GP+ D+WS G +L L + F E IS + P
Sbjct: 183 YRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW 242
Query: 315 -----------------------EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAW 350
E+ I PA +L+ +L KR TA + L W
Sbjct: 243 PDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 3e-12
Identities = 67/258 (25%), Positives = 112/258 (43%), Gaps = 38/258 (14%)
Query: 108 LGNGRFCTVRKARDRGTGQLVALKQIPRERQPQ----QITRAEYNLLS--------TLMH 155
LG G F V A +GT +L A+K + ++ Q + T E +L+ T +H
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67
Query: 156 AHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCL 215
+ T L+ VM+ V+G L+ H+ + E ++ L L
Sbjct: 68 SCFQTVDRLY----------FVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFL 117
Query: 216 HSQQIAHKDIRPENILMNG-AVLKLIDLG-------SSVSVSTVV-LPDLEFASPEMLTS 266
H + I ++D++ +N++++ +K+ D G V+ T PD + +PE++
Sbjct: 118 HRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPD--YIAPEIIAY 175
Query: 267 PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARE 326
G S D W+ GVLLY +L+G PF E E+E I + S+P +S A
Sbjct: 176 -QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKS----LSKEAVS 230
Query: 327 LIGQLLNTHADKRPTAGQ 344
+ L+ H KR G
Sbjct: 231 ICKGLMTKHPSKRLGCGP 248
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 5e-12
Identities = 67/276 (24%), Positives = 122/276 (44%), Gaps = 25/276 (9%)
Query: 108 LGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLSTLMHAHIPTALA 163
LG G F V +++ TG+ A+K + +E + T E +L H P A
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH---PFLTA 59
Query: 164 LFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQ-IAH 222
L + VM+ +G L HL R+ +E ++ SAL LHS++ + +
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 119
Query: 223 KDIRPENILMN-GAVLKLIDLG------SSVSVSTVVLPDLEFASPEMLTSPATAGPSTD 275
+D++ EN++++ +K+ D G + E+ +PE+L G + D
Sbjct: 120 RDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED-NDYGRAVD 178
Query: 276 MWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNTH 335
W LGV++Y ++ G PF ++ E+ I + + FP +S A+ L+ LL
Sbjct: 179 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT----LSPEAKSLLSGLLKKD 234
Query: 336 ADKRPTAG-----QLLQVAWFAEASCSEFDTERLLP 366
+R G +++Q +FA + ++L+P
Sbjct: 235 PKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLVP 270
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 6e-12
Identities = 61/219 (27%), Positives = 101/219 (46%), Gaps = 18/219 (8%)
Query: 108 LGNGRFCTVRKARDRGTGQLVALKQIPRERQPQ----QITRAEYNLLSTLMHAHIPTALA 163
LG G F V A +GT ++ A+K + ++ Q T E +L+ + A P A
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILA--LAAKHPFLTA 60
Query: 164 LFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHK 223
L VM+ V+G L+ + R E ++ AL LH + ++
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120
Query: 224 DIRPENILMNG-AVLKLIDLG-------SSVSVSTVV-LPDLEFASPEMLTSPATAGPST 274
D++ +NIL++ KL D G + V+ +T PD + +PE+L GPS
Sbjct: 121 DLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPD--YIAPEILQE-LEYGPSV 177
Query: 275 DMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFP 313
D W+LGVL+Y +++G PF ++E++ I D +P
Sbjct: 178 DWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYP 216
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 6e-12
Identities = 66/277 (23%), Positives = 115/277 (41%), Gaps = 58/277 (20%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPR----ERQPQQITRAEYNLLSTLMHAH 157
+E L+ +G G F VR + + TG + A+K + + E++ RAE ++L A
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 158 IPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHS 217
+ F++ ++M+ + G ++ L ++ T++E I + A+ +H
Sbjct: 63 VVKMFYSFQDKR---NLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQ 119
Query: 218 QQIAHKDIRPENILMNG-AVLKLIDLG--------------------------------- 243
H+DI+P+N+L++ +KL D G
Sbjct: 120 LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSK 179
Query: 244 ----------SSVSVSTVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPF 293
++ STV PD + +PE+ D WSLGV++Y +L G PF
Sbjct: 180 RKAETWKKNRRQLAYSTVGTPD--YIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIGYPPF 236
Query: 294 LDESEEETRAHIS--VADYSFPPEQCGHISVPARELI 328
E+ +ET + FPPE IS A++LI
Sbjct: 237 CSETPQETYRKVMNWKETLVFPPEV--PISEKAKDLI 271
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 7e-12
Identities = 64/205 (31%), Positives = 95/205 (46%), Gaps = 20/205 (9%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLMHAHI 158
Y LE+LG G + TV K R GQLVALK I + + P R E +LL L HA+I
Sbjct: 7 YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR-EASLLKGLKHANI 65
Query: 159 PTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESY-ICCIIRQLHSALHCLHS 217
+ L + T T V + +H + L Q++ + Y + + QL L +H
Sbjct: 66 ---VLLHDIIHTKETLTFVFEYMHTD-LAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHG 121
Query: 218 QQIAHKDIRPENILMNG-AVLKLIDLG--------SSVSVSTVVLPDLEFASPEMLTSPA 268
Q I H+D++P+N+L++ LKL D G S S VV L + P++L
Sbjct: 122 QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGAT 179
Query: 269 TAGPSTDMWSLGVLLYILLSGVSPF 293
+ D+W G + +L G F
Sbjct: 180 DYSSALDIWGAGCIFIEMLQGQPAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 7e-12
Identities = 72/268 (26%), Positives = 115/268 (42%), Gaps = 27/268 (10%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLM-HAHIPT 160
+E +E +G G + V K ++ G L A+K + + AEYN+L +L H ++
Sbjct: 24 WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVK 83
Query: 161 ALALFENAP--VPGTDTIVMQLVHGES---LIQHLCRQST-ITESYICCIIRQLHSALHC 214
+F A V G +V++L +G S L++ L + E+ I I+ L
Sbjct: 84 FYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQH 143
Query: 215 LHSQQIAHKDIRPENILMN--GAVLKLIDLGSSVSVSTVVLPDLE------FASPEMLTS 266
LH+ +I H+D++ NIL+ G V KL+D G S +++ L + +PE++
Sbjct: 144 LHNNRIIHRDVKGNNILLTTEGGV-KLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIAC 202
Query: 267 PATAGPS----TDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISV 322
S D+WSLG+ L G P D +T I PP H
Sbjct: 203 EQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIP----RNPPPTLLHPEK 258
Query: 323 PARE---LIGQLLNTHADKRPTAGQLLQ 347
R I Q L + RP+ LL+
Sbjct: 259 WCRSFNHFISQCLIKDFEARPSVTHLLE 286
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 7e-12
Identities = 67/250 (26%), Positives = 114/250 (45%), Gaps = 27/250 (10%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLL----STLMHAH 157
YE ++ +G G F V+ R + T ++ A+K + + + I R++ + A+
Sbjct: 45 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKF---EMIKRSDSAFFWEERDIMAFAN 101
Query: 158 IPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHS 217
P + LF +VM+ + G L+ +L + E + ++ AL +HS
Sbjct: 102 SPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDAIHS 160
Query: 218 QQIAHKDIRPENILMN-GAVLKLIDLGSSVSV---------STVVLPDLEFASPEMLTSP 267
H+D++P+N+L++ LKL D G+ + + + V PD + SPE+L S
Sbjct: 161 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD--YISPEVLKSQ 218
Query: 268 ATAG---PSTDMWSLGVLLYILLSGVSPFLDESEEETRAHI--SVADYSFPPEQCGHISV 322
G D WS+GV LY +L G +PF +S T + I +FP + IS
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDN--DISK 276
Query: 323 PARELIGQLL 332
A+ LI L
Sbjct: 277 EAKNLICAFL 286
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.7 bits (162), Expect = 7e-12
Identities = 78/291 (26%), Positives = 129/291 (44%), Gaps = 54/291 (18%)
Query: 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIP----RERQPQQITRAEYNLLSTLMH 155
+ YE ++++GNGRF V + + T + K I +ER+ Q+ E N++ L H
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLV-IEVNVMRELKH 71
Query: 156 AHIPTALALFENAPVPGTDTIVMQLVHGESLIQHL--CRQ--STITESYICCIIRQLHSA 211
+I + F N I+M+ L +++ C + I E I I RQL A
Sbjct: 72 KNIVRYIDRFLNKANQKL-YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHA 130
Query: 212 LHCLHS-------QQIAHKDIRPENILM-----------------NG-AVLKLIDLG--- 243
L H+ +++ H+D++P+NI + NG + K+ D G
Sbjct: 131 LAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK 190
Query: 244 ----SSVSVSTVVLPDLEFASPEMLTSPATA-GPSTDMWSLGVLLYILLSGVSPFLDESE 298
S++ S V P + SPE+L + +DMW+LG ++Y L SG +PF
Sbjct: 191 NIGIESMAHSCVGTP--YYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF----H 244
Query: 299 EETRAHISVADYSFPPEQCGHISVPARE---LIGQLLNTHADKRPTAGQLL 346
+ +++ P+ I ++E LI LLN A +RP+A Q L
Sbjct: 245 KANNFSQLISELKRGPDL--PIKGKSKELNILIKNLLNLSAKERPSALQCL 293
|
Length = 1021 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 9e-12
Identities = 69/252 (27%), Positives = 113/252 (44%), Gaps = 30/252 (11%)
Query: 105 LERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQ----QITRAEYNLLSTLMHAHIPT 160
L LG G F V A +GT +L A+K + ++ Q + T E +L+ T
Sbjct: 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLT 64
Query: 161 AL-ALFENAPVPGTDTI--VMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHS 217
L + F+ D + VM+ V+G L+ H+ + E + ++ L LHS
Sbjct: 65 QLHSCFQT-----MDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHS 119
Query: 218 QQIAHKDIRPENILMNG-AVLKLIDLG-------SSVSVSTVV-LPDLEFASPEM-LTSP 267
+ I ++D++ +N++++ +K+ D G + T PD + +PE+ P
Sbjct: 120 KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPD--YIAPEIIAYQP 177
Query: 268 ATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAREL 327
G S D W+ GVLLY +L+G PF E E+E I + S+P +S A +
Sbjct: 178 Y--GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKS----LSKEAVSI 231
Query: 328 IGQLLNTHADKR 339
LL H KR
Sbjct: 232 CKGLLTKHPAKR 243
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 9e-12
Identities = 63/244 (25%), Positives = 102/244 (41%), Gaps = 20/244 (8%)
Query: 108 LGNGRFCTVRKARDRGTGQLVALK-----QIPRERQPQQITRAEYNLLSTLMHAHIPTAL 162
+G G F V AR + + A+K I ++++ + I LL + H P +
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKH---PFLV 59
Query: 163 ALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAH 222
L + V+ ++G L HL R+ E ++ SAL LHS I +
Sbjct: 60 GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVY 119
Query: 223 KDIRPENILMNG-AVLKLIDLG------SSVSVSTVVLPDLEFASPEMLTSPATAGPSTD 275
+D++PENIL++ + L D G ++ E+ +PE+L + D
Sbjct: 120 RDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVL-HKQPYDRTVD 178
Query: 276 MWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNTH 335
W LG +LY +L G+ PF + E +I P +I+ AR L+ LL
Sbjct: 179 WWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKP----NITNSARHLLEGLLQKD 234
Query: 336 ADKR 339
KR
Sbjct: 235 RTKR 238
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 67/277 (24%), Positives = 116/277 (41%), Gaps = 58/277 (20%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPR----ERQPQQITRAEYNLLSTLMHAH 157
+E L+ +G G F VR + + TG + A+K + + E++ RAE ++L + A
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDIL---VEAD 59
Query: 158 IPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHS 217
+ +F + ++M+ + G ++ L ++ T+TE I + A+ +H
Sbjct: 60 SLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQ 119
Query: 218 QQIAHKDIRPENILMNG-AVLKLIDLG--------------------------------- 243
H+DI+P+N+L++ +KL D G
Sbjct: 120 LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSK 179
Query: 244 ----------SSVSVSTVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPF 293
++ STV PD + +PE+ D WSLGV++Y +L G PF
Sbjct: 180 RKAETWKRNRRQLAFSTVGTPD--YIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIGYPPF 236
Query: 294 LDESEEETRAHIS--VADYSFPPEQCGHISVPARELI 328
E+ +ET + FPPE IS A++LI
Sbjct: 237 CSETPQETYKKVMNWKETLIFPPEV--PISEKAKDLI 271
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 71/264 (26%), Positives = 113/264 (42%), Gaps = 24/264 (9%)
Query: 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQ-QITRAEYNLLSTLMHAH 157
+H YE ++R+G+G + V KAR+ TG+L A+K I E + + E ++ H +
Sbjct: 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCN 67
Query: 158 IPTALALFENAPVPGTDTIVMQLVHGESL--IQHLCRQSTITESYICCIIRQLHSALHCL 215
I +A F + I M+ G SL I H+ ++E I + R+ L L
Sbjct: 68 I---VAYFGSYLSREKLWICMEYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLAYL 122
Query: 216 HSQQIAHKDIRPENILM--NGAVLKLIDLGSSVSVSTVVLPDLEFASPEMLTSPATAGPS 273
HS+ H+DI+ NIL+ NG V KL D G + ++ + F +P A
Sbjct: 123 HSKGKMHRDIKGANILLTDNGDV-KLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVE 181
Query: 274 T--------DMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCG---HISV 322
D+W++G+ L P D RA ++ +F P + S
Sbjct: 182 KNGGYNQLCDIWAVGITAIELAELQPPMFD--LHPMRALFLMSKSNFQPPKLKDKTKWSS 239
Query: 323 PARELIGQLLNTHADKRPTAGQLL 346
+ L + KRPTA +LL
Sbjct: 240 TFHNFVKISLTKNPKKRPTAERLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 63/248 (25%), Positives = 113/248 (45%), Gaps = 23/248 (9%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLL----STLMHAH 157
Y+ ++ +G G F V+ R + + ++ A+K + + + I R++ + A+
Sbjct: 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKF---EMIKRSDSAFFWEERDIMAFAN 101
Query: 158 IPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHS 217
P + LF +VM+ + G L+ +L + E + ++ AL +HS
Sbjct: 102 SPWVVQLFCAFQDDKYLYMVMEYMPGGDLV-NLMSNYDVPEKWAKFYTAEVVLALDAIHS 160
Query: 218 QQIAHKDIRPENILMNG-AVLKLIDLGSSVSV---------STVVLPDLEFASPEMLTSP 267
+ H+D++P+N+L++ LKL D G+ + + + V PD + SPE+L S
Sbjct: 161 MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPD--YISPEVLKSQ 218
Query: 268 ATA---GPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPA 324
G D WS+GV L+ +L G +PF +S T + I S + IS A
Sbjct: 219 GGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHA 278
Query: 325 RELIGQLL 332
+ LI L
Sbjct: 279 KNLICAFL 286
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (155), Expect = 2e-11
Identities = 61/272 (22%), Positives = 101/272 (37%), Gaps = 48/272 (17%)
Query: 105 LERLGNGRFCTVRKAR----DRGTGQLVALKQIPRERQPQQIT--RAEYNLLSTLMHAHI 158
++LG G F V K GT VA+K + ++ E +++ L H +I
Sbjct: 4 GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNI 63
Query: 159 PTALAL-FENAPVPGTDTIVMQLVHGESLIQHL-CRQSTITESYICCIIRQLHSALHCLH 216
L + + P+ IV + + G L+ L +T + + Q+ + L
Sbjct: 64 VRLLGVCTQGEPL----YIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 217 SQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVSTVVLPDLEFASPEMLTSPATAGP--- 272
S+ H+D+ N L+ V+K+ D G L + P
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFG---------LSRDIYEDDYYRKRGGGKLPIKW 170
Query: 273 -------------STDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFP-PEQC 317
+D+WS GVLL+ + + G P+ S EE + Y P PE C
Sbjct: 171 MAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLE-DGYRLPRPENC 229
Query: 318 GHISVPAR--ELIGQLLNTHADKRPTAGQLLQ 347
P EL+ Q + RPT +L++
Sbjct: 230 -----PDELYELMLQCWAYDPEDRPTFSELVE 256
|
Length = 258 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 62/251 (24%), Positives = 117/251 (46%), Gaps = 18/251 (7%)
Query: 107 RLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFE 166
++G G V A ++ TG+ VA+K++ + + QQ +N + + H + ++
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKM--DLRKQQRRELLFNEVVIMRDYHHENVVDMYN 86
Query: 167 NAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIR 226
+ V +VM+ + G +L + + + E I + + AL LH+Q + H+DI+
Sbjct: 87 SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIK 145
Query: 227 PENILMNG-AVLKLIDLGSSVSVSTVVLPDLE-------FASPEMLTSPATAGPSTDMWS 278
++IL+ +KL D G VS V P + + +PE++ S G D+WS
Sbjct: 146 SDSILLTSDGRIKLSDFGFCAQVSKEV-PKRKSLVGTPYWMAPEVI-SRLPYGTEVDIWS 203
Query: 279 LGVLLYILLSGVSPFLDESEEETRAHISVADYSFPP--EQCGHISVPARELIGQLLNTHA 336
LG+++ ++ G P+ +E + I + PP + +S R + +L
Sbjct: 204 LGIMVIEMIDGEPPYFNEPPLQAMRRIR---DNLPPRVKDSHKVSSVLRGFLDLMLVREP 260
Query: 337 DKRPTAGQLLQ 347
+R TA +LLQ
Sbjct: 261 SQRATAQELLQ 271
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-11
Identities = 65/262 (24%), Positives = 104/262 (39%), Gaps = 22/262 (8%)
Query: 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQI-----PRERQPQQITRAEYNLLSTL 153
E + +L +G+G F V ARD T ++VA+K++ + Q I + E L L
Sbjct: 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIK-EVRFLQQL 72
Query: 154 MHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALH 213
H + + T +VM+ G + + + E I I L
Sbjct: 73 RHPNTIEYKGCYLRE---HTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLA 129
Query: 214 CLHSQQIAHKDIRPENILM-NGAVLKLIDLGSSVSV----STVVLPDLEFASPEMLTS-- 266
LHS + H+DI+ NIL+ +KL D GS+ V S V P + +PE++ +
Sbjct: 130 YLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFVGTP--YWMAPEVILAMD 187
Query: 267 PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPE-QCGHISVPAR 325
D+WSLG+ L P + + HI+ D P S R
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND---SPTLSSNDWSDYFR 244
Query: 326 ELIGQLLNTHADKRPTAGQLLQ 347
+ L RP++ +LL+
Sbjct: 245 NFVDSCLQKIPQDRPSSEELLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-11
Identities = 78/273 (28%), Positives = 119/273 (43%), Gaps = 35/273 (12%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQ-LVALKQI----------PRERQPQ-QITRAEYNL 149
Y LE LG+G F V K R + GQ L+ALK+I RER +E +
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 150 L-STLMHAHIPTALALF-ENAPVPGTDTIVMQLVHGESLIQHLC----RQSTITESYICC 203
+ L H +I F EN + IVM L+ G L +H ++ TE I
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRL----YIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWN 117
Query: 204 IIRQLHSALHCLHSQ-QIAHKDIRPENILM-NGAVLKLIDLG-----SSVSVSTVVLPDL 256
I Q+ AL LH + +I H+D+ P NI++ + + D G S T V+ +
Sbjct: 118 IFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTI 177
Query: 257 EFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQ 316
++ PE++ + G D+W+ G +LY + + PF + I A Y PE
Sbjct: 178 LYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPE- 235
Query: 317 CGHISVPARELIGQLLNTHADKRPTAGQLLQVA 349
G S ++I L A+ RP ++QV+
Sbjct: 236 -GMYSEDVTDVITSCLTPDAEARP---DIIQVS 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 49/150 (32%), Positives = 73/150 (48%), Gaps = 13/150 (8%)
Query: 207 QLHSALHCLHSQQIAHKDIRPENI-LMNGAVLKLIDLGSSVSVSTVVLPDLE-------- 257
Q+ AL +HS+++ H+D++ NI LM ++KL D G S S V D+
Sbjct: 177 QIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPY 236
Query: 258 FASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQC 317
+ +PE+ + DMWSLGV+LY LL+ PF S+ E + Y P C
Sbjct: 237 YLAPELWERKRYS-KKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD--PFPC 293
Query: 318 GHISVPARELIGQLLNTHADKRPTAGQLLQ 347
+S + L+ LL+ + RPT QLL
Sbjct: 294 P-VSSGMKALLDPLLSKNPALRPTTQQLLH 322
|
Length = 478 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 4e-11
Identities = 51/151 (33%), Positives = 77/151 (50%), Gaps = 17/151 (11%)
Query: 207 QLHSALHCLHSQQIAHKDIRPENILM--NGAVLKLIDLGSSVSVSTVVLPDL-------- 256
Q+ A+H +HS+ + H+DI+ NIL+ NG V KL D G S + V D+
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLV-KLGDFGFSKMYAATVSDDVGRTFCGTP 209
Query: 257 EFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYS-FPPE 315
+ +PE+ + DM+SLGVLLY LL+ PF E+ EE Y PP
Sbjct: 210 YYVAPEIWRRKPYS-KKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPS 268
Query: 316 QCGHISVPARELIGQLLNTHADKRPTAGQLL 346
IS +E++ LL++ +RP++ +LL
Sbjct: 269 ----ISPEMQEIVTALLSSDPKRRPSSSKLL 295
|
Length = 496 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 5e-11
Identities = 63/258 (24%), Positives = 114/258 (44%), Gaps = 46/258 (17%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER------------QPQQITRAEYNL 149
+ + LG G F V + R TG++ A K++ ++R + Q + +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 150 LSTLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCR---------QSTITESY 200
+ +L +A+ T AL +V+ L++G L H+ ++ +
Sbjct: 62 VVSLAYAY-ETKDAL----------CLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAE 110
Query: 201 ICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSV---STVV--LP 254
ICC L LH ++I ++D++PENIL++ +++ DLG +V V T+ +
Sbjct: 111 ICC-------GLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVG 163
Query: 255 DLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPP 314
+ + +PE++ + S D W+LG LLY +++G SPF ++ R +
Sbjct: 164 TVGYMAPEVVKNERYTF-SPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQE 222
Query: 315 EQCGHISVPARELIGQLL 332
E S AR L LL
Sbjct: 223 EYSEKFSPDARSLCKMLL 240
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 7e-11
Identities = 48/195 (24%), Positives = 91/195 (46%), Gaps = 9/195 (4%)
Query: 108 LGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQITRAEYNLLSTLMHAHIPTALA 163
+G G F V R TG++ A+K + ++R Q + + E +LS + P +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 164 LFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHK 223
+ P ++ L++G L HL + +E + ++ L +H++ + ++
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYR 121
Query: 224 DIRPENILMN-GAVLKLIDLGSSVSVST----VVLPDLEFASPEMLTSPATAGPSTDMWS 278
D++P NIL++ +++ DLG + S + + +PE+L S D +S
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFS 181
Query: 279 LGVLLYILLSGVSPF 293
LG +L+ LL G SPF
Sbjct: 182 LGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 7e-11
Identities = 74/278 (26%), Positives = 114/278 (41%), Gaps = 33/278 (11%)
Query: 108 LGNGRFCTVRKARDRGTGQLVALKQIPR----ERQPQQITRAEYNLLSTLMHAHIPTALA 163
LG G F V A +GT + A+K + + E + T E +L+ L H P
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLA-LAWEH-PFLTH 60
Query: 164 LFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITES----YICCIIRQLHSALHCLHSQQ 219
LF VM+ ++G L+ H+ E+ Y II L LH +
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEII----CGLQFLHKKG 116
Query: 220 IAHKDIRPENILMN--GAVLKLIDLG--------SSVSVSTVVLPDLEFASPEMLTSPAT 269
I ++D++ +N+L++ G + K+ D G + + PD + +PE+L
Sbjct: 117 IIYRDLKLDNVLLDKDGHI-KIADFGMCKENMNGEGKASTFCGTPD--YIAPEILKGQKY 173
Query: 270 AGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIG 329
S D WS GVLLY +L G SPF E E+E I FP IS A++ +
Sbjct: 174 NE-SVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPR----WISKEAKDCLS 228
Query: 330 QLLNTHADKR-PTAGQLLQVAWFAEASCSEFDTERLLP 366
+L KR G + Q +F + + P
Sbjct: 229 KLFERDPTKRLGVDGDIRQHPFFRGIDWERLEKREIPP 266
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 8e-11
Identities = 69/303 (22%), Positives = 133/303 (43%), Gaps = 46/303 (15%)
Query: 90 ETRWQQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNL 149
+T W+ + RY+ L +G+G + +V A D Q VA+K++ R Q R Y
Sbjct: 8 KTVWEVPE---RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRE 64
Query: 150 LSTLMHAHIPTALALFENAPVPGTDT-------IVMQLVHGESLIQHLCRQSTITESYIC 202
L L H + L + P T +V L+ + + ++ + +++ ++
Sbjct: 65 LRLLKHMKHENVIGLLD-VFTPATSIENFNEVYLVTNLMGAD--LNNIVKCQKLSDEHVQ 121
Query: 203 CIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS---TVVLPDLEF 258
+I QL L +HS I H+D++P N+ +N L+++D G + T + +
Sbjct: 122 FLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATRWY 181
Query: 259 ASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPF-----LDE----------------- 296
+PE++ + + D+WS+G ++ LL G + F +D+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLK 241
Query: 297 --SEEETRAHISVADYSFPPEQCGHI---SVP-ARELIGQLLNTHADKRPTAGQLLQVAW 350
S E R +I + P + I + P A +L+ ++L +DKR +A + L +
Sbjct: 242 KISSEHARKYIQSLPH-MPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPY 300
Query: 351 FAE 353
F++
Sbjct: 301 FSQ 303
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 8e-11
Identities = 67/274 (24%), Positives = 120/274 (43%), Gaps = 33/274 (12%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE-----RQPQQITRAEYNLLSTLMHA 156
+E ++ + NG + V R + T Q A+K+I ++ Q QQ+ E ++L+ A
Sbjct: 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVF-VERDILT---FA 58
Query: 157 HIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLH 216
P +++F + +VM+ V G L + + AL LH
Sbjct: 59 ENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLH 118
Query: 217 SQQIAHKDIRPENILMNG-AVLKLIDLGSS----VSVSTV-----------------VLP 254
+ I H+D++P+N+L+ +KL D G S +S++T V
Sbjct: 119 NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCG 178
Query: 255 DLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPP 314
E+ +PE++ P D W++G++LY L G PF ++ EE + ++D P
Sbjct: 179 TPEYIAPEVILRQGYGKP-VDWWAMGIILYEFLVGCVPFFGDTPEELFGQV-ISDDIEWP 236
Query: 315 EQCGHISVPARELIGQLLNTHADKRPTAGQLLQV 348
E + A++LI +LL + +R G +V
Sbjct: 237 EGDEALPADAQDLISRLLRQNPLERLGTGGAFEV 270
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 1e-10
Identities = 58/242 (23%), Positives = 110/242 (45%), Gaps = 12/242 (4%)
Query: 108 LGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQITRAEYNLLSTLMHAHIPTALA 163
+G G F V R TG++ A+K + ++R Q + + E +LS + P +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 164 LFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHK 223
+ P + ++ L++G L HL + +E+ + ++ L +H++ + ++
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYR 121
Query: 224 DIRPENILM--NGAVLKLIDLGSSVSVST----VVLPDLEFASPEMLTSPATAGPSTDMW 277
D++P NIL+ +G V ++ DLG + S + + +PE+L S D +
Sbjct: 122 DLKPANILLDEHGHV-RISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWF 180
Query: 278 SLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHAD 337
SLG +L+ LL G SPF + + + + I + E S R L+ LL +
Sbjct: 181 SLGCMLFKLLRGHSPF-RQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVN 239
Query: 338 KR 339
+R
Sbjct: 240 RR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 1e-10
Identities = 58/258 (22%), Positives = 105/258 (40%), Gaps = 34/258 (13%)
Query: 106 ERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALAL- 164
+G G F V RG Q VA+K + + Q AE ++++TL H ++ L +
Sbjct: 12 ATIGKGEFGDVMLGDYRG--QKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVV 69
Query: 165 FENAPVPGTDTIVMQLVHGESLI--------QHLCRQSTITESYICCIIRQLHSALHCLH 216
+ P+ IV + + SL+ + + + C + L
Sbjct: 70 LQGNPL----YIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVC------EGMEYLE 119
Query: 217 SQQIAHKDIRPENILMN-GAVLKLIDLG----SSVSVSTVVLPDLEFASPEMLTSPATAG 271
+ H+D+ N+L++ V K+ D G +S + LP +++ +PE L +
Sbjct: 120 EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLP-VKWTAPEALREKKFST 178
Query: 272 PSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQC-GHISVPARELIG 329
S D+WS G+LL+ + S G P+ ++ H+ PE C + +++
Sbjct: 179 KS-DVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEV----YKVMK 233
Query: 330 QLLNTHADKRPTAGQLLQ 347
KRPT QL +
Sbjct: 234 DCWELDPAKRPTFKQLRE 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 66/265 (24%), Positives = 110/265 (41%), Gaps = 21/265 (7%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLM-HAHIPT 160
+E +E +G G + V K ++ G A+K + + AEYN+L L H ++
Sbjct: 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVK 79
Query: 161 ALALFENAPVPGTDTI--VMQLVHGESLIQ----HLCRQSTITESYICCIIRQLHSALHC 214
++ V D + V++L +G S+ L R + E I I+ + L
Sbjct: 80 FYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQH 139
Query: 215 LHSQQIAHKDIRPENILM-NGAVLKLIDLGSSVSVSTVVLPDLE------FASPEMLTSP 267
LH + H+D++ NIL+ +KL+D G S +++ L + +PE++
Sbjct: 140 LHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACE 199
Query: 268 ----ATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHI-SV 322
+T D+WSLG+ L G P D RA + P + S
Sbjct: 200 QQLDSTYDARCDVWSLGITAIELGDGDPPLAD--LHPMRALFKIPRNPPPTLHQPELWSN 257
Query: 323 PARELIGQLLNTHADKRPTAGQLLQ 347
+ I + L +KRPT LLQ
Sbjct: 258 EFNDFIRKCLTKDYEKRPTVSDLLQ 282
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 70/266 (26%), Positives = 111/266 (41%), Gaps = 32/266 (12%)
Query: 103 EELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLM-H--AHIP 159
E L +G+G V K R + TG ++A+KQ+ R ++ R +L L H +I
Sbjct: 18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIV 77
Query: 160 TALALFENAPVPGTDT-IVMQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCL-H 216
F + +D I M+L+ L + L R Q I E + + + ALH L
Sbjct: 78 KCYGYF----ITDSDVFICMELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE 132
Query: 217 SQQIAHKDIRPENILMNGA-VLKLIDLG-------SSVSVSTVVLPDLEFASPEMLTSPA 268
+ H+D++P NIL++ + +KL D G S + + +PE + P
Sbjct: 133 KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCA--AYMAPERID-PP 189
Query: 269 TAGPS----TDMWSLGVLLYILLSGVSPF-LDESEEETRAHISVADYSFPPEQCGH--IS 321
P D+WSLG+ L L +G P+ ++E E I + PP + S
Sbjct: 190 DPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE---PPSLPPNEGFS 246
Query: 322 VPARELIGQLLNTHADKRPTAGQLLQ 347
+ L KRP +LLQ
Sbjct: 247 PDFCSFVDLCLTKDHRKRPKYRELLQ 272
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 59/215 (27%), Positives = 93/215 (43%), Gaps = 22/215 (10%)
Query: 98 FEHRYEELER-LGNGRFCTVRKAR----DRGTGQLVALKQIPRERQPQQIT--RAEYNLL 150
F RY + R LG G F V + GTG++VA+K + RE Q + + E N+L
Sbjct: 1 FHKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINIL 60
Query: 151 STLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHS 210
TL H +I G ++M+ V SL +L + + + + +Q+
Sbjct: 61 KTLYHENIVKYKGCCSEQGGKGL-QLIMEYVPLGSLRDYLPKHK-LNLAQLLLFAQQICE 118
Query: 211 ALHCLHSQQIAHKDIRPENILM-NGAVLKLIDLGSSVSVSTVVL----------PDLEFA 259
+ LHSQ H+D+ N+L+ N ++K+ D G + +V P +A
Sbjct: 119 GMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 178
Query: 260 SPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFL 294
E L + S D+WS GV LY LL+
Sbjct: 179 -VECLKENKFSYAS-DVWSFGVTLYELLTHCDSKQ 211
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 28/210 (13%)
Query: 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQI-PRERQP-QQITRAEYNLLSTLMHAH 157
RY+ L +G G + V A + TG VA+K+I P E Q Q T E +L H +
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64
Query: 158 IPTALALFENAPVPGTDT-----IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSAL 212
I + + + P ++ IV +L+ E+ + L + ++ +I + Q+ L
Sbjct: 65 I---IGILDIIRPPSFESFNDVYIVQELM--ETDLYKLIKTQHLSNDHIQYFLYQILRGL 119
Query: 213 HCLHSQQIAHKDIRPENILMNGAV-LKLIDLG-----SSVSVSTVVLPDLEFA------S 260
+HS + H+D++P N+L+N LK+ D G T L E+ +
Sbjct: 120 KYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFL--TEYVATRWYRA 177
Query: 261 PE-MLTSPATAGPSTDMWSLGVLLYILLSG 289
PE ML S + D+WS+G +L +LS
Sbjct: 178 PEIMLNS-KGYTKAIDIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 68/249 (27%), Positives = 108/249 (43%), Gaps = 24/249 (9%)
Query: 108 LGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYN-LLSTLMHAHIPTAL 162
+G G F V A+ + G A+K + ++ ++ Q AE N LL L H P +
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKH---PFLV 59
Query: 163 ALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAH 222
L + V+ V+G L HL R+ E ++ SA+ LHS I +
Sbjct: 60 GLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIY 119
Query: 223 KDIRPENILMN--GAVLKLIDLG------SSVSVSTVVLPDLEFASPEMLTSPATAGPST 274
+D++PENIL++ G V+ L D G ++ E+ +PE+L +
Sbjct: 120 RDLKPENILLDSQGHVV-LTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPY-DRTV 177
Query: 275 DMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNT 334
D W LG +LY +L G+ PF + +I P + +V A +L+ LL
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGK----TVAACDLLVGLL-- 231
Query: 335 HADKRPTAG 343
H D+R G
Sbjct: 232 HKDQRRRLG 240
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-10
Identities = 67/259 (25%), Positives = 110/259 (42%), Gaps = 27/259 (10%)
Query: 106 ERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRA---EYNLLSTLMHAHIPTAL 162
E++G G F V K +G VA+K R P + R E +L H +I +
Sbjct: 1 EKIGKGNFGDVYKGVLKGNT-EVAVKTC-RSTLPPDLKRKFLQEAEILKQYDHPNIVKLI 58
Query: 163 AL-FENAPVPGTDTIVMQLVHGESLIQHLCRQST-ITESYICCIIRQLHSALHCLHSQQI 220
+ + P+ IVM+LV G SL+ L ++ +T + + + + L S+
Sbjct: 59 GVCVQKQPI----YIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNC 114
Query: 221 AHKDIRPENILMN-GAVLKLIDLGSS---------VSVSTVVLPDLEFASPEMLTSPATA 270
H+D+ N L+ VLK+ D G S VS +P +++ +PE L
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIP-IKWTAPEALNYGRYT 173
Query: 271 GPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIG 329
S D+WS G+LL+ S G +P+ S ++TR I + Y P Q L+
Sbjct: 174 SES-DVWSYGILLWETFSLGDTPYPGMSNQQTRERIE-SGYRMPAPQ--LCPEEIYRLML 229
Query: 330 QLLNTHADKRPTAGQLLQV 348
Q + RP+ ++
Sbjct: 230 QCWAYDPENRPSFSEIYNE 248
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-10
Identities = 71/274 (25%), Positives = 117/274 (42%), Gaps = 41/274 (14%)
Query: 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQ-QITRAEYNLLSTLMHAH 157
E +E + LG+G F V KA+++ TG L A K I + + + + E ++L++ H +
Sbjct: 4 EEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 63
Query: 158 IPTALALF----------ENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQ 207
I L F E D ++++L + +TE I + +Q
Sbjct: 64 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL------------ERPLTEPQIRVVCKQ 111
Query: 208 LHSALHCLHSQQIAHKDIRPENIL--MNGAVLKLIDLGSSVSVSTVVLPDLEFASPEMLT 265
AL+ LH +I H+D++ NIL ++G + KL D G S + + F
Sbjct: 112 TLEALNYLHENKIIHRDLKAGNILFTLDGDI-KLADFGVSAKNTRTIQRRDSFIGTPYWM 170
Query: 266 SPATAGPST----------DMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPP- 314
+P T D+WSLG+ L I ++ + P E R + +A S PP
Sbjct: 171 APEVVMCETSKDRPYDYKADVWSLGITL-IEMAQIEPPHHEL-NPMRVLLKIAK-SEPPT 227
Query: 315 -EQCGHISVPARELIGQLLNTHADKRPTAGQLLQ 347
Q S ++ + + L + D R T QLLQ
Sbjct: 228 LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 6e-10
Identities = 55/206 (26%), Positives = 100/206 (48%), Gaps = 18/206 (8%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPT 160
RY +L+++G+G + TV A DR TG VA+K++ R Q + + Y L L H
Sbjct: 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHEN 75
Query: 161 ALALFENAPVPGTDT---------IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSA 211
+ L + V D +VM + G L + L + ++E I ++ Q+
Sbjct: 76 VIGLLD---VFTPDLSLDRFHDFYLVMPFM-GTDLGK-LMKHEKLSEDRIQFLVYQMLKG 130
Query: 212 LHCLHSQQIAHKDIRPENILMNGAV-LKLIDLG---SSVSVSTVVLPDLEFASPEMLTSP 267
L +H+ I H+D++P N+ +N LK++D G + S T + + +PE++ +
Sbjct: 131 LKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTRWYRAPEVILNW 190
Query: 268 ATAGPSTDMWSLGVLLYILLSGVSPF 293
+ D+WS+G ++ +L+G F
Sbjct: 191 MHYTQTVDIWSVGCIMAEMLTGKPLF 216
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 61/260 (23%), Positives = 110/260 (42%), Gaps = 52/260 (20%)
Query: 108 LGNGRFCTVRKARDRGTGQLVALKQIPRER------------QPQQITRAEYNLLSTLMH 155
LG G F V A +G G+ A+K + ++ + + + A N T ++
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 156 AHIPTALALFENAPVPGTDTIVMQLVHGESLIQHL-------CRQSTITESYICCIIRQL 208
T LF VM+ ++G L+ H+ ++T + I C
Sbjct: 63 CTFQTKEHLF----------FVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVC----- 107
Query: 209 HSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLG--------SSVSVSTVVLPDLEFA 259
L LHS+ I ++D++ +N++++ +K+ D G + + + PD +
Sbjct: 108 --GLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPD--YI 163
Query: 260 SPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGH 319
+PE+L S D WS GVLLY +L G SPF + E+E I V +P
Sbjct: 164 APEILQGLKYTF-SVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPR----W 218
Query: 320 ISVPARELIGQLLNTHADKR 339
I+ +++++ +L +R
Sbjct: 219 ITKESKDILEKLFERDPTRR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-09
Identities = 54/229 (23%), Positives = 92/229 (40%), Gaps = 24/229 (10%)
Query: 121 DRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQL 180
D T Q LK + + + + T++ +P + L + + +V+Q
Sbjct: 14 DTRTQQTFILKGLRKSSEYSRERL-------TIIPHCVPNMVCLHKYIVSEDSVFLVLQH 66
Query: 181 VHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGA-VLKL 239
G L H+ + I E + ++ AL LH + I +D+ P NIL++ ++L
Sbjct: 67 AEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQL 126
Query: 240 IDLGSSVSVSTVVLPDLEFASPEMLTSPATAGPS-----TDMWSLGVLLYILLSGVSPFL 294
V + A M +P G S D WSLG +L+ LL+G + +
Sbjct: 127 TYFSRWSEVEDSCDGE---AVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKT-LV 182
Query: 295 DESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAG 343
+ H ++ PE +S AR L+ QLL + +R AG
Sbjct: 183 ECHPSGINTHTTLN----IPE---WVSEEARSLLQQLLQFNPTERLGAG 224
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 52/206 (25%), Positives = 93/206 (45%), Gaps = 18/206 (8%)
Query: 101 RYEE---LERLGNGRFCTVRKARDR-GTGQLVALK-----QIPRERQPQQITRAEYNLLS 151
+YE+ + LG G F V A + VA+K +I +++Q + +E +L+
Sbjct: 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF-SERKILN 86
Query: 152 TLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSA 211
+ H P + L+ + +V++ V G L R C Q+
Sbjct: 87 YINH---PFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLI 143
Query: 212 LHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVST---VVLPDLEFASPEMLTSP 267
L S I ++D++PEN+L++ +K+ D G + V T + E+ +PE+L +
Sbjct: 144 FEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLCGTPEYIAPEILLN- 202
Query: 268 ATAGPSTDMWSLGVLLYILLSGVSPF 293
G + D W+LG+ +Y +L G PF
Sbjct: 203 VGHGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 63/258 (24%), Positives = 109/258 (42%), Gaps = 44/258 (17%)
Query: 108 LGNGRFCTVRKARDRGTGQLVALKQIPRER------------QPQQITRAEYNLLSTLMH 155
LG G F V + R TG++ A K++ ++R + Q + + + +L +
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67
Query: 156 AHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCR--QSTITESYICCIIRQLHSALH 213
A+ T AL +V+ L++G L H+ E ++ L
Sbjct: 68 AY-ETKDAL----------CLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLE 116
Query: 214 CLHSQQIAHKDIRPENILMN--GAVLKLIDLGSSVSVSTVVLPDLE----------FASP 261
LH ++I ++D++PENIL++ G + ++ DLG +V + P+ E + +P
Sbjct: 117 DLHRERIVYRDLKPENILLDDYGHI-RISDLGLAVEI-----PEGETIRGRVGTVGYMAP 170
Query: 262 EMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHIS 321
E++ + S D W LG L+Y ++ G SPF E+ R + E S
Sbjct: 171 EVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFS 229
Query: 322 VPARELIGQLLNTHADKR 339
AR + QLL R
Sbjct: 230 EAARSICRQLLTKDPGFR 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 62/256 (24%), Positives = 112/256 (43%), Gaps = 37/256 (14%)
Query: 108 LGNGRFCTVRKARDRGTGQLVALKQIPRE------------RQPQQITRAEYNLLSTLMH 155
+G G + V R + Q+ A+K + +E + +A N +H
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 156 AHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCL 215
+ T LF +V++ V+G L+ H+ RQ + E + ++ AL+ L
Sbjct: 63 SCFQTTSRLF----------LVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFL 112
Query: 216 HSQQIAHKDIRPENILMNG-AVLKLID-------LGSSVSVSTVV-LPDLEFASPEMLTS 266
H + I ++D++ +N+L++ +KL D LG + ST P+ + +PE+L
Sbjct: 113 HERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPN--YIAPEILRG 170
Query: 267 PATAGPSTDMWSLGVLLYILLSGVSPF---LDESEEETRAHISVADYSFPPEQCGHISVP 323
G S D W+LGVL++ +++G SPF D + T ++ P +SV
Sbjct: 171 -EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVK 229
Query: 324 ARELIGQLLNTHADKR 339
A ++ LN +R
Sbjct: 230 ASHVLKGFLNKDPKER 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 2e-09
Identities = 64/254 (25%), Positives = 110/254 (43%), Gaps = 33/254 (12%)
Query: 108 LGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQITRAEYNLLSTLMHAHIPTALA 163
LG G F V + R TG+L A K++ ++R + + E +L+ + H+ +LA
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLA 59
Query: 164 L-FENAPVPGTD-TIVMQLVHGESLIQHLC----RQSTITESYICCIIRQLHSALHCLHS 217
F+ TD +VM +++G L H+ E C Q+ S L LH
Sbjct: 60 YAFQTK----TDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ 115
Query: 218 QQIAHKDIRPENILM-NGAVLKLIDLGSSVSVSTVVLPDLE-----------FASPEMLT 265
++I ++D++PEN+L+ N +++ DLG +V L D + F +PE+L
Sbjct: 116 RRIIYRDLKPENVLLDNDGNVRISDLGLAVE-----LKDGQSKTKGYAGTPGFMAPELLQ 170
Query: 266 SPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAR 325
S D ++LGV LY +++ PF E+ + + S ++
Sbjct: 171 G-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASK 229
Query: 326 ELIGQLLNTHADKR 339
LL +KR
Sbjct: 230 SFCEALLAKDPEKR 243
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 5e-09
Identities = 63/229 (27%), Positives = 100/229 (43%), Gaps = 25/229 (10%)
Query: 106 ERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRA---EYNLLSTLMHAHIPTAL 162
ER+G G F V R R VA+K RE P + E +L H +I +
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSC-RETLPPDLKAKFLQEARILKQYSHPNIVRLI 59
Query: 163 AL-FENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSA---LHCLHSQ 218
+ + P+ IVM+LV G + L ++ + +I+ + +A + L S+
Sbjct: 60 GVCTQKQPI----YIVMELVQGGDFLTFL--RTEGPRLKVKELIQMVENAAAGMEYLESK 113
Query: 219 QIAHKDIRPENILMNGA-VLKLIDLGSS------VSVSTVVLPDL--EFASPEMLTSPAT 269
H+D+ N L+ VLK+ D G S V ST + + ++ +PE L
Sbjct: 114 HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRY 173
Query: 270 AGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQC 317
+ S D+WS G+LL+ S G P+ + S ++TR I PE C
Sbjct: 174 SSES-DVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELC 221
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 5e-09
Identities = 51/228 (22%), Positives = 98/228 (42%), Gaps = 40/228 (17%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQITRAEYNLLSTLMHAH 157
+ + LG G F V + R TG++ A K++ ++R + + + E +L +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 158 IPTALALFENAPVPGTDTIVMQLVHGESLIQHLC---------RQSTITESYICCIIRQL 208
+ +E +V+ +++G L H+ ++ + I C
Sbjct: 62 VVNLAYAYETKDAL---CLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILC----- 113
Query: 209 HSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVSTVVLPDLE---------- 257
L LH + ++D++PENIL++ +++ DLG +V + P+ E
Sbjct: 114 --GLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKI-----PEGESIRGRVGTVG 166
Query: 258 FASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHI 305
+ +PE+L + S D W LG L+Y ++ G SPF E+ R +
Sbjct: 167 YMAPEVLNN-QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV 213
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 5e-09
Identities = 60/211 (28%), Positives = 91/211 (43%), Gaps = 14/211 (6%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP---QQITRAEYNLLSTLMHAHI 158
+E + LG G V K + + +G ++A K I E +P QI R L L +
Sbjct: 7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRE----LQVLHECNS 62
Query: 159 PTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCI-IRQLHSALHCLHS 217
P + + G +I M+ + G SL Q L I E + + I L +
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK 122
Query: 218 QQIAHKDIRPENILMNG-AVLKLIDLGSS----VSVSTVVLPDLEFASPEMLTSPATAGP 272
QI H+D++P NIL+N +KL D G S S++ + + SPE L +
Sbjct: 123 HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQ 182
Query: 273 STDMWSLGVLLYILLSGVSPFLDESEEETRA 303
S D+WS+G+ L L G P +E A
Sbjct: 183 S-DIWSMGLSLVELAIGRYPIPPPDAKELEA 212
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 5e-09
Identities = 66/244 (27%), Positives = 111/244 (45%), Gaps = 38/244 (15%)
Query: 124 TGQLVALKQI----PRERQPQQITRAEYNLLSTLMHAHIPTALALFEN--APVPGTDTIV 177
TG VA+K + P E + R E L + L H +I +AL ++ AP PG V
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNI---VALLDSGEAP-PGLLFAV 57
Query: 178 MQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGAVL 237
+ V G +L + L + ++ Q+ AL C H+Q I H+D++P+NI+++ +
Sbjct: 58 FEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGV 117
Query: 238 ----KLIDLG-------------SSVSVSTVVLPDLEFASPEMLTS-PATAGPSTDMWSL 279
K++D G ++++ +T VL + +PE L P T P++D+++
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVT--PNSDLYAW 175
Query: 280 GVLLYILLSGVSPFLDESEEET-RAHISVADYSFPPEQCGHISVPARELIGQLLNTHADK 338
G++ L+G S E +S D S PP GH +GQ+L +K
Sbjct: 176 GLIFLECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGH-------PLGQVLRKALNK 228
Query: 339 RPTA 342
P
Sbjct: 229 DPRQ 232
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 6e-09
Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 27/211 (12%)
Query: 103 EELERLGNGRFCTVRKARDRGTGQLVALKQIPR----ERQPQQITRAEYNLLSTLMHAHI 158
++L +G G F TV K + +G ++A+K+I R E++ +++ L +M +
Sbjct: 7 KDLGEIGRGAFGTVNKMLHKPSGTIMAVKRI-RSTVDEKEQKRLLMD----LDVVMRSSD 61
Query: 159 PTALALFENAPVPGTDT-IVMQLVHGESL-----IQHLCRQSTITESYICCIIRQLHSAL 212
+ F A D I M+L+ SL + +S I E + I AL
Sbjct: 62 CPYIVKFYGALFREGDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKAL 120
Query: 213 HCLHSQ-QIAHKDIRPENILM--NGAVLKLIDLGSSVSVSTVVLPDLE-----FASPEML 264
+ L + +I H+D++P NIL+ NG + KL D G S + + + + +PE +
Sbjct: 121 NYLKEELKIIHRDVKPSNILLDRNGNI-KLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 179
Query: 265 TSPATAGPS--TDMWSLGVLLYILLSGVSPF 293
A G +D+WSLG+ LY + +G P+
Sbjct: 180 DPSARDGYDVRSDVWSLGITLYEVATGKFPY 210
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 6e-09
Identities = 56/256 (21%), Positives = 109/256 (42%), Gaps = 40/256 (15%)
Query: 108 LGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQITRAEYNLLSTLMHAHIPTALA 163
LG G F V + R TG++ A K++ ++R + + + E +L + + +
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 164 LFENAPVPGTDTIVMQLVHGESLIQHLC---------RQSTITESYICCIIRQLHSALHC 214
+E +V+ +++G L H+ +++ + +CC L
Sbjct: 68 AYETKDAL---CLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCC-------GLED 117
Query: 215 LHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVSTVVLPDLE----------FASPEM 263
L ++I ++D++PENIL++ +++ DLG +V + P+ E + +PE+
Sbjct: 118 LQRERIVYRDLKPENILLDDRGHIRISDLGLAVQI-----PEGETVRGRVGTVGYMAPEV 172
Query: 264 LTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVP 323
+ + S D W LG L+Y ++ G SPF E R + E S
Sbjct: 173 INNEKYTF-SPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSED 231
Query: 324 ARELIGQLLNTHADKR 339
A+ + LL + +R
Sbjct: 232 AKSICRMLLTKNPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 7e-09
Identities = 50/207 (24%), Positives = 96/207 (46%), Gaps = 22/207 (10%)
Query: 108 LGNGRFCTVRKARDRGTGQLVALKQIPRERQP----QQITRAEYNLLSTLMHAHIPTALA 163
LG G F V + + TG++ A K++ ++R +++ E +L + I
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 164 LFENAPVPGTDT---IVMQLVHGESLIQHLCR--QSTITESYICCIIRQLHSALHCLHSQ 218
FE + T +VM L++G L H+ + + + Q+ + LHS
Sbjct: 61 AFE------SKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSM 114
Query: 219 QIAHKDIRPENILMN-GAVLKLIDLGSSVSVS-----TVVLPDLEFASPEMLTSPATAGP 272
I ++D++PEN+L++ +L DLG +V + T + +PE+L + P
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYP 174
Query: 273 STDMWSLGVLLYILLSGVSPFLDESEE 299
D +++G +Y +++G +PF D E+
Sbjct: 175 -VDWFAMGCSIYEMVAGRTPFKDHKEK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 8e-09
Identities = 52/193 (26%), Positives = 88/193 (45%), Gaps = 5/193 (2%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPT 160
RY +L+ +G G F V ARD+ TGQ VA+K+I + + + Y L L H
Sbjct: 11 RYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHEN 70
Query: 161 ALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQI 220
++L + P D + + G L L + + +I + Q+ L +HS +
Sbjct: 71 IISLSDIFISPLEDIYFVTELLGTDL-HRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGV 129
Query: 221 AHKDIRPENILMN-GAVLKLIDLGSSV---SVSTVVLPDLEFASPEMLTSPATAGPSTDM 276
H+D++P NIL+N LK+ D G + T + + +PE++ + D+
Sbjct: 130 VHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDI 189
Query: 277 WSLGVLLYILLSG 289
WS G + +L G
Sbjct: 190 WSAGCIFAEMLEG 202
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 48/205 (23%), Positives = 92/205 (44%), Gaps = 30/205 (14%)
Query: 108 LGNGRFCTVRKARDRGTGQLVALKQIPRE------------RQPQQITRAEYNLLSTLMH 155
+G G + V R + T ++ A+K + +E + +A + +H
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 156 AHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCL 215
+ T LF V++ V+G L+ H+ RQ + E + ++ AL+ L
Sbjct: 63 SCFQTESRLF----------FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL 112
Query: 216 HSQQIAHKDIRPENILMNG-AVLKLIDLGSSVS------VSTVVLPDLEFASPEMLTSPA 268
H + I ++D++ +N+L++ +KL D G ++ + +PE+L
Sbjct: 113 HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG-E 171
Query: 269 TAGPSTDMWSLGVLLYILLSGVSPF 293
G S D W+LGVL++ +++G SPF
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 61/203 (30%), Positives = 92/203 (45%), Gaps = 20/203 (9%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP---QQITRAEYNLLSTLMHAHI 158
+E+L LG G V K R +G ++A K I E +P QI R L L +
Sbjct: 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRE----LKVLHECNS 58
Query: 159 PTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYI----CCIIRQLHSALHC 214
P + + G +I M+ + G SL Q L + I E+ + ++R L + L
Sbjct: 59 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGL-TYLRE 117
Query: 215 LHSQQIAHKDIRPENILMNG-AVLKLIDLGSS----VSVSTVVLPDLEFASPEMLTSPAT 269
H +I H+D++P NIL+N +KL D G S S++ + + SPE L
Sbjct: 118 KH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHY 175
Query: 270 AGPSTDMWSLGVLLYILLSGVSP 292
S D+WSLG+ L + G P
Sbjct: 176 TVQS-DIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 71/305 (23%), Positives = 130/305 (42%), Gaps = 81/305 (26%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER--QPQQIT--RAEYNLLSTLMHAH 157
+ ++ +G G F VR + + TG++ A+K + + + Q+ +AE ++L+ +
Sbjct: 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLA---ESD 59
Query: 158 IPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITES----YIC-CIIRQLHSAL 212
P ++L+ + ++M+ + G L+ L + T +E Y+ C++ A+
Sbjct: 60 SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVL-----AI 114
Query: 213 HCLHSQQIAHKDIRPENILMN-GAVLKLIDLG---------------------------- 243
+H H+DI+P+NIL++ G +KL D G
Sbjct: 115 EAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRID 174
Query: 244 --SSVSVSTVVL-------------------------PDLEFASPEMLTSPATAGPSTDM 276
+SV+V ++ L PD + +PE+ G D
Sbjct: 175 NRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPD--YIAPEIFLQQGY-GQECDW 231
Query: 277 WSLGVLLYILLSGVSPFLDESEEETRAHISVADYS--FPPEQCGHISVPARELIGQLLNT 334
WSLG +++ L G PF E+ ET I + FP + H+SV A +LI +L+ T
Sbjct: 232 WSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDI--HLSVEAEDLIRRLI-T 288
Query: 335 HADKR 339
+A+ R
Sbjct: 289 NAENR 293
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 58/232 (25%), Positives = 102/232 (43%), Gaps = 47/232 (20%)
Query: 108 LGNGRFCTVRKARDRGTGQLVALKQIPRE--RQPQQI-----------TRAEYNLLSTLM 154
+G G + V + T ++ A+K I +E + I T + + L L
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL- 61
Query: 155 HAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHC 214
H+ T LF V++ V G L+ H+ RQ + E + ++ AL+
Sbjct: 62 HSCFQTESRLF----------FVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNF 111
Query: 215 LHSQQIAHKDIRPENILMNG-AVLKLID-------LGSSVSVSTVV-LPDLEFASPEMLT 265
LH + I ++D++ +N+L++ +KL D + + ST P+ + +PE+L
Sbjct: 112 LHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPN--YIAPEILR 169
Query: 266 SPATAGPSTDMWSLGVLLYILLSGVSPF-----LDESEEETRAHISVADYSF 312
G S D W+LGVL++ +++G SPF D ++ T DY F
Sbjct: 170 G-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTE------DYLF 214
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 53/201 (26%), Positives = 92/201 (45%), Gaps = 17/201 (8%)
Query: 104 ELER-LGNGRFCTVRKARDRGTGQLVALKQIPRERQP-QQITRA--EYNLLSTLMHAHIP 159
E +R +G G F V D G+ VALK++P Q R E +L H ++
Sbjct: 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVL 62
Query: 160 TALALFENAPVPGTDTI--VMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHS 217
+AL + + + + I V +L+ + L + + ++ ++ + Q+ L LHS
Sbjct: 63 SALDILQPPHIDPFEEIYVVTELMQSD-LHKIIVSPQPLSSDHVKVFLYQILRGLKYLHS 121
Query: 218 QQIAHKDIRPENILMNG-AVLKLIDLG--------SSVSVSTVVLPDLEFASPEMLTSPA 268
I H+DI+P N+L+N VLK+ D G S ++ V+ + +PE+L
Sbjct: 122 AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YRAPEILMGSR 180
Query: 269 TAGPSTDMWSLGVLLYILLSG 289
+ D+WS+G + LL
Sbjct: 181 HYTSAVDIWSVGCIFAELLGR 201
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-08
Identities = 70/277 (25%), Positives = 119/277 (42%), Gaps = 26/277 (9%)
Query: 103 EELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTAL 162
E +E LG G + V K R TG ++A+K+I Q+ R +L ++ P +
Sbjct: 4 EVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTV 63
Query: 163 ----ALFENAPVPGTDTIVMQLVHGESL----IQHLCRQSTITESYICCIIRQLHSALHC 214
ALF V I M+++ SL + + TI E + I + AL
Sbjct: 64 TFYGALFREGDV----WICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEY 118
Query: 215 LHSQ-QIAHKDIRPENILMN--GAVLKLIDLGSSVSVSTVVLPDLE-----FASPEML-- 264
LHS+ + H+D++P N+L+N G V KL D G S + V ++ + +PE +
Sbjct: 119 LHSKLSVIHRDVKPSNVLINRNGQV-KLCDFGISGYLVDSVAKTIDAGCKPYMAPERINP 177
Query: 265 -TSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVP 323
+ +D+WSLG+ + L +G P+ D + + V + P S
Sbjct: 178 ELNQKGYDVKSDVWSLGITMIELATGRFPY-DSWKTPFQQLKQVVEEPSPQLPAEKFSPE 236
Query: 324 ARELIGQLLNTHADKRPTAGQLLQVAWFAEASCSEFD 360
++ + + L + +RP +LLQ +F D
Sbjct: 237 FQDFVNKCLKKNYKERPNYPELLQHPFFELHLSKNTD 273
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 3e-08
Identities = 48/201 (23%), Positives = 102/201 (50%), Gaps = 9/201 (4%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYN---LLSTLMHAH 157
RY L+++G+G + +V A D+ TG+ VA+K++ R Q + + Y LL + H +
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHEN 75
Query: 158 IPTALALFENAPV-PGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLH 216
+ L +F +A + + + ++ +Q + ++E + ++ Q+ L +H
Sbjct: 76 VIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKI-MGHPLSEDKVQYLVYQMLCGLKYIH 134
Query: 217 SQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS---TVVLPDLEFASPEMLTSPATAGP 272
S I H+D++P N+ +N LK++D G + T + + +PE++ +
Sbjct: 135 SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILNWMHYNQ 194
Query: 273 STDMWSLGVLLYILLSGVSPF 293
+ D+WS+G ++ +L+G + F
Sbjct: 195 TVDIWSVGCIMAEMLTGKTLF 215
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 3e-08
Identities = 63/261 (24%), Positives = 114/261 (43%), Gaps = 24/261 (9%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQI------PRERQPQQITRAEYNLLSTLMH 155
Y + +G G + V R R G+ +K++ RER+ + E LLS L H
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAE---QEAQLLSQLKH 58
Query: 156 AHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQ--STITESYICCIIRQLHSALH 213
+I +E G IVM G L L Q + E+ + Q+ AL
Sbjct: 59 PNIVAYRESWEGED--GLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQ 116
Query: 214 CLHSQQIAHKDIRPENI-LMNGAVLKLIDLG------SSVSVSTVVLPDLEFASPEMLTS 266
LH + I H+D++ +N+ L ++K+ DLG + +++ ++ + SPE+ ++
Sbjct: 117 YLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSN 176
Query: 267 PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARE 326
S D+W+LG +Y + + F +++ + + PP + S E
Sbjct: 177 KPYNYKS-DVWALGCCVYEMATLKHAF--NAKDMNSLVYRIIEGKLPPMPKDY-SPELGE 232
Query: 327 LIGQLLNTHADKRPTAGQLLQ 347
LI +L+ +KRP+ +L+
Sbjct: 233 LIATMLSKRPEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 4e-08
Identities = 64/262 (24%), Positives = 105/262 (40%), Gaps = 14/262 (5%)
Query: 95 QEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIP----RERQPQQITRAEYNLL 150
+E E + +L +G+G F V ARD T ++VA+K++ + + Q E L
Sbjct: 20 KEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFL 79
Query: 151 STLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHS 210
+ H P ++ T +VM+ G + + + E I I
Sbjct: 80 QRIKH---PNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQ 136
Query: 211 ALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSS--VSVSTVVLPDLEFASPEMLTS- 266
L LHS + H+DI+ NIL+ +KL D GS+ S + + + +PE++ +
Sbjct: 137 GLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVGTPYWMAPEVILAM 196
Query: 267 -PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAR 325
D+WSLG+ L P + + HI A P Q S R
Sbjct: 197 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--AQNESPTLQSNEWSDYFR 254
Query: 326 ELIGQLLNTHADKRPTAGQLLQ 347
+ L RPT+ +LL+
Sbjct: 255 NFVDSCLQKIPQDRPTSEELLK 276
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 4e-08
Identities = 68/295 (23%), Positives = 115/295 (38%), Gaps = 26/295 (8%)
Query: 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIP----RERQPQQITRAEYNLLSTLM 154
E + +L +G+G F V ARD ++VA+K++ + + Q E L L
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 155 HAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHC 214
H P + T +VM+ G + + + E I + L
Sbjct: 74 H---PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 130
Query: 215 LHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVSTVVLPDLEFA------SPEMLTS- 266
LHS + H+D++ NIL++ ++KL D GS ++++ P F +PE++ +
Sbjct: 131 LHSHNMIHRDVKAGNILLSEPGLVKLGDFGS----ASIMAPANXFVGTPYWMAPEVILAM 186
Query: 267 -PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAR 325
D+WSLG+ L P + + HI A P Q GH S R
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--AQNESPALQSGHWSEYFR 244
Query: 326 ELIGQLLNTHADKRPTAGQLLQVAWFAEASCSEFDTERLLPFSARRKQKFKEIQD 380
+ L RPT+ LL+ + E ++ R K +E+ +
Sbjct: 245 NFVDSCLQKIPQDRPTSEVLLKHRFV----LRERPPTVIMDLIQRTKDAVRELDN 295
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 4e-08
Identities = 56/207 (27%), Positives = 95/207 (45%), Gaps = 28/207 (13%)
Query: 108 LGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFEN 167
+GNG F V +A T + VA+K++ ++ PQ R E ++ L H +I +
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKVLQD--PQYKNR-ELLIMKNLNHINIIFLKDYYYT 130
Query: 168 APVPGTD-----TIVM----QLVHGESLIQHLCRQSTITESYICCIIR-QLHSALHCLHS 217
+ +VM Q VH ++H R + ++ + QL AL +HS
Sbjct: 131 ECFKKNEKNIFLNVVMEFIPQTVH--KYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS 188
Query: 218 QQIAHKDIRPENILM--NGAVLKLIDLGSSVSV-----STVVLPDLEFASPEMLTSPATA 270
+ I H+D++P+N+L+ N LKL D GS+ ++ S + + +PE++
Sbjct: 189 KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNY 248
Query: 271 GPSTDMWSLG------VLLYILLSGVS 291
D+WSLG +L Y + SG S
Sbjct: 249 TTHIDLWSLGCIIAEMILGYPIFSGQS 275
|
Length = 440 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 4e-08
Identities = 68/248 (27%), Positives = 112/248 (45%), Gaps = 20/248 (8%)
Query: 106 ERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALF 165
E +G G F V + TGQ VA+K I + Q E +++ L H ++ L +
Sbjct: 12 EIIGEGEFGAVLQGE--YTGQKVAVKNIKCDVTAQAFL-EETAVMTKLHHKNLVRLLGVI 68
Query: 166 ENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSA--LHCLHSQQIAHK 223
+ + IVM+L+ +L+ L + S I + L A + L S+++ H+
Sbjct: 69 LHNGL----YIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHR 124
Query: 224 DIRPENILMN-GAVLKLIDLG----SSVSVSTVVLPDLEFASPEMLTSPATAGPSTDMWS 278
D+ NIL++ V K+ D G S+ V LP +++ +PE L + S D+WS
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLP-VKWTAPEALKHKKFSSKS-DVWS 182
Query: 279 LGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHAD 337
GVLL+ + S G +P+ S +E + + PPE C L+ T
Sbjct: 183 YGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGC---PADVYVLMTSCWETEPK 239
Query: 338 KRPTAGQL 345
KRP+ +L
Sbjct: 240 KRPSFHKL 247
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 4e-08
Identities = 66/272 (24%), Positives = 109/272 (40%), Gaps = 25/272 (9%)
Query: 103 EELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP---QQITRAEYNLLSTLMHAHIP 159
E + LG G +V K + TG ++A K + + +QI R E ++ +I
Sbjct: 8 ETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILR-ELQIMHECRSPYIV 66
Query: 160 TALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHS-Q 218
+ F N + M+ + SL + + I + I + L L++
Sbjct: 67 SFYGAFLNEN---NICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH 123
Query: 219 QIAHKDIRPENILMNGA-VLKLIDLGSS----VSVSTVVLPDLEFASPEMLTSPATAGPS 273
+I H+DI+P NIL+N +KL D G S S++ + + SPE + S
Sbjct: 124 RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGKYTVKS 183
Query: 274 TDMWSLGVLLYILLSGVSPFLDESEEETRAH---ISVADY-----SFPPEQCGHISVPA- 324
D+WSLG+ + L G PF S + + + D PP + P
Sbjct: 184 -DVWSLGISIIELALGKFPF-AFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPED 241
Query: 325 -RELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355
R+ + L +RPT QL + F +A
Sbjct: 242 LRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 9e-08
Identities = 57/223 (25%), Positives = 93/223 (41%), Gaps = 20/223 (8%)
Query: 98 FEHRY-EELERLGNGRFCTVRKAR----DRGTGQLVALKQIPRERQPQQIT--RAEYNLL 150
FE R+ + +++LG G F V R TG+ VA+K + + Q + E +L
Sbjct: 1 FEKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEIL 60
Query: 151 STLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQS-TITESYICCIIRQLH 209
TL H +I + E ++M+ + SL +L R I + Q+
Sbjct: 61 RTLDHENIVKYKGVCEKPGGRSL-RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQIC 119
Query: 210 SALHCLHSQQIAHKDIRPENILM-NGAVLKLIDLGSSVSVST-----VVLPDLEFA---- 259
+ L SQ+ H+D+ NIL+ + ++K+ D G + + V E
Sbjct: 120 KGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY 179
Query: 260 SPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETR 302
+PE L + + S D+WS GV LY L + P E R
Sbjct: 180 APECLRTSKFSSAS-DVWSFGVTLYELFTYGDPSQSPPAEFLR 221
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 14/200 (7%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP---QQITRAEYNLLSTLMHAHI 158
+E++ LG G V K + +G ++A K I E +P QI R L L +
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRE----LQVLHECNS 62
Query: 159 PTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQ 218
P + + G +I M+ + G SL Q L + I E + + + L L +
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 122
Query: 219 -QIAHKDIRPENILMNG-AVLKLIDLGSS----VSVSTVVLPDLEFASPEMLTSPATAGP 272
+I H+D++P NIL+N +KL D G S S++ + + SPE L +
Sbjct: 123 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQ 182
Query: 273 STDMWSLGVLLYILLSGVSP 292
S D+WS+G+ L + G P
Sbjct: 183 S-DIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 54/201 (26%), Positives = 89/201 (44%), Gaps = 13/201 (6%)
Query: 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIP 159
+ E LG+G TV KA T +++A+K IP + + + + + L L P
Sbjct: 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVE-LQKQIMSELEILYKCDSP 59
Query: 160 TALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQ 219
+ + V +I + + G SL + I E + I + L L S +
Sbjct: 60 YIIGFYGAFFVENRISICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLK 115
Query: 220 IAHKDIRPENILMN--GAVLKLIDLGSSV----SVSTVVLPDLEFASPEMLTSPATAGPS 273
I H+D++P N+L+N G V KL D G S S++ + + +PE + S G
Sbjct: 116 ILHRDVKPSNMLVNTRGQV-KLCDFGVSTQLVNSIAKTYVGTNAYMAPERI-SGEQYGIH 173
Query: 274 TDMWSLGVLLYILLSGVSPFL 294
+D+WSLG+ L G P+
Sbjct: 174 SDVWSLGISFMELALGRFPYP 194
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 43/149 (28%), Positives = 70/149 (46%), Gaps = 15/149 (10%)
Query: 146 EYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCII 205
E LL L H P LAL + V G +V+ + R + + + +
Sbjct: 210 EARLLRRLSH---PAVLALLDVRVVGGLTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVA 266
Query: 206 RQLHSALHCLHSQQIAHKDIRPENILMNGAV-LKLIDLGS--------SVSVSTVVLPDL 256
RQL SA+ +H + I H+DI+ EN+L+NG + L D G+ S + +
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTV 326
Query: 257 EFASPEMLT-SPATAGPSTDMWSLGVLLY 284
+ +PE+L P T PS D+WS G++++
Sbjct: 327 DTNAPEVLAGDPYT--PSVDIWSAGLVIF 353
|
Length = 461 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 3e-07
Identities = 55/205 (26%), Positives = 92/205 (44%), Gaps = 17/205 (8%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQI----PRERQPQQITRAEYNLLSTLMHA 156
RY+ E +G G + V A D TG+ VA+K+I +I R E LL L H
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILR-EIKLLRLLRHP 59
Query: 157 HIPTALA-LFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCL 215
I + + D V+ + L Q + +T + + QL AL +
Sbjct: 60 DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYI 119
Query: 216 HSQQIAHKDIRPENILMNGAV-LKLIDLG-SSVSV----STVVLPDLE----FASPEMLT 265
H+ + H+D++P+NIL N LK+ D G + V+ + + D + +PE+
Sbjct: 120 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 179
Query: 266 SPATA-GPSTDMWSLGVLLYILLSG 289
S + P+ D+WS+G + +L+G
Sbjct: 180 SFFSKYTPAIDIWSIGCIFAEVLTG 204
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 50/205 (24%), Positives = 95/205 (46%), Gaps = 24/205 (11%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYN---LLSTLMHAH 157
RY+ L+ +G+G V A D + VA+K++ R Q Q + Y L+ + H +
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 158 IPTALALFENAPVPGTDT-----IVMQLVHGESLIQHLCR--QSTITESYICCIIRQLHS 210
I L +F P + IVM+L+ +LC+ Q + + ++ Q+
Sbjct: 85 IIGLLNVF--TPQKSLEEFQDVYIVMELMDA-----NLCQVIQMELDHERMSYLLYQMLC 137
Query: 211 ALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVSTVVLPDLE-----FASPEML 264
+ LHS I H+D++P NI++ LK++D G + + T + + +PE++
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 265 TSPATAGPSTDMWSLGVLLYILLSG 289
+ D+WS+G ++ ++ G
Sbjct: 198 LGMGYK-ENVDIWSVGCIMGEMIKG 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 4e-07
Identities = 53/206 (25%), Positives = 89/206 (43%), Gaps = 25/206 (12%)
Query: 106 ERLGNGRFCTVRKARDRGTGQLVALKQIP--------RERQPQQITRAEYNLLSTLMHAH 157
E LG G F + K R G L + R + +++S L H H
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60
Query: 158 IPTALALFENAPVPGTDTIVMQ-LVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCL 215
L L V G ++I++Q V SL +L + ++ I S+ + +QL ALH L
Sbjct: 61 ----LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFL 116
Query: 216 HSQQIAHKDIRPENILM---------NGAVLKLIDLGSSVSV--STVVLPDLEFASPEML 264
+ + H ++ +N+L+ N +KL D G S++V ++L + + PE +
Sbjct: 117 EDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECI 176
Query: 265 TSPATAGPSTDMWSLGVLLYILLSGV 290
+P + D WS G L+ + SG
Sbjct: 177 ENPQNLSLAADKWSFGTTLWEIFSGG 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.5 bits (119), Expect = 5e-07
Identities = 31/113 (27%), Positives = 47/113 (41%), Gaps = 12/113 (10%)
Query: 131 KQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHL 190
++I RER TR E ++S A + F + P IVM+ + GE L +
Sbjct: 39 ERIRRER-----TRREARIMSRARKAGVNVPAVYFVD---PENFIIVMEYIEGEPLKDLI 90
Query: 191 CRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGAVLKLIDLG 243
I R + LHS I H D+ N++++G + LID G
Sbjct: 91 NSNGMEELELSREIGRLV--GK--LHSAGIIHGDLTTSNMILSGGKIYLIDFG 139
|
Length = 211 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 7e-07
Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 24/211 (11%)
Query: 98 FEHRY-EELERLGNGRFCTVRKAR-----DRGTGQLVALKQIPRERQPQQIT--RAEYNL 149
FE R+ + + LG G F V R D TG+ VA+K + E I + E +
Sbjct: 1 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDN-TGEQVAVKSLKPESGGNHIADLKKEIEI 59
Query: 150 LSTLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCR-QSTITESYICCIIRQL 208
L L H +I + G ++M+ + SL ++L R ++ I Q+
Sbjct: 60 LRNLYHENIVKYKGICTEDGGNGI-KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQI 118
Query: 209 HSALHCLHSQQIAHKDIRPENILM-NGAVLKLIDLGSSVSVST-----VVLPDLEFASPE 262
+ L S+Q H+D+ N+L+ + +K+ D G + ++ T V DL+ SP
Sbjct: 119 CKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLD--SPV 176
Query: 263 MLTSPATAGPS-----TDMWSLGVLLYILLS 288
+P S +D+WS GV LY LL+
Sbjct: 177 FWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 46/154 (29%), Positives = 74/154 (48%), Gaps = 18/154 (11%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQ-QITRA--EYNLLSTLMHAH 157
RY+ L+ +G+G V A D TGQ VA+K++ R Q RA E L+ + H +
Sbjct: 17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKN 76
Query: 158 IPTALALFENAPVPGTDT-----IVMQLVHGE--SLIQHLCRQSTITESYICCIIRQLHS 210
I L +F P + +VM+L+ +IQ + SY+ + Q+
Sbjct: 77 IIGLLNVF--TPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERM--SYL---LYQMLC 129
Query: 211 ALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLG 243
+ LHS I H+D++P NI++ LK++D G
Sbjct: 130 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG 163
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 62/230 (26%), Positives = 95/230 (41%), Gaps = 39/230 (16%)
Query: 105 LERLGNGRFCTVRKAR-----DRGTGQLVALKQIPRERQP--QQITRAEYNLLSTLMHAH 157
LE LG G F V K +R + VA+K + +P QQ R E L+S L H +
Sbjct: 10 LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPN 69
Query: 158 IPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHC--- 214
I L + P T + L HG+ L + L R S ++ + S+L C
Sbjct: 70 IVCLLGVCTKE-QP-TCMLFEYLAHGD-LHEFLVRNSPHSDVGAESGDETVKSSLDCSDF 126
Query: 215 -------------LHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSV---------STV 251
L S H+D+ N L+ G +K+ D G S + S
Sbjct: 127 LHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186
Query: 252 VLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEE 300
+LP + + PE + +D+WS GV+L+ + S G+ P+ S +E
Sbjct: 187 LLP-VRWMPPEAILY-GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE 234
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 62/249 (24%), Positives = 104/249 (41%), Gaps = 49/249 (19%)
Query: 82 KVLYTVPFETRWQQEQF-----------EHRYEELERLGNGRFCTVRKARDRGTGQLVAL 130
KV Y +P ++R ++ F R++ L LG G F V +A DR + A+
Sbjct: 101 KVTYALPNQSR-EEGHFYVVLGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAV 159
Query: 131 K---QIPRERQPQQITRAEYNLLSTLMHAHIPTALAL------FENAPVPGTDTIVMQLV 181
K +P+ + +I E + + A L F+N G IVM
Sbjct: 160 KIVRNVPKYTRDAKI---EIQFMEKVRQADPADRFPLMKIQRYFQNET--GHMCIVMP-K 213
Query: 182 HGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQ-QIAHKDIRPENILMNGA----- 235
+G L+ + + + ++ II Q AL H++ + H D++PENILM +
Sbjct: 214 YGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVD 273
Query: 236 ------------VLKLIDLGSSVS---VSTVVLPDLEFASPEMLTSPATAGPSTDMWSLG 280
+++ DLG T ++ + SPE++ STDMWS+G
Sbjct: 274 PVTNRALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWM-YSTDMWSMG 332
Query: 281 VLLYILLSG 289
++Y L +G
Sbjct: 333 CIIYELYTG 341
|
Length = 467 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 34/123 (27%), Positives = 58/123 (47%), Gaps = 36/123 (29%)
Query: 192 RQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN--GAVLKLIDLGSSVSVS 249
R++ I ++ I+RQ+ AL LHS I H+D++P+NI+ + K+IDLG++ +
Sbjct: 252 RENKIIQT----IMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLR 307
Query: 250 TVV-------LPDLEFASPE---MLTSPATAGPST-------------------DMWSLG 280
+ L D +A+PE M T +A PS D++S G
Sbjct: 308 VGINYIPKEFLLDPRYAAPEQYIMSTQTPSA-PSAPVATALSPVLWQLNLPDRFDIYSAG 366
Query: 281 VLL 283
++
Sbjct: 367 LIF 369
|
Length = 566 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 60/292 (20%), Positives = 106/292 (36%), Gaps = 59/292 (20%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPR----ERQPQQITRAEYNLLSTLMHAH 157
+ +++ +G G F V R T L A+K + + R +AE ++L+ A
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILA---EAD 59
Query: 158 IPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHS 217
+ L+ + VM + G ++ L R E I +L A+ +H
Sbjct: 60 NEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHK 119
Query: 218 QQIAHKDIRPENILMN-GAVLKLIDL-----------------GSSVSVSTVVLPDL--- 256
H+DI+P+NIL++ +KL D G ++ +
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSE 179
Query: 257 -----------------------------EFASPEMLTSPATAGPSTDMWSLGVLLYILL 287
+ +PE+L D WS+GV+LY +L
Sbjct: 180 IDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEML 238
Query: 288 SGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHADKR 339
G PFL ++ ET+ + + + +S A +LI +L A+ R
Sbjct: 239 VGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDR 289
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 47/194 (24%), Positives = 92/194 (47%), Gaps = 14/194 (7%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYN---LLSTLMHAH 157
RY+ L+ +G+G V A D + VA+K++ R Q Q + Y L+ + H +
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 158 IPTALALFENAPVPGTDTIVMQLVHGESLIQHLCR--QSTITESYICCIIRQLHSALHCL 215
I + L +F P + + E + +LC+ Q + + ++ Q+ + L
Sbjct: 78 IISLLNVF--TPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 135
Query: 216 HSQQIAHKDIRPENILMNG-AVLKLIDLG--SSVSVSTVVLPDL---EFASPEMLTSPAT 269
HS I H+D++P NI++ LK++D G + S ++ P + + +PE++
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 195
Query: 270 AGPSTDMWSLGVLL 283
+ D+WS+G ++
Sbjct: 196 K-ENVDIWSVGCIM 208
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 52/205 (25%), Positives = 99/205 (48%), Gaps = 24/205 (11%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYN---LLSTLMHAH 157
RY++L+ +G+G V A D G VA+K++ R Q Q + Y LL + H +
Sbjct: 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKN 81
Query: 158 IPTALALFENAPVPGTDT-----IVMQLVHGESLIQHLCR--QSTITESYICCIIRQLHS 210
I + L +F P + +VM+L+ +LC+ + + ++ Q+
Sbjct: 82 IISLLNVF--TPQKSLEEFQDVYLVMELMDA-----NLCQVIHMELDHERMSYLLYQMLC 134
Query: 211 ALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVST--VVLPDL---EFASPEML 264
+ LHS I H+D++P NI++ LK++D G + + T ++ P + + +PE++
Sbjct: 135 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVI 194
Query: 265 TSPATAGPSTDMWSLGVLLYILLSG 289
+ D+WS+G ++ L+ G
Sbjct: 195 LGMGYK-ENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 62/320 (19%), Positives = 120/320 (37%), Gaps = 73/320 (22%)
Query: 101 RYEELERLGNGRFCTVRKAR--DRGTGQLVALKQI-PRERQPQQITRA---EYNLLSTLM 154
+YE +G G + V KA+ + G+ A+K+ + Q I+++ E LL L
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 155 HAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLC---RQS---TITESYICCIIRQL 208
H ++ + + +F ++ + + E + + RQ+ +I S + ++ Q+
Sbjct: 61 HENVVSLVEVFLE---HADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQI 117
Query: 209 HSALHCLHSQQIAHKDIRPENILMNGA-----VLKLIDLG----------SSVSVSTVVL 253
+ +H LHS + H+D++P NIL+ G V+K+ DLG + VV+
Sbjct: 118 LNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVV 177
Query: 254 PDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEE-------------- 299
+ + +PE+L + D+W++G + LL+ F +
Sbjct: 178 -TIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236
Query: 300 -----------------------ETRAHISVADYSFPP-----EQCGHISVPARELIGQL 331
Y E+ +L+ +L
Sbjct: 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKL 296
Query: 332 LNTHADKRPTAGQLLQVAWF 351
L KR TA + L+ +F
Sbjct: 297 LEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 47.6 bits (114), Expect = 2e-06
Identities = 33/111 (29%), Positives = 48/111 (43%), Gaps = 15/111 (13%)
Query: 133 IPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCR 192
I RER TR E LLS A + T + + P TIVM+ + G+ L
Sbjct: 39 IRRER-----TRNEARLLSRARKAGVNTPVVYDVD---PDNKTIVMEYIEGKPL------ 84
Query: 193 QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGAVLKLIDLG 243
+ E ++R++ + LH I H D+ NI++ L LID G
Sbjct: 85 -KDVIEEGNDELLREIGRLVGKLHKAGIVHGDLTTSNIIVRDDKLYLIDFG 134
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 58/262 (22%), Positives = 103/262 (39%), Gaps = 38/262 (14%)
Query: 105 LERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALAL 164
L+ LG+G+F V + RG VA+K I + E ++ L H P + L
Sbjct: 9 LKELGSGQFGVVHLGKWRGKID-VAIKMIREGAMSEDDFIEEAKVMMKLSH---PNLVQL 64
Query: 165 F----ENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYI---CCIIRQLHSALHCLHS 217
+ + P+ IV + + L+ +L + + C + A+ L S
Sbjct: 65 YGVCTKQRPI----FIVTEYMANGCLLNYLRERKGKLGTEWLLDMCS--DVCEAMEYLES 118
Query: 218 QQIAHKDIRPENILMNG-AVLKLIDLGSSVSVSTVVLPD-----------LEFASPEMLT 265
H+D+ N L+ V+K+ D G ++ VL D +++A PE+
Sbjct: 119 NGFIHRDLAARNCLVGEDNVVKVSDFG----LARYVLDDQYTSSQGTKFPVKWAPPEVFD 174
Query: 266 SPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPA 324
+ S D+WS GVL++ + S G P+ S E +S + P+
Sbjct: 175 YSRFSSKS-DVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLA---PTEV 230
Query: 325 RELIGQLLNTHADKRPTAGQLL 346
++ + + RP +LL
Sbjct: 231 YTIMYSCWHEKPEDRPAFKKLL 252
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 33/99 (33%), Positives = 50/99 (50%), Gaps = 4/99 (4%)
Query: 254 PDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFP 313
PD + +PE+L GP+ D W+LGV L+ L+G+ PF DE+ ++ +I D +P
Sbjct: 544 PD--YLAPELLLGKP-HGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWP 600
Query: 314 PEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFA 352
+ +SV A+ I LL KR +L Q F
Sbjct: 601 EGE-EKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLFH 638
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 3e-06
Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 11/94 (11%)
Query: 203 CIIRQLHSALHCLHSQQIAHKDIRPENILMNGA-VLKLIDLGSSVSVSTVVLPD------ 255
I +Q+ L LH+Q+I H+D++ ENI +N + + DLG+ + VV P
Sbjct: 161 IIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGA--AQFPVVAPAFLGLAG 218
Query: 256 -LEFASPEMLTSPATAGPSTDMWSLGVLLYILLS 288
+E +PE+L D+WS G++L+ +L+
Sbjct: 219 TVETNAPEVLAR-DKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 52/206 (25%), Positives = 97/206 (47%), Gaps = 27/206 (13%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPR---ERQPQQITRAEYNLLSTLMHAH 157
+Y ++ +G G + V A++ T + VA+K+I R + T E LL L H +
Sbjct: 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHEN 65
Query: 158 IPTALALFENAPVPGTDT-----IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSAL 212
+ +A+ + P P + IV +L+ + L Q + T+++ + + QL L
Sbjct: 66 V---IAIKDIMPPPHREAFNDVYIVYELMDTD-LHQIIRSSQTLSDDHCQYFLYQLLRGL 121
Query: 213 HCLHSQQIAHKDIRPENILMNGAV-LKLIDLGSSVSVSTVVLPDLEFAS----------P 261
+HS + H+D++P N+L+N LK+ D G + + S +F + P
Sbjct: 122 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE----KGDFMTEYVVTRWYRAP 177
Query: 262 EMLTSPATAGPSTDMWSLGVLLYILL 287
E+L + + + D+WS+G + LL
Sbjct: 178 ELLLNCSEYTTAIDVWSVGCIFAELL 203
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 3e-06
Identities = 54/266 (20%), Positives = 105/266 (39%), Gaps = 44/266 (16%)
Query: 106 ERLGNGRFCTVRKA--RDRGTGQL-VALKQIPRERQPQQITR--AEYNLLSTLMHAHIPT 160
+ LG+G F +V K + ++ VA+K + +E E ++++ L H I
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 161 ALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQI 220
+ + + P+ +VM+L L+++L ++ I S + + Q+ + L S+
Sbjct: 61 LIGVCKGEPL----MLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHF 116
Query: 221 AHKDIRPENILM-NGAVLKLIDLGSSVSVSTVVLPD-------------LEFASPEMLTS 266
H+D+ N+L+ N K+ D G S ++ L++ +PE +
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRALG----AGSDYYRATTAGRWPLKWYAPECINY 172
Query: 267 PATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAR 325
+D+WS GV L+ S G P+ + E A + E + P
Sbjct: 173 -GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAML---------ESGERLPRPEE 222
Query: 326 ------ELIGQLLNTHADKRPTAGQL 345
++ + RPT +L
Sbjct: 223 CPQEIYSIMLSCWKYRPEDRPTFSEL 248
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 5e-06
Identities = 37/133 (27%), Positives = 60/133 (45%), Gaps = 24/133 (18%)
Query: 204 IIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVSTVVLP-------D 255
I++QL A+ +H +++ H+DI+ ENI +N + L D G+++
Sbjct: 272 IMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGT 331
Query: 256 LEFASPEMLTSPATAGPS----TDMWSLGVLLYILLS-GVSPFLDESEEETRA------H 304
+ SPE+L AG TD+WS G++L +LS P D + +
Sbjct: 332 VATNSPEIL-----AGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDS 386
Query: 305 ISVADYSFPPEQC 317
+SV D FP C
Sbjct: 387 LSVCDEEFPDPPC 399
|
Length = 501 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 6e-06
Identities = 62/247 (25%), Positives = 105/247 (42%), Gaps = 36/247 (14%)
Query: 93 WQQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP-QQITRAEYNLLS 151
W++ + E E +LG+G F V + + + VA+K + + QQ + E L
Sbjct: 1 WERPREEFTLER--KLGSGYFGEVWEGLWKNRVR-VAIKILKSDDLLKQQDFQKEVQALK 57
Query: 152 TLMHAHIPTALALF----ENAPVPGTDTIVMQLVHGESLIQHLCRQS---TITESYICCI 204
L H H+ ++LF PV I+ +L+ SL R + + + +
Sbjct: 58 RLRHKHL---ISLFAVCSVGEPV----YIITELMEKGSL-LAFLRSPEGQVLPVASLIDM 109
Query: 205 IRQLHSALHCLHSQQIAHKDIRPENILM-NGAVLKLIDLGSSVSVSTVVLPDLEFAS--- 260
Q+ + L Q H+D+ NIL+ V K+ D G ++ ++ D+ +S
Sbjct: 110 ACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFG----LARLIKEDVYLSSDKK 165
Query: 261 -PEMLTSPATAGPST-----DMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFP 313
P T+P A T D+WS G+LLY + + G P+ + E I+ A Y P
Sbjct: 166 IPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-AGYRMP 224
Query: 314 -PEQCGH 319
P +C
Sbjct: 225 CPAKCPQ 231
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 7e-06
Identities = 62/263 (23%), Positives = 104/263 (39%), Gaps = 16/263 (6%)
Query: 95 QEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIP----RERQPQQITRAEYNLL 150
++ E + L +G+G F V A + T ++VA+K++ + + Q E L
Sbjct: 16 KDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFL 75
Query: 151 STLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHS 210
L H P + T +VM+ G + + + E I I
Sbjct: 76 QQLKH---PNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQ 132
Query: 211 ALHCLHSQQIAHKDIRPENILMN--GAVLKLIDLGSS--VSVSTVVLPDLEFASPEMLTS 266
L LHS + H+DI+ NIL+ G V KL D GS+ S + + + +PE++ +
Sbjct: 133 GLAYLHSHNMIHRDIKAGNILLTEPGQV-KLADFGSASKSSPANSFVGTPYWMAPEVILA 191
Query: 267 --PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPA 324
D+WSLG+ L P + + HI+ D P Q +
Sbjct: 192 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS--PTLQSNEWTDSF 249
Query: 325 RELIGQLLNTHADKRPTAGQLLQ 347
R + L +RP + +LL+
Sbjct: 250 RGFVDYCLQKIPQERPASAELLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 51/213 (23%), Positives = 88/213 (41%), Gaps = 31/213 (14%)
Query: 101 RYEELERLGNGRFCTVRKARDRGT--GQLVALKQIPRERQPQQITRAEYNLLSTLMH--A 156
RYE ++ LG G + V AR+ T + VA+K+I + + + L L H
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG 60
Query: 157 HIPTALALFENAPVPGTDTIVMQLVHGESLIQHL--CRQSTI-------TESYICCIIRQ 207
H L++ D + + L + L I T+++ I Q
Sbjct: 61 H-KNITCLYD------MDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQ 113
Query: 208 LHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVSTVVLPDLEFAS------ 260
+ L +HS + H+D++P N+L+N LK+ D G + S + F +
Sbjct: 114 ILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173
Query: 261 ----PEMLTSPATAGPSTDMWSLGVLLYILLSG 289
PE++ S + + D+WS+G +L LL
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAELLGR 206
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 48/189 (25%), Positives = 78/189 (41%), Gaps = 27/189 (14%)
Query: 145 AEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCI 204
E ++ H HI + + PV IVM+L L +L + +
Sbjct: 56 QEAYIMRQFDHPHIVKLIGVITENPV----WIVMELAPLGELRSYLQVNKYSLDLASLIL 111
Query: 205 -IRQLHSALHCLHSQQIAHKDIRPENILMNGA-VLKLIDLGSSVSV--------STVVLP 254
QL +AL L S++ H+DI N+L++ +KL D G S + S LP
Sbjct: 112 YSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLP 171
Query: 255 DLEFASPEML-----TSPATAGPSTDMWSLGVLLY-ILLSGVSPFLDESEEETRAHISVA 308
+++ +PE + TS ++D+W GV ++ IL+ GV PF + I
Sbjct: 172 -IKWMAPESINFRRFTS------ASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENG 224
Query: 309 DYSFPPEQC 317
+ P C
Sbjct: 225 ERLPMPPNC 233
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 50/221 (22%), Positives = 93/221 (42%), Gaps = 39/221 (17%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQ---QITRAEYNLLSTLMHAHI 158
+ + + K + T LVA+K+I + + ++ + E L H +I
Sbjct: 4 TLIGKCFEDLMIVHLAKHKP--TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNI 61
Query: 159 PTALALFENAPVPGTDT-IVMQLV-HG--ESLIQ-HLCRQSTITESYICCIIRQLHSALH 213
+ F + ++ +V L+ +G E L++ H + E I I++ + +AL
Sbjct: 62 LPYVTSF----IVDSELYVVSPLMAYGSCEDLLKTHFP--EGLPELAIAFILKDVLNALD 115
Query: 214 CLHSQQIAHKDIRPENILM--NGAVLKLIDLGSSVSV----------------STVVLPD 255
+HS+ H+ ++ +IL+ +G V L L SVS+ S LP
Sbjct: 116 YIHSKGFIHRSVKASHILLSGDGKV-VLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP- 173
Query: 256 LEFASPEMLTSPATA-GPSTDMWSLGVLLYILLSGVSPFLD 295
+ SPE+L +D++S+G+ L +G PF D
Sbjct: 174 --WLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 26/75 (34%), Positives = 44/75 (58%), Gaps = 10/75 (13%)
Query: 204 IIRQLHSALHCLHSQQIAHKDIRPENIL--MNGAVLKLIDLGSSVSVSTVV-------LP 254
++RQ+ + L LH I H+DI+PEN+L ++G V K+ID G++V + T + +
Sbjct: 314 VMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQV-KIIDFGAAVDMCTGINFNPLYGML 372
Query: 255 DLEFASPEMLTSPAT 269
D ++ PE L P +
Sbjct: 373 DPRYSPPEELVMPQS 387
|
Length = 507 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 43/154 (27%), Positives = 69/154 (44%), Gaps = 26/154 (16%)
Query: 146 EYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHGE-SLIQHLCRQSTITESYICCI 204
E ++L T+ H I + + T+ M + + L ++ R + I
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKS-----TVCMVMPKYKCDLFTYVDRSGPLPLEQAITI 190
Query: 205 IRQLHSALHCLHSQQIAHKDIRPENILMN---GAVLKLIDLGSSVSVSTVVLPD------ 255
R+L AL LH + I H+D++ ENI ++ AVL D G++ + PD
Sbjct: 191 QRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLG--DFGAACKLDAH--PDTPQCYG 246
Query: 256 ----LEFASPEMLT-SPATAGPSTDMWSLGVLLY 284
LE SPE+L P A TD+WS G++L+
Sbjct: 247 WSGTLETNSPELLALDPYCA--KTDIWSAGLVLF 278
|
Length = 392 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 5e-05
Identities = 38/149 (25%), Positives = 67/149 (44%), Gaps = 12/149 (8%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLSTLMHAH 157
+ +++ LG G F V AR T L A+K + ++ R +AE ++L+ +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 158 IPTALALFENAPVPGTDTI--VMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCL 215
+ F++ D + VM + G ++ L R E I +L A+ +
Sbjct: 63 VVRLYYSFQD-----KDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESV 117
Query: 216 HSQQIAHKDIRPENILMN-GAVLKLIDLG 243
H H+DI+P+NIL++ +KL D G
Sbjct: 118 HKMGFIHRDIKPDNILIDRDGHIKLTDFG 146
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 6e-05
Identities = 34/141 (24%), Positives = 57/141 (40%), Gaps = 13/141 (9%)
Query: 104 ELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHA--HIPTA 161
++ L G V + LK P + R E +L L +P
Sbjct: 2 SIKLLKGGLTNRVYLLGTKDED--YVLKINPSREKGADRER-EVAILQLLARKGLPVPKV 58
Query: 162 LALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIA 221
LA E+ ++M+ + GE+L + S + I + +L + LH L +
Sbjct: 59 LASGESDGWSY---LLMEWIEGETLDE----VSEEEKEDIAEQLAELLAKLHQLPLLVLC 111
Query: 222 HKDIRPENILM-NGAVLKLID 241
H D+ P NIL+ +G +L +ID
Sbjct: 112 HGDLHPGNILVDDGKILGIID 132
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 6e-05
Identities = 53/223 (23%), Positives = 98/223 (43%), Gaps = 33/223 (14%)
Query: 107 RLGNGRFCTVRKAR--DRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALAL 164
++G G + V KA+ D + ALKQI R E LL L H P +AL
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACR-EIALLRELKH---PNVIAL 63
Query: 165 FENAPVPGTDTIVMQLV-HGESLIQHLCR----------QSTITESYICCIIRQLHSALH 213
+ + +D V L + E + H+ + + S + ++ Q+ +H
Sbjct: 64 -QKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122
Query: 214 CLHSQQIAHKDIRPENILMNG-----AVLKLIDLGSSVSVSTVVLP--DLE-------FA 259
LH+ + H+D++P NIL+ G +K+ D+G + ++ + P DL+ +
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 260 SPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETR 302
+PE+L + D+W++G + LL+ P +E+ +
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCRQEDIK 224
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 9e-05
Identities = 54/235 (22%), Positives = 98/235 (41%), Gaps = 48/235 (20%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRA----EYNLLSTLMHA 156
RY+ + +G G V A D + VALK+I + + + E + + L+H
Sbjct: 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHP 62
Query: 157 HI-PTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESY---------ICCIIR 206
I P + PV T M + G +L + L + ES + +
Sbjct: 63 GIVPVYSICSDGDPVYYT----MPYIEGYTL-KSLLKSVWQKESLSKELAEKTSVGAFLS 117
Query: 207 QLH---SALHCLHSQQIAHKDIRPENILMN--GAVLKLIDLGSSVSVSTV--VLPDLEFA 259
H + + +HS+ + H+D++P+NIL+ G V+ ++D G+++ L D++
Sbjct: 118 IFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVV-ILDWGAAIFKKLEEEDLLDIDVD 176
Query: 260 SPEMLTSPAT---------------------AGPSTDMWSLGVLLYILLSGVSPF 293
+ S T A STD+++LGV+LY +L+ P+
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 63/274 (22%), Positives = 105/274 (38%), Gaps = 48/274 (17%)
Query: 108 LGNGRFCTVRKARDRG-----TGQLVALKQIPR--ERQPQQITRAEYNLLSTLMHAHIPT 160
LG+G F V + RG VA+K +P Q + E ++S H +I
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 161 ALAL-FENAPVPGTDTIVMQLVHGESLIQ-------HLCRQSTITESYICCIIRQLHSAL 212
+ + FE P I+++L+ G L R S++T + R +
Sbjct: 74 LIGVSFERLP----RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGC 129
Query: 213 HCLHSQQIAHKDIRPENILMN----GAVLKLIDLGSSVSV---------STVVLPDLEFA 259
L H+DI N L+ G V K+ D G + + +LP +++
Sbjct: 130 KYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLP-IKWM 188
Query: 260 SPE-----MLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFP 313
PE + TS TD+WS GVLL+ + S G P+ + +E ++ P
Sbjct: 189 PPEAFLDGIFTS------KTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDP 242
Query: 314 PEQCGHISVPARELIGQLLNTHADKRPTAGQLLQ 347
P+ C P ++ + RP +L+
Sbjct: 243 PKGC---PGPVYRIMTDCWQHTPEDRPNFATILE 273
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 52/217 (23%), Positives = 85/217 (39%), Gaps = 34/217 (15%)
Query: 149 LLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQST-ITESYICCIIRQ 207
L+S L H H L V + +V + V L L R+ ++ + + +Q
Sbjct: 54 LMSQLSHKH----LVKLYGVCVRDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQ 109
Query: 208 LHSALHCLHSQQIAHKDIRPENILM--------NGAVLKLIDLGSSVSVSTVVLP--DLE 257
L SALH L +++ H ++ +NIL+ +KL D G ++V + +
Sbjct: 110 LASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIP 169
Query: 258 FASPEMLTSPATAGPSTDM--WSLGVLLY-ILLSGVSPF--LDESEEETR---AHISVAD 309
+ +PE + + A + WS G L I +G P L SE+E H
Sbjct: 170 WIAPECIRNGQ-ASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHR---- 224
Query: 310 YSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLL 346
P C ++ LI Q KRP+ +L
Sbjct: 225 --LPMPDCAELA----NLINQCWTYDPTKRPSFRAIL 255
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 51/223 (22%), Positives = 87/223 (39%), Gaps = 35/223 (15%)
Query: 149 LLSTLMHAHIPTALALFENAPV-PGTDTIVMQLVHG-----------ESLIQH-----LC 191
+L L +H ALA FE A + I + VHG E ++H
Sbjct: 48 VLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCL 107
Query: 192 RQST--ITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILM--------NGAVLKLID 241
R+ + ++ + +QL SAL L + + H ++ +NIL+ +KL D
Sbjct: 108 RKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSD 167
Query: 242 LGSSVSVST--VVLPDLEFASPEMLTSPATAGPSTDMWSLG-VLLYILLSGVSPFLDESE 298
G S + + + + + +PE + + + D WS G LL I G P + +
Sbjct: 168 PGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP 227
Query: 299 EETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPT 341
E + + P C ++ LI Q L +RP+
Sbjct: 228 SE-KERFYEKKHRLPEPSCKELA----TLISQCLTYEPTQRPS 265
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 54/250 (21%), Positives = 103/250 (41%), Gaps = 26/250 (10%)
Query: 108 LGNGRFCTVRKA--RDRGTGQLVALKQIPRERQPQQITR---AEYNLLSTLMHAHIPTAL 162
LG+G F TV+K + + + + VA+K + + + E N++ L + +I +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 163 ALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAH 222
+ E +VM+L L + L + +TE I ++ Q+ + L H
Sbjct: 63 GICEAESW----MLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVH 118
Query: 223 KDIRPENILM-NGAVLKLIDLGSSVSV----------STVVLPDLEFASPEMLTSPATAG 271
+D+ N+L+ K+ D G S ++ + P +++ +PE + +
Sbjct: 119 RDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWP-VKWYAPECMNYYKFSS 177
Query: 272 PSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQ 330
S D+WS GVL++ S G P+ E I + P++C +L+
Sbjct: 178 KS-DVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRC---PPEMYDLMKL 233
Query: 331 LLNTHADKRP 340
D+RP
Sbjct: 234 CWTYGVDERP 243
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 2e-04
Identities = 39/153 (25%), Positives = 68/153 (44%), Gaps = 29/153 (18%)
Query: 211 ALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVSTVVLPD-----------LEF 258
+ L S+Q H+D+ N L++ +K+ D G +S VL D + +
Sbjct: 112 GMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFG----LSRYVLDDEYTSSVGSKFPVRW 167
Query: 259 ASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQC 317
+ PE+L + S D+W+ GVL++ + S G P+ + ET +S + P
Sbjct: 168 SPPEVLLYSKFSSKS-DVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHL- 225
Query: 318 GHISVPARELIGQLLNT----HADKRPTAGQLL 346
A E + ++ + A++RPT QLL
Sbjct: 226 ------ASEKVYAIMYSCWHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 57/228 (25%), Positives = 99/228 (43%), Gaps = 25/228 (10%)
Query: 106 ERLGNGRFCTVRKA--RDRGTGQLVALKQIPRERQPQQIT---RAEYNLLSTLMHAHIPT 160
E LG G F V K +D+ VA+K +E PQ++ +E +L H +I
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTP---VAVKTC-KEDLPQELKIKFLSEARILKQYDHPNIVK 56
Query: 161 ALAL-FENAPVPGTDTIVMQLVHGESLIQHLCRQS-TITESYICCIIRQLHSALHCLHSQ 218
+ + + P+ IVM+LV G + L ++ + + + + L S+
Sbjct: 57 LIGVCTQRQPI----YIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK 112
Query: 219 QIAHKDIRPENILM-NGAVLKLIDLGSS-------VSVSTVVLPDLEFASPEMLTSPATA 270
H+D+ N L+ VLK+ D G S S S + +++ +PE L +
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYS 172
Query: 271 GPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQC 317
S D+WS G+LL+ S GV P+ + ++ R + P++C
Sbjct: 173 SES-DVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKC 219
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 29/111 (26%), Positives = 47/111 (42%), Gaps = 15/111 (13%)
Query: 133 IPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCR 192
+ RER TR E +L+ A +P + + P IVM+ + GE L
Sbjct: 41 LRRER-----TRREARILAKAREAGVPVPIVYDVD---PDNGLIVMEYIEGELL------ 86
Query: 193 QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGAVLKLIDLG 243
E ++R++ + LH I H D+ NI+++G + ID G
Sbjct: 87 -KDALEEARPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGRIYFIDFG 136
|
Length = 204 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 60/247 (24%), Positives = 88/247 (35%), Gaps = 41/247 (16%)
Query: 105 LERLGNGRFCTV-----RKARDRGTGQLVALKQI--PRERQPQQITRAEYNLLSTLMHAH 157
LG G F V +LVA+K + ++ E LL+ H +
Sbjct: 10 KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHEN 69
Query: 158 IPTALALFENAPVPGTDTIVM---QLVHGE-------------SLIQHLCRQSTITESYI 201
I F G D +M + HG+ L +T S +
Sbjct: 70 IVK----FYGVCTEG-DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQL 124
Query: 202 CCIIRQLHSALHCLHSQQIAHKDIRPENILMNGA-VLKLIDLGSSVSVSTV--------- 251
I Q+ S + L SQ H+D+ N L+ V+K+ D G S V T
Sbjct: 125 LQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHT 184
Query: 252 VLPDLEFASPEMLTSPATAGPSTDMWSLGVLLY-ILLSGVSPFLDESEEETRAHISVADY 310
+LP + + PE + S D+WS GV+L+ I G P+ S EE I+
Sbjct: 185 MLP-IRWMPPESIMYRKFTTES-DVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRL 242
Query: 311 SFPPEQC 317
P C
Sbjct: 243 LQRPRTC 249
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 56/254 (22%), Positives = 106/254 (41%), Gaps = 31/254 (12%)
Query: 105 LERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALAL 164
+++LG G+F V + + VA+K + Q E NL+ TL H + A+
Sbjct: 11 VKKLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAV 69
Query: 165 F-ENAPVPGTDTIVMQLVHGESLIQHLCRQ--STITESYICCIIRQLHSALHCLHSQQIA 221
+ P+ I+ + + SL+ L + + Q+ + + +
Sbjct: 70 VTKEEPI----YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYI 125
Query: 222 HKDIRPENILMNGAVL-KLIDLGSSVSVSTVVLPDLEFASPEMLTSPA--TAGPS----- 273
H+D+R N+L++ +++ K+ D G + V+ D E+ + E P TA +
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLAR-----VIEDNEYTAREGAKFPIKWTAPEAINFGS 180
Query: 274 ----TDMWSLGVLLY-ILLSGVSPFLDESEEETRAHISVADYSFP-PEQCGHISVPAREL 327
+D+WS G+LLY I+ G P+ S + + + Y P E C ++
Sbjct: 181 FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG-YRMPRMENC---PDELYDI 236
Query: 328 IGQLLNTHADKRPT 341
+ A++RPT
Sbjct: 237 MKTCWKEKAEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 60/254 (23%), Positives = 107/254 (42%), Gaps = 32/254 (12%)
Query: 105 LERLGNGRFCTVRKARDRGTGQLVALKQI-PRERQPQQITRAEYNLLSTLMHAHIPTALA 163
+++LGNG+F V G + VA+K + P P+ E ++ L H + A
Sbjct: 11 IKKLGNGQFGEVWMGTWNGNTK-VAVKTLKPGTMSPESFLE-EAQIMKKLRHDKLVQLYA 68
Query: 164 LFENAPVPGTDTIVMQLVHGESLIQHL--CRQSTITESYICCIIRQLHSALHCLHSQQIA 221
+ P+ IV + + SL+ L + + + Q+ + + +
Sbjct: 69 VVSEEPI----YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYI 124
Query: 222 HKDIRPENILM-NGAVLKLIDLGSSVSVSTVVLPDLEFAS------PEMLTSPATA---- 270
H+D+R NIL+ +G V K+ D G + ++ D E+ + P T+P A
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLAR-----LIEDNEYTARQGAKFPIKWTAPEAALYGR 179
Query: 271 -GPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFP-PEQCGHISVPAREL 327
+D+WS G+LL L++ G P+ + E + Y P P+ C + EL
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG-YRMPCPQDC---PISLHEL 235
Query: 328 IGQLLNTHADKRPT 341
+ Q ++RPT
Sbjct: 236 MLQCWKKDPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 29/105 (27%), Positives = 50/105 (47%), Gaps = 25/105 (23%)
Query: 201 ICCIIRQLHSALHCLHSQQIAHKDIRPENILMN----------GAVLKLIDL------GS 244
I I R + A+ LH +I H+DI+ ENI +N GA +D+ G
Sbjct: 184 ILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGW 243
Query: 245 SVSVSTVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSG 289
+ +++T +PE+L GP+ D+WS G++L+ + +
Sbjct: 244 AGTIAT--------NAPELLARDPY-GPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 2e-04
Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 29/213 (13%)
Query: 98 FEHRY-EELERLGNGRFCTVRKAR----DRGTGQLVALKQI-PRERQPQQITRAEYNLLS 151
FE R+ + +++LG G F +V R TG++VA+K++ + + E +L
Sbjct: 1 FEERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILK 60
Query: 152 TLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCR-QSTITESYICCIIRQLHS 210
+L H +I + +A ++ L +G SL +L + + + + Q+
Sbjct: 61 SLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYG-SLRDYLQKHRERLDHRKLLLYASQICK 119
Query: 211 ALHCLHSQQIAHKDIRPENILM-NGAVLKLIDLGSSVSVSTVVLP-DLEFA--------- 259
+ L S++ H+D+ NIL+ + +K+ D G T VLP D E+
Sbjct: 120 GMEYLGSKRYVHRDLATRNILVESENRVKIGDFGL-----TKVLPQDKEYYKVREPGESP 174
Query: 260 ----SPEMLTSPATAGPSTDMWSLGVLLYILLS 288
+PE LT + S D+WS GV+LY L +
Sbjct: 175 IFWYAPESLTESKFSVAS-DVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 3e-04
Identities = 27/113 (23%), Positives = 57/113 (50%), Gaps = 15/113 (13%)
Query: 204 IIRQLHSALHCLHSQQIAHKDIRPENILMNG-----AVLKLIDLGSSVSVSTVVLP--DL 256
++ Q+ +H LH+ + H+D++P NIL+ G +K+ D+G + ++ + P DL
Sbjct: 113 LLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 172
Query: 257 E-------FASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETR 302
+ + +PE+L + D+W++G + LL+ P +E+ +
Sbjct: 173 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCRQEDIK 224
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 5e-04
Identities = 60/244 (24%), Positives = 103/244 (42%), Gaps = 33/244 (13%)
Query: 105 LERLGNGRFCTVRKARDRGTG-----QLVALKQIPR--ERQPQQITRAEYNLLSTLMHAH 157
+E LG RF V K GT Q VA+K + E ++ + E + S L H +
Sbjct: 10 MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPN 69
Query: 158 IPTALALF-ENAPV-------PGTDT---IVMQLVHGE--SLIQHLCRQSTITESYICCI 204
I L + + P+ +D +VM+ H + S +ST+ + I
Sbjct: 70 IVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHI 129
Query: 205 IRQLHSALHCLHSQQIAHKDIRPENILMNGAV-LKLIDLGSSVSVSTV---------VLP 254
+ Q+ + + L S + HKD+ N+L+ + +K+ DLG V +LP
Sbjct: 130 VTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP 189
Query: 255 DLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFP 313
+ + SPE + +D+WS GV+L+ + S G+ P+ S ++ I
Sbjct: 190 -IRWMSPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPC 247
Query: 314 PEQC 317
P+ C
Sbjct: 248 PDDC 251
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 5e-04
Identities = 35/116 (30%), Positives = 47/116 (40%), Gaps = 26/116 (22%)
Query: 133 IPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPV-----PGTDTIVMQLVHGESLI 187
+ ER TRAE LLS A +PT PV P TIVM+ + G+ L
Sbjct: 378 LRTER-----TRAEARLLSEARRAGVPT--------PVIYDVDPEEKTIVMEYIGGKDLK 424
Query: 188 QHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGAVLKLIDLG 243
L + + I+ +LH A I H D+ N ++ L LID G
Sbjct: 425 DVLEGNPELVRK-VGEIVAKLHKA-------GIVHGDLTTSNFIVRDDRLYLIDFG 472
|
Length = 535 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 6e-04
Identities = 65/271 (23%), Positives = 108/271 (39%), Gaps = 51/271 (18%)
Query: 108 LGNGRFCTVRK--ARD---RGTG-QLVALKQIPRERQPQQITR--AEYNLLSTLMHAHIP 159
LG+G F V + A D G+G VA+K + + Q+ E +L+S H +I
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 160 TALAL-FENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESY-----------ICCIIRQ 207
L + N P I+M+L+ G L+ +L R + + IC + +
Sbjct: 63 KLLGVCLLNEPQ----YIIMELMEGGDLLSYL-RDARVERFGPPLLTLKELLDICLDVAK 117
Query: 208 LHSALHCLHSQQIAHKDIRPENILMNGA------VLKLIDLGSSVSVSTV---------V 252
L H+D+ N L++ V+K+ D G + + +
Sbjct: 118 ---GCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGL 174
Query: 253 LPDLEFASPEMLTSPATAGPSTDMWSLGVLLY-ILLSGVSPFLDESEEETRAHISVADYS 311
LP + + +PE L S D+WS GVL++ IL G P+ + +E H++
Sbjct: 175 LP-VRWMAPESLLDGKFTTQS-DVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRL 232
Query: 312 FPPEQC-GHISVPARELIGQLLNTHADKRPT 341
PE C I +L+ +RPT
Sbjct: 233 QKPENCPDKI----YQLMTNCWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 7e-04
Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 40/187 (21%)
Query: 184 ESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDL 242
E+ + L ++ E IC Q+ + L S++ H+D+ NIL++ V+K+ D
Sbjct: 165 EAEQEDLYKKVLTLEDLICYSF-QVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDF 223
Query: 243 GSS---------VSVSTVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSP 292
G + V LP L++ +PE + S D+WS GVLL+ + S G SP
Sbjct: 224 GLARDIYKDPDYVRKGDARLP-LKWMAPETIFDRVYTIQS-DVWSFGVLLWEIFSLGASP 281
Query: 293 F----LDES-----EEETRAHISVADYSFPPEQCGHISVPARELIGQLLNT-HAD--KRP 340
+ +DE +E TR + DY+ P E+ +L+ H + +RP
Sbjct: 282 YPGVKIDEEFCRRLKEGTR--MRAPDYTTP------------EMYQTMLDCWHGEPSQRP 327
Query: 341 TAGQLLQ 347
T +L++
Sbjct: 328 TFSELVE 334
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 8e-04
Identities = 33/112 (29%), Positives = 56/112 (50%), Gaps = 13/112 (11%)
Query: 193 QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSS------ 245
+S +T + C Q+ + L S++ H+D+ NIL++ V+K+ D G +
Sbjct: 168 KSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD 227
Query: 246 ---VSVSTVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPF 293
V + LP L++ +PE + S D+WS GVLL+ + S G SP+
Sbjct: 228 PDYVRKGSARLP-LKWMAPESIFDKVYTTQS-DVWSFGVLLWEIFSLGASPY 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 8e-04
Identities = 57/258 (22%), Positives = 110/258 (42%), Gaps = 28/258 (10%)
Query: 105 LERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALAL 164
++ LG+G+F V + R + VA+K I ++ E ++ L H P + L
Sbjct: 9 MKELGSGQFGVVHLGKWRAQIK-VAIKAINEGAMSEEDFIEEAKVMMKLSH---PKLVQL 64
Query: 165 F----ENAPVPGTDTIVMQLVHGESLIQHL-CRQSTITESYICCIIRQLHSALHCLHSQQ 219
+ + P+ IV + + L+ +L RQ +++ + + + + + L
Sbjct: 65 YGVCTQQKPL----YIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS 120
Query: 220 IAHKDIRPENILMNGA-VLKLIDLGSS--------VSVSTVVLPDLEFASPEMLTSPATA 270
H+D+ N L++ V+K+ D G + S S P ++++ PE+ +
Sbjct: 121 FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFP-VKWSPPEVFNFSKYS 179
Query: 271 GPSTDMWSLGVLLY-ILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIG 329
S D+WS GVL++ + G PF +S E IS + P+ E++
Sbjct: 180 SKS-DVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMT---VYEVMY 235
Query: 330 QLLNTHADKRPTAGQLLQ 347
+ + RPT +LL+
Sbjct: 236 SCWHEKPEGRPTFAELLR 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 60/244 (24%), Positives = 101/244 (41%), Gaps = 33/244 (13%)
Query: 105 LERLGNGRFCTVRKARDRGTG----QLVALKQIPRERQPQQIT--RAEYNLLSTLMHAHI 158
+E LG F + K G QLVA+K + PQQ + E +L++ L H +I
Sbjct: 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNI 69
Query: 159 PTAL-ALFENAPVPGT----------DTIVMQLVH---GESLIQHLCRQSTITESYICCI 204
L + + PV + ++M+ H G S + +S++ I
Sbjct: 70 VCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHI 129
Query: 205 IRQLHSALHCLHSQQIAHKDIRPENILMNGAV-LKLIDLGSSVSV---------STVVLP 254
Q+ + + L S HKD+ NIL+ + +K+ DLG S + +LP
Sbjct: 130 AIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 255 DLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFP 313
+ + PE + + S D+WS GV+L+ + S G+ P+ S +E +
Sbjct: 190 -IRWMPPEAIMYGKFSSDS-DIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPC 247
Query: 314 PEQC 317
E C
Sbjct: 248 SEDC 251
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.001
Identities = 63/258 (24%), Positives = 107/258 (41%), Gaps = 39/258 (15%)
Query: 105 LERLGNGRFCTVRKARDRGTGQLVALKQI-PRERQPQQITRAEYNLLSTLMHAHIPTALA 163
+LG G+F V GT + VA+K + P P+ + E ++ L H + A
Sbjct: 11 ERKLGAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPEAFLQ-EAQIMKKLRHDKLVQLYA 68
Query: 164 LF-ENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCII---RQLHSALHCLHSQQ 219
+ E P+ IV + + SL+ L + + + ++ Q+ + L S+
Sbjct: 69 VCSEEEPI----YIVTEYMSKGSLLDFL-KSGEGKKLRLPQLVDMAAQIAEGMAYLESRN 123
Query: 220 IAHKDIRPENILM-NGAVLKLIDLGSSVSVSTVVLPDLEFAS------PEMLTSP--ATA 270
H+D+ NIL+ V K+ D G + ++ D E+ + P T+P A
Sbjct: 124 YIHRDLAARNILVGENLVCKIADFGLAR-----LIEDDEYTAREGAKFPIKWTAPEAANY 178
Query: 271 GPST---DMWSLGVLLY-ILLSGVSPFLDESEEETRAHISVADYSFP-PEQCGHISVPAR 325
G T D+WS G+LL I+ G P+ + E + Y P P C P
Sbjct: 179 GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE-RGYRMPRPPNC-----PEE 232
Query: 326 --ELIGQLLNTHADKRPT 341
+L+ Q + ++RPT
Sbjct: 233 LYDLMLQCWDKDPEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.001
Identities = 52/199 (26%), Positives = 93/199 (46%), Gaps = 19/199 (9%)
Query: 105 LERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALAL 164
L+ +G G F V RG VA+K I + Q AE ++++ L H+++ L +
Sbjct: 11 LQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQAFL-AEASVMTQLRHSNLVQLLGV 67
Query: 165 FENAPVPGTDTIVMQLVHGESLIQHL-CRQSTITESYICCIIR---QLHSALHCLHSQQI 220
G IV + + SL+ +L R ++ C+++ + A+ L +
Sbjct: 68 IVEEK--GGLYIVTEYMAKGSLVDYLRSRGRSVLGGD--CLLKFSLDVCEAMEYLEANNF 123
Query: 221 AHKDIRPENILMN-GAVLKLIDLGSSVSVS----TVVLPDLEFASPEMLTSPATAGPSTD 275
H+D+ N+L++ V K+ D G + S T LP +++ +PE L + S D
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP-VKWTAPEALREKKFSTKS-D 181
Query: 276 MWSLGVLLYILLS-GVSPF 293
+WS G+LL+ + S G P+
Sbjct: 182 VWSFGILLWEIYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.001
Identities = 60/254 (23%), Positives = 102/254 (40%), Gaps = 36/254 (14%)
Query: 107 RLGNGRFCTVRKARDRGTGQLVALKQI-PRERQPQQITRAEYNLLSTLMHAHIPTALALF 165
+LG G F V GT + VA+K + P P+ + E ++ L H + A+
Sbjct: 13 KLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQLYAVV 70
Query: 166 ENAPVPGTDTIVMQLVHGESLIQHLCRQST--ITESYICCIIRQLHSALHCLHSQQIAHK 223
P+ IV + + SL+ L + + + + Q+ S + + H+
Sbjct: 71 SEEPI----YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 126
Query: 224 DIRPENILM-NGAVLKLIDLGSSVSVSTVVLPDLEFAS------PEMLTSPATA-----G 271
D+R NIL+ V K+ D G + ++ D E+ + P T+P A
Sbjct: 127 DLRAANILVGENLVCKVADFGLA-----RLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 272 PSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFP-PEQCGHISVPA--REL 327
+D+WS G+LL L + G P+ E + Y P P +C P +L
Sbjct: 182 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPEC-----PESLHDL 235
Query: 328 IGQLLNTHADKRPT 341
+ Q ++RPT
Sbjct: 236 MCQCWRKEPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.002
Identities = 57/249 (22%), Positives = 99/249 (39%), Gaps = 21/249 (8%)
Query: 105 LERLGNGRFCTVRKARDRGTGQLVALKQI-PRERQPQQITRAEYNLLSTLMHAHIPTALA 163
L +LG G+F V + T VA+K + P P+ E ++ L H P +
Sbjct: 11 LRKLGAGQFGEVWEGLWNNTTP-VAVKTLKPGTMDPKDFLA-EAQIMKKLRH---PKLIQ 65
Query: 164 LFENAPVPGTDTIVMQLVHGESLIQHLCRQ--STITESYICCIIRQLHSALHCLHSQQIA 221
L+ + IV +L+ SL+++L + + + Q+ S + L +Q
Sbjct: 66 LYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYI 125
Query: 222 HKDIRPENILM-NGAVLKLIDLG-SSVSVSTVVLPDLEFASPEMLTSPATAGPS-----T 274
H+D+ N+L+ + K+ D G + V + P T+P A + +
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKS 185
Query: 275 DMWSLGVLLY-ILLSGVSPFLDESEEETRAHISVADYSFP-PEQCGHISVPARELIGQLL 332
D+WS G+LL I+ G P+ + E + Y P P C +++
Sbjct: 186 DVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD-QGYRMPCPPGC---PKELYDIMLDCW 241
Query: 333 NTHADKRPT 341
D RPT
Sbjct: 242 KEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.003
Identities = 40/163 (24%), Positives = 65/163 (39%), Gaps = 35/163 (21%)
Query: 150 LSTLMHAHIPTALALFENAPVPGTDTI-VMQLVHGESLIQHLCRQSTITESYICCIIRQL 208
L+ + AH P A+ L + P + + Q++H I Q+
Sbjct: 94 LNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH---------------------IASQI 132
Query: 209 HSALHCLHSQQIAHKDIRPENILM-NGAVLKLIDLGSSVSVST---------VVLPDLEF 258
S + L SQ H+D+ N L+ ++K+ D G S V + +LP + +
Sbjct: 133 ASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP-IRW 191
Query: 259 ASPEMLTSPATAGPSTDMWSLGVLLY-ILLSGVSPFLDESEEE 300
PE + S D+WS GV+L+ I G P+ S E
Sbjct: 192 MPPESIMYRKFTTES-DVWSFGVILWEIFTYGKQPWFQLSNTE 233
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.004
Identities = 37/147 (25%), Positives = 64/147 (43%), Gaps = 8/147 (5%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLSTLMHAH 157
+ +++ LG G F V A T L A+K + ++ R +AE ++L+ A
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILA---EAD 59
Query: 158 IPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHS 217
+ L+ + VM + G ++ L R E I +L A+ +H
Sbjct: 60 NEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHK 119
Query: 218 QQIAHKDIRPENILMN-GAVLKLIDLG 243
H+DI+P+NIL++ +KL D G
Sbjct: 120 MGFIHRDIKPDNILIDLDGHIKLTDFG 146
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 380 | |||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG0033|consensus | 355 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0581|consensus | 364 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| KOG0583|consensus | 370 | 100.0 | ||
| KOG0588|consensus | 786 | 100.0 | ||
| KOG0032|consensus | 382 | 100.0 | ||
| KOG0593|consensus | 396 | 100.0 | ||
| KOG0595|consensus | 429 | 100.0 | ||
| KOG0605|consensus | 550 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| KOG0599|consensus | 411 | 100.0 | ||
| KOG0659|consensus | 318 | 100.0 | ||
| KOG0661|consensus | 538 | 100.0 | ||
| KOG0585|consensus | 576 | 100.0 | ||
| KOG0663|consensus | 419 | 100.0 | ||
| KOG0580|consensus | 281 | 100.0 | ||
| KOG0600|consensus | 560 | 100.0 | ||
| KOG0694|consensus | 694 | 100.0 | ||
| KOG0591|consensus | 375 | 100.0 | ||
| KOG0611|consensus | 668 | 100.0 | ||
| KOG0578|consensus | 550 | 100.0 | ||
| KOG0198|consensus | 313 | 100.0 | ||
| KOG0604|consensus | 400 | 100.0 | ||
| KOG0597|consensus | 808 | 100.0 | ||
| KOG0660|consensus | 359 | 100.0 | ||
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0582|consensus | 516 | 100.0 | ||
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0610|consensus | 459 | 100.0 | ||
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0201|consensus | 467 | 100.0 | ||
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594|consensus | 323 | 100.0 | ||
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG4717|consensus | 864 | 100.0 | ||
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0607|consensus | 463 | 100.0 | ||
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667|consensus | 586 | 100.0 | ||
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0658|consensus | 364 | 100.0 | ||
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0690|consensus | 516 | 100.0 | ||
| KOG0192|consensus | 362 | 100.0 | ||
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4236|consensus | 888 | 100.0 | ||
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0589|consensus | 426 | 100.0 | ||
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0579|consensus | 1187 | 100.0 | ||
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0586|consensus | 596 | 100.0 | ||
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0197|consensus | 468 | 100.0 | ||
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0612|consensus | 1317 | 100.0 | ||
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0986|consensus | 591 | 100.0 | ||
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0577|consensus | 948 | 100.0 | ||
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG4279|consensus | 1226 | 100.0 | ||
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0662|consensus | 292 | 100.0 | ||
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0574|consensus | 502 | 100.0 | ||
| KOG1989|consensus | 738 | 100.0 | ||
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0671|consensus | 415 | 100.0 | ||
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0696|consensus | 683 | 100.0 | ||
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0596|consensus | 677 | 100.0 | ||
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG2345|consensus | 302 | 100.0 | ||
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4721|consensus | 904 | 100.0 | ||
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0669|consensus | 376 | 100.0 | ||
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0603|consensus | 612 | 100.0 | ||
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0614|consensus | 732 | 100.0 | ||
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0666|consensus | 438 | 100.0 | ||
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4645|consensus | 1509 | 100.0 | ||
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0983|consensus | 391 | 100.0 | ||
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1035|consensus | 1351 | 100.0 | ||
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0584|consensus | 632 | 100.0 | ||
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0193|consensus | 678 | 100.0 | ||
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0608|consensus | 1034 | 100.0 | ||
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0194|consensus | 474 | 100.0 | ||
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0587|consensus | 953 | 100.0 | ||
| KOG1151|consensus | 775 | 100.0 | ||
| KOG1026|consensus | 774 | 100.0 | ||
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG1187|consensus | 361 | 100.0 | ||
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1006|consensus | 361 | 100.0 | ||
| KOG0668|consensus | 338 | 100.0 | ||
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0196|consensus | 996 | 100.0 | ||
| KOG4250|consensus | 732 | 100.0 | ||
| KOG1095|consensus | 1025 | 100.0 | ||
| KOG0695|consensus | 593 | 100.0 | ||
| KOG0670|consensus | 752 | 100.0 | ||
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1290|consensus | 590 | 100.0 | ||
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG4278|consensus | 1157 | 100.0 | ||
| KOG0665|consensus | 369 | 100.0 | ||
| KOG4257|consensus | 974 | 100.0 | ||
| KOG0664|consensus | 449 | 100.0 | ||
| KOG1094|consensus | 807 | 100.0 | ||
| KOG0199|consensus | 1039 | 100.0 | ||
| KOG1027|consensus | 903 | 100.0 | ||
| KOG2052|consensus | 513 | 100.0 | ||
| KOG1152|consensus | 772 | 100.0 | ||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0576|consensus | 829 | 100.0 | ||
| KOG3653|consensus | 534 | 100.0 | ||
| KOG0200|consensus | 609 | 100.0 | ||
| KOG1167|consensus | 418 | 100.0 | ||
| KOG0984|consensus | 282 | 100.0 | ||
| KOG1345|consensus | 378 | 100.0 | ||
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG1025|consensus | 1177 | 100.0 | ||
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG0590|consensus | 601 | 99.96 | ||
| KOG1024|consensus | 563 | 99.96 | ||
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.95 | |
| KOG1164|consensus | 322 | 99.95 | ||
| KOG1163|consensus | 341 | 99.95 | ||
| KOG0603|consensus | 612 | 99.94 | ||
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG1165|consensus | 449 | 99.94 | ||
| KOG0606|consensus | 1205 | 99.93 | ||
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| KOG1240|consensus | 1431 | 99.91 | ||
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.91 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.91 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.89 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.89 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.87 | |
| KOG4158|consensus | 598 | 99.87 | ||
| PRK10345 | 210 | hypothetical protein; Provisional | 99.86 | |
| KOG1166|consensus | 974 | 99.85 | ||
| KOG0195|consensus | 448 | 99.82 | ||
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.82 | |
| KOG1033|consensus | 516 | 99.82 | ||
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.81 | |
| KOG0590|consensus | 601 | 99.81 | ||
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.8 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.78 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.77 | |
| KOG1023|consensus | 484 | 99.73 | ||
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.71 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.71 | |
| KOG0606|consensus | 1205 | 99.67 | ||
| KOG0601|consensus | 524 | 99.65 | ||
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.61 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.58 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.53 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.52 | |
| KOG1266|consensus | 458 | 99.48 | ||
| KOG0601|consensus | 524 | 99.44 | ||
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.33 | |
| KOG1243|consensus | 690 | 99.33 | ||
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.32 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.27 | |
| KOG3087|consensus | 229 | 99.23 | ||
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.14 | |
| KOG3741|consensus | 655 | 99.13 | ||
| KOG2137|consensus | 700 | 99.07 | ||
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.97 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.94 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.9 | |
| KOG0576|consensus | 829 | 98.84 | ||
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.76 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.68 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.68 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.67 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.62 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.54 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.5 | |
| KOG1035|consensus | 1351 | 98.38 | ||
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.37 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.27 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.23 | |
| KOG1235|consensus | 538 | 98.06 | ||
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.06 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.06 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.96 | |
| KOG2270|consensus | 520 | 97.91 | ||
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.9 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.84 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.8 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.69 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.68 | |
| KOG2268|consensus | 465 | 97.64 | ||
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.55 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.54 | |
| KOG1826|consensus | 2724 | 97.49 | ||
| PRK10593 | 297 | hypothetical protein; Provisional | 97.38 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.33 | |
| KOG1093|consensus | 725 | 97.24 | ||
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.18 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.16 | |
| PLN02236 | 344 | choline kinase | 97.05 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.04 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.88 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.83 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.82 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.81 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.7 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.7 | |
| KOG0613|consensus | 1205 | 96.6 | ||
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.31 | |
| PTZ00296 | 442 | choline kinase; Provisional | 96.2 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.19 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.18 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.85 | |
| PF00041 | 85 | fn3: Fibronectin type III domain; InterPro: IPR003 | 95.81 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.75 |
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-65 Score=470.11 Aligned_cols=259 Identities=31% Similarity=0.542 Sum_probs=235.8
Q ss_pred hhhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC--------chHHHHHHHHHHHhhccCCCcceeeecc
Q psy11098 95 QEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ--------PQQITRAEYNLLSTLMHAHIPTALALFE 166 (380)
Q Consensus 95 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--------~~~~~~~E~~il~~l~h~ni~~i~~~~~ 166 (380)
.+.+.+.|.+.+.||+|+||.|.+|..+.||+.||||++++... .....++|++||+.|+||||++++++|+
T Consensus 167 pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~ 246 (475)
T KOG0615|consen 167 PKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFE 246 (475)
T ss_pred cchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeee
Confidence 46688999999999999999999999999999999999965322 1233478999999999999999999999
Q ss_pred cccCCCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeCC----eeEEEeC
Q psy11098 167 NAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGA----VLKLIDL 242 (380)
Q Consensus 167 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~~----~ikl~DF 242 (380)
.. +..||||||+.||+|++++..++.+.|...+.+++|++.||.|||++||+||||||+|||+.+. .+||+||
T Consensus 247 ~~---ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 247 VP---DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred cC---CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEeccc
Confidence 85 6679999999999999999999999999999999999999999999999999999999999743 7999999
Q ss_pred CCccccc-----ccccCCCcccCCccccCCC--CCCCcccHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHhcccCCCCC
Q psy11098 243 GSSVSVS-----TVVLPDLEFASPEMLTSPA--TAGPSTDMWSLGVLLYILLSGVSPFLDESEEE-TRAHISVADYSFPP 314 (380)
Q Consensus 243 G~a~~~~-----~~~~gt~~y~aPE~~~~~~--~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~-~~~~i~~~~~~~~~ 314 (380)
|+|+..+ .++||||.|+|||++.+.. .+..++|||||||+||.+|+|.+||.+..... ..++|..+.|.+-+
T Consensus 324 GlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p 403 (475)
T KOG0615|consen 324 GLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGP 403 (475)
T ss_pred chhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccC
Confidence 9998774 6889999999999997642 33458899999999999999999999887666 89999999999999
Q ss_pred CcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCC
Q psy11098 315 EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASC 356 (380)
Q Consensus 315 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~ 356 (380)
..|..+|+++++||++||..||++|||++|+|+||||+..++
T Consensus 404 ~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~ 445 (475)
T KOG0615|consen 404 LQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPC 445 (475)
T ss_pred hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccc
Confidence 999999999999999999999999999999999999997754
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-60 Score=456.47 Aligned_cols=247 Identities=31% Similarity=0.550 Sum_probs=234.1
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecC----CCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPR----ERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~----~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
.+|...+.||+|||+.||.+++..+|+.||+|++.+ .....+...+||+|.+.|+||||++++++|++. +++|
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs---~nVY 94 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDS---NNVY 94 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecC---CceE
Confidence 689999999999999999999999999999999976 455677889999999999999999999999985 7899
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeCC-eeEEEeCCCccccc-----
Q psy11098 176 IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGA-VLKLIDLGSSVSVS----- 249 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~~-~ikl~DFG~a~~~~----- 249 (380)
||+|+|..++|.++++..+.++|.+++.+++||+.||.|||+++|+|||||..|+|++++ +|||+|||||..+.
T Consensus 95 ivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er 174 (592)
T KOG0575|consen 95 IVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER 174 (592)
T ss_pred EEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccc
Confidence 999999999999999999999999999999999999999999999999999999999976 99999999999875
Q ss_pred -ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHH
Q psy11098 250 -TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELI 328 (380)
Q Consensus 250 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 328 (380)
.+.||||.|.|||++.. ..+++.+||||+||++|.||.|++||...+..+++..|+..+|.+|. .+|.++++||
T Consensus 175 k~TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~----~ls~~A~dLI 249 (592)
T KOG0575|consen 175 KKTLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS----HLSAEAKDLI 249 (592)
T ss_pred cceecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc----ccCHHHHHHH
Confidence 57899999999999997 68899999999999999999999999999999999999999999986 5899999999
Q ss_pred HHhcccCCCCCCCHHHHHhccccccc
Q psy11098 329 GQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 329 ~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
.+||.+||.+|||++++|.|+||++.
T Consensus 250 ~~lL~~~P~~Rpsl~~vL~h~Ff~~g 275 (592)
T KOG0575|consen 250 RKLLRPNPSERPSLDEVLDHPFFKSG 275 (592)
T ss_pred HHHhcCCcccCCCHHHHhcCHhhhCC
Confidence 99999999999999999999999654
|
|
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-60 Score=413.29 Aligned_cols=274 Identities=30% Similarity=0.489 Sum_probs=248.7
Q ss_pred hhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC---CCchHHHHHHHHHHHhhccCCCcceeeecccccCCCc
Q psy11098 97 QFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE---RQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGT 173 (380)
Q Consensus 97 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~ 173 (380)
.|.+.|++.+.||+|.|+.|+++.+..||+.+|+|++... ...-+.+.+|++|.+.|+||||+++.+.+... +.
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~---~~ 84 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE---SF 84 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhccc---ce
Confidence 4788999999999999999999999999999999999532 33557788999999999999999999988775 66
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC---C-eeEEEeCCCccccc
Q psy11098 174 DTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG---A-VLKLIDLGSSVSVS 249 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~---~-~ikl~DFG~a~~~~ 249 (380)
.|||+|++.|++|..-|....-++|..+..+++||++||.|+|.+||||||+||+|+|+.+ + -+||+|||+|..++
T Consensus 85 ~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 85 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred eEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 7999999999999998888888999999999999999999999999999999999999953 2 79999999998775
Q ss_pred -----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHH
Q psy11098 250 -----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPA 324 (380)
Q Consensus 250 -----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 324 (380)
..+.|||.|||||++.. ..|+..+|||+.|||||.||.|.+||.+.+...+.++|+++.++++..+|+.+++++
T Consensus 165 ~g~~~~G~~GtP~fmaPEvvrk-dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~A 243 (355)
T KOG0033|consen 165 DGEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEA 243 (355)
T ss_pred CccccccccCCCcccCHHHhhc-CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHH
Confidence 35678999999999988 589999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhcccccccCCC------CCccccccchHHHHHHH
Q psy11098 325 RELIGQLLNTHADKRPTAGQLLQVAWFAEASCS------EFDTERLLPFSARRKQK 374 (380)
Q Consensus 325 ~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~~------~~~~~~~~~~~~~~~~~ 374 (380)
++||++||..||.+|+|+.|+|+|||+.+-..- .---+.|++|.+|||-|
T Consensus 244 k~LvrrML~~dP~kRIta~EAL~HpWi~~r~~~As~~H~~dtvd~lrkfNarRKLK 299 (355)
T KOG0033|consen 244 KSLIRRMLTVNPKKRITADEALKHPWICNRERVASAIHRQDTVDCLKKFNARRKLK 299 (355)
T ss_pred HHHHHHHhccChhhhccHHHHhCCchhcchHHHHHHhhhHHHHHHHHHhhHHHHHH
Confidence 999999999999999999999999999875421 22245789999999965
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-58 Score=420.30 Aligned_cols=263 Identities=28% Similarity=0.476 Sum_probs=238.8
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC----CchHHHHHHHHHHHhhccCCCcceeeecccccCCCce
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~ 174 (380)
-++|++++.||+|+||+||.++.+.|++.||+|++++.. .+.....+|..||..++||.|++++-.|+.. +.+
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~---~kL 100 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTE---EKL 100 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccC---CeE
Confidence 468999999999999999999999999999999997643 3456678899999999999999988888774 788
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccc-----
Q psy11098 175 TIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSV----- 248 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~----- 248 (380)
|+|+||+.||+|+..|++.+.++|..++.++.+|+.||.|||++|||||||||+|||+| .|.|+|+|||+++..
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~ 180 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD 180 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence 99999999999999999999999999999999999999999999999999999999999 689999999999743
Q ss_pred -cccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHH
Q psy11098 249 -STVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAREL 327 (380)
Q Consensus 249 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 327 (380)
+.+++||++|||||++.. ..|+..+|+||||+++|+|++|.+||.+.+..+..+.|..+....++. .++.++++|
T Consensus 181 ~t~tfcGT~eYmAPEil~~-~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~---~ls~~ardl 256 (357)
T KOG0598|consen 181 ATRTFCGTPEYMAPEILLG-KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPG---YLSEEARDL 256 (357)
T ss_pred ccccccCCccccChHHHhc-CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCc---cCCHHHHHH
Confidence 367899999999999999 488999999999999999999999999999999999999888544432 479999999
Q ss_pred HHHhcccCCCCCC----CHHHHHhcccccccCCCCCccccccchH
Q psy11098 328 IGQLLNTHADKRP----TAGQLLQVAWFAEASCSEFDTERLLPFS 368 (380)
Q Consensus 328 i~~~L~~dP~~Rp----t~~e~L~hpw~~~~~~~~~~~~~~~~~~ 368 (380)
|+++|.+||++|. .+.++-+||||....++++...++.|-+
T Consensus 257 l~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF 301 (357)
T KOG0598|consen 257 LKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSPPF 301 (357)
T ss_pred HHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCCCe
Confidence 9999999999996 7999999999999998888887776643
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-56 Score=409.78 Aligned_cols=258 Identities=29% Similarity=0.371 Sum_probs=226.2
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC--CCchHHHHHHHHHHHhhccCCCcceeeecccccCCC-ceE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE--RQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPG-TDT 175 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~-~~~ 175 (380)
.++.+.++.||+|..|+||+++|+.|++.+|+|++... .....++.+|+++++...||+|+.+++.|... + .++
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~---~~~is 154 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSN---GEEIS 154 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeC---CceEE
Confidence 45667788999999999999999999999999999543 33456778899999999999999999988874 4 489
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeecCCCCcEEEe-CCeeEEEeCCCccccc----
Q psy11098 176 IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHS-QQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS---- 249 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~-~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~---- 249 (380)
|+||||+||+|.+++...+.++|..+..++.+|++||.|||. ++||||||||+|||++ .|.|||||||.|..+.
T Consensus 155 I~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS~a 234 (364)
T KOG0581|consen 155 ICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNSIA 234 (364)
T ss_pred eehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhhhc
Confidence 999999999999999988999999999999999999999995 9999999999999998 5799999999988663
Q ss_pred ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHhcccCCCCCCcCCCCCHHH
Q psy11098 250 TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDE-----SEEETRAHISVADYSFPPEQCGHISVPA 324 (380)
Q Consensus 250 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~-----~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 324 (380)
++++||..|||||.+.+ ..|+.++||||||+.++|+++|+.||... ...+.+..|......-.+. ..+|+++
T Consensus 235 ~tfvGT~~YMsPERi~g-~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~--~~fS~ef 311 (364)
T KOG0581|consen 235 NTFVGTSAYMSPERISG-ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPE--GEFSPEF 311 (364)
T ss_pred ccccccccccChhhhcC-CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCc--ccCCHHH
Confidence 67899999999999999 58899999999999999999999999774 5667777776643322222 1489999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhcccccccCCCCCccc
Q psy11098 325 RELIGQLLNTHADKRPTAGQLLQVAWFAEASCSEFDTE 362 (380)
Q Consensus 325 ~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~~~~~~~ 362 (380)
++||..||++||.+|||++|+|+|||+++...+..+..
T Consensus 312 ~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~vd~~ 349 (364)
T KOG0581|consen 312 RSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPNVDMA 349 (364)
T ss_pred HHHHHHHhcCCcccCCCHHHHhcCHHHhhcccccccHH
Confidence 99999999999999999999999999998877766644
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-56 Score=396.33 Aligned_cols=260 Identities=26% Similarity=0.464 Sum_probs=238.3
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC----chHHHHHHHHHHHhhccCCCcceeeecccccCCCce
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ----PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~ 174 (380)
.++|+.++.||.|+||.|.+++++.+|..||+|++.+..- +.+...+|..+|+.+.||.++++...+... +.+
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~---~~l 119 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDN---SNL 119 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccC---CeE
Confidence 4678999999999999999999999999999999976532 345567899999999999998888777664 788
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc---c
Q psy11098 175 TIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS---T 250 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~---~ 250 (380)
||||||+.||+|+.++.+.++++|..++.++.||+.||+|||+++|++|||||||||+| +|.+||+|||+|+.+. -
T Consensus 120 ymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~rT~ 199 (355)
T KOG0616|consen 120 YMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGRTW 199 (355)
T ss_pred EEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCcEE
Confidence 99999999999999999999999999999999999999999999999999999999999 6899999999999886 4
Q ss_pred cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHH
Q psy11098 251 VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQ 330 (380)
Q Consensus 251 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 330 (380)
+.||||+|+|||++.. ..++.++|+|||||++|||+.|.+||.+.+...+.++|..+++.||. .++.+++|||++
T Consensus 200 TlCGTPeYLAPEii~s-k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~----~fs~~~kdLl~~ 274 (355)
T KOG0616|consen 200 TLCGTPEYLAPEIIQS-KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPS----YFSSDAKDLLKK 274 (355)
T ss_pred EecCCccccChHHhhc-CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCc----ccCHHHHHHHHH
Confidence 6899999999999999 58999999999999999999999999999999999999999999996 479999999999
Q ss_pred hcccCCCCC-----CCHHHHHhcccccccCCCCCccccccc
Q psy11098 331 LLNTHADKR-----PTAGQLLQVAWFAEASCSEFDTERLLP 366 (380)
Q Consensus 331 ~L~~dP~~R-----pt~~e~L~hpw~~~~~~~~~~~~~~~~ 366 (380)
+|+.|-.+| ....++.+||||....+..+...++.+
T Consensus 275 LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~ie~ 315 (355)
T KOG0616|consen 275 LLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKIEP 315 (355)
T ss_pred HHhhhhHhhhcCcCCCccccccCcccccccHHHHhhccccC
Confidence 999999999 367899999999998887777767643
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-54 Score=415.74 Aligned_cols=249 Identities=33% Similarity=0.530 Sum_probs=228.7
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC-----C-CchHHHHHHHHHHHhhc-cCCCcceeeecccccC
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE-----R-QPQQITRAEYNLLSTLM-HAHIPTALALFENAPV 170 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~-----~-~~~~~~~~E~~il~~l~-h~ni~~i~~~~~~~~~ 170 (380)
...+|.+.+.||+|+||+|++|++..+++.||+|++.+. . ...+.+.+|+.+++.++ ||||+++++++...
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~-- 92 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP-- 92 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC--
Confidence 467899999999999999999999999999999988654 1 23456678999999999 99999999998875
Q ss_pred CCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC--CeeEEEeCCCcccc
Q psy11098 171 PGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG--AVLKLIDLGSSVSV 248 (380)
Q Consensus 171 ~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~--~~ikl~DFG~a~~~ 248 (380)
..+|+||||+.||+|++++.+.+.+.|.+++.+++||+.||+|||++||+||||||+|||++. +++||+|||++...
T Consensus 93 -~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 93 -TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred -CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 558999999999999999999999999999999999999999999999999999999999984 69999999999866
Q ss_pred -c-----ccccCCCcccCCccccCCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCC-
Q psy11098 249 -S-----TVVLPDLEFASPEMLTSPA-TAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHI- 320 (380)
Q Consensus 249 -~-----~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~- 320 (380)
. .+.+||+.|+|||++.+.. +.+.++||||+||+||.|++|..||.+.+...+...|..+.+.+|.. +
T Consensus 172 ~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~----~~ 247 (370)
T KOG0583|consen 172 PGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSY----LL 247 (370)
T ss_pred CCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCC----cC
Confidence 1 6789999999999999976 66799999999999999999999999999999999999999988864 4
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHhcccccc
Q psy11098 321 SVPARELIGQLLNTHADKRPTAGQLLQVAWFAE 353 (380)
Q Consensus 321 s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~ 353 (380)
|.++++|+++||..||.+|+|+.++++||||+.
T Consensus 248 S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 248 SPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred CHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 999999999999999999999999999999997
|
|
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-54 Score=421.39 Aligned_cols=251 Identities=25% Similarity=0.441 Sum_probs=232.0
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC----CCchHHHHHHHHHHHhhccCCCcceeeecccccCCCce
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~ 174 (380)
-.-|++.+.||+|+-|.|-+|+|..||+.+|||++.+. ......+.+||-||+.+.|||++.+++.++.. ..+
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~---~~l 87 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENK---QHL 87 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccC---ceE
Confidence 34588899999999999999999999999999999755 22346678899999999999999988888874 678
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc----
Q psy11098 175 TIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS---- 249 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~---- 249 (380)
|+|+||+.||+|++++...+.++|.+++.+++||+.|+.|||..+|+||||||+|+|+| .++|||+|||+|....
T Consensus 88 ylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gkl 167 (786)
T KOG0588|consen 88 YLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKL 167 (786)
T ss_pred EEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCcc
Confidence 99999999999999999999999999999999999999999999999999999999998 4579999999997442
Q ss_pred -ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHH
Q psy11098 250 -TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELI 328 (380)
Q Consensus 250 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 328 (380)
.+.||.|.|.|||++.|..+.+.++||||+|||||.||+|+.||.+++...++.++..+.+.+|. .+|.++++||
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs----~Is~eaQdLL 243 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPS----NISSEAQDLL 243 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCC----cCCHHHHHHH
Confidence 67899999999999999888899999999999999999999999999999999999999999984 6999999999
Q ss_pred HHhcccCCCCCCCHHHHHhcccccccCC
Q psy11098 329 GQLLNTHADKRPTAGQLLQVAWFAEASC 356 (380)
Q Consensus 329 ~~~L~~dP~~Rpt~~e~L~hpw~~~~~~ 356 (380)
++||..||++|+|.+|+++|||+.....
T Consensus 244 r~ml~VDp~~RiT~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 244 RRMLDVDPSTRITTEEILKHPFLSGYTS 271 (786)
T ss_pred HHHhccCccccccHHHHhhCchhhcCCC
Confidence 9999999999999999999999987643
|
|
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-53 Score=412.56 Aligned_cols=254 Identities=35% Similarity=0.584 Sum_probs=236.2
Q ss_pred hhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC----chHHHHHHHHHHHhhc-cCCCcceeeecccccC
Q psy11098 96 EQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ----PQQITRAEYNLLSTLM-HAHIPTALALFENAPV 170 (380)
Q Consensus 96 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~E~~il~~l~-h~ni~~i~~~~~~~~~ 170 (380)
+.+...|++.+.||+|.||+||+|+++.||+.+|+|++.+... ......+|+.||+.+. ||||+.+.+.|+..
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~-- 108 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP-- 108 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC--
Confidence 4567899999999999999999999999999999999975543 3467899999999998 99999999999985
Q ss_pred CCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-----CeeEEEeCCCc
Q psy11098 171 PGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-----AVLKLIDLGSS 245 (380)
Q Consensus 171 ~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-----~~ikl~DFG~a 245 (380)
..+++|||++.||+|++.+... .++|.++..+++||+.|+.|||+.||+||||||+|+|+.. +.+|++|||+|
T Consensus 109 -~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 109 -DSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred -CeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 6789999999999999999877 4999999999999999999999999999999999999952 37999999999
Q ss_pred cccc-----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCC
Q psy11098 246 VSVS-----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHI 320 (380)
Q Consensus 246 ~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 320 (380)
.... ...+||+.|+|||++.. ..|+..+||||+||++|.|++|.+||.+.+..+...++..+++.|..+.|..+
T Consensus 187 ~~~~~~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~i 265 (382)
T KOG0032|consen 187 KFIKPGERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDI 265 (382)
T ss_pred eEccCCceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCcccc
Confidence 8775 46789999999999997 58899999999999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 321 SVPARELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 321 s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
|..+++||++||..||.+|+|+.++|+|||++..
T Consensus 266 s~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 266 SESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred CHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 9999999999999999999999999999999975
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-54 Score=389.03 Aligned_cols=250 Identities=26% Similarity=0.461 Sum_probs=217.2
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCc---hHHHHHHHHHHHhhccCCCcceeeecccccCCCceEE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP---QQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
++|+.+.++|+|+||+||+|+++.||+.||||+|.-+..+ .+...+||++|++|+|+|+++++.+|... ..+++
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrk---rklhL 78 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRK---RKLHL 78 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhc---ceeEE
Confidence 4688999999999999999999999999999999655443 46678899999999999999999998874 78899
Q ss_pred EEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-----
Q psy11098 177 VMQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS----- 249 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~----- 249 (380)
|+|||+ -++.+.+.. ...+++..++.+++|++.|+.|+|++++|||||||+|||++ ++.+||||||+|+.+.
T Consensus 79 VFE~~d-hTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~ 157 (396)
T KOG0593|consen 79 VFEYCD-HTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDN 157 (396)
T ss_pred Eeeecc-hHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcch
Confidence 999995 455565655 45799999999999999999999999999999999999998 6799999999999875
Q ss_pred -ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCC-----------------
Q psy11098 250 -TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYS----------------- 311 (380)
Q Consensus 250 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~----------------- 311 (380)
+..+.|.+|+|||.+.+...|+.++||||+||++.||++|.+.|.+.++-+.+..|.....+
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G 237 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG 237 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence 34567999999999999889999999999999999999999999999998887777543221
Q ss_pred --CCC--------CcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccc
Q psy11098 312 --FPP--------EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAE 353 (380)
Q Consensus 312 --~~~--------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~ 353 (380)
+|. ..+.+++.-+.||+++||..||++|++.+|+|.|+||..
T Consensus 238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 111 123467778899999999999999999999999999953
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-54 Score=398.23 Aligned_cols=252 Identities=28% Similarity=0.456 Sum_probs=227.9
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---chHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
..+|.+.++||+|+||+||+|+++.++..||||.+.+... ..+.+..|+.||+.++|+||+.++++.... +.+|
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~---~~i~ 85 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDD---DFIY 85 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecC---CeEE
Confidence 4679999999999999999999999999999999976542 345567899999999999999999988874 7899
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-------CeeEEEeCCCcccc
Q psy11098 176 IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-------AVLKLIDLGSSVSV 248 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-------~~ikl~DFG~a~~~ 248 (380)
+|||||+||+|.++|.+.+.++|..++.++.||+.||++||+++||||||||+|||++. -.+||+|||+|+.+
T Consensus 86 lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 86 LVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 99999999999999999999999999999999999999999999999999999999963 25899999999987
Q ss_pred c-----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHH
Q psy11098 249 S-----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVP 323 (380)
Q Consensus 249 ~-----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 323 (380)
. .+.||+|.|||||++.. ..|+.|+|+||+|+|+|+|++|+.||...+..+.+..+.++....+... ..++..
T Consensus 166 ~~~~~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~-~~~s~~ 243 (429)
T KOG0595|consen 166 QPGSMAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLP-AELSNP 243 (429)
T ss_pred CchhHHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchh-hhccCc
Confidence 5 57899999999999987 5888899999999999999999999999999999999888776655432 346777
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 324 ARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 324 ~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
..+++..+|..|+.+|.+..+.+.|+++....
T Consensus 244 ~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 244 LRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred hhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 88999999999999999999999999998665
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-54 Score=408.81 Aligned_cols=261 Identities=27% Similarity=0.471 Sum_probs=230.4
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC----chHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ----PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
++|+++..||+|+||.||+|+.+.||..||+|++++... +...++.|..||....++.+|+++-.|+.. +++|
T Consensus 141 ~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~---~~LY 217 (550)
T KOG0605|consen 141 DDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDK---EYLY 217 (550)
T ss_pred ccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCC---CeeE
Confidence 679999999999999999999999999999999987543 345678899999999999998888888774 7899
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccc------
Q psy11098 176 IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSV------ 248 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~------ 248 (380)
|||||+.||++..+|.+.+.|+|..++.++.+++.|+..||+.|+|||||||+|+||| .|++||+||||+.-+
T Consensus 218 LiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~ 297 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRI 297 (550)
T ss_pred EEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhh
Confidence 9999999999999999999999999999999999999999999999999999999999 689999999987311
Q ss_pred ---------------------c--------------------------ccccCCCcccCCccccCCCCCCCcccHHHHHH
Q psy11098 249 ---------------------S--------------------------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGV 281 (380)
Q Consensus 249 ---------------------~--------------------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv 281 (380)
. ...+|||.|||||++.+ ..|+..+|+|||||
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~-kgY~~~cDwWSLG~ 376 (550)
T KOG0605|consen 298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG-KGYGKECDWWSLGC 376 (550)
T ss_pred hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc-CCCCccccHHHHHH
Confidence 0 12478999999999999 47899999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHhccc--CCCCCCcCCCCCHHHHHHHHHhcccCCCCCCC---HHHHHhcccccccCC
Q psy11098 282 LLYILLSGVSPFLDESEEETRAHISVAD--YSFPPEQCGHISVPARELIGQLLNTHADKRPT---AGQLLQVAWFAEASC 356 (380)
Q Consensus 282 il~~lltg~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt---~~e~L~hpw~~~~~~ 356 (380)
|+||||.|.+||.+++..++..+|..-. +.+|.+ ..++++++|||.+||. ||++|.. ++||-+||||+...+
T Consensus 377 ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~--~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W 453 (550)
T KOG0605|consen 377 IMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEE--VDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDW 453 (550)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCc--CcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCc
Confidence 9999999999999999999999998766 455544 5688999999999999 9999984 999999999998877
Q ss_pred CCCccccccchH
Q psy11098 357 SEFDTERLLPFS 368 (380)
Q Consensus 357 ~~~~~~~~~~~~ 368 (380)
+.+-... .+|+
T Consensus 454 ~~l~~~~-apfv 464 (550)
T KOG0605|consen 454 DHLREMP-APFV 464 (550)
T ss_pred chhhcCC-CCCC
Confidence 6443333 4443
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-54 Score=408.95 Aligned_cols=252 Identities=29% Similarity=0.486 Sum_probs=228.8
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC----CchHHHHHHHHHHHhh-ccCCCcceeeecccccCCCc
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQITRAEYNLLSTL-MHAHIPTALALFENAPVPGT 173 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~~~~~ 173 (380)
-.+|...+.||.|+|++|++|+++.+++.||||++.+.- ....-+..|-++|..| .||.|++++-.|.+. ..
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~---~s 148 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDE---ES 148 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecc---cc
Confidence 467899999999999999999999999999999996542 2334456799999999 799988877777664 78
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc---
Q psy11098 174 DTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS--- 249 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~--- 249 (380)
+|+|+||+.+|+|+++|.+.+.|+|..++.++.||+.||+|||++|||||||||+|||+| ++.+||+|||.|+.++
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 899999999999999999999999999999999999999999999999999999999999 6799999999987552
Q ss_pred ----------------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCC
Q psy11098 250 ----------------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFP 313 (380)
Q Consensus 250 ----------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~ 313 (380)
..++||-.|++||++.. ...+..+|+|+||||+|+|+.|.+||.+.++--++++|...+|.|+
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp 307 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFP 307 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCC
Confidence 24789999999999998 5889999999999999999999999999999999999999999998
Q ss_pred CCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCCCC
Q psy11098 314 PEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASCSE 358 (380)
Q Consensus 314 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~~~ 358 (380)
+ ++++.++|||+++|..||.+|+|++|+-+||||....+..
T Consensus 308 ~----~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n 348 (604)
T KOG0592|consen 308 E----GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN 348 (604)
T ss_pred C----CCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence 6 5789999999999999999999999999999999876653
|
|
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-54 Score=379.41 Aligned_cols=256 Identities=28% Similarity=0.462 Sum_probs=232.9
Q ss_pred hhhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC------c---hHHHHHHHHHHHhh-ccCCCcceeee
Q psy11098 95 QEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ------P---QQITRAEYNLLSTL-MHAHIPTALAL 164 (380)
Q Consensus 95 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~------~---~~~~~~E~~il~~l-~h~ni~~i~~~ 164 (380)
.++|-..|.-.+.||+|..++|.+|.++.||+.+|+|++..... . .+..++|+.||+++ .||+|+.+.+.
T Consensus 12 a~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ 91 (411)
T KOG0599|consen 12 AKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV 91 (411)
T ss_pred HhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee
Confidence 35677788889999999999999999999999999999953211 1 13456799999998 59999999999
Q ss_pred cccccCCCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeCC-eeEEEeCC
Q psy11098 165 FENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGA-VLKLIDLG 243 (380)
Q Consensus 165 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~~-~ikl~DFG 243 (380)
|+.. ..+++|+|+|..|+|+|++...-+++|.+.+.+++|+++|+.|||.++|+||||||+|||+|++ ++||+|||
T Consensus 92 yes~---sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 92 YESD---AFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred ccCc---chhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccc
Confidence 9874 6679999999999999999999999999999999999999999999999999999999999866 99999999
Q ss_pred Cccccc-----ccccCCCcccCCcccc-----CCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCC
Q psy11098 244 SSVSVS-----TVVLPDLEFASPEMLT-----SPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFP 313 (380)
Q Consensus 244 ~a~~~~-----~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~ 313 (380)
+|+++. ...||||+|+|||.+. +...|+..+|+||+|||+|.||.|.+||......-++..|+.+.+.|.
T Consensus 169 Fa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~ 248 (411)
T KOG0599|consen 169 FACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFR 248 (411)
T ss_pred eeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccC
Confidence 999885 5689999999999874 334678899999999999999999999999888889999999999999
Q ss_pred CCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccc
Q psy11098 314 PEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAE 353 (380)
Q Consensus 314 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~ 353 (380)
.+.|.++|.+.+|||++||+.||++|.|++|+|.||||.+
T Consensus 249 speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 249 SPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred CcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 9999999999999999999999999999999999999964
|
|
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-52 Score=367.60 Aligned_cols=253 Identities=28% Similarity=0.400 Sum_probs=220.5
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCc---hHHHHHHHHHHHhhccCCCcceeeecccccCCCceEE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP---QQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
++|..+++||+|.||.||+|++..||+.||||.++..+.. .-...+||..|+.++|+||+.++++|... +++.|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~---~~l~l 78 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHK---SNLSL 78 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCC---CceEE
Confidence 5788899999999999999999999999999999765443 34567899999999999999999999875 78899
Q ss_pred EEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-----
Q psy11098 177 VMQLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS----- 249 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~----- 249 (380)
|+||+ ..+|...|+.. ..++..+++.++.+++.||+|||++.|+||||||.|+|++ +|.+||+|||+|+.+.
T Consensus 79 VfEfm-~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 79 VFEFM-PTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred EEEec-cccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 99999 67899888764 5699999999999999999999999999999999999998 6799999999999775
Q ss_pred -ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCC-------------
Q psy11098 250 -TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPE------------- 315 (380)
Q Consensus 250 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~------------- 315 (380)
...+.|.+|+|||.+.|.+.|+..+||||+|||+.||+-|.+-|.+.++-+.+..|-..-....++
T Consensus 158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~ 237 (318)
T KOG0659|consen 158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVK 237 (318)
T ss_pred cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence 334679999999999998999999999999999999999999999999888777764322111111
Q ss_pred -----------cCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCC
Q psy11098 316 -----------QCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASC 356 (380)
Q Consensus 316 -----------~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~ 356 (380)
.+...++++.||+.+||..||.+|+|+.|+|+|+||++...
T Consensus 238 ~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~ 289 (318)
T KOG0659|consen 238 IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPL 289 (318)
T ss_pred HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCC
Confidence 23456788999999999999999999999999999997543
|
|
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-53 Score=398.94 Aligned_cols=257 Identities=29% Similarity=0.422 Sum_probs=223.3
Q ss_pred hhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC--chHHHHHHHHHHHhhc-cCCCcceeeecccccCCCc
Q psy11098 97 QFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ--PQQITRAEYNLLSTLM-HAHIPTALALFENAPVPGT 173 (380)
Q Consensus 97 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~-h~ni~~i~~~~~~~~~~~~ 173 (380)
.+.++|.++++||.|+||.||+|+.+.+|..||||.+++.-. ++..-.+|+.-|++|. ||||+++.+++.+.. ..
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~--~~ 84 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDND--RI 84 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccC--ce
Confidence 467899999999999999999999999999999999976533 3445578999999998 999999998887642 27
Q ss_pred eEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc--
Q psy11098 174 DTIVMQLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS-- 249 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~-- 249 (380)
+|+||||| ..+|+++++.+ ..|+|..++.|++||++||+|+|++|+.|||+||||||+. ...|||+|||+|+.+.
T Consensus 85 L~fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 85 LYFVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK 163 (538)
T ss_pred EeeeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccC
Confidence 89999999 78999999764 6799999999999999999999999999999999999999 6799999999999875
Q ss_pred ---ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-------------------
Q psy11098 250 ---TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISV------------------- 307 (380)
Q Consensus 250 ---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~------------------- 307 (380)
+..+.|.+|+|||++.....|+.++||||+|||++|+++-++.|.|.++.+...+|..
T Consensus 164 pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~ 243 (538)
T KOG0661|consen 164 PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASA 243 (538)
T ss_pred CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHH
Confidence 4567799999999998878999999999999999999999999999988777666642
Q ss_pred ccCCCCCC-------cCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCC
Q psy11098 308 ADYSFPPE-------QCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASC 356 (380)
Q Consensus 308 ~~~~~~~~-------~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~ 356 (380)
..+.+|.. .....+.++.++|.+||.+||.+||||+|+|+||||+....
T Consensus 244 mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~ 299 (538)
T KOG0661|consen 244 MNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRA 299 (538)
T ss_pred hccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence 12233321 12347889999999999999999999999999999997643
|
|
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-52 Score=393.31 Aligned_cols=257 Identities=26% Similarity=0.449 Sum_probs=226.7
Q ss_pred hhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---------------chHHHHHHHHHHHhhccCCCcce
Q psy11098 97 QFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---------------PQQITRAEYNLLSTLMHAHIPTA 161 (380)
Q Consensus 97 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---------------~~~~~~~E~~il~~l~h~ni~~i 161 (380)
...++|++.+.||+|.||+|.+|++..+++.||||++.+... ..+..++||.||+++.|+|++++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 346789999999999999999999999999999999965321 22577899999999999999999
Q ss_pred eeecccccCCCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEE
Q psy11098 162 LALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLI 240 (380)
Q Consensus 162 ~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~ 240 (380)
+.+.+.-. .+.+|||+|||..|.+...=.....+++.+++.|+++++.||+|||.+|||||||||.|+|++ +|++||+
T Consensus 174 iEvLDDP~-s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIs 252 (576)
T KOG0585|consen 174 IEVLDDPE-SDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKIS 252 (576)
T ss_pred EEeecCcc-cCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEee
Confidence 99988644 468999999999998865443344499999999999999999999999999999999999997 6799999
Q ss_pred eCCCccccc-----------ccccCCCcccCCccccC---CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Q psy11098 241 DLGSSVSVS-----------TVVLPDLEFASPEMLTS---PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHIS 306 (380)
Q Consensus 241 DFG~a~~~~-----------~~~~gt~~y~aPE~~~~---~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~ 306 (380)
|||.+.... ....|||.|+|||...+ ....+++.|||||||+||+|+.|+.||.++...++..+|.
T Consensus 253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIv 332 (576)
T KOG0585|consen 253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIV 332 (576)
T ss_pred ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHh
Confidence 999987551 34689999999999876 3355789999999999999999999999999999999999
Q ss_pred cccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCC
Q psy11098 307 VADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASC 356 (380)
Q Consensus 307 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~ 356 (380)
.....+|.. ..+..+++|||.+||++||++|+++.++..|||......
T Consensus 333 n~pL~fP~~--pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~ 380 (576)
T KOG0585|consen 333 NDPLEFPEN--PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGD 380 (576)
T ss_pred cCcccCCCc--ccccHHHHHHHHHHhhcChhheeehhhheecceeccCCC
Confidence 998888864 468999999999999999999999999999999987643
|
|
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-52 Score=376.65 Aligned_cols=271 Identities=25% Similarity=0.393 Sum_probs=226.4
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCch---HHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQ---QITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~---~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
-+.|+.+++|++|+||.||+|+++.|++.||+|.++.+.... -...+||++|.+.+|+||+.+..+..-.. -+.+|
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~-~d~iy 153 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN-MDKIY 153 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc-cceee
Confidence 467999999999999999999999999999999997654332 23478999999999999999988876543 45799
Q ss_pred EEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc----
Q psy11098 176 IVMQLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS---- 249 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~---- 249 (380)
|||||| ..+|...+.+- .+|...+++.++.|++.|++|||.+.|+|||||++|+|++ .|.+||+|||+|+.++
T Consensus 154 ~VMe~~-EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k 232 (419)
T KOG0663|consen 154 IVMEYV-EHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK 232 (419)
T ss_pred eeHHHH-HhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCcc
Confidence 999999 56788888764 4899999999999999999999999999999999999997 5799999999999886
Q ss_pred --ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc-------------------
Q psy11098 250 --TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVA------------------- 308 (380)
Q Consensus 250 --~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~------------------- 308 (380)
+..+-|.+|+|||.+.+...|+.++||||+|||+.||+++++-|.+.+..+.+..|-..
T Consensus 233 ~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k 312 (419)
T KOG0663|consen 233 PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVK 312 (419)
T ss_pred cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhh
Confidence 34566999999999999899999999999999999999999999999888777766321
Q ss_pred cCCCCCC-------cCC--CCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCCCCCccccccchHHHHH
Q psy11098 309 DYSFPPE-------QCG--HISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASCSEFDTERLLPFSARRK 372 (380)
Q Consensus 309 ~~~~~~~-------~~~--~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~~~~~~~~~~~~~~~~~ 372 (380)
...++.. .+. .+++...+|++.+|..||.+|.||+|+|+|+||.+... ..+.+.+..|.+++.
T Consensus 313 ~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~-p~~P~~~Pt~P~k~~ 384 (419)
T KOG0663|consen 313 KMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPL-PIDPSMFPTWPAKSE 384 (419)
T ss_pred ccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCC-CCChhhcCCCccccc
Confidence 1111111 111 25688999999999999999999999999999998533 234455566665554
|
|
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-52 Score=364.57 Aligned_cols=248 Identities=30% Similarity=0.476 Sum_probs=229.5
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC----CchHHHHHHHHHHHhhccCCCcceeeecccccCCCce
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~ 174 (380)
-++|++.+.||+|.||.||+|+.+.++..||+|++.+++ ...+++++|++|...|+||||.+++++|.+. .++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~---~ri 97 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS---KRI 97 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc---cee
Confidence 467899999999999999999999999999999996653 3457789999999999999999999988874 788
Q ss_pred EEEEEecCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc--
Q psy11098 175 TIVMQLVHGESLIQHLC--RQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS-- 249 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~--~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~-- 249 (380)
|+++||..+|+|+..+. ....++|..++.+++|++.||.|+|..+++||||||+|+|++ .+.+||+|||.+...+
T Consensus 98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~ 177 (281)
T KOG0580|consen 98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSN 177 (281)
T ss_pred EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCCC
Confidence 99999999999999998 567899999999999999999999999999999999999998 6799999999998764
Q ss_pred --ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHH
Q psy11098 250 --TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAREL 327 (380)
Q Consensus 250 --~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 327 (380)
.+.|||..|.+||.+.+ ..++..+|+|++|+++||++.|.+||...+..++..+|.+.++.+|. .++.+++||
T Consensus 178 kR~tlcgt~dyl~pEmv~~-~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~----~is~~a~dl 252 (281)
T KOG0580|consen 178 KRKTLCGTLDYLPPEMVEG-RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPS----TISGGAADL 252 (281)
T ss_pred CceeeecccccCCHhhcCC-CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCc----ccChhHHHH
Confidence 67899999999999999 58888999999999999999999999999999999999999998883 699999999
Q ss_pred HHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 328 IGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 328 i~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
|++||.++|.+|.+..|++.|||+...
T Consensus 253 I~~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 253 ISRLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred HHHHhccCccccccHHHHhhhHHHHhc
Confidence 999999999999999999999999754
|
|
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-51 Score=391.29 Aligned_cols=255 Identities=29% Similarity=0.450 Sum_probs=219.6
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCc---hHHHHHHHHHHHhhccCCCcceeeecccccCCCce
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP---QQITRAEYNLLSTLMHAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~ 174 (380)
..+.|+.+++||+|+||.||+|++..||+.||+|.+..+..+ .....+||.||++|.||||+++.++.... ..+.+
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~-~~~si 193 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK-LSGSI 193 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec-CCceE
Confidence 457899999999999999999999999999999999765533 34557899999999999999999998764 34689
Q ss_pred EEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc---
Q psy11098 175 TIVMQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS--- 249 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~--- 249 (380)
|||+||| .-+|.-++.. .-.|++.+++.+++||+.||+|||++||+|||||..||||| +|.+||+|||||+.+.
T Consensus 194 YlVFeYM-dhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 194 YLVFEYM-DHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred EEEEecc-cchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 9999999 5667776755 45799999999999999999999999999999999999998 5799999999999664
Q ss_pred ----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCC----------CC--
Q psy11098 250 ----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYS----------FP-- 313 (380)
Q Consensus 250 ----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~----------~~-- 313 (380)
+..+-|.+|.|||.+.|...|+.++|+||+||||.||+.|++.|.+.++.+.++.|-..-.. +|
T Consensus 273 ~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~ 352 (560)
T KOG0600|consen 273 SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHA 352 (560)
T ss_pred CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcc
Confidence 34566999999999999999999999999999999999999999999988888777432111 11
Q ss_pred -------------CCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 314 -------------PEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 314 -------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
.+.+..++..+.+|+..||..||.+|.||.++|+|+||...
T Consensus 353 ~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~ 406 (560)
T KOG0600|consen 353 TIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTE 406 (560)
T ss_pred cccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccC
Confidence 01234678889999999999999999999999999999543
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-51 Score=402.90 Aligned_cols=259 Identities=25% Similarity=0.407 Sum_probs=233.0
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC----CCchHHHHHHHHHHHhhc-cCCCcceeeecccccCCCc
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLSTLM-HAHIPTALALFENAPVPGT 173 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~il~~l~-h~ni~~i~~~~~~~~~~~~ 173 (380)
.++|..++.||+|.||+|+++..+.+++.||||++++. +.+.+....|-+|+.... ||.+++++..|.. .++
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT---~~~ 443 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQT---KEH 443 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccccc---CCe
Confidence 46799999999999999999999999999999999875 345566777888888775 8888887777776 488
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccc----
Q psy11098 174 DTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSV---- 248 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~---- 248 (380)
+|+||||+.||++. .+.+.+.++|..++.|+..|+.||.|||++||||||||.+|||+| +|.+||+|||+++..
T Consensus 444 l~fvmey~~Ggdm~-~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g 522 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLM-HHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG 522 (694)
T ss_pred EEEEEEecCCCcEE-EEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCC
Confidence 99999999999943 344567899999999999999999999999999999999999999 689999999999754
Q ss_pred --cccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHH
Q psy11098 249 --STVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARE 326 (380)
Q Consensus 249 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 326 (380)
..++||||.|||||++.+ ..|+.++|+|||||+|||||.|.+||.+++.+++...|...++.+|. .+|.++.+
T Consensus 523 ~~TsTfCGTpey~aPEil~e-~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~----~ls~ea~~ 597 (694)
T KOG0694|consen 523 DRTSTFCGTPEFLAPEVLTE-QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FLSKEAIA 597 (694)
T ss_pred CccccccCChhhcChhhhcc-CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCC----cccHHHHH
Confidence 368999999999999998 68999999999999999999999999999999999999999988885 48999999
Q ss_pred HHHHhcccCCCCCCC-----HHHHHhcccccccCCCCCccccccc
Q psy11098 327 LIGQLLNTHADKRPT-----AGQLLQVAWFAEASCSEFDTERLLP 366 (380)
Q Consensus 327 li~~~L~~dP~~Rpt-----~~e~L~hpw~~~~~~~~~~~~~~~~ 366 (380)
++++||.+||++|.. ++++.+||||....++++...+++|
T Consensus 598 il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~P 642 (694)
T KOG0694|consen 598 IMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKP 642 (694)
T ss_pred HHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCC
Confidence 999999999999985 5889999999999998888888865
|
|
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-53 Score=373.38 Aligned_cols=239 Identities=31% Similarity=0.418 Sum_probs=210.6
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC---CCchHHHHHHHHHHHhhccCCCcceee-ecccccCCCce
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE---RQPQQITRAEYNLLSTLMHAHIPTALA-LFENAPVPGTD 174 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~il~~l~h~ni~~i~~-~~~~~~~~~~~ 174 (380)
...|+++++||+|.||+||++++..+|..+|.|.++-+ ....+....|+.+|+.|+||||++.++ .|... ...+
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~--~evl 95 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIED--NEVL 95 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhcc--chhh
Confidence 46799999999999999999999999999999999743 344566788999999999999987766 33332 3447
Q ss_pred EEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH--CC--cEeecCCCCcEEEe-CCeeEEEeCCCc
Q psy11098 175 TIVMQLVHGESLIQHLCR----QSTITESYICCIIRQLHSALHCLHS--QQ--IAHKDIRPENILMN-GAVLKLIDLGSS 245 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~----~~~l~e~~~~~i~~qil~al~~lH~--~~--iiHrDlKp~NIl~~-~~~ikl~DFG~a 245 (380)
+||||+|.+|+|...|+. ...++|..+++++.|++.||.+||+ .. |+||||||.||+++ +|.+||+|||++
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLG 175 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhH
Confidence 999999999999999964 4569999999999999999999998 45 99999999999998 679999999999
Q ss_pred cccc------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCC
Q psy11098 246 VSVS------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGH 319 (380)
Q Consensus 246 ~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 319 (380)
+.+. ...+|||.||+||++.. ..|+++||||||||++|||+.-.+||.+.+-.++..+|.++++...+ ...
T Consensus 176 r~l~s~~tfA~S~VGTPyYMSPE~i~~-~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p--~~~ 252 (375)
T KOG0591|consen 176 RFLSSKTTFAHSLVGTPYYMSPERIHE-SGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLP--DEH 252 (375)
T ss_pred hHhcchhHHHHhhcCCCcccCHHHHhc-CCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCc--HHH
Confidence 8775 56799999999999998 58999999999999999999999999999999999999999765222 246
Q ss_pred CCHHHHHHHHHhcccCCCCCCCH
Q psy11098 320 ISVPARELIGQLLNTHADKRPTA 342 (380)
Q Consensus 320 ~s~~~~~li~~~L~~dP~~Rpt~ 342 (380)
+|.++..+|.-|+..||+.||+.
T Consensus 253 YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 253 YSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred hhhHHHHHHHHHccCCcccCCCc
Confidence 89999999999999999999985
|
|
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-51 Score=381.58 Aligned_cols=249 Identities=31% Similarity=0.510 Sum_probs=228.7
Q ss_pred hhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCc----hHHHHHHHHHHHhhccCCCcceeeecccccCC
Q psy11098 96 EQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP----QQITRAEYNLLSTLMHAHIPTALALFENAPVP 171 (380)
Q Consensus 96 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~----~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~ 171 (380)
..+..+|++.+.||+|.||+|.+|.+...|+.||||.++++... .-.+++||+||..|+||||+.|+.+|+..
T Consensus 49 hnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENk--- 125 (668)
T KOG0611|consen 49 HNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENK--- 125 (668)
T ss_pred cchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCC---
Confidence 45688999999999999999999999999999999999765433 23468899999999999998888887764
Q ss_pred CceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-
Q psy11098 172 GTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS- 249 (380)
Q Consensus 172 ~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~- 249 (380)
+.+.|||||..+|+|++++...+.++|.+++.+++||+.|+.|||+++++|||||.+|||+| ++++||+|||++..+.
T Consensus 126 dKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 126 DKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred ceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 78899999999999999999999999999999999999999999999999999999999999 5699999999997653
Q ss_pred ----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHH
Q psy11098 250 ----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAR 325 (380)
Q Consensus 250 ----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 325 (380)
.++||.|-|.+||++++..+.+..+|.|||||+||.|..|..||.+.....+..+|..+.|.-|.. +.++.
T Consensus 206 ~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~-----PSdA~ 280 (668)
T KOG0611|consen 206 KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPET-----PSDAS 280 (668)
T ss_pred ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCC-----CchHH
Confidence 689999999999999997777899999999999999999999999999999999999999877654 67899
Q ss_pred HHHHHhcccCCCCCCCHHHHHhccccc
Q psy11098 326 ELIGQLLNTHADKRPTAGQLLQVAWFA 352 (380)
Q Consensus 326 ~li~~~L~~dP~~Rpt~~e~L~hpw~~ 352 (380)
-||++||..||++|.|++++..|=|+.
T Consensus 281 gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 281 GLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred HHHHHHHhcCcccchhHHHHhhhheee
Confidence 999999999999999999999998876
|
|
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-51 Score=393.86 Aligned_cols=253 Identities=25% Similarity=0.426 Sum_probs=223.5
Q ss_pred hhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC-chHHHHHHHHHHHhhccCCCcceeeecccccCCCce
Q psy11098 96 EQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ-PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 96 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~ 174 (380)
.+-...|...++||+|+-|.||.|+...+++.||||.+....+ ..+.+.+|+.+|+.++|+||+++++.|-.. +.+
T Consensus 269 ~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~---deL 345 (550)
T KOG0578|consen 269 GDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG---DEL 345 (550)
T ss_pred CChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhccc---cee
Confidence 4556789999999999999999999999999999999975544 567788999999999999999999999886 678
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc----
Q psy11098 175 TIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS---- 249 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~---- 249 (380)
++||||++||+|.+.+... .++|.+++.|++++++||+|||.+||+|||||.+|||++ +|.+||+|||++.++.
T Consensus 346 WVVMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 346 WVVMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred EEEEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 9999999999998877544 699999999999999999999999999999999999998 6799999999988764
Q ss_pred --ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHH
Q psy11098 250 --TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAREL 327 (380)
Q Consensus 250 --~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 327 (380)
.+.+|||.|||||++.. ..|+.++||||||++++||+-|++||..++....+..|... ..........+|.+++||
T Consensus 425 KR~TmVGTPYWMAPEVvtr-k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n-g~P~lk~~~klS~~~kdF 502 (550)
T KOG0578|consen 425 KRSTMVGTPYWMAPEVVTR-KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPKLKNPEKLSPELKDF 502 (550)
T ss_pred ccccccCCCCccchhhhhh-cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc-CCCCcCCccccCHHHHHH
Confidence 57899999999999988 58999999999999999999999999877666555555322 222233456799999999
Q ss_pred HHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 328 IGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 328 i~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
|.+||+.|+++|++|.|+|+||||+.+
T Consensus 503 L~~cL~~dv~~RasA~eLL~HpFl~~a 529 (550)
T KOG0578|consen 503 LDRCLVVDVEQRASAKELLEHPFLKMA 529 (550)
T ss_pred HHHHhhcchhcCCCHHHHhcChhhhhc
Confidence 999999999999999999999999655
|
|
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-51 Score=380.58 Aligned_cols=255 Identities=29% Similarity=0.434 Sum_probs=213.4
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCc-hHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP-QQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIV 177 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv 177 (380)
..+|...+.||+|+||.||++.+..+|+.+|||.+...... .+.+.+|+.+|+.|+|+||++.++....... ..++++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~-~~~~i~ 94 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSREN-DEYNIF 94 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccC-eeeEee
Confidence 34577789999999999999999999999999999655222 4557889999999999999888776544422 368999
Q ss_pred EEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC--CeeEEEeCCCccccc-----
Q psy11098 178 MQLVHGESLIQHLCRQS-TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG--AVLKLIDLGSSVSVS----- 249 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~~~-~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~--~~ikl~DFG~a~~~~----- 249 (380)
|||+.||+|.+++...+ .++|..++.+++||++||.|||++||+|+||||+|||++. +.+||+|||++....
T Consensus 95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~ 174 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK 174 (313)
T ss_pred eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence 99999999999998866 7999999999999999999999999999999999999986 599999999987554
Q ss_pred ----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcccCCCCCCcCCCCCHHH
Q psy11098 250 ----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLD-ESEEETRAHISVADYSFPPEQCGHISVPA 324 (380)
Q Consensus 250 ----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 324 (380)
....||+.|||||++.+......++|||||||++.||+||..||.. ....+....+.... ..| .....+|+++
T Consensus 175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~-~~P-~ip~~ls~~a 252 (313)
T KOG0198|consen 175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED-SLP-EIPDSLSDEA 252 (313)
T ss_pred ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC-CCC-CCCcccCHHH
Confidence 2468899999999998623444699999999999999999999987 33334344443333 222 3345699999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhcccccccCC
Q psy11098 325 RELIGQLLNTHADKRPTAGQLLQVAWFAEASC 356 (380)
Q Consensus 325 ~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~ 356 (380)
++||++||.+||++||||+++|+|||..+...
T Consensus 253 ~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 253 KDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred HHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 99999999999999999999999999987643
|
|
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-52 Score=371.02 Aligned_cols=263 Identities=30% Similarity=0.464 Sum_probs=227.1
Q ss_pred hhhceeee-eeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHH-hhccCCCcceeeeccccc-CCCce
Q psy11098 98 FEHRYEEL-ERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLS-TLMHAHIPTALALFENAP-VPGTD 174 (380)
Q Consensus 98 ~~~~y~~~-~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~-~l~h~ni~~i~~~~~~~~-~~~~~ 174 (380)
+.++|.+- ++||-|-.|.|-.|.++.|++.+|+|++... ...++|+++-- .-.|+||+.|+++|+... ....+
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 34556554 6799999999999999999999999988443 45677887744 447999999999998753 33567
Q ss_pred EEEEEecCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC----CeeEEEeCCCcccc
Q psy11098 175 TIVMQLVHGESLIQHLCRQST--ITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG----AVLKLIDLGSSVSV 248 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~~~--l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~----~~ikl~DFG~a~~~ 248 (380)
.+|||.++||+|+.+|+.++. ++|.++..|++||..|+.|||+.+|.||||||+|+|+.+ ..+||+|||+|+..
T Consensus 135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t 214 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKET 214 (400)
T ss_pred EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccccccc
Confidence 899999999999999988654 999999999999999999999999999999999999963 27899999999876
Q ss_pred c-----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhcccCCCCCCcCCC
Q psy11098 249 S-----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESE----EETRAHISVADYSFPPEQCGH 319 (380)
Q Consensus 249 ~-----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~ 319 (380)
. .+.+.||.|+|||++.. ..|+...|+||+||++|.||+|.+||..+.. .....+|..++|.||.+.|..
T Consensus 215 ~~~~~L~TPc~TPyYvaPevlg~-eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~ 293 (400)
T KOG0604|consen 215 QEPGDLMTPCFTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSC 293 (400)
T ss_pred CCCccccCCcccccccCHHHhCc-hhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhH
Confidence 4 45677999999999977 4689999999999999999999999976543 356788999999999999999
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCC---CCCcccccc
Q psy11098 320 ISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASC---SEFDTERLL 365 (380)
Q Consensus 320 ~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~---~~~~~~~~~ 365 (380)
+|++++|+|+.||..+|++|.|++++++|||+.+... ..+++.++.
T Consensus 294 VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl~t~~~l 342 (400)
T KOG0604|consen 294 VSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPLSTSRML 342 (400)
T ss_pred HHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCchhhhhc
Confidence 9999999999999999999999999999999987643 355555553
|
|
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-51 Score=392.96 Aligned_cols=246 Identities=30% Similarity=0.436 Sum_probs=225.1
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCc---hHHHHHHHHHHHhhccCCCcceeeecccccCCCceEE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP---QQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
++|-+.+.||+|+||.||+|+.+.|.+.||+|.+.+.... ...+++|++|++.|+||||+.+++.|+.. ..+++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~---~~~~v 78 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETS---AHLWV 78 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhccc---ceEEE
Confidence 4688889999999999999999999999999999765443 35678899999999999999999999885 67899
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------
Q psy11098 177 VMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------ 249 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------ 249 (380)
|+||+.| +|+.++...+.++|+.++.++.|++.||.|||+.+|+|||+||+|||++ .+.+|+||||+|+..+
T Consensus 79 Vte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vl 157 (808)
T KOG0597|consen 79 VTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVL 157 (808)
T ss_pred Eehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceee
Confidence 9999966 9999999999999999999999999999999999999999999999998 4699999999998765
Q ss_pred ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHH
Q psy11098 250 TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIG 329 (380)
Q Consensus 250 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 329 (380)
+...|||.|||||++.+ ..|+..+|+||||||+|||++|++||...+..+....|.......|. ..|.++++|+.
T Consensus 158 tsikGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~----~~S~~f~nfl~ 232 (808)
T KOG0597|consen 158 TSIKGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPS----TASSSFVNFLQ 232 (808)
T ss_pred eeccCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcc----cccHHHHHHHH
Confidence 45689999999999997 69999999999999999999999999999988998888877766665 58999999999
Q ss_pred HhcccCCCCCCCHHHHHhccccccc
Q psy11098 330 QLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 330 ~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
.+|++||.+|.|..++|.|||.+..
T Consensus 233 gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 233 GLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred HHhhcChhhcccHHHHhcChHHhhh
Confidence 9999999999999999999999853
|
|
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-51 Score=374.00 Aligned_cols=257 Identities=25% Similarity=0.361 Sum_probs=218.5
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecC---CCCchHHHHHHHHHHHhhccCCCcceeeeccccc--CCC
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPR---ERQPQQITRAEYNLLSTLMHAHIPTALALFENAP--VPG 172 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~---~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~--~~~ 172 (380)
...+|..++.||+|+||.|+.|.++.||+.||+|++.. .........+|+.+|+.++|+||+.+.+++.... .-.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 35667778999999999999999999999999999862 3334567788999999999999999999987622 235
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeCC-eeEEEeCCCccccc--
Q psy11098 173 TDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGA-VLKLIDLGSSVSVS-- 249 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~~-~ikl~DFG~a~~~~-- 249 (380)
.+|+|+|+| +.+|...++.+..+++..+..+++||+.||+|+|+.||+||||||.|+|++.+ .+||||||+|+...
T Consensus 100 DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~ 178 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF 178 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecccc
Confidence 679999999 88899999888889999999999999999999999999999999999999954 89999999999874
Q ss_pred ------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---------------
Q psy11098 250 ------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVA--------------- 308 (380)
Q Consensus 250 ------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~--------------- 308 (380)
+..+.|.+|.|||++.....|+.++||||+|||+.||++|++-|.|...-..+..|...
T Consensus 179 ~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~ 258 (359)
T KOG0660|consen 179 FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSE 258 (359)
T ss_pred CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccH
Confidence 34456999999999988889999999999999999999999999887665544444211
Q ss_pred --------cCCCCC----CcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 309 --------DYSFPP----EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 309 --------~~~~~~----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
....+. ..+.+.++.+.||+.+||..||.+|+|++|+|+||||....
T Consensus 259 ~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~h 317 (359)
T KOG0660|consen 259 KARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYH 317 (359)
T ss_pred HHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhc
Confidence 111111 12457899999999999999999999999999999999754
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-50 Score=379.06 Aligned_cols=250 Identities=26% Similarity=0.432 Sum_probs=220.9
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC----CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
++|++.+.||+|+||.||+|.++.+++.||+|++.... .....+.+|+.+++.+.||||+++++++.. .+..+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~~~~ 77 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD---QRFLY 77 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc---CCeEE
Confidence 36899999999999999999999999999999996432 234557789999999999999998877665 36789
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc---cc
Q psy11098 176 IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS---TV 251 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~---~~ 251 (380)
+||||+.+++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.... ..
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~ 157 (291)
T cd05612 78 MLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWT 157 (291)
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCccc
Confidence 9999999999999998888999999999999999999999999999999999999998 5699999999987654 34
Q ss_pred ccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHh
Q psy11098 252 VLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQL 331 (380)
Q Consensus 252 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 331 (380)
..||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......++. .++..+++||++|
T Consensus 158 ~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~~ 232 (291)
T cd05612 158 LCGTPEYLAPEVIQS-KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR----HLDLYAKDLIKKL 232 (291)
T ss_pred ccCChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCc----cCCHHHHHHHHHH
Confidence 578999999999987 46788999999999999999999999999888888888777665553 4688999999999
Q ss_pred cccCCCCCCC-----HHHHHhcccccccCCC
Q psy11098 332 LNTHADKRPT-----AGQLLQVAWFAEASCS 357 (380)
Q Consensus 332 L~~dP~~Rpt-----~~e~L~hpw~~~~~~~ 357 (380)
|+.||.+|++ ++++++||||......
T Consensus 233 l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~ 263 (291)
T cd05612 233 LVVDRTRRLGNMKNGADDVKNHRWFKSVDWD 263 (291)
T ss_pred cCCCHHHccCCccCCHHHHhcCccccCCCHH
Confidence 9999999995 9999999999875443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-50 Score=374.96 Aligned_cols=255 Identities=28% Similarity=0.370 Sum_probs=224.3
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC--CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER--QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
.+.|++.+.||.|..++||+|+...+++.||||++..+. ..-+.+++|+..|+.+.||||+..+..|... ..+++
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~---~~LWv 101 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVD---SELWV 101 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEec---ceeEE
Confidence 578999999999999999999999999999999997543 3457789999999999999999988888875 67899
Q ss_pred EEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccc-----
Q psy11098 177 VMQLVHGESLIQHLCRQ--STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSV----- 248 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~----- 248 (380)
||.||.+|+++++++.. ..++|..+..|.+++++||.|||++|.||||||+.||||+ +|.|||+|||.+..+
T Consensus 102 VmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 102 VMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred eehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 99999999999999874 4599999999999999999999999999999999999998 689999999976432
Q ss_pred ----c-ccccCCCcccCCcc-ccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCC------CCCCc
Q psy11098 249 ----S-TVVLPDLEFASPEM-LTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYS------FPPEQ 316 (380)
Q Consensus 249 ----~-~~~~gt~~y~aPE~-~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~------~~~~~ 316 (380)
. +++.|||.|||||+ ...-..|++|+||||||++..||.+|..||.......++....++... ++.+.
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~ 261 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDE 261 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHH
Confidence 1 67789999999999 555578999999999999999999999999998888777666665553 33344
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCC
Q psy11098 317 CGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASC 356 (380)
Q Consensus 317 ~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~ 356 (380)
...++..++.+|..||++||++|||++++|+|+||++...
T Consensus 262 ~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~ 301 (516)
T KOG0582|consen 262 DKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS 301 (516)
T ss_pred hhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence 5567888999999999999999999999999999998743
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-50 Score=383.54 Aligned_cols=251 Identities=28% Similarity=0.471 Sum_probs=222.8
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC----CchHHHHHHHHHHHhhccCCCcceeeecccccCCCce
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~ 174 (380)
.++|++.+.||+|+||.||+|+++.+++.||+|++.... ...+.+.+|+.+++.++|+||+++++.+... +..
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~---~~~ 93 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE---NRV 93 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC---CEE
Confidence 467999999999999999999999999999999996432 2335577899999999999999999888764 678
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc---c
Q psy11098 175 TIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS---T 250 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~---~ 250 (380)
|+||||+.|++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.... .
T Consensus 94 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 173 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF 173 (329)
T ss_pred EEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCcc
Confidence 99999999999999999888899999999999999999999999999999999999998 5699999999998664 3
Q ss_pred cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHH
Q psy11098 251 VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQ 330 (380)
Q Consensus 251 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 330 (380)
...||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+..+...++. .++.++++||++
T Consensus 174 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~~ 248 (329)
T PTZ00263 174 TLCGTPEYLAPEVIQS-KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN----WFDGRARDLVKG 248 (329)
T ss_pred eecCChhhcCHHHHcC-CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCC----CCCHHHHHHHHH
Confidence 4578999999999988 46788999999999999999999999998888888888777655543 378999999999
Q ss_pred hcccCCCCCCC-----HHHHHhcccccccCCC
Q psy11098 331 LLNTHADKRPT-----AGQLLQVAWFAEASCS 357 (380)
Q Consensus 331 ~L~~dP~~Rpt-----~~e~L~hpw~~~~~~~ 357 (380)
||+.||++|++ ++++++||||.+..+.
T Consensus 249 ~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~ 280 (329)
T PTZ00263 249 LLQTDHTKRLGTLKGGVADVKNHPYFHGANWD 280 (329)
T ss_pred HhhcCHHHcCCCCCCCHHHHhcCCccCCCCHH
Confidence 99999999997 7999999999875433
|
|
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-50 Score=371.68 Aligned_cols=252 Identities=30% Similarity=0.456 Sum_probs=226.5
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC----chHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ----PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
++|++++.||.|.-|+||+|..+.++..+|+|++.+... .......|.+||+.+.||.++.++..|+.. +..+
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~---~~~c 153 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETD---KYSC 153 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecc---ceeE
Confidence 678899999999999999999999999999999976543 334556699999999999999999999875 6779
Q ss_pred EEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccc----
Q psy11098 176 IVMQLVHGESLIQHLCRQ--STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSV---- 248 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~---- 248 (380)
++||||.||+|..+++++ +.+++..++.++.+|+.||+|||-+|||+|||||||||+. +|.|+|+||.|+.+.
T Consensus 154 l~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 154 LVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred EEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 999999999999999775 5799999999999999999999999999999999999996 789999999875211
Q ss_pred ----------------------------------------------------------cccccCCCcccCCccccCCCCC
Q psy11098 249 ----------------------------------------------------------STVVLPDLEFASPEMLTSPATA 270 (380)
Q Consensus 249 ----------------------------------------------------------~~~~~gt~~y~aPE~~~~~~~~ 270 (380)
++.++||-+|+|||++.|. ..
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~-GH 312 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE-GH 312 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC-CC
Confidence 0224678899999999994 77
Q ss_pred CCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCC----HHHHH
Q psy11098 271 GPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPT----AGQLL 346 (380)
Q Consensus 271 ~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt----~~e~L 346 (380)
+.++|+|+|||++||||.|..||.+.+.++++.+|......|+... .++..++|||+++|.+||.+|.. |.||-
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~--~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP--EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIK 390 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC--cchhHHHHHHHHHhccChhhhhccccchHHhh
Confidence 8899999999999999999999999999999999999999998764 68899999999999999999998 99999
Q ss_pred hcccccccCCC
Q psy11098 347 QVAWFAEASCS 357 (380)
Q Consensus 347 ~hpw~~~~~~~ 357 (380)
+||||....|.
T Consensus 391 ~HpFF~gVnWa 401 (459)
T KOG0610|consen 391 RHPFFEGVNWA 401 (459)
T ss_pred cCccccCCChh
Confidence 99999987765
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=380.55 Aligned_cols=244 Identities=26% Similarity=0.432 Sum_probs=215.6
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEecCCC----CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEEEec
Q psy11098 106 ERLGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLV 181 (380)
Q Consensus 106 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e~~ 181 (380)
+.||+|+||.||+|+++.+|+.||+|++.+.. .......+|+++++.++|+||++++..+... +..++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~---~~~~lv~e~~ 77 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTH---DRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcC---CEEEEEEeCC
Confidence 36999999999999999999999999996532 2234567799999999999999999888764 6789999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------ccccC
Q psy11098 182 HGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------TVVLP 254 (380)
Q Consensus 182 ~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------~~~~g 254 (380)
.|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.... ...+|
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~g 157 (323)
T cd05571 78 NGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 157 (323)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceec
Confidence 9999999998888999999999999999999999999999999999999997 5689999999987531 34578
Q ss_pred CCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhccc
Q psy11098 255 DLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNT 334 (380)
Q Consensus 255 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 334 (380)
|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+......++. .++.++++||++||.+
T Consensus 158 t~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~----~~~~~~~~li~~~L~~ 232 (323)
T cd05571 158 TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKSLLAGLLKK 232 (323)
T ss_pred CccccChhhhcC-CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHHccC
Confidence 999999999987 47789999999999999999999999998888888887777666553 5799999999999999
Q ss_pred CCCCCC-----CHHHHHhcccccccCCC
Q psy11098 335 HADKRP-----TAGQLLQVAWFAEASCS 357 (380)
Q Consensus 335 dP~~Rp-----t~~e~L~hpw~~~~~~~ 357 (380)
||++|| ++.++++||||....+.
T Consensus 233 dP~~R~~~~~~~~~~ll~h~~f~~~~~~ 260 (323)
T cd05571 233 DPKQRLGGGPEDAKEIMEHRFFASINWQ 260 (323)
T ss_pred CHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence 999999 89999999999876443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-49 Score=382.98 Aligned_cols=253 Identities=23% Similarity=0.380 Sum_probs=215.6
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC----CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
++|++.+.||+|+||+||+|+++.+++.||+|++.+.. .....+.+|+.++..+.|+||++++..+... +..|
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~---~~~~ 77 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDK---LNLY 77 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecC---CeEE
Confidence 36899999999999999999999999999999996532 2234567899999999999999999888764 6789
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-----
Q psy11098 176 IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS----- 249 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~----- 249 (380)
+||||+.||+|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 78 lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 78 LIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred EEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 9999999999999998888999999999999999999999999999999999999997 5699999999986432
Q ss_pred ------------------------------------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCC
Q psy11098 250 ------------------------------------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPF 293 (380)
Q Consensus 250 ------------------------------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf 293 (380)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|..||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC-CCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 13478999999999987 47788999999999999999999999
Q ss_pred CCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhcccCCC---CCCCHHHHHhcccccccCCC
Q psy11098 294 LDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHAD---KRPTAGQLLQVAWFAEASCS 357 (380)
Q Consensus 294 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~---~Rpt~~e~L~hpw~~~~~~~ 357 (380)
.+.+..+...++.........+....+++++++||.+|+. +|. .||+++|+++||||+...+.
T Consensus 237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~~ 302 (363)
T cd05628 237 CSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDWE 302 (363)
T ss_pred CCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCHH
Confidence 9988888888777543222222223579999999999875 444 45899999999999876443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-49 Score=368.94 Aligned_cols=260 Identities=22% Similarity=0.377 Sum_probs=213.8
Q ss_pred eeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC----CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEE
Q psy11098 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIV 177 (380)
Q Consensus 102 y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv 177 (380)
|++.+.||+|+||+||+|.+..+++.||+|.+.... .....+.+|+.+++.+.|++++.+...+... +..++|
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~---~~~~lv 78 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETK---DALCLV 78 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccC---CeEEEE
Confidence 778899999999999999999999999999986432 2234567899999999999999988887764 678999
Q ss_pred EEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-----
Q psy11098 178 MQLVHGESLIQHLCRQ--STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS----- 249 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~----- 249 (380)
|||+.+|+|.+.+... ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 79 ~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05631 79 LTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETV 158 (285)
T ss_pred EEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCee
Confidence 9999999998887543 4689999999999999999999999999999999999997 4689999999987643
Q ss_pred ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHH
Q psy11098 250 TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIG 329 (380)
Q Consensus 250 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 329 (380)
....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+..............++.++.+||+
T Consensus 159 ~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 237 (285)
T cd05631 159 RGRVGTVGYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICR 237 (285)
T ss_pred cCCCCCCCccCHhhhcC-CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHH
Confidence 34568999999999987 47788999999999999999999999876543222222211111112223458999999999
Q ss_pred HhcccCCCCCCC-----HHHHHhcccccccCCCCCcccccc
Q psy11098 330 QLLNTHADKRPT-----AGQLLQVAWFAEASCSEFDTERLL 365 (380)
Q Consensus 330 ~~L~~dP~~Rpt-----~~e~L~hpw~~~~~~~~~~~~~~~ 365 (380)
+||+.||++||| ++++++||||....+..+..+.++
T Consensus 238 ~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~~~~ 278 (285)
T cd05631 238 MLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANMLE 278 (285)
T ss_pred HHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHHhCcCC
Confidence 999999999997 999999999998866655555443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-49 Score=382.63 Aligned_cols=252 Identities=24% Similarity=0.367 Sum_probs=214.0
Q ss_pred ceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC----CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEE
Q psy11098 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
.|++++.||+|+||+||+|+++.+++.||+|++.+.. .....+.+|+++++.++|+||++++..+... +..|+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~---~~~~l 78 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDK---DNLYF 78 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecC---CEEEE
Confidence 5889999999999999999999999999999996532 2234567899999999999999999888763 67899
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------
Q psy11098 177 VMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------ 249 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------ 249 (380)
||||+.||+|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++ ++.+||+|||++....
T Consensus 79 v~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 79 VMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 999999999999998888899999999999999999999999999999999999998 5699999999874220
Q ss_pred -----------------------------------------------ccccCCCcccCCccccCCCCCCCcccHHHHHHH
Q psy11098 250 -----------------------------------------------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVL 282 (380)
Q Consensus 250 -----------------------------------------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi 282 (380)
...+||+.|+|||++.+ ..++.++|||||||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlG~i 237 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLCDWWSVGVI 237 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC-CCCCCccceeehhhH
Confidence 13468999999999987 467889999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhccc--CCCCCCCHHHHHhcccccccCC
Q psy11098 283 LYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNT--HADKRPTAGQLLQVAWFAEASC 356 (380)
Q Consensus 283 l~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~--dP~~Rpt~~e~L~hpw~~~~~~ 356 (380)
+|+|++|..||...+..+....+.........+....+++++++||.+||.. ++..|++++++++||||.+..+
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~ 313 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDF 313 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCCh
Confidence 9999999999998887776666654333333333346899999999997654 5555999999999999987543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-49 Score=377.79 Aligned_cols=250 Identities=23% Similarity=0.404 Sum_probs=220.6
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCC-cEEEEEEecCC----CCchHHHHHHHHHHHhhccCCCcceeeecccccCCCc
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTG-QLVALKQIPRE----RQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGT 173 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~-~~vAvK~~~~~----~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~ 173 (380)
.++|++.+.||+|+||.||+|.++.++ ..||+|.+.+. ......+.+|+.+++.++||||+++++++... +.
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~---~~ 105 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE---SY 105 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC---CE
Confidence 467999999999999999999977655 68999998642 22345567899999999999999999988764 67
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc---
Q psy11098 174 DTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS--- 249 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~--- 249 (380)
.++||||+.||+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~ 185 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT 185 (340)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCCc
Confidence 899999999999999999888999999999999999999999999999999999999997 5689999999997654
Q ss_pred ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHH
Q psy11098 250 TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIG 329 (380)
Q Consensus 250 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 329 (380)
....||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+.......+..+...++. .++++++++|+
T Consensus 186 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~ 260 (340)
T PTZ00426 186 YTLCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPK----FLDNNCKHLMK 260 (340)
T ss_pred ceecCChhhcCHHHHhC-CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHHHH
Confidence 35578999999999987 46788999999999999999999999998888888888777665553 47899999999
Q ss_pred HhcccCCCCCC-----CHHHHHhcccccccCC
Q psy11098 330 QLLNTHADKRP-----TAGQLLQVAWFAEASC 356 (380)
Q Consensus 330 ~~L~~dP~~Rp-----t~~e~L~hpw~~~~~~ 356 (380)
+||+.||++|+ |++++++||||.+..+
T Consensus 261 ~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~ 292 (340)
T PTZ00426 261 KLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDW 292 (340)
T ss_pred HHcccCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 99999999995 8999999999987543
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-48 Score=366.63 Aligned_cols=248 Identities=28% Similarity=0.408 Sum_probs=207.8
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC--CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER--QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIV 177 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv 177 (380)
++|++.+.||.|+||+||+|+++.+++.||+|+++... .......+|+.+++.++|+||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~lv 81 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTE---RCLTLV 81 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCC---CeEEEE
Confidence 57999999999999999999999999999999996433 2344567899999999999999999887653 568999
Q ss_pred EEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------
Q psy11098 178 MQLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------ 249 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------ 249 (380)
|||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 82 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~ 160 (288)
T cd07871 82 FEYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY 160 (288)
T ss_pred EeCCC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccc
Confidence 99996 5898888654 4579999999999999999999999999999999999998 5699999999986542
Q ss_pred ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC-------------------
Q psy11098 250 TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADY------------------- 310 (380)
Q Consensus 250 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~------------------- 310 (380)
....+++.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd07871 161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSY 240 (288)
T ss_pred cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcc
Confidence 2346789999999987756778899999999999999999999988877666554432111
Q ss_pred CCCC-------CcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy11098 311 SFPP-------EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 311 ~~~~-------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~ 351 (380)
.++. .....++.++++||++||+.||.+|||++|+|+||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 241 LFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred ccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 0110 0113468899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-49 Score=380.60 Aligned_cols=251 Identities=23% Similarity=0.416 Sum_probs=217.6
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC----CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
++|++.+.||+|+||+||+|++..+++.||||++.... .....+.+|+.+++.++|+||++++..+... +..+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~---~~~~ 77 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDE---NYLY 77 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC---CeEE
Confidence 36899999999999999999999999999999996432 2334567899999999999999999888764 6789
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccccc----
Q psy11098 176 IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVST---- 250 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~~---- 250 (380)
+||||+.||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..+..
T Consensus 78 lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 78 LIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred EEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 9999999999999998888899999999999999999999999999999999999998 56899999999864321
Q ss_pred ----------------------------------------cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCC
Q psy11098 251 ----------------------------------------VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGV 290 (380)
Q Consensus 251 ----------------------------------------~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~ 290 (380)
..+||+.|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-CCCCCeeeeecchhHHHHhhcCC
Confidence 2368999999999987 47789999999999999999999
Q ss_pred CCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCC---HHHHHhcccccccC
Q psy11098 291 SPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPT---AGQLLQVAWFAEAS 355 (380)
Q Consensus 291 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt---~~e~L~hpw~~~~~ 355 (380)
.||.+.+..+....+......+.......+++++++||++||. +|.+|++ ++|+|+||||+...
T Consensus 237 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~ 303 (364)
T cd05599 237 PPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVD 303 (364)
T ss_pred CCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence 9999988887777776544333333334679999999999997 9999998 99999999998753
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=375.10 Aligned_cols=252 Identities=24% Similarity=0.401 Sum_probs=218.9
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC----CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
++|++.+.||+|+||.||+|++..+++.||+|++.+.. .....+.+|++++..++|+||++++.++... +..|
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~---~~~~ 77 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDD---EYLY 77 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcC---CEEE
Confidence 36999999999999999999999999999999996432 2334567899999999999999999888764 6789
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc---cc
Q psy11098 176 IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS---TV 251 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~---~~ 251 (380)
+||||+.|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.... ..
T Consensus 78 lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~~~~ 157 (333)
T cd05600 78 LAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS 157 (333)
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCcccccccCC
Confidence 9999999999999998888899999999999999999999999999999999999998 5689999999997653 45
Q ss_pred ccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcC----CCCCHHHHHH
Q psy11098 252 VLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQC----GHISVPAREL 327 (380)
Q Consensus 252 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~----~~~s~~~~~l 327 (380)
..||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+......+..... ..+++++.+|
T Consensus 158 ~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~l 236 (333)
T cd05600 158 VVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDL 236 (333)
T ss_pred cccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHH
Confidence 6789999999999884 7889999999999999999999999988887777666543322211111 2578999999
Q ss_pred HHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 328 IGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 328 i~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
|.+||..+|.+|||++++++||||.+..
T Consensus 237 i~~~l~~~~~rr~s~~~ll~h~~~~~~~ 264 (333)
T cd05600 237 ITKLINDPSRRFGSLEDIKNHPFFKEVD 264 (333)
T ss_pred HHHHhhChhhhcCCHHHHHhCcccCCCC
Confidence 9999999999999999999999998753
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=382.42 Aligned_cols=250 Identities=25% Similarity=0.390 Sum_probs=216.2
Q ss_pred ceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC----CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEE
Q psy11098 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
+|++++.||+|+||+||+|++..+++.||+|++.+.. .....+.+|+++++.+.|+||++++..+... +..|+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~---~~~~l 78 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDK---DNLYF 78 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeC---CEEEE
Confidence 6889999999999999999999999999999996532 2334567899999999999999999988764 67899
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------
Q psy11098 177 VMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------ 249 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------ 249 (380)
||||+.||+|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 79 v~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 79 VMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 999999999999998888899999999999999999999999999999999999998 5799999999864210
Q ss_pred -----------------------------------------------ccccCCCcccCCccccCCCCCCCcccHHHHHHH
Q psy11098 250 -----------------------------------------------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVL 282 (380)
Q Consensus 250 -----------------------------------------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi 282 (380)
...+||+.|+|||++.+ ..++.++|||||||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvi 237 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVI 237 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC-CCCCCeeeEEechHH
Confidence 12468999999999987 477899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCC---HHHHHhcccccccC
Q psy11098 283 LYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPT---AGQLLQVAWFAEAS 355 (380)
Q Consensus 283 l~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt---~~e~L~hpw~~~~~ 355 (380)
+|+|++|..||.+.+..+....+.........+....+++++++||.+|+ .||++|++ ++++++||||+...
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~ 312 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTID 312 (382)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcC
Confidence 99999999999988887777776654444433344568999999999986 59999997 99999999998753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-48 Score=364.58 Aligned_cols=248 Identities=30% Similarity=0.402 Sum_probs=206.3
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
++|++.+.||+|+||+||+|+++.+++.||+|++..... ....+.+|+++++.++|+||+++++++... +..++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~l 77 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRR---GKLYL 77 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecC---CEEEE
Confidence 369999999999999999999999999999999965422 345667899999999999999988887653 67899
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------
Q psy11098 177 VMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------ 249 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------ 249 (380)
||||+.++.+..+......+++..++.++.||+.||.|||+.||+||||||+|||++ ++.+||+|||++....
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (287)
T cd07848 78 VFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN 157 (287)
T ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence 999998877765555556799999999999999999999999999999999999998 5689999999987653
Q ss_pred -ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC------------------
Q psy11098 250 -TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADY------------------ 310 (380)
Q Consensus 250 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~------------------ 310 (380)
....||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.+..+....+.....
T Consensus 158 ~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07848 158 YTEYVATRWYRSPELLLG-APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236 (287)
T ss_pred ccccccccccCCcHHHcC-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence 23467999999999987 4678899999999999999999999988766554433322110
Q ss_pred -CCCCC---------cCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy11098 311 -SFPPE---------QCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 311 -~~~~~---------~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~ 351 (380)
.++.. ....+|.++++||++||++||++|||++|+|+||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 01100 112368889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=371.40 Aligned_cols=240 Identities=29% Similarity=0.443 Sum_probs=212.1
Q ss_pred ecccCCeEEEEEEEcCCCcEEEEEEecCC----CCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEEEecCC
Q psy11098 108 LGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHG 183 (380)
Q Consensus 108 LG~G~fg~V~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e~~~g 183 (380)
||+|+||+||+|++..+++.||+|++.+. ......+.+|+.+++.++|+||++++..+... +..|+||||+.|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~lv~e~~~~ 77 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSP---EKLYLVLAFING 77 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecC---CeEEEEEcCCCC
Confidence 79999999999999999999999999643 22334567799999999999999998888753 678999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------ccccCCC
Q psy11098 184 ESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------TVVLPDL 256 (380)
Q Consensus 184 g~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------~~~~gt~ 256 (380)
|+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.... ....||+
T Consensus 78 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 157 (312)
T cd05585 78 GELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTP 157 (312)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCc
Confidence 99999998888899999999999999999999999999999999999997 5689999999987532 3457899
Q ss_pred cccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhcccCC
Q psy11098 257 EFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHA 336 (380)
Q Consensus 257 ~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 336 (380)
.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......++ ..++.++++||.+||..||
T Consensus 158 ~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~L~~dp 232 (312)
T cd05585 158 EYLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFP----DGFDRDAKDLLIGLLSRDP 232 (312)
T ss_pred ccCCHHHHcC-CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCC----CcCCHHHHHHHHHHcCCCH
Confidence 9999999988 5778899999999999999999999999888888887776665554 3578999999999999999
Q ss_pred CCCC---CHHHHHhcccccccC
Q psy11098 337 DKRP---TAGQLLQVAWFAEAS 355 (380)
Q Consensus 337 ~~Rp---t~~e~L~hpw~~~~~ 355 (380)
++|| ++.++|+||||.+..
T Consensus 233 ~~R~~~~~~~e~l~hp~~~~~~ 254 (312)
T cd05585 233 TRRLGYNGAQEIKNHPFFSQLS 254 (312)
T ss_pred HHcCCCCCHHHHHcCCCcCCCC
Confidence 9997 589999999998753
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-50 Score=377.40 Aligned_cols=266 Identities=27% Similarity=0.388 Sum_probs=227.6
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
...|+.++.||+|.||.||+|.+..|++.||+|++..+.. +.+.+.+|+.+|..++++||.+.+..|-.. ..+++
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g---~~Lwi 88 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKG---TKLWI 88 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeec---ccHHH
Confidence 5568888999999999999999999999999999976543 456778899999999999987777776664 67899
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------
Q psy11098 177 VMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------ 249 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------ 249 (380)
+||||.||++.+.++.+..++|..+..++++++.||.|||.++.+|||||+.|||+. ++.+||+|||.+.+..
T Consensus 89 iMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr 168 (467)
T KOG0201|consen 89 IMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR 168 (467)
T ss_pred HHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence 999999999999999888889999999999999999999999999999999999997 5799999999987664
Q ss_pred ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHH
Q psy11098 250 TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIG 329 (380)
Q Consensus 250 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 329 (380)
.+++|||.|||||++.+ ..|+.++||||||++.|||++|.+|+.+......+..|-+. .|+..-..+|..+++||.
T Consensus 169 ~tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~---~PP~L~~~~S~~~kEFV~ 244 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKS---APPRLDGDFSPPFKEFVE 244 (467)
T ss_pred ccccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCC---CCCccccccCHHHHHHHH
Confidence 67899999999999996 68899999999999999999999999887774444443322 233333478999999999
Q ss_pred HhcccCCCCCCCHHHHHhcccccccCCCCCccccccchHHHHH-HHH
Q psy11098 330 QLLNTHADKRPTAGQLLQVAWFAEASCSEFDTERLLPFSARRK-QKF 375 (380)
Q Consensus 330 ~~L~~dP~~Rpt~~e~L~hpw~~~~~~~~~~~~~~~~~~~~~~-~~~ 375 (380)
.||++||+.||||.++|+|+|++... ..-.|+..+.|++ |+.
T Consensus 245 ~CL~k~P~~RpsA~~LLKh~FIk~a~----k~s~L~~~i~r~~~~~~ 287 (467)
T KOG0201|consen 245 ACLDKNPEFRPSAKELLKHKFIKRAK----KTSELKELIDRYKRWRV 287 (467)
T ss_pred HHhhcCcccCcCHHHHhhhHHHHhcC----CchHHHHHHHHHHHHhh
Confidence 99999999999999999999999842 2334566666655 444
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=379.98 Aligned_cols=251 Identities=24% Similarity=0.401 Sum_probs=216.7
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC----CCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
++|++++.||+|+||+||+|+++.+++.||+|++.+. ......+.+|+++++.+.|+||++++..+... +..+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~---~~~~ 77 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDK---DNLY 77 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcC---CEEE
Confidence 3699999999999999999999999999999999642 22345567899999999999999999888763 6789
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-----
Q psy11098 176 IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS----- 249 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~----- 249 (380)
+||||+.||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|..+.
T Consensus 78 lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 78 FVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 9999999999999998888899999999999999999999999999999999999998 5689999999974210
Q ss_pred --------------------------------------------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHH
Q psy11098 250 --------------------------------------------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYI 285 (380)
Q Consensus 250 --------------------------------------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ 285 (380)
...+||+.|+|||++.+ ..++.++|||||||++|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilye 236 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILYE 236 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-CCCCcceeeeeccceeee
Confidence 12468999999999987 477889999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCC---CHHHHHhcccccccC
Q psy11098 286 LLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRP---TAGQLLQVAWFAEAS 355 (380)
Q Consensus 286 lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---t~~e~L~hpw~~~~~ 355 (380)
|++|+.||.+.+..+....+..............++.++.+||.+|+ .+|.+|+ |+.++++||||....
T Consensus 237 ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~ 308 (376)
T cd05598 237 MLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGID 308 (376)
T ss_pred hhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCC
Confidence 99999999998877776666554444443344568999999999976 5999999 999999999998653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-48 Score=357.87 Aligned_cols=256 Identities=30% Similarity=0.448 Sum_probs=216.3
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---chHHHHHHHHHHHhhccCC-Ccceeeeccccc---CC
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLMHAH-IPTALALFENAP---VP 171 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~h~n-i~~i~~~~~~~~---~~ 171 (380)
...|+.+++||+|+||+||+|+.+.+|+.||+|.++.+.. ......+|+-+|+.|+|+| |+.+.+++.... ..
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 4567788999999999999999999999999999976544 4566788999999999999 999888877653 12
Q ss_pred CceEEEEEecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcc
Q psy11098 172 GTDTIVMQLVHGESLIQHLCRQS----TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSV 246 (380)
Q Consensus 172 ~~~~lv~e~~~gg~L~~~l~~~~----~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~ 246 (380)
+.+++|+||+ .-+|..++.... .++...++.+++||+.||+|||++||+||||||+|||++ +|.+||+|||+|+
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHH
Confidence 3789999999 678999997654 578889999999999999999999999999999999998 5799999999998
Q ss_pred ccc------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc------------
Q psy11098 247 SVS------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVA------------ 308 (380)
Q Consensus 247 ~~~------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~------------ 308 (380)
... ..-++|.+|+|||++.+...|+..+||||+|||++||+++++.|.+.++.+....|-..
T Consensus 169 a~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v 248 (323)
T KOG0594|consen 169 AFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV 248 (323)
T ss_pred HhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence 654 34567999999999999888999999999999999999999999999988777766321
Q ss_pred ----cCC--CCCC--------cCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 309 ----DYS--FPPE--------QCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 309 ----~~~--~~~~--------~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
++. ++.. .....+.++.+++.+||+.+|.+|.|++.+|.||||.+..
T Consensus 249 ~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 249 SSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred cccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 111 1111 1122335889999999999999999999999999998764
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-48 Score=372.22 Aligned_cols=242 Identities=27% Similarity=0.453 Sum_probs=213.2
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEecCCC----CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEEEec
Q psy11098 106 ERLGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLV 181 (380)
Q Consensus 106 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e~~ 181 (380)
+.||+|+||.||+++++.+++.||+|++.+.. .....+.+|+++++.+.|+||+++...+... +..++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~---~~~~lv~Ey~ 77 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTK---DRLCFVMEYV 77 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC---CEEEEEEeCC
Confidence 36999999999999999999999999996532 2334567799999999999999998887764 6789999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------ccccC
Q psy11098 182 HGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------TVVLP 254 (380)
Q Consensus 182 ~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------~~~~g 254 (380)
.+|+|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.... ...+|
T Consensus 78 ~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 157 (328)
T cd05593 78 NGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCG 157 (328)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccC
Confidence 9999999998888899999999999999999999999999999999999998 5699999999987532 24568
Q ss_pred CCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhccc
Q psy11098 255 DLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNT 334 (380)
Q Consensus 255 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 334 (380)
|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......++. .++.++.+||++||.+
T Consensus 158 t~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~----~~~~~~~~li~~~L~~ 232 (328)
T cd05593 158 TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPR----TLSADAKSLLSGLLIK 232 (328)
T ss_pred CcCccChhhhcC-CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCC----CCCHHHHHHHHHHcCC
Confidence 999999999987 46788999999999999999999999988888877777766665553 5799999999999999
Q ss_pred CCCCCC-----CHHHHHhcccccccC
Q psy11098 335 HADKRP-----TAGQLLQVAWFAEAS 355 (380)
Q Consensus 335 dP~~Rp-----t~~e~L~hpw~~~~~ 355 (380)
||++|+ ++.++++||||....
T Consensus 233 dP~~R~~~~~~~~~~il~h~~~~~~~ 258 (328)
T cd05593 233 DPNKRLGGGPDDAKEIMRHSFFTGVN 258 (328)
T ss_pred CHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 999997 899999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-48 Score=379.12 Aligned_cols=251 Identities=25% Similarity=0.420 Sum_probs=213.7
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC----CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
++|++++.||+|+||+||+|+++.+++.||+|++.+.. .....+.+|+++++.+.|+||+++++++... +..|
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~---~~~~ 77 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDA---QYLY 77 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC---CeeE
Confidence 36899999999999999999999999999999986432 2234567899999999999999999888764 6789
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-----
Q psy11098 176 IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS----- 249 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~----- 249 (380)
+||||+.||+|.+++.....+++..++.++.|++.||.|||++||+||||||+|||++ ++.+||+|||+++...
T Consensus 78 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 78 LIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 9999999999999998888899999999999999999999999999999999999997 5699999999985321
Q ss_pred ------------------------------------------------ccccCCCcccCCccccCCCCCCCcccHHHHHH
Q psy11098 250 ------------------------------------------------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGV 281 (380)
Q Consensus 250 ------------------------------------------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv 281 (380)
...+||+.|+|||++.+ ..++.++|||||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGv 236 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLGA 236 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc-CCCCCceeeEecch
Confidence 02468999999999987 47789999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCC---CCHHHHHhcccccccC
Q psy11098 282 LLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHADKR---PTAGQLLQVAWFAEAS 355 (380)
Q Consensus 282 il~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R---pt~~e~L~hpw~~~~~ 355 (380)
++|+|++|..||.+.+..+....+.........+....++.++++||++||. +|.+| +|+.|+|+||||....
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~ 312 (377)
T cd05629 237 IMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVD 312 (377)
T ss_pred hhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence 9999999999999888777776665433222222234579999999999997 67765 5999999999998653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-48 Score=371.03 Aligned_cols=243 Identities=26% Similarity=0.438 Sum_probs=213.9
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEecCCC----CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEEEec
Q psy11098 106 ERLGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLV 181 (380)
Q Consensus 106 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e~~ 181 (380)
+.||+|+||.||+++++.+|+.||+|++.... .....+.+|+++++.++||||+++..++... +..|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~---~~~~lv~E~~ 77 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH---DRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecC---CEEEEEEeCC
Confidence 46999999999999999999999999996532 2234556799999999999999998888764 6789999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------ccccC
Q psy11098 182 HGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------TVVLP 254 (380)
Q Consensus 182 ~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------~~~~g 254 (380)
.|++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.... ....|
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 157 (323)
T cd05595 78 NGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 157 (323)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccC
Confidence 9999999998888899999999999999999999999999999999999998 4689999999886531 24568
Q ss_pred CCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhccc
Q psy11098 255 DLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNT 334 (380)
Q Consensus 255 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 334 (380)
|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+......++. .+++++++||++||.+
T Consensus 158 t~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~----~~~~~~~~li~~~L~~ 232 (323)
T cd05595 158 TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKK 232 (323)
T ss_pred CcCcCCcccccC-CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHHHHHHccC
Confidence 999999999987 47788999999999999999999999988888888777766666553 5799999999999999
Q ss_pred CCCCCC-----CHHHHHhcccccccCC
Q psy11098 335 HADKRP-----TAGQLLQVAWFAEASC 356 (380)
Q Consensus 335 dP~~Rp-----t~~e~L~hpw~~~~~~ 356 (380)
||++|+ ++.++++|+||.+..+
T Consensus 233 dP~~R~~~~~~~~~~~l~h~~~~~~~~ 259 (323)
T cd05595 233 DPKQRLGGGPSDAKEVMEHRFFLSINW 259 (323)
T ss_pred CHHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence 999998 9999999999987543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-49 Score=371.98 Aligned_cols=251 Identities=26% Similarity=0.482 Sum_probs=228.9
Q ss_pred hhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCc---hHHHHHHHHHHHhhccCCCcceeeecccccCCCc
Q psy11098 97 QFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP---QQITRAEYNLLSTLMHAHIPTALALFENAPVPGT 173 (380)
Q Consensus 97 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~ 173 (380)
.+..-|.+.+.||+|.|++|.+|+|..||+.||||++.+...+ ...+-+|++-|+.++||||++++.+.+. ...
T Consensus 15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDT---QTK 91 (864)
T KOG4717|consen 15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDT---QTK 91 (864)
T ss_pred ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcc---cce
Confidence 3466788889999999999999999999999999999876543 3456679999999999999887777665 478
Q ss_pred eEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe--CCeeEEEeCCCccccc-
Q psy11098 174 DTIVMQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN--GAVLKLIDLGSSVSVS- 249 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~--~~~ikl~DFG~a~~~~- 249 (380)
+|+|+|+-++|+|+++|.+ ...+.|..++++++||+.|+.|+|+..+|||||||+|+++- -|.|||.|||++..+.
T Consensus 92 lyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 92 LYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred EEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 8999999999999999965 56799999999999999999999999999999999999985 5799999999998764
Q ss_pred ----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHH
Q psy11098 250 ----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAR 325 (380)
Q Consensus 250 ----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 325 (380)
++.||...|.|||++.+..+...++||||||||||.|.+|.+||...++.+++..|+.+.|..|. .+|.+++
T Consensus 172 G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPs----hvS~eCr 247 (864)
T KOG4717|consen 172 GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPS----HVSKECR 247 (864)
T ss_pred cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCch----hhhHHHH
Confidence 67899999999999999777788999999999999999999999999999999999999999885 5899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 326 ELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 326 ~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
|||..||..||.+|.|.+++..|+|++..
T Consensus 248 dLI~sMLvRdPkkRAslEeI~s~~Wlq~~ 276 (864)
T KOG4717|consen 248 DLIQSMLVRDPKKRASLEEIVSTSWLQAG 276 (864)
T ss_pred HHHHHHHhcCchhhccHHHHhccccccCC
Confidence 99999999999999999999999999865
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-48 Score=364.72 Aligned_cols=253 Identities=27% Similarity=0.421 Sum_probs=205.3
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
.++|++.+.||+|+||+||+|+++.+++.||+|++..... ......+|+.+++.+.|+||+++++++... +..++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~l 80 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTK---ETLTL 80 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecC---CeEEE
Confidence 4689999999999999999999999999999999965432 234567899999999999999999988764 67899
Q ss_pred EEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-----
Q psy11098 177 VMQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS----- 249 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~----- 249 (380)
||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 81 v~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 159 (303)
T cd07869 81 VFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHT 159 (303)
T ss_pred EEECC-CcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCcc
Confidence 99999 5678777765 35689999999999999999999999999999999999998 5689999999986542
Q ss_pred -ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhcc--cC------------CCC
Q psy11098 250 -TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEE-ETRAHISVA--DY------------SFP 313 (380)
Q Consensus 250 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~-~~~~~i~~~--~~------------~~~ 313 (380)
....+|+.|+|||++.+...++.++|||||||++|+|++|..||.+..+. +....+... .. .+.
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (303)
T cd07869 160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFK 239 (303)
T ss_pred CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccc
Confidence 23567899999999876556788999999999999999999999875432 222222110 00 000
Q ss_pred CCc--------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 314 PEQ--------------CGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 314 ~~~--------------~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
.+. ...+++++++||++||+.||++|||++|+|+||||.+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 240 PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence 000 012457899999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=368.30 Aligned_cols=254 Identities=25% Similarity=0.320 Sum_probs=207.6
Q ss_pred ceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC---CchHHHHHHHHHHHhhccCCCcceeeecccccC--CCceE
Q psy11098 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER---QPQQITRAEYNLLSTLMHAHIPTALALFENAPV--PGTDT 175 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~--~~~~~ 175 (380)
+|++.+.||+|+||.||+|+++.+++.||+|.+.... .....+.+|+++++.++|+||+++++++..... ....|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5899999999999999999999999999999986432 223456789999999999999999988754321 23579
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-----
Q psy11098 176 IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS----- 249 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~----- 249 (380)
+||||+ +++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 81 lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 159 (338)
T cd07859 81 VVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 159 (338)
T ss_pred EEEecC-CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCc
Confidence 999999 678999998888899999999999999999999999999999999999998 5689999999987542
Q ss_pred ----ccccCCCcccCCccccCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-----------------
Q psy11098 250 ----TVVLPDLEFASPEMLTSP-ATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISV----------------- 307 (380)
Q Consensus 250 ----~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~----------------- 307 (380)
....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 160 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 239 (338)
T cd07859 160 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEK 239 (338)
T ss_pred cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhh
Confidence 234689999999998652 4678899999999999999999999987664433222110
Q ss_pred ----------ccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 308 ----------ADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 308 ----------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
.........+..++.++.+||.+||..||++|||++|+|+||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~ 297 (338)
T cd07859 240 ARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLA 297 (338)
T ss_pred HHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcC
Confidence 000001112345788899999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=367.06 Aligned_cols=248 Identities=25% Similarity=0.407 Sum_probs=215.3
Q ss_pred ceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC----CCchHHHHHHHHHHHhhccC-CCcceeeecccccCCCceE
Q psy11098 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLSTLMHA-HIPTALALFENAPVPGTDT 175 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~il~~l~h~-ni~~i~~~~~~~~~~~~~~ 175 (380)
+|++++.||+|+||.||+|+++.+++.||+|++.+. ......+..|.+++..+.|+ +++.+..++.. .+..|
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~---~~~~~ 77 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT---MDRLY 77 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc---CCEEE
Confidence 488999999999999999999999999999999653 22334567789999999775 46677777765 36789
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-----
Q psy11098 176 IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS----- 249 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~----- 249 (380)
+||||+.||+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 78 lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05587 78 FVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT 157 (324)
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCc
Confidence 9999999999999998888899999999999999999999999999999999999998 5689999999986431
Q ss_pred -ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHH
Q psy11098 250 -TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELI 328 (380)
Q Consensus 250 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 328 (380)
....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+....+......++. .++.++.+|+
T Consensus 158 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li 232 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAVSIC 232 (324)
T ss_pred eeeecCCccccChhhhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHH
Confidence 34568999999999987 46788999999999999999999999998888888888776655543 5799999999
Q ss_pred HHhcccCCCCCCCH-----HHHHhcccccccCC
Q psy11098 329 GQLLNTHADKRPTA-----GQLLQVAWFAEASC 356 (380)
Q Consensus 329 ~~~L~~dP~~Rpt~-----~e~L~hpw~~~~~~ 356 (380)
++||.+||.+|+++ +++++||||....+
T Consensus 233 ~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~ 265 (324)
T cd05587 233 KGLLTKHPAKRLGCGPTGERDIREHAFFRRIDW 265 (324)
T ss_pred HHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 99999999999986 89999999987543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-48 Score=373.52 Aligned_cols=250 Identities=29% Similarity=0.468 Sum_probs=218.5
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC----CCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
++|++.+.||+|+||+||+|++..+++.||+|++... ......+.+|++++..++|+|+++++..+.. .+..+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~~~~~ 77 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQD---EEHLY 77 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheec---CCeEE
Confidence 3699999999999999999999999999999999643 2344567889999999999999999887765 36789
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccccc----
Q psy11098 176 IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVST---- 250 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~~---- 250 (380)
+||||+.|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.....
T Consensus 78 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 78 LVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred EEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 9999999999999998888899999999999999999999999999999999999998 56999999999875432
Q ss_pred -------------------------------cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHH
Q psy11098 251 -------------------------------VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEE 299 (380)
Q Consensus 251 -------------------------------~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~ 299 (380)
...||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcC-CCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 3468999999999988 47889999999999999999999999998887
Q ss_pred HHHHHHhc--ccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCC-HHHHHhcccccccCC
Q psy11098 300 ETRAHISV--ADYSFPPEQCGHISVPARELIGQLLNTHADKRPT-AGQLLQVAWFAEASC 356 (380)
Q Consensus 300 ~~~~~i~~--~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-~~e~L~hpw~~~~~~ 356 (380)
+....+.. ....++. ...+++++.+||.+||. ||.+|++ ++++|+||||.+...
T Consensus 237 ~~~~~i~~~~~~~~~p~--~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~~ 293 (350)
T cd05573 237 ETYNKIINWKESLRFPP--DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDW 293 (350)
T ss_pred HHHHHHhccCCcccCCC--CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCCH
Confidence 77777766 3333332 23479999999999997 9999999 999999999987543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-48 Score=367.55 Aligned_cols=244 Identities=26% Similarity=0.441 Sum_probs=212.7
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEecCC----CCchHHHHHHHHHHHhh-ccCCCcceeeecccccCCCceEEEEEe
Q psy11098 106 ERLGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLSTL-MHAHIPTALALFENAPVPGTDTIVMQL 180 (380)
Q Consensus 106 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~~~~~~~lv~e~ 180 (380)
+.||+|+||+||+|+++.+++.||+|++.+. .........|..++..+ .|+|+++++.++... +..|+||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~---~~~~iv~Ey 77 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTP---DRLFFVMEF 77 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcC---CEEEEEEcC
Confidence 3699999999999999999999999999643 22334556788888776 699999999888764 678999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------cccc
Q psy11098 181 VHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------TVVL 253 (380)
Q Consensus 181 ~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------~~~~ 253 (380)
+.||+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.... ....
T Consensus 78 ~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (320)
T cd05590 78 VNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC 157 (320)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccc
Confidence 99999999998888999999999999999999999999999999999999998 5689999999986531 3457
Q ss_pred CCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhcc
Q psy11098 254 PDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLN 333 (380)
Q Consensus 254 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 333 (380)
||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......++. .++.++++||++||+
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~~L~ 232 (320)
T cd05590 158 GTPDYIAPEILQE-MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT----WLSQDAVDILKAFMT 232 (320)
T ss_pred cCccccCHHHHcC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHHHHHHcc
Confidence 8999999999987 47788999999999999999999999999888888888776655543 479999999999999
Q ss_pred cCCCCCCCH------HHHHhcccccccCCC
Q psy11098 334 THADKRPTA------GQLLQVAWFAEASCS 357 (380)
Q Consensus 334 ~dP~~Rpt~------~e~L~hpw~~~~~~~ 357 (380)
+||++|+++ +++++||||....+.
T Consensus 233 ~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~ 262 (320)
T cd05590 233 KNPTMRLGSLTLGGEEAILRHPFFKELDWE 262 (320)
T ss_pred cCHHHCCCCCCCCCHHHHHcCCCcCCCCHH
Confidence 999999998 999999999875443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-49 Score=354.69 Aligned_cols=256 Identities=29% Similarity=0.522 Sum_probs=225.4
Q ss_pred hhhhceeee-eeecccCCeEEEEEEEcCCCcEEEEEEecCCC-CchHHHHHHHHHHHhhc-cCCCcceeeecccccCCCc
Q psy11098 97 QFEHRYEEL-ERLGNGRFCTVRKARDRGTGQLVALKQIPRER-QPQQITRAEYNLLSTLM-HAHIPTALALFENAPVPGT 173 (380)
Q Consensus 97 ~~~~~y~~~-~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~il~~l~-h~ni~~i~~~~~~~~~~~~ 173 (380)
.|.+-|++. +.||+|+||.|--|....||..||||++.+.. .......+|++++.+-+ |+||+.++++|+.. ++
T Consensus 74 ~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd---~~ 150 (463)
T KOG0607|consen 74 KFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD---TR 150 (463)
T ss_pred hHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc---ce
Confidence 466667665 67999999999999999999999999997654 34567778999998874 99999999999885 78
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-C---eeEEEeCCCccccc
Q psy11098 174 DTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-A---VLKLIDLGSSVSVS 249 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~---~ikl~DFG~a~~~~ 249 (380)
+|+|||-|.||+|...|.+...++|.++..++++|+.||.+||.+||.||||||+|||+.+ + -||||||.+.....
T Consensus 151 FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k 230 (463)
T KOG0607|consen 151 FYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIK 230 (463)
T ss_pred EEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccc
Confidence 9999999999999999999999999999999999999999999999999999999999963 2 69999998875431
Q ss_pred -------------ccccCCCcccCCcccc----CCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC---------------
Q psy11098 250 -------------TVVLPDLEFASPEMLT----SPATAGPSTDMWSLGVLLYILLSGVSPFLDES--------------- 297 (380)
Q Consensus 250 -------------~~~~gt~~y~aPE~~~----~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~--------------- 297 (380)
.+.+|+-+|||||++. ....|+.+.|.||||||+|.||+|.+||.+.-
T Consensus 231 ~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~C 310 (463)
T KOG0607|consen 231 LNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVC 310 (463)
T ss_pred cCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHH
Confidence 3456777899999863 23578899999999999999999999996542
Q ss_pred HHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 298 EEETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 298 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
...+++.|..+.|.||++.|..+|.+++|+|+.+|..|+.+|.++.++|+|||++...
T Consensus 311 Q~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~ 368 (463)
T KOG0607|consen 311 QNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCA 368 (463)
T ss_pred HHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccc
Confidence 2457788999999999999999999999999999999999999999999999998753
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-48 Score=370.69 Aligned_cols=249 Identities=28% Similarity=0.458 Sum_probs=209.2
Q ss_pred ceeeeeeecccCCeEEEEEEEc---CCCcEEEEEEecCCC-----CchHHHHHHHHHHHhhc-cCCCcceeeecccccCC
Q psy11098 101 RYEELERLGNGRFCTVRKARDR---GTGQLVALKQIPRER-----QPQQITRAEYNLLSTLM-HAHIPTALALFENAPVP 171 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~---~~~~~vAvK~~~~~~-----~~~~~~~~E~~il~~l~-h~ni~~i~~~~~~~~~~ 171 (380)
+|++.+.||+|+||+||++++. .+++.||+|++.+.. ........|+++++.++ |++|+++...+...
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~--- 77 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTE--- 77 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecC---
Confidence 4889999999999999999864 478999999996421 22345677999999994 89999988887653
Q ss_pred CceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-
Q psy11098 172 GTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS- 249 (380)
Q Consensus 172 ~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~- 249 (380)
+..++||||+.||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 78 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 78 AKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 67899999999999999998888899999999999999999999999999999999999997 5699999999987542
Q ss_pred ------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHhcccCCCCCCcCCC
Q psy11098 250 ------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDE----SEEETRAHISVADYSFPPEQCGH 319 (380)
Q Consensus 250 ------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~----~~~~~~~~i~~~~~~~~~~~~~~ 319 (380)
....||+.|+|||++.+...++.++|||||||++|+|++|..||... ........+......++ ..
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~----~~ 233 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFP----SF 233 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCC----CC
Confidence 24568999999999987556788999999999999999999999643 23334444444333333 35
Q ss_pred CCHHHHHHHHHhcccCCCCCC-----CHHHHHhcccccccCC
Q psy11098 320 ISVPARELIGQLLNTHADKRP-----TAGQLLQVAWFAEASC 356 (380)
Q Consensus 320 ~s~~~~~li~~~L~~dP~~Rp-----t~~e~L~hpw~~~~~~ 356 (380)
++.++++||.+||..||++|| +++++++||||.+...
T Consensus 234 ~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~ 275 (332)
T cd05614 234 IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDW 275 (332)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 799999999999999999999 8899999999987543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=372.66 Aligned_cols=253 Identities=24% Similarity=0.406 Sum_probs=217.5
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC----CCchHHHHHHHHHHHhhccCCCcceeeecccccCCCce
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~ 174 (380)
.++|++.+.||+|+||.||+|+++.+++.||+|++.+. ......+.+|+.+++.++|+||++++.++... +..
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~---~~~ 118 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDD---KYL 118 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecC---CEE
Confidence 46899999999999999999999999999999999642 22334567899999999999999999888763 678
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc----
Q psy11098 175 TIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS---- 249 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~---- 249 (380)
|+||||+.||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 119 ~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~ 197 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM 197 (370)
T ss_pred EEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 999999999999998865 4689999999999999999999999999999999999998 5799999999987553
Q ss_pred ---ccccCCCcccCCccccCC---CCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHH
Q psy11098 250 ---TVVLPDLEFASPEMLTSP---ATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVP 323 (380)
Q Consensus 250 ---~~~~gt~~y~aPE~~~~~---~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 323 (380)
....||+.|+|||++.+. ..++.++|+|||||++|+|++|..||.+.+.......+.........+....+|.+
T Consensus 198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 277 (370)
T cd05596 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQ 277 (370)
T ss_pred ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHH
Confidence 245689999999998653 24688999999999999999999999998888887777665433333333468999
Q ss_pred HHHHHHHhcccCCCC--CCCHHHHHhcccccccC
Q psy11098 324 ARELIGQLLNTHADK--RPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 324 ~~~li~~~L~~dP~~--Rpt~~e~L~hpw~~~~~ 355 (380)
+++||++||..+|.+ |+|++++++||||++..
T Consensus 278 ~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~ 311 (370)
T cd05596 278 AKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQ 311 (370)
T ss_pred HHHHHHHHccChhhccCCCCHHHHhcCcccCCCC
Confidence 999999999999988 99999999999998743
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=384.40 Aligned_cols=252 Identities=25% Similarity=0.361 Sum_probs=205.3
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCC------CcceeeecccccCCC
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAH------IPTALALFENAPVPG 172 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~n------i~~i~~~~~~~~~~~ 172 (380)
.++|++.+.||+|+||+||+|.+..+++.||||+++...........|+++++.++|.+ +++++++|... .+
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~--~~ 205 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE--TG 205 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC--Cc
Confidence 57899999999999999999999999999999999654444445567888888887654 66677776543 34
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeecCCCCcEEEeCC----------------
Q psy11098 173 TDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHS-QQIAHKDIRPENILMNGA---------------- 235 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~-~~iiHrDlKp~NIl~~~~---------------- 235 (380)
..++|||++ |++|.+++.+...+++..++.++.||+.||.|||+ .||+||||||+|||++.+
T Consensus 206 ~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~ 284 (467)
T PTZ00284 206 HMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDP 284 (467)
T ss_pred eEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCC
Confidence 678999988 88999999888889999999999999999999998 599999999999999742
Q ss_pred -eeEEEeCCCccccc---ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCC
Q psy11098 236 -VLKLIDLGSSVSVS---TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYS 311 (380)
Q Consensus 236 -~ikl~DFG~a~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~ 311 (380)
.+||+|||++.... ...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+......
T Consensus 285 ~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~ 363 (467)
T PTZ00284 285 CRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGR 363 (467)
T ss_pred ceEEECCCCccccCccccccccCCccccCcHHhhc-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCC
Confidence 49999999876542 45688999999999988 57889999999999999999999999887766555444322111
Q ss_pred CCCCc------------------------------------C--CCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccc
Q psy11098 312 FPPEQ------------------------------------C--GHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAE 353 (380)
Q Consensus 312 ~~~~~------------------------------------~--~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~ 353 (380)
++... . ...++.+.|||++||++||++|||++|+|+||||.+
T Consensus 364 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~ 443 (467)
T PTZ00284 364 LPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLK 443 (467)
T ss_pred CCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccccc
Confidence 11000 0 001355789999999999999999999999999987
Q ss_pred c
Q psy11098 354 A 354 (380)
Q Consensus 354 ~ 354 (380)
.
T Consensus 444 ~ 444 (467)
T PTZ00284 444 Y 444 (467)
T ss_pred c
Confidence 5
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=366.70 Aligned_cols=244 Identities=25% Similarity=0.412 Sum_probs=213.3
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEecCCC----CchHHHHHHHHHHHhh-ccCCCcceeeecccccCCCceEEEEEe
Q psy11098 106 ERLGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQITRAEYNLLSTL-MHAHIPTALALFENAPVPGTDTIVMQL 180 (380)
Q Consensus 106 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~~~~~~~lv~e~ 180 (380)
+.||+|+||.||+|+++.+++.||+|++.+.. ........|.+++..+ +|+||+++++++... +..|+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~---~~~~lv~E~ 77 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTK---DRLFFVMEY 77 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC---CeEEEEEeC
Confidence 36999999999999999999999999996532 2234456788888866 799999999988764 678999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------cccc
Q psy11098 181 VHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------TVVL 253 (380)
Q Consensus 181 ~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------~~~~ 253 (380)
+.|++|...+.....+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.... ....
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05591 78 VNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC 157 (321)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccc
Confidence 99999999998888899999999999999999999999999999999999998 5699999999986531 3456
Q ss_pred CCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhcc
Q psy11098 254 PDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLN 333 (380)
Q Consensus 254 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 333 (380)
||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......++. .++.++.+||++||.
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~ll~~~L~ 232 (321)
T cd05591 158 GTPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPV----WLSKEAVSILKAFMT 232 (321)
T ss_pred cCccccCHHHHcC-CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHHhc
Confidence 8999999999987 47788999999999999999999999999988888888877665543 378999999999999
Q ss_pred cCCCCCC-------CHHHHHhcccccccCCC
Q psy11098 334 THADKRP-------TAGQLLQVAWFAEASCS 357 (380)
Q Consensus 334 ~dP~~Rp-------t~~e~L~hpw~~~~~~~ 357 (380)
+||++|+ +++++++||||....+.
T Consensus 233 ~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~ 263 (321)
T cd05591 233 KNPNKRLGCVASQGGEDAIKQHPFFKEIDWV 263 (321)
T ss_pred cCHHHcCCCCCCCCCHHHHhcCCccCCCCHH
Confidence 9999999 99999999999875443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-48 Score=370.04 Aligned_cols=253 Identities=26% Similarity=0.410 Sum_probs=216.4
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC----CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
++|++.+.||+|+||+||+|.++.+++.||+|+++... .....+.+|+.+++.+.|+||+++..++... +..+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~---~~~~ 77 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDK---DNLY 77 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecC---CeEE
Confidence 36899999999999999999999999999999997532 2345677899999999999999998887763 6789
Q ss_pred EEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc----
Q psy11098 176 IVMQLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS---- 249 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~---- 249 (380)
+||||+.|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 78 LVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred EEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 999999999999999775 6799999999999999999999999999999999999998 5699999999997653
Q ss_pred ---ccccCCCcccCCccccC-----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCC
Q psy11098 250 ---TVVLPDLEFASPEMLTS-----PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHIS 321 (380)
Q Consensus 250 ---~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 321 (380)
....||+.|+|||++.. ...++.++|||||||++|+|++|..||.+.+......++.........+....++
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVS 237 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCC
Confidence 23468999999999863 2456789999999999999999999999888877777766543222222223589
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhcccccccCC
Q psy11098 322 VPARELIGQLLNTHADKRPTAGQLLQVAWFAEASC 356 (380)
Q Consensus 322 ~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~ 356 (380)
.++.+||+.||. ||.+|||++++++||||.+..+
T Consensus 238 ~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~ 271 (330)
T cd05601 238 SDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDW 271 (330)
T ss_pred HHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCH
Confidence 999999999998 9999999999999999987543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-48 Score=378.11 Aligned_cols=255 Identities=29% Similarity=0.388 Sum_probs=213.4
Q ss_pred hhhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhc-c-----CCCcceeeecccc
Q psy11098 95 QEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLM-H-----AHIPTALALFENA 168 (380)
Q Consensus 95 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~-h-----~ni~~i~~~~~~~ 168 (380)
.+.+..+|++++.||+|+||+|.+|.+..|++.||||+++....--.+...|+.||..|+ | -|+++++++|..
T Consensus 181 ~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f- 259 (586)
T KOG0667|consen 181 NDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF- 259 (586)
T ss_pred cceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc-
Confidence 355667999999999999999999999999999999999887776677788999999997 3 255555555554
Q ss_pred cCCCceEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC---CeeEEEeCC
Q psy11098 169 PVPGTDTIVMQLVHGESLIQHLCRQ--STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG---AVLKLIDLG 243 (380)
Q Consensus 169 ~~~~~~~lv~e~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~---~~ikl~DFG 243 (380)
.++.|||+|++ +.+|+++++.+ ..++...++.++.||+.||.+||+.||||.||||||||+.+ ..|||||||
T Consensus 260 --r~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 260 --RNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred --ccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecc
Confidence 58889999999 89999999875 46899999999999999999999999999999999999963 389999999
Q ss_pred Ccccccccc---cCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC----------
Q psy11098 244 SSVSVSTVV---LPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADY---------- 310 (380)
Q Consensus 244 ~a~~~~~~~---~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~---------- 310 (380)
+|+..+... +.+..|+|||++.| ..|+.+.||||||||++||++|.+.|.+++..+.+..|.....
T Consensus 337 SSc~~~q~vytYiQSRfYRAPEVILG-lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~ 415 (586)
T KOG0667|consen 337 SSCFESQRVYTYIQSRFYRAPEVILG-LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA 415 (586)
T ss_pred cccccCCcceeeeeccccccchhhcc-CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 999887544 45788999999999 5889999999999999999999999999998887777642110
Q ss_pred ------------------------------------------CCCCC------cCC-CCCHHHHHHHHHhcccCCCCCCC
Q psy11098 311 ------------------------------------------SFPPE------QCG-HISVPARELIGQLLNTHADKRPT 341 (380)
Q Consensus 311 ------------------------------------------~~~~~------~~~-~~s~~~~~li~~~L~~dP~~Rpt 341 (380)
..|.. ... .-...+.|||++||..||.+|+|
T Consensus 416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t 495 (586)
T KOG0667|consen 416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT 495 (586)
T ss_pred cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence 00000 000 11234689999999999999999
Q ss_pred HHHHHhccccccc
Q psy11098 342 AGQLLQVAWFAEA 354 (380)
Q Consensus 342 ~~e~L~hpw~~~~ 354 (380)
+.|+|+||||...
T Consensus 496 p~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 496 PAQALNHPFLTGT 508 (586)
T ss_pred HHHHhcCcccccc
Confidence 9999999999843
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-48 Score=372.76 Aligned_cols=250 Identities=25% Similarity=0.452 Sum_probs=215.2
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC----CCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
+.|++.+.||+|+||+||+|+++.+++.||+|++... ......+++|+.++..++|+++++++..+... +..|
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~---~~~~ 77 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDK---RNLY 77 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC---CEEE
Confidence 3688999999999999999999999999999999642 22345667899999999999999998887753 6789
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-----
Q psy11098 176 IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS----- 249 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~----- 249 (380)
+||||+.||+|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 78 lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 78 LIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred EEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 9999999999999998888899999999999999999999999999999999999997 5699999999976431
Q ss_pred ------------------------------------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCC
Q psy11098 250 ------------------------------------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPF 293 (380)
Q Consensus 250 ------------------------------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf 293 (380)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|..||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC-CCCCCcceeccccceeeecccCCCCC
Confidence 13468999999999987 57788999999999999999999999
Q ss_pred CCCCHHHHHHHHhccc--CCCCCCcCCCCCHHHHHHHHHhcccCCCCCC---CHHHHHhcccccccCC
Q psy11098 294 LDESEEETRAHISVAD--YSFPPEQCGHISVPARELIGQLLNTHADKRP---TAGQLLQVAWFAEASC 356 (380)
Q Consensus 294 ~~~~~~~~~~~i~~~~--~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---t~~e~L~hpw~~~~~~ 356 (380)
.+.+..+....+.... ..++.. ..++.++++||.+|+ .||.+|+ +++++++||||....+
T Consensus 237 ~~~~~~~~~~~i~~~~~~~~~p~~--~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~ 301 (360)
T cd05627 237 CSETPQETYRKVMNWKETLVFPPE--VPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGVDW 301 (360)
T ss_pred CCCCHHHHHHHHHcCCCceecCCC--CCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCCCH
Confidence 9988888777776533 233322 347999999999987 4999998 5899999999987643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=371.98 Aligned_cols=254 Identities=23% Similarity=0.401 Sum_probs=216.5
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC----CCchHHHHHHHHHHHhhccCCCcceeeecccccCCCc
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGT 173 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~ 173 (380)
..++|++.+.||+|+||.||+|+++.+++.||+|++.+. ......+.+|+.+++.+.||||++++..+... +.
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~---~~ 117 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD---KY 117 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC---CE
Confidence 357899999999999999999999999999999998642 22344567899999999999999999888763 67
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc---
Q psy11098 174 DTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS--- 249 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~--- 249 (380)
.|+||||+.||+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|....
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~ 196 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG 196 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCC
Confidence 89999999999999988654 689999999999999999999999999999999999998 5699999999987653
Q ss_pred ----ccccCCCcccCCccccCC---CCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCH
Q psy11098 250 ----TVVLPDLEFASPEMLTSP---ATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISV 322 (380)
Q Consensus 250 ----~~~~gt~~y~aPE~~~~~---~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 322 (380)
....||+.|+|||++.+. ..++.++|+|||||++|+|++|..||.+.+.......+......+..+....++.
T Consensus 197 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~ 276 (370)
T cd05621 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISK 276 (370)
T ss_pred ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCH
Confidence 245689999999998753 2367899999999999999999999999888888887776543333333345799
Q ss_pred HHHHHHHHhcccCCCC--CCCHHHHHhcccccccC
Q psy11098 323 PARELIGQLLNTHADK--RPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 323 ~~~~li~~~L~~dP~~--Rpt~~e~L~hpw~~~~~ 355 (380)
.++++|.+||..++.+ |+|++|+++||||+...
T Consensus 277 ~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~ 311 (370)
T cd05621 277 HAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQ 311 (370)
T ss_pred HHHHHHHHHccCchhccCCCCHHHHhcCcccCCCC
Confidence 9999999999865544 89999999999998743
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-48 Score=368.44 Aligned_cols=242 Identities=26% Similarity=0.439 Sum_probs=212.6
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEecCCC----CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEEEec
Q psy11098 106 ERLGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLV 181 (380)
Q Consensus 106 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e~~ 181 (380)
+.||+|+||.||+|.+..+++.||+|++.+.. ........|+++++.++|+||+++...+... +..++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~---~~~~lv~E~~ 77 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH---DRLCFVMEYA 77 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcC---CEEEEEEeCC
Confidence 46999999999999999999999999996532 2234556799999999999999998888764 6789999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------cccc
Q psy11098 182 HGESLIQHLCRQSTITESYICCIIRQLHSALHCLHS-QQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------TVVL 253 (380)
Q Consensus 182 ~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~-~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------~~~~ 253 (380)
.||+|..++.....+++..++.++.||+.||.|||+ .||+||||||+|||++ ++.+||+|||++.... ....
T Consensus 78 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (325)
T cd05594 78 NGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC 157 (325)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccccc
Confidence 999999999888889999999999999999999997 7999999999999998 5689999999986432 2456
Q ss_pred CCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhcc
Q psy11098 254 PDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLN 333 (380)
Q Consensus 254 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 333 (380)
||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.++....+......++. .++.++.+||++||+
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~~~L~ 232 (325)
T cd05594 158 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKSLLSGLLK 232 (325)
T ss_pred CCcccCCHHHHcc-CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCHHHHHHHHHHhh
Confidence 8999999999987 47788999999999999999999999998888888877766666553 479999999999999
Q ss_pred cCCCCCC-----CHHHHHhcccccccC
Q psy11098 334 THADKRP-----TAGQLLQVAWFAEAS 355 (380)
Q Consensus 334 ~dP~~Rp-----t~~e~L~hpw~~~~~ 355 (380)
+||++|+ ++.++|+||||....
T Consensus 233 ~dP~~R~~~~~~~~~~il~h~~~~~~~ 259 (325)
T cd05594 233 KDPKQRLGGGPDDAKEIMQHKFFAGIV 259 (325)
T ss_pred cCHHHhCCCCCCCHHHHhcCCCcCCCC
Confidence 9999997 999999999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-47 Score=362.01 Aligned_cols=255 Identities=24% Similarity=0.323 Sum_probs=214.8
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
.++|++.+.||+|+||.||++++..++..||+|++..... ....+.+|+++++.++|+|++++++++... +..++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~l 80 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD---GEISI 80 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC---CEEEE
Confidence 4789999999999999999999999999999999975432 235678899999999999999999988764 67899
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeecCCCCcEEEe-CCeeEEEeCCCccccc----c
Q psy11098 177 VMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQ-QIAHKDIRPENILMN-GAVLKLIDLGSSVSVS----T 250 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~-~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~----~ 250 (380)
||||+.|++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++ ++.+||+|||++.... .
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 160 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 160 (331)
T ss_pred EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccccc
Confidence 999999999999998888899999999999999999999986 699999999999998 5689999999987553 3
Q ss_pred cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC--------------------
Q psy11098 251 VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADY-------------------- 310 (380)
Q Consensus 251 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~-------------------- 310 (380)
...||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||......+....+.....
T Consensus 161 ~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (331)
T cd06649 161 SFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRP 239 (331)
T ss_pred cCCCCcCcCCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccccc
Confidence 4568999999999987 4678899999999999999999999977665544332211000
Q ss_pred ------------------------CCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCCC
Q psy11098 311 ------------------------SFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASCS 357 (380)
Q Consensus 311 ------------------------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~~ 357 (380)
..+......+++++++||++||++||++|||++++|+||||+.....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~~ 310 (331)
T cd06649 240 VSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSEVE 310 (331)
T ss_pred ccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcccc
Confidence 00111122468899999999999999999999999999999876544
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=364.27 Aligned_cols=242 Identities=29% Similarity=0.529 Sum_probs=211.9
Q ss_pred eeecccCCeEEEEEEEc---CCCcEEEEEEecCCC-----CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEE
Q psy11098 106 ERLGNGRFCTVRKARDR---GTGQLVALKQIPRER-----QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIV 177 (380)
Q Consensus 106 ~~LG~G~fg~V~~~~~~---~~~~~vAvK~~~~~~-----~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv 177 (380)
+.||+|+||.||++++. .+++.||+|++.+.. .....+.+|+++++.++|+||+++++.+... +..|+|
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~---~~~~lv 78 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTG---GKLYLI 78 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecC---CeEEEE
Confidence 67999999999999864 478899999996432 2234567899999999999999999888764 678999
Q ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------c
Q psy11098 178 MQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------T 250 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------~ 250 (380)
|||+.|++|.+++...+.+.+..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.... .
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (323)
T cd05584 79 LEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH 158 (323)
T ss_pred EeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccc
Confidence 99999999999998888899999999999999999999999999999999999997 5699999999986431 3
Q ss_pred cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHH
Q psy11098 251 VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQ 330 (380)
Q Consensus 251 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 330 (380)
...||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+......++. .+++++.+||++
T Consensus 159 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~ 233 (323)
T cd05584 159 TFCGTIEYMAPEILMR-SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPP----YLTPEARDLLKK 233 (323)
T ss_pred ccCCCccccChhhccC-CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHH
Confidence 4578999999999987 46788999999999999999999999998888888888777665543 478999999999
Q ss_pred hcccCCCCCC-----CHHHHHhcccccccC
Q psy11098 331 LLNTHADKRP-----TAGQLLQVAWFAEAS 355 (380)
Q Consensus 331 ~L~~dP~~Rp-----t~~e~L~hpw~~~~~ 355 (380)
||.+||++|| +++++++||||....
T Consensus 234 ~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~ 263 (323)
T cd05584 234 LLKRNPSSRLGAGPGDAAEVQSHPFFRHVN 263 (323)
T ss_pred HcccCHhHcCCCCCCCHHHHhcCCCcCCCC
Confidence 9999999999 899999999998654
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-48 Score=356.87 Aligned_cols=253 Identities=26% Similarity=0.414 Sum_probs=214.5
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCC--ceE
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPG--TDT 175 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~--~~~ 175 (380)
..-.|...+.+|+|+||.||+|....+++.||||.+-.+.. ...+|.++|+.+.||||++++-+|......+ ...
T Consensus 22 ~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r---~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 22 VEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR---YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred eEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC---cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 34568888999999999999999999999999999855443 2345999999999999999999988765544 345
Q ss_pred EEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe--CCeeEEEeCCCccccc
Q psy11098 176 IVMQLVHGESLIQHLCR----QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN--GAVLKLIDLGSSVSVS 249 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~----~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~--~~~ikl~DFG~a~~~~ 249 (380)
+||||+ ..+|.+.+.. +..++...++.+++||+.||.|||+.||+||||||+|+|+| ++.+||||||.|+.+.
T Consensus 99 lVleym-P~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 99 LVLEYM-PETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HHHHhc-hHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 899999 7789888874 56789999999999999999999999999999999999998 4699999999998764
Q ss_pred -----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc---------------
Q psy11098 250 -----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVAD--------------- 309 (380)
Q Consensus 250 -----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~--------------- 309 (380)
.....|..|+|||.+.+...|+.+.||||.||++.||+-|.+-|.|++..+.+..|.+.-
T Consensus 178 ~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y 257 (364)
T KOG0658|consen 178 KGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNY 257 (364)
T ss_pred cCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccc
Confidence 334558899999999998999999999999999999999999999988877666654221
Q ss_pred --CCCCC---C-----cCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 310 --YSFPP---E-----QCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 310 --~~~~~---~-----~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
..++. . .....++++.+|+.++|..+|.+|.++.|+|.||||.+.
T Consensus 258 ~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdel 312 (364)
T KOG0658|consen 258 TEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDEL 312 (364)
T ss_pred ccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHh
Confidence 11110 0 234578999999999999999999999999999999864
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-47 Score=363.77 Aligned_cols=242 Identities=23% Similarity=0.417 Sum_probs=209.7
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEecCC----CCchHHHHHHHHHHHhh-ccCCCcceeeecccccCCCceEEEEEe
Q psy11098 106 ERLGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLSTL-MHAHIPTALALFENAPVPGTDTIVMQL 180 (380)
Q Consensus 106 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~~~~~~~lv~e~ 180 (380)
+.||+|+||.||+|+++.+|+.||+|++++. .........|..++..+ .|+|++++++++... +..|+||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~---~~~~lv~E~ 77 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTK---EHLFFVMEF 77 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeC---CEEEEEECC
Confidence 4699999999999999999999999999653 22334456677777754 899999999888764 678999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccc------ccccc
Q psy11098 181 VHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSV------STVVL 253 (380)
Q Consensus 181 ~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~------~~~~~ 253 (380)
+.|++|..++.....+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++... .....
T Consensus 78 ~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05620 78 LNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC 157 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccC
Confidence 99999999998888899999999999999999999999999999999999998 568999999998643 13467
Q ss_pred CCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhcc
Q psy11098 254 PDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLN 333 (380)
Q Consensus 254 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 333 (380)
||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......++. .++.++++||++||.
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~ 232 (316)
T cd05620 158 GTPDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPR----WITKESKDILEKLFE 232 (316)
T ss_pred CCcCccCHHHHcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHHHHHHHHcc
Confidence 8999999999987 47788999999999999999999999998888887777665544442 478999999999999
Q ss_pred cCCCCCCCH-HHHHhcccccccC
Q psy11098 334 THADKRPTA-GQLLQVAWFAEAS 355 (380)
Q Consensus 334 ~dP~~Rpt~-~e~L~hpw~~~~~ 355 (380)
.||++|+++ +++++||||....
T Consensus 233 ~dP~~R~~~~~~~~~h~~f~~~~ 255 (316)
T cd05620 233 RDPTRRLGVVGNIRGHPFFKTIN 255 (316)
T ss_pred CCHHHcCCChHHHHcCCCcCCCC
Confidence 999999997 5888999998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-47 Score=366.18 Aligned_cols=250 Identities=28% Similarity=0.422 Sum_probs=203.9
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
..+|+.++.||+|+||.||+|++..+++.||+|++..... ....+.+|+++++.++|+||+++++++... +..++
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~l 149 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHN---GEIQV 149 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccC---CeEEE
Confidence 3567888999999999999999999999999999965433 235678899999999999999999988764 67899
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------
Q psy11098 177 VMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------ 249 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------ 249 (380)
||||+.+++|... ...++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 150 v~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~ 225 (353)
T PLN00034 150 LLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC 225 (353)
T ss_pred EEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccccc
Confidence 9999999988543 3467888899999999999999999999999999999998 4689999999987653
Q ss_pred ccccCCCcccCCccccCC----CCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHH
Q psy11098 250 TVVLPDLEFASPEMLTSP----ATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAR 325 (380)
Q Consensus 250 ~~~~gt~~y~aPE~~~~~----~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 325 (380)
....||..|+|||++... ...+.++|||||||++|+|++|+.||......+....+..............++.+++
T Consensus 226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 305 (353)
T PLN00034 226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFR 305 (353)
T ss_pred cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHH
Confidence 345789999999987531 3445689999999999999999999974433222222211111222233346789999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 326 ELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 326 ~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
+||.+||..||++|||+.|+|+||||.+..
T Consensus 306 ~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 306 HFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred HHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 999999999999999999999999998863
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=364.26 Aligned_cols=249 Identities=24% Similarity=0.395 Sum_probs=215.7
Q ss_pred ceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC----CchHHHHHHHHHHHhh-ccCCCcceeeecccccCCCceE
Q psy11098 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQITRAEYNLLSTL-MHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
+|++.+.||+|+||.||+|+++.+++.||+|++.+.. ........|..++..+ .|++++++..++... +..|
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~---~~~~ 77 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTM---DRLY 77 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecC---CEEE
Confidence 4788999999999999999999999999999997532 1223455677777777 478888888887653 6789
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-----
Q psy11098 176 IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS----- 249 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~----- 249 (380)
+||||+.||+|.+.+.....+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 78 lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~ 157 (323)
T cd05616 78 FVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT 157 (323)
T ss_pred EEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCc
Confidence 9999999999999998888899999999999999999999999999999999999998 5689999999987532
Q ss_pred -ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHH
Q psy11098 250 -TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELI 328 (380)
Q Consensus 250 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 328 (380)
....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......++. .++.++.+|+
T Consensus 158 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li 232 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAIC 232 (323)
T ss_pred cccCCCChhhcCHHHhcC-CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----cCCHHHHHHH
Confidence 34578999999999987 47789999999999999999999999999888888888877666553 4799999999
Q ss_pred HHhcccCCCCCCC-----HHHHHhcccccccCCC
Q psy11098 329 GQLLNTHADKRPT-----AGQLLQVAWFAEASCS 357 (380)
Q Consensus 329 ~~~L~~dP~~Rpt-----~~e~L~hpw~~~~~~~ 357 (380)
++||++||++|++ ..++++||||....+.
T Consensus 233 ~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~ 266 (323)
T cd05616 233 KGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE 266 (323)
T ss_pred HHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 9999999999998 4899999999865433
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=379.68 Aligned_cols=252 Identities=23% Similarity=0.308 Sum_probs=206.2
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeeccccc-----CCCc
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAP-----VPGT 173 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~-----~~~~ 173 (380)
..+|++.+.||+|+||+||+|.+..+++.||||++.... ....+|+.+++.++|+||+++.++|.... ....
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence 468999999999999999999999999999999885432 23457999999999999999988764321 1124
Q ss_pred eEEEEEecCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-C-eeEEEeCCCccc
Q psy11098 174 DTIVMQLVHGESLIQHLC----RQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-A-VLKLIDLGSSVS 247 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~----~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~-~ikl~DFG~a~~ 247 (380)
+++||||+. ++|.+.+. ....+++..++.++.||+.||.|||++||+||||||+|||++. + .+||+|||+|+.
T Consensus 142 l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~ 220 (440)
T PTZ00036 142 LNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKN 220 (440)
T ss_pred EEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchh
Confidence 578999995 57777664 3467999999999999999999999999999999999999983 3 699999999976
Q ss_pred cc-----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc-------------
Q psy11098 248 VS-----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVAD------------- 309 (380)
Q Consensus 248 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~------------- 309 (380)
.. ....||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+....+....
T Consensus 221 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 300 (440)
T PTZ00036 221 LLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNP 300 (440)
T ss_pred ccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhch
Confidence 53 345679999999998775578899999999999999999999999887665555443211
Q ss_pred ----CCCCCC--------cCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 310 ----YSFPPE--------QCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 310 ----~~~~~~--------~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
..++.. .....++++++||++||.+||.+|||+.|+|+||||.+.
T Consensus 301 ~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 301 NYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred hhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 111111 012467899999999999999999999999999999764
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-47 Score=364.12 Aligned_cols=245 Identities=26% Similarity=0.437 Sum_probs=211.9
Q ss_pred eeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC----CCchHHHHHHHHHH---HhhccCCCcceeeecccccCCCce
Q psy11098 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLL---STLMHAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 102 y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~il---~~l~h~ni~~i~~~~~~~~~~~~~ 174 (380)
|++++.||+|+||.||+|.++.+++.||+|++++. ....+.+..|++++ +.++|+||+++++++... +..
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~---~~~ 77 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTE---DHV 77 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcC---CEE
Confidence 67889999999999999999999999999999643 22234455666655 466799999999988764 678
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc----
Q psy11098 175 TIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS---- 249 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~---- 249 (380)
|+||||+.|++|...+.. ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 78 ~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05589 78 CFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD 156 (324)
T ss_pred EEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC
Confidence 999999999999888754 5799999999999999999999999999999999999998 5699999999986432
Q ss_pred --ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHH
Q psy11098 250 --TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAREL 327 (380)
Q Consensus 250 --~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 327 (380)
....||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+..+....+......++. .++.++.+|
T Consensus 157 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~l 231 (324)
T cd05589 157 RTSTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FLSREAISI 231 (324)
T ss_pred cccccccCccccCHhHhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHHHH
Confidence 34578999999999987 47788999999999999999999999998888888888776665543 479999999
Q ss_pred HHHhcccCCCCCC-----CHHHHHhcccccccC
Q psy11098 328 IGQLLNTHADKRP-----TAGQLLQVAWFAEAS 355 (380)
Q Consensus 328 i~~~L~~dP~~Rp-----t~~e~L~hpw~~~~~ 355 (380)
|++||..||.+|| ++.++++||||.+..
T Consensus 232 i~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~ 264 (324)
T cd05589 232 MRRLLRRNPERRLGSGEKDAEDVKKQPFFRDIN 264 (324)
T ss_pred HHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCC
Confidence 9999999999999 799999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-47 Score=362.31 Aligned_cols=244 Identities=26% Similarity=0.425 Sum_probs=208.5
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEecCCC----CchHHHHHHHHHHHh-hccCCCcceeeecccccCCCceEEEEEe
Q psy11098 106 ERLGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQITRAEYNLLST-LMHAHIPTALALFENAPVPGTDTIVMQL 180 (380)
Q Consensus 106 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~il~~-l~h~ni~~i~~~~~~~~~~~~~~lv~e~ 180 (380)
+.||+|+||+||+|++..+++.||+|+++... ........|..++.. +.|+||++++.++... +..++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~---~~~~lv~e~ 77 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTK---EHLFFVMEY 77 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcC---CEEEEEEcC
Confidence 36999999999999999999999999996532 223344556666664 4899999999888753 678999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------cccc
Q psy11098 181 VHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------TVVL 253 (380)
Q Consensus 181 ~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------~~~~ 253 (380)
+.||+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.... ...+
T Consensus 78 ~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 157 (316)
T cd05592 78 LNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC 157 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccccc
Confidence 99999999998888899999999999999999999999999999999999997 5689999999987532 3457
Q ss_pred CCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhcc
Q psy11098 254 PDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLN 333 (380)
Q Consensus 254 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 333 (380)
||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......++ ..++.++.+||++||.
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~ll~~~l~ 232 (316)
T cd05592 158 GTPDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFP----RWISKEAKDCLSKLFE 232 (316)
T ss_pred CCccccCHHHHcC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHcc
Confidence 8999999999987 4678899999999999999999999999888888777765544443 3478999999999999
Q ss_pred cCCCCCCCH-HHHHhcccccccCCC
Q psy11098 334 THADKRPTA-GQLLQVAWFAEASCS 357 (380)
Q Consensus 334 ~dP~~Rpt~-~e~L~hpw~~~~~~~ 357 (380)
.||++||++ .++++||||....+.
T Consensus 233 ~~P~~R~~~~~~l~~h~~~~~~~~~ 257 (316)
T cd05592 233 RDPTKRLGVDGDIRQHPFFRGIDWE 257 (316)
T ss_pred CCHHHcCCChHHHHcCcccCCCCHH
Confidence 999999986 588899999876543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-47 Score=362.33 Aligned_cols=243 Identities=26% Similarity=0.440 Sum_probs=212.8
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEecCCC----CchHHHHHHHHHHHhh-ccCCCcceeeecccccCCCceEEEEEe
Q psy11098 106 ERLGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQITRAEYNLLSTL-MHAHIPTALALFENAPVPGTDTIVMQL 180 (380)
Q Consensus 106 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~~~~~~~lv~e~ 180 (380)
+.||+|+||+||+|.++.+++.||+|++.+.. ........|+++++.+ .|+|++++++++... +..++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~---~~~~lv~e~ 77 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTK---DRLFFVMEY 77 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC---CEEEEEEcC
Confidence 36999999999999999999999999997532 2334556788888887 699999999988763 678999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------cccc
Q psy11098 181 VHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------TVVL 253 (380)
Q Consensus 181 ~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------~~~~ 253 (380)
+.|++|..++.+...+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.... ...+
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (318)
T cd05570 78 VNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC 157 (318)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccccee
Confidence 99999999998888899999999999999999999999999999999999998 5699999999986431 3456
Q ss_pred CCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhcc
Q psy11098 254 PDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLN 333 (380)
Q Consensus 254 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 333 (380)
||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+.......+......++. .++.++.+||++||.
T Consensus 158 g~~~y~aPE~~~~-~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~~l~ 232 (318)
T cd05570 158 GTPDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPR----WLSKEAKSILKSFLT 232 (318)
T ss_pred cCccccCHHHhcC-CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC----cCCHHHHHHHHHHcc
Confidence 8999999999987 47788999999999999999999999988888888877766655543 478999999999999
Q ss_pred cCCCCCCCH-----HHHHhcccccccCC
Q psy11098 334 THADKRPTA-----GQLLQVAWFAEASC 356 (380)
Q Consensus 334 ~dP~~Rpt~-----~e~L~hpw~~~~~~ 356 (380)
.||.+|||+ .++++||||....+
T Consensus 233 ~dP~~R~s~~~~~~~~ll~~~~~~~~~~ 260 (318)
T cd05570 233 KNPEKRLGCLPTGEQDIKGHPFFREIDW 260 (318)
T ss_pred CCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 999999999 99999999987644
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=353.43 Aligned_cols=250 Identities=25% Similarity=0.348 Sum_probs=203.7
Q ss_pred hceeeeeeecccCCeEEEEEEEcC-CCcEEEEEEecCCCC---chHHHHHHHHHHHhh---ccCCCcceeeecccc--cC
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRG-TGQLVALKQIPRERQ---PQQITRAEYNLLSTL---MHAHIPTALALFENA--PV 170 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~-~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l---~h~ni~~i~~~~~~~--~~ 170 (380)
++|++.+.||+|+||+||+|++.. +++.||+|.+..... ......+|+.+++.+ .||||+++++++... ..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 479999999999999999999864 468899999864332 223455677777766 699999999887532 22
Q ss_pred CCceEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccc
Q psy11098 171 PGTDTIVMQLVHGESLIQHLCRQ--STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVS 247 (380)
Q Consensus 171 ~~~~~lv~e~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~ 247 (380)
....++||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 159 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence 356899999995 6898888653 4589999999999999999999999999999999999998 56899999999875
Q ss_pred cc-----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCC--------
Q psy11098 248 VS-----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPP-------- 314 (380)
Q Consensus 248 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~-------- 314 (380)
.. ....||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+........+
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (290)
T cd07862 160 YSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 238 (290)
T ss_pred ccCCcccccccccccccChHHHhC-CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhc
Confidence 53 34567999999999977 46788999999999999999999999988877766665432110000
Q ss_pred ---------------CcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy11098 315 ---------------EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 315 ---------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~ 351 (380)
.....++..+++||.+||+.||++|||+.|+|+||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 239 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred ccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 0113467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-47 Score=362.93 Aligned_cols=244 Identities=28% Similarity=0.419 Sum_probs=208.9
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEecCCC----CchHHHHHHH-HHHHhhccCCCcceeeecccccCCCceEEEEEe
Q psy11098 106 ERLGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQITRAEY-NLLSTLMHAHIPTALALFENAPVPGTDTIVMQL 180 (380)
Q Consensus 106 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~E~-~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e~ 180 (380)
+.||+|+||+||+|+++.+|+.||+|++.+.. .....+..|. .+++.++|+||++++..+... +..++||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~---~~~~lv~e~ 77 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTA---DKLYFVLDY 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeC---CEEEEEEcC
Confidence 36999999999999999999999999996432 1222333344 456789999999998888763 678999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------cccc
Q psy11098 181 VHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------TVVL 253 (380)
Q Consensus 181 ~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------~~~~ 253 (380)
+.||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.... ....
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (323)
T cd05575 78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC 157 (323)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccccc
Confidence 99999999998888899999999999999999999999999999999999997 5699999999986431 3456
Q ss_pred CCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhcc
Q psy11098 254 PDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLN 333 (380)
Q Consensus 254 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 333 (380)
||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.......+ ..++.++.+||++||+
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~ 232 (323)
T cd05575 158 GTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK----PNISVSARHLLEGLLQ 232 (323)
T ss_pred CChhhcChhhhcC-CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHhh
Confidence 8999999999987 4778899999999999999999999999888888777776655443 3579999999999999
Q ss_pred cCCCCCCCH----HHHHhcccccccCCC
Q psy11098 334 THADKRPTA----GQLLQVAWFAEASCS 357 (380)
Q Consensus 334 ~dP~~Rpt~----~e~L~hpw~~~~~~~ 357 (380)
.||.+||++ .++++||||....+.
T Consensus 233 ~~p~~R~~~~~~~~~il~~~~~~~~~~~ 260 (323)
T cd05575 233 KDRTKRLGAKDDFLEIKNHVFFSSINWD 260 (323)
T ss_pred cCHHhCCCCCCCHHHHHcCCCcCCCCHH
Confidence 999999987 699999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-47 Score=360.20 Aligned_cols=244 Identities=26% Similarity=0.417 Sum_probs=210.2
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEecCC----CCchHHHHHHHHHHHh-hccCCCcceeeecccccCCCceEEEEEe
Q psy11098 106 ERLGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLST-LMHAHIPTALALFENAPVPGTDTIVMQL 180 (380)
Q Consensus 106 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~il~~-l~h~ni~~i~~~~~~~~~~~~~~lv~e~ 180 (380)
+.||+|+||+||+|++..+++.||+|+++.. .........|..++.. +.||||+++++++... +..++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~---~~~~lv~ey 77 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTK---ENLFFVMEY 77 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeC---CEEEEEEeC
Confidence 4699999999999999999999999999653 2233445567777775 4899999999888764 678999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------cccc
Q psy11098 181 VHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------TVVL 253 (380)
Q Consensus 181 ~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------~~~~ 253 (380)
+.||+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.... ....
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05619 78 LNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC 157 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeec
Confidence 99999999998888899999999999999999999999999999999999998 4689999999986431 3456
Q ss_pred CCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhcc
Q psy11098 254 PDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLN 333 (380)
Q Consensus 254 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 333 (380)
||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+..+....+......++. .++.++++||.+||.
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~~l~ 232 (316)
T cd05619 158 GTPDYIAPEILLG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPR----WLTREAKDILVKLFV 232 (316)
T ss_pred CCccccCHHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCHHHHHHHHHHhc
Confidence 8999999999987 47788999999999999999999999998888887777655544432 478999999999999
Q ss_pred cCCCCCCCHH-HHHhcccccccCCC
Q psy11098 334 THADKRPTAG-QLLQVAWFAEASCS 357 (380)
Q Consensus 334 ~dP~~Rpt~~-e~L~hpw~~~~~~~ 357 (380)
.||++|+++. ++++||||....+.
T Consensus 233 ~~P~~R~~~~~~l~~h~~~~~~~~~ 257 (316)
T cd05619 233 REPERRLGVKGDIRQHPFFREIDWS 257 (316)
T ss_pred cCHhhcCCChHHHHcCcccCCCCHH
Confidence 9999999996 89999999886543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=366.48 Aligned_cols=244 Identities=27% Similarity=0.416 Sum_probs=209.8
Q ss_pred ecccCCeEEEEEEEcCCCcEEEEEEecCCCC----chHHHHHHHHHHHhh---ccCCCcceeeecccccCCCceEEEEEe
Q psy11098 108 LGNGRFCTVRKARDRGTGQLVALKQIPRERQ----PQQITRAEYNLLSTL---MHAHIPTALALFENAPVPGTDTIVMQL 180 (380)
Q Consensus 108 LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~E~~il~~l---~h~ni~~i~~~~~~~~~~~~~~lv~e~ 180 (380)
||+|+||+||+|+++.+++.||+|++.+... .......|..++..+ .|+||+.+...+... +..|+||||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~---~~~~lv~e~ 77 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTD---SDLYLVTDY 77 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecC---CeEEEEEcC
Confidence 7999999999999999999999999964321 122334466666655 699999998888764 678999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------cccc
Q psy11098 181 VHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------TVVL 253 (380)
Q Consensus 181 ~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------~~~~ 253 (380)
+.+|+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.... ....
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 157 (330)
T cd05586 78 MSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC 157 (330)
T ss_pred CCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCcc
Confidence 99999999998888999999999999999999999999999999999999998 5689999999986532 3457
Q ss_pred CCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhcc
Q psy11098 254 PDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLN 333 (380)
Q Consensus 254 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 333 (380)
||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+......++.. .+++++++||++||.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~---~~~~~~~~li~~~L~ 234 (330)
T cd05586 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKN---VLSDEGRQFVKGLLN 234 (330)
T ss_pred CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCc---cCCHHHHHHHHHHcC
Confidence 89999999999775567889999999999999999999999988888888887776666542 478999999999999
Q ss_pred cCCCCCC----CHHHHHhcccccccCCC
Q psy11098 334 THADKRP----TAGQLLQVAWFAEASCS 357 (380)
Q Consensus 334 ~dP~~Rp----t~~e~L~hpw~~~~~~~ 357 (380)
+||.+|| ++.++++||||.+..+.
T Consensus 235 ~~P~~R~~~~~~~~~ll~h~~~~~~~~~ 262 (330)
T cd05586 235 RNPQHRLGAHRDAVELKEHPFFADIDWD 262 (330)
T ss_pred CCHHHCCCCCCCHHHHhcCccccCCCHH
Confidence 9999998 79999999999876443
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-47 Score=362.64 Aligned_cols=242 Identities=24% Similarity=0.374 Sum_probs=205.2
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEecCCC----CchHHHHHHHHHHHhh-ccCCCcceeeecccccCCCceEEEEEe
Q psy11098 106 ERLGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQITRAEYNLLSTL-MHAHIPTALALFENAPVPGTDTIVMQL 180 (380)
Q Consensus 106 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~~~~~~~lv~e~ 180 (380)
+.||+|+||.||+|+++.+++.||+|++++.. .....+..|..++..+ +|+||+++++++... +..|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~---~~~~lv~e~ 77 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTE---SRLFFVIEF 77 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcC---CEEEEEEeC
Confidence 36999999999999999999999999997532 2234567799999888 699999999988764 678999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccc------ccccc
Q psy11098 181 VHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSV------STVVL 253 (380)
Q Consensus 181 ~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~------~~~~~ 253 (380)
+.||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++... .....
T Consensus 78 ~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (329)
T cd05588 78 VSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC 157 (329)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCcccccc
Confidence 99999999998888999999999999999999999999999999999999998 568999999998642 13457
Q ss_pred CCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC---------CHHHHHHHHhcccCCCCCCcCCCCCHHH
Q psy11098 254 PDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDE---------SEEETRAHISVADYSFPPEQCGHISVPA 324 (380)
Q Consensus 254 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~---------~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 324 (380)
||+.|+|||++.+ ..++.++|+|||||++|+|++|..||... ........+......++ ..++.++
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p----~~~~~~~ 232 (329)
T cd05588 158 GTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP----RSLSVKA 232 (329)
T ss_pred CCccccCHHHHcC-CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCC----CCCCHHH
Confidence 8999999999988 57788999999999999999999999531 11223444444444444 3478999
Q ss_pred HHHHHHhcccCCCCCCC------HHHHHhcccccccC
Q psy11098 325 RELIGQLLNTHADKRPT------AGQLLQVAWFAEAS 355 (380)
Q Consensus 325 ~~li~~~L~~dP~~Rpt------~~e~L~hpw~~~~~ 355 (380)
.+||++||+.||.+|+| ++++++||||....
T Consensus 233 ~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~ 269 (329)
T cd05588 233 SSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNID 269 (329)
T ss_pred HHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence 99999999999999987 78999999998643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=366.01 Aligned_cols=252 Identities=24% Similarity=0.415 Sum_probs=215.3
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC----CCchHHHHHHHHHHHhhccCCCcceeeecccccCCCce
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~ 174 (380)
.++|++.+.||+|+||.||+|+++.+++.||+|++.+. ......+.+|+.+++.++|+||++++..+... +..
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~---~~~ 118 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD---RYL 118 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC---CEE
Confidence 47899999999999999999999999999999998642 22334567899999999999999999888753 678
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc----
Q psy11098 175 TIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS---- 249 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~---- 249 (380)
++||||+.||+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 119 ~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~ 197 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 197 (371)
T ss_pred EEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc
Confidence 9999999999999988654 689999999999999999999999999999999999998 5699999999987653
Q ss_pred ---ccccCCCcccCCccccCCC---CCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHH
Q psy11098 250 ---TVVLPDLEFASPEMLTSPA---TAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVP 323 (380)
Q Consensus 250 ---~~~~gt~~y~aPE~~~~~~---~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 323 (380)
...+||+.|+|||++.+.. .++.++|||||||++|+|++|..||.+.+.......+......+.......++.+
T Consensus 198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 277 (371)
T cd05622 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKE 277 (371)
T ss_pred ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHH
Confidence 2456899999999987532 3678999999999999999999999998888888887765433333334568999
Q ss_pred HHHHHHHhcccCCCC--CCCHHHHHhccccccc
Q psy11098 324 ARELIGQLLNTHADK--RPTAGQLLQVAWFAEA 354 (380)
Q Consensus 324 ~~~li~~~L~~dP~~--Rpt~~e~L~hpw~~~~ 354 (380)
+++||.+||..++.+ |++++++++|+||++.
T Consensus 278 ~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 278 AKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred HHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 999999999854443 7899999999999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=353.24 Aligned_cols=260 Identities=23% Similarity=0.392 Sum_probs=214.2
Q ss_pred ceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC----chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEE
Q psy11098 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ----PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
.|++.+.||+|+||+||++.+..+++.||+|++..... ....+.+|+.+++.++|+||+.+...+... +..++
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~l 77 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK---DALCL 77 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCC---CeEEE
Confidence 47889999999999999999999999999999964322 223456799999999999999988887653 57899
Q ss_pred EEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCccccc----
Q psy11098 177 VMQLVHGESLIQHLCRQ--STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVS---- 249 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~---- 249 (380)
||||+.|++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||++++ +.++|+|||++....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 78 VLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred EEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 99999999999888553 46899999999999999999999999999999999999984 689999999987653
Q ss_pred -ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHH
Q psy11098 250 -TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELI 328 (380)
Q Consensus 250 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 328 (380)
....|++.|+|||++.+ ..++.++|+||+||++|+|++|..||.+.........+..............++..+.+||
T Consensus 158 ~~~~~~~~~y~aPE~~~~-~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC 236 (285)
T ss_pred cccccCCCCccCcHHhcC-CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHH
Confidence 23468999999999987 4678899999999999999999999988665443333322211222222345899999999
Q ss_pred HHhcccCCCCCC-----CHHHHHhcccccccCCCCCccccc
Q psy11098 329 GQLLNTHADKRP-----TAGQLLQVAWFAEASCSEFDTERL 364 (380)
Q Consensus 329 ~~~L~~dP~~Rp-----t~~e~L~hpw~~~~~~~~~~~~~~ 364 (380)
.+||..||.+|| +++++++||||.+..+....+..+
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 277 (285)
T cd05605 237 RQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGML 277 (285)
T ss_pred HHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHHHhhCCC
Confidence 999999999999 999999999999876554444333
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=352.93 Aligned_cols=248 Identities=24% Similarity=0.371 Sum_probs=202.9
Q ss_pred ecccCCeEEEEEEEcCCCcEEEEEEecCCCC----chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEEEecCC
Q psy11098 108 LGNGRFCTVRKARDRGTGQLVALKQIPRERQ----PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHG 183 (380)
Q Consensus 108 LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e~~~g 183 (380)
||+|+||+||++.++.+++.||+|.+..... ....+..|+++++.++|+|++++...+... +..++||||+.|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~---~~~~lv~e~~~~ 77 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTK---TDLCLVMTIMNG 77 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCC---CeEEEEEeCCCC
Confidence 7999999999999999999999999864322 123456799999999999999998887764 568999999999
Q ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------ccc
Q psy11098 184 ESLIQHLCR----QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------TVV 252 (380)
Q Consensus 184 g~L~~~l~~----~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------~~~ 252 (380)
|+|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.... ...
T Consensus 78 g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 157 (280)
T cd05608 78 GDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY 157 (280)
T ss_pred CCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccccc
Confidence 999887743 35689999999999999999999999999999999999998 4689999999987543 234
Q ss_pred cCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhc
Q psy11098 253 LPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLL 332 (380)
Q Consensus 253 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 332 (380)
.||+.|+|||++.+ ..++.++|+|||||++|+|++|..||...........+.......+......++.++.+|+.+||
T Consensus 158 ~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 236 (280)
T cd05608 158 AGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALL 236 (280)
T ss_pred CCCcCccCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHh
Confidence 68999999999988 47788999999999999999999999765432221121111111122223458999999999999
Q ss_pred ccCCCCCC-----CHHHHHhcccccccCCCCC
Q psy11098 333 NTHADKRP-----TAGQLLQVAWFAEASCSEF 359 (380)
Q Consensus 333 ~~dP~~Rp-----t~~e~L~hpw~~~~~~~~~ 359 (380)
+.||++|| |++++++||||+...+..+
T Consensus 237 ~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~~ 268 (280)
T cd05608 237 AKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQL 268 (280)
T ss_pred cCCHHHhcCCCCCCHHHHhcChhhhcCCHhHH
Confidence 99999999 8999999999988655443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=367.07 Aligned_cols=247 Identities=23% Similarity=0.306 Sum_probs=202.7
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVM 178 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~ 178 (380)
..+|++++.||+|+||.||+|.+..+++.||+|.... ....+|+++++.|+||||++++++|... +..++||
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-----~~~~~E~~il~~l~HpnIv~~~~~~~~~---~~~~lv~ 162 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-----GGTATEAHILRAINHPSIIQLKGTFTYN---KFTCLIL 162 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-----hhhHHHHHHHHhCCCCCCCCEeEEEEEC---CeeEEEE
Confidence 4689999999999999999999999999999997532 3457899999999999999999988764 5679999
Q ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-------c
Q psy11098 179 QLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS-------T 250 (380)
Q Consensus 179 e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~-------~ 250 (380)
|++ +++|..++.....+++.+++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|.... .
T Consensus 163 e~~-~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~ 241 (391)
T PHA03212 163 PRY-KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241 (391)
T ss_pred ecC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccccc
Confidence 999 578999998888899999999999999999999999999999999999998 5689999999986432 2
Q ss_pred cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHhccc--------------
Q psy11098 251 VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDES-------EEETRAHISVAD-------------- 309 (380)
Q Consensus 251 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~-------~~~~~~~i~~~~-------------- 309 (380)
...||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... .......+....
T Consensus 242 ~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~ 320 (391)
T PHA03212 242 GWAGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQAN 320 (391)
T ss_pred cccCccCCCChhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHH
Confidence 3578999999999987 478899999999999999999998875421 111111111000
Q ss_pred ------------CCCCC-----CcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 310 ------------YSFPP-----EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 310 ------------~~~~~-----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
...+. .....++.++.+||.+||+.||++|||++|+|+||||++..
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 383 (391)
T PHA03212 321 LDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP 383 (391)
T ss_pred HHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence 00000 00113567899999999999999999999999999998753
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=362.11 Aligned_cols=257 Identities=25% Similarity=0.369 Sum_probs=210.4
Q ss_pred hhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---chHHHHHHHHHHHhhccCCCcceeeeccccc---C
Q psy11098 97 QFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLMHAHIPTALALFENAP---V 170 (380)
Q Consensus 97 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~---~ 170 (380)
.+.++|++++.||+|+||+||+|.+..+++.||+|++..... ....+.+|+++++.++|+||+++++++.... .
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 456899999999999999999999999999999999965422 2344567999999999999999998876432 1
Q ss_pred CCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc
Q psy11098 171 PGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS 249 (380)
Q Consensus 171 ~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~ 249 (380)
....|++++++ +++|.+++. ...+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD 169 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecC
Confidence 23568999988 889987775 45799999999999999999999999999999999999998 5689999999998764
Q ss_pred ---ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC----------------
Q psy11098 250 ---TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADY---------------- 310 (380)
Q Consensus 250 ---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~---------------- 310 (380)
....||+.|+|||++.+...++.++|||||||++|+|++|..||.+....+....+.....
T Consensus 170 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (343)
T cd07878 170 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHAR 249 (343)
T ss_pred CCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHH
Confidence 3456899999999998755788899999999999999999999987665544433321110
Q ss_pred -------CCCC----CcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 311 -------SFPP----EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 311 -------~~~~----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
..+. ..+...++.+.+||.+||..||++|||+.|+|+||||.+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~ 305 (343)
T cd07878 250 KYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH 305 (343)
T ss_pred HHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence 0010 01224567789999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-46 Score=357.70 Aligned_cols=252 Identities=27% Similarity=0.473 Sum_probs=212.8
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC----CCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
++|++.+.||+|+||+||+++++.+++.||+|++.+. ......+.+|+.++..++|+||+.++.++... +..|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~---~~~~ 77 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDE---NNLY 77 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecC---CeEE
Confidence 4799999999999999999999999999999999642 22345577899999999999999999888764 6789
Q ss_pred EEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc----
Q psy11098 176 IVMQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS---- 249 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~---- 249 (380)
+||||+.||+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 99999999999999976 56799999999999999999999999999999999999997 5689999999986543
Q ss_pred ---ccccCCCcccCCccccC----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc--CCCCCCcCCCC
Q psy11098 250 ---TVVLPDLEFASPEMLTS----PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVAD--YSFPPEQCGHI 320 (380)
Q Consensus 250 ---~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~ 320 (380)
....||+.|+|||++.. ...++.++|||||||++|+|++|..||.+.+..+....+.... ..++. ....+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~-~~~~~ 236 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPP-DVTDV 236 (331)
T ss_pred ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCC-ccCCC
Confidence 12468999999999863 2356789999999999999999999999888777776665433 22332 23458
Q ss_pred CHHHHHHHHHhcccCCCC--CCCHHHHHhcccccccC
Q psy11098 321 SVPARELIGQLLNTHADK--RPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 321 s~~~~~li~~~L~~dP~~--Rpt~~e~L~hpw~~~~~ 355 (380)
+.++++||++||..++++ |++++++|+||||....
T Consensus 237 ~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~ 273 (331)
T cd05597 237 SEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGID 273 (331)
T ss_pred CHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCC
Confidence 999999999999765544 78999999999997653
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=360.27 Aligned_cols=243 Identities=23% Similarity=0.374 Sum_probs=204.8
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEecCCC----CchHHHHHHHHHHHhh-ccCCCcceeeecccccCCCceEEEEEe
Q psy11098 106 ERLGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQITRAEYNLLSTL-MHAHIPTALALFENAPVPGTDTIVMQL 180 (380)
Q Consensus 106 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~~~~~~~lv~e~ 180 (380)
+.||+|+||+||+|+++.+++.||+|++.+.. .....+..|+.++..+ +|+||+++++++... +..++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~---~~~~lv~E~ 77 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE---SRLFFVIEY 77 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeC---CEEEEEEeC
Confidence 36999999999999999999999999997532 2234466788888776 799999999988764 678999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------cccc
Q psy11098 181 VHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------TVVL 253 (380)
Q Consensus 181 ~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------~~~~ 253 (380)
+.+++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.... ....
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (329)
T cd05618 78 VNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC 157 (329)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcccccc
Confidence 99999999998888899999999999999999999999999999999999998 5699999999986531 3457
Q ss_pred CCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC---------CCHHHHHHHHhcccCCCCCCcCCCCCHHH
Q psy11098 254 PDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLD---------ESEEETRAHISVADYSFPPEQCGHISVPA 324 (380)
Q Consensus 254 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~---------~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 324 (380)
||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.. .........+......++ ..++.++
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----~~~~~~~ 232 (329)
T cd05618 158 GTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----RSLSVKA 232 (329)
T ss_pred CCccccCHHHHcC-CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCC----CCCCHHH
Confidence 8999999999987 4778899999999999999999999952 112223344444444444 3578999
Q ss_pred HHHHHHhcccCCCCCCC------HHHHHhcccccccCC
Q psy11098 325 RELIGQLLNTHADKRPT------AGQLLQVAWFAEASC 356 (380)
Q Consensus 325 ~~li~~~L~~dP~~Rpt------~~e~L~hpw~~~~~~ 356 (380)
.+||++||+.||++|+| +.++++||||.+..+
T Consensus 233 ~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~ 270 (329)
T cd05618 233 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 270 (329)
T ss_pred HHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 99999999999999998 589999999987543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=357.07 Aligned_cols=248 Identities=25% Similarity=0.406 Sum_probs=214.1
Q ss_pred ceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC----CchHHHHHHHHHHHhhcc-CCCcceeeecccccCCCceE
Q psy11098 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQITRAEYNLLSTLMH-AHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~il~~l~h-~ni~~i~~~~~~~~~~~~~~ 175 (380)
+|+..+.||+|+||+||+|+++.+|+.||+|++.+.. ........|..++..+.| ++++++..++... +..|
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~---~~~~ 77 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTV---DRLY 77 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecC---CEEE
Confidence 3677899999999999999999999999999996532 223445678888888864 6677787777653 6789
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-----
Q psy11098 176 IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS----- 249 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~----- 249 (380)
+||||+.||+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 78 lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~ 157 (323)
T cd05615 78 FVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT 157 (323)
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCcc
Confidence 9999999999999998888899999999999999999999999999999999999998 5689999999987532
Q ss_pred -ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHH
Q psy11098 250 -TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELI 328 (380)
Q Consensus 250 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 328 (380)
....||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.........+......++. .++.++.+++
T Consensus 158 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li 232 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAVSIC 232 (323)
T ss_pred ccCccCCccccCHHHHcC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCHHHHHHH
Confidence 34568999999999987 46788999999999999999999999998888888888776665553 4789999999
Q ss_pred HHhcccCCCCCCC-----HHHHHhcccccccCC
Q psy11098 329 GQLLNTHADKRPT-----AGQLLQVAWFAEASC 356 (380)
Q Consensus 329 ~~~L~~dP~~Rpt-----~~e~L~hpw~~~~~~ 356 (380)
.+||++||.+|++ .+++++||||....+
T Consensus 233 ~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~ 265 (323)
T cd05615 233 KGLMTKHPSKRLGCGPEGERDIREHAFFRRIDW 265 (323)
T ss_pred HHHcccCHhhCCCCCCCCHHHHhcCcccCCCCH
Confidence 9999999999997 579999999997543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=348.72 Aligned_cols=249 Identities=29% Similarity=0.410 Sum_probs=203.0
Q ss_pred ceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---chHHHHHHHHHHHhh---ccCCCcceeeeccccc--CCC
Q psy11098 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---PQQITRAEYNLLSTL---MHAHIPTALALFENAP--VPG 172 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l---~h~ni~~i~~~~~~~~--~~~ 172 (380)
+|++.+.||+|+||+||+|+++.+++.||+|.++.... ......+|+++++.+ .|+||+++++++.... ...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 58999999999999999999999999999999865322 223455677777766 6999999998876532 234
Q ss_pred ceEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc
Q psy11098 173 TDTIVMQLVHGESLIQHLCRQ--STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS 249 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~ 249 (380)
..+++||++. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~ 159 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS 159 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence 5789999996 5888888653 3589999999999999999999999999999999999998 5689999999987653
Q ss_pred -----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC-----------C--
Q psy11098 250 -----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADY-----------S-- 311 (380)
Q Consensus 250 -----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~-----------~-- 311 (380)
....+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.........+..... .
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07863 160 CQMALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLP 238 (288)
T ss_pred CcccCCCccccccccCchHhhC-CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccccc
Confidence 33567899999999987 4678899999999999999999999988776655544432100 0
Q ss_pred ---CC-------CCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy11098 312 ---FP-------PEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 312 ---~~-------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~ 351 (380)
+. ......++.++++||.+||++||++|||+.|+|.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 239 RGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00 01123568889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=359.66 Aligned_cols=244 Identities=25% Similarity=0.400 Sum_probs=207.7
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEecCCC----CchHHH-HHHHHHHHhhccCCCcceeeecccccCCCceEEEEEe
Q psy11098 106 ERLGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQIT-RAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQL 180 (380)
Q Consensus 106 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~-~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e~ 180 (380)
+.||+|+||+||+|+++.+++.||+|++.+.. ...... .++..+++.+.|+||++++..+... +..|+||||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~---~~~~lv~e~ 77 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA---DKLYFVLDY 77 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcC---CeEEEEEeC
Confidence 36999999999999999999999999996432 112222 3334457788999999998888764 678999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------cccc
Q psy11098 181 VHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------TVVL 253 (380)
Q Consensus 181 ~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------~~~~ 253 (380)
+.|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.... ....
T Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 157 (325)
T cd05602 78 INGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC 157 (325)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccccc
Confidence 99999999998888899999999999999999999999999999999999997 5689999999987531 3457
Q ss_pred CCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhcc
Q psy11098 254 PDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLN 333 (380)
Q Consensus 254 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 333 (380)
||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......++ ..++.++.++|++||+
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~ 232 (325)
T cd05602 158 GTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARHLLEGLLQ 232 (325)
T ss_pred CCccccCHHHHcC-CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCC----CCCCHHHHHHHHHHcc
Confidence 8999999999987 5778899999999999999999999999888887777765544433 3589999999999999
Q ss_pred cCCCCCCCHH----HHHhcccccccCCC
Q psy11098 334 THADKRPTAG----QLLQVAWFAEASCS 357 (380)
Q Consensus 334 ~dP~~Rpt~~----e~L~hpw~~~~~~~ 357 (380)
+||.+|+++. ++++|+||....+.
T Consensus 233 ~~p~~R~~~~~~~~~i~~~~~~~~~~~~ 260 (325)
T cd05602 233 KDRTKRLGAKDDFMEIKNHIFFSPINWD 260 (325)
T ss_pred cCHHHCCCCCCCHHHHhcCcccCCCCHH
Confidence 9999999876 89999999765443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-47 Score=360.79 Aligned_cols=242 Identities=27% Similarity=0.454 Sum_probs=211.6
Q ss_pred eeecccCCeEEEEEEE---cCCCcEEEEEEecCCC---CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEEE
Q psy11098 106 ERLGNGRFCTVRKARD---RGTGQLVALKQIPRER---QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQ 179 (380)
Q Consensus 106 ~~LG~G~fg~V~~~~~---~~~~~~vAvK~~~~~~---~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e 179 (380)
+.||+|+||.||++++ +.+|+.||+|++.+.. ........|+++++.++|+||+++++++... +..|+|||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~lv~e 78 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTE---GKLYLILD 78 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcC---CEEEEEEc
Confidence 5799999999999986 3578999999996532 2234456799999999999999999888763 67899999
Q ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------ccc
Q psy11098 180 LVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------TVV 252 (380)
Q Consensus 180 ~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------~~~ 252 (380)
|+.|++|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.... ...
T Consensus 79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 158 (318)
T cd05582 79 FLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF 158 (318)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecc
Confidence 999999999998888899999999999999999999999999999999999998 5689999999987542 245
Q ss_pred cCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhc
Q psy11098 253 LPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLL 332 (380)
Q Consensus 253 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 332 (380)
.||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......++. .++.++++||++||
T Consensus 159 ~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~~~l 233 (318)
T cd05582 159 CGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQ----FLSPEAQSLLRALF 233 (318)
T ss_pred cCChhhcCHHHHcC-CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHHh
Confidence 68999999999987 46788999999999999999999999998888888887776665553 47899999999999
Q ss_pred ccCCCCCCC-----HHHHHhcccccccC
Q psy11098 333 NTHADKRPT-----AGQLLQVAWFAEAS 355 (380)
Q Consensus 333 ~~dP~~Rpt-----~~e~L~hpw~~~~~ 355 (380)
+.||++||| ++++++||||....
T Consensus 234 ~~~P~~R~~a~~~~~~~~~~~~~~~~~~ 261 (318)
T cd05582 234 KRNPANRLGAGPDGVEEIKRHPFFSTID 261 (318)
T ss_pred hcCHhHcCCCCCCCHHHHhCCCCcCCCC
Confidence 999999999 78899999998754
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-46 Score=353.50 Aligned_cols=252 Identities=27% Similarity=0.438 Sum_probs=209.6
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIV 177 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv 177 (380)
++|++.+.||+|+||.||+|+++.+++.||+|.++.... ......+|+++++.++|+|++++++++... +..++|
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~lv 82 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTD---KSLTLV 82 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeC---CeEEEE
Confidence 579999999999999999999999999999999864432 334567799999999999999999988764 678999
Q ss_pred EEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------
Q psy11098 178 MQLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------ 249 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------ 249 (380)
|||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 83 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 161 (309)
T cd07872 83 FEYLD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY 161 (309)
T ss_pred EeCCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcccc
Confidence 99996 5888887654 4589999999999999999999999999999999999998 5689999999987542
Q ss_pred ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc-------------------cC
Q psy11098 250 TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVA-------------------DY 310 (380)
Q Consensus 250 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~-------------------~~ 310 (380)
....+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+... ..
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07872 162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNY 241 (309)
T ss_pred ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhh
Confidence 23457899999999876557788999999999999999999999887766554444221 11
Q ss_pred CCCC-------CcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 311 SFPP-------EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 311 ~~~~-------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
.++. .....++.++++||++||+.||++|||++|+|+||||....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 242 NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 1111 11235788999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-48 Score=348.42 Aligned_cols=258 Identities=26% Similarity=0.439 Sum_probs=230.1
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC----chHHHHHHHHHHHhhccCCCcceeeecccccCCCce
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ----PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~ 174 (380)
-++|..++.||+|.||+|-+|+.+.+++.||+|+++++.. +.....-|-++|+.-+||.+..+.-.|.. .+++
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt---~drl 243 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT---QDRL 243 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc---CceE
Confidence 4678889999999999999999999999999999987632 22334568999999999988666655554 5889
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccc-----
Q psy11098 175 TIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSV----- 248 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~----- 248 (380)
++||||..||+|+-.+.+...++|..++.+...|+.||.|||+++||.||||.+|+|+| +|.|||+|||+.+.-
T Consensus 244 CFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~ 323 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGD 323 (516)
T ss_pred EEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccccc
Confidence 99999999999999999999999999999999999999999999999999999999999 789999999998643
Q ss_pred -cccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHH
Q psy11098 249 -STVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAREL 327 (380)
Q Consensus 249 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 327 (380)
..++||||+|+|||++.. ..|+.++|+|.+||++|||++|+.||.....+.+...|..++..||. .++++++.|
T Consensus 324 t~kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr----~ls~eAktL 398 (516)
T KOG0690|consen 324 TTKTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPR----TLSPEAKTL 398 (516)
T ss_pred eeccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCc----cCCHHHHHH
Confidence 268999999999999998 58899999999999999999999999999999999999999999986 489999999
Q ss_pred HHHhcccCCCCCC-----CHHHHHhcccccccCCCCCccccc
Q psy11098 328 IGQLLNTHADKRP-----TAGQLLQVAWFAEASCSEFDTERL 364 (380)
Q Consensus 328 i~~~L~~dP~~Rp-----t~~e~L~hpw~~~~~~~~~~~~~~ 364 (380)
+..+|.+||.+|. .+.|+.+|+||....+.+.-.+++
T Consensus 399 LsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki 440 (516)
T KOG0690|consen 399 LSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKI 440 (516)
T ss_pred HHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhcc
Confidence 9999999999997 589999999999877654444444
|
|
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-46 Score=355.76 Aligned_cols=240 Identities=28% Similarity=0.383 Sum_probs=204.1
Q ss_pred eeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCc---hHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEEE
Q psy11098 103 EELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP---QQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQ 179 (380)
Q Consensus 103 ~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e 179 (380)
.+.+.||+|+||+||+|.++.+. .||+|++...... ...+.+|+.+|..++||||+.+++++.... ...+||||
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~-~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~--~~~~iVtE 120 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTD-VVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP--GSLCIVTE 120 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCce-eEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC--CceEEEEE
Confidence 44456999999999999988542 2999999754432 457899999999999999999999988642 26799999
Q ss_pred ecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC-cEeecCCCCcEEEeCC--eeEEEeCCCccccc-----
Q psy11098 180 LVHGESLIQHLCR--QSTITESYICCIIRQLHSALHCLHSQQ-IAHKDIRPENILMNGA--VLKLIDLGSSVSVS----- 249 (380)
Q Consensus 180 ~~~gg~L~~~l~~--~~~l~e~~~~~i~~qil~al~~lH~~~-iiHrDlKp~NIl~~~~--~ikl~DFG~a~~~~----- 249 (380)
|+.+|+|.+++.. ...++...+..++.||+.||.|||+++ ||||||||+|||++.. ++||+|||+++...
T Consensus 121 y~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~ 200 (362)
T KOG0192|consen 121 YMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTS 200 (362)
T ss_pred eCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccccc
Confidence 9999999999987 678999999999999999999999999 9999999999999854 89999999997543
Q ss_pred -ccccCCCcccCCccccC-CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHH
Q psy11098 250 -TVVLPDLEFASPEMLTS-PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAREL 327 (380)
Q Consensus 250 -~~~~gt~~y~aPE~~~~-~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 327 (380)
+...||+.|||||++.+ ...++.++|||||||++|||+||+.||.+.........+.......+.+ ...++.+..+
T Consensus 201 ~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p--~~~~~~l~~l 278 (362)
T KOG0192|consen 201 MTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIP--KECPPHLSSL 278 (362)
T ss_pred ccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC--ccCCHHHHHH
Confidence 23678999999999995 2688999999999999999999999999998866666665444333322 2378999999
Q ss_pred HHHhcccCCCCCCCHHHHHh
Q psy11098 328 IGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 328 i~~~L~~dP~~Rpt~~e~L~ 347 (380)
|.+||..||.+||+..+++.
T Consensus 279 ~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 279 MERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHHhCCCCCCcCCCHHHHHH
Confidence 99999999999999999973
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-47 Score=360.67 Aligned_cols=243 Identities=26% Similarity=0.379 Sum_probs=207.7
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEecCCC----CchHHHHHHH-HHHHhhccCCCcceeeecccccCCCceEEEEEe
Q psy11098 106 ERLGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQITRAEY-NLLSTLMHAHIPTALALFENAPVPGTDTIVMQL 180 (380)
Q Consensus 106 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~E~-~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e~ 180 (380)
+.||+|+||+||+|+++.+|+.||+|++.+.. .....+..|. .+++.++|+||++++..+... +..|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~---~~~~lv~e~ 77 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTT---EKLYFVLDF 77 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecC---CEEEEEEcC
Confidence 36999999999999999999999999996432 2223334444 457789999999998888763 678999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------cccc
Q psy11098 181 VHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------TVVL 253 (380)
Q Consensus 181 ~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------~~~~ 253 (380)
+.|++|..++.....+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.... ....
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (325)
T cd05604 78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFC 157 (325)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccccc
Confidence 99999999998888999999999999999999999999999999999999998 5689999999986431 3457
Q ss_pred CCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhcc
Q psy11098 254 PDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLN 333 (380)
Q Consensus 254 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 333 (380)
||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.......+ ..++.++.++|++||.
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ll~~ll~ 232 (325)
T cd05604 158 GTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR----PGASLTAWSILEELLE 232 (325)
T ss_pred CChhhCCHHHHcC-CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCC----CCCCHHHHHHHHHHhc
Confidence 8999999999987 4678899999999999999999999999888888777776554443 2478999999999999
Q ss_pred cCCCCCCCH----HHHHhcccccccCC
Q psy11098 334 THADKRPTA----GQLLQVAWFAEASC 356 (380)
Q Consensus 334 ~dP~~Rpt~----~e~L~hpw~~~~~~ 356 (380)
+||++||++ .++++||||....+
T Consensus 233 ~~p~~R~~~~~~~~~i~~h~~f~~~~~ 259 (325)
T cd05604 233 KDRQRRLGAKEDFLEIQEHPFFESLSW 259 (325)
T ss_pred cCHHhcCCCCCCHHHHhcCCCcCCCCH
Confidence 999999976 59999999987543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-48 Score=365.28 Aligned_cols=254 Identities=31% Similarity=0.531 Sum_probs=227.3
Q ss_pred hhhhhhceeee--eeecccCCeEEEEEEEcCCCcEEEEEEecCC---CCchHHHHHHHHHHHhhccCCCcceeeeccccc
Q psy11098 95 QEQFEHRYEEL--ERLGNGRFCTVRKARDRGTGQLVALKQIPRE---RQPQQITRAEYNLLSTLMHAHIPTALALFENAP 169 (380)
Q Consensus 95 ~~~~~~~y~~~--~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~ 169 (380)
.-+|..-|++. +.||+|.||+||-|+|+.+|+.||||++.+. ...+...++|+.||+.+.||.|+++--.|+.
T Consensus 557 ~vd~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET-- 634 (888)
T KOG4236|consen 557 NVDISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFET-- 634 (888)
T ss_pred hhhHHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecC--
Confidence 34566677776 7899999999999999999999999999754 3456788999999999999999999988887
Q ss_pred CCCceEEEEEecCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeCC----eeEEEeCC
Q psy11098 170 VPGTDTIVMQLVHGESLIQHLC--RQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGA----VLKLIDLG 243 (380)
Q Consensus 170 ~~~~~~lv~e~~~gg~L~~~l~--~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~~----~ikl~DFG 243 (380)
.+++++|||-+.| ++.+.|. +.+.++|...+.++.||+.||.|||.+||+|-||||+|||+.+. ++||||||
T Consensus 635 -~ervFVVMEKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFG 712 (888)
T KOG4236|consen 635 -PERVFVVMEKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFG 712 (888)
T ss_pred -CceEEEEehhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeecccc
Confidence 4789999999955 5555553 35789999999999999999999999999999999999999743 89999999
Q ss_pred Cccccc-----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCC
Q psy11098 244 SSVSVS-----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCG 318 (380)
Q Consensus 244 ~a~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 318 (380)
+|+.++ ...+|||.|+|||++++ +.|+..-||||+|||+|.-|+|..||.. ++++..+|.++.+-+|+..|.
T Consensus 713 fARiIgEksFRrsVVGTPAYLaPEVLrn-kGyNrSLDMWSVGVIiYVsLSGTFPFNE--dEdIndQIQNAaFMyPp~PW~ 789 (888)
T KOG4236|consen 713 FARIIGEKSFRRSVVGTPAYLAPEVLRN-KGYNRSLDMWSVGVIIYVSLSGTFPFNE--DEDINDQIQNAAFMYPPNPWS 789 (888)
T ss_pred ceeecchhhhhhhhcCCccccCHHHHhh-ccccccccceeeeEEEEEEecccccCCC--ccchhHHhhccccccCCCchh
Confidence 999875 57799999999999999 5889999999999999999999999954 567888999999999999999
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 319 HISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 319 ~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
+++.++.|||..+|+..-++|.|.+++|.|||+++..
T Consensus 790 eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq 826 (888)
T KOG4236|consen 790 EISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQ 826 (888)
T ss_pred hcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcch
Confidence 9999999999999999999999999999999999763
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-46 Score=359.57 Aligned_cols=253 Identities=23% Similarity=0.368 Sum_probs=204.2
Q ss_pred hhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC---CchHHHHHHHHHHHhhccCCCcceeeecccccC---
Q psy11098 97 QFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER---QPQQITRAEYNLLSTLMHAHIPTALALFENAPV--- 170 (380)
Q Consensus 97 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~--- 170 (380)
.+.++|++.+.||+|+||.||+|.+..+|+.||+|++.+.. .....+.+|+.+++.++|+||+++++++.....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 35689999999999999999999999999999999996532 233456789999999999999999998865421
Q ss_pred CCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc
Q psy11098 171 PGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS 249 (380)
Q Consensus 171 ~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~ 249 (380)
....|+||||+. ++|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 98 ~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~ 174 (359)
T cd07876 98 FQDVYLVMELMD-ANLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174 (359)
T ss_pred cceeEEEEeCCC-cCHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence 235799999995 46666663 3588999999999999999999999999999999999998 5699999999987543
Q ss_pred -----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-----------------
Q psy11098 250 -----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISV----------------- 307 (380)
Q Consensus 250 -----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~----------------- 307 (380)
....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+..
T Consensus 175 ~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (359)
T cd07876 175 TNFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV 253 (359)
T ss_pred cCccCCCCcccCCCCCchhccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHH
Confidence 34567999999999988 4778899999999999999999999987654433222111
Q ss_pred -----ccCCCC--------------C--CcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccc
Q psy11098 308 -----ADYSFP--------------P--EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAE 353 (380)
Q Consensus 308 -----~~~~~~--------------~--~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~ 353 (380)
....++ . ......++++++||.+||..||++|||+.|+|+||||..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 254 RNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 000000 0 011124678999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-46 Score=361.98 Aligned_cols=252 Identities=25% Similarity=0.349 Sum_probs=208.3
Q ss_pred ceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---chHHHHHHHHHHHhhccCCCcceeeecccccC--CCceE
Q psy11098 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLMHAHIPTALALFENAPV--PGTDT 175 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~--~~~~~ 175 (380)
+|++.+.||+|+||.||+|.+..+++.||+|.+..... ....+.+|+++++.++|+||+++++++..... ....|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 36788999999999999999999999999999864322 23456789999999999999999998875421 12579
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCccccc-----
Q psy11098 176 IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVS----- 249 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~----- 249 (380)
+||||+. ++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||++....
T Consensus 81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~ 159 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK 159 (372)
T ss_pred EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccc
Confidence 9999994 688888887888999999999999999999999999999999999999984 699999999987542
Q ss_pred --ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc-------------------
Q psy11098 250 --TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVA------------------- 308 (380)
Q Consensus 250 --~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~------------------- 308 (380)
....+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 239 (372)
T cd07853 160 HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAH 239 (372)
T ss_pred cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHH
Confidence 23456889999999987656788999999999999999999999887765544443211
Q ss_pred ----cCCCCC-----CcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccc
Q psy11098 309 ----DYSFPP-----EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAE 353 (380)
Q Consensus 309 ----~~~~~~-----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~ 353 (380)
....+. ......++++.+||.+||+.||++|||++|+|+||||..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 293 (372)
T cd07853 240 ILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE 293 (372)
T ss_pred HHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCC
Confidence 011110 112346889999999999999999999999999999987
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=357.70 Aligned_cols=253 Identities=23% Similarity=0.334 Sum_probs=206.7
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC---CchHHHHHHHHHHHhhccCCCcceeeeccccc---CC
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER---QPQQITRAEYNLLSTLMHAHIPTALALFENAP---VP 171 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~---~~ 171 (380)
+.++|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.++|+||+++++++.... ..
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4678999999999999999999999999999999996532 23345677999999999999999998876432 22
Q ss_pred CceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-
Q psy11098 172 GTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS- 249 (380)
Q Consensus 172 ~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~- 249 (380)
...|+||||+. ++|.+.+.. .+++..+..++.|++.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 178 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence 45799999995 577777743 488999999999999999999999999999999999998 5699999999997654
Q ss_pred ----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCC--------------
Q psy11098 250 ----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYS-------------- 311 (380)
Q Consensus 250 ----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~-------------- 311 (380)
....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 179 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (364)
T cd07875 179 SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR 257 (364)
T ss_pred CCcccCCcccCCcCCHHHHhC-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHH
Confidence 34567999999999988 47788999999999999999999999887765554443211000
Q ss_pred ----------------------C--CCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 312 ----------------------F--PPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 312 ----------------------~--~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
+ ........+.++++||.+||+.||.+|||++|+|+||||...
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~ 324 (364)
T cd07875 258 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 324 (364)
T ss_pred HHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 0 001112245678999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-46 Score=355.79 Aligned_cols=243 Identities=27% Similarity=0.407 Sum_probs=207.1
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEecCCC----CchHHHHHHH-HHHHhhccCCCcceeeecccccCCCceEEEEEe
Q psy11098 106 ERLGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQITRAEY-NLLSTLMHAHIPTALALFENAPVPGTDTIVMQL 180 (380)
Q Consensus 106 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~E~-~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e~ 180 (380)
+.||+|+||.||+|++..+++.||+|++.+.. .....+.+|. .+++.++|+||++++..+... +..|+||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~---~~~~lv~e~ 77 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTA---EKLYFVLDY 77 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcC---CEEEEEEcC
Confidence 36999999999999999999999999996432 1222333344 467889999999998887653 678999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------cccc
Q psy11098 181 VHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------TVVL 253 (380)
Q Consensus 181 ~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------~~~~ 253 (380)
+.|++|...+.....+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.... ....
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05603 78 VNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC 157 (321)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccccc
Confidence 99999999998888899999999999999999999999999999999999998 5699999999986431 3456
Q ss_pred CCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhcc
Q psy11098 254 PDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLN 333 (380)
Q Consensus 254 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 333 (380)
||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+......++ ...+.++.++|.+||+
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~ 232 (321)
T cd05603 158 GTPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP----GGKTVAACDLLVGLLH 232 (321)
T ss_pred CCcccCCHHHhcC-CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHcc
Confidence 8999999999987 4678899999999999999999999999888777777776654444 3468899999999999
Q ss_pred cCCCCCCCH----HHHHhcccccccCC
Q psy11098 334 THADKRPTA----GQLLQVAWFAEASC 356 (380)
Q Consensus 334 ~dP~~Rpt~----~e~L~hpw~~~~~~ 356 (380)
+||.+|+++ .++++|+||....+
T Consensus 233 ~~p~~R~~~~~~~~~~~~~~~~~~~~~ 259 (321)
T cd05603 233 KDQRRRLGAKADFLEIKNHVFFSPINW 259 (321)
T ss_pred CCHhhcCCCCCCHHHHhCCCCcCCCCH
Confidence 999999875 59999999986543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-46 Score=343.22 Aligned_cols=247 Identities=35% Similarity=0.544 Sum_probs=208.9
Q ss_pred eeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHH---HHHHHHHHhhccCCCcceeeecccccCCCceEEEE
Q psy11098 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQIT---RAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVM 178 (380)
Q Consensus 102 y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~---~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~ 178 (380)
|++.+.||+|+||+||++++..+++.||+|++.......... .+|+.+++.++|+||+++++++.. ....+++|
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~---~~~~~~v~ 77 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD---DNYLYIVM 77 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE---SSEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc---cccccccc
Confidence 789999999999999999999999999999998776544332 459999999999999999999887 36779999
Q ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccc------ccc
Q psy11098 179 QLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSV------STV 251 (380)
Q Consensus 179 e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~------~~~ 251 (380)
|++.+++|.+++.....+++..+..++.||+.||.+||+.||+|+||||+|||++ ++.++|+|||.+... ...
T Consensus 78 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 157 (260)
T PF00069_consen 78 EYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNP 157 (260)
T ss_dssp EEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999888999999999999999999999999999999999999999 579999999998642 145
Q ss_pred ccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhcccCCCCCCcCCCCCHHHHHHH
Q psy11098 252 VLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESE---EETRAHISVADYSFPPEQCGHISVPARELI 328 (380)
Q Consensus 252 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 328 (380)
..+++.|+|||++......+.++|+||||+++|+|++|..||..... ......................+.++.++|
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 237 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLI 237 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHH
Confidence 67799999999998335788999999999999999999999988733 333333332222222211122347999999
Q ss_pred HHhcccCCCCCCCHHHHHhcccc
Q psy11098 329 GQLLNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 329 ~~~L~~dP~~Rpt~~e~L~hpw~ 351 (380)
++||+.||++|||+.++++||||
T Consensus 238 ~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 238 KKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHccCChhHCcCHHHHhcCCCC
Confidence 99999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=352.91 Aligned_cols=253 Identities=23% Similarity=0.331 Sum_probs=211.4
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
.++|++.+.||+|+||.||++.+..++..+|+|++..... ....+.+|+++++.++|+||+++++++... +..++
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~l 80 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD---GEISI 80 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEEC---CEEEE
Confidence 5789999999999999999999999999999999875433 235678899999999999999999998764 67899
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeecCCCCcEEEe-CCeeEEEeCCCccccc----c
Q psy11098 177 VMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQ-QIAHKDIRPENILMN-GAVLKLIDLGSSVSVS----T 250 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~-~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~----~ 250 (380)
||||+.|++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++ ++.+||+|||++.... .
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~ 160 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 160 (333)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhccc
Confidence 999999999999998888899999999999999999999975 799999999999998 5689999999987553 3
Q ss_pred cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc----------------------
Q psy11098 251 VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVA---------------------- 308 (380)
Q Consensus 251 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~---------------------- 308 (380)
...||+.|+|||++.+ ..++.++|+|||||++|+|++|..||......+....+...
T Consensus 161 ~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (333)
T cd06650 161 SFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLS 239 (333)
T ss_pred cCCCCccccCHHHhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhh
Confidence 4568999999999987 46788999999999999999999999765544332211100
Q ss_pred --------------------cCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 309 --------------------DYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 309 --------------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
....+......++.++++||.+||++||++|||++|+|+||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 240 SYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred hhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 00000001123578899999999999999999999999999998764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-46 Score=355.35 Aligned_cols=253 Identities=27% Similarity=0.456 Sum_probs=213.6
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC----CCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
++|++.+.||+|+||+||+++++.+++.||+|++.+. ......+.+|+.++..++|++++++...+... +..+
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~---~~~~ 77 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDE---NNLY 77 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecC---CEEE
Confidence 3689999999999999999999999999999998542 22334567899999999999999998888754 6789
Q ss_pred EEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc----
Q psy11098 176 IVMQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS---- 249 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~---- 249 (380)
+||||+.||+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 78 lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred EEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 99999999999999976 46789999999999999999999999999999999999998 5689999999986542
Q ss_pred ---ccccCCCcccCCccccC----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCC-CCcCCCCC
Q psy11098 250 ---TVVLPDLEFASPEMLTS----PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFP-PEQCGHIS 321 (380)
Q Consensus 250 ---~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~s 321 (380)
...+||+.|+|||++.. ...++.++|||||||++|+|++|+.||.+.+..+....+......++ +.....++
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s 237 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVS 237 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCC
Confidence 23578999999999862 24578899999999999999999999999888888777765543222 12234689
Q ss_pred HHHHHHHHHhcccCCCC--CCCHHHHHhcccccccC
Q psy11098 322 VPARELIGQLLNTHADK--RPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 322 ~~~~~li~~~L~~dP~~--Rpt~~e~L~hpw~~~~~ 355 (380)
.++++||++||..++.+ |++++++++||||+...
T Consensus 238 ~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~ 273 (332)
T cd05623 238 EDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGID 273 (332)
T ss_pred HHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCC
Confidence 99999999999765544 68999999999998653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-46 Score=355.41 Aligned_cols=253 Identities=27% Similarity=0.456 Sum_probs=213.8
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC----CCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
++|++.+.||+|+||+||+++++.+++.||+|++.+. ......+.+|+.++..+.|++|+.+..++... +..|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~---~~~~ 77 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDE---NYLY 77 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC---CEEE
Confidence 4799999999999999999999999999999998642 22334567899999999999999999888763 6789
Q ss_pred EEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc----
Q psy11098 176 IVMQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS---- 249 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~---- 249 (380)
+||||+.||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 78 lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred EEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 99999999999999976 46799999999999999999999999999999999999997 5689999999987543
Q ss_pred ---ccccCCCcccCCccccCC----CCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCC-CCcCCCCC
Q psy11098 250 ---TVVLPDLEFASPEMLTSP----ATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFP-PEQCGHIS 321 (380)
Q Consensus 250 ---~~~~gt~~y~aPE~~~~~----~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~s 321 (380)
....||+.|+|||++.+. ..++.++|+|||||++|+|++|..||.+.+..+....+......++ +.....++
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~ 237 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVS 237 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCC
Confidence 235689999999998652 3567899999999999999999999998888777777765443222 22234679
Q ss_pred HHHHHHHHHhcccCCCC--CCCHHHHHhcccccccC
Q psy11098 322 VPARELIGQLLNTHADK--RPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 322 ~~~~~li~~~L~~dP~~--Rpt~~e~L~hpw~~~~~ 355 (380)
.++++||.+||..++++ |++++++++|+||....
T Consensus 238 ~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~ 273 (331)
T cd05624 238 EEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGID 273 (331)
T ss_pred HHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCC
Confidence 99999999999876654 57999999999998653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=356.28 Aligned_cols=254 Identities=22% Similarity=0.328 Sum_probs=205.3
Q ss_pred hhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---chHHHHHHHHHHHhhccCCCcceeeeccccc---C
Q psy11098 97 QFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLMHAHIPTALALFENAP---V 170 (380)
Q Consensus 97 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~---~ 170 (380)
.+.++|++.+.||+|+||.||+|.+..+++.||+|.+..... ......+|+.+++.++|+||+++++++.... .
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 356899999999999999999999999999999999965432 2345667999999999999999999876432 2
Q ss_pred CCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc
Q psy11098 171 PGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS 249 (380)
Q Consensus 171 ~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~ 249 (380)
....|+||||+. ++|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++...
T Consensus 94 ~~~~~lv~e~~~-~~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 94 FQDVYLVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_pred cceeEEEhhhhc-ccHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence 235799999995 567776643 588999999999999999999999999999999999998 5689999999997654
Q ss_pred -----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc---------------
Q psy11098 250 -----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVAD--------------- 309 (380)
Q Consensus 250 -----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~--------------- 309 (380)
....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+....+....
T Consensus 171 ~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (355)
T cd07874 171 TSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_pred CccccCCccccCCccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHH
Confidence 33567999999999987 467889999999999999999999998766443332221100
Q ss_pred ------------CCC-----------CCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 310 ------------YSF-----------PPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 310 ------------~~~-----------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
..+ ........+.++++||.+||..||++|||+.|+|+||||...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred HHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 000 001112346788999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=353.45 Aligned_cols=244 Identities=23% Similarity=0.363 Sum_probs=205.1
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEecCCC----CchHHHHHHHHHHHhh-ccCCCcceeeecccccCCCceEEEEEe
Q psy11098 106 ERLGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQITRAEYNLLSTL-MHAHIPTALALFENAPVPGTDTIVMQL 180 (380)
Q Consensus 106 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~~~~~~~lv~e~ 180 (380)
+.||+|+||+||+|+++.+++.||+|++.+.. .....+.+|..++..+ +|++|+.++.++... +..|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~---~~~~lv~e~ 77 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTT---SRLFLVIEY 77 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeC---CEEEEEEeC
Confidence 36999999999999999999999999997542 2234567788888888 699999999888764 678999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------cccc
Q psy11098 181 VHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------TVVL 253 (380)
Q Consensus 181 ~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------~~~~ 253 (380)
+.|++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.... ...+
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (327)
T cd05617 78 VNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC 157 (327)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceeccc
Confidence 99999999998888899999999999999999999999999999999999997 5689999999987431 3467
Q ss_pred CCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC-------CHHHHHHHHhcccCCCCCCcCCCCCHHHHH
Q psy11098 254 PDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDE-------SEEETRAHISVADYSFPPEQCGHISVPARE 326 (380)
Q Consensus 254 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~-------~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 326 (380)
||+.|+|||++.+ ..++.++|||||||++|+|++|..||... ..+.....+......++ ..++..+.+
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~ 232 (327)
T cd05617 158 GTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIP----RFLSVKASH 232 (327)
T ss_pred CCcccCCHHHHCC-CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCC----CCCCHHHHH
Confidence 8999999999987 57788999999999999999999999532 22233344444333333 357899999
Q ss_pred HHHHhcccCCCCCCC------HHHHHhcccccccCCC
Q psy11098 327 LIGQLLNTHADKRPT------AGQLLQVAWFAEASCS 357 (380)
Q Consensus 327 li~~~L~~dP~~Rpt------~~e~L~hpw~~~~~~~ 357 (380)
+|++||.+||++|++ ++++++||||....+.
T Consensus 233 li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~ 269 (327)
T cd05617 233 VLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWD 269 (327)
T ss_pred HHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHH
Confidence 999999999999998 5799999999876443
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=349.35 Aligned_cols=243 Identities=22% Similarity=0.328 Sum_probs=191.0
Q ss_pred eeecccCCeEEEEEEEc--CCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEEEecCC
Q psy11098 106 ERLGNGRFCTVRKARDR--GTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHG 183 (380)
Q Consensus 106 ~~LG~G~fg~V~~~~~~--~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e~~~g 183 (380)
++||+|+||+||+|+++ .+++.||+|.+..... .....+|+++++.++|+||+++++++.... ....+++|||+ +
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~lv~e~~-~ 83 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-SMSACREIALLRELKHPNVISLQKVFLSHA-DRKVWLLFDYA-E 83 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-cHHHHHHHHHHHhcCCCCCcceeeeEecCC-CcEEEEEEecc-C
Confidence 57999999999999976 4678999999965433 334677999999999999999999886432 34678999998 5
Q ss_pred CCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-----CCeeEEEeCCCccccc
Q psy11098 184 ESLIQHLCRQ---------STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-----GAVLKLIDLGSSVSVS 249 (380)
Q Consensus 184 g~L~~~l~~~---------~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-----~~~ikl~DFG~a~~~~ 249 (380)
++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~ 163 (317)
T cd07868 84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163 (317)
T ss_pred CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccC
Confidence 6888877532 2589999999999999999999999999999999999994 3489999999997543
Q ss_pred ---------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHhccc--
Q psy11098 250 ---------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEE---------ETRAHISVAD-- 309 (380)
Q Consensus 250 ---------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~---------~~~~~i~~~~-- 309 (380)
....+|+.|+|||++.+...++.++|||||||++|+|++|.+||...... .....+....
T Consensus 164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (317)
T cd07868 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGF 243 (317)
T ss_pred CCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCC
Confidence 23567999999999987557888999999999999999999999643321 1111110000
Q ss_pred --------------------------C------CCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy11098 310 --------------------------Y------SFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 310 --------------------------~------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~ 351 (380)
. .+........+.++.+||++||+.||++|||++|+|+||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 244 PADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred CChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 00000011235678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=368.74 Aligned_cols=254 Identities=26% Similarity=0.300 Sum_probs=216.4
Q ss_pred hhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---chHHHHHHHHHHHhhccCCCcceeeecccccCC--
Q psy11098 97 QFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLMHAHIPTALALFENAPVP-- 171 (380)
Q Consensus 97 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~-- 171 (380)
...++|++.+.||+|+||+||+|++..+++.||||++..... ....+.+|+.++..+.|+|++++...+......
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 346799999999999999999999999999999999965432 234567799999999999999888766543211
Q ss_pred ---CceEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCC
Q psy11098 172 ---GTDTIVMQLVHGESLIQHLCR----QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLG 243 (380)
Q Consensus 172 ---~~~~lv~e~~~gg~L~~~l~~----~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG 243 (380)
..+++||||+.+|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++ ++.+||+|||
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecc
Confidence 136799999999999998864 34689999999999999999999999999999999999998 5689999999
Q ss_pred Cccccc--------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCC
Q psy11098 244 SSVSVS--------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPE 315 (380)
Q Consensus 244 ~a~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~ 315 (380)
+++... ...+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+........
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~-- 265 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRR-KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPL-- 265 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCC--
Confidence 987542 34678999999999988 4788999999999999999999999999888887777766554322
Q ss_pred cCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 316 QCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 316 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
...+++++.+++.+||..||.+|||+.++|+|||++..
T Consensus 266 -~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 266 -PPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred -CCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 24579999999999999999999999999999998753
|
|
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-46 Score=356.82 Aligned_cols=248 Identities=28% Similarity=0.411 Sum_probs=223.5
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC---CchHHHHHHHHHHHhhccCCCcceeeecccccCCCc-e
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER---QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGT-D 174 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~-~ 174 (380)
-++|..++.+|+|+||.+++++++..++.||+|.+.... ..+....+|+.++++++||||+.+.+.|... +. .
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~---~~~l 79 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEED---GQLL 79 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcC---CceE
Confidence 357999999999999999999999999999999996543 3345678899999999999998888888764 55 8
Q ss_pred EEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc--
Q psy11098 175 TIVMQLVHGESLIQHLCRQ--STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS-- 249 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~-- 249 (380)
+|||+||+||+|.+.|.+. ..++|+.+..++.|++.|+.|||+++|+|||||+.|||++ ++.|||.|||+|+..+
T Consensus 80 ~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 80 CIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred EEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999999999764 4699999999999999999999999999999999999998 5688999999999875
Q ss_pred ----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHH
Q psy11098 250 ----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAR 325 (380)
Q Consensus 250 ----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 325 (380)
.+..|||.||.||++.+ .+|+.++|||||||++|||++-+++|...+......+|..+.+...+ ..++.+++
T Consensus 160 ~~~a~tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp---~~ys~el~ 235 (426)
T KOG0589|consen 160 DSLASTVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP---SMYSSELR 235 (426)
T ss_pred hhhhheecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC---ccccHHHH
Confidence 35789999999999999 69999999999999999999999999999999999999888754433 46799999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhcccccc
Q psy11098 326 ELIGQLLNTHADKRPTAGQLLQVAWFAE 353 (380)
Q Consensus 326 ~li~~~L~~dP~~Rpt~~e~L~hpw~~~ 353 (380)
.+|+.||.++|+.||++.++|.+|.++.
T Consensus 236 ~lv~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 236 SLVKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred HHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence 9999999999999999999999999884
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=344.74 Aligned_cols=250 Identities=24% Similarity=0.400 Sum_probs=205.3
Q ss_pred eeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC----chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEE
Q psy11098 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ----PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIV 177 (380)
Q Consensus 102 y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv 177 (380)
|++.+.||+|+||.||+|.+..+++.||+|.+..... ....+.+|+.+++.++|++++.+...+... +..++|
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~---~~~~lv 78 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETK---DALCLV 78 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecC---CEEEEE
Confidence 6778999999999999999999999999999864322 223456799999999999999988887654 578999
Q ss_pred EEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-----
Q psy11098 178 MQLVHGESLIQHLCRQ--STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS----- 249 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~----- 249 (380)
|||+.|++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++ ++.++|+|||++....
T Consensus 79 ~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05630 79 LTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI 158 (285)
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccc
Confidence 9999999999988543 3589999999999999999999999999999999999998 4689999999987543
Q ss_pred ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHH
Q psy11098 250 TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIG 329 (380)
Q Consensus 250 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 329 (380)
....|++.|+|||++.+ ..++.++|+||+||++|+|++|..||..........................++.++++|++
T Consensus 159 ~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (285)
T cd05630 159 KGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCK 237 (285)
T ss_pred cCCCCCccccChHHHcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHH
Confidence 23468999999999987 46788999999999999999999999865432111111111011111223457899999999
Q ss_pred HhcccCCCCCCC-----HHHHHhcccccccC
Q psy11098 330 QLLNTHADKRPT-----AGQLLQVAWFAEAS 355 (380)
Q Consensus 330 ~~L~~dP~~Rpt-----~~e~L~hpw~~~~~ 355 (380)
+||+.||++||| ++|+++||||++..
T Consensus 238 ~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05630 238 MLLCKDPKERLGCQGGGAREVKEHPLFKQIN 268 (285)
T ss_pred HHhhcCHHHccCCCCCchHHHHcChhhhccC
Confidence 999999999999 99999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-45 Score=341.75 Aligned_cols=253 Identities=22% Similarity=0.389 Sum_probs=211.5
Q ss_pred ceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC----chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEE
Q psy11098 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ----PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
.|+..+.||+|+||+||+|.+..+++.||+|.+..... ....+.+|+++++.++|+|++.+...+... +..++
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~---~~~~l 77 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETK---DALCL 77 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC---CEEEE
Confidence 36778999999999999999999999999999865422 223467799999999999999988887764 67899
Q ss_pred EEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc----
Q psy11098 177 VMQLVHGESLIQHLCRQ--STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS---- 249 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~---- 249 (380)
+|||+.+++|.+.+... ..+++..+..++.|++.||.|||+.||+||||||+||+++ ++.+||+|||++....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 78 VLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred EEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 99999999999888653 4699999999999999999999999999999999999997 4689999999986543
Q ss_pred -ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHH
Q psy11098 250 -TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELI 328 (380)
Q Consensus 250 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 328 (380)
....|++.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.........+..............++.++.+|+
T Consensus 158 ~~~~~g~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNN-QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSIC 236 (285)
T ss_pred ccCCCCCcCccChHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHH
Confidence 33568999999999987 4678899999999999999999999988766544444332222222223346789999999
Q ss_pred HHhcccCCCCCCC-----HHHHHhcccccccCCC
Q psy11098 329 GQLLNTHADKRPT-----AGQLLQVAWFAEASCS 357 (380)
Q Consensus 329 ~~~L~~dP~~Rpt-----~~e~L~hpw~~~~~~~ 357 (380)
.+||..||++||| ++++++|+||......
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05632 237 KMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFK 270 (285)
T ss_pred HHHccCCHhHcCCCcccChHHHHcChhhhcCCHH
Confidence 9999999999999 8999999999887544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-45 Score=343.49 Aligned_cols=253 Identities=28% Similarity=0.432 Sum_probs=209.5
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC--CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER--QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
.++|++.+.||+|+||.||+|+++.+++.||+|.+.... .......+|+.+++.++|+||+++++++... +..++
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~---~~~~l 81 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE---KSLTL 81 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecC---CeEEE
Confidence 357999999999999999999999999999999986433 2334567899999999999999999998753 67899
Q ss_pred EEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-----
Q psy11098 177 VMQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS----- 249 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~----- 249 (380)
||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.||+|+||||+|||++ ++.+||+|||++....
T Consensus 82 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 160 (301)
T cd07873 82 VFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 160 (301)
T ss_pred EEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc
Confidence 999995 688888865 45689999999999999999999999999999999999998 4689999999986542
Q ss_pred -ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc-------------------
Q psy11098 250 -TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVAD------------------- 309 (380)
Q Consensus 250 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~------------------- 309 (380)
....+++.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS 240 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccc
Confidence 234568899999998775567889999999999999999999998877655443332110
Q ss_pred CCCCC-------CcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 310 YSFPP-------EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 310 ~~~~~-------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
..++. .....+++++++||.+||+.||.+|||++|+|+||||....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 11111 11235788999999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=362.56 Aligned_cols=254 Identities=24% Similarity=0.316 Sum_probs=223.2
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecC-CCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEE
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPR-ERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~-~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
-.+.|+|+..||.|+||+||+|+.+.++-..|.|++.. ...+.+.+.-||+||....||+|++++..|... +.++|
T Consensus 30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~e---nkLwi 106 (1187)
T KOG0579|consen 30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFE---NKLWI 106 (1187)
T ss_pred HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhcc---CceEE
Confidence 35778999999999999999999999999999999964 344556778899999999999999999887764 78899
Q ss_pred EEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-----
Q psy11098 177 VMQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS----- 249 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~----- 249 (380)
++|||.||-+..++.. ...++|.++..+++|++.||.|||+++|||||||..|||+. +|.|+|+|||.+....
T Consensus 107 liEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qk 186 (1187)
T KOG0579|consen 107 LIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQK 186 (1187)
T ss_pred EEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhh
Confidence 9999999999887755 56899999999999999999999999999999999999998 8899999999986553
Q ss_pred -ccccCCCcccCCcccc----CCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHH
Q psy11098 250 -TVVLPDLEFASPEMLT----SPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPA 324 (380)
Q Consensus 250 -~~~~gt~~y~aPE~~~----~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 324 (380)
..+.|||+|||||++. ...+|++++||||||++|.+|..+.+|-...+...++..|.+...... -+...++.++
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTL-lqPS~Ws~~F 265 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL-LQPSHWSRSF 265 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcc-cCcchhhhHH
Confidence 5789999999999974 235789999999999999999999999999898888888766543222 1335689999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 325 RELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 325 ~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
.||+++||.+||+.||++.++|+||||++..
T Consensus 266 ~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~ 296 (1187)
T KOG0579|consen 266 SDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP 296 (1187)
T ss_pred HHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence 9999999999999999999999999999774
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=340.53 Aligned_cols=254 Identities=28% Similarity=0.486 Sum_probs=221.4
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC----CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
++|++.+.||+|+||.||++.+..+++.+|+|++.... .....+.+|+++++.+.|+||+++++++... +..+
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~ 77 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDD---SNLY 77 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcC---CeEE
Confidence 36899999999999999999999999999999986532 2345677899999999999999999988764 6789
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc---cc
Q psy11098 176 IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS---TV 251 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~---~~ 251 (380)
+||||+.+++|.+++.....+++..+..++.||+.||.|||+.||+|+||+|.|||++ ++.+||+|||++.... ..
T Consensus 78 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~ 157 (290)
T cd05580 78 LVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYT 157 (290)
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCCCCC
Confidence 9999999999999998888999999999999999999999999999999999999997 5689999999987654 34
Q ss_pred ccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHh
Q psy11098 252 VLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQL 331 (380)
Q Consensus 252 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 331 (380)
..+++.|+|||.+.+ ...+.++|+||||+++|+|++|..||......+....+......++. .++..++++|++|
T Consensus 158 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~ 232 (290)
T cd05580 158 LCGTPEYLAPEIILS-KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPS----FFSPDAKDLIRNL 232 (290)
T ss_pred CCCCccccChhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCc----cCCHHHHHHHHHH
Confidence 567899999999877 46788999999999999999999999888877777777655554443 4689999999999
Q ss_pred cccCCCCCC-----CHHHHHhcccccccCCCCCcc
Q psy11098 332 LNTHADKRP-----TAGQLLQVAWFAEASCSEFDT 361 (380)
Q Consensus 332 L~~dP~~Rp-----t~~e~L~hpw~~~~~~~~~~~ 361 (380)
|..||.+|+ +++|+++||||....+..+..
T Consensus 233 l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~ 267 (290)
T cd05580 233 LQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQ 267 (290)
T ss_pred ccCCHHHccCcccCCHHHHHcCcccccCCHHHHhh
Confidence 999999999 999999999998876543333
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-46 Score=360.80 Aligned_cols=261 Identities=28% Similarity=0.468 Sum_probs=234.9
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCch---HHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQ---QITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~---~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
...|.+...||+|.|++|.+|++..|+..||+|++.++.... ....+|+++|..|.||||++++.+++.. ..+|
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~---~~ly 131 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETE---ATLY 131 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeec---ceeE
Confidence 456889999999999999999999999999999998765543 4467799999999999999988888764 7889
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeCC-eeEEEeCCCccccc-----
Q psy11098 176 IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGA-VLKLIDLGSSVSVS----- 249 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~~-~ikl~DFG~a~~~~----- 249 (380)
+||||+.+|.+++++.+.+.+.+.+++.++.|++.|++|||+++|+|||||.+|||++.+ ++||+|||++..+.
T Consensus 132 lV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~l 211 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLML 211 (596)
T ss_pred EEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecccccc
Confidence 999999999999999999999999999999999999999999999999999999999965 69999999998775
Q ss_pred ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHH
Q psy11098 250 TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIG 329 (380)
Q Consensus 250 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 329 (380)
.+.+|++.|.|||++.+..+.+..+|+||+|+++|.|++|..||.+.+-.+.......+.+..+.. ++.++.++|+
T Consensus 212 qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~----ms~dce~lLr 287 (596)
T KOG0586|consen 212 QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFY----MSCDCEDLLR 287 (596)
T ss_pred cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccce----eechhHHHHH
Confidence 678999999999999998888999999999999999999999999999999999888888877753 7889999999
Q ss_pred HhcccCCCCCCCHHHHHhcccccccCCCCCccccccchHHH
Q psy11098 330 QLLNTHADKRPTAGQLLQVAWFAEASCSEFDTERLLPFSAR 370 (380)
Q Consensus 330 ~~L~~dP~~Rpt~~e~L~hpw~~~~~~~~~~~~~~~~~~~~ 370 (380)
++|.++|.+|++++++.+|.|+...-.. ..+++++++
T Consensus 288 k~lvl~Pskr~~~dqim~~~W~n~~~~~----~~l~p~~e~ 324 (596)
T KOG0586|consen 288 KFLVLNPSKRGPCDQIMKDRWRNDLLEA----RLLAPLIER 324 (596)
T ss_pred HhhccCccccCCHHHhhhhcccchhhhh----hhhhccccc
Confidence 9999999999999999999999765322 455555544
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-45 Score=364.90 Aligned_cols=248 Identities=24% Similarity=0.328 Sum_probs=214.9
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCC-CcEEEEEEecCCCC-chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGT-GQLVALKQIPRERQ-PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~-~~~vAvK~~~~~~~-~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
...|.+.+.||+|+||.||+|.+..+ ++.||+|.+..... ....+++|+.+++.++|+||+++++++... +..||
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~---~~~~l 142 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSD---DKLLL 142 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC---CEEEE
Confidence 44599999999999999999998887 78899998754432 334567899999999999999999988764 67899
Q ss_pred EEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc--
Q psy11098 177 VMQLVHGESLIQHLCR----QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS-- 249 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~----~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~-- 249 (380)
||||+.||+|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 9999999999987753 34689999999999999999999999999999999999998 5689999999997653
Q ss_pred ------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHH
Q psy11098 250 ------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVP 323 (380)
Q Consensus 250 ------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 323 (380)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+..+..... ...++.+
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~s~~ 298 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPF---PCPVSSG 298 (478)
T ss_pred cccccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---CccCCHH
Confidence 34468999999999987 4778899999999999999999999998888888777766554322 2357899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHhcccccc
Q psy11098 324 ARELIGQLLNTHADKRPTAGQLLQVAWFAE 353 (380)
Q Consensus 324 ~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~ 353 (380)
+++||.+||.+||++|||++++|.|+|++.
T Consensus 299 ~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 299 MKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred HHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 999999999999999999999999999974
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-45 Score=340.04 Aligned_cols=243 Identities=22% Similarity=0.375 Sum_probs=200.9
Q ss_pred ecccCCeEEEEEEEcCCCcEEEEEEecCCCC----chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEEEecCC
Q psy11098 108 LGNGRFCTVRKARDRGTGQLVALKQIPRERQ----PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHG 183 (380)
Q Consensus 108 LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e~~~g 183 (380)
||+|+||.||+++++.+|+.||+|.+..... .......|+++++.++|+|++++...+... ...++||||+.|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~---~~~~lv~e~~~g 77 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESK---THLCLVMSLMNG 77 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecC---CeEEEEEecCCC
Confidence 7999999999999999999999999964321 233455699999999999999998888764 677999999999
Q ss_pred CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-----ccccCC
Q psy11098 184 ESLIQHLCRQ--STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS-----TVVLPD 255 (380)
Q Consensus 184 g~L~~~l~~~--~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~-----~~~~gt 255 (380)
++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++ ++.++|+|||++.... ....|+
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 157 (277)
T cd05607 78 GDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGT 157 (277)
T ss_pred CCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCC
Confidence 9999888553 3588999999999999999999999999999999999998 4689999999987653 235678
Q ss_pred CcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHh
Q psy11098 256 LEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESE----EETRAHISVADYSFPPEQCGHISVPARELIGQL 331 (380)
Q Consensus 256 ~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 331 (380)
+.|+|||++.+. .++.++|+|||||++|+|++|..||.+... .+...........+. ...++.++++||++|
T Consensus 158 ~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~ 233 (277)
T cd05607 158 NGYMAPEILKEE-PYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFE---HQNFTEESKDICRLF 233 (277)
T ss_pred CCccCHHHHccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccc---cccCCHHHHHHHHHH
Confidence 999999999874 588999999999999999999999976433 223333332222222 235799999999999
Q ss_pred cccCCCCCCCH----HHHHhcccccccCCC
Q psy11098 332 LNTHADKRPTA----GQLLQVAWFAEASCS 357 (380)
Q Consensus 332 L~~dP~~Rpt~----~e~L~hpw~~~~~~~ 357 (380)
|++||++||++ ++++.||||+....+
T Consensus 234 L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~ 263 (277)
T cd05607 234 LAKKPEDRLGSREKNDDPRKHEFFKTINFP 263 (277)
T ss_pred hccCHhhCCCCccchhhhhcChhhcCCCHH
Confidence 99999999999 778899999875433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=331.18 Aligned_cols=246 Identities=27% Similarity=0.400 Sum_probs=210.6
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC------chHHHHHHHHHHHhhccCCCcceeeecccccCCCc
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ------PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGT 173 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~------~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~ 173 (380)
+.|++.+.||+|++|.||+|.+..+++.||+|.+..... ....+.+|+++++.+.|+|++++++++... +.
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~ 78 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDD---ET 78 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccC---Ce
Confidence 358889999999999999999999999999999864322 124567799999999999999999988764 57
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCccccc---
Q psy11098 174 DTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVS--- 249 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~--- 249 (380)
.++++||+.|++|.+.+.....+++..+..++.|++.||.|||+.||+||||||+||+++. +.++|+|||++....
T Consensus 79 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 79 LSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 8999999999999999988888999999999999999999999999999999999999984 699999999987542
Q ss_pred ------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHH
Q psy11098 250 ------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVP 323 (380)
Q Consensus 250 ------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 323 (380)
....++..|+|||++.+ ..++.++||||||+++|+|++|+.||.+.........+...... ......++.+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 235 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISG-EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN--PQLPSHVSPD 235 (263)
T ss_pred cccccccCCCcCccccCcceecc-CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCC--CCCCccCCHH
Confidence 22456788999999988 46788999999999999999999999877665555554433222 1223457899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy11098 324 ARELIGQLLNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 324 ~~~li~~~L~~dP~~Rpt~~e~L~hpw~ 351 (380)
+.+||++||.+||.+|||+.++|+|+||
T Consensus 236 ~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 236 ARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 9999999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=334.57 Aligned_cols=252 Identities=26% Similarity=0.393 Sum_probs=211.3
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhh-ccCCCcceeeecccccC---CCc
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTL-MHAHIPTALALFENAPV---PGT 173 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~~---~~~ 173 (380)
....|++.+.||+|+||.||+|.+..+++.||+|.+.........+.+|+.+++.+ +|+|++++++++..... ...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 83 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence 35678899999999999999999999999999999977666666778899999998 69999999998865432 245
Q ss_pred eEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-
Q psy11098 174 DTIVMQLVHGESLIQHLCRQ--STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS- 249 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~- 249 (380)
.+++|||+.+++|.+++... ..+++..+..++.|++.||.|||+++|+|+||||+||+++ ++.+||+|||++....
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~ 163 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 163 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceeccc
Confidence 78999999999999999763 4689999999999999999999999999999999999998 4589999999987543
Q ss_pred -----ccccCCCcccCCccccC----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCC
Q psy11098 250 -----TVVLPDLEFASPEMLTS----PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHI 320 (380)
Q Consensus 250 -----~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 320 (380)
....|++.|+|||++.+ ...++.++|+|||||++|+|++|..||.+.........+.... ........+
T Consensus 164 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~ 241 (272)
T cd06637 164 TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP--APRLKSKKW 241 (272)
T ss_pred ccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCC--CCCCCCCCc
Confidence 34567899999999863 2356789999999999999999999997766554444433222 111222357
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy11098 321 SVPARELIGQLLNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 321 s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~ 351 (380)
+.++.+||.+||..||.+|||+.++++||||
T Consensus 242 ~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 242 SKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 8899999999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=350.92 Aligned_cols=239 Identities=22% Similarity=0.315 Sum_probs=210.6
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEEE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQ 179 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e 179 (380)
+.++.++.||+|-||+|++|.++.+ ..||+|.++......+.+.+|+++|+.|+|+||+++++++... +.+|||||
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~---~piyIVtE 281 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQ---EPIYIVTE 281 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecC---CceEEEEE
Confidence 4566778999999999999999864 3699999988777878888999999999999999999888764 46899999
Q ss_pred ecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeCC-eeEEEeCCCcccccc------
Q psy11098 180 LVHGESLIQHLCR--QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGA-VLKLIDLGSSVSVST------ 250 (380)
Q Consensus 180 ~~~gg~L~~~l~~--~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~~-~ikl~DFG~a~~~~~------ 250 (380)
|+..|+|.++|.. +..+...+...++.||++||+||+++++|||||...|||++++ .+||+|||+|+....
T Consensus 282 ~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~ 361 (468)
T KOG0197|consen 282 YMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTAS 361 (468)
T ss_pred ecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceeec
Confidence 9999999999987 5679999999999999999999999999999999999999854 899999999996542
Q ss_pred -cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHH
Q psy11098 251 -VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELI 328 (380)
Q Consensus 251 -~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 328 (380)
.......|.|||.+.. ..++.+||||||||+||||+| |+.||.+.+..++...+..+..-..+ ...|+++.+++
T Consensus 362 ~~~kfPIkWtAPEa~~~-~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P---~~CP~~vY~lM 437 (468)
T KOG0197|consen 362 EGGKFPIKWTAPEALNY-GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRP---EGCPDEVYELM 437 (468)
T ss_pred CCCCCCceecCHHHHhh-CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCC---CCCCHHHHHHH
Confidence 1223567999999988 477889999999999999999 99999999999999999876543333 35799999999
Q ss_pred HHhcccCCCCCCCHHHHH
Q psy11098 329 GQLLNTHADKRPTAGQLL 346 (380)
Q Consensus 329 ~~~L~~dP~~Rpt~~e~L 346 (380)
..||..+|++|||.+.+.
T Consensus 438 ~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 438 KSCWHEDPEDRPTFETLR 455 (468)
T ss_pred HHHhhCCcccCCCHHHHH
Confidence 999999999999999665
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=345.90 Aligned_cols=243 Identities=21% Similarity=0.320 Sum_probs=197.8
Q ss_pred hhceeeeeeecccCCeEEEEEEEc-----CCCcEEEEEEecCCCC--chHHHHHHHHHHHhh-ccCCCcceeeecccccC
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDR-----GTGQLVALKQIPRERQ--PQQITRAEYNLLSTL-MHAHIPTALALFENAPV 170 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~~ 170 (380)
.++|++.+.||+|+||.||+|.+. .+++.||+|++..... ....+.+|+.++..+ +|+||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-- 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP-- 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC--
Confidence 468999999999999999999853 3457899999975432 234577899999999 899999999887643
Q ss_pred CCceEEEEEecCCCCHHHHHHhc---------------------------------------------------------
Q psy11098 171 PGTDTIVMQLVHGESLIQHLCRQ--------------------------------------------------------- 193 (380)
Q Consensus 171 ~~~~~lv~e~~~gg~L~~~l~~~--------------------------------------------------------- 193 (380)
.+..+++|||+.+|+|.+++...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 34679999999999999998642
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc--------ccccCCCccc
Q psy11098 194 -----STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS--------TVVLPDLEFA 259 (380)
Q Consensus 194 -----~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~--------~~~~gt~~y~ 259 (380)
..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++... ....+++.|+
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 243 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence 2377888999999999999999999999999999999998 5689999999997542 2234567899
Q ss_pred CCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHH-HHHHHhcccCCCCCCcCCCCCHHHHHHHHHhcccCCC
Q psy11098 260 SPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEE-TRAHISVADYSFPPEQCGHISVPARELIGQLLNTHAD 337 (380)
Q Consensus 260 aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 337 (380)
|||++.+ ..++.++|||||||++|+|++ |..||.+....+ ....+...... . ....++.++.+++.+||..||+
T Consensus 244 aPE~~~~-~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~l~~li~~cl~~dp~ 319 (338)
T cd05102 244 APESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM-R--APENATPEIYRIMLACWQGDPK 319 (338)
T ss_pred CcHHhhc-CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCC-C--CCCCCCHHHHHHHHHHccCChh
Confidence 9999987 477889999999999999997 999998755433 33333332221 1 1245789999999999999999
Q ss_pred CCCCHHHHHh
Q psy11098 338 KRPTAGQLLQ 347 (380)
Q Consensus 338 ~Rpt~~e~L~ 347 (380)
+|||+.|+++
T Consensus 320 ~RPs~~el~~ 329 (338)
T cd05102 320 ERPTFSALVE 329 (338)
T ss_pred hCcCHHHHHH
Confidence 9999999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=380.57 Aligned_cols=252 Identities=28% Similarity=0.453 Sum_probs=223.2
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecC----CCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCce
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPR----ERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~----~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~ 174 (380)
.++|++++.||+|+||.|.+++++.|++.||+|++++ .+.....|+.|..+|..-..+=|+++.-.|.. ..++
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD---~~~L 150 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD---ERYL 150 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC---ccce
Confidence 4789999999999999999999999999999999976 34456788899999887766666666555554 5889
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc----
Q psy11098 175 TIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS---- 249 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~---- 249 (380)
|+||||+.||+|..++.+...++|..++.|+..|+.||.-||+.|+|||||||+|||+| .|.|||+|||.+..+.
T Consensus 151 YlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~ 230 (1317)
T KOG0612|consen 151 YLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGT 230 (1317)
T ss_pred EEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCc
Confidence 99999999999999998887899999999999999999999999999999999999999 7899999999887664
Q ss_pred ---ccccCCCcccCCccccC----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc--cCCCCCCcCCCC
Q psy11098 250 ---TVVLPDLEFASPEMLTS----PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVA--DYSFPPEQCGHI 320 (380)
Q Consensus 250 ---~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~ 320 (380)
...+|||.|++||++.. .+.|+..+|+|||||++|||+.|..||..++-.+++.+|+.. .+.||++ ..+
T Consensus 231 V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~--~~V 308 (1317)
T KOG0612|consen 231 VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDE--TDV 308 (1317)
T ss_pred EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcc--ccc
Confidence 56789999999999853 256889999999999999999999999999999999999987 5677733 359
Q ss_pred CHHHHHHHHHhcccCCCCCCC---HHHHHhcccccccCC
Q psy11098 321 SVPARELIGQLLNTHADKRPT---AGQLLQVAWFAEASC 356 (380)
Q Consensus 321 s~~~~~li~~~L~~dP~~Rpt---~~e~L~hpw~~~~~~ 356 (380)
|.++++||.+++.- |+.|.. ++++-.||||....|
T Consensus 309 SeeakdLI~~ll~~-~e~RLgrngiedik~HpFF~g~~W 346 (1317)
T KOG0612|consen 309 SEEAKDLIEALLCD-REVRLGRNGIEDIKNHPFFEGIDW 346 (1317)
T ss_pred CHHHHHHHHHHhcC-hhhhcccccHHHHHhCccccCCCh
Confidence 99999999999864 789998 999999999998766
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=339.10 Aligned_cols=253 Identities=26% Similarity=0.341 Sum_probs=210.3
Q ss_pred ceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCc--hHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEE
Q psy11098 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP--QQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVM 178 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~ 178 (380)
+|++.+.||+|+||.||++.+..+++.+|+|.+...... ...+.+|+++++.++|+||+++++++... +..+++|
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~lv~ 78 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD---GEISICM 78 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC---CEEEEEe
Confidence 689999999999999999999999999999998754332 34567899999999999999999988764 6789999
Q ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeecCCCCcEEEe-CCeeEEEeCCCccccc----ccc
Q psy11098 179 QLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHS-QQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS----TVV 252 (380)
Q Consensus 179 e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~-~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~----~~~ 252 (380)
||+.|++|.+++.....+++..+..++.||+.||.|||+ .+++|+||||+|||++ ++.+||+|||++.... ...
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 158 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccccccC
Confidence 999999999999888889999999999999999999997 6999999999999998 4689999999987543 445
Q ss_pred cCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCC--------------------
Q psy11098 253 LPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSF-------------------- 312 (380)
Q Consensus 253 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~-------------------- 312 (380)
.+++.|+|||++.+ ..++.++|+||||+++|+|++|..||...+.......+.......
T Consensus 159 ~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (308)
T cd06615 159 VGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPM 237 (308)
T ss_pred CCCcCccChhHhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchh
Confidence 67899999999877 467889999999999999999999997655433332221110000
Q ss_pred --------------CCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCCC
Q psy11098 313 --------------PPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASCS 357 (380)
Q Consensus 313 --------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~~ 357 (380)
+......++.++++||.+||..||++|||++++++||||.+....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 296 (308)
T cd06615 238 AIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAELE 296 (308)
T ss_pred hHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcccc
Confidence 000012367889999999999999999999999999999876443
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=353.48 Aligned_cols=252 Identities=23% Similarity=0.315 Sum_probs=204.5
Q ss_pred hhhhceeeeeeecccCCeEEEEEEEcC--CCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCce
Q psy11098 97 QFEHRYEELERLGNGRFCTVRKARDRG--TGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 97 ~~~~~y~~~~~LG~G~fg~V~~~~~~~--~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~ 174 (380)
.+..+|++++.||+|+||.||+|.... +++.||+|.+.... ...+|+++++.++|+||+++++.+... +..
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~----~~~~E~~il~~l~h~~iv~~~~~~~~~---~~~ 161 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK----TPGREIDILKTISHRAIINLIHAYRWK---STV 161 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc----cHHHHHHHHHhcCCCCccceeeeEeeC---CEE
Confidence 345789999999999999999997643 56789999886432 345799999999999999999888764 577
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc----
Q psy11098 175 TIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS---- 249 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~---- 249 (380)
+++||++ +++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 162 ~lv~e~~-~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 162 CMVMPKY-KCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred EEEehhc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 9999999 578999997778899999999999999999999999999999999999998 5699999999987553
Q ss_pred ----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHhcc----cCCCCC----
Q psy11098 250 ----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEE---ETRAHISVA----DYSFPP---- 314 (380)
Q Consensus 250 ----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~---~~~~~i~~~----~~~~~~---- 314 (380)
....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.... ..+..+... ...++.
T Consensus 241 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 319 (392)
T PHA03207 241 TPQCYGWSGTLETNSPELLAL-DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST 319 (392)
T ss_pred cccccccccccCccCHhHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence 23568999999999987 46788999999999999999999999765321 111111110 000000
Q ss_pred --------------------C--cCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCCC
Q psy11098 315 --------------------E--QCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASCS 357 (380)
Q Consensus 315 --------------------~--~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~~ 357 (380)
. ....++.++++||++||..||++|||+.|+|.||||++....
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~ 384 (392)
T PHA03207 320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPIN 384 (392)
T ss_pred hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchh
Confidence 0 012356789999999999999999999999999999876543
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=340.26 Aligned_cols=255 Identities=29% Similarity=0.466 Sum_probs=218.9
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC----chHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ----PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... ....+..|+++++.+.|+||+++++.+... +..+
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~ 77 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTE---TYLC 77 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecC---CEEE
Confidence 368999999999999999999999999999999976432 234567899999999999999999887663 6789
Q ss_pred EEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc---
Q psy11098 176 IVMQLVHGESLIQHLCRQ--STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS--- 249 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~--- 249 (380)
++|||+.|++|.+++... ..+++..++.++.||+.||.|||+.|++|+||||+|||++ ++.++|+|||++....
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 78 LVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 999999999999998753 5689999999999999999999999999999999999998 5699999999876432
Q ss_pred --------------------------------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q psy11098 250 --------------------------------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDES 297 (380)
Q Consensus 250 --------------------------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~ 297 (380)
....||..|+|||++.+ ..++.++||||||+++|+|++|..||.+.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG-DGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC-CCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 12357889999999987 467889999999999999999999998888
Q ss_pred HHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCC----HHHHHhcccccccCCCCCc
Q psy11098 298 EEETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPT----AGQLLQVAWFAEASCSEFD 360 (380)
Q Consensus 298 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt----~~e~L~hpw~~~~~~~~~~ 360 (380)
..+....+......++.. ..++.+++++|.+||..||++||| ++++|+||||+...++.++
T Consensus 237 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~~~ 301 (316)
T cd05574 237 RDETFSNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIR 301 (316)
T ss_pred hHHHHHHHhcCCccCCCc--cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhhcc
Confidence 777777766555544432 337999999999999999999999 9999999999987655433
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=335.34 Aligned_cols=247 Identities=23% Similarity=0.373 Sum_probs=203.4
Q ss_pred ceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEE
Q psy11098 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIV 177 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv 177 (380)
+|++.+.||.|++|.||+|++..+++.||+|.+..... ....+.+|+.+++.+.|+|++++++++... +..++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~~v 77 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQE---SRLYLI 77 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC---CeEEEE
Confidence 48889999999999999999999999999999864322 235677899999999999999999988763 678999
Q ss_pred EEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc----
Q psy11098 178 MQLVHGESLIQHLCRQ---STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS---- 249 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~~---~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~---- 249 (380)
|||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 78 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 78 FEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred EecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 99996 6888887542 5689999999999999999999999999999999999997 5699999999987543
Q ss_pred --ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc------------------
Q psy11098 250 --TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVAD------------------ 309 (380)
Q Consensus 250 --~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~------------------ 309 (380)
....+++.|+|||++.+...++.++|+|||||++|+|++|.+||.+.........+....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK 236 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence 233568899999998765567889999999999999999999998766543332221100
Q ss_pred -------CCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy11098 310 -------YSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 310 -------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~ 351 (380)
..........+++++++||++||+.||++|||+.++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 000011123578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-46 Score=348.72 Aligned_cols=267 Identities=25% Similarity=0.422 Sum_probs=227.4
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC----CCchHHHHHHHHHHHhhccCCCcceeeecccccCCCce
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~ 174 (380)
.+.|+..+.||+||||.||-|+-+.||+.||+|.+.+. +.......+|-.||..++.+.|+.+--.|+.. +.+
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTk---d~L 260 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETK---DAL 260 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCC---Cce
Confidence 35678889999999999999999999999999998543 34456778899999999999999988888874 788
Q ss_pred EEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCccccc--
Q psy11098 175 TIVMQLVHGESLIQHLCRQS--TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVS-- 249 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~~--~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~-- 249 (380)
++||..|+||+|.-.|.+.+ .++|..++.++.+|+.||++||+.+||+|||||+|||+|+ |+|+|+|.|+|..+.
T Consensus 261 ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 261 CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 99999999999988887654 7999999999999999999999999999999999999984 799999999999875
Q ss_pred ---ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHH
Q psy11098 250 ---TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARE 326 (380)
Q Consensus 250 ---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 326 (380)
...+||.+|||||++.+. .|+...|+|||||++|+|+.|..||.......-...+.......+.+..+..|+++++
T Consensus 341 ~~~~~rvGT~GYMAPEvl~ne-~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eaks 419 (591)
T KOG0986|consen 341 KPIRGRVGTVGYMAPEVLQNE-VYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKS 419 (591)
T ss_pred CccccccCcccccCHHHHcCC-cccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHH
Confidence 345899999999999995 5999999999999999999999999765443333333333333344444678999999
Q ss_pred HHHHhcccCCCCCC-----CHHHHHhcccccccCCCCCccccc-cchHH
Q psy11098 327 LIGQLLNTHADKRP-----TAGQLLQVAWFAEASCSEFDTERL-LPFSA 369 (380)
Q Consensus 327 li~~~L~~dP~~Rp-----t~~e~L~hpw~~~~~~~~~~~~~~-~~~~~ 369 (380)
+.+.+|.+||.+|. +++++-+||||++..+..+...++ .||+.
T Consensus 420 lc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiP 468 (591)
T KOG0986|consen 420 LCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIP 468 (591)
T ss_pred HHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCC
Confidence 99999999999997 567999999999988877777777 44443
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=337.52 Aligned_cols=247 Identities=27% Similarity=0.446 Sum_probs=201.4
Q ss_pred ceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEE
Q psy11098 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIV 177 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv 177 (380)
+|++.+.||+|+||.||+|+++.+|+.||+|.++.... ....+.+|+.+++.++|+|++++++++... +..+++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~---~~~~lv 77 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSD---KKLTLV 77 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccC---CceEEE
Confidence 58899999999999999999999999999999965322 234567799999999999999988887654 678999
Q ss_pred EEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------
Q psy11098 178 MQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------ 249 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------ 249 (380)
+||+. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 78 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (284)
T cd07839 78 FEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY 156 (284)
T ss_pred EecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCc
Confidence 99995 578887754 56799999999999999999999999999999999999998 5689999999987553
Q ss_pred ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHhcc----------------cCC-
Q psy11098 250 TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFL-DESEEETRAHISVA----------------DYS- 311 (380)
Q Consensus 250 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~-~~~~~~~~~~i~~~----------------~~~- 311 (380)
....+++.|+|||++.+...++.++|+|||||++|+|++|..||. +.+..+....+... .+.
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07839 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP 236 (284)
T ss_pred CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccc
Confidence 234568899999998775567889999999999999999888854 44444333332211 000
Q ss_pred CC--------CCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy11098 312 FP--------PEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 312 ~~--------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~ 351 (380)
++ ......+++++++||.+||..||.+|||++++|+||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 00 01123578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=333.53 Aligned_cols=249 Identities=24% Similarity=0.361 Sum_probs=209.8
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC-chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ-PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIV 177 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv 177 (380)
.++|++.+.||+|+||.||+|++..+++.||+|+++.... ....+.+|+.+++.++|+|++++++.+... +..+++
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~---~~~~lv 84 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRR---DKLWIC 84 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC---CEEEEE
Confidence 4588999999999999999999999999999999875433 334567899999999999999999887664 678999
Q ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------c
Q psy11098 178 MQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------T 250 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------~ 250 (380)
|||+.+++|.+++...+.+++..+..++.|++.||.|||++|++|+||||+||+++ ++.+||+|||++.... .
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 164 (267)
T cd06645 85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRK 164 (267)
T ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccc
Confidence 99999999999998888999999999999999999999999999999999999998 5689999999986543 3
Q ss_pred cccCCCcccCCccccC--CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCC-cCCCCCHHHHHH
Q psy11098 251 VVLPDLEFASPEMLTS--PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPE-QCGHISVPAREL 327 (380)
Q Consensus 251 ~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~s~~~~~l 327 (380)
...|++.|+|||++.. ...++.++|+|||||++|+|++|..||...................+.. ....++..+.+|
T Consensus 165 ~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 244 (267)
T cd06645 165 SFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHF 244 (267)
T ss_pred cccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHH
Confidence 4568999999999742 2456789999999999999999999997765544444443333332211 112468899999
Q ss_pred HHHhcccCCCCCCCHHHHHhccc
Q psy11098 328 IGQLLNTHADKRPTAGQLLQVAW 350 (380)
Q Consensus 328 i~~~L~~dP~~Rpt~~e~L~hpw 350 (380)
|++||..||++|||++++|+|||
T Consensus 245 i~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 245 VKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHccCCchhCcCHHHHhcCCC
Confidence 99999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=338.06 Aligned_cols=266 Identities=27% Similarity=0.407 Sum_probs=215.2
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCc---hHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP---QQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
.++|++.+.||+|+||.||+|.++.+|+.||+|.++..... .....+|+.+++.++|+|++++++++.... .+..+
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~~~ 84 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKH-LDSIF 84 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCC-CCeEE
Confidence 46799999999999999999999999999999998644322 234567999999999999999999886532 24679
Q ss_pred EEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccccc---
Q psy11098 176 IVMQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVST--- 250 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~~--- 250 (380)
+||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.|++||||||+||+++ ++.+||+|||++.....
T Consensus 85 lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~ 163 (309)
T cd07845 85 LVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK 163 (309)
T ss_pred EEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccC
Confidence 9999995 578888765 36789999999999999999999999999999999999998 46899999999876542
Q ss_pred ---cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc------------------
Q psy11098 251 ---VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVAD------------------ 309 (380)
Q Consensus 251 ---~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~------------------ 309 (380)
...+++.|+|||++.+...++.++|+|||||++|+|++|..||.+.+..+....+....
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (309)
T cd07845 164 PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVG 243 (309)
T ss_pred CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccc
Confidence 22347789999998765567889999999999999999999998888777666554321
Q ss_pred -CCCCCC-------cCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCCCCCccccccch
Q psy11098 310 -YSFPPE-------QCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASCSEFDTERLLPF 367 (380)
Q Consensus 310 -~~~~~~-------~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~~~~~~~~~~~~ 367 (380)
+..+.. ....++.++.+||++||+.||++|||++++|.||||.+.+.. ...+.|..|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~-~~~~~~~~~ 308 (309)
T cd07845 244 KFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP-CEPEMMPTF 308 (309)
T ss_pred cccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC-CCCCcCCCC
Confidence 111110 112358889999999999999999999999999999877655 223444443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=336.80 Aligned_cols=255 Identities=26% Similarity=0.369 Sum_probs=210.5
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIV 177 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv 177 (380)
++|++++.||+|+||.||+|.+..+++.||+|.+..... ....+.+|+++++.++|+|++++++.+.. .+..++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~~~~~lv 77 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFI---EGAVYMC 77 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec---CCeEEEE
Confidence 368899999999999999999999999999999865432 23467789999999999999999988776 3678999
Q ss_pred EEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH-CCcEeecCCCCcEEEe-CCeeEEEeCCCccccc---
Q psy11098 178 MQLVHGESLIQHLCRQ---STITESYICCIIRQLHSALHCLHS-QQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS--- 249 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~~---~~l~e~~~~~i~~qil~al~~lH~-~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~--- 249 (380)
|||+.|++|..++... ..+++..+..++.||+.||.|||+ .||+||||||+|||++ ++.+||+|||++....
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 9999999998888663 378999999999999999999997 5999999999999998 4689999999987553
Q ss_pred -ccccCCCcccCCccccCCC-----CCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHH
Q psy11098 250 -TVVLPDLEFASPEMLTSPA-----TAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVP 323 (380)
Q Consensus 250 -~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 323 (380)
....+++.|+|||++.+.. .++.++|+|||||++|+|++|..||...........+.......+......++.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd06622 158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDD 237 (286)
T ss_pred cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHH
Confidence 3445788999999986532 3477999999999999999999999776554444333221111222223458999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHhcccccccCCC
Q psy11098 324 ARELIGQLLNTHADKRPTAGQLLQVAWFAEASCS 357 (380)
Q Consensus 324 ~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~~ 357 (380)
+.+||++||..+|++||+++++++||||......
T Consensus 238 ~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~ 271 (286)
T cd06622 238 AQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA 271 (286)
T ss_pred HHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence 9999999999999999999999999999877554
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=334.07 Aligned_cols=249 Identities=26% Similarity=0.438 Sum_probs=208.3
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
++|++.+.||+|+||.||+|+++.+++.||+|.+..... ....+.+|+.+++.++|+|++++++++... ...++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~---~~~~~ 77 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRK---RKLHL 77 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeC---CEEEE
Confidence 478999999999999999999999999999999864322 234567899999999999999999988764 57799
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccccc-----
Q psy11098 177 VMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVST----- 250 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~~----- 250 (380)
||||+.++.|..++.....+++..+..++.||+.||.|||+.|++||||||+||+++ ++.+||+|||++.....
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07847 78 VFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY 157 (286)
T ss_pred EEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccc
Confidence 999999888887776667899999999999999999999999999999999999998 56899999999876542
Q ss_pred -cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc-------------------C
Q psy11098 251 -VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVAD-------------------Y 310 (380)
Q Consensus 251 -~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~-------------------~ 310 (380)
...++..|+|||++.+...++.++|+||||+++|+|++|..||.+....+....+.... .
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence 34567889999998775567889999999999999999999998876655444332110 0
Q ss_pred CCCC--------CcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy11098 311 SFPP--------EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 311 ~~~~--------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~ 351 (380)
..+. .....++.++.+||.+||+.||++|||+.|+|.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0111 0123568889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-44 Score=333.94 Aligned_cols=252 Identities=25% Similarity=0.337 Sum_probs=212.2
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC-CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER-QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVM 178 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~ 178 (380)
+.|++.+.||.|+||.||+|.+..++..+|+|.+.... .....+.+|+++++.+.|+|++++++++... +..++|+
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~---~~~~~v~ 81 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYE---NNLWILI 81 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC---CEEEEEE
Confidence 44788999999999999999999999999999996543 2345667899999999999999999988764 6779999
Q ss_pred EecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------c
Q psy11098 179 QLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------T 250 (380)
Q Consensus 179 e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------~ 250 (380)
||+.+++|..++.. ...+++..+..++.||+.||.|||+.|++||||||+|||++ ++.+||+|||++.... .
T Consensus 82 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 161 (282)
T cd06643 82 EFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD 161 (282)
T ss_pred EecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccccc
Confidence 99999999888754 46799999999999999999999999999999999999998 5689999999986543 3
Q ss_pred cccCCCcccCCccccC----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHH
Q psy11098 251 VVLPDLEFASPEMLTS----PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARE 326 (380)
Q Consensus 251 ~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 326 (380)
...+++.|+|||++.. ...++.++|+|||||++|+|++|..||...+..+....+....... ......++.++++
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 240 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT-LAQPSRWSSEFKD 240 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCC-CCCccccCHHHHH
Confidence 3567899999999842 2346779999999999999999999998877666655554433221 1122457899999
Q ss_pred HHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 327 LIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 327 li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
||.+||..||.+|||++++++||||....
T Consensus 241 li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 269 (282)
T cd06643 241 FLKKCLEKNVDARWTTTQLLQHPFVTVNS 269 (282)
T ss_pred HHHHHccCChhhCcCHHHHhcCCCEeccC
Confidence 99999999999999999999999998763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=353.97 Aligned_cols=257 Identities=23% Similarity=0.318 Sum_probs=222.9
Q ss_pred hhhhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCc----hHHHHHHHHHHHhhccCCCcceeeeccccc
Q psy11098 94 QQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP----QQITRAEYNLLSTLMHAHIPTALALFENAP 169 (380)
Q Consensus 94 ~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~----~~~~~~E~~il~~l~h~ni~~i~~~~~~~~ 169 (380)
..++-.+.|.-++.||.|+||-||-|++..+.+.||||.+..+... =+.+.+|+..|+.++|||++...++|-..
T Consensus 20 ~k~DPEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre- 98 (948)
T KOG0577|consen 20 FKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLRE- 98 (948)
T ss_pred ccCCHHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeecc-
Confidence 3455667788899999999999999999999999999999644322 24567899999999999999999998875
Q ss_pred CCCceEEEEEecCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccc
Q psy11098 170 VPGTDTIVMQLVHGESLIQHLC-RQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVS 247 (380)
Q Consensus 170 ~~~~~~lv~e~~~gg~L~~~l~-~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~ 247 (380)
.+.++||||| -|+-.|++. ..+++.|.++..|+.+.+.||.|||+.+.||||||..|||++ .|.|||+|||.|..
T Consensus 99 --~TaWLVMEYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi 175 (948)
T KOG0577|consen 99 --HTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASI 175 (948)
T ss_pred --chHHHHHHHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhh
Confidence 5669999999 667778774 467899999999999999999999999999999999999997 57999999999977
Q ss_pred cc--ccccCCCcccCCccccC--CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHH
Q psy11098 248 VS--TVVLPDLEFASPEMLTS--PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVP 323 (380)
Q Consensus 248 ~~--~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 323 (380)
.. +.++|||.||||||+.. .+.|+-++|||||||++.||.-.++|+..++....+..|...+... -...++|+.
T Consensus 176 ~~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPt--Lqs~eWS~~ 253 (948)
T KOG0577|consen 176 MAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT--LQSNEWSDY 253 (948)
T ss_pred cCchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCC--CCCchhHHH
Confidence 64 78999999999999863 4577889999999999999999999999998888888876554332 234578999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHhcccccccCC
Q psy11098 324 ARELIGQLLNTHADKRPTAGQLLQVAWFAEASC 356 (380)
Q Consensus 324 ~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~ 356 (380)
+++|+..||.+-|.+|||+++||+|+|+...-.
T Consensus 254 F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp 286 (948)
T KOG0577|consen 254 FRNFVDSCLQKIPQERPTSEELLKHRFVLRERP 286 (948)
T ss_pred HHHHHHHHHhhCcccCCcHHHHhhcchhccCCC
Confidence 999999999999999999999999999987643
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-44 Score=331.34 Aligned_cols=263 Identities=27% Similarity=0.370 Sum_probs=220.4
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC--CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER--QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIV 177 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv 177 (380)
++|++.+.||.|+||.||+|++..+++.||+|.+.... .....+.+|+++++.++|+|++++++++... ...++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~~v 77 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG---SKLWII 77 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC---CeEEEE
Confidence 36888999999999999999999999999999997543 2334567899999999999999999887764 678999
Q ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------c
Q psy11098 178 MQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------T 250 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------~ 250 (380)
+||+.+++|.+++... .+++..++.++.|++.||.|||+++++|+||+|+||+++ ++.++|+|||++.... .
T Consensus 78 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (274)
T cd06609 78 MEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRN 156 (274)
T ss_pred EEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccccccc
Confidence 9999999999999765 889999999999999999999999999999999999998 5689999999987654 2
Q ss_pred cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHH
Q psy11098 251 VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQ 330 (380)
Q Consensus 251 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 330 (380)
...+++.|+|||++.+. .++.++||||||+++|+|++|..||...........+......... ...++.++.+++.+
T Consensus 157 ~~~~~~~y~~PE~~~~~-~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~ 233 (274)
T cd06609 157 TFVGTPFWMAPEVIKQS-GYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLE--GNKFSKPFKDFVSL 233 (274)
T ss_pred cccCCccccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCc--ccccCHHHHHHHHH
Confidence 34678889999999874 5889999999999999999999999877665555554443221111 12278899999999
Q ss_pred hcccCCCCCCCHHHHHhcccccccCCCCCccccccchHHHHHH
Q psy11098 331 LLNTHADKRPTAGQLLQVAWFAEASCSEFDTERLLPFSARRKQ 373 (380)
Q Consensus 331 ~L~~dP~~Rpt~~e~L~hpw~~~~~~~~~~~~~~~~~~~~~~~ 373 (380)
||..||++|||++++++||||++... ...+..+..+.|.
T Consensus 234 ~l~~~p~~Rpt~~~il~~~~~~~~~~----~~~~~~~~~~~~~ 272 (274)
T cd06609 234 CLNKDPKERPSAKELLKHKFIKKAKK----TSYLTLLIERIKK 272 (274)
T ss_pred HhhCChhhCcCHHHHhhChhhcCCCc----ccHHHHHHHHHHh
Confidence 99999999999999999999988633 2556666666553
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=324.83 Aligned_cols=245 Identities=23% Similarity=0.371 Sum_probs=208.6
Q ss_pred ceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEE
Q psy11098 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIV 177 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv 177 (380)
.|++.+.||+|++|.||++.++.+++.||+|.+..... ....+.+|+++++.++|+|++++.+.+... ....+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~lv 78 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE--DGLLYIV 78 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC--CCEEEEE
Confidence 48899999999999999999999999999999965432 334567899999999999999988776532 2457899
Q ss_pred EEecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-----
Q psy11098 178 MQLVHGESLIQHLCR--QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS----- 249 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~--~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~----- 249 (380)
|||+.+++|.+++.. ...+++.+++.++.|++.||.+||++|++||||||+||+++ ++.++|+|||++....
T Consensus 79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 158 (257)
T cd08223 79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDM 158 (257)
T ss_pred ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCc
Confidence 999999999999976 34589999999999999999999999999999999999998 4689999999987553
Q ss_pred -ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHH
Q psy11098 250 -TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELI 328 (380)
Q Consensus 250 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 328 (380)
....+++.|+|||++.+ ..++.++|+||||+++|+|++|..||...+.......+..+.... ....+++++.+|+
T Consensus 159 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li 234 (257)
T cd08223 159 ASTLIGTPYYMSPELFSN-KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP---MPKDYSPELGELI 234 (257)
T ss_pred cccccCCcCccChhHhcC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC---CccccCHHHHHHH
Confidence 23467899999999987 467889999999999999999999998877666655554443311 2245789999999
Q ss_pred HHhcccCCCCCCCHHHHHhcccc
Q psy11098 329 GQLLNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 329 ~~~L~~dP~~Rpt~~e~L~hpw~ 351 (380)
.+||+.||++|||+.++++||||
T Consensus 235 ~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 235 ATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHhccCcccCCCHHHHhcCCCC
Confidence 99999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-44 Score=345.75 Aligned_cols=245 Identities=24% Similarity=0.312 Sum_probs=195.4
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVM 178 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~ 178 (380)
...|++.+.||+|+||.||+|++..+++.||+|+..... ...|+.+++.++|+||+++++++... +..++||
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~-----~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~lv~ 136 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT-----TLIEAMLLQNVNHPSVIRMKDTLVSG---AITCMVL 136 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc-----cHHHHHHHHhCCCCCCcChhheEEeC---CeeEEEE
Confidence 357999999999999999999999999999999864332 34699999999999999999888764 5679999
Q ss_pred EecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-----cc
Q psy11098 179 QLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS-----TV 251 (380)
Q Consensus 179 e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~-----~~ 251 (380)
|++ .++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.... ..
T Consensus 137 e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 215 (357)
T PHA03209 137 PHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG 215 (357)
T ss_pred Ecc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCccccc
Confidence 999 5688888755 46799999999999999999999999999999999999998 4689999999987432 34
Q ss_pred ccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCC-CCCCH--H-------HHHHHHhcc----cCCCC----
Q psy11098 252 VLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPF-LDESE--E-------ETRAHISVA----DYSFP---- 313 (380)
Q Consensus 252 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf-~~~~~--~-------~~~~~i~~~----~~~~~---- 313 (380)
..||+.|+|||++.+ ..++.++|||||||++|+|+++..++ .+... . .....+... ...++
T Consensus 216 ~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 294 (357)
T PHA03209 216 LAGTVETNAPEVLAR-DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPG 294 (357)
T ss_pred ccccccccCCeecCC-CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCc
Confidence 568999999999987 46788999999999999999854444 33211 0 111111110 00011
Q ss_pred ----------------------CCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccc
Q psy11098 314 ----------------------PEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAE 353 (380)
Q Consensus 314 ----------------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~ 353 (380)
......++.++.+||++||+.||++|||+.|+|+||||++
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 295 SRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred cHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 0011245778889999999999999999999999999986
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=329.30 Aligned_cols=252 Identities=27% Similarity=0.408 Sum_probs=212.3
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhh-ccCCCcceeeecccccC---CCce
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTL-MHAHIPTALALFENAPV---PGTD 174 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~~---~~~~ 174 (380)
.++|++.+.||.|+||.||+|.++.+++.+|+|++.........+.+|+.+++.+ .|+|++++++++..... .+..
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL 84 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence 5789999999999999999999999999999999987666667788999999999 69999999999876432 3567
Q ss_pred EEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc
Q psy11098 175 TIVMQLVHGESLIQHLCR----QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS 249 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~----~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~ 249 (380)
++||||+.+++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++ ++.+||+|||++....
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~ 164 (275)
T cd06608 85 WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLD 164 (275)
T ss_pred EEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccceecc
Confidence 999999999999998865 35789999999999999999999999999999999999998 5689999999986543
Q ss_pred ------ccccCCCcccCCccccCC----CCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCC
Q psy11098 250 ------TVVLPDLEFASPEMLTSP----ATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGH 319 (380)
Q Consensus 250 ------~~~~gt~~y~aPE~~~~~----~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 319 (380)
....+++.|+|||++... ..++.++|||||||++|+|++|..||.+.........+....... ......
T Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~ 243 (275)
T cd06608 165 STLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPT-LKSPEN 243 (275)
T ss_pred cchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCC-CCchhh
Confidence 345578899999987542 345778999999999999999999998766555555554332211 111224
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy11098 320 ISVPARELIGQLLNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 320 ~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~ 351 (380)
++.++++||++||..||++|||+.++++|||+
T Consensus 244 ~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 244 WSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred cCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 78899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=330.31 Aligned_cols=249 Identities=24% Similarity=0.359 Sum_probs=208.9
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC-CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER-QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIV 177 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv 177 (380)
.++|++.+.||+|+||.||+|++..+++.||+|++.... .....+.+|+.+++.++|+|++++++.+... +..++|
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~---~~~~iv 84 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSR---EKLWIC 84 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeC---CEEEEE
Confidence 568999999999999999999999999999999996443 3345677899999999999999999888653 677999
Q ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------c
Q psy11098 178 MQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------T 250 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------~ 250 (380)
|||+.+++|.+++.....+++..+..++.|++.||.|||+.||+||||||+||+++ ++.+||+|||++.... .
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~ 164 (267)
T cd06646 85 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRK 164 (267)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccccC
Confidence 99999999999998888899999999999999999999999999999999999998 4589999999987653 2
Q ss_pred cccCCCcccCCccccC--CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCC-CcCCCCCHHHHHH
Q psy11098 251 VVLPDLEFASPEMLTS--PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPP-EQCGHISVPAREL 327 (380)
Q Consensus 251 ~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~s~~~~~l 327 (380)
...+++.|+|||.+.. ...++.++|+||+||++|+|++|..||......+....+....+..+. .....++.++.+|
T Consensus 165 ~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 244 (267)
T cd06646 165 SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNF 244 (267)
T ss_pred ccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHH
Confidence 3457889999998853 234677999999999999999999999766544443333333332221 1123578899999
Q ss_pred HHHhcccCCCCCCCHHHHHhccc
Q psy11098 328 IGQLLNTHADKRPTAGQLLQVAW 350 (380)
Q Consensus 328 i~~~L~~dP~~Rpt~~e~L~hpw 350 (380)
|++||..||++|||++++|+|+|
T Consensus 245 i~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 245 VKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHhhCChhhCcCHHHHhcCCC
Confidence 99999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-44 Score=335.22 Aligned_cols=252 Identities=30% Similarity=0.421 Sum_probs=209.4
Q ss_pred ceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCc------hHHHHHHHHHHHhhccCCCcceeeecccccCCCce
Q psy11098 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP------QQITRAEYNLLSTLMHAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~------~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~ 174 (380)
+|++.+.||+|+||.||+|.+..+++.||+|.+...... ...+..|+++++.++|+|++++++++.. .+..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~---~~~~ 77 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH---KSNI 77 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec---CCEE
Confidence 488889999999999999999999999999999754322 3445679999999999999999998876 3678
Q ss_pred EEEEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccccc--
Q psy11098 175 TIVMQLVHGESLIQHLCRQS-TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVST-- 250 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~~-~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~~-- 250 (380)
++||||+ +++|.+++.... .+++..+..++.||++||.|||++||+|+||||+|||++ ++.++|+|||++.....
T Consensus 78 ~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 78 NLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred EEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 9999999 999999997765 799999999999999999999999999999999999998 56899999999876542
Q ss_pred ----cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCC--------------
Q psy11098 251 ----VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSF-------------- 312 (380)
Q Consensus 251 ----~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~-------------- 312 (380)
...+++.|+|||.+.+...++.++|+|||||++|+|++|.+||.+....+....+.......
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T cd07841 157 RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDY 236 (298)
T ss_pred ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccc
Confidence 23457789999998765567889999999999999999988888776655444432110000
Q ss_pred ---------C-CCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCC
Q psy11098 313 ---------P-PEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASC 356 (380)
Q Consensus 313 ---------~-~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~ 356 (380)
+ .......+.++.+||.+||.+||++|||+.|+|+|+||.+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~ 290 (298)
T cd07841 237 VEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPA 290 (298)
T ss_pred ccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCC
Confidence 0 0112345788999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=334.68 Aligned_cols=250 Identities=25% Similarity=0.396 Sum_probs=215.9
Q ss_pred ceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC----chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEE
Q psy11098 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ----PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
+|++.+.||+|+||.||++.++.+++.||+|.+..... ....+.+|+++++.++|+||++++..+... +..++
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~---~~~~l 78 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETK---RHLCM 78 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecC---CEEEE
Confidence 68899999999999999999999999999999865432 234567899999999999999998887653 67799
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccc-------
Q psy11098 177 VMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSV------- 248 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~------- 248 (380)
||||+.|++|.+++.....+++..+..++.|++.||.|||++|++||||||+|||++ ++.+||+|||++...
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 79 VMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 999999999999998888899999999999999999999999999999999999998 468999999987531
Q ss_pred --------------cccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCC
Q psy11098 249 --------------STVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPP 314 (380)
Q Consensus 249 --------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~ 314 (380)
.....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+....+....+.......+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 237 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC
Confidence 012356788999999877 46788999999999999999999999988888877777666555444
Q ss_pred CcCCCCCHHHHHHHHHhcccCCCCCCC---HHHHHhcccccccC
Q psy11098 315 EQCGHISVPARELIGQLLNTHADKRPT---AGQLLQVAWFAEAS 355 (380)
Q Consensus 315 ~~~~~~s~~~~~li~~~L~~dP~~Rpt---~~e~L~hpw~~~~~ 355 (380)
.. ..++.+++++|++||++||++||| +.++|+||||....
T Consensus 238 ~~-~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~ 280 (305)
T cd05609 238 GD-EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLD 280 (305)
T ss_pred cc-ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCC
Confidence 32 257899999999999999999998 79999999997643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-44 Score=372.14 Aligned_cols=255 Identities=27% Similarity=0.379 Sum_probs=211.3
Q ss_pred hhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---chHHHHHHHHHHHhhccCCCcceeeecccccCCC
Q psy11098 96 EQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLMHAHIPTALALFENAPVPG 172 (380)
Q Consensus 96 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~ 172 (380)
+.+..+|++++.||+|+||+||+|++..+++.+|+|++..... ....+..|+.+++.|+|+||++++++|.... ..
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~-~~ 87 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA-NQ 87 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC-CC
Confidence 4456799999999999999999999999999999999865432 3456778999999999999999999875432 35
Q ss_pred ceEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-------CcEeecCCCCcEEEeC-------
Q psy11098 173 TDTIVMQLVHGESLIQHLCR----QSTITESYICCIIRQLHSALHCLHSQ-------QIAHKDIRPENILMNG------- 234 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~----~~~l~e~~~~~i~~qil~al~~lH~~-------~iiHrDlKp~NIl~~~------- 234 (380)
.+||||||+.+++|.++|.. ...+++..++.|+.||+.||.|||+. +|+||||||+|||++.
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 68999999999999999865 25799999999999999999999985 4999999999999953
Q ss_pred -----------CeeEEEeCCCccccc-----ccccCCCcccCCccccCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q psy11098 235 -----------AVLKLIDLGSSVSVS-----TVVLPDLEFASPEMLTSP-ATAGPSTDMWSLGVLLYILLSGVSPFLDES 297 (380)
Q Consensus 235 -----------~~ikl~DFG~a~~~~-----~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~~lltg~~Pf~~~~ 297 (380)
..+||+|||++.... ....||+.|+|||++.+. ..++.++||||||||+|+|++|..||....
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred ccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 148999999987653 345789999999998642 357889999999999999999999997665
Q ss_pred HHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 298 EEETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 298 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
..............++ ....+.++.+||..||..+|.+|||+.|+|.|+||+..
T Consensus 248 ~~~qli~~lk~~p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 248 NFSQLISELKRGPDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred cHHHHHHHHhcCCCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 4433333322222222 23568999999999999999999999999999999754
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=330.16 Aligned_cols=255 Identities=24% Similarity=0.379 Sum_probs=212.5
Q ss_pred hhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhh-ccCCCcceeeeccccc--CCCc
Q psy11098 97 QFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTL-MHAHIPTALALFENAP--VPGT 173 (380)
Q Consensus 97 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~--~~~~ 173 (380)
...++|++.+.||+|+||.||+|.+..+++.+|+|.+.........+.+|+.+++.+ +|+|++++++++.... ..+.
T Consensus 19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~ 98 (291)
T cd06639 19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQ 98 (291)
T ss_pred CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCe
Confidence 346889999999999999999999999999999999976555556677899999999 7999999999886532 2246
Q ss_pred eEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccc
Q psy11098 174 DTIVMQLVHGESLIQHLCR----QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSV 248 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~----~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~ 248 (380)
.++||||+.|++|.+++.. ...+++..++.++.|++.||.|||+.|++||||||+||+++ ++.+||+|||++...
T Consensus 99 ~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~ 178 (291)
T cd06639 99 LWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQL 178 (291)
T ss_pred eEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhc
Confidence 8999999999999998753 45789999999999999999999999999999999999998 468999999998754
Q ss_pred c------ccccCCCcccCCccccCCC----CCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCC
Q psy11098 249 S------TVVLPDLEFASPEMLTSPA----TAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCG 318 (380)
Q Consensus 249 ~------~~~~gt~~y~aPE~~~~~~----~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 318 (380)
. ....++..|+|||++.... .++.++|+|||||++|+|++|+.||...........+...... ......
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~ 257 (291)
T cd06639 179 TSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPP-TLLHPE 257 (291)
T ss_pred ccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCC-CCCccc
Confidence 3 2346788999999986432 2578999999999999999999999887766555555433211 111123
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHhccccc
Q psy11098 319 HISVPARELIGQLLNTHADKRPTAGQLLQVAWFA 352 (380)
Q Consensus 319 ~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~ 352 (380)
.++.++.+||.+||..||++||++.++|+||||+
T Consensus 258 ~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 258 KWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred ccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 4678899999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=323.22 Aligned_cols=244 Identities=26% Similarity=0.363 Sum_probs=211.1
Q ss_pred ceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC---CCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEE
Q psy11098 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE---RQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIV 177 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv 177 (380)
.|++.+.||+|++|.||+|.+..+++.||+|.+... ......+.+|+++++.++|+|++++++++... +..++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~lv 77 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK---GKLNIV 77 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC---CEEEEE
Confidence 478889999999999999999999999999998643 23445677899999999999999999887764 678999
Q ss_pred EEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCccccc-----
Q psy11098 178 MQLVHGESLIQHLCRQ--STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVS----- 249 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~----- 249 (380)
|||+.|++|.+++... ..+++..+..++.||+.||.|||+.|++|+||||+||+++. +.++|+|||++....
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 78 MEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred EEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 9999999999999764 57899999999999999999999999999999999999985 689999999987553
Q ss_pred -ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHH
Q psy11098 250 -TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELI 328 (380)
Q Consensus 250 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 328 (380)
....+++.|+|||++.+ ..++.++|+||||+++|+|++|..||...+..+....+......... ..++.++.++|
T Consensus 158 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~i 233 (256)
T cd08529 158 ANTIVGTPYYLSPELCED-KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVS---QMYSQQLAQLI 233 (256)
T ss_pred hhccccCccccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc---cccCHHHHHHH
Confidence 23467889999999987 46788999999999999999999999888877766666554432222 25789999999
Q ss_pred HHhcccCCCCCCCHHHHHhcccc
Q psy11098 329 GQLLNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 329 ~~~L~~dP~~Rpt~~e~L~hpw~ 351 (380)
.+||+.+|++||++.++++|||+
T Consensus 234 ~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 234 DQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHccCCcccCcCHHHHhhCCCC
Confidence 99999999999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=332.49 Aligned_cols=249 Identities=27% Similarity=0.445 Sum_probs=206.8
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
++|++.+.||+|+||.||+|.++.+++.||+|.+..... ....+.+|+++++.++|+|++++++++.. .+..++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~~l 77 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR---KKRLYL 77 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc---CCeEEE
Confidence 368999999999999999999999999999999864332 23456789999999999999999988865 367899
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------
Q psy11098 177 VMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------ 249 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------ 249 (380)
|+||+.++.|.++......+++..+..++.||+.||.|||+.|++|+||+|+||+++ ++.++|+|||++....
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07846 78 VFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY 157 (286)
T ss_pred EEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcccc
Confidence 999999988888776666799999999999999999999999999999999999998 4689999999987543
Q ss_pred ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCC------------------
Q psy11098 250 TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYS------------------ 311 (380)
Q Consensus 250 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~------------------ 311 (380)
....++..|+|||++.+...++.++|+||||+++|+|++|.+||......+....+......
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 23456888999999876556788999999999999999999999776654433333211110
Q ss_pred -CCC--------CcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy11098 312 -FPP--------EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 312 -~~~--------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~ 351 (380)
.+. .....++..+.+|+.+||..||++|||+.++|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 000 1123578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=336.72 Aligned_cols=243 Identities=22% Similarity=0.329 Sum_probs=189.4
Q ss_pred eeecccCCeEEEEEEEcC--CCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEEEecCC
Q psy11098 106 ERLGNGRFCTVRKARDRG--TGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHG 183 (380)
Q Consensus 106 ~~LG~G~fg~V~~~~~~~--~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e~~~g 183 (380)
.+||+|+||+||+|+++. ++..||+|.+...... ..+.+|+++++.++|+|++++++++... .....+++|||+ +
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~~lv~e~~-~ 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS-MSACREIALLRELKHPNVIALQKVFLSH-SDRKVWLLFDYA-E 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc-HHHHHHHHHHHhCCCCCeeeEEEEEecc-CCCeEEEEEeee-C
Confidence 579999999999999764 5689999998654432 3467799999999999999999987543 235679999998 4
Q ss_pred CCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-----CCeeEEEeCCCccccc
Q psy11098 184 ESLIQHLCRQ---------STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-----GAVLKLIDLGSSVSVS 249 (380)
Q Consensus 184 g~L~~~l~~~---------~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-----~~~ikl~DFG~a~~~~ 249 (380)
++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||+. ++.+||+|||+++...
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~ 163 (317)
T cd07867 84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163 (317)
T ss_pred CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccC
Confidence 6787777421 2488999999999999999999999999999999999993 3589999999997653
Q ss_pred ---------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHH---------HHHHHhcc---
Q psy11098 250 ---------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEE---------TRAHISVA--- 308 (380)
Q Consensus 250 ---------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~---------~~~~i~~~--- 308 (380)
....+|+.|+|||++.+...++.++|||||||++|+|++|.+||.....+. ....+...
T Consensus 164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (317)
T cd07867 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGF 243 (317)
T ss_pred CCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCC
Confidence 234678999999999875567889999999999999999999996543210 00000000
Q ss_pred -------------------------cCC------CCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy11098 309 -------------------------DYS------FPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 309 -------------------------~~~------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~ 351 (380)
.+. .........+..+.+||.+||+.||.+|||++|+|+||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 244 PADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred CChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000 0000111245678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=330.64 Aligned_cols=245 Identities=25% Similarity=0.321 Sum_probs=203.6
Q ss_pred ceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEE
Q psy11098 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVM 178 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~ 178 (380)
+|++.+.||+|+||.||+|++..+++.||+|.+..... ....+.+|+++++.+.|+|++++++.+... +..++||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~lv~ 78 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVE---NRISICT 78 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC---CEEEEEE
Confidence 57888999999999999999999999999999865432 234577899999999999999999988764 6779999
Q ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc----cccc
Q psy11098 179 QLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS----TVVL 253 (380)
Q Consensus 179 e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~----~~~~ 253 (380)
||+.+++|..+ ..+++..+..++.|++.||.|||+.||+|+||||+|||++ ++.++|+|||++.... ....
T Consensus 79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 154 (279)
T cd06619 79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV 154 (279)
T ss_pred ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccccccCCC
Confidence 99999988654 3578999999999999999999999999999999999998 5699999999987543 3457
Q ss_pred CCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHhcccCCCCCCcCCCCCHHHHH
Q psy11098 254 PDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEE-------ETRAHISVADYSFPPEQCGHISVPARE 326 (380)
Q Consensus 254 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~s~~~~~ 326 (380)
+|..|+|||++.+ ..++.++|+||||+++|+|++|..||...... .....+.... .+......++.++++
T Consensus 155 ~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 231 (279)
T cd06619 155 GTNAYMAPERISG-EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED--PPVLPVGQFSEKFVH 231 (279)
T ss_pred CChhhcCceeecC-CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC--CCCCCCCcCCHHHHH
Confidence 8999999999987 46788999999999999999999999653211 1112221111 111122357889999
Q ss_pred HHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 327 LIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 327 li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
||.+||+.||++||+++++++||||....
T Consensus 232 li~~~l~~~P~~Rp~~~eil~~~~~~~~~ 260 (279)
T cd06619 232 FITQCMRKQPKERPAPENLMDHPFIVQYN 260 (279)
T ss_pred HHHHHhhCChhhCCCHHHHhcCccccccc
Confidence 99999999999999999999999998763
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=352.42 Aligned_cols=245 Identities=23% Similarity=0.326 Sum_probs=199.7
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVM 178 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~ 178 (380)
...|.+.+.||+|+||.||+|.+..+++.||+|.... ....+|+++++.|+|+||+++++++... +..++||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-----~~~~~E~~iL~~L~HpnIv~l~~~~~~~---~~~~lv~ 239 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-----ASSVHEARLLRRLSHPAVLALLDVRVVG---GLTCLVL 239 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-----cCHHHHHHHHHHCCCCCCCcEEEEEEEC---CEEEEEE
Confidence 4579999999999999999999999999999996432 2346799999999999999999987653 6679999
Q ss_pred EecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCccccc-------
Q psy11098 179 QLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVS------- 249 (380)
Q Consensus 179 e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~------- 249 (380)
|++ .++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||+++...
T Consensus 240 e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 318 (461)
T PHA03211 240 PKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318 (461)
T ss_pred Ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccc
Confidence 999 57888888654 56999999999999999999999999999999999999984 689999999987542
Q ss_pred -ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHhcccCC---CCC---
Q psy11098 250 -TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDES--------EEETRAHISVADYS---FPP--- 314 (380)
Q Consensus 250 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~--------~~~~~~~i~~~~~~---~~~--- 314 (380)
....||+.|+|||++.+ ..++.++|||||||++|+|++|..|+.... .......+...... ++.
T Consensus 319 ~~~~~GT~~Y~APE~~~~-~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~ 397 (461)
T PHA03211 319 HYGIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG 397 (461)
T ss_pred ccccCCCcCCcCHHHHcC-CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence 23568999999999988 467889999999999999999876653321 22333333322211 110
Q ss_pred ---------------------C---cCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccc
Q psy11098 315 ---------------------E---QCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAE 353 (380)
Q Consensus 315 ---------------------~---~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~ 353 (380)
. ....++.++.+||.+||+.||++|||+.|+|+||||+.
T Consensus 398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 0 11245678999999999999999999999999999964
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=331.38 Aligned_cols=251 Identities=27% Similarity=0.434 Sum_probs=213.9
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC-CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEE
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER-QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
...+|++.+.||.|+||.||+|.+..+++.||+|.+.... .....+.+|+.+++.++|+|++.+++++... +..++
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~l 93 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVG---DELFV 93 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecC---ceEEE
Confidence 3467999999999999999999999999999999986443 3345678899999999999999999988753 67899
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------
Q psy11098 177 VMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------ 249 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------ 249 (380)
|+||+.+++|.+++... .+++.++..++.|++.||.|||++|++|+||||+||+++ ++.+||+|||++....
T Consensus 94 v~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 172 (296)
T cd06655 94 VMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR 172 (296)
T ss_pred EEEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccC
Confidence 99999999999988654 689999999999999999999999999999999999998 5689999999987543
Q ss_pred ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHH
Q psy11098 250 TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIG 329 (380)
Q Consensus 250 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 329 (380)
....+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.........+..... ........++..+++||+
T Consensus 173 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~ 250 (296)
T cd06655 173 STMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSPIFRDFLN 250 (296)
T ss_pred CCcCCCccccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-cccCCcccCCHHHHHHHH
Confidence 23467889999999987 4678899999999999999999999988776655544433221 112223468899999999
Q ss_pred HhcccCCCCCCCHHHHHhccccccc
Q psy11098 330 QLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 330 ~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
+||..||++|||+.++++||||...
T Consensus 251 ~~l~~dp~~Rpt~~~il~~~~~~~~ 275 (296)
T cd06655 251 RCLEMDVEKRGSAKELLQHPFLKLA 275 (296)
T ss_pred HHhhcChhhCCCHHHHhhChHhhhc
Confidence 9999999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=329.26 Aligned_cols=248 Identities=28% Similarity=0.432 Sum_probs=208.0
Q ss_pred ceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEE
Q psy11098 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIV 177 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv 177 (380)
+|++.+.||.|+||.||+|.+..+|+.||+|++..... ....+.+|+.+++.++|+|++++++++.. .+..++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~~~~~~v 77 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH---GSGFVLV 77 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec---CCeeEEE
Confidence 58899999999999999999999999999999975432 24567889999999999999999998876 3677999
Q ss_pred EEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------
Q psy11098 178 MQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------ 249 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------ 249 (380)
+||+ +++|.+++.. ...+++..++.++.||+.||.|||+.|++|+||||+||+++ ++.++|+|||++....
T Consensus 78 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (286)
T cd07832 78 MEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL 156 (286)
T ss_pred eccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence 9999 9999999865 45799999999999999999999999999999999999998 5689999999987653
Q ss_pred -ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc-------------------
Q psy11098 250 -TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVAD------------------- 309 (380)
Q Consensus 250 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~------------------- 309 (380)
....++..|+|||++.+...++.++||||||+++|+|++|.+||.+.+..+....+....
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07832 157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNK 236 (286)
T ss_pred cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhc
Confidence 234678899999998765567889999999999999999999998776655444432210
Q ss_pred CCCCC-------CcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccc
Q psy11098 310 YSFPP-------EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFA 352 (380)
Q Consensus 310 ~~~~~-------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~ 352 (380)
..++. ......+.++.+||++||..||++|||++++|+||||.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 237 ITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred ccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 00110 11235678999999999999999999999999999994
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=332.27 Aligned_cols=252 Identities=27% Similarity=0.438 Sum_probs=213.1
Q ss_pred hhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC-chHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 97 QFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ-PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 97 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
....+|++.+.||.|+||.||+|++..+++.||+|.+..... ....+.+|+.+++.+.|+|++++++.+... +..+
T Consensus 17 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~---~~~~ 93 (296)
T cd06654 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG---DELW 93 (296)
T ss_pred CcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeC---CEEE
Confidence 346789999999999999999999999999999999875433 345678899999999999999999988763 5789
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-----
Q psy11098 176 IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS----- 249 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~----- 249 (380)
+||||+.|++|.+++.. ..+++.++..++.|++.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 94 lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 172 (296)
T cd06654 94 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (296)
T ss_pred EeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence 99999999999998864 4689999999999999999999999999999999999998 5689999999887543
Q ss_pred -ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHH
Q psy11098 250 -TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELI 328 (380)
Q Consensus 250 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 328 (380)
....+++.|+|||.+.+ ...+.++|+|||||++|+|++|..||...........+.... ..+......++..+.+||
T Consensus 173 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li 250 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFRDFL 250 (296)
T ss_pred cCcccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCC-CCCCCCccccCHHHHHHH
Confidence 23578899999999887 467889999999999999999999998876644433333221 111122345788999999
Q ss_pred HHhcccCCCCCCCHHHHHhccccccc
Q psy11098 329 GQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 329 ~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
.+||..||++|||+.++++||||...
T Consensus 251 ~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 251 NRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred HHHCcCCcccCcCHHHHhhChhhhcc
Confidence 99999999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=339.61 Aligned_cols=248 Identities=23% Similarity=0.308 Sum_probs=200.2
Q ss_pred eeeeeccc--CCeEEEEEEEcCCCcEEEEEEecCCCC---chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEE
Q psy11098 104 ELERLGNG--RFCTVRKARDRGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVM 178 (380)
Q Consensus 104 ~~~~LG~G--~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~ 178 (380)
+++.||+| +||+||++.++.+|+.||+|++..... ....+.+|+++++.++||||+++++++... +..++||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~---~~~~lv~ 78 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD---NELWVVT 78 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC---CEEEEEE
Confidence 46789999 789999999999999999999975432 234567799999999999999999888764 6789999
Q ss_pred EecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------
Q psy11098 179 QLVHGESLIQHLCR--QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------ 249 (380)
Q Consensus 179 e~~~gg~L~~~l~~--~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------ 249 (380)
||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.++++|||.+....
T Consensus 79 e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 79 SFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred eccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 99999999999965 34589999999999999999999999999999999999998 5689999998643321
Q ss_pred -------ccccCCCcccCCccccCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCC---------
Q psy11098 250 -------TVVLPDLEFASPEMLTSP-ATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSF--------- 312 (380)
Q Consensus 250 -------~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~--------- 312 (380)
....++..|+|||++.+. ..++.++|||||||++|+|++|..||.+.................
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA 238 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence 123456779999998763 357889999999999999999999998765444332222111100
Q ss_pred ---------------------------------CCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 313 ---------------------------------PPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 313 ---------------------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
.......+++++++||++||+.||++|||++|+|+||||++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 000112356789999999999999999999999999999764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=325.61 Aligned_cols=244 Identities=27% Similarity=0.422 Sum_probs=207.1
Q ss_pred ceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCc----------hHHHHHHHHHHHhhccCCCcceeeecccccC
Q psy11098 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP----------QQITRAEYNLLSTLMHAHIPTALALFENAPV 170 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~----------~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~ 170 (380)
+|.+...||.|+||.||+|.+..+++.||+|.+...... ...+.+|+.+++.++|+|++++++++...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 78 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDA-- 78 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--
Confidence 477788999999999999999999999999988643221 13567799999999999999999887664
Q ss_pred CCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCccccc
Q psy11098 171 PGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVS 249 (380)
Q Consensus 171 ~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~ 249 (380)
+..+++|||+.+++|.+++.....+++..+..++.|++.||.|||+.|++||||+|+||++++ +.++|+|||++....
T Consensus 79 -~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 79 -DHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred -CccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 677999999999999999988888999999999999999999999999999999999999974 589999999887553
Q ss_pred c------------cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcC
Q psy11098 250 T------------VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQC 317 (380)
Q Consensus 250 ~------------~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 317 (380)
. ...++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.........+.... .+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~ 233 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQ-TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA---SPEIP 233 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhcc-CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC---CCcCC
Confidence 1 2346788999999987 467889999999999999999999998876655544443321 11222
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy11098 318 GHISVPARELIGQLLNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 318 ~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~ 351 (380)
..++.++.++|++||+.||++||++.++++||||
T Consensus 234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 234 SNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred cccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 4578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=330.40 Aligned_cols=253 Identities=26% Similarity=0.385 Sum_probs=212.5
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC-chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ-PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIV 177 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv 177 (380)
.+.|++++.||.|+||.||+|++..+++.+|+|.+..... ....+.+|+.+++.+.|+|++++++.+... +..++|
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~lv 87 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWD---GKLWIM 87 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC---CeEEEE
Confidence 5779999999999999999999999999999999975433 345667899999999999999999988764 678999
Q ss_pred EEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------
Q psy11098 178 MQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------ 249 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------ 249 (380)
|||+.|++|..++.+ ...+++..+..++.||+.||.|||+.|++||||||+||+++ ++.+||+|||++....
T Consensus 88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 167 (292)
T cd06644 88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRR 167 (292)
T ss_pred EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccccccc
Confidence 999999999887754 45789999999999999999999999999999999999998 5689999999886542
Q ss_pred ccccCCCcccCCccccC----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHH
Q psy11098 250 TVVLPDLEFASPEMLTS----PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAR 325 (380)
Q Consensus 250 ~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 325 (380)
....+++.|+|||++.+ ...++.++|+|||||++|+|++|..||...+..+...++...... .......++.++.
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 246 (292)
T cd06644 168 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP-TLSQPSKWSMEFR 246 (292)
T ss_pred ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCc-cCCCCcccCHHHH
Confidence 23457889999999853 234577899999999999999999999887766655555433221 1112345788999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 326 ELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 326 ~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
++|++||..||++||+++++|+||||....
T Consensus 247 ~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 276 (292)
T cd06644 247 DFLKTALDKHPETRPSAAQLLEHPFVSSVT 276 (292)
T ss_pred HHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 999999999999999999999999997653
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=330.99 Aligned_cols=252 Identities=25% Similarity=0.356 Sum_probs=213.6
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC-chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ-PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIV 177 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv 177 (380)
.++|++++.||.|+||.||++.+..+++.+|+|.+..... ....+.+|+++++.++|+|++++++.+... +..++|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYE---NKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecC---CeEEEE
Confidence 4679999999999999999999998999999999965432 335677899999999999999999988753 677999
Q ss_pred EEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------
Q psy11098 178 MQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------ 249 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------ 249 (380)
|||+.+++|.+++.. ...+++..++.++.|++.||.|||++||+|+||||+||+++ ++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR 160 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccccccc
Confidence 999999999999876 45799999999999999999999999999999999999998 5699999999886543
Q ss_pred ccccCCCcccCCccccC----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHH
Q psy11098 250 TVVLPDLEFASPEMLTS----PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAR 325 (380)
Q Consensus 250 ~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 325 (380)
....+++.|+|||++.. ...++.++|+||||+++|+|++|..||.+.........+........ .....++.++.
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 239 (280)
T cd06611 161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTL-DQPSKWSSSFN 239 (280)
T ss_pred ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCc-CCcccCCHHHH
Confidence 23467899999999752 23467789999999999999999999988776666656554432111 11235789999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 326 ELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 326 ~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
+||.+||..||.+|||++++|+||||.+.
T Consensus 240 ~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 240 DFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 99999999999999999999999999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=329.01 Aligned_cols=252 Identities=25% Similarity=0.378 Sum_probs=209.4
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhh-ccCCCcceeeeccccc---CCCc
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTL-MHAHIPTALALFENAP---VPGT 173 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~---~~~~ 173 (380)
....|++.+.||.|+||.||+|.+..+++.+|+|++.........+..|+.+++.+ .|+|++++++++.... ....
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 93 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQ 93 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCE
Confidence 45789999999999999999999999999999999976655556678899999998 6999999998875321 2356
Q ss_pred eEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-
Q psy11098 174 DTIVMQLVHGESLIQHLCRQ--STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS- 249 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~- 249 (380)
.+++|||+.+++|.+++... ..+++..+..++.||+.||.|||+.||+|+||||+||+++ ++.++|+|||++....
T Consensus 94 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~ 173 (282)
T cd06636 94 LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 173 (282)
T ss_pred EEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhc
Confidence 79999999999999998653 4588999999999999999999999999999999999998 5689999999987543
Q ss_pred -----ccccCCCcccCCccccC----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCC
Q psy11098 250 -----TVVLPDLEFASPEMLTS----PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHI 320 (380)
Q Consensus 250 -----~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 320 (380)
....|++.|+|||++.. ...++.++|+|||||++|+|++|..||.+....+....+.... .+......+
T Consensus 174 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~ 251 (282)
T cd06636 174 TVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP--PPKLKSKKW 251 (282)
T ss_pred cccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCC--CCCCccccc
Confidence 34567889999998753 2356779999999999999999999997766544443332221 122223457
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy11098 321 SVPARELIGQLLNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 321 s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~ 351 (380)
+.++.+||++||..||.+|||+.|+|+||||
T Consensus 252 ~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 252 SKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred CHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 8999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=331.79 Aligned_cols=252 Identities=28% Similarity=0.396 Sum_probs=202.7
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---chHHHHHHHHHHHhhccCCCcceeeecccccC-----
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLMHAHIPTALALFENAPV----- 170 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~----- 170 (380)
-++|++.+.||+|+||.||+|.+..+++.||+|.+..... ......+|+++++.++|+|++++++++.....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 5679999999999999999999999999999999864322 23345679999999999999999988765422
Q ss_pred CCceEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccc
Q psy11098 171 PGTDTIVMQLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSV 248 (380)
Q Consensus 171 ~~~~~lv~e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~ 248 (380)
.+..++||||+. ++|.+.+... ..+++.+++.++.||+.||.|||++|++|+||||+|||++ ++.+||+|||++...
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 169 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAF 169 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence 245699999994 5788877654 3789999999999999999999999999999999999998 468999999998755
Q ss_pred c----------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCC------
Q psy11098 249 S----------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSF------ 312 (380)
Q Consensus 249 ~----------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~------ 312 (380)
. ....++..|+|||++.+...++.++|+||||+++|+|++|..||.+.+.......+.......
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (310)
T cd07865 170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWP 249 (310)
T ss_pred cCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence 3 123467889999998775557889999999999999999999998876654443332211111
Q ss_pred -------------CCCc---------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy11098 313 -------------PPEQ---------CGHISVPARELIGQLLNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 313 -------------~~~~---------~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~ 351 (380)
+... ....+..+.+||.+||..||.+|||++++|+||||
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 250 GVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred cccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 1000 01135678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=327.09 Aligned_cols=248 Identities=23% Similarity=0.343 Sum_probs=201.5
Q ss_pred hhhhceeeeeee--cccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhh-ccCCCcceeeecccccCCCc
Q psy11098 97 QFEHRYEELERL--GNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTL-MHAHIPTALALFENAPVPGT 173 (380)
Q Consensus 97 ~~~~~y~~~~~L--G~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~~~~~ 173 (380)
.+.+.|++.+.+ |.|+||.||+++++.+++.+|+|.+....... .|+.....+ .|+|++++++.+... +.
T Consensus 11 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----~e~~~~~~~~~h~~iv~~~~~~~~~---~~ 83 (267)
T PHA03390 11 QFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA----IEPMVHQLMKDNPNFIKLYYSVTTL---KG 83 (267)
T ss_pred HHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch----hhHHHHHHhhcCCCEEEEEEEEecC---Ce
Confidence 455677777776 99999999999999999999999986543221 133333323 699999999888764 57
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-C-eeEEEeCCCccccc--
Q psy11098 174 DTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-A-VLKLIDLGSSVSVS-- 249 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~-~ikl~DFG~a~~~~-- 249 (380)
.++||||+.|++|.+++.....+++.+++.++.||+.||.|||+.|++||||||+||+++. + .++|+|||++....
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 163 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP 163 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC
Confidence 8999999999999999988779999999999999999999999999999999999999984 4 79999999987664
Q ss_pred ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHhcccCCCCCCcCCCCCHHHHHHH
Q psy11098 250 TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETR-AHISVADYSFPPEQCGHISVPARELI 328 (380)
Q Consensus 250 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~s~~~~~li 328 (380)
....++..|+|||++.+ ..++.++|+||||+++|+|++|..||.....+... ....... .........++..+++||
T Consensus 164 ~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li 241 (267)
T PHA03390 164 SCYDGTLDYFSPEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKLPFIKNVSKNANDFV 241 (267)
T ss_pred ccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccCCcccccCHHHHHHH
Confidence 34567899999999987 46788999999999999999999999865443321 1111111 222223346899999999
Q ss_pred HHhcccCCCCCCC-HHHHHhcccccc
Q psy11098 329 GQLLNTHADKRPT-AGQLLQVAWFAE 353 (380)
Q Consensus 329 ~~~L~~dP~~Rpt-~~e~L~hpw~~~ 353 (380)
.+||+.||.+|++ ++++|+||||.+
T Consensus 242 ~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 242 QSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred HHHhccChhhCCchHHHHhcCCcccC
Confidence 9999999999996 699999999964
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=325.57 Aligned_cols=248 Identities=25% Similarity=0.387 Sum_probs=207.9
Q ss_pred ceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC-----------chHHHHHHHHHHHhhccCCCcceeeeccccc
Q psy11098 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ-----------PQQITRAEYNLLSTLMHAHIPTALALFENAP 169 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-----------~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~ 169 (380)
+|.+.+.||.|+||.||+|.+..+++.||+|.+..... ..+.+.+|+.+++.++|+|++++++++...
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 80 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE- 80 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC-
Confidence 57888999999999999999999999999998853211 113467799999999999999999887653
Q ss_pred CCCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccc
Q psy11098 170 VPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSV 248 (380)
Q Consensus 170 ~~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~ 248 (380)
+..++||||+.|++|.+++.....+++..+..++.||+.||.|||++|++||||+|+||+++ ++.++|+|||++...
T Consensus 81 --~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 81 --EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred --CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 67899999999999999998888899999999999999999999999999999999999997 568999999998754
Q ss_pred c--------ccccCCCcccCCccccCCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc--cCCCCCCcC
Q psy11098 249 S--------TVVLPDLEFASPEMLTSPA-TAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVA--DYSFPPEQC 317 (380)
Q Consensus 249 ~--------~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~ 317 (380)
. ....++..|+|||++.... .++.++|+||||+++|+|++|..||......+....+... ...++....
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVS 238 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcccc
Confidence 3 2345788999999987643 4688999999999999999999999766554433333222 223333344
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy11098 318 GHISVPARELIGQLLNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 318 ~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~ 351 (380)
..++.++++||.+||.+||++|||++++|+||||
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 239 MNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred ccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 5678999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=322.50 Aligned_cols=249 Identities=28% Similarity=0.388 Sum_probs=211.9
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC-chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ-PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIV 177 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv 177 (380)
.++|++.+.||.|+||.||+|.+..+++.+|+|++..... ....+.+|+++++.++|+|++++++.+... +..+++
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~---~~~~l~ 78 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRR---DKLWIV 78 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeC---CEEEEE
Confidence 4679999999999999999999999999999999975433 446678899999999999999999887653 678999
Q ss_pred EEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------
Q psy11098 178 MQLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------ 249 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------ 249 (380)
|||+.+++|.+++... ..+++..+..++.|++.||.|||++||+|+||||+||+++ ++.+||+|||++....
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 158 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKR 158 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhcc
Confidence 9999999999998775 7899999999999999999999999999999999999998 4689999999987653
Q ss_pred ccccCCCcccCCccccCC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCC-CcCCCCCHHHHH
Q psy11098 250 TVVLPDLEFASPEMLTSP--ATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPP-EQCGHISVPARE 326 (380)
Q Consensus 250 ~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~s~~~~~ 326 (380)
....++..|+|||.+.+. ..++.++|+||||+++|+|++|..||.+.........+....+..+. .....++.++.+
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (262)
T cd06613 159 KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHD 238 (262)
T ss_pred ccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHH
Confidence 234678899999998763 25678999999999999999999999887766655555444332221 112346788999
Q ss_pred HHHHhcccCCCCCCCHHHHHhccc
Q psy11098 327 LIGQLLNTHADKRPTAGQLLQVAW 350 (380)
Q Consensus 327 li~~~L~~dP~~Rpt~~e~L~hpw 350 (380)
||++||..||.+|||+.+++.|+|
T Consensus 239 li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 239 FIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHcCCChhhCCCHHHHhcCCC
Confidence 999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=353.57 Aligned_cols=243 Identities=30% Similarity=0.472 Sum_probs=210.9
Q ss_pred eecccCCeEEEEEEEcCCCcEEEEEEec-CCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEEEecCCCC
Q psy11098 107 RLGNGRFCTVRKARDRGTGQLVALKQIP-RERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHGES 185 (380)
Q Consensus 107 ~LG~G~fg~V~~~~~~~~~~~vAvK~~~-~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e~~~gg~ 185 (380)
.||+|.||+||.|++..|...+|||-+. +.....+-...||.+-++|+|.||++.++.+.. ++.+-|.||-+.||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~se---nGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSE---NGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCC---CCeEEEEeecCCCCc
Confidence 6999999999999999999999999996 445556667889999999999999998888665 467789999999999
Q ss_pred HHHHHHh-cCCC--CHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe--CCeeEEEeCCCccccc------ccccC
Q psy11098 186 LIQHLCR-QSTI--TESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN--GAVLKLIDLGSSVSVS------TVVLP 254 (380)
Q Consensus 186 L~~~l~~-~~~l--~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~--~~~ikl~DFG~a~~~~------~~~~g 254 (380)
|.+++.. -+++ .|..+..+.+||++||.|||++.|||||||-+|+|++ +|.+||+|||-++++. .++.|
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTG 738 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTG 738 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccccccc
Confidence 9999976 4667 8999999999999999999999999999999999998 5899999999988763 67889
Q ss_pred CCcccCCcccc-CCCCCCCcccHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhc
Q psy11098 255 DLEFASPEMLT-SPATAGPSTDMWSLGVLLYILLSGVSPFLDE-SEEETRAHISVADYSFPPEQCGHISVPARELIGQLL 332 (380)
Q Consensus 255 t~~y~aPE~~~-~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 332 (380)
|..|||||++. |...|+.++|||||||++.||.||++||... +......++ +-+..-++....+|.+++.||.+|+
T Consensus 739 TLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkV--GmyKvHP~iPeelsaeak~FilrcF 816 (1226)
T KOG4279|consen 739 TLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKV--GMYKVHPPIPEELSAEAKNFILRCF 816 (1226)
T ss_pred chhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhh--cceecCCCCcHHHHHHHHHHHHHHc
Confidence 99999999985 5678999999999999999999999999654 233333333 3444444445678999999999999
Q ss_pred ccCCCCCCCHHHHHhccccccc
Q psy11098 333 NTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 333 ~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
.+||..||+|.++|..||++..
T Consensus 817 epd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 817 EPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred CCCcccCccHHHhccCcccccC
Confidence 9999999999999999999876
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=328.42 Aligned_cols=247 Identities=28% Similarity=0.436 Sum_probs=203.9
Q ss_pred ceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEE
Q psy11098 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIV 177 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv 177 (380)
.|++.+.||.|++|.||+|++..+++.||+|.+..... ....+.+|+++++.++|+|++++++++.. .+..++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~~v 77 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT---ENKLYLV 77 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhccc---CCcEEEE
Confidence 47889999999999999999999999999999864432 23467789999999999999999998765 3678999
Q ss_pred EEecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-----
Q psy11098 178 MQLVHGESLIQHLCR--QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS----- 249 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~--~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~----- 249 (380)
|||+. ++|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++ ++.+||+|||++....
T Consensus 78 ~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 156 (284)
T cd07860 78 FEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 156 (284)
T ss_pred eeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence 99995 688888865 35689999999999999999999999999999999999998 5689999999986543
Q ss_pred -ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC------------------
Q psy11098 250 -TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADY------------------ 310 (380)
Q Consensus 250 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~------------------ 310 (380)
....+++.|+|||++.+...++.++|+||||+++|+|++|..||.+.+..+...++.....
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP 236 (284)
T ss_pred cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHh
Confidence 2234678899999987755668899999999999999999999988776554443322110
Q ss_pred CCCC-------CcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy11098 311 SFPP-------EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 311 ~~~~-------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~ 351 (380)
.++. .....++.+++++|.+||+.||.+|||++++|+||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 237 SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred hcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 0000 0112468889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=327.63 Aligned_cols=253 Identities=24% Similarity=0.347 Sum_probs=207.6
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhh-ccCCCcceeeecccc--cCCCce
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTL-MHAHIPTALALFENA--PVPGTD 174 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~--~~~~~~ 174 (380)
..++|++.+.||+|+||.||+|.+..+++.+|+|++.........+.+|+.+++.+ .|+|++++++++... ...+..
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 95 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQL 95 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeE
Confidence 46789999999999999999999999999999999876554456678899999999 699999999987432 233568
Q ss_pred EEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc
Q psy11098 175 TIVMQLVHGESLIQHLCR----QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS 249 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~----~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~ 249 (380)
++||||+.|++|.+++.. ...+++..+..++.|++.||.|||+.+|+||||||+||+++ ++.+||+|||++....
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 175 (286)
T cd06638 96 WLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 175 (286)
T ss_pred EEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCceeecc
Confidence 999999999999988753 35689999999999999999999999999999999999998 4689999999987543
Q ss_pred ------ccccCCCcccCCccccCC----CCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCC
Q psy11098 250 ------TVVLPDLEFASPEMLTSP----ATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGH 319 (380)
Q Consensus 250 ------~~~~gt~~y~aPE~~~~~----~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 319 (380)
....|++.|+|||++... ..++.++|+|||||++|+|++|..||.+.........+..... ........
T Consensus 176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~ 254 (286)
T cd06638 176 STRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPP-PTLHQPEL 254 (286)
T ss_pred cCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCC-CcccCCCC
Confidence 234678999999998532 3467899999999999999999999987665443333222111 11111234
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy11098 320 ISVPARELIGQLLNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 320 ~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~ 351 (380)
++.++.+||.+||+.||++|||+.|+|+|+||
T Consensus 255 ~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 255 WSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred cCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 57889999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=338.03 Aligned_cols=256 Identities=23% Similarity=0.338 Sum_probs=205.6
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC--CchHHHHHHHHHHHhhccCCCcceeeeccccc--CCCc
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER--QPQQITRAEYNLLSTLMHAHIPTALALFENAP--VPGT 173 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~--~~~~ 173 (380)
+.++|++.+.||+|+||.||+|++..+|+.||+|.+.... .....+.+|+.+++.++|+|++++++++.... ....
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 4678999999999999999999999999999999986432 23345677999999999999999998765432 2235
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCccccc---
Q psy11098 174 DTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVS--- 249 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~--- 249 (380)
.++++||+. ++|.+.+. ...+++..++.++.||+.||.|||+.||+||||||+|||++. +.+||+|||++....
T Consensus 83 ~~lv~e~~~-~~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 83 VYIVQELME-TDLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160 (336)
T ss_pred EEEEehhcc-cCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence 799999994 58887774 457999999999999999999999999999999999999984 689999999987543
Q ss_pred ------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc--------------
Q psy11098 250 ------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVAD-------------- 309 (380)
Q Consensus 250 ------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~-------------- 309 (380)
....+|+.|+|||++.+...++.++|+|||||++|+|++|+.||.+.........+....
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (336)
T cd07849 161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL 240 (336)
T ss_pred cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhch
Confidence 224678899999987664567889999999999999999999997765433222211000
Q ss_pred --------CCCCC-----CcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 310 --------YSFPP-----EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 310 --------~~~~~-----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
..... .....++.++.+||.+||+.||++|||+.|+++||||.+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred hhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 00000 01234688899999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=328.63 Aligned_cols=252 Identities=26% Similarity=0.388 Sum_probs=204.0
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---chHHHHHHHHHHHhhc-cCCCcceeeecccccC--CCc
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLM-HAHIPTALALFENAPV--PGT 173 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~-h~ni~~i~~~~~~~~~--~~~ 173 (380)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... ....+.+|+.+++.+. |+|++++++++..... ...
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 368999999999999999999999999999999865432 2345677999999995 6999999988876432 123
Q ss_pred eEEEEEecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC--CeeEEEeCCCcc
Q psy11098 174 DTIVMQLVHGESLIQHLCRQ-----STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG--AVLKLIDLGSSV 246 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~-----~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~--~~ikl~DFG~a~ 246 (380)
.|++|||+.+ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||++.
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence 6999999975 788887542 35799999999999999999999999999999999999985 589999999987
Q ss_pred ccc------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCC---------
Q psy11098 247 SVS------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYS--------- 311 (380)
Q Consensus 247 ~~~------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~--------- 311 (380)
... ....+++.|+|||++.+...++.++|+||||+++|+|++|..||.+.+..+....+......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T cd07837 160 AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV 239 (295)
T ss_pred ecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcch
Confidence 543 22346788999999876556788999999999999999999999887665544333221000
Q ss_pred --------CC-------CCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccc
Q psy11098 312 --------FP-------PEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFA 352 (380)
Q Consensus 312 --------~~-------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~ 352 (380)
++ ......++.++.+||.+||..||.+|||++|+|.||||+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 240 SKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 00 011235788999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=323.77 Aligned_cols=249 Identities=24% Similarity=0.357 Sum_probs=210.4
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC--CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER--QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIV 177 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv 177 (380)
++|++.+.||.|+||+||+|....++..+|+|++.... .....+.+|+++++.++|+|+++++..+... +..+++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~iv 77 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVG---DELWLV 77 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeC---CEEEEE
Confidence 46899999999999999999999899999999986543 2446678899999999999999988877653 678999
Q ss_pred EEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc----
Q psy11098 178 MQLVHGESLIQHLCRQ---STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS---- 249 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~~---~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~---- 249 (380)
||++.|++|.+++... ..+++..++.++.||+.||.|||+.|++||||||+||+++ ++.++|+|||++....
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 9999999999999764 4589999999999999999999999999999999999998 4689999999886543
Q ss_pred ------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCC-CCCC-cCCCCC
Q psy11098 250 ------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYS-FPPE-QCGHIS 321 (380)
Q Consensus 250 ------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~-~~~~-~~~~~s 321 (380)
....++..|+|||++......+.++|+|||||++|+|++|..||...+.......+...... +... ....++
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYS 237 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCcccccccc
Confidence 22357889999999877446788999999999999999999999877665555554443221 1111 123678
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy11098 322 VPARELIGQLLNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 322 ~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~ 351 (380)
.++.+|+.+||..||++|||++++++||||
T Consensus 238 ~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 238 KSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 999999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=324.37 Aligned_cols=247 Identities=23% Similarity=0.346 Sum_probs=208.9
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEecCCCCc----hHHHHHHHHH-HHhhccCCCcceeeecccccCCCceEEEEEe
Q psy11098 106 ERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP----QQITRAEYNL-LSTLMHAHIPTALALFENAPVPGTDTIVMQL 180 (380)
Q Consensus 106 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~----~~~~~~E~~i-l~~l~h~ni~~i~~~~~~~~~~~~~~lv~e~ 180 (380)
+.||.|+||.||+|.+..+++.||+|++.+.... ......|..+ ...+.|+|++++++++... +..|+++||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~---~~~~lv~e~ 78 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSK---DYLYLVMEY 78 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcC---CeEEEEEec
Confidence 5699999999999999999999999999654321 1222334443 3455899999999888753 678999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc--ccccCCCc
Q psy11098 181 VHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS--TVVLPDLE 257 (380)
Q Consensus 181 ~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~--~~~~gt~~ 257 (380)
+.|++|.+++.....+++..+..++.||+.||.|||+.|++||||+|+|||++ ++.+||+|||++.... ....+++.
T Consensus 79 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 158 (260)
T cd05611 79 LNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPD 158 (260)
T ss_pred cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccccccCCCCcC
Confidence 99999999998888899999999999999999999999999999999999998 4689999999987543 45568899
Q ss_pred ccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhcccCCC
Q psy11098 258 FASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHAD 337 (380)
Q Consensus 258 y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 337 (380)
|+|||.+.+. .++.++|+||||+++|+|++|..||...+.......+......++......++.++.++|.+||+.||+
T Consensus 159 y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 237 (260)
T cd05611 159 YLAPETILGV-GDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPA 237 (260)
T ss_pred ccChhhhcCC-CCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHH
Confidence 9999999874 578899999999999999999999998888877777766665555544456899999999999999999
Q ss_pred CCC---CHHHHHhcccccccCC
Q psy11098 338 KRP---TAGQLLQVAWFAEASC 356 (380)
Q Consensus 338 ~Rp---t~~e~L~hpw~~~~~~ 356 (380)
+|| +++|+|.||||.+..+
T Consensus 238 ~R~~~~~~~~~l~~~~~~~~~~ 259 (260)
T cd05611 238 KRLGANGYQEIKSHPFFKSINW 259 (260)
T ss_pred HccCCCcHHHHHcChHhhcCCC
Confidence 999 4579999999987643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=332.83 Aligned_cols=253 Identities=26% Similarity=0.431 Sum_probs=212.8
Q ss_pred hhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC-CchHHHHHHHHHHHhhccCCCcceeeecccccCCCce
Q psy11098 96 EQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER-QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 96 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~ 174 (380)
.+...+|++.+.||.|+||.||+|.+..+++.||+|.+.... ...+.+.+|+.+++.++|+|++++++++... +..
T Consensus 15 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~---~~~ 91 (297)
T cd06656 15 GDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG---DEL 91 (297)
T ss_pred CChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecC---CEE
Confidence 345689999999999999999999999999999999996543 3345678899999999999999999988764 678
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc----
Q psy11098 175 TIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS---- 249 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~---- 249 (380)
++||||+.+++|.+++.+ ..+++..+..++.|++.||.|||+.|++||||||+|||++ ++.++|+|||++....
T Consensus 92 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 92 WVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred EEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 999999999999998865 4689999999999999999999999999999999999998 5689999999987543
Q ss_pred --ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHH
Q psy11098 250 --TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAREL 327 (380)
Q Consensus 250 --~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 327 (380)
....+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+.......+.... .........++..+++|
T Consensus 171 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l 248 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPERLSAVFRDF 248 (297)
T ss_pred CcCcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCC-CCCCCCccccCHHHHHH
Confidence 23467889999999987 467889999999999999999999997765543332222111 11112234578899999
Q ss_pred HHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 328 IGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 328 i~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
+.+||..||++|||++++|+||||...
T Consensus 249 i~~~l~~~p~~Rps~~~il~~~~~~~~ 275 (297)
T cd06656 249 LNRCLEMDVDRRGSAKELLQHPFLKLA 275 (297)
T ss_pred HHHHccCChhhCcCHHHHhcCchhccc
Confidence 999999999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=338.05 Aligned_cols=256 Identities=24% Similarity=0.338 Sum_probs=209.3
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC---CCchHHHHHHHHHHHhhccCCCcceeeecccccCC--C
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE---RQPQQITRAEYNLLSTLMHAHIPTALALFENAPVP--G 172 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~--~ 172 (380)
+..+|.+.+.||+|+||+||+|++..+++.||+|.+... ........+|+.+++.++|+|++++++++...... .
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 356899999999999999999999999999999998643 22334556799999999999999999877654221 3
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc--
Q psy11098 173 TDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS-- 249 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~-- 249 (380)
..|+++||+ +++|.+++.....+++..+..++.||+.||.|||++|++||||||+|||++ ++.+||+|||++....
T Consensus 83 ~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 161 (337)
T cd07858 83 DVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161 (337)
T ss_pred cEEEEEeCC-CCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence 479999999 578999998888899999999999999999999999999999999999998 5689999999987653
Q ss_pred ----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC---------------
Q psy11098 250 ----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADY--------------- 310 (380)
Q Consensus 250 ----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~--------------- 310 (380)
....++..|+|||++.+...++.++|+|||||++|+|++|..||.+.+.......+.....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07858 162 GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKA 241 (337)
T ss_pred cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhh
Confidence 2345788999999987644678899999999999999999999977654333322211000
Q ss_pred -------C-CC----CCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 311 -------S-FP----PEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 311 -------~-~~----~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
. .+ ......++.++.+||++||+.||++|||++++|+||||...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 242 RRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 0 00 01124578999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=298.99 Aligned_cols=251 Identities=25% Similarity=0.406 Sum_probs=212.6
Q ss_pred ceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEE
Q psy11098 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIV 177 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv 177 (380)
+|...++||+|.||+||+|+++.+++.||+|.++.+.. ......+||-+++.|+|.||++++++.... +.+.+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsd---kkltlv 79 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD---KKLTLV 79 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccC---ceeEEe
Confidence 46677899999999999999999999999999975543 346778899999999999999988887764 678999
Q ss_pred EEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccccc-----
Q psy11098 178 MQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVST----- 250 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~~----- 250 (380)
+||| ...|..+... ++.++.+.++.++.|++.||.++|++++.||||||+|+||+ +|.+|++|||+|+.++.
T Consensus 80 fe~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcy 158 (292)
T KOG0662|consen 80 FEFC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY 158 (292)
T ss_pred HHHh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEee
Confidence 9999 6778888765 67899999999999999999999999999999999999998 67999999999987762
Q ss_pred -cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcC-----------
Q psy11098 251 -VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQC----------- 317 (380)
Q Consensus 251 -~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~----------- 317 (380)
.-+-|.+|.+|.++.+.+-|+.+.||||.|||+.|+.. |.+.|.+....+.+.+|-........++|
T Consensus 159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~ 238 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKP 238 (292)
T ss_pred eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcc
Confidence 23458999999999998899999999999999999998 88889888877766666322111111111
Q ss_pred --------------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 318 --------------GHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 318 --------------~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
+.++...+|++.++|.-+|.+|++++.+|+||||.+.+
T Consensus 239 yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s 290 (292)
T KOG0662|consen 239 YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS 290 (292)
T ss_pred cCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence 23445578999999999999999999999999998764
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=337.62 Aligned_cols=268 Identities=25% Similarity=0.335 Sum_probs=213.1
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC-CchHHHHHHHHHHHhhccCCCcceeeecccccC------
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER-QPQQITRAEYNLLSTLMHAHIPTALALFENAPV------ 170 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~------ 170 (380)
+..+|++.+.||.|+||.||+|.++.+++.||+|.+.... .....+.+|+++++.++|+|++++++++.....
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 4689999999999999999999999999999999986543 334557789999999999999999887665321
Q ss_pred -----CCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe--CCeeEEEeCC
Q psy11098 171 -----PGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN--GAVLKLIDLG 243 (380)
Q Consensus 171 -----~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~--~~~ikl~DFG 243 (380)
....++||||+. ++|.+.+.. ..+++..++.++.||+.||.|||+.||+||||||+||+++ ++.+||+|||
T Consensus 83 ~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg 160 (342)
T cd07854 83 GSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFG 160 (342)
T ss_pred ccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcc
Confidence 134689999995 688887754 4789999999999999999999999999999999999997 3478999999
Q ss_pred Cccccc---------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC----
Q psy11098 244 SSVSVS---------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADY---- 310 (380)
Q Consensus 244 ~a~~~~---------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~---- 310 (380)
++.... ....++..|+|||++.....++.++|+|||||++|+|++|..||.+.+..+....+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07854 161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE 240 (342)
T ss_pred cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 987542 1235688899999876655778899999999999999999999987765444333321100
Q ss_pred ------------------CCC----CCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCCCCCccccccch
Q psy11098 311 ------------------SFP----PEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASCSEFDTERLLPF 367 (380)
Q Consensus 311 ------------------~~~----~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~~~~~~~~~~~~ 367 (380)
..+ ......++.++++||.+||+.||++|||++++|+||||+....+.-...+.++|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~~~~~~~~~~~ 319 (342)
T cd07854 241 EDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPFDEPVSLHPF 319 (342)
T ss_pred HHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCCccccCCCCCc
Confidence 000 001235788999999999999999999999999999998665544444444454
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=326.24 Aligned_cols=248 Identities=29% Similarity=0.467 Sum_probs=203.2
Q ss_pred eeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC--chHHHHHHHHHHHhhc-cCCCcceeeecccccCCCceEEEE
Q psy11098 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ--PQQITRAEYNLLSTLM-HAHIPTALALFENAPVPGTDTIVM 178 (380)
Q Consensus 102 y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~-h~ni~~i~~~~~~~~~~~~~~lv~ 178 (380)
|++.+.||+|+||.||+|.+..+++.||+|.++.... ......+|+.++..+. |+|++++++++.... .+..++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~-~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRK-TGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCC-CCcEEEEE
Confidence 6788999999999999999999999999999865422 2223346888888885 999999999887542 25789999
Q ss_pred EecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeCCeeEEEeCCCccccc-----ccc
Q psy11098 179 QLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGAVLKLIDLGSSVSVS-----TVV 252 (380)
Q Consensus 179 e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~~~ikl~DFG~a~~~~-----~~~ 252 (380)
||+. ++|.+.+.. ...+++..+..++.||+.||.|||+.|++||||||+||+++.+.+||+|||++.... ...
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~~~~kl~dfg~~~~~~~~~~~~~~ 158 (282)
T cd07831 80 ELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKDDILKLADFGSCRGIYSKPPYTEY 158 (282)
T ss_pred ecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcCCCeEEEecccccccccCCCcCCC
Confidence 9995 588888865 357899999999999999999999999999999999999999999999999987653 234
Q ss_pred cCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc------------------cCCCCC
Q psy11098 253 LPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVA------------------DYSFPP 314 (380)
Q Consensus 253 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~------------------~~~~~~ 314 (380)
.+++.|+|||++......+.++|+|||||++|+|++|..||.+.+..+....+... .+.++.
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
T cd07831 159 ISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPS 238 (282)
T ss_pred CCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcc
Confidence 57889999998765456788999999999999999999999887665544433211 111111
Q ss_pred C-------cCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy11098 315 E-------QCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 315 ~-------~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~ 351 (380)
. ....++.++.+||.+||.+||++|||++++|+||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 239 KKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 1 113468999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=337.57 Aligned_cols=259 Identities=25% Similarity=0.360 Sum_probs=211.6
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC---CchHHHHHHHHHHHhhccCCCcceeeeccccc-CCCc
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER---QPQQITRAEYNLLSTLMHAHIPTALALFENAP-VPGT 173 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~-~~~~ 173 (380)
+.++|++.+.||.|+||.||+|.++.+++.||+|.+.... .....+.+|+.+++.++|+||+++++++.... ....
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence 3578999999999999999999999999999999986542 23345667999999999999999998876533 3356
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc---
Q psy11098 174 DTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS--- 249 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~--- 249 (380)
.++||||+ +++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 83 ~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 161 (334)
T cd07855 83 VYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP 161 (334)
T ss_pred EEEEEehh-hhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence 79999999 568999998777899999999999999999999999999999999999998 5689999999986542
Q ss_pred -------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC------------
Q psy11098 250 -------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADY------------ 310 (380)
Q Consensus 250 -------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~------------ 310 (380)
....++..|+|||++.+...++.++|+|||||++|+|++|+.||.+.+.......+.....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~ 241 (334)
T cd07855 162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS 241 (334)
T ss_pred cCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhch
Confidence 1346788999999987645678899999999999999999999987654433222211000
Q ss_pred --------CCC-------CCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCCC
Q psy11098 311 --------SFP-------PEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASCS 357 (380)
Q Consensus 311 --------~~~-------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~~ 357 (380)
.++ ......++.++++||++||+.||++|||++++|.||||.+....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~ 303 (334)
T cd07855 242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDP 303 (334)
T ss_pred hhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCC
Confidence 000 01124578999999999999999999999999999999865443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=338.30 Aligned_cols=254 Identities=24% Similarity=0.368 Sum_probs=205.3
Q ss_pred hhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC---CchHHHHHHHHHHHhhccCCCcceeeeccccc---C
Q psy11098 97 QFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER---QPQQITRAEYNLLSTLMHAHIPTALALFENAP---V 170 (380)
Q Consensus 97 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~---~ 170 (380)
.+.++|++.+.||+|+||.||+|.+..+++.||+|.+.+.. .....+.+|+.+++.++|+|+++++++|.... .
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 35688999999999999999999999999999999986432 22345567999999999999999999876432 2
Q ss_pred CCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc
Q psy11098 171 PGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS 249 (380)
Q Consensus 171 ~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~ 249 (380)
....|+||||+ +++|.+.+... +++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 93 ~~~~~lv~e~~-~~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 93 FQDVYLVMELM-DANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred cCcEEEEEecc-CCCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 23579999999 56888887644 89999999999999999999999999999999999998 5689999999998654
Q ss_pred c-----cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC--------------
Q psy11098 250 T-----VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADY-------------- 310 (380)
Q Consensus 250 ~-----~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~-------------- 310 (380)
. ...+++.|+|||++.+ ..++.++|+|||||++|+|++|+.||...+.......+.....
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (353)
T cd07850 170 TSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTV 248 (353)
T ss_pred CCCCCCCCcccccccCHHHHhC-CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhh
Confidence 2 3457889999999987 5778899999999999999999999987654433333211000
Q ss_pred ----------------------CCCCC---cCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 311 ----------------------SFPPE---QCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 311 ----------------------~~~~~---~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
.++.. .....++++++||.+||..||++|||+.|+|+||||...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~ 317 (353)
T cd07850 249 RNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVW 317 (353)
T ss_pred hHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhc
Confidence 00000 011346678999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=323.25 Aligned_cols=247 Identities=28% Similarity=0.385 Sum_probs=205.4
Q ss_pred ceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC------chHHHHHHHHHHHhhccCCCcceeeecccccCCCce
Q psy11098 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ------PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~------~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~ 174 (380)
.|++.+.||+|+||.||+|.+..+++.||+|.+..... ....+.+|+.+++.++|+|++++++++... ..+..
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~ 81 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDR-AEKTL 81 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcC-CCCEE
Confidence 57888999999999999999999999999999864321 224567899999999999999999887643 23567
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCccccc----
Q psy11098 175 TIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVS---- 249 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~---- 249 (380)
++++||+.+++|.+++.....+++...+.++.||+.||.|||+.+|+||||||+||+++. +.+||+|||++....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 899999999999999988778999999999999999999999999999999999999984 589999999987542
Q ss_pred -----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHH
Q psy11098 250 -----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPA 324 (380)
Q Consensus 250 -----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 324 (380)
....++..|+|||++.+ ..++.++|+|||||++|+|++|+.||...........+...... +.....++..+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 238 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTN--PQLPSHISEHA 238 (266)
T ss_pred cCCccccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCC--CCCchhcCHHH
Confidence 12457889999999987 46788999999999999999999999876555444443322211 11123468889
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhccccc
Q psy11098 325 RELIGQLLNTHADKRPTAGQLLQVAWFA 352 (380)
Q Consensus 325 ~~li~~~L~~dP~~Rpt~~e~L~hpw~~ 352 (380)
++|| +||..||++|||++|+++||||+
T Consensus 239 ~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 239 RDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 9999 57778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-43 Score=327.15 Aligned_cols=249 Identities=29% Similarity=0.445 Sum_probs=201.0
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
.++|++.+.||.|++|.||+|.++.+++.||+|.+..... ....+.+|+++++.++|+||+++++++... +..++
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~~l 80 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTK---KTLTL 80 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecC---CeEEE
Confidence 3679999999999999999999999999999999864332 234456799999999999999999988754 67899
Q ss_pred EEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-----
Q psy11098 177 VMQLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS----- 249 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~----- 249 (380)
||||+. ++|.+++... ..+++..++.++.||++||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 81 v~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 159 (291)
T cd07844 81 VFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT 159 (291)
T ss_pred EEecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCcc
Confidence 999996 5899988654 4689999999999999999999999999999999999998 4689999999986542
Q ss_pred -ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhcc-------------------
Q psy11098 250 -TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDES-EEETRAHISVA------------------- 308 (380)
Q Consensus 250 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~-~~~~~~~i~~~------------------- 308 (380)
....++..|+|||++.+...++.++||||+|+++|+|++|..||.+.. ..+....+...
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK 239 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccc
Confidence 223467889999998765567889999999999999999999997655 22222211100
Q ss_pred cCCCCC-------CcCCCCC--HHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy11098 309 DYSFPP-------EQCGHIS--VPARELIGQLLNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 309 ~~~~~~-------~~~~~~s--~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~ 351 (380)
...+.. .....++ .++.++|.+||+.||++|||+.++|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000000 0111234 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=319.71 Aligned_cols=244 Identities=24% Similarity=0.420 Sum_probs=211.2
Q ss_pred ceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC---CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEE
Q psy11098 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER---QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIV 177 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv 177 (380)
+|++.+.||+|+||.||++.+..+++.||+|.+.... .....+.+|+.+++.++|+|++++.+++... +..++|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~lv 77 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEEN---GNLYIV 77 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC---CeEEEE
Confidence 5889999999999999999999999999999986432 2334678899999999999999999888654 678999
Q ss_pred EEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccccc----
Q psy11098 178 MQLVHGESLIQHLCRQ--STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVST---- 250 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~~---- 250 (380)
+||+.+++|.+.+... ..+++..+..++.|++.||.|||++|++|+||+|+|||++ ++.++|+|||++.....
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 157 (256)
T cd08218 78 MDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL 157 (256)
T ss_pred EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence 9999999999998654 3578999999999999999999999999999999999998 56899999999876532
Q ss_pred --cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHH
Q psy11098 251 --VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELI 328 (380)
Q Consensus 251 --~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 328 (380)
...+++.|+|||++.+ ...+.++|+|||||++|+|++|..||......+....+..+.... ....++.++.++|
T Consensus 158 ~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li 233 (256)
T cd08218 158 ARTCIGTPYYLSPEICEN-RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPP---VSSHYSYDLRNLV 233 (256)
T ss_pred hhhccCCccccCHHHhCC-CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCC---CcccCCHHHHHHH
Confidence 3457889999999887 467789999999999999999999998887777777766554322 2235789999999
Q ss_pred HHhcccCCCCCCCHHHHHhcccc
Q psy11098 329 GQLLNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 329 ~~~L~~dP~~Rpt~~e~L~hpw~ 351 (380)
.+||+.+|.+||++.++|+||||
T Consensus 234 ~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 234 SQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHhhCChhhCcCHHHHhhCcCC
Confidence 99999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=325.85 Aligned_cols=256 Identities=26% Similarity=0.342 Sum_probs=208.5
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIV 177 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv 177 (380)
++|+..+.||.|++|.||+|.+..+++.+|+|.+..... ....+.+|+++++.++|+||++++++|.... .+..++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDES-SSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccC-CCeEEEE
Confidence 368899999999999999999999999999999975433 3456788999999999999999999885432 3578999
Q ss_pred EEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc---
Q psy11098 178 MQLVHGESLIQHLCR----QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS--- 249 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~----~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~--- 249 (380)
|||+.|++|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++ ++.++|+|||++....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence 999999999887753 35689999999999999999999999999999999999998 4689999999986543
Q ss_pred -ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHhcccC-CCCCC--cCCCC
Q psy11098 250 -TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDE-----SEEETRAHISVADY-SFPPE--QCGHI 320 (380)
Q Consensus 250 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~-----~~~~~~~~i~~~~~-~~~~~--~~~~~ 320 (380)
....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||... ...+....+..... ..+.. ....+
T Consensus 160 ~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd06621 160 AGTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKW 238 (287)
T ss_pred cccccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCch
Confidence 23456889999999877 46788999999999999999999999765 22333333332111 11111 11235
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCCC
Q psy11098 321 SVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASCS 357 (380)
Q Consensus 321 s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~~ 357 (380)
++++.+||.+||..||.+|||+.|+++||||++...+
T Consensus 239 ~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~ 275 (287)
T cd06621 239 SEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKK 275 (287)
T ss_pred HHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccc
Confidence 6789999999999999999999999999999766433
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=321.83 Aligned_cols=245 Identities=25% Similarity=0.418 Sum_probs=206.3
Q ss_pred ceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC-------chHHHHHHHHHHHhhccCCCcceeeecccccCCCc
Q psy11098 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ-------PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGT 173 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-------~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~ 173 (380)
+|++.+.||.|+||.||+|.. .+++.+|+|.+..... ....+.+|+++++.++|+|++++++++... +.
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~ 76 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD---NT 76 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC---Ce
Confidence 477889999999999999986 4788999999864321 124567899999999999999999988764 67
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc---
Q psy11098 174 DTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS--- 249 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~--- 249 (380)
.++++||+.|++|.+++.+...+++..+..++.|++.||.|||+.||+|+||+|+||+++ ++.++|+|||++....
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 77 ISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 899999999999999998878899999999999999999999999999999999999998 5699999999886531
Q ss_pred ---------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCC
Q psy11098 250 ---------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHI 320 (380)
Q Consensus 250 ---------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 320 (380)
....++..|+|||++.+ ..++.++|+||||+++|+|++|..||...........+....... +.....+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 234 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINE-SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLM-PRLPDSF 234 (265)
T ss_pred ccccccccccccCCCccccChhhhcC-CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCC-CCCCCCC
Confidence 23457889999999987 467889999999999999999999998766555444443322222 1223457
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy11098 321 SVPARELIGQLLNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 321 s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~ 351 (380)
+.++.+||++||.+||.+|||+.++|+||||
T Consensus 235 ~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 235 SAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 8999999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=321.81 Aligned_cols=247 Identities=28% Similarity=0.361 Sum_probs=210.0
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVM 178 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~ 178 (380)
.++|++.+.||.|+||.||+|.+..+++.+|+|.+..... .+.+.+|+++++.++|+|++++++++... ...|+++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~---~~~~l~~ 77 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKN---TDLWIVM 77 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecC---CcEEEEE
Confidence 3578999999999999999999999899999999975543 56788899999999999999999988764 6789999
Q ss_pred EecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------c
Q psy11098 179 QLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------T 250 (380)
Q Consensus 179 e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------~ 250 (380)
||+.+++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++ ++.++|+|||++.... .
T Consensus 78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (256)
T cd06612 78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRN 157 (256)
T ss_pred ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccccc
Confidence 99999999999965 45789999999999999999999999999999999999998 5689999999987654 2
Q ss_pred cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHH
Q psy11098 251 VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQ 330 (380)
Q Consensus 251 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 330 (380)
...++..|+|||++.+ ..++.++||||||+++|+|++|..||...........+...... .......++.++.+||.+
T Consensus 158 ~~~~~~~y~~PE~~~~-~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~ 235 (256)
T cd06612 158 TVIGTPFWMAPEVIQE-IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPP-TLSDPEKWSPEFNDFVKK 235 (256)
T ss_pred cccCCccccCHHHHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCC-CCCchhhcCHHHHHHHHH
Confidence 3457889999999987 46788999999999999999999999876655444333222111 111123478899999999
Q ss_pred hcccCCCCCCCHHHHHhcccc
Q psy11098 331 LLNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 331 ~L~~dP~~Rpt~~e~L~hpw~ 351 (380)
||+.||++|||+.|+|.||||
T Consensus 236 ~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 236 CLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHhcChhhCcCHHHHhcCCCC
Confidence 999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-46 Score=332.18 Aligned_cols=252 Identities=23% Similarity=0.358 Sum_probs=214.9
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVM 178 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~ 178 (380)
.+-|.++++||+|+||.||+|.|+.+|+.+|+|.+..+..- +.+.+|+.|+++...+++++.++.|... ..++|||
T Consensus 32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDL-QEIIKEISIMQQC~S~yVVKYYGSYFK~---sDLWIVM 107 (502)
T KOG0574|consen 32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDL-QEIIKEISIMQQCKSKYVVKYYGSYFKH---SDLWIVM 107 (502)
T ss_pred HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchH-HHHHHHHHHHHHcCCchhhhhhhhhccC---CceEeeh
Confidence 45678899999999999999999999999999999776554 4456699999999999998888777653 5679999
Q ss_pred EecCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------c
Q psy11098 179 QLVHGESLIQHLC-RQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------T 250 (380)
Q Consensus 179 e~~~gg~L~~~l~-~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------~ 250 (380)
|||..|++.+++. ++++++|.++..+++..+.||+|||...-+|||||..|||++ +|..||+|||.|.++. +
T Consensus 108 EYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRN 187 (502)
T KOG0574|consen 108 EYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRN 187 (502)
T ss_pred hhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhC
Confidence 9999999999995 467899999999999999999999999999999999999998 6799999999998774 6
Q ss_pred cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-cccCCCCCCcCCCCCHHHHHHHH
Q psy11098 251 VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHIS-VADYSFPPEQCGHISVPARELIG 329 (380)
Q Consensus 251 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~-~~~~~~~~~~~~~~s~~~~~li~ 329 (380)
++.|||-|||||++.. -.|+.++||||||++..||.-|++||.+-.......-|- +....|. ....+|+++-|||+
T Consensus 188 TVIGTPFWMAPEVI~E-IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~--KPE~WS~~F~DFi~ 264 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEE-IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFK--KPEEWSSEFNDFIR 264 (502)
T ss_pred ccccCcccccHHHHHH-hccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCC--ChHhhhhHHHHHHH
Confidence 7899999999999988 478889999999999999999999998765433222111 1111111 22457999999999
Q ss_pred HhcccCCCCCCCHHHHHhcccccccCCC
Q psy11098 330 QLLNTHADKRPTAGQLLQVAWFAEASCS 357 (380)
Q Consensus 330 ~~L~~dP~~Rpt~~e~L~hpw~~~~~~~ 357 (380)
+||.++|++|-|+-++++|||+++...-
T Consensus 265 ~CLiK~PE~R~TA~~L~~H~FiknA~g~ 292 (502)
T KOG0574|consen 265 SCLIKKPEERKTALRLCEHTFIKNAPGC 292 (502)
T ss_pred HHhcCCHHHHHHHHHHhhhhhhcCCCcc
Confidence 9999999999999999999999987544
|
|
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=357.48 Aligned_cols=246 Identities=28% Similarity=0.449 Sum_probs=208.0
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEec-CCCCchHHHHHHHHHHHhhc-cCCCcceee-ecccccCCC---
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIP-RERQPQQITRAEYNLLSTLM-HAHIPTALA-LFENAPVPG--- 172 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~-~~~~~~~~~~~E~~il~~l~-h~ni~~i~~-~~~~~~~~~--- 172 (380)
..+++|.+.|.+|||+.||+|++...|..||+|++- .+.......++|+++|+.|+ |+|||.+++ ........+
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 457888999999999999999999888999999874 34445677899999999997 999999988 333222222
Q ss_pred ceEEEEEecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeecCCCCcEEEe-CCeeEEEeCCCccc
Q psy11098 173 TDTIVMQLVHGESLIQHLCR--QSTITESYICCIIRQLHSALHCLHSQQ--IAHKDIRPENILMN-GAVLKLIDLGSSVS 247 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~--~~~l~e~~~~~i~~qil~al~~lH~~~--iiHrDlKp~NIl~~-~~~ikl~DFG~a~~ 247 (380)
.++|.||||.||.|.+++.+ +..|+|.++++|++|+++||.+||..+ |||||||-|||||+ ++..||||||.|..
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt 195 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATT 195 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence 35799999999999999974 456999999999999999999999998 99999999999998 56899999999864
Q ss_pred cc---------------ccccCCCcccCCcccc--CCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC
Q psy11098 248 VS---------------TVVLPDLEFASPEMLT--SPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADY 310 (380)
Q Consensus 248 ~~---------------~~~~gt~~y~aPE~~~--~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~ 310 (380)
.. ...+.|+.|+|||.+. .....+.|+|||+|||+||-|+....||.+.. ...|..+.|
T Consensus 196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg----~laIlng~Y 271 (738)
T KOG1989|consen 196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG----KLAILNGNY 271 (738)
T ss_pred ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc----ceeEEeccc
Confidence 31 2346799999999864 23578999999999999999999999997653 246678888
Q ss_pred CCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccc
Q psy11098 311 SFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAW 350 (380)
Q Consensus 311 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw 350 (380)
.+|+. ..+++.+++||+.||+.||.+||++-|++.+=+
T Consensus 272 ~~P~~--p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~ 309 (738)
T KOG1989|consen 272 SFPPF--PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF 309 (738)
T ss_pred cCCCC--ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence 88864 678999999999999999999999999987633
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=327.50 Aligned_cols=246 Identities=23% Similarity=0.376 Sum_probs=197.0
Q ss_pred eecccCCeEEEEEEEcCCCcEEEEEEecCCCC----chHHHHHHHHHHHhh---ccCCCcceeeecccccCCCceEEEEE
Q psy11098 107 RLGNGRFCTVRKARDRGTGQLVALKQIPRERQ----PQQITRAEYNLLSTL---MHAHIPTALALFENAPVPGTDTIVMQ 179 (380)
Q Consensus 107 ~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~E~~il~~l---~h~ni~~i~~~~~~~~~~~~~~lv~e 179 (380)
.||+|+||.||++.+..+++.+|+|.+..... ......+|..+++.+ .|+|++.+...+... +..++|||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~---~~~~lv~e 77 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTP---DKLCFILD 77 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecC---CeEEEEEe
Confidence 48999999999999999999999999865422 122334455444443 688888877777653 67899999
Q ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc----ccccC
Q psy11098 180 LVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS----TVVLP 254 (380)
Q Consensus 180 ~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~----~~~~g 254 (380)
|+.|++|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++ ++.++|+|||++.... ....|
T Consensus 78 ~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 157 (279)
T cd05633 78 LMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG 157 (279)
T ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCccCcCC
Confidence 999999999998888899999999999999999999999999999999999997 5689999999986543 23468
Q ss_pred CCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhccc
Q psy11098 255 DLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNT 334 (380)
Q Consensus 255 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 334 (380)
|+.|+|||.+.+...++.++|+||+||++|+|++|..||......... .+..............++.++++||++||..
T Consensus 158 ~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 236 (279)
T cd05633 158 THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTVNVELPDSFSPELKSLLEGLLQR 236 (279)
T ss_pred CcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHhhcCCcCCccccCHHHHHHHHHHhcC
Confidence 999999999875456788999999999999999999999754321111 1111111222223345899999999999999
Q ss_pred CCCCCC-----CHHHHHhcccccccCC
Q psy11098 335 HADKRP-----TAGQLLQVAWFAEASC 356 (380)
Q Consensus 335 dP~~Rp-----t~~e~L~hpw~~~~~~ 356 (380)
||.+|+ |++++++||||+....
T Consensus 237 ~p~~R~~~~~~~~~~~~~h~~~~~~~~ 263 (279)
T cd05633 237 DVSKRLGCLGRGAQEVKEHVFFKGIDW 263 (279)
T ss_pred CHHHhcCCCCCCHHHHHhCccccCCCH
Confidence 999999 6999999999988653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=322.97 Aligned_cols=248 Identities=27% Similarity=0.435 Sum_probs=205.5
Q ss_pred ceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC-------chHHHHHHHHHHHhhccCCCcceeeecccccCCCc
Q psy11098 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ-------PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGT 173 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-------~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~ 173 (380)
+|+..+.||+|+||.||++.+..+++.||+|++..... ....+.+|+.+++.++|+|++++++++... +.
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~ 77 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCED---SH 77 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccC---Ce
Confidence 47788999999999999999999999999999964331 235677899999999999999999887653 67
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-C-eeEEEeCCCcccccc-
Q psy11098 174 DTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-A-VLKLIDLGSSVSVST- 250 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~-~ikl~DFG~a~~~~~- 250 (380)
.++|+||+.|++|.+++.+...+++..+..++.||+.||.|||++|++|+||||+||+++. + .+||+|||.+.....
T Consensus 78 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 78 FNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 7999999999999999988888999999999999999999999999999999999999974 3 699999999876531
Q ss_pred ---------cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-ccCCCCCCcCCCC
Q psy11098 251 ---------VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISV-ADYSFPPEQCGHI 320 (380)
Q Consensus 251 ---------~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~ 320 (380)
...++..|+|||++.+ ..++.++|+||||+++|+|++|..||...........+.. ............+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHL 236 (268)
T ss_pred cccCCccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhh
Confidence 2356889999999877 4678899999999999999999999965443222222211 1111122223457
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHhccccc
Q psy11098 321 SVPARELIGQLLNTHADKRPTAGQLLQVAWFA 352 (380)
Q Consensus 321 s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~ 352 (380)
+.++.+++.+||..||.+|||+.++|+||||.
T Consensus 237 ~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 237 SPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 89999999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=322.93 Aligned_cols=243 Identities=28% Similarity=0.436 Sum_probs=208.6
Q ss_pred ceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC----CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEE
Q psy11098 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
+|++.+.||.|+||.||+|.+..+++.||+|++.+.. .....+.+|+++++.++|+|+++++.++.. .+..++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~~l 77 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD---EENMYL 77 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC---CCeEEE
Confidence 4889999999999999999999999999999996532 234567889999999999999998888765 367899
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-----c
Q psy11098 177 VMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS-----T 250 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~-----~ 250 (380)
|+||+.|++|.+++.....+++..+..++.||++||.|||++|++|+||+|+||+++ ++.++|+|||++.... .
T Consensus 78 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 157 (258)
T cd05578 78 VVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTT 157 (258)
T ss_pred EEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcccc
Confidence 999999999999998777899999999999999999999999999999999999998 5699999999987653 3
Q ss_pred cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhcccCCCCCCcCCCCCHHHHHH
Q psy11098 251 VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESE---EETRAHISVADYSFPPEQCGHISVPAREL 327 (380)
Q Consensus 251 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 327 (380)
...++..|+|||++.+ ...+.++|+||||+++|+|++|..||..... .............++ ..++.++.++
T Consensus 158 ~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~ 232 (258)
T cd05578 158 STSGTPGYMAPEVLCR-QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYP----ATWSTEAIDA 232 (258)
T ss_pred ccCCChhhcCHHHHcc-cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCc----ccCcHHHHHH
Confidence 4567889999999987 4578899999999999999999999987663 333333322222222 3578999999
Q ss_pred HHHhcccCCCCCCCH--HHHHhcccc
Q psy11098 328 IGQLLNTHADKRPTA--GQLLQVAWF 351 (380)
Q Consensus 328 i~~~L~~dP~~Rpt~--~e~L~hpw~ 351 (380)
|++||..||.+||++ +|+++||||
T Consensus 233 i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 233 INKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHHHccCChhHcCCccHHHHhcCCCC
Confidence 999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=339.90 Aligned_cols=244 Identities=21% Similarity=0.314 Sum_probs=199.1
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCC-----cEEEEEEecCCCC--chHHHHHHHHHHHhh-ccCCCcceeeecccccC
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTG-----QLVALKQIPRERQ--PQQITRAEYNLLSTL-MHAHIPTALALFENAPV 170 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~-----~~vAvK~~~~~~~--~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~~ 170 (380)
.++|++.+.||+|+||.||+|++..++ +.||+|.+..... ....+.+|+++++.+ .|+||+++++.+...
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~-- 114 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG-- 114 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC--
Confidence 568999999999999999999875443 5799999975433 234567899999999 899999999887664
Q ss_pred CCceEEEEEecCCCCHHHHHHhc---------------------------------------------------------
Q psy11098 171 PGTDTIVMQLVHGESLIQHLCRQ--------------------------------------------------------- 193 (380)
Q Consensus 171 ~~~~~lv~e~~~gg~L~~~l~~~--------------------------------------------------------- 193 (380)
+..++||||+.+|+|.+++...
T Consensus 115 -~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 115 -GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred -CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 6789999999999999988542
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCccccc--------cc
Q psy11098 194 -------------STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVS--------TV 251 (380)
Q Consensus 194 -------------~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~--------~~ 251 (380)
..+++..++.++.||+.||.|||++||+||||||+|||+++ +.+||+|||++.... ..
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 23688889999999999999999999999999999999985 589999999987542 12
Q ss_pred ccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHH
Q psy11098 252 VLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQ 330 (380)
Q Consensus 252 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 330 (380)
..+++.|+|||++.+ ..++.++|||||||++|+|++ |..||..................... ...++.++.+++.+
T Consensus 274 ~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~ 350 (374)
T cd05106 274 ARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSR--PDFAPPEIYSIMKM 350 (374)
T ss_pred CCCccceeCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccC--CCCCCHHHHHHHHH
Confidence 234567999999977 478899999999999999997 99999876554444444333332222 23468999999999
Q ss_pred hcccCCCCCCCHHHHHhc
Q psy11098 331 LLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 331 ~L~~dP~~Rpt~~e~L~h 348 (380)
||+.||.+|||+.++++.
T Consensus 351 cl~~dp~~RPs~~~l~~~ 368 (374)
T cd05106 351 CWNLEPTERPTFSQISQL 368 (374)
T ss_pred HcCCChhhCcCHHHHHHH
Confidence 999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=317.97 Aligned_cols=244 Identities=27% Similarity=0.377 Sum_probs=213.4
Q ss_pred ceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC---CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEE
Q psy11098 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER---QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIV 177 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv 177 (380)
+|+.++.||.|+||.||.+++..+++.+|+|.+.... .....+.+|+++++.++|+|++++++++... +..+++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~---~~~~~~ 77 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD---NTLLIE 77 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC---CeEEEE
Confidence 5899999999999999999999999999999986432 2335567899999999999999999998764 678999
Q ss_pred EEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-----
Q psy11098 178 MQLVHGESLIQHLCRQ--STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS----- 249 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~----- 249 (380)
|||+.+++|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++ ++.+||+|||++....
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~ 157 (256)
T cd08221 78 MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM 157 (256)
T ss_pred EEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccccc
Confidence 9999999999999764 5689999999999999999999999999999999999998 4589999999987553
Q ss_pred -ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHH
Q psy11098 250 -TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELI 328 (380)
Q Consensus 250 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 328 (380)
....+++.|+|||++.+. ..+.++|+||||+++|+|++|..||......+....+..+.+.... ..++.++.++|
T Consensus 158 ~~~~~~~~~y~ape~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~i 233 (256)
T cd08221 158 AETVVGTPYYMSPELCQGV-KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVV---SVYSSELISLV 233 (256)
T ss_pred ccccCCCccccCHhhcCCC-CCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCc---cccCHHHHHHH
Confidence 245679999999999874 5778999999999999999999999888887777777665543322 46789999999
Q ss_pred HHhcccCCCCCCCHHHHHhcccc
Q psy11098 329 GQLLNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 329 ~~~L~~dP~~Rpt~~e~L~hpw~ 351 (380)
.+||..||++|||++++|+|+|+
T Consensus 234 ~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 234 HSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHcccCcccCCCHHHHhhCcCC
Confidence 99999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=326.52 Aligned_cols=246 Identities=25% Similarity=0.401 Sum_probs=204.1
Q ss_pred ecccCCeEEEEEEEcCCCcEEEEEEecCCC----CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEEEecCC
Q psy11098 108 LGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHG 183 (380)
Q Consensus 108 LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e~~~g 183 (380)
||+|+||+||+|.+..+|+.||+|.+.... .....+..|+++++.++|+|++++...+... +..|+||||+.|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~lv~e~~~~ 77 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETK---DDLCLVMTLMNG 77 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecC---CeEEEEEecCCC
Confidence 699999999999999999999999986432 2234556799999999999999998888764 678999999999
Q ss_pred CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCccccc-----ccccCC
Q psy11098 184 ESLIQHLCRQS--TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVS-----TVVLPD 255 (380)
Q Consensus 184 g~L~~~l~~~~--~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~-----~~~~gt 255 (380)
++|.+++.... .+++..+..++.|++.||.|||+.|++||||+|+||++++ +.+||+|||++.... ....++
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 157 (277)
T cd05577 78 GDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGT 157 (277)
T ss_pred CcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCC
Confidence 99999997755 7999999999999999999999999999999999999984 689999999887543 234567
Q ss_pred CcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhcccC
Q psy11098 256 LEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNTH 335 (380)
Q Consensus 256 ~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 335 (380)
..|+|||++.+. .++.++|+|||||++|+|++|..||...........+.......+......+++++.+||++||+.|
T Consensus 158 ~~y~~PE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 236 (277)
T cd05577 158 PGYMAPEVLQGE-VYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236 (277)
T ss_pred CCcCCHHHhcCC-CCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCC
Confidence 889999998874 5788999999999999999999999775442222222222222233333457999999999999999
Q ss_pred CCCCC-----CHHHHHhcccccccCCC
Q psy11098 336 ADKRP-----TAGQLLQVAWFAEASCS 357 (380)
Q Consensus 336 P~~Rp-----t~~e~L~hpw~~~~~~~ 357 (380)
|.+|| ++.++++||||.+..+.
T Consensus 237 p~~R~~~~~~~~~~ll~h~~~~~~~~~ 263 (277)
T cd05577 237 PEKRLGCRGGSADEVREHPLFKDLNWR 263 (277)
T ss_pred hhHccCCCcccHHHHHhChhhhcCChh
Confidence 99999 99999999999876554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=325.99 Aligned_cols=249 Identities=28% Similarity=0.396 Sum_probs=199.1
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
..+|++.+.||+|+||.||+|.+..+++.||+|.+..... ......+|+++++.+.|+|++++.+++... +..++
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---~~~~l 80 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTK---ETLTF 80 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecC---CeEEE
Confidence 4679999999999999999999999999999999965432 234567899999999999999999887653 67899
Q ss_pred EEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-----
Q psy11098 177 VMQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS----- 249 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~----- 249 (380)
||||+. ++|.+.+.. ...+++..+..++.||+.||.|||+.||+|+||||+|||++ ++.+||+|||++....
T Consensus 81 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 159 (291)
T cd07870 81 VFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT 159 (291)
T ss_pred EEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC
Confidence 999994 677776654 45678889999999999999999999999999999999997 5689999999987542
Q ss_pred -ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhccc--------------CCCC
Q psy11098 250 -TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEE-ETRAHISVAD--------------YSFP 313 (380)
Q Consensus 250 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~-~~~~~i~~~~--------------~~~~ 313 (380)
....+++.|+|||++.+...++.++|+|||||++|+|++|..||.+.... +....+.... ..+.
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYK 239 (291)
T ss_pred CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccccc
Confidence 23346889999999876455778999999999999999999999765432 2221111000 0000
Q ss_pred CC--------------cCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy11098 314 PE--------------QCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 314 ~~--------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~ 351 (380)
.. .....+.++.+|+.+||..||++|||++|+|.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 240 PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred chhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 00 001135689999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=326.16 Aligned_cols=238 Identities=16% Similarity=0.145 Sum_probs=202.3
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEecCCCCc----hHHHHHHHHHHHhhccCCCcceeeecccc-cCCCceEEEEEe
Q psy11098 106 ERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP----QQITRAEYNLLSTLMHAHIPTALALFENA-PVPGTDTIVMQL 180 (380)
Q Consensus 106 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~----~~~~~~E~~il~~l~h~ni~~i~~~~~~~-~~~~~~~lv~e~ 180 (380)
..||+|++|.||+|.. +|+.||+|.++..... .+.+.+|+.+|+.++|+||+++++++... ......++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5699999999999987 5889999999765433 25567899999999999999999987652 223467999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeecCCCCcEEEe-CCeeEEEeCCCccccc---ccccCC
Q psy11098 181 VHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHS-QQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS---TVVLPD 255 (380)
Q Consensus 181 ~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~-~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~---~~~~gt 255 (380)
+.||+|.+++.....+++.....++.|++.||.|||+ .+++||||||+|||++ ++.+||+|||++.... ....++
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~ 183 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNF 183 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccccccccCc
Confidence 9999999999888889999999999999999999998 4999999999999998 5689999999987654 235678
Q ss_pred CcccCCccccCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhccc
Q psy11098 256 LEFASPEMLTSP-ATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNT 334 (380)
Q Consensus 256 ~~y~aPE~~~~~-~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 334 (380)
+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+..+....+......++.. ...+.++++||.+||+.
T Consensus 184 ~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~~~~l~~li~~cl~~ 261 (283)
T PHA02988 184 MVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLP--LDCPLEIKCIVEACTSH 261 (283)
T ss_pred ccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC--CcCcHHHHHHHHHHhcC
Confidence 999999998752 467889999999999999999999999888877777765444333321 24789999999999999
Q ss_pred CCCCCCCHHHHHh
Q psy11098 335 HADKRPTAGQLLQ 347 (380)
Q Consensus 335 dP~~Rpt~~e~L~ 347 (380)
||++|||++++++
T Consensus 262 dp~~Rps~~ell~ 274 (283)
T PHA02988 262 DSIKRPNIKEILY 274 (283)
T ss_pred CcccCcCHHHHHH
Confidence 9999999999985
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=317.18 Aligned_cols=244 Identities=28% Similarity=0.415 Sum_probs=209.7
Q ss_pred ceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC---CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEE
Q psy11098 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER---QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIV 177 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv 177 (380)
+|++.+.||+|+||.||+|.+..+++.+|+|.+.... .....+.+|+++++.++|+|++++++.+.. .+..++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~~~~~lv 77 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE---DKALMIV 77 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec---CCEEEEE
Confidence 5889999999999999999999999999999996543 234567789999999999999999887765 3678999
Q ss_pred EEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC--CeeEEEeCCCccccc----
Q psy11098 178 MQLVHGESLIQHLCRQ--STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG--AVLKLIDLGSSVSVS---- 249 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~--~~ikl~DFG~a~~~~---- 249 (380)
|||+.|++|.+++... ..+++..+..++.|++.||.|||++|++|+||||+||+++. +.+||+|||++....
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 78 MEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred EecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 9999999999999763 45899999999999999999999999999999999999974 368999999987654
Q ss_pred -ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHH
Q psy11098 250 -TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELI 328 (380)
Q Consensus 250 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 328 (380)
....++..|+|||.+.+ ...+.++|+||||+++|+|++|..||...+.......+....... ....++.++++++
T Consensus 158 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li 233 (256)
T cd08220 158 AYTVVGTPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAP---ISDRYSPDLRQLI 233 (256)
T ss_pred ccccccCCcccCchhccC-CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCC---CCCCcCHHHHHHH
Confidence 23567889999999987 467889999999999999999999998877766666655443221 1235789999999
Q ss_pred HHhcccCCCCCCCHHHHHhcccc
Q psy11098 329 GQLLNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 329 ~~~L~~dP~~Rpt~~e~L~hpw~ 351 (380)
.+||..||.+|||+.|+|+||||
T Consensus 234 ~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 234 LSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHccCChhhCCCHHHHhhCCCC
Confidence 99999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=318.57 Aligned_cols=247 Identities=27% Similarity=0.431 Sum_probs=207.0
Q ss_pred ceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEE
Q psy11098 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIV 177 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv 177 (380)
+|++.+.||+|+||.||+|.+..+++.||+|.++.... ....+.+|+++++.++|+||++++++... .+..++|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~---~~~~~lv 77 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH---REKVYIF 77 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEec---CCEEEEE
Confidence 58899999999999999999999999999999976544 34567889999999999999999887654 3678999
Q ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCcccccc------
Q psy11098 178 MQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVST------ 250 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~~------ 250 (380)
+||+.+++|.+++.....+++..+..++.|++.||.|||+.||+|+||+|+||++++ +.+||+|||++.....
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~ 157 (264)
T cd06626 78 MEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157 (264)
T ss_pred EecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence 999999999999988777999999999999999999999999999999999999984 6899999999876531
Q ss_pred ----cccCCCcccCCccccCCC--CCCCcccHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhcccCCCCCCcCCCCCHH
Q psy11098 251 ----VVLPDLEFASPEMLTSPA--TAGPSTDMWSLGVLLYILLSGVSPFLDES-EEETRAHISVADYSFPPEQCGHISVP 323 (380)
Q Consensus 251 ----~~~gt~~y~aPE~~~~~~--~~~~~~DiwSlGvil~~lltg~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~ 323 (380)
...+++.|+|||++.+.. ..+.++||||||+++|++++|..||.... .......+... .....+....++..
T Consensus 158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 236 (264)
T cd06626 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAG-HKPPIPDSLQLSPE 236 (264)
T ss_pred ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcC-CCCCCCcccccCHH
Confidence 245678999999987632 26789999999999999999999997653 33333333322 11112223346899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy11098 324 ARELIGQLLNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 324 ~~~li~~~L~~dP~~Rpt~~e~L~hpw~ 351 (380)
+.+||.+||+.||++|||+.+++.|||+
T Consensus 237 ~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 237 GKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=319.15 Aligned_cols=248 Identities=26% Similarity=0.377 Sum_probs=206.4
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC------chHHHHHHHHHHHhhccCCCcceeeecccccCCCc
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ------PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGT 173 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~------~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~ 173 (380)
..|++.+.||+|+||.||+|.+..+++.||+|.+..... ....+.+|+.+++.+.|+|++++++++.... ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~ 80 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPM-ERT 80 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCC-Cce
Confidence 368889999999999999999999999999998853221 1245677999999999999999998875432 246
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCccccc---
Q psy11098 174 DTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVS--- 249 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~--- 249 (380)
.+++|||+.|++|.+++.....+++..+..++.|++.||.|||++|++|+||||+|||++. +.++|+|||++....
T Consensus 81 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~ 160 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC 160 (265)
T ss_pred EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence 7899999999999999988778999999999999999999999999999999999999984 689999999887532
Q ss_pred ------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHH
Q psy11098 250 ------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVP 323 (380)
Q Consensus 250 ------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 323 (380)
....++..|+|||++.+ ...+.++|+|||||++|+|++|+.||.+.........+...... ......++..
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 237 (265)
T cd06652 161 LSGTGMKSVTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN--PVLPPHVSDH 237 (265)
T ss_pred ccccccccCCCCccccChhhhcC-CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCC--CCCchhhCHH
Confidence 23457889999999987 46788999999999999999999999876555544444322211 1122357888
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHhccccc
Q psy11098 324 ARELIGQLLNTHADKRPTAGQLLQVAWFA 352 (380)
Q Consensus 324 ~~~li~~~L~~dP~~Rpt~~e~L~hpw~~ 352 (380)
+.++|++||. +|++|||++++++|||+.
T Consensus 238 ~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 238 CRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 9999999995 999999999999999983
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=324.47 Aligned_cols=247 Identities=26% Similarity=0.450 Sum_probs=204.6
Q ss_pred ceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEE
Q psy11098 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVM 178 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~ 178 (380)
+|++.+.||.|++|.||+|++..+|+.||+|.+..... ....+.+|+.+++.++|+|++++++++... +..++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~~lv~ 77 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTE---NKLMLVF 77 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeC---CcEEEEE
Confidence 48899999999999999999999999999999975432 345667899999999999999999988764 6779999
Q ss_pred EecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-----
Q psy11098 179 QLVHGESLIQHLCRQ---STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS----- 249 (380)
Q Consensus 179 e~~~gg~L~~~l~~~---~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~----- 249 (380)
||+. ++|.+++... ..+++..+..++.||+.||.|||+.|++||||||+||+++ ++.++|+|||++....
T Consensus 78 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 156 (284)
T cd07836 78 EYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT 156 (284)
T ss_pred ecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence 9996 4888887653 3689999999999999999999999999999999999998 4689999999987543
Q ss_pred -ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc------------------C
Q psy11098 250 -TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVAD------------------Y 310 (380)
Q Consensus 250 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~------------------~ 310 (380)
....+++.|+|||++.+...++.++|+|||||++|+|++|..||.+.+..+....+.... .
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcc
Confidence 234568899999998765567889999999999999999999998877655544432110 0
Q ss_pred CCCC-------CcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy11098 311 SFPP-------EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 311 ~~~~-------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~ 351 (380)
.++. .....++.+++++|.+||+.||++|||++++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred cccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 0000 0012457889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=324.37 Aligned_cols=246 Identities=25% Similarity=0.396 Sum_probs=204.6
Q ss_pred eeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEE
Q psy11098 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVM 178 (380)
Q Consensus 102 y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~ 178 (380)
|++.+.||.|++|.||+|.++.+|+.||+|++..... ....+.+|+++++.++|+|++++++++... +..+++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~---~~~~iv~ 77 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSE---NKLYLVF 77 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccC---CeEEEEE
Confidence 6778999999999999999999999999999865432 234567899999999999999999887754 6789999
Q ss_pred EecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------
Q psy11098 179 QLVHGESLIQHLCRQS--TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------ 249 (380)
Q Consensus 179 e~~~gg~L~~~l~~~~--~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------ 249 (380)
||+ +++|.+++.... .+++..+..++.|++.||.|||+++++||||+|+||+++ ++.++|+|||++....
T Consensus 78 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~ 156 (283)
T cd07835 78 EFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY 156 (283)
T ss_pred ecc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcccc
Confidence 999 578999987765 789999999999999999999999999999999999998 5689999999987553
Q ss_pred ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc--------------------
Q psy11098 250 TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVAD-------------------- 309 (380)
Q Consensus 250 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~-------------------- 309 (380)
....+++.|+|||++.+...++.++|+||||+++|+|++|..||...+.......+....
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT 236 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence 223458889999998765567889999999999999999999998776654433322110
Q ss_pred -----CCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy11098 310 -----YSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 310 -----~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~ 351 (380)
..........++.++.++|.+||+.||++|||++|+++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 001111234678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=325.69 Aligned_cols=251 Identities=25% Similarity=0.413 Sum_probs=205.6
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
++|++.+.||+|++|+||+|.++.+|+.||+|.+..... ....+.+|+++++.++|+|++++++++... +..++
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~l 78 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE---KRLYL 78 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecC---CeEEE
Confidence 479999999999999999999999999999999865432 234567899999999999999999988764 67899
Q ss_pred EEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC--CeeEEEeCCCccccc---
Q psy11098 177 VMQLVHGESLIQHLCRQS--TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG--AVLKLIDLGSSVSVS--- 249 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~~~--~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~--~~ikl~DFG~a~~~~--- 249 (380)
||||+ +++|.+.+.... .+++..++.++.||+.||.|||++|++|+||+|+||+++. +.+||+|||++....
T Consensus 79 v~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 79 VFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred EEecc-cccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 99999 468888886543 3588889999999999999999999999999999999973 479999999987543
Q ss_pred ---ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCC---------------
Q psy11098 250 ---TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYS--------------- 311 (380)
Q Consensus 250 ---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~--------------- 311 (380)
....+++.|+|||++.+...++.++|+|||||++|+|++|..||......+...++......
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (294)
T PLN00009 158 RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDY 237 (294)
T ss_pred cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhh
Confidence 23356789999999877556788999999999999999999999877665544443211000
Q ss_pred ---C---CC----CcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 312 ---F---PP----EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 312 ---~---~~----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
+ .. .....+++++.++|.+||+.||++||++.++|+||||.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 238 KSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred hhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 0 00 0123578899999999999999999999999999999865
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=325.32 Aligned_cols=249 Identities=28% Similarity=0.448 Sum_probs=206.3
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC---CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER---QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
++|++.+.||+|+||.||+|.++.+++.||+|.++... .....+.+|+++++.+.|+|++++++++.. .+..++
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~i 77 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR---KGRLYL 77 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE---CCEEEE
Confidence 36999999999999999999999999999999986532 234567889999999999999999998876 367899
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccccc-----
Q psy11098 177 VMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVST----- 250 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~~----- 250 (380)
+|||+.++.+..+..+...+++..+..++.||+.||.|||+.|++|+||+|+||+++ ++.+||+|||++.....
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 157 (288)
T cd07833 78 VFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157 (288)
T ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence 999998877766666667799999999999999999999999999999999999998 56999999999876532
Q ss_pred --cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC------------------
Q psy11098 251 --VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADY------------------ 310 (380)
Q Consensus 251 --~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~------------------ 310 (380)
...++..|+|||++.+...++.++|+||||+++|+|++|..||.+.+..+....+.....
T Consensus 158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07833 158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237 (288)
T ss_pred ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence 345678899999998754778899999999999999999999987765544333221100
Q ss_pred -CCCC---------CcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy11098 311 -SFPP---------EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 311 -~~~~---------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~ 351 (380)
.++. .....++.++++||++||..||++|||++++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0000 0112348889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=329.46 Aligned_cols=255 Identities=22% Similarity=0.367 Sum_probs=213.1
Q ss_pred hhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC-CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 97 QFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER-QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 97 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
+..+.|.....||.|+||.||++.+..+++.||+|.+.... .....+.+|+.+++.++|+|++++++.+... +..+
T Consensus 19 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~---~~~~ 95 (292)
T cd06658 19 DPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVG---DELW 95 (292)
T ss_pred chHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecC---CeEE
Confidence 34566666788999999999999999999999999986433 3345677899999999999999999887764 6779
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-----
Q psy11098 176 IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS----- 249 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~----- 249 (380)
+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++ ++.++|+|||++....
T Consensus 96 lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~ 174 (292)
T cd06658 96 VVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK 174 (292)
T ss_pred EEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc
Confidence 99999999999998754 4689999999999999999999999999999999999998 5689999999986542
Q ss_pred -ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHH
Q psy11098 250 -TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELI 328 (380)
Q Consensus 250 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 328 (380)
....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.........+..... ........++..+.+||
T Consensus 175 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li 252 (292)
T cd06658 175 RKSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLP-PRVKDSHKVSSVLRGFL 252 (292)
T ss_pred CceeecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-CccccccccCHHHHHHH
Confidence 23467889999999877 4678899999999999999999999988776665555443221 11122235788999999
Q ss_pred HHhcccCCCCCCCHHHHHhcccccccCCC
Q psy11098 329 GQLLNTHADKRPTAGQLLQVAWFAEASCS 357 (380)
Q Consensus 329 ~~~L~~dP~~Rpt~~e~L~hpw~~~~~~~ 357 (380)
.+||..||.+|||++++|+||||.....+
T Consensus 253 ~~~l~~~P~~Rpt~~~il~~~~~~~~~~~ 281 (292)
T cd06658 253 DLMLVREPSQRATAQELLQHPFLKLAGPP 281 (292)
T ss_pred HHHccCChhHCcCHHHHhhChhhhccCCc
Confidence 99999999999999999999999976544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=317.95 Aligned_cols=246 Identities=30% Similarity=0.447 Sum_probs=210.8
Q ss_pred ceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEE
Q psy11098 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIV 177 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv 177 (380)
+|++.+.||.|+||.||+|.+..+++.+|+|.+..... ..+.+..|+++++.++|+|++++++.+... .....+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR-SNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC-CCCEEEEE
Confidence 48899999999999999999999999999999865432 334567799999999999999998876542 23567999
Q ss_pred EEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----HCCcEeecCCCCcEEEeC-CeeEEEeCCCccc
Q psy11098 178 MQLVHGESLIQHLCR----QSTITESYICCIIRQLHSALHCLH-----SQQIAHKDIRPENILMNG-AVLKLIDLGSSVS 247 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~----~~~l~e~~~~~i~~qil~al~~lH-----~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~ 247 (380)
|||+.+++|.+++.. ...+++..++.++.||+.||.||| +.+++|+||||+||++++ +.+||+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999999865 357899999999999999999999 899999999999999985 6999999999876
Q ss_pred cc------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCC
Q psy11098 248 VS------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHIS 321 (380)
Q Consensus 248 ~~------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 321 (380)
.. ....+++.|+|||++.+ ...+.++|+||||+++|+|++|..||......+....+....... ....++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~ 235 (265)
T cd08217 160 LGHDSSFAKTYVGTPYYMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRR---IPYRYS 235 (265)
T ss_pred ccCCcccccccccCCCccChhhhcC-CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCC---CccccC
Confidence 53 23467899999999987 467889999999999999999999998887777666666554322 223578
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy11098 322 VPARELIGQLLNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 322 ~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~ 351 (380)
.++.+++.+||..+|++|||+.++|+|||+
T Consensus 236 ~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 236 SELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=323.14 Aligned_cols=250 Identities=27% Similarity=0.414 Sum_probs=209.1
Q ss_pred ceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC--CchHHHHHHHHHHHhhc---cCCCcceeeecccccCCCceE
Q psy11098 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER--QPQQITRAEYNLLSTLM---HAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~il~~l~---h~ni~~i~~~~~~~~~~~~~~ 175 (380)
.|++.+.||+|+||.||+|.+..+++.||+|.+.... .....+.+|+.+++.++ |+|++++++++... ...+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~---~~~~ 78 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG---PRLW 78 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC---CEEE
Confidence 4778899999999999999999999999999986543 23456778999999997 99999988887653 5679
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-----
Q psy11098 176 IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS----- 249 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~----- 249 (380)
++|||+.|++|.+++.. ..+++..+..++.|++.||.|||+.||+|+||+|+||+++ ++.++|+|||++....
T Consensus 79 lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06917 79 IIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK 157 (277)
T ss_pred EEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc
Confidence 99999999999998865 4799999999999999999999999999999999999998 5689999999987653
Q ss_pred -ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHH
Q psy11098 250 -TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELI 328 (380)
Q Consensus 250 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 328 (380)
....|+..|+|||.+.+...++.++|+|||||++|+|++|..||.+.........+... ..+......++.++.+|+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~i 235 (277)
T cd06917 158 RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS--KPPRLEDNGYSKLLREFV 235 (277)
T ss_pred cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC--CCCCCCcccCCHHHHHHH
Confidence 23467889999999876556788999999999999999999999877655444333222 111111223788999999
Q ss_pred HHhcccCCCCCCCHHHHHhcccccccCC
Q psy11098 329 GQLLNTHADKRPTAGQLLQVAWFAEASC 356 (380)
Q Consensus 329 ~~~L~~dP~~Rpt~~e~L~hpw~~~~~~ 356 (380)
.+||..||++|||+.+++.|+||++...
T Consensus 236 ~~~l~~~p~~R~~~~~il~~~~~~~~~~ 263 (277)
T cd06917 236 AACLDEEPKERLSAEELLKSKWIKAHSK 263 (277)
T ss_pred HHHcCCCcccCcCHHHHhhChHhhcccc
Confidence 9999999999999999999999987643
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=323.35 Aligned_cols=244 Identities=24% Similarity=0.389 Sum_probs=198.5
Q ss_pred eecccCCeEEEEEEEcCCCcEEEEEEecCCCCc----hHHHHHHHHHH---HhhccCCCcceeeecccccCCCceEEEEE
Q psy11098 107 RLGNGRFCTVRKARDRGTGQLVALKQIPRERQP----QQITRAEYNLL---STLMHAHIPTALALFENAPVPGTDTIVMQ 179 (380)
Q Consensus 107 ~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~----~~~~~~E~~il---~~l~h~ni~~i~~~~~~~~~~~~~~lv~e 179 (380)
.||+|+||.||+|.+..+++.||+|.+.+.... ......|..++ +...|++++.+...+... +..++|||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~---~~~~~v~e 77 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP---DKLSFILD 77 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC---CEEEEEEe
Confidence 389999999999999999999999998654221 22234444444 445688888877777653 67899999
Q ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc----ccccC
Q psy11098 180 LVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS----TVVLP 254 (380)
Q Consensus 180 ~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~----~~~~g 254 (380)
|+.|++|.+++.....+++..++.++.|++.||.|||+.+|+||||||+||+++ ++.+||+|||++.... ....|
T Consensus 78 ~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 157 (278)
T cd05606 78 LMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG 157 (278)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCCcCcCC
Confidence 999999999998888899999999999999999999999999999999999997 5689999999987543 34568
Q ss_pred CCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHh
Q psy11098 255 DLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDE---SEEETRAHISVADYSFPPEQCGHISVPARELIGQL 331 (380)
Q Consensus 255 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 331 (380)
+..|+|||++.+...++.++|+||+||++|+|++|..||.+. ........+.......+ ..++.++.+++.+|
T Consensus 158 ~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~s~~~~~li~~~ 233 (278)
T cd05606 158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----DSFSPELRSLLEGL 233 (278)
T ss_pred CcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCC----CcCCHHHHHHHHHH
Confidence 999999999976456788999999999999999999999776 33333222322222222 34689999999999
Q ss_pred cccCCCCCC-----CHHHHHhcccccccCCC
Q psy11098 332 LNTHADKRP-----TAGQLLQVAWFAEASCS 357 (380)
Q Consensus 332 L~~dP~~Rp-----t~~e~L~hpw~~~~~~~ 357 (380)
|..||.+|+ ++.++++||||.+....
T Consensus 234 l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~ 264 (278)
T cd05606 234 LQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQ 264 (278)
T ss_pred hhcCHHhccCCCCCCHHHHHhCccccCCCch
Confidence 999999999 99999999999887544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-43 Score=322.08 Aligned_cols=248 Identities=27% Similarity=0.367 Sum_probs=208.5
Q ss_pred ceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEE
Q psy11098 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVM 178 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~ 178 (380)
+|++.+.||+|+||.||+|.++.+++.+|+|.+..... ....+.+|+++++.+.|+|++++.+.+... +..++++
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~---~~~~lv~ 78 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNN---GDISICM 78 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecC---CEEEEEE
Confidence 57788999999999999999999999999999876532 345567899999999999999988887664 6789999
Q ss_pred EecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCcEeecCCCCcEEEeC-CeeEEEeCCCccccc----cc
Q psy11098 179 QLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHS-QQIAHKDIRPENILMNG-AVLKLIDLGSSVSVS----TV 251 (380)
Q Consensus 179 e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~-~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~----~~ 251 (380)
||+.+++|.+++... ..+++..+..++.|++.||.|||+ .|++|+||||+||++++ +.++|+|||.+.... ..
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~ 158 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT 158 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhhc
Confidence 999999999999775 789999999999999999999999 99999999999999984 689999999987553 23
Q ss_pred ccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHhcccCCCCCCcCCCCCHHHHH
Q psy11098 252 VLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDE-----SEEETRAHISVADYSFPPEQCGHISVPARE 326 (380)
Q Consensus 252 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~-----~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 326 (380)
..++..|+|||.+.+ ..++.++|+||||+++|+|++|..||... ...+....+..... +......++.++++
T Consensus 159 ~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 235 (265)
T cd06605 159 FVGTSSYMAPERIQG-NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP--PRLPSGKFSPDFQD 235 (265)
T ss_pred ccCChhccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCC--CCCChhhcCHHHHH
Confidence 678899999999987 47788999999999999999999999654 22233333332221 11111127889999
Q ss_pred HHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 327 LIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 327 li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
||.+||..||++|||+.+++.||||++.
T Consensus 236 li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 236 FVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred HHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 9999999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=319.58 Aligned_cols=240 Identities=27% Similarity=0.419 Sum_probs=206.4
Q ss_pred ecccCCeEEEEEEEcCCCcEEEEEEecCCC----CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEEEecCC
Q psy11098 108 LGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHG 183 (380)
Q Consensus 108 LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e~~~g 183 (380)
||.|+||.||+|++..+++.||+|++.+.. .....+.+|+.+++.+.|+|++++++.+... +..++++||+.+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~lv~e~~~~ 77 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDK---KYIYMLMEYCLG 77 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcC---CccEEEEecCCC
Confidence 699999999999999999999999996533 2345678899999999999999999987654 677999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccccc-----cccCCCc
Q psy11098 184 ESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVST-----VVLPDLE 257 (380)
Q Consensus 184 g~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~~-----~~~gt~~ 257 (380)
++|.+++.+...+++..+..++.||+.||.|||++|++|+||||+||+++ ++.++|+|||++..... ...+++.
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 157 (262)
T cd05572 78 GELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPE 157 (262)
T ss_pred CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcC
Confidence 99999998887899999999999999999999999999999999999997 56899999999876642 3567899
Q ss_pred ccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhc--ccCCCCCCcCCCCCHHHHHHHHHhcc
Q psy11098 258 FASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDES--EEETRAHISV--ADYSFPPEQCGHISVPARELIGQLLN 333 (380)
Q Consensus 258 y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~--~~~~~~~i~~--~~~~~~~~~~~~~s~~~~~li~~~L~ 333 (380)
|+|||.+.+ ..++.++|+||||+++|+|++|..||.... ..+....+.. ....++ ...++++.++|.+||.
T Consensus 158 ~~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~i~~~l~ 232 (262)
T cd05572 158 YVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFP----NYIDKAAKDLIKQLLR 232 (262)
T ss_pred ccChhHhcC-CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCC----cccCHHHHHHHHHHcc
Confidence 999999877 467889999999999999999999998766 5555555552 222222 2348899999999999
Q ss_pred cCCCCCCC-----HHHHHhcccccccC
Q psy11098 334 THADKRPT-----AGQLLQVAWFAEAS 355 (380)
Q Consensus 334 ~dP~~Rpt-----~~e~L~hpw~~~~~ 355 (380)
.||++||| ++|+++||||++..
T Consensus 233 ~~p~~R~~~~~~~~~~l~~~~~~~~~~ 259 (262)
T cd05572 233 RNPEERLGNLKGGIKDIKKHKWFNGFD 259 (262)
T ss_pred CChhhCcCCcccCHHHHhcChhhhCCC
Confidence 99999999 99999999998753
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=329.14 Aligned_cols=249 Identities=28% Similarity=0.413 Sum_probs=210.2
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
.+.|++.+.||+|+||.||+|.+..+++.||+|.+..... ....+.+|+++++.+.|+|++++++.+... +..++
T Consensus 3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~l 79 (277)
T cd06642 3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKG---TKLWI 79 (277)
T ss_pred HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccC---CceEE
Confidence 4567788999999999999999999999999999874432 335678899999999999999999988753 67899
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------
Q psy11098 177 VMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------ 249 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------ 249 (380)
||||+.+++|.+++.. ..+++..+..++.||+.||.|||++|++|+||+|+||+++ ++.++|+|||++....
T Consensus 80 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06642 80 IMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred EEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhh
Confidence 9999999999998854 5789999999999999999999999999999999999998 5689999999987653
Q ss_pred ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHH
Q psy11098 250 TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIG 329 (380)
Q Consensus 250 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 329 (380)
....++..|+|||++.+ ..++.++|+|||||++|+|++|..||.+.........+.... +......++.++.++|.
T Consensus 159 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~ 234 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQ-SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNS---PPTLEGQYSKPFKEFVE 234 (277)
T ss_pred hcccCcccccCHHHhCc-CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCC---CCCCCcccCHHHHHHHH
Confidence 23457889999999987 467889999999999999999999997766555544433222 11222357889999999
Q ss_pred HhcccCCCCCCCHHHHHhcccccccC
Q psy11098 330 QLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 330 ~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
+||..+|++|||+.++|+||||....
T Consensus 235 ~~l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06642 235 ACLNKDPRFRPTAKELLKHKFITRYT 260 (277)
T ss_pred HHccCCcccCcCHHHHHHhHHHHHHh
Confidence 99999999999999999999998764
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=332.44 Aligned_cols=256 Identities=26% Similarity=0.374 Sum_probs=210.2
Q ss_pred hhhceee-eeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCch---------------HHHHHHHHHHHhhccCCCcce
Q psy11098 98 FEHRYEE-LERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQ---------------QITRAEYNLLSTLMHAHIPTA 161 (380)
Q Consensus 98 ~~~~y~~-~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~---------------~~~~~E~~il~~l~h~ni~~i 161 (380)
+.++|.. .+.||.|+||+||+|.++.+++.||+|++....... ..+.+|+++++.++|+|++++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence 4677865 467999999999999999999999999986543221 135679999999999999999
Q ss_pred eeecccccCCCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEE
Q psy11098 162 LALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLI 240 (380)
Q Consensus 162 ~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~ 240 (380)
++++... +..+++|||+. ++|.+++.....+++..+..++.||+.||.|||+.||+|+||||+||+++ ++.+||+
T Consensus 86 ~~~~~~~---~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~ 161 (335)
T PTZ00024 86 VDVYVEG---DFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIA 161 (335)
T ss_pred eEEEecC---CcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEEC
Confidence 9988754 67799999995 68999998878899999999999999999999999999999999999998 4689999
Q ss_pred eCCCccccc--------------------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy11098 241 DLGSSVSVS--------------------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEE 300 (380)
Q Consensus 241 DFG~a~~~~--------------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~ 300 (380)
|||++.... ....+++.|+|||++.+...++.++|+|||||++|+|++|..||.+.+..+
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~ 241 (335)
T PTZ00024 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID 241 (335)
T ss_pred CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 999886543 122357789999999875567889999999999999999999998887766
Q ss_pred HHHHHhcccCCCCC------------------------CcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCC
Q psy11098 301 TRAHISVADYSFPP------------------------EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASC 356 (380)
Q Consensus 301 ~~~~i~~~~~~~~~------------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~ 356 (380)
....+......... ......+.++.+||++||..||++|||++|+|.||||.....
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~ 321 (335)
T PTZ00024 242 QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPL 321 (335)
T ss_pred HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCC
Confidence 55544321100000 011345788999999999999999999999999999987654
Q ss_pred C
Q psy11098 357 S 357 (380)
Q Consensus 357 ~ 357 (380)
.
T Consensus 322 ~ 322 (335)
T PTZ00024 322 P 322 (335)
T ss_pred C
Confidence 3
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=328.13 Aligned_cols=252 Identities=21% Similarity=0.402 Sum_probs=212.2
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC-CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER-QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVM 178 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~ 178 (380)
..|+....||+|+||.||+|.+..+++.||+|.+.... .....+.+|+.+++.+.|+|++++++.+... +..+++|
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~---~~~~iv~ 97 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVG---EELWVLM 97 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeC---CeEEEEE
Confidence 44555668999999999999999999999999986432 3445677899999999999999999888764 6789999
Q ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------cc
Q psy11098 179 QLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------TV 251 (380)
Q Consensus 179 e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------~~ 251 (380)
||+.+++|..++.. ..+++..++.++.|++.||.|||++|++||||||+|||++ ++.+||+|||++.... ..
T Consensus 98 e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~ 176 (297)
T cd06659 98 EFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS 176 (297)
T ss_pred ecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccc
Confidence 99999999887754 5789999999999999999999999999999999999998 5689999999986543 23
Q ss_pred ccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHh
Q psy11098 252 VLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQL 331 (380)
Q Consensus 252 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 331 (380)
..++..|+|||++.+ ..++.++|+|||||++|+|++|+.||......+....+...... .......++.++.+||++|
T Consensus 177 ~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~i~~~ 254 (297)
T cd06659 177 LVGTPYWMAPEVISR-TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPP-KLKNAHKISPVLRDFLERM 254 (297)
T ss_pred eecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCC-CccccCCCCHHHHHHHHHH
Confidence 567899999999987 46788999999999999999999999887766666555433222 1222346788999999999
Q ss_pred cccCCCCCCCHHHHHhcccccccCCC
Q psy11098 332 LNTHADKRPTAGQLLQVAWFAEASCS 357 (380)
Q Consensus 332 L~~dP~~Rpt~~e~L~hpw~~~~~~~ 357 (380)
|+.||++|||++++++||||.+..-.
T Consensus 255 l~~~P~~Rps~~~ll~~~~~~~~~~~ 280 (297)
T cd06659 255 LTREPQERATAQELLDHPFLLQTGLP 280 (297)
T ss_pred hcCCcccCcCHHHHhhChhhccCCCc
Confidence 99999999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=327.41 Aligned_cols=250 Identities=27% Similarity=0.411 Sum_probs=205.2
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCc---hHHHHHHHHHHHhhccCCCcceeeecccccCCCceEE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP---QQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
+.|++.+.||.|+||.||+|.++.+++.+|+|.++..... ...+.+|+.+++.++|+|++++.+++.... .+..|+
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-~~~~~l 83 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN-LDKIYM 83 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC-CCcEEE
Confidence 4789999999999999999999999999999999654322 234567999999999999999998876532 367899
Q ss_pred EEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCcccccc----
Q psy11098 177 VMQLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVST---- 250 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~~---- 250 (380)
||||+. ++|.+++... ..+++..++.++.||+.||.|||++|++|+||||+|||++. +.+||+|||++.....
T Consensus 84 v~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 162 (293)
T cd07843 84 VMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP 162 (293)
T ss_pred EehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCccc
Confidence 999996 5898888664 45899999999999999999999999999999999999984 6899999999876542
Q ss_pred --cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC------------------
Q psy11098 251 --VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADY------------------ 310 (380)
Q Consensus 251 --~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~------------------ 310 (380)
...+++.|+|||.+.+....+.++|+||||+++|+|++|..||......+....+.....
T Consensus 163 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (293)
T cd07843 163 YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKK 242 (293)
T ss_pred cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcc
Confidence 245688899999987755568899999999999999999999988776655544321100
Q ss_pred --------CCCCCcCCC--CCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy11098 311 --------SFPPEQCGH--ISVPARELIGQLLNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 311 --------~~~~~~~~~--~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~ 351 (380)
......+.. +++.+.+||++||+.||++|||+.|+|+||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 243 KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 000011122 48889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=324.92 Aligned_cols=250 Identities=27% Similarity=0.403 Sum_probs=212.6
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC--CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER--QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
...|+..+.||.|+||.||+|.+..+++.||+|.+.... .....+.+|+.+++.+.|+|++++++.+... +..++
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~l 79 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG---TKLWI 79 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC---CEEEE
Confidence 456888899999999999999999999999999987543 2345677899999999999999999988764 67899
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------
Q psy11098 177 VMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------ 249 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------ 249 (380)
||||+.|++|.+++.. ..+++..+..++.|++.||.|||+.+++|+||+|+||+++ ++.++|+|||++....
T Consensus 80 v~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06640 80 IMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred EEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcccc
Confidence 9999999999998864 4789999999999999999999999999999999999998 4689999999986553
Q ss_pred ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHH
Q psy11098 250 TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIG 329 (380)
Q Consensus 250 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 329 (380)
....++..|+|||++.+ ...+.++|+|||||++|+|++|..||.+.........+.... ++.....++.++.+++.
T Consensus 159 ~~~~~~~~y~apE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~ 234 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQ-SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN---PPTLTGEFSKPFKEFID 234 (277)
T ss_pred ccccCcccccCHhHhcc-CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCC---CCCCchhhhHHHHHHHH
Confidence 23356888999999877 467889999999999999999999998877665554443222 22233457889999999
Q ss_pred HhcccCCCCCCCHHHHHhcccccccCC
Q psy11098 330 QLLNTHADKRPTAGQLLQVAWFAEASC 356 (380)
Q Consensus 330 ~~L~~dP~~Rpt~~e~L~hpw~~~~~~ 356 (380)
+||..+|++|||++++++|+||.+...
T Consensus 235 ~~l~~~p~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06640 235 ACLNKDPSFRPTAKELLKHKFIVKNAK 261 (277)
T ss_pred HHcccCcccCcCHHHHHhChHhhhcch
Confidence 999999999999999999999987643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-44 Score=328.35 Aligned_cols=258 Identities=25% Similarity=0.369 Sum_probs=206.2
Q ss_pred hhhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhcc--C-CCcceeeecccccCC
Q psy11098 95 QEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMH--A-HIPTALALFENAPVP 171 (380)
Q Consensus 95 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h--~-ni~~i~~~~~~~~~~ 171 (380)
.+.+..+|.++..+|+|.||.|..+.+..++..||+|+++.-..-.+..+-|+++|+++.+ | +-.+++...+.....
T Consensus 84 gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 84 GDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred ccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 3456899999999999999999999999999999999997655566777889999999943 2 233344443333335
Q ss_pred CceEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe----------------
Q psy11098 172 GTDTIVMQLVHGESLIQHLCRQ--STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN---------------- 233 (380)
Q Consensus 172 ~~~~lv~e~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~---------------- 233 (380)
+..+||+|.+ |.|+++++..+ .+++...++.|++||++++++||+.+++|.||||+|||+.
T Consensus 164 ghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred CceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccce
Confidence 8889999999 88999999875 3689999999999999999999999999999999999981
Q ss_pred -----CCeeEEEeCCCccccc---ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHH---
Q psy11098 234 -----GAVLKLIDLGSSVSVS---TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETR--- 302 (380)
Q Consensus 234 -----~~~ikl~DFG~a~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~--- 302 (380)
+..|+|+|||.|+... ...+.|..|.|||++.+ -..+.++||||+||||+||.+|...|+...+.+.+
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLg-LGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMM 321 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILG-LGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMM 321 (415)
T ss_pred eccCCCcceEEEecCCcceeccCcceeeeccccCCchheec-cCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHH
Confidence 1148999999998765 56688999999999999 58899999999999999999999999887766533
Q ss_pred HHHhcc------------------cCCCCCCc-----------C----------CCCCHHHHHHHHHhcccCCCCCCCHH
Q psy11098 303 AHISVA------------------DYSFPPEQ-----------C----------GHISVPARELIGQLLNTHADKRPTAG 343 (380)
Q Consensus 303 ~~i~~~------------------~~~~~~~~-----------~----------~~~s~~~~~li~~~L~~dP~~Rpt~~ 343 (380)
+.|... ..+.+... + +..-.++.|||++||..||.+|+|+.
T Consensus 322 erIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~ 401 (415)
T KOG0671|consen 322 ERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLR 401 (415)
T ss_pred HHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHH
Confidence 333210 00101000 0 00112478999999999999999999
Q ss_pred HHHhccccccc
Q psy11098 344 QLLQVAWFAEA 354 (380)
Q Consensus 344 e~L~hpw~~~~ 354 (380)
|+|.||||+..
T Consensus 402 EAL~HpFF~~~ 412 (415)
T KOG0671|consen 402 EALSHPFFARL 412 (415)
T ss_pred HHhcCHHhhcC
Confidence 99999999865
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=316.64 Aligned_cols=246 Identities=27% Similarity=0.411 Sum_probs=207.9
Q ss_pred ceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC------chHHHHHHHHHHHhhccCCCcceeeecccccCCCce
Q psy11098 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ------PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~------~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~ 174 (380)
+|+..+.||+|+||+||+|....+++.||+|.+..... ....+.+|+.+++.++|+|++++.+++... +..
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~---~~~ 77 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE---DNL 77 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecC---CeE
Confidence 47778999999999999999998999999999864331 234577899999999999999999887653 678
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc----
Q psy11098 175 TIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS---- 249 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~---- 249 (380)
++++||+.+++|.+++.+...+++..+..++.||+.||.|||+.|++|+||+|+||+++ ++.+||+|||++....
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~ 157 (258)
T cd06632 78 YIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF 157 (258)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccccc
Confidence 99999999999999998887899999999999999999999999999999999999997 5689999999987543
Q ss_pred -ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHH
Q psy11098 250 -TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELI 328 (380)
Q Consensus 250 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 328 (380)
....+++.|+|||.+.....++.++|+||||+++|+|++|..||...........+.... .. ......++.++++|+
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~li 235 (258)
T cd06632 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK-EL-PPIPDHLSDEAKDFI 235 (258)
T ss_pred ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcc-cC-CCcCCCcCHHHHHHH
Confidence 345678899999998774347889999999999999999999997766544444443211 11 112245789999999
Q ss_pred HHhcccCCCCCCCHHHHHhcccc
Q psy11098 329 GQLLNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 329 ~~~L~~dP~~Rpt~~e~L~hpw~ 351 (380)
++||..||.+|||++++|.|||+
T Consensus 236 ~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 236 LKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHhhcCcccCcCHHHHhcCCCC
Confidence 99999999999999999999997
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-44 Score=329.85 Aligned_cols=257 Identities=24% Similarity=0.400 Sum_probs=227.2
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC----CchHHHHHHHHHHHhhc-cCCCcceeeecccccCCCce
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQITRAEYNLLSTLM-HAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~il~~l~-h~ni~~i~~~~~~~~~~~~~ 174 (380)
.+|..+..||+|+||+|-+|..+.|.+.||||+++++. .+.+-...|-++|.... -|.++.++.+|.. .+++
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT---mDRL 425 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT---MDRL 425 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh---hhhe
Confidence 56888999999999999999999999999999997653 23344456777887664 5566666666666 4899
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccc-----
Q psy11098 175 TIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSV----- 248 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~----- 248 (380)
|+||||+.||+|.-.|++-+.+.|..+..++..|+-||-+||++||++||||.+|||+| +|.|||+|||+.+..
T Consensus 426 yFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~ 505 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGV 505 (683)
T ss_pred eeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCCc
Confidence 99999999999999999999999999999999999999999999999999999999998 689999999998643
Q ss_pred -cccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHH
Q psy11098 249 -STVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAREL 327 (380)
Q Consensus 249 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 327 (380)
..+++|||.|+|||++.. .+|+.++|+||+||+||||+.|.+||.++..+++.+.|+.....+|. .+|.++.++
T Consensus 506 TTkTFCGTPdYiAPEIi~Y-qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPK----slSkEAv~i 580 (683)
T KOG0696|consen 506 TTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPK----SLSKEAVAI 580 (683)
T ss_pred ceeeecCCCcccccceEEe-cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcc----cccHHHHHH
Confidence 368899999999999998 69999999999999999999999999999999999999999888885 589999999
Q ss_pred HHHhcccCCCCCCCH-----HHHHhcccccccCCCCCccccc
Q psy11098 328 IGQLLNTHADKRPTA-----GQLLQVAWFAEASCSEFDTERL 364 (380)
Q Consensus 328 i~~~L~~dP~~Rpt~-----~e~L~hpw~~~~~~~~~~~~~~ 364 (380)
.+.+|.+.|.+|..+ .++-.||||....+..++...+
T Consensus 581 ckg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~ei 622 (683)
T KOG0696|consen 581 CKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREI 622 (683)
T ss_pred HHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccC
Confidence 999999999999753 6889999999887776655555
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=335.33 Aligned_cols=244 Identities=21% Similarity=0.324 Sum_probs=198.2
Q ss_pred hhceeeeeeecccCCeEEEEEEE-----cCCCcEEEEEEecCCCC--chHHHHHHHHHHHhh-ccCCCcceeeecccccC
Q psy11098 99 EHRYEELERLGNGRFCTVRKARD-----RGTGQLVALKQIPRERQ--PQQITRAEYNLLSTL-MHAHIPTALALFENAPV 170 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~-----~~~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~~ 170 (380)
.++|++.+.||+|+||+||+|.+ ..++..||+|+++.... ..+.+.+|+.+++.+ .||||+++++++...
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~-- 111 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG-- 111 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC--
Confidence 46799999999999999999974 34567899999964432 345677899999999 899999999988764
Q ss_pred CCceEEEEEecCCCCHHHHHHhcC--------------------------------------------------------
Q psy11098 171 PGTDTIVMQLVHGESLIQHLCRQS-------------------------------------------------------- 194 (380)
Q Consensus 171 ~~~~~lv~e~~~gg~L~~~l~~~~-------------------------------------------------------- 194 (380)
+..++||||+.||+|.+++....
T Consensus 112 -~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 112 -GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred -CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 56799999999999999986421
Q ss_pred -------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCcccccc----
Q psy11098 195 -------------------TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVST---- 250 (380)
Q Consensus 195 -------------------~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~~---- 250 (380)
.+++..+..++.||+.||.|||++||+||||||+|||++. +.+||+|||++.....
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 4678889999999999999999999999999999999985 5899999999875531
Q ss_pred ----cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHH
Q psy11098 251 ----VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAR 325 (380)
Q Consensus 251 ----~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 325 (380)
...++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.................. .....+.+++
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~-~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~ 347 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML--SPECAPSEMY 347 (375)
T ss_pred cccCCCCCCcceeChhHhcC-CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCC--CCCCCCHHHH
Confidence 2233567999999987 478899999999999999998 9999987654433333333222222 1234688999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhc
Q psy11098 326 ELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 326 ~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
+||.+||+.||++|||+.|+++.
T Consensus 348 ~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 348 DIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHHHHccCChhHCcCHHHHHHH
Confidence 99999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=321.29 Aligned_cols=242 Identities=21% Similarity=0.297 Sum_probs=206.7
Q ss_pred hhceeeeeeecccCCeEEEEEEEcC-----CCcEEEEEEecCCCCc--hHHHHHHHHHHHhhccCCCcceeeecccccCC
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRG-----TGQLVALKQIPRERQP--QQITRAEYNLLSTLMHAHIPTALALFENAPVP 171 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vAvK~~~~~~~~--~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~ 171 (380)
.++|.+.+.||+|+||.||+|.+.. +++.||+|++...... .+.+.+|+++++.+.|+|++++++++...
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--- 80 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEG--- 80 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecC---
Confidence 3568889999999999999998753 4678999999754433 46778899999999999999999988764
Q ss_pred CceEEEEEecCCCCHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCe
Q psy11098 172 GTDTIVMQLVHGESLIQHLCRQ--------------STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAV 236 (380)
Q Consensus 172 ~~~~lv~e~~~gg~L~~~l~~~--------------~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ 236 (380)
+..+++|||+.|++|.+++... ..+++..+..++.||+.||.|||++|++||||||+|||++ ++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence 6779999999999999999654 2478889999999999999999999999999999999997 569
Q ss_pred eEEEeCCCccccc--------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhc
Q psy11098 237 LKLIDLGSSVSVS--------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISV 307 (380)
Q Consensus 237 ikl~DFG~a~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~ 307 (380)
+||+|||++.... ....+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ 239 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhcc-CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 9999999987542 23344678999999987 467889999999999999998 9999998888887777775
Q ss_pred ccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy11098 308 ADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 308 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~ 347 (380)
.....+. ..++.++++++.+||..||++|||+.|+++
T Consensus 240 ~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 240 GRLLQRP---RTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CCcCCCC---CCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 5443332 357899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=318.53 Aligned_cols=241 Identities=27% Similarity=0.424 Sum_probs=209.1
Q ss_pred ecccCCeEEEEEEEcCCCcEEEEEEecCCCC----chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEEEecCC
Q psy11098 108 LGNGRFCTVRKARDRGTGQLVALKQIPRERQ----PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHG 183 (380)
Q Consensus 108 LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e~~~g 183 (380)
||.|+||.||++++..+|+.+|+|.+..... ....+.+|+++++.++|+|++++++.+.. .+..|+++||+.|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~---~~~~~lv~e~~~~ 77 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG---KKNLYLVMEYLPG 77 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheec---CcEEEEEEecCCC
Confidence 6899999999999999999999999965432 34567789999999999999998877765 4678999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-------------
Q psy11098 184 ESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------------- 249 (380)
Q Consensus 184 g~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------------- 249 (380)
++|.+++.+...+++..+..++.||+.||.|||+.|++|+||+|+||+++ ++.++|+|||++....
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 78 GDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 99999998877899999999999999999999999999999999999998 5689999999886532
Q ss_pred -ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHH
Q psy11098 250 -TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELI 328 (380)
Q Consensus 250 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 328 (380)
....++..|+|||.+... ..+.++|+||||+++|+|++|..||......+....+......++.. ..++.++.+|+
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i 234 (265)
T cd05579 158 DKRIVGTPDYIAPEVILGQ-GHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED--VEVSDEAIDLI 234 (265)
T ss_pred ccCcccCccccCHHHhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCcc--ccCCHHHHHHH
Confidence 124567889999998774 57889999999999999999999999888888877777655544432 23689999999
Q ss_pred HHhcccCCCCCCCH---HHHHhccccccc
Q psy11098 329 GQLLNTHADKRPTA---GQLLQVAWFAEA 354 (380)
Q Consensus 329 ~~~L~~dP~~Rpt~---~e~L~hpw~~~~ 354 (380)
++||+.+|++|||+ .++|+||||.+.
T Consensus 235 ~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 235 SKLLVPDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred HHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence 99999999999999 999999999865
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=321.62 Aligned_cols=242 Identities=24% Similarity=0.345 Sum_probs=205.8
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCC-----cEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCC
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTG-----QLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPG 172 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~-----~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~ 172 (380)
++|++.+.||+|+||.||+|.+...+ +.||+|.+..... ....+.+|+.+++.++|+|++++++++... +
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~---~ 81 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE---Q 81 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC---C
Confidence 57889999999999999999977655 6899999864432 234578899999999999999999988754 5
Q ss_pred ceEEEEEecCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-C
Q psy11098 173 TDTIVMQLVHGESLIQHLCRQ----------------STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-A 235 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~~----------------~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~ 235 (380)
..+++|||+.+++|.+++... ..+++..+..++.||+.||.|||++|++|+||||+|||+++ +
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC
Confidence 679999999999999999764 45788999999999999999999999999999999999985 5
Q ss_pred eeEEEeCCCccccc--------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHh
Q psy11098 236 VLKLIDLGSSVSVS--------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHIS 306 (380)
Q Consensus 236 ~ikl~DFG~a~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~ 306 (380)
.+||+|||++.... ....+++.|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+.+..+....+.
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY-GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR 240 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhcc-CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 89999999987542 23445788999999877 467889999999999999998 999999988888877776
Q ss_pred cccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 307 VADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 307 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
...... ....++.++.+|+++||+.||.+|||+.|++++
T Consensus 241 ~~~~~~---~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 241 SRQLLP---CPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred cCCcCC---CcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 554322 224679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=317.80 Aligned_cols=242 Identities=18% Similarity=0.248 Sum_probs=203.3
Q ss_pred hhceeeeeeecccCCeEEEEEEEc---CCCcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCCc
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDR---GTGQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGT 173 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~---~~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~ 173 (380)
..+|++.+.||+|+||.||+|.++ ..+..||+|.++.... ....+.+|+.+++.++|+|++++++++... +.
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~ 80 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRG---NT 80 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC---CC
Confidence 457999999999999999999875 3467899999975432 234567899999999999999999988753 67
Q ss_pred eEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc--
Q psy11098 174 DTIVMQLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS-- 249 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~-- 249 (380)
.++||||+.+++|.+++... ..+++..+..++.||+.||.|||++|++||||||+|||++ ++.+|++|||.+....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 89999999999999998764 5789999999999999999999999999999999999998 4589999999875432
Q ss_pred -----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHH
Q psy11098 250 -----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVP 323 (380)
Q Consensus 250 -----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 323 (380)
....++..|+|||++.+ ..++.++|||||||++|++++ |..||.+.+..+....+..... .+ ....++..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~ 236 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFR-LP--APRNCPNL 236 (266)
T ss_pred chhcccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC-CC--CCCCCCHH
Confidence 12234678999999887 577889999999999999775 9999998888777776654422 22 23457899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHh
Q psy11098 324 ARELIGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 324 ~~~li~~~L~~dP~~Rpt~~e~L~ 347 (380)
+.+++.+||+.+|++|||++++++
T Consensus 237 ~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 237 LHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHHHHcCCCchhCCCHHHHHH
Confidence 999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=320.78 Aligned_cols=252 Identities=23% Similarity=0.394 Sum_probs=213.3
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC-CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER-QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIV 177 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv 177 (380)
...|...+.||+|++|.||++.+..+++.+|+|.+.... .....+.+|+.+++.+.|+|++++++++... +..+++
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~---~~~~~v 94 (285)
T cd06648 18 RSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVG---DELWVV 94 (285)
T ss_pred hHhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcC---CeEEEE
Confidence 345666789999999999999999999999999986433 2345567899999999999999999987753 677999
Q ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------c
Q psy11098 178 MQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------T 250 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------~ 250 (380)
+||+.|++|.+++.. ..+++..+..++.|++.||.|||++||+||||+|+||+++ ++.++|+|||.+.... .
T Consensus 95 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~ 173 (285)
T cd06648 95 MEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK 173 (285)
T ss_pred EeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccc
Confidence 999999999999876 6789999999999999999999999999999999999998 5699999999876543 2
Q ss_pred cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHH
Q psy11098 251 VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQ 330 (380)
Q Consensus 251 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 330 (380)
...|++.|+|||++.+ ..++.++|+||||+++|+|++|..||...+..+....+........ .....++.++.+||.+
T Consensus 174 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~ 251 (285)
T cd06648 174 SLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKL-KNLHKVSPRLRSFLDR 251 (285)
T ss_pred cccCCccccCHHHhcC-CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCC-cccccCCHHHHHHHHH
Confidence 3457899999999877 4678899999999999999999999988777666666654422211 1223478899999999
Q ss_pred hcccCCCCCCCHHHHHhcccccccCC
Q psy11098 331 LLNTHADKRPTAGQLLQVAWFAEASC 356 (380)
Q Consensus 331 ~L~~dP~~Rpt~~e~L~hpw~~~~~~ 356 (380)
||..||++|||+.++|+||||.+...
T Consensus 252 ~l~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 252 MLVRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred HcccChhhCcCHHHHccCcccccCCC
Confidence 99999999999999999999988653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=323.11 Aligned_cols=251 Identities=23% Similarity=0.307 Sum_probs=210.3
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
.++|++.+.||+|+||+||++.+..+++.||+|++..... ....+.+|+++++.++|+|++++++++... +..++
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~~l 80 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNE---NNICM 80 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecC---CEEEE
Confidence 3678999999999999999999999999999999865432 345678899999999999999999988764 67899
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeecCCCCcEEEe-CCeeEEEeCCCccccc----c
Q psy11098 177 VMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHS-QQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS----T 250 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~-~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~----~ 250 (380)
||||+.+++|.+++...+.+++..+..++.+++.||.|||+ .+++||||||+||+++ ++.++|+|||++.... .
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~~ 160 (284)
T cd06620 81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD 160 (284)
T ss_pred EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhccC
Confidence 99999999999999887889999999999999999999997 6999999999999998 4689999999986542 3
Q ss_pred cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHH-----------HHHHHHhcccCCCCCCcCCC
Q psy11098 251 VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEE-----------ETRAHISVADYSFPPEQCGH 319 (380)
Q Consensus 251 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~-----------~~~~~i~~~~~~~~~~~~~~ 319 (380)
...|+..|+|||++.+ ..++.++|+|||||++|+|++|..||...... +....+.... .+......
T Consensus 161 ~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 237 (284)
T cd06620 161 TFVGTSTYMSPERIQG-GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP--PPRLPSSD 237 (284)
T ss_pred ccccCcccCCHHHHcc-CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc--CCCCCchh
Confidence 4578999999999877 47788999999999999999999999865542 1222222211 11111123
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 320 ISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 320 ~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
++.++.+|+++||.+||++|||++|+++|+||.+..
T Consensus 238 ~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 238 FPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred cCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 678999999999999999999999999999997753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=336.11 Aligned_cols=248 Identities=25% Similarity=0.347 Sum_probs=198.6
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC---CCchHHHHHHHHHHHhhc-cCCCcceeeecccccCCCce
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE---RQPQQITRAEYNLLSTLM-HAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~il~~l~-h~ni~~i~~~~~~~~~~~~~ 174 (380)
...|+++++||+||.+.||++.... .+.||+|.+... ......+.+|+.+|.+|+ |.+|+.++++ .-..+.+
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DY---Ev~d~~l 435 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDY---EVTDGYL 435 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeee---eccCceE
Confidence 4679999999999999999999654 567788776533 334567899999999996 6566555554 4446889
Q ss_pred EEEEEecCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeCCeeEEEeCCCccccc----
Q psy11098 175 TIVMQLVHGESLIQHLCRQST-ITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGAVLKLIDLGSSVSVS---- 249 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~~~-l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~~~ikl~DFG~a~~~~---- 249 (380)
|||||+- ..+|..+|.+... +....++.+.+|++.|+.++|+.||||-||||.|+|+-.|.+||||||.|..+.
T Consensus 436 YmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVkG~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 436 YMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVKGRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred EEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEeeeEEeeeechhcccCcccc
Confidence 9999986 6889999977654 333589999999999999999999999999999999999999999999997663
Q ss_pred ----ccccCCCcccCCccccCC----------CCCCCcccHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhcccC--CC
Q psy11098 250 ----TVVLPDLEFASPEMLTSP----------ATAGPSTDMWSLGVLLYILLSGVSPFLDES-EEETRAHISVADY--SF 312 (380)
Q Consensus 250 ----~~~~gt~~y~aPE~~~~~----------~~~~~~~DiwSlGvil~~lltg~~Pf~~~~-~~~~~~~i~~~~~--~~ 312 (380)
...+||+.||+||.+... -..+.++||||||||||+|+.|+.||...- ....+..|...+. .|
T Consensus 515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Ief 594 (677)
T KOG0596|consen 515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEF 594 (677)
T ss_pred ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccc
Confidence 457899999999987531 124679999999999999999999997653 4444555554433 33
Q ss_pred CCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 313 PPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 313 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
+.. . -..++.++++.||..||++|||+.++|+|||++-.
T Consensus 595 p~~--~-~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~ 633 (677)
T KOG0596|consen 595 PDI--P-ENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ 633 (677)
T ss_pred cCC--C-CchHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence 321 1 12349999999999999999999999999999874
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=315.43 Aligned_cols=242 Identities=18% Similarity=0.271 Sum_probs=206.9
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEEE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQ 179 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e 179 (380)
..|.+.+.||+|+||.||+|.++.+++.||+|.+..+......+.+|+++++.+.|+|++++++++... +..+++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~lv~e 82 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE---PPFYIITE 82 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCC---CCcEEEEE
Confidence 458889999999999999999999999999999976655556778899999999999999999887654 57799999
Q ss_pred ecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccccc------
Q psy11098 180 LVHGESLIQHLCRQ--STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVST------ 250 (380)
Q Consensus 180 ~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~~------ 250 (380)
|+.+++|.+++... ..+++..+..++.|++.||.|||++|++||||||+|||++ ++.+||+|||++.....
T Consensus 83 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~ 162 (263)
T cd05052 83 FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 162 (263)
T ss_pred eCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeecc
Confidence 99999999998653 3589999999999999999999999999999999999997 56899999999876542
Q ss_pred -cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHH
Q psy11098 251 -VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELI 328 (380)
Q Consensus 251 -~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 328 (380)
...++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+...++....+.... .......++.++.++|
T Consensus 163 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li 238 (263)
T cd05052 163 AGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY---RMERPEGCPPKVYELM 238 (263)
T ss_pred CCCCCccccCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC---CCCCCCCCCHHHHHHH
Confidence 1223567999999877 467889999999999999998 999998887777766665432 1222346789999999
Q ss_pred HHhcccCCCCCCCHHHHHhc
Q psy11098 329 GQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 329 ~~~L~~dP~~Rpt~~e~L~h 348 (380)
.+||..||++|||+.++++.
T Consensus 239 ~~cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 239 RACWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred HHHccCCcccCCCHHHHHHH
Confidence 99999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=321.11 Aligned_cols=244 Identities=28% Similarity=0.487 Sum_probs=212.7
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC----CchHHHHHHHHHHHhhc-cCCCcceeeecccccCCCce
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQITRAEYNLLSTLM-HAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~il~~l~-h~ni~~i~~~~~~~~~~~~~ 174 (380)
++|++.+.||+|+||.||+|....+++.||+|++.... .....+..|.++++.+. |+|++++++++... +..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~---~~~ 77 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE---ENL 77 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC---ceE
Confidence 36899999999999999999999999999999986532 22355677999999998 99999988877653 678
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccccc---
Q psy11098 175 TIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVST--- 250 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~~--- 250 (380)
+++||++.+++|.+++.+...+++..+..++.|++.||.|||+.|++|+||+|+||+++ ++.++|+|||++.....
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 78 YFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 99999999999999998888999999999999999999999999999999999999998 46899999999875532
Q ss_pred -----------------------cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Q psy11098 251 -----------------------VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISV 307 (380)
Q Consensus 251 -----------------------~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~ 307 (380)
...++..|+|||++.. ...+.++|+||||++++++++|..||...........+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 236 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILK 236 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh
Confidence 2346788999999877 4678899999999999999999999988877666666665
Q ss_pred ccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCH----HHHHhcccc
Q psy11098 308 ADYSFPPEQCGHISVPARELIGQLLNTHADKRPTA----GQLLQVAWF 351 (380)
Q Consensus 308 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~----~e~L~hpw~ 351 (380)
....++. .++..+.+||.+||+.||.+|||+ +++|+||||
T Consensus 237 ~~~~~~~----~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 237 LEYSFPP----NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred cCCCCCC----ccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 5555543 468999999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=329.85 Aligned_cols=255 Identities=26% Similarity=0.337 Sum_probs=213.1
Q ss_pred ceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC---CchHHHHHHHHHHHhhccCCCcceeeeccccc--CCCceE
Q psy11098 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER---QPQQITRAEYNLLSTLMHAHIPTALALFENAP--VPGTDT 175 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~--~~~~~~ 175 (380)
+|++.+.||.|+||.||+|++..+++.||+|.+.... .....+.+|+.+++.++|+|++++.+++.... .....|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5889999999999999999999999999999986543 23456788999999999999999998877643 223679
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccccc----
Q psy11098 176 IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVST---- 250 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~~---- 250 (380)
++|||+. ++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.++|+|||++.....
T Consensus 81 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~ 159 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159 (330)
T ss_pred EEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccc
Confidence 9999995 68999998777899999999999999999999999999999999999998 56999999999876532
Q ss_pred -----cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCC-----------
Q psy11098 251 -----VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPP----------- 314 (380)
Q Consensus 251 -----~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~----------- 314 (380)
...+++.|+|||++.+...++.++|+||||+++|+|++|.+||.+.+..+....+.......+.
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 239 (330)
T cd07834 160 KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA 239 (330)
T ss_pred cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccch
Confidence 2356888999999988547888999999999999999999999888776655554432111110
Q ss_pred ----------------CcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCC
Q psy11098 315 ----------------EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASC 356 (380)
Q Consensus 315 ----------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~ 356 (380)
.....++.++.+||.+||++||.+|||++++|.||||.+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred hhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 012346888999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=324.75 Aligned_cols=254 Identities=25% Similarity=0.339 Sum_probs=211.1
Q ss_pred hhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC----chHHHHHHHHHHHhhccCCCcceeeecccccCC
Q psy11098 96 EQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ----PQQITRAEYNLLSTLMHAHIPTALALFENAPVP 171 (380)
Q Consensus 96 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~ 171 (380)
.+..++|++.+.||+|+||.||+|.+..+++.||+|.+..... ....+.+|+++++.++|+|++++.+++...
T Consensus 11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~--- 87 (307)
T cd06607 11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE--- 87 (307)
T ss_pred CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC---
Confidence 3456789999999999999999999999999999999864322 224567899999999999999999988764
Q ss_pred CceEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc
Q psy11098 172 GTDTIVMQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS 249 (380)
Q Consensus 172 ~~~~lv~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~ 249 (380)
+..++||||+. |++.+.+.. ...+++..+..++.||+.||.|||+.||+||||+|+||+++ ++.+||+|||++....
T Consensus 88 ~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 88 HTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred CeEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 66799999995 677776653 56799999999999999999999999999999999999997 5689999999987553
Q ss_pred --ccccCCCcccCCccccC--CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHH
Q psy11098 250 --TVVLPDLEFASPEMLTS--PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAR 325 (380)
Q Consensus 250 --~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 325 (380)
....+++.|+|||++.+ ...++.++||||||+++|+|++|..||.+.........+..... +......++.+++
T Consensus 167 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 244 (307)
T cd06607 167 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS--PTLSSNDWSDYFR 244 (307)
T ss_pred CCCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC--CCCCchhhCHHHH
Confidence 44567889999998852 24577899999999999999999999988776665555443221 1111234688999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 326 ELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 326 ~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
++|.+||..||++|||+.+++.||||....
T Consensus 245 ~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 245 NFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred HHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 999999999999999999999999998764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=324.94 Aligned_cols=245 Identities=19% Similarity=0.247 Sum_probs=196.9
Q ss_pred hhceeeeeeecccCCeEEEEEEEcC----------------CCcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcc
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRG----------------TGQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPT 160 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~----------------~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~ 160 (380)
.++|++.+.||+|+||.||+|.+.. ++..||+|++..... ....+.+|++++..++|+||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4689999999999999999998542 345799999875433 2345778999999999999999
Q ss_pred eeeecccccCCCceEEEEEecCCCCHHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCcE
Q psy11098 161 ALALFENAPVPGTDTIVMQLVHGESLIQHLCRQS-------------------TITESYICCIIRQLHSALHCLHSQQIA 221 (380)
Q Consensus 161 i~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-------------------~l~e~~~~~i~~qil~al~~lH~~~ii 221 (380)
+++++... +..++||||+.+++|.+++.... .+++..+..++.||+.||.|||+.||+
T Consensus 84 ~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 84 LLGVCVDE---DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred EEEEEecC---CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 99988764 56799999999999999986531 357778899999999999999999999
Q ss_pred eecCCCCcEEEeC-CeeEEEeCCCccccc--------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh--CC
Q psy11098 222 HKDIRPENILMNG-AVLKLIDLGSSVSVS--------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS--GV 290 (380)
Q Consensus 222 HrDlKp~NIl~~~-~~ikl~DFG~a~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt--g~ 290 (380)
||||||+|||++. +.+||+|||++.... ....++..|+|||++.+ ..++.++||||||+++|+|++ +.
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM-GKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc-CCCCchhhhHHHHHHHHHHHHccCC
Confidence 9999999999984 589999999987542 23345778999999877 467889999999999999986 67
Q ss_pred CCCCCCCHHHHHHHHhcc----cCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy11098 291 SPFLDESEEETRAHISVA----DYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 291 ~Pf~~~~~~~~~~~i~~~----~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~ 347 (380)
.||.+.+..+....+... ...........++..+.+||.+||..||++|||++++.+
T Consensus 240 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 240 QPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred CCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 889877766655443221 001111112346889999999999999999999999953
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=322.05 Aligned_cols=255 Identities=27% Similarity=0.448 Sum_probs=218.8
Q ss_pred hhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 96 EQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 96 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
.+..+.|++.+.||.|+||.||+|.+..+++.+|+|++.........+.+|+++++.++|+|++++++.+... +..+
T Consensus 15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~ 91 (286)
T cd06614 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVG---DELW 91 (286)
T ss_pred CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEEC---CEEE
Confidence 3457789999999999999999999998999999999976554556678899999999999999999888764 6789
Q ss_pred EEEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc----
Q psy11098 176 IVMQLVHGESLIQHLCRQS-TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS---- 249 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~~-~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~---- 249 (380)
+++||+.|++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++ ++.++|+|||++....
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 92 VVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence 9999999999999998776 899999999999999999999999999999999999998 5689999999876543
Q ss_pred --ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHH
Q psy11098 250 --TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAREL 327 (380)
Q Consensus 250 --~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 327 (380)
....++..|+|||++.+ ..++.++|+||||+++|+|++|..||...........+...... .......++.++++|
T Consensus 172 ~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l 249 (286)
T cd06614 172 KRNSVVGTPYWMAPEVIKR-KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIP-PLKNPEKWSPEFKDF 249 (286)
T ss_pred hhccccCCcccCCHhHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-CCcchhhCCHHHHHH
Confidence 23457889999999887 46788999999999999999999999887766655555433221 112223478999999
Q ss_pred HHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 328 IGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 328 i~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
|++||+.+|.+|||+.++|+|+||.+..
T Consensus 250 i~~~l~~~p~~Rpt~~~il~~~~~~~~~ 277 (286)
T cd06614 250 LNKCLVKDPEKRPSAEELLQHPFLKKAC 277 (286)
T ss_pred HHHHhccChhhCcCHHHHhhChHhhccC
Confidence 9999999999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=315.15 Aligned_cols=241 Identities=26% Similarity=0.402 Sum_probs=207.6
Q ss_pred ceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC--CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEE
Q psy11098 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER--QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVM 178 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~ 178 (380)
+|++.+.||.|+||.||++.+..+++.+|+|.++... ...+...+|+.+++.++|+|++++.+.+... +..+++|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~lv~ 77 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEAD---GHLYIVM 77 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEEC---CEEEEEE
Confidence 5889999999999999999999999999999986433 2345667899999999999999999988764 6789999
Q ss_pred EecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------
Q psy11098 179 QLVHGESLIQHLCR--QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------ 249 (380)
Q Consensus 179 e~~~gg~L~~~l~~--~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------ 249 (380)
||+.+++|.+++.. ...+++..+..++.||+.||.|||++||+|+||||+|||++ ++.++|+|||++....
T Consensus 78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 157 (255)
T cd08219 78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYA 157 (255)
T ss_pred eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccccc
Confidence 99999999998865 34589999999999999999999999999999999999998 5689999999987553
Q ss_pred ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHH
Q psy11098 250 TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIG 329 (380)
Q Consensus 250 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 329 (380)
....+++.|+|||++.+ ..++.++|+||||+++|+|++|..||...+.......+........+ ..++.++++||.
T Consensus 158 ~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~ 233 (255)
T cd08219 158 CTYVGTPYYVPPEIWEN-MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLP---SHYSYELRSLIK 233 (255)
T ss_pred ccccCCccccCHHHHcc-CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCC---cccCHHHHHHHH
Confidence 23567889999999987 46788999999999999999999999988777776666655443222 357889999999
Q ss_pred HhcccCCCCCCCHHHHHhc
Q psy11098 330 QLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 330 ~~L~~dP~~Rpt~~e~L~h 348 (380)
+||+.||++|||+.++|.-
T Consensus 234 ~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 234 QMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHhCCcccCCCHHHHhhc
Confidence 9999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=315.09 Aligned_cols=244 Identities=27% Similarity=0.453 Sum_probs=208.6
Q ss_pred ceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC---CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEE
Q psy11098 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER---QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIV 177 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv 177 (380)
+|++.+.||+|+||.||++.++.+|..+|+|.+.... .....+.+|+++++.++|+|++++++.+... +..+++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~---~~~~lv 77 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQEN---GRLFIV 77 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccC---CeEEEE
Confidence 5888999999999999999999999999999996532 3345667899999999999999998887654 677999
Q ss_pred EEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeCC--eeEEEeCCCcccccc---
Q psy11098 178 MQLVHGESLIQHLCRQS--TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGA--VLKLIDLGSSVSVST--- 250 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~~~--~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~~--~ikl~DFG~a~~~~~--- 250 (380)
+||+.+++|.+++.... .+++..+..++.|++.||.|||+.+++|+||||+||+++++ .+||+|||.+.....
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 78 MEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 99999999999997643 57999999999999999999999999999999999999854 579999999876532
Q ss_pred ---cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHH
Q psy11098 251 ---VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAREL 327 (380)
Q Consensus 251 ---~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 327 (380)
...|++.|+|||++.+ ..++.++|+||||+++|+|++|..||...+..+....+...... +....++.+++++
T Consensus 158 ~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 233 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQN-RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFA---PISPNFSRDLRSL 233 (257)
T ss_pred cccccCCCccccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCC---CCCCCCCHHHHHH
Confidence 2357889999999877 46788999999999999999999999887766666655544322 1223578899999
Q ss_pred HHHhcccCCCCCCCHHHHHhcccc
Q psy11098 328 IGQLLNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 328 i~~~L~~dP~~Rpt~~e~L~hpw~ 351 (380)
|++||..+|++|||+.++++||||
T Consensus 234 i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 234 ISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHHhccChhhCcCHHHHhhCCCC
Confidence 999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=320.47 Aligned_cols=250 Identities=26% Similarity=0.386 Sum_probs=211.0
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
.+-|++.+.||+|+||.||+|.+..+++.||+|.+..... ....+.+|+++++.+.|+|++++++.+... +..++
T Consensus 3 ~~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~l 79 (277)
T cd06641 3 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD---TKLWI 79 (277)
T ss_pred HHhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeC---CeEEE
Confidence 3457888999999999999999999999999999864432 335677899999999999999999988764 67799
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccccc-----
Q psy11098 177 VMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVST----- 250 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~~----- 250 (380)
||||+.+++|.+++.. ..+++..+..++.|++.|+.|||+.|++|+||||+||+++ ++.++|+|||++.....
T Consensus 80 v~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06641 80 IMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred EEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhh
Confidence 9999999999998864 4689999999999999999999999999999999999998 45899999999865532
Q ss_pred -cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHH
Q psy11098 251 -VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIG 329 (380)
Q Consensus 251 -~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 329 (380)
...++..|+|||.+.+ ...+.++|+|||||++|+|++|..||...........+..... +.....++.++.+++.
T Consensus 159 ~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~i~ 234 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP---PTLEGNYSKPLKEFVE 234 (277)
T ss_pred ccccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCC---CCCCcccCHHHHHHHH
Confidence 3457889999999877 4667899999999999999999999987766655555433221 1222357889999999
Q ss_pred HhcccCCCCCCCHHHHHhcccccccCC
Q psy11098 330 QLLNTHADKRPTAGQLLQVAWFAEASC 356 (380)
Q Consensus 330 ~~L~~dP~~Rpt~~e~L~hpw~~~~~~ 356 (380)
+||..+|.+||++.++++||||.+...
T Consensus 235 ~~l~~~p~~Rp~~~~~l~~~~~~~~~~ 261 (277)
T cd06641 235 ACLNKEPSFRPTAKELLKHKFIVRFAK 261 (277)
T ss_pred HHccCChhhCcCHHHHHhCHHHhhhhh
Confidence 999999999999999999999988643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=316.82 Aligned_cols=247 Identities=29% Similarity=0.418 Sum_probs=212.8
Q ss_pred ceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEE
Q psy11098 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVM 178 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~ 178 (380)
+|++.+.||+|++|.||+|++..+++.||+|++..... ....+.+|+.++..++|+|++++++++... +..+++|
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~lv~ 78 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKE---GEISIVL 78 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccC---CeEEEEE
Confidence 68889999999999999999999999999999976543 356678899999999999999999888764 6789999
Q ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeecCCCCcEEEe-CCeeEEEeCCCcccccc------
Q psy11098 179 QLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHS-QQIAHKDIRPENILMN-GAVLKLIDLGSSVSVST------ 250 (380)
Q Consensus 179 e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~-~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~~------ 250 (380)
||+.+++|.+++.....+++..+..++.||+.||.|||+ .|++|+||+|+||+++ ++.++|+|||++.....
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 158 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN 158 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCccc
Confidence 999999999999887889999999999999999999999 9999999999999997 56899999999876531
Q ss_pred cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHhcccCCCCCCcCCC-CCHHHHH
Q psy11098 251 VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDE---SEEETRAHISVADYSFPPEQCGH-ISVPARE 326 (380)
Q Consensus 251 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~---~~~~~~~~i~~~~~~~~~~~~~~-~s~~~~~ 326 (380)
...++..|+|||.+.+ ..++.++|+||||+++|+|++|..||... ...+....+...... ..... ++..+.+
T Consensus 159 ~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~ 234 (264)
T cd06623 159 TFVGTVTYMSPERIQG-ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPP---SLPAEEFSPEFRD 234 (264)
T ss_pred ceeecccccCHhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCC---CCCcccCCHHHHH
Confidence 3456889999999887 47788999999999999999999999776 444455554432211 11223 7899999
Q ss_pred HHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 327 LIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 327 li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
+|.+||..+|++|||+.++|+||||+..
T Consensus 235 li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 235 FISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred HHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 9999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=331.04 Aligned_cols=258 Identities=27% Similarity=0.369 Sum_probs=209.0
Q ss_pred hhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---chHHHHHHHHHHHhhccCCCcceeeeccccc---
Q psy11098 96 EQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLMHAHIPTALALFENAP--- 169 (380)
Q Consensus 96 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~--- 169 (380)
..+.++|++.+.||+|+||.||+|.+..+++.||+|++..... ....+.+|+++++.++|+||+++++++....
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (345)
T cd07877 13 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 92 (345)
T ss_pred hhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccc
Confidence 3467899999999999999999999999999999999965322 2345677999999999999999998876432
Q ss_pred CCCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccc
Q psy11098 170 VPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSV 248 (380)
Q Consensus 170 ~~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~ 248 (380)
.....+++++++ |++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++ ++.+||+|||++...
T Consensus 93 ~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~ 170 (345)
T cd07877 93 EFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 170 (345)
T ss_pred ccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccc
Confidence 223467888887 8899887754 4699999999999999999999999999999999999998 568999999998765
Q ss_pred c---ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC---------------
Q psy11098 249 S---TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADY--------------- 310 (380)
Q Consensus 249 ~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~--------------- 310 (380)
. ....+++.|+|||++.+...++.++|+|||||++|+|++|..||...........+.....
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (345)
T cd07877 171 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 250 (345)
T ss_pred cccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhH
Confidence 4 2346788999999987645678899999999999999999999977665444333321110
Q ss_pred --------CCCCC----cCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 311 --------SFPPE----QCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 311 --------~~~~~----~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
..+.. .....+.++++||.+||+.||.+|||+.++|.||||++..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~ 307 (345)
T cd07877 251 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 307 (345)
T ss_pred HHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcC
Confidence 00110 1123578899999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=330.64 Aligned_cols=257 Identities=24% Similarity=0.354 Sum_probs=211.2
Q ss_pred hhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---chHHHHHHHHHHHhhccCCCcceeeecccccCC-
Q psy11098 96 EQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLMHAHIPTALALFENAPVP- 171 (380)
Q Consensus 96 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~- 171 (380)
..+.++|++.+.||+|+||.||+|.+..+++.||+|.+.+... ....+.+|+++++.++|+||+++++++......
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 3467899999999999999999999999999999999865332 234567899999999999999999988754322
Q ss_pred --CceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccc
Q psy11098 172 --GTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSV 248 (380)
Q Consensus 172 --~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~ 248 (380)
...++||||+ |++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++ ++.+||+|||++...
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 2458999999 8899887754 5799999999999999999999999999999999999998 568999999999766
Q ss_pred c---ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCC------------
Q psy11098 249 S---TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFP------------ 313 (380)
Q Consensus 249 ~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~------------ 313 (380)
. ....+++.|+|||++.+...++.++|+||||+++|+|++|..||.+.........+.......+
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (343)
T cd07880 169 DSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDA 248 (343)
T ss_pred ccCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhH
Confidence 4 2345688999999987644678899999999999999999999987765544443322111100
Q ss_pred ---------------CCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 314 ---------------PEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 314 ---------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
......++.++.++|.+||..||++|||+.+++.||||...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 249 KNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred HHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 01123578889999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=319.18 Aligned_cols=249 Identities=24% Similarity=0.356 Sum_probs=200.0
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC--chHHHHHHHHH-HHhhccCCCcceeeecccccCCCceEE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ--PQQITRAEYNL-LSTLMHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~E~~i-l~~l~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
++|++.+.||+|+||.||+|+++.+|+.||+|.++.... .......|+.+ ++.+.|+|++++++++... +..++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~---~~~~l 77 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFRE---GDVWI 77 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecC---CcEEE
Confidence 368899999999999999999999999999999975432 22334445554 6677899999999988653 56899
Q ss_pred EEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeecCCCCcEEEe-CCeeEEEeCCCccccc-
Q psy11098 177 VMQLVHGESLIQHLCR----QSTITESYICCIIRQLHSALHCLHSQ-QIAHKDIRPENILMN-GAVLKLIDLGSSVSVS- 249 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~----~~~l~e~~~~~i~~qil~al~~lH~~-~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~- 249 (380)
+|||+. ++|.+++.. ...+++..++.++.||+.||.|||++ +++||||||+|||++ ++.+||+|||++....
T Consensus 78 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 78 CMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred Ehhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 999995 678777654 34689999999999999999999997 999999999999998 5689999999987653
Q ss_pred ----ccccCCCcccCCccccCC---CCCCCcccHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcc-cCCCCCCcCCCC
Q psy11098 250 ----TVVLPDLEFASPEMLTSP---ATAGPSTDMWSLGVLLYILLSGVSPFLDE-SEEETRAHISVA-DYSFPPEQCGHI 320 (380)
Q Consensus 250 ----~~~~gt~~y~aPE~~~~~---~~~~~~~DiwSlGvil~~lltg~~Pf~~~-~~~~~~~~i~~~-~~~~~~~~~~~~ 320 (380)
....++..|+|||++.+. ..++.++|+|||||++|+|++|..||... ...+....+... ...++ ...+
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 233 (283)
T cd06617 157 SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLP---AEKF 233 (283)
T ss_pred ccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCC---cccc
Confidence 235678899999988652 34578999999999999999999999653 222223333222 22222 2347
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 321 SVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 321 s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
|.++.+||.+||..+|++|||++++++||||.+..
T Consensus 234 ~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 234 SPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 89999999999999999999999999999998864
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=312.50 Aligned_cols=240 Identities=21% Similarity=0.345 Sum_probs=204.4
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEEE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQ 179 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e 179 (380)
++|++.+.||+|+||.||++..+. +..+|+|.+.........+.+|+++++.++|+|++++++++... +..++|||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~iv~e 79 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ---KPLYIVTE 79 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccC---CCEEEEEE
Confidence 468889999999999999998764 56799999876655566788899999999999999999888664 56799999
Q ss_pred ecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCcccccc-------
Q psy11098 180 LVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVST------- 250 (380)
Q Consensus 180 ~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~~------- 250 (380)
|+.+|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||++++ +.+||+|||.+.....
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05114 80 FMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSS 159 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccC
Confidence 9999999999865 356899999999999999999999999999999999999984 5899999999875431
Q ss_pred cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHH
Q psy11098 251 VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIG 329 (380)
Q Consensus 251 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 329 (380)
...++..|+|||++.+ ..++.++|+||||+++|+|++ |..||...+..+....+........+ ...+.++.+++.
T Consensus 160 ~~~~~~~y~aPE~~~~-~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~---~~~~~~~~~li~ 235 (256)
T cd05114 160 GAKFPVKWSPPEVFNF-SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRP---KLASMTVYEVMY 235 (256)
T ss_pred CCCCchhhCChhhccc-CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCC---CCCCHHHHHHHH
Confidence 1233567999999987 467889999999999999999 99999988887777777665432222 246788999999
Q ss_pred HhcccCCCCCCCHHHHHh
Q psy11098 330 QLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 330 ~~L~~dP~~Rpt~~e~L~ 347 (380)
+||..||++|||++++++
T Consensus 236 ~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 236 SCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHccCCcccCcCHHHHHH
Confidence 999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=305.84 Aligned_cols=248 Identities=26% Similarity=0.385 Sum_probs=208.2
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC-CchHHHHHHHHHHHhhccCCCcceeeeccccc--CCCceE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER-QPQQITRAEYNLLSTLMHAHIPTALALFENAP--VPGTDT 175 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~--~~~~~~ 175 (380)
.+||++.+.||.|||+.||++++..+++.||+|.+.... .+.+...+|++.-+.++|+|+++++++.-... .....|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 579999999999999999999999999999999997655 56678899999999999999999987754432 234579
Q ss_pred EEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeecCCCCcEEEeC-CeeEEEeCCCcccc
Q psy11098 176 IVMQLVHGESLIQHLCR----QSTITESYICCIIRQLHSALHCLHSQQ--IAHKDIRPENILMNG-AVLKLIDLGSSVSV 248 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~----~~~l~e~~~~~i~~qil~al~~lH~~~--iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~ 248 (380)
|++.|...|+|.+.+.. +..++|.++..|+.+|+.||++||+.. ++||||||.|||+++ +.++|.|||.++..
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a 179 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQA 179 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCcccc
Confidence 99999999999999964 346999999999999999999999998 999999999999985 79999999998765
Q ss_pred cc---------------cccCCCcccCCccccCC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHhccc
Q psy11098 249 ST---------------VVLPDLEFASPEMLTSP--ATAGPSTDMWSLGVLLYILLSGVSPFLDESE--EETRAHISVAD 309 (380)
Q Consensus 249 ~~---------------~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~--~~~~~~i~~~~ 309 (380)
.. .-..|..|.|||.+.-+ ...+.++|||||||++|.|+.|..||..... ..+...+..++
T Consensus 180 ~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q 259 (302)
T KOG2345|consen 180 PIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQ 259 (302)
T ss_pred ceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeeccc
Confidence 31 12347889999998642 3557899999999999999999999954321 11222344567
Q ss_pred CCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 310 YSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 310 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
+.+|... .+|+.+.+||++||+.||.+||++.++|.+
T Consensus 260 ~s~P~~~--~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 260 ISIPNSS--RYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred cccCCCC--CccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 7777653 489999999999999999999999999965
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=331.57 Aligned_cols=259 Identities=25% Similarity=0.357 Sum_probs=212.1
Q ss_pred hhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC---CchHHHHHHHHHHHhhccCCCcceeeecccccC---
Q psy11098 97 QFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER---QPQQITRAEYNLLSTLMHAHIPTALALFENAPV--- 170 (380)
Q Consensus 97 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~--- 170 (380)
.+.++|++.+.||+|+||.||+|++..+++.||+|++.... .....+.+|+.+++.+.|+|++++++++.....
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 45788999999999999999999999999999999986432 223445679999999999999999887765421
Q ss_pred CCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc
Q psy11098 171 PGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS 249 (380)
Q Consensus 171 ~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~ 249 (380)
....++|+||+ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++ ++.+||+|||++....
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence 13479999999 7899998865 4799999999999999999999999999999999999998 4689999999987664
Q ss_pred ---ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCC-------------
Q psy11098 250 ---TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFP------------- 313 (380)
Q Consensus 250 ---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~------------- 313 (380)
....++..|+|||++.+...++.++|+|||||++|+|++|+.||.+....+....+.......+
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 249 (343)
T cd07851 170 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESAR 249 (343)
T ss_pred ccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHH
Confidence 3446788999999987645678899999999999999999999987766555444332111000
Q ss_pred ----------C----CcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCCC
Q psy11098 314 ----------P----EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASCS 357 (380)
Q Consensus 314 ----------~----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~~ 357 (380)
. .....++.++.+||++||+.||++|||+.++|+||||.+....
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~ 307 (343)
T cd07851 250 NYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP 307 (343)
T ss_pred HHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence 0 0112468899999999999999999999999999999876443
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=324.24 Aligned_cols=252 Identities=27% Similarity=0.397 Sum_probs=203.1
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---chHHHHHHHHHHHhhccCCCcceeeecccccC-----
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLMHAHIPTALALFENAPV----- 170 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~----- 170 (380)
.++|++.+.||.|+||.||+|.++.+++.+|+|.+..... ......+|+++++.++|+||+++++++.....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 5789999999999999999999999999999999864322 22356789999999999999999887654321
Q ss_pred CCceEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccc
Q psy11098 171 PGTDTIVMQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSV 248 (380)
Q Consensus 171 ~~~~~lv~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~ 248 (380)
....++|+||+. ++|...+.. ...+++..++.++.||++||.|||++||+|+||||+|||++ ++.+||+|||++...
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 165 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPY 165 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence 235699999995 567776654 45799999999999999999999999999999999999998 468999999998754
Q ss_pred cc-----------------cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCC
Q psy11098 249 ST-----------------VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYS 311 (380)
Q Consensus 249 ~~-----------------~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~ 311 (380)
.. ...+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+.......+......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~ 245 (311)
T cd07866 166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGT 245 (311)
T ss_pred cCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 31 1245778999999876556788999999999999999999999887766554443221100
Q ss_pred C-----------------------C---CCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy11098 312 F-----------------------P---PEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 312 ~-----------------------~---~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~ 351 (380)
. + ...+..++.++.+||.+||..||++|||+.++|.||||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 246 PTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 0 0 00123455788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=339.05 Aligned_cols=234 Identities=24% Similarity=0.381 Sum_probs=199.4
Q ss_pred eeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEEEec
Q psy11098 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLV 181 (380)
Q Consensus 102 y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e~~ 181 (380)
...++-||.|+.|-||+|+.. ++.||||+++ +...-+|+-|++|+|+||+.+.+++... -.++||||||
T Consensus 126 IsELeWlGSGaQGAVF~Grl~--netVAVKKV~------elkETdIKHLRkLkH~NII~FkGVCtqs---PcyCIiMEfC 194 (904)
T KOG4721|consen 126 ISELEWLGSGAQGAVFLGRLH--NETVAVKKVR------ELKETDIKHLRKLKHPNIITFKGVCTQS---PCYCIIMEFC 194 (904)
T ss_pred hhhhhhhccCcccceeeeecc--CceehhHHHh------hhhhhhHHHHHhccCcceeeEeeeecCC---ceeEEeeecc
Confidence 344678999999999999976 6789999883 2334478899999999999998888764 5679999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-----ccccCC
Q psy11098 182 HGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS-----TVVLPD 255 (380)
Q Consensus 182 ~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~-----~~~~gt 255 (380)
..|.|.+.|+....++...+..|..+|+.|+.|||.++|||||||.=||||. ++.|||+|||-++... ..++||
T Consensus 195 a~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGT 274 (904)
T KOG4721|consen 195 AQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGT 274 (904)
T ss_pred ccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhh
Confidence 9999999999999999999999999999999999999999999999999998 5689999999987654 467899
Q ss_pred CcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhcccC
Q psy11098 256 LEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNTH 335 (380)
Q Consensus 256 ~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 335 (380)
..|||||++.+ .+.+.|+|||||||+|||||||+.||.+.....+.--+-..-..++ .....++.++-||+.||+-.
T Consensus 275 VaWMAPEvIrn-ePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~Lp--vPstcP~GfklL~Kqcw~sK 351 (904)
T KOG4721|consen 275 VAWMAPEVIRN-EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLP--VPSTCPDGFKLLLKQCWNSK 351 (904)
T ss_pred HhhhCHHHhhc-CCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCccccc--CcccCchHHHHHHHHHHhcC
Confidence 99999999999 5889999999999999999999999977654433222222222222 23457889999999999999
Q ss_pred CCCCCCHHHHHhcc
Q psy11098 336 ADKRPTAGQLLQVA 349 (380)
Q Consensus 336 P~~Rpt~~e~L~hp 349 (380)
|+.||++.++|.|-
T Consensus 352 pRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 352 PRNRPSFRQILLHL 365 (904)
T ss_pred CCCCccHHHHHHHH
Confidence 99999999999993
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=320.80 Aligned_cols=252 Identities=25% Similarity=0.436 Sum_probs=208.3
Q ss_pred ceeeeeeecccCCeEEEEEEEc---CCCcEEEEEEecCCC-----CchHHHHHHHHHHHhh-ccCCCcceeeecccccCC
Q psy11098 101 RYEELERLGNGRFCTVRKARDR---GTGQLVALKQIPRER-----QPQQITRAEYNLLSTL-MHAHIPTALALFENAPVP 171 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~---~~~~~vAvK~~~~~~-----~~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~~~ 171 (380)
.|++.+.||.|+||.||+|.+. .+|+.||+|++.... ...+.+.+|+++++.+ +|+||+.+...+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~--- 77 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTD--- 77 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecC---
Confidence 4788999999999999999875 478999999996432 2235567899999999 589999998888764
Q ss_pred CceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccccc
Q psy11098 172 GTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVST 250 (380)
Q Consensus 172 ~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~~ 250 (380)
+..|+||||+.+++|.+++.....+++..+..++.||+.||.|||+.|++||||||+|||++ ++.+||+|||++.....
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 78 TKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred CeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 57799999999999999998888899999999999999999999999999999999999997 56899999999876532
Q ss_pred -------cccCCCcccCCccccCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhcccCCCCCCcCC
Q psy11098 251 -------VVLPDLEFASPEMLTSP-ATAGPSTDMWSLGVLLYILLSGVSPFLDESE----EETRAHISVADYSFPPEQCG 318 (380)
Q Consensus 251 -------~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~ 318 (380)
...|+..|+|||.+... ...+.++|+||||+++|+|++|..||..... .+....+......+ ..
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~ 233 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY----PQ 233 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCC----Cc
Confidence 34578899999998652 2467789999999999999999999964332 33333333333222 23
Q ss_pred CCCHHHHHHHHHhcccCCCCCC-----CHHHHHhcccccccCCCCC
Q psy11098 319 HISVPARELIGQLLNTHADKRP-----TAGQLLQVAWFAEASCSEF 359 (380)
Q Consensus 319 ~~s~~~~~li~~~L~~dP~~Rp-----t~~e~L~hpw~~~~~~~~~ 359 (380)
.++..+.+|+++||..||++|+ +++++++||||++..+..+
T Consensus 234 ~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~ 279 (290)
T cd05613 234 EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDL 279 (290)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHHH
Confidence 4788999999999999999997 8999999999998865443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=315.36 Aligned_cols=243 Identities=29% Similarity=0.415 Sum_probs=202.7
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC----CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
++|++.+.||+|+||.||+|+++.+++.||+|.+.... .....+.+|+++++.++|+|++++++++... +..+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~ 78 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED---NELN 78 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC---CeEE
Confidence 47899999999999999999999999999999885422 2234567799999999999999999888753 6779
Q ss_pred EEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-
Q psy11098 176 IVMQLVHGESLIQHLCR----QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS- 249 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~----~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~- 249 (380)
+++||+.+++|.+++.. ...+++..+..++.||+.||.|||++|++|+||||+|||++ ++.++|+|||++....
T Consensus 79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 79 IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999999988853 34589999999999999999999999999999999999998 5689999999987653
Q ss_pred -----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHhcccCCCCCCcCCCCCH
Q psy11098 250 -----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESE--EETRAHISVADYSFPPEQCGHISV 322 (380)
Q Consensus 250 -----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~s~ 322 (380)
....+++.|+|||.+.+ ...+.++|+||||+++|+|++|..||..... ......+.... ++......++.
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 235 (267)
T cd08228 159 KTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD--YPPLPTEHYSE 235 (267)
T ss_pred hhHHHhcCCCCccccChhhhcc-CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCC--CCCCChhhcCH
Confidence 24567889999999987 4678899999999999999999999966532 33444443322 33333345788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 323 PARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 323 ~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
.+.++|++||..+|++|||+.++|+.
T Consensus 236 ~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 236 KLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 99999999999999999999999964
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=348.25 Aligned_cols=256 Identities=20% Similarity=0.279 Sum_probs=192.4
Q ss_pred hhhhhhceeeeeeecccCCeEEEEEEEcCCC-cEEEEE------------------EecCCCCchHHHHHHHHHHHhhcc
Q psy11098 95 QEQFEHRYEELERLGNGRFCTVRKARDRGTG-QLVALK------------------QIPRERQPQQITRAEYNLLSTLMH 155 (380)
Q Consensus 95 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~-~~vAvK------------------~~~~~~~~~~~~~~E~~il~~l~h 155 (380)
.+.+.++|++++.||+|+||+||+|..+... ...+.| .+.........+.+|+++++.++|
T Consensus 143 ~~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~H 222 (501)
T PHA03210 143 DDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNH 222 (501)
T ss_pred chhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCC
Confidence 3557789999999999999999999765432 222222 111222233456789999999999
Q ss_pred CCCcceeeecccccCCCceEEEEEecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcE
Q psy11098 156 AHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQ-----STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENI 230 (380)
Q Consensus 156 ~ni~~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-----~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NI 230 (380)
+||+++++++... +..|++++++ +++|.+++... .......++.++.||+.||.|||++||+||||||+||
T Consensus 223 pnIv~l~~~~~~~---~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NI 298 (501)
T PHA03210 223 ENILKIEEILRSE---ANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENI 298 (501)
T ss_pred CCcCcEeEEEEEC---CeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 9999999998764 5679999998 56787777542 2344667889999999999999999999999999999
Q ss_pred EEe-CCeeEEEeCCCccccc-------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCC-CCCCC--H-
Q psy11098 231 LMN-GAVLKLIDLGSSVSVS-------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSP-FLDES--E- 298 (380)
Q Consensus 231 l~~-~~~ikl~DFG~a~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~P-f~~~~--~- 298 (380)
|++ ++.+||+|||++..+. ....||+.|+|||++.+ ..++.++|||||||++|+|++|..+ |.+.. .
T Consensus 299 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~ 377 (501)
T PHA03210 299 FLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG-DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG 377 (501)
T ss_pred EECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence 998 5699999999997653 23578999999999988 4788899999999999999998754 43322 1
Q ss_pred HHHHHHHhc---ccCCCCCC------------------------cCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy11098 299 EETRAHISV---ADYSFPPE------------------------QCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 299 ~~~~~~i~~---~~~~~~~~------------------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~ 351 (380)
......+.. ....++.. ....++.++.++|.+||+.||.+|||+.|+|.||||
T Consensus 378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f 457 (501)
T PHA03210 378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLF 457 (501)
T ss_pred HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhh
Confidence 122111110 11111110 011356778899999999999999999999999999
Q ss_pred cccC
Q psy11098 352 AEAS 355 (380)
Q Consensus 352 ~~~~ 355 (380)
....
T Consensus 458 ~~~~ 461 (501)
T PHA03210 458 SAEE 461 (501)
T ss_pred hcCC
Confidence 8653
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=326.03 Aligned_cols=253 Identities=24% Similarity=0.307 Sum_probs=204.7
Q ss_pred ceeeeeeecccCCeEEEEEEEcCC--CcEEEEEEecCCCC---chHHHHHHHHHHHhh-ccCCCcceeeecccc-cCCCc
Q psy11098 101 RYEELERLGNGRFCTVRKARDRGT--GQLVALKQIPRERQ---PQQITRAEYNLLSTL-MHAHIPTALALFENA-PVPGT 173 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~~--~~~vAvK~~~~~~~---~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~-~~~~~ 173 (380)
+|++.+.||+|+||.||++++..+ +..||+|.+..... ....+.+|+.+++.+ .|+||+++++..... .....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 488899999999999999999988 89999999864321 234567799999999 599999998875433 22345
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc---
Q psy11098 174 DTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS--- 249 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~--- 249 (380)
.+++++++ +++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 81 ~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~ 159 (332)
T cd07857 81 LYLYEELM-EADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159 (332)
T ss_pred EEEEEecc-cCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence 78899988 578999998888899999999999999999999999999999999999998 5689999999987543
Q ss_pred -------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC------------
Q psy11098 250 -------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADY------------ 310 (380)
Q Consensus 250 -------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~------------ 310 (380)
....||+.|+|||++.+...++.++|+|||||++|+|++|.+||.+.+.......+.....
T Consensus 160 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (332)
T cd07857 160 GENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGS 239 (332)
T ss_pred ccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhh
Confidence 2246789999999887655678899999999999999999999987664443332221100
Q ss_pred -----------CCC----CCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 311 -----------SFP----PEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 311 -----------~~~----~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
..+ ......++.++.+|+.+||+.||++|||+.+++.||||.+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~ 298 (332)
T cd07857 240 PKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298 (332)
T ss_pred hhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence 000 01123468899999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=320.87 Aligned_cols=265 Identities=27% Similarity=0.425 Sum_probs=216.4
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC-CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEE
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER-QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
..++|++.+.||.|+||.||++.+..+++.||+|.+.... ...+.+.+|+.+++.++|+|++++++.+... +..|+
T Consensus 17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~---~~~~l 93 (293)
T cd06647 17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVG---DELWV 93 (293)
T ss_pred chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeC---CcEEE
Confidence 3578999999999999999999999899999999986433 3345678899999999999999998887664 56799
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------
Q psy11098 177 VMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------ 249 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------ 249 (380)
|+||+.+++|.+++.+. .+++..+..++.|++.||.|||++|++|+||||+||+++ ++.++|+|||++....
T Consensus 94 v~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~ 172 (293)
T cd06647 94 VMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 172 (293)
T ss_pred EEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccccc
Confidence 99999999999988654 588999999999999999999999999999999999998 4589999999876543
Q ss_pred ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHH
Q psy11098 250 TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIG 329 (380)
Q Consensus 250 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 329 (380)
....+++.|+|||.+.+ ..++.++|+||||+++|++++|..||...+.......+.... .........++..+++||+
T Consensus 173 ~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~ 250 (293)
T cd06647 173 STMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFRDFLN 250 (293)
T ss_pred ccccCChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCC-CCCCCCccccCHHHHHHHH
Confidence 23467888999999877 467889999999999999999999998766544333222111 1111123357889999999
Q ss_pred HhcccCCCCCCCHHHHHhcccccccCCCCCccccccchHHHHH
Q psy11098 330 QLLNTHADKRPTAGQLLQVAWFAEASCSEFDTERLLPFSARRK 372 (380)
Q Consensus 330 ~~L~~dP~~Rpt~~e~L~hpw~~~~~~~~~~~~~~~~~~~~~~ 372 (380)
+||..+|++||++.+++.|+||... ..-..|.|.++--|
T Consensus 251 ~~l~~~p~~Rp~~~~il~h~~~~~~----~~~~~~~~~~~~~~ 289 (293)
T cd06647 251 RCLEMDVEKRGSAKELLQHPFLKIA----KPLSSLTPLIAAAK 289 (293)
T ss_pred HHccCChhhCcCHHHHhcCHHHhcC----cccccccchHHHhh
Confidence 9999999999999999999999876 23355666665544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=313.12 Aligned_cols=241 Identities=19% Similarity=0.308 Sum_probs=205.0
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVM 178 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~ 178 (380)
.++|++.++||+|+||.||+|... ++..||+|.+.......+.+.+|+.+++.++|+|++++++.+... +..+++|
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~lv~ 80 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE---EPIYIIT 80 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCC---CCcEEEE
Confidence 468999999999999999999965 456799999876555567788899999999999999998887653 5679999
Q ss_pred EecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCcccccc-----
Q psy11098 179 QLVHGESLIQHLCR--QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVST----- 250 (380)
Q Consensus 179 e~~~gg~L~~~l~~--~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~~----- 250 (380)
||+.+++|.+++.. ...+++..+..++.|++.||.|||+.+++||||||+||+++. +.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05072 81 EYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160 (261)
T ss_pred ecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence 99999999999865 356888999999999999999999999999999999999984 5899999999976532
Q ss_pred --cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHH
Q psy11098 251 --VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAREL 327 (380)
Q Consensus 251 --~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 327 (380)
...++..|+|||++.+ ..++.++|+|||||++|+|++ |..||.+.........+.... .. +....++.++.++
T Consensus 161 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~l 236 (261)
T cd05072 161 REGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY-RM--PRMENCPDELYDI 236 (261)
T ss_pred cCCCccceecCCHHHhcc-CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC-CC--CCCCCCCHHHHHH
Confidence 2234567999999877 467889999999999999998 999998888777777665442 22 2234678999999
Q ss_pred HHHhcccCCCCCCCHHHHHh
Q psy11098 328 IGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 328 i~~~L~~dP~~Rpt~~e~L~ 347 (380)
+.+||..||++|||++++++
T Consensus 237 i~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 237 MKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHccCCcccCcCHHHHHH
Confidence 99999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=317.65 Aligned_cols=248 Identities=34% Similarity=0.472 Sum_probs=205.0
Q ss_pred eeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC---CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEE
Q psy11098 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER---QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVM 178 (380)
Q Consensus 102 y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~ 178 (380)
|++.+.||.|+||.||+|.+..+++.+|+|.+.... .....+.+|+++++.+.|+|++++++++.... .+..++|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG-KGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC-CCcEEEEe
Confidence 678899999999999999999999999999997653 22345678999999999999999998887542 35789999
Q ss_pred EecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccccc------
Q psy11098 179 QLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVST------ 250 (380)
Q Consensus 179 e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~~------ 250 (380)
||+. ++|.+++... ..+++..++.++.||+.||.|||+.|++|+||||+|||++ ++.+||+|||++.....
T Consensus 80 e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (287)
T cd07840 80 EYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY 158 (287)
T ss_pred cccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccc
Confidence 9996 5888888664 5799999999999999999999999999999999999998 56899999999876542
Q ss_pred -cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCC---------------
Q psy11098 251 -VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPP--------------- 314 (380)
Q Consensus 251 -~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~--------------- 314 (380)
...++..|+|||.+.+...++.++||||||+++|+|++|+.||...+.......+.........
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07840 159 TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENL 238 (287)
T ss_pred cccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhc
Confidence 2355788999998876556788999999999999999999999887766555544321110000
Q ss_pred -----------CcCCC-CCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy11098 315 -----------EQCGH-ISVPARELIGQLLNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 315 -----------~~~~~-~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~ 351 (380)
..... ++.++.++|++||..||++|||++++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 239 KPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred cccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 01112 38889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=321.25 Aligned_cols=252 Identities=23% Similarity=0.327 Sum_probs=200.9
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC--chHHHHHHHHHHHhhc-cCCCcceeeecccccCCCceEE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ--PQQITRAEYNLLSTLM-HAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~-h~ni~~i~~~~~~~~~~~~~~l 176 (380)
++|+..+.||+|+||.||++.+..+++.||+|.+..... ....+.+|+.++..+. |+|++++++++... +..++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~---~~~~~ 80 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE---GDCWI 80 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC---CcEEE
Confidence 356667889999999999999999999999999975432 3445678999999996 99999999887653 56799
Q ss_pred EEEecCCCCHHHHH---H--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeecCCCCcEEEe-CCeeEEEeCCCccccc
Q psy11098 177 VMQLVHGESLIQHL---C--RQSTITESYICCIIRQLHSALHCLHSQ-QIAHKDIRPENILMN-GAVLKLIDLGSSVSVS 249 (380)
Q Consensus 177 v~e~~~gg~L~~~l---~--~~~~l~e~~~~~i~~qil~al~~lH~~-~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~ 249 (380)
+|||+. +++.++. . ....+++..+..++.|++.||+|||+. |++||||||+|||++ ++.+||+|||++....
T Consensus 81 ~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 81 CMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred EEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 999984 4554433 2 235799999999999999999999975 999999999999998 5689999999987543
Q ss_pred -----ccccCCCcccCCccccCC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhccc-CCCCCCcCCCC
Q psy11098 250 -----TVVLPDLEFASPEMLTSP--ATAGPSTDMWSLGVLLYILLSGVSPFLDESE-EETRAHISVAD-YSFPPEQCGHI 320 (380)
Q Consensus 250 -----~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~-~~~~~~i~~~~-~~~~~~~~~~~ 320 (380)
....+++.|+|||++.+. ..++.++|+|||||++|+|++|+.||..... .+...++.... ...+......+
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd06616 160 DSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREF 239 (288)
T ss_pred cCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCcc
Confidence 234678899999999774 3678899999999999999999999976542 12222222221 12222222458
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 321 SVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 321 s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
+.++.+||++||++||++|||++++++||||.+..
T Consensus 240 ~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~ 274 (288)
T cd06616 240 SPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE 274 (288)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence 89999999999999999999999999999998653
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=309.53 Aligned_cols=244 Identities=32% Similarity=0.473 Sum_probs=212.3
Q ss_pred ceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC---CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEE
Q psy11098 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER---QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIV 177 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv 177 (380)
+|++.+.||+|+||.||++.+..+++.||+|++.... .....+.+|+++++.++|+|++++.+.+... +..+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~---~~~~lv 77 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK---GKLCIV 77 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC---CEEEEE
Confidence 5888999999999999999999999999999997543 2445677899999999999999999888764 678999
Q ss_pred EEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCccccc---
Q psy11098 178 MQLVHGESLIQHLCRQ----STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVS--- 249 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~~----~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~--- 249 (380)
+|++.+++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||++++ +.++|+|||++....
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 78 MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred EEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999999999763 67999999999999999999999999999999999999985 699999999987653
Q ss_pred ---ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHH
Q psy11098 250 ---TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARE 326 (380)
Q Consensus 250 ---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 326 (380)
....+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||......+............. ...++.++.+
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 233 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQN-KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPI---PSQYSSELRN 233 (258)
T ss_pred ceecceeeeecccChhHhcc-CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCC---CCCCCHHHHH
Confidence 23567889999999877 4678899999999999999999999988777666666655443222 2357899999
Q ss_pred HHHHhcccCCCCCCCHHHHHhcccc
Q psy11098 327 LIGQLLNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 327 li~~~L~~dP~~Rpt~~e~L~hpw~ 351 (380)
++.+||..+|++|||+.++|+||||
T Consensus 234 ~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 234 LVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHHcCCChhhCcCHHHHhcCCCC
Confidence 9999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=328.11 Aligned_cols=256 Identities=25% Similarity=0.400 Sum_probs=206.9
Q ss_pred hhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---chHHHHHHHHHHHhhccCCCcceeeecccccC---
Q psy11098 97 QFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLMHAHIPTALALFENAPV--- 170 (380)
Q Consensus 97 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~--- 170 (380)
.+..+|.+.+.||+|+||.||+|++..+|+.||+|.+.+... ....+.+|+.+++.+.|+|++++++++.....
T Consensus 12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 91 (342)
T cd07879 12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE 91 (342)
T ss_pred ccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence 456789999999999999999999999999999999865322 23456789999999999999999998865422
Q ss_pred CCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc
Q psy11098 171 PGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS 249 (380)
Q Consensus 171 ~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~ 249 (380)
....++|+||+. .+|...+ ...+++..+..++.|++.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 92 ~~~~~lv~e~~~-~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~ 168 (342)
T cd07879 92 FQDFYLVMPYMQ-TDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD 168 (342)
T ss_pred CceEEEEecccc-cCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence 234689999994 5676654 34689999999999999999999999999999999999998 5699999999987654
Q ss_pred ---ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc-----------------
Q psy11098 250 ---TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVAD----------------- 309 (380)
Q Consensus 250 ---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~----------------- 309 (380)
....+++.|+|||++.+...++.++|+|||||++|+|++|+.||.+.+.......+....
T Consensus 169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (342)
T cd07879 169 AEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAK 248 (342)
T ss_pred CCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchH
Confidence 234568899999998764567889999999999999999999998876554443332210
Q ss_pred ------CCCCCC----cCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 310 ------YSFPPE----QCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 310 ------~~~~~~----~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
...+.. .....+.++.+||++||+.||++|||++++|.||||....
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 249 SYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred HHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 000111 1234678899999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=327.61 Aligned_cols=245 Identities=20% Similarity=0.304 Sum_probs=198.2
Q ss_pred hhceeeeeeecccCCeEEEEEEEcC-----CCcEEEEEEecCCCC--chHHHHHHHHHHHhh-ccCCCcceeeecccccC
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRG-----TGQLVALKQIPRERQ--PQQITRAEYNLLSTL-MHAHIPTALALFENAPV 170 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~~ 170 (380)
.++|++.+.||+|+||.||+|++.. +++.||+|+++.... ....+.+|++++..+ .|+||+++++++...
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~-- 83 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP-- 83 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC--
Confidence 4689999999999999999997543 457899999975432 234566799999999 799999999877543
Q ss_pred CCceEEEEEecCCCCHHHHHHhc---------------------------------------------------------
Q psy11098 171 PGTDTIVMQLVHGESLIQHLCRQ--------------------------------------------------------- 193 (380)
Q Consensus 171 ~~~~~lv~e~~~gg~L~~~l~~~--------------------------------------------------------- 193 (380)
....+++|||+.+++|.+++...
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 35678999999999999988542
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc--------ccccCCCcccC
Q psy11098 194 ----STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS--------TVVLPDLEFAS 260 (380)
Q Consensus 194 ----~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~--------~~~~gt~~y~a 260 (380)
..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..+. ....++..|+|
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 2578899999999999999999999999999999999998 5689999999997642 22345678999
Q ss_pred CccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCC
Q psy11098 261 PEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHADKR 339 (380)
Q Consensus 261 PE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 339 (380)
||++.+ ..++.++|||||||++|+|++ |..||.+....+............. .....+.++.+++.+||+.+|++|
T Consensus 244 PE~~~~-~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~cl~~~p~~R 320 (337)
T cd05054 244 PESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMR--APEYATPEIYSIMLDCWHNNPEDR 320 (337)
T ss_pred cHHhcC-CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCC--CCccCCHHHHHHHHHHccCChhhC
Confidence 999987 578889999999999999998 9999987544333322222221111 123568899999999999999999
Q ss_pred CCHHHHHhc
Q psy11098 340 PTAGQLLQV 348 (380)
Q Consensus 340 pt~~e~L~h 348 (380)
||++|+++|
T Consensus 321 Ps~~ell~~ 329 (337)
T cd05054 321 PTFSELVEI 329 (337)
T ss_pred cCHHHHHHH
Confidence 999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=323.82 Aligned_cols=249 Identities=24% Similarity=0.387 Sum_probs=198.9
Q ss_pred ceeeeeeecccCCeEEEEEEEcC--CCcEEEEEEecCCC----CchHHHHHHHHHHHhhccCCCcceeeecccccCCCce
Q psy11098 101 RYEELERLGNGRFCTVRKARDRG--TGQLVALKQIPRER----QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~--~~~~vAvK~~~~~~----~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~ 174 (380)
+|++.+.||+|+||.||+|.+.. +++.||+|.+.... .......+|+.+++.++|+|++++++++... ..+..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~ 79 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH-ADKSV 79 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC-CCceE
Confidence 58889999999999999999988 89999999997632 2235567799999999999999999998764 23568
Q ss_pred EEEEEecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-----CeeEEEeCCC
Q psy11098 175 TIVMQLVHGESLIQHLCRQ-----STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-----AVLKLIDLGS 244 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~-----~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-----~~ikl~DFG~ 244 (380)
++||||+. ++|.+.+... ..+++..++.++.||+.||.|||+.+|+||||||+|||++. +.+||+|||+
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~ 158 (316)
T cd07842 80 YLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGL 158 (316)
T ss_pred EEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence 99999995 5777766432 36899999999999999999999999999999999999974 5899999999
Q ss_pred ccccc---------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHH---------HHHHHh
Q psy11098 245 SVSVS---------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEE---------TRAHIS 306 (380)
Q Consensus 245 a~~~~---------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~---------~~~~i~ 306 (380)
+.... ....+++.|+|||++.+...++.++|+|||||++|+|++|..||.+..... ....+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (316)
T cd07842 159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF 238 (316)
T ss_pred ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence 87543 233568889999998775567889999999999999999999997654322 000000
Q ss_pred c--------------------------ccCCCCC-------CcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy11098 307 V--------------------------ADYSFPP-------EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 307 ~--------------------------~~~~~~~-------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~ 351 (380)
. ....++. +.....+.++.++|.+||..||++|||+.|+++||||
T Consensus 239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 0 0000000 0011467789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=316.74 Aligned_cols=250 Identities=20% Similarity=0.293 Sum_probs=205.7
Q ss_pred hhceeeeeeecccCCeEEEEEEEcC-----CCcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCC
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRG-----TGQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVP 171 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~ 171 (380)
.++|++.+.||+|+||.||+|.++. .+..||+|.+..... ....+.+|+.+++.+.|+|++++++++...
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--- 81 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG--- 81 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC---
Confidence 5789999999999999999997652 345899999865432 223456799999999999999999987654
Q ss_pred CceEEEEEecCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEE
Q psy11098 172 GTDTIVMQLVHGESLIQHLCRQ----------STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLI 240 (380)
Q Consensus 172 ~~~~lv~e~~~gg~L~~~l~~~----------~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~ 240 (380)
+..++||||+.+|+|.+++... ..++...+..++.||+.||.|||++||+||||||+|||++ ++.+||+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEEC
Confidence 5679999999999999999652 2346778899999999999999999999999999999998 4689999
Q ss_pred eCCCccccc--------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCC
Q psy11098 241 DLGSSVSVS--------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYS 311 (380)
Q Consensus 241 DFG~a~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~ 311 (380)
|||+++... ....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+...++....+......
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL 240 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhcc-CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 999987542 22244678999999877 467889999999999999998 89999888777766665544322
Q ss_pred CCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh------cccccccC
Q psy11098 312 FPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQ------VAWFAEAS 355 (380)
Q Consensus 312 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~------hpw~~~~~ 355 (380)
.. ....+.++++++.+||+.||++|||+.++++ ||||....
T Consensus 241 ~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~ 287 (288)
T cd05061 241 DQ---PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS 287 (288)
T ss_pred CC---CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence 11 2346789999999999999999999999987 99997653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=311.81 Aligned_cols=247 Identities=25% Similarity=0.364 Sum_probs=207.5
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC------CchHHHHHHHHHHHhhccCCCcceeeecccccCCCc
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER------QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGT 173 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~------~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~ 173 (380)
.+|++.+.||+|+||.||+|.+..+++.||+|.+.... .....+.+|+++++.++|+|++++++++.... .+.
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~-~~~ 80 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPE-EKK 80 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCC-CCE
Confidence 36889999999999999999999999999999885321 22346678999999999999999999875432 346
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc---
Q psy11098 174 DTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS--- 249 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~--- 249 (380)
.++++||+.+++|.+++.....+++..+..++.||+.||.|||+.|++|+||||+||+++ ++.++|+|||++....
T Consensus 81 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 160 (264)
T cd06653 81 LSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC 160 (264)
T ss_pred EEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccccc
Confidence 789999999999999998877899999999999999999999999999999999999998 4689999999987542
Q ss_pred ------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHH
Q psy11098 250 ------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVP 323 (380)
Q Consensus 250 ------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 323 (380)
....++..|+|||++.+ ...+.++|+|||||++|+|++|..||.+....+...++.... ..+.....++++
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~p~~~~~~ 237 (264)
T cd06653 161 MSGTGIKSVTGTPYWMSPEVISG-EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQP--TKPMLPDGVSDA 237 (264)
T ss_pred ccCccccccCCcccccCHhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCC--CCCCCCcccCHH
Confidence 23457889999999987 467889999999999999999999998776555544443222 112233568899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy11098 324 ARELIGQLLNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 324 ~~~li~~~L~~dP~~Rpt~~e~L~hpw~ 351 (380)
+.++|.+||. +|.+|||+.++|.|||.
T Consensus 238 ~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 238 CRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 9999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=331.21 Aligned_cols=243 Identities=20% Similarity=0.316 Sum_probs=198.6
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCC-----CcEEEEEEecCCCC--chHHHHHHHHHHHhhc-cCCCcceeeecccccC
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGT-----GQLVALKQIPRERQ--PQQITRAEYNLLSTLM-HAHIPTALALFENAPV 170 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~-----~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~-h~ni~~i~~~~~~~~~ 170 (380)
.++|++.+.||+|+||.||+|.+... +..||+|++..... ..+.+.+|+++++.+. ||||+++++++...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~-- 113 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS-- 113 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC--
Confidence 56899999999999999999987543 34799999965433 3456788999999996 99999999988654
Q ss_pred CCceEEEEEecCCCCHHHHHHhc---------------------------------------------------------
Q psy11098 171 PGTDTIVMQLVHGESLIQHLCRQ--------------------------------------------------------- 193 (380)
Q Consensus 171 ~~~~~lv~e~~~gg~L~~~l~~~--------------------------------------------------------- 193 (380)
+..||||||+.+|+|.+++..+
T Consensus 114 -~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 114 -GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred -CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 6789999999999999988542
Q ss_pred ---------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC
Q psy11098 194 ---------------------------------------STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG 234 (380)
Q Consensus 194 ---------------------------------------~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~ 234 (380)
..+++..+..++.||+.||.|||+.||+||||||+|||++.
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~ 272 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeC
Confidence 23678888999999999999999999999999999999985
Q ss_pred -CeeEEEeCCCccccc--------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q psy11098 235 -AVLKLIDLGSSVSVS--------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAH 304 (380)
Q Consensus 235 -~~ikl~DFG~a~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~ 304 (380)
+.+||+|||++.... ....+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.........
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~ 351 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD-NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN 351 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH
Confidence 589999999987542 22345778999999987 467889999999999999997 9999987654443333
Q ss_pred HhcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy11098 305 ISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 305 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~ 347 (380)
........+ ....++.++.+++.+||+.||++|||+.++.+
T Consensus 352 ~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 352 KIKSGYRMA--KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHhcCCCCC--CCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 333332222 22467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=313.77 Aligned_cols=241 Identities=30% Similarity=0.451 Sum_probs=198.0
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEecCCCC-chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEEEecCCC
Q psy11098 106 ERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ-PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHGE 184 (380)
Q Consensus 106 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e~~~gg 184 (380)
..||+|+||.||+|.+..+++.||+|.+..... ..+.+.+|+.+++.++|+|++++++++... +..++++||+.++
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~lv~e~~~~~ 90 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN---GFFKIFMEQVPGG 90 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC---CEEEEEEecCCCC
Confidence 579999999999999999999999999875543 445678899999999999999999887764 6789999999999
Q ss_pred CHHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe--CCeeEEEeCCCccccc------cccc
Q psy11098 185 SLIQHLCRQ-STI--TESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN--GAVLKLIDLGSSVSVS------TVVL 253 (380)
Q Consensus 185 ~L~~~l~~~-~~l--~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~--~~~ikl~DFG~a~~~~------~~~~ 253 (380)
+|.+++... ..+ ++..+..++.||+.||.|||++||+||||||+||+++ ++.++|+|||++.... ....
T Consensus 91 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 170 (268)
T cd06624 91 SLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT 170 (268)
T ss_pred CHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccccCC
Confidence 999999764 445 8888999999999999999999999999999999997 4589999999986542 2345
Q ss_pred CCCcccCCccccCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHhcccCCCCCCcCCCCCHHHHHHHHHh
Q psy11098 254 PDLEFASPEMLTSP-ATAGPSTDMWSLGVLLYILLSGVSPFLDESEEE-TRAHISVADYSFPPEQCGHISVPARELIGQL 331 (380)
Q Consensus 254 gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 331 (380)
+++.|+|||++.+. ..++.++|+||||+++|+|++|..||....... ...... ...........+++++++|+++|
T Consensus 171 ~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~ 248 (268)
T cd06624 171 GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVG--MFKIHPEIPESLSAEAKNFILRC 248 (268)
T ss_pred CCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhh--hhccCCCCCcccCHHHHHHHHHH
Confidence 78899999998652 346789999999999999999999997543221 111111 11111122245788999999999
Q ss_pred cccCCCCCCCHHHHHhcccc
Q psy11098 332 LNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 332 L~~dP~~Rpt~~e~L~hpw~ 351 (380)
|..+|.+|||+.|++.||||
T Consensus 249 l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 249 FEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred cCCCchhCCCHHHHHhCCCC
Confidence 99999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=310.18 Aligned_cols=241 Identities=20% Similarity=0.271 Sum_probs=204.7
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVM 178 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~ 178 (380)
.++|++.+.||+|++|.||+|.+.. ++.||+|.++........+.+|+.+++.++|+|++++++++... +..+++|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~lv~ 80 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE---EPIYIVT 80 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecC---CCeeeee
Confidence 4679999999999999999999764 56899999976655566788899999999999999999887664 5679999
Q ss_pred EecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccccc----
Q psy11098 179 QLVHGESLIQHLCRQS--TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVSTV---- 251 (380)
Q Consensus 179 e~~~gg~L~~~l~~~~--~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~~~---- 251 (380)
||+.+++|.+++.... .+++..+..++.|++.||.|||+.||+||||||+||+++ ++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05068 81 ELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA 160 (261)
T ss_pred ecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc
Confidence 9999999999997643 689999999999999999999999999999999999998 468999999998765421
Q ss_pred ccC---CCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHH
Q psy11098 252 VLP---DLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAREL 327 (380)
Q Consensus 252 ~~g---t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 327 (380)
..+ +..|+|||++.+ ..++.++|+||||+++|+|++ |+.||.+.........+.... ..+ ....++.++.++
T Consensus 161 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~l 236 (261)
T cd05068 161 REGAKFPIKWTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGY-RMP--CPPGCPKELYDI 236 (261)
T ss_pred cCCCcCceeccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCC--CCCcCCHHHHHH
Confidence 122 347999999887 467889999999999999999 999999888777776665432 222 123578999999
Q ss_pred HHHhcccCCCCCCCHHHHHh
Q psy11098 328 IGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 328 i~~~L~~dP~~Rpt~~e~L~ 347 (380)
+.+||..||++||++.++++
T Consensus 237 i~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 237 MLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHHhhcCcccCCCHHHHHH
Confidence 99999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=319.80 Aligned_cols=253 Identities=27% Similarity=0.400 Sum_probs=206.5
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC---CchHHHHHHHHHHHhhccCCCcceeeeccccc-----
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER---QPQQITRAEYNLLSTLMHAHIPTALALFENAP----- 169 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~----- 169 (380)
..++|++.+.||.|+||.||+|.++.+++.||+|.++... .......+|+++++.++|+|++++++++....
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 4678999999999999999999999999999999996532 22345677999999999999999998876543
Q ss_pred --CCCceEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCc
Q psy11098 170 --VPGTDTIVMQLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSS 245 (380)
Q Consensus 170 --~~~~~~lv~e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a 245 (380)
..+..++++||+.+ ++...+... ..+++..+..++.||+.||.|||+.||+|+||||+||++++ +.+||+|||++
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~ 163 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLA 163 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccccc
Confidence 23478999999965 777777553 46899999999999999999999999999999999999985 58999999998
Q ss_pred ccccc-------cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCC-----
Q psy11098 246 VSVST-------VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFP----- 313 (380)
Q Consensus 246 ~~~~~-------~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~----- 313 (380)
..... ...++..|+|||++.+....+.++|||||||++|+|++|+.||...+..+....+........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (302)
T cd07864 164 RLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWP 243 (302)
T ss_pred ccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcc
Confidence 76531 234577899999887655668899999999999999999999987766555444432110000
Q ss_pred ---------------------CCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy11098 314 ---------------------PEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 314 ---------------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~ 351 (380)
...+..++..+.++|.+||..||.+|||+++++.||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 244 DVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred cccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 01233578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=314.89 Aligned_cols=244 Identities=17% Similarity=0.251 Sum_probs=202.2
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcC-----CCcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccC
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRG-----TGQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPV 170 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~ 170 (380)
..++|++.+.||+|+||+||+|.++. ++..||+|.+..... ....+.+|+.+++.++|+|++++++++...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~-- 81 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG-- 81 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC--
Confidence 36789999999999999999998753 356899999864332 234567899999999999999999887653
Q ss_pred CCceEEEEEecCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEE
Q psy11098 171 PGTDTIVMQLVHGESLIQHLCRQS----------TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKL 239 (380)
Q Consensus 171 ~~~~~lv~e~~~gg~L~~~l~~~~----------~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl 239 (380)
+..++||||+.+++|.+++.... .++...+..++.|++.||.|||+.|++||||||+|||++ ++.++|
T Consensus 82 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 82 -QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred -CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEE
Confidence 56799999999999999986532 357788999999999999999999999999999999998 568999
Q ss_pred EeCCCccccc--------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccC
Q psy11098 240 IDLGSSVSVS--------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADY 310 (380)
Q Consensus 240 ~DFG~a~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~ 310 (380)
+|||++.... ....+++.|+|||++.+ ..++.++|+|||||++|+|++ |..||.+.+.++....+.....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~ 239 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGL 239 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc
Confidence 9999987542 12344678999999987 467889999999999999999 7999988887777766655433
Q ss_pred CCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 311 SFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 311 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
... ....++++.+++.+||+.||++|||+.|++++
T Consensus 240 ~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 240 LDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 221 23578899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=313.22 Aligned_cols=258 Identities=26% Similarity=0.384 Sum_probs=215.0
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC---CchHHHHHHHHHHHhhccCCCcceeeecccccCC----
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER---QPQQITRAEYNLLSTLMHAHIPTALALFENAPVP---- 171 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~---- 171 (380)
...|+.+.+||+|.||.||+|+.+.+|+.||+|++-.+. .-.....+|+.+|..|+|+|+++++.++.....+
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 457888899999999999999999999999999874322 2234567799999999999999999988765433
Q ss_pred -CceEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccc
Q psy11098 172 -GTDTIVMQLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSV 248 (380)
Q Consensus 172 -~~~~lv~e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~ 248 (380)
..+|+|+.+| ..+|.-++... ..++..++..+++++++||.|+|+..|+|||+|++|+||+ ++.+||+|||+++.+
T Consensus 96 r~t~ylVf~~c-ehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~f 174 (376)
T KOG0669|consen 96 RATFYLVFDFC-EHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAF 174 (376)
T ss_pred cceeeeeHHHh-hhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccce
Confidence 3479999999 56787777654 6799999999999999999999999999999999999999 589999999999755
Q ss_pred c----------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCC
Q psy11098 249 S----------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCG 318 (380)
Q Consensus 249 ~----------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 318 (380)
+ +..+-|.+|.+||.+.+...++.+.|||..|||+.+|++|.+-|.+++....+..|..-...+..+.|+
T Consensus 175 s~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP 254 (376)
T KOG0669|consen 175 STSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWP 254 (376)
T ss_pred ecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCC
Confidence 3 233448999999999999999999999999999999999999999999888877775332222221111
Q ss_pred ----------------------C---------CCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCCC
Q psy11098 319 ----------------------H---------ISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASCS 357 (380)
Q Consensus 319 ----------------------~---------~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~~ 357 (380)
. -.+++.||+..||..||.+|++++++|+|.||.+...+
T Consensus 255 ~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 255 NVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred CcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 1 13478899999999999999999999999999877544
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=308.10 Aligned_cols=244 Identities=29% Similarity=0.436 Sum_probs=210.9
Q ss_pred ceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEE
Q psy11098 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIV 177 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv 177 (380)
+|++.+.||+|++|.||++.+..+++.||+|.+..... ....+.+|+++++.++|+|++++++++... +..+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~v 77 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS---DSLYII 77 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC---CEEEEE
Confidence 58889999999999999999999999999999976543 345678899999999999999999887653 678999
Q ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCccccc------c
Q psy11098 178 MQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVS------T 250 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~------~ 250 (380)
||++.+++|.+++.....+++..+..++.|++.||.|||+.||+||||||+||+++. +.++|+|||++.... .
T Consensus 78 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 157 (254)
T cd06627 78 LEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDA 157 (254)
T ss_pred EecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccc
Confidence 999999999999988888999999999999999999999999999999999999984 689999999988664 2
Q ss_pred cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHH
Q psy11098 251 VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQ 330 (380)
Q Consensus 251 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 330 (380)
...++..|+|||...+. ..+.++|+||||+++|+|++|..||.................. .....++.++.+++.+
T Consensus 158 ~~~~~~~y~~pe~~~~~-~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~i~~ 233 (254)
T cd06627 158 SVVGTPYWMAPEVIEMS-GASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHP---PLPEGISPELKDFLMQ 233 (254)
T ss_pred ccccchhhcCHhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCC---CCCCCCCHHHHHHHHH
Confidence 34578899999998774 5788999999999999999999999876655554444432221 1224578999999999
Q ss_pred hcccCCCCCCCHHHHHhcccc
Q psy11098 331 LLNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 331 ~L~~dP~~Rpt~~e~L~hpw~ 351 (380)
||..+|++|||+.+++.||||
T Consensus 234 ~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 234 CFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHhCChhhCcCHHHHhcCCCC
Confidence 999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=321.44 Aligned_cols=242 Identities=19% Similarity=0.310 Sum_probs=201.1
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcE----EEEEEecCCC--CchHHHHHHHHHHHhhccCCCcceeeecccccCCC
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQL----VALKQIPRER--QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPG 172 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~----vAvK~~~~~~--~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~ 172 (380)
..+|++.+.||+|+||+||+|++..+++. ||+|.+.... .....+.+|+.+++.+.|+||+++++++.. +
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~----~ 81 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT----S 81 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC----C
Confidence 35799999999999999999998766654 8999986433 234567789999999999999999988764 3
Q ss_pred ceEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCcccccc
Q psy11098 173 TDTIVMQLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVST 250 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~~ 250 (380)
..++++||+.+|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||+++ +.+||+|||+++....
T Consensus 82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccC
Confidence 568999999999999999764 46889999999999999999999999999999999999984 6899999999976531
Q ss_pred --------cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCC
Q psy11098 251 --------VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHIS 321 (380)
Q Consensus 251 --------~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 321 (380)
...++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+... ...+. ....+
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~--~~~~~ 237 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-ERLPQ--PPICT 237 (316)
T ss_pred CCcceeccCCccceeecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCC-CCCCC--CCCCC
Confidence 1223568999999987 477889999999999999997 99999887766654444332 22222 23467
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 322 VPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 322 ~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
.++.+++.+||..||.+|||+.+++.+
T Consensus 238 ~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 238 IDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 899999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=310.85 Aligned_cols=241 Identities=23% Similarity=0.324 Sum_probs=204.4
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEEE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQ 179 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e 179 (380)
++|++.+.||+|+||+||+|.+.. +..+|+|.+.........+.+|+.+++.+.|+|++++++++... +..+++||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~lv~e 79 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ---RPIYIVTE 79 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccC---CCcEEEEE
Confidence 568999999999999999998764 44699999876655566788899999999999999999988653 56799999
Q ss_pred ecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccccc-------
Q psy11098 180 LVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVST------- 250 (380)
Q Consensus 180 ~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~~------- 250 (380)
|+.+++|.+++... ..+++..+..++.||+.||.|||+.|++|+||||+|||++ ++.+||+|||.+.....
T Consensus 80 ~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05113 80 YMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV 159 (256)
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecC
Confidence 99999999999764 4689999999999999999999999999999999999998 46899999999875421
Q ss_pred cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHH
Q psy11098 251 VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIG 329 (380)
Q Consensus 251 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 329 (380)
...++..|+|||++.+ ..++.++|+||||+++|+|++ |..||...+..+....+......... ...+.++++++.
T Consensus 160 ~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~ 235 (256)
T cd05113 160 GSKFPVRWSPPEVLLY-SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRP---HLASEKVYAIMY 235 (256)
T ss_pred CCccChhhCCHHHHhc-CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCC---CCCCHHHHHHHH
Confidence 1234567999999987 467889999999999999998 99999888777777777655433222 246889999999
Q ss_pred HhcccCCCCCCCHHHHHhc
Q psy11098 330 QLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 330 ~~L~~dP~~Rpt~~e~L~h 348 (380)
+||..||.+|||+.+++.+
T Consensus 236 ~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 236 SCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHcCCCcccCCCHHHHHHh
Confidence 9999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=311.01 Aligned_cols=240 Identities=21% Similarity=0.279 Sum_probs=202.7
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVM 178 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~ 178 (380)
.++|++.++||+|+||.||+|.+..++ .||+|++.........+.+|+++++.++|+|++++++.+.. +..++||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~----~~~~lv~ 79 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE----EPIYIVT 79 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECC----CCcEEEE
Confidence 567999999999999999999987654 69999998655556678889999999999999999887643 4579999
Q ss_pred EecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCcccccc-----
Q psy11098 179 QLVHGESLIQHLCRQ--STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVST----- 250 (380)
Q Consensus 179 e~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~~----- 250 (380)
||+.+++|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||++++ +.+||+|||.+.....
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~ 159 (262)
T cd05071 80 EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159 (262)
T ss_pred EcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence 999999999999753 45899999999999999999999999999999999999984 5899999999875531
Q ss_pred --cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHH
Q psy11098 251 --VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAREL 327 (380)
Q Consensus 251 --~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 327 (380)
...++..|+|||+..+ ..++.++|+||||+++|+|++ |..||.+....+....+.... ..+ ....++.++.++
T Consensus 160 ~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~l~~l 235 (262)
T cd05071 160 RQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-RMP--CPPECPESLHDL 235 (262)
T ss_pred ccCCcccceecCHhHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCC-CCC--CccccCHHHHHH
Confidence 2234567999999876 467889999999999999999 899998887777766654432 111 224578999999
Q ss_pred HHHhcccCCCCCCCHHHHHh
Q psy11098 328 IGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 328 i~~~L~~dP~~Rpt~~e~L~ 347 (380)
+.+||++||++|||++++++
T Consensus 236 i~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 236 MCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHHccCCcccCCCHHHHHH
Confidence 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=338.83 Aligned_cols=241 Identities=28% Similarity=0.444 Sum_probs=207.7
Q ss_pred hhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHh-hccCCCcceeeecccccCCCceE
Q psy11098 97 QFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLST-LMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 97 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~-l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
.+.+.|+....+|.|+|+.|..+.+..+++..|+|++.+... ...+|+.++.. -.|+|++++...+... ...|
T Consensus 319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~---~~~~e~~~~~~~~~h~niv~~~~v~~~~---~~~~ 392 (612)
T KOG0603|consen 319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD---DNQDEIPISLLVRDHPNIVKSHDVYEDG---KEIY 392 (612)
T ss_pred CcchhhccccccCCCCccceeeeeccccccchhheecccccc---ccccccchhhhhcCCCcceeecceecCC---ceee
Confidence 467889999999999999999999999999999999976522 23346655444 4799999999988875 5679
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe--CCeeEEEeCCCccccccc--
Q psy11098 176 IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN--GAVLKLIDLGSSVSVSTV-- 251 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~--~~~ikl~DFG~a~~~~~~-- 251 (380)
+|||++.|+.+.+.+.....+. .++..|+++|+.|+.|||++|++||||||+|||++ .++++|+|||.++.....
T Consensus 393 ~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~~ 471 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSCD 471 (612)
T ss_pred eeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchhhc
Confidence 9999999999999998776666 78889999999999999999999999999999994 568999999999887643
Q ss_pred -ccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhcccCCCCCCcCCCCCHHHHHHHH
Q psy11098 252 -VLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEE-ETRAHISVADYSFPPEQCGHISVPARELIG 329 (380)
Q Consensus 252 -~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 329 (380)
.+-|..|.|||++.. ..++.++|+||||++||+||+|..||...... ++...+..+.+. ..+|++++|||+
T Consensus 472 tp~~t~~y~APEvl~~-~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s------~~vS~~AKdLl~ 544 (612)
T KOG0603|consen 472 TPALTLQYVAPEVLAI-QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS------ECVSDEAKDLLQ 544 (612)
T ss_pred ccchhhcccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc------cccCHHHHHHHH
Confidence 455888999999986 68999999999999999999999999776544 565555544333 468999999999
Q ss_pred HhcccCCCCCCCHHHHHhcccc
Q psy11098 330 QLLNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 330 ~~L~~dP~~Rpt~~e~L~hpw~ 351 (380)
.||+.||.+|+++.+++.||||
T Consensus 545 ~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 545 QLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HhccCChhhCcChhhhccCcch
Confidence 9999999999999999999999
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=307.69 Aligned_cols=247 Identities=30% Similarity=0.439 Sum_probs=208.5
Q ss_pred ceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC---CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEE
Q psy11098 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER---QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIV 177 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv 177 (380)
+|.+.+.||+|++|.||+|.+..+++.|++|++.... ...+.+.+|+.+++.+.|+|++++++.+.... .+..+++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE-KNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC-CCeEEEE
Confidence 4778899999999999999999999999999997654 34567788999999999999999988877542 2577999
Q ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCcccccc------
Q psy11098 178 MQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVST------ 250 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~~------ 250 (380)
+|++.+++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++. +.++|+|||.+.....
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG 159 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence 999999999999988779999999999999999999999999999999999999985 6999999999876542
Q ss_pred --cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhcccCCCCCCcCCCCCHHHHHH
Q psy11098 251 --VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDES-EEETRAHISVADYSFPPEQCGHISVPAREL 327 (380)
Q Consensus 251 --~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 327 (380)
...++..|+|||.+.+. ..+.++|+||||+++|+|++|..||.... .......+.. ..........++.++.+|
T Consensus 160 ~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~~ 236 (260)
T cd06606 160 TGSVRGTPYWMAPEVIRGE-EYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS--SGEPPEIPEHLSEEAKDF 236 (260)
T ss_pred ccCCCCCccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccc--cCCCcCCCcccCHHHHHH
Confidence 34578899999999874 57889999999999999999999997765 2222222221 111112234568999999
Q ss_pred HHHhcccCCCCCCCHHHHHhcccc
Q psy11098 328 IGQLLNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 328 i~~~L~~dP~~Rpt~~e~L~hpw~ 351 (380)
|.+||..||++||++.++++||||
T Consensus 237 i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 237 LRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HHHhCcCChhhCCCHHHHhhCCCC
Confidence 999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=310.47 Aligned_cols=240 Identities=20% Similarity=0.293 Sum_probs=203.2
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVM 178 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~ 178 (380)
.++|++.+.||+|+||.||+|.+. .+..+|+|.+.......+.+.+|+.+++.++|+|+++++.++.. +..+++|
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~----~~~~lv~ 79 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE----EPIYIVT 79 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEECC----CCcEEEE
Confidence 568999999999999999999876 45679999997766666778899999999999999999887643 4579999
Q ss_pred EecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCcccccc-----
Q psy11098 179 QLVHGESLIQHLCRQ--STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVST----- 250 (380)
Q Consensus 179 e~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~~----- 250 (380)
||+.+++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||++++ +.++|+|||++.....
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 80 EYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence 999999999998653 45899999999999999999999999999999999999985 5899999999875531
Q ss_pred --cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHH
Q psy11098 251 --VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAREL 327 (380)
Q Consensus 251 --~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 327 (380)
...++..|+|||++.+ ..++.++|+||||+++|+|++ |..||.+.+..+....+.... .. +.....+.++.+|
T Consensus 160 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~l 235 (260)
T cd05070 160 RQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY-RM--PCPQDCPISLHEL 235 (260)
T ss_pred ccCCCCCccccChHHHhc-CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CC--CCCCcCCHHHHHH
Confidence 1233557999999876 467889999999999999999 999998888777777665432 12 2234578899999
Q ss_pred HHHhcccCCCCCCCHHHHHh
Q psy11098 328 IGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 328 i~~~L~~dP~~Rpt~~e~L~ 347 (380)
+.+||.+||++|||+.++++
T Consensus 236 i~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 236 MLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHcccCcccCcCHHHHHH
Confidence 99999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=325.16 Aligned_cols=256 Identities=29% Similarity=0.357 Sum_probs=208.7
Q ss_pred hhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC---CCchHHHHHHHHHHHhh-ccCCCcceeeecccccCCC
Q psy11098 97 QFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE---RQPQQITRAEYNLLSTL-MHAHIPTALALFENAPVPG 172 (380)
Q Consensus 97 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~~~~ 172 (380)
.+.++|++.+.||+|+||.||+|.+..+++.+|+|.+... ........+|+.+++.+ +|+||+++++++.... ..
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~-~~ 82 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEN-DK 82 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCC-Cc
Confidence 4678999999999999999999999999999999988532 22234456799999999 9999999999876532 24
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc--
Q psy11098 173 TDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS-- 249 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~-- 249 (380)
..++||||+. ++|.+++... .+++..+..++.||+.||.|||+.||+||||||+|||++ ++.+||+|||++....
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 83 DIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred eEEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 5799999995 6998888765 789999999999999999999999999999999999998 5689999999987542
Q ss_pred ---------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc-----------
Q psy11098 250 ---------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVAD----------- 309 (380)
Q Consensus 250 ---------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~----------- 309 (380)
....+++.|+|||++.+....+.++|+||||+++|+|++|+.||.+....+....+....
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence 123578899999988765567889999999999999999999998766554433322111
Q ss_pred ----------------CCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 310 ----------------YSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 310 ----------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
..........++.++.+||.+||+.||++|||+.++++||||.+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~ 302 (337)
T cd07852 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFH 302 (337)
T ss_pred HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhc
Confidence 0111122234788999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=314.55 Aligned_cols=242 Identities=21% Similarity=0.326 Sum_probs=201.4
Q ss_pred hceeeeeeecccCCeEEEEEEEc----CCCcEEEEEEecCCCCc--hHHHHHHHHHHHhhccCCCcceeeecccccCCCc
Q psy11098 100 HRYEELERLGNGRFCTVRKARDR----GTGQLVALKQIPRERQP--QQITRAEYNLLSTLMHAHIPTALALFENAPVPGT 173 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~----~~~~~vAvK~~~~~~~~--~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~ 173 (380)
+.|++.+.||+|+||+||+|... .+++.+|+|.+...... ...+.+|+++++.++|+|++++++++... +.
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~ 81 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE---QP 81 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC---Cc
Confidence 56889999999999999999853 45678999999643332 24567899999999999999999887664 56
Q ss_pred eEEEEEecCCCCHHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-C
Q psy11098 174 DTIVMQLVHGESLIQHLCRQ-----------------STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-A 235 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~-----------------~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~ 235 (380)
.+++|||+.+++|.+++... ..+++..+..++.|++.||.|||++|++||||||+|||+++ +
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC
Confidence 79999999999999998532 24788899999999999999999999999999999999985 5
Q ss_pred eeEEEeCCCccccc--------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHh
Q psy11098 236 VLKLIDLGSSVSVS--------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHIS 306 (380)
Q Consensus 236 ~ikl~DFG~a~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~ 306 (380)
.+||+|||++.... ....++..|+|||++.+ ..++.++|+|||||++|+|++ |..||.+.+..+....+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 240 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY-GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR 240 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 89999999987542 23344667999999987 467889999999999999998 999998887776666665
Q ss_pred cccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 307 VADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 307 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
..... .....++.++++++.+||+.||++||++.+++++
T Consensus 241 ~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 241 KRQLL---PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred cCCcC---CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 44322 1234578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=336.44 Aligned_cols=265 Identities=22% Similarity=0.330 Sum_probs=232.5
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC----CCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
.+.+++..||.||||.|=+++.+.....+|+|++++. ..+.+....|-+||...+.+.|++++..|... +.+|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~---kyvY 496 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDS---KYVY 496 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccc---hhhh
Confidence 4566778899999999999998876667999999753 33455667799999999999999888888764 7889
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-----
Q psy11098 176 IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS----- 249 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~----- 249 (380)
|+||-|-||+|+..+.+.+.|++..++.++..+++|++|||++|||+|||||+|.|++ +|-+||.|||+|+++.
T Consensus 497 mLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KT 576 (732)
T KOG0614|consen 497 MLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKT 576 (732)
T ss_pred hhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCce
Confidence 9999999999999999999999999999999999999999999999999999999998 5799999999999875
Q ss_pred ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHH
Q psy11098 250 TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIG 329 (380)
Q Consensus 250 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 329 (380)
-++||||+|+|||++.+ +..+.++|.||||+++||||+|.+||.+.+...++..|.++.-....+ ..++..+.+||+
T Consensus 577 wTFcGTpEYVAPEIILn-KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~P--r~I~k~a~~Lik 653 (732)
T KOG0614|consen 577 WTFCGTPEYVAPEIILN-KGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFP--RRITKTATDLIK 653 (732)
T ss_pred eeecCCcccccchhhhc-cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcc--cccchhHHHHHH
Confidence 47899999999999999 577899999999999999999999999999999999998765332222 468999999999
Q ss_pred HhcccCCCCCCC-----HHHHHhcccccccCCCCCccccccchHHH
Q psy11098 330 QLLNTHADKRPT-----AGQLLQVAWFAEASCSEFDTERLLPFSAR 370 (380)
Q Consensus 330 ~~L~~dP~~Rpt-----~~e~L~hpw~~~~~~~~~~~~~~~~~~~~ 370 (380)
++...+|.+|.. +.++-+|.||..-.+.-+-...|+|-+.+
T Consensus 654 ~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~ 699 (732)
T KOG0614|consen 654 KLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIP 699 (732)
T ss_pred HHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccc
Confidence 999999999986 89999999999888777777777665543
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=310.75 Aligned_cols=241 Identities=20% Similarity=0.296 Sum_probs=202.8
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEEE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQ 179 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e 179 (380)
.+|++.+.||+|+||.||+|.++ ++..+|+|++.........+.+|+++++.++|+|++++++++... +..++|||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~lv~e 79 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ---RPIFIVTE 79 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCC---CceEEEEe
Confidence 35788899999999999999986 466899999976555556678899999999999999988887654 56799999
Q ss_pred ecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccccc-------
Q psy11098 180 LVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVST------- 250 (380)
Q Consensus 180 ~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~~------- 250 (380)
|+.|++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+||+++ ++.+||+|||++.....
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (256)
T cd05059 80 YMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ 159 (256)
T ss_pred cCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence 9999999999965 34689999999999999999999999999999999999998 56899999999875431
Q ss_pred cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHH
Q psy11098 251 VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIG 329 (380)
Q Consensus 251 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 329 (380)
...++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||......+....+.... .. ......+.++.+++.
T Consensus 160 ~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~li~ 235 (256)
T cd05059 160 GTKFPVKWAPPEVFDY-SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY-RL--YRPKLAPTEVYTIMY 235 (256)
T ss_pred CCCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCC-cC--CCCCCCCHHHHHHHH
Confidence 1122357999999987 467889999999999999999 899998887777766665432 11 122357999999999
Q ss_pred HhcccCCCCCCCHHHHHhc
Q psy11098 330 QLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 330 ~~L~~dP~~Rpt~~e~L~h 348 (380)
+||..+|++|||+.++++.
T Consensus 236 ~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 236 SCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHhcCChhhCcCHHHHHHH
Confidence 9999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=312.08 Aligned_cols=244 Identities=26% Similarity=0.355 Sum_probs=204.9
Q ss_pred ceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC------CCchHHHHHHHHHHHhhccCCCcceeeecccccCCCce
Q psy11098 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE------RQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~------~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~ 174 (380)
+|.+.+.||+|+||.||++.+..++..+++|+++.. ......+..|+.+++.++|+|++++++++... +..
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 77 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLER---DAF 77 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC---Cce
Confidence 588999999999999999999888777777776431 12233456789999999999999988887654 567
Q ss_pred EEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeCCeeEEEeCCCccccc-
Q psy11098 175 TIVMQLVHGESLIQHLCR----QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGAVLKLIDLGSSVSVS- 249 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~----~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~~~ikl~DFG~a~~~~- 249 (380)
++|+||+.+++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||||+||+++++.+||+|||++....
T Consensus 78 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 78 CIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNLLKIGDFGVSRLLMG 157 (260)
T ss_pred EEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeecCCEeecccCceeecCC
Confidence 999999999999988853 457899999999999999999999999999999999999998899999999886542
Q ss_pred -----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHH
Q psy11098 250 -----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPA 324 (380)
Q Consensus 250 -----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 324 (380)
....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.........+...... .....++.++
T Consensus 158 ~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 233 (260)
T cd08222 158 SCDLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTP---SLPETYSRQL 233 (260)
T ss_pred CcccccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCC---CCcchhcHHH
Confidence 24557889999999876 46678999999999999999999999877766665555443221 1224578899
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhcccc
Q psy11098 325 RELIGQLLNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 325 ~~li~~~L~~dP~~Rpt~~e~L~hpw~ 351 (380)
.++|.+||..||++||++.++++||||
T Consensus 234 ~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 234 NSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=313.87 Aligned_cols=243 Identities=21% Similarity=0.332 Sum_probs=203.1
Q ss_pred hhceeeeeeecccCCeEEEEEEEcC-----CCcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCC
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRG-----TGQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVP 171 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~ 171 (380)
.++|.+.+.||+|+||.||+|.+.. ++..||+|.+..... ....+.+|+.+++.++|+|++++++++...
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--- 81 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFER--- 81 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC---
Confidence 4679999999999999999999987 778999998864432 234577899999999999999999877654
Q ss_pred CceEEEEEecCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeCC----eeEEE
Q psy11098 172 GTDTIVMQLVHGESLIQHLCRQS-------TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGA----VLKLI 240 (380)
Q Consensus 172 ~~~~lv~e~~~gg~L~~~l~~~~-------~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~~----~ikl~ 240 (380)
+..+++|||+.|++|.+++.... .+++..+..++.||+.||.|||+++++||||||+|||++.. .+||+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 56699999999999999997643 58999999999999999999999999999999999999742 69999
Q ss_pred eCCCcccccc--------cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCC
Q psy11098 241 DLGSSVSVST--------VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYS 311 (380)
Q Consensus 241 DFG~a~~~~~--------~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~ 311 (380)
|||++..... ....+..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~- 239 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGR- 239 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc-
Confidence 9999876521 2223467999999977 468899999999999999997 9999998877776655543321
Q ss_pred CCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 312 FPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 312 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
......++.++.+++.+||+.||++|||+.++|+|
T Consensus 240 --~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 240 --LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred --CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 11224578999999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=305.23 Aligned_cols=245 Identities=30% Similarity=0.424 Sum_probs=208.8
Q ss_pred ceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC-chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEEE
Q psy11098 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ-PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQ 179 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e 179 (380)
.|++.+.||+|++|.||++.+..+++.+|+|++..... ....+.+|+++++.+.|+|++++++.+... +..++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKK---DELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecC---CeEEEEEe
Confidence 47888999999999999999998999999999976544 456778899999999999999999988764 67799999
Q ss_pred ecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-----ccc
Q psy11098 180 LVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS-----TVV 252 (380)
Q Consensus 180 ~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~-----~~~ 252 (380)
|+.|++|.+++... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++ ++.++|+|||.+.... ...
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 157 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM 157 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccccccce
Confidence 99999999999775 6899999999999999999999999999999999999998 5689999999987664 345
Q ss_pred cCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhc
Q psy11098 253 LPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLL 332 (380)
Q Consensus 253 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 332 (380)
.++..|+|||.+.+. ..+.++|+||||+++|+|++|..||...+.......+........ .....++.++.++|.+||
T Consensus 158 ~~~~~~~~PE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l 235 (253)
T cd05122 158 VGTPYWMAPEVINGK-PYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGL-RNPEKWSDEFKDFLKKCL 235 (253)
T ss_pred ecCCcccCHHHHcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCc-CcccccCHHHHHHHHHHc
Confidence 678899999999874 578899999999999999999999987755554444443222111 111234889999999999
Q ss_pred ccCCCCCCCHHHHHhccc
Q psy11098 333 NTHADKRPTAGQLLQVAW 350 (380)
Q Consensus 333 ~~dP~~Rpt~~e~L~hpw 350 (380)
..||++|||+.++|+|||
T Consensus 236 ~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 236 QKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred cCChhhCCCHHHHhcCCC
Confidence 999999999999999999
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=309.45 Aligned_cols=241 Identities=20% Similarity=0.291 Sum_probs=205.0
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEE
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIV 177 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv 177 (380)
..+.|++.++||+|+||.||+|..+ +++.||+|.+.........+.+|+.+++.++|+|++++.+++.. +..+++
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~v 78 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ----EPIYII 78 (260)
T ss_pred chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEcc----CCcEEE
Confidence 4678999999999999999999865 57789999998766666778899999999999999999887643 467999
Q ss_pred EEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCccccc-----
Q psy11098 178 MQLVHGESLIQHLCRQ--STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVS----- 249 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~----- 249 (380)
|||+.+++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||++++ +.++|+|||++....
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 9999999999998653 46899999999999999999999999999999999999984 589999999987553
Q ss_pred --ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHH
Q psy11098 250 --TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARE 326 (380)
Q Consensus 250 --~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 326 (380)
....++..|+|||++.+ ..++.++|+||||+++|+|++ |+.||.+.+..+....+.... . .+.....+.++.+
T Consensus 159 ~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~ 234 (260)
T cd05067 159 AREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGY-R--MPRPDNCPEELYE 234 (260)
T ss_pred cccCCcccccccCHHHhcc-CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC-C--CCCCCCCCHHHHH
Confidence 12234568999999887 467889999999999999999 999998887777666654332 1 1223457889999
Q ss_pred HHHHhcccCCCCCCCHHHHHh
Q psy11098 327 LIGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 327 li~~~L~~dP~~Rpt~~e~L~ 347 (380)
+|.+||..||++|||+++++.
T Consensus 235 li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 235 LMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHHccCChhhCCCHHHHHH
Confidence 999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=315.03 Aligned_cols=242 Identities=22% Similarity=0.296 Sum_probs=204.0
Q ss_pred hhceeeeeeecccCCeEEEEEEEc-----CCCcEEEEEEecCCCC-chHHHHHHHHHHHhhccCCCcceeeecccccCCC
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDR-----GTGQLVALKQIPRERQ-PQQITRAEYNLLSTLMHAHIPTALALFENAPVPG 172 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vAvK~~~~~~~-~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~ 172 (380)
.+.|.+.+.||+|+||+||++... .++..+|+|.+..... ....+.+|+++++.+.|+|++++++++... +
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~ 80 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG---D 80 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC---C
Confidence 467899999999999999999852 3456799999865432 345678899999999999999999888753 6
Q ss_pred ceEEEEEecCCCCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeE
Q psy11098 173 TDTIVMQLVHGESLIQHLCRQS-------------TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLK 238 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~~~-------------~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ik 238 (380)
..+++|||+.+++|.+++...+ .+++..+..++.||+.||.|||++|++||||||+|||++ ++.+|
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence 7799999999999999996543 489999999999999999999999999999999999997 56899
Q ss_pred EEeCCCccccc--------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccc
Q psy11098 239 LIDLGSSVSVS--------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVAD 309 (380)
Q Consensus 239 l~DFG~a~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~ 309 (380)
|+|||++.... ....++..|+|||++.+ ..++.++|+|||||++|+|++ |..||......+....+....
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~ 239 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 239 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 99999987542 22334678999999987 477889999999999999998 999998888877777776654
Q ss_pred CCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy11098 310 YSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 310 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~ 347 (380)
.... ...++.++.+|+.+||+.||.+|||+.+++.
T Consensus 240 ~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 240 VLQR---PRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred cCCC---CCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 3222 2357889999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=308.10 Aligned_cols=235 Identities=23% Similarity=0.336 Sum_probs=196.8
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEEEecCC
Q psy11098 106 ERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHG 183 (380)
Q Consensus 106 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e~~~g 183 (380)
+.||+|+||.||+|.++.+++.||+|.+..... ....+.+|+++++.+.|+||+++++++... +..++||||+.+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~lv~e~~~~ 77 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK---QPIYIVMELVQG 77 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC---CCeEEEEeeccC
Confidence 469999999999999999999999998864432 235678899999999999999999988764 567999999999
Q ss_pred CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccccc--------cc
Q psy11098 184 ESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVSTV--------VL 253 (380)
Q Consensus 184 g~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~~~--------~~ 253 (380)
++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++ ++.+||+|||++...... ..
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 78 GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 9999999654 4689999999999999999999999999999999999998 458999999998754311 11
Q ss_pred CCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhc
Q psy11098 254 PDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLL 332 (380)
Q Consensus 254 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 332 (380)
.+..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...+.......+..... ......++..+.+|+.+||
T Consensus 158 ~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l 233 (252)
T cd05084 158 IPVKWTAPEALNY-GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR---LPCPELCPDAVYRLMERCW 233 (252)
T ss_pred CceeecCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC---CCCcccCCHHHHHHHHHHc
Confidence 2456999999987 467889999999999999998 9999988777666665544321 1222457899999999999
Q ss_pred ccCCCCCCCHHHHHh
Q psy11098 333 NTHADKRPTAGQLLQ 347 (380)
Q Consensus 333 ~~dP~~Rpt~~e~L~ 347 (380)
+.||++|||+.++++
T Consensus 234 ~~~p~~Rps~~~~~~ 248 (252)
T cd05084 234 EYDPGQRPSFSTVHQ 248 (252)
T ss_pred CCChhhCcCHHHHHH
Confidence 999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=308.70 Aligned_cols=233 Identities=21% Similarity=0.308 Sum_probs=196.8
Q ss_pred eecccCCeEEEEEEE--cCCCcEEEEEEecCCCCc---hHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEEEec
Q psy11098 107 RLGNGRFCTVRKARD--RGTGQLVALKQIPRERQP---QQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLV 181 (380)
Q Consensus 107 ~LG~G~fg~V~~~~~--~~~~~~vAvK~~~~~~~~---~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e~~ 181 (380)
.||+|+||.||+|.+ +.++..+|+|+++..... .+.+.+|+.+++.+.|+|++++++++.. +..++||||+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~lv~e~~ 77 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA----ESWMLVMELA 77 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC----CCcEEEEecC
Confidence 589999999999965 457789999998654332 3456789999999999999999988753 4569999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCcccccc---------c
Q psy11098 182 HGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVST---------V 251 (380)
Q Consensus 182 ~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~~---------~ 251 (380)
.+++|.+++.....+++..+..++.|++.||.|||++||+||||||.|||++. +.+||+|||++..... .
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 78 ELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence 99999999988788999999999999999999999999999999999999985 5899999999875531 1
Q ss_pred ccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHH
Q psy11098 252 VLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQ 330 (380)
Q Consensus 252 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 330 (380)
..++..|+|||.+.. ..++.++|+|||||++|+|++ |..||.+....+....+....... ....++.+++++|.+
T Consensus 158 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~---~~~~~~~~l~~li~~ 233 (257)
T cd05116 158 GKWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERME---CPQRCPPEMYDLMKL 233 (257)
T ss_pred CCCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCC---CCCCCCHHHHHHHHH
Confidence 223578999999876 467889999999999999998 999998888777777776544211 223578999999999
Q ss_pred hcccCCCCCCCHHHHHh
Q psy11098 331 LLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 331 ~L~~dP~~Rpt~~e~L~ 347 (380)
||+.||++||+++++.+
T Consensus 234 ~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 234 CWTYGVDERPGFAVVEL 250 (257)
T ss_pred HhccCchhCcCHHHHHH
Confidence 99999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=311.92 Aligned_cols=242 Identities=15% Similarity=0.209 Sum_probs=198.6
Q ss_pred eeeeeecccCCeEEEEEEEcCCCc--EEEEEEecCCC---CchHHHHHHHHHHHhhccCCCcceeeeccccc---CCCce
Q psy11098 103 EELERLGNGRFCTVRKARDRGTGQ--LVALKQIPRER---QPQQITRAEYNLLSTLMHAHIPTALALFENAP---VPGTD 174 (380)
Q Consensus 103 ~~~~~LG~G~fg~V~~~~~~~~~~--~vAvK~~~~~~---~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~---~~~~~ 174 (380)
.+.+.||+|+||.||+|+...++. .+|+|.++... .....+.+|+++++.++|+|++++++++.... .....
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 466889999999999999887775 69999986542 23455677999999999999999998754321 11246
Q ss_pred EEEEEecCCCCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccc
Q psy11098 175 TIVMQLVHGESLIQHLCR------QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVS 247 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~------~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~ 247 (380)
+++|||+.+|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 161 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKK 161 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccc
Confidence 899999999999988742 23478999999999999999999999999999999999998 46899999999876
Q ss_pred cc--------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCC
Q psy11098 248 VS--------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCG 318 (380)
Q Consensus 248 ~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 318 (380)
.. ....+++.|+|||++.+ ..++.++|+||||+++|+|++ |..||.+....+....+....... ...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~ 237 (272)
T cd05075 162 IYNGDYYRQGRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLK---QPP 237 (272)
T ss_pred cCcccceecCCcccCCcccCCHHHccC-CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC---CCC
Confidence 53 12245678999999987 477889999999999999999 899998887777766666543211 123
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 319 HISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 319 ~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
.++..+.++|.+||+.||++|||+.+++++
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 238 DCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=308.26 Aligned_cols=240 Identities=20% Similarity=0.280 Sum_probs=202.5
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVM 178 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~ 178 (380)
.++|++.+.||+|+||.||+|.+..++ .+|+|.+.......+.+.+|+++++.+.|+|+++++.++.. +..+++|
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~v~ 79 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE----EPIYIVT 79 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEcC----CCcEEEE
Confidence 467999999999999999999987654 69999987655556677889999999999999999887753 4579999
Q ss_pred EecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCcccccc-----
Q psy11098 179 QLVHGESLIQHLCRQ--STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVST----- 250 (380)
Q Consensus 179 e~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~~----- 250 (380)
||+.+++|.+++... ..+++..+..++.||+.||.|||+.|++|+||||+|||+++ +.++|+|||++.....
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 80 EFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred EcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence 999999999999653 34789999999999999999999999999999999999984 5899999999875431
Q ss_pred --cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHH
Q psy11098 251 --VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAREL 327 (380)
Q Consensus 251 --~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 327 (380)
...++..|+|||...+ ...+.++|+||||+++|+|++ |..||.+....+....+... +.. .....++..++++
T Consensus 160 ~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~l 235 (260)
T cd05069 160 RQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG-YRM--PCPQGCPESLHEL 235 (260)
T ss_pred cCCCccchhhCCHHHhcc-CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCC--CCCcccCHHHHHH
Confidence 1234567999999877 467889999999999999999 99999988877776666543 222 2224578999999
Q ss_pred HHHhcccCCCCCCCHHHHHh
Q psy11098 328 IGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 328 i~~~L~~dP~~Rpt~~e~L~ 347 (380)
+++||.+||++||+++++++
T Consensus 236 i~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 236 MKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHHccCCcccCcCHHHHHH
Confidence 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=318.17 Aligned_cols=242 Identities=22% Similarity=0.316 Sum_probs=199.6
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcE--EEEEEecCCC--CchHHHHHHHHHHHhh-ccCCCcceeeecccccCCCce
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQL--VALKQIPRER--QPQQITRAEYNLLSTL-MHAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~--vAvK~~~~~~--~~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~~~~~~ 174 (380)
++|++.+.||+|+||+||+|.++.++.. +|+|.+.... .....+.+|++++..+ +|+|++++++++... +..
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~---~~~ 83 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR---GYL 83 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC---CCc
Confidence 4789999999999999999998877754 5777665322 2334567899999999 899999999988764 567
Q ss_pred EEEEEecCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCee
Q psy11098 175 TIVMQLVHGESLIQHLCRQS----------------TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVL 237 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~~----------------~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~i 237 (380)
|+||||+.+++|.+++.... .+++..++.++.||+.||+|||++|++||||||+|||++ ++.+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA 163 (303)
T ss_pred eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcE
Confidence 99999999999999996532 578999999999999999999999999999999999997 5689
Q ss_pred EEEeCCCccccc-----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCC
Q psy11098 238 KLIDLGSSVSVS-----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYS 311 (380)
Q Consensus 238 kl~DFG~a~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~ 311 (380)
||+|||++.... ....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+....
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-- 240 (303)
T cd05088 164 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-- 240 (303)
T ss_pred EeCccccCcccchhhhcccCCCcccccCHHHHhc-cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC--
Confidence 999999986432 12233567999999877 467889999999999999998 999998887777666554321
Q ss_pred CCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 312 FPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 312 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
.......++.++.+||.+||+.||++|||++++|.+
T Consensus 241 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 241 -RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred -cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 111223578899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=310.32 Aligned_cols=258 Identities=24% Similarity=0.358 Sum_probs=206.3
Q ss_pred hhhhceeeeeeecccCCeEEEEEEEcCCCc----EEEEEEecCCCC---chHHHHHHHHHHHhhccCCCcceeeeccccc
Q psy11098 97 QFEHRYEELERLGNGRFCTVRKARDRGTGQ----LVALKQIPRERQ---PQQITRAEYNLLSTLMHAHIPTALALFENAP 169 (380)
Q Consensus 97 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~----~vAvK~~~~~~~---~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~ 169 (380)
+....|++...||+|+||.||+|..+.++. .+|+|.|+.+.. -....-+|+.+++.++|+|++.++.+|-..
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~- 99 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH- 99 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc-
Confidence 446789999999999999999997665543 789999975532 345566799999999999999999998875
Q ss_pred CCCceEEEEEecCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-C----CeeEE
Q psy11098 170 VPGTDTIVMQLVHGESLIQHLCR-----QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-G----AVLKL 239 (380)
Q Consensus 170 ~~~~~~lv~e~~~gg~L~~~l~~-----~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~----~~ikl 239 (380)
...+++++||. .-+|+.+|.. ...++...++.++.||+.|+.|||++=|+||||||.|||+. + |.|||
T Consensus 100 -d~~v~l~fdYA-EhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 100 -DKKVWLLFDYA-EHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred -CceEEEEehhh-hhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEe
Confidence 47889999999 6688888853 34689999999999999999999999999999999999995 4 69999
Q ss_pred EeCCCccccc---------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHH---------HH
Q psy11098 240 IDLGSSVSVS---------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEE---------ET 301 (380)
Q Consensus 240 ~DFG~a~~~~---------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~---------~~ 301 (380)
+|||+|+.+. ..++-|.+|.|||.+.|...|+.+.||||+|||+.||++-++-|.+.... +.
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ 257 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ 257 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence 9999998764 34456899999999999999999999999999999999998888653221 11
Q ss_pred HHHHhcc-------cC----CCCC----------CcC------------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 302 RAHISVA-------DY----SFPP----------EQC------------GHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 302 ~~~i~~~-------~~----~~~~----------~~~------------~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
+.+|... ++ .+|. ..+ ..-++.+.+|+.+||+.||.+|.|++|+|+|
T Consensus 258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 1222110 00 0000 011 1124458899999999999999999999999
Q ss_pred ccccccCCC
Q psy11098 349 AWFAEASCS 357 (380)
Q Consensus 349 pw~~~~~~~ 357 (380)
+||.+...+
T Consensus 338 ~yF~~d~lp 346 (438)
T KOG0666|consen 338 PYFTEDPLP 346 (438)
T ss_pred cccccCCCC
Confidence 999987544
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=320.41 Aligned_cols=255 Identities=26% Similarity=0.372 Sum_probs=207.3
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC---CchHHHHHHHHHHHhhccCCCcceeeecccccCCCce
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER---QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~ 174 (380)
+.++|++.+.||.|+||.||+|.+..+++.||+|.+.+.. .....+.+|+++++.++|||++++.++|... .+..
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~ 85 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP--LEDI 85 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC--CCcE
Confidence 5788999999999999999999999999999999885432 2345567899999999999999999987542 2467
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc---c
Q psy11098 175 TIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS---T 250 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~---~ 250 (380)
++++||+ +++|.+++.. ..+++..+..++.||++||.|||++||+||||+|.|||++ ++.+||+|||++.... .
T Consensus 86 ~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 163 (328)
T cd07856 86 YFVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMT 163 (328)
T ss_pred EEEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCCcC
Confidence 8999998 6788877754 4688999999999999999999999999999999999998 4689999999987654 2
Q ss_pred cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc---------------------
Q psy11098 251 VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVAD--------------------- 309 (380)
Q Consensus 251 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~--------------------- 309 (380)
...+++.|+|||++.+...++.++|+||||+++|+|++|..||...........+....
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (328)
T cd07856 164 GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQ 243 (328)
T ss_pred CCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHh
Confidence 34568899999998764567889999999999999999999997765433222211100
Q ss_pred -----CCCC-CCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCC
Q psy11098 310 -----YSFP-PEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASC 356 (380)
Q Consensus 310 -----~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~ 356 (380)
...+ ......++.+++++|++||+.+|++|||++++|.||||.....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~ 296 (328)
T cd07856 244 SLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHD 296 (328)
T ss_pred hccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccC
Confidence 0001 1122457889999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=316.33 Aligned_cols=254 Identities=24% Similarity=0.329 Sum_probs=211.2
Q ss_pred hhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC----chHHHHHHHHHHHhhccCCCcceeeecccccCC
Q psy11098 96 EQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ----PQQITRAEYNLLSTLMHAHIPTALALFENAPVP 171 (380)
Q Consensus 96 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~ 171 (380)
....+.|...+.||+|+||+||+|++..+++.||+|.+..... ....+.+|+++++.++|+|++++++++...
T Consensus 17 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--- 93 (313)
T cd06633 17 DDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE--- 93 (313)
T ss_pred CCHHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC---
Confidence 3455668888999999999999999999999999999864322 223466799999999999999999988764
Q ss_pred CceEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc
Q psy11098 172 GTDTIVMQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS 249 (380)
Q Consensus 172 ~~~~lv~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~ 249 (380)
...|+||||+. ++|.+.+.. ...+++..+..++.||+.||.|||++|++|+||||+||+++ ++.+||+|||++....
T Consensus 94 ~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~ 172 (313)
T cd06633 94 HTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS 172 (313)
T ss_pred CEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC
Confidence 56799999994 677777754 45789999999999999999999999999999999999997 4689999999986543
Q ss_pred --ccccCCCcccCCccccC--CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHH
Q psy11098 250 --TVVLPDLEFASPEMLTS--PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAR 325 (380)
Q Consensus 250 --~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 325 (380)
....++..|+|||++.. ...++.++|+|||||++|+|++|..||.+.........+.... .+......++..++
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~ 250 (313)
T cd06633 173 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND--SPTLQSNEWTDSFR 250 (313)
T ss_pred CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC--CCCCCccccCHHHH
Confidence 45578899999999852 2456789999999999999999999998877665555554332 22223345788899
Q ss_pred HHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 326 ELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 326 ~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
+|+.+||+.+|.+||++.++|.||||....
T Consensus 251 ~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 251 GFVDYCLQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred HHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 999999999999999999999999998764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=307.04 Aligned_cols=236 Identities=23% Similarity=0.343 Sum_probs=204.8
Q ss_pred eeecccCCeEEEEEEEcCC---CcEEEEEEecCCCCc--hHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEEEe
Q psy11098 106 ERLGNGRFCTVRKARDRGT---GQLVALKQIPRERQP--QQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQL 180 (380)
Q Consensus 106 ~~LG~G~fg~V~~~~~~~~---~~~vAvK~~~~~~~~--~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e~ 180 (380)
+.||+|+||.||+|.+... +..||+|++...... ...+.+|+++++.++|+|++++++++.. .+..+++|||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~~~~~lv~e~ 77 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE---EEPLYLVLEY 77 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC---CCceEEEEEe
Confidence 4699999999999999866 889999999765443 4677889999999999999999988876 4678999999
Q ss_pred cCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCcccccc
Q psy11098 181 VHGESLIQHLCRQ---------STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVST 250 (380)
Q Consensus 181 ~~gg~L~~~l~~~---------~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~~ 250 (380)
+.+++|.+++... ..+++..++.++.|++.||.|||++|++|+||||+||+++. +.+||+|||.+.....
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999999875 78999999999999999999999999999999999999985 7999999999876542
Q ss_pred --------cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCC
Q psy11098 251 --------VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHIS 321 (380)
Q Consensus 251 --------~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 321 (380)
...+++.|+|||.+.+. .++.++|+||||+++|+|++ |..||.+....+....+..... ......++
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~ 233 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYR---LPKPEYCP 233 (262)
T ss_pred ccccccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---CCCCccCC
Confidence 34568899999998874 77889999999999999999 6999998888777777765322 12224568
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 322 VPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 322 ~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
.++.+++.+||..||++|||+.|++++
T Consensus 234 ~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 234 DELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred hHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=312.51 Aligned_cols=242 Identities=28% Similarity=0.407 Sum_probs=200.9
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC----CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
++|++.+.||+|+||.||+|+++.+++.+|+|.+.... .....+.+|+.+++.+.|+|+++++.++... +..+
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~---~~~~ 78 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED---NELN 78 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeC---CeEE
Confidence 46888899999999999999999999999999886432 2234567899999999999999999888763 6779
Q ss_pred EEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-
Q psy11098 176 IVMQLVHGESLIQHLCR----QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS- 249 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~----~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~- 249 (380)
++|||+.|++|.+++.. ...+++..++.++.||+.||.|||++|++|+||||+||+++ ++.++|+|||++....
T Consensus 79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 79 IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999999998863 35689999999999999999999999999999999999998 4689999999886543
Q ss_pred -----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHhcccCCCCCCcCCCCCH
Q psy11098 250 -----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESE--EETRAHISVADYSFPPEQCGHISV 322 (380)
Q Consensus 250 -----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~s~ 322 (380)
....++..|+|||.+.+ ...+.++|+||||+++|+|++|..||.+... .+....+... ..+......++.
T Consensus 159 ~~~~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 235 (267)
T cd08229 159 KTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC--DYPPLPSDHYSE 235 (267)
T ss_pred CCcccccccCCcCccCHHHhcC-CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC--CCCCCCcccccH
Confidence 23467889999999977 4678899999999999999999999976543 2333333322 223333345788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHh
Q psy11098 323 PARELIGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 323 ~~~~li~~~L~~dP~~Rpt~~e~L~ 347 (380)
+++++|.+||..||++|||+.++++
T Consensus 236 ~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 236 ELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHHHHhcCCCcccCCCHHHHHH
Confidence 9999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=315.13 Aligned_cols=245 Identities=19% Similarity=0.277 Sum_probs=202.8
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCC----------------cEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcc
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTG----------------QLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPT 160 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~----------------~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~ 160 (380)
.++|++.+.||+|+||.||+|.+..++ ..||+|.+..... ....+.+|+++++.++|+|+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 468999999999999999999876544 4689999875543 3456778999999999999999
Q ss_pred eeeecccccCCCceEEEEEecCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCc
Q psy11098 161 ALALFENAPVPGTDTIVMQLVHGESLIQHLCRQS-----------TITESYICCIIRQLHSALHCLHSQQIAHKDIRPEN 229 (380)
Q Consensus 161 i~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-----------~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~N 229 (380)
+++++... +..+++||++.+++|.+++.... .+++..++.++.|++.||.|||+.||+||||||+|
T Consensus 84 ~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVD---PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EEEEEecC---CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 99988764 57799999999999999997655 68999999999999999999999999999999999
Q ss_pred EEEeC-CeeEEEeCCCccccc--------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh--CCCCCCCCCH
Q psy11098 230 ILMNG-AVLKLIDLGSSVSVS--------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS--GVSPFLDESE 298 (380)
Q Consensus 230 Il~~~-~~ikl~DFG~a~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt--g~~Pf~~~~~ 298 (380)
||+++ +.++|+|||++.... ....+++.|+|||++.+ ..++.++|||||||++|+|++ |..||...+.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL-GKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc-CCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 99985 599999999987542 23345778999999887 467889999999999999998 7889987777
Q ss_pred HHHHHHHhcc----cCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy11098 299 EETRAHISVA----DYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 299 ~~~~~~i~~~----~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~ 347 (380)
.+....+... ...........++.++.+++.+||+.||++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 240 QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 6666555432 111111122356789999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=322.46 Aligned_cols=247 Identities=23% Similarity=0.290 Sum_probs=197.3
Q ss_pred eeeccc--CCeEEEEEEEcCCCcEEEEEEecCCCCc---hHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEEEe
Q psy11098 106 ERLGNG--RFCTVRKARDRGTGQLVALKQIPRERQP---QQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQL 180 (380)
Q Consensus 106 ~~LG~G--~fg~V~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e~ 180 (380)
..||+| +||+||+|++..+|+.||+|++...... .+.+.+|+.+++.++|+||+++++++... +..++||||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~---~~~~~v~e~ 80 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTG---SWLWVISPF 80 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecC---CceEEEEec
Confidence 457777 9999999999999999999998754332 35667899999999999999999998764 677999999
Q ss_pred cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc--------
Q psy11098 181 VHGESLIQHLCRQ--STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS-------- 249 (380)
Q Consensus 181 ~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~-------- 249 (380)
+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.++++|||.+....
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 81 MAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred ccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 9999999998764 3589999999999999999999999999999999999998 5689999998543221
Q ss_pred -----ccccCCCcccCCccccCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCC----------
Q psy11098 250 -----TVVLPDLEFASPEMLTSP-ATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFP---------- 313 (380)
Q Consensus 250 -----~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~---------- 313 (380)
....++..|+|||++.+. ..++.++|||||||++|+|++|..||.+.................+
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE 240 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence 112235569999998763 3467899999999999999999999987655444333322111000
Q ss_pred ---------------------------------CCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 314 ---------------------------------PEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 314 ---------------------------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
.......++++.+||++||+.||++|||++|+|+||||.+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~ 315 (328)
T cd08226 241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK 315 (328)
T ss_pred hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence 001123567899999999999999999999999999998653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=316.47 Aligned_cols=257 Identities=28% Similarity=0.436 Sum_probs=207.7
Q ss_pred ceeeeeeecccCCeEEEEEEEc---CCCcEEEEEEecCCC-----CchHHHHHHHHHHHhh-ccCCCcceeeecccccCC
Q psy11098 101 RYEELERLGNGRFCTVRKARDR---GTGQLVALKQIPRER-----QPQQITRAEYNLLSTL-MHAHIPTALALFENAPVP 171 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~---~~~~~vAvK~~~~~~-----~~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~~~ 171 (380)
+|++.+.||+|+||.||++++. .+++.||+|++.+.. .....+.+|+.++..+ .|+|++++...+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~--- 77 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTD--- 77 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecC---
Confidence 4788999999999999999864 467889999986432 2234567799999999 599999998887653
Q ss_pred CceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-
Q psy11098 172 GTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS- 249 (380)
Q Consensus 172 ~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~- 249 (380)
+..++||||+.+++|.+.+.....+++..++.++.|++.||.|||+.|++||||||+||+++ ++.++|+|||++....
T Consensus 78 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 78 TKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred CEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 67799999999999999998877899999999999999999999999999999999999998 5689999999987543
Q ss_pred ------ccccCCCcccCCccccCCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHhcccCCCCCCcCC
Q psy11098 250 ------TVVLPDLEFASPEMLTSPA-TAGPSTDMWSLGVLLYILLSGVSPFLDES----EEETRAHISVADYSFPPEQCG 318 (380)
Q Consensus 250 ------~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlGvil~~lltg~~Pf~~~~----~~~~~~~i~~~~~~~~~~~~~ 318 (380)
....++..|+|||.+.+.. ..+.++|+||||+++|+|++|..||.... ..+....+....... ..
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~ 233 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPF----PK 233 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCC----Cc
Confidence 2245788999999987632 36789999999999999999999996432 223333333222222 23
Q ss_pred CCCHHHHHHHHHhcccCCCCCCC---HHHHHhcccccccCCCCCccccc
Q psy11098 319 HISVPARELIGQLLNTHADKRPT---AGQLLQVAWFAEASCSEFDTERL 364 (380)
Q Consensus 319 ~~s~~~~~li~~~L~~dP~~Rpt---~~e~L~hpw~~~~~~~~~~~~~~ 364 (380)
.++.+++++|.+||+.||++||| +.++|+||||+...+..+...++
T Consensus 234 ~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~~~~~~~~ 282 (288)
T cd05583 234 TMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDLAAKRI 282 (288)
T ss_pred ccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHHHHhhhcc
Confidence 47889999999999999999998 56779999999887765444443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=310.20 Aligned_cols=242 Identities=18% Similarity=0.254 Sum_probs=201.3
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCc----EEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCC
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQ----LVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPG 172 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~----~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~ 172 (380)
.++|++.+.||+|+||+||+|.+..+++ .||+|++..... ....+.+|+.+++.+.|+|++++++++.. .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----~ 81 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT----S 81 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC----C
Confidence 4678999999999999999999877776 489999864433 24556789999999999999999988764 3
Q ss_pred ceEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccccc
Q psy11098 173 TDTIVMQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVST 250 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~~ 250 (380)
..++++||+.+|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++....
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 46899999999999999976 45689999999999999999999999999999999999997 46899999999876531
Q ss_pred --------cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCC
Q psy11098 251 --------VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHIS 321 (380)
Q Consensus 251 --------~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 321 (380)
...+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||...........+...... + .....+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~~ 237 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILH-RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERL-P--QPPICT 237 (279)
T ss_pred ccceeecCCCccchhhCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcC-C--CCccCC
Confidence 1223567999999977 467889999999999999998 99999887766666555543322 1 123578
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 322 VPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 322 ~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
.++.+++.+||..||++|||+.+++..
T Consensus 238 ~~~~~li~~~l~~dp~~Rp~~~~l~~~ 264 (279)
T cd05109 238 IDVYMIMVKCWMIDSECRPRFRELVDE 264 (279)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999999943
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=363.27 Aligned_cols=252 Identities=26% Similarity=0.403 Sum_probs=213.6
Q ss_pred hhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC---CchHHHHHHHHHHHhhccCCCcceeeecccccCCCc
Q psy11098 97 QFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER---QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGT 173 (380)
Q Consensus 97 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~ 173 (380)
.+.-+++-...||.|.||.||-|.+..||+..|+|-++... .......+|..++..|+|||+++ +|....+++.
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~---YyGVEvHRek 1308 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVR---YYGVEVHREK 1308 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccc---cCceeecHHH
Confidence 34557777889999999999999999999999999886433 23345678999999999999855 5555555678
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc---
Q psy11098 174 DTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS--- 249 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~--- 249 (380)
++|.||||.||+|.+.+......+|.....+..|++.|+.|||++|||||||||+|||++ +|.+|++|||.|..+.
T Consensus 1309 v~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1309 VYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred HHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCch
Confidence 899999999999999999988899999999999999999999999999999999999998 5799999999998774
Q ss_pred -------ccccCCCcccCCccccCCC--CCCCcccHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcccCCCCCCcCCC
Q psy11098 250 -------TVVLPDLEFASPEMLTSPA--TAGPSTDMWSLGVLLYILLSGVSPFLDE-SEEETRAHISVADYSFPPEQCGH 319 (380)
Q Consensus 250 -------~~~~gt~~y~aPE~~~~~~--~~~~~~DiwSlGvil~~lltg~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~ 319 (380)
...+||+.|||||++.+.. ..+.++|||||||++.||+||+.||... ++..+...+..+.-..-+ ..
T Consensus 1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P---~~ 1465 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIP---ER 1465 (1509)
T ss_pred hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCc---hh
Confidence 3468999999999998743 4466899999999999999999999764 445566666544432222 24
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 320 ISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 320 ~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
+|.+.+|||..||+.||++|+++.|+|+|-|-+..
T Consensus 1466 ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1466 LSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred hhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 89999999999999999999999999999987654
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=311.29 Aligned_cols=246 Identities=29% Similarity=0.455 Sum_probs=202.8
Q ss_pred eeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC--chHHHHHHHHHHHhhc-cCCCcceeeecccccCCCceEEEE
Q psy11098 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ--PQQITRAEYNLLSTLM-HAHIPTALALFENAPVPGTDTIVM 178 (380)
Q Consensus 102 y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~-h~ni~~i~~~~~~~~~~~~~~lv~ 178 (380)
|++.+.||.|+||+||+|....+++.||+|.+..... ......+|+..++.++ |+|++++++++.. .+..++||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~---~~~~~lv~ 77 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE---NDELYFVF 77 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc---CCcEEEEE
Confidence 6778999999999999999999999999999865433 2334456899999999 9999999988876 46789999
Q ss_pred EecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCccccc-----c
Q psy11098 179 QLVHGESLIQHLCRQS--TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVS-----T 250 (380)
Q Consensus 179 e~~~gg~L~~~l~~~~--~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~-----~ 250 (380)
||+ +++|.+.+.... .+++..+..++.|++.||.|||++|++|+||+|+||++++ +.++|+|||++.... .
T Consensus 78 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 156 (283)
T cd07830 78 EYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYT 156 (283)
T ss_pred ecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcC
Confidence 999 889999887754 7899999999999999999999999999999999999985 699999999987654 2
Q ss_pred cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc-------------------CC
Q psy11098 251 VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVAD-------------------YS 311 (380)
Q Consensus 251 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~-------------------~~ 311 (380)
...++..|+|||++.....++.++|+||||+++|+|++|..||...+..+....+.... ..
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07830 157 DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFR 236 (283)
T ss_pred CCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccc
Confidence 34578889999998665567889999999999999999999998776554443332110 00
Q ss_pred CC-------CCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy11098 312 FP-------PEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 312 ~~-------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~ 351 (380)
++ .......+.++.+||++||..||++|||++|++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 237 FPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 00 00112336789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=310.63 Aligned_cols=248 Identities=31% Similarity=0.429 Sum_probs=201.4
Q ss_pred eeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCc---hHHHHHHHHHHHhh---ccCCCcceeeecccccCC--Cc
Q psy11098 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP---QQITRAEYNLLSTL---MHAHIPTALALFENAPVP--GT 173 (380)
Q Consensus 102 y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~E~~il~~l---~h~ni~~i~~~~~~~~~~--~~ 173 (380)
|++.+.||.|+||.||+|+++.+++.||+|.+...... ...+.+|+.+++.+ .|+|++++++++...... ..
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 67889999999999999999989999999999744322 23455688777766 599999999998764321 13
Q ss_pred eEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-
Q psy11098 174 DTIVMQLVHGESLIQHLCRQS--TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS- 249 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~~--~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~- 249 (380)
.+++||++. ++|.+++.... .+++..++.++.||+.||.|||+.|++|+||+|+||+++ ++.+||+|||++....
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~ 159 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF 159 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccC
Confidence 799999995 58988887643 589999999999999999999999999999999999998 4689999999987653
Q ss_pred ----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC-----C---------
Q psy11098 250 ----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADY-----S--------- 311 (380)
Q Consensus 250 ----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~-----~--------- 311 (380)
....++..|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.+..+....+..... .
T Consensus 160 ~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07838 160 EMALTSVVVTLWYRAPEVLLQ-SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPR 238 (287)
T ss_pred CcccccccccccccChHHhcc-CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccch
Confidence 23346888999999987 4678899999999999999999999998887776665532110 0
Q ss_pred --CC-------CCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy11098 312 --FP-------PEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 312 --~~-------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~ 351 (380)
++ ......++..+.+||.+||+.||.+||+++++|.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 239 SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred hhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 00 00112356788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=348.46 Aligned_cols=244 Identities=20% Similarity=0.307 Sum_probs=199.2
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC----chHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ----PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
++|++.+.||+|+||.||+|++..+++.||+|++..... ....+.+|+++++.++|||++++++++... +..+
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~---~~ly 78 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDG---DPVY 78 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeC---CEEE
Confidence 579999999999999999999999999999999965322 234567899999999999999999887763 6789
Q ss_pred EEEEecCCCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCC
Q psy11098 176 IVMQLVHGESLIQHLCRQ-----------STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLG 243 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~-----------~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG 243 (380)
++|||+.|++|.+++... ..++...+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||
T Consensus 79 LVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 79 YTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecC
Confidence 999999999999988641 2345667889999999999999999999999999999998 5689999999
Q ss_pred Cccccc------------------------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHH
Q psy11098 244 SSVSVS------------------------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEE 299 (380)
Q Consensus 244 ~a~~~~------------------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~ 299 (380)
++.... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g-~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC-CCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 987541 12468999999999987 46788999999999999999999999876544
Q ss_pred HHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 300 ETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 300 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
............ .......+++.+.+++.+||..||++|++..+.|.+
T Consensus 238 ki~~~~~i~~P~-~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 238 KISYRDVILSPI-EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhhhhhccChh-hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 333221111110 111234688999999999999999999887776654
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=309.27 Aligned_cols=241 Identities=22% Similarity=0.337 Sum_probs=206.4
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC-chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ-PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIV 177 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv 177 (380)
..+|++.+.||.|+||.||+|.+.. ++.+|+|.+..... ....+..|+++++.++|+|++++++++... +..++|
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~lv 80 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVG---EPVYII 80 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecC---CCeEEE
Confidence 5679999999999999999999987 88999999976544 456778899999999999999999887664 567999
Q ss_pred EEecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCccccc-----
Q psy11098 178 MQLVHGESLIQHLCR--QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVS----- 249 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~--~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~----- 249 (380)
|||+.+++|.+++.. ...+++..+..++.||+.||.|||++||+|+||||+|||+++ +.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 999999999999975 346899999999999999999999999999999999999984 589999999987653
Q ss_pred -ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHH
Q psy11098 250 -TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAREL 327 (380)
Q Consensus 250 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 327 (380)
....++..|+|||++.+ ..++.++|+||||+++|+|++ |..||.+....+....+... ...+ .....++++.++
T Consensus 161 ~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~ 236 (261)
T cd05148 161 SSDKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG-YRMP--CPAKCPQEIYKI 236 (261)
T ss_pred ccCCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhC-CcCC--CCCCCCHHHHHH
Confidence 22234678999999877 477889999999999999998 89999888877777776633 2222 224678999999
Q ss_pred HHHhcccCCCCCCCHHHHHh
Q psy11098 328 IGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 328 i~~~L~~dP~~Rpt~~e~L~ 347 (380)
+.+||..||.+|||+.++++
T Consensus 237 i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 237 MLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHHcCCCchhCcCHHHHHH
Confidence 99999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=305.57 Aligned_cols=236 Identities=32% Similarity=0.501 Sum_probs=205.6
Q ss_pred ecccCCeEEEEEEEcCCCcEEEEEEecCCCC----chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEEEecCC
Q psy11098 108 LGNGRFCTVRKARDRGTGQLVALKQIPRERQ----PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHG 183 (380)
Q Consensus 108 LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e~~~g 183 (380)
||.|+||.||++.+..+++.+|+|++..... ....+..|+++++.+.|+|+++++..+.. .+..+++||++.+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~~~v~e~~~~ 77 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQT---EEKLYLVLEYAPG 77 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeec---CCeeEEEEecCCC
Confidence 6999999999999998999999999865432 33467889999999999999999888765 3677999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------ccccCCC
Q psy11098 184 ESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------TVVLPDL 256 (380)
Q Consensus 184 g~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------~~~~gt~ 256 (380)
++|.+++.....+++..+..++.|++.||.|||+.+++|+||+|+||+++ ++.++|+|||++.... ....++.
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05123 78 GELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTP 157 (250)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCc
Confidence 99999998888899999999999999999999999999999999999998 4689999999987653 2456788
Q ss_pred cccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhcccCC
Q psy11098 257 EFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHA 336 (380)
Q Consensus 257 ~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 336 (380)
.|+|||.+.+ ...+.++|+||||+++|+|++|..||......+....+......++ ...+.++.++|++||..||
T Consensus 158 ~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~~i~~~l~~~p 232 (250)
T cd05123 158 EYLAPEVLLG-KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFP----EFLSPEARDLISGLLQKDP 232 (250)
T ss_pred cccChHHhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHhcCCH
Confidence 9999999987 4567899999999999999999999988777666666665444333 3468999999999999999
Q ss_pred CCCCCH---HHHHhcccc
Q psy11098 337 DKRPTA---GQLLQVAWF 351 (380)
Q Consensus 337 ~~Rpt~---~e~L~hpw~ 351 (380)
++|||+ +++++||||
T Consensus 233 ~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 233 TKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred hhCCCcccHHHHHhCCCC
Confidence 999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=305.77 Aligned_cols=244 Identities=25% Similarity=0.384 Sum_probs=210.1
Q ss_pred ceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC---CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEE
Q psy11098 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER---QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIV 177 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv 177 (380)
+|++.+.||+|+||.||++.++.+++.+|+|.+.... .....+.+|+++++.++|+|++++.+++... +..++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~v 77 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG---NKLCIV 77 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC---CEEEEE
Confidence 5889999999999999999999999999999987543 2234556799999999999999998887764 678999
Q ss_pred EEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCccccc---
Q psy11098 178 MQLVHGESLIQHLCR----QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVS--- 249 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~----~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~--- 249 (380)
+||+.+++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||++++ +.+||+|||++....
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 78 MEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred ehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 999999999998866 356899999999999999999999999999999999999984 589999999987653
Q ss_pred -ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHH
Q psy11098 250 -TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELI 328 (380)
Q Consensus 250 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 328 (380)
....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+..+....+....+... ...++.++++++
T Consensus 158 ~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li 233 (256)
T cd08530 158 AKTQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPI---PPIYSQDLQNFI 233 (256)
T ss_pred cccccCCccccCHHHHCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC---chhhCHHHHHHH
Confidence 23457889999999977 4678899999999999999999999988887777666654443222 235789999999
Q ss_pred HHhcccCCCCCCCHHHHHhcccc
Q psy11098 329 GQLLNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 329 ~~~L~~dP~~Rpt~~e~L~hpw~ 351 (380)
.+||..+|++|||+.++|+||++
T Consensus 234 ~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 234 RSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHcCCCcccCCCHHHHhcCCCC
Confidence 99999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=315.28 Aligned_cols=250 Identities=23% Similarity=0.404 Sum_probs=208.8
Q ss_pred ceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC-CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEEE
Q psy11098 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER-QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQ 179 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e 179 (380)
.|.....||+|+||.||++..+.+++.||+|.+.... .....+.+|+.+++.+.|+|++++++.+... +..+++||
T Consensus 21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~lv~e 97 (292)
T cd06657 21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG---DELWVVME 97 (292)
T ss_pred HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeC---CEEEEEEe
Confidence 3444477999999999999999999999999986433 2345677899999999999999999988764 67799999
Q ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------ccc
Q psy11098 180 LVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------TVV 252 (380)
Q Consensus 180 ~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------~~~ 252 (380)
|+.+++|.+++. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++ ++.++|+|||++.... ...
T Consensus 98 ~~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~ 176 (292)
T cd06657 98 FLEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL 176 (292)
T ss_pred cCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccccccccc
Confidence 999999998774 44689999999999999999999999999999999999998 4689999999876543 234
Q ss_pred cCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhc
Q psy11098 253 LPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLL 332 (380)
Q Consensus 253 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 332 (380)
.+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+....+....+...... .......++.++.+++.+||
T Consensus 177 ~~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l 254 (292)
T cd06657 177 VGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-KLKNLHKVSPSLKGFLDRLL 254 (292)
T ss_pred ccCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCc-ccCCcccCCHHHHHHHHHHH
Confidence 57889999999876 46688999999999999999999999887766655554432211 11123457899999999999
Q ss_pred ccCCCCCCCHHHHHhcccccccCC
Q psy11098 333 NTHADKRPTAGQLLQVAWFAEASC 356 (380)
Q Consensus 333 ~~dP~~Rpt~~e~L~hpw~~~~~~ 356 (380)
..||.+||++.++|.||||.+...
T Consensus 255 ~~~P~~R~~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 255 VRDPAQRATAAELLKHPFLAKAGP 278 (292)
T ss_pred hCCcccCcCHHHHhcChHHhccCC
Confidence 999999999999999999988754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=305.96 Aligned_cols=234 Identities=21% Similarity=0.290 Sum_probs=197.8
Q ss_pred eeecccCCeEEEEEEEcCCC---cEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEEEe
Q psy11098 106 ERLGNGRFCTVRKARDRGTG---QLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQL 180 (380)
Q Consensus 106 ~~LG~G~fg~V~~~~~~~~~---~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e~ 180 (380)
+.||+|+||.||+|....++ ..+|+|.+..... ....+.+|+.+++.+.|+|++++++++.. +..+++|||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG----EPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC----CceEEEEEe
Confidence 46999999999999876655 7899999976554 44567889999999999999999987653 457999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccccc---------
Q psy11098 181 VHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVST--------- 250 (380)
Q Consensus 181 ~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~~--------- 250 (380)
+.+++|.+++.....+++..+..++.|++.||.|||+.|++|+||||+|||++ ++.+||+|||++.....
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~ 156 (257)
T cd05060 77 APLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT 156 (257)
T ss_pred CCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCccccccc
Confidence 99999999998887899999999999999999999999999999999999998 46899999999875531
Q ss_pred cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHH
Q psy11098 251 VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIG 329 (380)
Q Consensus 251 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 329 (380)
...++..|+|||.+.+ ..++.++||||||+++|+|++ |..||...+..+....+...... .....++..++++|.
T Consensus 157 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~ 232 (257)
T cd05060 157 AGRWPLKWYAPECINY-GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERL---PRPEECPQEIYSIML 232 (257)
T ss_pred CccccccccCHHHhcC-CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcC---CCCCCCCHHHHHHHH
Confidence 1112457999999977 467889999999999999998 99999887777666666544321 223457899999999
Q ss_pred HhcccCCCCCCCHHHHHh
Q psy11098 330 QLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 330 ~~L~~dP~~Rpt~~e~L~ 347 (380)
+||..||++|||+.++++
T Consensus 233 ~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 233 SCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHhcCChhhCcCHHHHHH
Confidence 999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=347.10 Aligned_cols=144 Identities=23% Similarity=0.331 Sum_probs=129.3
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC----chHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ----PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
++|.+.+.||+|+||+||+|.+..+++.||+|+++.... ....+..|+.++..++|+||++++..+... +..|
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~---~~~~ 80 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSA---NNVY 80 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEEC---CEEE
Confidence 579999999999999999999999999999999965432 235677899999999999999998777653 6789
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcc
Q psy11098 176 IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSV 246 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~ 246 (380)
|||||+.|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++
T Consensus 81 lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 81 LVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999999998878899999999999999999999999999999999999998 5699999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=313.83 Aligned_cols=242 Identities=22% Similarity=0.300 Sum_probs=199.5
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCc--EEEEEEecCCC--CchHHHHHHHHHHHhh-ccCCCcceeeecccccCCCce
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQ--LVALKQIPRER--QPQQITRAEYNLLSTL-MHAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~--~vAvK~~~~~~--~~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~~~~~~ 174 (380)
++|++.+.||+|+||.||+|+.+.++. .+|+|.++... ...+.+.+|+++++.+ +|+|++++++++... +..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~---~~~ 78 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENR---GYL 78 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccC---Ccc
Confidence 468899999999999999999887764 46888876422 2334577899999999 799999999887654 567
Q ss_pred EEEEEecCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCee
Q psy11098 175 TIVMQLVHGESLIQHLCRQS----------------TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVL 237 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~~----------------~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~i 237 (380)
+++|||+.+++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++ ++.+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeE
Confidence 99999999999999996532 478899999999999999999999999999999999997 4589
Q ss_pred EEEeCCCccccc-----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCC
Q psy11098 238 KLIDLGSSVSVS-----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYS 311 (380)
Q Consensus 238 kl~DFG~a~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~ 311 (380)
||+|||++.... .....+..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+.... .
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~-~ 236 (297)
T cd05089 159 KIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNY-SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-R 236 (297)
T ss_pred EECCcCCCccccceeccCCCCcCccccCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC-C
Confidence 999999986432 11222456999999877 467889999999999999997 999999888777766655432 1
Q ss_pred CCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 312 FPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 312 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
. .....++.++++||.+||..||.+|||++++++.
T Consensus 237 ~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 237 M--EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred C--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1 1223578999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=312.44 Aligned_cols=242 Identities=23% Similarity=0.315 Sum_probs=203.3
Q ss_pred hceeeeeeecccCCeEEEEEEEcCC-----CcEEEEEEecCCCCc--hHHHHHHHHHHHhhccCCCcceeeecccccCCC
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGT-----GQLVALKQIPRERQP--QQITRAEYNLLSTLMHAHIPTALALFENAPVPG 172 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~-----~~~vAvK~~~~~~~~--~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~ 172 (380)
.+|++.+.||+|+||.||+|.+..+ ++.||+|.+...... ...+.+|+.++..++|+||+++++++... +
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~---~ 81 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE---Q 81 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC---C
Confidence 4588889999999999999987643 578999999754432 34567899999999999999999988764 5
Q ss_pred ceEEEEEecCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-C
Q psy11098 173 TDTIVMQLVHGESLIQHLCRQ----------------STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-A 235 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~~----------------~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~ 235 (380)
..++++||+.+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||+++ +
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC
Confidence 679999999999999998532 34788889999999999999999999999999999999974 5
Q ss_pred eeEEEeCCCccccc--------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHh
Q psy11098 236 VLKLIDLGSSVSVS--------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHIS 306 (380)
Q Consensus 236 ~ikl~DFG~a~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~ 306 (380)
.+||+|||+++... ....+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+.
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR 240 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 89999999987542 22345678999999876 467889999999999999998 999999888888888877
Q ss_pred cccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 307 VADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 307 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
....... ....+.++.+|+.+||+.+|++||++++++..
T Consensus 241 ~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 241 NRQVLPC---PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred cCCcCCC---CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 6654322 23578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=311.83 Aligned_cols=246 Identities=33% Similarity=0.482 Sum_probs=203.8
Q ss_pred eeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCc---hHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEE
Q psy11098 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP---QQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVM 178 (380)
Q Consensus 102 y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~ 178 (380)
|++.+.||.|++|.||+|.+..+++.+|+|.+...... ...+.+|+.+++.++|+|++++++++... +..++++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~v~ 77 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHK---GDLYLVF 77 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccC---CCEEEEE
Confidence 56788999999999999999999999999998654332 45667799999999999999999887764 6789999
Q ss_pred EecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCcccccc------
Q psy11098 179 QLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVST------ 250 (380)
Q Consensus 179 e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~~------ 250 (380)
||+. ++|.+.+.. ...+++..+..++.||+.||.|||++||+|+||||+||+++. +.++|+|||.+.....
T Consensus 78 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~ 156 (283)
T cd05118 78 EFMD-TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYT 156 (283)
T ss_pred eccC-CCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccccc
Confidence 9995 588888766 468999999999999999999999999999999999999984 6899999999876542
Q ss_pred cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc-------------------CC
Q psy11098 251 VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVAD-------------------YS 311 (380)
Q Consensus 251 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~-------------------~~ 311 (380)
...++..|+|||.+.+....+.++|+||||+++|+|++|+.||.+.+..+....+.... ..
T Consensus 157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05118 157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFS 236 (283)
T ss_pred CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhh
Confidence 24567889999998875477889999999999999999999998777655443332110 01
Q ss_pred CC-------CCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy11098 312 FP-------PEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 312 ~~-------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~ 351 (380)
++ ......++.++++||.+||.+||.+||++.++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 237 FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 11 01123468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=306.86 Aligned_cols=242 Identities=20% Similarity=0.310 Sum_probs=203.8
Q ss_pred hceeeeeeecccCCeEEEEEEEcCC---CcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCCce
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGT---GQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~---~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~ 174 (380)
++|++.+.||+|+||+||+|.++.+ ...||+|.++.... ....+.+|+.+++.++|+|++++++++... +..
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 80 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS---RPV 80 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecC---Cce
Confidence 5688999999999999999998654 45899999865433 234567899999999999999999987653 567
Q ss_pred EEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCccccc---
Q psy11098 175 TIVMQLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVS--- 249 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~--- 249 (380)
+++|||+.+++|.+++... ..+++..+..++.|++.||.|||++||+|+||||+|||+++ +.++|+|||++....
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 9999999999999999663 47899999999999999999999999999999999999984 589999999987653
Q ss_pred -----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHH
Q psy11098 250 -----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVP 323 (380)
Q Consensus 250 -----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 323 (380)
....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||......+....+.... ..+. ....+..
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~ 236 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY-RLPP--PMDCPSA 236 (266)
T ss_pred cceeccCCCCCccccChhhhcc-CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC-CCCC--CCCCCHH
Confidence 11233568999999987 467889999999999999998 999998888777777665432 2222 2357899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 324 ARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 324 ~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
+.+|+.+||+.||++||++++++++
T Consensus 237 l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 237 LYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHHHHcCCCcccCcCHHHHHHH
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=315.85 Aligned_cols=257 Identities=24% Similarity=0.325 Sum_probs=212.8
Q ss_pred hhhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC----chHHHHHHHHHHHhhccCCCcceeeecccccC
Q psy11098 95 QEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ----PQQITRAEYNLLSTLMHAHIPTALALFENAPV 170 (380)
Q Consensus 95 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~ 170 (380)
.......|+..+.||+|+||.||++++..++..+|+|.+..... ....+.+|+++++.++|+|++++++++...
T Consensus 20 ~~~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-- 97 (317)
T cd06635 20 KEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLRE-- 97 (317)
T ss_pred CCCchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC--
Confidence 34556678889999999999999999999999999999864322 123567799999999999999999988764
Q ss_pred CCceEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccc
Q psy11098 171 PGTDTIVMQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSV 248 (380)
Q Consensus 171 ~~~~~lv~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~ 248 (380)
+..++||||+. |+|.+.+.. ...+++..+..++.||+.||.|||++||+||||+|+||+++ ++.+||+|||++...
T Consensus 98 -~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~ 175 (317)
T cd06635 98 -HTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIA 175 (317)
T ss_pred -CeEEEEEeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCcccc
Confidence 56799999996 577777754 56789999999999999999999999999999999999998 468999999998755
Q ss_pred c--ccccCCCcccCCccccC--CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHH
Q psy11098 249 S--TVVLPDLEFASPEMLTS--PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPA 324 (380)
Q Consensus 249 ~--~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 324 (380)
. ....+++.|+|||++.. ...++.++|+|||||++|+|++|..||.+.........+...... ......++..+
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l 253 (317)
T cd06635 176 SPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP--TLQSNEWSDYF 253 (317)
T ss_pred CCcccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCC--CCCCccccHHH
Confidence 4 45578899999999742 245678999999999999999999999887766665555443322 22234578899
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhcccccccCCC
Q psy11098 325 RELIGQLLNTHADKRPTAGQLLQVAWFAEASCS 357 (380)
Q Consensus 325 ~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~~ 357 (380)
++||.+||+.+|.+|||+.++++|+|+......
T Consensus 254 ~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 286 (317)
T cd06635 254 RNFVDSCLQKIPQDRPTSEELLKHMFVLRERPE 286 (317)
T ss_pred HHHHHHHccCCcccCcCHHHHHhChhhhccCcc
Confidence 999999999999999999999999999876443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=311.81 Aligned_cols=242 Identities=21% Similarity=0.286 Sum_probs=203.3
Q ss_pred hceeeeeeecccCCeEEEEEEEcC-----CCcEEEEEEecCCCC-chHHHHHHHHHHHhhccCCCcceeeecccccCCCc
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRG-----TGQLVALKQIPRERQ-PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGT 173 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vAvK~~~~~~~-~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~ 173 (380)
.+|.+.+.||+|+||.||+|.+.. ++..+|+|.+..... ....+.+|+++++.++|+|++++++++... +.
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~ 81 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDG---DP 81 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccC---Cc
Confidence 468889999999999999998643 456799999865443 335678899999999999999999988764 56
Q ss_pred eEEEEEecCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCe
Q psy11098 174 DTIVMQLVHGESLIQHLCRQ----------------STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAV 236 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~----------------~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ 236 (380)
.++||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc
Confidence 79999999999999999653 2378999999999999999999999999999999999998 468
Q ss_pred eEEEeCCCccccc--------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhc
Q psy11098 237 LKLIDLGSSVSVS--------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISV 307 (380)
Q Consensus 237 ikl~DFG~a~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~ 307 (380)
++|+|||++.... ....++..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+....+..
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 240 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ 240 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhC
Confidence 9999999986542 23445778999999987 467889999999999999998 9999988887777766655
Q ss_pred ccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 308 ADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 308 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
...... ....+.++.+++.+||+.||++|||+.++++.
T Consensus 241 ~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~ 278 (291)
T cd05094 241 GRVLER---PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKI 278 (291)
T ss_pred CCCCCC---CccCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 443322 23468899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=311.06 Aligned_cols=246 Identities=29% Similarity=0.470 Sum_probs=205.0
Q ss_pred eeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC---CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEE
Q psy11098 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER---QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVM 178 (380)
Q Consensus 102 y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~ 178 (380)
|++.+.||+|++|.||+|++..+++.||+|.+.... .....+..|+.+++.+.|+|++++++++... +..++|+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~---~~~~~v~ 77 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE---RKLYLVF 77 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC---CceEEEe
Confidence 567788999999999999999999999999997642 2335567799999999999999999888764 6789999
Q ss_pred EecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCcccccc------
Q psy11098 179 QLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVST------ 250 (380)
Q Consensus 179 e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~~------ 250 (380)
||+. ++|.+++... ..+++..+..++.|++.||.|||++||+||||+|+||++++ +.++|+|||++.....
T Consensus 78 e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (282)
T cd07829 78 EYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYT 156 (282)
T ss_pred cCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccC
Confidence 9996 6899999776 58999999999999999999999999999999999999985 6899999999876532
Q ss_pred cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc------------------cCCC
Q psy11098 251 VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVA------------------DYSF 312 (380)
Q Consensus 251 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~------------------~~~~ 312 (380)
...++..|+|||.+.+...++.++|+|||||++|+|++|..||...+..+....+... ...+
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07829 157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF 236 (282)
T ss_pred ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccc
Confidence 2345778999999877557788999999999999999999999887765554443211 0011
Q ss_pred CC-------CcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy11098 313 PP-------EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 313 ~~-------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~ 351 (380)
+. .....++.++.++|++||..||++||++++++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 10 1123457889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=305.07 Aligned_cols=239 Identities=22% Similarity=0.327 Sum_probs=201.0
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEEE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQ 179 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e 179 (380)
++|++.+.||+|+||.||++... |..+|+|.++... ....+.+|+.+++.++|+|++++++++... .+..+++||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~lv~e 80 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEE--KGGLYIVTE 80 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcC--CCceEEEEE
Confidence 57899999999999999999865 6789999986543 345677899999999999999998875432 356799999
Q ss_pred ecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc---cccc
Q psy11098 180 LVHGESLIQHLCRQS--TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS---TVVL 253 (380)
Q Consensus 180 ~~~gg~L~~~l~~~~--~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~---~~~~ 253 (380)
|+.+++|.+++.... .+++..+..++.||+.||.|||++|++||||||+|||++ ++.+||+|||++.... ....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 160 (256)
T cd05082 81 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK 160 (256)
T ss_pred CCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccCCCCc
Confidence 999999999997643 488999999999999999999999999999999999997 5689999999987553 2334
Q ss_pred CCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhc
Q psy11098 254 PDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLL 332 (380)
Q Consensus 254 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 332 (380)
++..|+|||++.+ ..++.++|||||||++|+|++ |..||......+....+..... ......++..+.+++.+||
T Consensus 161 ~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l 236 (256)
T cd05082 161 LPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---MDAPDGCPPVVYDVMKQCW 236 (256)
T ss_pred cceeecCHHHHcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---CCCCCCCCHHHHHHHHHHh
Confidence 4668999999877 467889999999999999997 9999988877777766654421 2223467899999999999
Q ss_pred ccCCCCCCCHHHHHh
Q psy11098 333 NTHADKRPTAGQLLQ 347 (380)
Q Consensus 333 ~~dP~~Rpt~~e~L~ 347 (380)
..||++|||+.++++
T Consensus 237 ~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 237 HLDAATRPSFLQLRE 251 (256)
T ss_pred cCChhhCcCHHHHHH
Confidence 999999999999985
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=310.84 Aligned_cols=244 Identities=24% Similarity=0.316 Sum_probs=193.6
Q ss_pred hhce-eeeeeecccCCeEEEEEE----EcCCCcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCC
Q psy11098 99 EHRY-EELERLGNGRFCTVRKAR----DRGTGQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVP 171 (380)
Q Consensus 99 ~~~y-~~~~~LG~G~fg~V~~~~----~~~~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~ 171 (380)
.++| ++.+.||+|+||+||++. ...+++.||+|.+..... ....+.+|+++++.++|+|++++++++... ..
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~ 80 (283)
T cd05080 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ-GG 80 (283)
T ss_pred ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CC
Confidence 3556 899999999999998865 335678999999975433 345667899999999999999999877543 22
Q ss_pred CceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCcccccc
Q psy11098 172 GTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVST 250 (380)
Q Consensus 172 ~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~~ 250 (380)
...+++|||+.+++|.+++... .+++..++.++.|++.||.|||++||+||||||+|||+++ +.+||+|||++.....
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 4578999999999999998654 6999999999999999999999999999999999999974 5899999999875531
Q ss_pred ---------cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHH--HHH------------HHHhc
Q psy11098 251 ---------VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEE--ETR------------AHISV 307 (380)
Q Consensus 251 ---------~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~--~~~------------~~i~~ 307 (380)
...++..|+|||++.+ ...+.++|+||||+++|+|++|..||...... +.. .....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKE-NKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcc-cCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence 2234667999999877 46788999999999999999999998543211 110 00000
Q ss_pred ccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy11098 308 ADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 308 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~ 347 (380)
..... .....++.++.+++.+||+.||++|||++++++
T Consensus 239 ~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 239 RGMRL--PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred cCCCC--CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 01111 112356889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=301.24 Aligned_cols=253 Identities=24% Similarity=0.349 Sum_probs=203.2
Q ss_pred ceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchH--HHHHHHHHHHhh-ccCCCcceeeecccccCCCceEEE
Q psy11098 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQ--ITRAEYNLLSTL-MHAHIPTALALFENAPVPGTDTIV 177 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~--~~~~E~~il~~l-~h~ni~~i~~~~~~~~~~~~~~lv 177 (380)
..+.+..||.|+.|+|++++++.+|..+|||.+.+.....+ .+...+.++..- ..|.|++++++|-.. ..+++.
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n---~dV~Ic 169 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN---TDVFIC 169 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC---chHHHH
Confidence 45567889999999999999999999999999987655433 333344444333 368888888888764 556889
Q ss_pred EEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-----
Q psy11098 178 MQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHS-QQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS----- 249 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~-~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~----- 249 (380)
||.| +.-+..++.. .++++|.-+-++...++.||.||.+ +||+|||+||+|||+| .|+|||||||.|.++.
T Consensus 170 MelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh 248 (391)
T KOG0983|consen 170 MELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH 248 (391)
T ss_pred HHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccccc
Confidence 9998 4444444433 4679999999999999999999985 5999999999999999 5799999999997763
Q ss_pred ccccCCCcccCCccccCC--CCCCCcccHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcccCCCCCCcCCCCCHHHHH
Q psy11098 250 TVVLPDLEFASPEMLTSP--ATAGPSTDMWSLGVLLYILLSGVSPFLDE-SEEETRAHISVADYSFPPEQCGHISVPARE 326 (380)
Q Consensus 250 ~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlGvil~~lltg~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 326 (380)
+...|.+.|||||.+..+ ..|+.++||||||+.++||.||..||.+. ++.+++..+.+......+. -..+|+.+++
T Consensus 249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~-~~gFSp~F~~ 327 (391)
T KOG0983|consen 249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPG-HMGFSPDFQS 327 (391)
T ss_pred ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCc-ccCcCHHHHH
Confidence 456788999999998643 46788999999999999999999999884 5667777777644322222 2348999999
Q ss_pred HHHHhcccCCCCCCCHHHHHhcccccccCCCC
Q psy11098 327 LIGQLLNTHADKRPTAGQLLQVAWFAEASCSE 358 (380)
Q Consensus 327 li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~~~ 358 (380)
|+..||.+|+.+||...++|+|||+......+
T Consensus 328 fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a~ 359 (391)
T KOG0983|consen 328 FVKDCLTKDHRKRPKYNKLLEHPFIKRYETAE 359 (391)
T ss_pred HHHHHhhcCcccCcchHHHhcCcceeecchhh
Confidence 99999999999999999999999998775443
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=303.72 Aligned_cols=241 Identities=22% Similarity=0.306 Sum_probs=205.2
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVM 178 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~ 178 (380)
.++|++.+.||.|+||.||+|... |+.||+|.+.........+.+|+.+++.++|+|++++++++.. .+..++||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~~v~ 79 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ---GNPLYIVT 79 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcC---CCCeEEEE
Confidence 457888999999999999999875 7899999997665555677889999999999999999988775 36779999
Q ss_pred EecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccccc---cc
Q psy11098 179 QLVHGESLIQHLCRQS--TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVST---VV 252 (380)
Q Consensus 179 e~~~gg~L~~~l~~~~--~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~~---~~ 252 (380)
||+.+++|.+++.... .+++..+..++.|++.||.|||+.|++|+||||+||+++ ++.+||+|||.+..... ..
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~~~ 159 (256)
T cd05039 80 EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSG 159 (256)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccccC
Confidence 9999999999997765 699999999999999999999999999999999999998 56899999999876642 22
Q ss_pred cCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHh
Q psy11098 253 LPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQL 331 (380)
Q Consensus 253 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 331 (380)
..+..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...+..+....+..... ......+++++.++|++|
T Consensus 160 ~~~~~~~ape~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~ 235 (256)
T cd05039 160 KLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR---MEAPEGCPPEVYKVMKDC 235 (256)
T ss_pred CCcccccCchhhcC-CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC---CCCccCCCHHHHHHHHHH
Confidence 33567999999876 467889999999999999997 9999988877777666554321 122245789999999999
Q ss_pred cccCCCCCCCHHHHHhc
Q psy11098 332 LNTHADKRPTAGQLLQV 348 (380)
Q Consensus 332 L~~dP~~Rpt~~e~L~h 348 (380)
|..+|++|||++++++.
T Consensus 236 l~~~p~~Rp~~~~l~~~ 252 (256)
T cd05039 236 WELDPAKRPTFKQLREQ 252 (256)
T ss_pred hccChhhCcCHHHHHHH
Confidence 99999999999999863
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=311.87 Aligned_cols=243 Identities=23% Similarity=0.328 Sum_probs=202.3
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCC-----cEEEEEEecCCCC--chHHHHHHHHHHHhh-ccCCCcceeeecccccC
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTG-----QLVALKQIPRERQ--PQQITRAEYNLLSTL-MHAHIPTALALFENAPV 170 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~-----~~vAvK~~~~~~~--~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~~ 170 (380)
.++|++.+.||+|+||.||++.+...+ ..+|+|.+..... ....+.+|+++++.+ +|+|++++++++...
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-- 88 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE-- 88 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC--
Confidence 468999999999999999999986543 7899999875433 234567899999999 799999999887653
Q ss_pred CCceEEEEEecCCCCHHHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-
Q psy11098 171 PGTDTIVMQLVHGESLIQHLCR----------------QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN- 233 (380)
Q Consensus 171 ~~~~~lv~e~~~gg~L~~~l~~----------------~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~- 233 (380)
+..+++|||+.+++|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++
T Consensus 89 -~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 89 -GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTE 167 (293)
T ss_pred -CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcC
Confidence 578999999999999999854 24688999999999999999999999999999999999998
Q ss_pred CCeeEEEeCCCcccccc--------cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q psy11098 234 GAVLKLIDLGSSVSVST--------VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAH 304 (380)
Q Consensus 234 ~~~ikl~DFG~a~~~~~--------~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~ 304 (380)
++.+||+|||++..... ...++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 246 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 246 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 56899999999875431 1234567999999877 477889999999999999998 9999988887777666
Q ss_pred HhcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 305 ISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 305 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
+..... . ......+.++.+|+.+||..||++|||+.+++++
T Consensus 247 ~~~~~~-~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 247 LKEGYR-M--EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHcCCc-C--CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 654332 1 1223568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=306.35 Aligned_cols=243 Identities=15% Similarity=0.230 Sum_probs=200.3
Q ss_pred eeeeeeecccCCeEEEEEEEcC---CCcEEEEEEecCCCC---chHHHHHHHHHHHhhccCCCcceeeecccccC---CC
Q psy11098 102 YEELERLGNGRFCTVRKARDRG---TGQLVALKQIPRERQ---PQQITRAEYNLLSTLMHAHIPTALALFENAPV---PG 172 (380)
Q Consensus 102 y~~~~~LG~G~fg~V~~~~~~~---~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~---~~ 172 (380)
|.+.+.||+|+||.||+|.... ++..||+|.++.... ....+.+|+++++.+.|+|++++++++..... ..
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678899999999999998765 347899999975432 23467889999999999999999987755332 12
Q ss_pred ceEEEEEecCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCc
Q psy11098 173 TDTIVMQLVHGESLIQHLCRQ------STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSS 245 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~~------~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a 245 (380)
..+++|||+.+++|..++... ..+++..+..++.|++.||.|||++|++||||||+||++++ +.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 468999999999999888442 36899999999999999999999999999999999999985 58999999998
Q ss_pred ccccc--------cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCc
Q psy11098 246 VSVST--------VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQ 316 (380)
Q Consensus 246 ~~~~~--------~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 316 (380)
+.... ...++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+...... ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~---~~ 236 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRL---KQ 236 (273)
T ss_pred eeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CC
Confidence 76531 1234568999999876 577889999999999999999 99999888877777666544322 12
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 317 CGHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 317 ~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
...++.++.+++.+||+.||++|||+.+++++
T Consensus 237 ~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 237 PEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 34578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=315.80 Aligned_cols=255 Identities=24% Similarity=0.343 Sum_probs=209.9
Q ss_pred hhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC----chHHHHHHHHHHHhhccCCCcceeeecccccCCC
Q psy11098 97 QFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ----PQQITRAEYNLLSTLMHAHIPTALALFENAPVPG 172 (380)
Q Consensus 97 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~ 172 (380)
.....|...+.||+|+||.||+|+++.+++.+|+|.+..... ....+.+|+++++.++|+|++++.+++... +
T Consensus 12 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~ 88 (308)
T cd06634 12 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE---H 88 (308)
T ss_pred CcHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC---C
Confidence 345678888999999999999999999999999999864321 223456799999999999999999988764 5
Q ss_pred ceEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-
Q psy11098 173 TDTIVMQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS- 249 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~- 249 (380)
..++||||+. ++|.+.+.. ...+++..+..++.|++.||.|||+.+++||||||+|||++ ++.+||+|||++....
T Consensus 89 ~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 89 TAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred eeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 6799999995 678777644 45689999999999999999999999999999999999997 4689999999987654
Q ss_pred -ccccCCCcccCCccccC--CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHH
Q psy11098 250 -TVVLPDLEFASPEMLTS--PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARE 326 (380)
Q Consensus 250 -~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 326 (380)
....+++.|+|||++.+ ....+.++|||||||++|+|++|..||......+....+..... +......++..+++
T Consensus 168 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 245 (308)
T cd06634 168 ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES--PALQSGHWSEYFRN 245 (308)
T ss_pred cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC--CCcCcccccHHHHH
Confidence 44567899999999752 23567799999999999999999999987765555444443322 22223357889999
Q ss_pred HHHHhcccCCCCCCCHHHHHhcccccccCCC
Q psy11098 327 LIGQLLNTHADKRPTAGQLLQVAWFAEASCS 357 (380)
Q Consensus 327 li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~~ 357 (380)
||++||..+|++||+++++++|||+......
T Consensus 246 li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~~ 276 (308)
T cd06634 246 FVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 276 (308)
T ss_pred HHHHHhhCCcccCCCHHHHhhCccccccCCh
Confidence 9999999999999999999999999886443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=304.21 Aligned_cols=241 Identities=20% Similarity=0.294 Sum_probs=205.5
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVM 178 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~ 178 (380)
.++|++.+.||+|+||.||+|.+.. ++.+|+|.+.........+.+|+.+++.+.|+|++++++++... ...+++|
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~~v~ 80 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEE---EPIYIVT 80 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecC---CceEEEE
Confidence 5789999999999999999999764 57899999987666667788999999999999999998887653 5679999
Q ss_pred EecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccccc-----
Q psy11098 179 QLVHGESLIQHLCRQ--STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVST----- 250 (380)
Q Consensus 179 e~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~~----- 250 (380)
||+.+++|.+++... ..+++..+..++.||+.||.|||++|++|+||||+||+++ ++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (261)
T cd05034 81 EYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA 160 (261)
T ss_pred eccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhhh
Confidence 999999999999764 3689999999999999999999999999999999999997 56899999999876531
Q ss_pred --cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHH
Q psy11098 251 --VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAREL 327 (380)
Q Consensus 251 --~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 327 (380)
...++..|+|||.+.+ ...+.++|+||||+++|+|++ |+.||.+.........+.... ..+ .....+.++.++
T Consensus 161 ~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~ 236 (261)
T cd05034 161 REGAKFPIKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGY-RMP--RPPNCPEELYDL 236 (261)
T ss_pred hhccCCCccccCHHHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCC--CCCCCCHHHHHH
Confidence 2223567999999987 467889999999999999998 999998888777777665432 111 123458899999
Q ss_pred HHHhcccCCCCCCCHHHHHh
Q psy11098 328 IGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 328 i~~~L~~dP~~Rpt~~e~L~ 347 (380)
+.+||..||++|||++++++
T Consensus 237 i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 237 MLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHcccCcccCCCHHHHHH
Confidence 99999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=308.14 Aligned_cols=242 Identities=18% Similarity=0.268 Sum_probs=202.7
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCC-----CcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCC
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGT-----GQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVP 171 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~-----~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~ 171 (380)
.++|++.+.||+|+||.||+|.++.. +..||+|.+..... ....+.+|+.+++.+.|+|++++++++...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--- 81 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG--- 81 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC---
Confidence 56899999999999999999998754 37899999865432 234567899999999999999999987764
Q ss_pred CceEEEEEecCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEE
Q psy11098 172 GTDTIVMQLVHGESLIQHLCRQ----------STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLI 240 (380)
Q Consensus 172 ~~~~lv~e~~~gg~L~~~l~~~----------~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~ 240 (380)
+..++||||+.+++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++ ++.+||+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEEC
Confidence 6679999999999999998642 2367888999999999999999999999999999999998 5689999
Q ss_pred eCCCccccc--------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCC
Q psy11098 241 DLGSSVSVS--------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYS 311 (380)
Q Consensus 241 DFG~a~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~ 311 (380)
|||+++... ....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+....+......
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHL 240 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhc-CCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCC
Confidence 999987542 23345778999999876 467889999999999999998 99999888877777766633221
Q ss_pred CCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy11098 312 FPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 312 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~ 347 (380)
. .....+.++.++|.+||+.+|++|||+.++++
T Consensus 241 ~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 241 D---LPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred C---CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 1 12346899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=313.77 Aligned_cols=243 Identities=20% Similarity=0.287 Sum_probs=201.8
Q ss_pred hhceeeeeeecccCCeEEEEEEEcC-------CCcEEEEEEecCCCC--chHHHHHHHHHHHhh-ccCCCcceeeecccc
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRG-------TGQLVALKQIPRERQ--PQQITRAEYNLLSTL-MHAHIPTALALFENA 168 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~-------~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~ 168 (380)
.++|.+.+.||+|+||.||+|++.. +...+|+|.+..... ....+..|+++++.+ +|+|++++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 5789999999999999999998753 235799999975432 234567799999999 799999999988764
Q ss_pred cCCCceEEEEEecCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEE
Q psy11098 169 PVPGTDTIVMQLVHGESLIQHLCRQ----------------STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILM 232 (380)
Q Consensus 169 ~~~~~~~lv~e~~~gg~L~~~l~~~----------------~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~ 232 (380)
+..++||||+.+++|.+++... ..++...+..++.||+.||.|||++|++||||||+|||+
T Consensus 97 ---~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill 173 (307)
T cd05098 97 ---GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 173 (307)
T ss_pred ---CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEE
Confidence 5789999999999999999753 247888999999999999999999999999999999999
Q ss_pred e-CCeeEEEeCCCcccccc--------cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy11098 233 N-GAVLKLIDLGSSVSVST--------VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETR 302 (380)
Q Consensus 233 ~-~~~ikl~DFG~a~~~~~--------~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~ 302 (380)
+ ++.+||+|||++..... ...+++.|+|||++.+ ..++.++|+|||||++|+|++ |..||.+...++..
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~ 252 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 252 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhcc-CCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH
Confidence 8 56899999999875431 1223468999999987 467889999999999999998 99999888777776
Q ss_pred HHHhcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 303 AHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 303 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
..+..... .+....++.++++|+.+||..+|++|||+.+++++
T Consensus 253 ~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 253 KLLKEGHR---MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHcCCC---CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 66654432 12224578999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=312.70 Aligned_cols=243 Identities=21% Similarity=0.318 Sum_probs=200.2
Q ss_pred hhceeeeeeecccCCeEEEEEEEc-----CCCcEEEEEEecCCCC--chHHHHHHHHHHHhh-ccCCCcceeeecccccC
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDR-----GTGQLVALKQIPRERQ--PQQITRAEYNLLSTL-MHAHIPTALALFENAPV 170 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~~ 170 (380)
.++|.+.+.||+|+||.||++.+. .++..+|+|.++.... ..+.+.+|+.+++.+ +|+||+++++++...
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-- 111 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG-- 111 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC--
Confidence 468999999999999999999853 3456899999875433 234578899999999 799999999987664
Q ss_pred CCceEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCccc
Q psy11098 171 PGTDTIVMQLVHGESLIQHLCRQS--TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVS 247 (380)
Q Consensus 171 ~~~~~lv~e~~~gg~L~~~l~~~~--~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~ 247 (380)
+..+++|||+.+++|.+++.... .+++.++..++.||+.||.|||+++|+|+||||+|||+++ +.+||+|||++..
T Consensus 112 -~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 112 -GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred -CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccccc
Confidence 56799999999999999997543 3899999999999999999999999999999999999985 5899999999875
Q ss_pred ccc--------cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCC
Q psy11098 248 VST--------VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCG 318 (380)
Q Consensus 248 ~~~--------~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 318 (380)
... ...++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+............. ...
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~ 267 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMA--QPE 267 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhcc-CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCC--CCC
Confidence 431 2234678999999887 467889999999999999998 9999988765554444333322222 223
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy11098 319 HISVPARELIGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 319 ~~s~~~~~li~~~L~~dP~~Rpt~~e~L~ 347 (380)
..+.++.+|+.+||.++|++|||+.|+++
T Consensus 268 ~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 268 HAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 56889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=302.89 Aligned_cols=241 Identities=20% Similarity=0.321 Sum_probs=204.6
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEEE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQ 179 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e 179 (380)
.+|++.+.||.|+||.||++.+. .++.+|+|.+.........+.+|+++++.+.|+|++++++++... ...+++||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~v~e 79 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTER---SPICLVFE 79 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccC---CceEEEEE
Confidence 46888999999999999999876 467899999976666666788899999999999999998887664 56799999
Q ss_pred ecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccccc-------
Q psy11098 180 LVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVST------- 250 (380)
Q Consensus 180 ~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~~------- 250 (380)
|+.+++|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++ ++.+||+|||++.....
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05112 80 FMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST 159 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccccC
Confidence 99999999998754 4689999999999999999999999999999999999998 45899999999875431
Q ss_pred cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHH
Q psy11098 251 VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIG 329 (380)
Q Consensus 251 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 329 (380)
...++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||......+....+......+.+ ...+.++.+|+.
T Consensus 160 ~~~~~~~~~aPe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~ 235 (256)
T cd05112 160 GTKFPVKWSSPEVFSF-SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKP---RLASQSVYELMQ 235 (256)
T ss_pred CCccchhhcCHhHhcc-CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCC---CCCCHHHHHHHH
Confidence 2234568999999987 467889999999999999998 99999888877777776554322222 236889999999
Q ss_pred HhcccCCCCCCCHHHHHhc
Q psy11098 330 QLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 330 ~~L~~dP~~Rpt~~e~L~h 348 (380)
+||+.+|++|||+.+++++
T Consensus 236 ~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 236 HCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHcccChhhCCCHHHHHHh
Confidence 9999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=307.63 Aligned_cols=242 Identities=20% Similarity=0.296 Sum_probs=198.6
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCc----EEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCC
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQ----LVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPG 172 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~----~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~ 172 (380)
.++|++.+.||+|+||+||+|.+..+++ .+|+|.+..... ....+..|+.++..+.|+||+++++++.. .
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~----~ 81 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG----A 81 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC----C
Confidence 3578899999999999999999987776 477777753322 22445667788899999999999988643 4
Q ss_pred ceEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCccccc-
Q psy11098 173 TDTIVMQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVS- 249 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~- 249 (380)
..++++||+.+|+|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++. +.+||+|||+++...
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 56899999999999999976 457899999999999999999999999999999999999985 589999999987542
Q ss_pred -------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCC
Q psy11098 250 -------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHIS 321 (380)
Q Consensus 250 -------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 321 (380)
....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.........+..+...... ...+
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~ 237 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILF-GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQP---QICT 237 (279)
T ss_pred CCcccccCCCCCcccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCC---CCCC
Confidence 22345678999999987 467889999999999999998 99999888776665555544322221 2357
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 322 VPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 322 ~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
.++.+++.+||..||.+|||+.|+++.
T Consensus 238 ~~~~~li~~c~~~~p~~Rps~~el~~~ 264 (279)
T cd05111 238 IDVYMVMVKCWMIDENVRPTFKELANE 264 (279)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=319.74 Aligned_cols=244 Identities=21% Similarity=0.316 Sum_probs=196.2
Q ss_pred hhceeeeeeecccCCeEEEEEEE-----cCCCcEEEEEEecCCCC--chHHHHHHHHHHHhh-ccCCCcceeeecccccC
Q psy11098 99 EHRYEELERLGNGRFCTVRKARD-----RGTGQLVALKQIPRERQ--PQQITRAEYNLLSTL-MHAHIPTALALFENAPV 170 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~-----~~~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~~ 170 (380)
.++|++.+.||+|+||+||+|++ ..+++.||||+++.... ....+.+|+.++..+ +|+|++++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-- 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-- 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC--
Confidence 46899999999999999999985 34678999999975433 234567899999999 689999999877543
Q ss_pred CCceEEEEEecCCCCHHHHHHhc---------------------------------------------------------
Q psy11098 171 PGTDTIVMQLVHGESLIQHLCRQ--------------------------------------------------------- 193 (380)
Q Consensus 171 ~~~~~lv~e~~~gg~L~~~l~~~--------------------------------------------------------- 193 (380)
....+++|||+.+|+|.+++...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 34678999999999999998642
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc--------ccccC
Q psy11098 194 ----------STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS--------TVVLP 254 (380)
Q Consensus 194 ----------~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~--------~~~~g 254 (380)
..++...+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.... ....+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 1367778899999999999999999999999999999998 5689999999987542 12234
Q ss_pred CCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHH-HHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhc
Q psy11098 255 DLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEE-ETRAHISVADYSFPPEQCGHISVPARELIGQLL 332 (380)
Q Consensus 255 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 332 (380)
+..|+|||++.+ ..++.++|+||||+++|+|++ |..||.+.... .....+..... ... ....+.++.+++.+||
T Consensus 244 ~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~~cl 319 (343)
T cd05103 244 PLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-MRA--PDYTTPEMYQTMLDCW 319 (343)
T ss_pred CcceECcHHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCC-CCC--CCCCCHHHHHHHHHHc
Confidence 667999999877 467889999999999999997 99999775433 33333332221 111 1236788999999999
Q ss_pred ccCCCCCCCHHHHHhc
Q psy11098 333 NTHADKRPTAGQLLQV 348 (380)
Q Consensus 333 ~~dP~~Rpt~~e~L~h 348 (380)
+.||++|||+.++++|
T Consensus 320 ~~~p~~Rps~~eil~~ 335 (343)
T cd05103 320 HGEPSQRPTFSELVEH 335 (343)
T ss_pred cCChhhCcCHHHHHHH
Confidence 9999999999999987
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=312.96 Aligned_cols=254 Identities=24% Similarity=0.328 Sum_probs=202.1
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC--chHHHHHHHHHHHhhc-cCCCcceeeecccccCCCceE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ--PQQITRAEYNLLSTLM-HAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~-h~ni~~i~~~~~~~~~~~~~~ 175 (380)
.+.|++.+.||+|+||.||+|.+..+++.||+|.++.... .......|+.++..+. |+|++.+++++... ...|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~---~~~~ 90 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITD---SDVF 90 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecC---CeEE
Confidence 3678999999999999999999999999999999975433 2234455666666664 99999999988764 5689
Q ss_pred EEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeecCCCCcEEEe-CCeeEEEeCCCccccc---
Q psy11098 176 IVMQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHS-QQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS--- 249 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~-~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~--- 249 (380)
++|||+ ++.|.+.+.. ...+++..+..++.||+.||.|||+ .||+||||+|+||+++ ++.+||+|||++....
T Consensus 91 ~v~e~~-~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 91 ICMELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred EEeecc-CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 999998 5577776655 4578999999999999999999997 5999999999999998 4689999999987653
Q ss_pred --ccccCCCcccCCccccCC---CCCCCcccHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhcccCCCCCCcCCCCCHH
Q psy11098 250 --TVVLPDLEFASPEMLTSP---ATAGPSTDMWSLGVLLYILLSGVSPFLDESE-EETRAHISVADYSFPPEQCGHISVP 323 (380)
Q Consensus 250 --~~~~gt~~y~aPE~~~~~---~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~s~~ 323 (380)
....+++.|+|||.+.+. ..++.++|+||||+++|+|++|+.||..... .+....+........ .....++.+
T Consensus 170 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 248 (296)
T cd06618 170 AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSL-PPNEGFSPD 248 (296)
T ss_pred cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCC-CCCCCCCHH
Confidence 233467889999998753 2367899999999999999999999976432 334444333321111 112247889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHhcccccccCCC
Q psy11098 324 ARELIGQLLNTHADKRPTAGQLLQVAWFAEASCS 357 (380)
Q Consensus 324 ~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~~ 357 (380)
+.+||.+||..||++|||++++++||||.....+
T Consensus 249 l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 282 (296)
T cd06618 249 FCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETA 282 (296)
T ss_pred HHHHHHHHccCChhhCCCHHHHhcChhhhccchh
Confidence 9999999999999999999999999999876443
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=309.61 Aligned_cols=242 Identities=21% Similarity=0.284 Sum_probs=201.7
Q ss_pred hhceeeeeeecccCCeEEEEEEEc-----CCCcEEEEEEecCCC-CchHHHHHHHHHHHhhccCCCcceeeecccccCCC
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDR-----GTGQLVALKQIPRER-QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPG 172 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vAvK~~~~~~-~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~ 172 (380)
..+|.+.++||+|+||.||++... .++..+|+|.+.... .....+.+|+++++.+.|+||+++++++... +
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~ 80 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEG---R 80 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC---C
Confidence 356888999999999999999743 356789999886443 3345678899999999999999998887653 5
Q ss_pred ceEEEEEecCCCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-Ce
Q psy11098 173 TDTIVMQLVHGESLIQHLCRQS---------------TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AV 236 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~~~---------------~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ 236 (380)
..+++|||+.+++|.+++.... .+++..+..++.||+.||.|||+.|++||||||+|||+++ +.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC
Confidence 6799999999999999986542 4789999999999999999999999999999999999984 58
Q ss_pred eEEEeCCCccccc--------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhc
Q psy11098 237 LKLIDLGSSVSVS--------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISV 307 (380)
Q Consensus 237 ikl~DFG~a~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~ 307 (380)
+||+|||++.... ....+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||......+....+..
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ 239 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHc
Confidence 9999999986442 22334678999999987 467889999999999999998 9999988777776666655
Q ss_pred ccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy11098 308 ADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 308 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~ 347 (380)
.... .....+++++.+||.+||+.||.+||+++++++
T Consensus 240 ~~~~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 240 GREL---ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred CccC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 4322 122357899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=304.28 Aligned_cols=242 Identities=31% Similarity=0.450 Sum_probs=201.7
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC----CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
++|++.+.||+|+||.||+|.+..+|+.||+|.++... .....+.+|+++++.+.|+|++.+++.+... +..+
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~---~~~~ 78 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN---NELN 78 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC---CeEE
Confidence 47999999999999999999999999999999886322 2245678899999999999999999988764 6779
Q ss_pred EEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-
Q psy11098 176 IVMQLVHGESLIQHLCR----QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS- 249 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~----~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~- 249 (380)
++|||+.+++|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+||+++ ++.++|+|||++....
T Consensus 79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 79 IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999999998864 34589999999999999999999999999999999999997 5689999999986543
Q ss_pred -----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhcccCCCCCCcCCCCCH
Q psy11098 250 -----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDES--EEETRAHISVADYSFPPEQCGHISV 322 (380)
Q Consensus 250 -----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~s~ 322 (380)
....+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||.... ..+....+..+.. ++.....++.
T Consensus 159 ~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 235 (267)
T cd08224 159 KTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDY--PPLPADHYSE 235 (267)
T ss_pred CCcccceecCCccccCHHHhcc-CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCC--CCCChhhcCH
Confidence 23467889999999887 467889999999999999999999996543 2334444433322 2111235788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHh
Q psy11098 323 PARELIGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 323 ~~~~li~~~L~~dP~~Rpt~~e~L~ 347 (380)
++.++|.+||..+|++|||+.++++
T Consensus 236 ~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 236 ELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHHH
Confidence 9999999999999999999999885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=311.20 Aligned_cols=244 Identities=19% Similarity=0.298 Sum_probs=197.8
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCC--------------cEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCccee
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTG--------------QLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTAL 162 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~--------------~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~ 162 (380)
..+|++.+.||+|+||.||+|++..++ ..||+|.++.... ....+.+|+++++.++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 468999999999999999999875432 3589999975432 234578899999999999999999
Q ss_pred eecccccCCCceEEEEEecCCCCHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcE
Q psy11098 163 ALFENAPVPGTDTIVMQLVHGESLIQHLCRQS------------TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENI 230 (380)
Q Consensus 163 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~------------~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NI 230 (380)
+++... +..++||||+.+++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||
T Consensus 84 ~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSD---DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC 160 (295)
T ss_pred EEEcCC---CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence 988764 56799999999999999986432 368888999999999999999999999999999999
Q ss_pred EEeC-CeeEEEeCCCccccc--------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh--CCCCCCCCCHH
Q psy11098 231 LMNG-AVLKLIDLGSSVSVS--------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS--GVSPFLDESEE 299 (380)
Q Consensus 231 l~~~-~~ikl~DFG~a~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt--g~~Pf~~~~~~ 299 (380)
|+++ +.+||+|||++.... ....++..|+|||++.+ ..++.++|+|||||++|+|++ |..||...+..
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhcc-CCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 9984 589999999986542 12234678999999887 467889999999999999988 77899887766
Q ss_pred HHHHHHhcc-----cCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy11098 300 ETRAHISVA-----DYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 300 ~~~~~i~~~-----~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~ 347 (380)
+....+... ...+ ......++..+.+|+.+||..||++|||++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 240 QVIENTGEFFRNQGRQIY-LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHHhhhhcccccc-CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 655544221 1111 1122346889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=310.66 Aligned_cols=243 Identities=21% Similarity=0.280 Sum_probs=203.0
Q ss_pred hhceeeeeeecccCCeEEEEEEEc-------CCCcEEEEEEecCCC--CchHHHHHHHHHHHhh-ccCCCcceeeecccc
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDR-------GTGQLVALKQIPRER--QPQQITRAEYNLLSTL-MHAHIPTALALFENA 168 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~-------~~~~~vAvK~~~~~~--~~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~ 168 (380)
.++|.+.+.||+|+||.||+|++. .++..||+|.+.... .....+.+|+.+++.+ .|+||+++++.+...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 678999999999999999999753 234579999986532 2335677899999999 899999999988764
Q ss_pred cCCCceEEEEEecCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEE
Q psy11098 169 PVPGTDTIVMQLVHGESLIQHLCRQ----------------STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILM 232 (380)
Q Consensus 169 ~~~~~~~lv~e~~~gg~L~~~l~~~----------------~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~ 232 (380)
+..+++|||+.+++|.+++... ..++...+..++.||+.||.|||++||+||||||+|||+
T Consensus 94 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili 170 (304)
T cd05101 94 ---GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLV 170 (304)
T ss_pred ---CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEE
Confidence 5679999999999999999753 246778899999999999999999999999999999999
Q ss_pred e-CCeeEEEeCCCccccc--------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy11098 233 N-GAVLKLIDLGSSVSVS--------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETR 302 (380)
Q Consensus 233 ~-~~~ikl~DFG~a~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~ 302 (380)
+ ++.+||+|||++.... ....+++.|+|||++.+ ..++.++||||||+++|+|++ |..||.+.+..+..
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~ 249 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 249 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence 8 5689999999987653 12234678999999987 467889999999999999998 89999888888877
Q ss_pred HHHhcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 303 AHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 303 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
..+....... ....++.++++|+.+||..+|.+|||+.++++.
T Consensus 250 ~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 250 KLLKEGHRMD---KPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHcCCcCC---CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 7765443221 123578999999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=348.42 Aligned_cols=254 Identities=26% Similarity=0.389 Sum_probs=202.8
Q ss_pred hhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC--CchHHHHHHHHHHHhhccCCCcceeeeccc-------
Q psy11098 97 QFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER--QPQQITRAEYNLLSTLMHAHIPTALALFEN------- 167 (380)
Q Consensus 97 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~il~~l~h~ni~~i~~~~~~------- 167 (380)
....+|+.++.||+||||.||+++++-+|+.||||++.... ..-..+.+|+..|.+|+|||+++.+..+..
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 35677899999999999999999999999999999997653 334566789999999999999664433200
Q ss_pred ------------------------------------------------c-------------------------------
Q psy11098 168 ------------------------------------------------A------------------------------- 168 (380)
Q Consensus 168 ------------------------------------------------~------------------------------- 168 (380)
.
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence 0
Q ss_pred -----------------------cC-------CCceEEEEEecCCCCHHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHH
Q psy11098 169 -----------------------PV-------PGTDTIVMQLVHGESLIQHLCRQSTI-TESYICCIIRQLHSALHCLHS 217 (380)
Q Consensus 169 -----------------------~~-------~~~~~lv~e~~~gg~L~~~l~~~~~l-~e~~~~~i~~qil~al~~lH~ 217 (380)
.. .-.+||-||||+...|.+++..+... ....++.++++|++||.|+|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh
Confidence 00 01358999999888888877666444 578899999999999999999
Q ss_pred CCcEeecCCCCcEEEeC-CeeEEEeCCCcccc------------------------cccccCCCcccCCccccCCC--CC
Q psy11098 218 QQIAHKDIRPENILMNG-AVLKLIDLGSSVSV------------------------STVVLPDLEFASPEMLTSPA--TA 270 (380)
Q Consensus 218 ~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~------------------------~~~~~gt~~y~aPE~~~~~~--~~ 270 (380)
+|||||||||.||+++. +.|||+|||+|... .+..+||--|+|||++.+.. .|
T Consensus 716 ~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y 795 (1351)
T KOG1035|consen 716 QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY 795 (1351)
T ss_pred CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence 99999999999999994 69999999999761 03567899999999998755 68
Q ss_pred CCcccHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcc
Q psy11098 271 GPSTDMWSLGVLLYILLSGVSPFLDESE-EETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVA 349 (380)
Q Consensus 271 ~~~~DiwSlGvil~~lltg~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp 349 (380)
+.|+||||||||++||+ .||....+ ..++.++..+....+...+..--.....+|++||++||.+||||.|+|++.
T Consensus 796 n~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~ 872 (1351)
T KOG1035|consen 796 NSKIDMYSLGIVLFEML---YPFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSE 872 (1351)
T ss_pred cchhhhHHHHHHHHHHh---ccCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhcc
Confidence 99999999999999999 46755443 345556665555554222333345678899999999999999999999999
Q ss_pred cccc
Q psy11098 350 WFAE 353 (380)
Q Consensus 350 w~~~ 353 (380)
||..
T Consensus 873 llpp 876 (1351)
T KOG1035|consen 873 LLPP 876 (1351)
T ss_pred CCCc
Confidence 9984
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=301.02 Aligned_cols=238 Identities=24% Similarity=0.332 Sum_probs=204.3
Q ss_pred eeeeeecccCCeEEEEEEEcCCC----cEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEE
Q psy11098 103 EELERLGNGRFCTVRKARDRGTG----QLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 103 ~~~~~LG~G~fg~V~~~~~~~~~----~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
++.+.||.|+||.||+|++..++ ..||+|.+..... ....+..|+.+++.+.|+|++++++++... +..++
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~ 78 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE---EPLMI 78 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC---CeeEE
Confidence 56788999999999999998766 8999999975544 456778899999999999999999888764 67899
Q ss_pred EEEecCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCcccccc---
Q psy11098 177 VMQLVHGESLIQHLCRQST--ITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVST--- 250 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~~~~--l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~~--- 250 (380)
+||++.+++|.+++..... +++..+..++.|++.||.|||+.|++|+||||+||++++ +.++|+|||++.....
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 9999999999999976544 999999999999999999999999999999999999985 5899999999875532
Q ss_pred ----cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHH
Q psy11098 251 ----VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAR 325 (380)
Q Consensus 251 ----~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 325 (380)
...+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||...+.......+........ ...++.++.
T Consensus 159 ~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 234 (258)
T smart00219 159 YKKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPK---PENCPPEIY 234 (258)
T ss_pred cccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC---CCcCCHHHH
Confidence 1235688999999866 577889999999999999998 8999988887777777765543222 234789999
Q ss_pred HHHHHhcccCCCCCCCHHHHHh
Q psy11098 326 ELIGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 326 ~li~~~L~~dP~~Rpt~~e~L~ 347 (380)
+++.+||..||++|||+.|+++
T Consensus 235 ~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 235 KLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHHHCcCChhhCcCHHHHHh
Confidence 9999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=305.38 Aligned_cols=243 Identities=22% Similarity=0.366 Sum_probs=205.3
Q ss_pred hceeeeeeecccCCeEEEEEEEcC-----CCcEEEEEEecCCCCc--hHHHHHHHHHHHhhccCCCcceeeecccccCCC
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRG-----TGQLVALKQIPRERQP--QQITRAEYNLLSTLMHAHIPTALALFENAPVPG 172 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vAvK~~~~~~~~--~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~ 172 (380)
++|++.+.||+|+||.||+|+.+. +.+.+|+|.+...... ...+.+|+++++.++|+|++++++++... +
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~ 81 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREA---E 81 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCC---C
Confidence 678999999999999999999764 3468999988654432 45678899999999999999999987664 5
Q ss_pred ceEEEEEecCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeC
Q psy11098 173 TDTIVMQLVHGESLIQHLCRQS---------TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDL 242 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~~~---------~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DF 242 (380)
..++||||+.+++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++ ++.++|+||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 6799999999999999997655 689999999999999999999999999999999999998 568999999
Q ss_pred CCccccc-------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCC
Q psy11098 243 GSSVSVS-------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPP 314 (380)
Q Consensus 243 G~a~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~ 314 (380)
|++.... ....++..|+|||.+.+ ...+.++|+||||+++|+|++ |..||.+.........+.......+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 240 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQE-DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPV 240 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCC
Confidence 9986432 23345677999999877 356789999999999999999 89999887777777777655544332
Q ss_pred CcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 315 EQCGHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 315 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
...++..+.+++.+||..||++|||+.+++.+
T Consensus 241 --~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 241 --PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred --CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 23578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=330.81 Aligned_cols=243 Identities=26% Similarity=0.349 Sum_probs=209.6
Q ss_pred eeeecccCCeEEEEEEEcCCCcEEEEEEec-----CCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEEE
Q psy11098 105 LERLGNGRFCTVRKARDRGTGQLVALKQIP-----RERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQ 179 (380)
Q Consensus 105 ~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~-----~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e 179 (380)
.+.||+|+|-+||+|.+..+|..||.-.++ +.....+.+..|+.+|+.|+|+||++++..+..... ..+.+|+|
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n-~~in~iTE 123 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN-KTINFITE 123 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC-ceeeeeee
Confidence 467999999999999999999988865543 223334788899999999999999999988876543 56889999
Q ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeecCCCCcEEEe--CCeeEEEeCCCccccc----cc
Q psy11098 180 LVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQ--IAHKDIRPENILMN--GAVLKLIDLGSSVSVS----TV 251 (380)
Q Consensus 180 ~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~--iiHrDlKp~NIl~~--~~~ikl~DFG~a~~~~----~~ 251 (380)
++..|+|..++++.+.++...++.|++||+.||.|||++. |||||||.+||||+ .|.|||+|+|||.... ..
T Consensus 124 L~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~aks 203 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHAKS 203 (632)
T ss_pred cccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccccce
Confidence 9999999999999999999999999999999999999985 99999999999998 4699999999997653 56
Q ss_pred ccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcccCCCCCCcCCCC-CHHHHHHHH
Q psy11098 252 VLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDE-SEEETRAHISVADYSFPPEQCGHI-SVPARELIG 329 (380)
Q Consensus 252 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~-s~~~~~li~ 329 (380)
..|||+|||||.+.- .|+..+||||||+.+.||.|+.-||... +...++.++..+.- +..+..+ .+++++||.
T Consensus 204 vIGTPEFMAPEmYEE--~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiK---P~sl~kV~dPevr~fIe 278 (632)
T KOG0584|consen 204 VIGTPEFMAPEMYEE--NYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIK---PAALSKVKDPEVREFIE 278 (632)
T ss_pred eccCccccChHHHhh--hcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCC---HHHhhccCCHHHHHHHH
Confidence 799999999999984 7899999999999999999999999875 56667777766542 2222222 578999999
Q ss_pred HhcccCCCCCCCHHHHHhccccccc
Q psy11098 330 QLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 330 ~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
+||.. ..+|+|+.|||+||||...
T Consensus 279 kCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 279 KCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred HHhcC-chhccCHHHHhhChhhccc
Confidence 99999 8999999999999999976
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=302.71 Aligned_cols=233 Identities=20% Similarity=0.298 Sum_probs=193.5
Q ss_pred eecccCCeEEEEEEEc--CCCcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEEEecC
Q psy11098 107 RLGNGRFCTVRKARDR--GTGQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVH 182 (380)
Q Consensus 107 ~LG~G~fg~V~~~~~~--~~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e~~~ 182 (380)
.||+|+||.||+|.+. .++..||+|++..... ..+.+.+|+.+++.++|+|++++++++.. ...++||||+.
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~----~~~~lv~e~~~ 77 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA----EALMLVMEMAS 77 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC----CCeEEEEEeCC
Confidence 3899999999999765 3456799999865433 23557889999999999999999988753 46799999999
Q ss_pred CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCcccccc---------c
Q psy11098 183 GESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVST---------V 251 (380)
Q Consensus 183 gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~~---------~ 251 (380)
+++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++. +.+||+|||++..... .
T Consensus 78 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 78 GGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 9999999875 457899999999999999999999999999999999999984 5899999999875421 1
Q ss_pred ccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHH
Q psy11098 252 VLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQ 330 (380)
Q Consensus 252 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 330 (380)
..+++.|+|||++.+ ..++.++|+|||||++|+|++ |..||.+....+....+..+.... .....++++.++|.+
T Consensus 158 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~ 233 (257)
T cd05115 158 GKWPLKWYAPECINF-RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLD---CPAECPPEMYALMKD 233 (257)
T ss_pred CCCCcccCCHHHHcc-CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCC---CCCCCCHHHHHHHHH
Confidence 122568999999887 467889999999999999996 999999888777766665543211 123468999999999
Q ss_pred hcccCCCCCCCHHHHHh
Q psy11098 331 LLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 331 ~L~~dP~~Rpt~~e~L~ 347 (380)
||..||++||++.++++
T Consensus 234 c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 234 CWIYKWEDRPNFAKVEE 250 (257)
T ss_pred HcCCChhhCcCHHHHHH
Confidence 99999999999999975
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=314.62 Aligned_cols=241 Identities=22% Similarity=0.309 Sum_probs=191.1
Q ss_pred CCeEEEEEEEcCCCcEEEEEEecCC---CCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEEEecCCCCHHH
Q psy11098 112 RFCTVRKARDRGTGQLVALKQIPRE---RQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQ 188 (380)
Q Consensus 112 ~fg~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e~~~gg~L~~ 188 (380)
++|.||.+++..+++.||+|++... ......+.+|+++++.++|+||+++++++... +..+++|||+.+++|.+
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~---~~~~~~~e~~~~~~l~~ 88 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD---SELYVVSPLMAYGSCED 88 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecC---CeEEEEEeccCCCCHHH
Confidence 5566777777779999999999754 22345678899999999999999999887654 56799999999999999
Q ss_pred HHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-------------ccc
Q psy11098 189 HLCRQ--STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS-------------TVV 252 (380)
Q Consensus 189 ~l~~~--~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~-------------~~~ 252 (380)
++... ..+++..+..+++||+.||.|||++||+||||||+|||++ ++.+||+|||.+.... ...
T Consensus 89 ~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~ 168 (314)
T cd08216 89 LLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSS 168 (314)
T ss_pred HHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccc
Confidence 99753 4689999999999999999999999999999999999998 4799999999876432 223
Q ss_pred cCCCcccCCccccCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHhcccC------C-------------
Q psy11098 253 LPDLEFASPEMLTSP-ATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETR-AHISVADY------S------------- 311 (380)
Q Consensus 253 ~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~-~~i~~~~~------~------------- 311 (380)
.++..|+|||++... ..++.++|+||+||++|+|++|..||.+....... ..+..... .
T Consensus 169 ~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (314)
T cd08216 169 VKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRS 248 (314)
T ss_pred cccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccc
Confidence 457789999998763 35778999999999999999999999876543322 22210000 0
Q ss_pred ----------CCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 312 ----------FPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 312 ----------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
........++.++.+|+.+||..||++|||++++|+||||+...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 249 SNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred cccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 00001112356789999999999999999999999999998664
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=303.07 Aligned_cols=241 Identities=20% Similarity=0.324 Sum_probs=201.5
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCc---EEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCCce
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQ---LVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~---~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~ 174 (380)
.+|++.+.||+|+||.||+|.++.++. .+|+|.++.... ....+.+|+.+++.++|||++++.+++... +..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 80 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS---KPV 80 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC---Ccc
Confidence 578999999999999999999875543 799999865432 235678899999999999999999988653 677
Q ss_pred EEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccccc--
Q psy11098 175 TIVMQLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVST-- 250 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~~-- 250 (380)
++||||+.+++|.+++... ..+++.++..++.|++.||.|||++|++||||||+|||++ ++.++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999999999764 5689999999999999999999999999999999999997 46899999999875531
Q ss_pred -------cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCH
Q psy11098 251 -------VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISV 322 (380)
Q Consensus 251 -------~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 322 (380)
...++..|+|||.+.+ ..++.++|+||||+++|++++ |..||.+....+....+... ...+ ....++.
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-~~~~--~~~~~~~ 236 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG-YRLP--APMDCPA 236 (267)
T ss_pred ceeeecCCCccceeecCHhHhcc-CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC-CcCC--CCCCCCH
Confidence 1122457999999987 467889999999999999886 99999888777666666543 2222 2245788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHh
Q psy11098 323 PARELIGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 323 ~~~~li~~~L~~dP~~Rpt~~e~L~ 347 (380)
++.+++.+||+++|.+|||+.++++
T Consensus 237 ~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 237 ALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHHHHHHcccCchhCCCHHHHHH
Confidence 9999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=303.25 Aligned_cols=243 Identities=19% Similarity=0.297 Sum_probs=202.8
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCc---EEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCCc
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQ---LVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGT 173 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~---~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~ 173 (380)
.++|+..+.||+|+||.||+|.++.+++ .+|+|.+..... ....+.+|+++++.+.|+|++++.+++... +.
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~ 80 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF---KP 80 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC---CC
Confidence 3568888999999999999999876654 799999865432 345677899999999999999999888754 56
Q ss_pred eEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCcccccc-
Q psy11098 174 DTIVMQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVST- 250 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~~- 250 (380)
.++||||+.+++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||||+||++++ +.+||+|||++.....
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 7999999999999999865 457899999999999999999999999999999999999984 5899999999875531
Q ss_pred --------cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCC
Q psy11098 251 --------VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHIS 321 (380)
Q Consensus 251 --------~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 321 (380)
....+..|+|||++.+ ..++.++|+|||||++|+|++ |..||...+..+....+.... ..+ .....+
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~-~~~--~~~~~~ 236 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF-RLP--APMDCP 236 (268)
T ss_pred cccceeccCCCcCceecCHHHhhc-CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCC-CCC--CCCCCC
Confidence 1122457999999987 467889999999999999997 999998888777777776442 222 223578
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 322 VPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 322 ~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
.++.+++.+||..||++||++.++++.
T Consensus 237 ~~~~~li~~c~~~~p~~Rp~~~~i~~~ 263 (268)
T cd05063 237 SAVYQLMLQCWQQDRARRPRFVDIVNL 263 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 899999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=310.81 Aligned_cols=243 Identities=21% Similarity=0.307 Sum_probs=201.1
Q ss_pred hhceeeeeeecccCCeEEEEEEEcC-------CCcEEEEEEecCCCC--chHHHHHHHHHHHhh-ccCCCcceeeecccc
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRG-------TGQLVALKQIPRERQ--PQQITRAEYNLLSTL-MHAHIPTALALFENA 168 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~-------~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~ 168 (380)
.++|.+.+.||+|+||.||+|++.. ....+|+|.+..... ....+.+|+++++.+ .|+||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 5789999999999999999998643 345799999875433 234567899999999 699999999887653
Q ss_pred cCCCceEEEEEecCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEE
Q psy11098 169 PVPGTDTIVMQLVHGESLIQHLCRQ----------------STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILM 232 (380)
Q Consensus 169 ~~~~~~~lv~e~~~gg~L~~~l~~~----------------~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~ 232 (380)
+..+++|||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 91 ---~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill 167 (314)
T cd05099 91 ---GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV 167 (314)
T ss_pred ---CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE
Confidence 5689999999999999999653 347888999999999999999999999999999999999
Q ss_pred e-CCeeEEEeCCCcccccc--------cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy11098 233 N-GAVLKLIDLGSSVSVST--------VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETR 302 (380)
Q Consensus 233 ~-~~~ikl~DFG~a~~~~~--------~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~ 302 (380)
+ ++.+||+|||+++.... ...++..|+|||++.+ ..++.++|+|||||++|+|++ |..||.+....+..
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~ 246 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF 246 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHcc-CCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 8 56899999999975531 1123457999999887 577889999999999999999 99999888877777
Q ss_pred HHHhcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 303 AHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 303 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
..+...... .....++.++++++.+||..||++|||+.++++.
T Consensus 247 ~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 289 (314)
T cd05099 247 KLLREGHRM---DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEA 289 (314)
T ss_pred HHHHcCCCC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 766544321 1224578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=306.08 Aligned_cols=238 Identities=27% Similarity=0.378 Sum_probs=196.5
Q ss_pred eeeeeecccCCeEEEEEEEc----CCCcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEE
Q psy11098 103 EELERLGNGRFCTVRKARDR----GTGQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 103 ~~~~~LG~G~fg~V~~~~~~----~~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
++.+.||.|+||.||+|... ..+..|+||.++.... ..+.+.+|+++++.++|+||+++++++... +..++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~---~~~~l 78 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIEN---EPLFL 78 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESS---SSEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccc---ccccc
Confidence 45688999999999999988 4567899999965433 246788899999999999999999998843 55899
Q ss_pred EEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc----
Q psy11098 177 VMQLVHGESLIQHLCRQ--STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS---- 249 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~---- 249 (380)
|+||+.+|+|.+++... ..+++..+..++.||+.||.|||+++++|+||+++|||++ ++.+||+|||++....
T Consensus 79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999999876 7799999999999999999999999999999999999999 5699999999987662
Q ss_pred ----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHH
Q psy11098 250 ----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPA 324 (380)
Q Consensus 250 ----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 324 (380)
........|+|||.+.. ..++.++||||||+++|||++ |..||.+....+....+....... ....++..+
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~-~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 234 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKD-GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLP---IPDNCPKDI 234 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHH-SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETT---SBTTSBHHH
T ss_pred ccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccccccce---eccchhHHH
Confidence 22345678999999987 357889999999999999999 789999988888777775544322 123579999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHh
Q psy11098 325 RELIGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 325 ~~li~~~L~~dP~~Rpt~~e~L~ 347 (380)
.++|..||..||++|||+.++++
T Consensus 235 ~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 235 YSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHHHT-SSGGGS--HHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHh
Confidence 99999999999999999999985
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=300.86 Aligned_cols=241 Identities=20% Similarity=0.277 Sum_probs=202.5
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEE
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIV 177 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv 177 (380)
..++|++.+.||+|+||.||++.... +..+|+|.+.......+.+.+|+++++.++|+|++++..++.. ...+++
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~v 78 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK----EPIYII 78 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecC-CccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC----CCeEEE
Confidence 46789999999999999999998654 5579999987655555677889999999999999999888765 457999
Q ss_pred EEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCcccccc----
Q psy11098 178 MQLVHGESLIQHLCRQ--STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVST---- 250 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~~---- 250 (380)
|||+.+++|.+++... ..+++..+..++.||+.||.|||+.|++|+||||+||+++. +.+||+|||++.....
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 79 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred EEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 9999999999999763 45788889999999999999999999999999999999984 5899999999875531
Q ss_pred ---cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHH
Q psy11098 251 ---VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARE 326 (380)
Q Consensus 251 ---~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 326 (380)
...++..|+|||++.+ ..++.++|+|||||++|++++ |..||.+.+.......+.... .. +....++.++.+
T Consensus 159 ~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~ 234 (260)
T cd05073 159 AREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY-RM--PRPENCPEELYN 234 (260)
T ss_pred cccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC-CC--CCcccCCHHHHH
Confidence 2233567999999987 467889999999999999998 999998887776666655432 22 223467899999
Q ss_pred HHHHhcccCCCCCCCHHHHHh
Q psy11098 327 LIGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 327 li~~~L~~dP~~Rpt~~e~L~ 347 (380)
++.+||.+||++||++.++++
T Consensus 235 ~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 235 IMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHHcccCcccCcCHHHHHH
Confidence 999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=326.98 Aligned_cols=245 Identities=22% Similarity=0.311 Sum_probs=203.7
Q ss_pred hhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---chHHHHHHHHHHHhhccCCCcceeeecccccCCC
Q psy11098 96 EQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLMHAHIPTALALFENAPVPG 172 (380)
Q Consensus 96 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~ 172 (380)
+..-+...+.+.||+|+||+||+|++-++ ||||+++...- ..+.|++|+.+++.-+|.||+=+.+++...
T Consensus 388 eIp~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p---- 460 (678)
T KOG0193|consen 388 EIPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP---- 460 (678)
T ss_pred ccCHHHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC----
Confidence 34456677889999999999999999864 99999975433 446789999999999999999999988863
Q ss_pred ceEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCccccc-
Q psy11098 173 TDTIVMQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVS- 249 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~- 249 (380)
...||+.+|+|-+|+.+|.. ...|+....+.|++||++||.|||.++|||||||..|||+.+ +.|||+|||++..-.
T Consensus 461 ~~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~ 540 (678)
T KOG0193|consen 461 PLAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTR 540 (678)
T ss_pred ceeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeee
Confidence 44999999999999999954 456899999999999999999999999999999999999986 799999999986543
Q ss_pred -------ccccCCCcccCCccccC--CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCC-CCcCCC
Q psy11098 250 -------TVVLPDLEFASPEMLTS--PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFP-PEQCGH 319 (380)
Q Consensus 250 -------~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~ 319 (380)
....|...|||||+++. ..++++.+||||||+++|||++|..||...+.+..+-.+..+..... .....+
T Consensus 541 w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~ 620 (678)
T KOG0193|consen 541 WSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSN 620 (678)
T ss_pred eccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhcc
Confidence 22344567999999864 34789999999999999999999999997777666655555432222 122345
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy11098 320 ISVPARELIGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 320 ~s~~~~~li~~~L~~dP~~Rpt~~e~L~ 347 (380)
.+.++++|+..||..++++||+..++|.
T Consensus 621 ~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 621 CPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred CHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 6779999999999999999999999986
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=306.43 Aligned_cols=235 Identities=24% Similarity=0.359 Sum_probs=190.9
Q ss_pred eeecccCCeEEEEEEEcCCCc-------EEEEEEecCCCC-chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEE
Q psy11098 106 ERLGNGRFCTVRKARDRGTGQ-------LVALKQIPRERQ-PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIV 177 (380)
Q Consensus 106 ~~LG~G~fg~V~~~~~~~~~~-------~vAvK~~~~~~~-~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv 177 (380)
+.||+|+||.||+|.++.++. .+|+|.+..... ..+.+.+|..+++.+.|+|++++++++... +..++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~---~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCG---DESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeC---CCcEEE
Confidence 469999999999999876544 488888754332 335667799999999999999999888764 567999
Q ss_pred EEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeCC---------eeEEEeCCCccc
Q psy11098 178 MQLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGA---------VLKLIDLGSSVS 247 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~~---------~ikl~DFG~a~~ 247 (380)
|||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.. .++++|||++..
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 9999999999999764 458999999999999999999999999999999999999632 379999999875
Q ss_pred cc--ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHH
Q psy11098 248 VS--TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSG-VSPFLDESEEETRAHISVADYSFPPEQCGHISVPA 324 (380)
Q Consensus 248 ~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 324 (380)
.. ....+++.|+|||++.+...++.++|+|||||++|+|++| ..||........... ......++. ..+.++
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~ 232 (258)
T cd05078 158 VLPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF-YEDRHQLPA----PKWTEL 232 (258)
T ss_pred cCCchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH-HHccccCCC----CCcHHH
Confidence 54 3456788999999998755678899999999999999998 567665554443332 222223332 356889
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 325 RELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 325 ~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
.+||++||+.||++|||++++++.
T Consensus 233 ~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 233 ANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHHHHHHhccChhhCCCHHHHHHh
Confidence 999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=302.23 Aligned_cols=242 Identities=21% Similarity=0.250 Sum_probs=201.8
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCC---CcEEEEEEecCCC--CchHHHHHHHHHHHhhccCCCcceeeecccccCCCc
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGT---GQLVALKQIPRER--QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGT 173 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~---~~~vAvK~~~~~~--~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~ 173 (380)
.++|.+.+.||+|+||.||+|.+... ...||+|.+.... ...+.+.+|+.+++.+.|+|++++++++.. +.
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----~~ 80 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE----NP 80 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC----CC
Confidence 45688999999999999999987644 3478999886543 234567889999999999999999988764 45
Q ss_pred eEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCcccccc-
Q psy11098 174 DTIVMQLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVST- 250 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~~- 250 (380)
.++||||+.+++|.+++... ..+++..+..++.||+.||.|||+.|++|+||||+|||++. +.+||+|||++.....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 68999999999999999764 35899999999999999999999999999999999999984 6899999999875431
Q ss_pred ------cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHH
Q psy11098 251 ------VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVP 323 (380)
Q Consensus 251 ------~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 323 (380)
...++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||.+....+....+....... ....++.+
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 236 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLP---MPPNCPPT 236 (270)
T ss_pred cceecCCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCC---CCCCCCHH
Confidence 1223467999999877 467889999999999999986 999998888777766665543222 22457899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 324 ARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 324 ~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
+.++|.+||..+|.+|||+.+++..
T Consensus 237 ~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 237 LYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=299.63 Aligned_cols=235 Identities=21% Similarity=0.318 Sum_probs=198.0
Q ss_pred eeecccCCeEEEEEEEcC-CCc--EEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEEEe
Q psy11098 106 ERLGNGRFCTVRKARDRG-TGQ--LVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQL 180 (380)
Q Consensus 106 ~~LG~G~fg~V~~~~~~~-~~~--~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e~ 180 (380)
+.||+|++|.||+|.+.. .++ .||+|.+..... ....+.+|+++++.++|+|++++++.+.. ...+++|||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT----HPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC----CeEEEEEEe
Confidence 468999999999999865 333 699999976544 34567889999999999999999988765 567999999
Q ss_pred cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccccc-------
Q psy11098 181 VHGESLIQHLCRQS--TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVST------- 250 (380)
Q Consensus 181 ~~gg~L~~~l~~~~--~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~~------- 250 (380)
+.+++|.+.+.... .+++..++.++.|++.||.|||++|++|+||||+||+++ ++.+||+|||++.....
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999999997754 689999999999999999999999999999999999998 56899999999876532
Q ss_pred --cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHH
Q psy11098 251 --VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAREL 327 (380)
Q Consensus 251 --~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 327 (380)
...++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+....+.......+ ....++.++.++
T Consensus 157 ~~~~~~~~~y~~pE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l 233 (257)
T cd05040 157 EEHLKVPFAWCAPESLRT-RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLE--RPEACPQDIYNV 233 (257)
T ss_pred ccCCCCCceecCHHHhcc-cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCC--CCccCCHHHHHH
Confidence 2345678999999887 467889999999999999998 9999988877776666654332222 223578899999
Q ss_pred HHHhcccCCCCCCCHHHHHh
Q psy11098 328 IGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 328 i~~~L~~dP~~Rpt~~e~L~ 347 (380)
+.+||..+|++|||+.++++
T Consensus 234 i~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 234 MLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHHCCCCcccCCCHHHHHH
Confidence 99999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=306.35 Aligned_cols=240 Identities=22% Similarity=0.301 Sum_probs=198.5
Q ss_pred ceeeeeeecccCCeEEEEEEEcC-----CCcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCCc
Q psy11098 101 RYEELERLGNGRFCTVRKARDRG-----TGQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGT 173 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~ 173 (380)
+|++.+.||+|+||.||+|.+.. ....+|+|.+..... ....+.+|+.+++.+.|+||+++++.+... +.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~ 77 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQD---GP 77 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecC---CC
Confidence 47788999999999999998753 235789998865443 234677899999999999999999887654 56
Q ss_pred eEEEEEecCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCc
Q psy11098 174 DTIVMQLVHGESLIQHLCRQ------------------------STITESYICCIIRQLHSALHCLHSQQIAHKDIRPEN 229 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~------------------------~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~N 229 (380)
.++++||+.+++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n 157 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN 157 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence 79999999999999988642 247788899999999999999999999999999999
Q ss_pred EEEeC-CeeEEEeCCCccccc--------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHH
Q psy11098 230 ILMNG-AVLKLIDLGSSVSVS--------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEE 299 (380)
Q Consensus 230 Il~~~-~~ikl~DFG~a~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~ 299 (380)
||+++ +.+||+|||++.... ....++..|+|||++.+ ..++.++||||||+++|+|++ |..||.+...+
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc-CCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 99984 589999999987542 12244678999999877 467889999999999999998 99999888877
Q ss_pred HHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy11098 300 ETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 300 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~ 347 (380)
+....+... ...+ ....++.++.+|+.+||+.||++||++.++++
T Consensus 237 ~~~~~~~~~-~~~~--~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 237 RLFNLLKTG-YRME--RPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHHhCC-CCCC--CCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 766655433 2222 22457899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=305.59 Aligned_cols=242 Identities=20% Similarity=0.319 Sum_probs=202.5
Q ss_pred hhceeeeeeecccCCeEEEEEEEcC-----CCcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCC
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRG-----TGQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVP 171 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~ 171 (380)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+..... ....+.+|+.+++.+.|+|++++++++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~--- 80 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVG--- 80 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC---
Confidence 4679999999999999999999753 678999999875433 234577899999999999999999887764
Q ss_pred CceEEEEEecCCCCHHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCc
Q psy11098 172 GTDTIVMQLVHGESLIQHLCRQS----------------------TITESYICCIIRQLHSALHCLHSQQIAHKDIRPEN 229 (380)
Q Consensus 172 ~~~~lv~e~~~gg~L~~~l~~~~----------------------~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~N 229 (380)
+..+++|||+.+++|.+++.... .+++..+..++.||+.||.|||++|++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 56799999999999999996432 36788899999999999999999999999999999
Q ss_pred EEEe-CCeeEEEeCCCccccc--------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHH
Q psy11098 230 ILMN-GAVLKLIDLGSSVSVS--------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEE 299 (380)
Q Consensus 230 Il~~-~~~ikl~DFG~a~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~ 299 (380)
||++ ++.++|+|||++.... .....+..|+|||++.+ ..++.++|+|||||++|+|++ |..||.+.+..
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9997 5689999999987542 12234567999999887 467889999999999999997 88999888888
Q ss_pred HHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy11098 300 ETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 300 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~ 347 (380)
+....+....... .....+.++.+||.+||+.||.+|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 240 EVIYYVRDGNVLS---CPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHHhcCCCCC---CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 7777766554321 12357889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=299.30 Aligned_cols=238 Identities=24% Similarity=0.343 Sum_probs=200.6
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEEE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQ 179 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e 179 (380)
++|++.+.||+|+||.||++.. +++.||+|.++... ....+.+|+.+++.++|+|++++.+++.. +..+++||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----~~~~~v~e 78 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILH----NGLYIVME 78 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcC----CCcEEEEE
Confidence 5799999999999999999864 67889999986543 34567889999999999999999988754 34699999
Q ss_pred ecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccccc---ccc
Q psy11098 180 LVHGESLIQHLCRQS--TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVST---VVL 253 (380)
Q Consensus 180 ~~~gg~L~~~l~~~~--~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~~---~~~ 253 (380)
|+.+++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+|||++ ++.+||+|||++..... ...
T Consensus 79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (254)
T cd05083 79 LMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSK 158 (254)
T ss_pred CCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccCCCCC
Confidence 999999999997643 589999999999999999999999999999999999998 46899999999875432 223
Q ss_pred CCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhc
Q psy11098 254 PDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLL 332 (380)
Q Consensus 254 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 332 (380)
.+..|+|||.+.+ ..++.++|+||||+++|+|++ |..||......+....+.... .. .....++.++.+++.+||
T Consensus 159 ~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~li~~~l 234 (254)
T cd05083 159 LPVKWTAPEALKH-KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY-RM--EPPEGCPADVYVLMTSCW 234 (254)
T ss_pred CCceecCHHHhcc-CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCC-CC--CCCCcCCHHHHHHHHHHc
Confidence 3567999999877 467889999999999999998 999998888777766665442 22 223467899999999999
Q ss_pred ccCCCCCCCHHHHHhc
Q psy11098 333 NTHADKRPTAGQLLQV 348 (380)
Q Consensus 333 ~~dP~~Rpt~~e~L~h 348 (380)
..+|++|||++++++.
T Consensus 235 ~~~p~~Rp~~~~l~~~ 250 (254)
T cd05083 235 ETEPKKRPSFHKLREK 250 (254)
T ss_pred CCChhhCcCHHHHHHH
Confidence 9999999999999853
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=302.17 Aligned_cols=235 Identities=23% Similarity=0.337 Sum_probs=193.7
Q ss_pred eeecccCCeEEEEEEEcCCCc--EEEEEEecCCC--CchHHHHHHHHHHHhh-ccCCCcceeeecccccCCCceEEEEEe
Q psy11098 106 ERLGNGRFCTVRKARDRGTGQ--LVALKQIPRER--QPQQITRAEYNLLSTL-MHAHIPTALALFENAPVPGTDTIVMQL 180 (380)
Q Consensus 106 ~~LG~G~fg~V~~~~~~~~~~--~vAvK~~~~~~--~~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~~~~~~~lv~e~ 180 (380)
+.||+|+||.||+|+.+.++. .+|+|.+.... .....+.+|++++..+ .|+|++++++++... +..+++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~---~~~~lv~e~ 77 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR---GYLYLAIEY 77 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecC---CCceEEEEe
Confidence 358999999999999988776 46888886432 2345677899999999 799999999988764 567999999
Q ss_pred cCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCC
Q psy11098 181 VHGESLIQHLCRQS----------------TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLG 243 (380)
Q Consensus 181 ~~gg~L~~~l~~~~----------------~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG 243 (380)
+.+++|.+++.... .+++..+..++.|++.||+|||+.|++||||||+|||++ ++.+||+|||
T Consensus 78 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 78 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCC
Confidence 99999999996532 478899999999999999999999999999999999998 5689999999
Q ss_pred Cccccc-----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcC
Q psy11098 244 SSVSVS-----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQC 317 (380)
Q Consensus 244 ~a~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 317 (380)
++.... .....+..|+|||++.+ ..++.++|+|||||++|+|++ |..||.+.+..+....+.... .. +..
T Consensus 158 l~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-~~--~~~ 233 (270)
T cd05047 158 LSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-RL--EKP 233 (270)
T ss_pred CccccchhhhccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC-CC--CCC
Confidence 986432 12223567999999877 467889999999999999997 999998887777666654332 11 122
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy11098 318 GHISVPARELIGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 318 ~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~ 347 (380)
..++.++.+++.+||..||.+|||+.++++
T Consensus 234 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 234 LNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred CcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 357889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=301.88 Aligned_cols=242 Identities=21% Similarity=0.358 Sum_probs=201.2
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCc---EEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCCce
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQ---LVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~---~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~ 174 (380)
..|++.+.||+|+||.||+|.++.+++ .||+|.+..... ....+..|+.+++.+.|+|++++.+++... +..
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---~~~ 80 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS---RPV 80 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCC---Cce
Confidence 458899999999999999999887665 699999865422 345678899999999999999999887653 567
Q ss_pred EEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCccccccc-
Q psy11098 175 TIVMQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVSTV- 251 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~~~- 251 (380)
++||||+.+++|.+++.. .+.+++..+..++.|++.||.|||++|++|+||||+||+++. +.+||+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 999999999999999875 456899999999999999999999999999999999999984 58999999988654311
Q ss_pred --------cc--CCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCC
Q psy11098 252 --------VL--PDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHI 320 (380)
Q Consensus 252 --------~~--gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 320 (380)
.. .+..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+....+....+... ...+. ...+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~-~~~~~--~~~~ 236 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD-YRLPP--PMDC 236 (269)
T ss_pred cccccccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC-CcCCC--cccC
Confidence 11 1347999999987 467889999999999999886 99999888777766666432 22222 2457
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 321 SVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 321 s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
+.++.+++.+||..+|.+||++++++..
T Consensus 237 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 264 (269)
T cd05065 237 PTALHQLMLDCWQKDRNARPKFGQIVST 264 (269)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 8899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=296.51 Aligned_cols=235 Identities=21% Similarity=0.331 Sum_probs=196.4
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEecCCCCc--hHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEEEecCC
Q psy11098 106 ERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP--QQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHG 183 (380)
Q Consensus 106 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e~~~g 183 (380)
+.||+|+||.||+|... +++.+|+|.+...... ...+.+|+++++.+.|+|++++++++... +..++||||+.+
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~lv~e~~~~ 76 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQR---QPIYIVMELVPG 76 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecC---CccEEEEECCCC
Confidence 36899999999999865 6789999998654332 34567899999999999999999988764 567999999999
Q ss_pred CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccccc-------cccC
Q psy11098 184 ESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVST-------VVLP 254 (380)
Q Consensus 184 g~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~~-------~~~g 254 (380)
++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||+++ ++.+||+|||++..... ...+
T Consensus 77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 999998865 34689999999999999999999999999999999999997 46899999999875432 1233
Q ss_pred CCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhcc
Q psy11098 255 DLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLN 333 (380)
Q Consensus 255 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 333 (380)
+..|+|||++.+ ..++.++|+||||+++|++++ |..||.+.........+..... ......++.++.+++.+||.
T Consensus 157 ~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~ 232 (250)
T cd05085 157 PIKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYR---MSCPQKCPDDVYKVMQRCWD 232 (250)
T ss_pred cccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCCHHHHHHHHHHcc
Confidence 567999999987 467889999999999999998 9999988877777666654321 12223578999999999999
Q ss_pred cCCCCCCCHHHHHhc
Q psy11098 334 THADKRPTAGQLLQV 348 (380)
Q Consensus 334 ~dP~~Rpt~~e~L~h 348 (380)
.+|++|||+.++++.
T Consensus 233 ~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 233 YKPENRPKFSELQKE 247 (250)
T ss_pred cCcccCCCHHHHHHH
Confidence 999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=300.20 Aligned_cols=233 Identities=24% Similarity=0.336 Sum_probs=191.3
Q ss_pred eeecccCCeEEEEEEEcCCC----------cEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 106 ERLGNGRFCTVRKARDRGTG----------QLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 106 ~~LG~G~fg~V~~~~~~~~~----------~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
+.||+|+||.||+|.+..++ ..+++|.+.........+.+|+.+++.++|+|++++++++.. +..+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR----DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec----CCcE
Confidence 46999999999999998776 358888876554435677889999999999999999998765 3459
Q ss_pred EEEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-C-------eeEEEeCCCcc
Q psy11098 176 IVMQLVHGESLIQHLCRQS-TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-A-------VLKLIDLGSSV 246 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~~-~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~-------~ikl~DFG~a~ 246 (380)
+||||+.+++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++. + .+||+|||++.
T Consensus 77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~ 156 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156 (259)
T ss_pred EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence 9999999999999997765 7899999999999999999999999999999999999974 3 59999999988
Q ss_pred ccc--ccccCCCcccCCccccCC-CCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCH
Q psy11098 247 SVS--TVVLPDLEFASPEMLTSP-ATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISV 322 (380)
Q Consensus 247 ~~~--~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 322 (380)
... ....++..|+|||++.+. ..++.++|+||||+++|+|++ |..||......+........ ...+. ....
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~-~~~~~----~~~~ 231 (259)
T cd05037 157 TVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQ-HRLPM----PDCA 231 (259)
T ss_pred ccccccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcC-CCCCC----CCch
Confidence 654 245567889999998874 367889999999999999999 68888776544333333211 11111 1237
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHh
Q psy11098 323 PARELIGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 323 ~~~~li~~~L~~dP~~Rpt~~e~L~ 347 (380)
.+.++|.+||..||++|||+.++++
T Consensus 232 ~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 232 ELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred HHHHHHHHHhccChhhCCCHHHHHH
Confidence 8999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=311.35 Aligned_cols=244 Identities=21% Similarity=0.292 Sum_probs=201.7
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCC-------CcEEEEEEecCCCC--chHHHHHHHHHHHhh-ccCCCcceeeecccc
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGT-------GQLVALKQIPRERQ--PQQITRAEYNLLSTL-MHAHIPTALALFENA 168 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~-------~~~vAvK~~~~~~~--~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~ 168 (380)
..+|++.+.||+|+||.||+|++... +..||+|.+..... ....+.+|+++++.+ +|+||+++++++...
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 56899999999999999999986532 23689998875432 235677899999999 799999999887753
Q ss_pred cCCCceEEEEEecCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEE
Q psy11098 169 PVPGTDTIVMQLVHGESLIQHLCRQ----------------STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILM 232 (380)
Q Consensus 169 ~~~~~~~lv~e~~~gg~L~~~l~~~----------------~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~ 232 (380)
+..+++|||+.+++|.+++... ..++...+..++.||+.||.|||++||+||||||+|||+
T Consensus 91 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill 167 (334)
T cd05100 91 ---GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV 167 (334)
T ss_pred ---CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE
Confidence 5789999999999999999653 236778889999999999999999999999999999999
Q ss_pred e-CCeeEEEeCCCcccccc--------cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy11098 233 N-GAVLKLIDLGSSVSVST--------VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETR 302 (380)
Q Consensus 233 ~-~~~ikl~DFG~a~~~~~--------~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~ 302 (380)
+ ++.+||+|||+++.... ...++..|+|||++.+ ..++.++||||||+++|+|++ |..||.+.+.++..
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 246 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 246 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhcc-CCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 8 56899999999875431 1223467999999987 477889999999999999998 89999988887777
Q ss_pred HHHhcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcc
Q psy11098 303 AHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVA 349 (380)
Q Consensus 303 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp 349 (380)
..+...... +.....+.++.+|+.+||..+|++|||+.+++++-
T Consensus 247 ~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l 290 (334)
T cd05100 247 KLLKEGHRM---DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290 (334)
T ss_pred HHHHcCCCC---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 766543221 12235688999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=300.37 Aligned_cols=225 Identities=22% Similarity=0.285 Sum_probs=185.4
Q ss_pred cCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEEEecCCCCHHHHH
Q psy11098 111 GRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHL 190 (380)
Q Consensus 111 G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~l 190 (380)
|.||.||+++++.+++.||+|.+..... ...|...+....|+|++++++++... +..+++|||+.|++|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~----~~~~~~~~~~~~~~~i~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE----YSRERLTIIPHCVPNMVCLHKYIVSE---DSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh----hhhHHHHHHhcCCCceeehhhheecC---CeEEEEEecCCCCCHHHHH
Confidence 8999999999999999999999966432 23355555566789998888877653 6789999999999999999
Q ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccccc---cccCCCcccCCccccC
Q psy11098 191 CRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVST---VVLPDLEFASPEMLTS 266 (380)
Q Consensus 191 ~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~~---~~~gt~~y~aPE~~~~ 266 (380)
.+...+++..+..++.|++.||.|||++||+||||||+||+++ ++.++++|||++..... ...++..|+|||.+.+
T Consensus 77 ~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~aPE~~~~ 156 (237)
T cd05576 77 SKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAPEVGGI 156 (237)
T ss_pred HHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCccccCCcccCC
Confidence 8877899999999999999999999999999999999999998 56899999998766543 3445778999999876
Q ss_pred CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCH----
Q psy11098 267 PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTA---- 342 (380)
Q Consensus 267 ~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~---- 342 (380)
..++.++|+||+|+++|+|++|..||....... . .......+ ..++.++++||++||+.||.+|+|+
T Consensus 157 -~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-~---~~~~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~~ 227 (237)
T cd05576 157 -SEETEACDWWSLGAILFELLTGKTLVECHPSGI-N---THTTLNIP----EWVSEEARSLLQQLLQFNPTERLGAGVAG 227 (237)
T ss_pred -CCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-c---cccccCCc----ccCCHHHHHHHHHHccCCHHHhcCCCccc
Confidence 466889999999999999999998875432110 0 00111122 3478899999999999999999985
Q ss_pred -HHHHhcccc
Q psy11098 343 -GQLLQVAWF 351 (380)
Q Consensus 343 -~e~L~hpw~ 351 (380)
+++++||||
T Consensus 228 ~~~~~~h~~~ 237 (237)
T cd05576 228 VEDIKSHPFF 237 (237)
T ss_pred hHHHHcCCCC
Confidence 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=319.93 Aligned_cols=244 Identities=21% Similarity=0.331 Sum_probs=198.7
Q ss_pred hhceeeeeeecccCCeEEEEEEEc-----CCCcEEEEEEecCCCCc--hHHHHHHHHHHHhhc-cCCCcceeeecccccC
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDR-----GTGQLVALKQIPRERQP--QQITRAEYNLLSTLM-HAHIPTALALFENAPV 170 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vAvK~~~~~~~~--~~~~~~E~~il~~l~-h~ni~~i~~~~~~~~~ 170 (380)
.++|.+.+.||+|+||.||+|++. .+++.||+|+++..... .+.+.+|+.++..+. |+||+++++++...
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~-- 113 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG-- 113 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC--
Confidence 457889999999999999999964 34568999999754322 345778999999997 99999999887664
Q ss_pred CCceEEEEEecCCCCHHHHHHhcC--------------------------------------------------------
Q psy11098 171 PGTDTIVMQLVHGESLIQHLCRQS-------------------------------------------------------- 194 (380)
Q Consensus 171 ~~~~~lv~e~~~gg~L~~~l~~~~-------------------------------------------------------- 194 (380)
+..++||||+.+|+|.+++....
T Consensus 114 -~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 114 -GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred -CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 57899999999999999986431
Q ss_pred ------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEE
Q psy11098 195 ------------------------------------------TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILM 232 (380)
Q Consensus 195 ------------------------------------------~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~ 232 (380)
.+++..+..++.||+.||.|||+.+|+||||||+|||+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl 272 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI 272 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEE
Confidence 25667788999999999999999999999999999999
Q ss_pred eC-CeeEEEeCCCccccc--------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy11098 233 NG-AVLKLIDLGSSVSVS--------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETR 302 (380)
Q Consensus 233 ~~-~~ikl~DFG~a~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~ 302 (380)
++ +.+||+|||++.... ....+++.|+|||++.+ ..++.++|+|||||++|+|++ |..||......+..
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~ 351 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN-NLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF 351 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC-CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH
Confidence 85 589999999987542 22356788999999987 467889999999999999998 89999776554444
Q ss_pred HHHhcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 303 AHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 303 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
..........+ ....++.++.+|+.+||..||++||+++++++.
T Consensus 352 ~~~~~~~~~~~--~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 352 YNAIKRGYRMA--KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHHcCCCCC--CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 33333332222 223578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=302.55 Aligned_cols=243 Identities=19% Similarity=0.235 Sum_probs=202.8
Q ss_pred hhceeeeeeecccCCeEEEEEEEcC----CCcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCC
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRG----TGQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPG 172 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~----~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~ 172 (380)
.++|++.+.||+|+||.||+|.+.. ++..||+|++..... ....+.+|+.+++.+.|+|++++++++... ..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~ 82 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED--GE 82 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC--CC
Confidence 5689999999999999999999876 357899998864432 345567899999999999999999886543 35
Q ss_pred ceEEEEEecCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCC
Q psy11098 173 TDTIVMQLVHGESLIQHLCRQ--------STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLG 243 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~~--------~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG 243 (380)
..++++||+.+++|.+++... ..+++..+..++.||+.||.|||+++++||||||+|||++ ++.+||+|||
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g 162 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNA 162 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCC
Confidence 679999999999999998653 4589999999999999999999999999999999999997 4689999999
Q ss_pred Cccccc--------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCC
Q psy11098 244 SSVSVS--------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPP 314 (380)
Q Consensus 244 ~a~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~ 314 (380)
+++.+. ....++..|+|||++.+ ..++.++||||||+++|++++ |..||.+.+..+....+.... ...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~- 239 (280)
T cd05043 163 LSRDLFPMDYHCLGDNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY-RLA- 239 (280)
T ss_pred CcccccCCceEEeCCCCCcchhccCHHHHhc-CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC-CCC-
Confidence 997542 22345667999999977 467889999999999999999 999998877776665555432 222
Q ss_pred CcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy11098 315 EQCGHISVPARELIGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 315 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~ 347 (380)
....+++++.+++.+||..||++|||+.++++
T Consensus 240 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 240 -QPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred -CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 22356889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=301.50 Aligned_cols=235 Identities=19% Similarity=0.277 Sum_probs=188.5
Q ss_pred eeecccCCeEEEEEEEcC------------CCcEEEEEEecCCCC-chHHHHHHHHHHHhhccCCCcceeeecccccCCC
Q psy11098 106 ERLGNGRFCTVRKARDRG------------TGQLVALKQIPRERQ-PQQITRAEYNLLSTLMHAHIPTALALFENAPVPG 172 (380)
Q Consensus 106 ~~LG~G~fg~V~~~~~~~------------~~~~vAvK~~~~~~~-~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~ 172 (380)
+.||+|+||.||+|.... ....+|+|.+..... ....+.+|+.+++.++||||+++++++... .
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~---~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRD---V 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---C
Confidence 468999999999998532 233688998764432 334567789999999999999999987654 4
Q ss_pred ceEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-C-------eeEEEeCC
Q psy11098 173 TDTIVMQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-A-------VLKLIDLG 243 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~-------~ikl~DFG 243 (380)
..+++|||+.+++|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++. + .+|++|||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 56999999999999888865 456899999999999999999999999999999999999963 2 38999999
Q ss_pred Cccccc--ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCC
Q psy11098 244 SSVSVS--TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILL-SGVSPFLDESEEETRAHISVADYSFPPEQCGHI 320 (380)
Q Consensus 244 ~a~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll-tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 320 (380)
++.... ....++..|+|||++.....++.++|||||||++|+|+ .|..||......+.... ........ ...
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~-~~~~~~~~----~~~ 232 (262)
T cd05077 158 IPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERF-YEGQCMLV----TPS 232 (262)
T ss_pred CCccccCcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHH-HhcCccCC----CCC
Confidence 987653 34567889999999875467888999999999999998 58999877655443322 22222221 224
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 321 SVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 321 s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
++++.+||.+||+.||++||++.++|++
T Consensus 233 ~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 233 CKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred hHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 6789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=306.25 Aligned_cols=244 Identities=21% Similarity=0.313 Sum_probs=196.2
Q ss_pred hhceeeeeeecccCCeEEEEEEEcC----------------CCcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcc
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRG----------------TGQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPT 160 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~----------------~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~ 160 (380)
.++|++.+.||+|+||.||++.+.. ++..+|+|.+..... ....+.+|+++++.++|+|+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 4679999999999999999986442 345799999975432 2356788999999999999999
Q ss_pred eeeecccccCCCceEEEEEecCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCc
Q psy11098 161 ALALFENAPVPGTDTIVMQLVHGESLIQHLCRQS-----------TITESYICCIIRQLHSALHCLHSQQIAHKDIRPEN 229 (380)
Q Consensus 161 i~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-----------~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~N 229 (380)
+++++... +..+++|||+.+++|.+++.... .+++..+..++.||+.||.|||+.|++||||||+|
T Consensus 84 ~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITS---DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN 160 (296)
T ss_pred EEEEEecC---CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence 99988664 56799999999999999986532 36778899999999999999999999999999999
Q ss_pred EEEe-CCeeEEEeCCCccccc--------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh--CCCCCCCCCH
Q psy11098 230 ILMN-GAVLKLIDLGSSVSVS--------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS--GVSPFLDESE 298 (380)
Q Consensus 230 Il~~-~~~ikl~DFG~a~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt--g~~Pf~~~~~ 298 (380)
||++ ++.++|+|||++.... ....+++.|+|||+..+ ..++.++|+|||||++|+|++ |..||...+.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL-GKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc-CCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 9997 5689999999987542 12233578999998776 467889999999999999998 7899987766
Q ss_pred HHHHHHHhc-----ccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy11098 299 EETRAHISV-----ADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 299 ~~~~~~i~~-----~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~ 347 (380)
.+....... ..... .+....++..+.+|+.+||+.||++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 240 EQVIENTGEFFRDQGRQVY-LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHHHHhhcccccc-CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 555443311 01111 1112346789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=323.96 Aligned_cols=253 Identities=25% Similarity=0.394 Sum_probs=216.4
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC----CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
.-|..++.||-|+||+|.+++...|...||+|.+++.. ......++|..||..-...=+++++-.|.. .+++|
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQD---kdnLY 705 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQD---KDNLY 705 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEecc---CCceE
Confidence 45788999999999999999999999999999996532 233455779999998888777766666655 58999
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccc------
Q psy11098 176 IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSV------ 248 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~------ 248 (380)
+||+|+.||++..+|.+-+.|.|..++.++.++..|+++.|++|+|||||||+||||| +|.|||+||||..-+
T Consensus 706 FVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred EEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccc
Confidence 9999999999999999999999999999999999999999999999999999999999 789999999986422
Q ss_pred ------------------------------------------cccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHH
Q psy11098 249 ------------------------------------------STVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYIL 286 (380)
Q Consensus 249 ------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~l 286 (380)
....+||+.|+|||++.. ..++..+|+||.|||||||
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r-~g~~q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR-TGYTQLCDWWSVGVILYEM 864 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc-cCccccchhhHhhHHHHHH
Confidence 023578999999999988 4778899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCC---CHHHHHhcccccccCCC
Q psy11098 287 LSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRP---TAGQLLQVAWFAEASCS 357 (380)
Q Consensus 287 ltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp---t~~e~L~hpw~~~~~~~ 357 (380)
+.|.+||.+++..++..++.+=.-.+....+.++|.++.+||.++.. +++.|+ .++|+-.||||+....+
T Consensus 865 ~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgIDfs 937 (1034)
T KOG0608|consen 865 LVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGIDFS 937 (1034)
T ss_pred hhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccccchH
Confidence 99999999999888887776655555566778899999999998664 577887 47889999999876433
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=296.20 Aligned_cols=235 Identities=24% Similarity=0.355 Sum_probs=197.2
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEEEecCC
Q psy11098 106 ERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHG 183 (380)
Q Consensus 106 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e~~~g 183 (380)
+.||.|+||.||+|.+.. ++.||+|.+..... ....+.+|+++++.+.|+||+.+++++... +..++||||+.|
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~v~e~~~~ 76 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQK---QPIYIVMELVPG 76 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecC---CCeEEEEEcCCC
Confidence 469999999999999887 89999999875443 345678899999999999999988887664 567999999999
Q ss_pred CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc--------cccc
Q psy11098 184 ESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS--------TVVL 253 (380)
Q Consensus 184 g~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~--------~~~~ 253 (380)
++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+|||++ ++.+||+|||++.... ....
T Consensus 77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 999999965 45689999999999999999999999999999999999998 5689999999987543 1122
Q ss_pred CCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhc
Q psy11098 254 PDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLL 332 (380)
Q Consensus 254 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 332 (380)
++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||.+.........+.... ..+ .....+.++.+++.+||
T Consensus 157 ~~~~y~~PE~~~~-~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~li~~~l 232 (251)
T cd05041 157 IPIKWTAPEALNY-GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY-RMP--APQLCPEEIYRLMLQCW 232 (251)
T ss_pred ceeccCChHhhcc-CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC-CCC--CCccCCHHHHHHHHHHh
Confidence 3557999999877 467889999999999999999 899998887766666654432 221 22457889999999999
Q ss_pred ccCCCCCCCHHHHHhc
Q psy11098 333 NTHADKRPTAGQLLQV 348 (380)
Q Consensus 333 ~~dP~~Rpt~~e~L~h 348 (380)
..+|.+|||+.|+|+.
T Consensus 233 ~~~p~~Rp~~~ell~~ 248 (251)
T cd05041 233 AYDPENRPSFSEIYNE 248 (251)
T ss_pred ccChhhCcCHHHHHHH
Confidence 9999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=299.97 Aligned_cols=241 Identities=20% Similarity=0.312 Sum_probs=202.7
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCc----EEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCC
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQ----LVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPG 172 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~----~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~ 172 (380)
..+|++.+.||+|+||+||+|.++.+|+ .+|+|.+..... ....+.+|+.+++.+.|+|++++++++.. .
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~ 81 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS----S 81 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec----C
Confidence 4678999999999999999999877665 589998865543 23566789999999999999999998765 5
Q ss_pred ceEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccccc
Q psy11098 173 TDTIVMQLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVST 250 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~~ 250 (380)
..+++|||+.+|+|.+++... ..+++..+..++.||+.||.|||+.|++||||||+|||++ ++.+||+|||+++....
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 679999999999999999764 5689999999999999999999999999999999999997 56899999999876531
Q ss_pred --------cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCC
Q psy11098 251 --------VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHIS 321 (380)
Q Consensus 251 --------~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 321 (380)
...++..|+|||.+.. ..++.++|+||||+++|++++ |..||.+...++....+...... +. ....+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-~~--~~~~~ 237 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERL-PQ--PPICT 237 (279)
T ss_pred cccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCC-CC--CCCCC
Confidence 1122567999999876 477889999999999999998 99999988887777766654322 21 12467
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHh
Q psy11098 322 VPARELIGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 322 ~~~~~li~~~L~~dP~~Rpt~~e~L~ 347 (380)
.++.+++.+||..||.+|||+.++++
T Consensus 238 ~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 238 IDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 88999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=303.61 Aligned_cols=244 Identities=21% Similarity=0.267 Sum_probs=194.3
Q ss_pred hceeeeeeecccCCeEEEEEEE----cCCCcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCCc
Q psy11098 100 HRYEELERLGNGRFCTVRKARD----RGTGQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGT 173 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~----~~~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~ 173 (380)
..|++++.||+|+||.||+|.. +.+++.||+|.++.... ....+.+|+.+++.+.|+|++++.+++... ....
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~ 82 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED-GGNG 82 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC-CCCc
Confidence 3578899999999999999984 45788999999864432 235678899999999999999999887653 2246
Q ss_pred eEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc--
Q psy11098 174 DTIVMQLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS-- 249 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~-- 249 (380)
.++||||+.|++|.+++... ..+++..+..++.||+.||.|||++|++||||||+|||++ ++.++|+|||++....
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 162 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence 79999999999999999664 4589999999999999999999999999999999999997 4689999999987543
Q ss_pred -------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCH---------------HHHHHHHhc
Q psy11098 250 -------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESE---------------EETRAHISV 307 (380)
Q Consensus 250 -------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~---------------~~~~~~i~~ 307 (380)
....++..|+|||++.+ ..++.++||||||+++|+|+++..|+..... ......+..
T Consensus 163 ~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05079 163 KEYYTVKDDLDSPVFWYAPECLIQ-SKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE 241 (284)
T ss_pred ccceeecCCCCCCccccCHHHhcc-CCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc
Confidence 13345677999999877 4678899999999999999998766532110 111111111
Q ss_pred ccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 308 ADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 308 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
.. .. +....++.++.+|+.+||+.||++|||+++++++
T Consensus 242 ~~-~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 242 GK-RL--PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred Cc-cC--CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 11 11 1234578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=298.11 Aligned_cols=239 Identities=20% Similarity=0.276 Sum_probs=188.6
Q ss_pred eeecccCCeEEEEEEEcC--CCcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEEEec
Q psy11098 106 ERLGNGRFCTVRKARDRG--TGQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLV 181 (380)
Q Consensus 106 ~~LG~G~fg~V~~~~~~~--~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e~~ 181 (380)
+.||+|+||+||+|.... ....+|+|.+..... ....+.+|+.+++.++|+||+++++.+... +..++||||+
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~---~~~~lv~e~~ 77 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIES---IPYLLVLEFC 77 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCC---CceEEEEEeC
Confidence 359999999999996543 345788888764432 234567799999999999999999887653 6789999999
Q ss_pred CCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------
Q psy11098 182 HGESLIQHLCRQS-----TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------ 249 (380)
Q Consensus 182 ~gg~L~~~l~~~~-----~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------ 249 (380)
.+|+|.+++.... ..++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 9999999996642 246788899999999999999999999999999999998 4689999999986431
Q ss_pred --ccccCCCcccCCccccC------CCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcc-cCCCCCC-cCC
Q psy11098 250 --TVVLPDLEFASPEMLTS------PATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVA-DYSFPPE-QCG 318 (380)
Q Consensus 250 --~~~~gt~~y~aPE~~~~------~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~-~~~ 318 (380)
....+++.|+|||++.. ...++.++|||||||++|+|++ |..||......+....+... ....+.. ...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDL 237 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccc
Confidence 22344678999998753 2355779999999999999999 88999887766655554333 2233322 234
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 319 HISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 319 ~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
.++....+++..|+ .||++|||++++++-
T Consensus 238 ~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~ 266 (269)
T cd05042 238 KYSDRWYEVMQFCW-LDPETRPTAEEVHEL 266 (269)
T ss_pred cCCHHHHHHHHHHh-cCcccccCHHHHHHH
Confidence 57888999999998 599999999999863
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=304.34 Aligned_cols=244 Identities=16% Similarity=0.163 Sum_probs=185.8
Q ss_pred hhhhceeeeeeecccCCeEEEEEEEcCC---CcEEEEEEecCCCCch--H----------HHHHHHHHHHhhccCCCcce
Q psy11098 97 QFEHRYEELERLGNGRFCTVRKARDRGT---GQLVALKQIPRERQPQ--Q----------ITRAEYNLLSTLMHAHIPTA 161 (380)
Q Consensus 97 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~---~~~vAvK~~~~~~~~~--~----------~~~~E~~il~~l~h~ni~~i 161 (380)
...++|++.+.||+|+||+||+|.+..+ +..+|+|+........ + ....+...+..+.|+|++++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 3467899999999999999999998887 6778888654332211 1 01112334455679999888
Q ss_pred eeecccccCC-CceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEE
Q psy11098 162 LALFENAPVP-GTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKL 239 (380)
Q Consensus 162 ~~~~~~~~~~-~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl 239 (380)
+++....... ...+++++++ ..++.+.+......++..+..++.|++.||.|||+++|+||||||+|||++ ++.++|
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred EEeeeEecCCceEEEEEEehh-ccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEE
Confidence 8765443211 1236788877 457777776665678999999999999999999999999999999999998 468999
Q ss_pred EeCCCccccc-------------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCH-HHH----
Q psy11098 240 IDLGSSVSVS-------------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESE-EET---- 301 (380)
Q Consensus 240 ~DFG~a~~~~-------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~-~~~---- 301 (380)
+|||+|+... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+. .+.
T Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~ 246 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA 246 (294)
T ss_pred EEcCCceeeccCCcccccccccccccCCCccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence 9999987542 23468999999999987 4779999999999999999999999987633 221
Q ss_pred ----HHHHhcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy11098 302 ----RAHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 302 ----~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~ 347 (380)
..++..... .....+.++.++++.|+..+|++||+++++++
T Consensus 247 ~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 247 KCDFIKRLHEGKI-----KIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHHHHHhhhhhh-----ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 122222222 22346889999999999999999999999975
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=302.42 Aligned_cols=234 Identities=21% Similarity=0.311 Sum_probs=188.5
Q ss_pred eecccCCeEEEEEEEcCC------------------------CcEEEEEEecCCCC-chHHHHHHHHHHHhhccCCCcce
Q psy11098 107 RLGNGRFCTVRKARDRGT------------------------GQLVALKQIPRERQ-PQQITRAEYNLLSTLMHAHIPTA 161 (380)
Q Consensus 107 ~LG~G~fg~V~~~~~~~~------------------------~~~vAvK~~~~~~~-~~~~~~~E~~il~~l~h~ni~~i 161 (380)
.||+|+||.||+|....+ ...||+|++..... ....+.+|+.+++.++|+||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 599999999999985322 23588998864332 23456678899999999999999
Q ss_pred eeecccccCCCceEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC------
Q psy11098 162 LALFENAPVPGTDTIVMQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG------ 234 (380)
Q Consensus 162 ~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~------ 234 (380)
++++... +..++||||+.+++|..++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 82 ~~~~~~~---~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRG---SENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeC---CceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9987654 567999999999999998865 467899999999999999999999999999999999999963
Q ss_pred --CeeEEEeCCCccccc--ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHhccc
Q psy11098 235 --AVLKLIDLGSSVSVS--TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILL-SGVSPFLDESEEETRAHISVAD 309 (380)
Q Consensus 235 --~~ikl~DFG~a~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll-tg~~Pf~~~~~~~~~~~i~~~~ 309 (380)
..+|++|||++.... ....++..|+|||.+.+...++.++|+|||||++|+|+ +|..||......+...... ..
T Consensus 159 ~~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~ 237 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYE-KK 237 (274)
T ss_pred ccceeeecCCccccccccccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHH-hc
Confidence 148999999886542 34457888999999876556788999999999999985 6999998776555433322 22
Q ss_pred CCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 310 YSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 310 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
...+. ..+.++.++|.+||+.+|++|||+.++|++
T Consensus 238 ~~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 238 HRLPE----PSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred cCCCC----CCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 22222 346789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=304.41 Aligned_cols=242 Identities=20% Similarity=0.289 Sum_probs=199.4
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCc----EEEEEEecCCCCc--hHHHHHHHHHHHhhccCCCcceeeecccccCCC
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQ----LVALKQIPRERQP--QQITRAEYNLLSTLMHAHIPTALALFENAPVPG 172 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~----~vAvK~~~~~~~~--~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~ 172 (380)
..+|++.+.||+|+||.||+|.+..+++ .+|+|.+...... ...+.+|+.+++.+.|+|++++++++.. .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~----~ 81 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS----P 81 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC----C
Confidence 4568889999999999999999887776 4688888654332 2356789999999999999999998764 3
Q ss_pred ceEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-
Q psy11098 173 TDTIVMQLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS- 249 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~- 249 (380)
..++++||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccC
Confidence 457999999999999998764 3689999999999999999999999999999999999997 4689999999997543
Q ss_pred -------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCC
Q psy11098 250 -------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHIS 321 (380)
Q Consensus 250 -------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 321 (380)
....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.........+.... .++. ....+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~--~~~~~ 237 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGE-RLPQ--PPICT 237 (303)
T ss_pred cccccccCCCccccccCCHHHhcc-CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC-CCCC--CCCCC
Confidence 12234678999999887 577889999999999999997 999998876665555444332 2222 23467
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 322 VPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 322 ~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
.++.+++.+||..||++||+++++++.
T Consensus 238 ~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 238 IDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=300.39 Aligned_cols=246 Identities=21% Similarity=0.292 Sum_probs=194.6
Q ss_pred hhceeeeeeecccCCeEEEEEEE----cCCCcEEEEEEecCCCC-chHHHHHHHHHHHhhccCCCcceeeecccccCCCc
Q psy11098 99 EHRYEELERLGNGRFCTVRKARD----RGTGQLVALKQIPRERQ-PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGT 173 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~----~~~~~~vAvK~~~~~~~-~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~ 173 (380)
..+|++.+.||+|+||.||+|.. ..+++.||+|.+..... ....+.+|+++++.++|+|++++++++... ....
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~ 81 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSA-GRRN 81 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccC-CCCc
Confidence 35789999999999999999984 45788999999865433 345678899999999999999998876432 2346
Q ss_pred eEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccccc-
Q psy11098 174 DTIVMQLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVST- 250 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~~- 250 (380)
.++||||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.....
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 161 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD 161 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence 79999999999999999764 5689999999999999999999999999999999999997 46899999999886531
Q ss_pred --------cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHH---------------HHHHhc
Q psy11098 251 --------VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEET---------------RAHISV 307 (380)
Q Consensus 251 --------~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~---------------~~~i~~ 307 (380)
...++..|+|||++.+ ..++.++|+|||||++|+|++|..++........ ...+..
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05081 162 KEYYKVREPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK 240 (284)
T ss_pred CcceeecCCCCCceEeeCHHHhcc-CCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh
Confidence 1122345999999977 4678899999999999999998777643322110 001111
Q ss_pred ccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 308 ADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 308 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
....++ ....++.++.+|+.+||..+|++|||+.++++.
T Consensus 241 ~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05081 241 NNGRLP--APPGCPAEIYAIMKECWNNDPSQRPSFSELALQ 279 (284)
T ss_pred cCCcCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 111111 224578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=320.60 Aligned_cols=242 Identities=24% Similarity=0.328 Sum_probs=206.5
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCc---E-EEEEEecCC----CCchHHHHHHHHHHHhhccCCCcceeeecccccCC
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQ---L-VALKQIPRE----RQPQQITRAEYNLLSTLMHAHIPTALALFENAPVP 171 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~---~-vAvK~~~~~----~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~ 171 (380)
++-.+.++||+|+||.||+|..+..+. . ||+|..+.+ ......+.+|.++|+.++|+||++++++....
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~--- 233 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE--- 233 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC---
Confidence 444566899999999999998776432 3 899988742 23445667899999999999999988876654
Q ss_pred CceEEEEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeCC-eeEEEeCCCccccc
Q psy11098 172 GTDTIVMQLVHGESLIQHLCRQS-TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGA-VLKLIDLGSSVSVS 249 (380)
Q Consensus 172 ~~~~lv~e~~~gg~L~~~l~~~~-~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~~-~ikl~DFG~a~~~~ 249 (380)
..+|+|||+|.||+|.++|.+.+ .++..+...++.+.+.||+|||+++++||||-.+|+|++.+ .+||+|||+++...
T Consensus 234 ~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~ 313 (474)
T KOG0194|consen 234 EPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGS 313 (474)
T ss_pred CccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCc
Confidence 56799999999999999999876 49999999999999999999999999999999999999974 67999999987654
Q ss_pred c------cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCH
Q psy11098 250 T------VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISV 322 (380)
Q Consensus 250 ~------~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 322 (380)
. ...-...|+|||.+... .++.++||||+||++||+++ |..||.+....++...|....+..+.+. .-+.
T Consensus 314 ~~~~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~--~~p~ 390 (474)
T KOG0194|consen 314 QYVMKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPS--KTPK 390 (474)
T ss_pred ceeeccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCC--CCHH
Confidence 1 11235789999999984 88999999999999999999 8999999999999999977776665543 5688
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHh
Q psy11098 323 PARELIGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 323 ~~~~li~~~L~~dP~~Rpt~~e~L~ 347 (380)
++..++.+|+..||++|||+.++.+
T Consensus 391 ~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 391 ELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHHHHHhccCChhhccCHHHHHH
Confidence 8999999999999999999999864
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=296.50 Aligned_cols=237 Identities=19% Similarity=0.273 Sum_probs=191.4
Q ss_pred eeecccCCeEEEEEEEcC---CCcEEEEEEecCCC--CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEEEe
Q psy11098 106 ERLGNGRFCTVRKARDRG---TGQLVALKQIPRER--QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQL 180 (380)
Q Consensus 106 ~~LG~G~fg~V~~~~~~~---~~~~vAvK~~~~~~--~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e~ 180 (380)
+.||+|+||.||+|.+.. .+..+|+|.+.... .....+.+|+.+++.++|+|++++++++... .+..+++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS--EGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC--CCCcEEEEec
Confidence 368999999999998653 34579999885432 2345667899999999999999999866432 3457899999
Q ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCccccc---------
Q psy11098 181 VHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVS--------- 249 (380)
Q Consensus 181 ~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~--------- 249 (380)
+.+++|.+++... ..+++..+..++.||+.||.|||+.+++||||||+|||+++ +.+||+|||++....
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence 9999999999764 45678888999999999999999999999999999999984 589999999987542
Q ss_pred -ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHH
Q psy11098 250 -TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAREL 327 (380)
Q Consensus 250 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 327 (380)
....++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+....+....... ....+++.+.++
T Consensus 159 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l 234 (262)
T cd05058 159 HTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLL---QPEYCPDPLYEV 234 (262)
T ss_pred cccCcCCccccChhHhcc-CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCC---CCCcCCHHHHHH
Confidence 12344678999999877 467889999999999999999 677887777666665554432211 123468899999
Q ss_pred HHHhcccCCCCCCCHHHHHhc
Q psy11098 328 IGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 328 i~~~L~~dP~~Rpt~~e~L~h 348 (380)
+.+||..+|++||++.++++.
T Consensus 235 i~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 235 MLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HHHHcCCChhhCCCHHHHHHH
Confidence 999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=326.28 Aligned_cols=269 Identities=24% Similarity=0.379 Sum_probs=227.4
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhh-ccCCCcceeeeccccc--CCCce
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTL-MHAHIPTALALFENAP--VPGTD 174 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~--~~~~~ 174 (380)
-.+.|++.+.||+|.+|.||+++++.+++..|+|+........+.++.|++||+.+ .|||++..+++|.... ..+.+
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqL 96 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQL 96 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeE
Confidence 35678999999999999999999999999999999988888888889999999998 5899999988875442 34678
Q ss_pred EEEEEecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc--
Q psy11098 175 TIVMQLVHGESLIQHLCR--QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS-- 249 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~--~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~-- 249 (380)
+||||||.||+.-|+++. ...+.|..+..|++.++.|+.+||...++|||||-.|||++ ++.|||+|||.+..++
T Consensus 97 WLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT 176 (953)
T KOG0587|consen 97 WLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDST 176 (953)
T ss_pred EEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeecc
Confidence 999999999999999975 56799999999999999999999999999999999999998 5799999999998775
Q ss_pred ----ccccCCCcccCCccccCC----CCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCC
Q psy11098 250 ----TVVLPDLEFASPEMLTSP----ATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHIS 321 (380)
Q Consensus 250 ----~~~~gt~~y~aPE~~~~~----~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 321 (380)
++..|||.|||||++.-. ..|+..+|+||||++..||.-|.+|+.+.-....+..|-... ......+..++
T Consensus 177 ~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNP-PPkLkrp~kWs 255 (953)
T KOG0587|consen 177 VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP-PPKLKRPKKWS 255 (953)
T ss_pred cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCC-CccccchhhHH
Confidence 567899999999998532 345678999999999999999999999988776666554321 11122356789
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhcccccccCCCCCccccccchHHHH
Q psy11098 322 VPARELIGQLLNTHADKRPTAGQLLQVAWFAEASCSEFDTERLLPFSARR 371 (380)
Q Consensus 322 ~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~~~~~~~~~~~~~~~~ 371 (380)
.++.+||+.||.+|.++||+..++|+|||+++.. ..+.|..+++.+
T Consensus 256 ~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~~----~e~qir~~ik~~ 301 (953)
T KOG0587|consen 256 KKFNDFISTCLVKDYEQRPSTEELLKHPFITEQP----NERQVRIQIKDH 301 (953)
T ss_pred HHHHHHHHHHHhhccccCcchhhhccCCcccccc----cHHHHHHHHHHH
Confidence 9999999999999999999999999999998432 344444444443
|
|
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=311.85 Aligned_cols=254 Identities=26% Similarity=0.376 Sum_probs=215.3
Q ss_pred hhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCch--------HHHHHHHHHHHhhccCCCcceeeecccc
Q psy11098 97 QFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQ--------QITRAEYNLLSTLMHAHIPTALALFENA 168 (380)
Q Consensus 97 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~--------~~~~~E~~il~~l~h~ni~~i~~~~~~~ 168 (380)
.+.++|-++..||+|||+.||+|.+....+.||||+-....... ...-+|.+|-+.|.||.|++++++|..+
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 46689999999999999999999999999999999875443322 2234699999999999999999999876
Q ss_pred cCCCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--CcEeecCCCCcEEEeC----CeeEEEeC
Q psy11098 169 PVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQ--QIAHKDIRPENILMNG----AVLKLIDL 242 (380)
Q Consensus 169 ~~~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~--~iiHrDlKp~NIl~~~----~~ikl~DF 242 (380)
.+.++-|+|||+|-+|.-+++....++|.+++.|+.||+.||.||... -|||-||||.|||+-+ |.|||+||
T Consensus 540 --tdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 540 --TDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred --cccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeec
Confidence 457899999999999999999999999999999999999999999976 5999999999999964 47999999
Q ss_pred CCccccc-------------ccccCCCcccCCccccC---CCCCCCcccHHHHHHHHHHHHhCCCCCCCCC-HHHHHHH-
Q psy11098 243 GSSVSVS-------------TVVLPDLEFASPEMLTS---PATAGPSTDMWSLGVLLYILLSGVSPFLDES-EEETRAH- 304 (380)
Q Consensus 243 G~a~~~~-------------~~~~gt~~y~aPE~~~~---~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~-~~~~~~~- 304 (380)
|+++... ....||.+|++||.+.- +...+.++||||+|||+|.++.|+.||..+- ..+++..
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeN 697 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQEN 697 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhh
Confidence 9997653 35678999999998742 3456889999999999999999999996653 3344332
Q ss_pred --HhcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 305 --ISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 305 --i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
+......||.. +.++.++++||++||...-+.|..+.++..||+|-..
T Consensus 698 TIlkAtEVqFP~K--PvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh 747 (775)
T KOG1151|consen 698 TILKATEVQFPPK--PVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH 747 (775)
T ss_pred chhcceeccCCCC--CccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence 23345567655 4589999999999999999999999999999999753
|
|
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=330.74 Aligned_cols=240 Identities=24% Similarity=0.365 Sum_probs=209.5
Q ss_pred hceeeeeeecccCCeEEEEEEEcC-----CCcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCC
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRG-----TGQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPG 172 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~ 172 (380)
.+-+..+.||+|+||+||+|+... ....||||.++.... ....|++|++++..|+|+||+++++++... +
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~---~ 562 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG---D 562 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC---C
Confidence 445667899999999999998543 346899999975544 467899999999999999999999999875 6
Q ss_pred ceEEEEEecCCCCHHHHHHhc----------CC----CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeCC-ee
Q psy11098 173 TDTIVMQLVHGESLIQHLCRQ----------ST----ITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGA-VL 237 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~~----------~~----l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~~-~i 237 (380)
..+||+|||..|+|.++|... .. ++..+...|+.||+.||.||-++.+|||||..+|.||+++ .|
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVV 642 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEE
Confidence 789999999999999999632 12 8889999999999999999999999999999999999977 89
Q ss_pred EEEeCCCccccc--------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcc
Q psy11098 238 KLIDLGSSVSVS--------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVA 308 (380)
Q Consensus 238 kl~DFG~a~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~ 308 (380)
||+|||+++.+- ...+-..+|||||.+.. ..++.+|||||+||+|||+++ |+-||.+.+++++.+.|..+
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly-~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g 721 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY-GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAG 721 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhc-CcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcC
Confidence 999999998652 23334678999999988 578889999999999999999 99999999999999999998
Q ss_pred cCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q psy11098 309 DYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLL 346 (380)
Q Consensus 309 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L 346 (380)
.. ++. .++.+.++.+||..||+.+|.+|||++||-
T Consensus 722 ~l-L~~--Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 722 QL-LSC--PENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred Cc-ccC--CCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 87 332 246799999999999999999999999984
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=298.71 Aligned_cols=234 Identities=22% Similarity=0.330 Sum_probs=194.2
Q ss_pred eecccCCeEEEEEEEcCCC------cEEEEEEecCCC--CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEE
Q psy11098 107 RLGNGRFCTVRKARDRGTG------QLVALKQIPRER--QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVM 178 (380)
Q Consensus 107 ~LG~G~fg~V~~~~~~~~~------~~vAvK~~~~~~--~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~ 178 (380)
.||+|+||.||+|+++... +.+|+|.+.... .....+.+|+++++.++|+||+++++++... +..+++|
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~~v~ 78 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLN---EPQYIIM 78 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCC---CCeEEEE
Confidence 5899999999999986544 689999886543 3345677899999999999999999887653 5679999
Q ss_pred EecCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-C-----eeEEEeCCCc
Q psy11098 179 QLVHGESLIQHLCRQ-------STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-A-----VLKLIDLGSS 245 (380)
Q Consensus 179 e~~~gg~L~~~l~~~-------~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~-----~ikl~DFG~a 245 (380)
||+.+++|.+++... ..+++..+..++.||+.||.|||+.+++|+||||+|||++. + .++|+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999999642 34788999999999999999999999999999999999974 3 6999999998
Q ss_pred cccc--------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCc
Q psy11098 246 VSVS--------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQ 316 (380)
Q Consensus 246 ~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 316 (380)
.... ....++..|+|||++.+ ...+.++|||||||++|+|++ |..||...+..+....+..... + ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~-~--~~ 234 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGR-L--QK 234 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHcc-CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCc-c--CC
Confidence 6542 12344678999999987 467889999999999999998 9999988777776666543321 1 12
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy11098 317 CGHISVPARELIGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 317 ~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~ 347 (380)
...++.++.+||.+||..+|.+||+++++++
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred cccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 2457899999999999999999999999975
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=297.18 Aligned_cols=243 Identities=18% Similarity=0.263 Sum_probs=197.5
Q ss_pred eeeeeeecccCCeEEEEEEEc---CCCcEEEEEEecCCCC---chHHHHHHHHHHHhhccCCCcceeeecccccCCC---
Q psy11098 102 YEELERLGNGRFCTVRKARDR---GTGQLVALKQIPRERQ---PQQITRAEYNLLSTLMHAHIPTALALFENAPVPG--- 172 (380)
Q Consensus 102 y~~~~~LG~G~fg~V~~~~~~---~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~--- 172 (380)
|.+.+.||+|+||.||+|..+ .+++.||+|++..+.. ..+.+.+|+++++.+.|+|++++++++......+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999865 3578999999975432 2345678999999999999999999876543322
Q ss_pred ceEEEEEecCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCc
Q psy11098 173 TDTIVMQLVHGESLIQHLCRQ------STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSS 245 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~~------~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a 245 (380)
..+++++|+.+|+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||+++ ++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 237889999999998887432 2478899999999999999999999999999999999998 458999999998
Q ss_pred cccc--------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCc
Q psy11098 246 VSVS--------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQ 316 (380)
Q Consensus 246 ~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 316 (380)
.... ....+++.|++||.+.+ ..++.++|||||||++|+|++ |..||.+....+....+....... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~ 236 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLAD-NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLK---Q 236 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhc-CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCC---C
Confidence 7653 22234578999999887 467889999999999999999 999998887776666665433211 1
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 317 CGHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 317 ~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
....+.++.+++.+||..+|++|||+.+++++
T Consensus 237 ~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 237 PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 13467899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=294.88 Aligned_cols=238 Identities=20% Similarity=0.258 Sum_probs=187.8
Q ss_pred eeecccCCeEEEEEEEc--CCCcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEEEec
Q psy11098 106 ERLGNGRFCTVRKARDR--GTGQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLV 181 (380)
Q Consensus 106 ~~LG~G~fg~V~~~~~~--~~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e~~ 181 (380)
+.||+|+||.||+|... .++..+|+|.++.... ....+.+|+.+++.++|+|++++++.+... ...++||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~lv~e~~ 77 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEV---TPYLLVMEFC 77 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC---CCcEEEEECC
Confidence 35899999999999854 3567899999865433 234567799999999999999999887654 5679999999
Q ss_pred CCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCccccc------
Q psy11098 182 HGESLIQHLCRQ-----STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVS------ 249 (380)
Q Consensus 182 ~gg~L~~~l~~~-----~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~------ 249 (380)
.+++|.+++... ...++..+..++.|++.||.|||+.|++||||||+||+++. +.+||+|||++....
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 999999998643 24567788899999999999999999999999999999984 589999999986432
Q ss_pred --ccccCCCcccCCccccCCC------CCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH-HhcccCCCCCCc-CC
Q psy11098 250 --TVVLPDLEFASPEMLTSPA------TAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAH-ISVADYSFPPEQ-CG 318 (380)
Q Consensus 250 --~~~~gt~~y~aPE~~~~~~------~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~-i~~~~~~~~~~~-~~ 318 (380)
....++..|+|||++.+.. .++.++|+||||+++|+|++ |..||......+.... +.......+... ..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKL 237 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCC
Confidence 2345678899999986421 34779999999999999996 9999977665554333 222223333222 22
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy11098 319 HISVPARELIGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 319 ~~s~~~~~li~~~L~~dP~~Rpt~~e~L~ 347 (380)
..++.+.++++.|+ .+|++|||+++++.
T Consensus 238 ~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 238 PLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 46788999999998 68999999999984
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=326.47 Aligned_cols=251 Identities=20% Similarity=0.248 Sum_probs=176.1
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCC----CcEEEEEEecCCCCchHHHHHHHHHHHhhc---cCCCcceeeeccc---c
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGT----GQLVALKQIPRERQPQQITRAEYNLLSTLM---HAHIPTALALFEN---A 168 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~----~~~vAvK~~~~~~~~~~~~~~E~~il~~l~---h~ni~~i~~~~~~---~ 168 (380)
.++|++.+.||+|+||.||+|++..+ +..||+|.+...... |+.+...+. +.++..++..+.. .
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~------e~~~~e~l~~~~~~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV------EIWMNERVRRACPNSCADFVYGFLEPVSS 204 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh------HHHHHHHHHhhchhhHHHHHHhhhccccc
Confidence 56899999999999999999999988 899999988543221 222222222 2222222222111 1
Q ss_pred cCCCceEEEEEecCCCCHHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCC
Q psy11098 169 PVPGTDTIVMQLVHGESLIQHLCRQST--------------------ITESYICCIIRQLHSALHCLHSQQIAHKDIRPE 228 (380)
Q Consensus 169 ~~~~~~~lv~e~~~gg~L~~~l~~~~~--------------------l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~ 228 (380)
......++|+||+.+++|.+++..... ..+..+..++.||+.||.|||++||+||||||+
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~ 284 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQ 284 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHH
Confidence 234568999999999999998865321 123456789999999999999999999999999
Q ss_pred cEEEeC--CeeEEEeCCCccccc-------ccccCCCcccCCccccCCC---------------------CCCCcccHHH
Q psy11098 229 NILMNG--AVLKLIDLGSSVSVS-------TVVLPDLEFASPEMLTSPA---------------------TAGPSTDMWS 278 (380)
Q Consensus 229 NIl~~~--~~ikl~DFG~a~~~~-------~~~~gt~~y~aPE~~~~~~---------------------~~~~~~DiwS 278 (380)
|||+++ +.+||+|||+|..+. ....+|+.|+|||++.... .++.++||||
T Consensus 285 NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS 364 (566)
T PLN03225 285 NIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 364 (566)
T ss_pred HEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence 999984 589999999997542 4567899999999764211 1234669999
Q ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCC-----------CC------CcCCCCCHHHHHHHHHhcccCCCCCCC
Q psy11098 279 LGVLLYILLSGVSPFLDESEEETRAHISVADYSF-----------PP------EQCGHISVPARELIGQLLNTHADKRPT 341 (380)
Q Consensus 279 lGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~-----------~~------~~~~~~s~~~~~li~~~L~~dP~~Rpt 341 (380)
|||++|+|+++..++... .......+....... .. +..+.......+||++||++||++|||
T Consensus 365 lGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~t 443 (566)
T PLN03225 365 AGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRIS 443 (566)
T ss_pred HHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCC
Confidence 999999999976665322 112222222211110 00 001112344669999999999999999
Q ss_pred HHHHHhcccccccCC
Q psy11098 342 AGQLLQVAWFAEASC 356 (380)
Q Consensus 342 ~~e~L~hpw~~~~~~ 356 (380)
++|+|+||||.....
T Consensus 444 a~e~L~Hpff~~~~~ 458 (566)
T PLN03225 444 AKAALAHPYFDREGL 458 (566)
T ss_pred HHHHhCCcCcCCCCc
Confidence 999999999987644
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=297.58 Aligned_cols=245 Identities=22% Similarity=0.315 Sum_probs=197.4
Q ss_pred hhceeeeeeecccCCeEEEEEEEc----CCCcEEEEEEecCCCCc--hHHHHHHHHHHHhhccCCCcceeeecccccCCC
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDR----GTGQLVALKQIPRERQP--QQITRAEYNLLSTLMHAHIPTALALFENAPVPG 172 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~----~~~~~vAvK~~~~~~~~--~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~ 172 (380)
..+|++.+.||+|+||.||+|... .+++.+|+|.+...... ...+.+|+++++.+.|+|++++++++... ...
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~-~~~ 81 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKP-GGR 81 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecC-CCC
Confidence 356788899999999999999864 35789999999765553 56788899999999999999998877552 234
Q ss_pred ceEEEEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccccc
Q psy11098 173 TDTIVMQLVHGESLIQHLCRQS-TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVST 250 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~~~-~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~~ 250 (380)
..+++|||+.+++|.+++.... .+++..+..++.||+.||.|||++|++|+||||+|||++ ++.++|+|||++.....
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 6799999999999999997654 689999999999999999999999999999999999998 46899999999876541
Q ss_pred ---------cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHH--------------HHHHHhc
Q psy11098 251 ---------VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEE--------------TRAHISV 307 (380)
Q Consensus 251 ---------~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~--------------~~~~i~~ 307 (380)
...++..|+|||.+.+ ..++.++|+||||+++|+|++|..||....... .......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRT-SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHcc-CCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence 1233556999999877 467889999999999999999999986543221 1111111
Q ss_pred ccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy11098 308 ADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 308 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~ 347 (380)
.....+ .....+.++.+++.+||..||++|||+.|+++
T Consensus 241 ~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 241 EGERLP--RPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred cCCcCC--CCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 222222 12346789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=307.89 Aligned_cols=249 Identities=22% Similarity=0.288 Sum_probs=196.0
Q ss_pred hhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCc-hHHHHHHHHHHHhhccCCCcceeeecccccCCCce
Q psy11098 96 EQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP-QQITRAEYNLLSTLMHAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 96 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~ 174 (380)
..-.+.|.-...||+|+||.||+|.-.. +..||||.+...... ...+.+|+.++..++|+|++++++++..... ..
T Consensus 71 ~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~--~~ 147 (361)
T KOG1187|consen 71 RKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGE--HR 147 (361)
T ss_pred HHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCc--eE
Confidence 3445677777899999999999999765 489999988765544 4559999999999999999999999987532 46
Q ss_pred EEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cEeecCCCCcEEEeC-CeeEEEeCCCcccc
Q psy11098 175 TIVMQLVHGESLIQHLCRQS--TITESYICCIIRQLHSALHCLHSQQ---IAHKDIRPENILMNG-AVLKLIDLGSSVSV 248 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~~--~l~e~~~~~i~~qil~al~~lH~~~---iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~ 248 (380)
+||+||+.+|+|.+++.... .+++....+|+.+++.||+|||... |+|||||++|||+|. -+.||+|||+|+..
T Consensus 148 ~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~ 227 (361)
T KOG1187|consen 148 LLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLG 227 (361)
T ss_pred EEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccC
Confidence 99999999999999997654 8999999999999999999999854 999999999999995 49999999999655
Q ss_pred cc-c-----c-cCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC---HHHHH----HHHhcccC-CCC
Q psy11098 249 ST-V-----V-LPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDES---EEETR----AHISVADY-SFP 313 (380)
Q Consensus 249 ~~-~-----~-~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~---~~~~~----~~i~~~~~-~~~ 313 (380)
.. . . .||.+|+|||.+.. ...+.++|||||||++.||+||+.+..... ..... ..+..... ...
T Consensus 228 ~~~~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eii 306 (361)
T KOG1187|consen 228 PEGDTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIV 306 (361)
T ss_pred CccccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhhee
Confidence 32 1 1 78999999999987 577889999999999999999998886432 11111 12222111 111
Q ss_pred CCc-C-CCCC--HH---HHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 314 PEQ-C-GHIS--VP---ARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 314 ~~~-~-~~~s--~~---~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
+.. . ...+ .+ +..+..+|+..+|++||++.|+++.
T Consensus 307 D~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~ 348 (361)
T KOG1187|consen 307 DPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKE 348 (361)
T ss_pred CCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHH
Confidence 111 1 2233 23 4567788999999999999997543
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=293.62 Aligned_cols=242 Identities=28% Similarity=0.436 Sum_probs=199.5
Q ss_pred ceeeeeeecccCCeEEEEEEEcC-CCcEEEEEEecCCCC-----------chHHHHHHHHHHHh-hccCCCcceeeeccc
Q psy11098 101 RYEELERLGNGRFCTVRKARDRG-TGQLVALKQIPRERQ-----------PQQITRAEYNLLST-LMHAHIPTALALFEN 167 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~-~~~~vAvK~~~~~~~-----------~~~~~~~E~~il~~-l~h~ni~~i~~~~~~ 167 (380)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+..... ....+.+|+.++.. +.|+|++++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 37788999999999999999988 788999998853211 11234567777764 789999999998876
Q ss_pred ccCCCceEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeecCCCCcEEEe-CCeeEEEe
Q psy11098 168 APVPGTDTIVMQLVHGESLIQHLCR----QSTITESYICCIIRQLHSALHCLHS-QQIAHKDIRPENILMN-GAVLKLID 241 (380)
Q Consensus 168 ~~~~~~~~lv~e~~~gg~L~~~l~~----~~~l~e~~~~~i~~qil~al~~lH~-~~iiHrDlKp~NIl~~-~~~ikl~D 241 (380)
. +..+++|||+.|++|.+++.. ...+++..++.++.|++.||.|||+ .|++|+||||+|||++ ++.+||+|
T Consensus 81 ~---~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 N---DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred C---CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEec
Confidence 4 678999999999999988743 3568999999999999999999996 7899999999999998 46899999
Q ss_pred CCCccccc-----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCc
Q psy11098 242 LGSSVSVS-----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQ 316 (380)
Q Consensus 242 FG~a~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 316 (380)
||++.... ....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+....+....
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-- 234 (269)
T cd08528 158 FGLAKQKQPESKLTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLP-- 234 (269)
T ss_pred ccceeecccccccccccCcccCcChhhhcC-CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCC--
Confidence 99987654 23567889999999987 46788999999999999999999999887776666666554433221
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 317 CGHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 317 ~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
...++.++.++|.+||+.||++|||+.|+..+
T Consensus 235 ~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 235 EGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred cccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 23578999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=292.42 Aligned_cols=252 Identities=25% Similarity=0.344 Sum_probs=198.5
Q ss_pred eeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC--chHHHHHHHHHHHhh-ccCCCcceeeecccccCCCceEEEE
Q psy11098 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ--PQQITRAEYNLLSTL-MHAHIPTALALFENAPVPGTDTIVM 178 (380)
Q Consensus 102 y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~~~~~~~lv~ 178 (380)
.+-+..||.|+||+|++..|+.+|+..|||.++.... +..+++.|.+....- ..|||++++ ...-..+..+|.|
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfy---Ga~F~EGdcWiCM 142 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFY---GALFSEGDCWICM 142 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHh---hhhhcCCceeeeH
Confidence 3446789999999999999999999999999976544 334455565544332 455555544 4433347789999
Q ss_pred EecCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeecCCCCcEEEe-CCeeEEEeCCCccccc--
Q psy11098 179 QLVHGESLIQHLC-----RQSTITESYICCIIRQLHSALHCLHS-QQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS-- 249 (380)
Q Consensus 179 e~~~gg~L~~~l~-----~~~~l~e~~~~~i~~qil~al~~lH~-~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~-- 249 (380)
|+| ..||..+.+ ++..++|+-+-.|....+.||.||.. .+|||||+||+|||++ .|.|||||||.+..+.
T Consensus 143 ELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S 221 (361)
T KOG1006|consen 143 ELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS 221 (361)
T ss_pred HHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence 999 566644332 35679999999999999999999985 5999999999999999 6899999999987663
Q ss_pred ---ccccCCCcccCCccccCCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhcccCCCC--CCcCCCCCH
Q psy11098 250 ---TVVLPDLEFASPEMLTSPA-TAGPSTDMWSLGVLLYILLSGVSPFLDES-EEETRAHISVADYSFP--PEQCGHISV 322 (380)
Q Consensus 250 ---~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlGvil~~lltg~~Pf~~~~-~~~~~~~i~~~~~~~~--~~~~~~~s~ 322 (380)
+.-.|..-|||||.+.... .|+.+||+||||++|||+.||..||.+.+ ..+.+.++..++.... +..+-+++.
T Consensus 222 iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~ 301 (361)
T KOG1006|consen 222 IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSF 301 (361)
T ss_pred HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCH
Confidence 4557788899999997644 48899999999999999999999997754 4455555655554322 233456899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhcccccccCCC
Q psy11098 323 PARELIGQLLNTHADKRPTAGQLLQVAWFAEASCS 357 (380)
Q Consensus 323 ~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~~ 357 (380)
.+..||..||.+|-..||...+++++||+.....+
T Consensus 302 ~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~ 336 (361)
T KOG1006|consen 302 SMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAVE 336 (361)
T ss_pred HHHHHHHHHhhcccccCcchhhhhcCchhhhhhhc
Confidence 99999999999999999999999999999876443
|
|
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=283.36 Aligned_cols=250 Identities=24% Similarity=0.390 Sum_probs=203.4
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhc-cCCCcceeeecccccCCCceEEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLM-HAHIPTALALFENAPVPGTDTIV 177 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~-h~ni~~i~~~~~~~~~~~~~~lv 177 (380)
.++|++.+++|+|.++.||.|.+..+++.++||+++.- ....+.+|+.||+.|. |+||++++++..... .....+|
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV--kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~-SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV--KKKKIKREIKILQNLRGGPNIIKLLDIVKDPE-SKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH--HHHHHHHHHHHHHhccCCCCeeehhhhhcCcc-ccCchhH
Confidence 57899999999999999999999999999999998532 3456788999999997 999999999887643 3466899
Q ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC--CeeEEEeCCCccccc-----c
Q psy11098 178 MQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG--AVLKLIDLGSSVSVS-----T 250 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~--~~ikl~DFG~a~~~~-----~ 250 (380)
+|++.+.+...+. .+++..+++.++++++.||.|||++||+|||+||.|+|||. ..++|+|+|+|.... +
T Consensus 114 FE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYn 190 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 190 (338)
T ss_pred hhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCceee
Confidence 9999887665443 56888999999999999999999999999999999999995 489999999997663 5
Q ss_pred cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHh-------------cccCCCCC--
Q psy11098 251 VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLD-ESEEETRAHIS-------------VADYSFPP-- 314 (380)
Q Consensus 251 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~-~~~~~~~~~i~-------------~~~~~~~~-- 314 (380)
..+.+..|.-||.+-....|+.+-|+|||||++..|+..+-||.. .++-+.+-.|. +-...+++
T Consensus 191 VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~ 270 (338)
T KOG0668|consen 191 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQF 270 (338)
T ss_pred eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhH
Confidence 566788899999998878899999999999999999999888843 33222222221 11111111
Q ss_pred -----------------CcC-CCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 315 -----------------EQC-GHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 315 -----------------~~~-~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
... .-+++++.||+.++|..|..+|+||.|++.||||...
T Consensus 271 ~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~ 328 (338)
T KOG0668|consen 271 EDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV 328 (338)
T ss_pred hhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence 111 2357999999999999999999999999999999753
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=290.28 Aligned_cols=237 Identities=19% Similarity=0.228 Sum_probs=187.0
Q ss_pred eecccCCeEEEEEEEcCC--CcEEEEEEecCCC--CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEEEecC
Q psy11098 107 RLGNGRFCTVRKARDRGT--GQLVALKQIPRER--QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVH 182 (380)
Q Consensus 107 ~LG~G~fg~V~~~~~~~~--~~~vAvK~~~~~~--~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e~~~ 182 (380)
.||+|+||+||++..... ...+++|.+.... .....+.+|+.+++.++|+|++++++.+... ...++||||+.
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~---~~~~lv~e~~~ 78 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEA---IPYLLVFEYCE 78 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCC---CccEEEEecCC
Confidence 599999999999975433 3356777765443 2345678899999999999999999988754 56799999999
Q ss_pred CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccc--------c
Q psy11098 183 GESLIQHLCRQ----STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSV--------S 249 (380)
Q Consensus 183 gg~L~~~l~~~----~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~--------~ 249 (380)
+|+|.+++.+. ..+++..+..++.||+.||.|||+.+++||||||+|||++ ++.+||+|||++... .
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 99999999753 3467778889999999999999999999999999999998 468999999997542 1
Q ss_pred ccccCCCcccCCccccCC------CCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcc-cCCCC-CCcCCCC
Q psy11098 250 TVVLPDLEFASPEMLTSP------ATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVA-DYSFP-PEQCGHI 320 (380)
Q Consensus 250 ~~~~gt~~y~aPE~~~~~------~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~-~~~~~-~~~~~~~ 320 (380)
....++..|+|||++... ...+.++|||||||++|+|++ |..||......+....+... ..... +.....+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY 238 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence 345678899999997531 234678999999999999997 67899877776665554333 22222 2223357
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy11098 321 SVPARELIGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 321 s~~~~~li~~~L~~dP~~Rpt~~e~L~ 347 (380)
++.+.+++..|| .+|++|||++++++
T Consensus 239 ~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 239 SERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred cHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 889999999999 68999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=317.82 Aligned_cols=240 Identities=20% Similarity=0.336 Sum_probs=208.9
Q ss_pred eeeeeeecccCCeEEEEEEEcCCCc---EEEEEEecCCC--CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEE
Q psy11098 102 YEELERLGNGRFCTVRKARDRGTGQ---LVALKQIPRER--QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 102 y~~~~~LG~G~fg~V~~~~~~~~~~---~vAvK~~~~~~--~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
-.|.+.||.|.||.||+|+.+..|+ .||||.++..- .....|..|..||-++.||||+++-++.... ..++|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks---~PvMI 707 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS---KPVMI 707 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC---ceeEE
Confidence 4588999999999999999887664 79999998643 3456788899999999999999999988764 66799
Q ss_pred EEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeCC-eeEEEeCCCcccccc----
Q psy11098 177 VMQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGA-VLKLIDLGSSVSVST---- 250 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~~-~ikl~DFG~a~~~~~---- 250 (380)
|.|||++|+|..+|.+ .+.|+..++..|++.|+.|++||-++|+|||||...|||++.+ .+|++|||+++.+..
T Consensus 708 iTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~ 787 (996)
T KOG0196|consen 708 ITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 787 (996)
T ss_pred EhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCCc
Confidence 9999999999999965 4679999999999999999999999999999999999999987 789999999987731
Q ss_pred ---cccC--CCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHH
Q psy11098 251 ---VVLP--DLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPA 324 (380)
Q Consensus 251 ---~~~g--t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 324 (380)
+..| ..+|.|||.+.. ..++.++||||+||++||.++ |+.||.+.++.++...|..+-.-.++. +.+..+
T Consensus 788 ~ytt~GGKIPiRWTAPEAIa~-RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPm---DCP~aL 863 (996)
T KOG0196|consen 788 AYTTLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPM---DCPAAL 863 (996)
T ss_pred cccccCCccceeecChhHhhh-cccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCC---CCcHHH
Confidence 1112 467999999988 577889999999999999888 999999999999999998664443333 568999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 325 RELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 325 ~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
.+|+..||++|-.+||+..|++.+
T Consensus 864 ~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 864 YQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred HHHHHHHHHHHhhcCCCHHHHHHH
Confidence 999999999999999999999854
|
|
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=318.51 Aligned_cols=240 Identities=30% Similarity=0.442 Sum_probs=189.5
Q ss_pred ceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC--CchHHHHHHHHHHHhhccCCCcceeeeccccc---CCCceE
Q psy11098 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER--QPQQITRAEYNLLSTLMHAHIPTALALFENAP---VPGTDT 175 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~---~~~~~~ 175 (380)
-|...+.||+|+||.||+++++.||+.||||.++... ...+..-+|+++|++|+|+|||++.++-+... ....-.
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 3455688999999999999999999999999997643 34556677999999999999998887755432 012347
Q ss_pred EEEEecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe---CC--eeEEEeCCCccc
Q psy11098 176 IVMQLVHGESLIQHLCR---QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN---GA--VLKLIDLGSSVS 247 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~---~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~---~~--~ikl~DFG~a~~ 247 (380)
++||||.||+|...+.+ ...++|.++..+..++..||.|||++||+||||||.||++- +| .-||+|||.|+.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 99999999999999964 46799999999999999999999999999999999999984 23 579999999998
Q ss_pred cc-----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHhccc---------
Q psy11098 248 VS-----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDE----SEEETRAHISVAD--------- 309 (380)
Q Consensus 248 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~----~~~~~~~~i~~~~--------- 309 (380)
++ ..++||+.|.+||.+...++|+..+|.|||||++|++.||..||... +..++...+....
T Consensus 174 l~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~ 253 (732)
T KOG4250|consen 174 LDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQ 253 (732)
T ss_pred CCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeee
Confidence 85 57899999999999985468899999999999999999999999543 2223333332111
Q ss_pred ------C--CCCCCcCCCCCHH----HHHHHHHhcccCCCCCC
Q psy11098 310 ------Y--SFPPEQCGHISVP----ARELIGQLLNTHADKRP 340 (380)
Q Consensus 310 ------~--~~~~~~~~~~s~~----~~~li~~~L~~dP~~Rp 340 (380)
. ...-+....++.. +-..+..+|..||++|.
T Consensus 254 ~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 254 EEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred cccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 0 1111111233333 34567778999999998
|
|
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=328.54 Aligned_cols=241 Identities=22% Similarity=0.359 Sum_probs=205.6
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCc-----EEEEEEecCC--CCchHHHHHHHHHHHhhccCCCcceeeecccccCCC
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQ-----LVALKQIPRE--RQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPG 172 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~-----~vAvK~~~~~--~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~ 172 (380)
..-+....||+|+||.||.|....... .||+|.+.+. ..+...+.+|..+|+.+.||||++++++.-.. +
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~---~ 768 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS---G 768 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC---C
Confidence 455677899999999999998765332 4999999765 34567789999999999999999999998774 5
Q ss_pred ceEEEEEecCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCC
Q psy11098 173 TDTIVMQLVHGESLIQHLCRQ-------STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGS 244 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~~-------~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~ 244 (380)
..+|++|||+||+|..+|.+. ..++..++..++.||++|++||+++++|||||..+|+|++. ..+||+|||+
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccch
Confidence 569999999999999999764 45899999999999999999999999999999999999995 5899999999
Q ss_pred ccccc--------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCC
Q psy11098 245 SVSVS--------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPE 315 (380)
Q Consensus 245 a~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 315 (380)
|+.+- ....-...|||||.+.. ..++.++|||||||+|||++| |..||.+.++.+++.....+. .++.+
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL~~P 926 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RLDPP 926 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-ccCCC
Confidence 98442 11122468999999987 578889999999999999999 999999999999888665554 33322
Q ss_pred cCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy11098 316 QCGHISVPARELIGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 316 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~ 347 (380)
...++.+.++|..||..+|++||+...|++
T Consensus 927 --~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 927 --SYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred --CCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 357899999999999999999999999996
|
|
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=290.37 Aligned_cols=259 Identities=23% Similarity=0.376 Sum_probs=211.8
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC----chHHHHHHHHHHHh-hccCCCcceeeecccccCCCc
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ----PQQITRAEYNLLST-LMHAHIPTALALFENAPVPGT 173 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~E~~il~~-l~h~ni~~i~~~~~~~~~~~~ 173 (380)
.++|.++..||+|+|++|.+++++.|.+.||+|+++++-. +.+-.+.|-.+... -+||.++.+..+|.. ..+
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt---esr 325 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT---ESR 325 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc---cce
Confidence 3678999999999999999999999999999999976422 22223334444333 246666555555554 578
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccc----
Q psy11098 174 DTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSV---- 248 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~---- 248 (380)
+++|.||+.||+|.-.++++..++|+.++.+...|+.||.|||++|||.||||.+|+|+| .|.+||+|+|+.+..
T Consensus 326 lffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~g 405 (593)
T KOG0695|consen 326 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG 405 (593)
T ss_pred EEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCC
Confidence 999999999999999999999999999999999999999999999999999999999999 689999999998643
Q ss_pred --cccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC-------CCCHHHHHH-HHhcccCCCCCCcCC
Q psy11098 249 --STVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFL-------DESEEETRA-HISVADYSFPPEQCG 318 (380)
Q Consensus 249 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~-------~~~~~~~~~-~i~~~~~~~~~~~~~ 318 (380)
..+++|||.|.|||++++ ..|++++|+|+|||+++||+.|++||. +.+.++.+. -|...+...|.
T Consensus 406 d~tstfcgtpnyiapeilrg-eeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiripr---- 480 (593)
T KOG0695|consen 406 DTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR---- 480 (593)
T ss_pred cccccccCCCcccchhhhcc-cccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc----
Confidence 378999999999999999 589999999999999999999999993 234444443 44445555553
Q ss_pred CCCHHHHHHHHHhcccCCCCCC------CHHHHHhcccccccCCCCCcccccc
Q psy11098 319 HISVPARELIGQLLNTHADKRP------TAGQLLQVAWFAEASCSEFDTERLL 365 (380)
Q Consensus 319 ~~s~~~~~li~~~L~~dP~~Rp------t~~e~L~hpw~~~~~~~~~~~~~~~ 365 (380)
.+|-.+...++..|++||.+|. ...++-.|+||....++.+..+.+.
T Consensus 481 slsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~ 533 (593)
T KOG0695|consen 481 SLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVL 533 (593)
T ss_pred eeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccC
Confidence 4677888999999999999996 4689999999998777655555543
|
|
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=306.78 Aligned_cols=257 Identities=28% Similarity=0.373 Sum_probs=209.3
Q ss_pred hhhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccC---CCcceeeecccccCC
Q psy11098 95 QEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHA---HIPTALALFENAPVP 171 (380)
Q Consensus 95 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~---ni~~i~~~~~~~~~~ 171 (380)
.+.+..+|.+....|+|-|++|.+|.+..-|..||||+|.....-...=.+|++||+.|... +--+++.+|..+.+.
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk 506 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK 506 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence 46678999999999999999999999999999999999987665555557799999999632 222345555555556
Q ss_pred CceEEEEEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeCC--eeEEEeCCCcc
Q psy11098 172 GTDTIVMQLVHGESLIQHLCRQ---STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGA--VLKLIDLGSSV 246 (380)
Q Consensus 172 ~~~~lv~e~~~gg~L~~~l~~~---~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~~--~ikl~DFG~a~ 246 (380)
+++|||+|.+ .-+|.+.|++. -.|....++.|+.|+.-||..|...||+|-||||+|||++.+ .+||||||.|.
T Consensus 507 nHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~ 585 (752)
T KOG0670|consen 507 NHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSAS 585 (752)
T ss_pred ceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccc
Confidence 8899999998 78899999774 458899999999999999999999999999999999999864 78999999998
Q ss_pred cccccc----cCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCC-------
Q psy11098 247 SVSTVV----LPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPE------- 315 (380)
Q Consensus 247 ~~~~~~----~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~------- 315 (380)
..+..- .-+.-|.|||++.| ..|+...|+||+||.||||+||+..|.+.++..++...+.....||..
T Consensus 586 ~~~eneitPYLVSRFYRaPEIiLG-~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF 664 (752)
T KOG0670|consen 586 FASENEITPYLVSRFYRAPEIILG-LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQF 664 (752)
T ss_pred ccccccccHHHHHHhccCcceeec-CcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcch
Confidence 776332 22456999999999 588999999999999999999999999998887776554322222210
Q ss_pred ------------------------------------------cCCCCC-------HHHHHHHHHhcccCCCCCCCHHHHH
Q psy11098 316 ------------------------------------------QCGHIS-------VPARELIGQLLNTHADKRPTAGQLL 346 (380)
Q Consensus 316 ------------------------------------------~~~~~s-------~~~~~li~~~L~~dP~~Rpt~~e~L 346 (380)
....++ ..+++||.+||..||++|.|+.|+|
T Consensus 665 ~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL 744 (752)
T KOG0670|consen 665 KDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQAL 744 (752)
T ss_pred hhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHh
Confidence 000112 2478999999999999999999999
Q ss_pred hcccccc
Q psy11098 347 QVAWFAE 353 (380)
Q Consensus 347 ~hpw~~~ 353 (380)
+||||+.
T Consensus 745 ~HpFi~~ 751 (752)
T KOG0670|consen 745 KHPFITE 751 (752)
T ss_pred cCCcccC
Confidence 9999974
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=306.31 Aligned_cols=253 Identities=23% Similarity=0.332 Sum_probs=185.5
Q ss_pred hhceeeeeeecccCCeEEEEEEEc----------------CCCcEEEEEEecCCCCc---------------hHHHHHHH
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDR----------------GTGQLVALKQIPRERQP---------------QQITRAEY 147 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~----------------~~~~~vAvK~~~~~~~~---------------~~~~~~E~ 147 (380)
.++|++.++||+|+||+||+|... ..++.||||.+...... .+....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 578999999999999999999752 24568999998643221 11223467
Q ss_pred HHHHhhccCCC-----cceeeeccccc-----CCCceEEEEEecCCCCHHHHHHhc------------------------
Q psy11098 148 NLLSTLMHAHI-----PTALALFENAP-----VPGTDTIVMQLVHGESLIQHLCRQ------------------------ 193 (380)
Q Consensus 148 ~il~~l~h~ni-----~~i~~~~~~~~-----~~~~~~lv~e~~~gg~L~~~l~~~------------------------ 193 (380)
.++..++|.++ +++++++.... ..+..++|+||+.+++|.+++...
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777776654 45556654321 124579999999999999988532
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccccc-------cccCCCcccCCcccc
Q psy11098 194 STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVST-------VVLPDLEFASPEMLT 265 (380)
Q Consensus 194 ~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~~-------~~~gt~~y~aPE~~~ 265 (380)
..+++..++.++.|++.||.|||+++|+||||||+|||++ ++.+||+|||++..... ...+|+.|+|||++.
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~ 383 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELV 383 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhc
Confidence 1235667889999999999999999999999999999998 46899999999865421 223478999999976
Q ss_pred CCCC-------------------CC--CcccHHHHHHHHHHHHhCCC-CCCCCCHH-----------HHHHHHhcccCCC
Q psy11098 266 SPAT-------------------AG--PSTDMWSLGVLLYILLSGVS-PFLDESEE-----------ETRAHISVADYSF 312 (380)
Q Consensus 266 ~~~~-------------------~~--~~~DiwSlGvil~~lltg~~-Pf~~~~~~-----------~~~~~i~~~~~~~ 312 (380)
.... ++ .+.|+||+||++|+|++|.. ||.+.... .....+....+.+
T Consensus 384 ~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~ 463 (507)
T PLN03224 384 MPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDF 463 (507)
T ss_pred CCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCc
Confidence 4211 11 24799999999999999875 77542111 1111222233444
Q ss_pred CCCcCCCCCHHHHHHHHHhcccCC---CCCCCHHHHHhcccccc
Q psy11098 313 PPEQCGHISVPARELIGQLLNTHA---DKRPTAGQLLQVAWFAE 353 (380)
Q Consensus 313 ~~~~~~~~s~~~~~li~~~L~~dP---~~Rpt~~e~L~hpw~~~ 353 (380)
+ .+...++.++||+.+||.++| .+|+|++|+|+||||..
T Consensus 464 ~--~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 464 S--LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred c--cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 3 345689999999999999866 68999999999999964
|
|
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=292.47 Aligned_cols=261 Identities=25% Similarity=0.389 Sum_probs=199.2
Q ss_pred hhhhh-hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhc-----cC---CCcceeeec
Q psy11098 95 QEQFE-HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLM-----HA---HIPTALALF 165 (380)
Q Consensus 95 ~~~~~-~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~-----h~---ni~~i~~~~ 165 (380)
.+.|. .||-+.++||=|.|++||+|.+..+.+.||+|+++-...-.+....||++|++++ |+ +|+++++.|
T Consensus 72 GD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F 151 (590)
T KOG1290|consen 72 GDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF 151 (590)
T ss_pred cccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence 34566 8999999999999999999999999999999999776666777888999999985 33 467777777
Q ss_pred cccc-CCCceEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC-CcEeecCCCCcEEEeCC------
Q psy11098 166 ENAP-VPGTDTIVMQLVHGESLIQHLCRQ--STITESYICCIIRQLHSALHCLHSQ-QIAHKDIRPENILMNGA------ 235 (380)
Q Consensus 166 ~~~~-~~~~~~lv~e~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~al~~lH~~-~iiHrDlKp~NIl~~~~------ 235 (380)
.... ...+++||+|++ |.+|+.+|... ..++...++.|++|||.||.|||.. ||||.||||+|||+..+
T Consensus 152 khsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~ 230 (590)
T KOG1290|consen 152 KHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAK 230 (590)
T ss_pred eecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhh
Confidence 6543 334789999999 99999999763 5799999999999999999999964 99999999999998100
Q ss_pred --------------------------------------------------------------------------------
Q psy11098 236 -------------------------------------------------------------------------------- 235 (380)
Q Consensus 236 -------------------------------------------------------------------------------- 235 (380)
T Consensus 231 ~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n 310 (590)
T KOG1290|consen 231 DAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRIN 310 (590)
T ss_pred hhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCC
Confidence
Q ss_pred --------------------------------------------------------------------------------
Q psy11098 236 -------------------------------------------------------------------------------- 235 (380)
Q Consensus 236 -------------------------------------------------------------------------------- 235 (380)
T Consensus 311 ~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~d 390 (590)
T KOG1290|consen 311 GNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECD 390 (590)
T ss_pred ccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccc
Confidence
Q ss_pred -eeEEEeCCCccccc---ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC------CHHHHHHHH
Q psy11098 236 -VLKLIDLGSSVSVS---TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDE------SEEETRAHI 305 (380)
Q Consensus 236 -~ikl~DFG~a~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~------~~~~~~~~i 305 (380)
.|||+|||.|+-+. +.-..|..|+||||+.+ ..|+..+||||++|+++||+||...|... .+++.++.|
T Consensus 391 i~vKIaDlGNACW~~khFT~DIQTRQYRapEVllG-sgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i 469 (590)
T KOG1290|consen 391 IRVKIADLGNACWVHKHFTEDIQTRQYRAPEVLLG-SGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALI 469 (590)
T ss_pred eeEEEeeccchhhhhhhhchhhhhhhccCcceeec-CCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHH
Confidence 12344444443322 12234667999999999 58899999999999999999999988432 234444444
Q ss_pred hcccCCCCC-------------------------CcC---------CCC----CHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy11098 306 SVADYSFPP-------------------------EQC---------GHI----SVPARELIGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 306 ~~~~~~~~~-------------------------~~~---------~~~----s~~~~~li~~~L~~dP~~Rpt~~e~L~ 347 (380)
+.....+|. ..| -++ ..++.+||.-||+.+|++|+||.+||+
T Consensus 470 ~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~ 549 (590)
T KOG1290|consen 470 MELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLK 549 (590)
T ss_pred HHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhc
Confidence 311111110 000 012 234679999999999999999999999
Q ss_pred cccccccCCC
Q psy11098 348 VAWFAEASCS 357 (380)
Q Consensus 348 hpw~~~~~~~ 357 (380)
|||+.....+
T Consensus 550 hPwLn~~~~~ 559 (590)
T KOG1290|consen 550 HPWLNPVAGP 559 (590)
T ss_pred CccccCCCCC
Confidence 9999976543
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=273.85 Aligned_cols=235 Identities=36% Similarity=0.539 Sum_probs=200.4
Q ss_pred CCeEEEEEEEcCCCcEEEEEEecCCCCc--hHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEEEecCCCCHHHH
Q psy11098 112 RFCTVRKARDRGTGQLVALKQIPRERQP--QQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQH 189 (380)
Q Consensus 112 ~fg~V~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~ 189 (380)
+||.||+|.+..+++.+|+|++...... ...+.+|++.++.++|+|++++++++... ...++++|++.+++|.++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~---~~~~l~~e~~~~~~L~~~ 77 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDE---DKLYLVMEYCDGGDLFDL 77 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeC---CEEEEEEeCCCCCCHHHH
Confidence 5899999999999999999999754432 46788899999999999999998887764 567999999999999999
Q ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCccccc-----ccccCCCcccCCcc
Q psy11098 190 LCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVS-----TVVLPDLEFASPEM 263 (380)
Q Consensus 190 l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~-----~~~~gt~~y~aPE~ 263 (380)
+.....+++..+..++.+++.++.+||+.|++|+||+|.||++++ +.++|+|||.+.... ....++..|++||.
T Consensus 78 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~ 157 (244)
T smart00220 78 LKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEV 157 (244)
T ss_pred HHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHH
Confidence 987766999999999999999999999999999999999999985 699999999987664 34567889999999
Q ss_pred ccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCH
Q psy11098 264 LTSPATAGPSTDMWSLGVLLYILLSGVSPFLD-ESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTA 342 (380)
Q Consensus 264 ~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~ 342 (380)
+.+ ...+.++|+||||+++|+|++|..||.. .........+.......... ...++.++.+++.+||..||++||++
T Consensus 158 ~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~p~~Rp~~ 235 (244)
T smart00220 158 LLG-KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPP-EWKISPEAKDLIRKLLVKDPEKRLTA 235 (244)
T ss_pred Hcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccc-cccCCHHHHHHHHHHccCCchhccCH
Confidence 986 4667799999999999999999999977 55555555554444333221 12278899999999999999999999
Q ss_pred HHHHhcccc
Q psy11098 343 GQLLQVAWF 351 (380)
Q Consensus 343 ~e~L~hpw~ 351 (380)
.++++||||
T Consensus 236 ~~~~~~~~~ 244 (244)
T smart00220 236 EEALQHPFF 244 (244)
T ss_pred HHHhhCCCC
Confidence 999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=292.94 Aligned_cols=240 Identities=19% Similarity=0.291 Sum_probs=210.2
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEEE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQ 179 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e 179 (380)
.+..+.++||-|.||.||.|.++.-.-.||||.++.+..+.+.|.+|..+|+.++|||++++++++... -.+|||+|
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~E---pPFYIiTE 343 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE---PPFYIITE 343 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccC---CCeEEEEe
Confidence 345677899999999999999999888999999998888889999999999999999999999998875 56799999
Q ss_pred ecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeCC-eeEEEeCCCccccccc-----
Q psy11098 180 LVHGESLIQHLCRQ--STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGA-VLKLIDLGSSVSVSTV----- 251 (380)
Q Consensus 180 ~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~~-~ikl~DFG~a~~~~~~----- 251 (380)
||..|+|++++... ..++.-.+..++-||..|+.||..+++|||||...|.|+..+ .|||+|||+++.....
T Consensus 344 fM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAH 423 (1157)
T KOG4278|consen 344 FMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAH 423 (1157)
T ss_pred cccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceecc
Confidence 99999999999764 457777888999999999999999999999999999999855 7999999999877521
Q ss_pred --ccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHH
Q psy11098 252 --VLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELI 328 (380)
Q Consensus 252 --~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 328 (380)
......|.|||.+.. ..++.++|||+|||+|||+.| |..||.+.....++..+.++ |.+. ....+++.+.+|+
T Consensus 424 AGAKFPIKWTAPEsLAy-NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkg-yRM~--~PeGCPpkVYeLM 499 (1157)
T KOG4278|consen 424 AGAKFPIKWTAPESLAY-NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKG-YRMD--GPEGCPPKVYELM 499 (1157)
T ss_pred cCccCcccccCcccccc-cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcc-cccc--CCCCCCHHHHHHH
Confidence 223678999999987 477889999999999999998 99999999888887777654 3333 3357899999999
Q ss_pred HHhcccCCCCCCCHHHHH
Q psy11098 329 GQLLNTHADKRPTAGQLL 346 (380)
Q Consensus 329 ~~~L~~dP~~Rpt~~e~L 346 (380)
+.||++.|.+||+..|+-
T Consensus 500 raCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 500 RACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred HHHhcCCcccCccHHHHH
Confidence 999999999999998874
|
|
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=275.87 Aligned_cols=249 Identities=24% Similarity=0.385 Sum_probs=200.6
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC---CCchHHHHHHHHHHHhhccCCCcceeeecccccCC---C
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE---RQPQQITRAEYNLLSTLMHAHIPTALALFENAPVP---G 172 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~---~ 172 (380)
..||.-+..+|.|+- .|..|.+..+++.||+|..... ........+|..++..+.|+|+++++.+|.-.... .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 468888999999999 8899999999999999988543 22345567799999999999999999998754322 3
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccccc
Q psy11098 173 TDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVSTV 251 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~~~ 251 (380)
..|+|||++ ..+|...+. -.++-..+..+++|++.|++|||+.||+||||||+||++. +..+||.|||+|+.....
T Consensus 95 e~y~v~e~m-~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~ 171 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD 171 (369)
T ss_pred hHHHHHHhh-hhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcc
Confidence 569999999 778888776 4578889999999999999999999999999999999998 458999999999877643
Q ss_pred -----ccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc------------------
Q psy11098 252 -----VLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVA------------------ 308 (380)
Q Consensus 252 -----~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~------------------ 308 (380)
.+.|..|.|||++.+- .+...+||||+||++.||++|+..|.+...-+...++...
T Consensus 172 ~~mtpyVvtRyyrapevil~~-~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~ 250 (369)
T KOG0665|consen 172 FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRN 250 (369)
T ss_pred cccCchhheeeccCchheecc-CCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHH
Confidence 3457789999999984 5888999999999999999999999776544333222100
Q ss_pred ------c---C----CCCCCcCC-------CCCHHHHHHHHHhcccCCCCCCCHHHHHhccccc
Q psy11098 309 ------D---Y----SFPPEQCG-------HISVPARELIGQLLNTHADKRPTAGQLLQVAWFA 352 (380)
Q Consensus 309 ------~---~----~~~~~~~~-------~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~ 352 (380)
+ . .+|+..+. .-+.-+++++.+||..||++|.|++++|.|||++
T Consensus 251 yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 251 YVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 0 0 11111111 1234589999999999999999999999999997
|
|
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=292.42 Aligned_cols=237 Identities=22% Similarity=0.306 Sum_probs=203.4
Q ss_pred eeeeeeecccCCeEEEEEEEcCC----CcEEEEEEecCC--CCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 102 YEELERLGNGRFCTVRKARDRGT----GQLVALKQIPRE--RQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 102 y~~~~~LG~G~fg~V~~~~~~~~----~~~vAvK~~~~~--~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
....+.||.|-||.||+|....- .--||||.-+.+ ....+.+..|.-+|+.+.||||+++++++.+ ...+
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e----~P~W 466 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE----QPMW 466 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec----ccee
Confidence 34557899999999999985432 336888988753 3456788999999999999999999999987 4679
Q ss_pred EEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCccccc----
Q psy11098 176 IVMQLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVS---- 249 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~---- 249 (380)
||||++.-|+|..+++.+ ..++...+..+++||+.||.|||+.++|||||...|||+.+ ..|||+|||+++.+.
T Consensus 467 ivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~y 546 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAY 546 (974)
T ss_pred EEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccch
Confidence 999999999999999875 56899999999999999999999999999999999999985 589999999998774
Q ss_pred ---ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHH
Q psy11098 250 ---TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAR 325 (380)
Q Consensus 250 ---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 325 (380)
....-...|||||.++. ..++.++|||-|||.+||+++ |..||.+-.+.++...+.++....-+ ++.++.+.
T Consensus 547 YkaS~~kLPIKWmaPESINf-RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P---~nCPp~LY 622 (974)
T KOG4257|consen 547 YKASRGKLPIKWMAPESINF-RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCP---PNCPPALY 622 (974)
T ss_pred hhccccccceeecCccccch-hcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCC---CCCChHHH
Confidence 22222567999999998 477889999999999999998 99999999888888888877754444 35689999
Q ss_pred HHHHHhcccCCCCCCCHHHHH
Q psy11098 326 ELIGQLLNTHADKRPTAGQLL 346 (380)
Q Consensus 326 ~li~~~L~~dP~~Rpt~~e~L 346 (380)
.|+.+||..||.+||+..++.
T Consensus 623 slmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 623 SLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred HHHHHHhccCcccCCcHHHHH
Confidence 999999999999999988875
|
|
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=278.49 Aligned_cols=247 Identities=25% Similarity=0.365 Sum_probs=199.3
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEecCCC---CchHHHHHHHHHHHhhccCCCcceeeecccccCC--CceEEEEEe
Q psy11098 106 ERLGNGRFCTVRKARDRGTGQLVALKQIPRER---QPQQITRAEYNLLSTLMHAHIPTALALFENAPVP--GTDTIVMQL 180 (380)
Q Consensus 106 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~--~~~~lv~e~ 180 (380)
+.||-|+||+||.+.+..+|+.||+|++..-. .....+-+|+.+|..++|.|+...+++..-.... ..+|+++|+
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TEL 138 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTEL 138 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHH
Confidence 67999999999999999999999999885321 2335566799999999999998887765432110 134788888
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeCC-eeEEEeCCCccccc-------ccc
Q psy11098 181 VHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGA-VLKLIDLGSSVSVS-------TVV 252 (380)
Q Consensus 181 ~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~~-~ikl~DFG~a~~~~-------~~~ 252 (380)
+ ..+|..+|..-..++.+.++-+.+||+.||+|||+.||+||||||.|+|++++ .+||||||+|+... +.-
T Consensus 139 m-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMTqE 217 (449)
T KOG0664|consen 139 M-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMTHE 217 (449)
T ss_pred H-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhhhHHH
Confidence 8 66788888888889999999999999999999999999999999999999977 78999999998654 223
Q ss_pred cCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-----------------------cc
Q psy11098 253 LPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISV-----------------------AD 309 (380)
Q Consensus 253 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~-----------------------~~ 309 (380)
+-|..|.|||++.|...|+.++||||+|||+.||+.++..|...+.-+.++.|.. +.
T Consensus 218 VVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~ 297 (449)
T KOG0664|consen 218 VVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAG 297 (449)
T ss_pred HHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccC
Confidence 4478899999999989999999999999999999999999987776665554431 11
Q ss_pred CCCCCC-------cCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccc
Q psy11098 310 YSFPPE-------QCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAE 353 (380)
Q Consensus 310 ~~~~~~-------~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~ 353 (380)
...|.. ....-..++.+++..||..||++|.+.++++.|+++.+
T Consensus 298 ~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e 348 (449)
T KOG0664|consen 298 LRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEE 348 (449)
T ss_pred CCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccc
Confidence 111110 00122346789999999999999999999999999875
|
|
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=288.10 Aligned_cols=245 Identities=20% Similarity=0.261 Sum_probs=202.2
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
-.++..+.++||+|-||.|.+|.-.. +.+||||+++.... ....+.+|+++|.+|+||||+.+++.+... +.++
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D---ePic 611 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQD---DPLC 611 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecC---CchH
Confidence 35677888999999999999998553 68999999975543 346789999999999999999999988764 6789
Q ss_pred EEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCccccc---
Q psy11098 176 IVMQLVHGESLIQHLCRQ--STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVS--- 249 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~--- 249 (380)
||+||++.|+|.+++..+ ..+.-.....|+.||+.||+||.+.++|||||.+.|+|++. .++||+|||+++.+-
T Consensus 612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCC
Confidence 999999999999999876 33455566779999999999999999999999999999995 599999999998552
Q ss_pred -----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHhcccCCCC----CCcCC
Q psy11098 250 -----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS--GVSPFLDESEEETRAHISVADYSFP----PEQCG 318 (380)
Q Consensus 250 -----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt--g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~ 318 (380)
...+-..+|||+|.+.. ..++.++|+|++|+++||+++ ...||...++++..++...--.... .....
T Consensus 692 yy~vqgr~vlpiRwmawEsill-gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~ 770 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPP 770 (807)
T ss_pred ceeeecceeeeeeehhHHHHHh-ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCC
Confidence 23344688999998877 477889999999999999865 8999999998888776542211111 11223
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy11098 319 HISVPARELIGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 319 ~~s~~~~~li~~~L~~dP~~Rpt~~e~L~ 347 (380)
-.+.++.++|.+||..|-++|||.+++-.
T Consensus 771 ~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 771 ACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred cCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 46889999999999999999999999854
|
|
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=294.55 Aligned_cols=247 Identities=20% Similarity=0.312 Sum_probs=209.5
Q ss_pred hceeeeeeecccCCeEEEEEEEcCC-C--cEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCCce
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGT-G--QLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~-~--~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~ 174 (380)
++..+.++||+|.||+|++|.++.. | ..||||.++.... ....|.+|..+|..|+|+|+++++++... ...
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~----qp~ 185 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD----QPA 185 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc----chh
Confidence 4456678999999999999998763 3 3689999975543 45778999999999999999999888765 456
Q ss_pred EEEEEecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccccc-
Q psy11098 175 TIVMQLVHGESLIQHLCR--QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVST- 250 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~--~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~~- 250 (380)
.||||++..|+|.++|.+ ...|-...+..|+.||+.||.||.+++.|||||...|+|+- ...|||+||||.+.++.
T Consensus 186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 899999999999999976 45688888999999999999999999999999999999997 56999999999987641
Q ss_pred --------cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCC
Q psy11098 251 --------VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHIS 321 (380)
Q Consensus 251 --------~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 321 (380)
...-...|+|||.++. ..++.++|+|++||++|||++ |+.||.+.....++++|..+..-..++ ..+
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh-~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk---~cs 341 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRH-RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPK---YCS 341 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhcc-ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCC---CCh
Confidence 1222456999999998 577889999999999999999 999999999999999998555443333 468
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 322 VPARELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 322 ~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
+++.++++.||..+|.+|||+..+.+.-++...
T Consensus 342 edIY~imk~cWah~paDRptFsair~~~~l~ea 374 (1039)
T KOG0199|consen 342 EDIYQIMKNCWAHNPADRPTFSAIREDLVLAEA 374 (1039)
T ss_pred HHHHHHHHHhccCCccccccHHHHHHhHHHHhc
Confidence 999999999999999999999999766565544
|
|
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=304.26 Aligned_cols=240 Identities=26% Similarity=0.365 Sum_probs=190.5
Q ss_pred eeeeeecccCCe-EEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhh-ccCCCcceeeecccccCCCceEEEEEe
Q psy11098 103 EELERLGNGRFC-TVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTL-MHAHIPTALALFENAPVPGTDTIVMQL 180 (380)
Q Consensus 103 ~~~~~LG~G~fg-~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~~~~~~~lv~e~ 180 (380)
.-.+.+|.|+-| .||+|... |+.||||.+-.+ -...+.+|+..|+.- .|+|| +++|-...++...||.+|+
T Consensus 512 ~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e--~~~~A~rEi~lL~eSD~H~Nv---iRyyc~E~d~qF~YIalEL 584 (903)
T KOG1027|consen 512 SPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEE--FFDFAQREIQLLQESDEHPNV---IRYYCSEQDRQFLYIALEL 584 (903)
T ss_pred ccHHHcccCCCCcEEEEEeeC--CceehHHHHhhH--hHHHHHHHHHHHHhccCCCce---EEEEeeccCCceEEEEehH
Confidence 334678999987 67999864 789999987432 234678899999877 58887 6666667777889999999
Q ss_pred cCCCCHHHHHHhc-CC---CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC----C--eeEEEeCCCccccc-
Q psy11098 181 VHGESLIQHLCRQ-ST---ITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG----A--VLKLIDLGSSVSVS- 249 (380)
Q Consensus 181 ~~gg~L~~~l~~~-~~---l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~----~--~ikl~DFG~a~~~~- 249 (380)
| ..+|.+++... .. ......+.+..|++.||++||+.+||||||||+||||+. + .++|+|||+++++.
T Consensus 585 C-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 585 C-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred h-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 9 78999999763 11 111456889999999999999999999999999999963 2 78999999998774
Q ss_pred --------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCC
Q psy11098 250 --------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHI 320 (380)
Q Consensus 250 --------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 320 (380)
....||-+|+|||++... ..+.++||+||||++|+.++ |..||.+.... ..+|..+.+....-... -
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L~~~-~~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~~~~~L~~L~~~-~ 739 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQLRED-RKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILTGNYTLVHLEPL-P 739 (903)
T ss_pred CcchhhcccCCCCcccccCHHHHhcc-ccCcccchhhcCceEEEEecCCccCCCchHHh--hhhhhcCccceeeeccC-c
Confidence 355789999999999884 55669999999999999999 59999765443 34666666555432211 1
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 321 SVPARELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 321 s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
..+++|||.+||.+||..||+|.++|.||+|=..
T Consensus 740 d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ 773 (903)
T KOG1027|consen 740 DCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS 773 (903)
T ss_pred hHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence 1289999999999999999999999999999654
|
|
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=273.83 Aligned_cols=250 Identities=23% Similarity=0.265 Sum_probs=193.7
Q ss_pred hhhhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeeccccc-CCC
Q psy11098 94 QQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAP-VPG 172 (380)
Q Consensus 94 ~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~-~~~ 172 (380)
.+..+..+..+.+.||+|+||.||+|.++ |+.||||+|.........-+.||---.-|+|.||+.+++.-.... .-.
T Consensus 205 VQRTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 205 VQRTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred hHHhhhheeEEEEEecCccccceeecccc--CCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 35677889999999999999999999998 678999999766655555555666666779999988776643321 113
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CcEeecCCCCcEEEe-CCeeEEEeCC
Q psy11098 173 TDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQ--------QIAHKDIRPENILMN-GAVLKLIDLG 243 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~--------~iiHrDlKp~NIl~~-~~~ikl~DFG 243 (380)
.++||.+|.+.|||+|+|.. .+++-+...+++..++.||+|||-. .|.|||||..|||+. ++.+.|+|+|
T Consensus 283 QLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 56899999999999999987 5899999999999999999999942 599999999999997 6799999999
Q ss_pred Cccccc----------ccccCCCcccCCccccCCCCC----C-CcccHHHHHHHHHHHHhC----------CCCCCC---
Q psy11098 244 SSVSVS----------TVVLPDLEFASPEMLTSPATA----G-PSTDMWSLGVLLYILLSG----------VSPFLD--- 295 (380)
Q Consensus 244 ~a~~~~----------~~~~gt~~y~aPE~~~~~~~~----~-~~~DiwSlGvil~~lltg----------~~Pf~~--- 295 (380)
||.... +..+||.+|||||++...... + ..+||||||+++||++.+ ..||.+
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 997652 678999999999998653211 1 368999999999999854 678854
Q ss_pred --CCHHHHHHHHhcccCCCCCCcCCCCCHH---HHHHHHHhcccCCCCCCCHHHHH
Q psy11098 296 --ESEEETRAHISVADYSFPPEQCGHISVP---ARELIGQLLNTHADKRPTAGQLL 346 (380)
Q Consensus 296 --~~~~~~~~~i~~~~~~~~~~~~~~~s~~---~~~li~~~L~~dP~~Rpt~~e~L 346 (380)
.+.+++..-+....+....+....-.+. +..+|+.||..||.-|.||--+-
T Consensus 442 ~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 442 SDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred CCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 3455555554444443333332222333 45789999999999999876553
|
|
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=287.48 Aligned_cols=192 Identities=29% Similarity=0.497 Sum_probs=174.1
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCch---------HHHHHHHHHHHhhc---cCCCcceeeeccc
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQ---------QITRAEYNLLSTLM---HAHIPTALALFEN 167 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~---------~~~~~E~~il~~l~---h~ni~~i~~~~~~ 167 (380)
..|..++.||.|+||.|++|.++.+...|++|.+.+++--. .....||.||..|+ |+||++++++|+.
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 34999999999999999999999999999999997764321 23456999999998 9999999999998
Q ss_pred ccCCCceEEEEEec-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCc
Q psy11098 168 APVPGTDTIVMQLV-HGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSS 245 (380)
Q Consensus 168 ~~~~~~~~lv~e~~-~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a 245 (380)
. +.+||+||-. +|.+|+++|.....++|.+++.|++||+.|+++||++||||||||-+|+.++ +|.+||+|||.|
T Consensus 641 d---d~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsa 717 (772)
T KOG1152|consen 641 D---DYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSA 717 (772)
T ss_pred C---CeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccch
Confidence 5 7889999986 6789999999999999999999999999999999999999999999999998 579999999998
Q ss_pred cccc----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Q psy11098 246 VSVS----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFL 294 (380)
Q Consensus 246 ~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~ 294 (380)
.... ..+.||..|.|||++.|..+-+..-|||+||++||.+...+.||.
T Consensus 718 a~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 718 AYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 7654 578899999999999998888999999999999999999999985
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=315.78 Aligned_cols=241 Identities=20% Similarity=0.234 Sum_probs=184.9
Q ss_pred hhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEE
Q psy11098 97 QFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 97 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
+....|...+.||+|+||.||+|+++.+++.||+|.+...... ..+|+++++.++||||+++++++... +..++
T Consensus 687 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~l~~l~HpnIv~~~~~~~~~---~~~~l 760 (968)
T PLN00113 687 DILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI---PSSEIADMGKLQHPNIVKLIGLCRSE---KGAYL 760 (968)
T ss_pred HHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---cHHHHHHHhhCCCCCcceEEEEEEcC---CCCEE
Confidence 3445677778999999999999999999999999998643322 23578899999999999999998764 56799
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeecCCCCcEEEeCC-eeEEEeCCCcccc--cc
Q psy11098 177 VMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLH---SQQIAHKDIRPENILMNGA-VLKLIDLGSSVSV--ST 250 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH---~~~iiHrDlKp~NIl~~~~-~ikl~DFG~a~~~--~~ 250 (380)
||||+.+|+|.+++. .+++..+..++.||+.||.||| +.+|+||||||+||+++.+ ..++. ||.+... ..
T Consensus 761 v~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~~ 836 (968)
T PLN00113 761 IHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDT 836 (968)
T ss_pred EEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccCC
Confidence 999999999999995 3789999999999999999999 6799999999999999854 44443 6654432 23
Q ss_pred cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHh-cc------cCCCCC--Cc
Q psy11098 251 VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESE-----EETRAHIS-VA------DYSFPP--EQ 316 (380)
Q Consensus 251 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~-----~~~~~~i~-~~------~~~~~~--~~ 316 (380)
...+|+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .+...... .. +..... ..
T Consensus 837 ~~~~t~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (968)
T PLN00113 837 KCFISSAYVAPETRET-KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSV 915 (968)
T ss_pred CccccccccCcccccC-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCc
Confidence 4567899999999987 5788999999999999999999999954221 11110000 00 000000 00
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 317 CGHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 317 ~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
......++.+++.+||+.||++|||++|+++.
T Consensus 916 ~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 916 NQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred cHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 00112356789999999999999999999976
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=293.65 Aligned_cols=255 Identities=25% Similarity=0.346 Sum_probs=223.8
Q ss_pred hhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC-chHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 97 QFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ-PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 97 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
+-.++|+.++++|.|+||.||+++++.+++..|+|+++.... .-....+|+-+++.-+|+||+.+++.|-. .+..+
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr---~dklw 88 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLR---RDKLW 88 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhh---hcCcE
Confidence 457899999999999999999999999999999999987654 34566789999999999999877777765 47889
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-----
Q psy11098 176 IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS----- 249 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~----- 249 (380)
++||||.||+|.+.-.-.+.++|.++..+++..+.||+|||++|-+|||||-.|||++ .+.+|++|||.+..++
T Consensus 89 icMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~K 168 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAK 168 (829)
T ss_pred EEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhh
Confidence 9999999999999887788999999999999999999999999999999999999997 5799999999988775
Q ss_pred -ccccCCCcccCCcccc--CCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCC-cCCCCCHHHH
Q psy11098 250 -TVVLPDLEFASPEMLT--SPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPE-QCGHISVPAR 325 (380)
Q Consensus 250 -~~~~gt~~y~aPE~~~--~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~s~~~~ 325 (380)
..+.|||.|||||+.. ....|+..+|+|++|+...|+---.+|..+...........+-.+..+.. .-..+++.+.
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh 248 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFH 248 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHH
Confidence 5678999999999853 33578889999999999999999999988888777777777766655532 2345788999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 326 ELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 326 ~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
+|++.+|.++|++|||++.+|.|||....
T Consensus 249 ~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 249 NFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred HHHHHHhcCCCccCCChhhheeceeeccc
Confidence 99999999999999999999999999865
|
|
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=271.92 Aligned_cols=242 Identities=23% Similarity=0.310 Sum_probs=182.0
Q ss_pred ceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccC-CCceEEEEE
Q psy11098 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPV-PGTDTIVMQ 179 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~-~~~~~lv~e 179 (380)
..+.++.||+|+||.||+|+.. ++.||||+|..........+++|--+-.++|+||+.++..-..... ...+.||++
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE 288 (534)
T ss_pred chhhHHHhhcCccceeehhhcc--CceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence 4567789999999999999865 5899999996654444333444444446789999887766544321 225689999
Q ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---------CCcEeecCCCCcEEEe-CCeeEEEeCCCccccc
Q psy11098 180 LVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHS---------QQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS 249 (380)
Q Consensus 180 ~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~---------~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~ 249 (380)
|...|+|.+++..+ .+++.....++..++.||+|||+ ..|+|||||..|||+. +.++.|+|||+|.++.
T Consensus 289 fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~ 367 (534)
T KOG3653|consen 289 FHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLE 367 (534)
T ss_pred eccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEec
Confidence 99999999999755 89999999999999999999995 3599999999999997 5699999999998774
Q ss_pred --------ccccCCCcccCCccccCCCCCC-----CcccHHHHHHHHHHHHhCCC------------CCC-----CCCHH
Q psy11098 250 --------TVVLPDLEFASPEMLTSPATAG-----PSTDMWSLGVLLYILLSGVS------------PFL-----DESEE 299 (380)
Q Consensus 250 --------~~~~gt~~y~aPE~~~~~~~~~-----~~~DiwSlGvil~~lltg~~------------Pf~-----~~~~~ 299 (380)
...+||.+|||||++.+..... .+.||||+|.++|||+++.. ||. ..+.+
T Consensus 368 p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e 447 (534)
T KOG3653|consen 368 PGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLE 447 (534)
T ss_pred CCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHH
Confidence 3468999999999998743333 36899999999999998633 332 22334
Q ss_pred HHHHHHhcc--cCCCCCCcCC-CCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy11098 300 ETRAHISVA--DYSFPPEQCG-HISVPARELIGQLLNTHADKRPTAGQL 345 (380)
Q Consensus 300 ~~~~~i~~~--~~~~~~~~~~-~~s~~~~~li~~~L~~dP~~Rpt~~e~ 345 (380)
++...+... ...++..... ..-.-+++.+..||..||+.|.|+.=+
T Consensus 448 ~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 448 EMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred HHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 444444332 2233322211 123457899999999999999998643
|
|
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=283.63 Aligned_cols=239 Identities=23% Similarity=0.347 Sum_probs=199.4
Q ss_pred eeeeeeecccCCeEEEEEEEcC-------CCcEEEEEEecCCCC--chHHHHHHHHHHHhh-ccCCCcceeeecccccCC
Q psy11098 102 YEELERLGNGRFCTVRKARDRG-------TGQLVALKQIPRERQ--PQQITRAEYNLLSTL-MHAHIPTALALFENAPVP 171 (380)
Q Consensus 102 y~~~~~LG~G~fg~V~~~~~~~-------~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~~~ 171 (380)
..+.+.||+|+||.|++|.-.. ....||||..+.... +.+.+..|+++|+.+ +|+|++++++++.. .
T Consensus 298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~---~ 374 (609)
T KOG0200|consen 298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ---D 374 (609)
T ss_pred ccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc---C
Confidence 3566799999999999997431 145799999975443 456778899999999 49999999999887 4
Q ss_pred CceEEEEEecCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeCC
Q psy11098 172 GTDTIVMQLVHGESLIQHLCRQS----------------TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGA 235 (380)
Q Consensus 172 ~~~~lv~e~~~gg~L~~~l~~~~----------------~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~~ 235 (380)
+..++|+||+..|+|.+++.... .++..++..++.||+.|++||++.+++||||-.+|||+..+
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~ 454 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKN 454 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCC
Confidence 77899999999999999997654 48899999999999999999999999999999999999865
Q ss_pred -eeEEEeCCCccccc-------ccccC--CCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCC-HHHHHH
Q psy11098 236 -VLKLIDLGSSVSVS-------TVVLP--DLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDES-EEETRA 303 (380)
Q Consensus 236 -~ikl~DFG~a~~~~-------~~~~g--t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~-~~~~~~ 303 (380)
.+||+|||+|+... ....+ ...|||||.+.. ..++.++||||+||+|||++| |..||.+.. ..+...
T Consensus 455 ~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~ 533 (609)
T KOG0200|consen 455 KVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLE 533 (609)
T ss_pred CEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHH
Confidence 89999999998542 11111 345999999998 688999999999999999999 999998865 666666
Q ss_pred HHhcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy11098 304 HISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 304 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~ 347 (380)
.+..+.....+ ...++++.++++.||+.+|++||+..++.+
T Consensus 534 ~l~~G~r~~~P---~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 534 FLKEGNRMEQP---EHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHhcCCCCCCC---CCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 66655543333 345999999999999999999999999874
|
|
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=265.76 Aligned_cols=252 Identities=27% Similarity=0.389 Sum_probs=199.5
Q ss_pred hhhhhceeeeeeecccCCeEEEEEEEcC---CCcEEEEEEecCCCCchHHHHHHHHHHHhhc-cCCCcceeeecccccCC
Q psy11098 96 EQFEHRYEELERLGNGRFCTVRKARDRG---TGQLVALKQIPRERQPQQITRAEYNLLSTLM-HAHIPTALALFENAPVP 171 (380)
Q Consensus 96 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~---~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~-h~ni~~i~~~~~~~~~~ 171 (380)
..+...|.+.++||.|.|++||++.+.. .++.||+|.+...... ..+.+|+++|..+. +.||+++..++...
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p-~ri~~El~~L~~~gG~~ni~~~~~~~rnn--- 107 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP-SRILNELEMLYRLGGSDNIIKLNGCFRNN--- 107 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc-hHHHHHHHHHHHhccchhhhcchhhhccC---
Confidence 4567789999999999999999998877 7889999999765443 45778999999995 78888888887764
Q ss_pred CceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe--CCeeEEEeCCCcccc-
Q psy11098 172 GTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN--GAVLKLIDLGSSVSV- 248 (380)
Q Consensus 172 ~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~--~~~ikl~DFG~a~~~- 248 (380)
+...+||||+...+..++.. .++..+++.+++.++.||.++|.+|||||||||.|+|++ .+.-.|+|||+|...
T Consensus 108 d~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d 184 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD 184 (418)
T ss_pred CeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHH
Confidence 78899999998888777663 456888999999999999999999999999999999998 457889999998511
Q ss_pred --------------------c-----------------------------ccccCCCcccCCccccCCCCCCCcccHHHH
Q psy11098 249 --------------------S-----------------------------TVVLPDLEFASPEMLTSPATAGPSTDMWSL 279 (380)
Q Consensus 249 --------------------~-----------------------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl 279 (380)
+ ....||++|.|||++.....-+.++||||.
T Consensus 185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~ 264 (418)
T KOG1167|consen 185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA 264 (418)
T ss_pred hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence 0 123579999999999886677889999999
Q ss_pred HHHHHHHHhCCCCCCCCCHH-HHHHHHh--------------ccc------------------C-C-------------C
Q psy11098 280 GVLLYILLSGVSPFLDESEE-ETRAHIS--------------VAD------------------Y-S-------------F 312 (380)
Q Consensus 280 Gvil~~lltg~~Pf~~~~~~-~~~~~i~--------------~~~------------------~-~-------------~ 312 (380)
|||+.-++++..||....++ ....++. -+. + . .
T Consensus 265 GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~ 344 (418)
T KOG1167|consen 265 GVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNT 344 (418)
T ss_pred cceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccce
Confidence 99999999999999543221 1111110 000 0 0 0
Q ss_pred CCC-cCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 313 PPE-QCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 313 ~~~-~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
..+ ..+..+..+.||+.+||+.||.+|.|++++|+||||...
T Consensus 345 ~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~ 387 (418)
T KOG1167|consen 345 EREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA 387 (418)
T ss_pred eeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence 001 112345578999999999999999999999999999854
|
|
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=236.82 Aligned_cols=204 Identities=23% Similarity=0.329 Sum_probs=159.2
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC--chHHHHHHHHHHHhh-ccCCCcceeeecccccCCCceEE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ--PQQITRAEYNLLSTL-MHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
+....++.||+|++|.|-+.+|..+|...|+|.+...-. ......+|+++...- ..|.++ .+|......+.++|
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V---~FyGa~~regdvwI 122 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTV---HFYGALFREGDVWI 122 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEE---EeehhhhccccEEE
Confidence 334456789999999999999999999999999975433 334445565554433 345554 44444444578899
Q ss_pred EEEecCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeecCCCCcEEEe-CCeeEEEeCCCccccc-
Q psy11098 177 VMQLVHGESLIQHL----CRQSTITESYICCIIRQLHSALHCLHSQ-QIAHKDIRPENILMN-GAVLKLIDLGSSVSVS- 249 (380)
Q Consensus 177 v~e~~~gg~L~~~l----~~~~~l~e~~~~~i~~qil~al~~lH~~-~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~- 249 (380)
.||.| ..||..+- .++..++|..+-+|+..+++||.|||++ .++|||+||.|||++ +|++|+||||.+..+.
T Consensus 123 cME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 123 CMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred eHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 99999 66775544 3467899999999999999999999976 899999999999999 7899999999997664
Q ss_pred ----ccccCCCcccCCccccC---CCCCCCcccHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhc
Q psy11098 250 ----TVVLPDLEFASPEMLTS---PATAGPSTDMWSLGVLLYILLSGVSPFLD-ESEEETRAHISV 307 (380)
Q Consensus 250 ----~~~~gt~~y~aPE~~~~---~~~~~~~~DiwSlGvil~~lltg~~Pf~~-~~~~~~~~~i~~ 307 (380)
+...|..-|||||.+.. ...|+.++||||||+.+.||.+++.||.. .+..+.+.++..
T Consensus 202 SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 202 SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 23466778999999864 24778899999999999999999999965 355555555543
|
|
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=250.02 Aligned_cols=254 Identities=25% Similarity=0.344 Sum_probs=200.3
Q ss_pred hhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhc-cCCCcceeeecccccCCCce
Q psy11098 96 EQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLM-HAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 96 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~-h~ni~~i~~~~~~~~~~~~~ 174 (380)
-++.+.|.|.+.||.|.||.+-+|.|+.++..+|+|.+.+.......+.+|+.---.|. |.||+.-++. ..+..+.+
T Consensus 20 v~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~v--aFqt~d~Y 97 (378)
T KOG1345|consen 20 VDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEV--AFQTSDAY 97 (378)
T ss_pred cchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHH--HhhcCceE
Confidence 35788999999999999999999999999999999999888777777888877665664 6676443332 12334677
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe---CCeeEEEeCCCccccccc
Q psy11098 175 TIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN---GAVLKLIDLGSSVSVSTV 251 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~---~~~ikl~DFG~a~~~~~~ 251 (380)
++++||+.-|+|..-+.. ..+-|...+.++.|+++|+.|||++++||||||.+||||- ...|||||||+++..+..
T Consensus 98 vF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t 176 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT 176 (378)
T ss_pred EEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCce
Confidence 899999999999888765 4688999999999999999999999999999999999993 348999999999887643
Q ss_pred c---cCCCcccCCccccC----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHhcccCCCCCCcCCCC
Q psy11098 252 V---LPDLEFASPEMLTS----PATAGPSTDMWSLGVLLYILLSGVSPFLDESEE----ETRAHISVADYSFPPEQCGHI 320 (380)
Q Consensus 252 ~---~gt~~y~aPE~~~~----~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~ 320 (380)
+ ..+..|.|||+... .-..+..+|+|.||+++|.+|+|.+||+..... ....+-..+...-.+..+..+
T Consensus 177 V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~f 256 (378)
T KOG1345|consen 177 VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPF 256 (378)
T ss_pred ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhccc
Confidence 2 33677999997542 223466899999999999999999999743221 112222223323334556778
Q ss_pred CHHHHHHHHHhcccCCCCC---CCHHHHHhccccc
Q psy11098 321 SVPARELIGQLLNTHADKR---PTAGQLLQVAWFA 352 (380)
Q Consensus 321 s~~~~~li~~~L~~dP~~R---pt~~e~L~hpw~~ 352 (380)
|+.+..+.++-|.+++++| .++..-....|..
T Consensus 257 s~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 257 SEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred CHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 9999999999999999999 6777777777765
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-31 Score=235.10 Aligned_cols=204 Identities=34% Similarity=0.550 Sum_probs=181.6
Q ss_pred ecccCCeEEEEEEEcCCCcEEEEEEecCCCCc--hHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEEEecCCCC
Q psy11098 108 LGNGRFCTVRKARDRGTGQLVALKQIPRERQP--QQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHGES 185 (380)
Q Consensus 108 LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e~~~gg~ 185 (380)
||+|++|.||++....+++.+++|++...... ...+.+|++.++.++|+++++++.++... ...++++|++.|++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~---~~~~~~~e~~~~~~ 77 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDE---NHLYLVMEYCEGGS 77 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecC---CeEEEEEecCCCCc
Confidence 68999999999999988999999999766543 56788899999999999999998888764 67799999999999
Q ss_pred HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC--CeeEEEeCCCcccccc------cccCCC
Q psy11098 186 LIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG--AVLKLIDLGSSVSVST------VVLPDL 256 (380)
Q Consensus 186 L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~--~~ikl~DFG~a~~~~~------~~~gt~ 256 (380)
|.+++... ..+++..+..++.+++.+|.+||+.|++|+||+|.||+++. +.++|+|||.+..... ...+..
T Consensus 78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 157 (215)
T cd00180 78 LKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTP 157 (215)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCC
Confidence 99999765 57899999999999999999999999999999999999986 6999999999876542 245688
Q ss_pred cccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhcccCC
Q psy11098 257 EFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHA 336 (380)
Q Consensus 257 ~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 336 (380)
.|++||.+......+.++|+|++|+++++| ..+.+++.+||..||
T Consensus 158 ~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------~~~~~~l~~~l~~~p 202 (215)
T cd00180 158 AYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------PELKDLIRKMLQKDP 202 (215)
T ss_pred CccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------HHHHHHHHHHhhCCc
Confidence 899999987743677899999999999999 678999999999999
Q ss_pred CCCCCHHHHHhcc
Q psy11098 337 DKRPTAGQLLQVA 349 (380)
Q Consensus 337 ~~Rpt~~e~L~hp 349 (380)
++||++.++++|+
T Consensus 203 ~~R~~~~~l~~~~ 215 (215)
T cd00180 203 EKRPSAKEILEHL 215 (215)
T ss_pred ccCcCHHHHhhCC
Confidence 9999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=273.39 Aligned_cols=237 Identities=20% Similarity=0.260 Sum_probs=203.7
Q ss_pred eeeeeecccCCeEEEEEEEcCCCc----EEEEEEecCCC--CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEE
Q psy11098 103 EELERLGNGRFCTVRKARDRGTGQ----LVALKQIPRER--QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 103 ~~~~~LG~G~fg~V~~~~~~~~~~----~vAvK~~~~~~--~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
+..++||+|+||+||+|.+--.|+ +||+|++.... .....+.+|.-+|..|.|+|+++++++.... ...|
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s----~~ql 774 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS----TLQL 774 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc----hHHH
Confidence 445789999999999998765554 78999886443 3456778899999999999999999998863 4789
Q ss_pred EEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccccc----
Q psy11098 177 VMQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVST---- 250 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~~---- 250 (380)
|++|+.+|.|.+++.. ...+...+...|..||++||.|||.++++||||-.+|||+. .+.+||.|||+|+....
T Consensus 775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 9999999999999976 46789999999999999999999999999999999999997 57999999999987641
Q ss_pred ----cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHH
Q psy11098 251 ----VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAR 325 (380)
Q Consensus 251 ----~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 325 (380)
...-.+.|||=|.+.. ..++.++||||+||++||++| |..|+.+...+++-..++.++. ++. ....+-++.
T Consensus 855 y~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR-Lsq--PpiCtiDVy 930 (1177)
T KOG1025|consen 855 YSAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER-LSQ--PPICTIDVY 930 (1177)
T ss_pred ccccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc-CCC--CCCccHHHH
Confidence 1122567999999988 588999999999999999999 9999999999999988888776 332 235688999
Q ss_pred HHHHHhcccCCCCCCCHHHHHh
Q psy11098 326 ELIGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 326 ~li~~~L~~dP~~Rpt~~e~L~ 347 (380)
-++.+||..|+..||+++++..
T Consensus 931 ~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 931 MVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHHHHhccCcccCccHHHHHH
Confidence 9999999999999999999853
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-32 Score=286.05 Aligned_cols=192 Identities=22% Similarity=0.270 Sum_probs=145.0
Q ss_pred CCCcceeeeccccc----CCCceEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcE
Q psy11098 156 AHIPTALALFENAP----VPGTDTIVMQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENI 230 (380)
Q Consensus 156 ~ni~~i~~~~~~~~----~~~~~~lv~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NI 230 (380)
.||.++++.|.... ....++.++|++ +++|.+++.. ...+++.+++.+++||+.||.|||++||+||||||+||
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni 111 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF 111 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence 36666666663322 123567788887 7799999965 45699999999999999999999999999999999999
Q ss_pred EEe--------------------CCeeEEEeCCCccccc----------------------ccccCCCcccCCccccCCC
Q psy11098 231 LMN--------------------GAVLKLIDLGSSVSVS----------------------TVVLPDLEFASPEMLTSPA 268 (380)
Q Consensus 231 l~~--------------------~~~ikl~DFG~a~~~~----------------------~~~~gt~~y~aPE~~~~~~ 268 (380)
|++ ++.+|++|||+++... ...+||+.|||||++.+ .
T Consensus 112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~ 190 (793)
T PLN00181 112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNG-S 190 (793)
T ss_pred EEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhcc-C
Confidence 994 2357888888875321 11357889999999988 4
Q ss_pred CCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 269 TAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 269 ~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
.++.++|||||||+||||++|.+|+.... .....+.... +++.. .....+..+++.+||.+||.+|||+.|+|+|
T Consensus 191 ~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 191 SSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV--LPPQI-LLNWPKEASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred CCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh--cChhh-hhcCHHHHHHHHHhCCCChhhCcChHHHhhc
Confidence 67899999999999999999998875422 1222222111 12111 1124567899999999999999999999999
Q ss_pred cccccc
Q psy11098 349 AWFAEA 354 (380)
Q Consensus 349 pw~~~~ 354 (380)
|||.+.
T Consensus 266 ~~~~~~ 271 (793)
T PLN00181 266 EFINEP 271 (793)
T ss_pred hhhhhh
Confidence 999764
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=227.48 Aligned_cols=205 Identities=34% Similarity=0.511 Sum_probs=174.6
Q ss_pred eeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEEE
Q psy11098 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQ 179 (380)
Q Consensus 102 y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e 179 (380)
|.+.+.||.|++|.||++.+..+++.+|+|.+..... ....+.+|++.++.++|+|++++++++... +..++++|
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~---~~~~~v~e 77 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDP---EPLYLVME 77 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecC---CceEEEEe
Confidence 5677899999999999999998899999999976543 356778899999999999999999887764 67799999
Q ss_pred ecCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCccccc-------c
Q psy11098 180 LVHGESLIQHLCRQST-ITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVS-------T 250 (380)
Q Consensus 180 ~~~gg~L~~~l~~~~~-l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~-------~ 250 (380)
++.+++|.+++..... +++..+..++.+++.++.+||+.+++|+||+|.||+++. +.++|+|||.+.... .
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 78 YCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred ccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 9999999999987766 899999999999999999999999999999999999985 699999999887653 2
Q ss_pred cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC-CC-HHHHHHHHhccc
Q psy11098 251 VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLD-ES-EEETRAHISVAD 309 (380)
Q Consensus 251 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~-~~-~~~~~~~i~~~~ 309 (380)
...++..|++||.+......+.++|+||||+++++|++|+.||.. .+ .......+..+.
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 218 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV 218 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence 346678899999984334667799999999999999999999977 33 335555555443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=217.01 Aligned_cols=162 Identities=24% Similarity=0.237 Sum_probs=127.8
Q ss_pred CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCccccc-ccccCCCcccC
Q psy11098 184 ESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVS-TVVLPDLEFAS 260 (380)
Q Consensus 184 g~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~-~~~~gt~~y~a 260 (380)
|+|.+++.. ...+++..++.++.||+.||.|||+++ ||+|||++. +.+|+ ||++.... ....||+.|+|
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~~~g~~~y~a 72 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQSRVDPYFMA 72 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccccCCCcccccC
Confidence 689999976 456999999999999999999999999 999999984 57888 99987654 34478999999
Q ss_pred CccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhcccCCCCC---CcCCCCCH--HHHHHHHHhccc
Q psy11098 261 PEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEE-ETRAHISVADYSFPP---EQCGHISV--PARELIGQLLNT 334 (380)
Q Consensus 261 PE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~-~~~~~i~~~~~~~~~---~~~~~~s~--~~~~li~~~L~~ 334 (380)
||++.+ ..++.++|||||||++|+|++|..||...... .....+......... .....++. ++++||++||..
T Consensus 73 PE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~ 151 (176)
T smart00750 73 PEVIQG-QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCASR 151 (176)
T ss_pred hHHhcC-CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHHhc
Confidence 999988 47788999999999999999999999765432 222222221111111 11122344 699999999999
Q ss_pred CCCCCCCHHHHHhccccccc
Q psy11098 335 HADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 335 dP~~Rpt~~e~L~hpw~~~~ 354 (380)
||++|||+.|+++|+|+...
T Consensus 152 ~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 152 LPQRREAANHYLAHCRALFA 171 (176)
T ss_pred ccccccCHHHHHHHHHHHHH
Confidence 99999999999999998643
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.6e-30 Score=259.37 Aligned_cols=255 Identities=22% Similarity=0.372 Sum_probs=197.8
Q ss_pred hhce-eeeeeecccCCeEEEEEEEcCCCcEEEEEEecC----CCCchH---HHHHHHHHHHhhccCCCcceeeecccccC
Q psy11098 99 EHRY-EELERLGNGRFCTVRKARDRGTGQLVALKQIPR----ERQPQQ---ITRAEYNLLSTLMHAHIPTALALFENAPV 170 (380)
Q Consensus 99 ~~~y-~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~----~~~~~~---~~~~E~~il~~l~h~ni~~i~~~~~~~~~ 170 (380)
.+.| .-...+|.|++|.|+.+......+.++.|.+.. .....+ .+..|+.+-..|.|+|++..+.++...
T Consensus 316 ~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~-- 393 (601)
T KOG0590|consen 316 SEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEI-- 393 (601)
T ss_pred ccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhc--
Confidence 3445 455789999999999888887777777776542 111111 134577777788999987766666554
Q ss_pred CCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCccccc
Q psy11098 171 PGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVS 249 (380)
Q Consensus 171 ~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~ 249 (380)
...+-.||||.+ +|+.++.....++..++..+++|++.||+|||++||.|||||++|+++.. +.+||+|||.+....
T Consensus 394 -~~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 394 -DGILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFR 471 (601)
T ss_pred -ccchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeec
Confidence 333445999988 99999988888999999999999999999999999999999999999984 599999999886542
Q ss_pred ----------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHhcccCCC---CC
Q psy11098 250 ----------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETR--AHISVADYSF---PP 314 (380)
Q Consensus 250 ----------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~--~~i~~~~~~~---~~ 314 (380)
...+|...|+|||++.+..+.....||||.|++++.|++|+.||.-....+.. .......... +.
T Consensus 472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~ 551 (601)
T KOG0590|consen 472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPN 551 (601)
T ss_pred cCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChH
Confidence 45678899999999998767778899999999999999999999665443332 1111111111 11
Q ss_pred CcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCCC
Q psy11098 315 EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASCS 357 (380)
Q Consensus 315 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~~ 357 (380)
..+..++.+.+.+|.+||+.||.+|.|++++++.+||+...+-
T Consensus 552 ~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c 594 (601)
T KOG0590|consen 552 RLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECC 594 (601)
T ss_pred HHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcceE
Confidence 1234567889999999999999999999999999999987543
|
|
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=227.56 Aligned_cols=243 Identities=21% Similarity=0.215 Sum_probs=199.7
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCC-----CcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCC
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGT-----GQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVP 171 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~-----~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~ 171 (380)
..|++....+-+|.||.||.|.++.. .+.|-+|.++.... +-..+..|.-++..+.|+|+..+..+.-.. .
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~--~ 360 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIED--Y 360 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeec--c
Confidence 35678888899999999999976542 24566777765443 335667788889999999999988775543 2
Q ss_pred CceEEEEEecCCCCHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeCC-eeEEEeC
Q psy11098 172 GTDTIVMQLVHGESLIQHLCR--------QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGA-VLKLIDL 242 (380)
Q Consensus 172 ~~~~lv~e~~~gg~L~~~l~~--------~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~~-~ikl~DF 242 (380)
...+.++.++.-|+|..++.. ...++-.++..++.|++.|++|||+.|+||.||..+|.+||+. ++||+|=
T Consensus 361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDs 440 (563)
T KOG1024|consen 361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDS 440 (563)
T ss_pred CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccc
Confidence 455888899988999999972 1347778889999999999999999999999999999999987 8999999
Q ss_pred CCccccc--------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCC
Q psy11098 243 GSSVSVS--------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFP 313 (380)
Q Consensus 243 G~a~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~ 313 (380)
.+++.+- ..-.....||+||.+.+ ..++.++|+|||||++|||+| |+.|+.+-.+.++..-++.+..-..
T Consensus 441 aLSRDLFP~DYhcLGDnEnRPvkWMslEal~n-~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQ 519 (563)
T KOG1024|consen 441 ALSRDLFPGDYHCLGDNENRPVKWMSLEALQN-SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQ 519 (563)
T ss_pred hhccccCcccccccCCCCCCcccccCHHHHhh-hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecC
Confidence 9998653 22233567999999988 588899999999999999999 9999999999999888876643322
Q ss_pred CCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy11098 314 PEQCGHISVPARELIGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 314 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~ 347 (380)
.-+.++++...+--||..+|++||+.+|+..
T Consensus 520 ---P~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 520 ---PFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred ---CCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 2467999999999999999999999999863
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-26 Score=212.15 Aligned_cols=248 Identities=34% Similarity=0.499 Sum_probs=201.7
Q ss_pred eeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC----chHHHHHHHHHHHhhccC-CCcceeeecccccCCCceEE
Q psy11098 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ----PQQITRAEYNLLSTLMHA-HIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 102 y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~E~~il~~l~h~-ni~~i~~~~~~~~~~~~~~l 176 (380)
|.+.+.||.|+||.||++.+. ..+|+|.+..... ....+.+|+.++..+.|+ +++.+.+.+.. .+..++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~---~~~~~~ 75 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD---EGSLYL 75 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec---CCEEEE
Confidence 778899999999999999987 6899999965433 256678899999999988 69888888843 344799
Q ss_pred EEEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-C-eeEEEeCCCccccc--
Q psy11098 177 VMQLVHGESLIQHLCRQS---TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-A-VLKLIDLGSSVSVS-- 249 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~~~---~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~-~ikl~DFG~a~~~~-- 249 (380)
+++++.++++.+.+.... .+++.....++.|++.++.|+|+.+++|||+||+||+++. + .++++|||.+....
T Consensus 76 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 76 VMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred EEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 999999999997776664 7999999999999999999999999999999999999985 4 69999999886432
Q ss_pred ----------ccccCCCcccCCccccCC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhcccCC-C
Q psy11098 250 ----------TVVLPDLEFASPEMLTSP--ATAGPSTDMWSLGVLLYILLSGVSPFLDESE----EETRAHISVADYS-F 312 (380)
Q Consensus 250 ----------~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~----~~~~~~i~~~~~~-~ 312 (380)
....||..|+|||.+.+. ...+...|+||+|++++++++|..||..... ......+...... .
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccc
Confidence 455789999999999874 4778899999999999999999999877663 4455544444433 2
Q ss_pred CCCcCCCC----CHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 313 PPEQCGHI----SVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 313 ~~~~~~~~----s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
........ ...+.+++..++..+|..|.+..+...++|.....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~ 282 (384)
T COG0515 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLK 282 (384)
T ss_pred ccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCcc
Confidence 22111111 25789999999999999999999999997776543
|
|
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-26 Score=218.37 Aligned_cols=244 Identities=23% Similarity=0.283 Sum_probs=191.1
Q ss_pred ceeeeeeecccCCeEEEEEEEcCCC-cEEEEEEecCCCC-chHHHHHHHHHHHhhcc----CCCcceeeecccccCCCce
Q psy11098 101 RYEELERLGNGRFCTVRKARDRGTG-QLVALKQIPRERQ-PQQITRAEYNLLSTLMH----AHIPTALALFENAPVPGTD 174 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~~~-~~vAvK~~~~~~~-~~~~~~~E~~il~~l~h----~ni~~i~~~~~~~~~~~~~ 174 (380)
+|.+.+.||+|+||.||+|.+..++ ..+|+|....... ....+..|..++..+.. .+++.+++... ......
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~--~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR--STEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc--CCCcee
Confidence 8999999999999999999988774 6789998865432 22267789999999973 46777777764 223566
Q ss_pred EEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC------CeeEEEeCCCcc
Q psy11098 175 TIVMQLVHGESLIQHLCRQ--STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG------AVLKLIDLGSSV 246 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~------~~ikl~DFG~a~ 246 (380)
+|||+.+ |.+|.++.... ..++...+..++.|++.+|++||+.|++||||||+|+++.. ..+.|+|||+|+
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred EEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 9999999 99999988553 57999999999999999999999999999999999999963 369999999998
Q ss_pred --ccc--------------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC
Q psy11098 247 --SVS--------------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADY 310 (380)
Q Consensus 247 --~~~--------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~ 310 (380)
+.. ....||..|.++.+..+ ...+.+.|+||++.++.+|+.|..||.+...............
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~-~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~ 254 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG-IEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR 254 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHhCC-CccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence 320 12348999999999988 5778999999999999999999999977554322333322222
Q ss_pred CCCCC-cCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 311 SFPPE-QCGHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 311 ~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
..... .+...+.++..+...+-..+...+|....+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 255 KLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 11111 233356778888888888999999998888665
|
|
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.9e-27 Score=203.46 Aligned_cols=239 Identities=21% Similarity=0.273 Sum_probs=191.7
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhcc-CCCcceeeecccccCCCceEE
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMH-AHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h-~ni~~i~~~~~~~~~~~~~~l 176 (380)
...+|.++++||.|+||.+|+|.+-.+|+.||+|.-+......+ +..|..+.+.|++ ..|+.+..+.... ....+
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpq-L~yEskvY~iL~~g~GiP~i~~y~~e~---~ynvl 88 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQ-LLYESKVYRILQGGVGIPHIRHYGTEK---DYNVL 88 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcc-hhHHHHHHHHhccCCCCchhhhhcccc---cccee
Confidence 46789999999999999999999999999999998866554443 4568999999975 5677777776664 45599
Q ss_pred EEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC----CeeEEEeCCCccccc--
Q psy11098 177 VMQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG----AVLKLIDLGSSVSVS-- 249 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~----~~ikl~DFG~a~~~~-- 249 (380)
||+++ |.+|.+++.- ...++...+..++-|++.-++|+|.++++||||||+|.|+.- +.+-++|||+|++.-
T Consensus 89 VMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~ 167 (341)
T KOG1163|consen 89 VMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDI 167 (341)
T ss_pred eeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccc
Confidence 99999 9999998864 467999999999999999999999999999999999999963 478999999998652
Q ss_pred -----------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhcccCCCCCC
Q psy11098 250 -----------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESE---EETRAHISVADYSFPPE 315 (380)
Q Consensus 250 -----------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~---~~~~~~i~~~~~~~~~~ 315 (380)
....||..|.+=-...+ ...+.+.|+-|+|.++.++.-|..||++... ....+.|.......+.+
T Consensus 168 ~t~~HIpyre~r~ltGTaRYASinAh~g-~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie 246 (341)
T KOG1163|consen 168 RTRQHIPYREDRNLTGTARYASINAHLG-IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIE 246 (341)
T ss_pred cccccCccccCCccceeeeehhhhhhhh-hhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHH
Confidence 45678888877665555 3557789999999999999999999988543 34455565555555544
Q ss_pred -cCCCCCHHHHHHHHHhcccCCCCCCCH
Q psy11098 316 -QCGHISVPARELIGQLLNTHADKRPTA 342 (380)
Q Consensus 316 -~~~~~s~~~~~li~~~L~~dP~~Rpt~ 342 (380)
.|...+.|+.-.+..|=..-=++-|..
T Consensus 247 ~LC~G~P~EF~myl~Y~R~L~F~E~Pdy 274 (341)
T KOG1163|consen 247 VLCKGFPAEFAMYLNYCRGLGFEEKPDY 274 (341)
T ss_pred HHhCCCcHHHHHHHHHHhhcCCCCCCcH
Confidence 467888888888888766655555654
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-28 Score=240.77 Aligned_cols=243 Identities=26% Similarity=0.426 Sum_probs=205.1
Q ss_pred eecccCCeEEEEEEE---cCCCcEEEEEEecCCCC---chHHHHHHHHHHHhhc-cCCCcceeeecccccCCCceEEEEE
Q psy11098 107 RLGNGRFCTVRKARD---RGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLM-HAHIPTALALFENAPVPGTDTIVMQ 179 (380)
Q Consensus 107 ~LG~G~fg~V~~~~~---~~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~-h~ni~~i~~~~~~~~~~~~~~lv~e 179 (380)
.+|.|.||.|++++. ...|..||+|+.++... .......|..++...+ |+.++.+.-.++.. +..+++++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~---~kl~l~ld 77 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTD---GKLYLILD 77 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccc---cchhHhhh
Confidence 379999999998753 33577899998865322 1224456888899887 89998888777764 77899999
Q ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc--ccccCCC
Q psy11098 180 LVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS--TVVLPDL 256 (380)
Q Consensus 180 ~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~--~~~~gt~ 256 (380)
+..||.|+..+.+...+++...+.+...++-|++++|+.+|+|||+|++||+++ +|.+++.|||+++..- +..|||.
T Consensus 78 ~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~cgt~ 157 (612)
T KOG0603|consen 78 FLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIACGTY 157 (612)
T ss_pred hcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhcccch
Confidence 999999999999999999999999999999999999999999999999999998 6799999999998653 3348999
Q ss_pred cccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhcccCC
Q psy11098 257 EFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHA 336 (380)
Q Consensus 257 ~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 336 (380)
.|||||++++ ...++|.||+|+++++|++|..||.+ ++..+|......+|. .++.++++++..|+..+|
T Consensus 158 eymApEI~~g---h~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~----~l~~~a~~~~~~l~~r~p 226 (612)
T KOG0603|consen 158 EYRAPEIING---HLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPR----ELSAEARSLFRQLFKRNP 226 (612)
T ss_pred hhhhhHhhhc---cCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCch----hhhHHHHHHHHHHHhhCH
Confidence 9999999983 35689999999999999999999988 777788777777765 478899999999999999
Q ss_pred CCCCC-----HHHHHhcccccccCCCCCcccc
Q psy11098 337 DKRPT-----AGQLLQVAWFAEASCSEFDTER 363 (380)
Q Consensus 337 ~~Rpt-----~~e~L~hpw~~~~~~~~~~~~~ 363 (380)
..|.- +.++++|+||+...+..+....
T Consensus 227 ~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~ 258 (612)
T KOG0603|consen 227 ENRLGAGPDGVDEIKQHEFFQSIDWNELEARS 258 (612)
T ss_pred HHHhccCcchhHHHhccchheeeeHhhHhhcC
Confidence 99975 4799999999987665444333
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=221.10 Aligned_cols=158 Identities=24% Similarity=0.290 Sum_probs=125.6
Q ss_pred hhhhhceeeeeeecccCCeEEEEEEEcC-CCcEEEEEEecCC------CCchHHHHHHHHHHHhhccCCCcceeeecccc
Q psy11098 96 EQFEHRYEELERLGNGRFCTVRKARDRG-TGQLVALKQIPRE------RQPQQITRAEYNLLSTLMHAHIPTALALFENA 168 (380)
Q Consensus 96 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~-~~~~vAvK~~~~~------~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~ 168 (380)
..+..+|.+.+.||+|+||+||+|+++. +++.+|||++... ......+.+|+++|+.++|+|++..+.. .
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~--~- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA--T- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE--c-
Confidence 3467889999999999999999999886 6788899987532 1124567899999999999998753322 1
Q ss_pred cCCCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecC-CCCcEEEe-CCeeEEEeCCCcc
Q psy11098 169 PVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDI-RPENILMN-GAVLKLIDLGSSV 246 (380)
Q Consensus 169 ~~~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDl-Kp~NIl~~-~~~ikl~DFG~a~ 246 (380)
+..|+||||+.|++|.. +.. .. ...++.|+++||.|||++||+|||| ||+|||++ ++.+||+|||+|+
T Consensus 91 ---~~~~LVmE~~~G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~ 160 (365)
T PRK09188 91 ---GKDGLVRGWTEGVPLHL-ARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLAS 160 (365)
T ss_pred ---CCcEEEEEccCCCCHHH-hCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence 34699999999999963 211 11 1468899999999999999999999 99999997 4689999999998
Q ss_pred ccc--------------ccccCCCcccCCccccC
Q psy11098 247 SVS--------------TVVLPDLEFASPEMLTS 266 (380)
Q Consensus 247 ~~~--------------~~~~gt~~y~aPE~~~~ 266 (380)
... ...++++.|+|||.+..
T Consensus 161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 542 34566788999998754
|
|
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-25 Score=204.97 Aligned_cols=239 Identities=19% Similarity=0.293 Sum_probs=190.6
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhc-cCCCcceeeecccccCCCceEEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLM-HAHIPTALALFENAPVPGTDTIV 177 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~-h~ni~~i~~~~~~~~~~~~~~lv 177 (380)
.-.|++.++||.|.||+.+.|.+.-+++.||||.-.+.... .+++.|.+..+.|. .++|++++-+-.+. ....||
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A-PQLrdEYr~YKlL~g~~GIP~vYYFGqeG---~~NiLV 102 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA-PQLRDEYRTYKLLGGTEGIPQVYYFGQEG---KYNILV 102 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccCCc-chHHHHHHHHHHHcCCCCCCceeeecccc---chhhhh
Confidence 55799999999999999999999999999999987665443 45677999999886 56777766554443 445899
Q ss_pred EEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe------CCeeEEEeCCCccccc-
Q psy11098 178 MQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN------GAVLKLIDLGSSVSVS- 249 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~------~~~ikl~DFG~a~~~~- 249 (380)
||++ |.||.|++.- ...|+...+..++.|++.-++|+|++..|.|||||+|+||. .+.|.|+|||+|+...
T Consensus 103 idLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 103 IDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred hhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 9999 9999999864 56799999999999999999999999999999999999995 2379999999998652
Q ss_pred ------------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHhcccCCCC-
Q psy11098 250 ------------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDE---SEEETRAHISVADYSFP- 313 (380)
Q Consensus 250 ------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~---~~~~~~~~i~~~~~~~~- 313 (380)
....||-.||+--...+ ..-+.+.|+-|||-++++.|-|..||.+- +..+..++|-......+
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlG-rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i 260 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPI 260 (449)
T ss_pred ccccccCccccccccccceeeeEeecccc-chhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCH
Confidence 45678999999888888 46788999999999999999999999874 55666666654444333
Q ss_pred CCcCCCCCHHHHHHHHHhcccCCCCCCCHH
Q psy11098 314 PEQCGHISVPARELIGQLLNTHADKRPTAG 343 (380)
Q Consensus 314 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ 343 (380)
.+.|.+++.++..-++..=..+=.+-|..+
T Consensus 261 ~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYd 290 (449)
T KOG1165|consen 261 EVLCEGFPEEFATYLRYVRRLDFFETPDYD 290 (449)
T ss_pred HHHHhcCHHHHHHHHHHHHhcCcccCCCHH
Confidence 334666777766655555444555555543
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-26 Score=233.59 Aligned_cols=219 Identities=27% Similarity=0.439 Sum_probs=175.3
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEE
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIV 177 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv 177 (380)
....|+.++.|-.|++|-||.++|+.+.+.+|+| +++... |++ || +.+- ++.+.|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l----------ilR-----ni---lt~a------~npfvv 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL----------ILR-----NI---LTFA------GNPFVV 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhc-ccccch----------hhh-----cc---cccc------CCccee
Confidence 4578899999999999999999999999999995 332221 111 11 1111 122333
Q ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccc--------
Q psy11098 178 MQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSV-------- 248 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~-------- 248 (380)
|+-...++.-+.++.. ++.+++|||+.||+|||+||+|.+|. -|.+|+.|||++...
T Consensus 136 ------gDc~tllk~~g~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl 201 (1205)
T KOG0606|consen 136 ------GDCATLLKNIGPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNL 201 (1205)
T ss_pred ------chhhhhcccCCCCcch--------hhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchh
Confidence 3334445444455442 28899999999999999999999998 489999999987532
Q ss_pred -------------cccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCC
Q psy11098 249 -------------STVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPE 315 (380)
Q Consensus 249 -------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~ 315 (380)
...++|||+|.|||++.- ..|+..+|+|++|+|+|+.+.|..||.+++.++++..+...+..++++
T Consensus 202 ~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr-qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~ 280 (1205)
T KOG0606|consen 202 KEGHIEKDTHEFQDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEE 280 (1205)
T ss_pred hhcchHHHHHHhhhccccCCccccChhhhhh-hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccccc
Confidence 146799999999999988 588999999999999999999999999999999999999888888877
Q ss_pred cCCCCCHHHHHHHHHhcccCCCCCC---CHHHHHhcccccccCCC
Q psy11098 316 QCGHISVPARELIGQLLNTHADKRP---TAGQLLQVAWFAEASCS 357 (380)
Q Consensus 316 ~~~~~s~~~~~li~~~L~~dP~~Rp---t~~e~L~hpw~~~~~~~ 357 (380)
...++.|++++|.+||..+|..|. .+-++.+|+||+...+.
T Consensus 281 -dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 281 -DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred -CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 567899999999999999999995 57788899999976443
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.4e-25 Score=193.41 Aligned_cols=138 Identities=20% Similarity=0.257 Sum_probs=111.1
Q ss_pred eeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---c------------------------hHHHHHHHHHHHhhccCC
Q psy11098 105 LERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---P------------------------QQITRAEYNLLSTLMHAH 157 (380)
Q Consensus 105 ~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~------------------------~~~~~~E~~il~~l~h~n 157 (380)
.+.||+|+||.||+|.+. +|+.||+|+++.... . ......|++++..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999987 899999999965421 1 012245999999999887
Q ss_pred CcceeeecccccCCCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHCCcEeecCCCCcEEEeCCe
Q psy11098 158 IPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCL-HSQQIAHKDIRPENILMNGAV 236 (380)
Q Consensus 158 i~~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~l-H~~~iiHrDlKp~NIl~~~~~ 236 (380)
+.....+. . ...+|||||+.|+++...+.....+++..+..++.|++.+|.++ |+.||+||||||+|||++++.
T Consensus 81 v~~p~~~~-~----~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~~~ 155 (190)
T cd05147 81 IPCPEPIL-L----KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHDGK 155 (190)
T ss_pred CCCCcEEE-e----cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEECCc
Confidence 64332221 1 22389999998887766554566899999999999999999999 799999999999999999889
Q ss_pred eEEEeCCCcccc
Q psy11098 237 LKLIDLGSSVSV 248 (380)
Q Consensus 237 ikl~DFG~a~~~ 248 (380)
++|+|||+|...
T Consensus 156 v~LiDFG~a~~~ 167 (190)
T cd05147 156 LYIIDVSQSVEH 167 (190)
T ss_pred EEEEEccccccC
Confidence 999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.3e-25 Score=227.21 Aligned_cols=227 Identities=25% Similarity=0.306 Sum_probs=173.3
Q ss_pred ceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC--CchHHH---HHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER--QPQQIT---RAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~---~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
.|...+.||+++|=+|.+|++.. | .|+||+|-+.. ..-..+ ..|++ ...+++||..++....... ...|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~---kAAy 97 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTD---KAAY 97 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhh---HHHH
Confidence 56677899999999999999875 5 48999985433 222222 33444 5566899998877765543 5568
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCcccc--c---
Q psy11098 176 IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSV--S--- 249 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~--~--- 249 (380)
||-+|. .-+|+|++..+.-+...+.+.|+.||+.||..+|..||+|||||.||||+++ +-+.|+||..-+-. .
T Consensus 98 lvRqyv-khnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 98 LVRQYV-KHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred HHHHHH-hhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 999998 7899999999988999999999999999999999999999999999999986 56889999865422 1
Q ss_pred --------ccccCCCcccCCccccCCC---------C-CCCcccHHHHHHHHHHHHh-CCCCCCC-----------CCHH
Q psy11098 250 --------TVVLPDLEFASPEMLTSPA---------T-AGPSTDMWSLGVLLYILLS-GVSPFLD-----------ESEE 299 (380)
Q Consensus 250 --------~~~~gt~~y~aPE~~~~~~---------~-~~~~~DiwSlGvil~~llt-g~~Pf~~-----------~~~~ 299 (380)
.+...-..|.|||.+.... . .+.+.||||+||++.||++ |.+||.- ...+
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e 256 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPE 256 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHH
Confidence 1112234699999875421 1 3568899999999999999 8999831 1122
Q ss_pred HHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 300 ETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 300 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
..+++|. +..+++||..|++.||.+|.+|++.|+-
T Consensus 257 ~~Le~Ie--------------d~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 257 QLLEKIE--------------DVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHHhCc--------------CccHHHHHHHHHccCchhccCHHHHHHh
Confidence 2222221 3468999999999999999999999976
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=9e-24 Score=186.70 Aligned_cols=139 Identities=18% Similarity=0.250 Sum_probs=112.2
Q ss_pred eeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCc---------------------------hHHHHHHHHHHHhhccCC
Q psy11098 105 LERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP---------------------------QQITRAEYNLLSTLMHAH 157 (380)
Q Consensus 105 ~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---------------------------~~~~~~E~~il~~l~h~n 157 (380)
...||+|+||+||+|.+. +|+.||||+++..... ......|++.+..+.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 468999999999999987 8999999999754211 112357899999999998
Q ss_pred CcceeeecccccCCCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeecCCCCcEEEeCCe
Q psy11098 158 IPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHS-QQIAHKDIRPENILMNGAV 236 (380)
Q Consensus 158 i~~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~-~~iiHrDlKp~NIl~~~~~ 236 (380)
+.....+... ..+|||||+.|+++.........+++.++..++.|++.+|.++|+ .||+||||||+|||++++.
T Consensus 81 i~~p~~~~~~-----~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~~~~ 155 (190)
T cd05145 81 VPVPEPILLK-----KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYHDGK 155 (190)
T ss_pred CCCceEEEec-----CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEECCC
Confidence 7443333221 238999999888655443345678889999999999999999999 9999999999999999889
Q ss_pred eEEEeCCCccccc
Q psy11098 237 LKLIDLGSSVSVS 249 (380)
Q Consensus 237 ikl~DFG~a~~~~ 249 (380)
++|+|||++....
T Consensus 156 ~~liDFG~a~~~~ 168 (190)
T cd05145 156 PYIIDVSQAVELD 168 (190)
T ss_pred EEEEEcccceecC
Confidence 9999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.1e-24 Score=191.24 Aligned_cols=176 Identities=14% Similarity=0.133 Sum_probs=133.5
Q ss_pred hhhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHH----------HHHHHHHHHhhccCCCcceeee
Q psy11098 95 QEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQI----------TRAEYNLLSTLMHAHIPTALAL 164 (380)
Q Consensus 95 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~----------~~~E~~il~~l~h~ni~~i~~~ 164 (380)
.+-+..+|++.+.||.|+||.||++.. ++..+|+|++.......+. +++|++.+.++.|++++.+.++
T Consensus 26 ~~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~ 103 (232)
T PRK10359 26 DDFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDF 103 (232)
T ss_pred HHHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEe
Confidence 456789999999999999999999655 4668999999643322221 5789999999999999999888
Q ss_pred cccccC-----CCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeCCeeEE
Q psy11098 165 FENAPV-----PGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGAVLKL 239 (380)
Q Consensus 165 ~~~~~~-----~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~~~ikl 239 (380)
+..... .+..+|+|||++|.+|.+.. .+++ ....+++.+|..||+.|++|||+||+||+++.+.++|
T Consensus 104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~gi~l 175 (232)
T PRK10359 104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNGLRI 175 (232)
T ss_pred eeecccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCCEEE
Confidence 664321 24579999999999997763 2333 2466999999999999999999999999998544999
Q ss_pred EeCCCcccccccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHH
Q psy11098 240 IDLGSSVSVSTVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILL 287 (380)
Q Consensus 240 ~DFG~a~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ll 287 (380)
+|||.+........... ++.. ..++.++|+||||+++..+.
T Consensus 176 iDfg~~~~~~e~~a~d~------~vle-r~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 176 IDLSGKRCTAQRKAKDR------IDLE-RHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EECCCcccccchhhHHH------HHHH-hHhcccccccceeEeehHHH
Confidence 99998765431110000 2223 35567999999999887654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.3e-23 Score=179.92 Aligned_cols=178 Identities=16% Similarity=0.128 Sum_probs=136.9
Q ss_pred eeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCch-----HHHHHHHHHHHhhc-cCCCcceeeecccccCCCceEEE
Q psy11098 104 ELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQ-----QITRAEYNLLSTLM-HAHIPTALALFENAPVPGTDTIV 177 (380)
Q Consensus 104 ~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~-----~~~~~E~~il~~l~-h~ni~~i~~~~~~~~~~~~~~lv 177 (380)
+...|++|+||+|+.+.. .+..++.+.+....... ..+++|+++|+.|. |+++++++++ +..+++
T Consensus 6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~-------~~~~lv 76 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW-------DGRHLD 76 (218)
T ss_pred cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE-------cCEEEE
Confidence 457899999999997765 57788877775544322 26788999999995 4789888886 234999
Q ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecC-CCCcEEEe-CCeeEEEeCCCcccccc-----
Q psy11098 178 MQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDI-RPENILMN-GAVLKLIDLGSSVSVST----- 250 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDl-Kp~NIl~~-~~~ikl~DFG~a~~~~~----- 250 (380)
|||+.|.+|...+... ...++.|++.+|.++|++||+|||| ||+|||++ ++.++|+|||+|.....
T Consensus 77 meyI~G~~L~~~~~~~-------~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 77 RSYLAGAAMYQRPPRG-------DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred EeeecCccHHhhhhhh-------hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 9999999987544211 1357889999999999999999999 79999997 56899999999974431
Q ss_pred --------------cccCCCcccCCccccCCCCCC-CcccHHHHHHHHHHHHhCCCCCCCCC
Q psy11098 251 --------------VVLPDLEFASPEMLTSPATAG-PSTDMWSLGVLLYILLSGVSPFLDES 297 (380)
Q Consensus 251 --------------~~~gt~~y~aPE~~~~~~~~~-~~~DiwSlGvil~~lltg~~Pf~~~~ 297 (380)
....++.|++|+...--...+ ...++++.|+-+|.++|+..++.+++
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 112477888887654322333 46799999999999999988886654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-23 Score=194.48 Aligned_cols=230 Identities=25% Similarity=0.317 Sum_probs=144.7
Q ss_pred ceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCc----hHHHHHHHHHHHhhc----------cCCCcceeeec-
Q psy11098 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP----QQITRAEYNLLSTLM----------HAHIPTALALF- 165 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~----~~~~~~E~~il~~l~----------h~ni~~i~~~~- 165 (380)
.+...+.||.|+++.||.+.+..||+.+|+|++...... -+.+++|.-....+. |-.++..++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 456678999999999999999999999999998543322 233333432222211 21222222221
Q ss_pred --------ccccCCC-----ceEEEEEecCCCCHHHHHHh---cCCC----CHHHHHHHHHHHHHHHHHHHHCCcEeecC
Q psy11098 166 --------ENAPVPG-----TDTIVMQLVHGESLIQHLCR---QSTI----TESYICCIIRQLHSALHCLHSQQIAHKDI 225 (380)
Q Consensus 166 --------~~~~~~~-----~~~lv~e~~~gg~L~~~l~~---~~~l----~e~~~~~i~~qil~al~~lH~~~iiHrDl 225 (380)
....... +.+++|.-+ .++|.+.+.. .... .-.....+..|++..+++||+.|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 1111111 225677776 6788777642 2222 22223455689999999999999999999
Q ss_pred CCCcEEEe-CCeeEEEeCCCccccccc---ccCCCcccCCccccCC-------CCCCCcccHHHHHHHHHHHHhCCCCCC
Q psy11098 226 RPENILMN-GAVLKLIDLGSSVSVSTV---VLPDLEFASPEMLTSP-------ATAGPSTDMWSLGVLLYILLSGVSPFL 294 (380)
Q Consensus 226 Kp~NIl~~-~~~ikl~DFG~a~~~~~~---~~gt~~y~aPE~~~~~-------~~~~~~~DiwSlGvil~~lltg~~Pf~ 294 (380)
||+|+|++ +|.+.|+||+.....+.. ...+..|.+||..... ..++.+.|.|+||+++|.|+||..||.
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~ 251 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFG 251 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STC
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCC
Confidence 99999998 679999999987766532 2346778899876431 245778999999999999999999997
Q ss_pred CCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCC
Q psy11098 295 DESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHADKR 339 (380)
Q Consensus 295 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 339 (380)
....+..... ....|.++++.+++||+.||++||++|
T Consensus 252 ~~~~~~~~~~--------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 252 LSSPEADPEW--------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp CCGGGSTSGG--------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred CCCccccccc--------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 6543222111 223456789999999999999999988
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.6e-22 Score=180.91 Aligned_cols=145 Identities=18% Similarity=0.176 Sum_probs=115.6
Q ss_pred hhceeeeeeecccCCeEEEEEE-EcCCCcEEEEEEecCCCCc-------------------------hHHHHHHHHHHHh
Q psy11098 99 EHRYEELERLGNGRFCTVRKAR-DRGTGQLVALKQIPRERQP-------------------------QQITRAEYNLLST 152 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~-~~~~~~~vAvK~~~~~~~~-------------------------~~~~~~E~~il~~ 152 (380)
..-|++.+.||+|+||.||+|. +..+|+.||+|+++..... ......|++++..
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3458899999999999999999 7778999999999643210 1224679999999
Q ss_pred hccCCCcceeeecccccCCCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC-cEeecCCCCcEE
Q psy11098 153 LMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQ-IAHKDIRPENIL 231 (380)
Q Consensus 153 l~h~ni~~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~-iiHrDlKp~NIl 231 (380)
+.+. .+.+...+.. +..++||||+.|.+|.........+.+..+..++.||+.+|.+||+.| |+||||||+||+
T Consensus 107 L~~~-~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIl 181 (237)
T smart00090 107 LYEA-GVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNIL 181 (237)
T ss_pred HHhc-CCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEE
Confidence 9763 2333333332 234899999999888776655556777778899999999999999999 999999999999
Q ss_pred EeCCeeEEEeCCCcccc
Q psy11098 232 MNGAVLKLIDLGSSVSV 248 (380)
Q Consensus 232 ~~~~~ikl~DFG~a~~~ 248 (380)
++++.++|+|||.|...
T Consensus 182 i~~~~i~LiDFg~a~~~ 198 (237)
T smart00090 182 VHDGKVVIIDVSQSVEL 198 (237)
T ss_pred EECCCEEEEEChhhhcc
Confidence 99779999999998643
|
|
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.3e-22 Score=185.47 Aligned_cols=186 Identities=24% Similarity=0.366 Sum_probs=137.5
Q ss_pred ccCCCcceeeecccc------------------------cCCCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHH
Q psy11098 154 MHAHIPTALALFENA------------------------PVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLH 209 (380)
Q Consensus 154 ~h~ni~~i~~~~~~~------------------------~~~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil 209 (380)
+||||+.+...|-.. .++.++|+||.-. ..+|..++..+ ..+-...+.++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~-~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR-HRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC-CCchHHHHHHHHHHH
Confidence 599999887776321 1224678999887 67898888655 567778889999999
Q ss_pred HHHHHHHHCCcEeecCCCCcEEEe---CC--eeEEEeCCCccccc------------ccccCCCcccCCccccCCCCC--
Q psy11098 210 SALHCLHSQQIAHKDIRPENILMN---GA--VLKLIDLGSSVSVS------------TVVLPDLEFASPEMLTSPATA-- 270 (380)
Q Consensus 210 ~al~~lH~~~iiHrDlKp~NIl~~---~~--~ikl~DFG~a~~~~------------~~~~gt~~y~aPE~~~~~~~~-- 270 (380)
+|+.|||++||.|||+|.+|||+. ++ .+.|+|||.+---. ....|+-.-||||+...-...
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 999999999999999999999993 33 68999999753211 234567789999998752111
Q ss_pred ---CCcccHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy11098 271 ---GPSTDMWSLGVLLYILLSGVSPFLDESEE--ETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQL 345 (380)
Q Consensus 271 ---~~~~DiwSlGvil~~lltg~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~ 345 (380)
-.++|.|+.|.+.||++....||.+.... ++.. ....+ + +...+.+++.+++++..+|+.||.+|+++.-+
T Consensus 432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~-Yqe~q--L-Palp~~vpp~~rqlV~~lL~r~pskRvsp~iA 507 (598)
T KOG4158|consen 432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT-YQESQ--L-PALPSRVPPVARQLVFDLLKRDPSKRVSPNIA 507 (598)
T ss_pred eeccchhhhhhhhhhHHHHhccCCcccccchheechhh-hhhhh--C-CCCcccCChHHHHHHHHHhcCCccccCCccHH
Confidence 23899999999999999999999773221 1111 11111 1 12234678999999999999999999985543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.2e-21 Score=172.24 Aligned_cols=135 Identities=19% Similarity=0.219 Sum_probs=107.7
Q ss_pred eeeecccCCeEEEEEEEcCCCcEEEEEEecCC-CCchHHHHHHHHHHHhh-----ccCCCcceeeecccccCCCceE-EE
Q psy11098 105 LERLGNGRFCTVRKARDRGTGQLVALKQIPRE-RQPQQITRAEYNLLSTL-----MHAHIPTALALFENAPVPGTDT-IV 177 (380)
Q Consensus 105 ~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~il~~l-----~h~ni~~i~~~~~~~~~~~~~~-lv 177 (380)
.+.||+|+||.||. ++.++.. +||++... ......+.+|+.+++.+ .|+||++++++++.....+.++ +|
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 47899999999995 7777766 69988654 23456789999999999 5799999999998864434444 78
Q ss_pred EEe--cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHHCCcEeecCCCCcEEEeC-----CeeEEEeCCCc
Q psy11098 178 MQL--VHGESLIQHLCRQSTITESYICCIIRQLHSAL-HCLHSQQIAHKDIRPENILMNG-----AVLKLIDLGSS 245 (380)
Q Consensus 178 ~e~--~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al-~~lH~~~iiHrDlKp~NIl~~~-----~~ikl~DFG~a 245 (380)
+|| +.+++|.+++.+. .+++. ..++.|++.++ +|||+++|+||||||+|||++. ..++|+||+.+
T Consensus 84 ~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred ecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 999 4479999999664 56666 36688888888 9999999999999999999962 27999995443
|
|
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.5e-21 Score=199.32 Aligned_cols=188 Identities=21% Similarity=0.255 Sum_probs=150.4
Q ss_pred hhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhc---cCCCcceeeecccccCCC
Q psy11098 96 EQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLM---HAHIPTALALFENAPVPG 172 (380)
Q Consensus 96 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~---h~ni~~i~~~~~~~~~~~ 172 (380)
+.-...|.|.+.||+|+||+||+|.+.. |+.||+|+-+...-.+ +.-=.+++.+|+ -+.|.++..++.. .+
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE--fYI~~q~~~RLk~~~~~~~~~~~~a~~~---~~ 767 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE--FYICLQVMERLKPQMLPSIMHISSAHVF---QN 767 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee--eeehHHHHHhhchhhhcchHHHHHHHcc---CC
Confidence 3445789999999999999999999887 9999999876543322 111123333343 2233334433333 35
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe--------CCeeEEEeCCC
Q psy11098 173 TDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN--------GAVLKLIDLGS 244 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~--------~~~ikl~DFG~ 244 (380)
..++|+||...|+|.+++...+.+++..+..++.|++..|++||..+|||+||||+|.|+. ..-++|||||-
T Consensus 768 ~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~ 847 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGR 847 (974)
T ss_pred cceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEeccc
Confidence 6699999999999999999888999999999999999999999999999999999999993 12699999998
Q ss_pred ccccc--------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCC
Q psy11098 245 SVSVS--------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGV 290 (380)
Q Consensus 245 a~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~ 290 (380)
|..+. ...++|-.+-.+|...| ...++.+|.|.|+.+++.||.|+
T Consensus 848 siDm~lfp~~~~F~~~~~td~f~C~EM~~g-rpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 848 SIDMKLFPDGTKFKAVWHTDLFDCIEMREG-RPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred ceeeeEcCCCcEEeeeeccccchhHHHhcC-CCCchhhhhHHHHHHHHHHHHHH
Confidence 86442 34567888999999999 69999999999999999999984
|
|
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-20 Score=168.19 Aligned_cols=237 Identities=19% Similarity=0.235 Sum_probs=183.0
Q ss_pred eeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC---CCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEE
Q psy11098 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE---RQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVM 178 (380)
Q Consensus 102 y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~ 178 (380)
..++-+|.....|..|+|++.++ .+++|++... ......+..|.-.|+.+.||||..+++.+... .+..++.
T Consensus 192 lnl~tkl~e~hsgelwrgrwqgn--divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp---pnlv~is 266 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQGN--DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP---PNLVIIS 266 (448)
T ss_pred hhhhhhhccCCCcccccccccCc--chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC---CCceEee
Confidence 34556788899999999998864 4677877532 23345677799999999999999999888764 5679999
Q ss_pred EecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cEeecCCCCcEEEeCC---eeEEEeCCCccccccc
Q psy11098 179 QLVHGESLIQHLCRQS--TITESYICCIIRQLHSALHCLHSQQ--IAHKDIRPENILMNGA---VLKLIDLGSSVSVSTV 251 (380)
Q Consensus 179 e~~~gg~L~~~l~~~~--~l~e~~~~~i~~qil~al~~lH~~~--iiHrDlKp~NIl~~~~---~ikl~DFG~a~~~~~~ 251 (380)
.|+.-|+|+..+..+. ..+..++..++.+|+.|+.|||+.. |.---|....+++|+. .+-.+|--++.+. ..
T Consensus 267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe-~g 345 (448)
T KOG0195|consen 267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE-VG 345 (448)
T ss_pred eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeec-cc
Confidence 9999999999997643 3677889999999999999999874 4444677889999865 4555565444332 23
Q ss_pred ccCCCcccCCccccCCCCC--CCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHH
Q psy11098 252 VLPDLEFASPEMLTSPATA--GPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIG 329 (380)
Q Consensus 252 ~~gt~~y~aPE~~~~~~~~--~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 329 (380)
..-.|.||+||.+...... -.++|||||++++|||.|.+.||.+-+..+.-.+|........ ..+.++..+..|++
T Consensus 346 r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~--ippgis~hm~klm~ 423 (448)
T KOG0195|consen 346 RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVH--IPPGISRHMNKLMN 423 (448)
T ss_pred cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcccccc--CCCCccHHHHHHHH
Confidence 3347899999998763222 2478999999999999999999999888887766654443322 22478999999999
Q ss_pred HhcccCCCCCCCHHHHH
Q psy11098 330 QLLNTHADKRPTAGQLL 346 (380)
Q Consensus 330 ~~L~~dP~~Rpt~~e~L 346 (380)
-|++.||.+||..+.+.
T Consensus 424 icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 424 ICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHhcCCCCcCCCcceeh
Confidence 99999999999877654
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.1e-19 Score=160.94 Aligned_cols=133 Identities=22% Similarity=0.266 Sum_probs=109.2
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---------chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEE
Q psy11098 106 ERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---------PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 106 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---------~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
+.||+|++|.||+|.+ .|..+++|+...... ......+|+.++..+.|++++....++... +..++
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~---~~~~l 76 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP---ENFII 76 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC---CCCEE
Confidence 5799999999999987 567899998643221 113456799999999999886665554432 45699
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeCCeeEEEeCCCccc
Q psy11098 177 VMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGAVLKLIDLGSSVS 247 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~~~ikl~DFG~a~~ 247 (380)
+|||+.|++|.+.+..... ....++.+++.+|.++|+.|++|+|++|.|||++++.++|+|||++..
T Consensus 77 v~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~~~~~~liDf~~a~~ 143 (211)
T PRK14879 77 VMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILSGGKIYLIDFGLAEF 143 (211)
T ss_pred EEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEECCCEEEEECCcccC
Confidence 9999999999998865432 788999999999999999999999999999999988999999998864
|
|
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.5e-21 Score=183.89 Aligned_cols=170 Identities=26% Similarity=0.366 Sum_probs=133.7
Q ss_pred ceEEEEEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccc
Q psy11098 173 TDTIVMQLVHGESLIQHLCRQ---STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSV 248 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~~---~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~ 248 (380)
..||.|++|...+|.+++... ...+......++.|+..|++| +|.+|||+||.||++. +.++||.|||+....
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~ 406 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ 406 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence 468999999999999999754 346677789999999999999 9999999999999996 558999999997654
Q ss_pred c------------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhcccCCCCCC
Q psy11098 249 S------------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDES-EEETRAHISVADYSFPPE 315 (380)
Q Consensus 249 ~------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~-~~~~~~~i~~~~~~~~~~ 315 (380)
. +...||..||+||++.+ ..|+.++||||||+||+||++ +|.... ...+...+.. ..+|+.
T Consensus 407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g-~~y~~kvdIyaLGlil~EL~~---~f~T~~er~~t~~d~r~--g~ip~~ 480 (516)
T KOG1033|consen 407 DKDETVAPAAASHTQQVGTLLYMSPEQIRG-QQYSEKVDIYALGLILAELLI---QFSTQFERIATLTDIRD--GIIPPE 480 (516)
T ss_pred ccCCcccchhhhhhhcccccccCCHHHHhh-hhhhhhcchhhHHHHHHHHHH---HhccHHHHHHhhhhhhc--CCCChH
Confidence 3 34578999999999999 588999999999999999996 232211 1222333333 334433
Q ss_pred cCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccc
Q psy11098 316 QCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFA 352 (380)
Q Consensus 316 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~ 352 (380)
...+++ +..+|+.+||.+.|.+||++.+.-.|+|.+
T Consensus 481 ~~~d~p-~e~~ll~~lls~~p~~RP~~~~~~~~~~~~ 516 (516)
T KOG1033|consen 481 FLQDYP-EEYTLLQQLLSPSPEERPSAIEVALHEFLQ 516 (516)
T ss_pred HhhcCc-HHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence 333333 457899999999999999888888888864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.2e-19 Score=159.62 Aligned_cols=137 Identities=20% Similarity=0.210 Sum_probs=106.3
Q ss_pred ceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC-----------------------chHHHHHHHHHHHhhccCC
Q psy11098 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ-----------------------PQQITRAEYNLLSTLMHAH 157 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-----------------------~~~~~~~E~~il~~l~h~n 157 (380)
.|.+.+.||+|+||.||++.+. +|+.||||++..... .......|+.++..+.|.+
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 3788899999999999999875 799999998764321 0112467899999998875
Q ss_pred CcceeeecccccCCCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCe
Q psy11098 158 IPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAV 236 (380)
Q Consensus 158 i~~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ 236 (380)
+ .+...+.. +..+++|||+.|++|...... .....++.+++.++.++|+.||+||||||+||+++ ++.
T Consensus 95 i-~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~ 163 (198)
T cd05144 95 F-PVPKPIDW----NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEK 163 (198)
T ss_pred C-CCCceeec----CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCc
Confidence 3 22222222 345899999999988765421 34567889999999999999999999999999998 568
Q ss_pred eEEEeCCCccccc
Q psy11098 237 LKLIDLGSSVSVS 249 (380)
Q Consensus 237 ikl~DFG~a~~~~ 249 (380)
++|+|||++....
T Consensus 164 ~~liDfg~~~~~~ 176 (198)
T cd05144 164 IYIIDWPQMVSTD 176 (198)
T ss_pred EEEEECCccccCC
Confidence 9999999986544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.2e-21 Score=197.87 Aligned_cols=251 Identities=24% Similarity=0.370 Sum_probs=201.4
Q ss_pred hhceeeeeeecccCCeEEEEEEEcC-CCcEEEEEEecCCCC---chHHHHHHHHHHHhhc-cCCCcceeeecccccCCCc
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRG-TGQLVALKQIPRERQ---PQQITRAEYNLLSTLM-HAHIPTALALFENAPVPGT 173 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~-~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~-h~ni~~i~~~~~~~~~~~~ 173 (380)
...|.+.+.||+|+|+.|-++.... +...+|+|.+..... .......|..+-..+. |.|++++++..... ..
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~---~~ 95 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSP---RS 95 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCC---cc
Confidence 4567888889999999999888644 445778887765432 2334445788877777 99998887776664 66
Q ss_pred eEEEEEecCCCCHHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-HCCcEeecCCCCcEEEe-CC-eeEEEeCCCcccc
Q psy11098 174 DTIVMQLVHGESLIQHL-CRQS-TITESYICCIIRQLHSALHCLH-SQQIAHKDIRPENILMN-GA-VLKLIDLGSSVSV 248 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l-~~~~-~l~e~~~~~i~~qil~al~~lH-~~~iiHrDlKp~NIl~~-~~-~ikl~DFG~a~~~ 248 (380)
.++++++..|+++++.+ .... ..+...+..++.|+..++.|+| ..++.||||||+|.+++ ++ .++++|||+|...
T Consensus 96 ~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 96 YLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccc
Confidence 79999999999999999 5554 6788889999999999999999 99999999999999998 45 7999999999755
Q ss_pred c---------ccccC-CCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHhcccCCCCCCc
Q psy11098 249 S---------TVVLP-DLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEET--RAHISVADYSFPPEQ 316 (380)
Q Consensus 249 ~---------~~~~g-t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~--~~~i~~~~~~~~~~~ 316 (380)
. ...+| ++.|+|||...+....+...|+||+|+++.-+++|..|+........ ...+... ..+....
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~ 254 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK-GRFTQLP 254 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccc-cccccCc
Confidence 3 34577 99999999998866778899999999999999999999865443321 1111111 2222345
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccc
Q psy11098 317 CGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAE 353 (380)
Q Consensus 317 ~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~ 353 (380)
+..++....+++.++|..+|..|.+.+++-.++|+..
T Consensus 255 ~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 255 WNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cccCChhhhhcccccccCCchhccccccccccccccc
Confidence 6778999999999999999999999999999999988
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.80 E-value=7.5e-19 Score=156.00 Aligned_cols=129 Identities=24% Similarity=0.312 Sum_probs=102.1
Q ss_pred eecccCCeEEEEEEEcCCCcEEEEEEecCCCC---------chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEE
Q psy11098 107 RLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---------PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIV 177 (380)
Q Consensus 107 ~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---------~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv 177 (380)
.||+|+||.||+|.. ++..+++|....... ....+.+|+++++.+.|+++.....++.. .+..+++
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~---~~~~~lv 75 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD---PDNKTIV 75 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE---CCCCEEE
Confidence 389999999999985 467899998643211 11345679999999998765433333322 2456899
Q ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeCCeeEEEeCCCccc
Q psy11098 178 MQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGAVLKLIDLGSSVS 247 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~~~ikl~DFG~a~~ 247 (380)
|||+.|++|.+.+..... .++.+++.+|.+||+.|++|+|++|+|||++++.++++|||++..
T Consensus 76 ~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~~~~~~liDfg~a~~ 138 (199)
T TIGR03724 76 MEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVRDDKLYLIDFGLGKY 138 (199)
T ss_pred EEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEECCcEEEEECCCCcC
Confidence 999999999988754321 789999999999999999999999999999988999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.78 E-value=2e-18 Score=175.90 Aligned_cols=135 Identities=27% Similarity=0.346 Sum_probs=106.8
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEe-cCC-CC-------chHHHHHHHHHHHhhccCCCcceeeecccccC
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQI-PRE-RQ-------PQQITRAEYNLLSTLMHAHIPTALALFENAPV 170 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~-~~~-~~-------~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~ 170 (380)
..|...+.||+|+||+||++.+... .+++|+. .+. .. ....+.+|+++++.++|++++....+....
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-- 408 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP-- 408 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC--
Confidence 4456678999999999999987644 3444432 211 11 124567899999999999987765544432
Q ss_pred CCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeCCeeEEEeCCCccc
Q psy11098 171 PGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGAVLKLIDLGSSVS 247 (380)
Q Consensus 171 ~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~~~ikl~DFG~a~~ 247 (380)
...++||||+.|++|.+++. ....++.|++.+|.+||+.|++||||||+|||++++.++|+|||+++.
T Consensus 409 -~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~~~~~~liDFGla~~ 476 (535)
T PRK09605 409 -EEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVRDDRLYLIDFGLGKY 476 (535)
T ss_pred -CCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEECCcEEEEeCccccc
Confidence 45689999999999999885 356799999999999999999999999999999888999999999865
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.3e-18 Score=150.28 Aligned_cols=135 Identities=22% Similarity=0.318 Sum_probs=97.7
Q ss_pred eeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCch---HH----------------------HHHHHHHHHhhccCC--
Q psy11098 105 LERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQ---QI----------------------TRAEYNLLSTLMHAH-- 157 (380)
Q Consensus 105 ~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~---~~----------------------~~~E~~il~~l~h~n-- 157 (380)
.+.||+|+||+||+|.+. +++.||||++....... .. ...|.+.+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999977 78999999986532211 11 134666666665443
Q ss_pred CcceeeecccccCCCceEEEEEecCCCCHHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeecCCCCcEEEeCC
Q psy11098 158 IPTALALFENAPVPGTDTIVMQLVHGESLIQ-HLCRQSTITESYICCIIRQLHSALHCLHS-QQIAHKDIRPENILMNGA 235 (380)
Q Consensus 158 i~~i~~~~~~~~~~~~~~lv~e~~~gg~L~~-~l~~~~~l~e~~~~~i~~qil~al~~lH~-~~iiHrDlKp~NIl~~~~ 235 (380)
++..+.+ ...+++|||+.|+.+.. .+... ... ..+..++.+++.++.++|. .||+||||||+||+++++
T Consensus 81 ~~~~~~~-------~~~~lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~~~ 151 (187)
T cd05119 81 VPKPIDL-------NRHVLVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVDDG 151 (187)
T ss_pred CCceEec-------CCCEEEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEECC
Confidence 3333332 23489999998854321 11111 111 6678999999999999999 999999999999999988
Q ss_pred eeEEEeCCCccccc
Q psy11098 236 VLKLIDLGSSVSVS 249 (380)
Q Consensus 236 ~ikl~DFG~a~~~~ 249 (380)
.++|+|||.+....
T Consensus 152 ~~~liDfg~a~~~~ 165 (187)
T cd05119 152 KVYIIDVPQAVEID 165 (187)
T ss_pred cEEEEECccccccc
Confidence 99999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.8e-17 Score=160.41 Aligned_cols=194 Identities=21% Similarity=0.354 Sum_probs=152.2
Q ss_pred HHhhccCCCcceeeecccccCCCceEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCc-EeecCCC
Q psy11098 150 LSTLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQI-AHKDIRP 227 (380)
Q Consensus 150 l~~l~h~ni~~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~i-iHrDlKp 227 (380)
|+.+.|.|+.++++..... ...++|.+||..|+|.+.+.. ...++......++++|+.||.|||..-| .|+.|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~---~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG---PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecC---CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecc
Confidence 3568899999999888775 677999999999999999977 4578888899999999999999998765 9999999
Q ss_pred CcEEEeCC-eeEEEeCCCcccccc--------cccCCCcccCCccccCCCC------CCCcccHHHHHHHHHHHHhCCCC
Q psy11098 228 ENILMNGA-VLKLIDLGSSVSVST--------VVLPDLEFASPEMLTSPAT------AGPSTDMWSLGVLLYILLSGVSP 292 (380)
Q Consensus 228 ~NIl~~~~-~ikl~DFG~a~~~~~--------~~~gt~~y~aPE~~~~~~~------~~~~~DiwSlGvil~~lltg~~P 292 (380)
.|.++|.. .+||+|||+...... ...-..-|.|||.+.+... .+.+.|+||+|+++||+++...|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 99999976 899999999765531 1112345899999876311 35579999999999999999999
Q ss_pred CCCC----CHHHHHHHHhc-ccCCCCCCc--CCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Q psy11098 293 FLDE----SEEETRAHISV-ADYSFPPEQ--CGHISVPARELIGQLLNTHADKRPTAGQLL 346 (380)
Q Consensus 293 f~~~----~~~~~~~~i~~-~~~~~~~~~--~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L 346 (380)
|... ...+....+.. ....+.+.- .....+++..++.+||..+|.+||+++++-
T Consensus 158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~ 218 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIR 218 (484)
T ss_pred cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHH
Confidence 9652 23455555555 221122111 124566799999999999999999999985
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.1e-16 Score=144.47 Aligned_cols=135 Identities=20% Similarity=0.250 Sum_probs=101.1
Q ss_pred eeec-ccCCeEEEEEEEcCCCcEEEEEEecCCC--------------CchHHHHHHHHHHHhhccCCC--cceeeecccc
Q psy11098 106 ERLG-NGRFCTVRKARDRGTGQLVALKQIPRER--------------QPQQITRAEYNLLSTLMHAHI--PTALALFENA 168 (380)
Q Consensus 106 ~~LG-~G~fg~V~~~~~~~~~~~vAvK~~~~~~--------------~~~~~~~~E~~il~~l~h~ni--~~i~~~~~~~ 168 (380)
..|| .||.|+||.+... +..+|+|.+.+.. .....+.+|++++..|.|+++ +..+.+....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4577 7888888888764 6789999885321 122456779999999999885 5555553322
Q ss_pred cC-CCceEEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCc
Q psy11098 169 PV-PGTDTIVMQLVHG-ESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSS 245 (380)
Q Consensus 169 ~~-~~~~~lv~e~~~g-g~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a 245 (380)
.. ....++|||++.| .+|.+++.. ..+++. .+.||+.+|.+||+.||+||||||+|||++ ++.++|+|||.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 11 1123599999987 688888754 355654 367899999999999999999999999998 458999999987
Q ss_pred cc
Q psy11098 246 VS 247 (380)
Q Consensus 246 ~~ 247 (380)
..
T Consensus 190 ~~ 191 (239)
T PRK01723 190 EL 191 (239)
T ss_pred cc
Confidence 54
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.2e-16 Score=134.03 Aligned_cols=131 Identities=26% Similarity=0.302 Sum_probs=108.5
Q ss_pred eeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhcc--CCCcceeeecccccCCCceEEEEEec
Q psy11098 104 ELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMH--AHIPTALALFENAPVPGTDTIVMQLV 181 (380)
Q Consensus 104 ~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h--~ni~~i~~~~~~~~~~~~~~lv~e~~ 181 (380)
+.+.||+|.++.||++.... ..+++|.+..... ...+.+|+.+++.++| .++++++.++... +..+++|||+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~---~~~~~v~e~~ 75 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESD---GWSYLLMEWI 75 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC---CccEEEEEec
Confidence 45789999999999999754 6799999865543 5567889999999987 4888887777653 5679999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeecCCCCcEEEeC-CeeEEEeCCCccc
Q psy11098 182 HGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQ---QIAHKDIRPENILMNG-AVLKLIDLGSSVS 247 (380)
Q Consensus 182 ~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~---~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~ 247 (380)
.|+++... +......++.+++.+|.+||.. +++|+|++|+|||++. +.++++|||.+..
T Consensus 76 ~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 76 EGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 88877553 5566677899999999999985 7999999999999986 7999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.67 E-value=3e-17 Score=169.11 Aligned_cols=258 Identities=22% Similarity=0.345 Sum_probs=201.6
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC----chHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ----PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
+.+.+.+.+-+|.++.++.+.-..+|...+.|....... ..+..+.+-+++. |+..+-++..+.........+
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i---~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILI---TPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccc---cCCCCceecccCCCCCCCCcc
Confidence 445677788899999999998888886666665532211 1112222222222 233344444444445567789
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccc------
Q psy11098 176 IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSV------ 248 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~------ 248 (380)
++++|+.|++|...+...+..+++-++.++..+..++++||...+.|||++|.|+|+. ++..++.|||.....
T Consensus 881 L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~ 960 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT 960 (1205)
T ss_pred hhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCc
Confidence 9999999999999998888899999999999999999999999999999999999997 678999999732111
Q ss_pred -------------------------------cccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q psy11098 249 -------------------------------STVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDES 297 (380)
Q Consensus 249 -------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~ 297 (380)
.....+|+.|.|||...+ ...+..+|+|++|+++++.++|.+||....
T Consensus 961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg-~~hgs~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen 961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG-RRHGSAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred CCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc-ccCCCcchhhhhhhhhhhhhcCCCCCCCcc
Confidence 023467999999999998 466789999999999999999999999999
Q ss_pred HHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHH---HHHhcccccccCCCCCccc
Q psy11098 298 EEETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAG---QLLQVAWFAEASCSEFDTE 362 (380)
Q Consensus 298 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~---e~L~hpw~~~~~~~~~~~~ 362 (380)
.+...+++..++...+.- ....+.++++++..+|..+|.+|..+. +.-.|+||+...+..+..+
T Consensus 1040 pq~~f~ni~~~~~~~p~g-~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l~~q 1106 (1205)
T KOG0606|consen 1040 PQQIFENILNRDIPWPEG-PEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENLALQ 1106 (1205)
T ss_pred hhhhhhccccCCCCCCCC-ccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCccccccc
Confidence 999999998887665532 345789999999999999999999888 9999999998776644433
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.1e-16 Score=157.25 Aligned_cols=250 Identities=24% Similarity=0.269 Sum_probs=191.8
Q ss_pred hhhhhceeeeeeecc--cCCeEEEEEEE--cCCCcEEEEEEecCCC---CchHHHHHHHHHHHhh-ccCCCcceeeeccc
Q psy11098 96 EQFEHRYEELERLGN--GRFCTVRKARD--RGTGQLVALKQIPRER---QPQQITRAEYNLLSTL-MHAHIPTALALFEN 167 (380)
Q Consensus 96 ~~~~~~y~~~~~LG~--G~fg~V~~~~~--~~~~~~vAvK~~~~~~---~~~~~~~~E~~il~~l-~h~ni~~i~~~~~~ 167 (380)
..+...+.+.+.+|. |.+|.||.+.. ..++..+|+|.-+... .......+|+.-.+.+ .|.|.++....++.
T Consensus 110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~ 189 (524)
T KOG0601|consen 110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG 189 (524)
T ss_pred chhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc
Confidence 345677888899999 99999999998 8899999999743222 2223334455555555 37777664444444
Q ss_pred ccCCCceEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHH----HHHHHHHCCcEeecCCCCcEEEe-C-CeeEEE
Q psy11098 168 APVPGTDTIVMQLVHGESLIQHLCRQ-STITESYICCIIRQLHS----ALHCLHSQQIAHKDIRPENILMN-G-AVLKLI 240 (380)
Q Consensus 168 ~~~~~~~~lv~e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~----al~~lH~~~iiHrDlKp~NIl~~-~-~~ikl~ 240 (380)
.+..++-+|++ |.+|..+...- .-+.+..++..+.+... ||.++|+.+++|-|+||.||++. + ..++++
T Consensus 190 ---~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~ 265 (524)
T KOG0601|consen 190 ---SGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLT 265 (524)
T ss_pred ---CCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecC
Confidence 47779999999 67777777654 44889999999999999 99999999999999999999996 4 479999
Q ss_pred eCCCcccccc-----------cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc
Q psy11098 241 DLGSSVSVST-----------VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVAD 309 (380)
Q Consensus 241 DFG~a~~~~~-----------~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~ 309 (380)
|||+...++. ...|...|++||..++ -++...|++|||.++.+..+|..+........ -.++ ..
T Consensus 266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-W~~~--r~ 340 (524)
T KOG0601|consen 266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSS-WSQL--RQ 340 (524)
T ss_pred CcceeEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCC-cccc--cc
Confidence 9998876641 1256778999999987 56789999999999999998876653331000 0111 12
Q ss_pred CCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 310 YSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 310 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
...+.+.+...+.++...+..|+..+|..|++++.+++|+++...
T Consensus 341 ~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK 385 (524)
T ss_pred ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence 225667777888888889999999999999999999999999853
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.4e-14 Score=127.44 Aligned_cols=137 Identities=18% Similarity=0.250 Sum_probs=103.3
Q ss_pred eeecccCCeEEEEEEEcC------CCcEEEEEEecCCC------------C-----------chHHH----HHHHHHHHh
Q psy11098 106 ERLGNGRFCTVRKARDRG------TGQLVALKQIPRER------------Q-----------PQQIT----RAEYNLLST 152 (380)
Q Consensus 106 ~~LG~G~fg~V~~~~~~~------~~~~vAvK~~~~~~------------~-----------~~~~~----~~E~~il~~ 152 (380)
..||.|.=+.||.|.... .+..+|||+++... . ....+ ++|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 568999999999998553 35789999985321 0 01223 379999999
Q ss_pred hcc--CCCcceeeecccccCCCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHCCcEeecCCCCc
Q psy11098 153 LMH--AHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCL-HSQQIAHKDIRPEN 229 (380)
Q Consensus 153 l~h--~ni~~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~l-H~~~iiHrDlKp~N 229 (380)
+.. -+++.++.+. ..+|||||+.+..+..-..+...+++..+..+..+++.+|..| |+.|++|+||++.|
T Consensus 83 l~~~Gv~vP~pi~~~-------~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~N 155 (197)
T cd05146 83 MQKAGIPCPEVVVLK-------KHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYN 155 (197)
T ss_pred HHHcCCCCCeEEEec-------CCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 965 4666767642 3499999997654432222333566667788899999999999 89999999999999
Q ss_pred EEEeCCeeEEEeCCCccccc
Q psy11098 230 ILMNGAVLKLIDLGSSVSVS 249 (380)
Q Consensus 230 Il~~~~~ikl~DFG~a~~~~ 249 (380)
||++++.+.|+|||.|....
T Consensus 156 IL~~~~~v~iIDF~qav~~~ 175 (197)
T cd05146 156 MLWHDGKVWFIDVSQSVEPT 175 (197)
T ss_pred EEEECCcEEEEECCCceeCC
Confidence 99999999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.3e-14 Score=125.05 Aligned_cols=127 Identities=17% Similarity=0.173 Sum_probs=97.4
Q ss_pred eeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCC-cceeeecccccCCCceEEEEEecCC
Q psy11098 105 LERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHI-PTALALFENAPVPGTDTIVMQLVHG 183 (380)
Q Consensus 105 ~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni-~~i~~~~~~~~~~~~~~lv~e~~~g 183 (380)
.+.|+.|.++.||++... ++.|++|+............+|..+++.+.+.++ +.++.... +..++|||+++|
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~-----~~~~lv~e~i~G 75 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP-----ETGVLITEFIEG 75 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC-----CCCeEEEEecCC
Confidence 367899999999999865 6789999986554333445789999999976554 34444322 234899999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCc-----EeecCCCCcEEEeCCeeEEEeCCCcc
Q psy11098 184 ESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQI-----AHKDIRPENILMNGAVLKLIDLGSSV 246 (380)
Q Consensus 184 g~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~i-----iHrDlKp~NIl~~~~~ikl~DFG~a~ 246 (380)
.++... . ......+.+++.+|..||+.++ +|+|++|.||+++++.++++|||.+.
T Consensus 76 ~~l~~~-----~---~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~~~~~~liDf~~a~ 135 (170)
T cd05151 76 SELLTE-----D---FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLDDGRLWLIDWEYAG 135 (170)
T ss_pred Cccccc-----c---ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEECCeEEEEeccccc
Confidence 887543 1 1123467899999999999985 99999999999998899999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.53 E-value=5.1e-14 Score=141.55 Aligned_cols=143 Identities=17% Similarity=0.238 Sum_probs=97.4
Q ss_pred hhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCc-----------------------------------hH
Q psy11098 97 QFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP-----------------------------------QQ 141 (380)
Q Consensus 97 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~-----------------------------------~~ 141 (380)
++-..|+. +.||+|++|+||+|+.+.+|+.||||+.+..... ..
T Consensus 117 ~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~ 195 (537)
T PRK04750 117 EWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEK 195 (537)
T ss_pred HHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHH
Confidence 34455776 7999999999999999988999999999643210 01
Q ss_pred H------HHHHHHHHHhhc----cCCCcceeeecccccCCCceEEEEEecCCCCHHHH--HHhcC----CCCHHHHHHHH
Q psy11098 142 I------TRAEYNLLSTLM----HAHIPTALALFENAPVPGTDTIVMQLVHGESLIQH--LCRQS----TITESYICCII 205 (380)
Q Consensus 142 ~------~~~E~~il~~l~----h~ni~~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~--l~~~~----~l~e~~~~~i~ 205 (380)
. +.+|...+..++ +.+.+.+-.+|... .+..+|||||+.|+.+.+. +...+ .+.+..+..++
T Consensus 196 ~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~--st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~ 273 (537)
T PRK04750 196 TLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDY--CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFF 273 (537)
T ss_pred HHHHhhCHHHHHHHHHHHHHHccCCCCeecceeeccc--CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHH
Confidence 1 123444444442 34444444555432 2345899999999999774 33322 24444455555
Q ss_pred HHHHHHHHHHHHCCcEeecCCCCcEEEe-CC----eeEEEeCCCccccc
Q psy11098 206 RQLHSALHCLHSQQIAHKDIRPENILMN-GA----VLKLIDLGSSVSVS 249 (380)
Q Consensus 206 ~qil~al~~lH~~~iiHrDlKp~NIl~~-~~----~ikl~DFG~a~~~~ 249 (380)
.|++ ..|++|+|+||.||+++ ++ .++++|||++..++
T Consensus 274 ~Qif-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 274 TQVF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred HHHH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 5554 59999999999999997 44 89999999987664
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.3e-13 Score=136.66 Aligned_cols=138 Identities=18% Similarity=0.188 Sum_probs=96.0
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEecCCCCch-----------------------------------------HHHH
Q psy11098 106 ERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQ-----------------------------------------QITR 144 (380)
Q Consensus 106 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~-----------------------------------------~~~~ 144 (380)
+.||.|++|.||+|+.+ +|+.||||+.+...... -.+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 67999999999999965 68999999985432100 0122
Q ss_pred HHHHHHHhhc----cCCCcceeeecccccCCCceEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHHC
Q psy11098 145 AEYNLLSTLM----HAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQ-STITESYICCIIRQLHS-ALHCLHSQ 218 (380)
Q Consensus 145 ~E~~il~~l~----h~ni~~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~-al~~lH~~ 218 (380)
+|.+.+..+. |.+.+.+-..|... .+..+|||||+.|++|.+..... ...+ ...++.+++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~--~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDR--TSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhh--cCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhC
Confidence 3444444442 33334444454432 23459999999999998876432 1222 3345666665 46889999
Q ss_pred CcEeecCCCCcEEEe-CCeeEEEeCCCccccc
Q psy11098 219 QIAHKDIRPENILMN-GAVLKLIDLGSSVSVS 249 (380)
Q Consensus 219 ~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~ 249 (380)
|++|+|+||.||+++ ++.++++|||++..++
T Consensus 277 g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 999999999999997 5689999999987765
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266|consensus | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.1e-13 Score=126.85 Aligned_cols=233 Identities=20% Similarity=0.217 Sum_probs=163.1
Q ss_pred eEEEEEEEcCCCcEEEEEEecC----C-CCchHHHHHHHHHHHhhccCCCcceeeecccccC--CCceEEEEEecCCCCH
Q psy11098 114 CTVRKARDRGTGQLVALKQIPR----E-RQPQQITRAEYNLLSTLMHAHIPTALALFENAPV--PGTDTIVMQLVHGESL 186 (380)
Q Consensus 114 g~V~~~~~~~~~~~vAvK~~~~----~-~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~--~~~~~lv~e~~~gg~L 186 (380)
-.||++-++..|..|+--.++. + ....+..+.-+.-|-.+.|.|+++.+.++..... ..+..++.||+..|+|
T Consensus 80 d~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~ 159 (458)
T KOG1266|consen 80 DDVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSL 159 (458)
T ss_pred HHHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhH
Confidence 3577777777776665544421 1 1223344455666778889999999999887654 2467889999999999
Q ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC--CcEeecCCCCcEEEe-CCeeEEEeCCCcccc----------c
Q psy11098 187 IQHLCR----QSTITESYICCIIRQLHSALHCLHSQ--QIAHKDIRPENILMN-GAVLKLIDLGSSVSV----------S 249 (380)
Q Consensus 187 ~~~l~~----~~~l~e~~~~~i~~qil~al~~lH~~--~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~----------~ 249 (380)
..+|++ +..+......+|+-||+.||.|||+. -|+|+++..+-|++. ++.||+.--.-.... .
T Consensus 160 ~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek 239 (458)
T KOG1266|consen 160 KQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEK 239 (458)
T ss_pred HHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhh
Confidence 999965 45688889999999999999999987 599999999999998 456665421111100 1
Q ss_pred ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHH
Q psy11098 250 TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSP-FLDESEEETRAHISVADYSFPPEQCGHISVPARELI 328 (380)
Q Consensus 250 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~P-f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 328 (380)
....+-++|.|||.=.. ...+.++|||++|....+|..|..- -.+.+.-+...++....+... ..--++++
T Consensus 240 ~~~~~~~g~~a~~sg~~-tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~le-------n~lqr~~i 311 (458)
T KOG1266|consen 240 SVNTSLPGFSAPESGTT-TNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGLE-------NGLQRGSI 311 (458)
T ss_pred hccccCCccccCCcCcc-cccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeecc-------CccccCcC
Confidence 23345788999997554 3445689999999888899887654 222222222222222221111 11235789
Q ss_pred HHhcccCCCCCCCHHHHHhccccccc
Q psy11098 329 GQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 329 ~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
.+||+-.|..||++.++|.||-+.+.
T Consensus 312 ~kcl~~eP~~rp~ar~llfHpllfeV 337 (458)
T KOG1266|consen 312 TKCLEGEPNGRPDARLLLFHPLLFEV 337 (458)
T ss_pred cccccCCCCCCcchhhhhcCceeeec
Confidence 99999999999999999999988765
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.44 E-value=8.2e-14 Score=137.24 Aligned_cols=246 Identities=19% Similarity=0.231 Sum_probs=179.5
Q ss_pred hhceeeeeeecccCCeEEEEEEEc-CCCcEEEEEEecCCCC---chHHHHHHHHHHHhh-ccCCCcceeeecccccCCCc
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDR-GTGQLVALKQIPRERQ---PQQITRAEYNLLSTL-MHAHIPTALALFENAPVPGT 173 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~-~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~~~~~ 173 (380)
..+|..+..||.|.|+.|+.+..+ .++..|++|-..+... .+.....|..+...+ .|.+++.....+.. ...
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~---~r~ 340 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ---LRQ 340 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccc---ccc
Confidence 356778899999999999988755 6788999998754322 222234466666555 46666554444433 356
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC--CeeEEEeCCCccccc--
Q psy11098 174 DTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG--AVLKLIDLGSSVSVS-- 249 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~--~~ikl~DFG~a~~~~-- 249 (380)
.|+-.|||+++++...+.....+++...+.+..|++.++.++|++.++|+|+||.||++.+ ...++.|||....+.
T Consensus 341 ~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~ 420 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS 420 (524)
T ss_pred ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee
Confidence 6899999999999888876678999999999999999999999999999999999999976 688999999986543
Q ss_pred -ccccCCCccc-CCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHH
Q psy11098 250 -TVVLPDLEFA-SPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAREL 327 (380)
Q Consensus 250 -~~~~gt~~y~-aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 327 (380)
....++-++. ..|++.....+..++|++|||..+++.++|.+ +...... ...+..+..... ......+..+
T Consensus 421 ~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~-ls~~~~~--~~~i~~~~~p~~----~~~~~~~q~~ 493 (524)
T KOG0601|consen 421 SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP-LSESGVQ--SLTIRSGDTPNL----PGLKLQLQVL 493 (524)
T ss_pred cccccccccccccchhhccccccccccccccccccccccccCcc-cCccccc--ceeeecccccCC----CchHHhhhhh
Confidence 2333344455 36666655677889999999999999999844 3222111 111222221111 2234778899
Q ss_pred HHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 328 IGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 328 i~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
.+.+...++..|+.+.++..|.=|...
T Consensus 494 ~kv~~~~~~~~~~l~~~l~~~~~~~~~ 520 (524)
T KOG0601|consen 494 LKVMINPDRKRRPSAVELSLHSEFYRD 520 (524)
T ss_pred hhhhcCCccccchhhhhhcccchhhhh
Confidence 999999999999999999988766544
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.33 E-value=2.9e-11 Score=103.58 Aligned_cols=128 Identities=23% Similarity=0.342 Sum_probs=95.1
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEe-cCCCC--------chHHHHHHHHHHHhhccCCC--cceeeecccccCCCce
Q psy11098 106 ERLGNGRFCTVRKARDRGTGQLVALKQI-PRERQ--------PQQITRAEYNLLSTLMHAHI--PTALALFENAPVPGTD 174 (380)
Q Consensus 106 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~-~~~~~--------~~~~~~~E~~il~~l~h~ni--~~i~~~~~~~~~~~~~ 174 (380)
..+++|+=+.++.+... |..+++|.= ++.-. ......+|.+++..++-..+ +.++++. ++..
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD-----~~~~ 74 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD-----PDNG 74 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc-----CCCC
Confidence 35789999999999664 445666653 22211 12345679999999875543 3333332 3556
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeCCeeEEEeCCCccc
Q psy11098 175 TIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGAVLKLIDLGSSVS 247 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~~~ikl~DFG~a~~ 247 (380)
.|+|||+.|..|.+.+... ...+++.+-.-+.-||..||+|+||.++||++.++.+.++|||++..
T Consensus 75 ~I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~i~~IDfGLg~~ 140 (204)
T COG3642 75 LIVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGRIYFIDFGLGEF 140 (204)
T ss_pred EEEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCcEEEEECCcccc
Confidence 8999999988888888665 24577777777888999999999999999999999999999999853
|
|
| >KOG1243|consensus | Back alignment and domain information |
|---|
Probab=99.33 E-value=3.3e-11 Score=120.31 Aligned_cols=161 Identities=24% Similarity=0.297 Sum_probs=124.8
Q ss_pred EEEEcCCCcEEEEEEecCCCC-chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEEEecCCCCHHHHHHhcCCC
Q psy11098 118 KARDRGTGQLVALKQIPRERQ-PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTI 196 (380)
Q Consensus 118 ~~~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l 196 (380)
.|..+.++..|.|+.++.... ..+...+-++-|+.++||||+.+++.++.. ++.|||+|-+ ..|...+++.+
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~---~~~ylvTErV--~Pl~~~lk~l~-- 102 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEE---GTLYLVTERV--RPLETVLKELG-- 102 (690)
T ss_pred ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhccc---CceEEEeecc--ccHHHHHHHhH--
Confidence 466678889999999876554 234567788999999999999999888875 6889999998 35666665543
Q ss_pred CHHHHHHHHHHHHHHHHHHH-HCCcEeecCCCCcEEEe-CCeeEEEeCCCccccccccc------CCCcccCCccccCCC
Q psy11098 197 TESYICCIIRQLHSALHCLH-SQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVSTVVL------PDLEFASPEMLTSPA 268 (380)
Q Consensus 197 ~e~~~~~i~~qil~al~~lH-~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~~~~~------gt~~y~aPE~~~~~~ 268 (380)
...+..-++||+.||.||| +.+++|++|.-.-|+++ .|..||++|-++........ --..|..|+.+...
T Consensus 103 -~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s- 180 (690)
T KOG1243|consen 103 -KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPS- 180 (690)
T ss_pred -HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCcc-
Confidence 7778889999999999997 67899999999999998 67999999988765442221 11235555544321
Q ss_pred CCCCcccHHHHHHHHHHHHhC
Q psy11098 269 TAGPSTDMWSLGVLLYILLSG 289 (380)
Q Consensus 269 ~~~~~~DiwSlGvil~~lltg 289 (380)
+-..|.|-|||++++++.|
T Consensus 181 --~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 181 --EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred --ccchhhhhHHHHHHHHhCc
Confidence 1357999999999999999
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.9e-11 Score=109.67 Aligned_cols=139 Identities=27% Similarity=0.392 Sum_probs=104.7
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEecCCCC--chHHHHHHHHHHHhhccC--CCcceeeecccccCCCceEEEEEec
Q psy11098 106 ERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ--PQQITRAEYNLLSTLMHA--HIPTALALFENAPVPGTDTIVMQLV 181 (380)
Q Consensus 106 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~--ni~~i~~~~~~~~~~~~~~lv~e~~ 181 (380)
+.||.|..+.||++.... |+.+++|+...... .......|.++++.+.+. ++++++.+.......+..++|||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 678999999999998653 57899999865433 345678899999999764 4577777665432224568999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------------
Q psy11098 182 HGESLIQHLCRQSTITESYICCIIRQLHSALHCLHS-------------------------------------------- 217 (380)
Q Consensus 182 ~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~-------------------------------------------- 217 (380)
.|.++.+.+.. ..+++.....++.+++.+|..||+
T Consensus 83 ~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (223)
T cd05154 83 DGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL 161 (223)
T ss_pred CCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence 99888665432 356777777777777777777773
Q ss_pred ------------CCcEeecCCCCcEEEeC--C-eeEEEeCCCcc
Q psy11098 218 ------------QQIAHKDIRPENILMNG--A-VLKLIDLGSSV 246 (380)
Q Consensus 218 ------------~~iiHrDlKp~NIl~~~--~-~ikl~DFG~a~ 246 (380)
..++|+|+++.|||++. + .+.|+||+.+.
T Consensus 162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 24699999999999986 4 57899999764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.27 E-value=3.1e-11 Score=105.77 Aligned_cols=125 Identities=25% Similarity=0.344 Sum_probs=83.1
Q ss_pred EEEEEEEcCCCcEEEEEEecCCC--------------C-------------chHHHHHHHHHHHhhccC--CCcceeeec
Q psy11098 115 TVRKARDRGTGQLVALKQIPRER--------------Q-------------PQQITRAEYNLLSTLMHA--HIPTALALF 165 (380)
Q Consensus 115 ~V~~~~~~~~~~~vAvK~~~~~~--------------~-------------~~~~~~~E~~il~~l~h~--ni~~i~~~~ 165 (380)
.||.|... .|..+|+|+.+... . .....++|.+.|..+... +++.++.+.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 48889864 57799999985421 0 012346799999999765 567766553
Q ss_pred ccccCCCceEEEEEecC--CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHHCCcEeecCCCCcEEEeCCeeEEEeC
Q psy11098 166 ENAPVPGTDTIVMQLVH--GESLIQHLCRQSTITESYICCIIRQLHSALHC-LHSQQIAHKDIRPENILMNGAVLKLIDL 242 (380)
Q Consensus 166 ~~~~~~~~~~lv~e~~~--gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~-lH~~~iiHrDlKp~NIl~~~~~ikl~DF 242 (380)
. .+|||||+. |..+..+.... ++......++.+++..+.. +|+.||+|+||.+.|||++++.+.||||
T Consensus 80 ~-------~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~~~~iIDf 150 (188)
T PF01163_consen 80 R-------NVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDGKVYIIDF 150 (188)
T ss_dssp T-------TEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETTCEEE--G
T ss_pred C-------CEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecceEEEEec
Confidence 2 389999997 65554433222 2244566788888886655 5799999999999999999999999999
Q ss_pred CCccccc
Q psy11098 243 GSSVSVS 249 (380)
Q Consensus 243 G~a~~~~ 249 (380)
|.+....
T Consensus 151 ~qav~~~ 157 (188)
T PF01163_consen 151 GQAVDSS 157 (188)
T ss_dssp TTEEETT
T ss_pred CcceecC
Confidence 9886543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3087|consensus | Back alignment and domain information |
|---|
Probab=99.23 E-value=2.4e-10 Score=97.64 Aligned_cols=139 Identities=22% Similarity=0.323 Sum_probs=99.1
Q ss_pred eeeeecccCCeEEEEEEEcCCCcEEEEEEe-cCCC--------CchHHHHHHHHHHHhhccCCCcceeeecccccCCCce
Q psy11098 104 ELERLGNGRFCTVRKARDRGTGQLVALKQI-PRER--------QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 104 ~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~-~~~~--------~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~ 174 (380)
.+..|-+|+-+.|+++.+. |+.+.||.= .+.- .......+|+++|.++.--.|.--.-++-.. ...
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~---~~~ 85 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDT---YGG 85 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEec---CCC
Confidence 4678889999999999875 777788753 2221 1234557799999988755443322222221 344
Q ss_pred EEEEEecCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC--C--eeEEEeCCCccc
Q psy11098 175 TIVMQLVHG-ESLIQHLCRQ--STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG--A--VLKLIDLGSSVS 247 (380)
Q Consensus 175 ~lv~e~~~g-g~L~~~l~~~--~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~--~--~ikl~DFG~a~~ 247 (380)
.|+|||++| .++.+++... ..........++++|-+.+.-||..+|+|+||..+||++.+ + .+.++|||++..
T Consensus 86 ~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 86 QIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 899999977 4777777553 22333334789999999999999999999999999999963 2 458999999753
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.14 E-value=2.2e-09 Score=99.58 Aligned_cols=131 Identities=18% Similarity=0.143 Sum_probs=95.8
Q ss_pred eEEEEEEEcCCCcEEEEEEecCCCC------------chHHHHHHHHHHHhhccCCC--cceeeecccccC--CCceEEE
Q psy11098 114 CTVRKARDRGTGQLVALKQIPRERQ------------PQQITRAEYNLLSTLMHAHI--PTALALFENAPV--PGTDTIV 177 (380)
Q Consensus 114 g~V~~~~~~~~~~~vAvK~~~~~~~------------~~~~~~~E~~il~~l~h~ni--~~i~~~~~~~~~--~~~~~lv 177 (380)
..|++... .|+.|.||....... ....+.+|.+.+..|...+| +.++.+.+.... ....++|
T Consensus 36 rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 36 RRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred ceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 34556543 467899997743221 11236789999999965554 444556543221 1346899
Q ss_pred EEecCCC-CHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC--------CeeEEEeCCCcc
Q psy11098 178 MQLVHGE-SLIQHLCR--QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG--------AVLKLIDLGSSV 246 (380)
Q Consensus 178 ~e~~~gg-~L~~~l~~--~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~--------~~ikl~DFG~a~ 246 (380)
+|++.+. +|.+++.. ....++.....++.+++..+.-||+.||+|+|+++.|||++. ..+.||||+.+.
T Consensus 114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 9999875 78888754 345667788899999999999999999999999999999973 378999999874
|
|
| >KOG3741|consensus | Back alignment and domain information |
|---|
Probab=99.13 E-value=3.1e-09 Score=103.53 Aligned_cols=220 Identities=20% Similarity=0.232 Sum_probs=159.6
Q ss_pred CCeEEEEEEEcCCCcEEEEEEecCCCCch-HHHHHHHHHHHhhccCCCcceeeeccccc-CCCceEEEEEecCC-CCHHH
Q psy11098 112 RFCTVRKARDRGTGQLVALKQIPRERQPQ-QITRAEYNLLSTLMHAHIPTALALFENAP-VPGTDTIVMQLVHG-ESLIQ 188 (380)
Q Consensus 112 ~fg~V~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~E~~il~~l~h~ni~~i~~~~~~~~-~~~~~~lv~e~~~g-g~L~~ 188 (380)
.-.+.|++....+|..|++|.++..+... .....-.++++++.|.|++++..+|.... ....+++|++|..+ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 34688999999999999999995443322 23344678999999999999999887432 33467899999865 67877
Q ss_pred HHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeCC-eeEEEeCCCcccccccc
Q psy11098 189 HLCR---------------QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGA-VLKLIDLGSSVSVSTVV 252 (380)
Q Consensus 189 ~l~~---------------~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~~-~ikl~DFG~a~~~~~~~ 252 (380)
+.-. +...+|+.+|.++.||..||.++|+.|..-+-|.+.+||++.+ .++|.-.|..-.+....
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~ 447 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP 447 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC
Confidence 6532 2346789999999999999999999999999999999999976 88887666543222111
Q ss_pred cCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCC-CCCCCHHHH-HHHHhcccCCCCCCcCCCCCHHHHHHHHH
Q psy11098 253 LPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSP-FLDESEEET-RAHISVADYSFPPEQCGHISVPARELIGQ 330 (380)
Q Consensus 253 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~P-f~~~~~~~~-~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 330 (380)
. |-+.+. .+-|.=.||.++.-|.||..- +..+...+. ...|. ..+|.+++++|..
T Consensus 448 ------~--~~le~~----Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~-----------~~yS~D~rn~v~y 504 (655)
T KOG3741|consen 448 ------T--EPLESQ----QQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT-----------TTYSTDLRNVVEY 504 (655)
T ss_pred ------C--cchhHH----hhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh-----------hhhhHHHHHHHHH
Confidence 1 223321 256888999999999998432 222222222 22222 2468899999999
Q ss_pred hcccCCCCCCCHHHHHhc---ccccccC
Q psy11098 331 LLNTHADKRPTAGQLLQV---AWFAEAS 355 (380)
Q Consensus 331 ~L~~dP~~Rpt~~e~L~h---pw~~~~~ 355 (380)
+...++++ -++.+++.| .||...+
T Consensus 505 l~s~~~~~-ksI~~llp~~~~~ff~vme 531 (655)
T KOG3741|consen 505 LESLNFRE-KSIQDLLPMIGSRFFTVME 531 (655)
T ss_pred HHhcCccc-ccHHHHHHHHHHHHHHHHH
Confidence 99999987 788898866 5555443
|
|
| >KOG2137|consensus | Back alignment and domain information |
|---|
Probab=99.07 E-value=6.2e-11 Score=118.78 Aligned_cols=148 Identities=27% Similarity=0.443 Sum_probs=110.4
Q ss_pred HHHHHHHHHHC-CcEeecCCCCcEEEe-CCeeEEEeCCCcccccc---------------cccCCCcccCCccccCCCCC
Q psy11098 208 LHSALHCLHSQ-QIAHKDIRPENILMN-GAVLKLIDLGSSVSVST---------------VVLPDLEFASPEMLTSPATA 270 (380)
Q Consensus 208 il~al~~lH~~-~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~~---------------~~~gt~~y~aPE~~~~~~~~ 270 (380)
++.|+.|+|.. ++||+.|.|++|.++ .+.+||+-|+++..... -......|.|||++.+ ...
T Consensus 108 v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~~~ 186 (700)
T KOG2137|consen 108 VADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-TTN 186 (700)
T ss_pred ccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-ccc
Confidence 33999999964 999999999999998 56899999998754432 1122457999999988 577
Q ss_pred CCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCC-CCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 271 GPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFP-PEQCGHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 271 ~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
+.++|++|||+++|.+.. |+.-+...+.......-. ...+.. .....+++.++++=|.++|..++..||++.+++..
T Consensus 187 ~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~-~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 187 TPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR-NLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSI 265 (700)
T ss_pred cccccceeeeeEEEEEecCCcchhhccCCcchhhhhh-cccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhcc
Confidence 889999999999999995 655554443322222111 111111 11225789999999999999999999999999999
Q ss_pred ccccccCCC
Q psy11098 349 AWFAEASCS 357 (380)
Q Consensus 349 pw~~~~~~~ 357 (380)
|||.+..-.
T Consensus 266 ~ff~D~~~~ 274 (700)
T KOG2137|consen 266 PFFSDPGLK 274 (700)
T ss_pred cccCCchhh
Confidence 999987543
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=3.3e-09 Score=96.21 Aligned_cols=132 Identities=22% Similarity=0.277 Sum_probs=99.1
Q ss_pred eeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC-----------------------chHHHHHHHHHHHhhccC--
Q psy11098 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ-----------------------PQQITRAEYNLLSTLMHA-- 156 (380)
Q Consensus 102 y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-----------------------~~~~~~~E~~il~~l~h~-- 156 (380)
+.+...||.|.=+.||.|.+. .|..+|||+-+.... .....++|+++|..|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 456788999999999999976 588999997532210 113457799999999755
Q ss_pred CCcceeeecccccCCCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-C
Q psy11098 157 HIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-A 235 (380)
Q Consensus 157 ni~~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~ 235 (380)
.++..++. ++..+|||+++|-.|...- ++......++..|++-+.-+-..||+|+|+.+-|||+++ |
T Consensus 172 ~VP~P~~~-------nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg 239 (304)
T COG0478 172 KVPKPIAW-------NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDG 239 (304)
T ss_pred CCCCcccc-------ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCC
Confidence 66666554 4568999999997775532 234445566677777776666899999999999999985 5
Q ss_pred eeEEEeCCCcc
Q psy11098 236 VLKLIDLGSSV 246 (380)
Q Consensus 236 ~ikl~DFG~a~ 246 (380)
.+.++||=.+.
T Consensus 240 ~~~vIDwPQ~v 250 (304)
T COG0478 240 DIVVIDWPQAV 250 (304)
T ss_pred CEEEEeCcccc
Confidence 99999996554
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.7e-08 Score=90.30 Aligned_cols=109 Identities=24% Similarity=0.267 Sum_probs=85.7
Q ss_pred chHHHHHHHHHHHhhccCC--CcceeeecccccCC-CceEEEEEecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q psy11098 139 PQQITRAEYNLLSTLMHAH--IPTALALFENAPVP-GTDTIVMQLVHGE-SLIQHLCRQSTITESYICCIIRQLHSALHC 214 (380)
Q Consensus 139 ~~~~~~~E~~il~~l~h~n--i~~i~~~~~~~~~~-~~~~lv~e~~~gg-~L~~~l~~~~~l~e~~~~~i~~qil~al~~ 214 (380)
......+|.+.+..|.... .+..+.+.+..... ...++|+|+++|. +|.+++......+......++.+++..+.-
T Consensus 54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAK 133 (206)
T ss_pred cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHH
Confidence 3456778999998886544 45666665543221 2458999999874 799988875557788889999999999999
Q ss_pred HHHCCcEeecCCCCcEEEeCC----eeEEEeCCCccc
Q psy11098 215 LHSQQIAHKDIRPENILMNGA----VLKLIDLGSSVS 247 (380)
Q Consensus 215 lH~~~iiHrDlKp~NIl~~~~----~ikl~DFG~a~~ 247 (380)
||+.||+|+|+++.|||++.+ .+.++||+.+..
T Consensus 134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999999999999999854 599999997643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.90 E-value=2.5e-08 Score=89.65 Aligned_cols=135 Identities=19% Similarity=0.290 Sum_probs=95.4
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchH-------------------------HHHHHHHHHHhhc--cCCC
Q psy11098 106 ERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQ-------------------------ITRAEYNLLSTLM--HAHI 158 (380)
Q Consensus 106 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~-------------------------~~~~E~~il~~l~--h~ni 158 (380)
..|..|.-+.||+|.. .++..+|+|+++.....-. =.++|+..|+++. +-.+
T Consensus 54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 3566888899999985 4678999999964321110 0145888888885 3445
Q ss_pred cceeeecccccCCCceEEEEEecCCCC-HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeecCCCCcEEEeCCe
Q psy11098 159 PTALALFENAPVPGTDTIVMQLVHGES-LIQHLCRQSTITESYICCIIRQLHSALHCLHS-QQIAHKDIRPENILMNGAV 236 (380)
Q Consensus 159 ~~i~~~~~~~~~~~~~~lv~e~~~gg~-L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~-~~iiHrDlKp~NIl~~~~~ 236 (380)
+.-+.+... .|||||+.... -.-.|+ .-.+...++..+..++++.+.-|=. .++||+||..-|||+.++.
T Consensus 133 P~Pi~~~~n-------VLvMEfIg~~g~pAP~Lk-Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~~~~ 204 (268)
T COG1718 133 PEPIAFRNN-------VLVMEFIGDDGLPAPRLK-DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVHDGE 204 (268)
T ss_pred CCceeecCC-------eEEEEeccCCCCCCCCcc-cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEECCe
Confidence 555555443 89999993321 111111 1233444788889999999988766 8999999999999999999
Q ss_pred eEEEeCCCccccc
Q psy11098 237 LKLIDLGSSVSVS 249 (380)
Q Consensus 237 ikl~DFG~a~~~~ 249 (380)
+.|||||.|....
T Consensus 205 p~iID~~QaV~~~ 217 (268)
T COG1718 205 PYIIDVSQAVTID 217 (268)
T ss_pred EEEEECccccccC
Confidence 9999999987654
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=98.84 E-value=2.4e-10 Score=113.53 Aligned_cols=243 Identities=17% Similarity=0.117 Sum_probs=169.6
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVM 178 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~ 178 (380)
...|...+.+++|+++++++.+...+...+ .+++... ...+-++++|.+.+||| ..+.+++.....+...+.+
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~----l~~rl~~eLLdK~n~P~--~~v~~~~d~~~E~~~~i~~ 313 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT----LSRRLAIELLDKVNNPN--PVVRYLEDYDGEDYLWIPM 313 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc----hhhHHHHHHHHHccCCC--CcccccccCCcccccchhh
Confidence 344666778999999999999987766555 7777554 33455899999999999 2344445544456778999
Q ss_pred EecCCC-CHHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeCCeeEEEeCCCccccc-----cc
Q psy11098 179 QLVHGE-SLIQ-HLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGAVLKLIDLGSSVSVS-----TV 251 (380)
Q Consensus 179 e~~~gg-~L~~-~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~~~ikl~DFG~a~~~~-----~~ 251 (380)
+++.++ +... .-...-.+.+-+...+.+.-+.+++++|+.--+||| ||+..++..|..||+....++ +.
T Consensus 314 ~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~~~~~~~~~v~~~L~~~~~~~t 389 (829)
T KOG0576|consen 314 RICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEEEVKLLDFAVPPQLTRTMKPRT 389 (829)
T ss_pred hhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccccccccccccCCcccCccccccc
Confidence 999777 2222 112222355556677778888899999998889999 999999999999999876654 45
Q ss_pred ccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHH-HHHHH
Q psy11098 252 VLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAR-ELIGQ 330 (380)
Q Consensus 252 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~-~li~~ 330 (380)
..+|+.++|||+... ..+....|.||+|+--.++.-|.+|-.... .....+-.+.-.+....-...+.... ++...
T Consensus 390 ~~~~~~~~~pev~~~-~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~--~~~~~~g~~p~s~~L~~~~aw~~~~~~~~~~~ 466 (829)
T KOG0576|consen 390 AIGTPEPLAPEVIQE-NTIDGCPDSGSLAVSAIQMAPGLPPRSSPP--AVLPMIGNGPNSPMLTDKSAWSPVFHRDFPAP 466 (829)
T ss_pred CCCCCCCCCchhhcc-cccccCCCccCCCcchhhcCCCCCCCCCCc--cccCCCCCCCCccccchhhhcCcccccCCccc
Confidence 678999999998877 466778999999988778888877754311 01001111100000000011111122 58889
Q ss_pred hcccCCCCCCCHHHHHhcccccccC
Q psy11098 331 LLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 331 ~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
|+...|..|++...++.|.+|..+.
T Consensus 467 ~~~g~P~~pkv~mgacfsKvfngCp 491 (829)
T KOG0576|consen 467 CLNGLPPTPKVHMGACFSKVFNGCP 491 (829)
T ss_pred ccCCCCCCCcchhhHHHHHHhccCc
Confidence 9999999999999999999998654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.1e-07 Score=84.49 Aligned_cols=141 Identities=17% Similarity=0.222 Sum_probs=93.4
Q ss_pred hhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC-chHH---------HHHHHHHHHhhccCCCcceeeec
Q psy11098 96 EQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ-PQQI---------TRAEYNLLSTLMHAHIPTALALF 165 (380)
Q Consensus 96 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~---------~~~E~~il~~l~h~ni~~i~~~~ 165 (380)
+-...+|++.+.+-......|.+..- .|+.+++|..+.... .... ..+++..+..+....+..+.+.|
T Consensus 27 ~i~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~y 104 (229)
T PF06176_consen 27 KILDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPY 104 (229)
T ss_pred HHHhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccce
Confidence 44567899998888877777776653 467899998854322 1111 23345545555433332222211
Q ss_pred cc-----ccCCCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeCCeeEEE
Q psy11098 166 EN-----APVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGAVLKLI 240 (380)
Q Consensus 166 ~~-----~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~~~ikl~ 240 (380)
-. .......+|+|||++|.+|.+... +++ .+...|.+++.-||+.|+.|+|..|.|++++++.++++
T Consensus 105 l~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~i~iI 176 (229)
T PF06176_consen 105 LAAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNGIRII 176 (229)
T ss_pred eeeeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCcEEEE
Confidence 11 111133468999999988866532 333 24456778899999999999999999999999999999
Q ss_pred eCCCcc
Q psy11098 241 DLGSSV 246 (380)
Q Consensus 241 DFG~a~ 246 (380)
||+..+
T Consensus 177 D~~~k~ 182 (229)
T PF06176_consen 177 DTQGKR 182 (229)
T ss_pred ECcccc
Confidence 998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.3e-07 Score=80.61 Aligned_cols=128 Identities=21% Similarity=0.242 Sum_probs=94.0
Q ss_pred eeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEEEecC
Q psy11098 103 EELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVH 182 (380)
Q Consensus 103 ~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e~~~ 182 (380)
++.+.||+|++|.||++.+. |..+|+|+-+ .......+..|.++|..+..-++..=+-.|.. .++.|||++
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr-~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~------~~i~me~i~ 95 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRR-RDSPRRNLEKEAKILEILAGEGVTPEVYFYGE------DFIRMEYID 95 (201)
T ss_pred hhhhhhhcccccEEEEeecc--CceEEEEEec-CCcchhhHHHHHHHHHHhhhcCCCceEEEech------hhhhhhhhc
Confidence 45578999999999999976 5578888653 34455667889999999987776554444433 266799999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCC--CcEEEeCCeeEEEeCCCcc
Q psy11098 183 GESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRP--ENILMNGAVLKLIDLGSSV 246 (380)
Q Consensus 183 gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp--~NIl~~~~~ikl~DFG~a~ 246 (380)
|-+|.+..... + +.-+..++++-.-|-..||-|..|.- .||+++++.+.||||..|+
T Consensus 96 G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 96 GRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred Ccchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchh
Confidence 98887655322 2 23444566665567778999999983 5777778899999999875
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.68 E-value=3.2e-07 Score=82.59 Aligned_cols=81 Identities=20% Similarity=0.228 Sum_probs=59.3
Q ss_pred eeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCC--CcceeeecccccCCCceEEEEEecC
Q psy11098 105 LERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAH--IPTALALFENAPVPGTDTIVMQLVH 182 (380)
Q Consensus 105 ~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~n--i~~i~~~~~~~~~~~~~~lv~e~~~ 182 (380)
++.|+.|..+.||++.... ..+++|+.... ........|..+++.+.... ++.++............+++|+++.
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 4679999999999999765 48999998555 44566778999999997554 4566654434333445789999999
Q ss_pred CCCHHH
Q psy11098 183 GESLIQ 188 (380)
Q Consensus 183 gg~L~~ 188 (380)
|..+..
T Consensus 79 g~~~~~ 84 (239)
T PF01636_consen 79 GRPLDD 84 (239)
T ss_dssp SEEHHH
T ss_pred cccccc
Confidence 988777
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.67 E-value=7e-07 Score=79.15 Aligned_cols=136 Identities=14% Similarity=0.160 Sum_probs=99.7
Q ss_pred cccCCeEEEEEEEcCCCcEEEEEEecC----C---CCchHHHHHHHHHHHhhccCCCc--ceeeecccccCC--CceEEE
Q psy11098 109 GNGRFCTVRKARDRGTGQLVALKQIPR----E---RQPQQITRAEYNLLSTLMHAHIP--TALALFENAPVP--GTDTIV 177 (380)
Q Consensus 109 G~G~fg~V~~~~~~~~~~~vAvK~~~~----~---~~~~~~~~~E~~il~~l~h~ni~--~i~~~~~~~~~~--~~~~lv 177 (380)
|+||-+-|+..... |+.+-+|.-.. . ......+.+|+..|+.|...+++ .++ ++.....+ -..+||
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 67888889987654 34677886531 1 23456788999999999765554 333 33322211 135799
Q ss_pred EEecCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCe--eEEEeCCCccc
Q psy11098 178 MQLVHG-ESLIQHLCRQ--STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAV--LKLIDLGSSVS 247 (380)
Q Consensus 178 ~e~~~g-g~L~~~l~~~--~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~--ikl~DFG~a~~ 247 (380)
+|-+.| .+|.+++.+. .+.++.....++.+++..+.-||+.|+.|+|+-+.|||++ ++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 998744 6888887553 3457777889999999999999999999999999999997 554 99999986643
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.62 E-value=1.1e-06 Score=84.14 Aligned_cols=235 Identities=20% Similarity=0.227 Sum_probs=147.0
Q ss_pred eeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceee-----ecccccCCCceEEEEE
Q psy11098 105 LERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALA-----LFENAPVPGTDTIVMQ 179 (380)
Q Consensus 105 ~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~-----~~~~~~~~~~~~lv~e 179 (380)
...||+|+-+.+|-.-.-. -.+.|++....-..+.-+ -.++.+.-.||-+..=+. ++.-. ....+.++|.
T Consensus 16 gr~LgqGgea~ly~l~e~~---d~VAKIYh~Pppa~~aqk-~a~la~~p~~p~~~~rvaWPqa~L~G~~-~~~~iGflmP 90 (637)
T COG4248 16 GRPLGQGGEADLYTLGEVR---DQVAKIYHAPPPAAQAQK-VAELAATPDAPLLNYRVAWPQATLHGGR-RGKVIGFLMP 90 (637)
T ss_pred CccccCCccceeeecchhh---chhheeecCCCchHHHHH-HHHhccCCCCcchhhhhcccHHHhhCCC-ccceeEEecc
Confidence 4679999999999664332 246788865433222111 112222223443222111 12211 1223677888
Q ss_pred ecCCCCHHHHHH-------hcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccc-c-
Q psy11098 180 LVHGESLIQHLC-------RQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSV-S- 249 (380)
Q Consensus 180 ~~~gg~L~~~l~-------~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~-~- 249 (380)
.+.|..=-..+. .........+....+.|+.+..-||..|.+-+|+.++|+|++ ++.+.|+|-..-... +
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ng 170 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINANG 170 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceeeccCC
Confidence 887753322221 234578888999999999999999999999999999999997 468888875432111 1
Q ss_pred ---ccccCCCcccCCccccCC----CCCCCcccHHHHHHHHHHHHhC-CCCCCCCCH-----HHHHHHHhcccCCC----
Q psy11098 250 ---TVVLPDLEFASPEMLTSP----ATAGPSTDMWSLGVLLYILLSG-VSPFLDESE-----EETRAHISVADYSF---- 312 (380)
Q Consensus 250 ---~~~~gt~~y~aPE~~~~~----~~~~~~~DiwSlGvil~~lltg-~~Pf~~~~~-----~~~~~~i~~~~~~~---- 312 (380)
...+|.++|.+||.-+-+ ..-+...|.|-||++++++|.| +.||.+... ......|..+.+.+
T Consensus 171 ~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~ 250 (637)
T COG4248 171 TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASDQ 250 (637)
T ss_pred ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechhc
Confidence 234678999999975521 2335578999999999999985 999965311 11112333222211
Q ss_pred ------C--CCcCCCCCHHHHHHHHHhccc--CCCCCCCHHH
Q psy11098 313 ------P--PEQCGHISVPARELIGQLLNT--HADKRPTAGQ 344 (380)
Q Consensus 313 ------~--~~~~~~~s~~~~~li~~~L~~--dP~~Rpt~~e 344 (380)
+ ...+.-++++++.|..+|+.. ++.-|||++-
T Consensus 251 ~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 251 RRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred cCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 1 112345788899999999854 4678999864
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.54 E-value=1.9e-06 Score=78.16 Aligned_cols=133 Identities=17% Similarity=0.200 Sum_probs=80.5
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCC--cceeeecccccCCCceEEEEEecCC
Q psy11098 106 ERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHI--PTALALFENAPVPGTDTIVMQLVHG 183 (380)
Q Consensus 106 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni--~~i~~~~~~~~~~~~~~lv~e~~~g 183 (380)
..||+|..+.||+. .+..+++|...... ......+|.++++.+....+ +.++.+... .+...+|||++.|
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~---~~~~glv~e~i~G 78 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-DKETIKREFDASRKVFSLGIPTPHPFDLVED---GGRLGLIYELIVG 78 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcCCCCCceEEEEec---CCeeeeeeeecCC
Confidence 57899999999984 24467899886533 33456889999999975544 555555443 3456889999988
Q ss_pred CC-HH--------------HHHHh------c---CCCCHHH-HHHHHH----------HHHHH-HHHHH----HCCcEee
Q psy11098 184 ES-LI--------------QHLCR------Q---STITESY-ICCIIR----------QLHSA-LHCLH----SQQIAHK 223 (380)
Q Consensus 184 g~-L~--------------~~l~~------~---~~l~e~~-~~~i~~----------qil~a-l~~lH----~~~iiHr 223 (380)
.. +. ..+.. . ....... ...+.. .+... ..+|. ...++|+
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~Hg 158 (226)
T TIGR02172 79 KRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHG 158 (226)
T ss_pred ccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEec
Confidence 63 11 11111 0 0111110 000100 01111 11222 1257899
Q ss_pred cCCCCcEEEeCCeeEEEeCCCcc
Q psy11098 224 DIRPENILMNGAVLKLIDLGSSV 246 (380)
Q Consensus 224 DlKp~NIl~~~~~ikl~DFG~a~ 246 (380)
|+.|.||+++++.+.|+||+.+.
T Consensus 159 D~~~~Nii~~~~~~~iIDwe~a~ 181 (226)
T TIGR02172 159 DFQIGNLITSGKGTYWIDLGDFG 181 (226)
T ss_pred CCCCCcEEEcCCCcEEEechhcC
Confidence 99999999986559999999764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.50 E-value=1e-06 Score=88.56 Aligned_cols=138 Identities=18% Similarity=0.202 Sum_probs=89.7
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEecCCCCch-----------------------------------H------HHH
Q psy11098 106 ERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQ-----------------------------------Q------ITR 144 (380)
Q Consensus 106 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~-----------------------------------~------~~~ 144 (380)
+.|+.++-|+||+|+.+. |+.||||+.+..-... + .++
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 689999999999999764 9999999885432100 0 112
Q ss_pred HHHHHHHhhc----cCCCcceeeecccccCCCceEEEEEecCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHH-HHHHHHC
Q psy11098 145 AEYNLLSTLM----HAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLC-RQSTITESYICCIIRQLHSA-LHCLHSQ 218 (380)
Q Consensus 145 ~E~~il~~l~----h~ni~~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~-~~~~l~e~~~~~i~~qil~a-l~~lH~~ 218 (380)
+|...+..++ +..-+++-.+|... .+.-.|+|||++|..+.+... +...++... ++..++.+ +..+=..
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~--t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~---ia~~~~~~f~~q~~~d 284 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEY--TTRRVLTMEWIDGIKISDIAALKSAGIDRKE---LAELLVRAFLRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhc--cCCcEEEEEeeCCEecccHHHHHhcCCCHHH---HHHHHHHHHHHHHHhc
Confidence 2444444442 22223444444332 234589999999999988752 224455333 33333332 2233348
Q ss_pred CcEeecCCCCcEEEe-CCeeEEEeCCCccccc
Q psy11098 219 QIAHKDIRPENILMN-GAVLKLIDLGSSVSVS 249 (380)
Q Consensus 219 ~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~ 249 (380)
|+.|.|..|.||+++ ++.+.+.|||+...++
T Consensus 285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred CccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 999999999999998 5699999999987664
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=98.38 E-value=2.5e-06 Score=90.61 Aligned_cols=199 Identities=19% Similarity=0.198 Sum_probs=136.3
Q ss_pred HHHHHHHHhhccCCCcceeeecccccCCC-ceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q psy11098 144 RAEYNLLSTLMHAHIPTALALFENAPVPG-TDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAH 222 (380)
Q Consensus 144 ~~E~~il~~l~h~ni~~i~~~~~~~~~~~-~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiH 222 (380)
..|++.+..+.|+|+..+..+-......+ ...+..+++.+.++...+..-...+...++.+..++++||.|+|+....|
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~ 309 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLEH 309 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccce
Confidence 44667778889999988877765544444 23455688999999999999889999999999999999999999984443
Q ss_pred ecCCCC---cEEEe-CCeeEEE--eCCCccccccc-----ccCCCcccCCccccCC-CCCCCcccHHHHHHHHHHHHhCC
Q psy11098 223 KDIRPE---NILMN-GAVLKLI--DLGSSVSVSTV-----VLPDLEFASPEMLTSP-ATAGPSTDMWSLGVLLYILLSGV 290 (380)
Q Consensus 223 rDlKp~---NIl~~-~~~ikl~--DFG~a~~~~~~-----~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~~lltg~ 290 (380)
.-|... +.-.+ .+.+.+. ||+.+...... ...+..+.|+|..... ...+...|+|.+|.....+..|.
T Consensus 310 v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~ 389 (1351)
T KOG1035|consen 310 VVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGE 389 (1351)
T ss_pred eEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcC
Confidence 333222 11111 2244555 88877766422 2335667788877652 12233479999999999999875
Q ss_pred CCCCCCCHHHHHHHHhcccCCCCCCcCCCCC-HHHHHHHHHhcccCCCCCCCHHHHHhcccccccCC
Q psy11098 291 SPFLDESEEETRAHISVADYSFPPEQCGHIS-VPARELIGQLLNTHADKRPTAGQLLQVAWFAEASC 356 (380)
Q Consensus 291 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s-~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~ 356 (380)
.+-.-. .....+. ...+ .+..+++.+|+.-++++|+++.++|.|+|......
T Consensus 390 ~i~~~~---~~~~~~l-----------~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~~ 442 (1351)
T KOG1035|consen 390 DISEKS---AVPVSLL-----------DVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPTD 442 (1351)
T ss_pred cccccc---cchhhhh-----------ccccchhhhhhhhhhcchhhhhccchhhhhhchhcccccc
Confidence 432111 1111111 1111 26788999999999999999999999999986543
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.37 E-value=4e-06 Score=76.37 Aligned_cols=75 Identities=16% Similarity=0.073 Sum_probs=46.9
Q ss_pred eeecccCCe-EEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccC---CCcceeeecccccCCCceEEEEEec
Q psy11098 106 ERLGNGRFC-TVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHA---HIPTALALFENAPVPGTDTIVMQLV 181 (380)
Q Consensus 106 ~~LG~G~fg-~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~---ni~~i~~~~~~~~~~~~~~lv~e~~ 181 (380)
+.|+.|+.. .||+.. ..+++|+.+. ........+|.++++.+... .++.++.........+..+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRLG-----DDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEcC-----CceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 567877776 588762 3477887654 33345678899999998642 3444443322221112448899999
Q ss_pred CCCCH
Q psy11098 182 HGESL 186 (380)
Q Consensus 182 ~gg~L 186 (380)
.|.++
T Consensus 77 ~G~~l 81 (235)
T cd05155 77 EGETA 81 (235)
T ss_pred cCCCC
Confidence 88665
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.27 E-value=1.6e-05 Score=85.39 Aligned_cols=81 Identities=23% Similarity=0.402 Sum_probs=57.3
Q ss_pred eeeecccCCeEEEEEEEcCCC--cEEEEEEecCCC--CchHHHHHHHHHHHhhc-cCCC--cceeeecccccCCCceEEE
Q psy11098 105 LERLGNGRFCTVRKARDRGTG--QLVALKQIPRER--QPQQITRAEYNLLSTLM-HAHI--PTALALFENAPVPGTDTIV 177 (380)
Q Consensus 105 ~~~LG~G~fg~V~~~~~~~~~--~~vAvK~~~~~~--~~~~~~~~E~~il~~l~-h~ni--~~i~~~~~~~~~~~~~~lv 177 (380)
++.|+.|.+..+|+......+ ..+++|+..... .....+.+|+++++.+. |.++ ++++.++......+..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 577899999999998765432 467788765432 23356788999999996 6654 6666665543333567999
Q ss_pred EEecCCCC
Q psy11098 178 MQLVHGES 185 (380)
Q Consensus 178 ~e~~~gg~ 185 (380)
||++.|..
T Consensus 123 ME~v~G~~ 130 (822)
T PLN02876 123 MEYLEGRI 130 (822)
T ss_pred EEecCCcc
Confidence 99998864
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.6e-05 Score=72.80 Aligned_cols=75 Identities=19% Similarity=0.182 Sum_probs=50.4
Q ss_pred eecccCC-eEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhcc-CCCcceeeecccccCCCceEEEEEecCCC
Q psy11098 107 RLGNGRF-CTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMH-AHIPTALALFENAPVPGTDTIVMQLVHGE 184 (380)
Q Consensus 107 ~LG~G~f-g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h-~ni~~i~~~~~~~~~~~~~~lv~e~~~gg 184 (380)
.|-.|.. +.||++... +..+.+|+..... .....+|+++++.+.. --+++++.+... .+..++|||++.|.
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~---~~~~~lv~e~i~G~ 77 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSD---DGRAWLLTSAVPGV 77 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEec---CCccEEEEEeeCCc
Confidence 4555555 789999754 3578888875443 3346779999998853 344555555443 24569999999997
Q ss_pred CHHH
Q psy11098 185 SLIQ 188 (380)
Q Consensus 185 ~L~~ 188 (380)
+|..
T Consensus 78 ~l~~ 81 (244)
T cd05150 78 PAAA 81 (244)
T ss_pred cHhH
Confidence 7754
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235|consensus | Back alignment and domain information |
|---|
Probab=98.06 E-value=4.2e-05 Score=76.93 Aligned_cols=139 Identities=17% Similarity=0.165 Sum_probs=87.7
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEecCCCCch--------------------------------H------HHHHHH
Q psy11098 106 ERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQ--------------------------------Q------ITRAEY 147 (380)
Q Consensus 106 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~--------------------------------~------~~~~E~ 147 (380)
+.||.-+.|.||+|+.+. |+.||||+-+..-... . .+.+|.
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 689999999999999776 9999999875431110 0 111233
Q ss_pred HH----HHhhccCC---CcceeeecccccCCCceEEEEEecCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCC
Q psy11098 148 NL----LSTLMHAH---IPTALALFENAPVPGTDTIVMQLVHGESLIQHLC-RQSTITESYICCIIRQLHSALHCLHSQQ 219 (380)
Q Consensus 148 ~i----l~~l~h~n---i~~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~-~~~~l~e~~~~~i~~qil~al~~lH~~~ 219 (380)
+. .+.+.|-+ -+.+-.+|... ...-.|+||||+|..+.+.-. ....++...+..-+.+... .-|=..|
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~--~qIf~~G 321 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL--EQIFKTG 321 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH--HHHHhcC
Confidence 22 23344555 22233444332 134589999999987765432 2234665544333333222 2233578
Q ss_pred cEeecCCCCcEEEe-----CCeeEEEeCCCccccc
Q psy11098 220 IAHKDIRPENILMN-----GAVLKLIDLGSSVSVS 249 (380)
Q Consensus 220 iiHrDlKp~NIl~~-----~~~ikl~DFG~a~~~~ 249 (380)
++|.|=.|.||++. +..+.+-|||+...+.
T Consensus 322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 99999999999998 2379999999987665
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.06 E-value=8.9e-05 Score=65.39 Aligned_cols=127 Identities=25% Similarity=0.240 Sum_probs=85.0
Q ss_pred hceeeeeeecccCC-eEEEEEEEcCCCcEEEEEEecC---CC-------Cc------------hHHHHHHHHHHHhhccC
Q psy11098 100 HRYEELERLGNGRF-CTVRKARDRGTGQLVALKQIPR---ER-------QP------------QQITRAEYNLLSTLMHA 156 (380)
Q Consensus 100 ~~y~~~~~LG~G~f-g~V~~~~~~~~~~~vAvK~~~~---~~-------~~------------~~~~~~E~~il~~l~h~ 156 (380)
..++.++.||.|.- |.||+++.. |+.||+|++.. .. .. ..-+..|-+...+|++-
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 56788899999999 999999865 67999999421 00 00 01234566666666543
Q ss_pred ---CC--cceeeeccccc---------------CCCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q psy11098 157 ---HI--PTALALFENAP---------------VPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLH 216 (380)
Q Consensus 157 ---ni--~~i~~~~~~~~---------------~~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH 216 (380)
++ ++++++..... ..-...||-||+.... .++. .-+.+|+.-|..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~----~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQI----RDIPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccch----hHHHHHHHHHHHHH
Confidence 33 66666653221 1112357778775543 2232 34567777788899
Q ss_pred HCCcEeecCCCCcEEEeCCeeEEEeCCCc
Q psy11098 217 SQQIAHKDIRPENILMNGAVLKLIDLGSS 245 (380)
Q Consensus 217 ~~~iiHrDlKp~NIl~~~~~ikl~DFG~a 245 (380)
+.||+-+|+++.|.. .=||+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR----GGKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc----CCEEEecccC
Confidence 999999999999986 4578999864
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.06 E-value=6.2e-05 Score=68.35 Aligned_cols=75 Identities=15% Similarity=0.255 Sum_probs=48.8
Q ss_pred eeeecccCCeEEEEEEEcC-CCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCC-cceeeecccccCCCceEEEEEecC
Q psy11098 105 LERLGNGRFCTVRKARDRG-TGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHI-PTALALFENAPVPGTDTIVMQLVH 182 (380)
Q Consensus 105 ~~~LG~G~fg~V~~~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni-~~i~~~~~~~~~~~~~~lv~e~~~ 182 (380)
++.|..|-...+|++.... .++.|++|+........-...+|..+++.+...++ ++++.... . .++|||++
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~---~~l~e~i~ 75 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ----N---GLIYEFIP 75 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC----C---cEEEEeeC
Confidence 3568888888999997543 35688999875433222233569999999865444 33333221 1 47999998
Q ss_pred CCCH
Q psy11098 183 GESL 186 (380)
Q Consensus 183 gg~L 186 (380)
|.++
T Consensus 76 G~~l 79 (235)
T cd05157 76 GRTL 79 (235)
T ss_pred CCcC
Confidence 8664
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.96 E-value=5.5e-05 Score=69.78 Aligned_cols=131 Identities=18% Similarity=0.208 Sum_probs=77.3
Q ss_pred eecccCCeEEEEEEEcCCCcEEEEEEecCCCCch-HHHHHHHHHHHhhccCCC-cceeeecccccCCCceEEEEEecCCC
Q psy11098 107 RLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQ-QITRAEYNLLSTLMHAHI-PTALALFENAPVPGTDTIVMQLVHGE 184 (380)
Q Consensus 107 ~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~E~~il~~l~h~ni-~~i~~~~~~~~~~~~~~lv~e~~~gg 184 (380)
.+..|-...+|+.. .+++.+++|......... -...+|.++++.+....+ ++++.... .++||||++|.
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~-------~~~v~e~i~G~ 73 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE-------HWLLVEWLEGE 73 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC-------CEEEEEeccCc
Confidence 35667788999887 346678899765432221 134679999999975444 44443321 27899999886
Q ss_pred CHHH----------HH----Hh--c-----CCCCH-HHHHHHHHHH---------HHHHHHHHH--------CCcEeecC
Q psy11098 185 SLIQ----------HL----CR--Q-----STITE-SYICCIIRQL---------HSALHCLHS--------QQIAHKDI 225 (380)
Q Consensus 185 ~L~~----------~l----~~--~-----~~l~e-~~~~~i~~qi---------l~al~~lH~--------~~iiHrDl 225 (380)
.+.. .+ .+ . ..++. ..+..+..++ ...+..+-. ..++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 5431 11 11 0 11111 1122222122 111222211 25899999
Q ss_pred CCCcEEEeCCeeEEEeCCCcc
Q psy11098 226 RPENILMNGAVLKLIDLGSSV 246 (380)
Q Consensus 226 Kp~NIl~~~~~ikl~DFG~a~ 246 (380)
.|.||+++++.+.|+||..|.
T Consensus 154 ~~~Nil~~~~~~~lIDwE~a~ 174 (256)
T TIGR02721 154 HAYNLVVTPQGLKLIDWEYAS 174 (256)
T ss_pred CcCcEEEeCCCCEEEeccccC
Confidence 999999997668999998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG2270|consensus | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00015 Score=68.97 Aligned_cols=139 Identities=19% Similarity=0.270 Sum_probs=99.5
Q ss_pred eeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC-----------------------CchHH----HHHHHHHHHhhccC
Q psy11098 104 ELERLGNGRFCTVRKARDRGTGQLVALKQIPRER-----------------------QPQQI----TRAEYNLLSTLMHA 156 (380)
Q Consensus 104 ~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~-----------------------~~~~~----~~~E~~il~~l~h~ 156 (380)
+-..|..|.-+.||.|.. .+|..+|||+++.+. ....+ ..+|++.|.+|...
T Consensus 148 inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 345677888899999984 468889999985421 11111 24588889999877
Q ss_pred CCcceeeecccccCCCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHCCcEeecCCCCcEEEeCC
Q psy11098 157 HIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCL-HSQQIAHKDIRPENILMNGA 235 (380)
Q Consensus 157 ni~~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~l-H~~~iiHrDlKp~NIl~~~~ 235 (380)
.|+.--.++. ....|||+|+.+...-.-..+...++...+..+-.|++.-+.-| |..+.||.||.--|+|+-+|
T Consensus 227 GIP~PePIlL-----k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~LyhdG 301 (520)
T KOG2270|consen 227 GIPCPEPILL-----KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHDG 301 (520)
T ss_pred CCCCCCceee-----ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEECC
Confidence 7654443333 23489999994332222222345677778888888888888766 56799999999999999999
Q ss_pred eeEEEeCCCcccc
Q psy11098 236 VLKLIDLGSSVSV 248 (380)
Q Consensus 236 ~ikl~DFG~a~~~ 248 (380)
.+.|||-+.|...
T Consensus 302 ~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 302 KLYIIDVSQSVEH 314 (520)
T ss_pred EEEEEEccccccC
Confidence 9999999988654
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00034 Score=61.97 Aligned_cols=128 Identities=23% Similarity=0.322 Sum_probs=87.9
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEecCCC-----------------CchHHHHHHHHHHHhhc------cCCCccee
Q psy11098 106 ERLGNGRFCTVRKARDRGTGQLVALKQIPRER-----------------QPQQITRAEYNLLSTLM------HAHIPTAL 162 (380)
Q Consensus 106 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~-----------------~~~~~~~~E~~il~~l~------h~ni~~i~ 162 (380)
..||+|+.-.||.- .. +....||+..... ......++|+.....+. +..|++++
T Consensus 7 ~~i~~G~~R~cy~H--P~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQH--PD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEEC--CC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 56999999999954 33 2346789886554 22345667887777776 66777777
Q ss_pred eecccccCCCceEEEEEecCC------CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe---
Q psy11098 163 ALFENAPVPGTDTIVMQLVHG------ESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN--- 233 (380)
Q Consensus 163 ~~~~~~~~~~~~~lv~e~~~g------g~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~--- 233 (380)
++.+.. -...+|+|.+.+ .+|.+++.+ +.+++ . +...+-+-..||-+.+|+.+||+|.||++.
T Consensus 84 G~veT~---~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~ 155 (199)
T PF10707_consen 84 GFVETN---LGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRD 155 (199)
T ss_pred EEEecC---CceEEEEEEEECCCCCcCccHHHHHHc-CCccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecC
Confidence 777664 556888888743 357777743 35665 3 333444445688899999999999999995
Q ss_pred CC--eeEEEe-CCC
Q psy11098 234 GA--VLKLID-LGS 244 (380)
Q Consensus 234 ~~--~ikl~D-FG~ 244 (380)
++ .+.|+| ||.
T Consensus 156 ~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 156 SGEFRLVLIDGLGE 169 (199)
T ss_pred CCceEEEEEeCCCC
Confidence 22 578888 443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00053 Score=67.13 Aligned_cols=76 Identities=21% Similarity=0.222 Sum_probs=52.9
Q ss_pred eeeecccCCeEEEEEEEcCCCcEEEEEEecC------C--CCchHHHHHHHHHHHhhc---cCCCcceeeecccccCCCc
Q psy11098 105 LERLGNGRFCTVRKARDRGTGQLVALKQIPR------E--RQPQQITRAEYNLLSTLM---HAHIPTALALFENAPVPGT 173 (380)
Q Consensus 105 ~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~------~--~~~~~~~~~E~~il~~l~---h~ni~~i~~~~~~~~~~~~ 173 (380)
.+.||.|.+..||++.....++.++||.-.. . ....+....|.+.|+.+. ...+++++.+-. +.
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~-----~~ 105 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE-----EL 105 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC-----CC
Confidence 3679999999999999865445899998431 1 123456677888888874 235666666532 34
Q ss_pred eEEEEEecCCCC
Q psy11098 174 DTIVMQLVHGES 185 (380)
Q Consensus 174 ~~lv~e~~~gg~ 185 (380)
.++|||++.+..
T Consensus 106 ~~lVME~L~~~~ 117 (401)
T PRK09550 106 AVTVMEDLSDHK 117 (401)
T ss_pred CEEEEecCCCcc
Confidence 689999997644
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00018 Score=67.93 Aligned_cols=75 Identities=15% Similarity=0.194 Sum_probs=48.7
Q ss_pred eeecccCCeEEEEEEEcC------CCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCC-cceeeecccccCCCceEEEE
Q psy11098 106 ERLGNGRFCTVRKARDRG------TGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHI-PTALALFENAPVPGTDTIVM 178 (380)
Q Consensus 106 ~~LG~G~fg~V~~~~~~~------~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni-~~i~~~~~~~~~~~~~~lv~ 178 (380)
+.|..|-...+|++.... +++.|++|+............+|.++++.+....+ ++++.++.. .+|+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~-------~~v~ 76 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN-------GRIE 76 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC-------Cchh
Confidence 456666677889887543 25789999986544333445679999998865443 344444321 4588
Q ss_pred EecCCCCHH
Q psy11098 179 QLVHGESLI 187 (380)
Q Consensus 179 e~~~gg~L~ 187 (380)
||++|..+.
T Consensus 77 e~i~G~~l~ 85 (302)
T cd05156 77 EFIPSRTLT 85 (302)
T ss_pred heeCCCcCC
Confidence 998886653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00091 Score=63.71 Aligned_cols=138 Identities=17% Similarity=0.222 Sum_probs=77.6
Q ss_pred eeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCC--Ccceeeeccc---ccCCCceEEEEE
Q psy11098 105 LERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAH--IPTALALFEN---APVPGTDTIVMQ 179 (380)
Q Consensus 105 ~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~n--i~~i~~~~~~---~~~~~~~~lv~e 179 (380)
.+.|+.|....+|+.... .| .+++|++. .........|+.+++.|...+ ++.++..-.. ....+..+++++
T Consensus 27 ~~~l~~G~~n~~y~v~t~-~g-~~vLK~~~--~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTT-QG-EYVLTLFE--RLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeC-CC-cEEEEEec--cCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 356777887899998743 33 68899886 223344556778888885433 3444432110 011345689999
Q ss_pred ecCCCCH-----------HHHHHh----cCCC--------C--H-HH-H-----------HHHHHH-HHHHHHHHH----
Q psy11098 180 LVHGESL-----------IQHLCR----QSTI--------T--E-SY-I-----------CCIIRQ-LHSALHCLH---- 216 (380)
Q Consensus 180 ~~~gg~L-----------~~~l~~----~~~l--------~--e-~~-~-----------~~i~~q-il~al~~lH---- 216 (380)
+++|..+ ...+.+ ...+ . . .. . ...+.+ +...+..+.
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 9988643 111110 0000 0 0 00 0 001111 111122222
Q ss_pred ---HCCcEeecCCCCcEEEeCCee-EEEeCCCcc
Q psy11098 217 ---SQQIAHKDIRPENILMNGAVL-KLIDLGSSV 246 (380)
Q Consensus 217 ---~~~iiHrDlKp~NIl~~~~~i-kl~DFG~a~ 246 (380)
..++||+|+.|.|||++++.+ -|+||+.+.
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 248999999999999997765 799999763
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00042 Score=65.20 Aligned_cols=137 Identities=18% Similarity=0.234 Sum_probs=81.7
Q ss_pred eeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCC--Ccceeeeccc---ccCCCceEEEEE
Q psy11098 105 LERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAH--IPTALALFEN---APVPGTDTIVMQ 179 (380)
Q Consensus 105 ~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~n--i~~i~~~~~~---~~~~~~~~lv~e 179 (380)
.+.|..|....+|+.... +..+++|++.. ........|++++..|.+.+ ++.++..... ....+..+++++
T Consensus 19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTD--SGRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeC--CCcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 567788888899998643 34688998864 33455677999999996544 3444332110 012345689999
Q ss_pred ecCCCCHHH-----------HHHh----cCCCCH--------HHH------------HHHHHHHHHHHHHHHH-------
Q psy11098 180 LVHGESLIQ-----------HLCR----QSTITE--------SYI------------CCIIRQLHSALHCLHS------- 217 (380)
Q Consensus 180 ~~~gg~L~~-----------~l~~----~~~l~e--------~~~------------~~i~~qil~al~~lH~------- 217 (380)
+++|..+.. .+.+ ...+.. ... ......+..++.++.+
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 998865421 1100 000000 000 0011122334444443
Q ss_pred CCcEeecCCCCcEEEeCCe-eEEEeCCCc
Q psy11098 218 QQIAHKDIRPENILMNGAV-LKLIDLGSS 245 (380)
Q Consensus 218 ~~iiHrDlKp~NIl~~~~~-ikl~DFG~a 245 (380)
.+++|+|+.|.|||++++. +.|+||+.+
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a 203 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFA 203 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhh
Confidence 4799999999999999765 579999876
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG2268|consensus | Back alignment and domain information |
|---|
Probab=97.64 E-value=6.4e-05 Score=70.37 Aligned_cols=131 Identities=19% Similarity=0.248 Sum_probs=93.6
Q ss_pred ceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC-----------------------chHHHHHHHHHHHhhccC-
Q psy11098 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ-----------------------PQQITRAEYNLLSTLMHA- 156 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-----------------------~~~~~~~E~~il~~l~h~- 156 (380)
-|.+.+.||-|.-+.||.+.+. .|...++|+-+..+. ..-...+|+..|+.|...
T Consensus 93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 4678899999999999999865 477888886432110 011235688888888653
Q ss_pred -CCcceeeecccccCCCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-C
Q psy11098 157 -HIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-G 234 (380)
Q Consensus 157 -ni~~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~ 234 (380)
-+++.+++ ++.++|||++.|..|...-. ...+..+...++.-+.-|..+|+||+|..-=||+++ +
T Consensus 172 fpVPkpiD~-------~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd 238 (465)
T KOG2268|consen 172 FPVPKPIDH-------NRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDD 238 (465)
T ss_pred CCCCCcccc-------cceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecC
Confidence 33443333 45589999999988855331 112344666677777788999999999999999998 5
Q ss_pred CeeEEEeCCCc
Q psy11098 235 AVLKLIDLGSS 245 (380)
Q Consensus 235 ~~ikl~DFG~a 245 (380)
+.+++|||=..
T Consensus 239 ~~i~vIDFPQm 249 (465)
T KOG2268|consen 239 DKIVVIDFPQM 249 (465)
T ss_pred CCEEEeechHh
Confidence 68999999643
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00044 Score=60.77 Aligned_cols=98 Identities=27% Similarity=0.185 Sum_probs=77.6
Q ss_pred HHHHHHHHhhcc-CCCcceeeecccccCCCceEEEEEecCCCCHHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHH--
Q psy11098 144 RAEYNLLSTLMH-AHIPTALALFENAPVPGTDTIVMQLVHGESLIQH---LCRQSTITESYICCIIRQLHSALHCLHS-- 217 (380)
Q Consensus 144 ~~E~~il~~l~h-~ni~~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~---l~~~~~l~e~~~~~i~~qil~al~~lH~-- 217 (380)
..|.-+++.+.+ .+++++++.+.. +++.|+...+++... +.+-...++....+++.++++.+.+++.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~-------~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~ 79 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR-------FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGP 79 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC-------EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC
Confidence 348888999977 578888888764 779999976766431 2223456889999999999999999997
Q ss_pred -CCcEeecCCCCcEEEeC-CeeEEEeCCCcccc
Q psy11098 218 -QQIAHKDIRPENILMNG-AVLKLIDLGSSVSV 248 (380)
Q Consensus 218 -~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~ 248 (380)
..+.-.|++++|+-+++ +.+|++|...+...
T Consensus 80 ~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 80 LGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred CCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 45788899999999985 59999999876544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.0015 Score=61.87 Aligned_cols=138 Identities=16% Similarity=0.205 Sum_probs=80.2
Q ss_pred eeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCC--Ccceeeeccc---ccCCCceEEEEE
Q psy11098 105 LERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAH--IPTALALFEN---APVPGTDTIVMQ 179 (380)
Q Consensus 105 ~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~n--i~~i~~~~~~---~~~~~~~~lv~e 179 (380)
++.++.|....+|++... +| .+++|++..... ......|.+++..|.... ++.++..... ....+..+++++
T Consensus 27 i~~~~~G~~n~~y~v~t~-~~-~~vLK~~~~~~~-~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTD-VG-RYILTLYEKRVK-AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeC-CC-cEEEEEecCCCC-HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 456777877899988643 34 578898755322 334566888888886433 3444442211 012355689999
Q ss_pred ecCCCCHH-----------HHHH---h-cCCC--------CHHH-----HH----------HHHHHHHHHHHHHH-----
Q psy11098 180 LVHGESLI-----------QHLC---R-QSTI--------TESY-----IC----------CIIRQLHSALHCLH----- 216 (380)
Q Consensus 180 ~~~gg~L~-----------~~l~---~-~~~l--------~e~~-----~~----------~i~~qil~al~~lH----- 216 (380)
|++|.++. ..+. . ...+ .... .. .....+...++++.
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 99885431 1111 0 0111 0000 00 01112333455553
Q ss_pred --HCCcEeecCCCCcEEEeCCe-eEEEeCCCc
Q psy11098 217 --SQQIAHKDIRPENILMNGAV-LKLIDLGSS 245 (380)
Q Consensus 217 --~~~iiHrDlKp~NIl~~~~~-ikl~DFG~a 245 (380)
..+++|+|+.+.||+++++. +.|+||+.+
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~ 215 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFA 215 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeecccc
Confidence 26899999999999998664 589999976
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG1826|consensus | Back alignment and domain information |
|---|
Probab=97.49 E-value=9.9e-06 Score=88.18 Aligned_cols=207 Identities=14% Similarity=0.003 Sum_probs=131.5
Q ss_pred HHHHHHHHHHhhccCCCcceeeecccccCCCceEEEEEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH
Q psy11098 142 ITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQ----STITESYICCIIRQLHSALHCLHS 217 (380)
Q Consensus 142 ~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~----~~l~e~~~~~i~~qil~al~~lH~ 217 (380)
....|.+.++...|+++.....=... ......+..++++.+|.+++.|.++ ..+++.-+.....+.+.+..-+|+
T Consensus 1275 mll~e~de~~~~~h~~~~~~p~rI~p-s~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1275 MLLSERDELREAKHYLTEVDPLRIPP-SESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred hhhhhhhhhhhhhceeeecccccCCC-CCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence 33445556667788876443322211 1224558999999999999999654 335555555555555777777775
Q ss_pred C-----CcEeecCCCCcEEEeCC-eeEEEeCCCcc-ccc-----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHH
Q psy11098 218 Q-----QIAHKDIRPENILMNGA-VLKLIDLGSSV-SVS-----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYI 285 (380)
Q Consensus 218 ~-----~iiHrDlKp~NIl~~~~-~ikl~DFG~a~-~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~ 285 (380)
. -.+|++||+.|.+|..+ .+|+.++|+.+ +.. ....+++.|++|++.+. -.++.++|+|+.|+.+|+
T Consensus 1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~-ik~t~rsdilr~s~~ly~ 1432 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNE-IKFTKRSDILRRSLSLYL 1432 (2724)
T ss_pred cccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHH-HhhhhHHHHHHHHHHHHH
Confidence 4 27899999999999865 89999999998 332 34567888999998877 466767999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccc
Q psy11098 286 LLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAE 353 (380)
Q Consensus 286 lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~ 353 (380)
+.-|..+|-..........+..+. .+..+.. .|.++-.....+|-..-..||.-...+.-+.|..
T Consensus 1433 rs~~n~~fi~flq~~Lkgiidn~t-f~sIe~l--~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a~ 1497 (2724)
T KOG1826|consen 1433 RSDGNAYFIFFLQPALKGIIDNHT-FFSIEKL--KPGDANVEALHRLLWKYMERPGQYISLSRDHFAV 1497 (2724)
T ss_pred HhcccHHHHHHHHHHHcCcccccc-ccccccc--CCCcccHHHHHHHHHHhhhcchhhhhcccccccc
Confidence 998877763222222211111111 1111111 1223333333333344457888887777776653
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0017 Score=61.43 Aligned_cols=108 Identities=18% Similarity=0.225 Sum_probs=73.9
Q ss_pred eeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhcc---CCCcceeeecccccCCCceEEEE
Q psy11098 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMH---AHIPTALALFENAPVPGTDTIVM 178 (380)
Q Consensus 102 y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h---~ni~~i~~~~~~~~~~~~~~lv~ 178 (380)
-.-.+.||.|..+.||+..... + .+.+|.. +.......+..|.+.|+.|.. ..+++++.++......+..++||
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~-~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQ-G-NPMPLMA-RSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred hheeeecCCccceeEEEEEcCC-C-CEEEEEe-cccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 3445789999999999986432 3 4677774 332245688899999999964 35777777766544456689999
Q ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Q psy11098 179 QLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHS 217 (380)
Q Consensus 179 e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~ 217 (380)
|+++|.++.+. ..+......+..+++.+|.-||+
T Consensus 93 E~i~G~~~~~~-----~~~~~~~~~l~~~l~~~La~LH~ 126 (297)
T PRK10593 93 ERLRGVSVEAP-----ARTPERWEQLKDQIVEGLLAWHR 126 (297)
T ss_pred eccCCEecCCC-----CCCHHHHHHHHHHHHHHHHHHhC
Confidence 99999877541 12333344555666677777775
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0041 Score=59.90 Aligned_cols=73 Identities=16% Similarity=0.138 Sum_probs=46.6
Q ss_pred eecccCCeEEEEEEEcCCCcEEEEEEec----C-C---CCchHHHHHHHHHHHhhcc--C-CCcceeeecccccCCCceE
Q psy11098 107 RLGNGRFCTVRKARDRGTGQLVALKQIP----R-E---RQPQQITRAEYNLLSTLMH--A-HIPTALALFENAPVPGTDT 175 (380)
Q Consensus 107 ~LG~G~fg~V~~~~~~~~~~~vAvK~~~----~-~---~~~~~~~~~E~~il~~l~h--~-ni~~i~~~~~~~~~~~~~~ 175 (380)
.||.|....||++.....++.++||.-. . . .........|.+.|+...- | .+++++.+-. +...
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D~-----e~~~ 76 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFDT-----EMAV 76 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEcc-----ccce
Confidence 5799999999999976444679999742 1 1 2234555668888876642 3 3444443322 3457
Q ss_pred EEEEecCCC
Q psy11098 176 IVMQLVHGE 184 (380)
Q Consensus 176 lv~e~~~gg 184 (380)
+|||++...
T Consensus 77 ~vMEdL~~~ 85 (370)
T TIGR01767 77 TVMEDLSHH 85 (370)
T ss_pred ehHhhCccc
Confidence 999998543
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG1093|consensus | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.00072 Score=66.96 Aligned_cols=163 Identities=21% Similarity=0.234 Sum_probs=104.3
Q ss_pred HHHHHHHHHhhccCCCcceeeecccccCCCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q psy11098 143 TRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAH 222 (380)
Q Consensus 143 ~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiH 222 (380)
..--+++++.+.|.|....+++-.... .+..+|||++ +.+|.+.+..+. +-... ++ .+|+.|
T Consensus 29 ilgr~~~lktl~~~~l~~yl~~~r~~~--~r~IVV~e~~-~~Sled~~~~~~-l~~~s-------~~-------~~~~~~ 90 (725)
T KOG1093|consen 29 ILGRFQYLKSLQHDNLCQYLDFSRGKH--ERVIVVMEHY-TMSLEDILKTGN-LKDES-------LL-------AHGVLH 90 (725)
T ss_pred HhhhhHHHHhhcCccceeeEeeecCcc--ceEEEEehhh-ccchHHHHHhcc-cchhh-------hc-------ccccce
Confidence 344678899999999988877765543 3578999999 899999987765 22111 11 222222
Q ss_pred ecCCCCcEEEeCCeeEEEeCCCcccccccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy11098 223 KDIRPENILMNGAVLKLIDLGSSVSVSTVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETR 302 (380)
Q Consensus 223 rDlKp~NIl~~~~~ikl~DFG~a~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~ 302 (380)
. | .++.+| -++ |. | | ...+.++||||+|.++.++.-|..-+......+..
T Consensus 91 ~-----~------~~~~td-~~~---------t~-~--~------~~~~pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l 140 (725)
T KOG1093|consen 91 L-----N------IIYITD-HFL---------TK-Y--P------SPIGPKSDVWSLGFIILELYLGISLEAELTESEYL 140 (725)
T ss_pred e-----h------hhhccc-ccc---------cc-C--C------CCCCcchhhhhHHHHHHHHHHhhHHHHHHHHHHHH
Confidence 2 1 223334 111 00 0 1 12224999999999999999998877665554444
Q ss_pred HHHhcccCCCCCC---------cCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 303 AHISVADYSFPPE---------QCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 303 ~~i~~~~~~~~~~---------~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
..+.+-. ..+.+ .....+....++..+|+-..|..||...++.+++-|.+.
T Consensus 141 ~~i~k~~-~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 141 EILLKYY-TDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV 200 (725)
T ss_pred HHHHHhc-cCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence 4433211 11111 001234556789999999999999999999999999876
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0078 Score=56.92 Aligned_cols=28 Identities=25% Similarity=0.406 Sum_probs=25.3
Q ss_pred CCcEeecCCCCcEEEeCCeeEEEeCCCc
Q psy11098 218 QQIAHKDIRPENILMNGAVLKLIDLGSS 245 (380)
Q Consensus 218 ~~iiHrDlKp~NIl~~~~~ikl~DFG~a 245 (380)
.+++|+|+.+.||+++++.+.|+||+.+
T Consensus 187 ~~liHgD~~~~Nil~~~~~i~lIDfd~~ 214 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKDNEVYVIDFDYC 214 (313)
T ss_pred CceEcCCCCcccEEEeCCcEEEEECccc
Confidence 5799999999999999888899999865
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0052 Score=59.92 Aligned_cols=74 Identities=18% Similarity=0.187 Sum_probs=48.8
Q ss_pred eeeecccCCeEEEEEEEcCCCcEEEEEEe----cCC---CCchHHHHHHHHHHHhhc--cC-CCcceeeecccccCCCce
Q psy11098 105 LERLGNGRFCTVRKARDRGTGQLVALKQI----PRE---RQPQQITRAEYNLLSTLM--HA-HIPTALALFENAPVPGTD 174 (380)
Q Consensus 105 ~~~LG~G~fg~V~~~~~~~~~~~vAvK~~----~~~---~~~~~~~~~E~~il~~l~--h~-ni~~i~~~~~~~~~~~~~ 174 (380)
.+.||-|.-..||++.+...++.++||.- +.. ....+....|.+.|+.+. -| .+++++.+-. ...
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~-----e~~ 108 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDS-----VMN 108 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECc-----HHh
Confidence 57899999999999998543567899974 211 223456677888888764 23 3444444322 345
Q ss_pred EEEEEecCC
Q psy11098 175 TIVMQLVHG 183 (380)
Q Consensus 175 ~lv~e~~~g 183 (380)
.+|||++..
T Consensus 109 ~~vMEdL~~ 117 (409)
T PRK12396 109 CCVMEDLSD 117 (409)
T ss_pred hHHHHhCcc
Confidence 788988854
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.0075 Score=58.25 Aligned_cols=135 Identities=13% Similarity=0.134 Sum_probs=77.9
Q ss_pred eeeecccCCeEEEEEEEcC----CCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCc-ceeeecccccCCCceEEEEE
Q psy11098 105 LERLGNGRFCTVRKARDRG----TGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIP-TALALFENAPVPGTDTIVMQ 179 (380)
Q Consensus 105 ~~~LG~G~fg~V~~~~~~~----~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~-~i~~~~~~~~~~~~~~lv~e 179 (380)
+..|-.|-.-.+|++.... +++.|++|+........-...+|..+++.+...++. +++..+.. ..|.+
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~-------g~v~e 113 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPN-------GRVEE 113 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECC-------ceEEE
Confidence 3456557778899986432 346899998865432221236699999998765553 45554432 25789
Q ss_pred ecCCCCHHH----------HH----Hh--cCC------CC-HHHHHHHHHHH-----------------HHHHHHH----
Q psy11098 180 LVHGESLIQ----------HL----CR--QST------IT-ESYICCIIRQL-----------------HSALHCL---- 215 (380)
Q Consensus 180 ~~~gg~L~~----------~l----~~--~~~------l~-e~~~~~i~~qi-----------------l~al~~l---- 215 (380)
|+.|.+|.. .+ .+ +.. .+ ...+..+..++ ...+..|
T Consensus 114 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~ 193 (344)
T PLN02236 114 FIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKEL 193 (344)
T ss_pred eeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHh
Confidence 987765531 11 10 000 11 12222222111 1111122
Q ss_pred H----HCCcEeecCCCCcEEEeC--CeeEEEeCCCcc
Q psy11098 216 H----SQQIAHKDIRPENILMNG--AVLKLIDLGSSV 246 (380)
Q Consensus 216 H----~~~iiHrDlKp~NIl~~~--~~ikl~DFG~a~ 246 (380)
. ...++|+|+++.|||+++ +.+.++||..|.
T Consensus 194 ~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 194 SGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred cccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 1 236899999999999974 479999998764
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.0057 Score=57.18 Aligned_cols=28 Identities=32% Similarity=0.510 Sum_probs=23.9
Q ss_pred CcEeecCCCCcEEEeC-Ce-eEEEeCCCcc
Q psy11098 219 QIAHKDIRPENILMNG-AV-LKLIDLGSSV 246 (380)
Q Consensus 219 ~iiHrDlKp~NIl~~~-~~-ikl~DFG~a~ 246 (380)
.++|+|+.+.|||+++ +. +-|+||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence 4899999999999986 54 5699999874
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.01 Score=57.01 Aligned_cols=74 Identities=16% Similarity=0.201 Sum_probs=46.0
Q ss_pred eeecccCCeEEEEEEEcCC---CcEEEEEEecCCCCchHHHHHHHHHHHhhccCCC-cceeeecccccCCCceEEEEEec
Q psy11098 106 ERLGNGRFCTVRKARDRGT---GQLVALKQIPRERQPQQITRAEYNLLSTLMHAHI-PTALALFENAPVPGTDTIVMQLV 181 (380)
Q Consensus 106 ~~LG~G~fg~V~~~~~~~~---~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni-~~i~~~~~~~~~~~~~~lv~e~~ 181 (380)
+.|..|-.-.+|++..... +..|++|+........-...+|..+++.+...++ ++++.++.. .+|.+|+
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~~-------G~i~~fi 92 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFGN-------GMIQSFI 92 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeCC-------cEeehhh
Confidence 4555577778888865432 3478899885443322223569999999976666 345544421 2588888
Q ss_pred CCCCH
Q psy11098 182 HGESL 186 (380)
Q Consensus 182 ~gg~L 186 (380)
.|..|
T Consensus 93 ~g~~l 97 (330)
T PLN02421 93 NARTL 97 (330)
T ss_pred cCCCC
Confidence 77544
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.021 Score=54.20 Aligned_cols=141 Identities=20% Similarity=0.307 Sum_probs=75.8
Q ss_pred eeeeecccCCeEEEEEEEcCCCcEEEEEEecC-C--CCchHHHHHHHHHHHhhccCCC--cceeeecccccCCCceEEEE
Q psy11098 104 ELERLGNGRFCTVRKARDRGTGQLVALKQIPR-E--RQPQQITRAEYNLLSTLMHAHI--PTALALFENAPVPGTDTIVM 178 (380)
Q Consensus 104 ~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~-~--~~~~~~~~~E~~il~~l~h~ni--~~i~~~~~~~~~~~~~~lv~ 178 (380)
+.+.+-.|.--.+|..... ++.+++. ... . ........+|+.+++.+.---+ +..+.++.... -+..+.||
T Consensus 29 ~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~-~g~pf~v~ 104 (321)
T COG3173 29 IVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGY-LGTPFYVM 104 (321)
T ss_pred eeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCC-CCCceEEE
Confidence 3344433333345555443 7778888 332 1 1223455678888888865333 33344444433 35679999
Q ss_pred EecCCCCHH------------------HHHHh-------c----C---CCCHHHHHHHHHHH--------------HHHH
Q psy11098 179 QLVHGESLI------------------QHLCR-------Q----S---TITESYICCIIRQL--------------HSAL 212 (380)
Q Consensus 179 e~~~gg~L~------------------~~l~~-------~----~---~l~e~~~~~i~~qi--------------l~al 212 (380)
++++|..+. +.|.. . + .....++..+..+. ..-.
T Consensus 105 ~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~ 184 (321)
T COG3173 105 EWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLI 184 (321)
T ss_pred EEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHH
Confidence 999883221 11111 0 0 00111122222222 1112
Q ss_pred HHHHH--------CCcEeecCCCCcEEEeCC-eeEEEeCCCcccc
Q psy11098 213 HCLHS--------QQIAHKDIRPENILMNGA-VLKLIDLGSSVSV 248 (380)
Q Consensus 213 ~~lH~--------~~iiHrDlKp~NIl~~~~-~ikl~DFG~a~~~ 248 (380)
.+++. ..++|+|+.+.|++++++ .+-|+||+++..-
T Consensus 185 ~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 185 KWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 34432 248999999999999854 6889999988543
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.041 Score=52.69 Aligned_cols=73 Identities=22% Similarity=0.128 Sum_probs=44.1
Q ss_pred CCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccc----cCCCceEEEEEecCCCC
Q psy11098 112 RFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENA----PVPGTDTIVMQLVHGES 185 (380)
Q Consensus 112 ~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~----~~~~~~~lv~e~~~gg~ 185 (380)
.-..||+... .++..+++|+.+...........|.+.+..|....++-....-... ...+..+.+++++.|..
T Consensus 37 ~eN~vy~v~~-~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 37 YENRVYQFGD-EDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred ccceEEEEec-CCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 3456888874 3456799998865555666777899999988654332111110000 11245677889987753
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.03 Score=54.97 Aligned_cols=72 Identities=15% Similarity=0.140 Sum_probs=48.6
Q ss_pred eeeecccCCeEEEEEEEcCCCcEEEEEEec-----CCC---CchHHHHHHHHHHHhhc---cCCCcceeeecccccCCCc
Q psy11098 105 LERLGNGRFCTVRKARDRGTGQLVALKQIP-----RER---QPQQITRAEYNLLSTLM---HAHIPTALALFENAPVPGT 173 (380)
Q Consensus 105 ~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~-----~~~---~~~~~~~~E~~il~~l~---h~ni~~i~~~~~~~~~~~~ 173 (380)
.+.||.|....||+.... +..++||.-. ... ........|.+.|+.+. ...+++++.+.. +.
T Consensus 37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de-----d~ 109 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR-----TM 109 (418)
T ss_pred EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC-----CC
Confidence 577999999999999864 4468899764 111 13334455677776664 246677776665 33
Q ss_pred eEEEEEecCC
Q psy11098 174 DTIVMQLVHG 183 (380)
Q Consensus 174 ~~lv~e~~~g 183 (380)
.+++||++++
T Consensus 110 ~vlvME~L~~ 119 (418)
T PLN02756 110 ALIGMRYLEP 119 (418)
T ss_pred CEEEEeecCC
Confidence 5889999977
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.70 E-value=0.0059 Score=54.50 Aligned_cols=55 Identities=20% Similarity=0.238 Sum_probs=33.7
Q ss_pred CcEEEEEEecCCCCchHHHHHHHHHHHhhccCCC-cceeeecccccCCCceEEEEEecCCCCH
Q psy11098 125 GQLVALKQIPRERQPQQITRAEYNLLSTLMHAHI-PTALALFENAPVPGTDTIVMQLVHGESL 186 (380)
Q Consensus 125 ~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni-~~i~~~~~~~~~~~~~~lv~e~~~gg~L 186 (380)
++.|++++........-....|..+++.+...++ +.++..+.. .+|.+|+.|..|
T Consensus 2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~-------g~v~e~i~g~~l 57 (211)
T PF01633_consen 2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFFEN-------GRVEEFIEGRTL 57 (211)
T ss_dssp TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEETT-------EEEEE--SSEE-
T ss_pred CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEcCC-------CcEEEEeccccc
Confidence 4578899886664444445668999998876555 455555443 467799876553
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.70 E-value=0.033 Score=54.51 Aligned_cols=76 Identities=18% Similarity=0.262 Sum_probs=45.1
Q ss_pred eeeeecccCCeEEEEEEEcCC-Cc-----EEEEEEecCCCCchHHHHHHHHHHHhhccCCC-cceeeecccccCCCceEE
Q psy11098 104 ELERLGNGRFCTVRKARDRGT-GQ-----LVALKQIPRERQPQQITRAEYNLLSTLMHAHI-PTALALFENAPVPGTDTI 176 (380)
Q Consensus 104 ~~~~LG~G~fg~V~~~~~~~~-~~-----~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni-~~i~~~~~~~~~~~~~~l 176 (380)
.++.|..|--..+|++..... +. .|+++.........-.-.+|+++++.+...++ ++++..+.. ++
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~-------g~ 126 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD-------FT 126 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC-------EE
Confidence 345666688889999975432 12 24444432221111122558999999976655 445555432 78
Q ss_pred EEEecCCCCH
Q psy11098 177 VMQLVHGESL 186 (380)
Q Consensus 177 v~e~~~gg~L 186 (380)
+.||++|-+|
T Consensus 127 l~efIeGr~l 136 (383)
T PTZ00384 127 IQEWVEGNTM 136 (383)
T ss_pred EEEEeccccC
Confidence 9999988655
|
|
| >KOG0613|consensus | Back alignment and domain information |
|---|
Probab=96.60 E-value=0.00024 Score=76.34 Aligned_cols=171 Identities=9% Similarity=0.003 Sum_probs=126.6
Q ss_pred HHHHHHHHHHHHHHHCCcEeecCCCCcEEEeCC---eeEEEeCCCccccc-----ccccCCCcccCCccccCCCCCCCcc
Q psy11098 203 CIIRQLHSALHCLHSQQIAHKDIRPENILMNGA---VLKLIDLGSSVSVS-----TVVLPDLEFASPEMLTSPATAGPST 274 (380)
Q Consensus 203 ~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~~---~ikl~DFG~a~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~ 274 (380)
.-..+......++|....+|-++++.+++...+ ...+.|||...... .+..|+....+++.+.. ..++...
T Consensus 358 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ts~~~~~~~~~~~e~~~~~~~a~n~~g~~~~~~~~~vs~-~~~gt~~ 436 (1205)
T KOG0613|consen 358 LSGTQKPDEAQGYHGEEVSSESLGALPCPVGTVTSHTYTIKDAGPGEGYFTRVPAVNKGGTEQTIAESTVSE-EMPGTQP 436 (1205)
T ss_pred ccCCcCCchheeecccccccccccccccccccccCcchhhhhcCcccccccccceeccCCcccccchhhccc-ccCCCCC
Confidence 344567777889999999999999988888643 68899999765442 45677888989988877 5778899
Q ss_pred cHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHhcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccc
Q psy11098 275 DMWSLGVLLYILLSGVSPFLDESEEETRA--HISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFA 352 (380)
Q Consensus 275 DiwSlGvil~~lltg~~Pf~~~~~~~~~~--~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~ 352 (380)
+.|+.++..+-+|++..++.......... ......+....+.........++++..+|.+--..+.++..+..-.|.+
T Consensus 437 ~~~kk~~~~t~~L~~~~~i~~~~~~~s~~~~~~~~tt~~~~~~~s~~s~~l~r~~~tslLlk~~~~~~~A~~~~a~~~~~ 516 (1205)
T KOG0613|consen 437 PKFKKDVSTTDLLTVKDEITVRTPDSSTSMPMTTVTTIKDGLPLSDRSVTLTRDVLTSLLLKVASLSDGAQYTRALRTLQ 516 (1205)
T ss_pred ccccccccccccccCCcccccccCCCCccccceeEeeccCCcccccccccccccchhhheeeccCCCccchhhhhhhccC
Confidence 99999999999999888876544333222 3333444444444555667788999999999888999999999888888
Q ss_pred ccCCC-----CCccccccc-hHHHHHHH
Q psy11098 353 EASCS-----EFDTERLLP-FSARRKQK 374 (380)
Q Consensus 353 ~~~~~-----~~~~~~~~~-~~~~~~~~ 374 (380)
..... ...++...+ ++.+++|+
T Consensus 517 ~k~~~~~~~~l~~~~s~a~~~~~~~~~~ 544 (1205)
T KOG0613|consen 517 GKPVPSLDRKLPAAKSSAPKPIHTQENQ 544 (1205)
T ss_pred CCCCCcccccccccccCCcccccccccC
Confidence 65433 555566655 67666665
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.31 E-value=0.051 Score=52.05 Aligned_cols=135 Identities=21% Similarity=0.233 Sum_probs=80.3
Q ss_pred ecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeeccc-----ccCCC--ceEEEEEe
Q psy11098 108 LGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFEN-----APVPG--TDTIVMQL 180 (380)
Q Consensus 108 LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~-----~~~~~--~~~lv~e~ 180 (380)
|.+ .-..||+..... |+ +++|+.... ........|+..+..|.-..++-...+-.. ....+ +.+-+++|
T Consensus 34 l~s-~eN~~f~~~~~~-g~-~iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~ 109 (331)
T COG2334 34 LNS-EENSNFRVQTED-GR-YILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY 109 (331)
T ss_pred ccc-ccCceEEEEecC-CC-eEEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence 444 445688887543 43 499999877 666777889999999965554333221000 01123 66788999
Q ss_pred cCCCCHHH------------HHH------hcCC---------CCHH----H---------HHHHHHHHHHHHHHHHH---
Q psy11098 181 VHGESLIQ------------HLC------RQST---------ITES----Y---------ICCIIRQLHSALHCLHS--- 217 (380)
Q Consensus 181 ~~gg~L~~------------~l~------~~~~---------l~e~----~---------~~~i~~qil~al~~lH~--- 217 (380)
+.|..+.. .+. ++.+ .... . -.....++...+..+.+
T Consensus 110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~ 189 (331)
T COG2334 110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP 189 (331)
T ss_pred cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence 98876652 110 0111 1111 0 01123334444444442
Q ss_pred -----CC--cEeecCCCCcEEEeCCe--eEEEeCCCcc
Q psy11098 218 -----QQ--IAHKDIRPENILMNGAV--LKLIDLGSSV 246 (380)
Q Consensus 218 -----~~--iiHrDlKp~NIl~~~~~--ikl~DFG~a~ 246 (380)
.+ +||.|+.|.|||++.+. +.++|||.+.
T Consensus 190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 23 99999999999999763 8999999874
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.069 Score=53.32 Aligned_cols=75 Identities=11% Similarity=0.153 Sum_probs=47.9
Q ss_pred eeeeecccCCeEEEEEEEcC--------CCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCc-ceeeecccccCCCce
Q psy11098 104 ELERLGNGRFCTVRKARDRG--------TGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIP-TALALFENAPVPGTD 174 (380)
Q Consensus 104 ~~~~LG~G~fg~V~~~~~~~--------~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~-~i~~~~~~~~~~~~~ 174 (380)
-++.|..|-.-.+|++.... .++.|.+++.-.....--...+|..+++.+...++. ++++.+. -
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f~-------g 181 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTFS-------G 181 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEeC-------C
Confidence 45667667777889887542 256799998854433222335688888888765553 4454432 1
Q ss_pred EEEEEecCCCC
Q psy11098 175 TIVMQLVHGES 185 (380)
Q Consensus 175 ~lv~e~~~gg~ 185 (380)
+.|.||+.|-.
T Consensus 182 g~I~efi~g~~ 192 (442)
T PTZ00296 182 GRIEEWLYGDP 192 (442)
T ss_pred CEEEEeeCCcc
Confidence 56789998763
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.19 E-value=0.056 Score=50.79 Aligned_cols=75 Identities=13% Similarity=0.182 Sum_probs=47.1
Q ss_pred eeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhcc---CCCcceeeecccccCCCceEEEEE
Q psy11098 103 EELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMH---AHIPTALALFENAPVPGTDTIVMQ 179 (380)
Q Consensus 103 ~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h---~ni~~i~~~~~~~~~~~~~~lv~e 179 (380)
+-.+.++.|....+|+.. .+++.+.||+-. .....++..|.+-|+.|.. ..+++++.+.... +..+|+||
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~---~~~fLlle 92 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNS--ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYD---DDAFLLLE 92 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEE--GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-S---SCCEEEEE
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecC--hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeec---CCceEEEE
Confidence 445779999999999987 567789999876 3345678889999999943 3466666665543 34599999
Q ss_pred ecCCC
Q psy11098 180 LVHGE 184 (380)
Q Consensus 180 ~~~gg 184 (380)
|++.+
T Consensus 93 ~l~~~ 97 (288)
T PF03881_consen 93 FLEMG 97 (288)
T ss_dssp -----
T ss_pred eecCC
Confidence 99766
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.18 E-value=0.014 Score=55.85 Aligned_cols=100 Identities=14% Similarity=0.186 Sum_probs=64.7
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeecCCCCcEEEeCCeeEEEeCCCccccc-c
Q psy11098 173 TDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQ-QIAHKDIRPENILMNGAVLKLIDLGSSVSVS-T 250 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~-~iiHrDlKp~NIl~~~~~ikl~DFG~a~~~~-~ 250 (380)
..|++|++- |++|.. + .....+++..++.+-+..+.-+... ..-|||+.-.||||+.|+|.||||-+++... .
T Consensus 300 y~yl~~kdh-gt~is~-i---k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId~GnvtLIDfklsRl~~~q 374 (488)
T COG5072 300 YLYLHFKDH-GTPISI-I---KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILIDEGNVTLIDFKLSRLSYSQ 374 (488)
T ss_pred EEEEEEecC-Cceeee-e---ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeeecCceEEEEeeeeecccCC
Confidence 446677765 655532 2 2234566777877777766666543 6889999999999999999999999998332 2
Q ss_pred cccCCCcccCCccccCCCCCCCcccHHHH
Q psy11098 251 VVLPDLEFASPEMLTSPATAGPSTDMWSL 279 (380)
Q Consensus 251 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSl 279 (380)
........--|-.++|. .+..-|||-+
T Consensus 375 ~~isy~rldhp~lF~G~--dd~QFeIYrl 401 (488)
T COG5072 375 GIISYNRLDHPDLFNGV--DDYQFEIYRL 401 (488)
T ss_pred ceeeccccCchhhhcCc--cceeeeHHHH
Confidence 22223333345555552 2455666654
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.85 E-value=0.087 Score=49.94 Aligned_cols=28 Identities=11% Similarity=0.167 Sum_probs=24.5
Q ss_pred CcEeecCCCCcEEEeC-CeeEEEeCCCcc
Q psy11098 219 QIAHKDIRPENILMNG-AVLKLIDLGSSV 246 (380)
Q Consensus 219 ~iiHrDlKp~NIl~~~-~~ikl~DFG~a~ 246 (380)
+++|+|+.+.|+|+++ +.+.++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 7999999999999974 588999998763
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF00041 fn3: Fibronectin type III domain; InterPro: IPR003961 Fibronectins are multi-domain glycoproteins found in a soluble form in plasma, and in an insoluble form in loose connective tissue and basement membranes [] | Back alignment and domain information |
|---|
Probab=95.81 E-value=0.037 Score=40.91 Aligned_cols=65 Identities=18% Similarity=0.281 Sum_probs=46.5
Q ss_pred CCCeeeeecCCCCeeEEeecCCC--CCCcceeeeccccccCCc-EEe---cCCCCeEEeecCCCCceeeEEee
Q psy11098 12 TQPVINVHPLSESSVELALLTEN--LSSIRLCDHESGVWSDAR-WVI---SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 12 ~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~-~~~---~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
....+.. .+.+++.|.|..+. ...+..+.++-....+.. |.. +.....+.+.+|.|+..|.|++.
T Consensus 4 ~~l~v~~--~~~~sv~v~W~~~~~~~~~~~~y~v~~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~v~ 74 (85)
T PF00041_consen 4 ENLSVSN--ISPTSVTVSWKPPSSGNGPITGYRVEYRSVNSTSDWQEVTVPGNETSYTITGLQPGTTYEFRVR 74 (85)
T ss_dssp EEEEEEE--ECSSEEEEEEEESSSTSSSESEEEEEEEETTSSSEEEEEEEETTSSEEEEESCCTTSEEEEEEE
T ss_pred cCeEEEE--CCCCEEEEEEECCCCCCCCeeEEEEEEEecccceeeeeeeeeeeeeeeeeccCCCCCEEEEEEE
Confidence 4556666 78899999999996 333666776654444443 443 34455899999999999999973
|
They contain multiple copies of 3 repeat regions (types I, II and III), which bind to a variety of substances including heparin, collagen, DNA, actin, fibrin and fibronectin receptors on cell surfaces. The wide variety of these substances means that fibronectins are involved in a number of important functions: e.g., wound healing; cell adhesion; blood coagulation; cell differentiation and migration; maintenance of the cellular cytoskeleton; and tumour metastasis []. The role of fibronectin in cell differentiation is demonstrated by the marked reduction in the expression of its gene when neoplastic transformation occurs. Cell attachment has been found to be mediated by the binding of the tetrapeptide RGDS to integrins on the cell surface [], although related sequences can also display cell adhesion activity. Plasma fibronectin occurs as a dimer of 2 different subunits, linked together by 2 disulphide bonds near the C terminus. The difference in the 2 chains occurs in the type III repeat region and is caused by alternative splicing of the mRNA from one gene []. The observation that, in a given protein, an individual repeat of one of the 3 types (e.g., the first FnIII repeat) shows much less similarity to its subsequent tandem repeats within that protein than to its equivalent repeat between fibronectins from other species, has suggested that the repeating structure of fibronectin arose at an early stage of evolution. It also seems to suggest that the structure is subject to high selective pressure []. The fibronectin type III repeat region is an approximately 100 amino acid domain, different tandem repeats of which contain binding sites for DNA, heparin and the cell surface []. The superfamily of sequences believed to contain FnIII repeats represents 45 different families, the majority of which are involved in cell surface binding in some manner, or are receptor protein tyrosine kinases, or cytokine receptors.; GO: 0005515 protein binding; PDB: 1UEM_A 1TDQ_A 1X5I_A 2IC2_B 2IBG_C 2IBB_A 3R8Q_A 2FNB_A 1FNH_A 2EDB_A .... |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.75 E-value=0.2 Score=55.36 Aligned_cols=139 Identities=19% Similarity=0.240 Sum_probs=78.0
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhcc--CC--Ccceeeeccc------ccCCC--c
Q psy11098 106 ERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMH--AH--IPTALALFEN------APVPG--T 173 (380)
Q Consensus 106 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h--~n--i~~i~~~~~~------~~~~~--~ 173 (380)
+.|+ |..-.+|+... .+|+.+++|+.+... .......|..+|..|.. +. ++.++..... ....+ .
T Consensus 31 ~~L~-s~~d~nf~v~~-~~g~~yVLKi~~~~~-~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTT-DDGADYILKIVNPSE-PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEe-CCCCeEEEEEcCCcc-chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 4564 44577888874 356789999997542 33445557778877742 23 4444432211 01112 4
Q ss_pred eEEEEEecCCCCHHHH-------HH----------h---cC-------CCCH-----------------HHHHHHHHHHH
Q psy11098 174 DTIVMQLVHGESLIQH-------LC----------R---QS-------TITE-----------------SYICCIIRQLH 209 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~-------l~----------~---~~-------~l~e-----------------~~~~~i~~qil 209 (380)
.+-+++|+.|..+.+. +. . .. .+.+ ...+.++.+++
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 5678999998776541 00 0 00 0000 01122233333
Q ss_pred HHHH-----HHH--HCCcEeecCCCCcEEEeCC---eeE-EEeCCCccc
Q psy11098 210 SALH-----CLH--SQQIAHKDIRPENILMNGA---VLK-LIDLGSSVS 247 (380)
Q Consensus 210 ~al~-----~lH--~~~iiHrDlKp~NIl~~~~---~ik-l~DFG~a~~ 247 (380)
+... .+. ..++||.|+.+.|||++.+ .+. |+|||.+..
T Consensus 188 ~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 188 ARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 3322 121 2579999999999999854 454 999998754
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 380 | ||||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-37 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-36 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-36 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-34 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-34 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-34 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-34 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-34 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-34 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-34 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-34 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-34 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-34 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-34 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-33 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-33 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-33 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 8e-33 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-33 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-32 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-32 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-32 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-32 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-28 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-28 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-28 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-27 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-27 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-27 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-27 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-27 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-26 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-26 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 8e-26 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-26 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-25 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-25 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-25 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-25 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-25 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 9e-25 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-24 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-24 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-24 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-24 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-24 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-24 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-24 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 7e-24 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 8e-24 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-24 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 8e-24 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 8e-24 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-23 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-23 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-23 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-23 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-23 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-23 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-23 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-23 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-23 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-23 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-23 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-23 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 8e-23 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-22 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-22 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-22 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-22 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-22 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-22 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-22 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 6e-22 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 6e-22 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 7e-22 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 7e-22 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 7e-22 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 8e-22 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-21 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-21 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-21 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-21 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-21 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-21 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-21 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-21 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-21 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-21 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-21 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-21 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-21 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-21 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-21 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-21 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 8e-21 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 9e-21 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-20 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-20 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-20 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-20 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-20 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-20 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-20 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-20 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-20 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-20 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-20 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-20 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-20 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-20 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-20 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-20 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-20 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-20 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-20 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-20 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-20 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-20 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-20 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-20 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-20 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-20 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-20 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-20 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-20 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-20 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-20 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-20 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 8e-20 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-20 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-20 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 9e-20 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-20 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 9e-20 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 9e-20 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-19 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-19 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-19 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-19 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-19 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-19 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 8e-19 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 8e-19 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 9e-19 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 9e-19 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-18 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-18 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-18 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-18 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-17 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-17 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-17 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-17 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-17 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-17 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-17 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-17 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-17 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-17 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-17 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-17 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-17 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-17 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-17 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-17 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 7e-17 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 7e-17 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-17 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-16 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-16 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-16 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-16 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-16 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-16 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-16 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-16 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-16 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-16 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-16 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-16 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-16 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-16 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-16 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-16 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-16 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-16 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-16 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-16 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-16 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-16 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-16 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-16 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-16 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-16 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-16 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-15 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-15 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-15 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-15 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-15 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-15 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-15 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-15 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-15 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-15 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-15 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-15 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-15 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 6e-15 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-15 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 7e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 8e-15 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-14 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-14 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-14 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-14 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-14 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-14 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-14 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-14 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-14 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-14 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-14 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-14 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-14 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-14 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-14 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-14 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-14 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-14 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-14 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-14 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-14 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-14 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-14 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-14 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-14 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-14 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-14 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 7e-14 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-14 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 7e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 7e-14 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 7e-14 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 7e-14 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 8e-14 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 8e-14 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 8e-14 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-14 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 8e-14 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 8e-14 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-14 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 8e-14 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 8e-14 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 8e-14 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-14 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 9e-14 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 9e-14 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 9e-14 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 9e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 9e-14 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 9e-14 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 9e-14 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 9e-14 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 9e-14 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 9e-14 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 9e-14 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 9e-14 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 9e-14 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 9e-14 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 9e-14 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 9e-14 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 9e-14 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 9e-14 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 9e-14 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-13 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-13 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-13 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-13 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-13 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-13 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-13 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-13 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-13 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-13 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-13 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-13 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-13 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-13 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-13 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-13 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-13 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-13 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-13 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-13 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-13 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-13 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-13 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-13 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-13 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-13 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-13 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-13 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-13 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-13 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-13 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-13 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-13 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-13 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-13 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-13 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-13 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-13 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-13 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-13 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-13 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-13 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-13 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-13 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-13 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-13 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-13 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-13 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-13 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-13 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-13 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-13 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-13 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 6e-13 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 6e-13 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-13 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-13 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-13 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-13 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-13 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 7e-13 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 7e-13 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 7e-13 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-13 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-13 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 8e-13 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-13 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 8e-13 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 8e-13 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 8e-13 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 8e-13 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 8e-13 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 8e-13 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 9e-13 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 9e-13 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 9e-13 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 9e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-13 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 9e-13 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 9e-13 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 9e-13 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 9e-13 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 9e-13 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-12 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-12 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-12 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-12 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-12 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-12 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-12 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-12 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-12 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-12 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-12 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-12 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-12 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-12 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-12 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-12 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-12 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-12 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-12 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-12 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-12 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-11 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-11 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-11 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-11 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 9e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-10 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-10 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-10 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 3e-10 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 3e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-10 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-10 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 6e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 7e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 8e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 8e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 8e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 8e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 9e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-09 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-09 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-09 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-09 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-09 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-09 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-09 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-09 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-09 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-09 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-09 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-09 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-09 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 6e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 6e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 7e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 8e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 8e-09 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 8e-09 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-08 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-08 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-08 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-08 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-08 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-08 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-08 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-08 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-08 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 6e-08 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-08 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-08 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-08 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 7e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 7e-08 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 8e-08 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 8e-08 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-08 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 8e-08 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 9e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 9e-08 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-07 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 1e-07 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 1e-07 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 1e-07 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-07 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 1e-07 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-07 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-07 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 1e-07 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-07 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-07 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 1e-07 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 1e-07 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 1e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-07 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-07 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-07 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-07 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-07 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-07 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-07 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-07 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-07 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-07 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-07 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-07 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-07 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-07 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-07 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-07 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-07 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-07 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-07 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-07 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-07 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-07 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-07 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-07 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-07 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-07 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-07 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-07 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-07 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-07 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-07 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-07 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-07 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 3e-07 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-07 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 3e-07 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-07 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-07 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-07 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-07 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-07 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 4e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-07 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-07 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-07 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-07 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-07 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-07 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-07 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-07 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-07 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-07 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 9e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 9e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 9e-07 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-06 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-06 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-06 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-06 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-06 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 3e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-06 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-06 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 3e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-06 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-06 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-06 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-06 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-06 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-06 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-06 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-06 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-06 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-06 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 5e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-06 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 6e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-06 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 7e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 7e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 7e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 8e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 8e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 8e-06 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-05 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-05 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-05 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-05 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 1e-05 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 1e-05 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 1e-05 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 1e-05 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 1e-05 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 2e-05 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 2e-05 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-05 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-05 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-05 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-05 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-05 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-05 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-05 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-05 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-05 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-05 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-05 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 2e-05 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-05 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-05 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-05 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-05 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-05 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-05 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-05 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-05 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-05 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-05 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-05 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-05 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-05 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-05 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 7e-05 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 7e-05 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 8e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-04 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-04 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-04 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-04 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-04 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-04 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-04 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-04 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-04 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-04 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-04 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-04 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-04 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 2e-04 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-04 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-04 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 2e-04 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-04 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-04 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-04 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-04 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-04 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 3e-04 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 3e-04 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 3e-04 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-04 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-04 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-04 |
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 3e-66
Identities = 76/291 (26%), Positives = 131/291 (45%), Gaps = 15/291 (5%)
Query: 96 EQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMH 155
++ +Y E LG G F V + + + + K + + Q + + E ++L+ H
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH 60
Query: 156 AHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLC-RQSTITESYICCIIRQLHSALHC 214
+I FE+ ++ + + G + + + + E I + Q+ AL
Sbjct: 61 RNILHLHESFES---MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQF 117
Query: 215 LHSQQIAHKDIRPENILM---NGAVLKLIDLGSSVSVS-TVVLPDL----EFASPEMLTS 266
LHS I H DIRPENI+ + +K+I+ G + + L E+ +PE+
Sbjct: 118 LHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH 177
Query: 267 PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARE 326
+TDMWSLG L+Y+LLSG++PFL E+ ++ +I A+Y+F E IS+ A +
Sbjct: 178 DV-VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD 236
Query: 327 LIGQLLNTHADKRPTAGQLLQVAWFAEASCSEFDTERLLPFSARRK-QKFK 376
+ +LL R TA + LQ W + T+ + RR
Sbjct: 237 FVDRLLVKERKSRMTASEALQHPWLKQKI-ERVSTKVIRTLKHRRYYHTLI 286
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 218 bits (556), Expect = 6e-66
Identities = 87/335 (25%), Positives = 138/335 (41%), Gaps = 20/335 (5%)
Query: 56 SPHNGTIQVDDLAPGHTYTFCINNEYKVLYTVPFETRWQQEQFEHRYEELERLGNGRFCT 115
G I Y + + +K Y P E + + Y+ E LG G F
Sbjct: 115 VDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIK--HDHVLDHYDIHEELGTGAFGV 172
Query: 116 VRKARDRGTGQLVALKQIP-RERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTD 174
V + +R TG A K + ++ R E +S L H + FE+
Sbjct: 173 VHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED---DNEM 229
Query: 175 TIVMQLVHGESLIQHLC-RQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILM- 232
++ + + G L + + + ++E +RQ+ L +H H D++PENI+
Sbjct: 230 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFT 289
Query: 233 --NGAVLKLIDLGSSVSVS-TVVLPDL----EFASPEMLTSPATAGPSTDMWSLGVLLYI 285
LKLID G + + + EFA+PE+ G TDMWS+GVL YI
Sbjct: 290 TKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYI 348
Query: 286 LLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQL 345
LLSG+SPF E+++ET ++ D++ IS ++ I +LL + R T Q
Sbjct: 349 LLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQA 408
Query: 346 LQVAWF----AEASCSEFDTERLLPFSARRKQKFK 376
L+ W A S+ + R K K+
Sbjct: 409 LEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYD 443
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 213 bits (543), Expect = 6e-66
Identities = 81/318 (25%), Positives = 142/318 (44%), Gaps = 19/318 (5%)
Query: 73 YTFCINNEYKVLYTVPFETRWQQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQ 132
Y + +K P E + Q Y+ LE LG+G F V + ++ TG++ K
Sbjct: 26 YDKFYEDIWKKYVPQPVEVK--QGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKF 83
Query: 133 IP-RERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLC 191
I + + E ++++ L H + FE+ ++++ + G L +
Sbjct: 84 INTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFED---KYEMVLILEFLSGGELFDRIA 140
Query: 192 -RQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILM---NGAVLKLIDLGSSVS 247
++E+ + +RQ L +H I H DI+PENI+ + +K+ID G +
Sbjct: 141 AEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATK 200
Query: 248 VS-TVVLPDL----EFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETR 302
++ ++ EFA+PE++ G TDMW++GVL Y+LLSG+SPF E + ET
Sbjct: 201 LNPDEIVKVTTATAEFAAPEIVDREP-VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL 259
Query: 303 AHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWF---AEASCSEF 359
++ D+ F + +S A++ I LL KR T L+ W S
Sbjct: 260 QNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRI 319
Query: 360 DTERLLPFSARRKQKFKE 377
+ R + K+K+ +
Sbjct: 320 PSSRYNKIRQKIKEKYAD 337
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 7e-66
Identities = 90/307 (29%), Positives = 152/307 (49%), Gaps = 29/307 (9%)
Query: 93 WQQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIP-------RERQPQQITRA 145
++Q++ E Y+ E LG+G+F V+K R++ TG A K I R ++
Sbjct: 5 FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIER 64
Query: 146 EYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCII 205
E ++L ++H +I T ++EN ++++LV G L L ++ +++E I
Sbjct: 65 EVSILRQVLHPNIITLHDVYEN---RTDVVLILELVSGGELFDFLAQKESLSEEEATSFI 121
Query: 206 RQLHSALHCLHSQQIAHKDIRPENILM-----NGAVLKLIDLGSSVSVS-TVVLPDL--- 256
+Q+ ++ LH+++IAH D++PENI++ +KLID G + + V ++
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGT 181
Query: 257 -EFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPE 315
EF +PE++ G DMWS+GV+ YILLSG SPFL ++++ET A+I+ Y F E
Sbjct: 182 PEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEE 240
Query: 316 QCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASCSEFD--------TERLLPF 367
S A++ I +LL KR T + L+ W + E
Sbjct: 241 FFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLENFKKQ 300
Query: 368 SARRKQK 374
RR+ K
Sbjct: 301 YVRRRWK 307
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 2e-65
Identities = 88/299 (29%), Positives = 151/299 (50%), Gaps = 21/299 (7%)
Query: 94 QQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIP-------RERQPQQITRAE 146
+Q++ E Y+ E LG+G+F V+K R++ TG A K I R ++ E
Sbjct: 6 KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65
Query: 147 YNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIR 206
++L ++H ++ T ++EN ++++LV G L L ++ +++E I+
Sbjct: 66 VSILRQVLHHNVITLHDVYEN---RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK 122
Query: 207 QLHSALHCLHSQQIAHKDIRPENILM-----NGAVLKLIDLGSSVSVS-TVVLPDL---- 256
Q+ ++ LH+++IAH D++PENI++ +KLID G + + V ++
Sbjct: 123 QILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTP 182
Query: 257 EFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQ 316
EF +PE++ G DMWS+GV+ YILLSG SPFL ++++ET A+I+ Y F E
Sbjct: 183 EFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEF 241
Query: 317 CGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASCSEFDTERLLPFSARRKQKF 375
H S A++ I +LL KR T + L+ W + R + +K
Sbjct: 242 FSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLENFRKQ 300
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 3e-65
Identities = 90/301 (29%), Positives = 148/301 (49%), Gaps = 22/301 (7%)
Query: 91 TRWQQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQIT------- 143
T ++QE + Y+ E LG+G+F V+K R++ TG A K I + R
Sbjct: 2 TVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 144 RAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICC 203
E ++L + H ++ T ++EN ++++LV G L L + ++TE
Sbjct: 62 EREVSILKEIQHPNVITLHEVYEN---KTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 204 IIRQLHSALHCLHSQQIAHKDIRPENILM-----NGAVLKLIDLGSSVSVS-TVVLPDL- 256
++Q+ + ++ LHS QIAH D++PENI++ +K+ID G + + ++
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF 178
Query: 257 ---EFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFP 313
EF +PE++ G DMWS+GV+ YILLSG SPFL ++++ET A++S +Y F
Sbjct: 179 GTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE 237
Query: 314 PEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASCSEFDTERLLPFSARRKQ 373
E + S A++ I +LL KR T LQ W + + R K
Sbjct: 238 DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALS-RKASAVNMEKF 296
Query: 374 K 374
K
Sbjct: 297 K 297
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 2e-64
Identities = 84/304 (27%), Positives = 137/304 (45%), Gaps = 21/304 (6%)
Query: 88 PFETRW---QQEQFEHRYE--ELERLGNGRFCTVRKARDRGTGQLVALKQIP-RERQPQQ 141
PF+ R +Q Y + E LG GRF V K + TG +A K I R + ++
Sbjct: 72 PFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKE 131
Query: 142 ITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQH-LCRQSTITESY 200
+ E ++++ L HA++ FE+ +VM+ V G L + +TE
Sbjct: 132 EVKNEISVMNQLDHANLIQLYDAFES---KNDIVLVMEYVDGGELFDRIIDESYNLTELD 188
Query: 201 ICCIIRQLHSALHCLHSQQIAHKDIRPENILM---NGAVLKLIDLGSSVSVS-TVVLPDL 256
++Q+ + +H I H D++PENIL + +K+ID G + L
Sbjct: 189 TILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN 248
Query: 257 ----EFASPEMLT-SPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYS 311
EF +PE++ TDMWS+GV+ Y+LLSG+SPFL +++ ET +I +
Sbjct: 249 FGTPEFLAPEVVNYDFV--SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWD 306
Query: 312 FPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASCSEFDTERLLPFSARR 371
E+ IS A+E I +LL R +A + L+ W ++ + +
Sbjct: 307 LEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSAQKKKNRGSD 366
Query: 372 KQKF 375
Q F
Sbjct: 367 AQDF 370
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 1e-62
Identities = 83/295 (28%), Positives = 136/295 (46%), Gaps = 19/295 (6%)
Query: 94 QQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTL 153
++ +E LG G V + + +GT + ALK + + + + E +L L
Sbjct: 47 NRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRT-EIGVLLRL 105
Query: 154 MHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALH 213
H +I +FE P ++V++LV G L + + +E ++Q+ A+
Sbjct: 106 SHPNIIKLKEIFET---PTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVA 162
Query: 214 CLHSQQIAHKDIRPENILM----NGAVLKLIDLGSSVSVS-TVVLPDL----EFASPEML 264
LH I H+D++PEN+L A LK+ D G S V V++ + + +PE+L
Sbjct: 163 YLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEIL 222
Query: 265 TSPATAGPSTDMWSLGVLLYILLSGVSPFLDE-SEEETRAHISVADYSFPPEQCGHISVP 323
A GP DMWS+G++ YILL G PF DE ++ I +Y F +S+
Sbjct: 223 RGCAY-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLN 281
Query: 324 ARELIGQLLNTHADKRPTAGQLLQVAWFAEASCSEFDTERLLP----FSARRKQK 374
A++L+ +L+ KR T Q LQ W + + + F+ARRK K
Sbjct: 282 AKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANFVHMDTAQKKLQEFNARRKLK 336
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 200 bits (512), Expect = 2e-62
Identities = 92/275 (33%), Positives = 140/275 (50%), Gaps = 21/275 (7%)
Query: 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQIT-------RAEYNLL 150
E YE E LG+G+F VRK R +GTG+ A K I + R E N+L
Sbjct: 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 62
Query: 151 STLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHS 210
+ H +I T +FEN ++++LV G L L + ++TE ++Q+
Sbjct: 63 REIRHPNIITLHDIFEN---KTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD 119
Query: 211 ALHCLHSQQIAHKDIRPENILM-----NGAVLKLIDLGSSVSVS-TVVLPDL----EFAS 260
+H LHS++IAH D++PENI++ +KLID G + + ++ EF +
Sbjct: 120 GVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVA 179
Query: 261 PEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHI 320
PE++ G DMWS+GV+ YILLSG SPFL E+++ET +IS +Y F E +
Sbjct: 180 PEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNT 238
Query: 321 SVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355
S A++ I +LL +R T Q L+ +W
Sbjct: 239 SELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 3e-62
Identities = 77/275 (28%), Positives = 133/275 (48%), Gaps = 21/275 (7%)
Query: 95 QEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER--QPQQITRAEYNLLST 152
Q + + +LG+G F V +R +G +K I ++R P + AE +L +
Sbjct: 17 QGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKS 76
Query: 153 LMHAHIPTALALFENAPVPGTDTIVMQLVHG----ESLIQHLCRQSTITESYICCIIRQL 208
L H +I +FE+ IVM+ G E ++ R ++E Y+ +++Q+
Sbjct: 77 LDHPNIIKIFEVFED---YHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQM 133
Query: 209 HSALHCLHSQQIAHKDIRPENILM----NGAVLKLIDLGSSVSV-STVVLPDL----EFA 259
+AL HSQ + HKD++PENIL + +K+ID G + S + +
Sbjct: 134 MNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYM 193
Query: 260 SPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGH 319
+PE+ D+WS GV++Y LL+G PF S EE + + + ++ E C
Sbjct: 194 APEVFKRDV--TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVE-CRP 250
Query: 320 ISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEA 354
++ A +L+ Q+L ++RP+A Q+L WF +A
Sbjct: 251 LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 3e-62
Identities = 83/299 (27%), Positives = 130/299 (43%), Gaps = 22/299 (7%)
Query: 94 QQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER---QPQQITRAEYNLL 150
+F Y+ E LG G F VR+ + TG A K I ++ + Q E +
Sbjct: 23 ASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARIC 82
Query: 151 STLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHS 210
L H +I + +V LV G L + + + +E+ I+Q+
Sbjct: 83 RKLQHPNIVRLHDSIQE---ESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE 139
Query: 211 ALHCLHSQQIAHKDIRPENILM----NGAVLKLIDLGSSVSVS-TVVLPDL----EFASP 261
++ HS I H++++PEN+L+ GA +KL D G ++ V+ + + SP
Sbjct: 140 SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSP 199
Query: 262 EMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHIS 321
E+L D+W+ GV+LYILL G PF DE + A I Y +P + ++
Sbjct: 200 EVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVT 258
Query: 322 VPARELIGQLLNTHADKRPTAGQLLQVAWFAEASCSEFDT------ERLLPFSARRKQK 374
A+ LI +L + KR TA Q L+V W + L F+ARRK K
Sbjct: 259 PEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKKFNARRKLK 317
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 3e-62
Identities = 80/305 (26%), Positives = 130/305 (42%), Gaps = 27/305 (8%)
Query: 92 RWQQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQIT----RAEY 147
+ F RY+ LG G F V +D+ TGQ A+K I + + Q+ E
Sbjct: 18 QHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREV 77
Query: 148 NLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQ 207
LL L H +I FE+ G +V ++ G L + + +E IIRQ
Sbjct: 78 QLLKQLDHPNIMKLYEFFED---KGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQ 134
Query: 208 LHSALHCLHSQQIAHKDIRPENILMN----GAVLKLIDLGSSVSV-STVVLPDL----EF 258
+ S + +H +I H+D++PEN+L+ A +++ID G S ++ + D +
Sbjct: 135 VLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYY 194
Query: 259 ASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCG 318
+PE+L D+WS GV+LYILLSG PF +E + + Y+F Q
Sbjct: 195 IAPEVLHGTY--DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWK 252
Query: 319 HISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASCSEFDT---------ERLLPFSA 369
+S A++LI ++L R +A L W + + + F
Sbjct: 253 KVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQG 312
Query: 370 RRKQK 374
+K
Sbjct: 313 TQKLA 317
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 1e-61
Identities = 81/300 (27%), Positives = 127/300 (42%), Gaps = 23/300 (7%)
Query: 94 QQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP---QQITRAEYNLL 150
+F Y+ E LG G F VR+ GQ A I ++ Q E +
Sbjct: 5 TCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARIC 64
Query: 151 STLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHS 210
L H +I G ++ LV G L + + + +E+ I+Q+
Sbjct: 65 RLLKHPNIVRLHDSISE---EGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILE 121
Query: 211 ALHCLHSQQIAHKDIRPENILM----NGAVLKLIDLGSSVSV--STVVLPDL----EFAS 260
A+ H + H++++PEN+L+ GA +KL D G ++ V + S
Sbjct: 122 AVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLS 181
Query: 261 PEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHI 320
PE+L G D+W+ GV+LYILL G PF DE + I Y FP + +
Sbjct: 182 PEVLRKDPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTV 240
Query: 321 SVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASCSEFDT------ERLLPFSARRKQK 374
+ A++LI ++L + KR TA + L+ W + S + L F+ARRK K
Sbjct: 241 TPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLK 300
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 1e-61
Identities = 88/307 (28%), Positives = 130/307 (42%), Gaps = 35/307 (11%)
Query: 94 QQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER---QPQQITRAEYNLL 150
Q F RY + LG G F V K +DR T Q A+K I + + E LL
Sbjct: 16 FQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELL 75
Query: 151 STLMHAHIPTALALFENAPVPGTDT----IVMQLVHGESLIQHLCRQSTITESYICCIIR 206
L H +I + E D+ IV +L G L + ++ +E II+
Sbjct: 76 KKLDHPNIMKLFEILE-------DSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK 128
Query: 207 QLHSALHCLHSQQIAHKDIRPENILMN----GAVLKLIDLGSSVSVS-TVVLPDL----E 257
Q+ S + +H I H+D++PENIL+ +K+ID G S + D
Sbjct: 129 QVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAY 188
Query: 258 FASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQC 317
+ +PE+L D+WS GV+LYILLSG PF ++E + + Y+F Q
Sbjct: 189 YIAPEVLRGTY--DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQW 246
Query: 318 GHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASCSEFDT----------ERLLPF 367
IS A++LI ++L H R TA Q L+ W + S + F
Sbjct: 247 RTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQF 306
Query: 368 SARRKQK 374
A +K
Sbjct: 307 QAEKKLA 313
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 2e-61
Identities = 75/307 (24%), Positives = 133/307 (43%), Gaps = 35/307 (11%)
Query: 94 QQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER---QPQQITRAEYNLL 150
++ Y+ +++LG+G + V RD+ T A+K I + E +L
Sbjct: 31 KKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVL 90
Query: 151 STLMHAHIPTALALFENAPVPGTDT----IVMQLVHGESLIQHLCRQSTITESYICCIIR 206
L H +I FE D +VM+ G L + + E II+
Sbjct: 91 KLLDHPNIMKLYDFFE-------DKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIK 143
Query: 207 QLHSALHCLHSQQIAHKDIRPENILMN----GAVLKLIDLGSSVSVS-TVVLPDL----E 257
Q+ S + LH I H+D++PEN+L+ A++K++D G S + +
Sbjct: 144 QVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAY 203
Query: 258 FASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQC 317
+ +PE+L D+WS+GV+L+ILL+G PF ++++E + Y+F +
Sbjct: 204 YIAPEVLRKKY--DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEW 261
Query: 318 GHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASCSEFDT----------ERLLPF 367
++S A++LI Q+L + +R +A Q L+ W E + E + F
Sbjct: 262 KNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKF 321
Query: 368 SARRKQK 374
+K
Sbjct: 322 QNSQKLA 328
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 3e-61
Identities = 82/307 (26%), Positives = 129/307 (42%), Gaps = 31/307 (10%)
Query: 94 QQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIP------RERQPQQITRAEY 147
FE YE E +G G F VR+ +R TGQ A+K + + + E
Sbjct: 18 DDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREA 77
Query: 148 NLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHG----ESLIQHLCRQSTITESYICC 203
++ L H HI L + + G +V + + G +++ +E+
Sbjct: 78 SICHMLKHPHIVELLETYSS---DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASH 134
Query: 204 IIRQLHSALHCLHSQQIAHKDIRPENILM----NGAVLKLIDLGSSVSVS--TVVLPDL- 256
+RQ+ AL H I H+D++P +L+ N A +KL G ++ + +V
Sbjct: 135 YMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV 194
Query: 257 ---EFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFP 313
F +PE++ G D+W GV+L+ILLSG PF E I Y
Sbjct: 195 GTPHFMAPEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKERLFEG-IIKGKYKMN 252
Query: 314 PEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASCSEFDT------ERLLPF 367
P Q HIS A++L+ ++L +R T + L W E + E+L F
Sbjct: 253 PRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKF 312
Query: 368 SARRKQK 374
+ARRK K
Sbjct: 313 NARRKLK 319
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 8e-61
Identities = 73/270 (27%), Positives = 122/270 (45%), Gaps = 15/270 (5%)
Query: 95 QEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER-QPQQITRAEYNLLSTL 153
+ Y +G G + V+ A +GT A K+IP+ + + E ++ +L
Sbjct: 4 KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL 63
Query: 154 MHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALH 213
H +I FE+ +VM+L G L + + + ES I++ + SA+
Sbjct: 64 DHPNIIRLYETFED---NTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVA 120
Query: 214 CLHSQQIAHKDIRPENILM----NGAVLKLIDLGSSVSVS-TVVLPDL----EFASPEML 264
H +AH+D++PEN L + LKLID G + ++ + SP++L
Sbjct: 121 YCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL 180
Query: 265 TSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPA 324
GP D WS GV++Y+LL G PF ++ E I ++FP + ++S A
Sbjct: 181 EGLY--GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQA 238
Query: 325 RELIGQLLNTHADKRPTAGQLLQVAWFAEA 354
LI +LL +R T+ Q L+ WF +
Sbjct: 239 ESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 2e-60
Identities = 74/317 (23%), Positives = 129/317 (40%), Gaps = 45/317 (14%)
Query: 94 QQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER--------------QP 139
++ + Y ++ +LG+G + V +++ A+K I + + +
Sbjct: 30 KEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKF 89
Query: 140 QQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT----IVMQLVHGESLIQHLCRQST 195
+ E +LL +L H +I +FE D +V + G L + + +
Sbjct: 90 HEEIYNEISLLKSLDHPNIIKLFDVFE-------DKKYFYLVTEFYEGGELFEQIINRHK 142
Query: 196 ITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN----GAVLKLIDLGSSVSV-ST 250
E I++Q+ S + LH I H+DI+PENIL+ +K++D G S
Sbjct: 143 FDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD 202
Query: 251 VVLPDL----EFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHIS 306
L D + +PE+L D+WS GV++YILL G PF +++++ +
Sbjct: 203 YKLRDRLGTAYYIAPEVLKKKY--NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVE 260
Query: 307 VADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWF------AEASCSEFD 360
Y F +IS A+ELI +L +KR TA + L W S +
Sbjct: 261 KGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTL 320
Query: 361 T---ERLLPFSARRKQK 374
+ F +K
Sbjct: 321 CGALSNMRKFEGSQKLA 337
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 2e-60
Identities = 73/304 (24%), Positives = 133/304 (43%), Gaps = 27/304 (8%)
Query: 94 QQEQFEHRYEELER-LGNGRFCTVRKARDRGTGQLVALKQIPRERQPQ---QITRAEYNL 149
E F + Y + LG G+F VR+ + TGQ A K + + R+ Q E +
Sbjct: 22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAV 81
Query: 150 LSTLMHA-HIPTALALFENAPVPGTDTIVMQLVHGESLIQHLC--RQSTITESYICCIIR 206
L + ++EN ++++ G + ++E+ + +I+
Sbjct: 82 LELAKSCPRVINLHEVYEN---TSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIK 138
Query: 207 QLHSALHCLHSQQIAHKDIRPENILM----NGAVLKLIDLGSSVSVS-TVVLPDL----E 257
Q+ ++ LH I H D++P+NIL+ +K++D G S + L ++ E
Sbjct: 139 QILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPE 198
Query: 258 FASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQC 317
+ +PE+L +TDMW++G++ Y+LL+ SPF+ E +ET +IS + + E
Sbjct: 199 YLAPEILNYDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETF 257
Query: 318 GHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASCSEFD-------TERLLPFSAR 370
+S A + I LL + +KRPTA L +W + + + S R
Sbjct: 258 SSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSSSSQTQDHSVR 317
Query: 371 RKQK 374
+
Sbjct: 318 SSED 321
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 2e-60
Identities = 85/277 (30%), Positives = 126/277 (45%), Gaps = 17/277 (6%)
Query: 94 QQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER---QPQQITRAEYNLL 150
Q F RY + LG G F V K +DR T Q A+K I + + E LL
Sbjct: 16 FQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELL 75
Query: 151 STLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHS 210
L H +I + E+ + IV +L G L + ++ +E II+Q+ S
Sbjct: 76 KKLDHPNIMKLFEILED---SSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFS 132
Query: 211 ALHCLHSQQIAHKDIRPENILM----NGAVLKLIDLGSSVSVS-TVVLPDL----EFASP 261
+ +H I H+D++PENIL+ +K+ID G S + D + +P
Sbjct: 133 GITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAP 192
Query: 262 EMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHIS 321
E+L D+WS GV+LYILLSG PF ++E + + Y+F Q IS
Sbjct: 193 EVLRGTY--DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTIS 250
Query: 322 VPARELIGQLLNTHADKRPTAGQLLQVAWFAEASCSE 358
A++LI ++L H R TA Q L+ W + S E
Sbjct: 251 DDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSEE 287
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 1e-59
Identities = 76/272 (27%), Positives = 121/272 (44%), Gaps = 16/272 (5%)
Query: 96 EQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER---QPQQITRAEYNLLST 152
+F Y+ E LG G F VR+ + TG A K I ++ + Q E +
Sbjct: 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 61
Query: 153 LMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSAL 212
L H +I + +V LV G L + + + +E+ I+Q+ ++
Sbjct: 62 LQHPNIVRLHDSIQE---ESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESI 118
Query: 213 HCLHSQQIAHKDIRPENILM----NGAVLKLIDLGSSVSVS-TVVLPDL----EFASPEM 263
HS I H++++PEN+L+ GA +KL D G ++ V+ + + SPE+
Sbjct: 119 AYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEV 178
Query: 264 LTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVP 323
L D+W+ GV+LYILL G PF DE + A I Y +P + ++
Sbjct: 179 LKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPE 237
Query: 324 ARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355
A+ LI +L + KR TA Q L+V W
Sbjct: 238 AKSLIDSMLTVNPKKRITADQALKVPWICNRE 269
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 3e-59
Identities = 82/320 (25%), Positives = 131/320 (40%), Gaps = 63/320 (19%)
Query: 96 EQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQ------QITRAEYNL 149
+ + +Y +G G + VR A + T + A+K + + + Q + + E L
Sbjct: 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRL 81
Query: 150 LSTLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCR----------------- 192
+ L H +I ++E+ +VM+L HG L+ L
Sbjct: 82 MKKLHHPNIARLYEVYED---EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQ 138
Query: 193 -----------------------QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPEN 229
E I I+RQ+ SALH LH+Q I H+DI+PEN
Sbjct: 139 ICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPEN 198
Query: 230 ILM---NGAVLKLIDLGSSVSVSTVVLPDLE----------FASPEMLTSPATA-GPSTD 275
L +KL+D G S + + F +PE+L + + GP D
Sbjct: 199 FLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258
Query: 276 MWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNTH 335
WS GVLL++LL G PF ++ +T + + F +S AR+L+ LLN +
Sbjct: 259 AWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRN 318
Query: 336 ADKRPTAGQLLQVAWFAEAS 355
D+R A + LQ W ++ S
Sbjct: 319 VDERFDAMRALQHPWISQFS 338
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 1e-58
Identities = 77/300 (25%), Positives = 127/300 (42%), Gaps = 25/300 (8%)
Query: 96 EQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPR---------ERQPQQITRAE 146
+ Y + LG+G V+ A +R T + VA+K I + E P E
Sbjct: 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 147 YNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIR 206
+L L H I F+ IV++L+ G L + + E+
Sbjct: 66 IEILKKLNHPCIIKIKNFFDAEDY----YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 207 QLHSALHCLHSQQIAHKDIRPENILM----NGAVLKLIDLGSSVSVS-TVVLPDL----E 257
Q+ A+ LH I H+D++PEN+L+ ++K+ D G S + T ++ L
Sbjct: 122 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPT 181
Query: 258 FASPEMLTSPATA--GPSTDMWSLGVLLYILLSGVSPFLDESEEET-RAHISVADYSFPP 314
+ +PE+L S TA + D WSLGV+L+I LSG PF + + + + I+ Y+F P
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 241
Query: 315 EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASCSEFDTERLLPFSARRKQK 374
E +S A +L+ +LL R T + L+ W + + L +
Sbjct: 242 EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALP 301
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 4e-58
Identities = 61/299 (20%), Positives = 108/299 (36%), Gaps = 34/299 (11%)
Query: 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAH 157
+ +EE+ LG G F V KAR+ + A+K+I + +E LL++L H +
Sbjct: 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQY 63
Query: 158 IPTALALFENAPVPGTDT----------IVMQLVHGESLIQHLC-RQSTITESYICCIIR 206
+ A + I M+ +L + + R
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 207 QLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVSTVVLPDLEF------- 258
Q+ AL +HSQ I H+D++P NI ++ +K+ D G + +V +
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 259 -------------ASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHI 305
+ E+L DM+SLG++ + ++ +
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FSTGMERVNILKKL 241
Query: 306 SVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASCSEFDTERL 364
FPP+ + +++I L++ +KRP A LL W E E L
Sbjct: 242 RSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEVIKEAL 300
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 1e-57
Identities = 86/308 (27%), Positives = 132/308 (42%), Gaps = 28/308 (9%)
Query: 92 RWQQEQFEHRYE-ELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLL 150
++ Y+ + LG G V + R TGQ ALK + + +Q E +
Sbjct: 20 EPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ----EVDHH 75
Query: 151 STLM-HAHIPTALALFENAPVPGTDT-IVMQLVHGESLIQHLCRQSTI--TESYICCIIR 206
HI L ++EN I+M+ + G L + + TE I+R
Sbjct: 76 WQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMR 135
Query: 207 QLHSALHCLHSQQIAHKDIRPENILM----NGAVLKLIDLGSSVSVSTVVLPDL----EF 258
+ +A+ LHS IAH+D++PEN+L AVLKL D G + + L +
Sbjct: 136 DIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYY 195
Query: 259 ASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAH----ISVADYSFPP 314
+PE+L P S DMWSLGV++YILL G PF + + I + Y FP
Sbjct: 196 VAPEVL-GPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPN 254
Query: 315 EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAE---ASCSEFDTERLLPFSARR 371
+ +S A++LI LL T +R T Q + W + + T R+L
Sbjct: 255 PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVLQ---ED 311
Query: 372 KQKFKEIQ 379
K + E++
Sbjct: 312 KDHWDEVK 319
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 1e-57
Identities = 71/296 (23%), Positives = 129/296 (43%), Gaps = 24/296 (8%)
Query: 94 QQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTL 153
QF YE E +G G + ++ + T A+K I + ++ E +L
Sbjct: 16 NSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRY 72
Query: 154 M-HAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSAL 212
H +I T ++++ +V +L+ G L+ + RQ +E ++ + +
Sbjct: 73 GQHPNIITLKDVYDD---GKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTV 129
Query: 213 HCLHSQQIAHKDIRPENILM-----NGAVLKLIDLGSSVSVST--VVLPDL----EFASP 261
LH+Q + H+D++P NIL N +++ D G + + +L F +P
Sbjct: 130 EYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAP 189
Query: 262 EMLTSPATAGPSTDMWSLGVLLYILLSGVSPF---LDESEEETRAHISVADYSFPPEQCG 318
E+L + D+WSLGVLLY +L+G +PF D++ EE A I +S
Sbjct: 190 EVL-ERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWN 248
Query: 319 HISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASCSEFDTERLLPFSARRKQK 374
+S A++L+ ++L+ +R TA +L+ W + +L A K
Sbjct: 249 SVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW--DQLPQYQLNRQDAPHLVK 302
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 6e-57
Identities = 72/287 (25%), Positives = 117/287 (40%), Gaps = 25/287 (8%)
Query: 94 QQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP----------QQIT 143
F YE E LG G VR+ + T + A+K I ++ T
Sbjct: 11 STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70
Query: 144 RAEYNLLSTL-MHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYIC 202
E ++L + H +I +E +V L+ L +L + T++E
Sbjct: 71 LKEVDILRKVSGHPNIIQLKDTYET---NTFFFLVFDLMKKGELFDYLTEKVTLSEKETR 127
Query: 203 CIIRQLHSALHCLHSQQIAHKDIRPENILM-NGAVLKLIDLGSSVSVS-TVVLPDL---- 256
I+R L + LH I H+D++PENIL+ + +KL D G S + L ++
Sbjct: 128 KIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTP 187
Query: 257 EFASPEMLTSPATA-----GPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYS 311
+ +PE++ G DMWS GV++Y LL+G PF + I +Y
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 247
Query: 312 FPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASCSE 358
F + S ++L+ + L KR TA + L +F + E
Sbjct: 248 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEE 294
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 2e-56
Identities = 77/283 (27%), Positives = 126/283 (44%), Gaps = 27/283 (9%)
Query: 94 QQEQFEHRYE---ELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLL 150
+ F Y+ + + LG G F RK + + Q A+K I + + T+ E L
Sbjct: 2 KDSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEAN--TQKEITAL 59
Query: 151 STL-MHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLH 209
H +I +F + +VM+L++G L + + ++ +E+ I+R+L
Sbjct: 60 KLCEGHPNIVKLHEVFHD---QLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLV 116
Query: 210 SALHCLHSQQIAHKDIRPENILM----NGAVLKLIDLGSSVSV--STVVLPD----LEFA 259
SA+ +H + H+D++PEN+L + +K+ID G + L L +A
Sbjct: 117 SAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYA 176
Query: 260 SPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAH-------ISVADYSF 312
+PE+L S D+WSLGV+LY +LSG PF T I D+SF
Sbjct: 177 APELLN-QNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF 235
Query: 313 PPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355
E ++S A++LI LL +KR L W + S
Sbjct: 236 EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 3e-56
Identities = 75/284 (26%), Positives = 124/284 (43%), Gaps = 25/284 (8%)
Query: 96 EQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPR---------ERQPQQITRAE 146
+ Y + LG+G V+ A +R T + VA++ I + E P E
Sbjct: 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETE 190
Query: 147 YNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIR 206
+L L H I F+ IV++L+ G L + + E+
Sbjct: 191 IEILKKLNHPCIIKIKNFFDAEDY----YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 246
Query: 207 QLHSALHCLHSQQIAHKDIRPENILM----NGAVLKLIDLGSSVSVS-TVVLPDL----E 257
Q+ A+ LH I H+D++PEN+L+ ++K+ D G S + T ++ L
Sbjct: 247 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPT 306
Query: 258 FASPEMLTSPATA--GPSTDMWSLGVLLYILLSGVSPFLDESEEET-RAHISVADYSFPP 314
+ +PE+L S TA + D WSLGV+L+I LSG PF + + + + I+ Y+F P
Sbjct: 307 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 366
Query: 315 EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASCSE 358
E +S A +L+ +LL R T + L+ W +
Sbjct: 367 EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKR 410
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 7e-56
Identities = 78/304 (25%), Positives = 119/304 (39%), Gaps = 38/304 (12%)
Query: 92 RWQQEQFEHRYEELER-LGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLL 150
+ ++ Y+ + LG G V + ++ T + ALK + R E L
Sbjct: 9 QIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELH 64
Query: 151 STLM-HAHIPTALALFENAPVPGTDT-IVMQLVHGESLIQHLCRQSTI--TESYICCIIR 206
HI + ++EN IVM+ + G L + + TE I++
Sbjct: 65 WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK 124
Query: 207 QLHSALHCLHSQQIAHKDIRPENILM----NGAVLKLIDLGSSVSVSTVVLPDLEFASPE 262
+ A+ LHS IAH+D++PEN+L A+LKL D G FA E
Sbjct: 125 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG--------------FA-KE 169
Query: 263 MLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETR----AHISVADYSFPPEQCG 318
S DMWSLGV++YILL G PF I + Y FP +
Sbjct: 170 TTGEKY--DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 227
Query: 319 HISVPARELIGQLLNTHADKRPTAGQLLQVAWFAE---ASCSEFDTERLLP-FSARRKQK 374
+S + LI LL T +R T + + W + + T R+L R +
Sbjct: 228 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDV 287
Query: 375 FKEI 378
+E+
Sbjct: 288 KEEM 291
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 2e-55
Identities = 81/309 (26%), Positives = 136/309 (44%), Gaps = 43/309 (13%)
Query: 97 QFEHRYE-ELERLGNGRFCTVRKARDRGTGQLVALKQIP-RERQPQQITRAEYNLLSTLM 154
+FE Y+ + + LG G V+ + T Q A+K I + + E +L
Sbjct: 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQ 68
Query: 155 -HAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALH 213
H ++ + FE +V + + G S++ H+ ++ E +++ + SAL
Sbjct: 69 GHRNVLELIEFFEE---EDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALD 125
Query: 214 CLHSQQIAHKDIRPENILM----NGAVLKLIDLGSSVSV------STVVLPDL------- 256
LH++ IAH+D++PENIL + +K+ D + S + P+L
Sbjct: 126 FLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185
Query: 257 EFASPEMLTSPATA----GPSTDMWSLGVLLYILLSGVSPFLDESEEETRAH-------- 304
E+ +PE++ + + D+WSLGV+LYILLSG PF+ +
Sbjct: 186 EYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245
Query: 305 -------ISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFA-EASC 356
I Y FP + HIS A++LI +LL A +R +A Q+LQ W A
Sbjct: 246 QNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPE 305
Query: 357 SEFDTERLL 365
+ T +L
Sbjct: 306 NTLPTPMVL 314
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 6e-55
Identities = 81/307 (26%), Positives = 125/307 (40%), Gaps = 27/307 (8%)
Query: 94 QQEQFEHRYEELER-LGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLST 152
++ Y+ + LG G V + ++ T + ALK + R E L
Sbjct: 55 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWR 110
Query: 153 LM-HAHIPTALALFENAPVPGTDT-IVMQLVHGESLIQHLCRQSTI--TESYICCIIRQL 208
HI + ++EN IVM+ + G L + + TE I++ +
Sbjct: 111 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSI 170
Query: 209 HSALHCLHSQQIAHKDIRPENILM----NGAVLKLIDLGSSVSV-STVVLPD----LEFA 259
A+ LHS IAH+D++PEN+L A+LKL D G + S L +
Sbjct: 171 GEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYV 230
Query: 260 SPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRA----HISVADYSFPPE 315
+PE+L P S DMWSLGV++YILL G PF I + Y FP
Sbjct: 231 APEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 289
Query: 316 QCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAE---ASCSEFDTERLLP-FSARR 371
+ +S + LI LL T +R T + + W + + T R+L R
Sbjct: 290 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERW 349
Query: 372 KQKFKEI 378
+ +E+
Sbjct: 350 EDVKEEM 356
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 2e-54
Identities = 69/270 (25%), Positives = 118/270 (43%), Gaps = 35/270 (12%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALK-----QIPRERQPQQITRAEYNLLSTLMH 155
RY LG G F + D T ++ A K + + Q ++++ E ++ +L H
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM-EISIHRSLAH 74
Query: 156 AHIPTALALFENAPVPGTDT---IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSAL 212
H+ + + +V++L SL++ R+ +TE +RQ+
Sbjct: 75 QHV---VGFHG---FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC 128
Query: 213 HCLHSQQIAHKDIRPENILMNGA-VLKLIDLGSSVSVSTVVLPDLEF----------ASP 261
LH ++ H+D++ N+ +N +K+ D G ++T V D E +P
Sbjct: 129 QYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFG----LATKVEYDGERKKVLCGTPNYIAP 184
Query: 262 EMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHIS 321
E+L+ D+WS+G ++Y LL G PF +ET I +YS P HI+
Sbjct: 185 EVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HIN 239
Query: 322 VPARELIGQLLNTHADKRPTAGQLLQVAWF 351
A LI ++L T RPT +LL +F
Sbjct: 240 PVAASLIQKMLQTDPTARPTINELLNDEFF 269
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 3e-54
Identities = 69/271 (25%), Positives = 118/271 (43%), Gaps = 35/271 (12%)
Query: 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALK-----QIPRERQPQQITRAEYNLLSTLM 154
RY LG G F + D T ++ A K + + Q ++++ E ++ +L
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM-EISIHRSLA 99
Query: 155 HAHIPTALALFENAPVPGTDT---IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSA 211
H H+ + + +V++L SL++ R+ +TE +RQ+
Sbjct: 100 HQHV---VGFHG---FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLG 153
Query: 212 LHCLHSQQIAHKDIRPENILMNGA-VLKLIDLGSSVSVSTVVLPDLEF----------AS 260
LH ++ H+D++ N+ +N +K+ D G ++T V D E +
Sbjct: 154 CQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFG----LATKVEYDGERKKVLCGTPNYIA 209
Query: 261 PEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHI 320
PE+L+ D+WS+G ++Y LL G PF +ET I +YS P HI
Sbjct: 210 PEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HI 264
Query: 321 SVPARELIGQLLNTHADKRPTAGQLLQVAWF 351
+ A LI ++L T RPT +LL +F
Sbjct: 265 NPVAASLIQKMLQTDPTARPTINELLNDEFF 295
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 5e-54
Identities = 74/282 (26%), Positives = 126/282 (44%), Gaps = 30/282 (10%)
Query: 94 QQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER---------QPQQITR 144
++F +Y+ + +G G VR+ R TG A+K + + ++ TR
Sbjct: 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATR 147
Query: 145 AEYNLLSTLM-HAHIPTALALFENAPVPGTDT---IVMQLVHGESLIQHLCRQSTITESY 200
E ++L + H HI T + +E + + +V L+ L +L + ++E
Sbjct: 148 RETHILRQVAGHPHIITLIDSYE------SSSFMFLVFDLMRKGELFDYLTEKVALSEKE 201
Query: 201 ICCIIRQLHSALHCLHSQQIAHKDIRPENILM-NGAVLKLIDLGSSVSVS-TVVLPDL-- 256
I+R L A+ LH+ I H+D++PENIL+ + ++L D G S + L +L
Sbjct: 202 TRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCG 261
Query: 257 --EFASPEMLTSPATA-----GPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVAD 309
+ +PE+L G D+W+ GV+L+ LL+G PF + I
Sbjct: 262 TPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQ 321
Query: 310 YSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWF 351
Y F + S ++LI +LL + R TA Q LQ +F
Sbjct: 322 YQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFF 363
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 3e-52
Identities = 77/267 (28%), Positives = 126/267 (47%), Gaps = 31/267 (11%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALK-----QIPRERQPQQITRAEYNLLSTLMH 155
+E LG G+F V AR++ + ++ALK Q+ + Q+ R E + S L H
Sbjct: 10 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR-EVEIQSHLRH 68
Query: 156 AHIPTALALFENAPVPGTDT---IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSAL 212
+I L L+ T ++++ ++ + L + S E I +L +AL
Sbjct: 69 PNI---LRLYG---YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 122
Query: 213 HCLHSQQIAHKDIRPENILM--NGAVLKLIDLGSSVSVSTVVL------PDLEFASPEML 264
HS+++ H+DI+PEN+L+ G LK+ D G SV + D + PEM+
Sbjct: 123 SYCHSKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAPSSRRTDLCGTLD--YLPPEMI 179
Query: 265 TSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPA 324
D+WSLGVL Y L G PF + +ET IS +++FP ++ A
Sbjct: 180 EG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGA 234
Query: 325 RELIGQLLNTHADKRPTAGQLLQVAWF 351
R+LI +LL + +RP ++L+ W
Sbjct: 235 RDLISRLLKHNPSQRPMLREVLEHPWI 261
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 3e-52
Identities = 66/270 (24%), Positives = 117/270 (43%), Gaps = 34/270 (12%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE-----RQPQQITRAEYNLLSTLMH 155
++ LG G F V +A TG VA+K I ++ Q++ E + L H
Sbjct: 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQN-EVKIHCQLKH 70
Query: 156 AHIPTALALFENAPVPGTDT---IVMQLVHGESLIQHLCRQS-TITESYICCIIRQLHSA 211
I L L+ +V+++ H + ++L + +E+ + Q+ +
Sbjct: 71 PSI---LELYN---YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITG 124
Query: 212 LHCLHSQQIAHKDIRPENILMNGA-VLKLIDLGSSVSVSTVVLPD---------LEFASP 261
+ LHS I H+D+ N+L+ +K+ D G + + P + SP
Sbjct: 125 MLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM---PHEKHYTLCGTPNYISP 181
Query: 262 EMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHIS 321
E+ T + G +D+WSLG + Y LL G PF ++ + T + +ADY P +S
Sbjct: 182 EIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPS----FLS 236
Query: 322 VPARELIGQLLNTHADKRPTAGQLLQVAWF 351
+ A++LI QLL + R + +L +
Sbjct: 237 IEAKDLIHQLLRRNPADRLSLSSVLDHPFM 266
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 8e-51
Identities = 61/295 (20%), Positives = 111/295 (37%), Gaps = 33/295 (11%)
Query: 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIP-RERQPQQITRAEYNLLSTLMHAH 157
Y +++LG G F V G ALK+I E+Q ++ + E ++ H +
Sbjct: 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPN 87
Query: 158 IPTALALFENAPVPGTDT----IVMQLVHGESLIQHLCRQST----ITESYICCIIRQLH 209
I L L +++ +L + R +TE I ++ +
Sbjct: 88 I---LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGIC 144
Query: 210 SALHCLHSQQIAHKDIRPENILMNGA-VLKLIDLGSSVSVSTVVLPDLE----------- 257
L +H++ AH+D++P NIL+ L+DLGS V +
Sbjct: 145 RGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204
Query: 258 ----FASPEMLTSP--ATAGPSTDMWSLGVLLYILLSGVSPFLDESEE-ETRAHISVADY 310
+ +PE+ + TD+WSLG +LY ++ G P+ ++ ++ A
Sbjct: 205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQL 264
Query: 311 SFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASCSEFDTERLL 365
S P S +L+ ++ +RP LL + T ++L
Sbjct: 265 SIPQSP--RHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQHTTQIL 317
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 2e-50
Identities = 74/267 (27%), Positives = 118/267 (44%), Gaps = 31/267 (11%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALK-----QIPRERQPQQITRAEYNLLSTLMH 155
++ LG G+F V AR++ ++ALK Q+ +E Q+ R E + S L H
Sbjct: 15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRR-EIEIQSHLRH 73
Query: 156 AHIPTALALFENAPVPGTDT---IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSAL 212
+I L ++ ++++ L + L + E + +L AL
Sbjct: 74 PNI---LRMYN---YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADAL 127
Query: 213 HCLHSQQIAHKDIRPENILM--NGAVLKLIDLGSSVSVSTVVL------PDLEFASPEML 264
H H +++ H+DI+PEN+LM G LK+ D G SV ++ D + PEM+
Sbjct: 128 HYCHERKVIHRDIKPENLLMGYKG-ELKIADFGWSVHAPSLRRRTMCGTLD--YLPPEMI 184
Query: 265 TSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPA 324
T D+W GVL Y L G+ PF S ET I D FPP +S +
Sbjct: 185 EG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPP----FLSDGS 239
Query: 325 RELIGQLLNTHADKRPTAGQLLQVAWF 351
++LI +LL H +R +++ W
Sbjct: 240 KDLISKLLRYHPPQRLPLKGVMEHPWV 266
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 5e-50
Identities = 74/276 (26%), Positives = 126/276 (45%), Gaps = 34/276 (12%)
Query: 94 QQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQITRAEYNL 149
++ Y L+ +G G F V+ AR TG+ VA+K I + + Q++ R E +
Sbjct: 9 DEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRI 67
Query: 150 LSTLMHAHIPTALALFENAPVPGTDT---IVMQLVHGESLIQHLCRQSTITESYICCIIR 206
+ L H +I + LFE V T+ ++M+ G + +L + E R
Sbjct: 68 MKILNHPNI---VKLFE---VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR 121
Query: 207 QLHSALHCLHSQQIAHKDIRPENILM--NGAVLKLIDLGSSVSVSTVVLPD--------- 255
Q+ SA+ H ++I H+D++ EN+L+ + + K+ D G S
Sbjct: 122 QIVSAVQYCHQKRIVHRDLKAENLLLDADMNI-KIADFG----FSNEFTVGGKLDAFCGA 176
Query: 256 LEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPE 315
+A+PE+ GP D+WSLGV+LY L+SG PF ++ +E R + Y P
Sbjct: 177 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF- 235
Query: 316 QCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWF 351
++S L+ + L + KR T Q+++ W
Sbjct: 236 ---YMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWI 268
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 7e-49
Identities = 55/277 (19%), Positives = 109/277 (39%), Gaps = 33/277 (11%)
Query: 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQIT---RAEYNLLSTLMH- 155
Y L+++G+G V + + Q+ A+K + E Q R E L+ L
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 86
Query: 156 -AHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHC 214
I + L++ +VM+ + + L L ++ +I + + A+H
Sbjct: 87 SDKI---IRLYDYEITDQYIYMVMECGNID-LNSWLKKKKSIDPWERKSYWKNMLEAVHT 142
Query: 215 LHSQQIAHKDIRPENILMNGAVLKLIDLGSSVSVSTVVLPDLE--------FASPEMLTS 266
+H I H D++P N L+ +LKLID G + + ++ + PE +
Sbjct: 143 IHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202
Query: 267 PATA----------GPSTDMWSLGVLLYILLSGVSPFLDESEE-ETRAHISVADYSFP-P 314
+++ P +D+WSLG +LY + G +PF + I ++ P
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 262
Query: 315 EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWF 351
+ ++++ L +R + +LL +
Sbjct: 263 D---IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 1e-48
Identities = 58/283 (20%), Positives = 116/283 (40%), Gaps = 41/283 (14%)
Query: 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAH 157
F ++E+E +G+G F V KA+ R G+ +K++ + + R E L+ L H +
Sbjct: 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE--KAER-EVKALAKLDHVN 65
Query: 158 I-------------PTALALFENAPVPGTDTIVMQLVHGESLIQHL--CRQSTITESYIC 202
I P + + I M+ +L Q + R + +
Sbjct: 66 IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL 125
Query: 203 CIIRQLHSALHCLHSQQIAHKDIRPENI-LMNGAVLKLIDLGSSVSVSTVVLPDLEFA-- 259
+ Q+ + +HS+++ ++D++P NI L++ +K+ D G + T + D +
Sbjct: 126 ELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFG----LVTSLKNDGKRTRS 181
Query: 260 -------SPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSF 312
SPE ++S G D+++LG++L LL + S+ T + D
Sbjct: 182 KGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFETSKFFTD----LRDGII 236
Query: 313 PPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355
+ L+ +LL+ + RP ++L+ + S
Sbjct: 237 SD----IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 2e-48
Identities = 54/277 (19%), Positives = 111/277 (40%), Gaps = 33/277 (11%)
Query: 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRA---EYNLLSTLMH- 155
Y L+++G+G V + + Q+ A+K + E Q + E L+ L
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 67
Query: 156 -AHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHC 214
I + L++ +VM+ + + L L ++ +I + + A+H
Sbjct: 68 SDKI---IRLYDYEITDQYIYMVMECGNID-LNSWLKKKKSIDPWERKSYWKNMLEAVHT 123
Query: 215 LHSQQIAHKDIRPENILMNGAVLKLIDLGSSVSVSTVVLPDLE--------FASPEMLTS 266
+H I H D++P N L+ +LKLID G + + ++ + PE +
Sbjct: 124 IHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183
Query: 267 PATA----------GPSTDMWSLGVLLYILLSGVSPFLDESEEETR-AHISVADYSFP-P 314
+++ P +D+WSLG +LY + G +PF + ++ I ++ P
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 243
Query: 315 EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWF 351
+ ++++ L +R + +LL +
Sbjct: 244 D---IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 277
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 3e-48
Identities = 68/276 (24%), Positives = 118/276 (42%), Gaps = 32/276 (11%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP---QQITRAEYNLLSTLMHAH 157
YE L +G G + +K R + G+++ K++ +Q+ +E NLL L H +
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 158 IPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQS----TITESYICCIIRQLHSALH 213
I + T IVM+ G L + + + + E ++ ++ QL AL
Sbjct: 67 IVRYYDRIID-RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 214 CLHSQ-----QIAHKDIRPENI-LMNGAVLKLIDLGSSVSVSTVVLPDLEFA-------- 259
H + + H+D++P N+ L +KL D G ++ ++ D FA
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG----LARILNHDTSFAKTFVGTPY 181
Query: 260 --SPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQC 317
SPE + + +D+WSLG LLY L + + PF S++E I + P
Sbjct: 182 YMSPEQMNRMSY-NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPY-- 238
Query: 318 GHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAE 353
S E+I ++LN RP+ ++L+ E
Sbjct: 239 -RYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-47
Identities = 59/311 (18%), Positives = 101/311 (32%), Gaps = 60/311 (19%)
Query: 94 QQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER--QPQQITRAEYNLLS 151
Q H + + LG G V + R + TG L A+K +P + E+ +L
Sbjct: 3 SQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLK 62
Query: 152 TLMHAHIPTALALFENAPVPGTDTI--VMQLVHGESL---IQHLCRQSTITESYICCIIR 206
L H +I + LF T +M+ SL ++ + ES ++R
Sbjct: 63 KLNHKNI---VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR 119
Query: 207 QLHSALHCLHSQQIAHKDIRPENILMNG-----AVLKLIDLGSSVSVSTVVLPD------ 255
+ ++ L I H++I+P NI+ +V KL D G + + D
Sbjct: 120 DVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG----AARELEDDEQFVSL 175
Query: 256 ---LEFASPEMLTSPATA-------GPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHI 305
E+ P+M G + D+WS+GV Y +G PF +
Sbjct: 176 YGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235
Query: 306 ---------------------SVADYSFPPEQCGHISVPARE----LIGQLLNTHADKRP 340
D+S +S + ++ +L +K
Sbjct: 236 MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCW 295
Query: 341 TAGQLLQVAWF 351
Q
Sbjct: 296 GFDQFFAETSD 306
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 165 bits (418), Expect = 1e-47
Identities = 52/313 (16%), Positives = 93/313 (29%), Gaps = 55/313 (17%)
Query: 88 PFETRWQQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALK--------------QI 133
PF + + LG +A D+ TG+ + Q+
Sbjct: 61 PFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQM 120
Query: 134 PRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPG--------TDTIVMQLV---- 181
E ++ R N +H L ++ D V+
Sbjct: 121 KEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYP 180
Query: 182 --------HGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN 233
GE L+ H ++ + Q+ L LH + H +RP +I+++
Sbjct: 181 RMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD 240
Query: 234 G-AVLKLIDLGSSVSVSTVVLPD--LEFASPEMLTSPAT----------AGPSTDMWSLG 280
+ L V V+ F PE+ AT S D W+LG
Sbjct: 241 QRGGVFLTGFEHLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALG 300
Query: 281 VLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRP 340
+++Y + P ++ I C +I P R L+ L + R
Sbjct: 301 LVIYWIWCADLPITKDAALGGSEWIF--------RSCKNIPQPVRALLEGFLRYPKEDRL 352
Query: 341 TAGQLLQVAWFAE 353
Q ++ + +
Sbjct: 353 LPLQAMETPEYEQ 365
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-47
Identities = 79/275 (28%), Positives = 124/275 (45%), Gaps = 31/275 (11%)
Query: 94 QQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER----------QPQQIT 143
+ ++ +Y + LG+G F V A D+ + V +K I +E+ + ++T
Sbjct: 18 CEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVT 77
Query: 144 RAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQL-VHGESLIQHLCRQSTITESYIC 202
E +LS + HA+I L +FEN G +VM+ G L + R + E
Sbjct: 78 L-EIAILSRVEHANIIKVLDIFEN---QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLAS 133
Query: 203 CIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVSTVVLPD-----L 256
I RQL SA+ L + I H+DI+ ENI++ +KLID GS+ + L +
Sbjct: 134 YIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTI 193
Query: 257 EFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQ 316
E+ +PE+L GP +MWSLGV LY L+ +PF + E A P
Sbjct: 194 EYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEAAIHPPY-- 245
Query: 317 CGHISVPARELIGQLLNTHADKRPTAGQLLQVAWF 351
+S L+ LL ++R T +L+ W
Sbjct: 246 --LVSKELMSLVSGLLQPVPERRTTLEKLVTDPWV 278
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 2e-47
Identities = 64/269 (23%), Positives = 111/269 (41%), Gaps = 27/269 (10%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQ---QITRAEYNLLSTLMHAH 157
+Y L+++G G F + G+ +K+I R + +R E +L+ + H +
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPN 84
Query: 158 IPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQ--STITESYICCIIRQLHSALHCL 215
I FE G+ IVM G L + + Q E I Q+ AL +
Sbjct: 85 IVQYRESFEE---NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141
Query: 216 HSQQIAHKDIRPENILMNGA-VLKLIDLGSSVSVSTVVLPDLEFA----------SPEML 264
H ++I H+DI+ +NI + ++L D G ++ V+ +E A SPE+
Sbjct: 142 HDRKILHRDIKSQNIFLTKDGTVQLGDFG----IARVLNSTVELARACIGTPYYLSPEIC 197
Query: 265 TSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPA 324
+ +D+W+LG +LY L + F S + I + H S
Sbjct: 198 ENKP-YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSL---HYSYDL 253
Query: 325 RELIGQLLNTHADKRPTAGQLLQVAWFAE 353
R L+ QL + RP+ +L+ + A+
Sbjct: 254 RSLVSQLFKRNPRDRPSVNSILEKGFIAK 282
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 3e-47
Identities = 65/268 (24%), Positives = 110/268 (41%), Gaps = 24/268 (8%)
Query: 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP---QQITRAEYNLLSTLM 154
F+ ++ L RLG+G + V K R + G+L A+K+ + + AE +
Sbjct: 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVG 114
Query: 155 -HAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQ-STITESYICCIIRQLHSAL 212
H + L + G + +L SL QH +++ E+ + +R AL
Sbjct: 115 QHPCC---VRLEQAWEEGGILYLQTELCGP-SLQQHCEAWGASLPEAQVWGYLRDTLLAL 170
Query: 213 HCLHSQQIAHKDIRPENILMNGA-VLKLIDLGSSVSVSTVVLP-----DLEFASPEMLTS 266
LHSQ + H D++P NI + KL D G V + T D + +PE+L
Sbjct: 171 AHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG 230
Query: 267 PATAGPSTDMWSLGVLLYILLSGVS-PFLDESEEETRAHISVADYSFPPEQCGHISVPAR 325
G + D++SLG+ + + + P E ++ R PPE +S R
Sbjct: 231 S--YGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGY------LPPEFTAGLSSELR 282
Query: 326 ELIGQLLNTHADKRPTAGQLLQVAWFAE 353
++ +L R TA LL + +
Sbjct: 283 SVLVMMLEPDPKLRATAEALLALPVLRQ 310
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 9e-47
Identities = 46/309 (14%), Positives = 87/309 (28%), Gaps = 43/309 (13%)
Query: 88 PFETRWQQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQIT---- 143
Q E + + +E L G V RD + ALK + +
Sbjct: 50 ETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERL 109
Query: 144 RAEYNLLSTLMHAHIPTA------LALFENAPVPGTDTI-----------------VMQL 180
+ L+ A L + V +M
Sbjct: 110 HEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPA 169
Query: 181 VHG------ESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG 234
+L + + + QL L S+ + H P+N+ +
Sbjct: 170 ASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMP 229
Query: 235 -AVLKLIDLGSSVSVSTVVLPD---LEFASPEMLTSPATA-GPSTDMWSLGVLLYILLSG 289
L L D+ + V T + +A E L + + + W LG+ +Y +
Sbjct: 230 DGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289
Query: 290 VSPFLDESEEETRAHISVADYSFPPEQ-----CGHISVPARELIGQLLNTHADKRPTAGQ 344
PF + + + + C + + LIG+ LN +R +
Sbjct: 290 FLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLE 349
Query: 345 LLQVAWFAE 353
++ F +
Sbjct: 350 AMETPEFLQ 358
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 2e-46
Identities = 79/267 (29%), Positives = 119/267 (44%), Gaps = 25/267 (9%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER-QPQQITRAEYNLLSTLMHAHIP 159
RY+ ++ +G+G F R RD+ T +LVA+K I R + + R E +L H +I
Sbjct: 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQR-EIINHRSLRHPNI- 78
Query: 160 TALALFENAPVPGTDT---IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLH 216
+ E V T T I+M+ G L + +C +E +QL S + H
Sbjct: 79 --VRFKE---VILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCH 133
Query: 217 SQQIAHKDIRPENILMNGAV---LKLIDLGSSVSVSTVVLPD-----LEFASPEMLTSPA 268
S QI H+D++ EN L++G+ LK+ D G S S P + +PE+L
Sbjct: 134 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQE 193
Query: 269 TAGPSTDMWSLGVLLYILLSGVSPFLDESEEE----TRAHISVADYSFPPEQCGHISVPA 324
G D+WS GV LY++L G PF D E T I YS P + IS
Sbjct: 194 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDI--RISPEC 251
Query: 325 RELIGQLLNTHADKRPTAGQLLQVAWF 351
LI ++ R + ++ +WF
Sbjct: 252 CHLISRIFVADPATRISIPEIKTHSWF 278
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-46
Identities = 64/284 (22%), Positives = 110/284 (38%), Gaps = 27/284 (9%)
Query: 94 QQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER--------QPQQITRA 145
++E E +Y+ LG+G F +V VA+K + ++R ++
Sbjct: 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM- 95
Query: 146 EYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHGE-SLIQHLCRQSTITESYICCI 204
E LL + + L + P + ++++ L + + + E
Sbjct: 96 EVVLLKKVSSGF-SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 154
Query: 205 IRQLHSALHCLHSQQIAHKDIRPENILMNGAV--LKLIDLGSSVSVSTVVLPD----LEF 258
Q+ A+ H+ + H+DI+ ENIL++ LKLID GS + V D +
Sbjct: 155 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVY 214
Query: 259 ASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCG 318
+ PE + G S +WSLG+LLY ++ G PF + E I F
Sbjct: 215 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ---- 264
Query: 319 HISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASCSEFDTE 362
+S + LI L RPT ++ W + + E
Sbjct: 265 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 308
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 3e-46
Identities = 57/277 (20%), Positives = 111/277 (40%), Gaps = 33/277 (11%)
Query: 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQIT---RAEYNLLSTLMH- 155
Y L+++G+G V + + Q+ A+K + E Q R E L+ L
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 114
Query: 156 -AHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHC 214
I + L++ +VM+ + + L L ++ +I + + A+H
Sbjct: 115 SDKI---IRLYDYEITDQYIYMVMECGNID-LNSWLKKKKSIDPWERKSYWKNMLEAVHT 170
Query: 215 LHSQQIAHKDIRPENILMNGAVLKLIDLGSSVSVSTVVLPDLE--------FASPEMLT- 265
+H I H D++P N L+ +LKLID G + + ++ + PE +
Sbjct: 171 IHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230
Query: 266 ---------SPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAH-ISVADYSFP-P 314
S + P +D+WSLG +LY + G +PF + ++ H I ++ P
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 290
Query: 315 EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWF 351
+ ++++ L +R + +LL +
Sbjct: 291 D---IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 7e-46
Identities = 75/267 (28%), Positives = 123/267 (46%), Gaps = 29/267 (10%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER-----QPQQITRAEYNLLSTLMH 155
Y + LG G F V+ + TG VA+K + R++ +I R E L H
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR-EIQNLKLFRH 70
Query: 156 AHIPTALALFENAPVPGTDT---IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSAL 212
HI + L++ V T T +VM+ V G L ++C+ + E + +Q+ SA+
Sbjct: 71 PHI---IKLYQ---VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAV 124
Query: 213 HCLHSQQIAHKDIRPENILMNGAV-LKLIDLG-SSVSVSTVVL------PDLEFASPEML 264
H + H+D++PEN+L++ + K+ D G S++ L P+ +A+PE++
Sbjct: 125 DYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN--YAAPEVI 182
Query: 265 TSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPA 324
+ AGP D+WS GV+LY LL G PF DE I + P +++
Sbjct: 183 SGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPE----YLNRSV 238
Query: 325 RELIGQLLNTHADKRPTAGQLLQVAWF 351
L+ +L KR T + + WF
Sbjct: 239 ATLLMHMLQVDPLKRATIKDIREHEWF 265
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 1e-45
Identities = 70/274 (25%), Positives = 111/274 (40%), Gaps = 29/274 (10%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRA----EYNLLSTLMHA 156
+ +++G G+F V +A G VALK++ RA E +LL L H
Sbjct: 33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 157 HIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQ----STITESYICCIIRQLHSAL 212
++ + + + IV++L L + + I E + QL SAL
Sbjct: 93 NV---IKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSAL 149
Query: 213 HCLHSQQIAHKDIRPENILM--NGAVLKLIDLGSSVSVSTVVLPDLEFA----------S 260
+HS+++ H+DI+P N+ + G V KL DLG + A S
Sbjct: 150 EHMHSRRVMHRDIKPANVFITATGVV-KLGDLG----LGRFFSSKTTAAHSLVGTPYYMS 204
Query: 261 PEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHI 320
PE + +D+WSLG LLY + + SPF + + +PP H
Sbjct: 205 PERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHY 263
Query: 321 SVPARELIGQLLNTHADKRPTAGQLLQVAWFAEA 354
S R+L+ +N +KRP + VA A
Sbjct: 264 SEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA 297
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 4e-45
Identities = 71/280 (25%), Positives = 111/280 (39%), Gaps = 39/280 (13%)
Query: 94 QQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER--------QPQQITRA 145
+E FE Y LG G F TV VA+K IPR R
Sbjct: 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL- 83
Query: 146 EYNLLSTL----MHAHIPTALALFENAPVPGTDT---IVMQL-VHGESLIQHLCRQSTIT 197
E LL + H + + L + T +V++ + + L ++ + +
Sbjct: 84 EVALLWKVGAGGGHPGV---IRLLD---WFETQEGFMLVLERPLPAQDLFDYITEKGPLG 137
Query: 198 ESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGA--VLKLIDLGSSVSVSTVVLPD 255
E C Q+ +A+ HS+ + H+DI+ ENIL++ KLID GS + D
Sbjct: 138 EGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD 197
Query: 256 ----LEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYS 311
++ PE ++ +WSLG+LLY ++ G PF + E I A+
Sbjct: 198 FDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEAELH 251
Query: 312 FPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWF 351
FP H+S LI + L RP+ ++L W
Sbjct: 252 FPA----HVSPDCCALIRRCLAPKPSSRPSLEEILLDPWM 287
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 7e-45
Identities = 65/293 (22%), Positives = 111/293 (37%), Gaps = 47/293 (16%)
Query: 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRA--EYNLLSTLMH 155
+ +E ++ LG G F V +A+++ A+K+I + + E L+ L H
Sbjct: 3 YLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEH 62
Query: 156 AHIPTALALFENAPVPGTDT---------IVMQLVHGESLIQHLCRQSTIT---ESYICC 203
I + I MQL E+L + + TI S
Sbjct: 63 PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122
Query: 204 IIRQLHSALHCLHSQQIAHKDIRPENI-LMNGAVLKLIDLGSSVSVSTVVLPDLEFA--- 259
I Q+ A+ LHS+ + H+D++P NI V+K+ D G + T + D E
Sbjct: 123 IFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFG----LVTAMDQDEEEQTVL 178
Query: 260 -------------------SPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEE 300
SPE + + D++SLG++L+ LL PF + E
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELL---YPFSTQMERV 234
Query: 301 TRAHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAE 353
V + FPP ++ +L+ +RP A +++ A F +
Sbjct: 235 RTLTD-VRNLKFPPLFT-QKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED 285
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 5e-44
Identities = 57/270 (21%), Positives = 107/270 (39%), Gaps = 31/270 (11%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER---QPQQITRAEYNLLSTLMHAH 157
++ ++ LG G + V+ A +R T + VA+K + +R P+ I + E + L H +
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK-EICINKMLNHEN 66
Query: 158 IPTALALFENAPVPGTDT---IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHC 214
+ + + + ++ G L + + E QL + +
Sbjct: 67 V---VKFYG---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 215 LHSQQIAHKDIRPENIL----MNGAVLKLIDLG-SSVSVSTVVLPDLE-------FASPE 262
LH I H+DI+PEN+L N LK+ D G ++V L + +PE
Sbjct: 121 LHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 263 MLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETR-AHISVADYSFPPEQCGHIS 321
+L D+WS G++L +L+G P+ S+ + P + I
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWK--KID 235
Query: 322 VPARELIGQLLNTHADKRPTAGQLLQVAWF 351
L+ ++L + R T + + W+
Sbjct: 236 SAPLALLHKILVENPSARITIPDIKKDRWY 265
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 8e-44
Identities = 77/267 (28%), Positives = 128/267 (47%), Gaps = 30/267 (11%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER-----QPQQITRAEYNLLSTLMH 155
Y E LG G F V+ A T Q VALK I R+ ++ R E + L L H
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVER-EISYLKLLRH 68
Query: 156 AHIPTALALFENAPVPGTDT---IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSAL 212
HI + L++ V T T +V++ GE L ++ + +TE +Q+ A+
Sbjct: 69 PHI---IKLYD---VITTPTDIVMVIEYAGGE-LFDYIVEKKRMTEDEGRRFFQQIICAI 121
Query: 213 HCLHSQQIAHKDIRPENILMNGAV-LKLIDLG-SSVSVSTVVL------PDLEFASPEML 264
H +I H+D++PEN+L++ + +K+ D G S++ L P+ +A+PE++
Sbjct: 122 EYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPN--YAAPEVI 179
Query: 265 TSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPA 324
AGP D+WS G++LY++L G PF DE ++ Y P +S A
Sbjct: 180 NGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPD----FLSPGA 235
Query: 325 RELIGQLLNTHADKRPTAGQLLQVAWF 351
+ LI +++ +R T ++ + WF
Sbjct: 236 QSLIRRMIVADPMQRITIQEIRRDPWF 262
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-43
Identities = 62/287 (21%), Positives = 118/287 (41%), Gaps = 44/287 (15%)
Query: 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIP-RERQPQQITRAEYNLLSTLM-HA 156
E R L G F V +A+D G+G+ ALK++ E + + E + L H
Sbjct: 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHP 86
Query: 157 HIPTALALFENAPVPGTDT--------IVMQLVHGESL--IQHLCRQSTITESYICCIIR 206
+I + A + ++ ++ +L G+ + ++ + + ++ + I
Sbjct: 87 NI---VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFY 143
Query: 207 QLHSALHCLHSQQ--IAHKDIRPENILMNGA-VLKLIDLGSSVSVSTVVLPDLE------ 257
Q A+ +H Q+ I H+D++ EN+L++ +KL D GS+ ++S
Sbjct: 144 QTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRAL 203
Query: 258 ------------FASPEM--LTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRA 303
+ +PE+ L S G D+W+LG +LY+L PF E+ +
Sbjct: 204 VEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF----EDGAKL 259
Query: 304 HISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAW 350
I YS PP LI +L + ++R + +++
Sbjct: 260 RIVNGKYSIPPHD--TQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-43
Identities = 59/309 (19%), Positives = 102/309 (33%), Gaps = 58/309 (18%)
Query: 94 QQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER--QPQQITRAEYNLLS 151
Q H + + LG G V + R + TG L A+K +P + E+ +L
Sbjct: 3 SQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLK 62
Query: 152 TLMHAHIPTALALFENAPVPGTDT-----IVMQLVHGESLIQHLC---RQSTITESYICC 203
L H +I + LF + T ++M+ SL L + ES
Sbjct: 63 KLNHKNI---VKLFA---IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLI 116
Query: 204 IIRQLHSALHCLHSQQIAHKDIRPENILMNG-----AVLKLIDLGSSVSVSTVVLPD--- 255
++R + ++ L I H++I+P NI+ +V KL D G++ +
Sbjct: 117 VLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY 176
Query: 256 --LEFASPEMLTSPATA-------GPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHI- 305
E+ P+M G + D+WS+GV Y +G PF +
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236
Query: 306 --------------------SVADYSFPPEQCGHISVPARE----LIGQLLNTHADKRPT 341
D+S +S + ++ +L +K
Sbjct: 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG 296
Query: 342 AGQLLQVAW 350
Q
Sbjct: 297 FDQFFAETS 305
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-42
Identities = 57/270 (21%), Positives = 108/270 (40%), Gaps = 31/270 (11%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER---QPQQITRAEYNLLSTLMHAH 157
++ ++ LG G + V+ A +R T + VA+K + +R P+ I + E + L H +
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK-EICINKMLNHEN 66
Query: 158 IPTALALFENAPVPGTDT---IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHC 214
+ + + + ++ G L + + E QL + +
Sbjct: 67 V---VKFYG---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 215 LHSQQIAHKDIRPENIL----MNGAVLKLIDLG-SSVSVSTVVLPDLE-------FASPE 262
LH I H+DI+PEN+L N LK+ D G ++V L + +PE
Sbjct: 121 LHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 263 MLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEE-ETRAHISVADYSFPPEQCGHIS 321
+L D+WS G++L +L+G P+ S+ + + P + I
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWK--KID 235
Query: 322 VPARELIGQLLNTHADKRPTAGQLLQVAWF 351
L+ ++L + R T + + W+
Sbjct: 236 SAPLALLHKILVENPSARITIPDIKKDRWY 265
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-42
Identities = 62/334 (18%), Positives = 126/334 (37%), Gaps = 73/334 (21%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER-------------------QPQQ 141
Y + L G+F + + ALK+ + +
Sbjct: 32 DYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 142 ITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT---IVMQLVHGESLIQHLCRQSTITE 198
E +++ + + + L + I+ + + +S+++ + +
Sbjct: 90 FKN-ELQIITDIKNEYC---LTCEG---IITNYDEVYIIYEYMENDSILKFDEYFFVLDK 142
Query: 199 SYIC--------CIIRQLHSALHCLHSQ-QIAHKDIRPENILM--NGAVLKLIDLGSSVS 247
+Y C CII+ + ++ +H++ I H+D++P NILM NG +KL D G S
Sbjct: 143 NYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNG-RVKLSDFGESEY 201
Query: 248 VSTVVL------PDLEFASPEMLTS-PATAGPSTDMWSLGVLLYILLSGVSPFLDE-SEE 299
+ + + F PE ++ + G D+WSLG+ LY++ V PF + S
Sbjct: 202 MVDKKIKGSRGTYE--FMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV 259
Query: 300 ETRAHISVADYSFPPEQCG---------------HISVPARELIGQLLNTHADKRPTAGQ 344
E +I + +P ++ +S + + L + +R T+
Sbjct: 260 ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSED 319
Query: 345 LLQVAWFAEASCSEFDTERLLPFSARRKQKFKEI 378
L+ W ++ + E L FS +K K++
Sbjct: 320 ALKHEWL-----ADTNIEDLREFSKELYKKRKKL 348
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-42
Identities = 66/274 (24%), Positives = 114/274 (41%), Gaps = 35/274 (12%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER------QPQQITRAEYNLLSTLM 154
+Y + LG G + V++ D T A+K + +++ + + E LL L
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKK-EIQLLRRLR 64
Query: 155 HAHIPTALALFENAPVPGTDT-----IVMQLVHG--ESLIQHLCRQSTITESYICCIIRQ 207
H ++ + L + V + +VM+ + ++ + + Q
Sbjct: 65 HKNV---IQLVD---VLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR-FPVCQAHGYFCQ 117
Query: 208 LHSALHCLHSQQIAHKDIRPENILM-NGAVLKLIDLGSSVSVSTVVLPDL--------EF 258
L L LHSQ I HKDI+P N+L+ G LK+ LG + ++ D F
Sbjct: 118 LIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAF 177
Query: 259 ASPEMLTSPAT-AGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQC 317
PE+ T +G D+WS GV LY + +G+ PF ++ + +I Y+ P
Sbjct: 178 QPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPG--- 234
Query: 318 GHISVPARELIGQLLNTHADKRPTAGQLLQVAWF 351
P +L+ +L KR + Q+ Q +WF
Sbjct: 235 -DCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWF 267
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-41
Identities = 66/301 (21%), Positives = 116/301 (38%), Gaps = 38/301 (12%)
Query: 90 ETRWQQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITR--AEY 147
+ Q +E ERLG G F V + + TG+ VA+KQ +E P+ R E
Sbjct: 4 RSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEI 63
Query: 148 NLLSTLMHAHIPTALALFENAPVPGTDT---IVMQLVHGESLIQHLC---RQSTITESYI 201
++ L H ++ +A + + + + M+ G L ++L + E I
Sbjct: 64 QIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPI 123
Query: 202 CCIIRQLHSALHCLHSQQIAHKDIRPENILM----NGAVLKLIDLGSSVSVSTVVLPD-- 255
++ + SAL LH +I H+D++PENI++ + K+IDLG + + L
Sbjct: 124 RTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF 183
Query: 256 ---LEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSF 312
L++ +PE+L + D WS G L + ++G PFL + +
Sbjct: 184 VGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNE 242
Query: 313 PPEQCGHISVPAR--------------------ELIGQLLNTHADKRPTAGQLLQVAWFA 352
++ + + +L H +R T Q V F
Sbjct: 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQ 302
Query: 353 E 353
Sbjct: 303 A 303
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 2e-41
Identities = 51/303 (16%), Positives = 88/303 (29%), Gaps = 59/303 (19%)
Query: 101 RYEEL---ERLGNGRFCTVRKARDRGTGQLVALKQIP--------------RERQPQQIT 143
R L LG +A D+ TG+ + E ++
Sbjct: 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL 135
Query: 144 RAEYNLLSTLMHAHIPTALALFENAPVP--------GTDTIVMQLV------------HG 183
R N +H L ++ D V+ G
Sbjct: 136 RGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFG 195
Query: 184 ESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILM--NGAVLKLID 241
E L+ H ++ + Q+ L LH + H +RP +I++ G V L
Sbjct: 196 EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGV-FLTG 254
Query: 242 LGSSVSVSTVVLPDL-------EFASPEMLT----SPATAGPSTDMWSLGVLLYILLSGV 290
V + + E + ML P + D W+LG+ +Y +
Sbjct: 255 FEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
Query: 291 SPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAW 350
P D++ I C +I P R L+ L + R Q ++
Sbjct: 315 LPNTDDAALGGSEWIF--------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPE 366
Query: 351 FAE 353
+ +
Sbjct: 367 YEQ 369
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-41
Identities = 73/272 (26%), Positives = 120/272 (44%), Gaps = 39/272 (14%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER-----QPQQITRAEYNLLSTLMH 155
Y + LG G F V+ + TG VA+K + R++ +I R E L H
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR-EIQNLKLFRH 75
Query: 156 AHIPTALALFENAPVPGTDT---IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSAL 212
HI + L++ V T + +VM+ V G L ++C+ + E + +Q+ S +
Sbjct: 76 PHI---IKLYQ---VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGV 129
Query: 213 HCLHSQQIAHKDIRPENIL----MNGAVLKLIDLGSSVSVSTVVLPD--LE-------FA 259
H + H+D++PEN+L MN K+ D G +S ++ L +A
Sbjct: 130 DYCHRHMVVHRDLKPENVLLDAHMN---AKIADFG----LSNMMSDGEFLRTSCGSPNYA 182
Query: 260 SPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGH 319
+PE+++ AGP D+WS GV+LY LL G PF D+ I + P +
Sbjct: 183 APEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQ----Y 238
Query: 320 ISVPARELIGQLLNTHADKRPTAGQLLQVAWF 351
++ L+ +L KR T + + WF
Sbjct: 239 LNPSVISLLKHMLQVDPMKRATIKDIREHEWF 270
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-40
Identities = 58/279 (20%), Positives = 103/279 (36%), Gaps = 36/279 (12%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTL-MHAHIP 159
+ + LG+G T+ R + VA+K+I E E LL H ++
Sbjct: 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF--SFADREVQLLRESDEHPNVI 81
Query: 160 TALALFENAPVPGTDT---IVMQLVHGE--SLIQHLCRQSTITESYICCIIRQLHSALHC 214
+ I ++L ++ + +++Q S L
Sbjct: 82 RYFCTEK------DRQFQYIAIELCAATLQEYVEQ--KDFAHLGLEPITLLQQTTSGLAH 133
Query: 215 LHSQQIAHKDIRPENILMNGA------VLKLIDLGSSV-----SVSTVVLPDLE----FA 259
LHS I H+D++P NIL++ + D G S + +
Sbjct: 134 LHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 260 SPEMLTSPATAGPST--DMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQ 316
+PEML+ P+ D++S G + Y ++S G PF + + + +
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPE 253
Query: 317 CGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355
H V ARELI +++ KRP+A +L+ +F
Sbjct: 254 -KHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLE 291
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-40
Identities = 62/294 (21%), Positives = 119/294 (40%), Gaps = 54/294 (18%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER----------------------- 137
+Y + +G G + V+ A + A+K + +++
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 138 -----QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTI--VMQLVHGESLIQHL 190
+Q+ + E +L L H ++ + L E P D + V +LV+ +++
Sbjct: 74 IQPRGPIEQVYQ-EIAILKKLDHPNV---VKLVEVLDDPNEDHLYMVFELVNQGPVMEVP 129
Query: 191 CRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGA-VLKLIDLGSSVSVS 249
+ ++E + L + LH Q+I H+DI+P N+L+ +K+ D G VS
Sbjct: 130 TLKP-LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFG----VS 184
Query: 250 TVVLPD---LE-------FASPEMLTSPAT--AGPSTDMWSLGVLLYILLSGVSPFLDES 297
L F +PE L+ +G + D+W++GV LY + G PF+DE
Sbjct: 185 NEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244
Query: 298 EEETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWF 351
+ I FP + I+ ++LI ++L+ + + R ++ W
Sbjct: 245 IMCLHSKIKSQALEFPDQP--DIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-38
Identities = 64/301 (21%), Positives = 116/301 (38%), Gaps = 55/301 (18%)
Query: 95 QEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLM 154
++ ++ + LG G TV + G+ VA+K++ + I E LL+
Sbjct: 10 EQSLKNLVVSEKILGYGSSGTV-VFQGSFQGRPVAVKRMLIDFC--DIALMEIKLLTESD 66
Query: 155 -HAHIPTALALFENAPVPGTDT---IVMQLVHGE--SLIQH----LCRQSTITESYICCI 204
H ++ TD I ++L + L++ E +
Sbjct: 67 DHPNVIRYYCSET------TDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISL 120
Query: 205 IRQLHSALHCLHSQQIAHKDIRPENIL--------------MNGAVLKLIDLGSSVSVST 250
+RQ+ S + LHS +I H+D++P+NIL + + D G + +
Sbjct: 121 LRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180
Query: 251 VVLPDLEFAS----------PEMLTSPATA------GPSTDMWSLGVLLYILLS-GVSPF 293
+ PE+L S D++S+G + Y +LS G PF
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240
Query: 294 LDESEEETRAHISVADYSFPPEQCG---HISVPARELIGQLLNTHADKRPTAGQLLQVAW 350
D+ E ++I +S +C + A +LI Q+++ KRPTA ++L+
Sbjct: 241 GDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 298
Query: 351 F 351
F
Sbjct: 299 F 299
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-38
Identities = 59/291 (20%), Positives = 109/291 (37%), Gaps = 45/291 (15%)
Query: 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP----QQITRAEYNLLSTL 153
+ + ELE++G+G F +V K R G + A+K+ + Q R Y
Sbjct: 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLG 68
Query: 154 MHAHIPTALALFENAPVPGTDT---IVMQLVHGESLIQHLCRQ----STITESYICCIIR 206
H+H+ + + D I + +G SL + S E+ + ++
Sbjct: 69 QHSHVVRYFSAWA------EDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLL 122
Query: 207 QLHSALHCLHSQQIAHKDIRPENILMN--------------------GAVLKLIDLGSSV 246
Q+ L +HS + H DI+P NI ++ + K+ DLG
Sbjct: 123 QVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 182
Query: 247 SVS--TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAH 304
+S V D F + E+L T P D+++L + + +
Sbjct: 183 RISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP---RNGDQWHE 239
Query: 305 ISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355
I P+ +S EL+ +++ ++RP+A L++ + AS
Sbjct: 240 IRQGRLPRIPQ---VLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 287
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 9e-38
Identities = 51/277 (18%), Positives = 95/277 (34%), Gaps = 24/277 (8%)
Query: 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHI 158
H R+G G F V + +D+ TG A+K++ E + E + L I
Sbjct: 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE----ELVACAGLSSPRI 112
Query: 159 PTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQ 218
I M+L+ G SL Q + + + E + Q L LH++
Sbjct: 113 VPLYGAVR---EGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTR 169
Query: 219 QIAHKDIRPENIL--MNGAVLKLIDLGSSVSVSTVVLPDLEFASPEMLTSP--------- 267
+I H D++ +N+L +G+ L D G ++ + L + +
Sbjct: 170 RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 229
Query: 268 -ATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRA--HISVADYSFPPEQCGHISVPA 324
D+WS ++ +L+G P+ I ++ E +
Sbjct: 230 GKPCDAKVDIWSSCCMMLHMLNGCHPWTQ--YFRGPLCLKI-ASEPPPIREIPPSCAPLT 286
Query: 325 RELIGQLLNTHADKRPTAGQLLQVAWFAEASCSEFDT 361
+ I + L R +A +L + A +
Sbjct: 287 AQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKS 323
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 7e-37
Identities = 75/303 (24%), Positives = 124/303 (40%), Gaps = 27/303 (8%)
Query: 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLM-HAH 157
+E +E +GNG + V K R TGQL A+K + ++ + E N+L H +
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRN 82
Query: 158 IPTALALFENAPVPGTDT---IVMQLVHGESL--IQHLCRQSTITESYICCIIRQLHSAL 212
I T F PG D +VM+ S+ + + +T+ E +I I R++ L
Sbjct: 83 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 142
Query: 213 HCLHSQQIAHKDIRPENILM--NGAVLKLIDLGSSVSVSTVVLPDLEFA------SPEML 264
LH ++ H+DI+ +N+L+ N V KL+D G S + V F +PE++
Sbjct: 143 SHLHQHKVIHRDIKGQNVLLTENAEV-KLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 201
Query: 265 TSPATAGPS----TDMWSLGVLLYILLSGVSPFLDESEEETRA--HISVADYSFPPE-QC 317
+ +D+WSLG+ + G P D RA I P +
Sbjct: 202 ACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD--MHPMRALFLIPRNP---APRLKS 256
Query: 318 GHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASCSEFDTERLLPFSARRKQKFKE 377
S + I L + +RP QL++ + + +L R K+K E
Sbjct: 257 KKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLKDHIDRTKKKRGE 316
Query: 378 IQD 380
+
Sbjct: 317 KDE 319
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-36
Identities = 73/288 (25%), Positives = 111/288 (38%), Gaps = 28/288 (9%)
Query: 91 TRWQQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP--QQITRAEYN 148
LG G + V RD +A+K+IP Q + E
Sbjct: 22 DENGDRVV---------LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPL-HEEIA 71
Query: 149 LLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHG---ESLIQHLCRQSTITESYICCII 205
L L H +I L F G I M+ V G +L++ E I
Sbjct: 72 LHKHLKHKNIVQYLGSFS---ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYT 128
Query: 206 RQLHSALHCLHSQQIAHKDIRPENILMNGA--VLKLIDLGSSVSVSTVVLPDLEFA---- 259
+Q+ L LH QI H+DI+ +N+L+N VLK+ D G+S ++ + F
Sbjct: 129 KQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQ 188
Query: 260 --SPEMLTSPAT-AGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQ 316
+PE++ G + D+WSLG + + +G PF E E A V + PE
Sbjct: 189 YMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF-YELGEPQAAMFKVGMFKVHPEI 247
Query: 317 CGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASCSEFDTERL 364
+S A+ I + DKR A LL + +S + +L
Sbjct: 248 PESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQPKL 295
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 8e-35
Identities = 57/269 (21%), Positives = 105/269 (39%), Gaps = 18/269 (6%)
Query: 101 RYEEL-ERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP----QQITRAEYNLLSTLMH 155
R+ + +G G F TV K D T VA ++ + Q+ + E +L L H
Sbjct: 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRF-KEEAEMLKGLQH 84
Query: 156 AHIPTAL-ALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHC 214
+I + +V +L+ +L +L R + + RQ+ L
Sbjct: 85 PNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQF 144
Query: 215 LHSQQ--IAHKDIRPENILMNGA--VLKLIDLGSSVSVSTVVLPDL----EFASPEMLTS 266
LH++ I H+D++ +NI + G +K+ DLG + + EF +PEM
Sbjct: 145 LHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE 204
Query: 267 PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARE 326
S D+++ G+ + + + P+ + V P +E
Sbjct: 205 K--YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR-VTSGVKPASFDKVAIPEVKE 261
Query: 327 LIGQLLNTHADKRPTAGQLLQVAWFAEAS 355
+I + + D+R + LL A+F E +
Sbjct: 262 IIEGCIRQNKDERYSIKDLLNHAFFQEET 290
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-34
Identities = 45/292 (15%), Positives = 83/292 (28%), Gaps = 47/292 (16%)
Query: 89 FETRWQQEQFEHRYEELERLGNGRFCTVRKARDRG-----TGQLVALKQI-PRERQPQQI 142
+ + + + LG G F V +A Q LK P I
Sbjct: 54 IKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYI 113
Query: 143 TRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCR-----QSTIT 197
L M + +V +L +L+ + + +
Sbjct: 114 GTQLMERLKPSMQHMFMKFYSAHLF---QNGSVLVGELYSYGTLLNAINLYKNTPEKVMP 170
Query: 198 ESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGAV------------LKLIDLGSS 245
+ + ++ + +H +I H DI+P+N ++ L LIDLG S
Sbjct: 171 QGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQS 230
Query: 246 VSVSTVVLPD----------LEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLD 295
+ + + P F EML++ D + + +Y +L G +
Sbjct: 231 IDMK--LFPKGTIFTAKCETSGFQCVEMLSNKPW-NYQIDYFGVAATVYCMLFGTYMKVK 287
Query: 296 ESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQ 347
E + E +LN + LL+
Sbjct: 288 NEGGECKPEGLFRRLPHLDMW--------NEFFHVMLNIPDCHHLPSLDLLR 331
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-34
Identities = 74/289 (25%), Positives = 124/289 (42%), Gaps = 28/289 (9%)
Query: 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQIT--RAEYNLLSTLMHA 156
E + +LE++G G F V K D T ++VA+K I E +I + E +LS
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 157 HIPTALALFENAPVPGTDT-IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCL 215
++ + + T I+M+ + G S L + E+ I I+R++ L L
Sbjct: 81 YVTKYYGSY----LKDTKLWIIMEYLGGGSA-LDLLEPGPLDETQIATILREILKGLDYL 135
Query: 216 HSQQIAHKDIRPENILM--NGAVLKLIDLGSSVSVSTVVLPDLEFA------SPEMLTSP 267
HS++ H+DI+ N+L+ +G V KL D G + ++ + F +PE++
Sbjct: 136 HSEKKIHRDIKAANVLLSEHGEV-KLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ- 193
Query: 268 ATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRA--HISVADYSFPPEQCGHISVPAR 325
+ D+WSLG+ L G P + + I + PP G+ S P +
Sbjct: 194 SAYDSKADIWSLGITAIELARGEPPHSE--LHPMKVLFLIPKNN---PPTLEGNYSKPLK 248
Query: 326 ELIGQLLNTHADKRPTAGQLLQVAWFAEASCSEFDTERLLPFSARRKQK 374
E + LN RPTA +LL+ + + T L R K+
Sbjct: 249 EFVEACLNKEPSFRPTAKELLKHKFILRNAKK---TSYLTELIDRYKRW 294
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-32
Identities = 69/280 (24%), Positives = 122/280 (43%), Gaps = 45/280 (16%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALK-----QIPRERQPQQITRAEYNLLSTLMHA 156
++ + LG G F TV AR+ T + A+K I +E + E +++S L H
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY-VTRERDVMSRLDHP 90
Query: 157 HIPTALALFENAPVPGTDT---IVMQLVHGESLIQHLCRQSTITES----YICCIIRQLH 209
F+ D + L++++ + + E+ Y I+
Sbjct: 91 FFVKLYFTFQ------DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV---- 140
Query: 210 SALHCLHSQQIAHKDIRPENILM--NGAVLKLIDLGSSVSVSTVVLPDL--------EFA 259
SAL LH + I H+D++PENIL+ + + ++ D G++ +S ++
Sbjct: 141 SALEYLHGKGIIHRDLKPENILLNEDMHI-QITDFGTAKVLSPESKQARANSFVGTAQYV 199
Query: 260 SPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGH 319
SPE+LT +A S+D+W+LG ++Y L++G+ PF +E I +Y FP
Sbjct: 200 SPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE----K 254
Query: 320 ISVPARELIGQLLNTHADKRPTAGQLLQVA------WFAE 353
AR+L+ +LL A KR ++ +F
Sbjct: 255 FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 294
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-32
Identities = 68/295 (23%), Positives = 118/295 (40%), Gaps = 39/295 (13%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQIT--RAEYNLLSTLMHAHI 158
YE E +G+G V+ A + VA+K+I E+ + E +S H +I
Sbjct: 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 75
Query: 159 PTALALFENAPVPGTDT-IVMQLVHGESL--------IQHLCRQSTITESYICCIIRQLH 209
+ F V + +VM+L+ G S+ + + + ES I I+R++
Sbjct: 76 VSYYTSF----VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 210 SALHCLHSQQIAHKDIRPENILM--NGAVLKLIDLGSSVSVSTVVLPDLEFA-------- 259
L LH H+D++ NIL+ +G+V ++ D G S ++T
Sbjct: 132 EGLEYLHKNGQIHRDVKAGNILLGEDGSV-QIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 260 ---SPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFP--- 313
+PE++ D+WS G+ L +G +P+ + + P
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHK--YPPMKVLMLTLQNDPPSLE 248
Query: 314 -----PEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASCSEFDTER 363
E R++I L +KRPTA +LL+ +F +A EF E+
Sbjct: 249 TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEFLQEK 303
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-32
Identities = 60/287 (20%), Positives = 127/287 (44%), Gaps = 24/287 (8%)
Query: 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP-QQITRAEYNLLSTLMHAH 157
+ ++G G V AR++ +G+ VA+K + +Q +++ E ++ H +
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 158 IPTALALFENAPVPGTDT-IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLH 216
+ + + G + ++M+ + G +L + Q + E I + + AL LH
Sbjct: 104 VVE----MYKSYLVGEELWVLMEFLQGGAL-TDIVSQVRLNEEQIATVCEAVLQALAYLH 158
Query: 217 SQQIAHKDIRPENIL--MNGAVLKLIDLGSSVSVSTVVLPDLEFA------SPEMLTSPA 268
+Q + H+DI+ ++IL ++G V KL D G +S V +PE+++ +
Sbjct: 159 AQGVIHRDIKSDSILLTLDGRV-KLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR-S 216
Query: 269 TAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPP-EQCGHISVPAREL 327
D+WSLG+++ ++ G P+ + +A + D P + +S R+
Sbjct: 217 LYATEVDIWSLGIMVIEMVDGEPPYFS--DSPVQAMKRLRDSPPPKLKNSHKVSPVLRDF 274
Query: 328 IGQLLNTHADKRPTAGQLLQVAWFAEASCSEFDTERLLPFSARRKQK 374
+ ++L +R TA +LL + + E L+P +++
Sbjct: 275 LERMLVRDPQERATAQELLDHPFLLQTG----LPECLVPLIQLYRKQ 317
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 5e-32
Identities = 78/291 (26%), Positives = 136/291 (46%), Gaps = 26/291 (8%)
Query: 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP-QQITRAEYNLLSTLMHAH 157
+ +Y E++G G TV A D TGQ VA++Q+ ++QP +++ E ++ + +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 158 IPTALALFENAPVPGTDT-IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLH 216
I L + + G + +VM+ + G SL + ++ + E I + R+ AL LH
Sbjct: 79 IVNYLDSY----LVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 217 SQQIAHKDIRPENIL--MNGAVLKLIDLGSSVSVSTVVLPDLEFA------SPEMLTSPA 268
S Q+ H+DI+ +NIL M+G+V KL D G ++ +PE++T
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSV-KLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-K 191
Query: 269 TAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPP--EQCGHISVPARE 326
GP D+WSLG++ ++ G P+L+E+ I+ P + +S R+
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG---TPELQNPEKLSAIFRD 248
Query: 327 LIGQLLNTHADKRPTAGQLLQVAWFAEASCSEFDTERLLPFSARRKQKFKE 377
+ + L +KR +A +LLQ + A L P A K+ K
Sbjct: 249 FLNRCLEMDVEKRGSAKELLQHQFLKIAK----PLSSLTPLIAAAKEATKN 295
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 5e-32
Identities = 73/300 (24%), Positives = 129/300 (43%), Gaps = 37/300 (12%)
Query: 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQ-QITRAEYNLLSTLMHAH 157
+E + LG+G F V KA+++ TG L A K I + + + + E +L+T H +
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 158 IPTALALFENAPVPGTD-TIVMQLVHGES---LIQHLCRQSTITESYICCIIRQLHSALH 213
I L + I+++ G + ++ L R +TE I + RQ+ AL+
Sbjct: 78 IVKLLGAY----YHDGKLWIMIEFCPGGAVDAIMLELDR--GLTEPQIQVVCRQMLEALN 131
Query: 214 CLHSQQIAHKDIRPENIL--MNGAVLKLIDLGSSVSVSTVVLPDLEFA------SPEMLT 265
LHS++I H+D++ N+L + G + +L D G S + F +PE++
Sbjct: 132 FLHSKRIIHRDLKAGNVLMTLEGDI-RLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVM 190
Query: 266 SPATA----GPSTDMWSLGVLLYILLSGVSPFLDESEEETRA--HISVADYSFPP--EQC 317
D+WSLG+ L + P + + R I+ +D PP
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN--PMRVLLKIAKSD---PPTLLTP 245
Query: 318 GHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASCSEFDTERLLPFSARRKQKFKE 377
SV R+ + L+ + + RP+A QLL+ + + + + L A K + E
Sbjct: 246 SKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT----SNKALRELVAEAKAEVME 301
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-31
Identities = 67/298 (22%), Positives = 113/298 (37%), Gaps = 32/298 (10%)
Query: 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQ----QITRAEYNLLSTLM 154
E + +L +G+G F V ARD ++VA+K++ + Q E L L
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 155 HAHIPTALALFENAPVPGTDT-IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALH 213
H + + + +VM+ G + + + E I + L
Sbjct: 113 HPNTIQYRGCY----LREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLA 168
Query: 214 CLHSQQIAHKDIRPENIL--MNGAVLKLIDLGSSVSVS---TVV-LPDLEFASPEMLTSP 267
LHS + H+D++ NIL G V KL D GS+ ++ + V P + +PE++ +
Sbjct: 169 YLHSHNMIHRDVKAGNILLSEPGLV-KLGDFGSASIMAPANSFVGTP--YWMAPEVILAM 225
Query: 268 ATAG--PSTDMWSLGVLLYILLSGVSPFLDESEEETRA--HISVADYSFPPE-QCGHISV 322
D+WSLG+ L P + A HI+ + P Q GH S
Sbjct: 226 DEGQYDGKVDVWSLGITCIELAERKPPLFN--MNAMSALYHIAQNE---SPALQSGHWSE 280
Query: 323 PARELIGQLLNTHADKRPTAGQLLQVAWFAEASCSEFDTERLLPFSARRKQKFKEIQD 380
R + L RPT+ LL+ + ++ R K +E+ +
Sbjct: 281 YFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER----PPTVIMDLIQRTKDAVRELDN 334
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-30
Identities = 73/263 (27%), Positives = 114/263 (43%), Gaps = 26/263 (9%)
Query: 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHI 158
E ++ LE+LG G + +V KA + TGQ+VA+KQ+P E Q+I + E +++ H+
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIK-EISIMQQCDSPHV 86
Query: 159 PTALALFENAPVPGTDT-IVMQLVHGESLIQHL-CRQSTITESYICCIIRQLHSALHCLH 216
+ TD IVM+ S+ + R T+TE I I++ L LH
Sbjct: 87 VKYYGSY----FKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH 142
Query: 217 SQQIAHKDIRPENIL--MNGAVLKLIDLGSSVSVSTVVLPDLEFA------SPEMLTSPA 268
+ H+DI+ NIL G KL D G + ++ + +PE++
Sbjct: 143 FMRKIHRDIKAGNILLNTEGHA-KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-I 200
Query: 269 TAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRA--HISVADYSFPP--EQCGHISVPA 324
D+WSLG+ + G P+ D RA I PP + S
Sbjct: 201 GYNCVADIWSLGITAIEMAEGKPPYAD--IHPMRAIFMIPTNP---PPTFRKPELWSDNF 255
Query: 325 RELIGQLLNTHADKRPTAGQLLQ 347
+ + Q L ++R TA QLLQ
Sbjct: 256 TDFVKQCLVKSPEQRATATQLLQ 278
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-30
Identities = 66/350 (18%), Positives = 120/350 (34%), Gaps = 73/350 (20%)
Query: 99 EHRYEELERLGNGR--FCTVRKARDRGTGQLVALKQIPRERQPQ---QITRAEYNLLSTL 153
YE L +G G TV AR + TG+ V +++I E + E ++
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 154 MHAHIPTALALFENAPVPGTDT-IVMQLVHGESL--IQHLCRQSTITESYICCIIRQLHS 210
H +I A F + + +V + S + + E I I++ +
Sbjct: 84 NHPNIVPYRATF----IADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLK 139
Query: 211 ALHCLHSQQIAHKDIRPENIL--MNGAVLKLIDLGSSVSVS-------TVVLPDLEFA-- 259
AL +H H+ ++ +IL ++G V L L S++S+ V
Sbjct: 140 ALDYIHHMGYVHRSVKASHILISVDGKV-YLSGLRSNLSMISHGQRQRVVHDFPKYSVKV 198
Query: 260 ----SPEMLT-SPATAGPSTDMWSLGV-------------------LLYILLSGVSPFLD 295
SPE+L + +D++S+G+ +L L+G P L
Sbjct: 199 LPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL 258
Query: 296 ESEEETRAHISVADYSFPPEQCGHISVPA-----------------------RELIGQLL 332
++ ++++ S+ + Q L
Sbjct: 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCL 318
Query: 333 NTHADKRPTAGQLLQVAWF--AEASCSEFDTERLLPFSARRKQKFKEIQD 380
+ D RP+A LL ++F + SE E L P + + + QD
Sbjct: 319 QRNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFEGSQSQD 368
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-30
Identities = 60/274 (21%), Positives = 109/274 (39%), Gaps = 47/274 (17%)
Query: 108 LGNGRFCTVRKARDRGTGQLVALKQIPRER--QPQQI--TRAEYNLLSTLMHAHI----- 158
+G G F V + T ++ A+K + +++ + ++ E ++ L H +
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82
Query: 159 --PTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITES----YICCIIRQLHSAL 212
+F +V+ L+ G L HL + E +IC ++ AL
Sbjct: 83 SFQDEEDMF----------MVVDLLLGGDLRYHLQQNVHFKEETVKLFICELV----MAL 128
Query: 213 HCLHSQQIAHKDIRPENILM--NGAVLKLIDLGSSVSVSTVVLPD-----LEFASPEMLT 265
L +Q+I H+D++P+NIL+ +G V + D + + + +PEM +
Sbjct: 129 DYLQNQRIIHRDMKPDNILLDEHGHV-HITDFNIAAMLPRETQITTMAGTKPYMAPEMFS 187
Query: 266 SPATAG--PSTDMWSLGVLLYILLSGVSPF---LDESEEETRAHISVADYSFPPEQCGHI 320
S AG + D WSLGV Y LL G P+ S +E ++P
Sbjct: 188 SRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPS----AW 243
Query: 321 SVPARELIGQLLNTHADKR-PTAGQLLQVAWFAE 353
S L+ +LL + D+R + + +
Sbjct: 244 SQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-29
Identities = 64/274 (23%), Positives = 114/274 (41%), Gaps = 42/274 (15%)
Query: 89 FETRWQQEQFEHR----YEELERLGNGRFCTVRKARDRGTGQLVALK-----QIPRERQP 139
F +W+ ++ ++ LG G F V + + +G A+K ++ + +Q
Sbjct: 26 FLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ- 84
Query: 140 QQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT---IVMQLVHGESLIQHLCRQSTI 196
+ T E +L + + F+ ++ +VM+ V G + HL R
Sbjct: 85 IEHTLNEKRILQAVNFPFLVKLEFSFK------DNSNLYMVMEYVAGGEMFSHLRRIGRF 138
Query: 197 TES----YICCIIRQLHSALHCLHSQQIAHKDIRPENILM--NGAVLKLIDLGSS--VSV 248
+E Y I+ LHS + ++D++PEN+L+ G + ++ D G + V
Sbjct: 139 SEPHARFYAAQIV----LTFEYLHSLDLIYRDLKPENLLIDQQGYI-QVTDFGFAKRVKG 193
Query: 249 STVVL---PDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHI 305
T L P E +PE++ S + D W+LGVL+Y + +G PF + + I
Sbjct: 194 RTWTLCGTP--EALAPEIILSKGY-NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250
Query: 306 SVADYSFPPEQCGHISVPARELIGQLLNTHADKR 339
FP H S ++L+ LL KR
Sbjct: 251 VSGKVRFPS----HFSSDLKDLLRNLLQVDLTKR 280
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-28
Identities = 67/291 (23%), Positives = 115/291 (39%), Gaps = 43/291 (14%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQ---QITRAEYN-LLSTLMHAH 157
E L +G+G V K R R TG ++A+KQ+ R + +I + + +L + +
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILM-DLDVVLKSHDCPY 85
Query: 158 IPTAL-ALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLH 216
I N V I M+L+ + Q I E + + + AL+ L
Sbjct: 86 IVQCFGTFITNTDV----FIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK 141
Query: 217 SQ-QIAHKDIRPENILMN--GAVLKLIDLG------SSVSVSTVVLPDLEFA------SP 261
+ + H+D++P NIL++ G + KL D G + A +P
Sbjct: 142 EKHGVIHRDVKPSNILLDERGQI-KLCDFGISGRLVDDKAKDR-------SAGCAAYMAP 193
Query: 262 EMLTSPATAGPS----TDMWSLGVLLYILLSGVSPFLD-ESEEETRAHISVADYSFPPEQ 316
E + P P D+WSLG+ L L +G P+ + +++ E + + PP
Sbjct: 194 ERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE---PPLL 250
Query: 317 CGHI--SVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASCSEFDTERLL 365
GH+ S + + L KRP +LL+ ++ E D
Sbjct: 251 PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWF 301
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-27
Identities = 69/257 (26%), Positives = 115/257 (44%), Gaps = 38/257 (14%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALK-----QIPRERQPQQITRAEYNLLSTLMHA 156
++ L LG G F V R R G+ A+K + R +Q + T E +LS + H
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQ-VEHTNDERLMLSIVTHP 66
Query: 157 HIPTALALFENAPVPGTDT---IVMQLVHGESLIQHLCRQSTITES----YICCIIRQLH 209
I F+ ++M + G L L + Y +
Sbjct: 67 FIIRMWGTFQ------DAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVC---- 116
Query: 210 SALHCLHSQQIAHKDIRPENILM--NGAVLKLIDLGSS--VSVSTVVL---PDLEFASPE 262
AL LHS+ I ++D++PENIL+ NG + K+ D G + V T L P ++ +PE
Sbjct: 117 LALEYLHSKDIIYRDLKPENILLDKNGHI-KITDFGFAKYVPDVTYTLCGTP--DYIAPE 173
Query: 263 MLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISV 322
++++ S D WS G+L+Y +L+G +PF D + +T I A+ FPP +
Sbjct: 174 VVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP----FFNE 228
Query: 323 PARELIGQLLNTHADKR 339
++L+ +L+ +R
Sbjct: 229 DVKDLLSRLITRDLSQR 245
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-27
Identities = 66/286 (23%), Positives = 112/286 (39%), Gaps = 42/286 (14%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITR--AEYN-LLSTLMHAHI 158
E + LG G + V K R +GQ++A+K+I Q+ R + + + T+
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFT 68
Query: 159 PTAL-ALFENAPVPGTDTIVMQLVHG---ESLIQHLCRQSTITESYICCIIRQLHSALHC 214
T ALF V I M+L+ + Q + + TI E + I + AL
Sbjct: 69 VTFYGALFREGDV----WICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 215 LHSQ-QIAHKDIRPENILMN--GAVLKLIDLG------SSVSVSTVVLPDLEFA------ 259
LHS+ + H+D++P N+L+N G V K+ D G V+ A
Sbjct: 125 LHSKLSVIHRDVKPSNVLINALGQV-KMCDFGISGYLVDDVAKDI-------DAGCKPYM 176
Query: 260 SPEMLTSPATAGP---STDMWSLGVLLYILLSGVSPFLD-ESEEETRAHISVADYSFPPE 315
+PE + +D+WSLG+ + L P+ + + + P+
Sbjct: 177 APERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVV---EEPSPQ 233
Query: 316 -QCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASCSEFD 360
S + Q L ++ +RPT +L+Q +F D
Sbjct: 234 LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGTD 279
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 70/287 (24%), Positives = 114/287 (39%), Gaps = 40/287 (13%)
Query: 79 NEYKVLYTVPFETRWQQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPR--- 135
+ + E R Q++ FE L+ +G G F V + + TGQ+ A+K + +
Sbjct: 44 QWAEPIVVRLKEVRLQRDDFEI----LKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDM 99
Query: 136 -ERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT---IVMQLVHGESLIQHLC 191
+R R E ++L I F+ + +VM+ G L+ L
Sbjct: 100 LKRGEVSCFREERDVLVNGDRRWITQLHFAFQ------DENYLYLVMEYYVGGDLLTLLS 153
Query: 192 RQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILM--NGAVLKLIDLGSS--- 245
+ I + ++ A+ +H H+DI+P+NIL+ G + +L D GS
Sbjct: 154 KFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHI-RLADFGSCLKL 212
Query: 246 -----VSVSTVV-LPDLEFASPEMLTSPATA------GPSTDMWSLGVLLYILLSGVSPF 293
V V P ++ SPE+L + GP D W+LGV Y + G +PF
Sbjct: 213 RADGTVRSLVAVGTP--DYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF 270
Query: 294 LDESEEETRAHISVADYSFP-PEQCGHISVPARELIGQLLNTHADKR 339
+S ET I P + AR+ I +LL + R
Sbjct: 271 YADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLL-CPPETR 316
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 71/294 (24%), Positives = 117/294 (39%), Gaps = 48/294 (16%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ----PQQITRAEYNLLSTLMHA 156
+YE++ ++G G + V K R+R TGQ+VA+K+ + R E +L L H
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR-EIRMLKQLKHP 62
Query: 157 HIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQST-ITESYICCIIRQLHSALHCL 215
++ + L E +V + +++ L R + E + I Q A++
Sbjct: 63 NL---VNLLEVFRRKRRLHLVFEYCD-HTVLHELDRYQRGVPEHLVKSITWQTLQAVNFC 118
Query: 216 HSQQIAHKDIRPENILMNGA-VLKLIDLG------SSVSVST--VVLPDLEFASPEMLTS 266
H H+D++PENIL+ V+KL D G V + SPE+L
Sbjct: 119 HKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVAT--RWYRSPELLVG 176
Query: 267 PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHIS-------------------V 307
GP D+W++G + LLSGV + +S+ + I
Sbjct: 177 DTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236
Query: 308 ADYSFPPEQCG--------HISVPARELIGQLLNTHADKRPTAGQLLQVAWFAE 353
+ P + +IS PA L+ L+ +R T QLL +F
Sbjct: 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFEN 290
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 4e-27
Identities = 56/255 (21%), Positives = 104/255 (40%), Gaps = 22/255 (8%)
Query: 101 RYEELERLGNGRFCTVRKARDRG-TGQLVALKQIPRERQPQQITRA--EYNLLSTLMHAH 157
+YE + +G + A DR G+ V LK + + A E L+ ++H
Sbjct: 81 QYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPS 140
Query: 158 IPTALALFENAPVPGTDT--IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCL 215
I E+ G IVM+ V G+SL + ++ + E + ++ AL L
Sbjct: 141 IVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAE--AIAYLLEILPALSYL 198
Query: 216 HSQQIAHKDIRPENILMNGAVLKLIDLG--SSVSVSTVVLPDLEFASPEMLTSPATAGPS 273
HS + + D++PENI++ LKLIDLG S ++ + F +PE++ + T +
Sbjct: 199 HSIGLVYNDLKPENIMLTEEQLKLIDLGAVSRINSFGYLYGTPGFQAPEIVRTGPT--VA 256
Query: 274 TDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLN 333
TD++++G L L + + + L+ + ++
Sbjct: 257 TDIYTVGRTLAALTLDLPTRNGRYVDGLP----------EDDPVLKTYDSYGRLLRRAID 306
Query: 334 THADKRP-TAGQLLQ 347
+R TA ++
Sbjct: 307 PDPRQRFTTAEEMSA 321
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-27
Identities = 75/295 (25%), Positives = 125/295 (42%), Gaps = 40/295 (13%)
Query: 88 PFETRWQQEQFE-HRYEELERLGNGRFCTVRKARDRGTGQLVALK-----QIPRERQPQQ 141
PF ++ +Q + +E L+ +G G F V + + ++ A+K ++ + +
Sbjct: 61 PFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETAC 120
Query: 142 ITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT---IVMQLVHGESLIQHLCRQSTI-T 197
R E ++L I T F+ D +VM G L+ L +
Sbjct: 121 -FREERDVLVNGDSKWITTLHYAFQ------DDNNLYLVMDYYVGGDLLTLLSKFEDRLP 173
Query: 198 ESYICCIIRQLHSALHCLHSQQIAHKDIRPENILM--NGAVLKLIDLGSS------VSVS 249
E + ++ A+ +H H+DI+P+NILM NG + +L D GS +V
Sbjct: 174 EEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHI-RLADFGSCLKLMEDGTVQ 232
Query: 250 TVVL---PDLEFASPEMLTSPATA----GPSTDMWSLGVLLYILLSGVSPFLDESEEETR 302
+ V P ++ SPE+L + GP D WSLGV +Y +L G +PF ES ET
Sbjct: 233 SSVAVGTP--DYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY 290
Query: 303 AHISVADYSFP-PEQCGHISVPARELIGQLLNTHADKRPTAGQLLQV---AWFAE 353
I F P Q +S A++LI +L+ + R + +F+
Sbjct: 291 GKIMNHKERFQFPTQVTDVSENAKDLIRRLI-CSREHRLGQNGIEDFKKHPFFSG 344
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 9e-27
Identities = 66/295 (22%), Positives = 120/295 (40%), Gaps = 50/295 (16%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ----PQQITRAEYNLLSTLMHA 156
+YE L +G G + V K R++ TG++VA+K+ + R E LL L H
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR-EIKLLKQLRHE 84
Query: 157 HIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQST-ITESYICCIIRQLHSALHCL 215
++ + L E +V + V +++ L + + + Q+ + +
Sbjct: 85 NL---VNLLEVCKKKKRWYLVFEFVD-HTILDDLELFPNGLDYQVVQKYLFQIINGIGFC 140
Query: 216 HSQQIAHKDIRPENILMNGA-VLKLIDLGSSVSVSTVVLPDLEFA---------SPEMLT 265
HS I H+DI+PENIL++ + V+KL D G + +++ P + +PE+L
Sbjct: 141 HSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA---APGEVYDDEVATRWYRAPELLV 197
Query: 266 SPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHI----------------SVAD 309
G + D+W++G L+ + G F +S+ + HI
Sbjct: 198 GDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257
Query: 310 Y---SFPP--------EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAE 353
+ P + +S +L + L+ DKRP +LL +F
Sbjct: 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-26
Identities = 69/294 (23%), Positives = 120/294 (40%), Gaps = 49/294 (16%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ----PQQITRAEYNLLSTLMHA 156
+YE+LE++G G + TV KA++R T ++VALK++ + P R E LL L H
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHK 61
Query: 157 HIPTALALFENAPVPGTDTIVMQLVHG--ESLIQHLCRQSTITESYICCIIRQLHSALHC 214
+I + L + T+V + + + + + QL L
Sbjct: 62 NI---VRLHDVLHSDKKLTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGF 116
Query: 215 LHSQQIAHKDIRPENILMNGA-VLKLIDLG----SSVSVST----VVLPDLEFASPEMLT 265
HS+ + H+D++P+N+L+N LKL + G + V VV L + P++L
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVT--LWYRPPDVLF 174
Query: 266 SPATAGPSTDMWSLGVLLYILLSGVSPFLD-ESEEETRAHI----------------SVA 308
S DMWS G + L + P ++ I +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234
Query: 309 DY-SFPP--------EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAE 353
DY +P ++ R+L+ LL + +R +A + LQ +F++
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-26
Identities = 73/260 (28%), Positives = 117/260 (45%), Gaps = 49/260 (18%)
Query: 108 LGNGRFCTV---RKARDRGTGQLVALKQ-----IPRERQPQQITRAEYNLLSTLMHAHIP 159
LG G + V RK TG++ A+K I R + T+AE N+L + H I
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 160 TALALFENAPVPGTDT---IVMQLVHGESLIQHLCRQSTITES----YICCIIRQLHSAL 212
+ F+ T ++++ + G L L R+ E Y+ I AL
Sbjct: 85 DLIYAFQ------TGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEIS----MAL 134
Query: 213 HCLHSQQIAHKDIRPENILM--NGAVLKLIDLG-SSVSVS----------TVVLPDLEFA 259
LH + I ++D++PENI++ G V KL D G S+ T+ E+
Sbjct: 135 GHLHQKGIIYRDLKPENIMLNHQGHV-KLTDFGLCKESIHDGTVTHTFCGTI-----EYM 188
Query: 260 SPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGH 319
+PE+L + D WSLG L+Y +L+G PF E+ ++T I + PP +
Sbjct: 189 APEILMRSGH-NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPP----Y 243
Query: 320 ISVPARELIGQLLNTHADKR 339
++ AR+L+ +LL +A R
Sbjct: 244 LTQEARDLLKKLLKRNAASR 263
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-26
Identities = 64/297 (21%), Positives = 123/297 (41%), Gaps = 51/297 (17%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ----PQQITRAEYNLLSTLMHA 156
RY + +LG G + V KA D T + VA+K+I E + P R E +LL L H
Sbjct: 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR-EVSLLKELQHR 93
Query: 157 HIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLH 216
+I + L ++ + + L +++ + ++ I + QL + ++ H
Sbjct: 94 NI---IELKSVIHHNHRLHLIFEYAEND-LKKYMDKNPDVSMRVIKSFLYQLINGVNFCH 149
Query: 217 SQQIAHKDIRPENILMNGA------VLKLIDLG----SSVSVST----VVLPDLEFASPE 262
S++ H+D++P+N+L++ + VLK+ D G + + ++ L + PE
Sbjct: 150 SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIIT--LWYRPPE 207
Query: 263 MLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHI----------------S 306
+L S D+WS+ + +L F +SE + I +
Sbjct: 208 ILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTA 267
Query: 307 VADY--SFPPEQ--------CGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAE 353
+ D+ SFP + + +L+ +L KR +A L+ +F+
Sbjct: 268 LPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSH 324
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 74/297 (24%), Positives = 120/297 (40%), Gaps = 48/297 (16%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ-------PQQITRAEYNLLSTL 153
RYE + +G G + TV KARD +G VALK + P R E LL L
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVR-EVALLRRL 68
Query: 154 MHAHIPTALALFENAPVPGTD-----TIVMQLVHG--ESLIQHLCRQSTITESYICCIIR 206
P + L + TD T+V + V + + + I ++R
Sbjct: 69 EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDK-APPPGLPAETIKDLMR 127
Query: 207 QLHSALHCLHSQQIAHKDIRPENILMNGA-VLKLIDLG------SSVSVSTVVLPDLEFA 259
Q L LH+ I H+D++PENIL+ +KL D G ++++ VV+ L +
Sbjct: 128 QFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVT-LWYR 186
Query: 260 SPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHI-------------- 305
+PE+L +T DMWS+G + + F SE + I
Sbjct: 187 APEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 245
Query: 306 --SVADYSFPP-------EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAE 353
S+ +FPP + +L+ ++L + KR +A + LQ ++ +
Sbjct: 246 DVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 302
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-26
Identities = 61/289 (21%), Positives = 112/289 (38%), Gaps = 34/289 (11%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITR--AEYN-LLSTLMHAHI 158
++L +G G + +V K + +GQ++A+K+I ++ + + + ++ + +I
Sbjct: 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYI 83
Query: 159 PTAL-ALFENAPVPGTDTIVMQLVHGESL----IQHLCRQSTITESYICCIIRQLHSALH 213
ALF I M+L+ + I E + I AL+
Sbjct: 84 VQFYGALFREGDC----WICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALN 139
Query: 214 CLHSQ-QIAHKDIRPENILMN--GAVLKLIDLGSSVS---VSTVVLPDLEFA------SP 261
L +I H+DI+P NIL++ G + KL D G +S V ++ A +P
Sbjct: 140 HLKENLKIIHRDIKPSNILLDRSGNI-KLCDFG--ISGQLVDSIA--KTRDAGCRPYMAP 194
Query: 262 EMLTSPATAGP---STDMWSLGVLLYILLSGVSPFLD-ESEEETRAHISVADY-SFPPEQ 316
E + A+ +D+WSLG+ LY L +G P+ S + + D +
Sbjct: 195 ERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSE 254
Query: 317 CGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASCSEFDTERLL 365
S + L KRP +LL+ + + +
Sbjct: 255 EREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVACYV 303
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-26
Identities = 68/258 (26%), Positives = 109/258 (42%), Gaps = 47/258 (18%)
Query: 108 LGNGRFCTV---RKARDRGTGQLVALKQIPRER--QPQQI-TRAEYNLLSTLMHAHIPTA 161
LG G F V +K QL A+K + + ++ T+ E ++L + H I
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 162 LALFENAPVPGTDT---IVMQLVHGESLIQHLCRQSTITES----YICCIIRQLHSALHC 214
F+ T+ +++ + G L L ++ TE Y+ + AL
Sbjct: 92 HYAFQ------TEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELA----LALDH 141
Query: 215 LHSQQIAHKDIRPENILM--NGAVLKLIDLG-SSVSVS----------TVVLPDLEFASP 261
LHS I ++D++PENIL+ G + KL D G S S+ TV E+ +P
Sbjct: 142 LHSLGIIYRDLKPENILLDEEGHI-KLTDFGLSKESIDHEKKAYSFCGTV-----EYMAP 195
Query: 262 EMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHIS 321
E++ S D WS GVL++ +L+G PF + +ET I A P +S
Sbjct: 196 EVVNRRGH-TQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ----FLS 250
Query: 322 VPARELIGQLLNTHADKR 339
A+ L+ L + R
Sbjct: 251 PEAQSLLRMLFKRNPANR 268
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-26
Identities = 68/253 (26%), Positives = 112/253 (44%), Gaps = 39/253 (15%)
Query: 108 LGNGRFCTVRKARDRGTGQLVALKQIPRER--QPQQI--TRAEYNLLSTLMHAHIPTALA 163
LG G F V R++ TG+ A+K + +E ++ T E +L H +
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 164 LFENAPVPGTDT---IVMQLVHGESLIQHLCRQSTITES----YICCIIRQLHSALHCLH 216
F+ T VM+ +G L HL R+ TE Y I+ SAL LH
Sbjct: 73 AFQ------THDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV----SALEYLH 122
Query: 217 SQQIAHKDIRPENILM--NGAVLKLIDLG-------SSVSVSTVV-LPDLEFASPEMLTS 266
S+ + ++DI+ EN+++ +G + K+ D G ++ T P E+ +PE+L
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHI-KITDFGLCKEGISDGATMKTFCGTP--EYLAPEVLED 179
Query: 267 PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARE 326
G + D W LGV++Y ++ G PF ++ E I + + FP +S A+
Sbjct: 180 NDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKS 234
Query: 327 LIGQLLNTHADKR 339
L+ LL +R
Sbjct: 235 LLAGLLKKDPKQR 247
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 62/264 (23%), Positives = 103/264 (39%), Gaps = 56/264 (21%)
Query: 108 LGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLSTLMHAHIP---- 159
+G G F V R TG++ A+K + ++ +Q + + E +LS + P
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 160 ------TALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITES----YICCIIRQLH 209
T L ++ L++G L HL + +E+ Y II
Sbjct: 257 MSYAFHTPDKLS----------FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEII---- 302
Query: 210 SALHCLHSQQIAHKDIRPENILM--NGAVLKLIDLGSSVSVS---------TVVLPDLEF 258
L +H++ + ++D++P NIL+ +G V ++ DLG + S T +
Sbjct: 303 LGLEHMHNRFVVYRDLKPANILLDEHGHV-RISDLGLACDFSKKKPHASVGTH-----GY 356
Query: 259 ASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESE---EETRAHISVADYSFPPE 315
+PE+L S D +SLG +L+ LL G SPF E P
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD- 415
Query: 316 QCGHISVPARELIGQLLNTHADKR 339
S R L+ LL ++R
Sbjct: 416 ---SFSPELRSLLEGLLQRDVNRR 436
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 8e-26
Identities = 74/317 (23%), Positives = 126/317 (39%), Gaps = 51/317 (16%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLMHAH 157
Y +L++LG G + TV K + + T LVALK+I E + P R E +LL L HA+
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHAN 61
Query: 158 IPTALALFENAPVPGTDTIVMQLVHG--ESLIQHLCRQSTITESYICCIIRQLHSALHCL 215
I + L + + T+V + + + + + I + + QL L
Sbjct: 62 I---VTLHDIIHTEKSLTLVFEYLDKDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYC 116
Query: 216 HSQQIAHKDIRPENILMNGA-VLKLIDLG----SSVSVST----VVLPDLEFASPEMLTS 266
H Q++ H+D++P+N+L+N LKL D G S+ T VV L + P++L
Sbjct: 117 HRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVT--LWYRPPDILLG 174
Query: 267 PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHI----------------SVADY 310
DMW +G + Y + +G F + EE I S ++
Sbjct: 175 STDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 234
Query: 311 ---SFPP-------EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASCSEF- 359
++P + +L+ +LL R +A ++ +F
Sbjct: 235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHK 294
Query: 360 --DTERLLPFSARRKQK 374
DT + + QK
Sbjct: 295 LPDTTSIFALKEIQLQK 311
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 8e-26
Identities = 65/284 (22%), Positives = 118/284 (41%), Gaps = 40/284 (14%)
Query: 79 NEYKVLYTVPFETRWQQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALK-----QI 133
+ YK + R + E +E ++ +G G F V+ R + T ++ A+K ++
Sbjct: 52 SRYKDTINKIRDLRMKAEDYEV----VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM 107
Query: 134 PRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT---IVMQLVHGESLIQHL 190
+ E ++++ + F+ D +VM+ + G L+ +
Sbjct: 108 IKRSDSAF-FWEERDIMAFANSPWVVQLFYAFQ------DDRYLYMVMEYMPGGDLVNLM 160
Query: 191 CRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN----------GAVLKLI 240
+ E + ++ AL +HS H+D++P+N+L++ G +K+
Sbjct: 161 SNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 219
Query: 241 DLGSSVSVSTVVLPDLEFASPEMLTSPATA---GPSTDMWSLGVLLYILLSGVSPFLDES 297
G + V P ++ SPE+L S G D WS+GV LY +L G +PF +S
Sbjct: 220 KEGMVRCDTAVGTP--DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 277
Query: 298 EEETRAHI--SVADYSFPPEQCGHISVPARELIGQLLNTHADKR 339
T + I +FP + IS A+ LI L T + R
Sbjct: 278 LVGTYSKIMNHKNSLTFPDDN--DISKEAKNLICAFL-TDREVR 318
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 9e-26
Identities = 68/312 (21%), Positives = 115/312 (36%), Gaps = 62/312 (19%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP---QQITRAEYNLLSTLMHAHI 158
+E++ LG G V K + +G ++A K I E +P QI R E +L +I
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR-ELQVLHECNSPYI 93
Query: 159 PTAL-ALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHS 217
A + + + +I M+ + G SL Q L + I E + + + L L
Sbjct: 94 VGFYGAFYSDGEI----SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 149
Query: 218 Q-QIAHKDIRPENILMN--GAVLKLIDLG------SSVSVSTVVLPDLEFASPEMLTSPA 268
+ +I H+D++P NIL+N G + KL D G S++ S V + SPE L
Sbjct: 150 KHKIMHRDVKPSNILVNSRGEI-KLCDFGVSGQLIDSMANSFVGTR--SYMSPERL-QGT 205
Query: 269 TAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPP-------------- 314
+D+WS+G+ L + G P +E
Sbjct: 206 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN 265
Query: 315 -------------EQCGHI-------------SVPARELIGQLLNTHADKRPTAGQLLQV 348
E +I S+ ++ + + L + +R QL+
Sbjct: 266 KFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325
Query: 349 AWFAEASCSEFD 360
A+ + E D
Sbjct: 326 AFIKRSDAEEVD 337
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 9e-26
Identities = 63/254 (24%), Positives = 110/254 (43%), Gaps = 40/254 (15%)
Query: 108 LGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLSTLMHAHIPTALA 163
LG G F V +++ TG+ A+K + +E + T E +L H +
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 215
Query: 164 LFENAPVPGTDT---IVMQLVHGESLIQHLCRQSTITES----YICCIIRQLHSALHCLH 216
F+ T VM+ +G L HL R+ +E Y I+ SAL LH
Sbjct: 216 SFQ------THDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIV----SALDYLH 265
Query: 217 SQQ-IAHKDIRPENILM--NGAVLKLIDLGSS-----VSVSTVVL---PDLEFASPEMLT 265
S++ + ++D++ EN+++ +G + K+ D G + P E+ +PE+L
Sbjct: 266 SEKNVVYRDLKLENLMLDKDGHI-KITDFGLCKEGIKDGATMKTFCGTP--EYLAPEVLE 322
Query: 266 SPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAR 325
G + D W LGV++Y ++ G PF ++ E+ I + + FP + A+
Sbjct: 323 DNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLGPEAK 377
Query: 326 ELIGQLLNTHADKR 339
L+ LL +R
Sbjct: 378 SLLSGLLKKDPKQR 391
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-25
Identities = 55/219 (25%), Positives = 94/219 (42%), Gaps = 18/219 (8%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE--RQPQQITR--AEYNLLSTLMHA 156
Y +G G V +A D ++VALK + P TR E L
Sbjct: 35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEP 94
Query: 157 HIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLH 216
H+ + + + + G + M+L++G L L RQ + I+RQ+ SAL H
Sbjct: 95 HV---VPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAH 151
Query: 217 SQQIAHKDIRPENILM--NGAVLKLIDLG-------SSVSVSTVVLPDLEFASPEMLTSP 267
+ H+D++PENIL+ + L+D G ++ + L + +PE +
Sbjct: 152 AAGATHRDVKPENILVSADDFA-YLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSE- 209
Query: 268 ATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHIS 306
+ A D+++L +LY L+G P+ + AHI+
Sbjct: 210 SHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHIN 248
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-25
Identities = 63/293 (21%), Positives = 125/293 (42%), Gaps = 49/293 (16%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ----PQQITRAEYNLLSTLMHA 156
+Y LE++G G + V KA++ G+ ALK+I E++ P R E ++L L H+
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIR-EISILKELKHS 60
Query: 157 HIPTALALFENAPVPGTDTIVMQLVHG--ESLIQHLCRQSTITESYICCIIRQLHSALHC 214
+I + L++ +V + + + L+ + + + QL + +
Sbjct: 61 NI---VKLYDVIHTKKRLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAY 115
Query: 215 LHSQQIAHKDIRPENILMNGA-VLKLIDLG----SSVSVST----VVLPDLEFASPEMLT 265
H +++ H+D++P+N+L+N LK+ D G + V +V L + +P++L
Sbjct: 116 CHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV--TLWYRAPDVLM 173
Query: 266 SPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHI----------------SVAD 309
+ D+WS+G + +++G F SE + I +
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 310 Y--SFPP-------EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAE 353
Y +F + +L+ ++L ++R TA Q L+ A+F E
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 68/309 (22%), Positives = 131/309 (42%), Gaps = 51/309 (16%)
Query: 86 TVPFETRWQQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ----PQQ 141
+ E + Q E +Y++LE++G G + V KA+D G++VALK+I + + P
Sbjct: 8 SSGRENLYFQGLME-KYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPST 65
Query: 142 ITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHG--ESLIQHLCRQSTITES 199
R E +LL L H +I ++L + T+V + + + ++ ++ + +S
Sbjct: 66 AIR-EISLLKELHHPNI---VSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGLQDS 119
Query: 200 YICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGA-VLKLIDLG------SSVSVST-- 250
I + QL + H +I H+D++P+N+L+N LKL D G V T
Sbjct: 120 QIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHE 179
Query: 251 VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHI----- 305
VV L + +P++L S D+WS+G + +++G F ++++ I
Sbjct: 180 VV--TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILG 237
Query: 306 -----------SVADY---SFPP-------EQCGHISVPARELIGQLLNTHADKRPTAGQ 344
+ + +F +L+ +L +KR +A
Sbjct: 238 TPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARD 297
Query: 345 LLQVAWFAE 353
+ +F +
Sbjct: 298 AMNHPYFKD 306
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-25
Identities = 49/200 (24%), Positives = 78/200 (39%), Gaps = 32/200 (16%)
Query: 176 IVMQLVHGESL---IQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILM 232
I MQL E+L + C I Q+ A+ LHS+ + H+D++P NI
Sbjct: 138 IQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFF 197
Query: 233 NGA-VLKLIDLG------SSVSVSTVVLPDLEFA------------SPEMLTSPATAGPS 273
V+K+ D G TV+ P +A SPE +
Sbjct: 198 TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHG-NNYSHK 256
Query: 274 TDMWSLGVLLYILLSGVSPFLDESEEETRAHI--SVADYSFPPEQCGHISVPARELIGQL 331
D++SLG++L+ LL F + E R I V + FP ++ +
Sbjct: 257 VDIFSLGLILFELL---YSFSTQME---RVRIITDVRNLKFPLL-FTQKYPQEHMMVQDM 309
Query: 332 LNTHADKRPTAGQLLQVAWF 351
L+ +RP A +++ A F
Sbjct: 310 LSPSPTERPEATDIIENAIF 329
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 2e-09
Identities = 18/139 (12%), Positives = 41/139 (29%), Gaps = 6/139 (4%)
Query: 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRA--EYNLLSTLMH 155
+ +E ++ +G G F V +A+++ A+K+I + + E L+ L H
Sbjct: 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEH 63
Query: 156 AHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCL 215
I + P + + S+ + + +
Sbjct: 64 PGIVRYFNAWLETPPEKWQEEMDE--IWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTK 121
Query: 216 HSQQIAHKDIRPEN--ILM 232
++ I M
Sbjct: 122 NTVGQLQPSSPKVYLYIQM 140
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 4e-25
Identities = 66/254 (25%), Positives = 113/254 (44%), Gaps = 36/254 (14%)
Query: 108 LGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLSTLMHAHIPTALA 163
LG G F V + R TG++ A K++ ++ R+ + + E +L + + +
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251
Query: 164 LFENAPVPGTDTIVMQLVHGESLIQHL--CRQSTITES----YICCIIRQLHSALHCLHS 217
+E +V+ L++G L H+ Q+ E+ Y I L LH
Sbjct: 252 AYET---KDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEIC----CGLEDLHR 304
Query: 218 QQIAHKDIRPENILM--NGAVLKLIDLGSSVSVS----------TVVLPDLEFASPEMLT 265
++I ++D++PENIL+ +G + ++ DLG +V V TV + +PE++
Sbjct: 305 ERIVYRDLKPENILLDDHGHI-RISDLGLAVHVPEGQTIKGRVGTV-----GYMAPEVVK 358
Query: 266 SPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAR 325
+ S D W+LG LLY +++G SPF ++ R + P E S AR
Sbjct: 359 NERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQAR 417
Query: 326 ELIGQLLNTHADKR 339
L QLL +R
Sbjct: 418 SLCSQLLCKDPAER 431
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-25
Identities = 68/258 (26%), Positives = 112/258 (43%), Gaps = 48/258 (18%)
Query: 108 LGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLSTL--------MH 155
LG G F V AR + TG L A+K + ++ + T E +LS +
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90
Query: 156 AHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITES----YICCIIRQLHSA 211
T LF VM+ V+G L+ H+ + E+ Y II SA
Sbjct: 91 CCFQTPDRLF----------FVMEFVNGGDLMFHIQKSRRFDEARARFYAAEII----SA 136
Query: 212 LHCLHSQQIAHKDIRPENILM--NGAVLKLIDLG-------SSVSVSTVV-LPDLEFASP 261
L LH + I ++D++ +N+L+ G KL D G + V+ +T P ++ +P
Sbjct: 137 LMFLHDKGIIYRDLKLDNVLLDHEGHC-KLADFGMCKEGICNGVTTATFCGTP--DYIAP 193
Query: 262 EMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHIS 321
E+L GP+ D W++GVLLY +L G +PF E+E++ I + +P +
Sbjct: 194 EILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT----WLH 248
Query: 322 VPARELIGQLLNTHADKR 339
A ++ + + R
Sbjct: 249 EDATGILKSFMTKNPTMR 266
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 7e-25
Identities = 81/295 (27%), Positives = 124/295 (42%), Gaps = 50/295 (16%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQ-----IT--RAEYNLLSTL 153
RYE+L+ LG G+F TV KARD+ T Q+VA+K+I + + T R E LL L
Sbjct: 11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR-EIKLLQEL 69
Query: 154 MHAHIPTALALFENAPVPGTDTIVMQLVHG--ESLIQHLCRQSTITESYICCIIRQLHSA 211
H +I + L + ++V + E +I+ +T S+I +
Sbjct: 70 SHPNI---IGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMTLQG 124
Query: 212 LHCLHSQQIAHKDIRPENILMNGA-VLKLIDLG------SSVSVST--VVLPDLEFASPE 262
L LH I H+D++P N+L++ VLKL D G S T VV + +PE
Sbjct: 125 LEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVT--RWYRAPE 182
Query: 263 MLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHI----------------S 306
+L G DMW++G +L LL V +S+ + I S
Sbjct: 183 LLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 242
Query: 307 VADY-SFPP-------EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAE 353
+ DY +F +LI L + R TA Q L++ +F+
Sbjct: 243 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 8e-25
Identities = 73/300 (24%), Positives = 126/300 (42%), Gaps = 53/300 (17%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLMHAH 157
++++LE+LGNG + TV K ++ TG VALK++ + + P R E +L+ L H +
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR-EISLMKELKHEN 64
Query: 158 IPTALALFENAPVPGTDTIVMQLVHG--ESLIQHL---CRQSTITESYICCIIRQLHSAL 212
I + L++ T+V + + + + + + + QL L
Sbjct: 65 I---VRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121
Query: 213 HCLHSQQIAHKDIRPENILMNGA-VLKLIDLG----SSVSVST----VVLPDLEFASPEM 263
H +I H+D++P+N+L+N LKL D G + V+T VV L + +P++
Sbjct: 122 AFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVT--LWYRAPDV 179
Query: 264 LTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHI----------------SV 307
L T S D+WS G +L +++G F ++EE I +
Sbjct: 180 LMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL 239
Query: 308 ADYS--------------FPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAE 353
Y+ P + + + LL + D R +A Q L WFAE
Sbjct: 240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAE 299
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-25
Identities = 60/262 (22%), Positives = 113/262 (43%), Gaps = 20/262 (7%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE--RQPQQITR--AEYNLLSTLMHA 156
RY+ +++LG G TV A D VA+K I + + + R E + S L H
Sbjct: 12 RYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQ 71
Query: 157 HIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLH 216
+I +++ + +VM+ + G +L +++ ++ Q+ + H
Sbjct: 72 NI---VSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAH 128
Query: 217 SQQIAHKDIRPENILM--NGAVLKLIDLG-------SSVSVSTVVLPDLEFASPEMLTSP 267
+I H+DI+P+NIL+ N + K+ D G +S++ + VL +++ SPE
Sbjct: 129 DMRIVHRDIKPQNILIDSNKTL-KIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG- 186
Query: 268 ATAGPSTDMWSLGVLLYILLSGVSPFLDESEEET-RAHISVADYSFPPEQCGHISVPARE 326
TD++S+G++LY +L G PF E+ HI + + + I
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSN 246
Query: 327 LIGQLLNTHADKRP-TAGQLLQ 347
+I + R T ++
Sbjct: 247 VILRATEKDKANRYKTIQEMKD 268
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-24
Identities = 40/250 (16%), Positives = 68/250 (27%), Gaps = 35/250 (14%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIP----RERQPQQITRAEYNLLSTLMHA 156
RY L G +A D + VAL + Q T + LS +
Sbjct: 32 RYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKP 91
Query: 157 HIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLH 216
+ L + +V + + G SL + + + ++ L +A H
Sbjct: 92 GVARVLDVVHTRAGG---LVVAEWIRGGSLQEVADTSPSPVGAIR--AMQSLAAAADAAH 146
Query: 217 SQQIAHKDIRPENILMNGAVLKLIDLGSSVSVSTVVLPDLEFASPEMLTSPATAGPSTDM 276
+A P + ++ VVL A P D+
Sbjct: 147 RAGVALSIDHPSRVRVSID-------------GDVVLAYPATMPD--------ANPQDDI 185
Query: 277 WSLGVLLYILLSGVSPFLDESEEET--RAHISVADYSFPPEQCGHISVPA--RELIGQLL 332
+G LY LL P + A A P +P + + +
Sbjct: 186 RGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDR-DIPFQISAVAARSV 244
Query: 333 NTHADKRPTA 342
R +
Sbjct: 245 QGDGGIRSAS 254
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-24
Identities = 69/258 (26%), Positives = 107/258 (41%), Gaps = 48/258 (18%)
Query: 108 LGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLSTL--------MH 155
LG G F V A + T Q A+K + ++ + T E +LS M
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 156 AHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITES----YICCIIRQLHSA 211
T LF VM+ ++G L+ H+ S Y II
Sbjct: 85 CTFQTKENLF----------FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEII----LG 130
Query: 212 LHCLHSQQIAHKDIRPENILM--NGAVLKLIDLG-------SSVSVSTVV-LPDLEFASP 261
L LHS+ I ++D++ +NIL+ +G + K+ D G +T P ++ +P
Sbjct: 131 LQFLHSKGIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNTFCGTP--DYIAP 187
Query: 262 EMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHIS 321
E+L S D WS GVLLY +L G SPF + EEE I + + +P +
Sbjct: 188 EILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR----WLE 242
Query: 322 VPARELIGQLLNTHADKR 339
A++L+ +L +KR
Sbjct: 243 KEAKDLLVKLFVREPEKR 260
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-24
Identities = 72/273 (26%), Positives = 118/273 (43%), Gaps = 37/273 (13%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE--RQPQQITR--AEYNLLSTLMHA 156
RYE E LG G V ARD + VA+K + + R P R E + L H
Sbjct: 13 RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 72
Query: 157 HIPTALALF----ENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSAL 212
I +A++ P IVM+ V G +L + + +T +I AL
Sbjct: 73 AI---VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 129
Query: 213 HCLHSQQIAHKDIRPENILM--NGAVLKLIDLG---------SSVSVSTVVLPDLEFASP 261
+ H I H+D++P NI++ AV K++D G +SV+ + V+ ++ SP
Sbjct: 130 NFSHQNGIIHRDVKPANIMISATNAV-KVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188
Query: 262 EMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVA------DYSFPPE 315
E + +D++SLG +LY +L+G PF +S +SVA D P
Sbjct: 189 E-QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPIPPSA 241
Query: 316 QCGHISVPARELIGQLLNTHADKRP-TAGQLLQ 347
+ +S ++ + L + + R TA ++
Sbjct: 242 RHEGLSADLDAVVLKALAKNPENRYQTAAEMRA 274
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-24
Identities = 70/318 (22%), Positives = 130/318 (40%), Gaps = 61/318 (19%)
Query: 101 RYEELERLGNGRFCTVRKARD-RGTGQLVALKQIPRERQ----PQQITRAEYNLLSTLMH 155
+YE + +G G + V KARD + G+ VALK++ + P R E +L L
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLET 70
Query: 156 AHIPTALALFENAPVPGTD-----TIVMQLVHG--ESLIQHLCRQSTITESYICCIIRQL 208
P + LF+ V TD T+V + V + + + + I ++ QL
Sbjct: 71 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQL 129
Query: 209 HSALHCLHSQQIAHKDIRPENILMNGA-VLKLIDLG------SSVSVSTVVLPDLEFASP 261
L LHS ++ H+D++P+NIL+ + +KL D G +++++VV+ L + +P
Sbjct: 130 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVT-LWYRAP 188
Query: 262 EMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHI---------------- 305
E+L ++ D+WS+G + + F S+ + I
Sbjct: 189 EVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 247
Query: 306 SVADYSFPP-------EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEA---- 354
++ +F + I ++L+ + L + KR +A L +F +
Sbjct: 248 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK 307
Query: 355 -----------SCSEFDT 361
+ SE +T
Sbjct: 308 ENLDSHLPPSQNTSELNT 325
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-24
Identities = 64/258 (24%), Positives = 110/258 (42%), Gaps = 48/258 (18%)
Query: 108 LGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLSTL--------MH 155
LG G F V + +GT +L A+K + ++ + T E +L+ +H
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 156 AHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITES----YICCIIRQLHSA 211
+ T L+ VM+ V+G L+ H+ + E Y I
Sbjct: 88 SCFQTMDRLY----------FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIA----IG 133
Query: 212 LHCLHSQQIAHKDIRPENILM--NGAVLKLIDLG-------SSVSVSTVV-LPDLEFASP 261
L L S+ I ++D++ +N+++ G + K+ D G V+ T P ++ +P
Sbjct: 134 LFFLQSKGIIYRDLKLDNVMLDSEGHI-KIADFGMCKENIWDGVTTKTFCGTP--DYIAP 190
Query: 262 EMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHIS 321
E++ G S D W+ GVLLY +L+G +PF E E+E I + ++P +S
Sbjct: 191 EIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMS 245
Query: 322 VPARELIGQLLNTHADKR 339
A + L+ H KR
Sbjct: 246 KEAVAICKGLMTKHPGKR 263
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-23
Identities = 74/274 (27%), Positives = 118/274 (43%), Gaps = 69/274 (25%)
Query: 108 LGNGRFCTV---RKARDRGTGQLVALKQ------IPRERQPQQITRAEYNLLSTLMHAHI 158
LG G + V RK TG+L A+K + + + + TR E +L +
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEH-TRTERQVLEHI--RQS 118
Query: 159 P----------TALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITES----YICCI 204
P T L +++ ++G L HL ++ TE Y+ I
Sbjct: 119 PFLVTLHYAFQTETKLH----------LILDYINGGELFTHLSQRERFTEHEVQIYVGEI 168
Query: 205 IRQLHSALHCLHSQQIAHKDIRPENILM--NGAVLKLIDLG-SSVSVS-----------T 250
+ AL LH I ++DI+ ENIL+ NG V L D G S V+ T
Sbjct: 169 V----LALEHLHKLGIIYRDIKLENILLDSNGHV-VLTDFGLSKEFVADETERAYDFCGT 223
Query: 251 VVLPDLEFASPEMLTSPATA-GPSTDMWSLGVLLYILLSGVSPFLDESEEETRAH----I 305
+ E+ +P+++ + + D WSLGVL+Y LL+G SPF + E+ ++A I
Sbjct: 224 I-----EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI 278
Query: 306 SVADYSFPPEQCGHISVPARELIGQLLNTHADKR 339
++ +P +S A++LI +LL KR
Sbjct: 279 LKSEPPYPQ----EMSALAKDLIQRLLMKDPKKR 308
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 2e-23
Identities = 76/318 (23%), Positives = 128/318 (40%), Gaps = 51/318 (16%)
Query: 79 NEYKVLYTVPFETRWQQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ 138
+ KV V + E Y + + +GNG F V +A+ +G+LVA+K++ Q
Sbjct: 33 DGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---LQ 89
Query: 139 PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT---IVMQLVHGESL---IQHLCR 192
++ E ++ L H +I F ++ + +V+ V E++ +H R
Sbjct: 90 DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSR 148
Query: 193 QS-TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG--AVLKLIDLGSSVSVS 249
T+ Y+ + QL +L +HS I H+DI+P+N+L++ AVLKL D GS+ +
Sbjct: 149 AKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208
Query: 250 TVVLPDLEFAS---------PEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEE 300
S PE++ S D+WS G +L LL G F +S +
Sbjct: 209 ----RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD 264
Query: 301 ------------TRAHI-----SVADYSFPPEQ--------CGHISVPARELIGQLLNTH 335
TR I + ++ FP + A L +LL
Sbjct: 265 QLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYT 324
Query: 336 ADKRPTAGQLLQVAWFAE 353
R T + ++F E
Sbjct: 325 PTARLTPLEACAHSFFDE 342
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 2e-23
Identities = 56/227 (24%), Positives = 88/227 (38%), Gaps = 41/227 (18%)
Query: 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHI 158
+ RY + +LG G F TV A+D VA+K + ++ + E LL + A
Sbjct: 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADN 77
Query: 159 PTALALFENAPVPGTDTIVMQL---VHGESLIQHLC-----------------RQSTITE 198
G + I+ L H H+ I
Sbjct: 78 -------TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPL 130
Query: 199 SYICCIIRQLHSALHCLHSQ-QIAHKDIRPENILMNG-------AVLKLIDLGSSVSVST 250
Y+ I +QL L +H + I H DI+PEN+LM +K+ DLG++
Sbjct: 131 IYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE 190
Query: 251 VVLPDL---EFASPE-MLTSPATAGPSTDMWSLGVLLYILLSGVSPF 293
+ E+ SPE +L +P G D+WS L++ L++G F
Sbjct: 191 HYTNSIQTREYRSPEVLLGAP--WGCGADIWSTACLIFELITGDFLF 235
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 3e-23
Identities = 68/261 (26%), Positives = 107/261 (40%), Gaps = 54/261 (20%)
Query: 108 LGNGRFCTVRKARDRGTGQLVALKQIPR----ERQPQQITRAEYNLLS--------TLMH 155
+G G F V AR + A+K + + +++ ++ +E N+L +H
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105
Query: 156 AHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITES----YICCIIRQLHSA 211
TA L+ V+ ++G L HL R+ E Y I SA
Sbjct: 106 FSFQTADKLY----------FVLDYINGGELFYHLQRERCFLEPRARFYAAEIA----SA 151
Query: 212 LHCLHSQQIAHKDIRPENILM--NGAVLKLIDLG--------SSVSVS---TVVLPDLEF 258
L LHS I ++D++PENIL+ G + L D G +S + + T E+
Sbjct: 152 LGYLHSLNIVYRDLKPENILLDSQGHI-VLTDFGLCKENIEHNSTTSTFCGTP-----EY 205
Query: 259 ASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCG 318
+PE+L + D W LG +LY +L G+ PF + E +I P
Sbjct: 206 LAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKP---- 260
Query: 319 HISVPARELIGQLLNTHADKR 339
+I+ AR L+ LL KR
Sbjct: 261 NITNSARHLLEGLLQKDRTKR 281
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 62/264 (23%), Positives = 109/264 (41%), Gaps = 53/264 (20%)
Query: 108 LGNGRFCTVRKARDRGTGQLVALKQIPRER--QPQQI--TRAEYNLLSTLMHAHIPTALA 163
LG G F V + + TG+L A K++ ++R + + E +L+ + I +
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 164 LFENAPVPGTDT---IVMQLVHGESLIQHLC----RQSTITES----YICCIIRQLHSAL 212
FE T T +VM +++G + H+ E Y I+ S L
Sbjct: 253 AFE------TKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIV----SGL 302
Query: 213 HCLHSQQIAHKDIRPENILM--NGAVLKLIDLGSSVSVS-----------TVVLPDLEFA 259
LH + I ++D++PEN+L+ +G V ++ DLG +V + T F
Sbjct: 303 EHLHQRNIIYRDLKPENVLLDDDGNV-RISDLGLAVELKAGQTKTKGYAGTP-----GFM 356
Query: 260 SPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAH----ISVADYSFPPE 315
+PE+L S D ++LGV LY +++ PF E+ + ++P
Sbjct: 357 APELLLGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD- 414
Query: 316 QCGHISVPARELIGQLLNTHADKR 339
S +++ LL +KR
Sbjct: 415 ---KFSPASKDFCEALLQKDPEKR 435
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 100 bits (249), Expect = 4e-23
Identities = 63/250 (25%), Positives = 106/250 (42%), Gaps = 32/250 (12%)
Query: 108 LGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLSTLMHAHIPTALA 163
LG G F V + +GT +L A+K + ++ + T E +L+ P
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK-P-PFLTQ 406
Query: 164 LFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITES----YICCIIRQLHSALHCLHSQQ 219
L VM+ V+G L+ H+ + E Y I L L S+
Sbjct: 407 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIA----IGLFFLQSKG 462
Query: 220 IAHKDIRPENILM--NGAVLKLIDLG-------SSVSVSTVV-LPDLEFASPEMLTSPAT 269
I ++D++ +N+++ G + K+ D G V+ T P ++ +PE++
Sbjct: 463 IIYRDLKLDNVMLDSEGHI-KIADFGMCKENIWDGVTTKTFCGTP--DYIAPEIIAY-QP 518
Query: 270 AGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIG 329
G S D W+ GVLLY +L+G +PF E E+E I + ++P +S A +
Sbjct: 519 YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAICK 574
Query: 330 QLLNTHADKR 339
L+ H KR
Sbjct: 575 GLMTKHPGKR 584
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 6e-23
Identities = 63/267 (23%), Positives = 109/267 (40%), Gaps = 57/267 (21%)
Query: 108 LGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLSTL--------MH 155
+G G + V R + T ++ A+K + +E + + E ++ +H
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 156 AHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITES----YICCIIRQLHSA 211
+ T LF V++ V+G L+ H+ RQ + E Y I A
Sbjct: 77 SCFQTESRLF----------FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEIS----LA 122
Query: 212 LHCLHSQQIAHKDIRPENILM--NGAVLKLIDLG-------SSVSVSTVV-LPDLEFASP 261
L+ LH + I ++D++ +N+L+ G + KL D G + ST P + +P
Sbjct: 123 LNYLHERGIIYRDLKLDNVLLDSEGHI-KLTDYGMCKEGLRPGDTTSTFCGTP--NYIAP 179
Query: 262 EMLTSPATAGPSTDMWSLGVLLYILLSGVSPFL---------DESEEETRAHISVADYSF 312
E+L G S D W+LGVL++ +++G SPF +E+ I
Sbjct: 180 EILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI 238
Query: 313 PPEQCGHISVPARELIGQLLNTHADKR 339
P +SV A ++ LN +R
Sbjct: 239 PR----SLSVKAASVLKSFLNKDPKER 261
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 4e-22
Identities = 56/220 (25%), Positives = 100/220 (45%), Gaps = 30/220 (13%)
Query: 93 WQQE----QFE--HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAE 146
W E ++ Y+ + +LG G++ V +A + + V +K + + + ++I R E
Sbjct: 23 WDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL-KPVKKKKIKR-E 80
Query: 147 YNLLSTLM-HAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCII 205
+L L +I T + ++ PV T +V + V+ Q T+T+ I +
Sbjct: 81 IKILENLRGGPNIITLADIVKD-PVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYM 136
Query: 206 RQLHSALHCLHSQQIAHKDIRPENILMNGA--VLKLIDLG----------SSVSVSTVVL 253
++ AL HS I H+D++P N++++ L+LID G +V V++
Sbjct: 137 YEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY- 195
Query: 254 PDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPF 293
F PE+L S DMWSLG +L ++ PF
Sbjct: 196 ----FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 5e-22
Identities = 60/267 (22%), Positives = 108/267 (40%), Gaps = 57/267 (21%)
Query: 108 LGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLSTL--------MH 155
+G G + V R + T ++ A++ + +E + + E ++ +H
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119
Query: 156 AHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITES----YICCIIRQLHSA 211
+ T LF V++ V+G L+ H+ RQ + E Y I A
Sbjct: 120 SCFQTESRLF----------FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEIS----LA 165
Query: 212 LHCLHSQQIAHKDIRPENILM--NGAVLKLIDLGSSVSVSTVVLPDL--------EFASP 261
L+ LH + I ++D++ +N+L+ G + KL D G + + D + +P
Sbjct: 166 LNYLHERGIIYRDLKLDNVLLDSEGHI-KLTDYG--MCKEGLRPGDTTSTFCGTPNYIAP 222
Query: 262 EMLTSPATAGPSTDMWSLGVLLYILLSGVSPFL---------DESEEETRAHISVADYSF 312
E+L G S D W+LGVL++ +++G SPF +E+ I
Sbjct: 223 EILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI 281
Query: 313 PPEQCGHISVPARELIGQLLNTHADKR 339
P +SV A ++ LN +R
Sbjct: 282 PR----SLSVKAASVLKSFLNKDPKER 304
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 2e-21
Identities = 56/228 (24%), Positives = 95/228 (41%), Gaps = 37/228 (16%)
Query: 96 EQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMH 155
+ +RYE L+ +G G F V KA D Q VALK + E++ + E +L L
Sbjct: 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRK 152
Query: 156 A------HIPTALALFENAPVPGTDT--------IVMQLVHGESLIQHLCRQST--ITES 199
++ + + + +L+ +L + + + +
Sbjct: 153 QDKDNTMNV-----------IHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLP 200
Query: 200 YICCIIRQLHSALHCLHSQQIAHKDIRPENILM---NGAVLKLIDLGSSVSVSTVVLPDL 256
+ + L LH +I H D++PENIL+ + +K+ID GSS V +
Sbjct: 201 LVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYI 260
Query: 257 E---FASPE-MLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEE 300
+ + +PE +L + G DMWSLG +L LL+G E E +
Sbjct: 261 QSRFYRAPEVILGAR--YGMPIDMWSLGCILAELLTGYPLLPGEDEGD 306
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 3e-21
Identities = 75/339 (22%), Positives = 124/339 (36%), Gaps = 74/339 (21%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQ--QIT--RAEYNLLSTLMHA 156
+YE+L ++G G F V KAR R TGQ VALK++ E + + IT R E +L L H
Sbjct: 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHE 76
Query: 157 HIPTALALF-ENAPVPGTDTIVMQLV-----HG-ESLIQHLCRQSTITESYICCIIRQLH 209
++ + + A + LV H L+ + T S I +++ L
Sbjct: 77 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVMQMLL 134
Query: 210 SALHCLHSQQIAHKDIRPENILMNGA-VLKLIDLG----SSVSVSTVVLP------DLEF 258
+ L+ +H +I H+D++ N+L+ VLKL D G S++ ++ L +
Sbjct: 135 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 194
Query: 259 ASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHIS------------ 306
PE+L GP D+W G ++ + + +E+ A IS
Sbjct: 195 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 254
Query: 307 -------VADYSFPP-------EQCGHISVP--ARELIGQLLNTHADKRPTAGQLLQVAW 350
++ A +LI +LL +R + L +
Sbjct: 255 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 314
Query: 351 FAE---------------ASCSEFDTERLLPFSARRKQK 374
F S E+ RRK
Sbjct: 315 FWSDPMPSDLKGMLSTHLTSMFEYLAPP------RRKHH 347
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-21
Identities = 54/289 (18%), Positives = 107/289 (37%), Gaps = 36/289 (12%)
Query: 86 TVPFETRWQQEQFEHRYEEL---ERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQI 142
+T ++++ +E+L E +G GRF V R G VA++ I ER +
Sbjct: 16 RKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQ 72
Query: 143 TRA---EYNLLSTLMHAHIPTALALFENA-PVPGTDTIVMQLVHGESLIQHL-CRQSTIT 197
+A E H ++ LF A P I+ L G +L + + +
Sbjct: 73 LKAFKREVMAYRQTRHENV----VLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLD 128
Query: 198 ESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGAVLKLIDLG-SSVSVSTVVLPDL 256
+ I +++ + LH++ I HKD++ +N+ + + + D G S+S
Sbjct: 129 VNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDNGKVVITDFGLFSISGVLQAGRRE 188
Query: 257 EFAS----------PEMLTSPATAGPST--------DMWSLGVLLYILLSGVSPFLDESE 298
+ PE++ + D+++LG + Y L + PF +
Sbjct: 189 DKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA 248
Query: 299 EETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQ 347
E + P + +++ ++RPT +L+
Sbjct: 249 EAIIW--QMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-20
Identities = 72/318 (22%), Positives = 132/318 (41%), Gaps = 55/318 (17%)
Query: 79 NEYKVLYTVPFETRWQQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ 138
N+ + +T Q+E Y + +GNG F V +A+ + + VA+K++ Q
Sbjct: 22 NKVIKVLASDGKTGEQREI---AYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKV---LQ 74
Query: 139 PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT---IVMQLVHGESL---IQHLCR 192
++ E ++ + H ++ A F + + +V++ V E++ +H +
Sbjct: 75 DKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAK 133
Query: 193 QS-TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG--AVLKLIDLGSSVSVS 249
T+ I + QL +L +HS I H+DI+P+N+L++ VLKLID GS +
Sbjct: 134 LKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGS----A 189
Query: 250 TVVLPDLEFAS---------PEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEE 300
+++ S PE++ + D+WS G ++ L+ G F ES +
Sbjct: 190 KILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID 249
Query: 301 ------------TRAHI-----SVADYSFPPEQ--------CGHISVPARELIGQLLNTH 335
+R I + ++ FP + A +LI +LL
Sbjct: 250 QLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYT 309
Query: 336 ADKRPTAGQLLQVAWFAE 353
R TA + L +F E
Sbjct: 310 PSARLTAIEALCHPFFDE 327
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 7e-20
Identities = 70/336 (20%), Positives = 137/336 (40%), Gaps = 67/336 (19%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE-RQPQQITRA--EYNLLSTLMHAH 157
Y +G+G + +V A D+ +G+ VA+K++ R + RA E LL + H +
Sbjct: 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHEN 84
Query: 158 IPTALALFENAPVPGTDT---IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHC 214
+ L +F A +VM + ++ +Q + +E I ++ Q+ L
Sbjct: 85 VIGLLDVFTPASSLRNFYDFYLVMPFM--QTDLQKIMGLK-FSEEKIQYLVYQMLKGLKY 141
Query: 215 LHSQQIAHKDIRPENILMNGA-VLKLIDLGSSVSVSTVVLPDLE-------FASPEMLTS 266
+HS + H+D++P N+ +N LK++D G + ++ + +PE++ S
Sbjct: 142 IHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD----AEMTGYVVTRWYRAPEVILS 197
Query: 267 PATAGPSTDMWSLGVLLYILLSGVSPF--------LDE----------------SEEETR 302
+ D+WS+G ++ +L+G + F L + +++ +
Sbjct: 198 WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAK 257
Query: 303 AHISVADYSFPP-------EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFA--- 352
++I S P + S A +L+ ++L DKR TA Q L +F
Sbjct: 258 SYIQ----SLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 313
Query: 353 ----EASCSE---FDTERL-LPFSARRKQKFKEIQD 380
E + E L ++ +KEI +
Sbjct: 314 DPEEETEAQQPFDDSLEHEKLTVDEWKQHIYKEIVN 349
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 1e-19
Identities = 70/329 (21%), Positives = 135/329 (41%), Gaps = 53/329 (16%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE-RQPQQITRA--EYNLLSTLMHAH 157
Y +L+ +G+G + V A D TG VA+K++ R + RA E LL + H +
Sbjct: 26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHEN 85
Query: 158 IPTALALFENAPVPGTDT-----IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSAL 212
+ L +F P D +VM + + + L + + E I ++ Q+ L
Sbjct: 86 VIGLLDVFT--PDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGL 141
Query: 213 HCLHSQQIAHKDIRPENILMNGA-VLKLIDLGSSVSVSTVVLPDLE---FASPEMLTSPA 268
+H+ I H+D++P N+ +N LK++D G + + + + + +PE++ +
Sbjct: 142 RYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWM 201
Query: 269 TAGPSTDMWSLGVLLYILLSGVSPF--------LDE--------SEEETRAHIS--VADY 310
+ D+WS+G ++ +++G + F L E E + S +Y
Sbjct: 202 RYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNY 261
Query: 311 --SFPP-------EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFA-------EA 354
P + S A L+ ++L A++R TAG+ L +F E
Sbjct: 262 MKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEP 321
Query: 355 SCSEFDTE---RLLPFSARRKQKFKEIQD 380
++D ++ +KE+
Sbjct: 322 QVQKYDDSFDDVDRTLDEWKRVTYKEVLS 350
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-19
Identities = 67/323 (20%), Positives = 120/323 (37%), Gaps = 63/323 (19%)
Query: 83 VLYTVPFETRWQQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQI 142
E ++ R++ G G F TV+ +++ TG VA+K++ ++ + +
Sbjct: 9 NAAAAADERSRKEMD---RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNR 65
Query: 143 TRAEYNLLSTLMHAHIPTALALFENAPVPGTD----TIVMQLVHGESL---IQHLCRQS- 194
L+ L H +I + F +VM+ V ++L ++ R+
Sbjct: 66 ELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQV 124
Query: 195 TITESYICCIIRQLHSALHCLH--SQQIAHKDIRPENILMNGA--VLKLIDLGSS----- 245
I + QL ++ CLH S + H+DI+P N+L+N A LKL D GS+
Sbjct: 125 APPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP 184
Query: 246 --VSVSTVVLPDLEFAS-----PEMLTSPATAGPSTDMWSLGVLLYILLSGVSPF----- 293
+V+ + S PE++ + D+WS+G + ++ G F
Sbjct: 185 SEPNVAYIC-------SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS 237
Query: 294 ---LDE--------SEEETRAHIS-VADYSFP-----------PEQCGHISVPARELIGQ 330
L E S E R D + + A +L+
Sbjct: 238 AGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSA 297
Query: 331 LLNTHADKRPTAGQLLQVAWFAE 353
LL ++R + L +F E
Sbjct: 298 LLQYLPEERMKPYEALCHPYFDE 320
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-19
Identities = 64/297 (21%), Positives = 108/297 (36%), Gaps = 53/297 (17%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ--PQQITRAEYNLLSTLMH--- 155
RY +L+ LG G V A D + VA+K+I + R E ++ L H
Sbjct: 12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR-EIKIIRRLDHDNI 70
Query: 156 ---AHIPTALALFENAPVPGTDT-----IVMQLVHGESLIQHLCRQSTITESYICCIIRQ 207
I V IV + + E+ + ++ Q + E + + Q
Sbjct: 71 VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM--ETDLANVLEQGPLLEEHARLFMYQ 128
Query: 208 LHSALHCLHSQQIAHKDIRPENILMNGA--VLKLIDLGSSVSVSTVVLPDLEFA------ 259
L L +HS + H+D++P N+ +N VLK+ D G + + +
Sbjct: 129 LLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188
Query: 260 ---SPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPF---------------LDESEEET 301
SP +L SP + DMW+ G + +L+G + F + EE
Sbjct: 189 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEED 248
Query: 302 RAHIS--VADY--SFPP-------EQCGHISVPARELIGQLLNTHADKRPTAGQLLQ 347
R + + Y + + IS A + + Q+L R TA + L
Sbjct: 249 RQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 2e-19
Identities = 61/270 (22%), Positives = 115/270 (42%), Gaps = 34/270 (12%)
Query: 98 FEHRYEEL---ERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLM 154
Y+E+ E +G G F V KA+ R + VA+KQI E + + E LS +
Sbjct: 3 HMIDYKEIEVEEVVGRGAFGVVCKAKWRA--KDVAIKQIESESERKAFIV-ELRQLSRVN 59
Query: 155 HAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQ---STITESYICCIIRQLHSA 211
H +I N +VM+ G SL L T ++ Q
Sbjct: 60 HPNIVKLYGACLNPV-----CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQG 114
Query: 212 LHCLHSQQ---IAHKDIRPENILM--NGAVLKLIDLGSSVSVSTVVLPD---LEFASPEM 263
+ LHS Q + H+D++P N+L+ G VLK+ D G++ + T + + + +PE+
Sbjct: 115 VAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEV 174
Query: 264 LTSPATAGPST---DMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFP--PEQCG 318
+ D++S G++L+ +++ PF + R +V + + P +
Sbjct: 175 FEG----SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLP 230
Query: 319 HISVPARELIGQLLNTHADKRPTAGQLLQV 348
P L+ + + +RP+ +++++
Sbjct: 231 K---PIESLMTRCWSKDPSQRPSMEEIVKI 257
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 2e-19
Identities = 52/286 (18%), Positives = 101/286 (35%), Gaps = 46/286 (16%)
Query: 105 LERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALAL 164
E +G GRF V + + RG + VA+K + AE L H +I +A
Sbjct: 47 QESIGKGRFGEVWRGKWRG--EEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 165 FENAPVPGTDT-IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQ---- 219
T +V SL +L + T+T + + S L LH +
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 163
Query: 220 ----IAHKDIRPENILM-NGAVLKLIDLGSSVSVSTVVLPDLEFA----------SPEML 264
IAH+D++ +NIL+ + DLG +V + +PE+L
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 223
Query: 265 --TSPATAGPST---DMWSLGVLLYILLSGVSPFLDESE------EETRAHISVADY--- 310
+ S D++++G++ + + S + + + SV +
Sbjct: 224 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 283
Query: 311 --------SFPPEQCGHISVPA-RELIGQLLNTHADKRPTAGQLLQ 347
+ P ++ +++ + + R TA ++ +
Sbjct: 284 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 3e-19
Identities = 63/352 (17%), Positives = 120/352 (34%), Gaps = 76/352 (21%)
Query: 101 RYE-ELERLGNGRFCTVRKARDR--GTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAH 157
+E E ++G G + V KA+ + + ALKQI R E LL L H +
Sbjct: 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR-EIALLRELKHPN 79
Query: 158 IPTALALFENAPVPGTDTIVM----------QLVHGESLIQHLCRQSTITESYICCIIRQ 207
+ ++L + + + ++ + + + + ++ Q
Sbjct: 80 V---ISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 136
Query: 208 LHSALHCLHSQQIAHKDIRPENILMNGA-----VLKLIDLG--SSVSVSTVVLPDLEFA- 259
+ +H LH+ + H+D++P NIL+ G +K+ D+G + L DL+
Sbjct: 137 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196
Query: 260 ------SPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVAD---- 309
+PE+L + D+W++G + LL+ F E+ ++ D
Sbjct: 197 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 256
Query: 310 ---------------------------------------YSFPPEQCGHISVPARELIGQ 330
+ + A L+ +
Sbjct: 257 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQK 316
Query: 331 LLNTHADKRPTAGQLLQVAWFAEA--SCSEFDTERLLPFSARRKQKFKEIQD 380
LL KR T+ Q +Q +F E S+ +P+ R +E D
Sbjct: 317 LLTMDPIKRITSEQAMQDPYFLEDPLPTSDVFAGCQIPYPKREFLTEEEPDD 368
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 4e-19
Identities = 62/282 (21%), Positives = 115/282 (40%), Gaps = 29/282 (10%)
Query: 88 PFETRWQQEQFEHRYEEL---ERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITR 144
+R + +E ++ +R+G+G F TV K + G VA+K + Q +
Sbjct: 9 HHGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQ 65
Query: 145 A---EYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHL-CRQSTITESY 200
A E +L H +I LF IV Q G SL HL ++
Sbjct: 66 AFKNEVGVLRKTRHVNI----LLFMGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKK 121
Query: 201 ICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLG-SSVSVSTVVLPDLEF 258
+ I RQ + LH++ I H+D++ NI ++ +K+ D G ++ E
Sbjct: 122 LIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQ 181
Query: 259 AS-------PEMLTSPATAGPST---DMWSLGVLLYILLSGVSPFLDESEEETRAHISVA 308
S PE++ + P + D+++ G++LY L++G P+ + + + +
Sbjct: 182 LSGSILWMAPEVIRM-QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGR 240
Query: 309 DYSFPPEQCGHISVPA--RELIGQLLNTHADKRPTAGQLLQV 348
P + P + L+ + L D+RP+ ++L
Sbjct: 241 GSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAE 282
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 4e-19
Identities = 73/331 (22%), Positives = 136/331 (41%), Gaps = 57/331 (17%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE-RQPQQITRA--EYNLLSTLMHAH 157
RY+ L +G+G + +V A D TG VA+K++ R + R E LL + H +
Sbjct: 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 89
Query: 158 IPTALALFENAPVPGTDT---IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHC 214
+ L +F A +V L+ + + ++ + +T+ ++ +I Q+ L
Sbjct: 90 VIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKY 147
Query: 215 LHSQQIAHKDIRPENILMNGA-VLKLIDLGSSVSVSTVVLPDLE-------FASPEMLTS 266
+HS I H+D++P N+ +N LK++D G + + ++ + +PE++ +
Sbjct: 148 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA----DEMTGYVATRWYRAPEIMLN 203
Query: 267 PATAGPSTDMWSLGVLLYILLSGVSPF---------------LDESEEETRAHIS---VA 308
+ D+WS+G ++ LL+G + F + E IS
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 263
Query: 309 DY--SFPP-------EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFA------- 352
+Y S + A +L+ ++L +DKR TA Q L A+FA
Sbjct: 264 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD 323
Query: 353 EASCSEFDTE---RLLPFSARRKQKFKEIQD 380
E +D R L + + E+
Sbjct: 324 EPVADPYDQSLESRDLLIDEWKSLTYDEVIS 354
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 1e-18
Identities = 61/306 (19%), Positives = 122/306 (39%), Gaps = 60/306 (19%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE-RQPQQITRA--EYNLLSTLMHAH 157
RY+ L+ +G+G V A D + VA+K++ R + RA E L+ + H +
Sbjct: 26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 85
Query: 158 IPTALALFENAPVPGTDT-----IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSAL 212
I L +F P + IVM+L+ ++ + + + + + ++ Q+ +
Sbjct: 86 IIGLLNVF--TPQKSLEEFQDVYIVMELM--DANLCQVIQME-LDHERMSYLLYQMLCGI 140
Query: 213 HCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVSTVVLPDLEFA-----SPE-MLT 265
LHS I H+D++P NI++ LK++D G + + T + +PE +L
Sbjct: 141 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG 200
Query: 266 SPATAGPSTDMWSLGVLLYILLSGV--------------------SP---FLDESEEETR 302
+ D+WS+G ++ ++ G +P F+ + + R
Sbjct: 201 MGYK--ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR 258
Query: 303 AHIS---------------VADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQ 347
++ + E + AR+L+ ++L A KR + + LQ
Sbjct: 259 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318
Query: 348 VAWFAE 353
+
Sbjct: 319 HPYINV 324
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-18
Identities = 42/264 (15%), Positives = 86/264 (32%), Gaps = 27/264 (10%)
Query: 96 EQFEHRYEEL---ERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRA---EYNL 149
+ +++L +L + K R +G + +K + + +R E
Sbjct: 3 KHSGIDFKQLNFLTKLNENHSGELWKGRWQG--NDIVVKVLKVRDWSTRKSRDFNEECPR 60
Query: 150 LSTLMHAHIPTALALFE---NAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCII- 205
L H ++ +P T++ + SL L + +
Sbjct: 61 LRIFSHPNV----LPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKF 116
Query: 206 -RQLHSALHCLHSQQ--IAHKDIRPENILMN-GAVLKLIDLGSS-VSVSTVVLPDLEFAS 260
+ + LH+ + I + +++++ ++ S + + +
Sbjct: 117 ALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAPAWVA 176
Query: 261 PEMLTSPATAGPST--DMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFP-PEQC 317
PE L DMWS VLL+ L++ PF D S E +++ P
Sbjct: 177 PEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGI 236
Query: 318 GHISVPARELIGQLLNTHADKRPT 341
S +L+ +N KRP
Sbjct: 237 ---SPHVSKLMKICMNEDPAKRPK 257
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-18
Identities = 69/337 (20%), Positives = 120/337 (35%), Gaps = 89/337 (26%)
Query: 95 QEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLM 154
E +Y + LG G F V + D +G+ ALK++ Q + E +++ L
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKV---LQDPRYKNRELDIMKVLD 58
Query: 155 HAHI-------------------------------PTALALFENAPVPGTDT----IVMQ 179
H +I ++ V + ++M+
Sbjct: 59 HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118
Query: 180 LVHGESL---IQHLCRQS-TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGA 235
V ++L ++ R +I + I I QL A+ +HS I H+DI+P+N+L+N
Sbjct: 119 YV-PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSK 177
Query: 236 --VLKLIDLGSS-------VSVSTVVLPDLEFAS-----PEMLTSPATAGPSTDMWSLGV 281
LKL D GS+ SV+ + S PE++ PS D+WS+G
Sbjct: 178 DNTLKLCDFGSAKKLIPSEPSVAYI-------CSRFYRAPELMLGATEYTPSIDLWSIGC 230
Query: 282 LLYILLSGVSPF--------LDE--------SEEETRAHIS-VADYSFPPEQ-------- 316
+ L+ G F L ++E+ + FP +
Sbjct: 231 VFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKIL 290
Query: 317 CGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAE 353
A +L+ Q+L D R + + +F
Sbjct: 291 PEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDH 327
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 5e-18
Identities = 51/286 (17%), Positives = 99/286 (34%), Gaps = 46/286 (16%)
Query: 105 LERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALAL 164
LE +G GR+ V + +G + VA+K + E L H +I +A
Sbjct: 13 LECVGKGRYGEVWRGSWQG--ENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIAS 70
Query: 165 FENAPVPGTDT-IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQ---- 219
+ T ++ SL +L + +T+ I+ + S L LH +
Sbjct: 71 DMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 220 ----IAHKDIRPENILM-NGAVLKLIDLGSSVSVSTVVLPDLEFA----------SPEML 264
IAH+D++ +NIL+ + DLG +V S +PE+L
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 265 -----TSPATAGPSTDMWSLGVLLYILLSGVSPFLDES------EEETRAHISVADY--- 310
+ D+W+ G++L+ + + + S D
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKV 249
Query: 311 --------SFPPEQCGHISVPA-RELIGQLLNTHADKRPTAGQLLQ 347
+ P ++ + +L+ + + R TA ++ +
Sbjct: 250 VCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 6e-18
Identities = 56/222 (25%), Positives = 97/222 (43%), Gaps = 23/222 (10%)
Query: 96 EQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMH 155
E++ RYE +G G F V KA DR + VA+K I ++ + E LL +
Sbjct: 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNK 109
Query: 156 A------HIPTALALFENAPVPGTDTIVMQLVHGESLIQHL--CRQSTITESYICCIIRQ 207
+I F +V +++ +L L ++ + +Q
Sbjct: 110 HDTEMKYYIVHLKRHFMFR---NHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQ 165
Query: 208 LHSALHCLHSQ--QIAHKDIRPENILM---NGAVLKLIDLGSSVSVSTVVLPDLE---FA 259
+ +AL L + I H D++PENIL+ + +K++D GSS + + ++ +
Sbjct: 166 MCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYR 225
Query: 260 SPE-MLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEE 300
SPE +L P + DMWSLG +L + +G F +E +
Sbjct: 226 SPEVLLGMPY--DLAIDMWSLGCILVEMHTGEPLFSGANEVD 265
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 7e-18
Identities = 52/288 (18%), Positives = 100/288 (34%), Gaps = 46/288 (15%)
Query: 103 EELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTAL 162
+ ++++G GR+ V + RG + VA+K + E + H +I +
Sbjct: 40 QMVKQIGKGRYGEVWMGKWRG--EKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFI 97
Query: 163 ALFENAPVPGTDT-IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQ-- 219
A T ++ SL +L + +T+ + + S L LH++
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYL-KSTTLDAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 220 ------IAHKDIRPENILMNGA-VLKLIDLGSSVSVSTVVLPDLEFA----------SPE 262
IAH+D++ +NIL+ + DLG +V + PE
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216
Query: 263 ML--TSPATAGPST---DMWSLGVLLYILLSGVSPFLDESE------EETRAHISVADY- 310
+L + S DM+S G++L+ + E + + S D
Sbjct: 217 VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMR 276
Query: 311 ----------SFPPEQCGHISVPA-RELIGQLLNTHADKRPTAGQLLQ 347
SFP + +L+ + + R TA ++ +
Sbjct: 277 EIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 7e-18
Identities = 56/350 (16%), Positives = 111/350 (31%), Gaps = 71/350 (20%)
Query: 96 EQFE--HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRA-------- 145
E Y + +G + V D G VA+K++ +
Sbjct: 16 ELHAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCK 74
Query: 146 ----EYNLLSTLMHAHIPTALALFENAPVPGTDTI--VMQLVHGESLIQHL-CRQSTITE 198
E LL+ H +I +F + P + V +L+ L Q + ++ I+
Sbjct: 75 RVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISP 133
Query: 199 SYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGA-VLKLIDLGSSVSVSTVVLPDLE 257
+I + + LH LH + H+D+ P NIL+ + + D ++ D
Sbjct: 134 QHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFN----LAREDTADAN 189
Query: 258 FA---------SPEMLTSPATAGPSTDMWSLGVLLYILLSGV------------------ 290
+PE++ DMWS G ++ + +
Sbjct: 190 KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEV 249
Query: 291 --SPFLDE----SEEETRAHISVADYSFPP----EQCGHISVPARELIGQLLNTHADKRP 340
+P +++ S R ++ + + P A +LI ++L + +R
Sbjct: 250 VGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRI 309
Query: 341 TAGQLLQVAWFA-------EASCSEFD---TERLLPFSARRKQKFKEIQD 380
+ Q L+ +F E + K E++
Sbjct: 310 STEQALRHPYFESLFDPLDLTEGLSERFHFDESVTDVYDMHKIFTAEVER 359
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 9e-18
Identities = 59/309 (19%), Positives = 112/309 (36%), Gaps = 65/309 (21%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRA--EYNLLSTLMHAHI 158
++ LG G + V A + TG++VA+K+I +P R E +L H +I
Sbjct: 12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENI 71
Query: 159 PTALALFENAPVPGTDT-----IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALH 213
T + + I+ +L+ ++ + + +++ +I I Q A+
Sbjct: 72 ITIFNIQ---RPDSFENFNEVYIIQELM--QTDLHRVISTQMLSDDHIQYFIYQTLRAVK 126
Query: 214 CLHSQQIAHKDIRPENILMNGA-VLKLIDLGSSVSVSTVVLPDLEFAS------------ 260
LH + H+D++P N+L+N LK+ D G + + + E
Sbjct: 127 VLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATR 186
Query: 261 ----PEMLTSPATAGPSTDMWSLGVLLYILLSGV--------------------SPFLDE 296
PE++ + A + D+WS G +L L +P D
Sbjct: 187 WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN 246
Query: 297 -----SEEETRAHISVADYSFPP-------EQCGHISVPARELIGQLLNTHADKRPTAGQ 344
R +I S P + ++ +L+ ++L KR TA +
Sbjct: 247 DLRCIESPRAREYIK----SLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKE 302
Query: 345 LLQVAWFAE 353
L+ +
Sbjct: 303 ALEHPYLQT 311
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 9e-18
Identities = 56/272 (20%), Positives = 103/272 (37%), Gaps = 33/272 (12%)
Query: 102 YEEL---ERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRA--------EYNLL 150
E+ +++G G F V K R +VA+K + + E ++
Sbjct: 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIM 77
Query: 151 STLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHL-CRQSTITESYICCIIRQLH 209
S L H +I L N P +VM+ V L L + I S ++ +
Sbjct: 78 SNLNHPNIVKLYGLMHNPPR-----MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIA 132
Query: 210 SALHCLHSQ--QIAHKDIRPENILMNGA------VLKLIDLGSS---VSVSTVVLPDLEF 258
+ + +Q I H+D+R NI + K+ D G S V + +L + ++
Sbjct: 133 LGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNFQW 192
Query: 259 ASPEMLTSPATAGPST---DMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPE 315
+PE + + T D +S ++LY +L+G PF + S + + + + P
Sbjct: 193 MAPETIGA--EEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT 250
Query: 316 QCGHISVPARELIGQLLNTHADKRPTAGQLLQ 347
R +I + KRP +++
Sbjct: 251 IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 1e-17
Identities = 56/281 (19%), Positives = 96/281 (34%), Gaps = 76/281 (27%)
Query: 96 EQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMH 155
+ F RY + +LG G F TV + D + VA+K + + E LL ++ +
Sbjct: 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRN 92
Query: 156 A--------HIPTALALFENAPVPGTDT----IVMQLVHGESL--IQHLCRQSTITESYI 201
+ + L F+ + G + +V + V G L + +
Sbjct: 93 SDPNDPNREMVVQLLDDFK---ISGVNGTHICMVFE-VLGHHLLKWIIKSNYQGLPLPCV 148
Query: 202 CCIIRQLHSALHCLHSQ-QIAHKDIRPENILMN--------------------------- 233
II+Q+ L LH++ +I H DI+PENIL++
Sbjct: 149 KKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS 208
Query: 234 -----------------------GAVLKLIDLGSSVSVSTVVLPD---LEFASPEMLTSP 267
+K+ DLG++ V D ++ S E+L
Sbjct: 209 AVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLI-G 267
Query: 268 ATAGPSTDMWSLGVLLYILLSGVSPF---LDESEEETRAHI 305
+ D+WS + + L +G F E HI
Sbjct: 268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHI 308
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 72/333 (21%), Positives = 119/333 (35%), Gaps = 56/333 (16%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRA--EYNLLSTLMHAHI 158
RY L +G G + V A D VA+K+I R E +L H +I
Sbjct: 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 159 PTALALFENAPVPGTDT---IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCL 215
+ AP IV L+ E+ + L + ++ +IC + Q+ L +
Sbjct: 88 IGINDIIR-APTIEQMKDVYIVQDLM--ETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 144
Query: 216 HSQQIAHKDIRPENILMNGA-VLKLIDLGSSVSVSTVVLPDLE---------FASPEMLT 265
HS + H+D++P N+L+N LK+ D G + + +PE++
Sbjct: 145 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 266 SPATAGPSTDMWSLGVLLYILLSGVSPF---------------LDESEEETRAHIS---V 307
+ S D+WS+G +L +LS F L +E I
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 308 ADY--SFPPEQ-------CGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFA------ 352
+Y S P + + A +L+ ++L + KR Q L +
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 324
Query: 353 -EASCSE---FDTE-RLLPFSARRKQKFKEIQD 380
E FD E LP ++ F+E
Sbjct: 325 DEPIAEAPFKFDMELDDLPKEKLKELIFEETAR 357
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 7e-17
Identities = 57/316 (18%), Positives = 122/316 (38%), Gaps = 59/316 (18%)
Query: 89 FETRWQQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE-RQPQQITRA-- 145
++ + RY+ L+ +G+G V A D + VA+K++ R + RA
Sbjct: 54 GDSTFT---VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR 110
Query: 146 EYNLLSTLMHAHIPTALALFENAPVPGTDT---IVMQLVHGESLIQHLCRQSTITESYIC 202
E L+ + H +I + L +F +VM+L+ ++ + + + + +
Sbjct: 111 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM--DANLCQVIQME-LDHERMS 167
Query: 203 CIIRQLHSALHCLHSQQIAHKDIRPENILMNGA-VLKLIDLGSSVSVSTVVLPDLEFA-- 259
++ Q+ + LHS I H+D++P NI++ LK++D G + + T +
Sbjct: 168 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 227
Query: 260 ---SPE-MLTSPATAGPSTDMWSLGVLLYILLSGV--------------------SP--- 292
+PE +L + D+WS+G ++ ++ +P
Sbjct: 228 YYRAPEVILGMGYK--ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 285
Query: 293 FLDESEEETRAHIS---------------VADYSFPPEQCGHISVPARELIGQLLNTHAD 337
F+ + + R ++ + + E + AR+L+ ++L
Sbjct: 286 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 345
Query: 338 KRPTAGQLLQVAWFAE 353
KR + LQ +
Sbjct: 346 KRISVDDALQHPYINV 361
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 3e-16
Identities = 36/151 (23%), Positives = 67/151 (44%), Gaps = 11/151 (7%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHA-HIP 159
RY ++G+G F + D G+ VA+K + + Q+ E + + IP
Sbjct: 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI-ESKIYKMMQGGVGIP 68
Query: 160 TALALFENAPVPGTDTIVMQLVHGESLIQHLCRQS-TITESYICCIIRQLHSALHCLHSQ 218
T + + +VM+L+ G SL S + + + Q+ S + +HS+
Sbjct: 69 T---IRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK 124
Query: 219 QIAHKDIRPENILM----NGAVLKLIDLGSS 245
H+D++P+N LM G ++ +ID G +
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 6e-16
Identities = 33/153 (21%), Positives = 63/153 (41%), Gaps = 13/153 (8%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHA-HIP 159
Y+ R+G G F + + + Q VA+K PR Q+ EY L IP
Sbjct: 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD-EYRTYKLLAGCTGIP 69
Query: 160 TALALFENAPVPGTDTIVMQLVHGESLIQHLCRQS-TITESYICCIIRQLHSALHCLHSQ 218
++ + +V+ L G SL L + + +Q+ + + +H +
Sbjct: 70 N---VYYFGQEGLHNVLVIDL-LGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 125
Query: 219 QIAHKDIRPENILM------NGAVLKLIDLGSS 245
+ ++DI+P+N L+ N ++ ++D G
Sbjct: 126 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 8e-16
Identities = 63/279 (22%), Positives = 104/279 (37%), Gaps = 43/279 (15%)
Query: 98 FEHRYEEL---ERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQIT-----RAEYNL 149
E + EL E +G G F V +A G VA+K + R E L
Sbjct: 2 LEIDFAELTLEEIIGIGGFGKVYRAFWIG--DEVAVKAARHDPDEDISQTIENVRQEAKL 59
Query: 150 LSTLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLH 209
+ L H +I +AL +VM+ G L + L I + Q+
Sbjct: 60 FAMLKHPNI---IALRGVCLKEPNLCLVMEFARGGPLNRVL-SGKRIPPDILVNWAVQIA 115
Query: 210 SALHCLHSQ---QIAHKDIRPENILMNGA---------VLKLIDLG-----SSVSVSTVV 252
++ LH + I H+D++ NIL+ +LK+ D G + +
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA 175
Query: 253 LPDLEFASPEMLTSPATAGPST---DMWSLGVLLYILLSGVSPFLDESEEETRAHISVAD 309
+ +PE++ + + D+WS GVLL+ LL+G PF +++
Sbjct: 176 GA-YAWMAPEVIRA----SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNK 230
Query: 310 YSFP-PEQCGHISVPARELIGQLLNTHADKRPTAGQLLQ 347
+ P P C P +L+ N RP+ +L
Sbjct: 231 LALPIPSTC---PEPFAKLMEDCWNPDPHSRPSFTNILD 266
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 8e-16
Identities = 36/153 (23%), Positives = 68/153 (44%), Gaps = 13/153 (8%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHA-HIP 159
+ +++G G F +R ++ T + VA+K P + + Q+ EY L IP
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL-EYRFYKQLGSGDGIP 68
Query: 160 TALALFENAPVPGTDTIVMQLVHGESLIQHLCRQS-TITESYICCIIRQLHSALHCLHSQ 218
++ P + +V++L G SL T + + I QL S + +HS+
Sbjct: 69 Q---VYYFGPCGKYNAMVLEL-LGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK 124
Query: 219 QIAHKDIRPENILM------NGAVLKLIDLGSS 245
+ ++D++PEN L+ V+ +ID +
Sbjct: 125 NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 3e-15
Identities = 55/296 (18%), Positives = 104/296 (35%), Gaps = 48/296 (16%)
Query: 96 EQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMH 155
+ LE GRF V KA+ + VA+K P + + E L + H
Sbjct: 20 YFQSMPLQLLEVKARGRFGCVWKAQLLN--EYVAVKIFPIQDKQSWQNEYEVYSLPGMKH 77
Query: 156 AHIPTALALFENAPVPGTDT-IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHC 214
+I + + D ++ SL L + + ++ + +C I + L
Sbjct: 78 ENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-KANVVSWNELCHIAETMARGLAY 136
Query: 215 LHSQQ----------IAHKDIRPENILM--NGAVLKLIDLGSSVSVSTVVLPD------- 255
LH I+H+DI+ +N+L+ N + D G ++
Sbjct: 137 LHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA-CIADFGLALKFEAGKSAGDTHGQVG 195
Query: 256 -LEFASPEML-TSPATAGPST---DMWSLGVLLYILLSGVSPFLDESEE-------ETRA 303
+ +PE+L + + DM+++G++L+ L S + +E E
Sbjct: 196 TRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ 255
Query: 304 HISVADY-----------SFPPEQCGHISVPA-RELIGQLLNTHADKRPTAGQLLQ 347
H S+ D H + E I + + A+ R +AG + +
Sbjct: 256 HPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 4e-15
Identities = 58/300 (19%), Positives = 117/300 (39%), Gaps = 36/300 (12%)
Query: 71 HTYTFCINNEYKVLYTVPFETRWQQEQFEHRYEEL---ERLGNGRFCTVRKARDRGTGQL 127
H + + + + F+ + + + +L E++G G F TV +A G
Sbjct: 5 HHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHG--SD 62
Query: 128 VALKQIPRERQPQQITRA---EYNLLSTLMHAHIPTALALFENA-PVPGTDTIVMQLVHG 183
VA+K + + + E ++ L H +I LF A P +IV + +
Sbjct: 63 VAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI----VLFMGAVTQPPNLSIVTEYLSR 118
Query: 184 ESLIQHLCRQST---ITESYICCIIRQLHSALHCLHSQ--QIAHKDIRPENILMNGA-VL 237
SL + L + + E + + ++ LH++ I H++++ N+L++ +
Sbjct: 119 GSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTV 178
Query: 238 KLIDLGSSVSVSTVVLPDLEFA------SPEMLTSPATAGPST---DMWSLGVLLYILLS 288
K+ D G S ++ L A +PE+L PS D++S GV+L+ L +
Sbjct: 179 KVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRD----EPSNEKSDVYSFGVILWELAT 234
Query: 289 GVSPFLDESEEETRAHISVADYSFP-PEQCGHISVPARELIGQLLNTHADKRPTAGQLLQ 347
P+ + + + A + P + +I KRP+ ++
Sbjct: 235 LQQPWGNLNPAQVVAAVGFKCKRLEIPRNL---NPQVAAIIEGCWTNEPWKRPSFATIMD 291
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 75.0 bits (184), Expect = 6e-15
Identities = 32/151 (21%), Positives = 64/151 (42%), Gaps = 11/151 (7%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHA-HIP 159
++ ++G+G F + + T + VA+K + + Q+ E + L IP
Sbjct: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY-ESKIYRILQGGTGIP 66
Query: 160 TALALFENAPVPGTDTIVMQLVHGESLIQHLCRQS-TITESYICCIIRQLHSALHCLHSQ 218
+ + +VM L+ G SL S ++ + + Q+ + + +HS+
Sbjct: 67 N---VRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
Query: 219 QIAHKDIRPENILM----NGAVLKLIDLGSS 245
H+DI+P+N LM + +ID G +
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 45/259 (17%), Positives = 88/259 (33%), Gaps = 77/259 (29%)
Query: 96 EQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQI---PRERQPQQITRAEYNLLST 152
+ + + ++G+G F V + + A+K + + + +I E ++L
Sbjct: 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI---EADILKK 87
Query: 153 LMHA-----HIPTALALFENAPVPGTDT--------IVMQLVHGESLIQHLCRQS--TIT 197
+ + +I V ++ + + G SL + + R +
Sbjct: 88 IQNDDINNNNI-----------VKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFH 135
Query: 198 ESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG----------------------- 234
I ++ AL+ L + H D++PENIL++
Sbjct: 136 IEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYR 195
Query: 235 ---AVLKLIDLGSSV----SVSTVVLPDLEFAS-----PE-MLTSPATAGPSTDMWSLGV 281
+KLID G + +++ + PE +L S+DMWS G
Sbjct: 196 TKSTGIKLIDFGCATFKSDYHGSII------NTRQYRAPEVILNLG--WDVSSDMWSFGC 247
Query: 282 LLYILLSGVSPFLDESEEE 300
+L L +G F E
Sbjct: 248 VLAELYTGSLLFRTHEHME 266
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 3e-14
Identities = 52/288 (18%), Positives = 99/288 (34%), Gaps = 47/288 (16%)
Query: 95 QEQFEHRYEEL---ERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQIT-RAEYNLL 150
R +L E LG G F K R TG+++ +K++ R + Q T E ++
Sbjct: 2 MPHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVM 61
Query: 151 STLMHAHIPTALALFENAPV-PGTDTIVMQLVHGESLIQHLCRQ-STITESYICCIIRQL 208
L H ++ F + + + G +L + S S + +
Sbjct: 62 RCLEHPNV----LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDI 117
Query: 209 HSALHCLHSQQIAHKDIRPENILMNGA-VLKLIDLG--------------------SSVS 247
S + LHS I H+D+ N L+ + + D G
Sbjct: 118 ASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRK 177
Query: 248 VSTVVLPDLEFASPEMLTSPATAGPST---DMWSLGVLLYILLSGVSPFLDESEEETRAH 304
V+ + + +PEM+ D++S G++L ++ V+ D
Sbjct: 178 KRYTVVGNPYWMAPEMING----RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG 233
Query: 305 ISVADYS--FPPEQCGHISVPA--RELIGQLLNTHADKRPTAGQLLQV 348
++V + + P C P + + + +KRP+ +L
Sbjct: 234 LNVRGFLDRYCPPNC-----PPSFFPITVRCCDLDPEKRPSFVKLEHW 276
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 3e-14
Identities = 55/222 (24%), Positives = 92/222 (41%), Gaps = 37/222 (16%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE-RQPQQITRA--EYNLLSTL-MHA 156
+YE +++LG G + V K+ DR TG++VA+K+I + R E +L+ L H
Sbjct: 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHE 69
Query: 157 HIPTALALFENAPVPGTDT-IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCL 215
+I L + D +V + E+ + + R + + + ++ QL + L
Sbjct: 70 NIVNLLNVLR--ADNDRDVYLVFDYM--ETDLHAVIRANILEPVHKQYVVYQLIKVIKYL 125
Query: 216 HSQQIAHKDIRPENILMNGA-VLKLIDLGSSVSVSTVVLPDLEFAS-------------- 260
HS + H+D++P NIL+N +K+ D G S S +
Sbjct: 126 HSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQP 185
Query: 261 -------------PEMLTSPATAGPSTDMWSLGVLLYILLSG 289
PE+L DMWSLG +L +L G
Sbjct: 186 ILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG 227
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 5e-14
Identities = 56/296 (18%), Positives = 100/296 (33%), Gaps = 57/296 (19%)
Query: 106 ERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALF 165
E +G GR+ V K + VA+K + I + + H +I +
Sbjct: 19 ELIGRGRYGAVYKGSLDE--RPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGD 76
Query: 166 ENAPVPGTDT--IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQ----- 218
E G +VM+ SL ++L T C + + L LH++
Sbjct: 77 ERVTADGRMEYLLVMEYYPNGSLXKYL-SLHTSDWVSSCRLAHSVTRGLAYLHTELPRGD 135
Query: 219 ----QIAHKDIRPENILM-NGAVLKLIDLGSSVSVSTVVLPDLEFA-------------- 259
I+H+D+ N+L+ N + D G S+ ++ L
Sbjct: 136 HYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYM 195
Query: 260 SPEML------TSPATAGPSTDMWSLGVLLYILLSGVS-------------PFLDE---- 296
+PE+L +A DM++LG++ + + + F E
Sbjct: 196 APEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNH 255
Query: 297 -SEEETRAHISVADYSFP-PEQCGHISVPAR---ELIGQLLNTHADKRPTAGQLLQ 347
+ E+ + +S PE S+ R E I + A+ R TA +
Sbjct: 256 PTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 1e-13
Identities = 45/224 (20%), Positives = 90/224 (40%), Gaps = 50/224 (22%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ----PQQITRAEYNLLSTLMHA 156
RYE +G G + V +A D+ ++VA+K+I R + ++I R E +L+ L H
Sbjct: 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR-EIAILNRLNHD 112
Query: 157 HIPTALALFENAPVPGTDT-----IVMQLVHGES-LIQHLCRQSTITESYICCIIRQLHS 210
H+ + + + + +V+++ +S + +TE +I ++ L
Sbjct: 113 HV---VKVLDIVIPKDVEKFDELYVVLEIA--DSDFKKLFRTPVYLTELHIKTLLYNLLV 167
Query: 211 ALHCLHSQQIAHKDIRPENILMNGA-VLKLIDLGSSVSVSTVVLPDLEFAS--------- 260
+ +HS I H+D++P N L+N +K+ D G + +V + +
Sbjct: 168 GVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNL 227
Query: 261 ------------------------PEMLTSPATAGPSTDMWSLG 280
PE++ + D+WS+G
Sbjct: 228 VTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIG 271
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-13
Identities = 27/164 (16%), Positives = 53/164 (32%), Gaps = 20/164 (12%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPT 160
++ +++G+G F + A + A + E Q +E +
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK 97
Query: 161 ALALFENAPVPGTDTI----------------VMQLVHGESLIQHLCRQSTITESYICCI 204
+ G VM+ G L + + T +S + +
Sbjct: 98 KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMER-LGIDLQKISGQNGTFKKSTVLQL 156
Query: 205 IRQLHSALHCLHSQQIAHKDIRPENILM---NGAVLKLIDLGSS 245
++ L +H + H DI+ N+L+ N + L D G S
Sbjct: 157 GIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLS 200
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 59/288 (20%), Positives = 102/288 (35%), Gaps = 25/288 (8%)
Query: 76 CINNEYKVLYTVPFETRWQQEQFEHRYEEL---ERLGNGRFCTVRKARDRGTGQLVALKQ 132
C + P ++ +E E L +LG G F V GT + VA+K
Sbjct: 157 CHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKT 215
Query: 133 IPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHL-- 190
+ + E ++ L H + A+ P+ IV + + SL+ L
Sbjct: 216 LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI----YIVTEYMSKGSLLDFLKG 271
Query: 191 CRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGA-VLKLIDLGSS---- 245
+ + + Q+ S + + H+D+R NIL+ V K+ D G +
Sbjct: 272 ETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 331
Query: 246 ----VSVSTVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEE 300
+ P +++ +PE S D+WS G+LL L + G P+ E
Sbjct: 332 DNEYTARQGAKFP-IKWTAPEAALYGRFTIKS-DVWSFGILLTELTTKGRVPYPGMVNRE 389
Query: 301 TRAHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQV 348
+ P +C +L+ Q ++RPT L
Sbjct: 390 VLDQVERGYRMPCPPEC---PESLHDLMCQCWRKEPEERPTFEYLQAF 434
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 45/227 (19%), Positives = 83/227 (36%), Gaps = 37/227 (16%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE-RQPQQITRA--EYNLLSTLMHAH 157
Y +G G + V A D+ T + VA+K++ R R E +L+ L +
Sbjct: 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDY 86
Query: 158 IPTALALFENAPVPGTDT---IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHC 214
I L IV+++ L + +TE +I I+ L +
Sbjct: 87 IIRLYDLII-PDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLGENF 144
Query: 215 LHSQQIAHKDIRPENILMNGA-VLKLIDLGSSVSVSTVVLPDLEFAS------------- 260
+H I H+D++P N L+N +K+ D G + ++++ ++
Sbjct: 145 IHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNL 204
Query: 261 ---------------PEMLTSPATAGPSTDMWSLGVLLYILLSGVSP 292
PE++ S D+WS G + LL+ +
Sbjct: 205 KKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 3e-13
Identities = 55/252 (21%), Positives = 91/252 (36%), Gaps = 67/252 (26%)
Query: 96 EQFEHRYEELERLGNGRFCTVRKARDRGTGQ-LVALKQIPRERQPQQITRAEYNLLSTLM 154
+ + RYE + LG G F V + D G+ VALK I + ++ R E N+L +
Sbjct: 15 DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIK 74
Query: 155 HA------HIPTALALFENAPVPGTDT--------IVMQLVHGESLIQHLCRQST--ITE 198
V +D I +L+ G++ + L +
Sbjct: 75 EKDKENKFLC-----------VLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPL 122
Query: 199 SYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN--------------------GAVLK 238
++ + QL AL LH Q+ H D++PENIL ++
Sbjct: 123 PHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIR 182
Query: 239 LIDLGSSV----SVSTVVLPDLEFAS-----PE-MLTSPATAGPSTDMWSLGVLLYILLS 288
+ D GS+ +T+V + PE +L D+WS+G +L+
Sbjct: 183 VADFGSATFDHEHHTTIVA------TRHYRPPEVILELG--WAQPCDVWSIGCILFEYYR 234
Query: 289 GVSPFLDESEEE 300
G + F E
Sbjct: 235 GFTLFQTHENRE 246
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 4e-13
Identities = 56/244 (22%), Positives = 93/244 (38%), Gaps = 51/244 (20%)
Query: 96 EQFEHRYEELERLGNGRFCTVRKARDRGTG-QLVALKQIPRERQPQQITRAEYNLLSTLM 154
+ RYE ++ LG G F V + D G + VA+K + + + R+E +L L
Sbjct: 10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLN 69
Query: 155 HA------HIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQST--ITESYICCIIR 206
L FE+ G IV +L+ G S + +I +
Sbjct: 70 TTDPNSTFRCVQMLEWFEHH---GHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAY 125
Query: 207 QLHSALHCLHSQQIAHKDIRPENILMN--------------------GAVLKLIDLGSSV 246
Q+ +++ LHS ++ H D++PENIL +K++D GS+
Sbjct: 126 QICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSAT 185
Query: 247 ----SVSTVVLPDLEFAS-----PE-MLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDE 296
ST+V + PE +L D+WS+G +L G + F
Sbjct: 186 YDDEHHSTLVS------TRHYRAPEVILALG--WSQPCDVWSIGCILIEYYLGFTVFPTH 237
Query: 297 SEEE 300
+E
Sbjct: 238 DSKE 241
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 6e-13
Identities = 57/277 (20%), Positives = 100/277 (36%), Gaps = 25/277 (9%)
Query: 87 VPFETRWQQEQFEHRYEEL---ERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQIT 143
P ++ +E E L +LG G F V GT + VA+K + +
Sbjct: 251 KPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAF 309
Query: 144 RAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHL--CRQSTITESYI 201
E ++ L H + A+ P+ IV + + SL+ L + +
Sbjct: 310 LQEAQVMKKLRHEKLVQLYAVVSEEPI----YIVTEYMSKGSLLDFLKGETGKYLRLPQL 365
Query: 202 CCIIRQLHSALHCLHSQQIAHKDIRPENILMNGA-VLKLIDLGSS--------VSVSTVV 252
+ Q+ S + + H+D+R NIL+ V K+ D G + +
Sbjct: 366 VDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK 425
Query: 253 LPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYS 311
P +++ +PE +D+WS G+LL L + G P+ E +
Sbjct: 426 FP-IKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM 483
Query: 312 FPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQV 348
P +C +L+ Q ++RPT L
Sbjct: 484 PCPPEC---PESLHDLMCQCWRKEPEERPTFEYLQAF 517
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 67/287 (23%), Positives = 115/287 (40%), Gaps = 41/287 (14%)
Query: 86 TVPFETRWQQEQFEHRYEEL---ERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQI 142
V ++++ +E+L E++G G F V R R LVA+K P
Sbjct: 97 GVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLK 156
Query: 143 TR--AEYNLLSTLMHAHIPTALAL-FENAPVPGTDTIVMQLVHGESLIQHL-CRQSTITE 198
+ E +L H +I + + + P+ IVM+LV G + L + +
Sbjct: 157 AKFLQEARILKQYSHPNIVRLIGVCTQKQPI----YIVMELVQGGDFLTFLRTEGARLRV 212
Query: 199 SYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGA-VLKLIDLGSS---------VSV 248
+ ++ + + L S+ H+D+ N L+ VLK+ D G S S
Sbjct: 213 KTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASG 272
Query: 249 STVVLPDLEFASPEMLT----SPATAGPSTDMWSLGVLLY-ILLSGVSPFLDESEEETRA 303
+P +++ +PE L S +D+WS G+LL+ G SP+ + S ++TR
Sbjct: 273 GLRQVP-VKWTAPEALNYGRYSSE-----SDVWSFGILLWETFSLGASPYPNLSNQQTRE 326
Query: 304 HISVADYSFP-PEQCGHISVPAR--ELIGQLLNTHADKRPTAGQLLQ 347
+ P PE C P L+ Q +RP+ + Q
Sbjct: 327 FVE-KGGRLPCPELC-----PDAVFRLMEQCWAYEPGQRPSFSTIYQ 367
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 5e-12
Identities = 55/301 (18%), Positives = 121/301 (40%), Gaps = 27/301 (8%)
Query: 82 KVLYTVPFETRWQQEQFEHRYEEL---ERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ 138
K + +++E ++ +LG G++ V + + VA+K + +
Sbjct: 199 KRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM 258
Query: 139 PQQITRAEYNLLSTLMHAHIPTALAL-FENAPVPGTDTIVMQLVHGESLIQHL--CRQST 195
+ E ++ + H ++ L + P I+ + + +L+ +L C +
Sbjct: 259 EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF----YIITEFMTYGNLLDYLRECNRQE 314
Query: 196 ITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGA-VLKLIDLGSS--------V 246
++ + + Q+ SA+ L + H+++ N L+ ++K+ D G S
Sbjct: 315 VSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT 374
Query: 247 SVSTVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHI 305
+ + P +++ +PE L + S D+W+ GVLL+ + + G+SP+ + +
Sbjct: 375 AHAGAKFP-IKWTAPESLAYNKFSIKS-DVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 432
Query: 306 SVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQV--AWFAEASCSEFDTER 363
PE C EL+ + RP+ ++ Q F E+S S+ +
Sbjct: 433 EKDYRMERPEGC---PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKE 489
Query: 364 L 364
L
Sbjct: 490 L 490
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 5e-10
Identities = 60/260 (23%), Positives = 105/260 (40%), Gaps = 30/260 (11%)
Query: 105 LERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALAL 164
++LG G+F V A + VA+K + + AE N++ TL H + A+
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 165 FENAPVPGTDTIVMQLVHGESLIQHL--CRQSTITESYICCIIRQLHSALHCLHSQQIAH 222
P+ I+ + + SL+ L S + Q+ + + + H
Sbjct: 252 VTKEPI----YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIH 307
Query: 223 KDIRPENILMNGA-VLKLIDLGSSVSVSTVVLPDLEFASPEML------TSP--ATAGPS 273
+D+R NIL++ + V K+ D G + V+ D E+ + E T+P G
Sbjct: 308 RDLRAANILVSASLVCKIADFGLA-----RVIEDNEYTAREGAKFPIKWTAPEAINFGSF 362
Query: 274 T---DMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFP-PEQCGHISVPARELI 328
T D+WS G+LL +++ G P+ S E + Y P PE C ++
Sbjct: 363 TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENC---PEELYNIM 418
Query: 329 GQLLNTHADKRPTAGQLLQV 348
+ ++RPT + V
Sbjct: 419 MRCWKNRPEERPTFEYIQSV 438
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 5e-09
Identities = 31/203 (15%), Positives = 57/203 (28%), Gaps = 44/203 (21%)
Query: 65 DDLAPGHTYTFCINNEYKVLYTVPFETRWQQEQFEHRYEELERLGNGRFCTVRKARDR-- 122
+ A G T +KV +G G F + A
Sbjct: 21 EQFAVGEIITDMAAAAWKVG---------------------LPIGQGGFGCIYLADMNSS 59
Query: 123 ---GTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVP-----GTD 174
G+ +K P + P Y + + VP G
Sbjct: 60 ESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLH 119
Query: 175 T--------IVMQLVHGESLIQHLCRQS-TITESYICCIIRQLHSALHCLHSQQIAHKDI 225
++M G L + + + + + ++ L +H + H DI
Sbjct: 120 DKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDI 178
Query: 226 RPENILM---NGAVLKLIDLGSS 245
+ N+L+ N + L+D G +
Sbjct: 179 KASNLLLNYKNPDQVYLVDYGLA 201
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 7e-09
Identities = 57/286 (19%), Positives = 115/286 (40%), Gaps = 46/286 (16%)
Query: 105 LERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALAL 164
+LG G++ V + + VA+K + + + E ++ + H ++ L +
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 165 -FENAPVPGTDTIVMQLVHGESLIQHL--CRQSTITESYICCIIRQLHSALHCLHSQQIA 221
P I+ + + +L+ +L C + ++ + + Q+ SA+ L +
Sbjct: 78 CTREPPF----YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFI 133
Query: 222 HKDIRPENILMN-GAVLKLIDLGSSVSVSTVVLPDLEFAS-----------PEML----- 264
H+D+ N L+ ++K+ D G +S ++ D A PE L
Sbjct: 134 HRDLAARNCLVGENHLVKVADFG----LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 189
Query: 265 TSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFP-PEQCGHISV 322
+ +D+W+ GVLL+ + + G+SP+ + + DY PE C
Sbjct: 190 SI------KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGC----- 237
Query: 323 PAR--ELIGQLLNTHADKRPTAGQLLQV--AWFAEASCSEFDTERL 364
P + EL+ + RP+ ++ Q F E+S S+ + L
Sbjct: 238 PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 283
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 8e-09
Identities = 47/234 (20%), Positives = 90/234 (38%), Gaps = 37/234 (15%)
Query: 105 LERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALAL 164
++ +G+G+F V + VA+K I ++ E ++ L H + +
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 165 -FENAPVPGTDTIVMQLVHGESLIQHL-CRQSTITESYICCIIRQLHSALHCLHSQQIAH 222
E AP+ +V + + L +L ++ + + + + L + H
Sbjct: 72 CLEQAPI----CLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIH 127
Query: 223 KDIRPENILMN-GAVLKLIDLGSSVSVSTVVLPDLEFAS-----------PEML-----T 265
+D+ N L+ V+K+ D G ++ VL D +S PE+ +
Sbjct: 128 RDLAARNCLVGENQVIKVSDFG----MTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 183
Query: 266 SPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFP-PEQC 317
S +D+WS GVL++ + S G P+ + S E IS + P
Sbjct: 184 S------KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLA 230
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 1e-08
Identities = 54/249 (21%), Positives = 101/249 (40%), Gaps = 40/249 (16%)
Query: 93 WQQEQFEHRYEEL---ERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNL 149
W ++++E E L ERLG G+F V G + VA+K + + AE NL
Sbjct: 3 WWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANL 61
Query: 150 LSTLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHL--CRQSTITESYICCIIRQ 207
+ L H + A+ P+ I+ + + SL+ L +T + + + Q
Sbjct: 62 MKQLQHQRLVRLYAVVTQEPI----YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 208 LHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVSTVVLPDLEFAS------ 260
+ + + + H+D+R NIL++ K+ D G ++ ++ + A
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFG----LARLIEDNEYTAREGAKFP 173
Query: 261 -----PEML-----TSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVAD 309
PE + T +D+WS G+LL +++ G P+ + E ++
Sbjct: 174 IKWTAPEAINYGTFTI------KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RG 226
Query: 310 YSFP-PEQC 317
Y P+ C
Sbjct: 227 YRMVRPDNC 235
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 60/228 (26%), Positives = 99/228 (43%), Gaps = 32/228 (14%)
Query: 84 LYTVPFETRWQQEQFEHRYEELER-LGNGRFCTVRKAR----DRGTGQLVALKQIPRERQ 138
V F+ F RY + R LG G F V + GTG++VA+K + +
Sbjct: 14 ALEVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAG 73
Query: 139 PQQIT--RAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTI 196
PQ + + E ++L TL H HI E+A +VM+ V SL +L + +I
Sbjct: 74 PQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASL-QLVMEYVPLGSLRDYL-PRHSI 131
Query: 197 TESYICCIIRQLHSALHCLHSQQIAHKDIRPENILM-NGAVLKLIDLGSS---------- 245
+ + +Q+ + LH+Q H+D+ N+L+ N ++K+ D G +
Sbjct: 132 GLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY 191
Query: 246 VSVSTVVLPDLEFASPEML-----TSPATAGPSTDMWSLGVLLYILLS 288
P + + +PE L ++D+WS GV LY LL+
Sbjct: 192 RVREDGDSP-VFWYAPECLKEYKFYY------ASDVWSFGVTLYELLT 232
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 24/167 (14%), Positives = 54/167 (32%), Gaps = 27/167 (16%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQL--------VALKQIPRERQPQQITRAEYNLLST 152
+++ + +A T +LK + + + + +
Sbjct: 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAK 101
Query: 153 LMHAHIPTALALFENAPVP-----GTDT-----IVMQLVHGESLIQHL---CRQSTITES 199
+ + L +P G +V+ + G SL Q + ++E
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSL-QSALDVSPKHVLSER 159
Query: 200 YICCIIRQLHSALHCLHSQQIAHKDIRPENILM---NGAVLKLIDLG 243
+ + +L AL LH + H ++ ENI + + + + L G
Sbjct: 160 SVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYG 206
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 56/265 (21%), Positives = 99/265 (37%), Gaps = 37/265 (13%)
Query: 105 LERLGNGRFCTVRKARDRGTGQ---LVALKQIPRERQPQQITR--AEYNLLSTLMHAHIP 159
+G G+F V + VA+K + E + H HI
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 160 TALALFENAPVPGTDTIVMQLVHGESLIQHL-CRQSTITESYICCIIRQLHSALHCLHSQ 218
+ + PV I+M+L L L R+ ++ + + QL +AL L S+
Sbjct: 455 KLIGVITENPV----WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK 510
Query: 219 QIAHKDIRPENILMN-GAVLKLIDLG-------SSVSVSTVVLPDLEFASPEML-----T 265
+ H+DI N+L++ +KL D G S+ ++ +++ +PE + T
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 570
Query: 266 SPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPA 324
S ++D+W GV ++ +L GV PF + I + P C P
Sbjct: 571 S------ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC-----PP 619
Query: 325 R--ELIGQLLNTHADKRPTAGQLLQ 347
L+ + +RP +L
Sbjct: 620 TLYSLMTKCWAYDPSRRPRFTELKA 644
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 3e-08
Identities = 53/270 (19%), Positives = 99/270 (36%), Gaps = 48/270 (17%)
Query: 107 RLGNGRFCTVRKARDRGTGQL--VALKQIPRERQPQQITR---AEYNLLSTLMHAHIPTA 161
LG+G F TV+K + + VA+K + E + AE N++ L + +I
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 162 LALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIA 221
+ + E +VM++ L ++L + + + I ++ Q+ + L
Sbjct: 84 IGICEAESW----MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFV 139
Query: 222 HKDIRPENILMN-GAVLKLIDLGSSVSVSTVVLPDLEF-------------ASPEML--- 264
H+D+ N+L+ K+ D G +S + D + +PE +
Sbjct: 140 HRDLAARNVLLVTQHYAKISDFG----LSKALRADENYYKAQTHGKWPVKWYAPECINYY 195
Query: 265 --TSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFP-PEQCGHI 320
+S +D+WS GVL++ S G P+ E A + P C
Sbjct: 196 KFSS------KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGC--- 245
Query: 321 SVPAR--ELIGQLLNTHADKRPTAGQLLQV 348
P +L+ + RP +
Sbjct: 246 --PREMYDLMNLCWTYDVENRPGFAAVELR 273
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 3e-08
Identities = 47/234 (20%), Positives = 91/234 (38%), Gaps = 37/234 (15%)
Query: 105 LERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALAL 164
L+ LG+G+F V+ + +G VA+K I + E + L H + +
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 165 -FENAPVPGTDTIVMQLVHGESLIQHL-CRQSTITESYICCIIRQLHSALHCLHSQQIAH 222
+ P+ IV + + L+ +L + S + + + + L S Q H
Sbjct: 72 CSKEYPI----YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIH 127
Query: 223 KDIRPENILMN-GAVLKLIDLGSSVSVSTVVLPDLEFAS-----------PEML-----T 265
+D+ N L++ +K+ D G ++ VL D +S PE+ +
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFG----MTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYS 183
Query: 266 SPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFP-PEQC 317
S +D+W+ G+L++ + S G P+ + E +S + P
Sbjct: 184 S------KSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS-QGHRLYRPHLA 230
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 53.8 bits (129), Expect = 5e-08
Identities = 50/234 (21%), Positives = 94/234 (40%), Gaps = 35/234 (14%)
Query: 107 RLGNGRFCTVRKA--RDRGTGQLVALKQIPRERQPQQITR--AEYNLLSTLMHAHIPTAL 162
LG G F +VR+ R R VA+K + + + E ++ L + +I +
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 163 ALFENAPVPGTDTIVMQLVHGESLIQHL-CRQSTITESYICCIIRQLHSALHCLHSQQIA 221
+ + + +VM++ G L + L ++ I S + ++ Q+ + L +
Sbjct: 403 GVCQAEAL----MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 458
Query: 222 HKDIRPENILMN-GAVLKLIDLGSS----------VSVSTVVLPDLEFASPEML-----T 265
H+++ N+L+ K+ D G S + S P L++ +PE + +
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP-LKWYAPECINFRKFS 517
Query: 266 SPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFP-PEQC 317
S +D+WS GV ++ LS G P+ E A I P +C
Sbjct: 518 S------RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPEC 564
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 6e-08
Identities = 43/240 (17%), Positives = 95/240 (39%), Gaps = 42/240 (17%)
Query: 105 LERLGNGRFCTVRKAR----DRGTGQLVALKQIPRERQPQQITR--AEYNLLSTLMHAHI 158
++ LG+G F TV K VA+K++ P+ E +++++ + H+
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 159 PTALALFENAPVPGTDTIVMQLVHGESLIQHL-CRQSTITESYICCIIRQLHSALHCLHS 217
L + + V ++ QL+ L+ ++ + I Y+ Q+ ++ L
Sbjct: 80 CRLLGICLTSTV----QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 135
Query: 218 QQIAHKDIRPENILMN-GAVLKLIDLGSSVSVSTVVLPDLEFAS------------PEML 264
+++ H+D+ N+L+ +K+ D G ++ ++ + + E +
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFG----LAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 265 -----TSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFP-PEQC 317
T +D+WS GV ++ L++ G P+ E + + P P C
Sbjct: 192 LHRIYTH------QSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPIC 244
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 8e-08
Identities = 60/282 (21%), Positives = 116/282 (41%), Gaps = 37/282 (13%)
Query: 86 TVPFETRWQQEQFEHRYEEL---ERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQI 142
TV + + + + +EL + +G G F V RG VA+K I + Q
Sbjct: 176 TVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGN--KVAVKCIKNDATAQAF 233
Query: 143 TRAEYNLLSTLMHAHIPTALA--LFENAPVPGTDTIVMQLVHGESLIQHL--CRQSTITE 198
E ++++ L H+++ L + E + IV + + SL+ +L +S +
Sbjct: 234 LA-EASVMTQLRHSNLVQLLGVIVEEKGGL----YIVTEYMAKGSLVDYLRSRGRSVLGG 288
Query: 199 SYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVSTVV----L 253
+ + A+ L H+D+ N+L++ V K+ D G + S+ L
Sbjct: 289 DCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL 348
Query: 254 PDLEFASPEML-----TSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISV 307
P +++ +PE L ++ +D+WS G+LL+ + S G P+ ++ +
Sbjct: 349 P-VKWTAPEALREKKFST------KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE- 400
Query: 308 ADYSFP-PEQCGHISVPARELIGQLLNTHADKRPTAGQLLQV 348
Y P+ C +++ + A RPT QL +
Sbjct: 401 KGYKMDAPDGC---PPAVYDVMKNCWHLDAATRPTFLQLREQ 439
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 9e-08
Identities = 50/267 (18%), Positives = 96/267 (35%), Gaps = 33/267 (12%)
Query: 105 LERLGNGRFCTVRKARDRGTGQL-------VALKQIPRERQPQQIT-RAEYNLLSTLMHA 156
E LG G F + K R G V LK + + + + +++S L H
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 157 HIPTALAL-FENAPVPGTDTIVMQLVHGESLIQHL-CRQSTITESYICCIIRQLHSALHC 214
H+ + +V + V SL +L ++ I + + +QL +A+H
Sbjct: 73 HLVLNYGVCVCGDEN----ILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHF 128
Query: 215 LHSQQIAHKDIRPENILMNGAVLKLIDLGSSVSVS----TVVLPDLEF-------ASPEM 263
L + H ++ +NIL+ + + +S ++ + + PE
Sbjct: 129 LEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPEC 188
Query: 264 LTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFP-PEQCGHIS 321
+ +P +TD WS G L+ + S G P + + P P+
Sbjct: 189 IENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE-DRHQLPAPKAA---- 243
Query: 322 VPARELIGQLLNTHADKRPTAGQLLQV 348
LI ++ D RP+ +++
Sbjct: 244 -ELANLINNCMDYEPDHRPSFRAIIRD 269
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 51.9 bits (124), Expect = 1e-07
Identities = 29/143 (20%), Positives = 54/143 (37%), Gaps = 22/143 (15%)
Query: 107 RLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFE 166
++G+ F V++ RD G + + R E+ L L +P A
Sbjct: 123 KVGHTSFKKVKEKRDYG--------DLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEG 174
Query: 167 NAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIR 226
NA ++M+L+ + L + R E + + + + I H D+
Sbjct: 175 NA-------VLMELIDAKELYR--VRVENPDEVL-----DMILEEVAKFYHRGIVHGDLS 220
Query: 227 PENILMNGAVLKLIDLGSSVSVS 249
N+L++ + +ID SV V
Sbjct: 221 QYNVLVSEEGIWIIDFPQSVEVG 243
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 51/260 (19%), Positives = 95/260 (36%), Gaps = 46/260 (17%)
Query: 90 ETRWQQEQFEHRYEEL---ERLGNGRFCTVRKAR---DRGTGQLVALKQIPRERQPQQIT 143
E Q ++L E+LG+G F VR+ G VA+K + + Q
Sbjct: 5 EGPLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEA 64
Query: 144 R----AEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHL-CRQSTITE 198
E N + +L H ++ + P+ +V +L SL+ L Q
Sbjct: 65 MDDFIREVNAMHSLDHRNLIRLYGVVLTPPM----KMVTELAPLGSLLDRLRKHQGHFLL 120
Query: 199 SYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGA-VLKLIDLGSSVSVSTVVLPDLE 257
+ Q+ + L S++ H+D+ N+L+ ++K+ D G + + + +
Sbjct: 121 GTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFG----LMRALPQNDD 176
Query: 258 FA-------------SPEML-----TSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESE 298
+PE L + ++D W GV L+ + + G P++ +
Sbjct: 177 HYVMQEHRKVPFAWCAPESLKTRTFSH------ASDTWMFGVTLWEMFTYGQEPWIGLNG 230
Query: 299 EETRAHISVADYSFP-PEQC 317
+ I P PE C
Sbjct: 231 SQILHKIDKEGERLPRPEDC 250
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 1e-07
Identities = 55/267 (20%), Positives = 102/267 (38%), Gaps = 42/267 (15%)
Query: 107 RLGNGRFCTVRKARDRGTGQ--LVALKQIPRERQPQQITR--AEYNLLSTLMHAHIPTAL 162
LG G F +VR+ R + VA+K + + + E ++ L + +I +
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 163 ALFENAPVPGTDTIVMQLVHGESLIQHL-CRQSTITESYICCIIRQLHSALHCLHSQQIA 221
+ + + +VM++ G L + L ++ I S + ++ Q+ + L +
Sbjct: 77 GVCQAEAL----MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 132
Query: 222 HKDIRPENILMN-GAVLKLIDLGSS----------VSVSTVVLPDLEFASPEML-----T 265
H+D+ N+L+ K+ D G S + S P L++ +PE + +
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP-LKWYAPECINFRKFS 191
Query: 266 SPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFP-PEQCGHISVP 323
S +D+WS GV ++ LS G P+ E A I P +C P
Sbjct: 192 S------RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPEC-----P 239
Query: 324 AR--ELIGQLLNTHADKRPTAGQLLQV 348
L+ + RP + Q
Sbjct: 240 PELYALMSDCWIYKWEDRPDFLTVEQR 266
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 1e-07
Identities = 53/254 (20%), Positives = 105/254 (41%), Gaps = 40/254 (15%)
Query: 86 TVPFETRWQQEQFEHRYEEL---ERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQI 142
+V + + + + +EL + +G G F V RG VA+K I + Q
Sbjct: 4 SVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGN--KVAVKCIKNDATAQAF 61
Query: 143 TRAEYNLLSTLMHAHIPTALALF-----ENAPVPGTDTIVMQLVHGESLIQHL--CRQST 195
E ++++ L H+++ + L E + IV + + SL+ +L +S
Sbjct: 62 LA-EASVMTQLRHSNL---VQLLGVIVEEKGGL----YIVTEYMAKGSLVDYLRSRGRSV 113
Query: 196 ITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSS----VSVST 250
+ + + A+ L H+D+ N+L++ V K+ D G + + T
Sbjct: 114 LGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT 173
Query: 251 VVLPDLEFASPEML-----TSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAH 304
LP +++ +PE L ++ +D+WS G+LL+ + S G P+ ++
Sbjct: 174 GKLP-VKWTAPEALREKKFST------KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR 226
Query: 305 ISVADYSFP-PEQC 317
+ Y P+ C
Sbjct: 227 VE-KGYKMDAPDGC 239
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 1e-07
Identities = 57/271 (21%), Positives = 96/271 (35%), Gaps = 47/271 (17%)
Query: 105 LERLGNGRFCTVRKARDRGTGQ---LVALKQIPRERQPQQITR--AEYNLLSTLMHAHIP 159
+G G+F V + VA+K + E + H HI
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 160 TALALFENAPVPGTDTIVMQLVHGESLIQHL-CRQSTITESYICCIIRQLHSALHCLHSQ 218
+ + PV I+M+L L L R+ ++ + + QL +AL L S+
Sbjct: 80 KLIGVITENPV----WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK 135
Query: 219 QIAHKDIRPENILMN-GAVLKLIDLGSSVSVSTVVLPDLEFAS-----------PEML-- 264
+ H+DI N+L++ +KL D G +S + + + PE +
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFG----LSRYMEDSTYYKASKGKLPIKWMAPESINF 191
Query: 265 ---TSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFP-PEQCGH 319
TS ++D+W GV ++ +L GV PF + I P P C
Sbjct: 192 RRFTS------ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNC-- 242
Query: 320 ISVPAR--ELIGQLLNTHADKRPTAGQLLQV 348
P L+ + +RP +L
Sbjct: 243 ---PPTLYSLMTKCWAYDPSRRPRFTELKAQ 270
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 49/241 (20%), Positives = 95/241 (39%), Gaps = 43/241 (17%)
Query: 105 LERLGNGRFCTVRKARDRGTGQ---LVALKQIPRERQPQQITR--AEYNLLSTLMHAHIP 159
+ +G+G V R R GQ VA+K + +Q +E +++ H +I
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 160 TALA-LFENAPVPGTDTIVMQLVHGESLIQHL-CRQSTITESYICCIIRQLHSALHCLHS 217
+ IV + + SL L T + ++R + + + L
Sbjct: 114 RLEGVVTRGRLA----MIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD 169
Query: 218 QQIAHKDIRPENILMN-GAVLKLIDLGSSVSVSTVVLPDLEFA-------------SPEM 263
H+D+ N+L++ V K+ D G +S V+ D + A +PE
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFG----LSRVLEDDPDAAYTTTGGKIPIRWTAPEA 225
Query: 264 L-----TSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFP-PEQ 316
+ +S ++D+WS GV+++ +L+ G P+ + + + + + Y P P
Sbjct: 226 IAFRTFSS------ASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE-EGYRLPAPMG 278
Query: 317 C 317
C
Sbjct: 279 C 279
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 55/241 (22%), Positives = 97/241 (40%), Gaps = 43/241 (17%)
Query: 105 LERLGNGRFCTVRKARDRGTGQ---LVALKQIPRERQPQQITR--AEYNLLSTLMHAHIP 159
+ +G G F V R + + VA+K + +Q E +++ H +I
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 160 TALA-LFENAPVPGTDTIVMQLVHGESLIQHL-CRQSTITESYICCIIRQLHSALHCLHS 217
+ ++ PV IV + + SL L + T + ++R + S + L
Sbjct: 110 RLEGVVTKSKPV----MIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 165
Query: 218 QQIAHKDIRPENILMN-GAVLKLIDLGSSVSVSTVVLPDLEFA-------------SPEM 263
H+D+ NIL+N V K+ D G + V+ D E A SPE
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFG----LGRVLEDDPEAAYTTRGGKIPIRWTSPEA 221
Query: 264 L-----TSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFP-PEQ 316
+ TS ++D+WS G++L+ ++S G P+ + S ++ + Y P P
Sbjct: 222 IAYRKFTS------ASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGYRLPPPMD 274
Query: 317 C 317
C
Sbjct: 275 C 275
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 2e-07
Identities = 54/234 (23%), Positives = 96/234 (41%), Gaps = 37/234 (15%)
Query: 105 LERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALAL 164
L+ LG G+F V+ + RG VA+K I + E ++ L H + +
Sbjct: 29 LKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 165 -FENAPVPGTDTIVMQLVHGESLIQHL-CRQSTITESYICCIIRQLHSALHCLHSQQIAH 222
+ P+ I+ + + L+ +L + + + + + A+ L S+Q H
Sbjct: 88 CTKQRPI----FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 143
Query: 223 KDIRPENILMNGA-VLKLIDLGSSVSVSTVVLPDLEFAS-----------PEML-----T 265
+D+ N L+N V+K+ D G +S VL D +S PE+L +
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFG----LSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 199
Query: 266 SPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFP-PEQC 317
S +D+W+ GVL++ + S G P+ + ET HI+ P
Sbjct: 200 S------KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLA 246
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 50.3 bits (119), Expect = 4e-07
Identities = 29/188 (15%), Positives = 57/188 (30%), Gaps = 49/188 (26%)
Query: 92 RWQQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRA------ 145
+ + + E++G G F V + T VA+K I E
Sbjct: 12 PFSHCLPTEKLQRCEKIGEGVFGEVFQTIADHT--PVAIKIIAIEGPDLVNGSHQKTFEE 69
Query: 146 ---------EYNLLSTLMHAHIPTALALFENAPVPGTDT--------------------- 175
E +LLS + + L V G+
Sbjct: 70 ILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRP 129
Query: 176 ---------IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQ-QIAHKDI 225
IV++ G ++ + + + + I+ QL ++L + + H+D+
Sbjct: 130 DFFKDDQLFIVLEFEFGGIDLEQMRTK-LSSLATAKSILHQLTASLAVAEASLRFEHRDL 188
Query: 226 RPENILMN 233
N+L+
Sbjct: 189 HWGNVLLK 196
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 5e-07
Identities = 53/250 (21%), Positives = 96/250 (38%), Gaps = 49/250 (19%)
Query: 81 YKVLYTVPFETRWQQEQFEHRYEELER-LGNGRFCTVRKAR----DRGTGQLVALKQIPR 135
+ + + + FE R+ + LG G F +V R TG LVA+KQ+ +
Sbjct: 4 HHHHHAQLYACQDPTI-FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL-Q 61
Query: 136 ERQPQQIT--RAEYNLLSTLMHAHIPTALALFENAPVPGTDT----IVMQLVHGESLIQH 189
P Q + E +L L I + G +VM+ + L
Sbjct: 62 HSGPDQQRDFQREIQILKALHSDFIVKYRGV-----SYGPGRQSLRLVMEYLPSGCLRDF 116
Query: 190 L-CRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILM-NGAVLKLIDLGSSVS 247
L ++ + S + Q+ + L S++ H+D+ NIL+ + A +K+ D G
Sbjct: 117 LQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFG---- 172
Query: 248 VSTVVLPDLEFA-------------SPEML-----TSPATAGPSTDMWSLGVLLYILLS- 288
++ ++ D ++ +PE L + +D+WS GV+LY L +
Sbjct: 173 LAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSR------QSDVWSFGVVLYELFTY 226
Query: 289 GVSPFLDESE 298
+E
Sbjct: 227 CDKSCSPSAE 236
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 7e-07
Identities = 40/227 (17%), Positives = 92/227 (40%), Gaps = 40/227 (17%)
Query: 105 LERLGNGRFCTVRKAR----DRGTGQLVALKQIPRERQPQQITR--AEYNLLSTLMHAHI 158
++ LG+G F TV K VA+K++ P+ E +++++ + H+
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 159 PTALALFENAPVPGTDTIVMQLVHGESLIQHL-CRQSTITESYICCIIRQLHSALHCLHS 217
L + + V ++ QL+ L+ ++ + I Y+ Q+ ++ L
Sbjct: 80 CRLLGICLTSTV----QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 135
Query: 218 QQIAHKDIRPENILMN-GAVLKLIDLGSSVSVSTVVLPDLEFAS------------PEML 264
+++ H+D+ N+L+ +K+ D G ++ ++ + + E +
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFG----LAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 265 -----TSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHI 305
T +D+WS GV ++ L++ G P+ E + +
Sbjct: 192 LHRIYTH------QSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 8e-07
Identities = 49/238 (20%), Positives = 89/238 (37%), Gaps = 40/238 (16%)
Query: 105 LERLGNGRFCTVRKARDRGTGQL---VALKQIPRERQPQQITR--AEYNLLSTLMHAHIP 159
LG G F V + VA+K ++ + +E ++ L H HI
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 160 TALALFENAPVPGTDTIVMQLVHGESLIQHL-CRQSTITESYICCIIRQLHSALHCLHSQ 218
+ + E P I+M+L L +L ++++ + Q+ A+ L S
Sbjct: 77 KLIGIIEEEPT----WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI 132
Query: 219 QIAHKDIRPENILMN-GAVLKLIDLGSSVSVSTVVLPDLEFAS-----------PEML-- 264
H+DI NIL+ +KL D G +S + + + + PE +
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFG----LSRYIEDEDYYKASVTRLPIKWMSPESINF 188
Query: 265 ---TSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFP-PEQC 317
T+ ++D+W V ++ +LS G PF ++ + P P+ C
Sbjct: 189 RRFTT------ASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-KGDRLPKPDLC 239
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 9e-07
Identities = 42/215 (19%), Positives = 84/215 (39%), Gaps = 42/215 (19%)
Query: 106 ERLGNGRFCTVRKAR----DRGTGQLVA---LKQIPRERQPQQITRAEYNLLSTLMHAHI 158
+ LG+G F TV K V ++ + Q +T + +L HAHI
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTD-HMLAIGSLDHAHI 77
Query: 159 PTALALFENAPVPGTDTIVMQLVHGESLIQHL-CRQSTITESYICCIIRQLHSALHCLHS 217
L L + + +V Q + SL+ H+ + + + Q+ ++ L
Sbjct: 78 VRLLGLCPGSSL----QLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE 133
Query: 218 QQIAHKDIRPENILMN-GAVLKLIDLGSSVSVSTVVLPDLEFAS------------PEML 264
+ H+++ N+L+ + +++ D G V+ ++ PD + E +
Sbjct: 134 HGMVHRNLAARNVLLKSPSQVQVADFG----VADLLPPDDKQLLYSEAKTPIKWMALESI 189
Query: 265 -----TSPATAGPSTDMWSLGVLLYILLS-GVSPF 293
T +D+WS GV ++ L++ G P+
Sbjct: 190 HFGKYTH------QSDVWSYGVTVWELMTFGAEPY 218
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 48/242 (19%), Positives = 97/242 (40%), Gaps = 44/242 (18%)
Query: 105 LERLGNGRFCTVRKARDRGTG----QLVALKQIPRERQPQQITR--AEYNLLSTLMHAHI 158
+ +G G F V K + + VA+K + +Q E ++ H +I
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 159 PTALAL-FENAPVPGTDTIVMQLVHGESLIQHL-CRQSTITESYICCIIRQLHSALHCLH 216
+ + P+ I+ + + +L + L + + + ++R + + + L
Sbjct: 109 IRLEGVISKYKPM----MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA 164
Query: 217 SQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVSTVVLPDLEFA-------------SPE 262
+ H+D+ NIL+N V K+ D G +S V+ D E +PE
Sbjct: 165 NMNYVHRDLAARNILVNSNLVCKVSDFG----LSRVLEDDPEATYTTSGGKIPIRWTAPE 220
Query: 263 ML-----TSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFP-PE 315
+ TS ++D+WS G++++ +++ G P+ + S E I+ + P P
Sbjct: 221 AISYRKFTS------ASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFRLPTPM 273
Query: 316 QC 317
C
Sbjct: 274 DC 275
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 2e-06
Identities = 53/241 (21%), Positives = 101/241 (41%), Gaps = 46/241 (19%)
Query: 78 NNEYKVLYTVPFETRWQQEQFEHRYEELER-LGNGRFCTVRKAR----DRGTGQLVALKQ 132
N ++ FE R + FE R+ + + LG G F +V R TG++VA+K+
Sbjct: 19 NLYFQGAMGSAFEDRDPTQ-FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK 77
Query: 133 IPRERQPQQIT--RAEYNLLSTLMHAHIPTALAL---FENAPVPGTDTIVMQLVHGESLI 187
+ + + + E +L +L H +I + + ++M+ + SL
Sbjct: 78 L-QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL----KLIMEYLPYGSLR 132
Query: 188 QHL-CRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILM-NGAVLKLIDLGSS 245
+L + I + Q+ + L +++ H+D+ NIL+ N +K+ D G
Sbjct: 133 DYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG-- 190
Query: 246 VSVSTVVLPDLEFA-------------SPEML-----TSPATAGPSTDMWSLGVLLYILL 287
++ V+ D E+ +PE L + ++D+WS GV+LY L
Sbjct: 191 --LTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSV------ASDVWSFGVVLYELF 242
Query: 288 S 288
+
Sbjct: 243 T 243
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 2e-06
Identities = 51/222 (22%), Positives = 95/222 (42%), Gaps = 45/222 (20%)
Query: 97 QFEHRYEELER-LGNGRFCTVRKAR----DRGTGQLVALKQIPRERQPQQIT--RAEYNL 149
QFE R+ + + LG G F +V R TG++VA+K++ + + + E +
Sbjct: 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHLRDFEREIEI 64
Query: 150 LSTLMHAHIPTALAL---FENAPVPGTDTIVMQLVHGESLIQHL-CRQSTITESYICCII 205
L +L H +I + + ++M+ + SL +L + I +
Sbjct: 65 LKSLQHDNIVKYKGVCYSAGRRNL----KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 120
Query: 206 RQLHSALHCLHSQQIAHKDIRPENILM-NGAVLKLIDLGSSVSVSTVVLPDLEFA----- 259
Q+ + L +++ H+D+ NIL+ N +K+ D G ++ V+ D EF
Sbjct: 121 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG----LTKVLPQDKEFFKVKEP 176
Query: 260 --------SPEML-----TSPATAGPSTDMWSLGVLLYILLS 288
+PE L + ++D+WS GV+LY L +
Sbjct: 177 GESPIFWYAPESLTESKFSV------ASDVWSFGVVLYELFT 212
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 52/236 (22%), Positives = 91/236 (38%), Gaps = 44/236 (18%)
Query: 83 VLYTVPFETRWQQEQFEHRYEELER-LGNGRFCTVRKAR----DRGTGQLVALKQIPRER 137
++ T FE R+ + R LG G F V R TG+ VA+K + E
Sbjct: 3 IVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES 62
Query: 138 QPQQIT--RAEYNLLSTLMHAHIPTALA---LFENAPVPGTDTIVMQLVHGESLIQHL-C 191
I + E +L L H +I + ++M+ + SL ++L
Sbjct: 63 GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI----KLIMEFLPSGSLKEYLPK 118
Query: 192 RQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILM-NGAVLKLIDLGSSVSVST 250
++ I Q+ + L S+Q H+D+ N+L+ + +K+ D G ++
Sbjct: 119 NKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFG----LTK 174
Query: 251 VVLPDLEFAS-------------PEML-----TSPATAGPSTDMWSLGVLLYILLS 288
+ D E+ + PE L ++D+WS GV L+ LL+
Sbjct: 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYI------ASDVWSFGVTLHELLT 224
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 45.2 bits (106), Expect = 3e-05
Identities = 49/306 (16%), Positives = 87/306 (28%), Gaps = 95/306 (31%)
Query: 77 INNEYKVLYTVPFETRWQQEQFEHR-YEE-LERLGNGRFCTVRKARDRGTGQLVALKQIP 134
+ YK L + P +T +Q R Y E +RL N Q+ A +
Sbjct: 87 LRINYKFLMS-PIKTEQRQPSMMTRMYIEQRDRLYND-------------NQVFAKYNVS 132
Query: 135 RERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHG------ESLIQ 188
R + ++ + AL E P ++ + G +
Sbjct: 133 RLQPYLKLRQ------------------ALLELRPAKN---VL---IDGVLGSGKTWVAL 168
Query: 189 HLCRQSTITES------YI----CC----IIRQLHSALH---------CLHSQQIAHK-- 223
+C + ++ C ++ L L+ HS I +
Sbjct: 169 DVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIH 228
Query: 224 DIRPE-NILMNGAVLK--LIDLGSSVSVSTVVLPDLEFASPEMLTSPATAGPS-TDMWSL 279
I+ E L+ + L+ L +V + + +LT T TD S
Sbjct: 229 SIQAELRRLLKSKPYENCLLVL-LNVQ-NAKAWNAFNLSCKILLT---TRFKQVTDFLSA 283
Query: 280 GVLLYILLSGVSPFLDESEEET----RAHISVADYSFPPEQCG----HISVPARELIGQL 331
+I L S L E ++ D P E +S +I +
Sbjct: 284 ATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQD--LPREVLTTNPRRLS-----IIAES 336
Query: 332 LNTHAD 337
+
Sbjct: 337 IRDGLA 342
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 3e-04
Identities = 22/98 (22%), Positives = 48/98 (48%), Gaps = 12/98 (12%)
Query: 212 LHCLHSQQIAHKDIRPENILMNG---AVL------KLIDLGSSVSVSTVVLPDLEFASPE 262
++ LH H+DI+ NIL++ A + + + + +++ ++ + +PE
Sbjct: 146 INFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPE 205
Query: 263 MLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEE 300
L T +D++S GV+L +++G+ +DE E
Sbjct: 206 ALRGEITP--KSDIYSFGVVLLEIITGLPA-VDEHREP 240
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 4e-04
Identities = 48/241 (19%), Positives = 88/241 (36%), Gaps = 37/241 (15%)
Query: 103 EELERLGNGRFCTVRKARDRGTGQ---LVA---LKQIPRERQPQQITRAEYNLLSTLMHA 156
+G G F V Q A L +I +Q + R E L+ L H
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLR-EGLLMRGLNHP 82
Query: 157 HIPTALAL-FENAPVPGTDTIVMQLVHGESLIQHL-CRQSTITESYICCIIRQLHSALHC 214
++ + + +P +++ + L+Q + Q T + Q+ +
Sbjct: 83 NVLALIGIMLPPEGLP---HVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEY 139
Query: 215 LHSQQIAHKDIRPENILMN-GAVLKLIDLG-----------SSVSVSTVVLPDLEFASPE 262
L Q+ H+D+ N +++ +K+ D G S LP +++ + E
Sbjct: 140 LAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLP-VKWTALE 198
Query: 263 ML-----TSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQ 316
L T+ +D+WS GVLL+ LL+ G P+ + ++ PE
Sbjct: 199 SLQTYRFTT------KSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEY 252
Query: 317 C 317
C
Sbjct: 253 C 253
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 4e-04
Identities = 43/274 (15%), Positives = 95/274 (34%), Gaps = 41/274 (14%)
Query: 105 LERLGNGRFCTVRKAR---DRGTGQLVALKQIPRERQPQQITRA---EYNLLSTLMHAHI 158
LG G F +VR+A+ + G+ VA+K + + E + H H+
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 159 PTALAL-FENAPVPGTDT--IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHC- 214
+ + + +++ + L L + + + +
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 215 -----LHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSV---------STVVLPDLEFA 259
L S+ H+D+ N ++ + + D G S + LP +++
Sbjct: 148 CGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLP-VKWL 206
Query: 260 SPEML-----TSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFP 313
+ E L T +D+W+ GV ++ +++ G +P+ E ++ +
Sbjct: 207 ALESLADNLYTV------HSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQ 260
Query: 314 PEQCGHISVPARELIGQLLNTHADKRPTAGQLLQ 347
P +C +L+ Q + +RP+ L
Sbjct: 261 PPEC---MEEVYDLMYQCWSADPKQRPSFTCLRM 291
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 6e-04
Identities = 73/307 (23%), Positives = 112/307 (36%), Gaps = 90/307 (29%)
Query: 102 YEELER----------LGNGRFCTVRKARDRGTGQLVALKQIPRE-RQPQQITRAEYNLL 150
+LE +G+G F V K R G VALK+ E Q + E L
Sbjct: 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD-GAKVALKRRTPESSQGIEEFETEIETL 89
Query: 151 STLMHAHIPTALALFENAPVP--G--TDTIVMQLV-----HGESLIQHLCRQSTITES-- 199
S H H+ V G + M L+ +G +L +HL T S
Sbjct: 90 SFCRHPHL-----------VSLIGFCDERNEMILIYKYMENG-NLKRHLYGSDLPTMSMS 137
Query: 200 -----YICCIIRQLHSA--LHCLHSQQIAHKDIRPENILMNGA-VLKLIDLGSSVS---- 247
IC + +A LH LH++ I H+D++ NIL++ V K+ D G S
Sbjct: 138 WEQRLEIC-----IGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTEL 192
Query: 248 ----VSTVVL-----PDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESE 298
+STVV D E+ LT + D++S GV+L+ +L S + +S
Sbjct: 193 DQTHLSTVVKGTLGYIDPEYFIKGRLTEKS------DVYSFGVVLFEVLCARSA-IVQSL 245
Query: 299 EETRAHI--------------SVADYSFPPEQCGHISVPARELIGQL----LNTHADKRP 340
++ + D P I + G L ++ RP
Sbjct: 246 PREMVNLAEWAVESHNNGQLEQIVD----PNLADKIRPESLRKFGDTAVKCLALSSEDRP 301
Query: 341 TAGQLLQ 347
+ G +L
Sbjct: 302 SMGDVLW 308
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 6e-04
Identities = 47/273 (17%), Positives = 98/273 (35%), Gaps = 40/273 (14%)
Query: 105 LERLGNGRFCTVRKAR---DRGTGQLVALKQIPRERQPQQITR---AEYNLLSTLMHAHI 158
+ LG G F +V + + GT VA+K + + Q+ +E + H ++
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 159 PTALAL-FENAPVPGTDT-IVMQLVHGESLIQHL--CR----QSTITESYICCIIRQLHS 210
L + E + +++ + L +L R I + + +
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 211 ALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSV---------STVVLPDLEFAS 260
+ L ++ H+D+ N ++ + + D G S + +P +++ +
Sbjct: 159 GMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMP-VKWIA 217
Query: 261 PEML-----TSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPP 314
E L TS +D+W+ GV ++ + + G++P+ E ++ P
Sbjct: 218 IESLADRVYTS------KSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQP 271
Query: 315 EQCGHISVPARELIGQLLNTHADKRPTAGQLLQ 347
E C E++ T RPT L
Sbjct: 272 EDC---LDELYEIMYSCWRTDPLDRPTFSVLRL 301
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 8e-04
Identities = 20/118 (16%), Positives = 40/118 (33%), Gaps = 27/118 (22%)
Query: 131 KQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPV-----PGTDTIVMQLVHGES 185
+ I + R T E L+ + IP P I+M ++G+
Sbjct: 379 ENIRKSR-----TAREARYLALVKDFGIPA--------PYIFDVDLDNKRIMMSYINGKL 425
Query: 186 LIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGAVLKLIDLG 243
+ I ++ ++ + LH + H D+ N + + + +ID G
Sbjct: 426 A------KDVIEDNLDIA--YKIGEIVGKLHKNDVIHNDLTTSNFIFDKDLY-IIDFG 474
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 39.9 bits (94), Expect = 9e-04
Identities = 46/252 (18%), Positives = 88/252 (34%), Gaps = 39/252 (15%)
Query: 93 WQQEQFEHRYEELERLGNGRFCTVRKAR---DRGTGQLVA---LKQIPRERQPQQITRAE 146
E +G G F V + G A L +I + Q E
Sbjct: 18 VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLT-E 76
Query: 147 YNLLSTLMHAHIPTALA--LFENAPVPGTDTIVMQLVHGESLIQHL-CRQSTITESYICC 203
++ H ++ + L L +V+ + L + T +
Sbjct: 77 GIIMKDFSHPNVLSLLGICLRSEGSP----LVVLPYMKHGDLRNFIRNETHNPTVKDLIG 132
Query: 204 IIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLG-----------SSVSVSTV 251
Q+ + L S++ H+D+ N +++ +K+ D G S + +
Sbjct: 133 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 192
Query: 252 VLPDLEFASPEML-----TSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHI 305
LP +++ + E L T+ +D+WS GVLL+ L++ G P+ D + + ++
Sbjct: 193 KLP-VKWMALESLQTQKFTT------KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 245
Query: 306 SVADYSFPPEQC 317
PE C
Sbjct: 246 LQGRRLLQPEYC 257
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 380 | |||
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.89 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.79 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.45 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.3 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.26 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.15 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.91 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.76 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.6 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.58 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.58 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.46 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.4 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.22 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.05 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 98.05 | |
| 1bpv_A | 112 | Titin, A71, connectin; fibronectin type III; NMR { | 98.04 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.9 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.85 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.83 | |
| 1wfu_A | 120 | Unnamed protein product; FN3 domain, similar to 17 | 97.78 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.74 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.71 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.7 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.53 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.5 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.36 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.34 | |
| 1x5x_A | 109 | Fibronectin type-III domain containing protein 3A; | 97.33 | |
| 2ic2_A | 115 | CG9211-PA, GH03927P; IHOG, hedgehog, fibronectin t | 97.26 | |
| 2db8_A | 110 | Tripartite motif protein 9, isoform 2; ring finger | 97.2 | |
| 2crz_A | 110 | Fibronectin type-III domain containing protein 3A; | 97.14 | |
| 1x5y_A | 111 | Myosin binding protein C, fast-type; fast MYBP-C, | 97.14 | |
| 2yuw_A | 110 | Myosin binding protein C, SLOW type; fibronectin I | 97.1 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.06 | |
| 1x4x_A | 106 | Fibronectin type-III domain containing protein 3A; | 96.94 | |
| 2yux_A | 120 | Myosin-binding protein C, SLOW-type; fibronectin I | 96.91 | |
| 2crm_A | 120 | Fibronectin type-III domain containing protein 3A; | 96.85 | |
| 2kbg_A | 114 | N-CAM 2, neural cell adhesion molecule 2; fibronec | 96.78 | |
| 1x4z_A | 121 | Biregional cell adhesion molecule-related/DOWN- re | 96.76 | |
| 1wis_A | 124 | KIAA1514 protein; FNIII domain, sidekick-2, struct | 96.73 | |
| 1x3d_A | 118 | Fibronectin type-III domain containing protein 3A; | 96.61 | |
| 1v5j_A | 108 | KIAA1355 protein, RSGI RUH-008; FN3 domain, human | 96.56 | |
| 2dmk_A | 127 | Midline 2 isoform 2; midline defect 2, tripartite | 96.53 | |
| 2yrz_A | 118 | Integrin beta-4; GP150, CD104 antigen, structural | 96.42 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.37 | |
| 2ed8_A | 106 | Netrin receptor DCC; tumor suppressor protein DCC, | 96.29 | |
| 1wf5_A | 121 | Sidekick 2 protein; FNIII domain, structural genom | 96.18 | |
| 2dju_A | 106 | Receptor-type tyrosine-protein phosphatase F; LAR | 96.15 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.13 | |
| 1uem_A | 117 | KIAA1568 protein; immunoglobulin-like beta-sandwic | 96.08 | |
| 2edy_A | 103 | Receptor-type tyrosine-protein phosphatase F; LAR | 96.0 | |
| 2rb8_A | 104 | Tenascin; beta sheet,loop design, alternative spli | 95.93 | |
| 2dn7_A | 107 | Receptor-type tyrosine-protein phosphatase F; LAR | 95.93 | |
| 2ed7_A | 119 | Netrin receptor DCC; tumor suppressor protein DCC, | 95.91 | |
| 2cui_A | 112 | Tenascin-X; fibronectin type III domain, extracell | 95.87 | |
| 1x5z_A | 115 | Receptor-type tyrosine-protein phosphatase delta; | 95.86 | |
| 1x5g_A | 116 | Neogenin; RGM binding, fibronectin type III domain | 95.85 | |
| 2djs_A | 108 | Ephrin type-B receptor 1; tyrosine-protein kinase | 95.75 | |
| 3b83_A | 100 | Ten-D3; beta sheet, computational redesigned prote | 95.71 | |
| 2dm4_A | 108 | Sortilin-related receptor; beta-sandwich, sorting | 95.62 | |
| 3tes_A | 98 | Tencon; fibronectin type III domain, FN3, consensu | 95.59 | |
| 1x5f_A | 120 | Neogenin; RGM binding, fibronectin type III domain | 95.41 | |
| 1k85_A | 88 | Chitinase A1; fibronectin type III domain, chitin | 95.4 | |
| 3teu_A | 98 | Fibcon; FN3 domain, fibronectin TPYE III domain, c | 95.32 | |
| 1x5l_A | 111 | Ephrin type-A receptor 8; FN3 domain, structural g | 95.31 | |
| 2edb_A | 116 | Netrin receptor DCC; tumor suppressor protein DCC, | 95.19 | |
| 2cum_A | 105 | Tenascin-X; hexabrachion-like, fibronectin type II | 95.18 | |
| 1x5j_A | 113 | Neogenin; RGM binding, fibronectin type III domain | 95.03 | |
| 1x4y_A | 114 | Biregional cell adhesion molecule-related/DOWN- re | 95.03 | |
| 2e7h_A | 109 | Ephrin type-B receptor 4; FN3 domain, tyrosine- pr | 94.99 | |
| 2dkm_A | 104 | Collagen alpha-1(XX) chain; FN3 domain, KIAA1510, | 94.96 | |
| 2ibg_A | 214 | CG9211-PA, GH03927P; IHOG, fibronectin type III, p | 94.88 | |
| 2ekj_A | 105 | Collagen alpha-1(XX) chain; KIAA1510, structural g | 94.86 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.84 | |
| 2ede_A | 114 | Netrin receptor DCC; tumor suppressor protein DCC, | 94.82 | |
| 2ed9_A | 124 | Netrin receptor DCC; tumor suppressor protein DCC, | 94.82 | |
| 1uey_A | 127 | KIAA0343 protein; immunoglobulin-like beta-sandwic | 94.78 | |
| 2haz_A | 105 | N-CAM 1, neural cell adhesion molecule 1; fibronec | 94.59 | |
| 3t04_D | 103 | Monobody 7C12; engineered binding protein, antibod | 94.47 | |
| 2e3v_A | 122 | Neural cell adhesion molecule 1, 140 kDa isoform; | 94.45 | |
| 1x5i_A | 126 | Neogenin; RGM binding, fibronectin type III domain | 94.29 | |
| 1wfo_A | 130 | Sidekick 2; FN3, cell adhesion, structural genomic | 94.28 | |
| 1j8k_A | 94 | Fibronectin; EDA, TYPEIII domain, protein binding; | 94.26 | |
| 3qht_C | 97 | Monobody YSMB-1; fibronectin type III, yeast small | 94.14 | |
| 3lpw_A | 197 | A77-A78 domain from titin; intracellular FNIII-tan | 94.08 | |
| 3n1f_C | 102 | Cell adhesion molecule-related/DOWN-regulated BY; | 94.08 | |
| 2ocf_D | 121 | Fibronectin; estrogen receptor, LBD, monobody, est | 94.07 | |
| 1wfn_A | 119 | Sidekick 2; FN3, cell adhesion, structural genomic | 94.06 | |
| 3qwq_B | 114 | Adnectin; cell surface receptor, tyrosine kinase, | 93.91 | |
| 3r8q_A | 290 | Fibronectin; heparin, FNIII, heparin binding, cell | 93.82 | |
| 2vkw_A | 209 | Neural cell adhesion molecule 1,140 kDa isoform; a | 93.8 | |
| 2ibg_A | 214 | CG9211-PA, GH03927P; IHOG, fibronectin type III, p | 93.72 | |
| 3lpw_A | 197 | A77-A78 domain from titin; intracellular FNIII-tan | 93.59 | |
| 3k2m_C | 101 | Monobody HA4; engineered binding protein, antibody | 93.44 | |
| 2ee3_A | 108 | Collagen alpha-1(XX) chain; KIAA1510, structural g | 93.42 | |
| 1x5h_A | 132 | Neogenin; RGM binding, fibronectin type III domain | 93.42 | |
| 2cuh_A | 115 | Tenascin-X; fibronectin type III domain, extracell | 93.41 | |
| 3p4l_A | 211 | Neogenin; iron homeostasis, hemojuvelin receptor, | 93.39 | |
| 2ee2_A | 119 | Contactin-1; neural cell surface protein F3, glyco | 93.12 | |
| 2edx_A | 134 | Protein tyrosine phosphatase, receptor type, F; LA | 93.11 | |
| 1x5a_A | 107 | Ephrin type-A receptor 1; tyrosine-protein kinase | 93.06 | |
| 2nzi_A | 305 | Titin; IG-domain, FNIII-domain, transferase; 2.90A | 93.01 | |
| 1wk0_A | 137 | KIAA0970 protein; fibronectin type III domain, str | 92.98 | |
| 2edd_A | 123 | Netrin receptor DCC; tumor suppressor protein DCC, | 92.94 | |
| 1uc6_A | 109 | CNTF receptor, ciliary neurotrophic factor recepto | 92.82 | |
| 2gee_A | 203 | Hypothetical protein; fibronectin, EIIIB, cancer, | 92.8 | |
| 2h41_A | 95 | Fibronectin; beta sandwich, cell adhesion, structu | 92.78 | |
| 2ha1_A | 201 | Fibronectin; beta sandwich, protein-protein comple | 92.64 | |
| 1uen_A | 125 | KIAA0343 protein; immunoglobulin-like beta-sandwic | 92.28 | |
| 2dbj_A | 124 | Proto-oncogene tyrosine-protein kinase MER precurs | 92.25 | |
| 2dlh_A | 121 | Receptor-type tyrosine-protein phosphatase delta; | 92.23 | |
| 2gee_A | 203 | Hypothetical protein; fibronectin, EIIIB, cancer, | 92.23 | |
| 1bqu_A | 215 | Protein (GP130); cytokine receptor, glycoprotein 1 | 92.19 | |
| 1qr4_A | 186 | Protein (tenascin); fibronectin type-III, heparin, | 92.06 | |
| 2ha1_A | 201 | Fibronectin; beta sandwich, protein-protein comple | 91.93 | |
| 1qr4_A | 186 | Protein (tenascin); fibronectin type-III, heparin, | 91.82 | |
| 1va9_A | 122 | DOWN syndrome cell adhesion molecule like- protein | 91.56 | |
| 2vkw_A | 209 | Neural cell adhesion molecule 1,140 kDa isoform; a | 91.28 | |
| 2jll_A | 389 | NCAM2, neural cell adhesion molecule 2; immunoglob | 91.26 | |
| 1i1r_A | 303 | GP130, interleukin-6 receptor beta chain; cytokine | 90.99 | |
| 1cfb_A | 205 | Drosophila neuroglian; neural adhesion molecule; H | 90.96 | |
| 2qbw_A | 195 | PDZ-fibronectin fusion protein; fibronectin PDZ, u | 90.53 | |
| 3fl7_A | 536 | Ephrin receptor; ATP-binding, kinase, nucleotide-b | 90.42 | |
| 3mpc_A | 103 | FN3-like protein; fibronectin, FN(III), unknown fu | 90.28 | |
| 2w1n_A | 238 | O-GLCNACASE NAGJ; hexosaminidase, glycoside hydrol | 90.1 | |
| 3f7q_A | 234 | Integrin beta-4, GP150; hemidesmosome, cell adhesi | 90.08 | |
| 2dle_A | 104 | Receptor-type tyrosine-protein phosphatase ETA; pr | 89.84 | |
| 1cfb_A | 205 | Drosophila neuroglian; neural adhesion molecule; H | 89.51 | |
| 3t1w_A | 375 | Four-domain fibronectin fragment; human fibronecti | 88.99 | |
| 1fnf_A | 368 | Fibronectin; RGD, extracellular matrix, cell adhes | 88.99 | |
| 3f7q_A | 234 | Integrin beta-4, GP150; hemidesmosome, cell adhesi | 88.78 | |
| 3r8q_A | 290 | Fibronectin; heparin, FNIII, heparin binding, cell | 88.56 | |
| 1cd9_B | 215 | G-CSF-R, protein (G-CSF receptor); class1 cytokine | 87.63 | |
| 4go6_B | 232 | HCF C-terminal chain 1; tandem fibronectin repeat, | 87.56 | |
| 1zlg_A | 680 | Anosmin 1; insulin-like growth factor receptor Cys | 87.21 | |
| 1fnf_A | 368 | Fibronectin; RGD, extracellular matrix, cell adhes | 86.94 | |
| 1tdq_A | 283 | Tenascin-R; extracellular matrix, lecticans, tenas | 86.58 | |
| 3n06_B | 210 | PRL-R, prolactin receptor; PH dependence, hematopo | 86.44 | |
| 3t1w_A | 375 | Four-domain fibronectin fragment; human fibronecti | 85.87 | |
| 1n26_A | 325 | IL-6 receptor alpha chain; transmembrane, glycopro | 85.68 | |
| 3l5i_A | 290 | Interleukin-6 receptor subunit beta; cytokine rece | 85.4 | |
| 1ujt_A | 120 | KIAA1568 protein; fibronectin type III domain, str | 85.34 | |
| 2b5i_C | 199 | Cytokine receptor common gamma chain; four-helix b | 85.29 | |
| 2d9q_B | 313 | Granulocyte colony-stimulating factor receptor; cy | 84.8 | |
| 1tdq_A | 283 | Tenascin-R; extracellular matrix, lecticans, tenas | 84.61 | |
| 1wj3_A | 117 | KIAA1496 protein; beta sandwich, PANG, structural | 83.7 | |
| 3p4l_A | 211 | Neogenin; iron homeostasis, hemojuvelin receptor, | 83.15 | |
| 3fl7_A | 536 | Ephrin receptor; ATP-binding, kinase, nucleotide-b | 82.89 | |
| 3l5h_A | 589 | Interleukin-6 receptor subunit beta; IG-like, FNII | 82.21 | |
| 2erj_C | 247 | Cytokine receptor common gamma chain; immune syste | 81.13 | |
| 1bqu_A | 215 | Protein (GP130); cytokine receptor, glycoprotein 1 | 80.77 | |
| 3mtr_A | 215 | N-CAM-1, NCAM-1, neural cell adhesion molecule 1; | 80.46 |
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-69 Score=547.56 Aligned_cols=361 Identities=26% Similarity=0.442 Sum_probs=306.0
Q ss_pred CCCCCeeeeecCCCCeeEEeecCCCCCC---cceeeeccccccCCcEEe--cCCCCeEEeecCCCCceeeEEe--eccce
Q psy11098 10 PATQPVINVHPLSESSVELALLTENLSS---IRLCDHESGVWSDARWVI--SPHNGTIQVDDLAPGHTYTFCI--NNEYK 82 (380)
Q Consensus 10 p~~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~~f~~--~~~~~ 82 (380)
||+.|.+.. .+.+||+|+|..|.+|| +..|.+|.....+.+|.. ......+.|.+|.+|+.|.|++ .|..+
T Consensus 12 pP~~P~v~~--~~~~sv~L~W~~P~~DGgs~I~~Y~vE~~~~~~~~W~~v~~~~~t~~~V~~L~~g~~Y~FRV~A~N~~G 89 (573)
T 3uto_A 12 PPRFPIIEN--ILDEAVILSWKPPALDGGSLVTNYTIEKREAMGGSWSPCAKSRYTYTTIEGLRAGKQYEFRIIAENKHG 89 (573)
T ss_dssp CCEEEEEEE--ECSSCEEEEEECCSCCSSSCCCEEEEEEEESSSCCCEEEEEESSSEEEECCCCTTCEEEEEEEEEETTE
T ss_pred cCCCCEEEE--eeCCEEEEEECCCCcCCCCcccEEEEEEEECCCCceEEeccccCCEEEeCCCCCCCcEeEEEEEEcCce
Confidence 568899999 99999999999999887 667888888888889986 3446789999999999999998 33322
Q ss_pred e--------eeecccc------------------------------------------chhhhhhhhhceeeeeeecccC
Q psy11098 83 V--------LYTVPFE------------------------------------------TRWQQEQFEHRYEELERLGNGR 112 (380)
Q Consensus 83 ~--------~~~~~~~------------------------------------------~~~~~~~~~~~y~~~~~LG~G~ 112 (380)
. ....+.. .....+.+.++|++++.||+|+
T Consensus 90 ~s~PS~~s~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~il~~Y~i~~~lG~G~ 169 (573)
T 3uto_A 90 QSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGA 169 (573)
T ss_dssp ECCCCCCCCCEECC-------CCCEECSSSCEECCCCCCCSCGGGGCCCHHHHCCCCCCCCBSSCGGGTEEEEEEEEEET
T ss_pred EcCCcCCCCCEEcCCCCcccccccccccccccccccccccccccccccccccccCCcccccCCCcCccccEEEEEEeecc
Confidence 2 0111000 0001223457899999999999
Q ss_pred CeEEEEEEEcCCCcEEEEEEecCCCC-chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEEEecCCCCHHHHHH
Q psy11098 113 FCTVRKARDRGTGQLVALKQIPRERQ-PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLC 191 (380)
Q Consensus 113 fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~ 191 (380)
||+||+|+++.+|+.||+|++..... ..+.+.+|+++|+.|+||||++++++|... +.+|||||||.||+|+++|.
T Consensus 170 fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---~~~~iv~E~~~gg~L~~~i~ 246 (573)
T 3uto_A 170 FGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD---NEMVMIYEFMSGGELFEKVA 246 (573)
T ss_dssp TEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECS---SEEEEEEECCCCCBHHHHHT
T ss_pred CeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEEC---CEEEEEEeecCCCcHHHHHH
Confidence 99999999999999999999976543 456678899999999999999999998864 78899999999999999996
Q ss_pred h-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC---CeeEEEeCCCccccc-----ccccCCCcccCCc
Q psy11098 192 R-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG---AVLKLIDLGSSVSVS-----TVVLPDLEFASPE 262 (380)
Q Consensus 192 ~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~---~~ikl~DFG~a~~~~-----~~~~gt~~y~aPE 262 (380)
. ...+++.+++.+++||+.||.|||++||+||||||+|||++. +.+||+|||+|+.+. ...+||+.|||||
T Consensus 247 ~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APE 326 (573)
T 3uto_A 247 DEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPE 326 (573)
T ss_dssp CTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHH
T ss_pred HhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCceeeeEECccccCHH
Confidence 4 467999999999999999999999999999999999999973 589999999998764 4568999999999
Q ss_pred cccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCH
Q psy11098 263 MLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTA 342 (380)
Q Consensus 263 ~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~ 342 (380)
++.+ ..++.++|||||||++|+|++|.+||.+.+..++..++....+.++...+..+|+++++||++||++||++|||+
T Consensus 327 v~~~-~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~ 405 (573)
T 3uto_A 327 VAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTI 405 (573)
T ss_dssp HHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCH
T ss_pred HhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCH
Confidence 9998 578999999999999999999999999999999999999999999888888999999999999999999999999
Q ss_pred HHHHhcccccccCCC----CCccccccchHHHHHHHHh
Q psy11098 343 GQLLQVAWFAEASCS----EFDTERLLPFSARRKQKFK 376 (380)
Q Consensus 343 ~e~L~hpw~~~~~~~----~~~~~~~~~~~~~~~~~~~ 376 (380)
+|+|+||||+..... .+...+..++....+.+++
T Consensus 406 ~e~l~Hpw~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 443 (573)
T 3uto_A 406 HQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYD 443 (573)
T ss_dssp HHHHHSTTTSCCCCTTTTCEECGGGGHHHHHHHHHHTT
T ss_pred HHHhcCcCcCCCCCCCchhhCCCcccccchhhhhhhhh
Confidence 999999999976544 3444555555555444443
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-66 Score=485.28 Aligned_cols=255 Identities=26% Similarity=0.441 Sum_probs=232.5
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC----CCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
++|++++.||+|+||+||+|+++.+|+.||||++.+. ......+.+|+++|+.|+||||++++++|+.. +.+|
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~---~~~y 108 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD---EKLY 108 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS---SEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC---CEEE
Confidence 5699999999999999999999999999999999643 33456788999999999999999999999864 7889
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-----
Q psy11098 176 IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS----- 249 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~----- 249 (380)
||||||.||+|.+++.+.+.++|.+++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|+.+.
T Consensus 109 ivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 109 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 9999999999999999989999999999999999999999999999999999999998 5799999999998652
Q ss_pred ---ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHH
Q psy11098 250 ---TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARE 326 (380)
Q Consensus 250 ---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 326 (380)
...+||+.|||||++.+ ..++.++|||||||++|+|++|..||.+.+..++..++....+.++. .+|+++++
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~~~~d 263 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPE----KFFPKARD 263 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHH-SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT----TCCHHHHH
T ss_pred ccccCcccCcccCCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc----ccCHHHHH
Confidence 35689999999999988 57899999999999999999999999999999999999998887764 58999999
Q ss_pred HHHHhcccCCCCCCCHHH------HHhcccccccCCCCCccc
Q psy11098 327 LIGQLLNTHADKRPTAGQ------LLQVAWFAEASCSEFDTE 362 (380)
Q Consensus 327 li~~~L~~dP~~Rpt~~e------~L~hpw~~~~~~~~~~~~ 362 (380)
||++||++||++|||++| +++||||+...+..+...
T Consensus 264 li~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~~~ 305 (311)
T 4aw0_A 264 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQ 305 (311)
T ss_dssp HHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGS
T ss_pred HHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhcCC
Confidence 999999999999999998 589999998877766443
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-64 Score=483.06 Aligned_cols=253 Identities=23% Similarity=0.389 Sum_probs=225.9
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC-CCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEE
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE-RQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
..+.|+++++||+|+||+||+|+++.+|+.||||++... ....+.+.+|+++|+.++||||++++++|... +.+||
T Consensus 72 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~---~~~~i 148 (346)
T 4fih_A 72 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG---DELWV 148 (346)
T ss_dssp GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEET---TEEEE
T ss_pred hhHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC---CEEEE
Confidence 357799999999999999999999999999999999643 33456678899999999999999999998874 78899
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------
Q psy11098 177 VMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------ 249 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------ 249 (380)
|||||.||+|.+++.+ ..+++.+++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|+.+.
T Consensus 149 vmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~ 227 (346)
T 4fih_A 149 VMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 227 (346)
T ss_dssp EECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCB
T ss_pred EEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcc
Confidence 9999999999998865 5799999999999999999999999999999999999998 5799999999998653
Q ss_pred ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHH
Q psy11098 250 TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIG 329 (380)
Q Consensus 250 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 329 (380)
...+||+.|||||++.+ ..|+.++|||||||++|+|++|..||.+.+..+....+..... .....+..+|+++++||+
T Consensus 228 ~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~~~~~~~s~~~~dli~ 305 (346)
T 4fih_A 228 KSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRLKNLHKVSPSLKGFLD 305 (346)
T ss_dssp CCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-CCCSCGGGSCHHHHHHHH
T ss_pred cccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCCccccCCHHHHHHHH
Confidence 46789999999999988 5789999999999999999999999999998888888765432 223344578999999999
Q ss_pred HhcccCCCCCCCHHHHHhcccccccCC
Q psy11098 330 QLLNTHADKRPTAGQLLQVAWFAEASC 356 (380)
Q Consensus 330 ~~L~~dP~~Rpt~~e~L~hpw~~~~~~ 356 (380)
+||++||++|||++|+|+||||++...
T Consensus 306 ~~L~~dP~~R~ta~e~l~Hp~~~~~~~ 332 (346)
T 4fih_A 306 RLLVRDPAQRATAAELLKHPFLAKAGP 332 (346)
T ss_dssp HHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred HHcCCChhHCcCHHHHhcCHhhcCCCC
Confidence 999999999999999999999998653
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-64 Score=469.56 Aligned_cols=247 Identities=30% Similarity=0.471 Sum_probs=214.5
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC----CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
++|++.+.||+|+||+||+|+++.+|+.||+|++++.. .....+.+|+++++.++||||++++++|... +.+|
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~---~~~~ 89 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSK---DEII 89 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECS---SEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC---CEEE
Confidence 58999999999999999999999999999999997543 2345678999999999999999999998764 7789
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-----
Q psy11098 176 IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS----- 249 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~----- 249 (380)
|||||+ +|+|.+++.+.+.+++.+++.+++||+.||+|||++||+||||||+|||++ ++.+||+|||+|+...
T Consensus 90 ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~ 168 (275)
T 3hyh_A 90 MVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFL 168 (275)
T ss_dssp EEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred EEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCcc
Confidence 999999 789999999999999999999999999999999999999999999999998 5699999999997653
Q ss_pred ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHH
Q psy11098 250 TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIG 329 (380)
Q Consensus 250 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 329 (380)
...+||+.|||||++.+..+++.++|||||||++|+|++|+.||.+.+..+....+....+.++. .+|+++++||+
T Consensus 169 ~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~ 244 (275)
T 3hyh_A 169 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK----FLSPGAAGLIK 244 (275)
T ss_dssp ------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT----TSCHHHHHHHH
T ss_pred CCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHH
Confidence 45789999999999998656678999999999999999999999999999999999888777653 58999999999
Q ss_pred HhcccCCCCCCCHHHHHhccccccc
Q psy11098 330 QLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 330 ~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
+||++||++|||++|+|+||||+..
T Consensus 245 ~~L~~dP~~R~s~~eil~hpw~k~~ 269 (275)
T 3hyh_A 245 RMLIVNPLNRISIHEIMQDDWFKVD 269 (275)
T ss_dssp HHSCSSGGGSCCHHHHHHCHHHHTT
T ss_pred HHccCChhHCcCHHHHHcCcccccC
Confidence 9999999999999999999999754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-64 Score=482.05 Aligned_cols=248 Identities=25% Similarity=0.406 Sum_probs=218.2
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
++|++++.||+|+||+||+|+++.+|+.||||++.+... ..+.+.+|+++|+.|+||||++++++|... +.+||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~---~~~yi 100 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEEN---GSLYI 100 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET---TEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEEC---CEEEE
Confidence 689999999999999999999999999999999976543 245678899999999999999999998764 78899
Q ss_pred EEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc----
Q psy11098 177 VMQLVHGESLIQHLCRQ--STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS---- 249 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~---- 249 (380)
|||||.||+|.++|... ..++|..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|+...
T Consensus 101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 180 (350)
T 4b9d_A 101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE 180 (350)
T ss_dssp EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH
T ss_pred EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcc
Confidence 99999999999999654 4579999999999999999999999999999999999998 5799999999998764
Q ss_pred --ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHH
Q psy11098 250 --TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAREL 327 (380)
Q Consensus 250 --~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 327 (380)
...+||+.|||||++.+ ..|+.++|||||||++|+|++|+.||.+.+..++..++..+.+... ...+|+++++|
T Consensus 181 ~~~~~~GT~~YmAPE~l~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~---~~~~s~~~~~l 256 (350)
T 4b9d_A 181 LARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPV---SLHYSYDLRSL 256 (350)
T ss_dssp HHHHHHSCCTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC---CTTSCHHHHHH
T ss_pred cccccCCCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC---CccCCHHHHHH
Confidence 35689999999999998 5789999999999999999999999999999999999887765322 34689999999
Q ss_pred HHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 328 IGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 328 i~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
|.+||++||++|||++|+|+||||++.
T Consensus 257 i~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 257 VSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp HHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred HHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 999999999999999999999999864
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-63 Score=485.20 Aligned_cols=253 Identities=23% Similarity=0.390 Sum_probs=226.4
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC-CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEE
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER-QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
..++|+++++||+|+||+||+|+++.+|+.||||++.... ...+.+.+|+.+|+.++||||++++++|... +.+||
T Consensus 149 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~---~~~~i 225 (423)
T 4fie_A 149 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG---DELWV 225 (423)
T ss_dssp GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEET---TEEEE
T ss_pred hhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEEC---CEEEE
Confidence 4578999999999999999999999999999999997543 3456788999999999999999999999874 68899
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------
Q psy11098 177 VMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------ 249 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------ 249 (380)
|||||.||+|.+++.. ..+++..++.+++||+.||.|||++||+||||||+|||++ ++.+||+|||+|+.+.
T Consensus 226 VmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~ 304 (423)
T 4fie_A 226 VMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 304 (423)
T ss_dssp EEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCB
T ss_pred EEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccc
Confidence 9999999999998865 5799999999999999999999999999999999999998 5799999999998653
Q ss_pred ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHH
Q psy11098 250 TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIG 329 (380)
Q Consensus 250 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 329 (380)
...+||+.|||||++.+ ..|+.++|||||||++|+|++|..||.+.+..+....+..... .....+..+|+++++||+
T Consensus 305 ~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~~~~~~~s~~~~dli~ 382 (423)
T 4fie_A 305 KSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRLKNLHKVSPSLKGFLD 382 (423)
T ss_dssp CCCEECTTTCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CCCSCTTSSCHHHHHHHH
T ss_pred cccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCcccccCCHHHHHHHH
Confidence 45789999999999988 5789999999999999999999999999999888888765432 223345678999999999
Q ss_pred HhcccCCCCCCCHHHHHhcccccccCC
Q psy11098 330 QLLNTHADKRPTAGQLLQVAWFAEASC 356 (380)
Q Consensus 330 ~~L~~dP~~Rpt~~e~L~hpw~~~~~~ 356 (380)
+||++||++|||++|+|+||||++...
T Consensus 383 ~~L~~dP~~R~ta~ell~Hp~~~~~~~ 409 (423)
T 4fie_A 383 RLLVRDPAQRATAAELLKHPFLAKAGP 409 (423)
T ss_dssp HHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred HHcCCChhHCcCHHHHhcCHHhcCCCC
Confidence 999999999999999999999998643
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-64 Score=474.14 Aligned_cols=257 Identities=26% Similarity=0.432 Sum_probs=223.7
Q ss_pred hceeeeeeecccCCeEEEEEEEc---CCCcEEEEEEecCCC---CchHHHHHHHHHHHhhccCCCcceeeecccccCCCc
Q psy11098 100 HRYEELERLGNGRFCTVRKARDR---GTGQLVALKQIPRER---QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGT 173 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~---~~~~~vAvK~~~~~~---~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~ 173 (380)
++|++++.||+|+||+||+|++. .+++.||+|++++.. .....+.+|+++|+.++||||++++++|... +.
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~---~~ 100 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTE---GK 100 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEET---TE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC---CE
Confidence 57999999999999999999984 468899999996542 2234577899999999999999999998864 78
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc---
Q psy11098 174 DTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS--- 249 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~--- 249 (380)
+|||||||.||+|.+++.+.+.+++.+++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|+...
T Consensus 101 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 180 (304)
T 3ubd_A 101 LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180 (304)
T ss_dssp EEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred EEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence 899999999999999999999999999999999999999999999999999999999998 5799999999997542
Q ss_pred ---ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHH
Q psy11098 250 ---TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARE 326 (380)
Q Consensus 250 ---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 326 (380)
...+||+.|||||++.+ ..++.++|||||||++|+|++|..||.+.+..++...+....+.+|. .+|+++++
T Consensus 181 ~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~ 255 (304)
T 3ubd_A 181 KKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ----FLSPEAQS 255 (304)
T ss_dssp CCCCSCCCCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHH
T ss_pred ccccccccCcccCCHHHhcc-CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCC----cCCHHHHH
Confidence 46789999999999988 57889999999999999999999999999999999999888777653 58999999
Q ss_pred HHHHhcccCCCCCCC-----HHHHHhcccccccCCCCCccccc
Q psy11098 327 LIGQLLNTHADKRPT-----AGQLLQVAWFAEASCSEFDTERL 364 (380)
Q Consensus 327 li~~~L~~dP~~Rpt-----~~e~L~hpw~~~~~~~~~~~~~~ 364 (380)
||++||++||++||| ++|+|+||||+...+..+...++
T Consensus 256 li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l~~~~~ 298 (304)
T 3ubd_A 256 LLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREI 298 (304)
T ss_dssp HHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCS
T ss_pred HHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHHHHhCCC
Confidence 999999999999998 58999999999876555544444
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-62 Score=459.86 Aligned_cols=249 Identities=22% Similarity=0.301 Sum_probs=213.5
Q ss_pred eeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---chHHHHHHHHHHHhhccCCCcceeeeccccc-CCCceEEE
Q psy11098 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLMHAHIPTALALFENAP-VPGTDTIV 177 (380)
Q Consensus 102 y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~-~~~~~~lv 177 (380)
|++.++||+|+||+||+|+++.+++.||+|++..... ..+.+.+|+++|+.|+||||++++++|.... ..+.+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 3677889999999999999999999999999964432 3456788999999999999999999987532 23567999
Q ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeecCCCCcEEEe--CCeeEEEeCCCccccc----
Q psy11098 178 MQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQ--IAHKDIRPENILMN--GAVLKLIDLGSSVSVS---- 249 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~--iiHrDlKp~NIl~~--~~~ikl~DFG~a~~~~---- 249 (380)
||||.||+|.+++.+...+++..++.++.||+.||.|||++| |+||||||+|||++ ++.+||+|||+|+...
T Consensus 108 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~~~ 187 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA 187 (290)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTTSB
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCCcc
Confidence 999999999999999899999999999999999999999998 99999999999997 4699999999997543
Q ss_pred ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhcccCCCCCCcCCCCCHHHHHHH
Q psy11098 250 TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDES-EEETRAHISVADYSFPPEQCGHISVPARELI 328 (380)
Q Consensus 250 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 328 (380)
...+||+.|||||++.+ .++.++|||||||++|+|+||..||.+.. .......+..... +......+++++++||
T Consensus 188 ~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~li 263 (290)
T 3fpq_A 188 KAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--PASFDKVAIPEVKEII 263 (290)
T ss_dssp EESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--CGGGGGCCCHHHHHHH
T ss_pred CCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCC--CCCCCccCCHHHHHHH
Confidence 46789999999999976 58899999999999999999999997754 4445555544322 2223345789999999
Q ss_pred HHhcccCCCCCCCHHHHHhccccccc
Q psy11098 329 GQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 329 ~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
.+||.+||++|||++|+|+||||++.
T Consensus 264 ~~~L~~dP~~R~s~~e~l~Hp~~~~~ 289 (290)
T 3fpq_A 264 EGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp HHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred HHHccCChhHCcCHHHHhcCccccCC
Confidence 99999999999999999999999874
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-61 Score=470.53 Aligned_cols=257 Identities=25% Similarity=0.353 Sum_probs=224.3
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCc---hHHHHHHHHHHHhhccCCCcceeeecccc---cCC
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP---QQITRAEYNLLSTLMHAHIPTALALFENA---PVP 171 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~E~~il~~l~h~ni~~i~~~~~~~---~~~ 171 (380)
+.++|++++.||+|+||+||+|+++.+|+.||||++++.... ...+.+|+++|+.|+||||+++++++... ...
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 131 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF 131 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence 356899999999999999999999999999999999765432 34567899999999999999999987643 234
Q ss_pred CceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-
Q psy11098 172 GTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS- 249 (380)
Q Consensus 172 ~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~- 249 (380)
+.+||||||| +|+|.+++.+.+.+++..++.+++||+.||.|||++||+||||||+|||++ ++.+||+|||+|+.+.
T Consensus 132 ~~~~ivmE~~-~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~ 210 (398)
T 4b99_A 132 KSVYVVLDLM-ESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCT 210 (398)
T ss_dssp CCEEEEEECC-SEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred CEEEEEEeCC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence 6789999999 578999999888999999999999999999999999999999999999998 5699999999997542
Q ss_pred ---------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCC-----
Q psy11098 250 ---------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPE----- 315 (380)
Q Consensus 250 ---------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~----- 315 (380)
...+||+.|||||++.+..+++.++||||+||++|+|++|.+||.+.+..+.+..|......++..
T Consensus 211 ~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~ 290 (398)
T 4b99_A 211 SPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAV 290 (398)
T ss_dssp -----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC--
T ss_pred CccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhh
Confidence 356899999999999886678999999999999999999999999999988888876544333221
Q ss_pred ----------------------cCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 316 ----------------------QCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 316 ----------------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
.+..++++++|||++||++||++|||++|+|+||||++..
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 291 GAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp ---CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred hhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 1235789999999999999999999999999999999753
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-62 Score=464.18 Aligned_cols=248 Identities=21% Similarity=0.300 Sum_probs=219.1
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVM 178 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~ 178 (380)
.+.|++.++||+|+||+||+|+++.+|+.||||+++.+... .+|+.+++.++||||++++++|... +.+||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~----~~E~~il~~l~HpnIV~l~~~~~~~---~~~~ivm 129 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR----VEELVACAGLSSPRIVPLYGAVREG---PWVNIFM 129 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC----THHHHTTTTCCCTTBCCEEEEEEET---TEEEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH----HHHHHHHHhCCCCCCCcEEEEEEEC---CEEEEEE
Confidence 35789999999999999999999999999999999765432 4699999999999999999998764 6789999
Q ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CC-eeEEEeCCCccccc-------
Q psy11098 179 QLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GA-VLKLIDLGSSVSVS------- 249 (380)
Q Consensus 179 e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~-~ikl~DFG~a~~~~------- 249 (380)
|||.||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++ ++ .+||+|||+|+.+.
T Consensus 130 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~ 209 (336)
T 4g3f_A 130 ELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKS 209 (336)
T ss_dssp CCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC--------
T ss_pred eccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccc
Confidence 9999999999999888999999999999999999999999999999999999998 45 69999999997652
Q ss_pred ----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHH
Q psy11098 250 ----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAR 325 (380)
Q Consensus 250 ----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 325 (380)
...+||+.|||||++.+ ..++.++|||||||++|+|++|..||.+.+..++..++......+. +....+|++++
T Consensus 210 ~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~s~~~~ 287 (336)
T 4g3f_A 210 LLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIR-EIPPSCAPLTA 287 (336)
T ss_dssp ----CCCCCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGG-GSCTTSCHHHH
T ss_pred eecCCccccCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCch-hcCccCCHHHH
Confidence 23579999999999998 5789999999999999999999999998887777777766543322 23457899999
Q ss_pred HHHHHhcccCCCCCCCHHHH-------------HhcccccccC
Q psy11098 326 ELIGQLLNTHADKRPTAGQL-------------LQVAWFAEAS 355 (380)
Q Consensus 326 ~li~~~L~~dP~~Rpt~~e~-------------L~hpw~~~~~ 355 (380)
+||.+||++||++|||+.|+ |+|||+.+..
T Consensus 288 ~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~ 330 (336)
T 4g3f_A 288 QAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYK 330 (336)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCC
T ss_pred HHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCC
Confidence 99999999999999999997 5799998764
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-59 Score=448.58 Aligned_cols=252 Identities=25% Similarity=0.372 Sum_probs=209.9
Q ss_pred hhhhhceeeeeeecccCCeEEEEEEEc---CCCcEEEEEEecCCCCchHHHHHHHHHHHhh-ccCCCcceeeecccccCC
Q psy11098 96 EQFEHRYEELERLGNGRFCTVRKARDR---GTGQLVALKQIPRERQPQQITRAEYNLLSTL-MHAHIPTALALFENAPVP 171 (380)
Q Consensus 96 ~~~~~~y~~~~~LG~G~fg~V~~~~~~---~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~~~ 171 (380)
..+.++|++.+.||+|+||+||+|+++ .+++.||+|++..... ...+.+|+++|+.+ .||||++++++|...
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~--- 92 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-PIRIAAELQCLTVAGGQDNVMGVKYCFRKN--- 92 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-HHHHHHHHHHHHHTCSBTTBCCCSEEEEET---
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-HHHHHHHHHHHHHhcCCCCCceEEEEEEEC---
Confidence 357789999999999999999999975 4678999999865543 44567899999998 699999999998764
Q ss_pred CceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC--CeeEEEeCCCccccc
Q psy11098 172 GTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG--AVLKLIDLGSSVSVS 249 (380)
Q Consensus 172 ~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~--~~ikl~DFG~a~~~~ 249 (380)
+.+||||||+.||+|.+++ ..+++.+++.+++||+.||.|||++||+||||||+|||++. +.+||+|||+|+...
T Consensus 93 ~~~~lvmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~ 169 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH 169 (361)
T ss_dssp TEEEEEEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred CEEEEEEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence 7889999999999999988 35999999999999999999999999999999999999984 689999999996432
Q ss_pred ----------------------------------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Q psy11098 250 ----------------------------------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLD 295 (380)
Q Consensus 250 ----------------------------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~ 295 (380)
...+||+.|+|||++.+...++.++||||+||++|+|++|+.||.+
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence 2347999999999998866789999999999999999999999965
Q ss_pred CC-HHHHHHHHhcc--------------------------------------cC------------CCCCCcCCCCCHHH
Q psy11098 296 ES-EEETRAHISVA--------------------------------------DY------------SFPPEQCGHISVPA 324 (380)
Q Consensus 296 ~~-~~~~~~~i~~~--------------------------------------~~------------~~~~~~~~~~s~~~ 324 (380)
.+ +.+.+..|... .. ....+.+..+|+++
T Consensus 250 ~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a 329 (361)
T 4f9c_A 250 ASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEA 329 (361)
T ss_dssp CSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHH
T ss_pred CCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHH
Confidence 43 33433333210 00 01112345789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 325 RELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 325 ~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
+|||++||++||++|+|++|+|+||||++.
T Consensus 330 ~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 330 YDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp HHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 999999999999999999999999999875
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-59 Score=439.29 Aligned_cols=251 Identities=25% Similarity=0.356 Sum_probs=201.5
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccC-----
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPV----- 170 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~----- 170 (380)
+.++|++++.||+|+||+||+|+++.+|+.||||+++.... ..+.+.+|+++|+.|+||||++++++|.....
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 3 YLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HHHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred cchhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence 45679999999999999999999999999999999975443 33567889999999999999999999875432
Q ss_pred ----CCceEEEEEecCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeC
Q psy11098 171 ----PGTDTIVMQLVHGESLIQHLCRQST---ITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDL 242 (380)
Q Consensus 171 ----~~~~~lv~e~~~gg~L~~~l~~~~~---l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DF 242 (380)
...+|||||||.||+|.+++..... .++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+||
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccC
Confidence 1246899999999999999987654 45567889999999999999999999999999999998 579999999
Q ss_pred CCccccc------------------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHH-HHHH
Q psy11098 243 GSSVSVS------------------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEE-ETRA 303 (380)
Q Consensus 243 G~a~~~~------------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~-~~~~ 303 (380)
|+|+... ...+||+.|||||++.+ ..++.++|||||||++|||++ ||.+.... ....
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~ 238 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLT 238 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcC-CCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHH
Confidence 9997653 23479999999999998 578999999999999999996 88654322 2233
Q ss_pred HHhcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 304 HISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 304 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
.+.. ..+++ .+...++++++||++||++||++|||+.|+|+||||++..
T Consensus 239 ~~~~--~~~p~-~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~ 287 (299)
T 4g31_A 239 DVRN--LKFPP-LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287 (299)
T ss_dssp HHHT--TCCCH-HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred HHhc--CCCCC-CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence 3332 23332 2334577889999999999999999999999999998753
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-58 Score=469.50 Aligned_cols=253 Identities=23% Similarity=0.385 Sum_probs=218.7
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC----CCchHHHHHH---HHHHHhhccCCCcceeeecccccCCC
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAE---YNLLSTLMHAHIPTALALFENAPVPG 172 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~E---~~il~~l~h~ni~~i~~~~~~~~~~~ 172 (380)
++|++++.||+|+||+||+|+++.+|+.||||++.+. ........+| +.+++.+.||||++++.+|... +
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~---~ 265 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP---D 265 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS---S
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC---C
Confidence 6799999999999999999999999999999999643 2233344445 4555566899999999988764 7
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc--
Q psy11098 173 TDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS-- 249 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~-- 249 (380)
.+|||||||.||+|.++|.+.+.++|..++.|+.||+.||.|||++|||||||||+|||++ +|.+||+|||+|+...
T Consensus 266 ~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~ 345 (689)
T 3v5w_A 266 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 345 (689)
T ss_dssp EEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCC
Confidence 8899999999999999999999999999999999999999999999999999999999998 5799999999998764
Q ss_pred --ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhcccCCCCCCcCCCCCHHH
Q psy11098 250 --TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDES---EEETRAHISVADYSFPPEQCGHISVPA 324 (380)
Q Consensus 250 --~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~s~~~ 324 (380)
...+||+.|||||++.....|+.++|||||||++|+|++|.+||.+.+ ..++...+......++ ..+|+++
T Consensus 346 ~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p----~~~S~~a 421 (689)
T 3v5w_A 346 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----DSFSPEL 421 (689)
T ss_dssp CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCC----TTSCHHH
T ss_pred CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCC----ccCCHHH
Confidence 467999999999999764578999999999999999999999997643 3455556665655554 3589999
Q ss_pred HHHHHHhcccCCCCCCC-----HHHHHhcccccccCCCCC
Q psy11098 325 RELIGQLLNTHADKRPT-----AGQLLQVAWFAEASCSEF 359 (380)
Q Consensus 325 ~~li~~~L~~dP~~Rpt-----~~e~L~hpw~~~~~~~~~ 359 (380)
++||++||++||++|++ ++|+++||||+...+..+
T Consensus 422 ~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l 461 (689)
T 3v5w_A 422 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMV 461 (689)
T ss_dssp HHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHH
T ss_pred HHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHH
Confidence 99999999999999998 799999999998655443
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-57 Score=427.95 Aligned_cols=246 Identities=22% Similarity=0.295 Sum_probs=212.1
Q ss_pred hhceeeeeeecccCCeEEEEEEEc-----CCCcEEEEEEecCCCC-chHHHHHHHHHHHhhccCCCcceeeecccccCCC
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDR-----GTGQLVALKQIPRERQ-PQQITRAEYNLLSTLMHAHIPTALALFENAPVPG 172 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vAvK~~~~~~~-~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~ 172 (380)
.++|.+.+.||+|+||+||+|++. .+++.||||+++.... ..+.+.+|+++|+.++||||+++++++... +
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~---~ 88 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG---D 88 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS---S
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC---C
Confidence 467999999999999999999875 3678999999975433 346688999999999999999999998764 6
Q ss_pred ceEEEEEecCCCCHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeE
Q psy11098 173 TDTIVMQLVHGESLIQHLCRQ-------------STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLK 238 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~~-------------~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ik 238 (380)
..|||||||.||+|.+++... ..+++.++..++.||+.||.|||+++|+||||||+|||++. +.+|
T Consensus 89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEE
Confidence 789999999999999999753 36999999999999999999999999999999999999984 5999
Q ss_pred EEeCCCccccc--------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccc
Q psy11098 239 LIDLGSSVSVS--------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVAD 309 (380)
Q Consensus 239 l~DFG~a~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~ 309 (380)
|+|||+|+... ....||+.|||||++.+ ..++.++|||||||++|||+| |+.||.+.+..+....+..+.
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~ 247 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 247 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTC
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 99999997542 23468999999999988 478999999999999999998 999999999999988888765
Q ss_pred CCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccc
Q psy11098 310 YSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAE 353 (380)
Q Consensus 310 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~ 353 (380)
.... ...+|+++.+||.+||+.||++|||++|+ |+|+.+
T Consensus 248 ~~~~---p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~ 286 (299)
T 4asz_A 248 VLQR---PRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQN 286 (299)
T ss_dssp CCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHH
T ss_pred CCCC---CccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHH
Confidence 4222 24689999999999999999999999999 567764
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-56 Score=422.87 Aligned_cols=245 Identities=23% Similarity=0.332 Sum_probs=204.1
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---chHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
.+++++.++||+|+||+||+|+++. .||||+++.... ..+.+.+|+++++.++||||+++++++.. +..+
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~----~~~~ 107 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK----DNLA 107 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS----SSCE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC----CeEE
Confidence 4578889999999999999998653 599999975433 23567889999999999999999998753 4679
Q ss_pred EEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCccccc----
Q psy11098 176 IVMQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVS---- 249 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~---- 249 (380)
||||||.||+|.+++.. ...+++.++..|+.||+.||.|||+++||||||||+|||+++ +.+||+|||+|+...
T Consensus 108 iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 108 IVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp EEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 99999999999999965 467999999999999999999999999999999999999985 589999999997542
Q ss_pred ----ccccCCCcccCCccccCC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCC--CCcCCCCC
Q psy11098 250 ----TVVLPDLEFASPEMLTSP--ATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFP--PEQCGHIS 321 (380)
Q Consensus 250 ----~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~~~s 321 (380)
...+||+.|||||++.+. ..++.++|||||||++|||+||+.||.+.+.......+.......+ ......++
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 267 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCP 267 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSC
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccch
Confidence 346899999999999652 3578899999999999999999999988766555444443333332 23345789
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhccc
Q psy11098 322 VPARELIGQLLNTHADKRPTAGQLLQVAW 350 (380)
Q Consensus 322 ~~~~~li~~~L~~dP~~Rpt~~e~L~hpw 350 (380)
+++.+||.+||+.||++|||+.|++++-.
T Consensus 268 ~~l~~li~~cl~~dP~~RPs~~ei~~~Le 296 (307)
T 3omv_A 268 KAMKRLVADCVKKVKEERPLFPQILSSIE 296 (307)
T ss_dssp HHHHHHHHHHTCSSSTTSCCHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 99999999999999999999999876543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-56 Score=423.55 Aligned_cols=243 Identities=19% Similarity=0.272 Sum_probs=206.6
Q ss_pred hhceeeeeeecccCCeEEEEEEEc-----CCCcEEEEEEecCCCC-chHHHHHHHHHHHhhccCCCcceeeecccccCCC
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDR-----GTGQLVALKQIPRERQ-PQQITRAEYNLLSTLMHAHIPTALALFENAPVPG 172 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vAvK~~~~~~~-~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~ 172 (380)
.++|.+.++||+|+||+||+|+++ .+++.||||+++.... ..+.+.+|+++|+.++||||+++++++... +
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~---~ 116 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEG---R 116 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS---S
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC---C
Confidence 357888999999999999999875 3688999999975433 346788999999999999999999998764 6
Q ss_pred ceEEEEEecCCCCHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-Ce
Q psy11098 173 TDTIVMQLVHGESLIQHLCRQ---------------STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AV 236 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~~---------------~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ 236 (380)
..|||||||.+|+|.+++.+. ..+++.++..|+.||+.||.|||+++|+||||||+|||++. +.
T Consensus 117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCc
Confidence 789999999999999999653 35899999999999999999999999999999999999985 59
Q ss_pred eEEEeCCCccccc--------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhc
Q psy11098 237 LKLIDLGSSVSVS--------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISV 307 (380)
Q Consensus 237 ikl~DFG~a~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~ 307 (380)
+||+|||+|+... ...+||+.|||||++.+ ..++.++|||||||++|||+| |+.||.+.+..+....+..
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~ 275 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ 275 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHH
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcC-CCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 9999999997542 34678999999999988 578999999999999999999 9999999999888888876
Q ss_pred ccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 308 ADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 308 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
+... +....+++++.+||.+||+.||++|||++|++++
T Consensus 276 g~~~---~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 276 GREL---ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp TCCC---CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred CCCC---CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 5421 1224689999999999999999999999999865
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-56 Score=431.26 Aligned_cols=278 Identities=32% Similarity=0.548 Sum_probs=243.6
Q ss_pred hhhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC-------chHHHHHHHHHHHhhccCCCcceeeeccc
Q psy11098 95 QEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ-------PQQITRAEYNLLSTLMHAHIPTALALFEN 167 (380)
Q Consensus 95 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-------~~~~~~~E~~il~~l~h~ni~~i~~~~~~ 167 (380)
...+.++|++.+.||+|+||+||+|+++.+|+.||+|++.+... ..+.+.+|+.+++.++||||++++++|..
T Consensus 7 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 86 (361)
T 2yab_A 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN 86 (361)
T ss_dssp CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CCChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe
Confidence 45678999999999999999999999999999999999975432 24678899999999999999999999876
Q ss_pred ccCCCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-C----eeEEEeC
Q psy11098 168 APVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-A----VLKLIDL 242 (380)
Q Consensus 168 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~----~ikl~DF 242 (380)
. +..++||||+.||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+++ + .+||+||
T Consensus 87 ~---~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 87 R---TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp S---SEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred C---CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 4 678999999999999999988889999999999999999999999999999999999999963 3 6999999
Q ss_pred CCccccc-----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcC
Q psy11098 243 GSSVSVS-----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQC 317 (380)
Q Consensus 243 G~a~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 317 (380)
|++.... ...+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+....+.++...+
T Consensus 164 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 242 (361)
T 2yab_A 164 GLAHEIEDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFF 242 (361)
T ss_dssp SSCEECCTTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred CCceEcCCCCccccCCCCccEECchHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhc
Confidence 9997653 35679999999999987 47889999999999999999999999999999999999999888887777
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCC--------CCCccccccchHHHHHHHHh
Q psy11098 318 GHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASC--------SEFDTERLLPFSARRKQKFK 376 (380)
Q Consensus 318 ~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~--------~~~~~~~~~~~~~~~~~~~~ 376 (380)
..+++++++||++||.+||++|||++|+|+||||+.... ...+.++++++..+|+|+..
T Consensus 243 ~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (361)
T 2yab_A 243 SQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLENFKKQYVRRRWKLS 309 (361)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSSHHHHHHHHTCBCCHHHHHHHTC-------
T ss_pred cCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCchhhhhhcccchhhHHHHHHHHHHhHHHHH
Confidence 889999999999999999999999999999999986432 24556778888888888754
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-56 Score=418.76 Aligned_cols=243 Identities=21% Similarity=0.290 Sum_probs=210.4
Q ss_pred hhceeeeeeecccCCeEEEEEEEc-----CCCcEEEEEEecCCC--CchHHHHHHHHHHHhhccCCCcceeeecccccCC
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDR-----GTGQLVALKQIPRER--QPQQITRAEYNLLSTLMHAHIPTALALFENAPVP 171 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vAvK~~~~~~--~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~ 171 (380)
...+++.++||+|+||+||+|+.. .+++.||||+++... ...+.+.+|+.+++.++||||+++++++...
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~--- 101 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD--- 101 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC---
Confidence 356888999999999999999864 467899999996443 3456789999999999999999999998764
Q ss_pred CceEEEEEecCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-
Q psy11098 172 GTDTIVMQLVHGESLIQHLCRQ----------------STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG- 234 (380)
Q Consensus 172 ~~~~lv~e~~~gg~L~~~l~~~----------------~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~- 234 (380)
+..+||||||.+|+|.++|... ..+++.++..++.||+.||.|||+++||||||||+|||+++
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDK 181 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCC
Confidence 5679999999999999999642 35899999999999999999999999999999999999985
Q ss_pred CeeEEEeCCCccccc--------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q psy11098 235 AVLKLIDLGSSVSVS--------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHI 305 (380)
Q Consensus 235 ~~ikl~DFG~a~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i 305 (380)
+.+||+|||+|+... ....||+.|||||++.+ ..++.++|||||||++|||+| |..||.+.+..+....+
T Consensus 182 ~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i 260 (308)
T 4gt4_A 182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI 260 (308)
T ss_dssp GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHH
T ss_pred CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 599999999997652 34578999999999988 478999999999999999998 89999999999988888
Q ss_pred hcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 306 SVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 306 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
..+.... ....+++++.+|+.+||+.||++|||+.|++++
T Consensus 261 ~~~~~~~---~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 261 RNRQVLP---CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HcCCCCC---CcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 7655322 224689999999999999999999999999876
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-55 Score=432.57 Aligned_cols=276 Identities=30% Similarity=0.494 Sum_probs=245.2
Q ss_pred hhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---chHHHHHHHHHHHhhccCCCcceeeecccccCCC
Q psy11098 96 EQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLMHAHIPTALALFENAPVPG 172 (380)
Q Consensus 96 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~ 172 (380)
..+.++|++.+.||+|+||+||+|.++.+|+.||+|++..... ....+.+|+++++.++||||+++++++... +
T Consensus 7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~---~ 83 (444)
T 3soa_A 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEE---G 83 (444)
T ss_dssp CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECS---S
T ss_pred ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEEC---C
Confidence 4578999999999999999999999999999999999976543 235578899999999999999999988764 6
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe----CCeeEEEeCCCcccc
Q psy11098 173 TDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN----GAVLKLIDLGSSVSV 248 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~----~~~ikl~DFG~a~~~ 248 (380)
..|+||||+.||+|.+.+.....+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|...
T Consensus 84 ~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 84 HHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp EEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 7899999999999999999988999999999999999999999999999999999999997 358999999999765
Q ss_pred c------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCH
Q psy11098 249 S------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISV 322 (380)
Q Consensus 249 ~------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 322 (380)
. ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+..+.+.++...+..+++
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 242 (444)
T 3soa_A 164 EGEQQAWFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTP 242 (444)
T ss_dssp CTTCCBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred cCCCceeecccCCcccCCHHHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCH
Confidence 3 34578999999999987 4788999999999999999999999999999999999999999998888889999
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhcccccccCC--C----CCccccccchHHHHHHHH
Q psy11098 323 PARELIGQLLNTHADKRPTAGQLLQVAWFAEASC--S----EFDTERLLPFSARRKQKF 375 (380)
Q Consensus 323 ~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~--~----~~~~~~~~~~~~~~~~~~ 375 (380)
++++||++||+.||++|||+.|+|+||||+.... . ....+.++.|.++||++.
T Consensus 243 ~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~klk~ 301 (444)
T 3soa_A 243 EAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKG 301 (444)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHHHHHSCCCCCHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHcCCChhHCCCHHHHhcCccccCCccccccchhhHHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999975421 1 122457789999998764
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-54 Score=414.39 Aligned_cols=276 Identities=33% Similarity=0.572 Sum_probs=242.6
Q ss_pred hhhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC-------chHHHHHHHHHHHhhccCCCcceeeeccc
Q psy11098 95 QEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ-------PQQITRAEYNLLSTLMHAHIPTALALFEN 167 (380)
Q Consensus 95 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-------~~~~~~~E~~il~~l~h~ni~~i~~~~~~ 167 (380)
.+.+.++|++.+.||+|+||.||+|.++.+|+.||+|++..... ..+.+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 85 (326)
T 2y0a_A 6 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN 85 (326)
T ss_dssp CSCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred cCCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 45678999999999999999999999999999999999965432 34678899999999999999999999876
Q ss_pred ccCCCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-C----eeEEEeC
Q psy11098 168 APVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-A----VLKLIDL 242 (380)
Q Consensus 168 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~----~ikl~DF 242 (380)
. +..++||||+.|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++. + .+||+||
T Consensus 86 ~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 86 K---TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp S---SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred C---CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 3 678999999999999999988888999999999999999999999999999999999999974 3 6999999
Q ss_pred CCccccc-----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcC
Q psy11098 243 GSSVSVS-----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQC 317 (380)
Q Consensus 243 G~a~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 317 (380)
|++.... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+....+.++...+
T Consensus 163 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (326)
T 2y0a_A 163 GLAHKIDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 241 (326)
T ss_dssp TTCEECCTTSCCCCCCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHH
T ss_pred CCCeECCCCCccccccCCcCcCCceeecC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCcccc
Confidence 9997653 35678999999999987 47889999999999999999999999999999988888888877777667
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCC--------CCCccccccchHHHHHHH
Q psy11098 318 GHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASC--------SEFDTERLLPFSARRKQK 374 (380)
Q Consensus 318 ~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~--------~~~~~~~~~~~~~~~~~~ 374 (380)
..++.++++||++||..||++|||++|+|+||||+.... .....+++++|..|++++
T Consensus 242 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (326)
T 2y0a_A 242 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAVNMEKFKKFAARKKSN 306 (326)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCSHHHHHHHHHCBCCHHHHHHHTTC----
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCcchhhhhhhcccccHHHHHHHHHHHHhh
Confidence 789999999999999999999999999999999986532 245667788888888765
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-54 Score=412.74 Aligned_cols=255 Identities=28% Similarity=0.509 Sum_probs=233.5
Q ss_pred hhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEE
Q psy11098 97 QFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 97 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
++.++|++.+.||+|+||+||+|.++.+++.||+|++.........+.+|+.+++.++||||+++++++... +..++
T Consensus 2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---~~~~l 78 (321)
T 1tki_A 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESM---EELVM 78 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEET---TEEEE
T ss_pred chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecC---CEEEE
Confidence 367899999999999999999999999999999999987666667788999999999999999999998764 67899
Q ss_pred EEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe---CCeeEEEeCCCccccc---
Q psy11098 177 VMQLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN---GAVLKLIDLGSSVSVS--- 249 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~---~~~ikl~DFG~a~~~~--- 249 (380)
||||+.|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred EEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 99999999999999765 4799999999999999999999999999999999999997 4689999999997653
Q ss_pred --ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHH
Q psy11098 250 --TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAREL 327 (380)
Q Consensus 250 --~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 327 (380)
....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+....+.++...+..++.++++|
T Consensus 159 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 237 (321)
T 1tki_A 159 NFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237 (321)
T ss_dssp EEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHH
T ss_pred ccccccCChhhcCcHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHH
Confidence 34578999999999987 467889999999999999999999999999999999999888888877778899999999
Q ss_pred HHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 328 IGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 328 i~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
|++||..||++|||+.|+|+||||++..
T Consensus 238 i~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 265 (321)
T 1tki_A 238 VDRLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp HHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred HHHHcCCChhHCcCHHHHhcChhhccCc
Confidence 9999999999999999999999998753
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-55 Score=418.92 Aligned_cols=244 Identities=21% Similarity=0.313 Sum_probs=206.1
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCC-----cEEEEEEecCCCCc--hHHHHHHHHHHHhhcc-CCCcceeeecccccC
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTG-----QLVALKQIPRERQP--QQITRAEYNLLSTLMH-AHIPTALALFENAPV 170 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~-----~~vAvK~~~~~~~~--~~~~~~E~~il~~l~h-~ni~~i~~~~~~~~~ 170 (380)
.++|++.+.||+|+||+||+|.+..++ +.||||++...... ...+.+|+++|..+.| |||+++++++...
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~-- 140 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-- 140 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT--
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec--
Confidence 578999999999999999999987643 68999999765432 3567889999999966 8999999987543
Q ss_pred CCceEEEEEecCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-
Q psy11098 171 PGTDTIVMQLVHGESLIQHLCRQ----------------STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN- 233 (380)
Q Consensus 171 ~~~~~lv~e~~~gg~L~~~l~~~----------------~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~- 233 (380)
.+.++||||||.+|+|.++|... ..+++..+..++.||+.||.|||+++||||||||+|||++
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 220 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 220 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCC
Confidence 24679999999999999999652 3489999999999999999999999999999999999998
Q ss_pred CCeeEEEeCCCccccc--------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCH-HHHHH
Q psy11098 234 GAVLKLIDLGSSVSVS--------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESE-EETRA 303 (380)
Q Consensus 234 ~~~ikl~DFG~a~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~-~~~~~ 303 (380)
++.+||+|||+|+... ...+||+.|||||++.+ ..++.++|||||||++|||+| |..||.+.+. +....
T Consensus 221 ~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~ 299 (353)
T 4ase_A 221 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 299 (353)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred CCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc-CCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 5699999999998652 34568999999999988 578999999999999999998 9999988654 44444
Q ss_pred HHhcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 304 HISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 304 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
.+..+. .++ ....+++++.+||.+||+.||++|||+.|+++|
T Consensus 300 ~i~~g~-~~~--~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 300 RLKEGT-RMR--APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHTC-CCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCC-CCC--CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 444432 222 224579999999999999999999999999998
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-54 Score=408.40 Aligned_cols=251 Identities=28% Similarity=0.461 Sum_probs=226.5
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---chHHHHHHHHHHHhhccCCCcceeeecccccCCCce
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~ 174 (380)
..++|++.+.||+|+||.||+|++..+|+.||+|++..... ....+.+|+++++.++|+||+++++++... +..
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~---~~~ 89 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETE---KTL 89 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS---SEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC---CEE
Confidence 45789999999999999999999999999999999965433 234567899999999999999999998764 678
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc----
Q psy11098 175 TIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS---- 249 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~---- 249 (380)
|+||||+.|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 169 (328)
T 3fe3_A 90 YLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK 169 (328)
T ss_dssp EEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG
T ss_pred EEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc
Confidence 99999999999999998888999999999999999999999999999999999999998 5699999999997653
Q ss_pred -ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHH
Q psy11098 250 -TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELI 328 (380)
Q Consensus 250 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 328 (380)
...+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+..+.+.++. .+++++.+||
T Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li 245 (328)
T 3fe3_A 170 LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF----YMSTDCENLL 245 (328)
T ss_dssp GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHH
T ss_pred cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHHHHH
Confidence 45689999999999988655568999999999999999999999999999999999888776664 4799999999
Q ss_pred HHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 329 GQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 329 ~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
++||..||.+|||++|+|+||||+...
T Consensus 246 ~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 246 KRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp HHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred HHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 999999999999999999999998653
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-54 Score=415.30 Aligned_cols=276 Identities=30% Similarity=0.490 Sum_probs=244.4
Q ss_pred hhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---chHHHHHHHHHHHhhccCCCcceeeecccccCCC
Q psy11098 96 EQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLMHAHIPTALALFENAPVPG 172 (380)
Q Consensus 96 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~ 172 (380)
..+.++|++.+.||+|+||.||+|.++.+++.||+|++..... ..+.+.+|+.+++.++||||+++++++... +
T Consensus 25 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~---~ 101 (362)
T 2bdw_A 25 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE---S 101 (362)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS---S
T ss_pred CCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC---C
Confidence 3567899999999999999999999999999999999976543 235677899999999999999999988764 6
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC----CeeEEEeCCCcccc
Q psy11098 173 TDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG----AVLKLIDLGSSVSV 248 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~----~~ikl~DFG~a~~~ 248 (380)
..|+||||+.||+|.+.+.....+++..+..++.||+.||.|||++||+||||||+|||++. +.+||+|||++...
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 102 FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp EEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred EEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 78999999999999999988888999999999999999999999999999999999999973 36999999999766
Q ss_pred c-----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHH
Q psy11098 249 S-----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVP 323 (380)
Q Consensus 249 ~-----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 323 (380)
. ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+..+.+.++...+..++++
T Consensus 182 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 260 (362)
T 2bdw_A 182 NDSEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPE 260 (362)
T ss_dssp TTCCSCCCSCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHH
T ss_pred cCCcccccCCCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence 4 34578999999999987 47889999999999999999999999999999999999999888888777889999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHhcccccccCC--C----CCccccccchHHHHHHHH
Q psy11098 324 ARELIGQLLNTHADKRPTAGQLLQVAWFAEASC--S----EFDTERLLPFSARRKQKF 375 (380)
Q Consensus 324 ~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~--~----~~~~~~~~~~~~~~~~~~ 375 (380)
+++||.+||..||++|||+.|+|+||||..... + ....+.++.|..+||++-
T Consensus 261 ~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 318 (362)
T 2bdw_A 261 AKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKKFNARRKLKG 318 (362)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHTTSHHHHTHHHHSCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcCcccCCCcccccccchhhHHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999975321 1 122356788888888764
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-53 Score=407.32 Aligned_cols=250 Identities=26% Similarity=0.442 Sum_probs=225.7
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC----CCchHHHHHHHHHHHhhccCCCcceeeecccccCCCce
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~ 174 (380)
.++|++++.||+|+||+||+|+++.+|+.||+|++++. ......+.+|+++++.++||||++++.++... +..
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~---~~~ 80 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH---DRL 80 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS---SEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeC---CEE
Confidence 36899999999999999999999999999999999643 33456678899999999999999999988764 678
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc----
Q psy11098 175 TIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS---- 249 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~---- 249 (380)
|+||||+.||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 81 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 160 (337)
T 1o6l_A 81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC
Confidence 99999999999999999888999999999999999999999999999999999999998 5799999999997532
Q ss_pred --ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHH
Q psy11098 250 --TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAREL 327 (380)
Q Consensus 250 --~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 327 (380)
...+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+..+....+......++. .+++++++|
T Consensus 161 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~l 235 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSL 235 (337)
T ss_dssp CBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHH
T ss_pred cccccccChhhCChhhhcC-CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHH
Confidence 45678999999999988 47899999999999999999999999999998888888877766653 589999999
Q ss_pred HHHhcccCCCCCC-----CHHHHHhcccccccCC
Q psy11098 328 IGQLLNTHADKRP-----TAGQLLQVAWFAEASC 356 (380)
Q Consensus 328 i~~~L~~dP~~Rp-----t~~e~L~hpw~~~~~~ 356 (380)
|++||.+||++|| +++|+++||||....+
T Consensus 236 i~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~ 269 (337)
T 1o6l_A 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 269 (337)
T ss_dssp HHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred HHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCH
Confidence 9999999999999 9999999999986543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-53 Score=410.87 Aligned_cols=276 Identities=30% Similarity=0.501 Sum_probs=228.7
Q ss_pred hhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 96 EQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 96 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
+.+.++|++.+.||+|+||.||+|+++.+++.||+|++.... ..+.+.+|+++++.++|+||+++++++... +..+
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~ 124 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETP---TEIS 124 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECS---SEEE
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecC---CeEE
Confidence 346789999999999999999999999999999999997543 345577899999999999999999998764 6789
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe----CCeeEEEeCCCccccc--
Q psy11098 176 IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN----GAVLKLIDLGSSVSVS-- 249 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~----~~~ikl~DFG~a~~~~-- 249 (380)
+||||+.|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp EEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 9999999999999998888899999999999999999999999999999999999996 4689999999987653
Q ss_pred ---ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhcccCCCCCCcCCCCCHHHH
Q psy11098 250 ---TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEE-ETRAHISVADYSFPPEQCGHISVPAR 325 (380)
Q Consensus 250 ---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~~~ 325 (380)
....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.... .....+....+.++...+..++.+++
T Consensus 205 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 283 (349)
T 2w4o_A 205 VLMKTVCGTPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAK 283 (349)
T ss_dssp --------CGGGSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred cccccccCCCCccCHHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHH
Confidence 35678999999999988 47789999999999999999999999876544 46677777777777666778999999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhcccccccCCC----CCccccccchHHHHHHHHh
Q psy11098 326 ELIGQLLNTHADKRPTAGQLLQVAWFAEASCS----EFDTERLLPFSARRKQKFK 376 (380)
Q Consensus 326 ~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~~----~~~~~~~~~~~~~~~~~~~ 376 (380)
+||++||..||++|||+.|+|+||||...... .....+++.|.++|+++..
T Consensus 284 ~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (349)
T 2w4o_A 284 DLVRKLIVLDPKKRLTTFQALQHPWVTGKAANFVHMDTAQKKLQEFNARRKLKAA 338 (349)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHSTTTTSTTCCCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHhcCcccCCCccchhhhcchHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999876543 3345678999999998753
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-54 Score=412.96 Aligned_cols=251 Identities=25% Similarity=0.431 Sum_probs=223.4
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC----CCchHHHHHHHHHHHhh-ccCCCcceeeecccccCCCc
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLSTL-MHAHIPTALALFENAPVPGT 173 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~~~~~ 173 (380)
.++|++++.||+|+||+||+|+++.+++.||+|++++. ........+|.++++.+ .||||++++.++... +.
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~---~~ 98 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP---DR 98 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS---SE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC---CE
Confidence 46899999999999999999999999999999999653 23345567899999988 699999999998764 67
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc---
Q psy11098 174 DTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS--- 249 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~--- 249 (380)
.|+||||+.||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|+...
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~ 178 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG 178 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCC
Confidence 899999999999999999888999999999999999999999999999999999999998 5799999999997532
Q ss_pred ---ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHH
Q psy11098 250 ---TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARE 326 (380)
Q Consensus 250 ---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 326 (380)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......++. .++.++++
T Consensus 179 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~ 253 (353)
T 3txo_A 179 VTTATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT----WLHEDATG 253 (353)
T ss_dssp -------CCGGGCCHHHHHH-HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHH
T ss_pred ccccccCCCcCeEChhhcCC-CCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHH
Confidence 45689999999999987 47789999999999999999999999999999999999988877764 47999999
Q ss_pred HHHHhcccCCCCCCCH------HHHHhcccccccCCC
Q psy11098 327 LIGQLLNTHADKRPTA------GQLLQVAWFAEASCS 357 (380)
Q Consensus 327 li~~~L~~dP~~Rpt~------~e~L~hpw~~~~~~~ 357 (380)
||++||.+||++||++ +|+++||||++..+.
T Consensus 254 li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~ 290 (353)
T 3txo_A 254 ILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWA 290 (353)
T ss_dssp HHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHH
T ss_pred HHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHH
Confidence 9999999999999999 899999999976544
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-53 Score=400.38 Aligned_cols=251 Identities=26% Similarity=0.474 Sum_probs=227.1
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC----CCchHHHHHHHHHHHhhccCCCcceeeecccccCCCce
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~ 174 (380)
.++|++.+.||+|+||+||+|+++.+|+.||+|++++. ....+.+.+|..+++.+.||||+++++++... +..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~---~~~ 81 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA---QQI 81 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS---SEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeC---CEE
Confidence 46899999999999999999999999999999999643 23446677899999999999999999998764 678
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc---c
Q psy11098 175 TIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS---T 250 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~---~ 250 (380)
|+||||+.||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.... .
T Consensus 82 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~~ 161 (318)
T 1fot_A 82 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY 161 (318)
T ss_dssp EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCBC
T ss_pred EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCccc
Confidence 99999999999999999888999999999999999999999999999999999999998 5799999999998664 4
Q ss_pred cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHH
Q psy11098 251 VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQ 330 (380)
Q Consensus 251 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 330 (380)
..+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+..+....+......++. .++.++++||++
T Consensus 162 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~~ 236 (318)
T 1fot_A 162 TLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP----FFNEDVKDLLSR 236 (318)
T ss_dssp CCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHHHH
T ss_pred cccCCccccCHhHhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHHHHHHH
Confidence 5689999999999988 47889999999999999999999999999998888888887776653 579999999999
Q ss_pred hcccCCCCCC-----CHHHHHhcccccccCCC
Q psy11098 331 LLNTHADKRP-----TAGQLLQVAWFAEASCS 357 (380)
Q Consensus 331 ~L~~dP~~Rp-----t~~e~L~hpw~~~~~~~ 357 (380)
||..||++|| +++++++||||+...+.
T Consensus 237 lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~ 268 (318)
T 1fot_A 237 LITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE 268 (318)
T ss_dssp HTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred HhccCHHHcCCCcCCCHHHHhcCccccCCCHH
Confidence 9999999999 99999999999876443
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-53 Score=408.74 Aligned_cols=274 Identities=29% Similarity=0.469 Sum_probs=233.1
Q ss_pred hhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC------CCchHHHHHHHHHHHhhccCCCcceeeecccccC
Q psy11098 97 QFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE------RQPQQITRAEYNLLSTLMHAHIPTALALFENAPV 170 (380)
Q Consensus 97 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~------~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~ 170 (380)
.+.++|++.+.||+|+||+||+|+++.+++.||+|++... ....+.+.+|+.+++.++||||+++++++...
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-- 98 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD-- 98 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET--
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--
Confidence 4678999999999999999999999999999999998532 22456788999999999999999999998764
Q ss_pred CCceEEEEEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-C---eeEEEeC
Q psy11098 171 PGTDTIVMQLVHGESLIQHLCRQ----STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-A---VLKLIDL 242 (380)
Q Consensus 171 ~~~~~lv~e~~~gg~L~~~l~~~----~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~---~ikl~DF 242 (380)
+..|+||||+.|++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++. + .+||+||
T Consensus 99 -~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 99 -GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp -TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred -CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecC
Confidence 6789999999999999888543 35899999999999999999999999999999999999973 2 4999999
Q ss_pred CCccccc------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCc
Q psy11098 243 GSSVSVS------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQ 316 (380)
Q Consensus 243 G~a~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 316 (380)
|++.... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+. ..+....+....+.++...
T Consensus 178 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~ 255 (351)
T 3c0i_A 178 GVAIQLGESGLVAGGRVGTPHFMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQ 255 (351)
T ss_dssp TTCEECCTTSCBCCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHH
T ss_pred cceeEecCCCeeecCCcCCcCccCHHHHcC-CCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCccc
Confidence 9997653 34578999999999988 46789999999999999999999999875 4566677777777777666
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCC----C--CCccccccchHHHHHHHH
Q psy11098 317 CGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASC----S--EFDTERLLPFSARRKQKF 375 (380)
Q Consensus 317 ~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~----~--~~~~~~~~~~~~~~~~~~ 375 (380)
+..++.++++||++||..||++|||+.|+|+||||++... . ....++++.|..+||++.
T Consensus 256 ~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 320 (351)
T 3c0i_A 256 WSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARRKLKG 320 (351)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHHHHSCCSCCHHHHHHHHHHHHHHC---
T ss_pred cccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCccccccccchHHHHHHHHHHHHHHHHH
Confidence 6789999999999999999999999999999999986421 1 122466778888888654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-53 Score=406.03 Aligned_cols=254 Identities=26% Similarity=0.392 Sum_probs=227.0
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC----CCchHHHHHHHHHHHhh-ccCCCcceeeecccccCCCc
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLSTL-MHAHIPTALALFENAPVPGT 173 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~~~~~ 173 (380)
.++|++.+.||+|+||+||+|+++.+|+.||+|++++. .........|.+++..+ +||||++++.++... +.
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~---~~ 92 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK---EN 92 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS---SE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC---CE
Confidence 47899999999999999999999999999999999653 33445677899999877 899999999988764 67
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccc----
Q psy11098 174 DTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSV---- 248 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~---- 248 (380)
.|+||||+.||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++..
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 172 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 172 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC
Confidence 899999999999999999888999999999999999999999999999999999999998 579999999999753
Q ss_pred --cccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHH
Q psy11098 249 --STVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARE 326 (380)
Q Consensus 249 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 326 (380)
....+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+..+....+......++. .++.++++
T Consensus 173 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~ 247 (345)
T 1xjd_A 173 AKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR----WLEKEAKD 247 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHH
T ss_pred CcccCCCCCcccCChhhhcC-CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCc----ccCHHHHH
Confidence 245689999999999988 47899999999999999999999999999999999888877766653 48999999
Q ss_pred HHHHhcccCCCCCCCHH-HHHhcccccccCCCCCc
Q psy11098 327 LIGQLLNTHADKRPTAG-QLLQVAWFAEASCSEFD 360 (380)
Q Consensus 327 li~~~L~~dP~~Rpt~~-e~L~hpw~~~~~~~~~~ 360 (380)
||++||..||++||++. ++++||||+...+..+.
T Consensus 248 li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~~l~ 282 (345)
T 1xjd_A 248 LLVKLFVREPEKRLGVRGDIRQHPLFREINWEELE 282 (345)
T ss_dssp HHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHHHH
T ss_pred HHHHHhcCCHhHcCCChHHHHcCccccCCCHHHHh
Confidence 99999999999999998 99999999976554333
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-52 Score=411.50 Aligned_cols=255 Identities=24% Similarity=0.410 Sum_probs=223.5
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC----CCchHHHHHHHHHHHhhccCCCcceeeecccccCCCce
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~ 174 (380)
.++|++.+.||+|+||+||+|+++.+++.||+|++.+. ......+.+|+.+++.++||||++++.++... +..
T Consensus 68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~---~~~ 144 (410)
T 3v8s_A 68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD---RYL 144 (410)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS---SEE
T ss_pred ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC---CEE
Confidence 47899999999999999999999999999999999642 23345577899999999999999999998764 678
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc----
Q psy11098 175 TIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS---- 249 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~---- 249 (380)
|+||||+.||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|....
T Consensus 145 ~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~ 223 (410)
T 3v8s_A 145 YMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 223 (410)
T ss_dssp EEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE
T ss_pred EEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCc
Confidence 999999999999998865 4799999999999999999999999999999999999998 5799999999997653
Q ss_pred ---ccccCCCcccCCccccCCC---CCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHH
Q psy11098 250 ---TVVLPDLEFASPEMLTSPA---TAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVP 323 (380)
Q Consensus 250 ---~~~~gt~~y~aPE~~~~~~---~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 323 (380)
...+||+.|+|||++.+.. .++.++|||||||++|+|++|..||.+.+..+...++......+..+....+|.+
T Consensus 224 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~ 303 (410)
T 3v8s_A 224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKE 303 (410)
T ss_dssp EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHH
T ss_pred ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHH
Confidence 3568999999999998632 2678999999999999999999999999999998888765433333334568999
Q ss_pred HHHHHHHhcccCCCC--CCCHHHHHhcccccccCCC
Q psy11098 324 ARELIGQLLNTHADK--RPTAGQLLQVAWFAEASCS 357 (380)
Q Consensus 324 ~~~li~~~L~~dP~~--Rpt~~e~L~hpw~~~~~~~ 357 (380)
+++||++||..+|.+ |++++|+++||||+...+.
T Consensus 304 ~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~ 339 (410)
T 3v8s_A 304 AKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWA 339 (410)
T ss_dssp HHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCC
T ss_pred HHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHH
Confidence 999999999999988 9999999999999987554
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-52 Score=408.37 Aligned_cols=253 Identities=22% Similarity=0.374 Sum_probs=219.4
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC----CchHHHHHHHHHHHhh-ccCCCcceeeecccccCCCc
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQITRAEYNLLSTL-MHAHIPTALALFENAPVPGT 173 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~~~~~ 173 (380)
.++|++++.||+|+||+||+|+++.+++.||+|++++.. .....+.+|..++..+ +||||++++.++... +.
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~---~~ 127 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE---SR 127 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECS---SE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEEC---CE
Confidence 468999999999999999999999999999999997532 2234567899999887 899999999998764 67
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccc----
Q psy11098 174 DTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSV---- 248 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~---- 248 (380)
.|+||||+.||+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|+..
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 207 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 207 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCC
Confidence 899999999999999999888999999999999999999999999999999999999998 569999999999752
Q ss_pred --cccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC---------CHHHHHHHHhcccCCCCCCcC
Q psy11098 249 --STVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDE---------SEEETRAHISVADYSFPPEQC 317 (380)
Q Consensus 249 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~---------~~~~~~~~i~~~~~~~~~~~~ 317 (380)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||... ........+......++.
T Consensus 208 ~~~~~~~gt~~Y~aPE~l~~-~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~--- 283 (396)
T 4dc2_A 208 DTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--- 283 (396)
T ss_dssp CCBCCCCBCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCT---
T ss_pred CccccccCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCC---
Confidence 246789999999999988 57899999999999999999999999532 234455666666666653
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCH------HHHHhcccccccCCCCC
Q psy11098 318 GHISVPARELIGQLLNTHADKRPTA------GQLLQVAWFAEASCSEF 359 (380)
Q Consensus 318 ~~~s~~~~~li~~~L~~dP~~Rpt~------~e~L~hpw~~~~~~~~~ 359 (380)
.++.++++||++||++||++||++ +|+++||||+...+..+
T Consensus 284 -~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l 330 (396)
T 4dc2_A 284 -SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMM 330 (396)
T ss_dssp -TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHH
T ss_pred -cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHH
Confidence 489999999999999999999985 89999999987654433
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-52 Score=389.57 Aligned_cols=267 Identities=26% Similarity=0.425 Sum_probs=226.4
Q ss_pred hhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC-CCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 97 QFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE-RQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 97 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
...++|++.+.||+|+||+||+|.+..+++.||+|++... ....+.+.+|+.+++.++||||+++++++... +..+
T Consensus 17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~---~~~~ 93 (297)
T 3fxz_A 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG---DELW 93 (297)
T ss_dssp CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET---TEEE
T ss_pred ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEEC---CEEE
Confidence 4578999999999999999999999999999999998643 33456778899999999999999999998764 6789
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-----
Q psy11098 176 IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS----- 249 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~----- 249 (380)
+||||+.|++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 94 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 172 (297)
T 3fxz_A 94 VVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (297)
T ss_dssp EEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred EEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc
Confidence 999999999999998765 699999999999999999999999999999999999998 5699999999987653
Q ss_pred -ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHH
Q psy11098 250 -TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELI 328 (380)
Q Consensus 250 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 328 (380)
....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+...... .......++..+++||
T Consensus 173 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li 250 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-ELQNPEKLSAIFRDFL 250 (297)
T ss_dssp BCCCCSCGGGCCHHHHHC-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC-CCSCGGGSCHHHHHHH
T ss_pred cCCccCCcCccChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CCCCccccCHHHHHHH
Confidence 34578999999999988 47889999999999999999999999988877666555433221 1112346899999999
Q ss_pred HHhcccCCCCCCCHHHHHhcccccccCCCCCccccccchHHHHHH
Q psy11098 329 GQLLNTHADKRPTAGQLLQVAWFAEASCSEFDTERLLPFSARRKQ 373 (380)
Q Consensus 329 ~~~L~~dP~~Rpt~~e~L~hpw~~~~~~~~~~~~~~~~~~~~~~~ 373 (380)
.+||+.||++|||++|+|+||||+... ....+.|..+..+.
T Consensus 251 ~~~l~~dp~~Rps~~ell~h~~~~~~~----~~~~~~p~~~~~~~ 291 (297)
T 3fxz_A 251 NRCLEMDVEKRGSAKELLQHQFLKIAK----PLSSLTPLIAAAKE 291 (297)
T ss_dssp HHHSCSSTTTSCCHHHHTTCGGGGGCC----CGGGGHHHHHHHHH
T ss_pred HHHccCChhHCcCHHHHhhChhhcccC----cccccchHHHHHhh
Confidence 999999999999999999999998653 22344455544443
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-52 Score=404.46 Aligned_cols=256 Identities=29% Similarity=0.518 Sum_probs=231.2
Q ss_pred hhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC-chHHHHHHHHHHHhhccCCCcceeeecccccCCCce
Q psy11098 96 EQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ-PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 96 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~ 174 (380)
..+.++|++.+.||+|+||+||+|.++.+++.||+|++..... ....+.+|+++++.++|+||+++++++... +..
T Consensus 47 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~---~~~ 123 (387)
T 1kob_A 47 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK---YEM 123 (387)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS---SEE
T ss_pred CccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeC---CEE
Confidence 3467899999999999999999999999999999999976533 345678899999999999999999998764 678
Q ss_pred EEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC---CeeEEEeCCCccccc-
Q psy11098 175 TIVMQLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG---AVLKLIDLGSSVSVS- 249 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~---~~ikl~DFG~a~~~~- 249 (380)
++||||+.|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||++....
T Consensus 124 ~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 124 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 9999999999999999764 47999999999999999999999999999999999999973 479999999998664
Q ss_pred ----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHH
Q psy11098 250 ----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAR 325 (380)
Q Consensus 250 ----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 325 (380)
....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+....+.++...+..++++++
T Consensus 204 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 282 (387)
T 1kob_A 204 DEIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 282 (387)
T ss_dssp TSCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred CcceeeeccCCCccCchhccC-CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHH
Confidence 34578999999999987 4778899999999999999999999999999999999988888888777788999999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 326 ELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 326 ~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
+||++||..||++|||+.|+|+||||+...
T Consensus 283 ~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 283 DFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 999999999999999999999999998754
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-52 Score=402.37 Aligned_cols=250 Identities=24% Similarity=0.419 Sum_probs=226.6
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC----CCchHHHHHHHHHHHhhccCCCcceeeecccccCCCce
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~ 174 (380)
.++|++++.||+|+||.||+|+++.+|+.||+|++.+. ......+.+|+++++.+.||||++++.++... +..
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~---~~~ 116 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN---SNL 116 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS---SEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC---CEE
Confidence 47899999999999999999999999999999999643 23445678899999999999999999988764 678
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc---c
Q psy11098 175 TIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS---T 250 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~---~ 250 (380)
|+||||+.||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.... .
T Consensus 117 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~~ 196 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 196 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCBC
T ss_pred EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCCcc
Confidence 99999999999999999888999999999999999999999999999999999999998 5699999999998664 3
Q ss_pred cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHH
Q psy11098 251 VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQ 330 (380)
Q Consensus 251 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 330 (380)
..+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......++. .++.++++||++
T Consensus 197 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~~ 271 (350)
T 1rdq_E 197 TLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRN 271 (350)
T ss_dssp CCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TCCHHHHHHHHH
T ss_pred cccCCccccCHHHhcC-CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHH
Confidence 5678999999999988 47889999999999999999999999999999999998888776653 589999999999
Q ss_pred hcccCCCCCCC-----HHHHHhcccccccCC
Q psy11098 331 LLNTHADKRPT-----AGQLLQVAWFAEASC 356 (380)
Q Consensus 331 ~L~~dP~~Rpt-----~~e~L~hpw~~~~~~ 356 (380)
||+.||++||+ ++++++||||+...+
T Consensus 272 lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w 302 (350)
T 1rdq_E 272 LLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp HSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred HhhcCHHhccCCccCCHHHHHhCcCcCCCCH
Confidence 99999999998 999999999987543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=397.36 Aligned_cols=277 Identities=32% Similarity=0.554 Sum_probs=240.2
Q ss_pred hhhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC-------chHHHHHHHHHHHhhccCCCcceeeeccc
Q psy11098 95 QEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ-------PQQITRAEYNLLSTLMHAHIPTALALFEN 167 (380)
Q Consensus 95 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-------~~~~~~~E~~il~~l~h~ni~~i~~~~~~ 167 (380)
...+.++|++.+.||+|+||.||+|+++.+|+.||+|++..... ..+.+.+|+.+++.+.|+||+++++++..
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 86 (321)
T 2a2a_A 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN 86 (321)
T ss_dssp CSCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred chhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 34578899999999999999999999999999999999965432 24668899999999999999999999876
Q ss_pred ccCCCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-C----eeEEEeC
Q psy11098 168 APVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-A----VLKLIDL 242 (380)
Q Consensus 168 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~----~ikl~DF 242 (380)
. +..++||||+.|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++. + .+||+||
T Consensus 87 ~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 87 R---TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp S---SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred C---CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccC
Confidence 4 678999999999999999988888999999999999999999999999999999999999974 3 6999999
Q ss_pred CCccccc-----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcC
Q psy11098 243 GSSVSVS-----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQC 317 (380)
Q Consensus 243 G~a~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 317 (380)
|++.... ....||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+..+....+....+.++...+
T Consensus 164 g~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 242 (321)
T 2a2a_A 164 GLAHEIEDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFF 242 (321)
T ss_dssp TTCEECCTTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred ccceecCccccccccCCCCCccCcccccC-CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhh
Confidence 9997654 34568999999999987 47789999999999999999999999999999998888888777776666
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCC--------CCCccccccchHHHHHHHH
Q psy11098 318 GHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASC--------SEFDTERLLPFSARRKQKF 375 (380)
Q Consensus 318 ~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~--------~~~~~~~~~~~~~~~~~~~ 375 (380)
..++.++++||++||..||++|||++|+|+||||..... +....+.+++...+++|+.
T Consensus 243 ~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (321)
T 2a2a_A 243 SHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLENFRKQYVRRRWKL 308 (321)
T ss_dssp TTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSHHHHHHHHHCEECHHHHHHHHHHCC---
T ss_pred cccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCCcccccccccchhhHHHHHHHHHHHHHHH
Confidence 778999999999999999999999999999999986532 2344455666666666653
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-52 Score=402.99 Aligned_cols=251 Identities=24% Similarity=0.391 Sum_probs=225.4
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC----CCchHHHHHHHHHHHhh-ccCCCcceeeecccccCCCc
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLSTL-MHAHIPTALALFENAPVPGT 173 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~~~~~ 173 (380)
.++|++++.||+|+||+||+|+++.+++.||+|++++. .........|.+++..+ +|++|++++.++... +.
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~---~~ 95 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM---DR 95 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS---SE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC---CE
Confidence 46899999999999999999999999999999999653 23445677899999887 799999999998764 67
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccc----
Q psy11098 174 DTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSV---- 248 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~---- 248 (380)
.|+||||+.||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++...
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 175 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 175 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC
Confidence 899999999999999999888999999999999999999999999999999999999998 579999999999753
Q ss_pred --cccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHH
Q psy11098 249 --STVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARE 326 (380)
Q Consensus 249 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 326 (380)
....+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+..+....+......++. .++.++++
T Consensus 176 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~ 250 (353)
T 2i0e_A 176 VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVA 250 (353)
T ss_dssp CCBCCCCSCGGGCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHH
T ss_pred cccccccCCccccChhhhcC-CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHHHHH
Confidence 245689999999999987 47799999999999999999999999999999999999888777664 58999999
Q ss_pred HHHHhcccCCCCCC-----CHHHHHhcccccccCCC
Q psy11098 327 LIGQLLNTHADKRP-----TAGQLLQVAWFAEASCS 357 (380)
Q Consensus 327 li~~~L~~dP~~Rp-----t~~e~L~hpw~~~~~~~ 357 (380)
||++||.+||++|| +++++++||||+...+.
T Consensus 251 li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~ 286 (353)
T 2i0e_A 251 ICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE 286 (353)
T ss_dssp HHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHH
T ss_pred HHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHH
Confidence 99999999999999 47999999999875443
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=401.61 Aligned_cols=252 Identities=26% Similarity=0.484 Sum_probs=224.5
Q ss_pred hhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhh-ccCCCcceeeecccccCCCce
Q psy11098 96 EQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTL-MHAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 96 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~~~~~~ 174 (380)
..+.++|++.+.||+|+||+||+|.++.+++.||+|++.+.... ..+|++++..+ .||||+++++++... +..
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~---~~~E~~~l~~~~~hp~iv~~~~~~~~~---~~~ 91 (342)
T 2qr7_A 18 IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD---PTEEIEILLRYGQHPNIITLKDVYDDG---KYV 91 (342)
T ss_dssp -CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC---CHHHHHHHHHHTTSTTBCCEEEEEECS---SEE
T ss_pred cCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC---hHHHHHHHHHhcCCCCcCeEEEEEEcC---CEE
Confidence 35789999999999999999999999999999999999765432 34688888888 799999999998764 678
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC--C---eeEEEeCCCccccc
Q psy11098 175 TIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG--A---VLKLIDLGSSVSVS 249 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~--~---~ikl~DFG~a~~~~ 249 (380)
|+||||+.||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+.+ + .+||+|||++....
T Consensus 92 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 92 YVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp EEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 999999999999999998889999999999999999999999999999999999999842 2 59999999997653
Q ss_pred ------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHhcccCCCCCCcCCCC
Q psy11098 250 ------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLD---ESEEETRAHISVADYSFPPEQCGHI 320 (380)
Q Consensus 250 ------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~---~~~~~~~~~i~~~~~~~~~~~~~~~ 320 (380)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+ .+..+....+..+.+.++...+..+
T Consensus 172 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 250 (342)
T 2qr7_A 172 AENGLLMTPCYTANFVAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSV 250 (342)
T ss_dssp CTTCCBCCSSCCSSCCCHHHHHH-HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTS
T ss_pred CCCCceeccCCCccccCHHHhcC-CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccC
Confidence 35678999999999987 4678899999999999999999999975 4667788888888888887777889
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 321 SVPARELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 321 s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
++++++||++||..||++|||+.++|+||||.+.
T Consensus 251 s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 251 SDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 9999999999999999999999999999999753
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-53 Score=397.41 Aligned_cols=247 Identities=21% Similarity=0.201 Sum_probs=192.6
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccC-CCceEEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPV-PGTDTIV 177 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~-~~~~~lv 177 (380)
.++|.+.+.||+|+||+||+|++ +|+.||||+++.........+.|+..+..++||||+++++++..... ...+|||
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 46789999999999999999987 48899999997654444444556777778999999999999876432 1357999
Q ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CcEeecCCCCcEEEe-CCeeEEEeCCCcccc
Q psy11098 178 MQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQ--------QIAHKDIRPENILMN-GAVLKLIDLGSSVSV 248 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~--------~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~ 248 (380)
||||.||+|.+++... .+++..+..++.|++.||.|||++ +|+||||||+|||++ ++.+||+|||+|+..
T Consensus 80 ~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp EECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred ecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence 9999999999999654 699999999999999999999987 999999999999998 569999999999754
Q ss_pred c----------ccccCCCcccCCccccCCC-----CCCCcccHHHHHHHHHHHHhCCCCCCCC---------------CH
Q psy11098 249 S----------TVVLPDLEFASPEMLTSPA-----TAGPSTDMWSLGVLLYILLSGVSPFLDE---------------SE 298 (380)
Q Consensus 249 ~----------~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwSlGvil~~lltg~~Pf~~~---------------~~ 298 (380)
. ...+||+.|||||++.+.. .++.++|||||||++|||+||.+||... ..
T Consensus 159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~ 238 (303)
T 3hmm_A 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence 2 2357999999999997632 3466899999999999999997765321 22
Q ss_pred HHHHHHHhcccCCCCCCc-C--CCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 299 EETRAHISVADYSFPPEQ-C--GHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 299 ~~~~~~i~~~~~~~~~~~-~--~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
++....+.......+.+. + ...+..+.+|+.+||+.||++|||+.|+++.
T Consensus 239 ~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp HHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 333333333332221111 1 1133568899999999999999999999864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=386.72 Aligned_cols=251 Identities=25% Similarity=0.396 Sum_probs=210.5
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
++|++.+.||+|+||+||+|+++.+++.||+|++..... ....+.+|+.+++.++|+||+++++++... +..++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~l 78 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD---KKLTL 78 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEET---TEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeC---CEEEE
Confidence 579999999999999999999999999999999975433 235677899999999999999999998764 67899
Q ss_pred EEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-----
Q psy11098 177 VMQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS----- 249 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~----- 249 (380)
||||+.+ +|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 79 v~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (292)
T 3o0g_A 79 VFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp EEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC
T ss_pred EEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc
Confidence 9999965 55555544 67899999999999999999999999999999999999998 5699999999997653
Q ss_pred -ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHhcccCCCCC-------------
Q psy11098 250 -TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSP-FLDESEEETRAHISVADYSFPP------------- 314 (380)
Q Consensus 250 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~P-f~~~~~~~~~~~i~~~~~~~~~------------- 314 (380)
....||+.|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+....+.........
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccc
Confidence 3457799999999998765689999999999999999987777 5556666665555432111111
Q ss_pred ------------CcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 315 ------------EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 315 ------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
.....++.++++||++||+.||++|||++|+|+||||++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred ccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 1123578999999999999999999999999999999875
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-52 Score=416.66 Aligned_cols=257 Identities=33% Similarity=0.515 Sum_probs=233.5
Q ss_pred hhhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecC---CCCchHHHHHHHHHHHhhccCCCcceeeecccccCC
Q psy11098 95 QEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPR---ERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVP 171 (380)
Q Consensus 95 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~---~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~ 171 (380)
+..+.++|++.+.||+|+||+||+|+++.+++.||||++.+ .......+.+|+++++.++||||+++++++...
T Consensus 17 ~g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--- 93 (486)
T 3mwu_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS--- 93 (486)
T ss_dssp CCHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECS---
T ss_pred cCChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcC---
Confidence 44688999999999999999999999999999999999853 234456788999999999999999999998764
Q ss_pred CceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe----CCeeEEEeCCCccc
Q psy11098 172 GTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN----GAVLKLIDLGSSVS 247 (380)
Q Consensus 172 ~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~----~~~ikl~DFG~a~~ 247 (380)
+..++||||+.|++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|..
T Consensus 94 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 94 SSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 67899999999999999998888999999999999999999999999999999999999995 24799999999976
Q ss_pred cc-----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCH
Q psy11098 248 VS-----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISV 322 (380)
Q Consensus 248 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 322 (380)
.. ....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+..+.+.++.+.+..+|+
T Consensus 174 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 251 (486)
T 3mwu_A 174 FQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISD 251 (486)
T ss_dssp BCCC----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCH
T ss_pred CCCCCccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCH
Confidence 53 35578999999999987 478899999999999999999999999999999999999988888777888999
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhcccccccCC
Q psy11098 323 PARELIGQLLNTHADKRPTAGQLLQVAWFAEASC 356 (380)
Q Consensus 323 ~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~ 356 (380)
++++||++||..||++|||+.|+|+||||++...
T Consensus 252 ~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 252 DAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (486)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence 9999999999999999999999999999987644
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-52 Score=400.12 Aligned_cols=251 Identities=29% Similarity=0.461 Sum_probs=211.9
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVM 178 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~ 178 (380)
.++|++.+.||+|+||+||+|+++.+++.||+|++.........+.+|+.+++.++|+||+++++++... +..++||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~---~~~~lv~ 95 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTP---THLAIIM 95 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECS---SEEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeC---CEEEEEE
Confidence 5789999999999999999999999999999999987766667788999999999999999999998764 6789999
Q ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeCC---eeEEEeCCCccccc-----c
Q psy11098 179 QLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGA---VLKLIDLGSSVSVS-----T 250 (380)
Q Consensus 179 e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~~---~ikl~DFG~a~~~~-----~ 250 (380)
||+.||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+|+... .
T Consensus 96 e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~ 175 (361)
T 3uc3_A 96 EYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 175 (361)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC----------
T ss_pred EeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCC
Confidence 999999999999888899999999999999999999999999999999999999743 49999999987432 4
Q ss_pred cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhcccCCCCCCcCCCCCHHHHH
Q psy11098 251 VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESE----EETRAHISVADYSFPPEQCGHISVPARE 326 (380)
Q Consensus 251 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 326 (380)
...||+.|+|||++.+....+.++|||||||++|+|++|..||.+... ......+....+.++.. ..+++++++
T Consensus 176 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~~ 253 (361)
T 3uc3_A 176 STVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDD--IRISPECCH 253 (361)
T ss_dssp -----CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTT--SCCCHHHHH
T ss_pred CCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCc--CCCCHHHHH
Confidence 567899999999998854445559999999999999999999977543 44555555555555432 458999999
Q ss_pred HHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 327 LIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 327 li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
||++||..||++|||++|+|+||||.+.
T Consensus 254 li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 254 LISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp HHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred HHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 9999999999999999999999999764
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=390.86 Aligned_cols=256 Identities=24% Similarity=0.414 Sum_probs=213.3
Q ss_pred hhhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---chHHHHHHHHHHHhhccCCCcceeeecccccCC
Q psy11098 95 QEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLMHAHIPTALALFENAPVP 171 (380)
Q Consensus 95 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~ 171 (380)
.+.+.++|++++.||+|+||+||+|++. +++.||+|++..... ....+.+|+++++.++|+||+++++++...
T Consensus 16 ~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--- 91 (311)
T 3niz_A 16 FQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSE--- 91 (311)
T ss_dssp EECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS---
T ss_pred ecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccC---
Confidence 3457899999999999999999999986 589999999965433 235677899999999999999999998764
Q ss_pred CceEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc
Q psy11098 172 GTDTIVMQLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS 249 (380)
Q Consensus 172 ~~~~lv~e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~ 249 (380)
+..++||||+. ++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 92 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 170 (311)
T 3niz_A 92 RCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFG 170 (311)
T ss_dssp SCEEEEEECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred CEEEEEEcCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecC
Confidence 67899999996 5788877654 4599999999999999999999999999999999999998 5699999999997653
Q ss_pred ------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCC--------
Q psy11098 250 ------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPE-------- 315 (380)
Q Consensus 250 ------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~-------- 315 (380)
....+|+.|+|||++.+...++.++|||||||++|+|++|..||.+....+....+..........
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 250 (311)
T 3niz_A 171 IPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL 250 (311)
T ss_dssp SCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTS
T ss_pred CCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhcc
Confidence 345789999999999875678999999999999999999999998877666555553311111110
Q ss_pred ------------------cCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 316 ------------------QCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 316 ------------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
....+++++++||++||+.||++|||++|+|+||||++..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 1234788999999999999999999999999999998753
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-51 Score=381.54 Aligned_cols=255 Identities=29% Similarity=0.506 Sum_probs=230.9
Q ss_pred hhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---chHHHHHHHHHHHhhccCCCcceeeecccccCCCc
Q psy11098 97 QFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGT 173 (380)
Q Consensus 97 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~ 173 (380)
.+.++|++.+.||+|+||.||+|.++.+++.||+|++..... ....+.+|+.+++.++|+||+++++++... +.
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~ 79 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE---SF 79 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS---SE
T ss_pred hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcC---CE
Confidence 468899999999999999999999999999999999965432 235567899999999999999999998753 66
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-C---eeEEEeCCCccccc
Q psy11098 174 DTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-A---VLKLIDLGSSVSVS 249 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~---~ikl~DFG~a~~~~ 249 (380)
.++||||+.|++|.+.+.....+++..+..++.||+.||.|||++||+||||||+|||++. + .+||+|||++....
T Consensus 80 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 80 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 7999999999999999988889999999999999999999999999999999999999963 2 49999999997654
Q ss_pred -----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHH
Q psy11098 250 -----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPA 324 (380)
Q Consensus 250 -----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 324 (380)
....||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.........+......++...+..+++++
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T 3kk8_A 160 DSEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA 238 (284)
T ss_dssp SSCBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred cCccccCCCCCcCCcCchhhcC-CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHH
Confidence 34578999999999988 477899999999999999999999999999999999998888888887778899999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 325 RELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 325 ~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
.+||.+||+.||++|||++|+|+||||++..
T Consensus 239 ~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 239 KSLIDSMLTVNPKKRITADQALKVPWICNRE 269 (284)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred HHHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence 9999999999999999999999999998753
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=397.18 Aligned_cols=250 Identities=23% Similarity=0.379 Sum_probs=218.0
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC----chHHHHHHHHHHHhh-ccCCCcceeeecccccCCCc
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ----PQQITRAEYNLLSTL-MHAHIPTALALFENAPVPGT 173 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~~~~~ 173 (380)
.++|++.+.||+|+||+||+|+++.+++.||+|++.+... ....+.+|..++..+ +||||+++++++... +.
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~---~~ 84 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE---SR 84 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS---SE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC---CE
Confidence 4689999999999999999999999999999999975432 234567899999887 899999999998764 67
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccc----
Q psy11098 174 DTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSV---- 248 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~---- 248 (380)
.|+||||+.||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++..
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence 899999999999999998888999999999999999999999999999999999999998 579999999998753
Q ss_pred --cccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCC---------CCHHHHHHHHhcccCCCCCCcC
Q psy11098 249 --STVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLD---------ESEEETRAHISVADYSFPPEQC 317 (380)
Q Consensus 249 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~---------~~~~~~~~~i~~~~~~~~~~~~ 317 (380)
....+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.. .........+......++.
T Consensus 165 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~--- 240 (345)
T 3a8x_A 165 DTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--- 240 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCT---
T ss_pred CcccccCCCccccCccccCC-CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCC---
Confidence 245689999999999988 4779999999999999999999999965 2344555666666655553
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCH------HHHHhcccccccCC
Q psy11098 318 GHISVPARELIGQLLNTHADKRPTA------GQLLQVAWFAEASC 356 (380)
Q Consensus 318 ~~~s~~~~~li~~~L~~dP~~Rpt~------~e~L~hpw~~~~~~ 356 (380)
.++.++++||++||++||++||++ +|+++||||....+
T Consensus 241 -~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w 284 (345)
T 3a8x_A 241 -SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 284 (345)
T ss_dssp -TSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCH
T ss_pred -CCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCH
Confidence 589999999999999999999995 89999999987544
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-52 Score=410.44 Aligned_cols=257 Identities=26% Similarity=0.457 Sum_probs=224.5
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC----CCchHHHHHHHHHHHhhccCCCcceeeecccccCCCce
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~ 174 (380)
.++|++.+.||+|+||+||+|+++.+++.||+|++.+. ......+.+|..++..++|+||++++.++... +..
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~---~~~ 149 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD---NNL 149 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS---SEE
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC---CEE
Confidence 57899999999999999999999999999999999642 22334478899999999999999999988764 678
Q ss_pred EEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc---
Q psy11098 175 TIVMQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS--- 249 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~--- 249 (380)
|+||||+.||+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|+...
T Consensus 150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 229 (437)
T 4aw2_A 150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 229 (437)
T ss_dssp EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC
Confidence 999999999999999987 57899999999999999999999999999999999999998 5799999999997552
Q ss_pred ----ccccCCCcccCCcccc----CCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc--CCCCCCcCCC
Q psy11098 250 ----TVVLPDLEFASPEMLT----SPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVAD--YSFPPEQCGH 319 (380)
Q Consensus 250 ----~~~~gt~~y~aPE~~~----~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~ 319 (380)
...+||+.|+|||++. +...++.++|||||||++|+|++|..||.+.+..+....+.... +.++. ....
T Consensus 230 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~-~~~~ 308 (437)
T 4aw2_A 230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPT-QVTD 308 (437)
T ss_dssp CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCS-SCCC
T ss_pred CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCc-cccc
Confidence 3468999999999986 23567899999999999999999999999999988888886543 34432 2356
Q ss_pred CCHHHHHHHHHhcccCCCC--CCCHHHHHhcccccccCCCCC
Q psy11098 320 ISVPARELIGQLLNTHADK--RPTAGQLLQVAWFAEASCSEF 359 (380)
Q Consensus 320 ~s~~~~~li~~~L~~dP~~--Rpt~~e~L~hpw~~~~~~~~~ 359 (380)
+++++++||++||..+|++ |++++|+++||||+...+..+
T Consensus 309 ~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l 350 (437)
T 4aw2_A 309 VSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNI 350 (437)
T ss_dssp SCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTG
T ss_pred CCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHH
Confidence 8999999999999998888 999999999999997665544
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-52 Score=416.64 Aligned_cols=256 Identities=30% Similarity=0.492 Sum_probs=233.6
Q ss_pred hhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC----CCchHHHHHHHHHHHhhccCCCcceeeecccccCC
Q psy11098 96 EQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLSTLMHAHIPTALALFENAPVP 171 (380)
Q Consensus 96 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~ 171 (380)
..+.++|++.+.||+|+||+||+|+++.+++.||||++.+. ......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--- 98 (484)
T 3nyv_A 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDK--- 98 (484)
T ss_dssp CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECS---
T ss_pred CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC---
Confidence 45788999999999999999999999999999999999654 23456788999999999999999999998763
Q ss_pred CceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe----CCeeEEEeCCCccc
Q psy11098 172 GTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN----GAVLKLIDLGSSVS 247 (380)
Q Consensus 172 ~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~----~~~ikl~DFG~a~~ 247 (380)
+..++||||+.|++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|..
T Consensus 99 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 99 GYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 67899999999999999999888999999999999999999999999999999999999994 35899999999876
Q ss_pred cc-----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCH
Q psy11098 248 VS-----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISV 322 (380)
Q Consensus 248 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 322 (380)
.. ....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+..+.+.++.+.+..+|+
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 256 (484)
T 3nyv_A 179 FEASKKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSE 256 (484)
T ss_dssp BCCCCSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCH
T ss_pred cccccccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCH
Confidence 54 34578999999999977 578899999999999999999999999999999999999988888777888999
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhcccccccCC
Q psy11098 323 PARELIGQLLNTHADKRPTAGQLLQVAWFAEASC 356 (380)
Q Consensus 323 ~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~ 356 (380)
++++||++||++||++|||+.|+|+||||+....
T Consensus 257 ~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~ 290 (484)
T 3nyv_A 257 SAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK 290 (484)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence 9999999999999999999999999999987644
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=413.77 Aligned_cols=254 Identities=28% Similarity=0.502 Sum_probs=228.6
Q ss_pred hhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC---CchHHHHHHHHHHHhhccCCCcceeeecccccCCC
Q psy11098 96 EQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER---QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPG 172 (380)
Q Consensus 96 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~ 172 (380)
..+.++|++++.||+|+||+||+|+++.+++.||+|++.+.. .....+.+|+.+++.++||||+++++++... +
T Consensus 33 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~---~ 109 (494)
T 3lij_A 33 GHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDK---R 109 (494)
T ss_dssp CCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECS---S
T ss_pred CchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC---C
Confidence 357889999999999999999999999999999999997542 3356778899999999999999999998764 6
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC----CeeEEEeCCCcccc
Q psy11098 173 TDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG----AVLKLIDLGSSVSV 248 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~----~~ikl~DFG~a~~~ 248 (380)
..|+||||+.||+|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||+|...
T Consensus 110 ~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 110 NYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 78999999999999999988889999999999999999999999999999999999999963 35999999999765
Q ss_pred c-----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHH
Q psy11098 249 S-----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVP 323 (380)
Q Consensus 249 ~-----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 323 (380)
. ...+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+..+.+.++...+..++++
T Consensus 190 ~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 267 (494)
T 3lij_A 190 ENQKKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEG 267 (494)
T ss_dssp BTTBCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHH
T ss_pred CCCccccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHH
Confidence 3 35678999999999875 5788999999999999999999999999999999999999998888888899999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 324 ARELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 324 ~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
+++||++||+.||++|||+.|+|+||||++.
T Consensus 268 ~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 268 AKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred HHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 9999999999999999999999999999863
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-51 Score=380.86 Aligned_cols=254 Identities=29% Similarity=0.491 Sum_probs=230.3
Q ss_pred hhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC-CCchHHHHHHHHHHHhhccCCCcceeeecccccCCCce
Q psy11098 96 EQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE-RQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 96 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~ 174 (380)
..+.++|++.+.||+|+||.||+|.++.+++.+|+|++... ....+.+.+|+++++.++|+||+++++++... +..
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~ 81 (277)
T 3f3z_A 5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDN---TDI 81 (277)
T ss_dssp -CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS---SEE
T ss_pred hhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecC---CeE
Confidence 35788999999999999999999999999999999999653 34456788999999999999999999998763 678
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEE---e-CCeeEEEeCCCccccc-
Q psy11098 175 TIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILM---N-GAVLKLIDLGSSVSVS- 249 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~---~-~~~ikl~DFG~a~~~~- 249 (380)
++||||+.|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+ + ++.+||+|||++....
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 82 YLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred EEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 9999999999999999888899999999999999999999999999999999999999 4 4589999999997653
Q ss_pred ----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHH
Q psy11098 250 ----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAR 325 (380)
Q Consensus 250 ----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 325 (380)
....||+.|+|||++.+ .++.++||||||+++|+|++|..||.+....+....+......++...+..+++++.
T Consensus 162 ~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (277)
T 3f3z_A 162 GKMMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAE 239 (277)
T ss_dssp TSCBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHH
T ss_pred ccchhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHH
Confidence 45678999999999876 478899999999999999999999999999999999988888887766678899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 326 ELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 326 ~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
+||++||+.||++|||+.++|+||||++.
T Consensus 240 ~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 240 SLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp HHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 99999999999999999999999999864
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=391.59 Aligned_cols=250 Identities=28% Similarity=0.509 Sum_probs=217.2
Q ss_pred hhceeeeeeecccCCeEEEEEEEc---CCCcEEEEEEecCCC-----CchHHHHHHHHHHHhhccCCCcceeeecccccC
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDR---GTGQLVALKQIPRER-----QPQQITRAEYNLLSTLMHAHIPTALALFENAPV 170 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~---~~~~~vAvK~~~~~~-----~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~ 170 (380)
.++|++.+.||+|+||.||+|++. .+++.||+|++++.. .....+.+|+.+++.++|+||+++++++...
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-- 93 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG-- 93 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS--
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC--
Confidence 578999999999999999999985 689999999997542 2334567899999999999999999988764
Q ss_pred CCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc
Q psy11098 171 PGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS 249 (380)
Q Consensus 171 ~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~ 249 (380)
+..|+||||+.|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 94 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 94 -GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp -SCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred -CEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 67899999999999999999888999999999999999999999999999999999999997 5699999999987542
Q ss_pred ------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHH
Q psy11098 250 ------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVP 323 (380)
Q Consensus 250 ------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 323 (380)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......++. .++.+
T Consensus 173 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~----~~~~~ 247 (327)
T 3a62_A 173 HDGTVTHTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPP----YLTQE 247 (327)
T ss_dssp ------CTTSSCCTTSCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCT----TSCHH
T ss_pred cCCccccccCCCcCccCHhhCcC-CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC----CCCHH
Confidence 35678999999999987 46789999999999999999999999999998888888877766653 47999
Q ss_pred HHHHHHHhcccCCCCCC-----CHHHHHhcccccccCC
Q psy11098 324 ARELIGQLLNTHADKRP-----TAGQLLQVAWFAEASC 356 (380)
Q Consensus 324 ~~~li~~~L~~dP~~Rp-----t~~e~L~hpw~~~~~~ 356 (380)
+++||++||..||++|| +++|+|+||||....+
T Consensus 248 ~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~ 285 (327)
T 3a62_A 248 ARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINW 285 (327)
T ss_dssp HHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCH
T ss_pred HHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCH
Confidence 99999999999999999 8999999999987643
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=414.64 Aligned_cols=256 Identities=27% Similarity=0.458 Sum_probs=229.9
Q ss_pred hhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC--------------CchHHHHHHHHHHHhhccCCCcce
Q psy11098 96 EQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER--------------QPQQITRAEYNLLSTLMHAHIPTA 161 (380)
Q Consensus 96 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~--------------~~~~~~~~E~~il~~l~h~ni~~i 161 (380)
..+.++|++.+.||+|+||+||+|+++.+++.||+|++.... ...+.+.+|+.+++.++||||+++
T Consensus 32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~ 111 (504)
T 3q5i_A 32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL 111 (504)
T ss_dssp SCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCE
T ss_pred CCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 346889999999999999999999999999999999997543 224567889999999999999999
Q ss_pred eeecccccCCCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeCC----ee
Q psy11098 162 LALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGA----VL 237 (380)
Q Consensus 162 ~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~~----~i 237 (380)
++++... +..++||||+.||+|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.+ .+
T Consensus 112 ~~~~~~~---~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 112 FDVFEDK---KYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EEEEECS---SEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSE
T ss_pred EEEEEcC---CEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccE
Confidence 9998764 6789999999999999999888899999999999999999999999999999999999999743 69
Q ss_pred EEEeCCCccccc-----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCC
Q psy11098 238 KLIDLGSSVSVS-----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSF 312 (380)
Q Consensus 238 kl~DFG~a~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~ 312 (380)
||+|||++.... ....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+..+.+.+
T Consensus 189 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 266 (504)
T 3q5i_A 189 KIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYF 266 (504)
T ss_dssp EECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred EEEECCCCEEcCCCCccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 999999997654 45678999999999875 57889999999999999999999999999999999999998888
Q ss_pred CCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCC
Q psy11098 313 PPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASC 356 (380)
Q Consensus 313 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~ 356 (380)
+...+..+|+++++||++||..||.+|||++|+|+||||++...
T Consensus 267 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 310 (504)
T 3q5i_A 267 DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN 310 (504)
T ss_dssp CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence 87777889999999999999999999999999999999987643
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-52 Score=393.83 Aligned_cols=253 Identities=30% Similarity=0.498 Sum_probs=208.2
Q ss_pred hhhhceeee---eeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhc-cCCCcceeeecccccCCC
Q psy11098 97 QFEHRYEEL---ERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLM-HAHIPTALALFENAPVPG 172 (380)
Q Consensus 97 ~~~~~y~~~---~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~-h~ni~~i~~~~~~~~~~~ 172 (380)
.|.++|++. +.||+|+||+||+|+++.+++.||||++... ......+|+.+++.+. |+||+++++++... +
T Consensus 5 ~f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~---~ 79 (325)
T 3kn6_A 5 PFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQ---L 79 (325)
T ss_dssp HHHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECS---S
T ss_pred cchhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcC---C
Confidence 456788876 7899999999999999999999999999643 3456678999999997 99999999998764 6
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-C---eeEEEeCCCcccc
Q psy11098 173 TDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-A---VLKLIDLGSSVSV 248 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~---~ikl~DFG~a~~~ 248 (380)
..|+||||+.|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++. + .+||+|||++...
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 80 HTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159 (325)
T ss_dssp EEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred EEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence 77999999999999999999889999999999999999999999999999999999999974 2 7999999999754
Q ss_pred c------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHhcccCCCCCC
Q psy11098 249 S------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDES-------EEETRAHISVADYSFPPE 315 (380)
Q Consensus 249 ~------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~-------~~~~~~~i~~~~~~~~~~ 315 (380)
. ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.. ..+....+..+.+.++.+
T Consensus 160 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (325)
T 3kn6_A 160 PPDNQPLKTPCFTLHYAAPELLNQ-NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGE 238 (325)
T ss_dssp CC-----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSH
T ss_pred CCCCCcccccCCCcCccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcc
Confidence 3 35567999999999987 477889999999999999999999997643 356777787788777777
Q ss_pred cCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 316 QCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 316 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
.+..+++++++||++||..||++|||++|+|+||||++..
T Consensus 239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~ 278 (325)
T 3kn6_A 239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278 (325)
T ss_dssp HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred cccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence 6778999999999999999999999999999999998753
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=400.57 Aligned_cols=249 Identities=28% Similarity=0.438 Sum_probs=217.5
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC----CCchHHHHHHHHHHHhhccCCCcceeeecccccCCCc
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGT 173 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~ 173 (380)
..++|++.+.||+|+||+||+|++..+++.||+|++.+. ......+.+|+.+++.++||||+++++++... +.
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~---~~ 83 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTP---TD 83 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS---SE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC---CE
Confidence 357899999999999999999999999999999999643 22345678899999999999999999998764 67
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCccccc---
Q psy11098 174 DTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVS--- 249 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~--- 249 (380)
.++||||+ +|+|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||+++ +.+||+|||++....
T Consensus 84 ~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 84 IVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp EEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred EEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 89999999 8999999988889999999999999999999999999999999999999985 599999999997653
Q ss_pred --ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHH
Q psy11098 250 --TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAREL 327 (380)
Q Consensus 250 --~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 327 (380)
...+||+.|+|||++.+....+.++|||||||++|+|++|..||.+....+....+....+.++ ..+++++++|
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~l 238 (336)
T 3h4j_B 163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMP----DFLSPGAQSL 238 (336)
T ss_dssp TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCC----TTSCHHHHHH
T ss_pred ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCc----ccCCHHHHHH
Confidence 4567899999999998855557899999999999999999999988765554444444444333 3579999999
Q ss_pred HHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 328 IGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 328 i~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
|++||..||.+|||++|+++||||+..
T Consensus 239 i~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 239 IRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp HHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred HHHHcCCChhHCcCHHHHHhChhhccC
Confidence 999999999999999999999999864
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-51 Score=384.90 Aligned_cols=257 Identities=28% Similarity=0.386 Sum_probs=211.7
Q ss_pred hhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC------CchHHHHHHHHHHHhhc---cCCCcceeeeccc
Q psy11098 97 QFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER------QPQQITRAEYNLLSTLM---HAHIPTALALFEN 167 (380)
Q Consensus 97 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~------~~~~~~~~E~~il~~l~---h~ni~~i~~~~~~ 167 (380)
.+.++|++.+.||+|+||+||+|++..+++.||+|++.... .......+|+.+++.++ |+||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 35789999999999999999999999999999999996322 12345677888888776 9999999999876
Q ss_pred ccCCC--ceEEEEEecCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeC
Q psy11098 168 APVPG--TDTIVMQLVHGESLIQHLCRQST--ITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDL 242 (380)
Q Consensus 168 ~~~~~--~~~lv~e~~~gg~L~~~l~~~~~--l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DF 242 (380)
..... ..++|||++. ++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df 164 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF 164 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence 43222 4689999995 699999987644 99999999999999999999999999999999999997 569999999
Q ss_pred CCccccc-----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCC--
Q psy11098 243 GSSVSVS-----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPE-- 315 (380)
Q Consensus 243 G~a~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~-- 315 (380)
|++.... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.......+..
T Consensus 165 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 243 (308)
T 3g33_A 165 GLARIYSYQMALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 243 (308)
T ss_dssp SCTTTSTTCCCSGGGGCCCSSCCHHHHHT-SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred ccccccCCCcccCCccccccccCchHHcC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence 9997653 45678999999999987 467899999999999999999999999998888777765432211111
Q ss_pred ---------------------cCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 316 ---------------------QCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 316 ---------------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
....+++++.+||.+||+.||++|||+.|+|+||||++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 244 PRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp CSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred cchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence 1135789999999999999999999999999999998753
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-51 Score=399.57 Aligned_cols=250 Identities=24% Similarity=0.396 Sum_probs=219.6
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC----CCchHHHHHHHHHHHhhccCCCcceeeecccccCCCce
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~ 174 (380)
.++|++++.||+|+||.||+|+++.+++.||+|++.+. ......+.+|+++++.++||||++++.+|... +..
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~---~~~ 90 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE---EDM 90 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS---SEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC---CEE
Confidence 47899999999999999999999999999999999643 23446678899999999999999999988764 678
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc----
Q psy11098 175 TIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS---- 249 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~---- 249 (380)
|+||||+.||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 170 (384)
T 4fr4_A 91 FMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ 170 (384)
T ss_dssp EEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCCc
Confidence 99999999999999999888999999999999999999999999999999999999998 5699999999997653
Q ss_pred -ccccCCCcccCCccccCC--CCCCCcccHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHhcccCCCCCCcCCCCCHH
Q psy11098 250 -TVVLPDLEFASPEMLTSP--ATAGPSTDMWSLGVLLYILLSGVSPFLD---ESEEETRAHISVADYSFPPEQCGHISVP 323 (380)
Q Consensus 250 -~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlGvil~~lltg~~Pf~~---~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 323 (380)
...+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.. ....+....+......++. .++.+
T Consensus 171 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~----~~s~~ 246 (384)
T 4fr4_A 171 ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPS----AWSQE 246 (384)
T ss_dssp BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCT----TSCHH
T ss_pred eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCC----cCCHH
Confidence 456899999999999742 3578899999999999999999999974 3445555666555555543 57999
Q ss_pred HHHHHHHhcccCCCCCCC-HHHHHhcccccccC
Q psy11098 324 ARELIGQLLNTHADKRPT-AGQLLQVAWFAEAS 355 (380)
Q Consensus 324 ~~~li~~~L~~dP~~Rpt-~~e~L~hpw~~~~~ 355 (380)
+.+||++||..||++||+ ++++++||||....
T Consensus 247 ~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~ 279 (384)
T 4fr4_A 247 MVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDIN 279 (384)
T ss_dssp HHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCC
T ss_pred HHHHHHHHhcCCHhHhcccHHHHHcChhhhcCC
Confidence 999999999999999998 99999999998754
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-52 Score=393.62 Aligned_cols=253 Identities=21% Similarity=0.353 Sum_probs=215.0
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
|.++|++.+.||+|+||+||+|+++.+++.||+|++..... ..+.+.+|+.+++.++|+||+++++++... +..|
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---~~~~ 81 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG---NIQY 81 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECS---SEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecC---CeEE
Confidence 56899999999999999999999999999999999965432 345678899999999999999999988764 6779
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCccccc-----
Q psy11098 176 IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVS----- 249 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~----- 249 (380)
+||||+.|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||++....
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 99999999999999988888999999999999999999999999999999999999984 699999999997542
Q ss_pred ---ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhcccCCCCCCcCCCCCHHHH
Q psy11098 250 ---TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEE-ETRAHISVADYSFPPEQCGHISVPAR 325 (380)
Q Consensus 250 ---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~~~ 325 (380)
....||+.|+|||++.+...++.++|||||||++|+|++|..||.+.... ............. ..+..++.++.
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 239 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL--NPWKKIDSAPL 239 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTS--TTGGGSCHHHH
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccC--CccccCCHHHH
Confidence 35678999999999987555577899999999999999999999876543 2222222222222 22356899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 326 ELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 326 ~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
+||++||..||++|||++|+|+||||++..
T Consensus 240 ~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 240 ALLHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence 999999999999999999999999998653
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=403.18 Aligned_cols=253 Identities=29% Similarity=0.458 Sum_probs=213.5
Q ss_pred hhhceeee-eeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHH-hhccCCCcceeeecccc-cCCCce
Q psy11098 98 FEHRYEEL-ERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLS-TLMHAHIPTALALFENA-PVPGTD 174 (380)
Q Consensus 98 ~~~~y~~~-~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~-~l~h~ni~~i~~~~~~~-~~~~~~ 174 (380)
+.++|.+. +.||+|+||+||+|.++.+++.||||++... ....+|++++. .++|+||++++++|... ...+..
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 45677776 7899999999999999999999999999632 45677888874 55899999999998752 223567
Q ss_pred EEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC----CeeEEEeCCCcccc
Q psy11098 175 TIVMQLVHGESLIQHLCRQ--STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG----AVLKLIDLGSSVSV 248 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~----~~ikl~DFG~a~~~ 248 (380)
|+||||+.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||++...
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~ 214 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 214 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccccccc
Confidence 9999999999999999764 35999999999999999999999999999999999999973 58999999999865
Q ss_pred c-----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHhcccCCCCCCcCCC
Q psy11098 249 S-----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEE----ETRAHISVADYSFPPEQCGH 319 (380)
Q Consensus 249 ~-----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~~~ 319 (380)
. ...+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.... .....+..+.+.++...+..
T Consensus 215 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 293 (400)
T 1nxk_A 215 TSHNSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 293 (400)
T ss_dssp C-----------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTT
T ss_pred CCCCccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCccccc
Confidence 3 45678999999999987 57889999999999999999999999775432 24556667777777777778
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 320 ISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 320 ~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
++.++++||++||..||++|||++|+|+||||.+..
T Consensus 294 ~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 294 VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 999999999999999999999999999999998653
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-51 Score=386.44 Aligned_cols=256 Identities=29% Similarity=0.480 Sum_probs=228.4
Q ss_pred hhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC-chHHHHHHHHHHHhhccCCCcceeeecccccCCCce
Q psy11098 96 EQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ-PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 96 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~ 174 (380)
..+.++|++.+.||+|+||.||+|++..+|+.||+|++..... ....+.+|+.+++.++|+||+++++++... +..
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 81 (304)
T 2jam_A 5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYEST---THY 81 (304)
T ss_dssp -CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECS---SEE
T ss_pred cchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccC---CEE
Confidence 4578899999999999999999999999999999999975433 345678899999999999999999988764 678
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEE---e-CCeeEEEeCCCccccc-
Q psy11098 175 TIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILM---N-GAVLKLIDLGSSVSVS- 249 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~---~-~~~ikl~DFG~a~~~~- 249 (380)
++||||+.|++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||+ + ++.+||+|||++....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 82 YLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp EEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred EEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 9999999999999999888899999999999999999999999999999999999999 4 4589999999987554
Q ss_pred ---ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHH
Q psy11098 250 ---TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARE 326 (380)
Q Consensus 250 ---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 326 (380)
....||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+..+....+....+.++...+..++.++++
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 240 (304)
T 2jam_A 162 GIMSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKD 240 (304)
T ss_dssp BTTHHHHSCCCBCCTTTBSS-CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHH
T ss_pred CccccccCCCCccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHH
Confidence 23468999999999987 47788999999999999999999999999988888888888877777667789999999
Q ss_pred HHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 327 LIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 327 li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
||.+||..||++|||++|+|+||||....
T Consensus 241 li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 241 FICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp HHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred HHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 99999999999999999999999998754
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-51 Score=384.84 Aligned_cols=251 Identities=22% Similarity=0.435 Sum_probs=214.5
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---------------------------chHHHHHHHHHHH
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---------------------------PQQITRAEYNLLS 151 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---------------------------~~~~~~~E~~il~ 151 (380)
.++|++.+.||+|+||.||+|++..+++.||+|++..... ..+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 4689999999999999999999999999999999965431 1245778999999
Q ss_pred hhccCCCcceeeecccccCCCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEE
Q psy11098 152 TLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENIL 231 (380)
Q Consensus 152 ~l~h~ni~~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl 231 (380)
.++|+||+++++++.... .+..++||||+.+++|.+++ ....+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 92 ~l~h~~iv~~~~~~~~~~-~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil 169 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPN-EDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLL 169 (298)
T ss_dssp TCCCTTBCCEEEEEECSS-SSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred hCCCCCCCeEEEEEEcCC-CCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence 999999999999987532 35789999999999998754 3457999999999999999999999999999999999999
Q ss_pred Ee-CCeeEEEeCCCccccc------ccccCCCcccCCccccCCCC--CCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy11098 232 MN-GAVLKLIDLGSSVSVS------TVVLPDLEFASPEMLTSPAT--AGPSTDMWSLGVLLYILLSGVSPFLDESEEETR 302 (380)
Q Consensus 232 ~~-~~~ikl~DFG~a~~~~------~~~~gt~~y~aPE~~~~~~~--~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~ 302 (380)
++ ++.+||+|||++.... ....||+.|+|||++.+... ++.++|||||||++|+|++|..||.+.......
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 249 (298)
T 2zv2_A 170 VGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLH 249 (298)
T ss_dssp ECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred ECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHH
Confidence 98 5699999999997653 34578999999999976432 467899999999999999999999998888877
Q ss_pred HHHhcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccc
Q psy11098 303 AHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAE 353 (380)
Q Consensus 303 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~ 353 (380)
..+......++. ...+++++++||.+||+.||++|||+.|+|+||||++
T Consensus 250 ~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 250 SKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp HHHHHCCCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred HHHhcccCCCCC--ccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 777766655543 3468999999999999999999999999999999964
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-51 Score=381.82 Aligned_cols=250 Identities=24% Similarity=0.379 Sum_probs=210.2
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
++|++.+.||+|+||+||+|++ .+++.||+|++..... ....+.+|+++++.++||||+++++++... +..++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~l 77 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK---KRLVL 77 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS---SCEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccC---CeEEE
Confidence 5799999999999999999998 6789999999965433 235677899999999999999999998764 67899
Q ss_pred EEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-----
Q psy11098 177 VMQLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS----- 249 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~----- 249 (380)
||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 78 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 156 (288)
T 1ob3_A 78 VFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK 156 (288)
T ss_dssp EEECCS-EEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred EEEecC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccc
Confidence 999996 4899988764 6799999999999999999999999999999999999998 5699999999987543
Q ss_pred -ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCC---------------
Q psy11098 250 -TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFP--------------- 313 (380)
Q Consensus 250 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~--------------- 313 (380)
....||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+........
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccc
Confidence 3457899999999998756789999999999999999999999999887776665543111000
Q ss_pred ----------CCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 314 ----------PEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 314 ----------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
......+++++++||++||+.||++|||++|+|+||||++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred ccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 01124578999999999999999999999999999999864
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-51 Score=407.42 Aligned_cols=258 Identities=23% Similarity=0.300 Sum_probs=199.6
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---chHHHHHHHHHHHhhccCCCcceeeecccc--cCCC
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLMHAHIPTALALFENA--PVPG 172 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~h~ni~~i~~~~~~~--~~~~ 172 (380)
+.++|++.+.||+|+||+||+|+++.+++.||||++..... ....+.+|+++|+.++|+||+++++++... ...+
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 45789999999999999999999999999999999965433 235677899999999999999999998543 2235
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc--
Q psy11098 173 TDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS-- 249 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~-- 249 (380)
.+|+||||+ +++|.+++.....+++..++.+++||+.||.|||++||+||||||+|||++ ++.+||+|||+|+...
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 209 (458)
T 3rp9_A 131 ELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209 (458)
T ss_dssp CEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred eEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence 689999998 789999998888899999999999999999999999999999999999998 4699999999997642
Q ss_pred -------------------------------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh----------
Q psy11098 250 -------------------------------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS---------- 288 (380)
Q Consensus 250 -------------------------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt---------- 288 (380)
...+||+.|+|||++.....++.++|||||||++|+|++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~ 289 (458)
T 3rp9_A 210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHA 289 (458)
T ss_dssp TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGG
T ss_pred cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccc
Confidence 234679999999987654678999999999999999999
Q ss_pred -CCCCCCCCCH--------------------HHHHHHHhcc---------------------------cCCCCCCcCCCC
Q psy11098 289 -GVSPFLDESE--------------------EETRAHISVA---------------------------DYSFPPEQCGHI 320 (380)
Q Consensus 289 -g~~Pf~~~~~--------------------~~~~~~i~~~---------------------------~~~~~~~~~~~~ 320 (380)
|.++|.+... .+....+... ......+.+..+
T Consensus 290 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (458)
T 3rp9_A 290 DRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPAS 369 (458)
T ss_dssp GCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTS
T ss_pred cccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCC
Confidence 7777766431 1111111100 000001224567
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCC
Q psy11098 321 SVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASC 356 (380)
Q Consensus 321 s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~ 356 (380)
+.++.+||++||..||++|||++|+|+||||++...
T Consensus 370 s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~ 405 (458)
T 3rp9_A 370 SADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRI 405 (458)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCC
T ss_pred CHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCC
Confidence 999999999999999999999999999999997643
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-51 Score=393.21 Aligned_cols=264 Identities=27% Similarity=0.361 Sum_probs=221.7
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---chHHHHHHHHHHHhhccCCCcceeeecccccC----
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLMHAHIPTALALFENAPV---- 170 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~---- 170 (380)
..++|++.+.||+|+||+||+|+++.+|+.||+|++..... ....+.+|+++++.++|+||+++++++.....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 35789999999999999999999999999999999864432 23566789999999999999999999876432
Q ss_pred -CCceEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccc
Q psy11098 171 -PGTDTIVMQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVS 247 (380)
Q Consensus 171 -~~~~~lv~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~ 247 (380)
.+..++||||+. ++|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..
T Consensus 95 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 173 (351)
T 3mi9_A 95 CKGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 173 (351)
T ss_dssp --CEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CCceEEEEEeccC-CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccc
Confidence 356899999996 477777755 46799999999999999999999999999999999999998 56999999999875
Q ss_pred cc----------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcC
Q psy11098 248 VS----------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQC 317 (380)
Q Consensus 248 ~~----------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 317 (380)
.. ....||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+.......+...+
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 253 (351)
T 3mi9_A 174 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 253 (351)
T ss_dssp CCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred ccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence 43 34567999999999987667899999999999999999999999999888887777655444443333
Q ss_pred CC----------------------------CCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCCCCCccc
Q psy11098 318 GH----------------------------ISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASCSEFDTE 362 (380)
Q Consensus 318 ~~----------------------------~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~~~~~~~ 362 (380)
.. .++++++||++||+.||++|||++|+|+||||+....+...+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~ 326 (351)
T 3mi9_A 254 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDLKG 326 (351)
T ss_dssp TTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCCCSHH
T ss_pred cccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCcccccc
Confidence 22 2678999999999999999999999999999988765544333
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=400.24 Aligned_cols=251 Identities=26% Similarity=0.405 Sum_probs=216.7
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC----chHHHHHHHHH-HHhhccCCCcceeeecccccCCCc
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ----PQQITRAEYNL-LSTLMHAHIPTALALFENAPVPGT 173 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~E~~i-l~~l~h~ni~~i~~~~~~~~~~~~ 173 (380)
.++|++++.||+|+||+||+|+++.+++.||+|++.+... ....+..|..+ ++.++|+||++++.++... +.
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~---~~ 113 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA---DK 113 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECS---SE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC---CE
Confidence 4689999999999999999999999999999999965432 22334556665 5678999999999988764 67
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccc----
Q psy11098 174 DTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSV---- 248 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~---- 248 (380)
.|+||||+.||+|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++..
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~ 193 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN 193 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCC
Confidence 899999999999999999888999999999999999999999999999999999999998 579999999999753
Q ss_pred --cccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHH
Q psy11098 249 --STVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARE 326 (380)
Q Consensus 249 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 326 (380)
....+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+..+....+......++. .++.++++
T Consensus 194 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~ 268 (373)
T 2r5t_A 194 STTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKP----NITNSARH 268 (373)
T ss_dssp CCCCSBSCCCCCCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCS----SSCHHHHH
T ss_pred CccccccCCccccCHHHhCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCC----CCCHHHHH
Confidence 245689999999999988 57889999999999999999999999999999999988877666553 58999999
Q ss_pred HHHHhcccCCCCCCCH----HHHHhcccccccCCC
Q psy11098 327 LIGQLLNTHADKRPTA----GQLLQVAWFAEASCS 357 (380)
Q Consensus 327 li~~~L~~dP~~Rpt~----~e~L~hpw~~~~~~~ 357 (380)
||++||++||++||++ .++++||||+...+.
T Consensus 269 li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~ 303 (373)
T 2r5t_A 269 LLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWD 303 (373)
T ss_dssp HHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHH
T ss_pred HHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHH
Confidence 9999999999999986 699999999875443
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=408.47 Aligned_cols=253 Identities=25% Similarity=0.435 Sum_probs=219.3
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC----CCchHHHHHHHHHHHhhccCCCcceeeecccccCCCce
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~ 174 (380)
.++|++.+.||+|+||.||+|+++.+|+.||+|++... ......+.+|+++++.++|+||+++++++... +..
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~---~~~ 223 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH---DRL 223 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEET---TEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeC---CEE
Confidence 46899999999999999999999999999999999642 23334567799999999999999999998764 678
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeecCCCCcEEEe-CCeeEEEeCCCccccc---
Q psy11098 175 TIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHS-QQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS--- 249 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~-~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~--- 249 (380)
++||||+.||+|.+++.....+++..++.++.||+.||.|||+ +||+||||||+|||++ ++.+||+|||+|....
T Consensus 224 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 303 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 303 (446)
T ss_dssp EEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred EEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence 9999999999999999988899999999999999999999998 9999999999999998 5699999999997532
Q ss_pred ---ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHH
Q psy11098 250 ---TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARE 326 (380)
Q Consensus 250 ---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 326 (380)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......++. .+++++++
T Consensus 304 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~~~~~~~ 378 (446)
T 4ejn_A 304 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLGPEAKS 378 (446)
T ss_dssp ---CCSSSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHH
T ss_pred cccccccCCccccCHhhcCC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCHHHHH
Confidence 45689999999999988 57899999999999999999999999999999998888887776654 47999999
Q ss_pred HHHHhcccCCCCCC-----CHHHHHhcccccccCCCCC
Q psy11098 327 LIGQLLNTHADKRP-----TAGQLLQVAWFAEASCSEF 359 (380)
Q Consensus 327 li~~~L~~dP~~Rp-----t~~e~L~hpw~~~~~~~~~ 359 (380)
||.+||.+||++|| |++|+|+||||+...+..+
T Consensus 379 li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~ 416 (446)
T 4ejn_A 379 LLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHV 416 (446)
T ss_dssp HHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHH
T ss_pred HHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHHH
Confidence 99999999999999 9999999999998654433
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=404.04 Aligned_cols=256 Identities=26% Similarity=0.421 Sum_probs=221.5
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC----CchHHHHHHHHHHHhhccCCCcceeeecccccCCCce
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~ 174 (380)
.++|++.+.||+|+||+||+|+++.+|+.||+|++++.. .....+.+|..++..++|+||++++.++... +..
T Consensus 60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~---~~~ 136 (412)
T 2vd5_A 60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE---NYL 136 (412)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS---SEE
T ss_pred hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC---CEE
Confidence 578999999999999999999999999999999996422 2334567899999999999999999988764 678
Q ss_pred EEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc---
Q psy11098 175 TIVMQLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS--- 249 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~--- 249 (380)
|+||||+.||+|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~ 216 (412)
T 2vd5_A 137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG 216 (412)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCC
Confidence 9999999999999999775 4799999999999999999999999999999999999998 5799999999997653
Q ss_pred ----ccccCCCcccCCccccC------CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc--CCCCCCcC
Q psy11098 250 ----TVVLPDLEFASPEMLTS------PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVAD--YSFPPEQC 317 (380)
Q Consensus 250 ----~~~~gt~~y~aPE~~~~------~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~ 317 (380)
...+||+.|+|||++.. ...++.++|||||||++|+|++|..||.+.+..+...++.... ..++. ..
T Consensus 217 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~-~~ 295 (412)
T 2vd5_A 217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPL-VD 295 (412)
T ss_dssp CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----
T ss_pred ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCc-cc
Confidence 24589999999999873 2467889999999999999999999999999988888887533 33332 23
Q ss_pred CCCCHHHHHHHHHhcccCCCCC---CCHHHHHhcccccccCCCCC
Q psy11098 318 GHISVPARELIGQLLNTHADKR---PTAGQLLQVAWFAEASCSEF 359 (380)
Q Consensus 318 ~~~s~~~~~li~~~L~~dP~~R---pt~~e~L~hpw~~~~~~~~~ 359 (380)
..+|.++++||++||. +|++| ++++|+++||||+...+..+
T Consensus 296 ~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l 339 (412)
T 2vd5_A 296 EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGL 339 (412)
T ss_dssp -CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTS
T ss_pred cCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence 4689999999999999 99998 59999999999998766655
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-51 Score=386.13 Aligned_cols=254 Identities=26% Similarity=0.399 Sum_probs=203.1
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC--CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER--QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
.++|++++.||+|+||+||+|.++.+|+.||+|++.... .....+.+|+++++.++||||+++++++... +..++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~---~~~~l 80 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTE---NKLTL 80 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCT---TEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEEC---CeEEE
Confidence 468999999999999999999999999999999997543 2346678899999999999999999998764 67899
Q ss_pred EEEecCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc
Q psy11098 177 VMQLVHGESLIQHLCRQ------STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS 249 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~~------~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~ 249 (380)
||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 81 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 81 VFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp EEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred EEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 999996 6999988653 3589999999999999999999999999999999999998 5699999999997653
Q ss_pred ------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCC----------
Q psy11098 250 ------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFP---------- 313 (380)
Q Consensus 250 ------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~---------- 313 (380)
....||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+.......+
T Consensus 160 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (317)
T 2pmi_A 160 IPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL 239 (317)
T ss_dssp SCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGC
T ss_pred CCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhh
Confidence 3457899999999998755788999999999999999999999999888877766643211100
Q ss_pred --------------------CCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCC
Q psy11098 314 --------------------PEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASC 356 (380)
Q Consensus 314 --------------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~ 356 (380)
......++.++++||++||+.||++|||++|+|+||||++...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 302 (317)
T 2pmi_A 240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH 302 (317)
T ss_dssp TTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred hhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence 0011257889999999999999999999999999999998643
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=376.85 Aligned_cols=254 Identities=30% Similarity=0.551 Sum_probs=219.5
Q ss_pred hhhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC--CCchHHHHHHHHHHHhhccCCCcceeeecccccCCC
Q psy11098 95 QEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE--RQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPG 172 (380)
Q Consensus 95 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~ 172 (380)
+..+.++|++.+.||+|+||+||+|.++.+++.+|+|++... ......+.+|+++++.++|+||+++++++... +
T Consensus 17 ~g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~---~ 93 (285)
T 3is5_A 17 QGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDY---H 93 (285)
T ss_dssp SSCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS---S
T ss_pred CCChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecC---C
Confidence 345789999999999999999999999999999999999654 33457788999999999999999999998764 6
Q ss_pred ceEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe----CCeeEEEeCCC
Q psy11098 173 TDTIVMQLVHGESLIQHLCR----QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN----GAVLKLIDLGS 244 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~----~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~----~~~ikl~DFG~ 244 (380)
..++||||+.+++|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+
T Consensus 94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~ 173 (285)
T 3is5_A 94 NMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGL 173 (285)
T ss_dssp EEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCC
T ss_pred eEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeec
Confidence 78999999999999999854 36799999999999999999999999999999999999995 24799999999
Q ss_pred ccccc-----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCC
Q psy11098 245 SVSVS-----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGH 319 (380)
Q Consensus 245 a~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 319 (380)
+.... ....||+.|+|||++.+ .++.++||||||+++|+|++|..||.+....+....+......+... ...
T Consensus 174 a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~ 250 (285)
T 3is5_A 174 AELFKSDEHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVE-CRP 250 (285)
T ss_dssp CCC----------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC---CC
T ss_pred ceecCCcccCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccc-cCc
Confidence 97543 45678999999999865 56889999999999999999999999998888877776665554432 345
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 320 ISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 320 ~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
+++++.+||++||+.||++|||+.|+|+||||+++
T Consensus 251 ~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~a 285 (285)
T 3is5_A 251 LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285 (285)
T ss_dssp CCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC-
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhcC
Confidence 79999999999999999999999999999999863
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-51 Score=388.84 Aligned_cols=255 Identities=23% Similarity=0.323 Sum_probs=213.4
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCc---hHHHHHHHHHHHhhccCCCcceeeecccccCCCce
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP---QQITRAEYNLLSTLMHAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~ 174 (380)
..++|++.+.||+|+||+||+|++..+++.||+|++...... ...+.+|+++++.++|+||+++++++... +..
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~ 108 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHN---HRL 108 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEET---TEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecC---CEE
Confidence 467899999999999999999999999999999999754332 34556899999999999999999998764 678
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC------CeeEEEeCCCcccc
Q psy11098 175 TIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG------AVLKLIDLGSSVSV 248 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~------~~ikl~DFG~a~~~ 248 (380)
++||||+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||++...
T Consensus 109 ~lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 109 HLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187 (329)
T ss_dssp EEEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred EEEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence 99999996 599999998889999999999999999999999999999999999999952 25999999998765
Q ss_pred c------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcC-----
Q psy11098 249 S------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQC----- 317 (380)
Q Consensus 249 ~------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~----- 317 (380)
. ....||+.|+|||++.+...++.++|||||||++|+|++|..||.+....+....+.......+...+
T Consensus 188 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (329)
T 3gbz_A 188 GIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTA 267 (329)
T ss_dssp C-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred CCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhh
Confidence 3 34567999999999987556899999999999999999999999998887777666533211111111
Q ss_pred ---------------------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCC
Q psy11098 318 ---------------------GHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASC 356 (380)
Q Consensus 318 ---------------------~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~ 356 (380)
..+++++++||++||+.||++|||++|+|+||||++...
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 327 (329)
T 3gbz_A 268 LPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF 327 (329)
T ss_dssp STTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred hhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence 116789999999999999999999999999999987643
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=390.76 Aligned_cols=256 Identities=28% Similarity=0.486 Sum_probs=227.9
Q ss_pred hhhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCc---------hHHHHHHHHHHHhh-ccCCCcceeee
Q psy11098 95 QEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP---------QQITRAEYNLLSTL-MHAHIPTALAL 164 (380)
Q Consensus 95 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---------~~~~~~E~~il~~l-~h~ni~~i~~~ 164 (380)
...+.++|++.+.||+|+||.||+|+++.+|+.||||++...... ...+.+|+.+++.+ .|+||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 356778999999999999999999999999999999999754321 34567899999999 79999999998
Q ss_pred cccccCCCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCC
Q psy11098 165 FENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLG 243 (380)
Q Consensus 165 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG 243 (380)
+... +..++||||+.|++|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++ ++.+||+|||
T Consensus 169 ~~~~---~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG 245 (365)
T 2y7j_A 169 YESS---SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFG 245 (365)
T ss_dssp EEBS---SEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EeeC---CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecC
Confidence 8764 67899999999999999998888999999999999999999999999999999999999998 5699999999
Q ss_pred Cccccc-----ccccCCCcccCCccccCC-----CCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCC
Q psy11098 244 SSVSVS-----TVVLPDLEFASPEMLTSP-----ATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFP 313 (380)
Q Consensus 244 ~a~~~~-----~~~~gt~~y~aPE~~~~~-----~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~ 313 (380)
++.... ....||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.........+....+.++
T Consensus 246 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 325 (365)
T 2y7j_A 246 FSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFS 325 (365)
T ss_dssp TCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred cccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 987654 346789999999998631 3578899999999999999999999999888888888888877777
Q ss_pred CCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccc
Q psy11098 314 PEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAE 353 (380)
Q Consensus 314 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~ 353 (380)
.+.+..++.++.+||++||..||++|||++|+|+||||++
T Consensus 326 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 326 SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 6666788999999999999999999999999999999974
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=381.90 Aligned_cols=255 Identities=27% Similarity=0.430 Sum_probs=215.1
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCc---hHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP---QQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
.++|++.+.||+|+||+||+|++..+|+.||+|++...... ...+.+|+++++.++|+||+++++++... +..+
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~~ 78 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRK---RRLH 78 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET---TEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecC---CeEE
Confidence 46899999999999999999999999999999999665443 34567899999999999999999998764 6789
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-----
Q psy11098 176 IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS----- 249 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~----- 249 (380)
+||||+.+++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 79 LVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp EEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence 9999999999999888888899999999999999999999999999999999999998 5699999999997654
Q ss_pred -ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC------------------
Q psy11098 250 -TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADY------------------ 310 (380)
Q Consensus 250 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~------------------ 310 (380)
....||+.|+|||++.+...++.++||||||+++|+|++|..||.+....+....+.....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence 3457899999999998756789999999999999999999999999887776655432111
Q ss_pred -CCCCC--------cCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCC
Q psy11098 311 -SFPPE--------QCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASC 356 (380)
Q Consensus 311 -~~~~~--------~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~ 356 (380)
..+.. ....++.++.+||++||..||++|||++|+|+||||++...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 293 (311)
T 4agu_A 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293 (311)
T ss_dssp CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-
T ss_pred CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccC
Confidence 11110 12468899999999999999999999999999999998643
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-51 Score=396.20 Aligned_cols=253 Identities=30% Similarity=0.494 Sum_probs=221.2
Q ss_pred hhhceee--eeeecccCCeEEEEEEEcCCCcEEEEEEecCCC-CchHHHHHHHHHHHhhccCCCcceeeecccccCCCce
Q psy11098 98 FEHRYEE--LERLGNGRFCTVRKARDRGTGQLVALKQIPRER-QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 98 ~~~~y~~--~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~ 174 (380)
+...|.+ .+.||+|+||.||+|.+..+|+.||+|+++... ...+.+.+|+++++.++|+||+++++++... +..
T Consensus 85 ~~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---~~~ 161 (373)
T 2x4f_A 85 VNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESK---NDI 161 (373)
T ss_dssp GGGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS---SEE
T ss_pred cccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC---CEE
Confidence 3445555 678999999999999999999999999997654 3456778999999999999999999998764 678
Q ss_pred EEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe---CCeeEEEeCCCccccc-
Q psy11098 175 TIVMQLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN---GAVLKLIDLGSSVSVS- 249 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~---~~~ikl~DFG~a~~~~- 249 (380)
++||||+.|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 162 ~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~ 241 (373)
T 2x4f_A 162 VLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP 241 (373)
T ss_dssp EEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCT
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCC
Confidence 9999999999999988654 5699999999999999999999999999999999999994 3589999999998653
Q ss_pred ----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHH
Q psy11098 250 ----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAR 325 (380)
Q Consensus 250 ----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 325 (380)
....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+....+.++...+..++++++
T Consensus 242 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 320 (373)
T 2x4f_A 242 REKLKVNFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAK 320 (373)
T ss_dssp TCBCCCCCSSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHH
T ss_pred ccccccccCCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHH
Confidence 34568999999999987 4778899999999999999999999999999999999988888888777788999999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 326 ELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 326 ~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
+||.+||..||++|||++|+|+||||.+.
T Consensus 321 ~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 321 EFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred HHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 99999999999999999999999999875
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-51 Score=385.25 Aligned_cols=256 Identities=29% Similarity=0.493 Sum_probs=218.0
Q ss_pred hhhhceeee-eeecccCCeEEEEEEEcCCCcEEEEEEecCCC-CchHHHHHHHHHHHhh-ccCCCcceeeecccccCCCc
Q psy11098 97 QFEHRYEEL-ERLGNGRFCTVRKARDRGTGQLVALKQIPRER-QPQQITRAEYNLLSTL-MHAHIPTALALFENAPVPGT 173 (380)
Q Consensus 97 ~~~~~y~~~-~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~~~~~ 173 (380)
.|.++|++. +.||+|+||+||+|++..+++.||||++.... .....+.+|++++..+ +|+||+++++++... +.
T Consensus 9 ~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~---~~ 85 (316)
T 2ac3_A 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE---DR 85 (316)
T ss_dssp CTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET---TE
T ss_pred ccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC---CE
Confidence 467899996 78999999999999999999999999997553 3456778899999885 799999999998764 67
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-C---eeEEEeCCCccccc
Q psy11098 174 DTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-A---VLKLIDLGSSVSVS 249 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~---~ikl~DFG~a~~~~ 249 (380)
.++||||+.|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++. + .+||+|||++....
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred EEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 8999999999999999988889999999999999999999999999999999999999974 3 39999999987542
Q ss_pred -------------ccccCCCcccCCccccCC----CCCCCcccHHHHHHHHHHHHhCCCCCCCCC---------------
Q psy11098 250 -------------TVVLPDLEFASPEMLTSP----ATAGPSTDMWSLGVLLYILLSGVSPFLDES--------------- 297 (380)
Q Consensus 250 -------------~~~~gt~~y~aPE~~~~~----~~~~~~~DiwSlGvil~~lltg~~Pf~~~~--------------- 297 (380)
....||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+..
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 234589999999998641 346789999999999999999999997754
Q ss_pred HHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 298 EEETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 298 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
.......+....+.++...+..++.++++||++||..||++|||++|+|+||||+...
T Consensus 246 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 246 QNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp HHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred HHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 2445666777777777655667899999999999999999999999999999998753
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-51 Score=393.41 Aligned_cols=252 Identities=20% Similarity=0.316 Sum_probs=216.3
Q ss_pred hhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhc-----cCCCcceeeecccccC
Q psy11098 96 EQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLM-----HAHIPTALALFENAPV 170 (380)
Q Consensus 96 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~-----h~ni~~i~~~~~~~~~ 170 (380)
..+.++|++.+.||+|+||+||+|++..+++.||||++............|+++++.+. |+||+++++++...
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~-- 108 (360)
T 3llt_A 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY-- 108 (360)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET--
T ss_pred eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC--
Confidence 34678999999999999999999999999999999999765555566778999999997 99999999988764
Q ss_pred CCceEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe---------------
Q psy11098 171 PGTDTIVMQLVHGESLIQHLCRQS--TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN--------------- 233 (380)
Q Consensus 171 ~~~~~lv~e~~~gg~L~~~l~~~~--~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~--------------- 233 (380)
+..++||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 109 -~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~ 186 (360)
T 3llt_A 109 -DHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVT 186 (360)
T ss_dssp -TEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred -CeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccc
Confidence 6789999999 999999997654 599999999999999999999999999999999999996
Q ss_pred -----------CCeeEEEeCCCccccc---ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHH
Q psy11098 234 -----------GAVLKLIDLGSSVSVS---TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEE 299 (380)
Q Consensus 234 -----------~~~ikl~DFG~a~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~ 299 (380)
++.+||+|||+|.... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..
T Consensus 187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 265 (360)
T 3llt_A 187 DGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILN-LGWDVSSDMWSFGCVLAELYTGSLLFRTHEHM 265 (360)
T ss_dssp TCCEEEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccccccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcC-CCCCCccchHHHHHHHHHHHHCCCCCCCCcHH
Confidence 4589999999997654 45678999999999988 47889999999999999999999999998887
Q ss_pred HHHHHHhcccCCCCCCc------------------------------------------CCCCCHHHHHHHHHhcccCCC
Q psy11098 300 ETRAHISVADYSFPPEQ------------------------------------------CGHISVPARELIGQLLNTHAD 337 (380)
Q Consensus 300 ~~~~~i~~~~~~~~~~~------------------------------------------~~~~s~~~~~li~~~L~~dP~ 337 (380)
+....+......++... ....++.+.+||++||+.||+
T Consensus 266 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 345 (360)
T 3llt_A 266 EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPT 345 (360)
T ss_dssp HHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChh
Confidence 77666654332222100 001246788999999999999
Q ss_pred CCCCHHHHHhccccc
Q psy11098 338 KRPTAGQLLQVAWFA 352 (380)
Q Consensus 338 ~Rpt~~e~L~hpw~~ 352 (380)
+|||++|+|+||||+
T Consensus 346 ~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 346 LRPSPAELLKHKFLE 360 (360)
T ss_dssp GSCCHHHHTTSGGGC
T ss_pred hCCCHHHHhcCcccC
Confidence 999999999999995
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=395.80 Aligned_cols=255 Identities=27% Similarity=0.379 Sum_probs=207.9
Q ss_pred hhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---chHHHHHHHHHHHhhc-cCCCcceeeecccccCC
Q psy11098 96 EQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLM-HAHIPTALALFENAPVP 171 (380)
Q Consensus 96 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~-h~ni~~i~~~~~~~~~~ 171 (380)
..+.++|++.+.||+|+||+||+|.++.+|+.||+|++..... ......+|+.+++.+. |+||+++++++.... .
T Consensus 5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~-~ 83 (388)
T 3oz6_A 5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN-D 83 (388)
T ss_dssp HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT-S
T ss_pred CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC-C
Confidence 4567899999999999999999999999999999999865432 3345677999999997 999999999987532 2
Q ss_pred CceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-
Q psy11098 172 GTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS- 249 (380)
Q Consensus 172 ~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~- 249 (380)
...|+||||+. ++|.+.+.. ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|+...
T Consensus 84 ~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 161 (388)
T 3oz6_A 84 RDVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVN 161 (388)
T ss_dssp SCEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSS
T ss_pred CEEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccc
Confidence 46899999995 689888865 5799999999999999999999999999999999999998 5699999999997542
Q ss_pred --------------------------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy11098 250 --------------------------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRA 303 (380)
Q Consensus 250 --------------------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~ 303 (380)
...+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~ 241 (388)
T 3oz6_A 162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLE 241 (388)
T ss_dssp CCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred cccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 235789999999999876678999999999999999999999999988877776
Q ss_pred HHhcccCCCCCC--------------------------------------------cCCCCCHHHHHHHHHhcccCCCCC
Q psy11098 304 HISVADYSFPPE--------------------------------------------QCGHISVPARELIGQLLNTHADKR 339 (380)
Q Consensus 304 ~i~~~~~~~~~~--------------------------------------------~~~~~s~~~~~li~~~L~~dP~~R 339 (380)
.+... ..++.. ....+++++.+||++||+.||++|
T Consensus 242 ~i~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R 320 (388)
T 3oz6_A 242 RIIGV-IDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKR 320 (388)
T ss_dssp HHHHH-HCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHHh-cCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccC
Confidence 66421 111110 012578999999999999999999
Q ss_pred CCHHHHHhccccccc
Q psy11098 340 PTAGQLLQVAWFAEA 354 (380)
Q Consensus 340 pt~~e~L~hpw~~~~ 354 (380)
||++|+|+||||+..
T Consensus 321 ~t~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 321 ISANDALKHPFVSIF 335 (388)
T ss_dssp CCHHHHTTSTTTTTT
T ss_pred CCHHHHhCCHHHHHh
Confidence 999999999999754
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=391.08 Aligned_cols=256 Identities=24% Similarity=0.365 Sum_probs=212.6
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCc---hHHHHHHHHHHHhhccCCCcceeeecccccC---C
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP---QQITRAEYNLLSTLMHAHIPTALALFENAPV---P 171 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~---~ 171 (380)
+.++|++.+.||+|+||.||+|.+..+|+.||||++...... ...+.+|+++++.++|+||+++++++..... .
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 467899999999999999999999999999999999654332 3456789999999999999999999876432 1
Q ss_pred CceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-
Q psy11098 172 GTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS- 249 (380)
Q Consensus 172 ~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~- 249 (380)
...|+||||+ |++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++...
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 180 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence 4569999999 8999998876 5799999999999999999999999999999999999998 5699999999998764
Q ss_pred --ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCC--------------
Q psy11098 250 --TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFP-------------- 313 (380)
Q Consensus 250 --~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~-------------- 313 (380)
....+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+.......+
T Consensus 181 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~ 260 (367)
T 1cm8_A 181 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN 260 (367)
T ss_dssp SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHH
T ss_pred ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHH
Confidence 4557899999999998756789999999999999999999999999887776665543211111
Q ss_pred -------------CCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 314 -------------PEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 314 -------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
...+..+++++.+||++||..||++|||++|+|+||||++..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 261 YMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp HHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 012346789999999999999999999999999999998753
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-51 Score=407.09 Aligned_cols=253 Identities=22% Similarity=0.308 Sum_probs=206.3
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC---CchHHHHHHHHHHHhhccCCCcceeeeccccc---CC
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER---QPQQITRAEYNLLSTLMHAHIPTALALFENAP---VP 171 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~---~~ 171 (380)
+.++|++++.||+|+||+||+|++..+++.||||++.+.. .....+.+|+.+++.++|+||+++++++.... ..
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 3678999999999999999999999999999999997542 23456678999999999999999999986542 22
Q ss_pred CceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-
Q psy11098 172 GTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS- 249 (380)
Q Consensus 172 ~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~- 249 (380)
...|+||||+.+ .|.+.+. ..+++..++.+++||+.||.|||++||+||||||+|||++ ++.+||+|||+|+...
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred CeEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence 467999999955 5767664 3599999999999999999999999999999999999998 5699999999998664
Q ss_pred ----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcC--------
Q psy11098 250 ----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQC-------- 317 (380)
Q Consensus 250 ----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~-------- 317 (380)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+........++..
T Consensus 217 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~ 295 (464)
T 3ttj_A 217 SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 295 (464)
T ss_dssp CCCC----CCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHH
T ss_pred CcccCCCcccccccCHHHHcC-CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhh
Confidence 34678999999999988 47889999999999999999999999998877766665432111100000
Q ss_pred ------------------C------------CCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 318 ------------------G------------HISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 318 ------------------~------------~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
. ..++++++||++||..||++|||++|+|+||||+..
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~ 362 (464)
T 3ttj_A 296 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 362 (464)
T ss_dssp HHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred hHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence 0 015679999999999999999999999999999853
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-51 Score=389.66 Aligned_cols=260 Identities=32% Similarity=0.498 Sum_probs=226.2
Q ss_pred hhhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC------CCchHHHHHHHHHHHhhccCCCcceeeecccc
Q psy11098 95 QEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE------RQPQQITRAEYNLLSTLMHAHIPTALALFENA 168 (380)
Q Consensus 95 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~------~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~ 168 (380)
...+.++|++.+.||+|+||+||+|.+..+++.||+|++... ......+.+|+++++.++||||+++++++...
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 356789999999999999999999999999999999998542 33456788899999999999999999998763
Q ss_pred cCCCceEEEEEecCCCCHHHHHHh----------------------------------------cCCCCHHHHHHHHHHH
Q psy11098 169 PVPGTDTIVMQLVHGESLIQHLCR----------------------------------------QSTITESYICCIIRQL 208 (380)
Q Consensus 169 ~~~~~~~lv~e~~~gg~L~~~l~~----------------------------------------~~~l~e~~~~~i~~qi 208 (380)
+..++||||+.||+|.+++.. ...+++..++.++.||
T Consensus 101 ---~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi 177 (345)
T 3hko_A 101 ---QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI 177 (345)
T ss_dssp ---SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHH
T ss_pred ---CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHH
Confidence 678999999999999998852 1124678899999999
Q ss_pred HHHHHHHHHCCcEeecCCCCcEEEeC-C--eeEEEeCCCccccc----------ccccCCCcccCCccccCC-CCCCCcc
Q psy11098 209 HSALHCLHSQQIAHKDIRPENILMNG-A--VLKLIDLGSSVSVS----------TVVLPDLEFASPEMLTSP-ATAGPST 274 (380)
Q Consensus 209 l~al~~lH~~~iiHrDlKp~NIl~~~-~--~ikl~DFG~a~~~~----------~~~~gt~~y~aPE~~~~~-~~~~~~~ 274 (380)
+.||.|||++||+||||||+|||++. + .+||+|||++.... ....||+.|+|||++.+. ..++.++
T Consensus 178 ~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 178 FSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999999999999999999999973 3 79999999997542 345789999999998752 4678899
Q ss_pred cHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 275 DMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 275 DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
|||||||++|+|++|..||.+.+..+....+......++...+..+++++++||.+||+.||++|||+.|+|+||||++.
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~ 337 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQF 337 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTT
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccC
Confidence 99999999999999999999999999888888888777777777789999999999999999999999999999999887
Q ss_pred CCC
Q psy11098 355 SCS 357 (380)
Q Consensus 355 ~~~ 357 (380)
...
T Consensus 338 ~~~ 340 (345)
T 3hko_A 338 SDK 340 (345)
T ss_dssp SSC
T ss_pred hHh
Confidence 543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=375.56 Aligned_cols=253 Identities=36% Similarity=0.611 Sum_probs=226.8
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC-------chHHHHHHHHHHHhhccCCCcceeeecccccC
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ-------PQQITRAEYNLLSTLMHAHIPTALALFENAPV 170 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-------~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~ 170 (380)
+.++|++.+.||+|+||.||+|++..+++.||+|++..... ..+.+.+|+.+++.++|+||+++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-- 80 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENK-- 80 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS--
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCC--
Confidence 46789999999999999999999999999999999965422 256788999999999999999999998764
Q ss_pred CCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-C----eeEEEeCCCc
Q psy11098 171 PGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-A----VLKLIDLGSS 245 (380)
Q Consensus 171 ~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~----~ikl~DFG~a 245 (380)
+..++||||+.+++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++. + .+||+|||++
T Consensus 81 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 81 -TDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp -SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred -CeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 678999999999999999988889999999999999999999999999999999999999974 3 7999999999
Q ss_pred cccc-----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCC
Q psy11098 246 VSVS-----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHI 320 (380)
Q Consensus 246 ~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 320 (380)
.... ....||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+....+....+......++...+..+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T 3bhy_A 160 HKIEAGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNT 238 (283)
T ss_dssp EECC--------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTC
T ss_pred eeccCCCcccccCCCcCccCcceecC-CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccC
Confidence 7653 34568999999999987 47788999999999999999999999999988888888877777766666788
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 321 SVPARELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 321 s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
+.++.+||++||..||++|||+.|+|+||||+..
T Consensus 239 ~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 239 SELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 9999999999999999999999999999999865
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-51 Score=407.24 Aligned_cols=250 Identities=27% Similarity=0.440 Sum_probs=224.4
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC----CchHHHHHHHHHHHhhccCCCcceeeecccccCCCc
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGT 173 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~ 173 (380)
..++|.+.+.||+|+||+||+|++..+|+.||||++.... .....+.+|+.+++.++||||+++++++... +.
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~---~~ 90 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP---SD 90 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS---SE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC---CE
Confidence 3578999999999999999999999999999999996432 2345678899999999999999999988764 67
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc---
Q psy11098 174 DTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS--- 249 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~--- 249 (380)
.|+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 91 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 91 IFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp EEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 899999999999999998888899999999999999999999999999999999999998 5699999999997653
Q ss_pred --ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHH
Q psy11098 250 --TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAREL 327 (380)
Q Consensus 250 --~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 327 (380)
...+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+..+.+..+ ..+++++++|
T Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~L 246 (476)
T 2y94_A 171 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTP----QYLNPSVISL 246 (476)
T ss_dssp CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCC----TTCCHHHHHH
T ss_pred cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCC----ccCCHHHHHH
Confidence 3567899999999998855557899999999999999999999999988888888887766554 3479999999
Q ss_pred HHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 328 IGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 328 i~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
|++||..||++|||++|+++||||++.
T Consensus 247 i~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 247 LKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp HHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred HHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 999999999999999999999999864
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=421.30 Aligned_cols=258 Identities=23% Similarity=0.394 Sum_probs=230.1
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC----CCchHHHHHHHHHHHhh-ccCCCcceeeecccccCCCc
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLSTL-MHAHIPTALALFENAPVPGT 173 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~~~~~ 173 (380)
.++|++++.||+|+||+||+|+++.+++.||||++++. .........|.+++..+ +|++|+.++.++... +.
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~---~~ 416 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM---DR 416 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS---SE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC---CE
Confidence 36799999999999999999999999999999999642 33445667799999887 799999999988764 67
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccc----
Q psy11098 174 DTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSV---- 248 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~---- 248 (380)
+||||||+.||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|+..
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 496 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 496 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT
T ss_pred EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCC
Confidence 899999999999999999888999999999999999999999999999999999999998 569999999999753
Q ss_pred --cccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHH
Q psy11098 249 --STVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARE 326 (380)
Q Consensus 249 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 326 (380)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......++. .++.++++
T Consensus 497 ~~~~~~~GT~~Y~APE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~ 571 (674)
T 3pfq_A 497 VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVA 571 (674)
T ss_dssp CCBCCCCSCSSSCCHHHHTC-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCT----TSCHHHHH
T ss_pred cccccccCCCcccCHhhhcC-CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCHHHHH
Confidence 245789999999999987 57899999999999999999999999999999999999988877764 58999999
Q ss_pred HHHHhcccCCCCCCCH-----HHHHhcccccccCCCCCccccc
Q psy11098 327 LIGQLLNTHADKRPTA-----GQLLQVAWFAEASCSEFDTERL 364 (380)
Q Consensus 327 li~~~L~~dP~~Rpt~-----~e~L~hpw~~~~~~~~~~~~~~ 364 (380)
||++||++||++||++ +|+++||||+...+..+...++
T Consensus 572 li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~~~ 614 (674)
T 3pfq_A 572 ICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEI 614 (674)
T ss_dssp HHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTTTCS
T ss_pred HHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHhCCC
Confidence 9999999999999997 9999999999876654444443
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-51 Score=388.63 Aligned_cols=253 Identities=26% Similarity=0.389 Sum_probs=210.6
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCc--hHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP--QQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIV 177 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv 177 (380)
++|++++.||+|+||+||+|++..+++.||+|++...... ...+.+|+++++.++|+||+++++++... +..++|
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~lv 78 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE---KSLTLV 78 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECS---SCEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeC---CEEEEE
Confidence 4799999999999999999999999999999999654322 12345699999999999999999998764 678999
Q ss_pred EEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------
Q psy11098 178 MQLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------ 249 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------ 249 (380)
|||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 157 (324)
T 3mtl_A 79 FEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 157 (324)
T ss_dssp EECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred ecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcccc
Confidence 99995 6898888764 4699999999999999999999999999999999999998 5699999999987543
Q ss_pred ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCC--------------
Q psy11098 250 TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPE-------------- 315 (380)
Q Consensus 250 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~-------------- 315 (380)
....||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+..........
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY 237 (324)
T ss_dssp -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHT
T ss_pred ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccc
Confidence 345679999999999876678999999999999999999999999998887777665422211111
Q ss_pred ------------cCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCC
Q psy11098 316 ------------QCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASC 356 (380)
Q Consensus 316 ------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~ 356 (380)
....+++++++||++||+.||++|||++|+|+||||.+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 238 NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 12357889999999999999999999999999999987643
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-51 Score=402.69 Aligned_cols=256 Identities=28% Similarity=0.478 Sum_probs=217.2
Q ss_pred hhhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC---------CchHHHHHHHHHHHhhccCCCcceeeec
Q psy11098 95 QEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER---------QPQQITRAEYNLLSTLMHAHIPTALALF 165 (380)
Q Consensus 95 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~---------~~~~~~~~E~~il~~l~h~ni~~i~~~~ 165 (380)
...+.++|.+.+.||+|+||+||+|.++.+++.||+|++.+.. .....+.+|+++++.++||||+++++++
T Consensus 130 ~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~ 209 (419)
T 3i6u_A 130 PKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF 209 (419)
T ss_dssp CHHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEE
T ss_pred chhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 4567899999999999999999999999999999999996432 1123467899999999999999999987
Q ss_pred ccccCCCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC----CeeEEEe
Q psy11098 166 ENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG----AVLKLID 241 (380)
Q Consensus 166 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~----~~ikl~D 241 (380)
.. +..++||||+.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++. ..+||+|
T Consensus 210 ~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 210 DA----EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp ES----SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred ec----CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEee
Confidence 54 457999999999999999988889999999999999999999999999999999999999963 2599999
Q ss_pred CCCccccc-----ccccCCCcccCCccccC--CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhcccCCCC
Q psy11098 242 LGSSVSVS-----TVVLPDLEFASPEMLTS--PATAGPSTDMWSLGVLLYILLSGVSPFLDESE-EETRAHISVADYSFP 313 (380)
Q Consensus 242 FG~a~~~~-----~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~-~~~~~~i~~~~~~~~ 313 (380)
||+|.... ...+||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+... ......+....+.+.
T Consensus 286 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~ 365 (419)
T 3i6u_A 286 FGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 365 (419)
T ss_dssp SSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCC
T ss_pred cccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCC
Confidence 99998664 35678999999999864 24667799999999999999999999976543 345556666777776
Q ss_pred CCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 314 PEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 314 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
++.+..+++++.+||++||+.||++|||++|+|+||||++.
T Consensus 366 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 366 PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406 (419)
T ss_dssp HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred chhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence 66677899999999999999999999999999999999765
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-50 Score=375.24 Aligned_cols=259 Identities=27% Similarity=0.418 Sum_probs=227.9
Q ss_pred hhhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC----------chHHHHHHHHHHHhhc-cCCCcceee
Q psy11098 95 QEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ----------PQQITRAEYNLLSTLM-HAHIPTALA 163 (380)
Q Consensus 95 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~----------~~~~~~~E~~il~~l~-h~ni~~i~~ 163 (380)
...+.++|++.+.||+|+||.||+|.++.+|+.||+|++..... ..+.+.+|+++++.+. |+||+++++
T Consensus 12 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (298)
T 1phk_A 12 THGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD 91 (298)
T ss_dssp ---CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred CcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeee
Confidence 34578899999999999999999999999999999999975431 1245678999999996 999999999
Q ss_pred ecccccCCCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeC
Q psy11098 164 LFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDL 242 (380)
Q Consensus 164 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DF 242 (380)
++... +..++||||+.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+||
T Consensus 92 ~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 92 TYETN---TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp EEECS---SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred eeccC---CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecc
Confidence 98763 67899999999999999998888999999999999999999999999999999999999998 469999999
Q ss_pred CCccccc-----ccccCCCcccCCcccc-----CCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCC
Q psy11098 243 GSSVSVS-----TVVLPDLEFASPEMLT-----SPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSF 312 (380)
Q Consensus 243 G~a~~~~-----~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~ 312 (380)
|++.... ....+|+.|+|||++. ....++.++||||||+++|+|++|..||.+.+..+....+......+
T Consensus 169 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (298)
T 1phk_A 169 GFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 248 (298)
T ss_dssp TTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred cchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCccc
Confidence 9997653 3457899999999985 22467889999999999999999999999999888888888888777
Q ss_pred CCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCC
Q psy11098 313 PPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASC 356 (380)
Q Consensus 313 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~ 356 (380)
+.+.+..++.++.+||.+||..||++|||++|+|+||||++...
T Consensus 249 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 292 (298)
T 1phk_A 249 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVV 292 (298)
T ss_dssp CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC-
T ss_pred CcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccc
Confidence 76666778999999999999999999999999999999987643
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=383.89 Aligned_cols=259 Identities=27% Similarity=0.478 Sum_probs=229.6
Q ss_pred hhhhhhceeee-eeecccCCeEEEEEEEcCCCcEEEEEEecCCC---CchHHHHHHHHHHHhhc-cCCCcceeeeccccc
Q psy11098 95 QEQFEHRYEEL-ERLGNGRFCTVRKARDRGTGQLVALKQIPRER---QPQQITRAEYNLLSTLM-HAHIPTALALFENAP 169 (380)
Q Consensus 95 ~~~~~~~y~~~-~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~il~~l~-h~ni~~i~~~~~~~~ 169 (380)
.+.|.++|.+. +.||+|+||+||+|+++.+++.||+|++.... .....+.+|+.+++.+. |+||+++++++...
T Consensus 23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~- 101 (327)
T 3lm5_A 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT- 101 (327)
T ss_dssp HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-
T ss_pred HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC-
Confidence 56789999998 89999999999999999999999999996532 23466788999999995 69999999998764
Q ss_pred CCCceEEEEEecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC----CeeEEEeCC
Q psy11098 170 VPGTDTIVMQLVHGESLIQHLCR--QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG----AVLKLIDLG 243 (380)
Q Consensus 170 ~~~~~~lv~e~~~gg~L~~~l~~--~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~----~~ikl~DFG 243 (380)
+..++||||+.|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||
T Consensus 102 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg 179 (327)
T 3lm5_A 102 --SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFG 179 (327)
T ss_dssp --SEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred --CeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCc
Confidence 678999999999999998854 367999999999999999999999999999999999999975 689999999
Q ss_pred Cccccc-----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCC
Q psy11098 244 SSVSVS-----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCG 318 (380)
Q Consensus 244 ~a~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 318 (380)
++.... ....||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+....+....+......++.+.+.
T Consensus 180 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 258 (327)
T 3lm5_A 180 MSRKIGHACELREIMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFS 258 (327)
T ss_dssp GCEEC---------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTT
T ss_pred cccccCCccccccccCCcCccCCeeecC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhc
Confidence 998654 34578999999999987 477899999999999999999999999999999888888888888877778
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCCC
Q psy11098 319 HISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASCS 357 (380)
Q Consensus 319 ~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~~ 357 (380)
.++.++++||.+||..||++|||++|+|+||||++....
T Consensus 259 ~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~ 297 (327)
T 3lm5_A 259 SVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFE 297 (327)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTT
T ss_pred ccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccc
Confidence 899999999999999999999999999999999886544
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=374.72 Aligned_cols=249 Identities=30% Similarity=0.508 Sum_probs=221.8
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC----CchHHHHHHHHHHHhhccCCCcceeeecccccCCCce
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~ 174 (380)
.++|++.+.||+|+||+||+|.+..+++.||+|++.... .....+.+|+.+++.++|+||+++++++... +..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 84 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA---TRV 84 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS---SEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecC---CEE
Confidence 578999999999999999999999999999999985432 2345678899999999999999999998764 678
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc----
Q psy11098 175 TIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS---- 249 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~---- 249 (380)
++||||+.+++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 164 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR 164 (279)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcccc
Confidence 99999999999999998888999999999999999999999999999999999999997 5699999999886553
Q ss_pred ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHH
Q psy11098 250 TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIG 329 (380)
Q Consensus 250 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 329 (380)
....||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+....+....+......++. .+++++++||.
T Consensus 165 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~ 239 (279)
T 3fdn_A 165 TDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLIS 239 (279)
T ss_dssp ---CCCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCT----TSCHHHHHHHH
T ss_pred cccCCCCCccCHhHhcc-CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCC----cCCHHHHHHHH
Confidence 45678999999999987 47788999999999999999999999999988888888777666553 47999999999
Q ss_pred HhcccCCCCCCCHHHHHhcccccccC
Q psy11098 330 QLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 330 ~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
+||..||++|||++|+|+||||+...
T Consensus 240 ~~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 240 RLLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp HHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred HHhccChhhCCCHHHHhhCccccCCc
Confidence 99999999999999999999998754
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-50 Score=392.15 Aligned_cols=254 Identities=23% Similarity=0.309 Sum_probs=211.7
Q ss_pred hhceeeeeeeccc--CCeEEEEEEEcCCCcEEEEEEecCCCC---chHHHHHHHHHHHhhccCCCcceeeecccccCCCc
Q psy11098 99 EHRYEELERLGNG--RFCTVRKARDRGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGT 173 (380)
Q Consensus 99 ~~~y~~~~~LG~G--~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~ 173 (380)
.++|++.+.||+| +||.||+|+++.+|+.||||++..... ....+.+|+.+++.++|+||+++++++... +.
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~ 100 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD---NE 100 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET---TE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC---CE
Confidence 6789999999999 999999999999999999999975433 235667899999999999999999998864 67
Q ss_pred eEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-
Q psy11098 174 DTIVMQLVHGESLIQHLCRQ--STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS- 249 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~- 249 (380)
.++||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 89999999999999999775 6799999999999999999999999999999999999998 5799999999875431
Q ss_pred ------------ccccCCCcccCCccccCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCC-----
Q psy11098 250 ------------TVVLPDLEFASPEMLTSP-ATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYS----- 311 (380)
Q Consensus 250 ------------~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~----- 311 (380)
....||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 260 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 260 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccc
Confidence 234789999999999873 46788999999999999999999999876554444333222110
Q ss_pred -------------------------------------CCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 312 -------------------------------------FPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 312 -------------------------------------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
........+++++++||++||+.||++|||++|+|+||||++.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~ 340 (389)
T 3gni_B 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 340 (389)
T ss_dssp ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC
T ss_pred cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHH
Confidence 0011234578999999999999999999999999999999875
Q ss_pred C
Q psy11098 355 S 355 (380)
Q Consensus 355 ~ 355 (380)
.
T Consensus 341 ~ 341 (389)
T 3gni_B 341 K 341 (389)
T ss_dssp -
T ss_pred h
Confidence 4
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-50 Score=394.94 Aligned_cols=261 Identities=22% Similarity=0.276 Sum_probs=210.6
Q ss_pred hhhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---chHHHHHHHHHHHhhccCCCcceeeeccccc--
Q psy11098 95 QEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLMHAHIPTALALFENAP-- 169 (380)
Q Consensus 95 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~-- 169 (380)
.-.+.++|++.+.||+|+||+||+|+++.+++.||||++..... ....+.+|+++|+.++|+||+++++++....
T Consensus 21 ~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 100 (432)
T 3n9x_A 21 NVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLL 100 (432)
T ss_dssp GCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTT
T ss_pred cceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCC
Confidence 34567899999999999999999999999999999999975433 2356778999999999999999999987542
Q ss_pred CCCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccc
Q psy11098 170 VPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSV 248 (380)
Q Consensus 170 ~~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~ 248 (380)
..+..|+||||+ +++|.+++.....+++..++.+++||+.||.|||++||+||||||+|||++ ++.+||+|||+|+..
T Consensus 101 ~~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 101 KFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp TCCCEEEEEECC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred cCCeEEEEEecC-CcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 124689999998 569999998888899999999999999999999999999999999999998 469999999999764
Q ss_pred c----------------------------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhC-----------
Q psy11098 249 S----------------------------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSG----------- 289 (380)
Q Consensus 249 ~----------------------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg----------- 289 (380)
. ...+||+.|+|||++.....++.++|||||||++|+|++|
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~ 259 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNR 259 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGC
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccc
Confidence 2 3457899999999976556789999999999999999984
Q ss_pred CCCCCCCC-----------------HHHHHHHH------------------------hcccCCCCC---CcCCCCCHHHH
Q psy11098 290 VSPFLDES-----------------EEETRAHI------------------------SVADYSFPP---EQCGHISVPAR 325 (380)
Q Consensus 290 ~~Pf~~~~-----------------~~~~~~~i------------------------~~~~~~~~~---~~~~~~s~~~~ 325 (380)
.++|.+.+ ..+....+ .......+. ..+..+++++.
T Consensus 260 ~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 339 (432)
T 3n9x_A 260 FPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGI 339 (432)
T ss_dssp CCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHH
T ss_pred cccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHH
Confidence 44444432 01111111 110111110 12246899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhcccccccCC
Q psy11098 326 ELIGQLLNTHADKRPTAGQLLQVAWFAEASC 356 (380)
Q Consensus 326 ~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~ 356 (380)
+||++||..||++|||++|+|+||||++...
T Consensus 340 dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 370 (432)
T 3n9x_A 340 NLLESMLKFNPNKRITIDQALDHPYLKDVRK 370 (432)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHTCGGGTTTCC
T ss_pred HHHHHHhcCCcccCCCHHHHhcChhhhhccC
Confidence 9999999999999999999999999997643
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=378.23 Aligned_cols=267 Identities=20% Similarity=0.371 Sum_probs=224.6
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC-CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER-QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIV 177 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv 177 (380)
...|+..+.||+|+||.||+|+++.+|+.||||++.... ...+.+.+|+.+++.++|+||+++++++... +..++|
T Consensus 44 ~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~lv 120 (321)
T 2c30_A 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVG---EELWVL 120 (321)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEET---TEEEEE
T ss_pred hhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEEC---CEEEEE
Confidence 345888899999999999999999999999999997543 3456778899999999999999999988764 678999
Q ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------c
Q psy11098 178 MQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------T 250 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------~ 250 (380)
|||+.|++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.... .
T Consensus 121 ~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 199 (321)
T 2c30_A 121 MEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK 199 (321)
T ss_dssp ECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred EecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccc
Confidence 999999999998864 4799999999999999999999999999999999999998 5699999999987653 3
Q ss_pred cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHH
Q psy11098 251 VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQ 330 (380)
Q Consensus 251 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 330 (380)
...||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+....+....+........ .....+++++++||.+
T Consensus 200 ~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~ 277 (321)
T 2c30_A 200 SLVGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKL-KNSHKVSPVLRDFLER 277 (321)
T ss_dssp CCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC-TTGGGSCHHHHHHHHH
T ss_pred cccCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCc-CccccCCHHHHHHHHH
Confidence 4578999999999987 4778899999999999999999999999888777776654432211 1234578999999999
Q ss_pred hcccCCCCCCCHHHHHhcccccccCCCCCccccccchHHHHHHHH
Q psy11098 331 LLNTHADKRPTAGQLLQVAWFAEASCSEFDTERLLPFSARRKQKF 375 (380)
Q Consensus 331 ~L~~dP~~Rpt~~e~L~hpw~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (380)
||..||++|||++|+|+||||.+... .+.+.+++...+.+.
T Consensus 278 ~l~~dp~~Rps~~ell~hp~~~~~~~----~~~~~~~~~~~~~~~ 318 (321)
T 2c30_A 278 MLVRDPQERATAQELLDHPFLLQTGL----PECLVPLIQLYRKQT 318 (321)
T ss_dssp HSCSSTTTSCCHHHHHTSGGGGGCCC----GGGGHHHHHHC----
T ss_pred HccCChhhCcCHHHHhcChhhccCCC----cccchHHHHHHHHhh
Confidence 99999999999999999999987642 334555555544443
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=371.38 Aligned_cols=250 Identities=28% Similarity=0.473 Sum_probs=223.9
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC----CCchHHHHHHHHHHHhhccCCCcceeeecccccCCCce
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~ 174 (380)
.++|++.+.||+|+||.||+|++..+++.||+|++... ......+.+|+++++.++|+||+++++++... +..
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 89 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDR---KRI 89 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS---SEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcC---CEE
Confidence 47899999999999999999999999999999999543 22346678899999999999999999998763 678
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc----
Q psy11098 175 TIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS---- 249 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~---- 249 (380)
++||||+.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 169 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR 169 (284)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSCB
T ss_pred EEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccccc
Confidence 99999999999999998888899999999999999999999999999999999999998 5699999999987553
Q ss_pred ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHH
Q psy11098 250 TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIG 329 (380)
Q Consensus 250 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 329 (380)
....||+.|+|||++.+ ..++.++||||||+++|+|++|..||......+....+......++ ..++.++++||.
T Consensus 170 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~ 244 (284)
T 2vgo_A 170 RTMCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP----PFLSDGSKDLIS 244 (284)
T ss_dssp CCCCSCGGGCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCHHHHHHHH
T ss_pred ccccCCCCcCCHHHhcc-CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCC----CcCCHHHHHHHH
Confidence 35678999999999988 4678899999999999999999999999888888888877666554 357999999999
Q ss_pred HhcccCCCCCCCHHHHHhcccccccCC
Q psy11098 330 QLLNTHADKRPTAGQLLQVAWFAEASC 356 (380)
Q Consensus 330 ~~L~~dP~~Rpt~~e~L~hpw~~~~~~ 356 (380)
+||..||++|||++++|+||||+....
T Consensus 245 ~~l~~~p~~Rps~~~ll~h~~~~~~~~ 271 (284)
T 2vgo_A 245 KLLRYHPPQRLPLKGVMEHPWVKANSR 271 (284)
T ss_dssp HHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred HHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence 999999999999999999999987643
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=385.00 Aligned_cols=256 Identities=24% Similarity=0.324 Sum_probs=215.6
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCc--hHHHHHHHHHHHhhccCCCcceeeeccccc--CCCc
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP--QQITRAEYNLLSTLMHAHIPTALALFENAP--VPGT 173 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~E~~il~~l~h~ni~~i~~~~~~~~--~~~~ 173 (380)
+..+|++.+.||+|+||.||+|++..+++.||+|++...... ...+.+|+++++.++|+||+++++++.... ....
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 357999999999999999999999999999999999754332 356778999999999999999999986542 2246
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc---
Q psy11098 174 DTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS--- 249 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~--- 249 (380)
.++|||++. ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 105 ~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 182 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182 (364)
T ss_dssp EEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence 799999995 699998865 4699999999999999999999999999999999999998 4589999999997653
Q ss_pred ------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCC-----------
Q psy11098 250 ------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSF----------- 312 (380)
Q Consensus 250 ------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~----------- 312 (380)
....||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+.......
T Consensus 183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 262 (364)
T 3qyz_A 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 262 (364)
T ss_dssp CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence 234789999999998765668899999999999999999999998887766665553211111
Q ss_pred ---------C-------CCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 313 ---------P-------PEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 313 ---------~-------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
+ ......++.++.+||++||..||++|||++|+|+||||++..
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 321 (364)
T 3qyz_A 263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321 (364)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhcc
Confidence 0 011245789999999999999999999999999999999753
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=411.47 Aligned_cols=250 Identities=24% Similarity=0.424 Sum_probs=218.5
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC----CCchHHHHHHHHHHHhhccCCCcceeeecccccCCCce
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~ 174 (380)
.++|++.+.||+|+||.||+|+++.+|+.||+|++.+. ......+.+|+++|+.++|+||++++.++... +..
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~---~~l 259 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK---DAL 259 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS---SEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeC---CEE
Confidence 46799999999999999999999999999999999643 33445678899999999999999999988764 678
Q ss_pred EEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc--
Q psy11098 175 TIVMQLVHGESLIQHLCRQS--TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS-- 249 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~~--~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~-- 249 (380)
|+||||+.||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|....
T Consensus 260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 99999999999999997654 499999999999999999999999999999999999998 5799999999998653
Q ss_pred ---ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHhcccCCCCCCcCCCCCH
Q psy11098 250 ---TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDES----EEETRAHISVADYSFPPEQCGHISV 322 (380)
Q Consensus 250 ---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~s~ 322 (380)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.. ..+....+......++ ..++.
T Consensus 340 ~~~~~~~GT~~Y~APEvl~~-~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p----~~~s~ 414 (576)
T 2acx_A 340 QTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS----ERFSP 414 (576)
T ss_dssp CCEECCCSCGGGCCHHHHTT-CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCC----TTSCH
T ss_pred ccccccCCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCC----ccCCH
Confidence 34689999999999988 478899999999999999999999998753 3455555555444443 46899
Q ss_pred HHHHHHHHhcccCCCCCC-----CHHHHHhcccccccCC
Q psy11098 323 PARELIGQLLNTHADKRP-----TAGQLLQVAWFAEASC 356 (380)
Q Consensus 323 ~~~~li~~~L~~dP~~Rp-----t~~e~L~hpw~~~~~~ 356 (380)
++++||++||++||++|| +++|+++||||+...+
T Consensus 415 ~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w 453 (576)
T 2acx_A 415 QARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNF 453 (576)
T ss_dssp HHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCH
T ss_pred HHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCH
Confidence 999999999999999999 8999999999997543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-50 Score=380.65 Aligned_cols=255 Identities=28% Similarity=0.478 Sum_probs=217.9
Q ss_pred hhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---------chHHHHHHHHHHHhhccCCCcceeeecc
Q psy11098 96 EQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---------PQQITRAEYNLLSTLMHAHIPTALALFE 166 (380)
Q Consensus 96 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---------~~~~~~~E~~il~~l~h~ni~~i~~~~~ 166 (380)
..+.++|++.+.||+|+||.||+|+++.+++.||||++..... ....+.+|+++++.++|+||+++++++.
T Consensus 6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 85 (322)
T 2ycf_A 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 85 (322)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc
Confidence 4578899999999999999999999999999999999965321 2234678999999999999999999986
Q ss_pred cccCCCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-C---eeEEEeC
Q psy11098 167 NAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-A---VLKLIDL 242 (380)
Q Consensus 167 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~---~ikl~DF 242 (380)
. +..++||||+.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++. + .+||+||
T Consensus 86 ~----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 86 A----EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp S----SSEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred C----CceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccC
Confidence 5 347999999999999999988889999999999999999999999999999999999999973 2 4999999
Q ss_pred CCccccc-----ccccCCCcccCCcccc--CCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhcccCCCCC
Q psy11098 243 GSSVSVS-----TVVLPDLEFASPEMLT--SPATAGPSTDMWSLGVLLYILLSGVSPFLDESEE-ETRAHISVADYSFPP 314 (380)
Q Consensus 243 G~a~~~~-----~~~~gt~~y~aPE~~~--~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~-~~~~~i~~~~~~~~~ 314 (380)
|++.... ....||+.|+|||++. +...++.++|||||||++|+|++|..||...... .....+....+.+.+
T Consensus 162 g~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 241 (322)
T 2ycf_A 162 GHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 241 (322)
T ss_dssp TTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCH
T ss_pred ccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCc
Confidence 9998664 2456899999999974 2346788999999999999999999999765432 344555556665555
Q ss_pred CcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 315 EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 315 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
..+..++.++.+||++||..||++|||++++|+||||++.
T Consensus 242 ~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 242 EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281 (322)
T ss_dssp HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence 5556789999999999999999999999999999999864
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=378.10 Aligned_cols=278 Identities=24% Similarity=0.357 Sum_probs=229.8
Q ss_pred hhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhh-ccCCCcceeeecccccC---CC
Q psy11098 97 QFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTL-MHAHIPTALALFENAPV---PG 172 (380)
Q Consensus 97 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~~---~~ 172 (380)
...++|++.+.||+|+||.||+|++..+++.||+|++.........+.+|+.+++.+ +|+||+++++++..... .+
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 100 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 100 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCC
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccc
Confidence 347889999999999999999999999999999999987766677888999999999 79999999999876421 35
Q ss_pred ceEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc
Q psy11098 173 TDTIVMQLVHGESLIQHLCRQ--STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS 249 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~ 249 (380)
..++||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 180 (326)
T 2x7f_A 101 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 180 (326)
T ss_dssp EEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC---
T ss_pred eEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecC
Confidence 789999999999999999764 5799999999999999999999999999999999999998 5699999999987653
Q ss_pred ------ccccCCCcccCCccccC----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCC
Q psy11098 250 ------TVVLPDLEFASPEMLTS----PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGH 319 (380)
Q Consensus 250 ------~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 319 (380)
....||+.|+|||++.. ...++.++|||||||++|+|++|..||.+.........+..... +......
T Consensus 181 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~ 258 (326)
T 2x7f_A 181 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA--PRLKSKK 258 (326)
T ss_dssp ----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC--CCCSCSC
T ss_pred cCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc--ccCCccc
Confidence 34578999999999862 24678899999999999999999999988887766655544332 2222346
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCCCCCccccccchHHHHHHHHh
Q psy11098 320 ISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASCSEFDTERLLPFSARRKQKFK 376 (380)
Q Consensus 320 ~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (380)
++.++++||.+||..||++|||++++|+||||++..........++.++.+.+.+..
T Consensus 259 ~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (326)
T 2x7f_A 259 WSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLKDHIDRTKKKRG 315 (326)
T ss_dssp SCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTTHHHHHHHHHHHHHHHHHCC-
T ss_pred cCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCccccceeehhhhhhhhhccccc
Confidence 799999999999999999999999999999999876554445556777777765543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=382.47 Aligned_cols=259 Identities=23% Similarity=0.315 Sum_probs=221.4
Q ss_pred hhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCc----hHHHHHHHHHHHhhccCCCcceeeecccccCC
Q psy11098 96 EQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP----QQITRAEYNLLSTLMHAHIPTALALFENAPVP 171 (380)
Q Consensus 96 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~----~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~ 171 (380)
..+.++|++.+.||+|+||.||+|++..+++.||+|++...... ...+.+|+++++.++||||+++++++......
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 87 (311)
T 3ork_A 8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 87 (311)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETT
T ss_pred ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCC
Confidence 35688999999999999999999999999999999999764332 24567899999999999999999988764322
Q ss_pred -CceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc
Q psy11098 172 -GTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS 249 (380)
Q Consensus 172 -~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~ 249 (380)
...|+||||+.|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 88 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 88 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred CcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 23499999999999999998888999999999999999999999999999999999999998 5699999999997543
Q ss_pred ---------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCC
Q psy11098 250 ---------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHI 320 (380)
Q Consensus 250 ---------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 320 (380)
....||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+....+....+.......+......+
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 246 (311)
T ss_dssp --------------CCTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTC
T ss_pred ccccccccccccCcCcccCCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCC
Confidence 23568999999999988 47788999999999999999999999999888877777666655554455678
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 321 SVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 321 s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
+.++.+||.+||..||++||++.++|.|+|+....
T Consensus 247 ~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 247 SADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred CHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 99999999999999999999999999999998543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=382.21 Aligned_cols=254 Identities=29% Similarity=0.390 Sum_probs=210.3
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCc------hHHHHHHHHHHHhhccCCCcceeeecccccCC
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP------QQITRAEYNLLSTLMHAHIPTALALFENAPVP 171 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~------~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~ 171 (380)
..++|++.+.||+|+||.||+|++..+|+.||+|++...... ...+.+|+++++.++|+||+++++++...
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--- 84 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK--- 84 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT---
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC---
Confidence 467899999999999999999999999999999999643221 23567899999999999999999998764
Q ss_pred CceEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc
Q psy11098 172 GTDTIVMQLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS 249 (380)
Q Consensus 172 ~~~~lv~e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~ 249 (380)
+..++||||+.+ +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 85 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (346)
T 1ua2_A 85 SNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163 (346)
T ss_dssp TCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred CceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceecc
Confidence 677999999965 888888664 4689999999999999999999999999999999999998 5699999999997653
Q ss_pred ------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCC--------
Q psy11098 250 ------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPE-------- 315 (380)
Q Consensus 250 ------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~-------- 315 (380)
....||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+....+..........
T Consensus 164 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 243 (346)
T 1ua2_A 164 SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 243 (346)
T ss_dssp SCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred CCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccC
Confidence 345789999999999775568889999999999999999999999988887777665432111111
Q ss_pred ----------------cCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 316 ----------------QCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 316 ----------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
.+..+++++++||++||..||++|||++|+|+||||.+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~ 299 (346)
T 1ua2_A 244 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 299 (346)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred cccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence 1145678999999999999999999999999999998753
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-50 Score=382.81 Aligned_cols=247 Identities=30% Similarity=0.475 Sum_probs=213.1
Q ss_pred hhhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---------chHHHHHHHHHHHhhccCCCcceeeec
Q psy11098 95 QEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---------PQQITRAEYNLLSTLMHAHIPTALALF 165 (380)
Q Consensus 95 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---------~~~~~~~E~~il~~l~h~ni~~i~~~~ 165 (380)
...+.++|++.+.||+|+||+||+|+++.+++.||+|++..... ....+.+|+.+++.++|+||+++++++
T Consensus 19 ~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~ 98 (335)
T 3dls_A 19 EGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF 98 (335)
T ss_dssp TTHHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE
T ss_pred CcccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 34678999999999999999999999999999999999976532 223456799999999999999999998
Q ss_pred ccccCCCceEEEEEecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCC
Q psy11098 166 ENAPVPGTDTIVMQLVHGE-SLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLG 243 (380)
Q Consensus 166 ~~~~~~~~~~lv~e~~~gg-~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG 243 (380)
... +..++||||+.+| +|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||
T Consensus 99 ~~~---~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 99 ENQ---GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp ECS---SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred eeC---CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecc
Confidence 764 6789999999666 9999999888999999999999999999999999999999999999998 5699999999
Q ss_pred Cccccc-----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCC
Q psy11098 244 SSVSVS-----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCG 318 (380)
Q Consensus 244 ~a~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 318 (380)
++.... ....||+.|+|||++.+...++.++|||||||++|+|++|..||.+... ....... ...
T Consensus 176 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~~----~~~ 245 (335)
T 3dls_A 176 SAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEAAIH----PPY 245 (335)
T ss_dssp TCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTTCCC----CSS
T ss_pred cceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhhccC----CCc
Confidence 997654 3457899999999998855558899999999999999999999976321 1111111 123
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 319 HISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 319 ~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
.++.++++||++||..||++|||++++|+||||++.
T Consensus 246 ~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 246 LVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp CCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 479999999999999999999999999999999864
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=371.57 Aligned_cols=257 Identities=33% Similarity=0.511 Sum_probs=230.5
Q ss_pred hhhhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC---CCchHHHHHHHHHHHhhccCCCcceeeecccccC
Q psy11098 94 QQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE---RQPQQITRAEYNLLSTLMHAHIPTALALFENAPV 170 (380)
Q Consensus 94 ~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~ 170 (380)
.+..+.++|++.+.||+|+||.||+|++..+++.||+|++... ......+.+|+++++.++|+||+++++++...
T Consensus 16 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 93 (287)
T 2wei_A 16 FQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS-- 93 (287)
T ss_dssp HTHHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--
T ss_pred HHHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCC--
Confidence 4677889999999999999999999999999999999999643 23456778899999999999999999988763
Q ss_pred CCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC----CeeEEEeCCCcc
Q psy11098 171 PGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG----AVLKLIDLGSSV 246 (380)
Q Consensus 171 ~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~----~~ikl~DFG~a~ 246 (380)
+..++|||++.+++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++. ..+||+|||++.
T Consensus 94 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 94 -SSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp -SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred -CeEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 678999999999999999988889999999999999999999999999999999999999963 269999999987
Q ss_pred ccc-----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCC
Q psy11098 247 SVS-----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHIS 321 (380)
Q Consensus 247 ~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 321 (380)
... ....+|+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+..+....+....+.++...+..++
T Consensus 173 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (287)
T 2wei_A 173 CFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTIS 250 (287)
T ss_dssp TBCCCSSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSC
T ss_pred eecCCCccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcC
Confidence 654 23356889999999876 47889999999999999999999999999888888888888777766677899
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 322 VPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 322 ~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
+++.+||++||..||++|||++|+|+||||++..
T Consensus 251 ~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 284 (287)
T 2wei_A 251 DDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (287)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred HHHHHHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence 9999999999999999999999999999998764
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=387.98 Aligned_cols=254 Identities=25% Similarity=0.366 Sum_probs=210.4
Q ss_pred hhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeeccccc-------
Q psy11098 97 QFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAP------- 169 (380)
Q Consensus 97 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~------- 169 (380)
...++|++.+.||+|+||+||+|++..+|+.||+|++...... ..+|+++++.++|+||+++++++....
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 80 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPP 80 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS---CCHHHHHHTTCCCTTBCCEEEEEEEC--------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch---HHHHHHHHHHcCCCCccchhheeeecCccccccc
Confidence 3467899999999999999999999999999999999654332 236999999999999999999885431
Q ss_pred ----------------------------CCCceEEEEEecCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH
Q psy11098 170 ----------------------------VPGTDTIVMQLVHGESLIQHLC----RQSTITESYICCIIRQLHSALHCLHS 217 (380)
Q Consensus 170 ----------------------------~~~~~~lv~e~~~gg~L~~~l~----~~~~l~e~~~~~i~~qil~al~~lH~ 217 (380)
.....++||||+. ++|.+.+. ....+++..++.++.||+.||.|||+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 159 (383)
T 3eb0_A 81 QPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS 159 (383)
T ss_dssp -----------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred ccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 2234789999996 57766664 35789999999999999999999999
Q ss_pred CCcEeecCCCCcEEEe--CCeeEEEeCCCccccc-----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCC
Q psy11098 218 QQIAHKDIRPENILMN--GAVLKLIDLGSSVSVS-----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGV 290 (380)
Q Consensus 218 ~~iiHrDlKp~NIl~~--~~~ikl~DFG~a~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~ 290 (380)
+||+||||||+|||++ ++.+||+|||+|.... ....+|+.|+|||++.+...++.++|||||||++|+|++|.
T Consensus 160 ~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~ 239 (383)
T 3eb0_A 160 LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239 (383)
T ss_dssp TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSS
T ss_pred CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCC
Confidence 9999999999999997 4689999999998653 35578999999999987666899999999999999999999
Q ss_pred CCCCCCCHHHHHHHHhccc-----------------CCCCCC--------cCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy11098 291 SPFLDESEEETRAHISVAD-----------------YSFPPE--------QCGHISVPARELIGQLLNTHADKRPTAGQL 345 (380)
Q Consensus 291 ~Pf~~~~~~~~~~~i~~~~-----------------~~~~~~--------~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~ 345 (380)
.||.+.+..+....+.... ..++.. ....++.++++||++||..||++|||+.|+
T Consensus 240 ~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~ 319 (383)
T 3eb0_A 240 PLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEA 319 (383)
T ss_dssp CSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 9999988877766654311 111110 123478899999999999999999999999
Q ss_pred Hhccccccc
Q psy11098 346 LQVAWFAEA 354 (380)
Q Consensus 346 L~hpw~~~~ 354 (380)
|+||||++.
T Consensus 320 l~hp~f~~~ 328 (383)
T 3eb0_A 320 MAHPFFDHL 328 (383)
T ss_dssp HTSGGGHHH
T ss_pred hcCHHHHHH
Confidence 999999853
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-50 Score=395.24 Aligned_cols=255 Identities=27% Similarity=0.364 Sum_probs=211.6
Q ss_pred hhhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhc------cCCCcceeeecccc
Q psy11098 95 QEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLM------HAHIPTALALFENA 168 (380)
Q Consensus 95 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~------h~ni~~i~~~~~~~ 168 (380)
.+.+..+|++.+.||+|+||+||+|.+..+++.||||++.........+.+|+++++.++ |+||+.+++.+..
T Consensus 92 ~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~- 170 (429)
T 3kvw_A 92 HDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF- 170 (429)
T ss_dssp TCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE-
T ss_pred CCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc-
Confidence 345678999999999999999999999999999999999776555567778999999885 4477777766655
Q ss_pred cCCCceEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-Ce--eEEEeCC
Q psy11098 169 PVPGTDTIVMQLVHGESLIQHLCRQS--TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AV--LKLIDLG 243 (380)
Q Consensus 169 ~~~~~~~lv~e~~~gg~L~~~l~~~~--~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~--ikl~DFG 243 (380)
.+..++||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. +. +||+|||
T Consensus 171 --~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 171 --RNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp --TTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred --CCeEEEEEecc-CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecc
Confidence 46789999999 579999997653 4999999999999999999999999999999999999984 44 9999999
Q ss_pred Cccccc---ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCC------
Q psy11098 244 SSVSVS---TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPP------ 314 (380)
Q Consensus 244 ~a~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~------ 314 (380)
+|.... ....||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+.......+.
T Consensus 248 ~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~ 326 (429)
T 3kvw_A 248 SSCYEHQRVYTYIQSRFYRAPEVILG-ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDAS 326 (429)
T ss_dssp TCEETTCCCCSSCSCGGGCCHHHHHT-BCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTB
T ss_pred cceecCCcccccCCCCCccChHHHhC-CCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhh
Confidence 997654 45678999999999988 46899999999999999999999999998887766655421100000
Q ss_pred ------------------------------------------C-------cCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy11098 315 ------------------------------------------E-------QCGHISVPARELIGQLLNTHADKRPTAGQL 345 (380)
Q Consensus 315 ------------------------------------------~-------~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~ 345 (380)
. .....++++.+||++||+.||++|||++|+
T Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~ 406 (429)
T 3kvw_A 327 KRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQA 406 (429)
T ss_dssp TTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred hhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHH
Confidence 0 001237789999999999999999999999
Q ss_pred Hhccccccc
Q psy11098 346 LQVAWFAEA 354 (380)
Q Consensus 346 L~hpw~~~~ 354 (380)
|+||||++.
T Consensus 407 L~Hpw~~~~ 415 (429)
T 3kvw_A 407 LRHPWLRRR 415 (429)
T ss_dssp HTSTTTC--
T ss_pred hCChhhccC
Confidence 999999875
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-49 Score=373.43 Aligned_cols=247 Identities=26% Similarity=0.361 Sum_probs=204.7
Q ss_pred hhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCch---HHHHHHHHHHHhh-ccCCCcceeeecccccCC
Q psy11098 96 EQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQ---QITRAEYNLLSTL-MHAHIPTALALFENAPVP 171 (380)
Q Consensus 96 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~---~~~~~E~~il~~l-~h~ni~~i~~~~~~~~~~ 171 (380)
+.+.++|++.+.||+|+||+||+|+++.+++.||||++....... .....|+..+..+ .|+||+++++++...
T Consensus 53 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~--- 129 (311)
T 3p1a_A 53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG--- 129 (311)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET---
T ss_pred chhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC---
Confidence 456789999999999999999999999999999999986543322 2334455555444 899999999998764
Q ss_pred CceEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc
Q psy11098 172 GTDTIVMQLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS 249 (380)
Q Consensus 172 ~~~~lv~e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~ 249 (380)
+..++||||+ +++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 130 ~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 130 GILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp TEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred CEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 6789999999 77998888664 4699999999999999999999999999999999999997 5699999999987654
Q ss_pred -----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHH
Q psy11098 250 -----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPA 324 (380)
Q Consensus 250 -----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 324 (380)
....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+... ...+... ..+......+++++
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~--~~~~~~~~~~~~~l 281 (311)
T 3p1a_A 209 TAGAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQG--YLPPEFTAGLSSEL 281 (311)
T ss_dssp ------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTT--CCCHHHHTTSCHHH
T ss_pred cCCCCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhcc--CCCcccccCCCHHH
Confidence 34568999999999986 578899999999999999999777755432 2222222 12333345689999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhcccccc
Q psy11098 325 RELIGQLLNTHADKRPTAGQLLQVAWFAE 353 (380)
Q Consensus 325 ~~li~~~L~~dP~~Rpt~~e~L~hpw~~~ 353 (380)
.+||.+||+.||++|||++|+|+||||++
T Consensus 282 ~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 282 RSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 99999999999999999999999999986
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=402.73 Aligned_cols=250 Identities=24% Similarity=0.394 Sum_probs=218.9
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC----CCchHHHHHHHHHHHhhccCCCcceeeecccccCCCce
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~ 174 (380)
.++|++.+.||+|+||+||+|+++.+|+.||+|++.+. ......+.+|+++++.++|+||++++.++... +..
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~---~~l 260 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETK---TDL 260 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS---SEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeC---CEE
Confidence 47899999999999999999999999999999999643 23345678899999999999999999988764 678
Q ss_pred EEEEEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc
Q psy11098 175 TIVMQLVHGESLIQHLCRQ----STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS 249 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~----~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~ 249 (380)
|+||||+.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 9999999999999999763 4699999999999999999999999999999999999998 5699999999997653
Q ss_pred ------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHhcccCCCCCCcCCC
Q psy11098 250 ------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDE----SEEETRAHISVADYSFPPEQCGH 319 (380)
Q Consensus 250 ------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~----~~~~~~~~i~~~~~~~~~~~~~~ 319 (380)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+. ...+....+......++ ..
T Consensus 341 ~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p----~~ 415 (543)
T 3c4z_A 341 AGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP----DK 415 (543)
T ss_dssp TTCCCBCCCCSCTTTSCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCC----TT
T ss_pred CCCcccccccCCccccChhhhcC-CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCC----cc
Confidence 23589999999999988 57899999999999999999999999775 34566666666655555 35
Q ss_pred CCHHHHHHHHHhcccCCCCCCC-----HHHHHhcccccccCC
Q psy11098 320 ISVPARELIGQLLNTHADKRPT-----AGQLLQVAWFAEASC 356 (380)
Q Consensus 320 ~s~~~~~li~~~L~~dP~~Rpt-----~~e~L~hpw~~~~~~ 356 (380)
++.++++||++||++||++||+ ++++++||||+...+
T Consensus 416 ~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w 457 (543)
T 3c4z_A 416 FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISW 457 (543)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCH
T ss_pred cCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCH
Confidence 8999999999999999999996 589999999997543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=369.59 Aligned_cols=249 Identities=27% Similarity=0.448 Sum_probs=194.8
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC----CchHHHHHHHHHHHhhccCCCcceeeecccccCCCce
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~ 174 (380)
.++|++.+.||+|+||.||+|++..+|+.||+|++.... .....+.+|+.+++.++|+||+++++++... +..
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 86 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDS---NYV 86 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECS---SEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccC---CeE
Confidence 467999999999999999999999999999999996432 2346678899999999999999999998763 678
Q ss_pred EEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc---
Q psy11098 175 TIVMQLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS--- 249 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~--- 249 (380)
++||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 87 YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp EEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 9999999999999999765 6799999999999999999999999999999999999998 5699999999997653
Q ss_pred ---ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHH
Q psy11098 250 ---TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARE 326 (380)
Q Consensus 250 ---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 326 (380)
....||+.|+|||++.+ ..++.++||||||+++|+|++|..||......+....+....+..+ ..++.++++
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ 241 (278)
T 3cok_A 167 EKHYTLCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMP----SFLSIEAKD 241 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCC----TTSCHHHHH
T ss_pred CcceeccCCCCcCCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCc----cccCHHHHH
Confidence 24568999999999987 4678899999999999999999999988766555555544444333 357999999
Q ss_pred HHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 327 LIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 327 li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
||.+||..||++|||++++|+||||.+..
T Consensus 242 li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 242 LIHQLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp HHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred HHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence 99999999999999999999999998764
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-49 Score=377.89 Aligned_cols=255 Identities=24% Similarity=0.340 Sum_probs=218.8
Q ss_pred hhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCc----hHHHHHHHHHHHhhccCCCcceeeecccccCC
Q psy11098 96 EQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP----QQITRAEYNLLSTLMHAHIPTALALFENAPVP 171 (380)
Q Consensus 96 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~----~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~ 171 (380)
+...++|++.+.||+|+||+||+|++..+++.||||++...... ...+.+|+++++.++|+||+++++++...
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--- 126 (348)
T 1u5q_A 50 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE--- 126 (348)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET---
T ss_pred cchhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC---
Confidence 34567899999999999999999999999999999999754332 24567899999999999999999998764
Q ss_pred CceEEEEEecCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCccccc
Q psy11098 172 GTDTIVMQLVHGESLIQHLC-RQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVS 249 (380)
Q Consensus 172 ~~~~lv~e~~~gg~L~~~l~-~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~ 249 (380)
+..++||||+. |+|.+.+. ....+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||++....
T Consensus 127 ~~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 127 HTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205 (348)
T ss_dssp TEEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred CeEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence 67899999996 67888775 4567999999999999999999999999999999999999984 699999999997664
Q ss_pred --ccccCCCcccCCccccC--CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHH
Q psy11098 250 --TVVLPDLEFASPEMLTS--PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAR 325 (380)
Q Consensus 250 --~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 325 (380)
....||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+.+..+....+...... ......++++++
T Consensus 206 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~ 283 (348)
T 1u5q_A 206 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP--ALQSGHWSEYFR 283 (348)
T ss_dssp SBCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC--CCCCTTSCHHHH
T ss_pred CCCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC--CCCCCCCCHHHH
Confidence 45688999999999852 346788999999999999999999999988877766666544322 222346799999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhcccccccCC
Q psy11098 326 ELIGQLLNTHADKRPTAGQLLQVAWFAEASC 356 (380)
Q Consensus 326 ~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~ 356 (380)
+||.+||+.||++|||++++|+||||.....
T Consensus 284 ~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~ 314 (348)
T 1u5q_A 284 NFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 314 (348)
T ss_dssp HHHHHHTCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred HHHHHHcccChhhCcCHHHHhhChhhhccCC
Confidence 9999999999999999999999999987643
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=365.69 Aligned_cols=250 Identities=27% Similarity=0.435 Sum_probs=215.5
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC----CCchHHHHHHHHHHHhhccCCCcceeeecccccCCCce
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~ 174 (380)
.++|++.+.||+|+||.||+|.+..+|+.||+|++... ......+.+|+.+++.++|+||+++++++... +..
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 86 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP---TDF 86 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS---SEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC---CeE
Confidence 57899999999999999999999999999999999643 23345678899999999999999999988764 678
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc----
Q psy11098 175 TIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS---- 249 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~---- 249 (380)
++||||+.+++|.+++.....+++..++.++.||+.||.|||++||+|+||||+|||++ ++.+||+|||++....
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 166 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 166 (276)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred EEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCcc
Confidence 99999999999999998888899999999999999999999999999999999999998 5699999999987654
Q ss_pred -ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHH
Q psy11098 250 -TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELI 328 (380)
Q Consensus 250 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 328 (380)
....+|+.|+|||++.+....+.++||||||+++|+|++|..||.+.........+.......+ ..++.++.+||
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li 242 (276)
T 2h6d_A 167 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIP----EYLNRSVATLL 242 (276)
T ss_dssp ----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHH
T ss_pred eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCc----hhcCHHHHHHH
Confidence 3456899999999998854456799999999999999999999999888888887776655444 34789999999
Q ss_pred HHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 329 GQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 329 ~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
.+||+.||++|||++|+|+||||++..
T Consensus 243 ~~~l~~~p~~Rps~~~~l~h~~~~~~~ 269 (276)
T 2h6d_A 243 MHMLQVDPLKRATIKDIREHEWFKQDL 269 (276)
T ss_dssp HHHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred HHHccCChhhCCCHHHHHhChhhccCc
Confidence 999999999999999999999998763
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=385.99 Aligned_cols=256 Identities=27% Similarity=0.375 Sum_probs=200.7
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---chHHHHHHHHHHHhhccCCCcceeeecccc---cCC
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLMHAHIPTALALFENA---PVP 171 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~h~ni~~i~~~~~~~---~~~ 171 (380)
+.++|++++.||+|+||.||+|.+..+|+.||||++..... ....+.+|+++++.++|+||+++++++... ...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 46799999999999999999999999999999999975433 235567899999999999999999998653 123
Q ss_pred CceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-
Q psy11098 172 GTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS- 249 (380)
Q Consensus 172 ~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~- 249 (380)
...|+|+|++ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++...
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~ 184 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184 (367)
T ss_dssp CCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred CeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence 5679999999 8899888865 5799999999999999999999999999999999999998 5699999999998664
Q ss_pred --ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCC---------------
Q psy11098 250 --TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSF--------------- 312 (380)
Q Consensus 250 --~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~--------------- 312 (380)
....||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+.......
T Consensus 185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~ 264 (367)
T 2fst_X 185 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 264 (367)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHH
T ss_pred cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHH
Confidence 456789999999999875678899999999999999999999999988776666554321110
Q ss_pred --------CC----CcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 313 --------PP----EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 313 --------~~----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
+. ..+...++++.+||++||..||++|||++|+|+||||++..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~ 319 (367)
T 2fst_X 265 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319 (367)
T ss_dssp HHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence 10 11235688999999999999999999999999999998753
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-49 Score=369.40 Aligned_cols=274 Identities=25% Similarity=0.352 Sum_probs=228.2
Q ss_pred hhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC-CchHHHHHHHHHHHhhccCCCcceeeecccccCCCce
Q psy11098 96 EQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER-QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 96 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~ 174 (380)
....++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+++++.++||||+++++++... +..
T Consensus 15 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 91 (302)
T 2j7t_A 15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHD---GKL 91 (302)
T ss_dssp SCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC----CE
T ss_pred cCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC---CeE
Confidence 346789999999999999999999999999999999996543 3456778899999999999999999988764 678
Q ss_pred EEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccc----
Q psy11098 175 TIVMQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSV---- 248 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~---- 248 (380)
++||||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++...
T Consensus 92 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 92 WIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp EEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred EEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 999999999999998865 56799999999999999999999999999999999999998 569999999987543
Q ss_pred --cccccCCCcccCCcccc----CCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCH
Q psy11098 249 --STVVLPDLEFASPEMLT----SPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISV 322 (380)
Q Consensus 249 --~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 322 (380)
.....||+.|+|||++. ....++.++||||||+++|+|++|..||...+.......+........ .....++.
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 250 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTL-LTPSKWSV 250 (302)
T ss_dssp HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-SSGGGSCH
T ss_pred cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCccc-CCccccCH
Confidence 23457899999999984 235678899999999999999999999998887777666655443221 12245789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhcccccccCCCCCccccccchHHHHHHHHhh
Q psy11098 323 PARELIGQLLNTHADKRPTAGQLLQVAWFAEASCSEFDTERLLPFSARRKQKFKE 377 (380)
Q Consensus 323 ~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (380)
++.+||.+||..||++|||++++|+||||.+.. ..+.++..+++.+.++.|
T Consensus 251 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~----~~~~~~~~~~~~~~~~~e 301 (302)
T 2j7t_A 251 EFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT----SNKALRELVAEAKAEVME 301 (302)
T ss_dssp HHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC----CCHHHHHHHHHHHHHHTC
T ss_pred HHHHHHHHHcccChhhCCCHHHHhcChHHhhhc----cchhHHHHHHHHhhhhhc
Confidence 999999999999999999999999999998764 345677777777766543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-49 Score=365.63 Aligned_cols=250 Identities=23% Similarity=0.328 Sum_probs=210.0
Q ss_pred hhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC---CchHHHHHHHHHHHhh-ccCCCcceeeecccccCCC
Q psy11098 97 QFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER---QPQQITRAEYNLLSTL-MHAHIPTALALFENAPVPG 172 (380)
Q Consensus 97 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~~~~ 172 (380)
.+.++|++.+.||+|+||+||+|++..+++.||+|++.... .....+.+|+.++..+ +||||+++++++... +
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~---~ 84 (289)
T 1x8b_A 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED---D 84 (289)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET---T
T ss_pred cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC---C
Confidence 46789999999999999999999999999999999997542 2345667799999998 999999999988764 6
Q ss_pred ceEEEEEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC--------------
Q psy11098 173 TDTIVMQLVHGESLIQHLCRQ----STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-------------- 234 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~~----~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-------------- 234 (380)
..++||||+.|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 85 HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---------------
T ss_pred eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 789999999999999999764 67999999999999999999999999999999999999962
Q ss_pred ------CeeEEEeCCCccccc--ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Q psy11098 235 ------AVLKLIDLGSSVSVS--TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHIS 306 (380)
Q Consensus 235 ------~~ikl~DFG~a~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~ 306 (380)
..+||+|||++.... ....||+.|+|||++.+...++.++|||||||++|+|++|.+++..... ...+.
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~~~ 241 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHEIR 241 (289)
T ss_dssp -----CCCEEECCCTTCEETTCSCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---HHHHH
T ss_pred cccCCceEEEEcccccccccCCccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---HHHHH
Confidence 268999999998764 4556899999999998755666799999999999999999888755432 23333
Q ss_pred cccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 307 VADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 307 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
..... .....+++++.+||++||..||++|||+.|+|+||||++..
T Consensus 242 ~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 287 (289)
T 1x8b_A 242 QGRLP---RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 287 (289)
T ss_dssp TTCCC---CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred cCCCC---CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence 33221 12246899999999999999999999999999999998764
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=380.00 Aligned_cols=253 Identities=25% Similarity=0.410 Sum_probs=215.1
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCc---hHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP---QQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
.++|++.+.||+|+||.||+|++..+|+.||+|++...... ...+.+|+++++.++|+||+++++++... +..+
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~ 100 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKK---KRWY 100 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET---TEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecC---CEEE
Confidence 57899999999999999999999999999999998655433 34567899999999999999999998764 6789
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-----
Q psy11098 176 IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS----- 249 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~----- 249 (380)
+||||+.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 101 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 180 (331)
T 4aaa_A 101 LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV 180 (331)
T ss_dssp EEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred EEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccc
Confidence 9999999999988887778899999999999999999999999999999999999998 5699999999997543
Q ss_pred -ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCC-----------------
Q psy11098 250 -TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYS----------------- 311 (380)
Q Consensus 250 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~----------------- 311 (380)
....||+.|+|||++.+...++.++|||||||++|+|++|..||.+....+....+......
T Consensus 181 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (331)
T 4aaa_A 181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAG 260 (331)
T ss_dssp ---CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTT
T ss_pred cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccccc
Confidence 34578999999999987557889999999999999999999999998877766555322111
Q ss_pred --CCC--------CcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 312 --FPP--------EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 312 --~~~--------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
.+. ..+..+++++.+||.+||..||++|||++|+|+||||+..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 261 VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp CCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred ccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 110 1123578999999999999999999999999999999865
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=380.42 Aligned_cols=255 Identities=30% Similarity=0.474 Sum_probs=191.1
Q ss_pred hhhhceeeee-eecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccC-CCce
Q psy11098 97 QFEHRYEELE-RLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPV-PGTD 174 (380)
Q Consensus 97 ~~~~~y~~~~-~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~-~~~~ 174 (380)
.+.++|++.+ .||+|+||+||+|+++.+++.||+|++.... ....+....++.+.|+||+++++++..... ....
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP---KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH---HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 4678999965 5999999999999999999999999996532 222334445677899999999999876433 2457
Q ss_pred EEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC----CeeEEEeCCCcccc
Q psy11098 175 TIVMQLVHGESLIQHLCRQS--TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG----AVLKLIDLGSSVSV 248 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~~--~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~----~~ikl~DFG~a~~~ 248 (380)
++||||+.||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||++...
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~ 181 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET 181 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceec
Confidence 99999999999999997653 6999999999999999999999999999999999999973 36999999999765
Q ss_pred c----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHhcccCCCCCCcCCCC
Q psy11098 249 S----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEET----RAHISVADYSFPPEQCGHI 320 (380)
Q Consensus 249 ~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~ 320 (380)
. ....+|+.|+|||++.+ ..++.++||||||+++|+|++|..||.+...... ...+......++...+..+
T Consensus 182 ~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (336)
T 3fhr_A 182 TQNALQTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEV 260 (336)
T ss_dssp -----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTC
T ss_pred cccccccCCCCcCccChhhhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccC
Confidence 4 45577999999999977 4678899999999999999999999977665443 3344445556666666789
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 321 SVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 321 s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
+.++++||++||..||++|||++|+|+||||++..
T Consensus 261 ~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 261 SEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 99999999999999999999999999999998753
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-49 Score=368.11 Aligned_cols=251 Identities=27% Similarity=0.456 Sum_probs=223.8
Q ss_pred hhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC----CchHHHHHHHHHHHhhccCCCcceeeecccccCCC
Q psy11098 97 QFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPG 172 (380)
Q Consensus 97 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~ 172 (380)
...++|++.+.||+|+||.||+|.+..+++.||+|++.... ...+.+.+|+.+++.+.|+||+++++++... +
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~ 88 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN---D 88 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS---S
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccC---C
Confidence 45689999999999999999999999999999999996542 2345677899999999999999999998763 6
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc--
Q psy11098 173 TDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS-- 249 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~-- 249 (380)
..++||||+.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 89 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 89 FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 7899999999999999998888999999999999999999999999999999999999998 4699999999997653
Q ss_pred ----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHH
Q psy11098 250 ----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAR 325 (380)
Q Consensus 250 ----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 325 (380)
....||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+....+....+......++. .++.++.
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~ 243 (294)
T 2rku_A 169 GERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAA 243 (294)
T ss_dssp TCCBCCCCSCCSSCCHHHHTT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT----TSCHHHH
T ss_pred ccccccccCCCCcCCcchhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCcc----ccCHHHH
Confidence 34568999999999987 46788999999999999999999999999888888777776655543 5789999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 326 ELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 326 ~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
+||++||+.||++|||++|+|+||||.+..
T Consensus 244 ~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 273 (294)
T 2rku_A 244 SLIQKMLQTDPTARPTINELLNDEFFTSGY 273 (294)
T ss_dssp HHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred HHHHHHcccChhhCcCHHHHhhChheecCC
Confidence 999999999999999999999999998754
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=365.73 Aligned_cols=253 Identities=21% Similarity=0.343 Sum_probs=216.3
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC--CCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE--RQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
+.++|++.+.||+|+||.||+|+++.+++.||+|++... ....+.+.+|+.+++.++|+||+++++++... +..+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~ 81 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG---NIQY 81 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEET---TEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcC---CEEE
Confidence 568999999999999999999999999999999999643 23456778899999999999999999988763 6779
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-----
Q psy11098 176 IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS----- 249 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~----- 249 (380)
+||||+.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 9999999999999998777899999999999999999999999999999999999998 4699999999987542
Q ss_pred ---ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhcccCCCCCCcCCCCCHHHH
Q psy11098 250 ---TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEE-ETRAHISVADYSFPPEQCGHISVPAR 325 (380)
Q Consensus 250 ---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~~~ 325 (380)
....||+.|+|||++.+...++.++||||||+++|+|++|..||.+.... .....+.......+ .+..++.+++
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 239 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN--PWKKIDSAPL 239 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTST--TGGGSCHHHH
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccC--chhhcCHHHH
Confidence 34578999999999987545577899999999999999999999876543 22233332222222 2346899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 326 ELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 326 ~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
+||++||..||++|||++|+|+||||++..
T Consensus 240 ~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 240 ALLHKILVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence 999999999999999999999999998763
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-49 Score=376.60 Aligned_cols=250 Identities=28% Similarity=0.455 Sum_probs=223.4
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC----CchHHHHHHHHHHHhhccCCCcceeeecccccCCCc
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGT 173 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~ 173 (380)
..++|.+.+.||+|+||.||+|++..+++.||+|++.... ...+.+.+|+.+++.++|+||+++++++... +.
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~ 115 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN---DF 115 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS---SE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC---Ce
Confidence 4678999999999999999999999999999999996542 2345677899999999999999999998764 67
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc---
Q psy11098 174 DTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS--- 249 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~--- 249 (380)
.++||||+.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 116 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 116 VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195 (335)
T ss_dssp EEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence 899999999999999998888999999999999999999999999999999999999998 4689999999997653
Q ss_pred ---ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHH
Q psy11098 250 ---TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARE 326 (380)
Q Consensus 250 ---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 326 (380)
....||+.|+|||++.+ ..++.++||||||+++|+|++|..||......+....+....+.++. .++.++.+
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~ 270 (335)
T 2owb_A 196 ERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAAS 270 (335)
T ss_dssp CCBCCCCSCCSSCCHHHHHT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCT----TSCHHHHH
T ss_pred ccccccCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCc----cCCHHHHH
Confidence 34578999999999987 46788999999999999999999999998888888777776665543 57899999
Q ss_pred HHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 327 LIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 327 li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
||++||..||++|||++|+|+||||....
T Consensus 271 li~~~l~~dp~~Rps~~ell~~~~~~~~~ 299 (335)
T 2owb_A 271 LIQKMLQTDPTARPTINELLNDEFFTSGY 299 (335)
T ss_dssp HHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred HHHHHccCChhHCcCHHHHhcCccccCCC
Confidence 99999999999999999999999998754
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=373.38 Aligned_cols=256 Identities=24% Similarity=0.396 Sum_probs=215.1
Q ss_pred hhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccc--------
Q psy11098 97 QFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENA-------- 168 (380)
Q Consensus 97 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~-------- 168 (380)
.+.++|++.+.||+|+||.||+|++..+++.||+|++.........+.+|+.+++.++|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred cccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 367899999999999999999999999999999999976544556778899999999999999999887542
Q ss_pred --cCCCceEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCC
Q psy11098 169 --PVPGTDTIVMQLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGS 244 (380)
Q Consensus 169 --~~~~~~~lv~e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~ 244 (380)
...+..++||||+.|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 162 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGL 162 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcc
Confidence 1235679999999999999999754 4688999999999999999999999999999999999998 56899999999
Q ss_pred ccccc--------------------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC-CHHHHHH
Q psy11098 245 SVSVS--------------------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDE-SEEETRA 303 (380)
Q Consensus 245 a~~~~--------------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~-~~~~~~~ 303 (380)
+.... ....||+.|+|||++.+...++.++|||||||++|+|++ ||... ...+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~ 239 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILK 239 (303)
T ss_dssp CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHH
Confidence 87542 234679999999999875578899999999999999998 56433 3445556
Q ss_pred HHhcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 304 HISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 304 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
.+......++.......+..+++||++||..||.+|||++++|+||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (303)
T 1zy4_A 240 KLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKH 291 (303)
T ss_dssp HHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCC
T ss_pred hccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCC
Confidence 6666666666666667888999999999999999999999999999997653
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=375.30 Aligned_cols=251 Identities=22% Similarity=0.339 Sum_probs=205.5
Q ss_pred hhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC--CchHHHHHHHHHHHhhccCCCcceeeecccccC----
Q psy11098 97 QFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER--QPQQITRAEYNLLSTLMHAHIPTALALFENAPV---- 170 (380)
Q Consensus 97 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~---- 170 (380)
.+.++|++.+.||+|+||+||+|+++.+|+.||||++.... ...+.+.+|+++++.++||||+++++++.....
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 36789999999999999999999999999999999997543 345678899999999999999999998754321
Q ss_pred --------------------------------------------------CCceEEEEEecCCCCHHHHHHhcC---CCC
Q psy11098 171 --------------------------------------------------PGTDTIVMQLVHGESLIQHLCRQS---TIT 197 (380)
Q Consensus 171 --------------------------------------------------~~~~~lv~e~~~gg~L~~~l~~~~---~l~ 197 (380)
....++||||+.|++|.+++.... ..+
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 162 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE 162 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence 123799999999999999997753 356
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccccc------------------cccCCCcc
Q psy11098 198 ESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVST------------------VVLPDLEF 258 (380)
Q Consensus 198 e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~~------------------~~~gt~~y 258 (380)
+..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..... ...||+.|
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred hHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 667899999999999999999999999999999998 56999999999976532 24689999
Q ss_pred cCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhcccCCCC
Q psy11098 259 ASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHADK 338 (380)
Q Consensus 259 ~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 338 (380)
+|||++.+ ..++.++|||||||++|+|++|..|+.. .......+... .++ ......++++++||.+||+.||++
T Consensus 243 ~aPE~~~~-~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~--~~~-~~~~~~~~~~~~li~~~l~~~p~~ 316 (332)
T 3qd2_B 243 MSPEQIHG-NNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNL--KFP-LLFTQKYPQEHMMVQDMLSPSPTE 316 (332)
T ss_dssp SCHHHHHC-CCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTT--CCC-HHHHHHCHHHHHHHHHHHCSSGGG
T ss_pred cChHHhcC-CCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhcc--CCC-cccccCChhHHHHHHHHccCCCCc
Confidence 99999988 4778999999999999999999776522 12222222222 222 222345788999999999999999
Q ss_pred CCCHHHHHhcccccc
Q psy11098 339 RPTAGQLLQVAWFAE 353 (380)
Q Consensus 339 Rpt~~e~L~hpw~~~ 353 (380)
|||++|+|+||||++
T Consensus 317 Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 317 RPEATDIIENAIFEN 331 (332)
T ss_dssp SCCHHHHHHSTTCCC
T ss_pred CCCHHHHhhchhhhc
Confidence 999999999999975
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-49 Score=376.43 Aligned_cols=251 Identities=21% Similarity=0.307 Sum_probs=208.2
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCc---hHHHHHHHHHHHhhcc--CCCcceeeecccccCCC
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP---QQITRAEYNLLSTLMH--AHIPTALALFENAPVPG 172 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~E~~il~~l~h--~ni~~i~~~~~~~~~~~ 172 (380)
..++|++.+.||+|+||.||+|.+. +++.||+|++...... ...+.+|+.+++.+.| +||+++++++... +
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~---~ 82 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD---Q 82 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS---S
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC---C
Confidence 3678999999999999999999974 6889999999755433 2566889999999987 8999999988764 6
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeCCeeEEEeCCCccccc---
Q psy11098 173 TDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGAVLKLIDLGSSVSVS--- 249 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~~~ikl~DFG~a~~~~--- 249 (380)
..++|||+ .+++|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||++++.+||+|||++....
T Consensus 83 ~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 83 YIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp EEEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTEEEECCCSSSCCC----
T ss_pred EEEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEECCcEEEeecccccccCccc
Confidence 78999995 58999999999889999999999999999999999999999999999999999999999999997653
Q ss_pred -----ccccCCCcccCCccccC----------CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhcccCCCC
Q psy11098 250 -----TVVLPDLEFASPEMLTS----------PATAGPSTDMWSLGVLLYILLSGVSPFLDESEE-ETRAHISVADYSFP 313 (380)
Q Consensus 250 -----~~~~gt~~y~aPE~~~~----------~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~-~~~~~i~~~~~~~~ 313 (380)
....||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+.... .....+.......
T Consensus 162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~- 240 (343)
T 3dbq_A 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI- 240 (343)
T ss_dssp --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC-
T ss_pred ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCccc-
Confidence 34578999999999853 246778999999999999999999999875432 3333433332222
Q ss_pred CCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 314 PEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 314 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
......+.++.+||.+||..||++|||+.|+|+||||+...
T Consensus 241 -~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 281 (343)
T 3dbq_A 241 -EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 281 (343)
T ss_dssp -CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred -CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence 12234678999999999999999999999999999998643
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-49 Score=381.03 Aligned_cols=254 Identities=24% Similarity=0.355 Sum_probs=211.8
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCc---hHHHHHHHHHHHhhccCCCcceeeecccccCC---
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP---QQITRAEYNLLSTLMHAHIPTALALFENAPVP--- 171 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~--- 171 (380)
+.++|.+.+.||+|+||+||+|+++.+|+.||+|++...... ...+.+|+.+++.++|+||+++++++......
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 467999999999999999999999999999999999764433 35667899999999999999999998764321
Q ss_pred CceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-
Q psy11098 172 GTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS- 249 (380)
Q Consensus 172 ~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~- 249 (380)
...++||||+. ++|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 196 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 196 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred eeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence 12399999995 68887773 4599999999999999999999999999999999999998 5689999999998664
Q ss_pred --ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCC--------------
Q psy11098 250 --TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFP-------------- 313 (380)
Q Consensus 250 --~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~-------------- 313 (380)
....||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+.......+
T Consensus 197 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 276 (371)
T 4exu_A 197 EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKS 276 (371)
T ss_dssp ---CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHH
T ss_pred CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhh
Confidence 4567899999999998756788999999999999999999999999887776666543211110
Q ss_pred ---------C----CcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 314 ---------P----EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 314 ---------~----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
. ..+..+++++++||++||+.||++|||++|+|+||||...
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 277 YIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp HHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred hhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 0 1124578999999999999999999999999999999864
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-49 Score=378.01 Aligned_cols=259 Identities=23% Similarity=0.321 Sum_probs=204.5
Q ss_pred hhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccC----C
Q psy11098 96 EQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPV----P 171 (380)
Q Consensus 96 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~----~ 171 (380)
....++|++.+.||+|+||+||+|+++.+|+.||||++...........+|++.+..++|+||+++++++..... .
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 98 (360)
T 3e3p_A 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD 98 (360)
T ss_dssp HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence 344678999999999999999999999999999999997665555566778888999999999999999865422 1
Q ss_pred CceEEEEEecCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHH--HCCcEeecCCCCcEEEe--CCeeEEEeCC
Q psy11098 172 GTDTIVMQLVHGESLIQHL----CRQSTITESYICCIIRQLHSALHCLH--SQQIAHKDIRPENILMN--GAVLKLIDLG 243 (380)
Q Consensus 172 ~~~~lv~e~~~gg~L~~~l----~~~~~l~e~~~~~i~~qil~al~~lH--~~~iiHrDlKp~NIl~~--~~~ikl~DFG 243 (380)
...++||||+.+ +|...+ .....+++..++.++.||+.||.||| ++||+||||||+|||++ ++.+||+|||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg 177 (360)
T 3e3p_A 99 IYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFG 177 (360)
T ss_dssp EEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCT
T ss_pred eeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCC
Confidence 236899999976 444443 34567999999999999999999999 99999999999999998 4699999999
Q ss_pred Cccccc-----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCC-----
Q psy11098 244 SSVSVS-----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFP----- 313 (380)
Q Consensus 244 ~a~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~----- 313 (380)
++.... ....||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+.......+.......+
T Consensus 178 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (360)
T 3e3p_A 178 SAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLR 257 (360)
T ss_dssp TCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred CceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHH
Confidence 998654 3457899999999997756689999999999999999999999999888777666643211100
Q ss_pred -----------------------CCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 314 -----------------------PEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 314 -----------------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
.......++++++||.+||+.||++|||+.|+|+||||++..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 258 KLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp HHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred hcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 001122567899999999999999999999999999999763
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-50 Score=386.18 Aligned_cols=258 Identities=27% Similarity=0.448 Sum_probs=215.4
Q ss_pred hhceeeeeeecccCCeEEEEEEEc---CCCcEEEEEEecCCC-----CchHHHHHHHHHHHhh-ccCCCcceeeeccccc
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDR---GTGQLVALKQIPRER-----QPQQITRAEYNLLSTL-MHAHIPTALALFENAP 169 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~---~~~~~vAvK~~~~~~-----~~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~ 169 (380)
.++|++.+.||+|+||+||+|++. .+++.||||+++... .....+.+|+++++.+ .|+||++++.++...
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~- 131 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE- 131 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC-
Confidence 468999999999999999999984 589999999986432 2335567799999999 599999999988764
Q ss_pred CCCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccc
Q psy11098 170 VPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSV 248 (380)
Q Consensus 170 ~~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~ 248 (380)
+..++||||+.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++...
T Consensus 132 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 132 --TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209 (355)
T ss_dssp --TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred --ceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence 67899999999999999998888999999999999999999999999999999999999998 569999999998754
Q ss_pred c-------ccccCCCcccCCccccCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHhcccCCCCCCc
Q psy11098 249 S-------TVVLPDLEFASPEMLTSP-ATAGPSTDMWSLGVLLYILLSGVSPFLDE----SEEETRAHISVADYSFPPEQ 316 (380)
Q Consensus 249 ~-------~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~~lltg~~Pf~~~----~~~~~~~~i~~~~~~~~~~~ 316 (380)
. ...+||+.|+|||++.+. ..++.++|||||||++|+|++|..||... ........+......++
T Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--- 286 (355)
T 1vzo_A 210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP--- 286 (355)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC---
T ss_pred ccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCC---
Confidence 2 345789999999999862 35688999999999999999999999653 33444444444433333
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCC-----CHHHHHhcccccccCCCCCcccc
Q psy11098 317 CGHISVPARELIGQLLNTHADKRP-----TAGQLLQVAWFAEASCSEFDTER 363 (380)
Q Consensus 317 ~~~~s~~~~~li~~~L~~dP~~Rp-----t~~e~L~hpw~~~~~~~~~~~~~ 363 (380)
..++..+++||++||..||++|| |++|+++||||++..+..+...+
T Consensus 287 -~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l~~~~ 337 (355)
T 1vzo_A 287 -QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKK 337 (355)
T ss_dssp -TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTC
T ss_pred -cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhHhhhcc
Confidence 45899999999999999999999 99999999999987554444433
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-49 Score=382.60 Aligned_cols=250 Identities=21% Similarity=0.299 Sum_probs=210.2
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCc---hHHHHHHHHHHHhhc--cCCCcceeeecccccCCCc
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP---QQITRAEYNLLSTLM--HAHIPTALALFENAPVPGT 173 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~E~~il~~l~--h~ni~~i~~~~~~~~~~~~ 173 (380)
..+|++.+.||+|+||+||+|.+.. ++.||||++...... ...+.+|+.+++.+. |+||+++++++... +.
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~---~~ 130 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD---QY 130 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS---SE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC---CE
Confidence 4579999999999999999999765 899999999755432 356788999999997 49999999887764 56
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeCCeeEEEeCCCccccc----
Q psy11098 174 DTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGAVLKLIDLGSSVSVS---- 249 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~~~ikl~DFG~a~~~~---- 249 (380)
.|+||| +.+++|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||++++.+||+|||++....
T Consensus 131 ~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 131 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp EEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESSSCEEECCCSSSCCC-----
T ss_pred EEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEECCeEEEEecCccccccCCCc
Confidence 899999 568999999998889999999999999999999999999999999999999998999999999997653
Q ss_pred ----ccccCCCcccCCccccCC----------CCCCCcccHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhcccCCCCC
Q psy11098 250 ----TVVLPDLEFASPEMLTSP----------ATAGPSTDMWSLGVLLYILLSGVSPFLDESE-EETRAHISVADYSFPP 314 (380)
Q Consensus 250 ----~~~~gt~~y~aPE~~~~~----------~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~-~~~~~~i~~~~~~~~~ 314 (380)
...+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+... ......+......+..
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 289 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 289 (390)
T ss_dssp ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCC
T ss_pred cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCC
Confidence 345799999999998651 3578899999999999999999999987543 3444555444433322
Q ss_pred CcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 315 EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 315 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
. ...+.++++||++||..||++|||+.|+|+||||+...
T Consensus 290 ~--~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 290 P--DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp C--CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred C--ccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 2 33588999999999999999999999999999998653
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=384.67 Aligned_cols=253 Identities=26% Similarity=0.393 Sum_probs=208.9
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccC---CCceE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPV---PGTDT 175 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~---~~~~~ 175 (380)
..+|++.+.||+|+||+||+|+++.+|+.||||++..... ...+|+++++.++|+||++++++|..... ....+
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 4579999999999999999999999999999999965432 23469999999999999999988754321 12357
Q ss_pred EEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-C-CeeEEEeCCCccccc
Q psy11098 176 IVMQLVHGESLIQHLCR----QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-G-AVLKLIDLGSSVSVS 249 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~----~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~-~~ikl~DFG~a~~~~ 249 (380)
+||||+.+ +|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++ + +.+||+|||+++...
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~ 208 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence 89999964 66665542 56799999999999999999999999999999999999998 3 478999999998653
Q ss_pred -----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc----------------
Q psy11098 250 -----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVA---------------- 308 (380)
Q Consensus 250 -----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~---------------- 308 (380)
....||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 209 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~ 288 (420)
T 1j1b_A 209 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 288 (420)
T ss_dssp TTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCC
T ss_pred cCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhh
Confidence 34578999999999987557899999999999999999999999998876666555431
Q ss_pred -cCCCCCC--------cCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 309 -DYSFPPE--------QCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 309 -~~~~~~~--------~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
.+.++.. ....++.++++||++||..||++|||+.|+|+||||.+..
T Consensus 289 ~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 289 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp CCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 1122211 1135689999999999999999999999999999998653
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=365.37 Aligned_cols=252 Identities=22% Similarity=0.295 Sum_probs=213.4
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---chHHHHHHHHHHHhhccCCCcceeeeccccc-CCCce
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLMHAHIPTALALFENAP-VPGTD 174 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~-~~~~~ 174 (380)
...|++.+.||+|+||.||+|.+..++..||+|++..... ....+.+|+.+++.++|+||+++++++.... .....
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 4568999999999999999999999999999999964332 3456788999999999999999999886532 23567
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeecCCCCcEEEe--CCeeEEEeCCCccccc-
Q psy11098 175 TIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQ--IAHKDIRPENILMN--GAVLKLIDLGSSVSVS- 249 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~--iiHrDlKp~NIl~~--~~~ikl~DFG~a~~~~- 249 (380)
++||||+.+++|.+++.....+++..++.++.||+.||.|||++| |+||||||+|||++ ++.+||+|||++....
T Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~ 184 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence 999999999999999988889999999999999999999999999 99999999999997 4699999999987553
Q ss_pred ---ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhcccCCCCCCcCCCCCHHHH
Q psy11098 250 ---TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESE-EETRAHISVADYSFPPEQCGHISVPAR 325 (380)
Q Consensus 250 ---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~s~~~~ 325 (380)
....||+.|+|||++.+ .++.++||||||+++|+|++|..||.+... ......+..... +.......++++.
T Consensus 185 ~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~ 260 (290)
T 1t4h_A 185 SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--PASFDKVAIPEVK 260 (290)
T ss_dssp TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--CGGGGGCCCHHHH
T ss_pred cccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC--ccccCCCCCHHHH
Confidence 34678999999999875 478899999999999999999999988544 444444433221 2222345688999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 326 ELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 326 ~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
+||.+||..||++|||++|+|+||||++.
T Consensus 261 ~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 261 EIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred HHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 99999999999999999999999999864
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-49 Score=375.10 Aligned_cols=254 Identities=24% Similarity=0.374 Sum_probs=212.8
Q ss_pred hhhhhceeeeeeecccCCeEEEEEEE-cCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCC------Ccceeeecccc
Q psy11098 96 EQFEHRYEELERLGNGRFCTVRKARD-RGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAH------IPTALALFENA 168 (380)
Q Consensus 96 ~~~~~~y~~~~~LG~G~fg~V~~~~~-~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~n------i~~i~~~~~~~ 168 (380)
+.+.++|++.+.||+|+||+||+|.+ ..+++.||+|++.........+.+|+++++.++|++ ++++++++..
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~- 88 (339)
T 1z57_A 10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH- 88 (339)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE-
T ss_pred CCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc-
Confidence 45678999999999999999999998 568899999999765555567888999999998775 6777777665
Q ss_pred cCCCceEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC------------
Q psy11098 169 PVPGTDTIVMQLVHGESLIQHLCRQS--TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG------------ 234 (380)
Q Consensus 169 ~~~~~~~lv~e~~~gg~L~~~l~~~~--~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~------------ 234 (380)
.+..++||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 89 --~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 89 --HGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp --TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----
T ss_pred --CCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccc
Confidence 46789999999 999999997764 6899999999999999999999999999999999999963
Q ss_pred --------CeeEEEeCCCccccc---ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy11098 235 --------AVLKLIDLGSSVSVS---TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRA 303 (380)
Q Consensus 235 --------~~ikl~DFG~a~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~ 303 (380)
+.+||+|||++.... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+...
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 244 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA 244 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHH
T ss_pred cccccccCCCceEeeCcccccCccccccccCCccccChHHhhC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 369999999997654 45678999999999987 477899999999999999999999999887776655
Q ss_pred HHhcccCCCCCC----------------------------------------cCCCCCHHHHHHHHHhcccCCCCCCCHH
Q psy11098 304 HISVADYSFPPE----------------------------------------QCGHISVPARELIGQLLNTHADKRPTAG 343 (380)
Q Consensus 304 ~i~~~~~~~~~~----------------------------------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ 343 (380)
.+.......+.. .....++++.+||++||..||++|||++
T Consensus 245 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ 324 (339)
T 1z57_A 245 MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLR 324 (339)
T ss_dssp HHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHH
Confidence 543322111110 0012346788999999999999999999
Q ss_pred HHHhccccccc
Q psy11098 344 QLLQVAWFAEA 354 (380)
Q Consensus 344 e~L~hpw~~~~ 354 (380)
|+|+||||+..
T Consensus 325 ell~hp~f~~~ 335 (339)
T 1z57_A 325 EALKHPFFDLL 335 (339)
T ss_dssp HHTTSGGGGGG
T ss_pred HHhcCHHHHHH
Confidence 99999999865
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=370.22 Aligned_cols=251 Identities=24% Similarity=0.362 Sum_probs=209.2
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhc-cCCCcceeeecccccCCCceEEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLM-HAHIPTALALFENAPVPGTDTIV 177 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~-h~ni~~i~~~~~~~~~~~~~~lv 177 (380)
.++|++.+.||+|+||+||+|++..+++.||+|++... ....+.+|+.+++.++ |+||+++++++.... ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~-~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPV-SRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTT-TCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc--chHHHHHHHHHHHHcCCCCCEEEeeeeeccCC-CCceEEE
Confidence 57899999999999999999999999999999999643 3466788999999997 999999999987532 3567999
Q ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CC-eeEEEeCCCccccc-----c
Q psy11098 178 MQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GA-VLKLIDLGSSVSVS-----T 250 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~-~ikl~DFG~a~~~~-----~ 250 (380)
|||+.+++|.+++. .+++..++.++.||+.||.|||++||+||||||+|||++ ++ .+||+|||++.... .
T Consensus 112 ~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~ 188 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN 188 (330)
T ss_dssp EECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCC
T ss_pred EeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCccc
Confidence 99999999988874 489999999999999999999999999999999999998 44 89999999997553 3
Q ss_pred cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHH-------------hcccCCCC---
Q psy11098 251 VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDE-SEEETRAHI-------------SVADYSFP--- 313 (380)
Q Consensus 251 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~-~~~~~~~~i-------------~~~~~~~~--- 313 (380)
...+|+.|+|||++.+...++.++|||||||++|+|++|..||... ...+....+ ........
T Consensus 189 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (330)
T 3nsz_A 189 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF 268 (330)
T ss_dssp SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHH
T ss_pred cccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccch
Confidence 5578999999999987567899999999999999999999999543 332222221 11111111
Q ss_pred -----------------CCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 314 -----------------PEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 314 -----------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
......+++++++||++||+.||++|||++|+|+||||++..
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 269 NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp HHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred hhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 111223799999999999999999999999999999998764
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-49 Score=380.58 Aligned_cols=253 Identities=23% Similarity=0.327 Sum_probs=204.4
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCc---hHHHHHHHHHHHhhccCCCcceeeeccccc---CC
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP---QQITRAEYNLLSTLMHAHIPTALALFENAP---VP 171 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~E~~il~~l~h~ni~~i~~~~~~~~---~~ 171 (380)
+.++|++.+.||+|+||.||+|++..+++.||||++...... ...+.+|+.+++.++|+||+++++++.... ..
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 357899999999999999999999999999999999754332 345678999999999999999999987542 12
Q ss_pred CceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-
Q psy11098 172 GTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS- 249 (380)
Q Consensus 172 ~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~- 249 (380)
...++||||+. ++|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 103 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 179 (371)
T 2xrw_A 103 QDVYIVMELMD-ANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179 (371)
T ss_dssp CEEEEEEECCS-EEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred cceEEEEEcCC-CCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence 36799999995 57888885 4599999999999999999999999999999999999998 5699999999997654
Q ss_pred ----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCc---------
Q psy11098 250 ----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQ--------- 316 (380)
Q Consensus 250 ----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~--------- 316 (380)
....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+........++.
T Consensus 180 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 258 (371)
T 2xrw_A 180 SFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR 258 (371)
T ss_dssp ----------CTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHH
T ss_pred ccccCCceecCCccCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHH
Confidence 34578999999999988 4788999999999999999999999999888777666654321110000
Q ss_pred ----------------------C-------CCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 317 ----------------------C-------GHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 317 ----------------------~-------~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
. ...+.++++||++||..||++|||++|+|+||||+..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 325 (371)
T 2xrw_A 259 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 325 (371)
T ss_dssp HHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence 0 0115678999999999999999999999999999853
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-49 Score=380.03 Aligned_cols=257 Identities=24% Similarity=0.333 Sum_probs=217.9
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
..++|++.+.||+|+||+||+|.+..+++.||+|++..... ....+.+|+.+++.++|+||+++++++... +..+
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~ 107 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD---GEIS 107 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET---TEEE
T ss_pred ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC---CEEE
Confidence 46789999999999999999999999999999999976533 235678899999999999999999988764 6789
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeecCCCCcEEEe-CCeeEEEeCCCccccc----
Q psy11098 176 IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQ-QIAHKDIRPENILMN-GAVLKLIDLGSSVSVS---- 249 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~-~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~---- 249 (380)
+||||+.|++|.+++.....+++..+..++.||+.||.|||++ ||+||||||+|||++ ++.+||+|||++....
T Consensus 108 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 187 (360)
T 3eqc_A 108 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA 187 (360)
T ss_dssp EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC-
T ss_pred EEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccccc
Confidence 9999999999999999888999999999999999999999996 999999999999998 5699999999997543
Q ss_pred ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------------------------
Q psy11098 250 TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHI------------------------ 305 (380)
Q Consensus 250 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i------------------------ 305 (380)
....||+.|+|||++.+ ..++.++|||||||++|+|++|..||......+....+
T Consensus 188 ~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (360)
T 3eqc_A 188 NSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNK 266 (360)
T ss_dssp ---CCCCTTCCHHHHTT-CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------------
T ss_pred cCCCCCCCeECHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccc
Confidence 45688999999999988 47788999999999999999999999877655443222
Q ss_pred ------------------hcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCCCCCc
Q psy11098 306 ------------------SVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASCSEFD 360 (380)
Q Consensus 306 ------------------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~~~~~ 360 (380)
.... .+......++.++++||++||..||++|||++|+|+||||++.....++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~ 337 (360)
T 3eqc_A 267 FGMDSRPPMAIFELLDYIVNEP--PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVD 337 (360)
T ss_dssp -------CCCHHHHHHHHHHSC--CCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHSCCC
T ss_pred cccCCCCcccchhhhhHHhccC--CCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHhhhh
Confidence 1111 1111223478999999999999999999999999999999986554443
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=387.16 Aligned_cols=260 Identities=22% Similarity=0.304 Sum_probs=198.6
Q ss_pred hhhhhhhceeee-eeecccCCeEEEEEEEc--CCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccC
Q psy11098 94 QQEQFEHRYEEL-ERLGNGRFCTVRKARDR--GTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPV 170 (380)
Q Consensus 94 ~~~~~~~~y~~~-~~LG~G~fg~V~~~~~~--~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~ 170 (380)
..+.+.+.|++. ++||+|+||+||+|+++ .+++.||+|++...... ..+.+|+.+|+.++|+||+++++++... .
T Consensus 14 ~~~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~E~~~l~~l~hpniv~~~~~~~~~-~ 91 (405)
T 3rgf_A 14 ERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-MSACREIALLRELKHPNVISLQKVFLSH-A 91 (405)
T ss_dssp HCCCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC-HHHHHHHHHHHHCCCTTBCCCCEEEEET-T
T ss_pred hhhhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC-HHHHHHHHHHHhcCCCCeeeEeeEEecC-C
Confidence 345677889884 57999999999999976 57889999999755433 4567899999999999999999998542 2
Q ss_pred CCceEEEEEecCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEE----e-CCe
Q psy11098 171 PGTDTIVMQLVHGESLIQHLCRQ---------STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILM----N-GAV 236 (380)
Q Consensus 171 ~~~~~lv~e~~~gg~L~~~l~~~---------~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~----~-~~~ 236 (380)
....++||||+. ++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||+ + ++.
T Consensus 92 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 92 DRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp TTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTC
T ss_pred CCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCc
Confidence 357899999994 6888887532 249999999999999999999999999999999999999 3 358
Q ss_pred eEEEeCCCccccc---------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHH--------
Q psy11098 237 LKLIDLGSSVSVS---------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEE-------- 299 (380)
Q Consensus 237 ikl~DFG~a~~~~---------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~-------- 299 (380)
+||+|||+|+... ...+||+.|+|||++.+...++.++|||||||++|+|++|..||.+....
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~ 250 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH 250 (405)
T ss_dssp EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence 9999999997653 34578999999999987556899999999999999999999999765542
Q ss_pred -HHHHHHhcccCCCCCCcC----------------------------------CCCCHHHHHHHHHhcccCCCCCCCHHH
Q psy11098 300 -ETRAHISVADYSFPPEQC----------------------------------GHISVPARELIGQLLNTHADKRPTAGQ 344 (380)
Q Consensus 300 -~~~~~i~~~~~~~~~~~~----------------------------------~~~s~~~~~li~~~L~~dP~~Rpt~~e 344 (380)
+....+.......+...+ ...+.++.+||++||..||.+|||++|
T Consensus 251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e 330 (405)
T 3rgf_A 251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ 330 (405)
T ss_dssp HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 222222211111111111 123778999999999999999999999
Q ss_pred HHhcccccccCC
Q psy11098 345 LLQVAWFAEASC 356 (380)
Q Consensus 345 ~L~hpw~~~~~~ 356 (380)
+|+||||.+...
T Consensus 331 ~L~hp~f~~~~~ 342 (405)
T 3rgf_A 331 AMQDPYFLEDPL 342 (405)
T ss_dssp HHTSGGGTSSSC
T ss_pred HhcChhhccCCC
Confidence 999999987643
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=385.40 Aligned_cols=256 Identities=25% Similarity=0.374 Sum_probs=206.7
Q ss_pred hhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhc--------cCCCcceeeeccc
Q psy11098 96 EQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLM--------HAHIPTALALFEN 167 (380)
Q Consensus 96 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~--------h~ni~~i~~~~~~ 167 (380)
+.+.++|++.+.||+|+||+||+|++..+++.||+|++.........+.+|+++++.++ |+||+++++.+..
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred hhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 34578999999999999999999999999999999999766555667788999999997 6678888887763
Q ss_pred cc-CCCceEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC-CcEeecCCCCcEEEeCC--------
Q psy11098 168 AP-VPGTDTIVMQLVHGESLIQHLCRQ--STITESYICCIIRQLHSALHCLHSQ-QIAHKDIRPENILMNGA-------- 235 (380)
Q Consensus 168 ~~-~~~~~~lv~e~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~al~~lH~~-~iiHrDlKp~NIl~~~~-------- 235 (380)
.. .....++||||+ +++|.+.+... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.+
T Consensus 113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 113 SGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp EETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred cCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhh
Confidence 32 235679999999 77777777554 5699999999999999999999998 99999999999999743
Q ss_pred ------------------------------------------eeEEEeCCCccccc---ccccCCCcccCCccccCCCCC
Q psy11098 236 ------------------------------------------VLKLIDLGSSVSVS---TVVLPDLEFASPEMLTSPATA 270 (380)
Q Consensus 236 ------------------------------------------~ikl~DFG~a~~~~---~~~~gt~~y~aPE~~~~~~~~ 270 (380)
.+||+|||+|.... ....||+.|+|||++.+ ..+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~ 270 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIG-SGY 270 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHHT-SCC
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhcC-CCC
Confidence 69999999997654 45678999999999988 468
Q ss_pred CCcccHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHhcccCCCCC------------------------------
Q psy11098 271 GPSTDMWSLGVLLYILLSGVSPFLDES------EEETRAHISVADYSFPP------------------------------ 314 (380)
Q Consensus 271 ~~~~DiwSlGvil~~lltg~~Pf~~~~------~~~~~~~i~~~~~~~~~------------------------------ 314 (380)
+.++|||||||++|+|++|..||.+.+ .......+.......+.
T Consensus 271 ~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (397)
T 1wak_A 271 NTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGL 350 (397)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCH
T ss_pred CcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcch
Confidence 899999999999999999999997644 22222222111000000
Q ss_pred --------CcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccc
Q psy11098 315 --------EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAE 353 (380)
Q Consensus 315 --------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~ 353 (380)
......+.++++||.+||+.||++|||++|+|+||||++
T Consensus 351 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 351 FEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp HHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred hHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 001123457889999999999999999999999999974
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=380.86 Aligned_cols=254 Identities=26% Similarity=0.328 Sum_probs=209.8
Q ss_pred hhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhc-cCC-----Ccceeeeccccc
Q psy11098 96 EQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLM-HAH-----IPTALALFENAP 169 (380)
Q Consensus 96 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~-h~n-----i~~i~~~~~~~~ 169 (380)
+.+.++|++.+.||+|+||+||+|++..+++.||||+++...........|+++++.+. |++ ++.+.+++..
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~-- 127 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF-- 127 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE--
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc--
Confidence 45678999999999999999999999999999999999765444566778999999886 443 7777777665
Q ss_pred CCCceEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCcEeecCCCCcEEEe---CCeeEEEeC
Q psy11098 170 VPGTDTIVMQLVHGESLIQHLCRQ--STITESYICCIIRQLHSALHCLH--SQQIAHKDIRPENILMN---GAVLKLIDL 242 (380)
Q Consensus 170 ~~~~~~lv~e~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~al~~lH--~~~iiHrDlKp~NIl~~---~~~ikl~DF 242 (380)
.+..++||||+ +++|.+++... ..+++..++.++.||+.||.||| +.||+||||||+|||++ ++.+||+||
T Consensus 128 -~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 128 -RNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp -TTEEEEEEECC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred -CCceEEEEecC-CCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 36789999999 46999999765 46999999999999999999999 57999999999999995 357999999
Q ss_pred CCccccc---ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCC-----
Q psy11098 243 GSSVSVS---TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPP----- 314 (380)
Q Consensus 243 G~a~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~----- 314 (380)
|+|.... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.......+.
T Consensus 206 G~a~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 284 (382)
T 2vx3_A 206 GSSCQLGQRIYQYIQSRFYRSPEVLLG-MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQ 284 (382)
T ss_dssp TTCEETTCCCCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred cCceecccccccccCCccccChHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 9998764 45678999999999988 47889999999999999999999999998887777666432111100
Q ss_pred ------------------------------CcCCC-------------------------CCHHHHHHHHHhcccCCCCC
Q psy11098 315 ------------------------------EQCGH-------------------------ISVPARELIGQLLNTHADKR 339 (380)
Q Consensus 315 ------------------------------~~~~~-------------------------~s~~~~~li~~~L~~dP~~R 339 (380)
..... .++++++||++||+.||++|
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R 364 (382)
T 2vx3_A 285 APKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTR 364 (382)
T ss_dssp CTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTS
T ss_pred hHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhC
Confidence 00000 01378999999999999999
Q ss_pred CCHHHHHhccccccc
Q psy11098 340 PTAGQLLQVAWFAEA 354 (380)
Q Consensus 340 pt~~e~L~hpw~~~~ 354 (380)
||++|+|+||||++.
T Consensus 365 pta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 365 IQPYYALQHSFFKKT 379 (382)
T ss_dssp CCHHHHTTSGGGCC-
T ss_pred CCHHHHhcCcccccC
Confidence 999999999999875
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-48 Score=364.15 Aligned_cols=252 Identities=25% Similarity=0.371 Sum_probs=220.3
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC--CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER--QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
..++|++.+.||+|+||.||+|++..+++.||+|++.... .....+.+|+.+++.+.|+||+++++++... +..+
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~ 96 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD---TKLW 96 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEET---TEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC---CeEE
Confidence 4678999999999999999999999999999999997543 3456788899999999999999999988764 6789
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-----
Q psy11098 176 IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS----- 249 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~----- 249 (380)
+||||+.|++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 97 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 175 (303)
T 3a7i_A 97 IIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 175 (303)
T ss_dssp EEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC
T ss_pred EEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccc
Confidence 99999999999998864 5799999999999999999999999999999999999997 5699999999997653
Q ss_pred -ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHH
Q psy11098 250 -TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELI 328 (380)
Q Consensus 250 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 328 (380)
....||+.|+|||++.+ ..++.++||||||+++|+|++|..||...........+...... .....++.++.+||
T Consensus 176 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li 251 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPP---TLEGNYSKPLKEFV 251 (303)
T ss_dssp BCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC---CCCSSCCHHHHHHH
T ss_pred cCccCCCcCccCHHHHhc-CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCC---CCccccCHHHHHHH
Confidence 34568999999999987 47788999999999999999999999988877776666544322 22346899999999
Q ss_pred HHhcccCCCCCCCHHHHHhcccccccCCC
Q psy11098 329 GQLLNTHADKRPTAGQLLQVAWFAEASCS 357 (380)
Q Consensus 329 ~~~L~~dP~~Rpt~~e~L~hpw~~~~~~~ 357 (380)
.+||..||++|||++++|+||||.+....
T Consensus 252 ~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 280 (303)
T 3a7i_A 252 EACLNKEPSFRPTAKELLKHKFILRNAKK 280 (303)
T ss_dssp HHHCCSSGGGSCCHHHHTTCHHHHHHCCC
T ss_pred HHHcCCChhhCcCHHHHhhChhhhcCCCc
Confidence 99999999999999999999999876543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=381.33 Aligned_cols=255 Identities=25% Similarity=0.347 Sum_probs=208.0
Q ss_pred hhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccC---CCc
Q psy11098 97 QFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPV---PGT 173 (380)
Q Consensus 97 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~---~~~ 173 (380)
....+|++.+.||+|+||+||+|++..+++ +|+|++...... ..+|+++++.++|+||+++++++..... ...
T Consensus 37 ~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~---~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 112 (394)
T 4e7w_A 37 QREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF---KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112 (394)
T ss_dssp EEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS---CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred cccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch---HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence 346789999999999999999999988766 888887543322 2369999999999999999999865422 123
Q ss_pred eEEEEEecCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe--CCeeEEEeCCCccc
Q psy11098 174 DTIVMQLVHGESLIQHLC----RQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN--GAVLKLIDLGSSVS 247 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~----~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~--~~~ikl~DFG~a~~ 247 (380)
.++||||+.++ +...+. ....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|+.
T Consensus 113 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 113 LNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 68999999664 444332 256799999999999999999999999999999999999998 56899999999976
Q ss_pred cc-----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccc-------------
Q psy11098 248 VS-----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVAD------------- 309 (380)
Q Consensus 248 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~------------- 309 (380)
.. ....+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 192 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 271 (394)
T 4e7w_A 192 LIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNP 271 (394)
T ss_dssp CCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCG
T ss_pred ccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh
Confidence 52 356789999999999876678999999999999999999999999988777666554321
Q ss_pred ----CCCCC--------CcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCC
Q psy11098 310 ----YSFPP--------EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASC 356 (380)
Q Consensus 310 ----~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~ 356 (380)
..++. .....+++++++||.+||+.||++|||+.|+|+||||++...
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 272 NYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp GGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred hhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 11111 011247899999999999999999999999999999987543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=365.66 Aligned_cols=253 Identities=23% Similarity=0.326 Sum_probs=214.0
Q ss_pred hhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC----chHHHHHHHHHHHhhccCCCcceeeecccccCC
Q psy11098 96 EQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ----PQQITRAEYNLLSTLMHAHIPTALALFENAPVP 171 (380)
Q Consensus 96 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~ 171 (380)
+.+.++|++.+.||+|+||.||+|++..+++.||+|++..... ....+.+|+.+++.++||||+++++++...
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~--- 83 (294)
T 4eqm_A 7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEED--- 83 (294)
T ss_dssp SCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECS---
T ss_pred hHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeC---
Confidence 3467899999999999999999999999999999999864332 234667899999999999999999988763
Q ss_pred CceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-
Q psy11098 172 GTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS- 249 (380)
Q Consensus 172 ~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~- 249 (380)
+..++||||+.|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 84 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 84 DCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred CeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 67899999999999999999888999999999999999999999999999999999999997 5699999999997653
Q ss_pred ------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCC-CCCcCCCCCH
Q psy11098 250 ------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSF-PPEQCGHISV 322 (380)
Q Consensus 250 ------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~s~ 322 (380)
....||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+..+............ +......+++
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (294)
T 4eqm_A 164 TSLTQTNHVLGTVQYFSPEQAKG-EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQ 242 (294)
T ss_dssp -----------CCSSCCHHHHHT-CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCH
T ss_pred ccccccCccccCccccCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCH
Confidence 34568999999999988 467889999999999999999999999988776655554433221 1223456899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhccccc
Q psy11098 323 PARELIGQLLNTHADKRPTAGQLLQVAWFA 352 (380)
Q Consensus 323 ~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~ 352 (380)
.+.++|.+||.+||++||+..+.+.+.|..
T Consensus 243 ~l~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 243 SLSNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp HHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred HHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 999999999999999999777777777754
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-48 Score=371.66 Aligned_cols=257 Identities=22% Similarity=0.321 Sum_probs=214.6
Q ss_pred hhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCc--hHHHHHHHHHHHhhccCCCcceeeecccc--cCCC
Q psy11098 97 QFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP--QQITRAEYNLLSTLMHAHIPTALALFENA--PVPG 172 (380)
Q Consensus 97 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~E~~il~~l~h~ni~~i~~~~~~~--~~~~ 172 (380)
.+.++|++.+.||+|+||.||+|++..+|+.||||++...... ...+.+|+++++.++|+||+++++++... ....
T Consensus 8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 4678999999999999999999999999999999999654332 34567899999999999999999987653 2235
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc--
Q psy11098 173 TDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS-- 249 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~-- 249 (380)
..++||||+. ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred eEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence 6899999995 689888865 5799999999999999999999999999999999999998 5699999999997653
Q ss_pred --------------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC-----
Q psy11098 250 --------------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADY----- 310 (380)
Q Consensus 250 --------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~----- 310 (380)
....||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T 2b9h_A 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD 245 (353)
T ss_dssp --------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCST
T ss_pred cccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchh
Confidence 1246799999999987656788899999999999999999999998877665544432100
Q ss_pred -------------------CCC----CCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 311 -------------------SFP----PEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 311 -------------------~~~----~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
..+ ...+..+++++++||++||..||++|||++|+|+||||+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp TTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred ccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 000 011246899999999999999999999999999999998753
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=368.55 Aligned_cols=260 Identities=25% Similarity=0.318 Sum_probs=212.4
Q ss_pred hhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC-chHHHHHHHHHHHhhccCCCcceeeecccc------
Q psy11098 96 EQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ-PQQITRAEYNLLSTLMHAHIPTALALFENA------ 168 (380)
Q Consensus 96 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~il~~l~h~ni~~i~~~~~~~------ 168 (380)
..+.++|++.+.||+|+||.||+|.+..+++.||+|++..... ....+.+|+++++.++|+||+++++++...
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 86 (320)
T 2i6l_A 7 FDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD 86 (320)
T ss_dssp EEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred CccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence 3467899999999999999999999999999999999975432 345678899999999999999999887432
Q ss_pred -----cCCCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe--CCeeEEEe
Q psy11098 169 -----PVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN--GAVLKLID 241 (380)
Q Consensus 169 -----~~~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~--~~~ikl~D 241 (380)
...+..++||||+. |+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|
T Consensus 87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~D 164 (320)
T 2i6l_A 87 DVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGD 164 (320)
T ss_dssp ----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred ccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEcc
Confidence 23357799999996 699998854 5799999999999999999999999999999999999997 34899999
Q ss_pred CCCccccc---------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCC
Q psy11098 242 LGSSVSVS---------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSF 312 (380)
Q Consensus 242 FG~a~~~~---------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~ 312 (380)
||++.... ....+|+.|+|||++.+...++.++||||||+++|+|++|..||.+....+....+.......
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 244 (320)
T 2i6l_A 165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV 244 (320)
T ss_dssp CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCC
T ss_pred CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 99997653 234568999999998765678889999999999999999999999988777666554322111
Q ss_pred ----------------------C----CCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCCC
Q psy11098 313 ----------------------P----PEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASCS 357 (380)
Q Consensus 313 ----------------------~----~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~~ 357 (380)
+ ......++.++++||++||+.||++|||++|+|+||||+....+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p 315 (320)
T 2i6l_A 245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP 315 (320)
T ss_dssp CHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-
T ss_pred chhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCc
Confidence 0 01124689999999999999999999999999999999876543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=372.39 Aligned_cols=255 Identities=25% Similarity=0.383 Sum_probs=211.2
Q ss_pred hhhhhceeeeeeecccCCeEEEEEEEcCCC-cEEEEEEecCCCCchHHHHHHHHHHHhhccCC------Ccceeeecccc
Q psy11098 96 EQFEHRYEELERLGNGRFCTVRKARDRGTG-QLVALKQIPRERQPQQITRAEYNLLSTLMHAH------IPTALALFENA 168 (380)
Q Consensus 96 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~-~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~n------i~~i~~~~~~~ 168 (380)
+.+.++|++.+.||+|+||+||+|.+..++ +.||+|+++........+.+|+++++.++|++ ++.+.+++..
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~- 93 (355)
T 2eu9_A 15 DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF- 93 (355)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE-
T ss_pred ceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee-
Confidence 346789999999999999999999998877 68999999766555677788999999998876 5666666655
Q ss_pred cCCCceEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEE--------------
Q psy11098 169 PVPGTDTIVMQLVHGESLIQHLCRQ--STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILM-------------- 232 (380)
Q Consensus 169 ~~~~~~~lv~e~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~-------------- 232 (380)
.+..++||||+ +++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 94 --~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 94 --HGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp --TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred --CCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccc
Confidence 46789999999 77788877654 369999999999999999999999999999999999999
Q ss_pred -----e-CCeeEEEeCCCccccc---ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy11098 233 -----N-GAVLKLIDLGSSVSVS---TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRA 303 (380)
Q Consensus 233 -----~-~~~ikl~DFG~a~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~ 303 (380)
+ ++.+||+|||++.... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+...
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 249 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLV 249 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred ccccccCCCcEEEeecCccccccccccCCcCCCcccCCeeeec-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 3 4589999999997654 45678999999999987 477899999999999999999999999888776655
Q ss_pred HHhcccCCCCCC----------------------------------------cCCCCCHHHHHHHHHhcccCCCCCCCHH
Q psy11098 304 HISVADYSFPPE----------------------------------------QCGHISVPARELIGQLLNTHADKRPTAG 343 (380)
Q Consensus 304 ~i~~~~~~~~~~----------------------------------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ 343 (380)
.+.......+.. .....+.++.+||++||..||++|||++
T Consensus 250 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ 329 (355)
T 2eu9_A 250 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLA 329 (355)
T ss_dssp HHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHH
Confidence 543322111110 0011245788999999999999999999
Q ss_pred HHHhcccccccC
Q psy11098 344 QLLQVAWFAEAS 355 (380)
Q Consensus 344 e~L~hpw~~~~~ 355 (380)
|+|+||||++..
T Consensus 330 e~l~hp~f~~~~ 341 (355)
T 2eu9_A 330 EALLHPFFAGLT 341 (355)
T ss_dssp HHTTSGGGGGCC
T ss_pred HHhcChhhcCCC
Confidence 999999999764
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=363.58 Aligned_cols=253 Identities=25% Similarity=0.375 Sum_probs=216.5
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC-----CCchHHHHHHHHHHHhhccCCCcceeeecccccCCC
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE-----RQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPG 172 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~-----~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~ 172 (380)
+.++|++.+.||+|+||.||+|.+..+++.||+|++... ......+.+|+++++.++|+||+++++++... ..+
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~ 81 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE-EKQ 81 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC----
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcC-CCC
Confidence 467899999999999999999999999999999999643 23456778899999999999999999987432 235
Q ss_pred ceEEEEEecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc
Q psy11098 173 TDTIVMQLVHGESLIQHLCR--QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS 249 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~--~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~ 249 (380)
..++||||+.++ |.+.+.. ...+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 82 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 82 KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 789999999766 7777765 45799999999999999999999999999999999999997 5699999999987643
Q ss_pred --------ccccCCCcccCCccccCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCC
Q psy11098 250 --------TVVLPDLEFASPEMLTSP-ATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHI 320 (380)
Q Consensus 250 --------~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 320 (380)
....||+.|+|||++.+. ..++.++||||||+++|+|++|..||.+.+..+....+....+.++. .+
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~----~~ 236 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPG----DC 236 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCS----SS
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCC----cc
Confidence 345689999999998763 23467899999999999999999999999988888888777665543 57
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCC
Q psy11098 321 SVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASC 356 (380)
Q Consensus 321 s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~ 356 (380)
+.++.+||++||..||++|||++|+|+||||++...
T Consensus 237 ~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 237 GPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 899999999999999999999999999999987543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-48 Score=363.18 Aligned_cols=256 Identities=27% Similarity=0.351 Sum_probs=212.9
Q ss_pred hhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 96 EQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 96 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
+...++|++.+.||+|+||.||+|.+..+|+.||+|++..... ...+.+|+.+++.++|+||+++++++... +..+
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~ 100 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-LQEIIKEISIMQQCDSPHVVKYYGSYFKN---TDLW 100 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-CHHHHHHHHHHHTCCCTTBCCEEEEEEET---TEEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-HHHHHHHHHHHHhCCCCCCccEEEEEEeC---CEEE
Confidence 4467899999999999999999999999999999999976543 45678899999999999999999988763 6789
Q ss_pred EEEEecCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc----
Q psy11098 176 IVMQLVHGESLIQHLC-RQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS---- 249 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~-~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~---- 249 (380)
+||||+.+++|.+++. ....+++..++.++.||+.||.|||++||+|+||||+|||++ ++.+||+|||++....
T Consensus 101 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp EEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred EEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 9999999999999996 456899999999999999999999999999999999999997 5699999999997653
Q ss_pred --ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHH
Q psy11098 250 --TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAREL 327 (380)
Q Consensus 250 --~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 327 (380)
....||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.........+...... .......++.++.+|
T Consensus 181 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l 258 (314)
T 3com_A 181 KRNTVIGTPFWMAPEVIQE-IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPP-TFRKPELWSDNFTDF 258 (314)
T ss_dssp CBCCCCSCGGGCCHHHHSS-SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-CCSSGGGSCHHHHHH
T ss_pred ccCccCCCCCccChhhcCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCc-ccCCcccCCHHHHHH
Confidence 34568999999999987 46788999999999999999999999887766655544433211 111223478999999
Q ss_pred HHHhcccCCCCCCCHHHHHhcccccccCCC
Q psy11098 328 IGQLLNTHADKRPTAGQLLQVAWFAEASCS 357 (380)
Q Consensus 328 i~~~L~~dP~~Rpt~~e~L~hpw~~~~~~~ 357 (380)
|.+||..||++|||+.++|+||||+.....
T Consensus 259 i~~~l~~dp~~Rpt~~~ll~~~~~~~~~~~ 288 (314)
T 3com_A 259 VKQCLVKSPEQRATATQLLQHPFVRSAKGV 288 (314)
T ss_dssp HHHHTCSCTTTSCCHHHHTTSHHHHTCCCG
T ss_pred HHHHccCChhhCcCHHHHHhCHHHhcCCcc
Confidence 999999999999999999999999876543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-48 Score=369.81 Aligned_cols=255 Identities=24% Similarity=0.350 Sum_probs=211.4
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCc---hHHHHHHHHHHHhhccCCCcceeeecccccCC---
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP---QQITRAEYNLLSTLMHAHIPTALALFENAPVP--- 171 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~--- 171 (380)
+.++|.+.+.||+|+||.||+|+++.+|+.||||++...... ...+.+|+.+++.++|+||+++++++......
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 467899999999999999999999999999999999764432 34567899999999999999999998764221
Q ss_pred CceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-
Q psy11098 172 GTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS- 249 (380)
Q Consensus 172 ~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~- 249 (380)
...++||||+. ++|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 178 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred eeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence 24599999995 68877764 3599999999999999999999999999999999999998 5689999999998654
Q ss_pred --ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCC----------------
Q psy11098 250 --TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYS---------------- 311 (380)
Q Consensus 250 --~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~---------------- 311 (380)
....+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 179 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 258 (353)
T 3coi_A 179 EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKS 258 (353)
T ss_dssp -----CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHH
T ss_pred CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHH
Confidence 34578999999999987567889999999999999999999999988876665554321100
Q ss_pred -----------CCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 312 -----------FPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 312 -----------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
.....+..++.++++||++||..||++|||++|+|+||||+...
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 313 (353)
T 3coi_A 259 YIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 313 (353)
T ss_dssp HHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence 00112346799999999999999999999999999999998653
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=363.54 Aligned_cols=252 Identities=23% Similarity=0.319 Sum_probs=197.5
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCch---HHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQ---QITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~---~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
.++|++.+.||+|+||+||+|++..+|+.||+|++....... ....++...++.+.|+||+++++++... +..+
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~---~~~~ 82 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE---GDVW 82 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS---SSEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeecc---CCEE
Confidence 578999999999999999999999999999999997654322 2334455557888999999999988763 6789
Q ss_pred EEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeecCCCCcEEEeC-CeeEEEeCCCccccc
Q psy11098 176 IVMQLVHGESLIQHLCR----QSTITESYICCIIRQLHSALHCLHSQ-QIAHKDIRPENILMNG-AVLKLIDLGSSVSVS 249 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~----~~~l~e~~~~~i~~qil~al~~lH~~-~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~ 249 (380)
+||||+. ++|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++. +.+||+|||++....
T Consensus 83 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 83 ICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred EEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9999996 588777643 56899999999999999999999998 9999999999999985 699999999997653
Q ss_pred -----ccccCCCcccCCcccc---CCCCCCCcccHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcccCCCCCCcCCCC
Q psy11098 250 -----TVVLPDLEFASPEMLT---SPATAGPSTDMWSLGVLLYILLSGVSPFLDE-SEEETRAHISVADYSFPPEQCGHI 320 (380)
Q Consensus 250 -----~~~~gt~~y~aPE~~~---~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~ 320 (380)
....||+.|+|||++. ....++.++||||||+++|+|++|..||... .............. +......+
T Consensus 162 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 239 (290)
T 3fme_A 162 DDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS--PQLPADKF 239 (290)
T ss_dssp --------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCC--CCCCTTTS
T ss_pred ccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCC--CCcccccC
Confidence 3457899999999973 3356788999999999999999999999763 33333333332221 11223468
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCC
Q psy11098 321 SVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASC 356 (380)
Q Consensus 321 s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~ 356 (380)
+.++.+||.+||+.||++|||++|+|+||||+....
T Consensus 240 ~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~~ 275 (290)
T 3fme_A 240 SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHES 275 (290)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred CHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCcc
Confidence 999999999999999999999999999999987543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=383.88 Aligned_cols=254 Identities=18% Similarity=0.149 Sum_probs=191.6
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC----chHHHHHHHHHHHhh--ccCCCcceee-------ecc
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ----PQQITRAEYNLLSTL--MHAHIPTALA-------LFE 166 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~E~~il~~l--~h~ni~~i~~-------~~~ 166 (380)
..|++.+.||+|+||+||+|++..+|+.||+|++..... ....+++|+.+++.| .||||++++. ++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 459999999999999999999999999999999987543 334567786666666 4999877442 222
Q ss_pred cccCC--------------CceEEEEEecCCCCHHHHHHhc-CCCCHHHH------HHHHHHHHHHHHHHHHCCcEeecC
Q psy11098 167 NAPVP--------------GTDTIVMQLVHGESLIQHLCRQ-STITESYI------CCIIRQLHSALHCLHSQQIAHKDI 225 (380)
Q Consensus 167 ~~~~~--------------~~~~lv~e~~~gg~L~~~l~~~-~~l~e~~~------~~i~~qil~al~~lH~~~iiHrDl 225 (380)
....+ ...|+||||+. ++|.+++... ..+.+... ..++.||+.||.|||++||+||||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi 220 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF 220 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence 21110 23799999997 8999999763 33444444 577799999999999999999999
Q ss_pred CCCcEEEe-CCeeEEEeCCCcccccc---cccCCCcccCCccccC-CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy11098 226 RPENILMN-GAVLKLIDLGSSVSVST---VVLPDLEFASPEMLTS-PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEE 300 (380)
Q Consensus 226 Kp~NIl~~-~~~ikl~DFG~a~~~~~---~~~gt~~y~aPE~~~~-~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~ 300 (380)
||+|||++ ++.+||+|||+|..... ...+|+.|+|||++.+ ...++.++|||||||++|+|++|..||.+.....
T Consensus 221 kp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~ 300 (371)
T 3q60_A 221 TPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI 300 (371)
T ss_dssp SGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTC
T ss_pred CHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCccc
Confidence 99999998 56999999999987652 4567899999999975 2367889999999999999999999997764321
Q ss_pred HH--HH---HhcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 301 TR--AH---ISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 301 ~~--~~---i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
.. .. .......+....+..+++++++||.+||+.||++|||+.|+|+||||++.
T Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 359 (371)
T 3q60_A 301 KGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359 (371)
T ss_dssp TTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred ccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence 10 00 11111222233345789999999999999999999999999999999865
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-50 Score=387.79 Aligned_cols=246 Identities=16% Similarity=0.186 Sum_probs=197.4
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC----CCchHHHHHHHH---HHHhhccCCCccee-------ee
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYN---LLSTLMHAHIPTAL-------AL 164 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~---il~~l~h~ni~~i~-------~~ 164 (380)
.++|++.+.||+|+||+||+|+++.+|+.||||++... ....+.+.+|+. +++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 57899999999999999999999999999999999643 233466788994 45555799998887 44
Q ss_pred cccccC---------CC-----ceEEEEEecCCCCHHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHHCCcEee
Q psy11098 165 FENAPV---------PG-----TDTIVMQLVHGESLIQHLCRQSTITE-------SYICCIIRQLHSALHCLHSQQIAHK 223 (380)
Q Consensus 165 ~~~~~~---------~~-----~~~lv~e~~~gg~L~~~l~~~~~l~e-------~~~~~i~~qil~al~~lH~~~iiHr 223 (380)
+..... .+ ..|++|||+ +|+|.+++.....+++ ..+..++.||+.||.|||++||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 333210 01 368999999 7899999987655555 7888899999999999999999999
Q ss_pred cCCCCcEEEe-CCeeEEEeCCCccccc---ccccCCCcccCCccccCC----------CCCCCcccHHHHHHHHHHHHhC
Q psy11098 224 DIRPENILMN-GAVLKLIDLGSSVSVS---TVVLPDLEFASPEMLTSP----------ATAGPSTDMWSLGVLLYILLSG 289 (380)
Q Consensus 224 DlKp~NIl~~-~~~ikl~DFG~a~~~~---~~~~gt~~y~aPE~~~~~----------~~~~~~~DiwSlGvil~~lltg 289 (380)
||||+|||++ ++.+||+|||+|+... ....| +.|+|||++.+. ..++.++|||||||++|+|++|
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg 309 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CCCHHHEEEcCCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHC
Confidence 9999999998 5699999999998654 45567 999999999873 2678899999999999999999
Q ss_pred CCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 290 VSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 290 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
..||.+.........+.. .+..+++++++||.+||+.||++|||+.|+|+||||++.
T Consensus 310 ~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 366 (377)
T 3byv_A 310 DLPITKDAALGGSEWIFR--------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 366 (377)
T ss_dssp SCCC------CCSGGGGS--------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHH
T ss_pred CCCCcccccccchhhhhh--------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHH
Confidence 999977654333322221 224689999999999999999999999999999999764
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-49 Score=368.42 Aligned_cols=257 Identities=24% Similarity=0.347 Sum_probs=194.9
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC--CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER--QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.++|+||+++++++... +..++
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~l 90 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK---DELWL 90 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESS---SCEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeec---CCcEE
Confidence 578999999999999999999999999999999986442 2345567899999999999999999988764 56899
Q ss_pred EEEecCCCCHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccc
Q psy11098 177 VMQLVHGESLIQHLCR--------QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVS 247 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~--------~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~ 247 (380)
||||+.|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 170 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAF 170 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence 9999999999999964 45699999999999999999999999999999999999998 56999999998865
Q ss_pred cc-----------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCC----
Q psy11098 248 VS-----------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSF---- 312 (380)
Q Consensus 248 ~~-----------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~---- 312 (380)
.. ....||+.|+|||++.+...++.++||||||+++|+|++|..||.+.................
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 250 (303)
T 2vwi_A 171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETG 250 (303)
T ss_dssp CC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-
T ss_pred eccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccc
Confidence 42 245689999999998764467889999999999999999999998876655544443332211
Q ss_pred --CCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCCCC
Q psy11098 313 --PPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASCSE 358 (380)
Q Consensus 313 --~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~~~ 358 (380)
.......++.++++||.+||..||.+|||+.++|+||||++.....
T Consensus 251 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~ 298 (303)
T 2vwi_A 251 VQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKE 298 (303)
T ss_dssp ----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-------
T ss_pred cccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCCc
Confidence 1122356889999999999999999999999999999998765443
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=366.36 Aligned_cols=252 Identities=24% Similarity=0.395 Sum_probs=206.4
Q ss_pred hhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC--CchHHHHHHHHHHHhhccCCCcceeeecccccCCCce
Q psy11098 97 QFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER--QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 97 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~ 174 (380)
.+.++|++.+.||+|+||+||+|++..+++.||+|++.... .....+.+|+++++.++|+||+++++++.... ....
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~ 84 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT-TRHK 84 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT-TCCE
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCC-CceE
Confidence 35789999999999999999999999999999999996433 33466778999999999999999999887542 2467
Q ss_pred EEEEEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEE----eC-CeeEEEeCCCcc
Q psy11098 175 TIVMQLVHGESLIQHLCRQS---TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILM----NG-AVLKLIDLGSSV 246 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~~---~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~----~~-~~ikl~DFG~a~ 246 (380)
++||||+.|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+ +. +.+||+|||++.
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 99999999999999997643 39999999999999999999999999999999999998 43 379999999997
Q ss_pred ccc-----ccccCCCcccCCccccC-------CCCCCCcccHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHhcccC
Q psy11098 247 SVS-----TVVLPDLEFASPEMLTS-------PATAGPSTDMWSLGVLLYILLSGVSPFLDE----SEEETRAHISVADY 310 (380)
Q Consensus 247 ~~~-----~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwSlGvil~~lltg~~Pf~~~----~~~~~~~~i~~~~~ 310 (380)
... ....||+.|+|||++.. ...++.++|||||||++|+|++|..||... ...+....+.....
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p 244 (319)
T 4euu_A 165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (319)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCC
T ss_pred ecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCC
Confidence 653 34578999999999862 257788999999999999999999999642 22344444433221
Q ss_pred -------------------CCC--CCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcc
Q psy11098 311 -------------------SFP--PEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVA 349 (380)
Q Consensus 311 -------------------~~~--~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp 349 (380)
.++ ......++..+.+||++||+.||++|||++|+|+||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred cccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 111 111123456789999999999999999999999997
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-48 Score=371.87 Aligned_cols=259 Identities=20% Similarity=0.262 Sum_probs=209.7
Q ss_pred hhhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCc------------hHHHHHHHHHHHhhccCCCccee
Q psy11098 95 QEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP------------QQITRAEYNLLSTLMHAHIPTAL 162 (380)
Q Consensus 95 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~------------~~~~~~E~~il~~l~h~ni~~i~ 162 (380)
...+.++|++.+.||+|+||.||+|.+.. |+.||||++...... ...+.+|+++++.++|+||++++
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 95 (362)
T 3pg1_A 17 LHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLR 95 (362)
T ss_dssp HHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred HHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcccee
Confidence 45678999999999999999999999865 899999998543211 15678899999999999999999
Q ss_pred eeccccc--CCCceEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeE
Q psy11098 163 ALFENAP--VPGTDTIVMQLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLK 238 (380)
Q Consensus 163 ~~~~~~~--~~~~~~lv~e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ik 238 (380)
+++.... .....++||||+. |+|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+|
T Consensus 96 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~k 174 (362)
T 3pg1_A 96 DIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDIT 174 (362)
T ss_dssp EEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEE
T ss_pred eeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEE
Confidence 9985532 2246799999996 6888887654 4799999999999999999999999999999999999998 56999
Q ss_pred EEeCCCccccc-----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccC---
Q psy11098 239 LIDLGSSVSVS-----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADY--- 310 (380)
Q Consensus 239 l~DFG~a~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~--- 310 (380)
|+|||++.... ....+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 254 (362)
T 3pg1_A 175 ICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK 254 (362)
T ss_dssp ECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred EEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 99999997543 3457899999999998756788999999999999999999999999887776665542111
Q ss_pred ---------------------CCCC----CcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 311 ---------------------SFPP----EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 311 ---------------------~~~~----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
..+. .....+++.+.+||.+||..||++|||++|+|+||||+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 255 IEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF 324 (362)
T ss_dssp HHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence 1111 11235688999999999999999999999999999999763
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=360.87 Aligned_cols=257 Identities=25% Similarity=0.338 Sum_probs=213.5
Q ss_pred hhhceeeeeeecccCCeEEEEEEEc-CCCcEEEEEEecCCC---CchHHHHHHHHHHHhh---ccCCCcceeeeccccc-
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDR-GTGQLVALKQIPRER---QPQQITRAEYNLLSTL---MHAHIPTALALFENAP- 169 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~-~~~~~vAvK~~~~~~---~~~~~~~~E~~il~~l---~h~ni~~i~~~~~~~~- 169 (380)
..++|++.+.||+|+||.||+|++. .+++.||+|++.... .....+.+|+.+++.+ .|+||+++++++....
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4689999999999999999999995 678999999986432 2234566788888777 7999999999886321
Q ss_pred -CCCceEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCc
Q psy11098 170 -VPGTDTIVMQLVHGESLIQHLCRQ--STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSS 245 (380)
Q Consensus 170 -~~~~~~lv~e~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a 245 (380)
..+..++||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~ 167 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 167 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccc
Confidence 2356799999996 6999999764 3499999999999999999999999999999999999997 569999999999
Q ss_pred cccc-----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCC--------
Q psy11098 246 VSVS-----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSF-------- 312 (380)
Q Consensus 246 ~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~-------- 312 (380)
.... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+....+.......
T Consensus 168 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (326)
T 1blx_A 168 RIYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 246 (326)
T ss_dssp CCCCGGGGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred ccccCCCCccccccccceeCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccc
Confidence 7654 34678999999999987 467889999999999999999999999988877766654311000
Q ss_pred ---------------CCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCC
Q psy11098 313 ---------------PPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASC 356 (380)
Q Consensus 313 ---------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~ 356 (380)
.......++.++++||.+||..||++|||+.|+|+||||++...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 305 (326)
T 1blx_A 247 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 305 (326)
T ss_dssp CSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred cccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence 01122468899999999999999999999999999999987643
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=371.99 Aligned_cols=254 Identities=22% Similarity=0.426 Sum_probs=218.9
Q ss_pred hhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC----ch--------------HHHHHHHHHHHhhccCCC
Q psy11098 97 QFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ----PQ--------------QITRAEYNLLSTLMHAHI 158 (380)
Q Consensus 97 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~----~~--------------~~~~~E~~il~~l~h~ni 158 (380)
.+.++|++.+.||+|+||.||+|.+ +++.||+|++..... .. ..+.+|+.+++.++|+||
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 105 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYC 105 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTB
T ss_pred cccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCc
Confidence 3467999999999999999999998 899999999964211 11 678899999999999999
Q ss_pred cceeeecccccCCCceEEEEEecCCCCHHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeecCCCCc
Q psy11098 159 PTALALFENAPVPGTDTIVMQLVHGESLIQH------LCR--QSTITESYICCIIRQLHSALHCLHS-QQIAHKDIRPEN 229 (380)
Q Consensus 159 ~~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~------l~~--~~~l~e~~~~~i~~qil~al~~lH~-~~iiHrDlKp~N 229 (380)
+++++++... +..++||||+.+++|.++ +.. ...+++..++.++.||+.||.|||+ +||+||||||+|
T Consensus 106 ~~~~~~~~~~---~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~N 182 (348)
T 2pml_X 106 LTCEGIITNY---DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN 182 (348)
T ss_dssp CCCSEEEESS---SEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGG
T ss_pred ceEEEEEeeC---CeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHh
Confidence 9999998764 678999999999999998 655 5679999999999999999999999 999999999999
Q ss_pred EEEe-CCeeEEEeCCCccccc----ccccCCCcccCCccccCCCCCCC-cccHHHHHHHHHHHHhCCCCCCCCCH-HHHH
Q psy11098 230 ILMN-GAVLKLIDLGSSVSVS----TVVLPDLEFASPEMLTSPATAGP-STDMWSLGVLLYILLSGVSPFLDESE-EETR 302 (380)
Q Consensus 230 Il~~-~~~ikl~DFG~a~~~~----~~~~gt~~y~aPE~~~~~~~~~~-~~DiwSlGvil~~lltg~~Pf~~~~~-~~~~ 302 (380)
||++ ++.+||+|||++.... ....||+.|+|||++.+...++. ++||||||+++|+|++|..||..... .+..
T Consensus 183 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 262 (348)
T 2pml_X 183 ILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262 (348)
T ss_dssp EEECTTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH
T ss_pred EEEcCCCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 9997 5699999999997653 45678999999999987535555 89999999999999999999988776 7777
Q ss_pred HHHhcccCCCCCCc---------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 303 AHISVADYSFPPEQ---------------CGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 303 ~~i~~~~~~~~~~~---------------~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
..+......++... ...++.++.+||++||+.||++|||++|+|+||||++..
T Consensus 263 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~ 330 (348)
T 2pml_X 263 NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN 330 (348)
T ss_dssp HHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred HHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence 77777666555321 146899999999999999999999999999999998763
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-48 Score=357.11 Aligned_cols=253 Identities=25% Similarity=0.395 Sum_probs=217.7
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---chHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
.++|++.+.||+|+||.||+|+++.+++.||+|++..... ..+.+.+|+.+++.++|+||+++++++... ..+..+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~~ 83 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR-TNTTLY 83 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG-GGTEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC-CCceEE
Confidence 5789999999999999999999999999999999975443 335678899999999999999999876432 235789
Q ss_pred EEEEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC-----cEeecCCCCcEEEe-CCeeEEEeCCCc
Q psy11098 176 IVMQLVHGESLIQHLCRQ----STITESYICCIIRQLHSALHCLHSQQ-----IAHKDIRPENILMN-GAVLKLIDLGSS 245 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~----~~l~e~~~~~i~~qil~al~~lH~~~-----iiHrDlKp~NIl~~-~~~ikl~DFG~a 245 (380)
+||||+.|++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ ++.+||+|||++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 999999999999999753 34999999999999999999999999 99999999999998 568999999998
Q ss_pred cccc------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCC
Q psy11098 246 VSVS------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGH 319 (380)
Q Consensus 246 ~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 319 (380)
.... ....||+.|+|||++.+ ..++.++||||||+++|+|++|..||...+..+....+..+..... ...
T Consensus 164 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~ 239 (279)
T 2w5a_A 164 RILNHDTSFAKTFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI---PYR 239 (279)
T ss_dssp HHC---CHHHHHHHSCCTTCCHHHHHC-C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC---CTT
T ss_pred eeeccccccccccCCCccccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccC---Ccc
Confidence 7653 23578999999999987 4678899999999999999999999999888888777776654322 235
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCC
Q psy11098 320 ISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASC 356 (380)
Q Consensus 320 ~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~ 356 (380)
++.++.++|.+||..||++|||++|+|+|+|+.....
T Consensus 240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~ 276 (279)
T 2w5a_A 240 YSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHH 276 (279)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGGS
T ss_pred cCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhcc
Confidence 7999999999999999999999999999999987643
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=351.61 Aligned_cols=242 Identities=19% Similarity=0.294 Sum_probs=213.3
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVM 178 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~ 178 (380)
.++|++.+.||+|+||.||+|.+. +++.||+|++.......+.+.+|+++++.++|+||+++++++... +..++||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~~lv~ 84 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ---APICLVF 84 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSS---SSEEEEE
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecC---CceEEEE
Confidence 468999999999999999999987 477899999988777777889999999999999999999988764 6689999
Q ss_pred EecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-------
Q psy11098 179 QLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------- 249 (380)
Q Consensus 179 e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------- 249 (380)
||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (269)
T 4hcu_A 85 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 164 (269)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred EeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccccccc
Confidence 99999999999965 45689999999999999999999999999999999999997 5689999999997553
Q ss_pred ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHH
Q psy11098 250 TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELI 328 (380)
Q Consensus 250 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 328 (380)
....+|+.|+|||++.+ ..++.++||||||+++|+|++ |..||.+....+....+........ ...+++++.++|
T Consensus 165 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li 240 (269)
T 4hcu_A 165 TGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLASTHVYQIM 240 (269)
T ss_dssp TSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC---CTTSCHHHHHHH
T ss_pred cCcccccccCCHHHhcC-CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCC---CCcCCHHHHHHH
Confidence 34456788999999987 467889999999999999999 9999999998888888776533222 235799999999
Q ss_pred HHhcccCCCCCCCHHHHHhc
Q psy11098 329 GQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 329 ~~~L~~dP~~Rpt~~e~L~h 348 (380)
.+||..||++|||++++++|
T Consensus 241 ~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 241 NHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHccCCcccCcCHHHHHHH
Confidence 99999999999999999987
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-47 Score=358.77 Aligned_cols=248 Identities=19% Similarity=0.278 Sum_probs=205.7
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCch---HHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQ---QITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~---~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
..+|++.+.||+|+||+||+|++ +|+.||+|++....... ..+.+|+++++.++|+||+++++++... +..+
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~---~~~~ 110 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP---PNLS 110 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST---TCCE
T ss_pred hhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC---CceE
Confidence 57899999999999999999987 47889999997654332 4567899999999999999999998764 5679
Q ss_pred EEEEecCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--cEeecCCCCcEEEeC-CeeEEEeCCCccccc
Q psy11098 176 IVMQLVHGESLIQHLCRQST---ITESYICCIIRQLHSALHCLHSQQ--IAHKDIRPENILMNG-AVLKLIDLGSSVSVS 249 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~~~---l~e~~~~~i~~qil~al~~lH~~~--iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~ 249 (380)
+||||+.+++|.+++..... +++..++.++.||+.||.|||++| |+||||||+|||++. +.+||+|||++....
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 99999999999999976543 999999999999999999999999 999999999999985 599999999987543
Q ss_pred ------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHH
Q psy11098 250 ------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVP 323 (380)
Q Consensus 250 ------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 323 (380)
....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+........ ....++++
T Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 267 (309)
T 3p86_A 191 STFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE--IPRNLNPQ 267 (309)
T ss_dssp -----------CCTTSCHHHHTT-CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCC--CCTTSCHH
T ss_pred ccccccccCCCCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CCccCCHH
Confidence 34678999999999988 4678899999999999999999999999888877776643333222 22468999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHh--ccccccc
Q psy11098 324 ARELIGQLLNTHADKRPTAGQLLQ--VAWFAEA 354 (380)
Q Consensus 324 ~~~li~~~L~~dP~~Rpt~~e~L~--hpw~~~~ 354 (380)
+.+||++||..||++|||++++++ .++++..
T Consensus 268 l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 268 VAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 999999999999999999999997 5776654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-47 Score=350.32 Aligned_cols=242 Identities=20% Similarity=0.288 Sum_probs=213.1
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVM 178 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~ 178 (380)
.++|++.+.||+|+||.||+|.++ ++..||+|++.........+.+|+++++.++|+||+++++++... +..++||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~~lv~ 82 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKE---YPIYIVT 82 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSS---SSEEEEE
T ss_pred hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccC---CceEEEE
Confidence 578999999999999999999876 567899999987777777889999999999999999999988653 6789999
Q ss_pred EecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-------
Q psy11098 179 QLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------- 249 (380)
Q Consensus 179 e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------- 249 (380)
||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 162 (268)
T 3sxs_A 83 EYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS 162 (268)
T ss_dssp ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEEC
T ss_pred EccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhcc
Confidence 999999999999765 4599999999999999999999999999999999999998 5689999999997553
Q ss_pred ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHH
Q psy11098 250 TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELI 328 (380)
Q Consensus 250 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 328 (380)
....+|+.|+|||++.+ ..++.++||||||+++|+|++ |..||......+....+........+ ...++++.+||
T Consensus 163 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li 238 (268)
T 3sxs_A 163 VGTKFPVKWSAPEVFHY-FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRP---HLASDTIYQIM 238 (268)
T ss_dssp CSCCCCGGGCCHHHHHH-SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC---TTSCHHHHHHH
T ss_pred cCCCcCcccCCHHHHhc-cCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCC---CcChHHHHHHH
Confidence 23445778999999987 467889999999999999999 99999998888887777765543333 34689999999
Q ss_pred HHhcccCCCCCCCHHHHHhc
Q psy11098 329 GQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 329 ~~~L~~dP~~Rpt~~e~L~h 348 (380)
.+||+.||++|||+.+++++
T Consensus 239 ~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 239 YSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHTTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999987
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-48 Score=366.13 Aligned_cols=248 Identities=25% Similarity=0.393 Sum_probs=211.8
Q ss_pred hhhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC-------chHHHHHHHHHHHhhc--cCCCcceeeec
Q psy11098 95 QEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ-------PQQITRAEYNLLSTLM--HAHIPTALALF 165 (380)
Q Consensus 95 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-------~~~~~~~E~~il~~l~--h~ni~~i~~~~ 165 (380)
.+.+.++|++.+.||+|+||.||+|++..+++.||+|++..... ....+.+|+.+++.+. |+|++++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 45678899999999999999999999999999999999965422 2244567999999996 59999999998
Q ss_pred ccccCCCceEEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe--CCeeEEEeC
Q psy11098 166 ENAPVPGTDTIVMQLVHG-ESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN--GAVLKLIDL 242 (380)
Q Consensus 166 ~~~~~~~~~~lv~e~~~g-g~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~--~~~ikl~DF 242 (380)
... +..++|||++.+ ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+||
T Consensus 118 ~~~---~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 118 ERP---DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp ECS---SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred ecC---CcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 764 678999999976 89999999888999999999999999999999999999999999999998 369999999
Q ss_pred CCccccc----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCC
Q psy11098 243 GSSVSVS----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCG 318 (380)
Q Consensus 243 G~a~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 318 (380)
|++.... ....||+.|+|||++.+...++.++||||||+++|+|++|..||.... .+......++ .
T Consensus 195 g~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~----~ 264 (320)
T 3a99_A 195 GSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFR----Q 264 (320)
T ss_dssp TTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCS----S
T ss_pred ccccccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhccccccc----c
Confidence 9997664 345689999999999875555778999999999999999999996542 1222222222 4
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 319 HISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 319 ~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
.+++++.+||++||..||++|||++|+|+||||++..
T Consensus 265 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 265 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp CCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 5899999999999999999999999999999998763
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-48 Score=372.58 Aligned_cols=254 Identities=27% Similarity=0.421 Sum_probs=206.3
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhc-----------cCCCcceeeeccc
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLM-----------HAHIPTALALFEN 167 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~-----------h~ni~~i~~~~~~ 167 (380)
..+|++.+.||+|+||+||+|++..+++.||+|++.........+.+|+.+++.+. |+||+++++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 56899999999999999999999999999999999766555667788999999887 7899999998876
Q ss_pred cc-CCCceEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC-CcEeecCCCCcEEEe-----C--Ce
Q psy11098 168 AP-VPGTDTIVMQLVHGESLIQHLCRQ--STITESYICCIIRQLHSALHCLHSQ-QIAHKDIRPENILMN-----G--AV 236 (380)
Q Consensus 168 ~~-~~~~~~lv~e~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~al~~lH~~-~iiHrDlKp~NIl~~-----~--~~ 236 (380)
.. .....+++||++ +++|.+++... ..+++..++.++.||+.||.|||++ ||+||||||+|||++ + +.
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~ 176 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ 176 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcce
Confidence 42 123678999999 99999999763 4599999999999999999999998 999999999999995 1 27
Q ss_pred eEEEeCCCccccc---ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHhc
Q psy11098 237 LKLIDLGSSVSVS---TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESE------EETRAHISV 307 (380)
Q Consensus 237 ikl~DFG~a~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~------~~~~~~i~~ 307 (380)
+||+|||++.... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+... .+....+..
T Consensus 177 ~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (373)
T 1q8y_A 177 IKIADLGNACWYDEHYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 255 (373)
T ss_dssp EEECCCTTCEETTBCCCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHH
T ss_pred EEEcccccccccCCCCCCCCCCccccCcHHHhC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHH
Confidence 9999999997664 45678999999999988 4678999999999999999999999976542 222222221
Q ss_pred ccCCCCC--------------------------------------CcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcc
Q psy11098 308 ADYSFPP--------------------------------------EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVA 349 (380)
Q Consensus 308 ~~~~~~~--------------------------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp 349 (380)
.....+. .....++.++.+||++||+.||++|||++|+|+||
T Consensus 256 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 335 (373)
T 1q8y_A 256 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHP 335 (373)
T ss_dssp HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCG
T ss_pred hcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhCh
Confidence 1101000 00112456789999999999999999999999999
Q ss_pred ccccc
Q psy11098 350 WFAEA 354 (380)
Q Consensus 350 w~~~~ 354 (380)
||++.
T Consensus 336 ~f~~~ 340 (373)
T 1q8y_A 336 WLKDT 340 (373)
T ss_dssp GGTTC
T ss_pred hhhcc
Confidence 99975
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-47 Score=352.29 Aligned_cols=242 Identities=23% Similarity=0.326 Sum_probs=211.2
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVM 178 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~ 178 (380)
.++|++.+.||+|+||+||+|.+. +++.||+|++.........+.+|+++++.++|+||+++++++... +..++||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~~lv~ 98 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ---RPIFIIT 98 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSS---SSEEEEE
T ss_pred HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecC---CCeEEEE
Confidence 578999999999999999999877 577899999987777777889999999999999999999988763 6789999
Q ss_pred EecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-------
Q psy11098 179 QLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------- 249 (380)
Q Consensus 179 e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------- 249 (380)
||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 178 (283)
T 3gen_A 99 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 178 (283)
T ss_dssp CCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHST
T ss_pred eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccccccc
Confidence 99999999999976 56799999999999999999999999999999999999998 4699999999997653
Q ss_pred ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHH
Q psy11098 250 TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELI 328 (380)
Q Consensus 250 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 328 (380)
....+|+.|+|||++.+ ..++.++||||||+++|+|++ |..||......+....+........+ ...++++.+||
T Consensus 179 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li 254 (283)
T 3gen_A 179 VGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP---HLASEKVYTIM 254 (283)
T ss_dssp TSTTSCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC---TTCCHHHHHHH
T ss_pred cCCccCcccCCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCC---CcCCHHHHHHH
Confidence 23456788999999987 467889999999999999998 99999999888888887765433332 35689999999
Q ss_pred HHhcccCCCCCCCHHHHHhc
Q psy11098 329 GQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 329 ~~~L~~dP~~Rpt~~e~L~h 348 (380)
.+||..||++|||++++|+|
T Consensus 255 ~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 255 YSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp HHTTCSSGGGSCCHHHHHHH
T ss_pred HHHccCChhHCcCHHHHHHH
Confidence 99999999999999999987
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=362.30 Aligned_cols=247 Identities=29% Similarity=0.446 Sum_probs=203.4
Q ss_pred hhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC-------chHHHHHHHHHHHhh----ccCCCcceeee
Q psy11098 96 EQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ-------PQQITRAEYNLLSTL----MHAHIPTALAL 164 (380)
Q Consensus 96 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-------~~~~~~~E~~il~~l----~h~ni~~i~~~ 164 (380)
+.+.++|++.+.||+|+||.||+|++..+++.||+|++..... ....+.+|+.++..+ +|+||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 3467899999999999999999999999999999999965432 223345699999999 89999999998
Q ss_pred cccccCCCceEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe--CCeeEEEe
Q psy11098 165 FENAPVPGTDTIVMQL-VHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN--GAVLKLID 241 (380)
Q Consensus 165 ~~~~~~~~~~~lv~e~-~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~--~~~ikl~D 241 (380)
+... +..++|||+ +.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|
T Consensus 107 ~~~~---~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~d 183 (312)
T 2iwi_A 107 FETQ---EGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLID 183 (312)
T ss_dssp C--------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECC
T ss_pred EecC---CeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEE
Confidence 8764 567999999 78999999999888899999999999999999999999999999999999998 46899999
Q ss_pred CCCccccc----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcC
Q psy11098 242 LGSSVSVS----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQC 317 (380)
Q Consensus 242 FG~a~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 317 (380)
||++.... ....||+.|+|||++.+....+.++||||||+++|+|++|..||.... .+......++
T Consensus 184 fg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~---- 253 (312)
T 2iwi_A 184 FGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHFP---- 253 (312)
T ss_dssp CSSCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCCC----
T ss_pred cchhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCCc----
Confidence 99987654 345689999999998875455568999999999999999999996542 2222333333
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 318 GHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 318 ~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
..++.++++||.+||..||++|||++|+|+||||+...
T Consensus 254 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 254 AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 35799999999999999999999999999999998763
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=355.39 Aligned_cols=250 Identities=28% Similarity=0.430 Sum_probs=204.8
Q ss_pred eeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC-CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEEEe
Q psy11098 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER-QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQL 180 (380)
Q Consensus 102 y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e~ 180 (380)
|.....||+|+||.||+|.+..+++.||+|++.... ...+.+.+|+.+++.++|+||+++++++... +..++||||
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~lv~e~ 100 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN---GFIKIFMEQ 100 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEET---TEEEEEEEC
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC---CcEEEEEEe
Confidence 334458999999999999999999999999997543 3456778899999999999999999998764 678999999
Q ss_pred cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe--CCeeEEEeCCCccccc------
Q psy11098 181 VHGESLIQHLCRQ---STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN--GAVLKLIDLGSSVSVS------ 249 (380)
Q Consensus 181 ~~gg~L~~~l~~~---~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~--~~~ikl~DFG~a~~~~------ 249 (380)
+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~ 180 (295)
T 2clq_A 101 VPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCT 180 (295)
T ss_dssp CSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----
T ss_pred CCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCcc
Confidence 9999999999764 2567999999999999999999999999999999999998 4689999999997653
Q ss_pred ccccCCCcccCCccccCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHhcccCCCCCCcCCCCCHHHHHH
Q psy11098 250 TVVLPDLEFASPEMLTSP-ATAGPSTDMWSLGVLLYILLSGVSPFLDESEEE-TRAHISVADYSFPPEQCGHISVPAREL 327 (380)
Q Consensus 250 ~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~~~~~l 327 (380)
....||+.|+|||++.+. ..++.++||||||+++|+|++|..||.+..... ....... ..........++.++.+|
T Consensus 181 ~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l 258 (295)
T 2clq_A 181 ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGM--FKVHPEIPESMSAEAKAF 258 (295)
T ss_dssp CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHH--HCCCCCCCTTSCHHHHHH
T ss_pred cccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcc--ccccccccccCCHHHHHH
Confidence 345789999999998753 236789999999999999999999997643322 2222111 112222334689999999
Q ss_pred HHHhcccCCCCCCCHHHHHhcccccccCC
Q psy11098 328 IGQLLNTHADKRPTAGQLLQVAWFAEASC 356 (380)
Q Consensus 328 i~~~L~~dP~~Rpt~~e~L~hpw~~~~~~ 356 (380)
|.+||..||++|||++++|+||||+....
T Consensus 259 i~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 287 (295)
T 2clq_A 259 ILKCFEPDPDKRACANDLLVDEFLKVSSK 287 (295)
T ss_dssp HHHTTCSSTTTSCCHHHHHTSGGGCC---
T ss_pred HHHHccCChhhCCCHHHHhcChhhhhccc
Confidence 99999999999999999999999987643
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=363.21 Aligned_cols=256 Identities=16% Similarity=0.244 Sum_probs=196.8
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCc---EEEEEEecCCC---CchHHHHHHHHHHHhhccCCCcceeeecccccCC
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQ---LVALKQIPRER---QPQQITRAEYNLLSTLMHAHIPTALALFENAPVP 171 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~---~vAvK~~~~~~---~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~ 171 (380)
..++|++.+.||+|+||+||+|++..++. .||+|++.... .....+.+|+++++.++|+||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 35789999999999999999999887765 89999997542 3346678899999999999999999998764322
Q ss_pred C---ceEEEEEecCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEe
Q psy11098 172 G---TDTIVMQLVHGESLIQHLCRQS------TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLID 241 (380)
Q Consensus 172 ~---~~~lv~e~~~gg~L~~~l~~~~------~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~D 241 (380)
+ ..++||||+.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~D 180 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVAD 180 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECC
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEee
Confidence 2 2389999999999999996532 599999999999999999999999999999999999998 45999999
Q ss_pred CCCccccc--------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCC
Q psy11098 242 LGSSVSVS--------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSF 312 (380)
Q Consensus 242 FG~a~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~ 312 (380)
||++.... ....+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+.......
T Consensus 181 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~ 259 (323)
T 3qup_A 181 FGLSRKIYSGDYYRQGCASKLPVKWLALESLAD-NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLK 259 (323)
T ss_dssp CCC-----------------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC
T ss_pred ccccccccccccccccccccCcccccCchhhcC-CCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCCC
Confidence 99997653 23456788999999987 477889999999999999999 999999888877777766544222
Q ss_pred CCCcCCCCCHHHHHHHHHhcccCCCCCCC-------HHHHHhcccccccCCC
Q psy11098 313 PPEQCGHISVPARELIGQLLNTHADKRPT-------AGQLLQVAWFAEASCS 357 (380)
Q Consensus 313 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt-------~~e~L~hpw~~~~~~~ 357 (380)
....+++++.+||.+||..||++||| +++++.|+|+...+..
T Consensus 260 ---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~ 308 (323)
T 3qup_A 260 ---QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQD 308 (323)
T ss_dssp ---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---------
T ss_pred ---CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCC
Confidence 22468999999999999999999999 8889999999887554
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=365.62 Aligned_cols=243 Identities=21% Similarity=0.292 Sum_probs=208.8
Q ss_pred hhceeeeeeecccCCeEEEEEEEc-------CCCcEEEEEEecCCCCc--hHHHHHHHHHHHhh-ccCCCcceeeecccc
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDR-------GTGQLVALKQIPRERQP--QQITRAEYNLLSTL-MHAHIPTALALFENA 168 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~-------~~~~~vAvK~~~~~~~~--~~~~~~E~~il~~l-~h~ni~~i~~~~~~~ 168 (380)
.++|++.+.||+|+||+||+|++. .++..||+|+++..... ...+.+|+.+++.+ +||||+++++++...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 578999999999999999999975 34568999999765432 34678899999999 899999999988764
Q ss_pred cCCCceEEEEEecCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEE
Q psy11098 169 PVPGTDTIVMQLVHGESLIQHLCRQS----------------TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILM 232 (380)
Q Consensus 169 ~~~~~~~lv~e~~~gg~L~~~l~~~~----------------~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~ 232 (380)
+..|+||||+.||+|.+++.... .+++.++..++.||+.||.|||++||+||||||+|||+
T Consensus 160 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 ---GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 236 (370)
T ss_dssp ---SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred ---CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE
Confidence 67899999999999999997643 47999999999999999999999999999999999999
Q ss_pred e-CCeeEEEeCCCccccc--------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy11098 233 N-GAVLKLIDLGSSVSVS--------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETR 302 (380)
Q Consensus 233 ~-~~~ikl~DFG~a~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~ 302 (380)
+ ++.+||+|||++.... ....+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+..
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~ 315 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 315 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 8 5699999999997553 23456789999999988 478899999999999999999 99999998887777
Q ss_pred HHHhcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 303 AHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 303 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
..+...... .....++.++.+||.+||..||++|||+.|++++
T Consensus 316 ~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 316 KLLKEGHRM---DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HHHHTTCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 766654322 2224679999999999999999999999999975
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=369.74 Aligned_cols=250 Identities=20% Similarity=0.322 Sum_probs=214.0
Q ss_pred hhhceeeeeeecccCCeEEEEEE-----EcCCCcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccC
Q psy11098 98 FEHRYEELERLGNGRFCTVRKAR-----DRGTGQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPV 170 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~-----~~~~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~ 170 (380)
..++|++.+.||+|+||+||+|+ +..+++.||||++..... ....+.+|+.+++.++|+||+++++++...
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-- 146 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS-- 146 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC--
Confidence 36789999999999999999999 455788999999965433 334577899999999999999999998764
Q ss_pred CCceEEEEEecCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-C---eeEE
Q psy11098 171 PGTDTIVMQLVHGESLIQHLCRQ-------STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-A---VLKL 239 (380)
Q Consensus 171 ~~~~~lv~e~~~gg~L~~~l~~~-------~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~---~ikl 239 (380)
+..++||||+.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. + .+||
T Consensus 147 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 147 -LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp -SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred -CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEE
Confidence 5679999999999999999764 35899999999999999999999999999999999999972 2 5999
Q ss_pred EeCCCccccc--------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccC
Q psy11098 240 IDLGSSVSVS--------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADY 310 (380)
Q Consensus 240 ~DFG~a~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~ 310 (380)
+|||+++... ....+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+.....
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~ 304 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 304 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 9999997442 34567899999999987 478889999999999999998 9999999998888888776553
Q ss_pred CCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 311 SFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 311 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
... ...++.++.+||.+||+.||++|||+.++++|.|+...
T Consensus 305 ~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 305 MDP---PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp CCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCC---CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 222 24679999999999999999999999999999888654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-47 Score=360.04 Aligned_cols=244 Identities=20% Similarity=0.286 Sum_probs=209.7
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCc---EEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCC
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQ---LVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPG 172 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~---~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~ 172 (380)
..++|++.+.||+|+||+||+|.+..+++ .||||++..... ....+.+|+.+++.++|+||+++++++... +
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~ 123 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG---R 123 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG---G
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC---C
Confidence 36789999999999999999999986655 599999976433 345678899999999999999999998764 5
Q ss_pred ceEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-
Q psy11098 173 TDTIVMQLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS- 249 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~- 249 (380)
..++||||+.|++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 124 LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp CCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred ccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 679999999999999999654 6799999999999999999999999999999999999998 4699999999997653
Q ss_pred --------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCC
Q psy11098 250 --------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHI 320 (380)
Q Consensus 250 --------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 320 (380)
....+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+...... + ....+
T Consensus 204 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~ 279 (325)
T 3kul_A 204 DPDAAYTTTGGKIPIRWTAPEAIAF-RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRL-P--APMGC 279 (325)
T ss_dssp ---CCEECC---CCGGGSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC-C--CCTTC
T ss_pred CccceeeccCCCCcccccCHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCC-C--CCCCc
Confidence 22345778999999987 477889999999999999999 99999999988888877655322 1 23468
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 321 SVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 321 s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
++++.+||.+||..||++|||+.++++.
T Consensus 280 ~~~l~~li~~~l~~dp~~Rps~~eil~~ 307 (325)
T 3kul_A 280 PHALHQLMLDCWHKDRAQRPRFSQIVSV 307 (325)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999999999999999999999864
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=355.32 Aligned_cols=250 Identities=21% Similarity=0.302 Sum_probs=206.9
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---chHHHHHHHHHHHhhcc--CCCcceeeecccccCCCc
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLMH--AHIPTALALFENAPVPGT 173 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~h--~ni~~i~~~~~~~~~~~~ 173 (380)
.++|++.+.||+|+||.||+|.+. +++.||+|++..... ....+.+|+.+++.++| +||+++++++... +.
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~---~~ 102 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD---QY 102 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS---SE
T ss_pred cceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC---CE
Confidence 578999999999999999999975 588999999975433 23567889999999974 9999999887764 57
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeCCeeEEEeCCCccccc----
Q psy11098 174 DTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGAVLKLIDLGSSVSVS---- 249 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~~~ikl~DFG~a~~~~---- 249 (380)
.++||| +.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++++.+||+|||++....
T Consensus 103 ~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~kL~Dfg~~~~~~~~~~ 181 (313)
T 3cek_A 103 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTT 181 (313)
T ss_dssp EEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTEEEECCCSSSCC------
T ss_pred EEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEECCeEEEeeccccccccCccc
Confidence 899999 558999999998889999999999999999999999999999999999999999999999999997653
Q ss_pred ----ccccCCCcccCCccccCC----------CCCCCcccHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhcccCCCCC
Q psy11098 250 ----TVVLPDLEFASPEMLTSP----------ATAGPSTDMWSLGVLLYILLSGVSPFLDESE-EETRAHISVADYSFPP 314 (380)
Q Consensus 250 ----~~~~gt~~y~aPE~~~~~----------~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~-~~~~~~i~~~~~~~~~ 314 (380)
....||+.|+|||++.+. ..++.++||||||+++|+|++|..||.+... ......+........
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~- 260 (313)
T 3cek_A 182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE- 260 (313)
T ss_dssp --------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCC-
T ss_pred cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccC-
Confidence 244689999999998651 3567799999999999999999999977543 333344433332222
Q ss_pred CcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 315 EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 315 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
.....+.++.+||++||..||++|||++|+|+||||+...
T Consensus 261 -~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 300 (313)
T 3cek_A 261 -FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 300 (313)
T ss_dssp -CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred -CcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence 2234688999999999999999999999999999998754
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=360.75 Aligned_cols=243 Identities=19% Similarity=0.279 Sum_probs=205.6
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhh-ccCCCcceeeecccccCCCceEE
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTL-MHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
+.++|++.+.||+|+||+||+|++..+++.||||++..... ...+.+|+++++.+ +|+||+++++++... +..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~---~~~~l 82 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-APQLHLEYRFYKQLGSGDGIPQVYYFGPCG---KYNAM 82 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-SCCHHHHHHHHHHHCSCTTSCCEEEEEEET---TEEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHhhCCCCCCEEEEEEecC---CccEE
Confidence 46789999999999999999999999999999999975543 34577899999999 999999999988774 67799
Q ss_pred EEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeCC-e-----eEEEeCCCccccc
Q psy11098 177 VMQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGA-V-----LKLIDLGSSVSVS 249 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~~-~-----ikl~DFG~a~~~~ 249 (380)
||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+ . +||+|||++....
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 83 VLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred EEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 99999 9999999976 4689999999999999999999999999999999999999843 4 9999999997542
Q ss_pred -------------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHhcccCCCC
Q psy11098 250 -------------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDE---SEEETRAHISVADYSFP 313 (380)
Q Consensus 250 -------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~---~~~~~~~~i~~~~~~~~ 313 (380)
....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+. ...+....+.......+
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 240 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLG-KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP 240 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC
T ss_pred cCCCCccccccccCCcCCCccccChHHHcC-CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC
Confidence 24578999999999988 57788999999999999999999999873 34445555544433333
Q ss_pred CCc-CCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy11098 314 PEQ-CGHISVPARELIGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 314 ~~~-~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~ 347 (380)
.+. +...+ ++.+||..||..||.+||+++++++
T Consensus 241 ~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 241 IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 322 22344 9999999999999999999999876
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=365.59 Aligned_cols=246 Identities=21% Similarity=0.299 Sum_probs=205.2
Q ss_pred hhhceeeeeeecccCCeEEEEEE-----EcCCCcEEEEEEecCCCCc--hHHHHHHHHHHHhh-ccCCCcceeeeccccc
Q psy11098 98 FEHRYEELERLGNGRFCTVRKAR-----DRGTGQLVALKQIPRERQP--QQITRAEYNLLSTL-MHAHIPTALALFENAP 169 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~-----~~~~~~~vAvK~~~~~~~~--~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~ 169 (380)
..++|++.+.||+|+||.||+|+ +..+++.||||+++..... ...+.+|++++..+ +||||+++++++...
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~- 98 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 98 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC-
Confidence 46899999999999999999999 5567789999999765432 34678899999999 789999999988763
Q ss_pred CCCceEEEEEecCCCCHHHHHHhcCC------------------------------------------------------
Q psy11098 170 VPGTDTIVMQLVHGESLIQHLCRQST------------------------------------------------------ 195 (380)
Q Consensus 170 ~~~~~~lv~e~~~gg~L~~~l~~~~~------------------------------------------------------ 195 (380)
.+..++||||+.||+|.+++.....
T Consensus 99 -~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (359)
T 3vhe_A 99 -GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177 (359)
T ss_dssp -TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------
T ss_pred -CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhh
Confidence 2457999999999999999976432
Q ss_pred ------------CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc--------ccccC
Q psy11098 196 ------------ITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS--------TVVLP 254 (380)
Q Consensus 196 ------------l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~--------~~~~g 254 (380)
+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.... ....|
T Consensus 178 ~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 257 (359)
T 3vhe_A 178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257 (359)
T ss_dssp ------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEE
T ss_pred hcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCC
Confidence 89999999999999999999999999999999999998 5689999999997542 34566
Q ss_pred CCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhcc
Q psy11098 255 DLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLN 333 (380)
Q Consensus 255 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 333 (380)
|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+............. ....+++++.++|.+||.
T Consensus 258 t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~ 334 (359)
T 3vhe_A 258 PLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR--APDYTTPEMYQTMLDCWH 334 (359)
T ss_dssp CGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCC--CCTTCCHHHHHHHHHHTC
T ss_pred CceeEChhhhcC-CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCC--CCCCCCHHHHHHHHHHcc
Confidence 889999999987 477889999999999999998 9999988664433333322222222 224579999999999999
Q ss_pred cCCCCCCCHHHHHhc
Q psy11098 334 THADKRPTAGQLLQV 348 (380)
Q Consensus 334 ~dP~~Rpt~~e~L~h 348 (380)
.||++|||++|+++|
T Consensus 335 ~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 335 GEPSQRPTFSELVEH 349 (359)
T ss_dssp SSGGGSCCHHHHHHH
T ss_pred CChhhCCCHHHHHHH
Confidence 999999999999987
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=353.17 Aligned_cols=243 Identities=22% Similarity=0.292 Sum_probs=209.3
Q ss_pred hhceeeeeeecccCCeEEEEEEEc-----CCCcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCC
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDR-----GTGQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVP 171 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~ 171 (380)
.++|++.+.||+|+||.||+|.+. .+++.||+|++..... ....+.+|+++++.++||||+++++++...
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--- 98 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD--- 98 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS---
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC---
Confidence 678999999999999999999983 4568999999975443 235677899999999999999999988764
Q ss_pred CceEEEEEecCCCCHHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCC
Q psy11098 172 GTDTIVMQLVHGESLIQHLCRQST------------------------ITESYICCIIRQLHSALHCLHSQQIAHKDIRP 227 (380)
Q Consensus 172 ~~~~lv~e~~~gg~L~~~l~~~~~------------------------l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp 227 (380)
+..++||||+.|++|.+++..... +++..++.++.||+.||.|||++||+||||||
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp 178 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAA 178 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccch
Confidence 667999999999999999976543 89999999999999999999999999999999
Q ss_pred CcEEEe-CCeeEEEeCCCccccc--------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCC
Q psy11098 228 ENILMN-GAVLKLIDLGSSVSVS--------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDES 297 (380)
Q Consensus 228 ~NIl~~-~~~ikl~DFG~a~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~ 297 (380)
+|||++ ++.+||+|||++.... ....+|+.|+|||++.+ ..++.++||||||+++|+|++ |..||.+..
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcC-CCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999998 4689999999997552 23456788999999987 467889999999999999999 999999888
Q ss_pred HHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 298 EEETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 298 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
..+....+...... .....+++++.+||.+||..||++|||+.+++++
T Consensus 258 ~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 258 PERLFNLLKTGHRM---ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp GGGHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhhcCCcC---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 77777666554322 2234689999999999999999999999999976
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=348.28 Aligned_cols=244 Identities=23% Similarity=0.329 Sum_probs=204.2
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCch--------HHHHHHHHHHHhhccCCCcceeeeccccc
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQ--------QITRAEYNLLSTLMHAHIPTALALFENAP 169 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~--------~~~~~E~~il~~l~h~ni~~i~~~~~~~~ 169 (380)
..++|++.+.||+|+||+||+|++..+++.||+|++....... ..+.+|+++++.++|+||+++++++...
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 95 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP- 95 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT-
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC-
Confidence 3578999999999999999999999999999999996433211 5678899999999999999999988643
Q ss_pred CCCceEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cEeecCCCCcEEEeC-Ce-----eEEE
Q psy11098 170 VPGTDTIVMQLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQ--IAHKDIRPENILMNG-AV-----LKLI 240 (380)
Q Consensus 170 ~~~~~~lv~e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~--iiHrDlKp~NIl~~~-~~-----ikl~ 240 (380)
.++||||+.+++|.+.+... ..+++..++.++.||+.||.|||++| |+||||||+|||++. +. +||+
T Consensus 96 ----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 96 ----PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp ----TEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred ----CeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 37999999999999988654 57999999999999999999999999 999999999999973 33 9999
Q ss_pred eCCCccccc---ccccCCCcccCCccccC-CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHhcccCCCCC
Q psy11098 241 DLGSSVSVS---TVVLPDLEFASPEMLTS-PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEET--RAHISVADYSFPP 314 (380)
Q Consensus 241 DFG~a~~~~---~~~~gt~~y~aPE~~~~-~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~--~~~i~~~~~~~~~ 314 (380)
|||++.... ....||+.|+|||++.+ ...++.++|||||||++|+|++|..||........ ...+.... ...
T Consensus 172 Dfg~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~--~~~ 249 (287)
T 4f0f_A 172 DFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG--LRP 249 (287)
T ss_dssp CCTTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSC--CCC
T ss_pred CCCccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccC--CCC
Confidence 999997654 45678999999999853 24567899999999999999999999987654333 33333322 222
Q ss_pred CcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 315 EQCGHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 315 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
.....+++++.+||.+||+.||++|||++|+++.
T Consensus 250 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 283 (287)
T 4f0f_A 250 TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283 (287)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 3345689999999999999999999999999863
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=351.56 Aligned_cols=242 Identities=22% Similarity=0.333 Sum_probs=203.4
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCC-------cEEEEEEecCCC-CchHHHHHHHHHHHhhccCCCcceeeecccccC
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTG-------QLVALKQIPRER-QPQQITRAEYNLLSTLMHAHIPTALALFENAPV 170 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~-------~~vAvK~~~~~~-~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~ 170 (380)
.++|++.+.||+|+||+||+|+++.++ ..||+|++.... ...+.+.+|+++++.++|+||+++++++...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 84 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG-- 84 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT--
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC--
Confidence 678999999999999999999998877 479999996543 3456788899999999999999999998764
Q ss_pred CCceEEEEEecCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-Ce--------eEEE
Q psy11098 171 PGTDTIVMQLVHGESLIQHLCRQST-ITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AV--------LKLI 240 (380)
Q Consensus 171 ~~~~~lv~e~~~gg~L~~~l~~~~~-l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~--------ikl~ 240 (380)
+..++||||+.|++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++. +. +||+
T Consensus 85 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 85 -DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp -TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred -CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeec
Confidence 567999999999999999977544 999999999999999999999999999999999999973 33 9999
Q ss_pred eCCCccccc--ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHhcccCCCCCCcC
Q psy11098 241 DLGSSVSVS--TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSG-VSPFLDESEEETRAHISVADYSFPPEQC 317 (380)
Q Consensus 241 DFG~a~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 317 (380)
|||++.... ....+|+.|+|||++.+...++.++||||||+++|+|++| .+||........... ......++
T Consensus 164 Dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~-~~~~~~~~---- 238 (289)
T 4fvq_A 164 DPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF-YEDRHQLP---- 238 (289)
T ss_dssp CCCSCTTTSCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH-HHTTCCCC----
T ss_pred cCcccccccCccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHH-hhccCCCC----
Confidence 999997654 3456789999999998755788899999999999999995 555555444444333 33333333
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 318 GHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 318 ~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
...+.++.+||++||+.||++|||++++++|
T Consensus 239 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 239 APKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 2357889999999999999999999999987
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=344.61 Aligned_cols=241 Identities=23% Similarity=0.345 Sum_probs=201.0
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC-----chHHHHHHHHHHHhhccCCCcceeeecccccCCCc
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ-----PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGT 173 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-----~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~ 173 (380)
.++|++.+.||+|+||.||+|.+. ++.||+|++..... ..+.+.+|+++++.++|+||+++++++... +.
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~ 80 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKE---PN 80 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC-----
T ss_pred hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC---Cc
Confidence 468999999999999999999975 78999999865422 235678899999999999999999998764 56
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeecCCCCcEEEe---------CCeeEEEe
Q psy11098 174 DTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQ---IAHKDIRPENILMN---------GAVLKLID 241 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~---iiHrDlKp~NIl~~---------~~~ikl~D 241 (380)
.++||||+.|++|.+++. ...+++..++.++.||+.||.|||++| |+||||||+|||++ ++.+||+|
T Consensus 81 ~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred eEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 799999999999998885 458999999999999999999999999 99999999999996 35799999
Q ss_pred CCCccccc----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcC
Q psy11098 242 LGSSVSVS----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQC 317 (380)
Q Consensus 242 FG~a~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 317 (380)
||++.... ....||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.........+.......+. .
T Consensus 160 fg~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~ 236 (271)
T 3dtc_A 160 FGLAREWHRTTKMSAAGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI--P 236 (271)
T ss_dssp CCC-------------CCGGGSCHHHHHH-CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCC--C
T ss_pred CCcccccccccccCCCCccceeCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCC--C
Confidence 99997653 34578999999999987 46788999999999999999999999998888777777665544432 3
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 318 GHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 318 ~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
..+++++.+||.+||..||++|||+.|+++|
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 237 STCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 5689999999999999999999999999976
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=360.59 Aligned_cols=244 Identities=20% Similarity=0.282 Sum_probs=211.3
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCC-------cEEEEEEecCCCCc--hHHHHHHHHHHHhh-ccCCCcceeeeccc
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTG-------QLVALKQIPRERQP--QQITRAEYNLLSTL-MHAHIPTALALFEN 167 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~-------~~vAvK~~~~~~~~--~~~~~~E~~il~~l-~h~ni~~i~~~~~~ 167 (380)
..++|++.+.||+|+||+||+|++..++ ..||+|++...... ...+.+|+++++.+ +|+||+++++++..
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 4689999999999999999999976433 57999999765443 35677899999999 99999999999876
Q ss_pred ccCCCceEEEEEecCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEE
Q psy11098 168 APVPGTDTIVMQLVHGESLIQHLCRQS----------------TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENIL 231 (380)
Q Consensus 168 ~~~~~~~~lv~e~~~gg~L~~~l~~~~----------------~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl 231 (380)
. +..++||||+.+|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 147 ~---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 D---GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 223 (382)
T ss_dssp S---SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred C---CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEE
Confidence 4 66799999999999999997653 4999999999999999999999999999999999999
Q ss_pred Ee-CCeeEEEeCCCccccc--------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q psy11098 232 MN-GAVLKLIDLGSSVSVS--------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEET 301 (380)
Q Consensus 232 ~~-~~~ikl~DFG~a~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~ 301 (380)
++ ++.+||+|||++.... ....+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+.
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~ 302 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 302 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 98 5699999999997543 23456788999999988 578889999999999999999 9999999988888
Q ss_pred HHHHhcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 302 RAHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 302 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
...+........ ...+++++.+||++||..||++|||++|++++
T Consensus 303 ~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 303 FKLLKEGHRMDK---PSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHTTCCCCC---CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCCCCC---CccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 877765543222 24689999999999999999999999999987
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=356.87 Aligned_cols=244 Identities=19% Similarity=0.290 Sum_probs=211.7
Q ss_pred hhhceeeeeeecccCCeEEEEEEEc-----CCCcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccC
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDR-----GTGQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPV 170 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~ 170 (380)
..++|++.+.||+|+||.||+|++. .+++.||+|+++.... ....+.+|+.+++.++|+||+++++++...
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-- 122 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG-- 122 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS--
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC--
Confidence 4678999999999999999999987 3558999999976543 245678899999999999999999998764
Q ss_pred CCceEEEEEecCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCC
Q psy11098 171 PGTDTIVMQLVHGESLIQHLCRQ------------------------STITESYICCIIRQLHSALHCLHSQQIAHKDIR 226 (380)
Q Consensus 171 ~~~~~lv~e~~~gg~L~~~l~~~------------------------~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlK 226 (380)
+..++||||+.+++|.+++... ..+++.+++.++.||+.||.|||++||+|||||
T Consensus 123 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk 201 (343)
T 1luf_A 123 -KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 201 (343)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred -CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 6779999999999999999763 569999999999999999999999999999999
Q ss_pred CCcEEEe-CCeeEEEeCCCccccc--------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCC
Q psy11098 227 PENILMN-GAVLKLIDLGSSVSVS--------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDE 296 (380)
Q Consensus 227 p~NIl~~-~~~ikl~DFG~a~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~ 296 (380)
|+|||++ ++.+||+|||++.... ....+|+.|+|||++.+ ..++.++||||||+++|+|++ |..||.+.
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~ 280 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGM 280 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhcc-CCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence 9999998 4699999999987542 23456889999999987 467889999999999999999 99999999
Q ss_pred CHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 297 SEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 297 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
...+....+........ ...++.++.+||++||..||++|||+.+++++
T Consensus 281 ~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 281 AHEEVIYYVRDGNILAC---PENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp CHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ChHHHHHHHhCCCcCCC---CCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 98888888776654322 24679999999999999999999999999865
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=342.07 Aligned_cols=242 Identities=20% Similarity=0.292 Sum_probs=212.8
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVM 178 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~ 178 (380)
.++|++.+.||+|+||.||+|.+. +++.||+|++.......+.+.+|+++++.++|+||+++++++... +..++||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~lv~ 82 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ---APICLVT 82 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSS---SSCEEEE
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccC---CCeEEEE
Confidence 468999999999999999999987 577899999987776777889999999999999999999988764 5679999
Q ss_pred EecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-------
Q psy11098 179 QLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------- 249 (380)
Q Consensus 179 e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------- 249 (380)
||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 162 (267)
T 3t9t_A 83 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 162 (267)
T ss_dssp CCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred eCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccccccc
Confidence 999999999999765 5689999999999999999999999999999999999997 5689999999987653
Q ss_pred ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHH
Q psy11098 250 TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELI 328 (380)
Q Consensus 250 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 328 (380)
....+|+.|+|||++.+ ..++.++||||||+++|+|++ |..||.+....+....+........ ...++.++.++|
T Consensus 163 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~~~~l~~li 238 (267)
T 3t9t_A 163 TGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLASTHVYQIM 238 (267)
T ss_dssp TSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC---CTTSCHHHHHHH
T ss_pred ccccccccccChhhhcC-CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCC---CccCcHHHHHHH
Confidence 33456788999999987 467889999999999999999 9999999888888877766533222 235789999999
Q ss_pred HHhcccCCCCCCCHHHHHhc
Q psy11098 329 GQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 329 ~~~L~~dP~~Rpt~~e~L~h 348 (380)
.+||..||++|||+.+++++
T Consensus 239 ~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 239 NHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHccCChhhCcCHHHHHHH
Confidence 99999999999999999975
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=347.23 Aligned_cols=243 Identities=21% Similarity=0.263 Sum_probs=200.8
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCC---CcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCC
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGT---GQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPG 172 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~---~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~ 172 (380)
..++|++.+.||+|+||.||+|.+..+ +..||+|++..... ..+.+.+|+.+++.++||||+++++++.. +
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~ 88 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE----N 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS----S
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc----C
Confidence 467999999999999999999998754 45799999875433 23567889999999999999999998743 5
Q ss_pred ceEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-
Q psy11098 173 TDTIVMQLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS- 249 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~- 249 (380)
..++||||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 89 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCc
Confidence 679999999999999999765 4699999999999999999999999999999999999998 6799999999997653
Q ss_pred ------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCH
Q psy11098 250 ------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISV 322 (380)
Q Consensus 250 ------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 322 (380)
....+|+.|+|||++.+ ..++.++||||||+++|+|++ |..||.+....+....+....... ....+++
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~---~~~~~~~ 244 (281)
T 1mp8_A 169 STYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP---MPPNCPP 244 (281)
T ss_dssp ----------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC---CCTTCCH
T ss_pred ccccccccCCCcccccChhhccc-CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCC---CCCCCCH
Confidence 23355788999999987 467889999999999999997 999999888777777776544221 2346899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 323 PARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 323 ~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
++.+||.+||..||++|||+.+++++
T Consensus 245 ~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 245 TLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999999865
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=349.15 Aligned_cols=246 Identities=20% Similarity=0.277 Sum_probs=206.8
Q ss_pred hhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhh-ccCCCcceeeecccccCCCceE
Q psy11098 97 QFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTL-MHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 97 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
.+.++|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+|+.+++.+ +|+|+++++.++... ...+
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~---~~~~ 82 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-APQLRDEYRTYKLLAGCTGIPNVYYFGQEG---LHNV 82 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-SCCHHHHHHHHHHTTTCTTCCCEEEEEEET---TEEE
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-cHHHHHHHHHHHHHhcCCCCCeEEeecCCC---ceeE
Confidence 357889999999999999999999999999999999865433 34567899999999 799999999988753 6779
Q ss_pred EEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-C-----eeEEEeCCCcccc
Q psy11098 176 IVMQLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-A-----VLKLIDLGSSVSV 248 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~-----~ikl~DFG~a~~~ 248 (380)
+||||+ +++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++. + .+||+|||++...
T Consensus 83 lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 83 LVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred EEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 999999 99999999764 46999999999999999999999999999999999999973 3 3999999999754
Q ss_pred c-------------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHhcccCCC
Q psy11098 249 S-------------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDE---SEEETRAHISVADYSF 312 (380)
Q Consensus 249 ~-------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~---~~~~~~~~i~~~~~~~ 312 (380)
. ....||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+. ...+....+.......
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 240 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred ccccccccccccCccCCCCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence 3 23468999999999988 46788999999999999999999999873 3444444443332222
Q ss_pred C-CCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 313 P-PEQCGHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 313 ~-~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
+ ......+++++.+||.+||..||++|||++++++.
T Consensus 241 ~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 241 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred cHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 2 22234689999999999999999999999999754
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=353.21 Aligned_cols=257 Identities=24% Similarity=0.333 Sum_probs=198.0
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCch---HHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQ---QITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~---~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
.++|++.+.||+|+||.||+|+++.+|+.||||++....... ....++..+++.+.|+||+++++++... +..+
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~---~~~~ 100 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN---TDVF 100 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS---SEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC---CcEE
Confidence 468999999999999999999999999999999997654432 2334455678888999999999998764 6789
Q ss_pred EEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeecCCCCcEEEe-CCeeEEEeCCCccccc---
Q psy11098 176 IVMQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQ-QIAHKDIRPENILMN-GAVLKLIDLGSSVSVS--- 249 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~-~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~--- 249 (380)
+||||+ ++.+..+... ...+++..++.++.||+.||.|||++ ||+||||||+|||++ ++.+||+|||++....
T Consensus 101 lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 101 IAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK 179 (318)
T ss_dssp EEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred EEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence 999999 6666665543 56799999999999999999999995 999999999999998 5699999999987553
Q ss_pred --ccccCCCcccCCccccC----CCCCCCcccHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcccCCCCCCcCCCCCH
Q psy11098 250 --TVVLPDLEFASPEMLTS----PATAGPSTDMWSLGVLLYILLSGVSPFLD-ESEEETRAHISVADYSFPPEQCGHISV 322 (380)
Q Consensus 250 --~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGvil~~lltg~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~ 322 (380)
....+|+.|+|||++.+ ...++.++||||||+++|+|++|..||.. ....+....+........+ ....++.
T Consensus 180 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 258 (318)
T 2dyl_A 180 AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLP-GHMGFSG 258 (318)
T ss_dssp -------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCC-SSSCCCH
T ss_pred cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCC-ccCCCCH
Confidence 34578999999999852 24678899999999999999999999987 3455555555544432222 2345899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhcccccccCCCCCc
Q psy11098 323 PARELIGQLLNTHADKRPTAGQLLQVAWFAEASCSEFD 360 (380)
Q Consensus 323 ~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~~~~~ 360 (380)
++.+||.+||..||.+|||++++|+||||++......+
T Consensus 259 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~ 296 (318)
T 2dyl_A 259 DFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVD 296 (318)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHHHSCCC
T ss_pred HHHHHHHHHccCChhHCcCHHHHhhCHHHHhcccccch
Confidence 99999999999999999999999999999876443333
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=348.90 Aligned_cols=244 Identities=18% Similarity=0.266 Sum_probs=213.4
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEE
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIV 177 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv 177 (380)
..++|++.+.||+|+||.||+|.++.+++.||+|++.......+.+.+|+++++.++|+||+++++++... +..++|
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~~~v 87 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE---PPFYII 87 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---SSEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC---CCEEEE
Confidence 36789999999999999999999999999999999987777777888999999999999999999988764 678999
Q ss_pred EEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-----
Q psy11098 178 MQLVHGESLIQHLCRQ--STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS----- 249 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~----- 249 (380)
|||+.|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 167 (288)
T 3kfa_A 88 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 167 (288)
T ss_dssp EECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSE
T ss_pred EEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCccc
Confidence 9999999999999764 4599999999999999999999999999999999999997 4689999999987653
Q ss_pred --ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHH
Q psy11098 250 --TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARE 326 (380)
Q Consensus 250 --~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 326 (380)
....+|+.|+|||++.+ ..++.++||||||+++|+|++ |..||.+.........+..... ......+++++.+
T Consensus 168 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~ 243 (288)
T 3kfa_A 168 AHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR---MERPEGCPEKVYE 243 (288)
T ss_dssp EETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC---CCCCTTCCHHHHH
T ss_pred cccCCccccCcCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCC---CCCCCCCCHHHHH
Confidence 23345788999999987 467889999999999999999 9999988877766666654322 1223468999999
Q ss_pred HHHHhcccCCCCCCCHHHHHhc
Q psy11098 327 LIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 327 li~~~L~~dP~~Rpt~~e~L~h 348 (380)
||++||..||++|||++++++.
T Consensus 244 li~~~l~~dp~~Rps~~~~~~~ 265 (288)
T 3kfa_A 244 LMRACWQWNPSDRPSFAEIHQA 265 (288)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhCCChhhCcCHHHHHHH
Confidence 9999999999999999999863
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=355.77 Aligned_cols=242 Identities=19% Similarity=0.297 Sum_probs=202.3
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcE----EEEEEecCCC--CchHHHHHHHHHHHhhccCCCcceeeecccccCCC
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQL----VALKQIPRER--QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPG 172 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~----vAvK~~~~~~--~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~ 172 (380)
.++|++.+.||+|+||+||+|++..+++. ||+|.+.... .....+.+|+.+++.++|+||+++++++.. +
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~ 89 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT----S 89 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES----S
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec----C
Confidence 57899999999999999999999888765 4777775332 345678889999999999999999999875 3
Q ss_pred ceEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-
Q psy11098 173 TDTIVMQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS- 249 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~- 249 (380)
..++|+|++.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|+...
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 90 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 57899999999999999976 46799999999999999999999999999999999999998 5799999999987553
Q ss_pred -------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCC
Q psy11098 250 -------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHIS 321 (380)
Q Consensus 250 -------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 321 (380)
....+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+....... ....++
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~ 245 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP---QPPICT 245 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC---CCTTBC
T ss_pred CcccccccCCCccccccChHHhcc-CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCC---CCccCC
Confidence 23455889999999987 577899999999999999999 999999888777766665543222 224578
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 322 VPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 322 ~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
.++.+++.+||+.||++|||+.+++++
T Consensus 246 ~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 246 IDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 999999999999999999999999976
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=351.47 Aligned_cols=240 Identities=29% Similarity=0.454 Sum_probs=195.0
Q ss_pred hhhhhceeee-eeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHH-HhhccCCCcceeeeccccc-CCC
Q psy11098 96 EQFEHRYEEL-ERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLL-STLMHAHIPTALALFENAP-VPG 172 (380)
Q Consensus 96 ~~~~~~y~~~-~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il-~~l~h~ni~~i~~~~~~~~-~~~ 172 (380)
..+.++|.+. +.||+|+||.||+|.++.+++.||+|++.. .....+|+.++ +.+.|+||+++++++.... ..+
T Consensus 13 ~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 88 (299)
T 3m2w_A 13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRK 88 (299)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence 4567788887 789999999999999999999999999964 24567788887 6668999999999987521 235
Q ss_pred ceEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC----CeeEEEeCCCcc
Q psy11098 173 TDTIVMQLVHGESLIQHLCRQS--TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG----AVLKLIDLGSSV 246 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~~~--~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~----~~ikl~DFG~a~ 246 (380)
..++||||+.|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||++.
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 89 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp EEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred eEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 6799999999999999998754 6999999999999999999999999999999999999973 589999999986
Q ss_pred cccccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----hcccCCCCCCcCCCCCH
Q psy11098 247 SVSTVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHI----SVADYSFPPEQCGHISV 322 (380)
Q Consensus 247 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i----~~~~~~~~~~~~~~~s~ 322 (380)
... + ..++.++|||||||++|+|++|..||.+.......... ......++...+..+++
T Consensus 169 ~~~----------------~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (299)
T 3m2w_A 169 ETT----------------G-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 231 (299)
T ss_dssp ECT----------------T-CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCH
T ss_pred ccc----------------c-ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCH
Confidence 433 1 35677999999999999999999999876654433222 22223333333356899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhcccccccCC
Q psy11098 323 PARELIGQLLNTHADKRPTAGQLLQVAWFAEASC 356 (380)
Q Consensus 323 ~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~ 356 (380)
++++||.+||+.||++|||++|+|+||||++...
T Consensus 232 ~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~ 265 (299)
T 3m2w_A 232 EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 265 (299)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGG
T ss_pred HHHHHHHHHcccChhhCCCHHHHhcChhhccccc
Confidence 9999999999999999999999999999987643
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=355.98 Aligned_cols=243 Identities=19% Similarity=0.259 Sum_probs=205.1
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC-CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER-QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIV 177 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv 177 (380)
.++|++.+.||+|+||+||+|.+..+++.||+|++.... .....+.+|+++++.++|+||+++++++... +..++|
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~---~~~~lv 85 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD---KRLNFI 85 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET---TEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC---CeeEEE
Confidence 468999999999999999999999999999999985533 3456678899999999999999999998764 678999
Q ss_pred EEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccccc-----
Q psy11098 178 MQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVST----- 250 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~~----- 250 (380)
|||+.|++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.....
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 86 TEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp EECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred EEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 999999999999987 56799999999999999999999999999999999999998 45899999999975421
Q ss_pred ---------------cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHhcccC
Q psy11098 251 ---------------VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEET-----RAHISVADY 310 (380)
Q Consensus 251 ---------------~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~-----~~~i~~~~~ 310 (380)
...||+.|+|||++.+ ..++.++||||||+++|+|++|..||........ .......
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~-- 242 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR-- 242 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH--
T ss_pred cccccccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc--
Confidence 4578999999999988 5778999999999999999999999865322110 0000000
Q ss_pred CCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccc
Q psy11098 311 SFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAE 353 (380)
Q Consensus 311 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~ 353 (380)
. ....+++++.+||.+||+.||++|||++++++ |+.+
T Consensus 243 ~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~ 279 (310)
T 3s95_A 243 Y----CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLET 279 (310)
T ss_dssp T----CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred c----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHH
Confidence 0 12357889999999999999999999999987 5543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-46 Score=349.51 Aligned_cols=245 Identities=25% Similarity=0.355 Sum_probs=202.8
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCc----hHHHHHHHHHHHhhccCCCcceeeecccccCCCc
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP----QQITRAEYNLLSTLMHAHIPTALALFENAPVPGT 173 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~----~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~ 173 (380)
..++|++.+.||+|+||.||+|++..+++.||+|++...... ...+.+|+.+++.++|+||+++++++... +.
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~---~~ 108 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID---GQ 108 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET---TE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC---Ce
Confidence 357899999999999999999999999999999999754322 25677899999999999999999998763 67
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc---
Q psy11098 174 DTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS--- 249 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~--- 249 (380)
.++||||+.|++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 109 LYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK 188 (309)
T ss_dssp EEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence 899999999999999999888999999999999999999999999999999999999998 5699999999987553
Q ss_pred ----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHH
Q psy11098 250 ----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAR 325 (380)
Q Consensus 250 ----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 325 (380)
....||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.........+. .....+......++.++.
T Consensus 189 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~ 266 (309)
T 2h34_A 189 LTQLGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHIN-QAIPRPSTVRPGIPVAFD 266 (309)
T ss_dssp --------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHH-SCCCCGGGTSTTCCTHHH
T ss_pred cccccccCCCcCccCHHHHcC-CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhc-cCCCCccccCCCCCHHHH
Confidence 24568999999999987 477889999999999999999999998877665444443 333333334467899999
Q ss_pred HHHHHhcccCCCCCC-CHHHHHh
Q psy11098 326 ELIGQLLNTHADKRP-TAGQLLQ 347 (380)
Q Consensus 326 ~li~~~L~~dP~~Rp-t~~e~L~ 347 (380)
++|.+||..||++|| |++++++
T Consensus 267 ~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 267 AVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHHhccCCHHHHHHhHHHHHH
Confidence 999999999999999 7888774
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=357.12 Aligned_cols=242 Identities=20% Similarity=0.296 Sum_probs=205.7
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcE----EEEEEecCCC--CchHHHHHHHHHHHhhccCCCcceeeecccccCCC
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQL----VALKQIPRER--QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPG 172 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~----vAvK~~~~~~--~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~ 172 (380)
.++|++.+.||+|+||+||+|++..+++. ||+|.+.... .....+.+|+.+++.++|+||+++++++.. +
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~ 87 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG----S 87 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB----S
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC----C
Confidence 56899999999999999999999988876 7777775332 233456779999999999999999998863 5
Q ss_pred ceEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-
Q psy11098 173 TDTIVMQLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS- 249 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~- 249 (380)
..++||||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 689999999999999999764 5799999999999999999999999999999999999997 5699999999997653
Q ss_pred -------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCC
Q psy11098 250 -------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHIS 321 (380)
Q Consensus 250 -------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 321 (380)
....+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+........+ ..++
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~ 243 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHF-GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQP---QICT 243 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCC---TTBC
T ss_pred ccccccccCCCCcccccChHHhcc-CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCC---CcCc
Confidence 33456789999999987 467889999999999999999 99999998877777777655432222 2467
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 322 VPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 322 ~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
.++.++|.+||..||++|||+.++++|
T Consensus 244 ~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 244 IDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp TTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 889999999999999999999999987
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=355.08 Aligned_cols=247 Identities=20% Similarity=0.303 Sum_probs=206.6
Q ss_pred hhceeeeeeecccCCeEEEEEEEc-----CCCcEEEEEEecCCC--CchHHHHHHHHHHHhh-ccCCCcceeeecccccC
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDR-----GTGQLVALKQIPRER--QPQQITRAEYNLLSTL-MHAHIPTALALFENAPV 170 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vAvK~~~~~~--~~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~~ 170 (380)
.++|++.+.||+|+||.||+|.+. .+++.||+|++.... .....+.+|+.+++.+ .||||+++++++...
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-- 121 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS-- 121 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC--
Confidence 578999999999999999999973 466789999997532 3446778899999999 899999999988764
Q ss_pred CCceEEEEEecCCCCHHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCC
Q psy11098 171 PGTDTIVMQLVHGESLIQHLCRQS-----------------------TITESYICCIIRQLHSALHCLHSQQIAHKDIRP 227 (380)
Q Consensus 171 ~~~~~lv~e~~~gg~L~~~l~~~~-----------------------~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp 227 (380)
+..++||||+.+|+|.+++.... .+++..++.++.||+.||.|||++||+||||||
T Consensus 122 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp 200 (344)
T 1rjb_A 122 -GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 200 (344)
T ss_dssp -SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred -CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCh
Confidence 67799999999999999997643 379999999999999999999999999999999
Q ss_pred CcEEEe-CCeeEEEeCCCccccc--------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCC
Q psy11098 228 ENILMN-GAVLKLIDLGSSVSVS--------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDES 297 (380)
Q Consensus 228 ~NIl~~-~~~ikl~DFG~a~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~ 297 (380)
+|||++ ++.+||+|||++.... ....+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+..
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc-CCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 999998 5699999999997553 23456788999999987 467889999999999999998 999998876
Q ss_pred HHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy11098 298 EEETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 298 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~ 351 (380)
.......+.......+ ....+++++.+||.+||..||++|||+.++++|-.-
T Consensus 280 ~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~ 331 (344)
T 1rjb_A 280 VDANFYKLIQNGFKMD--QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 331 (344)
T ss_dssp CSHHHHHHHHTTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cHHHHHHHHhcCCCCC--CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 5554444443333322 224579999999999999999999999999988543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-46 Score=347.53 Aligned_cols=246 Identities=21% Similarity=0.291 Sum_probs=201.3
Q ss_pred hhhceeeeeeecccCCeEEEEEE----EcCCCcEEEEEEecCCCC-chHHHHHHHHHHHhhccCCCcceeeecccccCCC
Q psy11098 98 FEHRYEELERLGNGRFCTVRKAR----DRGTGQLVALKQIPRERQ-PQQITRAEYNLLSTLMHAHIPTALALFENAPVPG 172 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~----~~~~~~~vAvK~~~~~~~-~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~ 172 (380)
..++|++.+.||+|+||+||+|+ +..+++.||+|++..... ....+.+|+++++.++|+||+++++++.... ..
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 86 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG-RR 86 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH-HT
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-CC
Confidence 46899999999999999999998 567899999999975443 3356788999999999999999999875432 24
Q ss_pred ceEEEEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-
Q psy11098 173 TDTIVMQLVHGESLIQHLCRQS-TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS- 249 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~~~-~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~- 249 (380)
..++||||+.+++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC----
T ss_pred ceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccC
Confidence 5799999999999999997753 599999999999999999999999999999999999998 6799999999997653
Q ss_pred --------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHH
Q psy11098 250 --------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEE----------------ETRAHI 305 (380)
Q Consensus 250 --------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~----------------~~~~~i 305 (380)
....+++.|+|||++.+ ..++.++||||||+++|+|++|..||...... .....+
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (295)
T 3ugc_A 167 DKEFFKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245 (295)
T ss_dssp ---------CTTCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred CcceeeeccCCCCccceeCcHHhcC-CCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHH
Confidence 23346777999999987 46788999999999999999999998654322 111111
Q ss_pred hcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 306 SVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 306 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
.. .... .....+++++.+||++||..||++|||+.|+++.
T Consensus 246 ~~-~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~ 285 (295)
T 3ugc_A 246 KN-NGRL--PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 285 (295)
T ss_dssp HT-TCCC--CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hc-cCcC--CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 11 1111 2234689999999999999999999999999853
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=356.41 Aligned_cols=254 Identities=23% Similarity=0.321 Sum_probs=189.0
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCc--hHHHHHHHH-HHHhhccCCCcceeeecccccCCCceE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP--QQITRAEYN-LLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~E~~-il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
.++|++.+.||+|+||.||+|.++.+|+.||||++...... ......|+. +++.++|+||+++++++... +..+
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~---~~~~ 97 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE---GDCW 97 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS---SEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC---CceE
Confidence 47899999999999999999999999999999999765432 223344554 67778999999999988764 6789
Q ss_pred EEEEecCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeecCCCCcEEEe-CCeeEEEeCCCcccc
Q psy11098 176 IVMQLVHGESLIQHLCR-----QSTITESYICCIIRQLHSALHCLHSQ-QIAHKDIRPENILMN-GAVLKLIDLGSSVSV 248 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~-----~~~l~e~~~~~i~~qil~al~~lH~~-~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~ 248 (380)
+||||+. ++|.+++.. ...+++..+..++.|++.||.|||+. ||+||||||+|||++ ++.+||+|||++...
T Consensus 98 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 98 ICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp EEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred EEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 9999996 588887753 56799999999999999999999999 999999999999998 569999999999765
Q ss_pred c-----ccccCCCcccCCcccc---CCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhccc-CCCCCCcCC
Q psy11098 249 S-----TVVLPDLEFASPEMLT---SPATAGPSTDMWSLGVLLYILLSGVSPFLDESEE-ETRAHISVAD-YSFPPEQCG 318 (380)
Q Consensus 249 ~-----~~~~gt~~y~aPE~~~---~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~-~~~~~i~~~~-~~~~~~~~~ 318 (380)
. ....||+.|+|||++. ....++.++||||||+++|+|++|..||.+.... +....+.... ..++.....
T Consensus 177 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T 3aln_A 177 VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEER 256 (327)
T ss_dssp -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSC
T ss_pred ccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcccc
Confidence 3 2347899999999984 2246788999999999999999999999775432 2222222221 122333345
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCC
Q psy11098 319 HISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASC 356 (380)
Q Consensus 319 ~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~ 356 (380)
.++.++.+||++||..||++|||+.++|+||||.+...
T Consensus 257 ~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~ 294 (327)
T 3aln_A 257 EFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEE 294 (327)
T ss_dssp CCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred cCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHh
Confidence 68999999999999999999999999999999987643
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=363.23 Aligned_cols=242 Identities=24% Similarity=0.361 Sum_probs=208.2
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCc--hHHHHHHHHHHHhhccCCCcceeeecccccCCCceEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP--QQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
.++|++.+.||+|+||.||+|+++.+++.||||+++..... ...+.+|+++++.++||||+++++++... +..++
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~---~~~~l 189 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK---QPIYI 189 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS---SSCEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC---CCcEE
Confidence 46899999999999999999999999999999999754322 24567899999999999999999998654 56799
Q ss_pred EEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccccc----
Q psy11098 177 VMQLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVST---- 250 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~~---- 250 (380)
||||+.||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++....
T Consensus 190 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~ 269 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269 (377)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence 99999999999999764 4699999999999999999999999999999999999998 56999999999976431
Q ss_pred ----cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHH
Q psy11098 251 ----VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAR 325 (380)
Q Consensus 251 ----~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 325 (380)
...+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+..... .+ ....+++++.
T Consensus 270 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~l~ 345 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEALNY-GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGR-LP--CPELCPDAVF 345 (377)
T ss_dssp CCSSCCEEEGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCC-CC--CCTTCCHHHH
T ss_pred ecCCCCCCCcCcCCHhHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CC--CCCCCCHHHH
Confidence 1224667999999987 467889999999999999998 9999999888887777665432 22 1235789999
Q ss_pred HHHHHhcccCCCCCCCHHHHHh
Q psy11098 326 ELIGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 326 ~li~~~L~~dP~~Rpt~~e~L~ 347 (380)
+||.+||..||++|||++++++
T Consensus 346 ~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 346 RLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHcCCCchhCcCHHHHHH
Confidence 9999999999999999999985
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=342.37 Aligned_cols=241 Identities=20% Similarity=0.289 Sum_probs=210.2
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEE
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIV 177 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv 177 (380)
..++|++.+.||+|+||.||+|.+. +++.||+|++.......+.+.+|+++++.++|+||+++++++.. +..++|
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~v 85 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ----EPIYII 85 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS----SSCEEE
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC----CCcEEE
Confidence 3578999999999999999999976 56789999998776677788999999999999999999998763 457999
Q ss_pred EEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCccccc-----
Q psy11098 178 MQLVHGESLIQHLCRQ--STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVS----- 249 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~----- 249 (380)
|||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++. +.+||+|||++....
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T 1qpc_A 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (279)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred EecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence 9999999999999654 37999999999999999999999999999999999999984 589999999997653
Q ss_pred --ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHH
Q psy11098 250 --TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARE 326 (380)
Q Consensus 250 --~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 326 (380)
....+++.|+|||++.+ ..++.++||||||+++|+|++ |..||.+....+....+...... .....++.++.+
T Consensus 166 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~ 241 (279)
T 1qpc_A 166 AREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM---VRPDNCPEELYQ 241 (279)
T ss_dssp CCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTTCCHHHHH
T ss_pred cccCCCCccCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCC---CCcccccHHHHH
Confidence 23345788999999987 467889999999999999999 99999998888877777654322 223468999999
Q ss_pred HHHHhcccCCCCCCCHHHHHh
Q psy11098 327 LIGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 327 li~~~L~~dP~~Rpt~~e~L~ 347 (380)
||.+||..||++|||++++++
T Consensus 242 li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 242 LMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhccChhhCCCHHHHHH
Confidence 999999999999999999986
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-46 Score=350.64 Aligned_cols=250 Identities=17% Similarity=0.248 Sum_probs=213.9
Q ss_pred hhhceeeeeeecccCCeEEEEEEEc-----CCCcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccC
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDR-----GTGQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPV 170 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~ 170 (380)
..++|++.+.||+|+||.||+|.++ .+++.||+|++..... ....+.+|+.+++.++|+||+++++++...
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-- 100 (322)
T 1p4o_A 23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG-- 100 (322)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS--
T ss_pred hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC--
Confidence 4678999999999999999999887 4678999999975443 234577899999999999999999988764
Q ss_pred CCceEEEEEecCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEE
Q psy11098 171 PGTDTIVMQLVHGESLIQHLCRQ----------STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKL 239 (380)
Q Consensus 171 ~~~~~lv~e~~~gg~L~~~l~~~----------~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl 239 (380)
+..++||||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||
T Consensus 101 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl 179 (322)
T 1p4o_A 101 -QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 179 (322)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEE
T ss_pred -CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEE
Confidence 5679999999999999999652 4579999999999999999999999999999999999998 469999
Q ss_pred EeCCCccccc--------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccC
Q psy11098 240 IDLGSSVSVS--------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADY 310 (380)
Q Consensus 240 ~DFG~a~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~ 310 (380)
+|||++.... ....+|+.|+|||++.+ ..++.++||||||+++|+|++ |..||.+....+....+.....
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 258 (322)
T 1p4o_A 180 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL 258 (322)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC
T ss_pred CcCccccccccccccccccCCCCCCCccChhhhcc-CCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCc
Confidence 9999997553 23355889999999987 467889999999999999999 8999999888888777766543
Q ss_pred CCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc------cccccc
Q psy11098 311 SFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQV------AWFAEA 354 (380)
Q Consensus 311 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h------pw~~~~ 354 (380)
... ...++.++.+||.+||..||++|||+.|+++| +||.+.
T Consensus 259 ~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~ 305 (322)
T 1p4o_A 259 LDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 305 (322)
T ss_dssp CCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHH
T ss_pred CCC---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCccc
Confidence 222 24689999999999999999999999999987 666544
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=357.31 Aligned_cols=247 Identities=20% Similarity=0.221 Sum_probs=199.0
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccC-CCceEEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPV-PGTDTIV 177 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~-~~~~~lv 177 (380)
.++|++.+.||+|+||+||+|++. ++.||||++...........+|+.+++.++|+||+++++++..... ....++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 468999999999999999999876 7899999997665555666779999999999999999999886532 2347999
Q ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC----------CcEeecCCCCcEEEeC-CeeEEEeCCCcc
Q psy11098 178 MQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQ----------QIAHKDIRPENILMNG-AVLKLIDLGSSV 246 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~----------~iiHrDlKp~NIl~~~-~~ikl~DFG~a~ 246 (380)
|||+.+|+|.+++... .+++..++.++.||+.||.|||+. ||+||||||+|||++. +.+||+|||++.
T Consensus 101 ~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~ 179 (322)
T 3soc_A 101 TAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL 179 (322)
T ss_dssp EECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCccc
Confidence 9999999999999664 699999999999999999999999 9999999999999984 599999999997
Q ss_pred ccc--------ccccCCCcccCCccccCC----CCCCCcccHHHHHHHHHHHHhCCCCCCCCC----------------H
Q psy11098 247 SVS--------TVVLPDLEFASPEMLTSP----ATAGPSTDMWSLGVLLYILLSGVSPFLDES----------------E 298 (380)
Q Consensus 247 ~~~--------~~~~gt~~y~aPE~~~~~----~~~~~~~DiwSlGvil~~lltg~~Pf~~~~----------------~ 298 (380)
... ....||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.. .
T Consensus 180 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 259 (322)
T 3soc_A 180 KFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSL 259 (322)
T ss_dssp EECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCH
T ss_pred ccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCch
Confidence 543 235789999999999863 234557899999999999999999996542 2
Q ss_pred HHHHHHHhcccCCCCCC-cC--CCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 299 EETRAHISVADYSFPPE-QC--GHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 299 ~~~~~~i~~~~~~~~~~-~~--~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
......+.......... .+ ...+.++.+||.+||+.||++|||+.|+++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 312 (322)
T 3soc_A 260 EDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER 312 (322)
T ss_dssp HHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 22222222222111111 11 1124559999999999999999999999864
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-46 Score=343.86 Aligned_cols=249 Identities=21% Similarity=0.347 Sum_probs=210.5
Q ss_pred hhhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeeccccc-----
Q psy11098 95 QEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAP----- 169 (380)
Q Consensus 95 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~----- 169 (380)
...+..+|++.+.||+|+||.||+|.+..+++.||+|++.... ..+.+|+++++.++|+||+++++++....
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 6 DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp CHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred cchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence 4567899999999999999999999999999999999997543 34678999999999999999999875421
Q ss_pred --------CCCceEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeE
Q psy11098 170 --------VPGTDTIVMQLVHGESLIQHLCRQ--STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLK 238 (380)
Q Consensus 170 --------~~~~~~lv~e~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ik 238 (380)
.....++||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+|
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEE
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEE
Confidence 124579999999999999999654 6799999999999999999999999999999999999997 56999
Q ss_pred EEeCCCccccc-----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCC
Q psy11098 239 LIDLGSSVSVS-----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFP 313 (380)
Q Consensus 239 l~DFG~a~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~ 313 (380)
|+|||++.... ....||+.|+|||++.+ ..++.++||||||+++|+|++|..||... ......+.... .
T Consensus 163 l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~~~--~- 236 (284)
T 2a19_B 163 IGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRDGI--I- 236 (284)
T ss_dssp ECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHC-SCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHTTC--C-
T ss_pred ECcchhheeccccccccccCCcccccChhhhcc-CCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhccc--c-
Confidence 99999987653 34568999999999987 46788999999999999999999987432 22233333222 1
Q ss_pred CCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 314 PEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 314 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
...++.++++||.+||..||++|||+.|+++|.|..+..
T Consensus 237 ---~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 237 ---SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp ---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred ---cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 135789999999999999999999999999998876543
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=345.70 Aligned_cols=247 Identities=20% Similarity=0.270 Sum_probs=204.3
Q ss_pred hhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEE
Q psy11098 97 QFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 97 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
.+.++|++.+.||+|+||.||+|++..+++.||+|++...... ..+.+|+.+++.++|++++..+..+... .+..++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~~~~l 82 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-PQLHIESKIYKMMQGGVGIPTIRWCGAE--GDYNVM 82 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-CHHHHHHHHHHHHTTSTTCCCEEEEEEE--TTEEEE
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-hHHHHHHHHHHHhhcCCCCCccccccCC--CCceEE
Confidence 3578999999999999999999999999999999998765433 3577899999999999877776665442 467799
Q ss_pred EEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe----CCeeEEEeCCCccccc--
Q psy11098 177 VMQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN----GAVLKLIDLGSSVSVS-- 249 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~----~~~ikl~DFG~a~~~~-- 249 (380)
||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 99999 9999999974 56799999999999999999999999999999999999993 5689999999987543
Q ss_pred -----------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhcccCCCCC-
Q psy11098 250 -----------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDES---EEETRAHISVADYSFPP- 314 (380)
Q Consensus 250 -----------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~---~~~~~~~i~~~~~~~~~- 314 (380)
....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.. ..+....+.......+.
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 240 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred ccccccccccccccccccccCChhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH
Confidence 24568999999999988 467889999999999999999999997632 22233333332222221
Q ss_pred CcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 315 EQCGHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 315 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
.....+++++.+||.+||+.||++|||++++++.
T Consensus 241 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 274 (296)
T 3uzp_A 241 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL 274 (296)
T ss_dssp HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHH
T ss_pred HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHH
Confidence 1234689999999999999999999999999863
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=348.04 Aligned_cols=245 Identities=21% Similarity=0.327 Sum_probs=207.0
Q ss_pred hhhceeeeeeecccCCeEEEEEEE-----cCCCcEEEEEEecCCCC--chHHHHHHHHHHHhh-ccCCCcceeeeccccc
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARD-----RGTGQLVALKQIPRERQ--PQQITRAEYNLLSTL-MHAHIPTALALFENAP 169 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~-----~~~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~ 169 (380)
..++|++.+.||+|+||.||+|.+ ..+++.||+|++..... ..+.+.+|+.+++.+ +|+||+++++++...
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~- 99 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG- 99 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC-
Confidence 357999999999999999999985 45778999999976543 346678899999999 999999999998764
Q ss_pred CCCceEEEEEecCCCCHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEE
Q psy11098 170 VPGTDTIVMQLVHGESLIQHLCRQS------------------TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENIL 231 (380)
Q Consensus 170 ~~~~~~lv~e~~~gg~L~~~l~~~~------------------~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl 231 (380)
+..++||||+.+|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 100 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil 177 (313)
T 1t46_A 100 --GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL 177 (313)
T ss_dssp --SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred --CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEE
Confidence 56799999999999999997653 4899999999999999999999999999999999999
Q ss_pred Ee-CCeeEEEeCCCccccc--------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q psy11098 232 MN-GAVLKLIDLGSSVSVS--------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEET 301 (380)
Q Consensus 232 ~~-~~~ikl~DFG~a~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~ 301 (380)
++ ++.+||+|||++.... ....+|+.|+|||++.+ ..++.++||||||+++|+|++ |..||.+......
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 256 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence 98 5699999999987653 23345788999999987 477889999999999999999 9999988765444
Q ss_pred HHHHhcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 302 RAHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 302 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
............ ....++.++.+||.+||..||++|||+.|++++
T Consensus 257 ~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 257 FYKMIKEGFRML--SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHHHHTCCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhccCCCCC--CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 444333332222 234689999999999999999999999999975
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=343.03 Aligned_cols=241 Identities=20% Similarity=0.284 Sum_probs=206.3
Q ss_pred hhceeeee-eecccCCeEEEEEE--EcCCCcEEEEEEecCCCC---chHHHHHHHHHHHhhccCCCcceeeecccccCCC
Q psy11098 99 EHRYEELE-RLGNGRFCTVRKAR--DRGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLMHAHIPTALALFENAPVPG 172 (380)
Q Consensus 99 ~~~y~~~~-~LG~G~fg~V~~~~--~~~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~ 172 (380)
.++|++.+ .||+|+||+||+|. +..+++.||+|++..... ....+.+|+++++.++|+||+++++++.. +
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~ 90 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA----E 90 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES----S
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECC----C
Confidence 46899988 99999999999995 456788999999975432 24567889999999999999999999842 5
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc--
Q psy11098 173 TDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS-- 249 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~-- 249 (380)
..++||||+.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 170 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred CcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccC
Confidence 7899999999999999999888899999999999999999999999999999999999997 6799999999997653
Q ss_pred -------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCC
Q psy11098 250 -------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHIS 321 (380)
Q Consensus 250 -------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 321 (380)
....+|+.|+|||++.+ ..++.++||||||+++|+|++ |..||.+....+....+...... .....++
T Consensus 171 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~ 246 (291)
T 1xbb_A 171 ENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM---GCPAGCP 246 (291)
T ss_dssp CSEEEC----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTTCC
T ss_pred CCcccccccCCCCceeeChHHhcc-CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCC
Confidence 12345788999999987 467889999999999999999 99999998888877777654422 1234689
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHh
Q psy11098 322 VPARELIGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 322 ~~~~~li~~~L~~dP~~Rpt~~e~L~ 347 (380)
+++.++|.+||..||++|||+.++++
T Consensus 247 ~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 247 REMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999999999985
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=366.58 Aligned_cols=241 Identities=20% Similarity=0.288 Sum_probs=210.6
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEE
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIV 177 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv 177 (380)
..++|++.+.||+|+||+||+|.++. +..||||+++......+.+.+|+++++.++|+||+++++++.. +..++|
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~----~~~~lv 260 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK----EPIYII 260 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEECS----SSCEEE
T ss_pred chHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEeC----CccEEE
Confidence 35789999999999999999999864 6789999998776677888999999999999999999998763 567999
Q ss_pred EEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-----
Q psy11098 178 MQLVHGESLIQHLCRQ--STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS----- 249 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~----- 249 (380)
|||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++...
T Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 340 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 340 (454)
T ss_dssp ECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHH
T ss_pred EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCcee
Confidence 9999999999999753 3689999999999999999999999999999999999998 4699999999998653
Q ss_pred --ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHH
Q psy11098 250 --TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARE 326 (380)
Q Consensus 250 --~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 326 (380)
....+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+..+. ..+ ....+++++.+
T Consensus 341 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~-~~~--~~~~~~~~l~~ 416 (454)
T 1qcf_A 341 AREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY-RMP--RPENCPEELYN 416 (454)
T ss_dssp TTCSSSSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTC-CCC--CCTTSCHHHHH
T ss_pred ccCCCcccccccCHHHhcc-CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCC--CCCCCCHHHHH
Confidence 23345788999999987 467889999999999999999 999999998888877776542 222 22468999999
Q ss_pred HHHHhcccCCCCCCCHHHHHh
Q psy11098 327 LIGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 327 li~~~L~~dP~~Rpt~~e~L~ 347 (380)
||.+||..||++|||++++++
T Consensus 417 li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 417 IMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHccCChhHCcCHHHHHH
Confidence 999999999999999999985
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=371.22 Aligned_cols=242 Identities=17% Similarity=0.277 Sum_probs=211.8
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVM 178 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~ 178 (380)
..+|++.+.||+|+||.||+|+++.+++.||||+++......+.+.+|+.+++.++|+||+++++++... +..++||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~---~~~~lv~ 295 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE---PPFYIIT 295 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS---SSCEEEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecC---CcEEEEE
Confidence 4679999999999999999999999999999999987766777889999999999999999999998764 5679999
Q ss_pred EecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------
Q psy11098 179 QLVHGESLIQHLCRQ--STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------ 249 (380)
Q Consensus 179 e~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------ 249 (380)
||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++...
T Consensus 296 E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 375 (495)
T 1opk_A 296 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 375 (495)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEEC
T ss_pred EccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCceee
Confidence 999999999999763 4589999999999999999999999999999999999997 5689999999997653
Q ss_pred -ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHH
Q psy11098 250 -TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAREL 327 (380)
Q Consensus 250 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 327 (380)
....+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+.... .. .....+++++.+|
T Consensus 376 ~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~l~~l 451 (495)
T 1opk_A 376 HAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY-RM--ERPEGCPEKVYEL 451 (495)
T ss_dssp CTTCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-CC--CCCTTCCHHHHHH
T ss_pred cCCCcCCcceeCHhHHhc-CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CC--CCCCCCCHHHHHH
Confidence 23345678999999987 467889999999999999999 999999887777666665432 22 2234689999999
Q ss_pred HHHhcccCCCCCCCHHHHHh
Q psy11098 328 IGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 328 i~~~L~~dP~~Rpt~~e~L~ 347 (380)
|.+||+.||++|||+.++++
T Consensus 452 i~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 452 MRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCcChhHCcCHHHHHH
Confidence 99999999999999999986
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=341.22 Aligned_cols=242 Identities=21% Similarity=0.255 Sum_probs=205.8
Q ss_pred hhceeeeeeecccCCeEEEEEEEcC---CCcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCCc
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRG---TGQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGT 173 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~---~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~ 173 (380)
.++|++.+.||+|+||+||+|++.. ++..||+|++..... ..+.+.+|+.+++.++||||+++++++.. +.
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~ 86 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE----EP 86 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS----SS
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC----CC
Confidence 5789999999999999999998654 345699999976533 34667889999999999999999998764 45
Q ss_pred eEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc--
Q psy11098 174 DTIVMQLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS-- 249 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~-- 249 (380)
.++||||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 87 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 166 (281)
T 3cc6_A 87 TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166 (281)
T ss_dssp CEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred CEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence 69999999999999999765 4599999999999999999999999999999999999997 6799999999987653
Q ss_pred -----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHH
Q psy11098 250 -----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVP 323 (380)
Q Consensus 250 -----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 323 (380)
....+|+.|+|||++.+ ..++.++||||||+++|+|++ |..||......+....+....... ....++++
T Consensus 167 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 242 (281)
T 3cc6_A 167 DYYKASVTRLPIKWMSPESINF-RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLP---KPDLCPPV 242 (281)
T ss_dssp ------CCCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCC---CCTTCCHH
T ss_pred cccccccCCCCcceeCchhhcc-CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCC---CCCCCCHH
Confidence 23456788999999987 467889999999999999998 999998877766666665443221 12357999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 324 ARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 324 ~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
+.++|.+||..||++|||+.|++++
T Consensus 243 l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 243 LYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCCchhCcCHHHHHHH
Confidence 9999999999999999999999976
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=348.51 Aligned_cols=243 Identities=21% Similarity=0.284 Sum_probs=208.2
Q ss_pred hhceeeeeeecccCCeEEEEEEEc-------CCCcEEEEEEecCCCC--chHHHHHHHHHHHhh-ccCCCcceeeecccc
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDR-------GTGQLVALKQIPRERQ--PQQITRAEYNLLSTL-MHAHIPTALALFENA 168 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~-------~~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~ 168 (380)
.++|++.+.||+|+||.||+|.+. .+++.||+|++..... ....+.+|+++++.+ +|+||+++++++...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 579999999999999999999986 4567899999976543 235677899999999 899999999988764
Q ss_pred cCCCceEEEEEecCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEE
Q psy11098 169 PVPGTDTIVMQLVHGESLIQHLCRQS----------------TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILM 232 (380)
Q Consensus 169 ~~~~~~~lv~e~~~gg~L~~~l~~~~----------------~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~ 232 (380)
+..++||||+.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 114 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 ---GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 190 (334)
T ss_dssp ---SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred ---CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE
Confidence 67799999999999999997643 38999999999999999999999999999999999999
Q ss_pred e-CCeeEEEeCCCccccc--------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy11098 233 N-GAVLKLIDLGSSVSVS--------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETR 302 (380)
Q Consensus 233 ~-~~~ikl~DFG~a~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~ 302 (380)
+ ++.+||+|||++.... ....+|+.|+|||++.+ ..++.++||||||+++|+|++ |..||.+....+..
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 269 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcC-CCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH
Confidence 8 5699999999997553 23456788999999987 467889999999999999999 99999998888877
Q ss_pred HHHhcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 303 AHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 303 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
..+....... ....++.++.+||.+||..||++|||+.|++++
T Consensus 270 ~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 270 KLLKEGHRMD---KPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCCCCC---CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 7776554221 224679999999999999999999999999976
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=350.30 Aligned_cols=242 Identities=19% Similarity=0.299 Sum_probs=203.7
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEE----EEEEecCC--CCchHHHHHHHHHHHhhccCCCcceeeecccccCCC
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLV----ALKQIPRE--RQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPG 172 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~v----AvK~~~~~--~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~ 172 (380)
.++|++.+.||+|+||+||+|++..+++.+ |+|.+... ......+.+|+.+++.++|+||+++++++.. +
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~ 89 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT----S 89 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES----S
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec----C
Confidence 578999999999999999999999888765 66666432 3345678889999999999999999999875 3
Q ss_pred ceEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-
Q psy11098 173 TDTIVMQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS- 249 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~- 249 (380)
..++++|++.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 90 ~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 90 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 57899999999999999976 46799999999999999999999999999999999999997 5799999999997653
Q ss_pred -------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCC
Q psy11098 250 -------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHIS 321 (380)
Q Consensus 250 -------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 321 (380)
....+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+....... ....++
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~ 245 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP---QPPICT 245 (327)
T ss_dssp ----------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC---CCTTBC
T ss_pred ccccccccCCCccccccCHHHHcC-CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC---CCccCC
Confidence 23455788999999987 477889999999999999999 999999888777776665543222 224579
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 322 VPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 322 ~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
.++.+||++||..||.+|||+.|+++.
T Consensus 246 ~~l~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 246 IDVYMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 999999999999999999999999974
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=342.04 Aligned_cols=244 Identities=20% Similarity=0.272 Sum_probs=208.4
Q ss_pred hhceeeee-eecccCCeEEEEEEEc--CCCcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCCc
Q psy11098 99 EHRYEELE-RLGNGRFCTVRKARDR--GTGQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGT 173 (380)
Q Consensus 99 ~~~y~~~~-~LG~G~fg~V~~~~~~--~~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~ 173 (380)
.++|.+.+ .||+|+||.||+|.+. .+++.||+|+++.... ..+.+.+|+++++.++|+||+++++++.. +.
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~ 83 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA----EA 83 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES----SS
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC----CC
Confidence 46777777 9999999999999864 4678899999976433 34567889999999999999999999843 56
Q ss_pred eEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc--
Q psy11098 174 DTIVMQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS-- 249 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~-- 249 (380)
.++||||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 84 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred cEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 8999999999999999965 35699999999999999999999999999999999999997 6799999999997653
Q ss_pred -------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCC
Q psy11098 250 -------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHIS 321 (380)
Q Consensus 250 -------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 321 (380)
....+|+.|+|||++.+ ..++.++||||||+++|+|++ |..||.+....+....+...... .....++
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~---~~~~~~~ 239 (287)
T 1u59_A 164 DSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM---ECPPECP 239 (287)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC---CCCTTCC
T ss_pred cceeeccccccccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcC---CCCCCcC
Confidence 23345789999999987 467889999999999999998 99999988887777777654322 1224689
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhccc
Q psy11098 322 VPARELIGQLLNTHADKRPTAGQLLQVAW 350 (380)
Q Consensus 322 ~~~~~li~~~L~~dP~~Rpt~~e~L~hpw 350 (380)
+++.++|.+||..||++|||+.++++|.+
T Consensus 240 ~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 240 PELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 99999999999999999999999998854
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=351.35 Aligned_cols=251 Identities=21% Similarity=0.319 Sum_probs=211.0
Q ss_pred hhhhceeeeeeecccCCeEEEEEE-----EcCCCcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeeccccc
Q psy11098 97 QFEHRYEELERLGNGRFCTVRKAR-----DRGTGQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAP 169 (380)
Q Consensus 97 ~~~~~y~~~~~LG~G~fg~V~~~~-----~~~~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~ 169 (380)
...++|++.+.||+|+||.||+|+ +..+++.||+|++..... ....+.+|+.+++.++|+||+++++++...
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~- 105 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS- 105 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC-
Confidence 346899999999999999999999 566888999999964432 345677899999999999999999988764
Q ss_pred CCCceEEEEEecCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC----CeeE
Q psy11098 170 VPGTDTIVMQLVHGESLIQHLCRQ-------STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG----AVLK 238 (380)
Q Consensus 170 ~~~~~~lv~e~~~gg~L~~~l~~~-------~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~----~~ik 238 (380)
+..++||||+.|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. ..+|
T Consensus 106 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 106 --LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp --SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred --CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence 5679999999999999999765 34899999999999999999999999999999999999972 3699
Q ss_pred EEeCCCccccc--------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccc
Q psy11098 239 LIDLGSSVSVS--------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVAD 309 (380)
Q Consensus 239 l~DFG~a~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~ 309 (380)
|+|||++.... ....+|+.|+|||++.+ ..++.++||||||+++|+|++ |..||.+....+....+....
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 262 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 262 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCC
Confidence 99999986432 34567899999999977 467889999999999999998 999999988888877776554
Q ss_pred CCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 310 YSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 310 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
.... ...++.++.+||.+||..||++|||+.++++|.|+...
T Consensus 263 ~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 263 RMDP---PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp CCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCC---CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 3222 24679999999999999999999999999999998654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=362.96 Aligned_cols=240 Identities=22% Similarity=0.329 Sum_probs=206.7
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVM 178 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~ 178 (380)
.++|++.+.||+|+||.||+|.+. ++.||||+++... ..+.+.+|+++++.++|+||+++++++... .+..++||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~~iv~ 266 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEE--KGGLYIVT 266 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECT--TSCEEEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcC--CCceEEEE
Confidence 368999999999999999999986 6799999997654 456678899999999999999999987653 24689999
Q ss_pred EecCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc---ccc
Q psy11098 179 QLVHGESLIQHLCRQST--ITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS---TVV 252 (380)
Q Consensus 179 e~~~gg~L~~~l~~~~~--l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~---~~~ 252 (380)
||+.+|+|.+++..... +++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++... ...
T Consensus 267 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 346 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 346 (450)
T ss_dssp ECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccccCC
Confidence 99999999999987543 79999999999999999999999999999999999998 5699999999997653 234
Q ss_pred cCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHh
Q psy11098 253 LPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQL 331 (380)
Q Consensus 253 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 331 (380)
.+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+..+.. . .....+++++.+||.+|
T Consensus 347 ~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~-~--~~p~~~~~~l~~li~~c 422 (450)
T 1k9a_A 347 KLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK-M--DAPDGCPPAVYDVMKNC 422 (450)
T ss_dssp CCCTTTSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCC-C--CCCTTCCHHHHHHHHHH
T ss_pred CCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-C--CCCCcCCHHHHHHHHHH
Confidence 66889999999987 478889999999999999998 9999998877777777665432 2 22346899999999999
Q ss_pred cccCCCCCCCHHHHHh
Q psy11098 332 LNTHADKRPTAGQLLQ 347 (380)
Q Consensus 332 L~~dP~~Rpt~~e~L~ 347 (380)
|..||++|||+.++++
T Consensus 423 l~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 423 WHLDAATRPTFLQLRE 438 (450)
T ss_dssp TCSSGGGSCCHHHHHH
T ss_pred cCCChhHCcCHHHHHH
Confidence 9999999999999985
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=345.70 Aligned_cols=245 Identities=29% Similarity=0.405 Sum_probs=198.3
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC----chHHHHHHHHHHHhhccCCCcceeeecccccCCCc
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ----PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGT 173 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~ 173 (380)
..++|++.+.||+|+||.||+|.+..+|+.||+|++..... ....+.+|+.+++.++|+||+++++++... +.
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~ 106 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED---NE 106 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET---TE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC---Cc
Confidence 35689999999999999999999999999999999975322 235567899999999999999999988764 67
Q ss_pred eEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccc
Q psy11098 174 DTIVMQLVHGESLIQHLCR----QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSV 248 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~----~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~ 248 (380)
.++||||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++...
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 8999999999999999864 45699999999999999999999999999999999999998 569999999998765
Q ss_pred c------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHhcccCCCCCCcCCCC
Q psy11098 249 S------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDE--SEEETRAHISVADYSFPPEQCGHI 320 (380)
Q Consensus 249 ~------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~ 320 (380)
. ....||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+. ........+....+ +......+
T Consensus 187 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 263 (310)
T 2wqm_A 187 SSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY--PPLPSDHY 263 (310)
T ss_dssp ------------CCSSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCS--CCCCTTTS
T ss_pred cCCCccccccCCCeeEeChHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccC--CCCccccc
Confidence 3 34568999999999987 47788999999999999999999999764 33344455544433 33233568
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 321 SVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 321 s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
+.++.+||.+||..||++|||+.+++++
T Consensus 264 ~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 264 SEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 9999999999999999999999999964
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=350.46 Aligned_cols=243 Identities=22% Similarity=0.314 Sum_probs=207.1
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEE--EEEEecCC--CCchHHHHHHHHHHHhh-ccCCCcceeeecccccCCCc
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLV--ALKQIPRE--RQPQQITRAEYNLLSTL-MHAHIPTALALFENAPVPGT 173 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~v--AvK~~~~~--~~~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~~~~~ 173 (380)
.++|++.+.||+|+||.||+|+++.++..+ |+|.+... ......+.+|+++++.+ +|+||+++++++... +.
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~---~~ 100 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR---GY 100 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET---TE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeC---Cc
Confidence 468999999999999999999999988865 99998643 22345678899999999 899999999998764 67
Q ss_pred eEEEEEecCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCe
Q psy11098 174 DTIVMQLVHGESLIQHLCRQS----------------TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAV 236 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~~----------------~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ 236 (380)
.++||||+.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ ++.
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC
T ss_pred eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCe
Confidence 899999999999999997653 699999999999999999999999999999999999998 459
Q ss_pred eEEEeCCCccccc-----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccC
Q psy11098 237 LKLIDLGSSVSVS-----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADY 310 (380)
Q Consensus 237 ikl~DFG~a~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~ 310 (380)
+||+|||++.... ....+++.|+|||++.+ ..++.++||||||+++|+|++ |..||.+....+....+.....
T Consensus 181 ~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~ 259 (327)
T 1fvr_A 181 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 259 (327)
T ss_dssp EEECCTTCEESSCEECCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC
T ss_pred EEEcccCcCccccccccccCCCCCccccChhhhcc-ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCC
Confidence 9999999987543 33456889999999987 467889999999999999998 9999999988888777765422
Q ss_pred CCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 311 SFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 311 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
......+++++.+||.+||..||++|||+++++++
T Consensus 260 ---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 260 ---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp ---CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 12224679999999999999999999999999987
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=338.17 Aligned_cols=245 Identities=18% Similarity=0.249 Sum_probs=207.6
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---chHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
.++|++.+.||+|+||+||+|++. ++.||+|++..... ....+.+|+.+++.++|+||+++++++.... .+..+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~ 85 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP-APHPT 85 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT-SSSCE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC-CCCeE
Confidence 468999999999999999999985 78899999976543 2346788999999999999999999886542 25679
Q ss_pred EEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cEeecCCCCcEEEeC-CeeEEEeCCCccccc-
Q psy11098 176 IVMQLVHGESLIQHLCRQS--TITESYICCIIRQLHSALHCLHSQQ--IAHKDIRPENILMNG-AVLKLIDLGSSVSVS- 249 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~~--~l~e~~~~~i~~qil~al~~lH~~~--iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~- 249 (380)
+||||+.|++|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++. +.++|+|||++....
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 86 LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp EEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred eeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 9999999999999998754 4899999999999999999999999 999999999999984 588998888765443
Q ss_pred ccccCCCcccCCccccCCCCC--CCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHH
Q psy11098 250 TVVLPDLEFASPEMLTSPATA--GPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAREL 327 (380)
Q Consensus 250 ~~~~gt~~y~aPE~~~~~~~~--~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 327 (380)
....||+.|+|||++.+.... +.++||||||+++|+|++|..||.+.+..+....+........ ....+++++.+|
T Consensus 166 ~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l 243 (271)
T 3kmu_A 166 PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT--IPPGISPHVSKL 243 (271)
T ss_dssp TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCC--CCTTCCHHHHHH
T ss_pred cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCC--CCCCCCHHHHHH
Confidence 556789999999999874222 2379999999999999999999999888877766665543332 234689999999
Q ss_pred HHHhcccCCCCCCCHHHHHhc
Q psy11098 328 IGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 328 i~~~L~~dP~~Rpt~~e~L~h 348 (380)
|.+||..||++|||++++++.
T Consensus 244 i~~~l~~~p~~Rps~~~il~~ 264 (271)
T 3kmu_A 244 MKICMNEDPAKRPKFDMIVPI 264 (271)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999863
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=342.81 Aligned_cols=246 Identities=20% Similarity=0.267 Sum_probs=198.7
Q ss_pred hhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEE
Q psy11098 97 QFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 97 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
.+.++|++.+.||+|+||+||+|++..+++.||+|++...... ..+.+|+++++.++|++++..+..+... .+..++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~~~~l 82 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-PQLHIESKIYKMMQGGVGIPTIRWCGAE--GDYNVM 82 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-CCHHHHHHHHHHHTTSTTCCCEEEEEEE--TTEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-hHHHHHHHHHHHhcCCCCCCeeeeecCC--CCceEE
Confidence 3578999999999999999999999999999999987654332 3467799999999999887777666443 467799
Q ss_pred EEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEE---e-CCeeEEEeCCCccccc--
Q psy11098 177 VMQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILM---N-GAVLKLIDLGSSVSVS-- 249 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~---~-~~~ikl~DFG~a~~~~-- 249 (380)
||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ + ++.+||+|||++....
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp EEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 99999 9999999975 5679999999999999999999999999999999999999 3 5689999999997553
Q ss_pred -----------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHhcccCCCCC-
Q psy11098 250 -----------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEE---ETRAHISVADYSFPP- 314 (380)
Q Consensus 250 -----------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~---~~~~~i~~~~~~~~~- 314 (380)
....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.... .....+.......+.
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T 4hgt_A 162 RTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 240 (296)
T ss_dssp TTCCBCCCCCSCCCCSCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred ccCccCCCCcccccCCCccccchHHhcC-CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhh
Confidence 24578999999999988 46788999999999999999999999764321 222222222222221
Q ss_pred CcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy11098 315 EQCGHISVPARELIGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 315 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~ 347 (380)
.....+++++.+||.+||+.||++|||++++++
T Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 241 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 123467999999999999999999999999986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=348.41 Aligned_cols=245 Identities=21% Similarity=0.306 Sum_probs=205.0
Q ss_pred hhhceeeeeeecccCCeEEEEEEE-----cCCCcEEEEEEecCCCCc--hHHHHHHHHHHHhh-ccCCCcceeeeccccc
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARD-----RGTGQLVALKQIPRERQP--QQITRAEYNLLSTL-MHAHIPTALALFENAP 169 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~-----~~~~~~vAvK~~~~~~~~--~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~ 169 (380)
..++|++.+.||+|+||+||+|.+ ..+++.||+|++...... ...+.+|+.+++.+ +|+||+++++++...
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~- 103 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 103 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC-
Confidence 357999999999999999999985 356789999999765442 34677899999999 789999999988653
Q ss_pred CCCceEEEEEecCCCCHHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe
Q psy11098 170 VPGTDTIVMQLVHGESLIQHLCRQST----------------ITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN 233 (380)
Q Consensus 170 ~~~~~~lv~e~~~gg~L~~~l~~~~~----------------l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~ 233 (380)
.+..++||||+.|++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 104 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~ 182 (316)
T 2xir_A 104 -GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS 182 (316)
T ss_dssp -TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred -CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC
Confidence 2457999999999999999976543 89999999999999999999999999999999999997
Q ss_pred -CCeeEEEeCCCccccc--------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHH-HHH
Q psy11098 234 -GAVLKLIDLGSSVSVS--------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEE-ETR 302 (380)
Q Consensus 234 -~~~ikl~DFG~a~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~-~~~ 302 (380)
++.+||+|||++.... ....+|+.|+|||++.+ ..++.++||||||+++|+|++ |..||.+.... ...
T Consensus 183 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~ 261 (316)
T 2xir_A 183 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 261 (316)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred CCCCEEECCCccccccccCccceeccCCCcceeecCchhhcc-ccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHH
Confidence 5689999999987542 23456889999999987 477889999999999999998 99999876533 333
Q ss_pred HHHhcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 303 AHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 303 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
..+..... .. ....+++++.++|.+||..||.+|||+.|+++|
T Consensus 262 ~~~~~~~~-~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 262 RRLKEGTR-MR--APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHTCC-CC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhccCcc-CC--CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 33333321 11 223579999999999999999999999999987
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=362.21 Aligned_cols=247 Identities=20% Similarity=0.280 Sum_probs=210.5
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVM 178 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~ 178 (380)
.++|++.+.||+|+||.||+|.++. +..||||+++......+.+.+|+++++.++|+||+++++++.. +..++||
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~~iv~ 257 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE----EPIYIVT 257 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS----SSCEEEE
T ss_pred hhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC----CceEEEe
Confidence 4789999999999999999999876 4579999998766667788999999999999999999998764 4679999
Q ss_pred EecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------
Q psy11098 179 QLVHGESLIQHLCR--QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------ 249 (380)
Q Consensus 179 e~~~gg~L~~~l~~--~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------ 249 (380)
||+.+|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++...
T Consensus 258 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 337 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 337 (452)
T ss_dssp CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred hhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceec
Confidence 99999999999964 35699999999999999999999999999999999999998 4589999999997653
Q ss_pred -ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHH
Q psy11098 250 -TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAREL 327 (380)
Q Consensus 250 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 327 (380)
....+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+..+.. .+ ....+++++.+|
T Consensus 338 ~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~-~~--~~~~~~~~l~~l 413 (452)
T 1fmk_A 338 RQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-MP--CPPECPESLHDL 413 (452)
T ss_dssp -----CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-CC--CCTTSCHHHHHH
T ss_pred ccCCcccccccCHhHHhc-CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CC--CCCCCCHHHHHH
Confidence 23345788999999987 477889999999999999999 9999999988888877765432 22 224679999999
Q ss_pred HHHhcccCCCCCCCHHHHHhc--cccccc
Q psy11098 328 IGQLLNTHADKRPTAGQLLQV--AWFAEA 354 (380)
Q Consensus 328 i~~~L~~dP~~Rpt~~e~L~h--pw~~~~ 354 (380)
|.+||..||++|||++++++. .++...
T Consensus 414 i~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 414 MCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 999999999999999999863 566543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=342.38 Aligned_cols=244 Identities=19% Similarity=0.243 Sum_probs=199.9
Q ss_pred hhceeeeeeecccCCeEEEEEE----EcCCCcEEEEEEecCCC--CchHHHHHHHHHHHhhccCCCcceeeecccccCCC
Q psy11098 99 EHRYEELERLGNGRFCTVRKAR----DRGTGQLVALKQIPRER--QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPG 172 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~----~~~~~~~vAvK~~~~~~--~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~ 172 (380)
..+|++.+.||+|+||.||+|+ +..+++.||+|++.... .....+.+|+++++.++|+||+++++++.... ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~ 98 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG-GN 98 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC----C
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC-Cc
Confidence 5679999999999999999999 56789999999997443 33467788999999999999999999887532 24
Q ss_pred ceEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-
Q psy11098 173 TDTIVMQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS- 249 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~- 249 (380)
..++||||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 99 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 178 (302)
T 4e5w_A 99 GIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 178 (302)
T ss_dssp CEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred eEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccC
Confidence 67999999999999999954 46799999999999999999999999999999999999997 6799999999997553
Q ss_pred --------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC--------------H-HHHHHHHh
Q psy11098 250 --------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDES--------------E-EETRAHIS 306 (380)
Q Consensus 250 --------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~--------------~-~~~~~~i~ 306 (380)
....+|+.|+|||++.+ ..++.++||||||+++|+|++|..|+.... . ......+.
T Consensus 179 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (302)
T 4e5w_A 179 DKEYYTVKDDRDSPVFWYAPECLMQ-SKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK 257 (302)
T ss_dssp TCCEEECCCCTTCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHH
T ss_pred CCcceeccCCCCCCccccCCeeecC-CCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHh
Confidence 34567888999999987 467789999999999999999998763221 1 12222222
Q ss_pred cccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy11098 307 VADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 307 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~ 347 (380)
.. .. ......+++++.+||++||..||++|||+.++++
T Consensus 258 ~~-~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 258 EG-KR--LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp TT-CC--CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred cc-CC--CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 21 11 2223468999999999999999999999999986
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=347.86 Aligned_cols=248 Identities=23% Similarity=0.383 Sum_probs=202.0
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC-CchHHHHHHHHHHHhhccCCCcceeeeccccc-CCCceEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER-QPQQITRAEYNLLSTLMHAHIPTALALFENAP-VPGTDTI 176 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~-~~~~~~l 176 (380)
.++|++.+.||+|+||.||+|++..+++.||+|++.... .....+.+|+++++.++|+||+++++++.... .....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 568999999999999999999999999999999986543 34566788999999999999999999886332 2346799
Q ss_pred EEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc--
Q psy11098 177 VMQLVHGESLIQHLCR----QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS-- 249 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~----~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~-- 249 (380)
||||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 187 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIH 187 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEE
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcccc
Confidence 9999999999999975 46799999999999999999999999999999999999997 5699999999987542
Q ss_pred -------------ccccCCCcccCCccccCCC--CCCCcccHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHhcccCCC
Q psy11098 250 -------------TVVLPDLEFASPEMLTSPA--TAGPSTDMWSLGVLLYILLSGVSPFLDESE--EETRAHISVADYSF 312 (380)
Q Consensus 250 -------------~~~~gt~~y~aPE~~~~~~--~~~~~~DiwSlGvil~~lltg~~Pf~~~~~--~~~~~~i~~~~~~~ 312 (380)
....||+.|+|||++.+.. .++.++||||||+++|+|++|..||..... ......+. ....+
T Consensus 188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~ 266 (317)
T 2buj_A 188 VEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ-NQLSI 266 (317)
T ss_dssp EESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH-CC--C
T ss_pred cccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh-ccCCC
Confidence 1245699999999987632 358899999999999999999999953211 11111222 22222
Q ss_pred CCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcc
Q psy11098 313 PPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVA 349 (380)
Q Consensus 313 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hp 349 (380)
+ ....++.++.+||.+||..||.+|||+++++++-
T Consensus 267 ~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 301 (317)
T 2buj_A 267 P--QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301 (317)
T ss_dssp C--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred C--ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence 2 2346799999999999999999999999999874
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=354.23 Aligned_cols=249 Identities=16% Similarity=0.160 Sum_probs=197.0
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcC---CCcEEEEEEecCCCCc------------hHHHHHHHHHHHhhccCCCccee
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRG---TGQLVALKQIPRERQP------------QQITRAEYNLLSTLMHAHIPTAL 162 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~---~~~~vAvK~~~~~~~~------------~~~~~~E~~il~~l~h~ni~~i~ 162 (380)
..++|++.+.||+|+||.||+|.+.. ++..+|+|++...... ...+.+|+.+++.+.|+||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 35789999999999999999999987 7889999999765421 12345678888999999999999
Q ss_pred eecccc-cCCCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CC--eeE
Q psy11098 163 ALFENA-PVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GA--VLK 238 (380)
Q Consensus 163 ~~~~~~-~~~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~--~ik 238 (380)
+++... ...+..++||||+ |++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++ .+|
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~k 193 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY 193 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEE
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEE
Confidence 988763 2235789999999 999999998877899999999999999999999999999999999999997 34 899
Q ss_pred EEeCCCccccc-------------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC--CHHHHHH
Q psy11098 239 LIDLGSSVSVS-------------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDE--SEEETRA 303 (380)
Q Consensus 239 l~DFG~a~~~~-------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~--~~~~~~~ 303 (380)
|+|||+++... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+. .......
T Consensus 194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~ 272 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG-VALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT 272 (345)
T ss_dssp ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH
T ss_pred EEeCCCceecccccccccchhccccccCCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHH
Confidence 99999997542 34478999999999988 47789999999999999999999999653 2222222
Q ss_pred HHhcccCCCCCC-----cCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 304 HISVADYSFPPE-----QCGHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 304 ~i~~~~~~~~~~-----~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
.........+.. ....++.++++||.+||..||++|||++++++.
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 273 AKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 221111122211 012689999999999999999999999999865
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=348.64 Aligned_cols=244 Identities=21% Similarity=0.328 Sum_probs=206.1
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCc-----EEEEEEecCCCC--chHHHHHHHHHHHhh-ccCCCcceeeecccccC
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQ-----LVALKQIPRERQ--PQQITRAEYNLLSTL-MHAHIPTALALFENAPV 170 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~-----~vAvK~~~~~~~--~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~~ 170 (380)
.++|++.+.||+|+||.||+|.+..+++ .||+|++..... ....+.+|+.+++.+ +|+||+++++++...
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-- 122 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG-- 122 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC--
Confidence 5789999999999999999999987665 799999976543 345678899999999 899999999998764
Q ss_pred CCceEEEEEecCCCCHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CC
Q psy11098 171 PGTDTIVMQLVHGESLIQHLCRQ--------------STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GA 235 (380)
Q Consensus 171 ~~~~~lv~e~~~gg~L~~~l~~~--------------~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~ 235 (380)
+..++||||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ ++
T Consensus 123 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 123 -GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp -SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGG
T ss_pred -CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCC
Confidence 6779999999999999999652 3589999999999999999999999999999999999998 46
Q ss_pred eeEEEeCCCccccc--------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHh
Q psy11098 236 VLKLIDLGSSVSVS--------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHIS 306 (380)
Q Consensus 236 ~ikl~DFG~a~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~ 306 (380)
.+||+|||++.... ....+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.........+.
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 280 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLV 280 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHH
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhcc-CCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHH
Confidence 89999999997542 23345788999999987 467889999999999999998 999998876554444444
Q ss_pred cccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 307 VADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 307 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
........ ....+.++.+||.+||+.||.+|||+.|++++
T Consensus 281 ~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 281 KDGYQMAQ--PAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HHTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcCCCCCC--CCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 33333222 23578999999999999999999999999974
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=355.51 Aligned_cols=242 Identities=19% Similarity=0.285 Sum_probs=198.9
Q ss_pred hhceeeeeeecccCCeEEEEEEEc---CCCcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCCc
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDR---GTGQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGT 173 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~---~~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~ 173 (380)
..+|++.+.||+|+||.||+|+++ .++..||||+++.... ....+.+|+.+++.++|+||+++++++... +.
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~ 120 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS---KP 120 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS---SS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC---Cc
Confidence 568999999999999999999987 4677899999975433 335678899999999999999999998764 56
Q ss_pred eEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccccc-
Q psy11098 174 DTIVMQLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVST- 250 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~~- 250 (380)
.++||||+.|++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.....
T Consensus 121 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 121 VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred eEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 79999999999999999764 4699999999999999999999999999999999999998 46999999999976531
Q ss_pred --------cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCC
Q psy11098 251 --------VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHIS 321 (380)
Q Consensus 251 --------~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 321 (380)
...+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+...... + ....++
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~-~--~~~~~~ 276 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAY-RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRL-P--PPMDCP 276 (373)
T ss_dssp -------------CTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEEC-C--CCTTCB
T ss_pred CccceeccCCCcCCCccChhhhcc-CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-C--CCcccc
Confidence 1234678999999987 477889999999999999998 99999998888877777654322 2 123578
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHh
Q psy11098 322 VPARELIGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 322 ~~~~~li~~~L~~dP~~Rpt~~e~L~ 347 (380)
.++.+||.+||+.||++|||+.++++
T Consensus 277 ~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 277 AALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 99999999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=362.57 Aligned_cols=249 Identities=24% Similarity=0.315 Sum_probs=195.5
Q ss_pred hhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhh-ccCCCcceeeecccccCCCce
Q psy11098 96 EQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTL-MHAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 96 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~~~~~~ 174 (380)
..+.+.|.+.+.||+|+||+||.+ ...+|+.||||++.... .+.+.+|+.+++.+ +||||+++++++.. .+..
T Consensus 11 ~~l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~~~~~~~~---~~~~ 84 (434)
T 2rio_A 11 QSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF--CDIALMEIKLLTESDDHPNVIRYYCSETT---DRFL 84 (434)
T ss_dssp CSCSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG--HHHHHHHHHHHHHHTTSTTBCCEEEEEEC---SSEE
T ss_pred hhhhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEec---CCeE
Confidence 346678888899999999999875 45679999999986532 34567899999887 89999999888765 3678
Q ss_pred EEEEEecCCCCHHHHHHhcCCC-------CHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-------------
Q psy11098 175 TIVMQLVHGESLIQHLCRQSTI-------TESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG------------- 234 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~~~l-------~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~------------- 234 (380)
|+||||+ +|+|.+++...... ++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 85 ~lv~E~~-~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~ 163 (434)
T 2rio_A 85 YIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAE 163 (434)
T ss_dssp EEEECCC-SEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCC
T ss_pred EEEEecC-CCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCC
Confidence 9999999 56999999765432 23345789999999999999999999999999999963
Q ss_pred -CeeEEEeCCCccccc----------ccccCCCcccCCccccC------CCCCCCcccHHHHHHHHHHHHh-CCCCCCCC
Q psy11098 235 -AVLKLIDLGSSVSVS----------TVVLPDLEFASPEMLTS------PATAGPSTDMWSLGVLLYILLS-GVSPFLDE 296 (380)
Q Consensus 235 -~~ikl~DFG~a~~~~----------~~~~gt~~y~aPE~~~~------~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~ 296 (380)
..+||+|||++.... ....||+.|+|||++.+ ...++.++|||||||++|+|++ |..||.+.
T Consensus 164 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 243 (434)
T 2rio_A 164 NLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243 (434)
T ss_dssp SCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred ceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence 279999999997653 23478999999999865 2467889999999999999999 99999776
Q ss_pred CHHHHHHHHhcccCCCCCCc---CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccc
Q psy11098 297 SEEETRAHISVADYSFPPEQ---CGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAE 353 (380)
Q Consensus 297 ~~~~~~~~i~~~~~~~~~~~---~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~ 353 (380)
...+ ..+.......+... ...++.++++||.+||+.||++|||+.++|+||||..
T Consensus 244 ~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 244 YSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp TTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred hhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 5443 23333433333221 1134678999999999999999999999999999964
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=344.88 Aligned_cols=247 Identities=22% Similarity=0.268 Sum_probs=194.8
Q ss_pred hhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHh--hccCCCcceeeecccc-cCCCc
Q psy11098 97 QFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLST--LMHAHIPTALALFENA-PVPGT 173 (380)
Q Consensus 97 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~--l~h~ni~~i~~~~~~~-~~~~~ 173 (380)
.+.++|++.+.||+|+||+||+|++ +++.||||++... .......|.+++.. ++|+||+++++++... ...+.
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~ 80 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR--DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ 80 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG--GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc--cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence 4678999999999999999999987 5889999999653 33445557777776 7999999999886543 22356
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HCCcEeecCCCCcEEEe-CCeeEEEeCCC
Q psy11098 174 DTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLH--------SQQIAHKDIRPENILMN-GAVLKLIDLGS 244 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH--------~~~iiHrDlKp~NIl~~-~~~ikl~DFG~ 244 (380)
.++||||+.+|+|.+++. ...+++..+..++.||+.||.||| +.||+||||||+|||++ ++.+||+|||+
T Consensus 81 ~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 159 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL 159 (301)
T ss_dssp EEEEECCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred eEEehhhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCC
Confidence 799999999999999995 457999999999999999999999 99999999999999998 56999999999
Q ss_pred ccccc----------ccccCCCcccCCccccCCCC-----CCCcccHHHHHHHHHHHHhC----------CCCCCCCC--
Q psy11098 245 SVSVS----------TVVLPDLEFASPEMLTSPAT-----AGPSTDMWSLGVLLYILLSG----------VSPFLDES-- 297 (380)
Q Consensus 245 a~~~~----------~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwSlGvil~~lltg----------~~Pf~~~~-- 297 (380)
|.... ....||+.|+|||++.+... ++.++|||||||++|+|++| ..||.+..
T Consensus 160 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~ 239 (301)
T 3q4u_A 160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239 (301)
T ss_dssp CEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred eeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCC
Confidence 86542 23478999999999987432 33589999999999999999 88985532
Q ss_pred --HHHHHHHHhcccCCCCCC----cCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 298 --EEETRAHISVADYSFPPE----QCGHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 298 --~~~~~~~i~~~~~~~~~~----~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
...............+.. .....+.++.+||.+||+.||++|||++++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~ 296 (301)
T 3q4u_A 240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT 296 (301)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred CcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 122222222221111111 012245789999999999999999999999863
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=343.94 Aligned_cols=244 Identities=18% Similarity=0.288 Sum_probs=204.2
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCC----cEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCC
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTG----QLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVP 171 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~----~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~ 171 (380)
..++|++.+.||+|+||+||+|.++.++ ..||+|++..... ....+.+|+++++.++|+||+++++++...
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--- 118 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY--- 118 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS---
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC---
Confidence 3578999999999999999999987654 3599999975443 234577899999999999999999998763
Q ss_pred CceEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc
Q psy11098 172 GTDTIVMQLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS 249 (380)
Q Consensus 172 ~~~~lv~e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~ 249 (380)
+..++||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 6789999999999999999764 6799999999999999999999999999999999999998 4699999999997653
Q ss_pred ---------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCC
Q psy11098 250 ---------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGH 319 (380)
Q Consensus 250 ---------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 319 (380)
....+|+.|+|||++.+ ..++.++||||||+++|+|++ |..||.+....+....+..... .+ ....
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~-~~--~~~~ 274 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR-LP--TPMD 274 (333)
T ss_dssp ------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-CC--CCTT
T ss_pred cccccccccCCCCccccccCchhccc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCc-CC--Cccc
Confidence 12345778999999987 477889999999999999999 9999999888888777765432 12 2246
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 320 ISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 320 ~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
++.++.++|.+||..||++|||+.+++++
T Consensus 275 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 275 CPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp CBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 79999999999999999999999999875
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=355.98 Aligned_cols=249 Identities=15% Similarity=0.176 Sum_probs=194.8
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCC-----CcEEEEEEecCCCCch------------HHHHHHHHHHHhhccCCCcc
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGT-----GQLVALKQIPRERQPQ------------QITRAEYNLLSTLMHAHIPT 160 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~-----~~~vAvK~~~~~~~~~------------~~~~~E~~il~~l~h~ni~~ 160 (380)
..++|++.+.||+|+||+||+|.++.+ ++.||+|++....... .....|+..++.++|+||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 456899999999999999999998765 5889999987554211 11223455566778999999
Q ss_pred eeeecccccC-CCceEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe---CC
Q psy11098 161 ALALFENAPV-PGTDTIVMQLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN---GA 235 (380)
Q Consensus 161 i~~~~~~~~~-~~~~~lv~e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~---~~ 235 (380)
+++++..... ....+|||||+ |++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence 9998876432 23479999999 99999999775 6799999999999999999999999999999999999997 35
Q ss_pred eeEEEeCCCccccc-------------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy11098 236 VLKLIDLGSSVSVS-------------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETR 302 (380)
Q Consensus 236 ~ikl~DFG~a~~~~-------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~ 302 (380)
.+||+|||+|+... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.......
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~ 270 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG-VAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY 270 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH
T ss_pred eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCccccccCHHH
Confidence 89999999997542 23348999999999988 46889999999999999999999999864322221
Q ss_pred HHHhcccC--CCC---C--CcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 303 AHISVADY--SFP---P--EQCGHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 303 ~~i~~~~~--~~~---~--~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
.......+ ..+ . .....++.++.+||..||..||++|||++++++.
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~ 323 (364)
T 3op5_A 271 VRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDI 323 (364)
T ss_dssp HHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHH
Confidence 11111000 000 0 0014579999999999999999999999999853
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-45 Score=342.58 Aligned_cols=246 Identities=15% Similarity=0.208 Sum_probs=200.6
Q ss_pred hhceeeeeeecccCCeEEEEEEEcC---CCcEEEEEEecCCCCc---hHHHHHHHHHHHhhccCCCcceeeecccccCC-
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRG---TGQLVALKQIPRERQP---QQITRAEYNLLSTLMHAHIPTALALFENAPVP- 171 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~---~~~~vAvK~~~~~~~~---~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~- 171 (380)
.++|++.+.||+|+||.||+|.+.. +++.||+|++...... ...+.+|+.+++.++|+||+++++++......
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 112 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence 5789999999999999999998765 5668999999755332 35577899999999999999999998764322
Q ss_pred -CceEEEEEecCCCCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCC
Q psy11098 172 -GTDTIVMQLVHGESLIQHLCR------QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLG 243 (380)
Q Consensus 172 -~~~~lv~e~~~gg~L~~~l~~------~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG 243 (380)
...++||||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||
T Consensus 113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg 192 (313)
T 3brb_A 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFG 192 (313)
T ss_dssp --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCS
T ss_pred CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecC
Confidence 246999999999999999843 356999999999999999999999999999999999999984 599999999
Q ss_pred Cccccc--------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCC
Q psy11098 244 SSVSVS--------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPP 314 (380)
Q Consensus 244 ~a~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~ 314 (380)
++.... ....+++.|+|||++.+ ..++.++||||||+++|+|++ |..||.+....+....+......
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~--- 268 (313)
T 3brb_A 193 LSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRL--- 268 (313)
T ss_dssp CC----------------CCGGGSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC---
T ss_pred cceecccccccCcccccCCCccccCchhhcC-CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCC---
Confidence 997553 23456889999999987 577889999999999999999 99999888877777666554321
Q ss_pred CcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 315 EQCGHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 315 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
.....+++++.+||.+||..||++|||+.+++++
T Consensus 269 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 269 KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2234689999999999999999999999999976
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=360.43 Aligned_cols=251 Identities=24% Similarity=0.404 Sum_probs=203.2
Q ss_pred hhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC--CchHHHHHHHHHHHhhccCCCcceeeecccccCCCce
Q psy11098 97 QFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER--QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 97 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~ 174 (380)
.+.++|++.+.||+|+||+||+|++..+|+.||+|++.... .....+.+|+++++.++|+||+++++++.... ....
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~~~ 84 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT-TRHK 84 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT-TCCE
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCC-CCee
Confidence 35789999999999999999999999999999999996433 33466778999999999999999999887542 2467
Q ss_pred EEEEEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEE----eC-CeeEEEeCCCcc
Q psy11098 175 TIVMQLVHGESLIQHLCRQS---TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILM----NG-AVLKLIDLGSSV 246 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~~---~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~----~~-~~ikl~DFG~a~ 246 (380)
++||||+.|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+ +. +.+||+|||++.
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 99999999999999997543 39999999999999999999999999999999999998 33 379999999997
Q ss_pred ccc-----ccccCCCcccCCccccCC-------CCCCCcccHHHHHHHHHHHHhCCCCCCC----CCHHHHHHHHhcccC
Q psy11098 247 SVS-----TVVLPDLEFASPEMLTSP-------ATAGPSTDMWSLGVLLYILLSGVSPFLD----ESEEETRAHISVADY 310 (380)
Q Consensus 247 ~~~-----~~~~gt~~y~aPE~~~~~-------~~~~~~~DiwSlGvil~~lltg~~Pf~~----~~~~~~~~~i~~~~~ 310 (380)
... ....||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+ ....+....+.....
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p 244 (396)
T 4eut_A 165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (396)
T ss_dssp ECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCC
T ss_pred EccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCC
Confidence 653 345789999999998641 3556789999999999999999999964 223444444443321
Q ss_pred C-------------------CC--CCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 311 S-------------------FP--PEQCGHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 311 ~-------------------~~--~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
. ++ ......++..+.+||++||..||++|||++|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred cccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 1 00 01112245578899999999999999999998544
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=339.46 Aligned_cols=245 Identities=22% Similarity=0.341 Sum_probs=195.0
Q ss_pred hhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCc---hHHHHHHHHHHHhhccCCCcceeeecccccCCCc
Q psy11098 97 QFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP---QQITRAEYNLLSTLMHAHIPTALALFENAPVPGT 173 (380)
Q Consensus 97 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~ 173 (380)
-..++|++.+.||+|+||+||+|++.. .||+|+++..... .+.+.+|+++++.++|+||+.++++... +.
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~ 93 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA----PQ 93 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS----SS
T ss_pred cCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccC----Cc
Confidence 346789999999999999999998653 5999999754432 3567889999999999999999886543 56
Q ss_pred eEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc--
Q psy11098 174 DTIVMQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS-- 249 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~-- 249 (380)
.++||||+.|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 94 LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp CEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred cEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccc
Confidence 7999999999999999954 45799999999999999999999999999999999999998 5699999999987543
Q ss_pred ------ccccCCCcccCCccccC--CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHhcccCCCC-CCcCCC
Q psy11098 250 ------TVVLPDLEFASPEMLTS--PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEE-TRAHISVADYSFP-PEQCGH 319 (380)
Q Consensus 250 ------~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~-~~~~i~~~~~~~~-~~~~~~ 319 (380)
....||+.|+|||++.. ...++.++||||||+++|+|++|..||.+....+ ....+........ ......
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSN 253 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTT
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhcccc
Confidence 34568999999999862 2466789999999999999999999998765444 4444443333322 223356
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 320 ISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 320 ~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
+++++.+||.+||..||++|||+.++++.
T Consensus 254 ~~~~l~~li~~~l~~~p~~Rps~~ell~~ 282 (289)
T 3og7_A 254 CPKRMKRLMAECLKKKRDERPSFPRILAE 282 (289)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 89999999999999999999999999863
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=346.73 Aligned_cols=245 Identities=22% Similarity=0.287 Sum_probs=204.2
Q ss_pred hhceeeeeeecccCCeEEEEEE----EcCCCcEEEEEEecCCCC-chHHHHHHHHHHHhhccCCCcceeeecccccCCCc
Q psy11098 99 EHRYEELERLGNGRFCTVRKAR----DRGTGQLVALKQIPRERQ-PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGT 173 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~----~~~~~~~vAvK~~~~~~~-~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~ 173 (380)
.++|++.+.||+|+||.||+|+ +..+++.||+|++..... ....+.+|+++++.++|+||+++++++... ..+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~ 100 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGP-GRQS 100 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SSCE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC-CCce
Confidence 5789999999999999999999 467899999999976543 345678899999999999999999887532 2356
Q ss_pred eEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc--
Q psy11098 174 DTIVMQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS-- 249 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~-- 249 (380)
.++||||+.|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 180 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD 180 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTT
T ss_pred EEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecccC
Confidence 8999999999999999976 45699999999999999999999999999999999999997 6799999999997553
Q ss_pred -------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHH---------------HHHHHhc
Q psy11098 250 -------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEE---------------TRAHISV 307 (380)
Q Consensus 250 -------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~---------------~~~~i~~ 307 (380)
....+|+.|+|||++.+ ..++.++||||||+++|+|++|..||....... ....+..
T Consensus 181 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (327)
T 3lxl_A 181 KDYYVVREPGQSPIFWYAPESLSD-NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE 259 (327)
T ss_dssp CSEEECSSCCCSCGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHT
T ss_pred CccceeeccCCccccccCHHHhcc-CCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhc
Confidence 23457888999999987 467889999999999999999999996544321 1122221
Q ss_pred ccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 308 ADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 308 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
. . .......+++++.+||.+||..||++|||++|++++
T Consensus 260 ~-~--~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 260 G-Q--RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp T-C--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred c-c--CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1 1 122235689999999999999999999999999755
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=338.21 Aligned_cols=240 Identities=22% Similarity=0.321 Sum_probs=199.8
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVM 178 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~ 178 (380)
.++|++.+.||+|+||.||+|.+. |+.||+|+++... ..+.+.+|+++++.++|+||+++++++... .+..++||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~~lv~ 94 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEE--KGGLYIVT 94 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC----CCEEEE
T ss_pred hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--CCceEEEE
Confidence 478999999999999999999875 7899999997544 445678899999999999999999986542 24679999
Q ss_pred EecCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc---ccc
Q psy11098 179 QLVHGESLIQHLCRQST--ITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS---TVV 252 (380)
Q Consensus 179 e~~~gg~L~~~l~~~~~--l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~---~~~ 252 (380)
||+.+++|.+++..... +++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.... ...
T Consensus 95 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 174 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 174 (278)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred ecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccccccCC
Confidence 99999999999976543 89999999999999999999999999999999999998 5699999999987654 344
Q ss_pred cCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHh
Q psy11098 253 LPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQL 331 (380)
Q Consensus 253 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 331 (380)
.+++.|+|||++.+ ..++.++||||||+++|+|++ |..||......+....+..... ......+++++.++|++|
T Consensus 175 ~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~ 250 (278)
T 1byg_A 175 KLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---MDAPDGCPPAVYEVMKNC 250 (278)
T ss_dssp -CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC---CCCCTTCCHHHHHHHHHH
T ss_pred CccccccCHHHhCC-CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---CCCcccCCHHHHHHHHHH
Confidence 67889999999987 467889999999999999998 9999988877777666654421 222346899999999999
Q ss_pred cccCCCCCCCHHHHHh
Q psy11098 332 LNTHADKRPTAGQLLQ 347 (380)
Q Consensus 332 L~~dP~~Rpt~~e~L~ 347 (380)
|..||++|||+.|+++
T Consensus 251 l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 251 WHLDAAMRPSFLQLRE 266 (278)
T ss_dssp TCSSGGGSCCHHHHHH
T ss_pred hcCChhhCCCHHHHHH
Confidence 9999999999999986
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=366.64 Aligned_cols=247 Identities=20% Similarity=0.280 Sum_probs=213.6
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVM 178 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~ 178 (380)
.++|++.+.||+|+||.||+|.+.. +..||||+++......+.+.+|+++|+.++|+||+++++++.. +..+|||
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~lv~ 340 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE----EPIYIVT 340 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS----SSCEEEE
T ss_pred hhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee----ccceEee
Confidence 4689999999999999999999876 4679999998766667788999999999999999999998764 4679999
Q ss_pred EecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------
Q psy11098 179 QLVHGESLIQHLCR--QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------ 249 (380)
Q Consensus 179 e~~~gg~L~~~l~~--~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------ 249 (380)
||+.+|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++...
T Consensus 341 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 420 (535)
T 2h8h_A 341 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 420 (535)
T ss_dssp CCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHT
T ss_pred ehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceec
Confidence 99999999999964 35699999999999999999999999999999999999998 4589999999997653
Q ss_pred -ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHH
Q psy11098 250 -TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAREL 327 (380)
Q Consensus 250 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 327 (380)
....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+..+.. .+ ....++.++.+|
T Consensus 421 ~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~-~~--~~~~~~~~l~~l 496 (535)
T 2h8h_A 421 RQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-MP--CPPECPESLHDL 496 (535)
T ss_dssp TCSTTSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCC-CC--CCTTCCHHHHHH
T ss_pred ccCCcCcccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CC--CCCCCCHHHHHH
Confidence 23445788999999987 467889999999999999999 9999999988888877765432 22 224679999999
Q ss_pred HHHhcccCCCCCCCHHHHHhc--cccccc
Q psy11098 328 IGQLLNTHADKRPTAGQLLQV--AWFAEA 354 (380)
Q Consensus 328 i~~~L~~dP~~Rpt~~e~L~h--pw~~~~ 354 (380)
|.+||..||++|||++++++. .++...
T Consensus 497 i~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 497 MCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred HHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 999999999999999999864 566543
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=344.43 Aligned_cols=247 Identities=23% Similarity=0.370 Sum_probs=186.7
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC-chHHHHHHHHHHHhhc-cCCCcceeeecccc-----cCC
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ-PQQITRAEYNLLSTLM-HAHIPTALALFENA-----PVP 171 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~il~~l~-h~ni~~i~~~~~~~-----~~~ 171 (380)
..+|++.+.||+|+||.||+|++..+++.||+|++..... ....+.+|+.+++.+. |+||+++++++... ...
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 4689999999999999999999999999999999865433 3456788999999996 99999999988432 223
Q ss_pred CceEEEEEecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeecCCCCcEEEeC-CeeEEEeCCCc
Q psy11098 172 GTDTIVMQLVHGESLIQHLCR---QSTITESYICCIIRQLHSALHCLHSQQ--IAHKDIRPENILMNG-AVLKLIDLGSS 245 (380)
Q Consensus 172 ~~~~lv~e~~~gg~L~~~l~~---~~~l~e~~~~~i~~qil~al~~lH~~~--iiHrDlKp~NIl~~~-~~ikl~DFG~a 245 (380)
...+++|||+ +|+|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++. +.+||+|||++
T Consensus 107 ~~~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 185 (337)
T 3ll6_A 107 AEFLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185 (337)
T ss_dssp EEEEEEEECC-SEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTC
T ss_pred ceEEEEEEec-CCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccc
Confidence 4578999999 5789888865 467999999999999999999999999 999999999999984 69999999999
Q ss_pred ccccc------------------cccCCCcccCCcccc--CCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy11098 246 VSVST------------------VVLPDLEFASPEMLT--SPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHI 305 (380)
Q Consensus 246 ~~~~~------------------~~~gt~~y~aPE~~~--~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i 305 (380)
..... ...||+.|+|||++. ....++.++|||||||++|+|++|..||.+........
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~-- 263 (337)
T 3ll6_A 186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVN-- 263 (337)
T ss_dssp BCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred eeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhc--
Confidence 76532 445899999999984 22467889999999999999999999997655433322
Q ss_pred hcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccc
Q psy11098 306 SVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFA 352 (380)
Q Consensus 306 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~ 352 (380)
.....+ .....+..+.+||++||+.||++|||+.|+++|-+-.
T Consensus 264 --~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~ 306 (337)
T 3ll6_A 264 --GKYSIP--PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI 306 (337)
T ss_dssp ----CCCC--TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred --CcccCC--cccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 222222 2245678899999999999999999999999985543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=339.12 Aligned_cols=238 Identities=23% Similarity=0.347 Sum_probs=194.8
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVM 178 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~ 178 (380)
.++|++.+.||+|+||+||+|++. ++.||+|++... .....+.+|+++++.++|+||+++++++. +..++||
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~lv~ 78 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACL-----NPVCLVM 78 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCT-----TTTEEEE
T ss_pred HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----CCcEEEE
Confidence 468999999999999999999975 688999999643 34466788999999999999999998876 3469999
Q ss_pred EecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcEeecCCCCcEEEeC-C-eeEEEeCCCccccc-
Q psy11098 179 QLVHGESLIQHLCRQS---TITESYICCIIRQLHSALHCLHS---QQIAHKDIRPENILMNG-A-VLKLIDLGSSVSVS- 249 (380)
Q Consensus 179 e~~~gg~L~~~l~~~~---~l~e~~~~~i~~qil~al~~lH~---~~iiHrDlKp~NIl~~~-~-~ikl~DFG~a~~~~- 249 (380)
||+.|++|.+++.... .+++..+..++.||+.||.|||+ +||+||||||+|||++. + .+||+|||++....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 79 EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp ECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred EcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 9999999999997654 47899999999999999999999 89999999999999974 4 48999999997654
Q ss_pred --ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHhcccCCCCCCcCCCCCHHHH
Q psy11098 250 --TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESE--EETRAHISVADYSFPPEQCGHISVPAR 325 (380)
Q Consensus 250 --~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~s~~~~ 325 (380)
....||+.|+|||++.+ ..++.++||||||+++|+|++|..||..... ......+.... .......++.++.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~ 234 (307)
T 2eva_A 159 HMTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT---RPPLIKNLPKPIE 234 (307)
T ss_dssp ------CCTTSSCHHHHTC-CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTC---CCCCBTTCCHHHH
T ss_pred ccccCCCCCceEChhhhCC-CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCC---CCCcccccCHHHH
Confidence 34568999999999987 4778999999999999999999999975432 22332332222 2223456899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhc
Q psy11098 326 ELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 326 ~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
++|.+||..||++|||+++++++
T Consensus 235 ~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 235 SLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhcCChhhCcCHHHHHHH
Confidence 99999999999999999999974
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=360.91 Aligned_cols=247 Identities=23% Similarity=0.324 Sum_probs=195.4
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhh-ccCCCcceeeecccccCCCceEEEE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTL-MHAHIPTALALFENAPVPGTDTIVM 178 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~~~~~~~lv~ 178 (380)
.+|++.+.||+|+||+|+. ....+++.||||++..... ....+|+++++.+ +||||+++++++... +..|+||
T Consensus 24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~--~~~~~E~~~l~~l~~HpnIv~l~~~~~~~---~~~~lv~ 97 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF--SFADREVQLLRESDEHPNVIRYFCTEKDR---QFQYIAI 97 (432)
T ss_dssp EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE--EECHHHHHHHHHSCCCTTBCCEEEEEEET---TEEEEEE
T ss_pred EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH--HHHHHHHHHHHhccCCCCcCeEEEEEecC---CEEEEEE
Confidence 4689999999999999764 4456789999999965433 2356799999999 799999999887653 6779999
Q ss_pred EecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe----CC--eeEEEeCCCccccc--
Q psy11098 179 QLVHGESLIQHLCRQS-TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN----GA--VLKLIDLGSSVSVS-- 249 (380)
Q Consensus 179 e~~~gg~L~~~l~~~~-~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~----~~--~ikl~DFG~a~~~~-- 249 (380)
||+ +|+|.+++.... .+.+..+..++.||+.||.|||++||+||||||+|||++ ++ .+||+|||+|....
T Consensus 98 E~~-~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~ 176 (432)
T 3p23_A 98 ELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176 (432)
T ss_dssp ECC-SEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred ECC-CCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence 999 569999997643 466667789999999999999999999999999999995 22 57899999987653
Q ss_pred -------ccccCCCcccCCccccC--CCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCC
Q psy11098 250 -------TVVLPDLEFASPEMLTS--PATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGH 319 (380)
Q Consensus 250 -------~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 319 (380)
....||+.|+|||++.+ ...++.++|||||||++|+|++ |..||...........+......... ....
T Consensus 177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~ 255 (432)
T 3p23_A 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLH-PEKH 255 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSC-TTCH
T ss_pred CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccC-cccc
Confidence 34568999999999974 2456779999999999999999 99999766555444333322222111 1122
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 320 ISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 320 ~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
.+..+++||.+||+.||++|||++|+|+||||...
T Consensus 256 ~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~ 290 (432)
T 3p23_A 256 EDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290 (432)
T ss_dssp HHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred ccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence 45668999999999999999999999999999753
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=337.99 Aligned_cols=243 Identities=21% Similarity=0.314 Sum_probs=200.9
Q ss_pred hhceeeeeeecccCCeEEEEEEEcC-CCc--EEEEEEecCCC----CchHHHHHHHHHHHhhccCCCcceeeecccccCC
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRG-TGQ--LVALKQIPRER----QPQQITRAEYNLLSTLMHAHIPTALALFENAPVP 171 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~-~~~--~vAvK~~~~~~----~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~ 171 (380)
.++|++.+.||+|+||+||+|++.. +++ .||+|+++... ...+.+.+|+++++.++|+||+++++++...
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 93 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--- 93 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC---
Confidence 5789999999999999999998654 333 68999986542 2345678899999999999999999998753
Q ss_pred CceEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc
Q psy11098 172 GTDTIVMQLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS 249 (380)
Q Consensus 172 ~~~~lv~e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~ 249 (380)
..++||||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 94 -~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 94 -PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp -SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred -CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 479999999999999999764 5799999999999999999999999999999999999997 6799999999987653
Q ss_pred ---------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCC
Q psy11098 250 ---------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGH 319 (380)
Q Consensus 250 ---------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 319 (380)
....+|+.|+|||++.+ ..++.++||||||+++|+|++ |..||.+.+..+....+.......+. ...
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~ 249 (291)
T 1u46_A 173 QNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR--PED 249 (291)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC--CTT
T ss_pred ccccchhhhccCCCCceeeCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCC--CcC
Confidence 23456788999999987 467889999999999999999 99999999888888887765544432 346
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 320 ISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 320 ~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
++.++.++|.+||..||++|||+.+++++
T Consensus 250 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 250 CPQDIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 89999999999999999999999999973
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=351.14 Aligned_cols=242 Identities=17% Similarity=0.167 Sum_probs=196.9
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCC--------CcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcce---------
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGT--------GQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTA--------- 161 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~--------~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i--------- 161 (380)
.++|++.+.||+|+||.||+|++..+ ++.||+|++... ..+.+|+++++.++|+||+++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 57899999999999999999999884 889999999754 357789999999999998873
Q ss_pred ------eeecccccCCCceEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe
Q psy11098 162 ------LALFENAPVPGTDTIVMQLVHGESLIQHLCRQ--STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN 233 (380)
Q Consensus 162 ------~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~ 233 (380)
++++.. ..+..++||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 117 ~~i~~~~~~~~~--~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~ 193 (352)
T 2jii_A 117 LAIPTCMGFGVH--QDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVD 193 (352)
T ss_dssp CSCCCCCEEEEE--TTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEE
T ss_pred cCccchhhcccc--CCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEc
Confidence 333322 146789999999 99999999875 7899999999999999999999999999999999999998
Q ss_pred CC---eeEEEeCCCccccc-------------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q psy11098 234 GA---VLKLIDLGSSVSVS-------------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDES 297 (380)
Q Consensus 234 ~~---~ikl~DFG~a~~~~-------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~ 297 (380)
.+ .+||+|||++.... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..
T Consensus 194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG-CGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 54 79999999997543 23478999999999988 477889999999999999999999997753
Q ss_pred --HHHHHHHHh---cccCCCC--CCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 298 --EEETRAHIS---VADYSFP--PEQCGHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 298 --~~~~~~~i~---~~~~~~~--~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
......... .....+. ...+..++.++.+||.+||..||++|||++++++.
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 330 (352)
T 2jii_A 273 PNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN 330 (352)
T ss_dssp TCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred cCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence 333322222 1111111 11223579999999999999999999999999864
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=338.01 Aligned_cols=245 Identities=18% Similarity=0.260 Sum_probs=204.0
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCC---CcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCC
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGT---GQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPG 172 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~---~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~ 172 (380)
...+|++.+.||+|+||.||+|.+..+ ...+|+|.+..... ....+.+|+.+++.++|+||+++++++... .+
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~ 100 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS--EG 100 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS--SS
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC--CC
Confidence 456899999999999999999997643 34689999875443 335678899999999999999999985432 35
Q ss_pred ceEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCccccc-
Q psy11098 173 TDTIVMQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVS- 249 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~- 249 (380)
..++||||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||++....
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred ceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence 67999999999999999975 456899999999999999999999999999999999999984 599999999987542
Q ss_pred ---------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCC
Q psy11098 250 ---------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGH 319 (380)
Q Consensus 250 ---------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 319 (380)
....+|+.|+|||++.+ ..++.++||||||+++|+|++ |.+||.+.+..+....+........+ ..
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 256 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP---EY 256 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCC---TT
T ss_pred cchhccccccCCCCCccccChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCC---cc
Confidence 23456788999999987 467889999999999999999 77788777776666666655443332 35
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 320 ISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 320 ~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
+++++.++|.+||..||++|||++|+++.
T Consensus 257 ~~~~l~~li~~~l~~~p~~Rps~~ell~~ 285 (298)
T 3f66_A 257 CPDPLYEVMLKCWHPKAEMRPSFSELVSR 285 (298)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 78999999999999999999999999863
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-46 Score=351.73 Aligned_cols=249 Identities=22% Similarity=0.301 Sum_probs=202.0
Q ss_pred hhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC-CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 97 QFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER-QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 97 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
...++|++.+.||+|+||.||+|+++ +++.||+|++.... ...+.+.+|+++++.++|+||+++++++... +..+
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~ 111 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER---NEMI 111 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT---TCCE
T ss_pred HHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC---CeEE
Confidence 35678999999999999999999964 68999999986543 3456778899999999999999999998764 6779
Q ss_pred EEEEecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-
Q psy11098 176 IVMQLVHGESLIQHLCRQS----TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS- 249 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~~----~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~- 249 (380)
+||||+.+++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 191 (321)
T 2qkw_B 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTE 191 (321)
T ss_dssp EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSS
T ss_pred EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9999999999999886542 589999999999999999999999999999999999998 4699999999987542
Q ss_pred -------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHhcccC-----
Q psy11098 250 -------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETR-------AHISVADY----- 310 (380)
Q Consensus 250 -------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~-------~~i~~~~~----- 310 (380)
....||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+....+.. ........
T Consensus 192 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (321)
T 2qkw_B 192 LDQTHLSTVVKGTLGYIDPEYFIK-GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD 270 (321)
T ss_dssp SSCCCCBCCCEEETTTCCHHHHHH-CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSS
T ss_pred ccccccccccCCCccccCHHHhcC-CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcC
Confidence 23457999999999987 46789999999999999999999999765432211 11111111
Q ss_pred -CCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccc
Q psy11098 311 -SFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAW 350 (380)
Q Consensus 311 -~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw 350 (380)
..........+.++.+++.+||..||++|||+.|+++|-.
T Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 311 (321)
T 2qkw_B 271 PNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311 (321)
T ss_dssp SSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred hhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 0111111224567899999999999999999999998754
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=334.80 Aligned_cols=244 Identities=18% Similarity=0.247 Sum_probs=203.3
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCc---EEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCCc
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQ---LVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGT 173 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~---~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~ 173 (380)
...|++.+.||+|+||+||+|.+..+++ .||+|++..... ..+.+.+|+.+++.++|+||+++++++... .+.
T Consensus 20 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~ 97 (298)
T 3pls_A 20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP--EGL 97 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS--SSC
T ss_pred ceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecC--CCC
Confidence 4567788999999999999999766554 799999975443 235677899999999999999999998753 234
Q ss_pred eEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCccccc--
Q psy11098 174 DTIVMQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVS-- 249 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~-- 249 (380)
.++||||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||++....
T Consensus 98 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 98 PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp CEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred cEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 4899999999999999976 467899999999999999999999999999999999999985 599999999997442
Q ss_pred --------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCC
Q psy11098 250 --------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHI 320 (380)
Q Consensus 250 --------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 320 (380)
....+|+.|+|||++.+ ..++.++||||||+++|+|++ |.+||......+....+....... ....+
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 253 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQT-YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLP---QPEYC 253 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTT-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCC---CCTTC
T ss_pred cccccccCcCCCCCccccChhhhcc-CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCC---CCccc
Confidence 23456889999999987 477889999999999999999 556666666666666655444222 22457
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 321 SVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 321 s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
++++.+||.+||..||.+|||++++++.
T Consensus 254 ~~~l~~li~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 254 PDSLYQVMQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999999999999999999999864
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=357.28 Aligned_cols=244 Identities=17% Similarity=0.141 Sum_probs=192.2
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---------chHHHHHHHHHHHhhc---------cCCCcc
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---------PQQITRAEYNLLSTLM---------HAHIPT 160 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---------~~~~~~~E~~il~~l~---------h~ni~~ 160 (380)
.++|++.+.||+|+||+||+|++ +|+.||||++..... ....+.+|+.+++.++ |+|++.
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 57899999999999999999998 689999999975432 2266788999999996 666655
Q ss_pred eeee-----------------ccc----------ccCCCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q psy11098 161 ALAL-----------------FEN----------APVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALH 213 (380)
Q Consensus 161 i~~~-----------------~~~----------~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~ 213 (380)
+.+. |.. ....+..|+||||+.+|++.+.+.+ ..+++..++.++.||+.||.
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHH
Confidence 5443 332 0124688999999999987777744 57899999999999999999
Q ss_pred HHH-HCCcEeecCCCCcEEEeC-C--------------------eeEEEeCCCccccc-ccccCCCcccCCccccCCCCC
Q psy11098 214 CLH-SQQIAHKDIRPENILMNG-A--------------------VLKLIDLGSSVSVS-TVVLPDLEFASPEMLTSPATA 270 (380)
Q Consensus 214 ~lH-~~~iiHrDlKp~NIl~~~-~--------------------~ikl~DFG~a~~~~-~~~~gt~~y~aPE~~~~~~~~ 270 (380)
||| ++||+||||||+|||++. + .+||+|||+|+... ....||+.|+|||++.+. .
T Consensus 176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~~~~gt~~y~aPE~~~g~-~- 253 (336)
T 2vuw_A 176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGD-G- 253 (336)
T ss_dssp HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETTEEECCCCTTCSGGGCCC-S-
T ss_pred HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCCcEEEeecccChhhhcCC-C-
Confidence 999 999999999999999974 3 89999999998764 456899999999999874 3
Q ss_pred CCcccHHHHHHH-HHHHHhCCCCCCCCCH-HHHHHHHhc-cc--CCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy11098 271 GPSTDMWSLGVL-LYILLSGVSPFLDESE-EETRAHISV-AD--YSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQL 345 (380)
Q Consensus 271 ~~~~DiwSlGvi-l~~lltg~~Pf~~~~~-~~~~~~i~~-~~--~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~ 345 (380)
+.++||||||++ .+++++|..||.+... ......+.. .. ..........+++++++||++||++| |++|+
T Consensus 254 ~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~ 328 (336)
T 2vuw_A 254 DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDL 328 (336)
T ss_dssp SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHH
T ss_pred ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHH
Confidence 789999998777 7889999999954322 112222221 11 11122223457889999999999987 99999
Q ss_pred H-hccccc
Q psy11098 346 L-QVAWFA 352 (380)
Q Consensus 346 L-~hpw~~ 352 (380)
| +||||+
T Consensus 329 l~~Hp~f~ 336 (336)
T 2vuw_A 329 LCQHSLFK 336 (336)
T ss_dssp HHHCGGGC
T ss_pred HhcCCCcC
Confidence 9 999995
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=371.34 Aligned_cols=234 Identities=21% Similarity=0.295 Sum_probs=202.0
Q ss_pred eeecccCCeEEEEEEE--cCCCcEEEEEEecCCCC---chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEEEe
Q psy11098 106 ERLGNGRFCTVRKARD--RGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQL 180 (380)
Q Consensus 106 ~~LG~G~fg~V~~~~~--~~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e~ 180 (380)
+.||+|+||+||+|.+ +.+++.||||+++.... ....+.+|+++++.++|+||+++++++.. +..++||||
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----~~~~lv~E~ 450 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA----ESWMLVMEM 450 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES----SSEEEEEEC
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec----CCEEEEEEc
Confidence 4799999999999954 45678999999975432 24678889999999999999999998864 457999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc---------c
Q psy11098 181 VHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS---------T 250 (380)
Q Consensus 181 ~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~---------~ 250 (380)
+.+|+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|+... .
T Consensus 451 ~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 530 (635)
T 4fl3_A 451 AELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 530 (635)
T ss_dssp CTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---------
T ss_pred cCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccccc
Confidence 99999999999888999999999999999999999999999999999999998 5689999999987552 2
Q ss_pred cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHH
Q psy11098 251 VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIG 329 (380)
Q Consensus 251 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 329 (380)
...+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+....... ....+++++.+||.
T Consensus 531 ~~~~t~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~---~p~~~~~~l~~li~ 606 (635)
T 4fl3_A 531 HGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG---CPAGCPREMYDLMN 606 (635)
T ss_dssp ----CGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCTTCCHHHHHHHH
T ss_pred CCCCceeeeChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CCCCCCHHHHHHHH
Confidence 3345788999999987 477889999999999999998 999999999888888877654322 22468999999999
Q ss_pred HhcccCCCCCCCHHHHHh
Q psy11098 330 QLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 330 ~~L~~dP~~Rpt~~e~L~ 347 (380)
+||..||++|||++++++
T Consensus 607 ~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 607 LCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHTCSSTTTSCCHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHH
Confidence 999999999999999985
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=342.75 Aligned_cols=248 Identities=21% Similarity=0.259 Sum_probs=195.2
Q ss_pred hhhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHh--hccCCCcceeeecccccC-C
Q psy11098 95 QEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLST--LMHAHIPTALALFENAPV-P 171 (380)
Q Consensus 95 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~--l~h~ni~~i~~~~~~~~~-~ 171 (380)
...+.++|++.+.||+|+||.||+|++. ++.||||++..... .....|.+++.. ++|+||+++++++..... .
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~--~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE--ASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecccc--chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 4567899999999999999999999986 88999999965433 333445555554 489999999998766422 1
Q ss_pred CceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CcEeecCCCCcEEEe-CCeeEEEeC
Q psy11098 172 GTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQ--------QIAHKDIRPENILMN-GAVLKLIDL 242 (380)
Q Consensus 172 ~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~--------~iiHrDlKp~NIl~~-~~~ikl~DF 242 (380)
...++||||+.+|+|.+++... .+++..++.++.|++.||.|||++ ||+||||||+|||++ ++.+||+||
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 186 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL 186 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred CceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence 5679999999999999999654 799999999999999999999999 999999999999998 569999999
Q ss_pred CCccccc----------ccccCCCcccCCccccCCCCCCCc------ccHHHHHHHHHHHHhC----------CCCCCCC
Q psy11098 243 GSSVSVS----------TVVLPDLEFASPEMLTSPATAGPS------TDMWSLGVLLYILLSG----------VSPFLDE 296 (380)
Q Consensus 243 G~a~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~------~DiwSlGvil~~lltg----------~~Pf~~~ 296 (380)
|++.... ....||+.|+|||++.+. ..+.. +|||||||++|+|++| ..||...
T Consensus 187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~ 265 (337)
T 3mdy_A 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDES-LNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265 (337)
T ss_dssp TTCEECC---------CCSSCSCGGGCCHHHHTTC-CCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCceeeccccccccCCCCCCccCcceeChhhcccc-cCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence 9997542 245789999999999874 33333 8999999999999999 7777543
Q ss_pred -----CHHHHHHHHhcccCCCCCCc---CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 297 -----SEEETRAHISVADYSFPPEQ---CGHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 297 -----~~~~~~~~i~~~~~~~~~~~---~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
........+........... ...+++++.+||.+||+.||++|||+.|+++|
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 266 VPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 22233333322222111111 12456779999999999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=358.50 Aligned_cols=246 Identities=18% Similarity=0.246 Sum_probs=203.4
Q ss_pred hhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEE
Q psy11098 97 QFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 97 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
.+.++|++.+.||+|+||.||+|++..+++.||||++...... ..+.+|+++++.|.|.+++..+..|... .+..+|
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-~~~~~E~~il~~L~~~~~i~~i~~~~~~--~~~~~l 80 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-PQLLYESKIYRILQGGTGIPNVRWFGVE--GDYNVL 80 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-CCHHHHHHHHHHTTTSTTCCCEEEEEEE--TTEEEE
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-HHHHHHHHHHHHhcCCCCCCeEEEEEee--CCEEEE
Confidence 3578999999999999999999999999999999998755433 3467899999999987666666555443 467799
Q ss_pred EEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe----CCeeEEEeCCCccccc--
Q psy11098 177 VMQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN----GAVLKLIDLGSSVSVS-- 249 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~----~~~ikl~DFG~a~~~~-- 249 (380)
||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 81 vme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 99999 9999999975 56799999999999999999999999999999999999993 5689999999997653
Q ss_pred -----------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhcccCCCC-C
Q psy11098 250 -----------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDES---EEETRAHISVADYSFP-P 314 (380)
Q Consensus 250 -----------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~---~~~~~~~i~~~~~~~~-~ 314 (380)
....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.. ..+....+........ .
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE 238 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred ccccccccccccccCCCccccCHHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH
Confidence 15678999999999988 477889999999999999999999997743 3333333332222111 1
Q ss_pred CcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy11098 315 EQCGHISVPARELIGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 315 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~ 347 (380)
..+..++.++.+||.+||..||++||+++++++
T Consensus 239 ~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 223567999999999999999999999998865
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=347.76 Aligned_cols=256 Identities=21% Similarity=0.304 Sum_probs=191.7
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeeccccc--CCCceEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAP--VPGTDTI 176 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~--~~~~~~l 176 (380)
.++|++.+.||+|+||.||+|++ +++.||||++............|+..+..++|+||++++..+.... .....++
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~l 89 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLL 89 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEE
Confidence 47899999999999999999976 5889999999754433333334444455689999999987654332 2235689
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---------CcEeecCCCCcEEEeC-CeeEEEeCCCcc
Q psy11098 177 VMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQ---------QIAHKDIRPENILMNG-AVLKLIDLGSSV 246 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~---------~iiHrDlKp~NIl~~~-~~ikl~DFG~a~ 246 (380)
||||+.+|+|.+++... ..++..++.++.||+.||.|||+. ||+||||||+|||++. +.+||+|||++.
T Consensus 90 v~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~ 168 (336)
T 3g2f_A 90 VMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSM 168 (336)
T ss_dssp EECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecccee
Confidence 99999999999999655 458999999999999999999999 9999999999999984 699999999997
Q ss_pred ccc--------------ccccCCCcccCCccccCC------CCCCCcccHHHHHHHHHHHHhCCCCCCCCCH--------
Q psy11098 247 SVS--------------TVVLPDLEFASPEMLTSP------ATAGPSTDMWSLGVLLYILLSGVSPFLDESE-------- 298 (380)
Q Consensus 247 ~~~--------------~~~~gt~~y~aPE~~~~~------~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~-------- 298 (380)
... ....||+.|+|||++.+. ..++.++|||||||++|+|++|..||.....
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~ 248 (336)
T 3g2f_A 169 RLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAF 248 (336)
T ss_dssp ECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTT
T ss_pred ecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhh
Confidence 543 234689999999999762 2345689999999999999999776633211
Q ss_pred ----------HHHHHHHhccc--CCCCCC--cCCCCCHHHHHHHHHhcccCCCCCCCHHHH------HhcccccccCCC
Q psy11098 299 ----------EETRAHISVAD--YSFPPE--QCGHISVPARELIGQLLNTHADKRPTAGQL------LQVAWFAEASCS 357 (380)
Q Consensus 299 ----------~~~~~~i~~~~--~~~~~~--~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~------L~hpw~~~~~~~ 357 (380)
......+.... ..++.. ....+++++.+||.+||..||++|||++|+ |.++|-++...+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~~~~ 327 (336)
T 3g2f_A 249 QTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVS 327 (336)
T ss_dssp HHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC-----
T ss_pred hcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhcccCC
Confidence 11111111111 111111 011234579999999999999999999999 667888776543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=343.21 Aligned_cols=252 Identities=19% Similarity=0.224 Sum_probs=200.4
Q ss_pred hhhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCC
Q psy11098 95 QEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPG 172 (380)
Q Consensus 95 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~ 172 (380)
.....++|++.+.||+|+||.||+|++. +++.||+|++..... ....+.+|+++++.++|+||+++++++... +
T Consensus 25 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~ 100 (326)
T 3uim_A 25 LQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP---T 100 (326)
T ss_dssp HHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCS---S
T ss_pred HHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecC---C
Confidence 3445789999999999999999999854 688999999965432 233578899999999999999999998764 5
Q ss_pred ceEEEEEecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcEeecCCCCcEEEeC-CeeEEEeCCC
Q psy11098 173 TDTIVMQLVHGESLIQHLCRQS----TITESYICCIIRQLHSALHCLHSQ---QIAHKDIRPENILMNG-AVLKLIDLGS 244 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~~~----~l~e~~~~~i~~qil~al~~lH~~---~iiHrDlKp~NIl~~~-~~ikl~DFG~ 244 (380)
..++||||+.+++|.+++.... .+++..+..++.||+.||.|||++ ||+||||||+|||++. +.+||+|||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 180 (326)
T 3uim_A 101 ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180 (326)
T ss_dssp CCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSS
T ss_pred ceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcc
Confidence 6799999999999999997643 499999999999999999999999 9999999999999985 5999999999
Q ss_pred ccccc-------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHhcc-
Q psy11098 245 SVSVS-------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDES--------EEETRAHISVA- 308 (380)
Q Consensus 245 a~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~--------~~~~~~~i~~~- 308 (380)
+.... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... ..+........
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 259 (326)
T 3uim_A 181 AKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 259 (326)
T ss_dssp CEECCSSSSCEECCCCSCGGGCCHHHHHH-SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSC
T ss_pred ccccCcccccccccccCCcCccCHHHhcc-CCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhch
Confidence 97553 34458999999999977 467889999999999999999999995211 11111110000
Q ss_pred c------CCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy11098 309 D------YSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 309 ~------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~ 351 (380)
. ...........+.++.+|+.+||+.||.+|||+.|+++|-+-
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 260 KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp CSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 0 000111111234678999999999999999999999998654
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=350.00 Aligned_cols=244 Identities=18% Similarity=0.253 Sum_probs=197.8
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCC---cEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCCc
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTG---QLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGT 173 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~---~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~ 173 (380)
...|++.+.||+|+||+||+|.+..++ ..||+|.++.... ....+.+|+.+++.++||||+++++++... .+.
T Consensus 88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~ 165 (373)
T 3c1x_A 88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS--EGS 165 (373)
T ss_dssp TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC--SSC
T ss_pred hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC--CCC
Confidence 356889999999999999999976433 4689999865433 345678899999999999999999976432 256
Q ss_pred eEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc--
Q psy11098 174 DTIVMQLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS-- 249 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~-- 249 (380)
.++||||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++...
T Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred eEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccc
Confidence 79999999999999999764 4689999999999999999999999999999999999998 4699999999997542
Q ss_pred --------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCC
Q psy11098 250 --------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHI 320 (380)
Q Consensus 250 --------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 320 (380)
....+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+........ ...+
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~---p~~~ 321 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ---PEYC 321 (373)
T ss_dssp ------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCC---CTTC
T ss_pred ccccccccCCCCCcccccChHHhcC-CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCC---CCCC
Confidence 23456788999999987 477889999999999999999 7889987776666666655543322 2357
Q ss_pred CHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 321 SVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 321 s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
+.++.++|.+||..||++|||++|++++
T Consensus 322 ~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 322 PDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 8999999999999999999999999975
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=342.73 Aligned_cols=244 Identities=25% Similarity=0.342 Sum_probs=199.3
Q ss_pred hhhce-eeeeeecccCCeEEEEEEE----cCCCcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccC
Q psy11098 98 FEHRY-EELERLGNGRFCTVRKARD----RGTGQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPV 170 (380)
Q Consensus 98 ~~~~y-~~~~~LG~G~fg~V~~~~~----~~~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~ 170 (380)
+.++| ++++.||+|+||+||++.. ..+++.||+|++..... ....+.+|+++++.++|+||+++++++....
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 106 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG- 106 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC-
Confidence 45566 9999999999999988754 45788999999976543 2456788999999999999999999987642
Q ss_pred CCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCccccc
Q psy11098 171 PGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVS 249 (380)
Q Consensus 171 ~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~ 249 (380)
....++||||+.+++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||++....
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 107 AASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp TTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred CceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 24679999999999999998655 5999999999999999999999999999999999999984 589999999997653
Q ss_pred ---------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHH---------------HHHHH
Q psy11098 250 ---------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEE---------------TRAHI 305 (380)
Q Consensus 250 ---------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~---------------~~~~i 305 (380)
....+|+.|+|||++.+ ..++.++||||||+++|+|++|..||....... ....+
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKE-YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence 23457888999999987 467789999999999999999999996543221 11111
Q ss_pred hcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy11098 306 SVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 306 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~ 347 (380)
... ........++.++.+||++||..||++|||++|+++
T Consensus 265 ~~~---~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 265 ERG---ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HTT---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hcc---cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 111 122233568999999999999999999999999985
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=364.74 Aligned_cols=246 Identities=20% Similarity=0.275 Sum_probs=206.1
Q ss_pred hceeeee-eecccCCeEEEEEEEcC--CCcEEEEEEecCCC--CchHHHHHHHHHHHhhccCCCcceeeecccccCCCce
Q psy11098 100 HRYEELE-RLGNGRFCTVRKARDRG--TGQLVALKQIPRER--QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 100 ~~y~~~~-~LG~G~fg~V~~~~~~~--~~~~vAvK~~~~~~--~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~ 174 (380)
+++.+.+ .||+|+||.||+|.++. ++..||||+++... ...+.+.+|+++|+.++|+||+++++++.. +..
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~----~~~ 410 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA----EAL 410 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES----SSE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc----CCe
Confidence 3455555 89999999999998763 56679999997543 345678899999999999999999999864 458
Q ss_pred EEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc---
Q psy11098 175 TIVMQLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS--- 249 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~--- 249 (380)
++||||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++...
T Consensus 411 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~ 490 (613)
T 2ozo_A 411 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490 (613)
T ss_dssp EEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred EEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence 9999999999999999654 5699999999999999999999999999999999999998 5799999999998653
Q ss_pred ------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCH
Q psy11098 250 ------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISV 322 (380)
Q Consensus 250 ------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 322 (380)
....+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+..+... .....+++
T Consensus 491 ~~~~~~~~~~~~~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~---~~p~~~~~ 566 (613)
T 2ozo_A 491 SYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM---ECPPECPP 566 (613)
T ss_dssp -----------CCTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCC---CCCTTCCH
T ss_pred ceeeeccCCCCccceeCHhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC---CCCCcCCH
Confidence 12234688999999987 478889999999999999998 99999998888888877765422 12245899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHH---hcccccc
Q psy11098 323 PARELIGQLLNTHADKRPTAGQLL---QVAWFAE 353 (380)
Q Consensus 323 ~~~~li~~~L~~dP~~Rpt~~e~L---~hpw~~~ 353 (380)
++.+||.+||..||++|||+.+++ ++.|+..
T Consensus 567 ~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 567 ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp HHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 999999999999999999999984 5555543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=344.82 Aligned_cols=242 Identities=19% Similarity=0.201 Sum_probs=193.4
Q ss_pred hhceeeeeeecccCCeEEEEE-----EEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhc---cCCCcceeeecccccC
Q psy11098 99 EHRYEELERLGNGRFCTVRKA-----RDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLM---HAHIPTALALFENAPV 170 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~-----~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~---h~ni~~i~~~~~~~~~ 170 (380)
.++|++.+.||+|+||+||+| .+..+++.||+|++... ....+..|+++++.++ |+|++.+++++...
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~-- 139 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ-- 139 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS--
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC--
Confidence 578999999999999999999 46778999999999654 3455677888888887 78888887777653
Q ss_pred CCceEEEEEecCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-----------
Q psy11098 171 PGTDTIVMQLVHGESLIQHLCR-----QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG----------- 234 (380)
Q Consensus 171 ~~~~~lv~e~~~gg~L~~~l~~-----~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~----------- 234 (380)
+..++||||+.||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 140 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~ 218 (365)
T 3e7e_A 140 -NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDL 218 (365)
T ss_dssp -SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------
T ss_pred -CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccc
Confidence 677999999999999999974 457999999999999999999999999999999999999965
Q ss_pred -CeeEEEeCCCccccc--------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy11098 235 -AVLKLIDLGSSVSVS--------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHI 305 (380)
Q Consensus 235 -~~ikl~DFG~a~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i 305 (380)
+.+||+|||+|+... ...+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......
T Consensus 219 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----- 292 (365)
T 3e7e_A 219 SAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE----- 292 (365)
T ss_dssp CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-----
T ss_pred cCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC-CCCCccccHHHHHHHHHHHHhCCCccccCCCCc-----
Confidence 589999999996432 45678999999999988 468999999999999999999999996543210
Q ss_pred hcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh---ccccccc
Q psy11098 306 SVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQ---VAWFAEA 354 (380)
Q Consensus 306 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~---hpw~~~~ 354 (380)
......+.. ...++...+++..||+.+|.+|++..+.|. ..|+.+.
T Consensus 293 ~~~~~~~~~---~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 293 CKPEGLFRR---LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp EEECSCCTT---CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred eeechhccc---cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 000111111 124677899999999999999966544443 4566554
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=340.12 Aligned_cols=242 Identities=19% Similarity=0.239 Sum_probs=203.2
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC---CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER---QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
.++|++.+.||+|+||.||+|.+.. .+|+|++.... .....+.+|+.+++.++|+||+++++++... +..+
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~ 105 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP---PHLA 105 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS---SCEE
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC---CceE
Confidence 5789999999999999999999864 49999986432 2234567799999999999999999988764 5689
Q ss_pred EEEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeCCeeEEEeCCCccccc-----
Q psy11098 176 IVMQLVHGESLIQHLCRQS-TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGAVLKLIDLGSSVSVS----- 249 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~~-~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~~~ikl~DFG~a~~~~----- 249 (380)
+||||+.|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++++.+||+|||++....
T Consensus 106 iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~~~~~~l~Dfg~~~~~~~~~~~ 185 (319)
T 2y4i_B 106 IITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDNGKVVITDFGLFSISGVLQAG 185 (319)
T ss_dssp EECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC--CCEECCCSCCC--------
T ss_pred EEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEeCCCEEEeecCCcccccccccc
Confidence 9999999999999997654 6999999999999999999999999999999999999999999999999976432
Q ss_pred ------ccccCCCcccCCccccC--------CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCC
Q psy11098 250 ------TVVLPDLEFASPEMLTS--------PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPE 315 (380)
Q Consensus 250 ------~~~~gt~~y~aPE~~~~--------~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~ 315 (380)
....||+.|+|||++.+ ...++.++||||||+++|+|++|..||.+.........+....... .
T Consensus 186 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~ 263 (319)
T 2y4i_B 186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPN--L 263 (319)
T ss_dssp --CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCC--C
T ss_pred ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCC--C
Confidence 23457899999999875 2346789999999999999999999999988888777776553322 2
Q ss_pred cCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 316 QCGHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 316 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
....++.++.++|.+||..||++|||+.++++.
T Consensus 264 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 264 SQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296 (319)
T ss_dssp CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 223578899999999999999999999999964
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=370.37 Aligned_cols=256 Identities=26% Similarity=0.389 Sum_probs=203.7
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccc---cCCC
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENA---PVPG 172 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~---~~~~ 172 (380)
..++|++.+.||+|+||.||+|.+..+|+.||+|++..... ....+.+|+++++.++||||+++++++... ...+
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 35789999999999999999999999999999999875433 245678899999999999999999987652 2246
Q ss_pred ceEEEEEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeCC----eeEEEeCCCc
Q psy11098 173 TDTIVMQLVHGESLIQHLCRQS---TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGA----VLKLIDLGSS 245 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~~~---~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~~----~ikl~DFG~a 245 (380)
..++||||+.|++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.+ .+||+|||++
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence 7799999999999999997643 68999999999999999999999999999999999999843 4899999999
Q ss_pred cccc-----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHH---------HHH-----h
Q psy11098 246 VSVS-----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETR---------AHI-----S 306 (380)
Q Consensus 246 ~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~---------~~i-----~ 306 (380)
.... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....... ..+ .
T Consensus 172 ~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l 250 (676)
T 3qa8_A 172 KELDQGELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDL 250 (676)
T ss_dssp CBTTSCCCCCCCCSCCTTCSSCSSCC-SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCC
T ss_pred cccccccccccccCCcccCChHHhcc-CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhh
Confidence 8654 34578999999999987 57789999999999999999999999765332211 000 0
Q ss_pred cccCCCC------CCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 307 VADYSFP------PEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 307 ~~~~~~~------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
.+...+. ......+++++.+||.+||..||++|||++|+|+||||+..
T Consensus 251 ~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l 304 (676)
T 3qa8_A 251 TGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQAL 304 (676)
T ss_dssp SSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHH
T ss_pred ccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHH
Confidence 1111111 11122357889999999999999999999999999999853
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=334.92 Aligned_cols=245 Identities=21% Similarity=0.295 Sum_probs=200.7
Q ss_pred hhhceeeeeeecccCCeEEEEEE----EcCCCcEEEEEEecCCCC-chHHHHHHHHHHHhhccCCCcceeeecccccCCC
Q psy11098 98 FEHRYEELERLGNGRFCTVRKAR----DRGTGQLVALKQIPRERQ-PQQITRAEYNLLSTLMHAHIPTALALFENAPVPG 172 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~----~~~~~~~vAvK~~~~~~~-~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~ 172 (380)
..++|++.+.||+|+||.||+|+ +..+++.||+|++..... ....+.+|+++++.++|+||+++++++.... ..
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 117 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG-RR 117 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-----
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC-CC
Confidence 35789999999999999999998 466899999999976443 3456788999999999999999999876532 24
Q ss_pred ceEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-
Q psy11098 173 TDTIVMQLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS- 249 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~- 249 (380)
..++||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~ 197 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred ceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence 679999999999999999775 4699999999999999999999999999999999999998 6799999999997653
Q ss_pred --------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHH
Q psy11098 250 --------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEE----------------ETRAHI 305 (380)
Q Consensus 250 --------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~----------------~~~~~i 305 (380)
....++..|+|||++.+ ..++.++||||||+++|+|++|..||...... .....+
T Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (326)
T 2w1i_A 198 DKEYYKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 276 (326)
T ss_dssp SCSEEECSSCCSCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred cccccccccCCCCceeEECchhhcC-CCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHh
Confidence 23356778999999987 46788999999999999999999998643211 111111
Q ss_pred hcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy11098 306 SVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 306 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~ 347 (380)
.. .... .....++.++.+||++||..||++|||+.|+++
T Consensus 277 ~~-~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 277 KN-NGRL--PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HT-TCCC--CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hc-CCCC--CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11 1111 223468999999999999999999999999985
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=353.95 Aligned_cols=245 Identities=17% Similarity=0.176 Sum_probs=190.9
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC----CchHHHHHHHHHHHhhccCC-Ccc--------------
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQITRAEYNLLSTLMHAH-IPT-------------- 160 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~il~~l~h~n-i~~-------------- 160 (380)
..|...+.||+|+||+||+|++..+|+.||||++.... ...+.+++|+.+++.+.|.. ...
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 45888899999999999999999999999999987332 22467788999999998722 111
Q ss_pred -------eeeecccc--cCCCceEEEEEecCCCCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeec
Q psy11098 161 -------ALALFENA--PVPGTDTIVMQLVHGESLIQHLCR-------QSTITESYICCIIRQLHSALHCLHSQQIAHKD 224 (380)
Q Consensus 161 -------i~~~~~~~--~~~~~~~lv~e~~~gg~L~~~l~~-------~~~l~e~~~~~i~~qil~al~~lH~~~iiHrD 224 (380)
+..++... ......+++|+++ +++|.+++.. ...+++..+..++.||+.||.|||++||+|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrD 236 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 236 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 11111110 0012356777766 7899998842 23477888999999999999999999999999
Q ss_pred CCCCcEEEe-CCeeEEEeCCCccccc---ccccCCCcccCCcccc---------CCCCCCCcccHHHHHHHHHHHHhCCC
Q psy11098 225 IRPENILMN-GAVLKLIDLGSSVSVS---TVVLPDLEFASPEMLT---------SPATAGPSTDMWSLGVLLYILLSGVS 291 (380)
Q Consensus 225 lKp~NIl~~-~~~ikl~DFG~a~~~~---~~~~gt~~y~aPE~~~---------~~~~~~~~~DiwSlGvil~~lltg~~ 291 (380)
|||+|||++ ++.+||+|||+++... ...+| +.|+|||++. ....++.++|||||||++|+|++|+.
T Consensus 237 iKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~ 315 (413)
T 3dzo_A 237 LRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315 (413)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSC
T ss_pred cccceEEEecCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCC
Confidence 999999998 5689999999987664 45577 9999999983 22457789999999999999999999
Q ss_pred CCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 292 PFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 292 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
||.+.+..+....+. ..+..+++++++||.+||..||++|||+.++|+||||.+.
T Consensus 316 Pf~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~ 370 (413)
T 3dzo_A 316 PNTDDAALGGSEWIF--------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 370 (413)
T ss_dssp CCCTTGGGSCSGGGG--------SSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred CCCCcchhhhHHHHH--------hhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence 998766443322221 1234679999999999999999999999999999999864
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=333.98 Aligned_cols=249 Identities=21% Similarity=0.246 Sum_probs=200.8
Q ss_pred hhhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHh--hccCCCcceeeecccccCC-
Q psy11098 95 QEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLST--LMHAHIPTALALFENAPVP- 171 (380)
Q Consensus 95 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~--l~h~ni~~i~~~~~~~~~~- 171 (380)
...+.++|++.+.||+|+||.||+|++ +++.||+|++... ....+.+|.+++.. ++|+||+++++++......
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred cccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 456789999999999999999999998 4889999999643 34556778888887 7899999999998764311
Q ss_pred CceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HCCcEeecCCCCcEEEe-CCeeEEEeC
Q psy11098 172 GTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLH--------SQQIAHKDIRPENILMN-GAVLKLIDL 242 (380)
Q Consensus 172 ~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH--------~~~iiHrDlKp~NIl~~-~~~ikl~DF 242 (380)
...++||||+.+|+|.+++.. ..+++..++.++.||+.||.||| +.||+||||||+|||++ ++.+||+||
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 191 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 191 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred ceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence 368999999999999999965 47999999999999999999999 89999999999999998 569999999
Q ss_pred CCccccc----------ccccCCCcccCCccccCCCCC-----CCcccHHHHHHHHHHHHhC----------CCCCCCC-
Q psy11098 243 GSSVSVS----------TVVLPDLEFASPEMLTSPATA-----GPSTDMWSLGVLLYILLSG----------VSPFLDE- 296 (380)
Q Consensus 243 G~a~~~~----------~~~~gt~~y~aPE~~~~~~~~-----~~~~DiwSlGvil~~lltg----------~~Pf~~~- 296 (380)
|++.... ....||+.|+|||++.+.... +.++|||||||++|+|++| ..||.+.
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 9997553 234789999999999774222 2589999999999999999 7898664
Q ss_pred ----CHHHHHHHHhcccCCCCCCc---CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 297 ----SEEETRAHISVADYSFPPEQ---CGHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 297 ----~~~~~~~~i~~~~~~~~~~~---~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
........+........... ....++.+.+||.+||+.||++|||+.++++|
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 272 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 23344444433322221111 11234678999999999999999999999976
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=333.32 Aligned_cols=240 Identities=20% Similarity=0.324 Sum_probs=194.2
Q ss_pred eeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC-----CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEE
Q psy11098 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER-----QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 102 y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~-----~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
|...+.||+|+||.||+|.+ +++.||+|++.... ...+.+.+|+.+++.++|+||+++++++... +..++
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~~l 107 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDG---DDLCL 107 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---SSCEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecC---CceEE
Confidence 44458999999999999986 57899999986432 2346678899999999999999999988764 56799
Q ss_pred EEEecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCccccc---
Q psy11098 177 VMQLVHGESLIQHLCR---QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVS--- 249 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~---~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~--- 249 (380)
||||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||++....
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 187 (307)
T 2nru_A 108 VYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187 (307)
T ss_dssp EEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCS
T ss_pred EEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccc
Confidence 9999999999999964 356999999999999999999999999999999999999984 599999999987543
Q ss_pred -----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHhcccCCC-------C
Q psy11098 250 -----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEE----TRAHISVADYSF-------P 313 (380)
Q Consensus 250 -----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~----~~~~i~~~~~~~-------~ 313 (380)
....||+.|+|||++.+ .++.++||||||+++|+|++|..||.+..... ....+......+ .
T Consensus 188 ~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (307)
T 2nru_A 188 QTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM 265 (307)
T ss_dssp SCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSC
T ss_pred ccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccc
Confidence 23578999999999876 46889999999999999999999997654322 222221111100 0
Q ss_pred CCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 314 PEQCGHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 314 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
.......+..+.+++.+||..||.+|||+++++++
T Consensus 266 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 266 NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 01112245678999999999999999999999975
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=361.12 Aligned_cols=243 Identities=21% Similarity=0.264 Sum_probs=207.6
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCC---CcEEEEEEecCCCCc--hHHHHHHHHHHHhhccCCCcceeeecccccCCC
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGT---GQLVALKQIPRERQP--QQITRAEYNLLSTLMHAHIPTALALFENAPVPG 172 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~---~~~vAvK~~~~~~~~--~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~ 172 (380)
..++|++.+.||+|+||+||+|.+..+ +..||+|++...... .+.+.+|+.+++.++||||+++++++.. +
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~ 463 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE----N 463 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----S
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec----C
Confidence 357899999999999999999998754 457999998654332 3567889999999999999999998743 4
Q ss_pred ceEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-
Q psy11098 173 TDTIVMQLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS- 249 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~- 249 (380)
..++||||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 543 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence 679999999999999999764 4699999999999999999999999999999999999998 6799999999997653
Q ss_pred ------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCH
Q psy11098 250 ------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISV 322 (380)
Q Consensus 250 ------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 322 (380)
....+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+....... ....+++
T Consensus 544 ~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~~~ 619 (656)
T 2j0j_A 544 STYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP---MPPNCPP 619 (656)
T ss_dssp ----------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCC---CCTTCCH
T ss_pred CcceeccCCCCCcceeCHHHhcC-CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC---CCccccH
Confidence 23456789999999987 477889999999999999997 999999998888887776654322 2246899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 323 PARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 323 ~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
++.+||.+||..||++|||+.++++.
T Consensus 620 ~l~~li~~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 620 TLYSLMTKCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99999999999999999999999854
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=323.80 Aligned_cols=223 Identities=18% Similarity=0.157 Sum_probs=183.7
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCch----HHHHHHHHHHHhhccCCCcceeeecccccCCCc
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQ----QITRAEYNLLSTLMHAHIPTALALFENAPVPGT 173 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~----~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~ 173 (380)
+.++|++.+.||+|+||.||+|++..+++.||+|++....... ..+.+|+.++..+.|+||+++++++... +.
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~---~~ 105 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR---AG 105 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET---TE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC---Cc
Confidence 4678999999999999999999999999999999997654332 5678899999999999999999998764 67
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccccccc
Q psy11098 174 DTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVSTVV 252 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~~~~ 252 (380)
.|+||||+.|++|.+++..+ ....++..++.||+.||.|||++||+||||||+|||++ ++.+||+++|
T Consensus 106 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~--------- 174 (286)
T 3uqc_A 106 GLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA--------- 174 (286)
T ss_dssp EEEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred EEEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc---------
Confidence 89999999999999999543 46678899999999999999999999999999999998 5688988554
Q ss_pred cCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHhcccCCCCCCcCCCCCHHHHHHHH
Q psy11098 253 LPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRA---HISVADYSFPPEQCGHISVPARELIG 329 (380)
Q Consensus 253 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~s~~~~~li~ 329 (380)
|++ .++.++|||||||++|+|++|..||.+.+..+... .........+......+++++.+||.
T Consensus 175 -----~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 241 (286)
T 3uqc_A 175 -----TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAA 241 (286)
T ss_dssp -----CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHH
T ss_pred -----ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHH
Confidence 333 35779999999999999999999998765432111 11111111112233568999999999
Q ss_pred HhcccCCCCCCCHHHHHhc
Q psy11098 330 QLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 330 ~~L~~dP~~Rpt~~e~L~h 348 (380)
+||++||++| |+.|+++.
T Consensus 242 ~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 242 RSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp HHHCTTSSCC-CHHHHHHH
T ss_pred HHcccCCccC-CHHHHHHH
Confidence 9999999999 99999974
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=364.68 Aligned_cols=242 Identities=22% Similarity=0.312 Sum_probs=200.6
Q ss_pred hhhhceeeeeeecccCCeEEEEEEEcC-CCcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCC-
Q psy11098 97 QFEHRYEELERLGNGRFCTVRKARDRG-TGQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPG- 172 (380)
Q Consensus 97 ~~~~~y~~~~~LG~G~fg~V~~~~~~~-~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~- 172 (380)
.+.++|++.+.||+|+||+||+|.+.. +++.||||++..... ....+.+|+++++.++||||+++++++......+
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 156 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD 156 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence 456899999999999999999999986 789999999865433 2346678999999999999999999988753211
Q ss_pred -ceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeCCeeEEEeCCCccccc--
Q psy11098 173 -TDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGAVLKLIDLGSSVSVS-- 249 (380)
Q Consensus 173 -~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~~~ikl~DFG~a~~~~-- 249 (380)
..||||||+.|++|.+.+.. .+++..++.++.||+.||.|||++||+||||||+|||++.+.+||+|||++....
T Consensus 157 ~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~~~kl~DFG~a~~~~~~ 234 (681)
T 2pzi_A 157 PVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQLKLIDLGAVSRINSF 234 (681)
T ss_dssp EEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSCEEECCCTTCEETTCC
T ss_pred ceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCCcEEEEecccchhcccC
Confidence 15999999999999887754 7999999999999999999999999999999999999998899999999998765
Q ss_pred ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHH
Q psy11098 250 TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIG 329 (380)
Q Consensus 250 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 329 (380)
....||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.... ... ........++++.+||.
T Consensus 235 ~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~---------~~~-~~~~~~~~~~~l~~li~ 302 (681)
T 2pzi_A 235 GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVD---------GLP-EDDPVLKTYDSYGRLLR 302 (681)
T ss_dssp SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECS---------SCC-TTCHHHHHCHHHHHHHH
T ss_pred CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCcccccc---------ccc-ccccccccCHHHHHHHh
Confidence 456799999999999763 378999999999999999999998653210 000 11111124678999999
Q ss_pred HhcccCCCCCCCHHHHHhccccc
Q psy11098 330 QLLNTHADKRPTAGQLLQVAWFA 352 (380)
Q Consensus 330 ~~L~~dP~~Rpt~~e~L~hpw~~ 352 (380)
+||.+||++||+..+.+.|+|+.
T Consensus 303 ~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 303 RAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp HHTCSSGGGSCSSHHHHHHHHHH
T ss_pred hhccCChhhCCCHHHHHHHHHHH
Confidence 99999999999999999999875
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=307.46 Aligned_cols=179 Identities=22% Similarity=0.195 Sum_probs=131.8
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEecCCCC-----------chHHHHHHHHHHHhh-ccCCCcceeeecccccCCCc
Q psy11098 106 ERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ-----------PQQITRAEYNLLSTL-MHAHIPTALALFENAPVPGT 173 (380)
Q Consensus 106 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-----------~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~~~~~ 173 (380)
..++.|++|.+..++...+|+.||+|++.+... ..+.+.+|+++|+++ .|+||++++++++.. +.
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~---~~ 316 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENA---QS 316 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECS---SE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEEC---CE
Confidence 457888899888888888999999999965421 124578899999999 799999999999875 67
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc---
Q psy11098 174 DTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS--- 249 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~--- 249 (380)
.||||||+.|++|.++|...+.+++. .|+.||+.||.|||++|||||||||+|||++ ++.+||+|||+|+...
T Consensus 317 ~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 317 GWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp EEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred EEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence 89999999999999999998889875 4889999999999999999999999999998 5799999999997653
Q ss_pred ---ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCC
Q psy11098 250 ---TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSP 292 (380)
Q Consensus 250 ---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~P 292 (380)
...+||+.|||||++.+ .+..++|+||+|+++++|.++..+
T Consensus 394 ~~~~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 394 SWPTNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp CCSHHHHHHHHHHHHHHC-------------------CCCCTTHHH
T ss_pred ccccCceechhhccHHHhCC--CCCCcccccccccchhhhccccch
Confidence 35678999999999987 356689999999998888766444
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-28 Score=250.08 Aligned_cols=177 Identities=16% Similarity=0.175 Sum_probs=136.7
Q ss_pred eeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCc---------hHHHHHHHHHHHhhccCCCcceeeecccccCCCc
Q psy11098 103 EELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP---------QQITRAEYNLLSTLMHAHIPTALALFENAPVPGT 173 (380)
Q Consensus 103 ~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---------~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~ 173 (380)
...+.||+|+||+||+|. ..++.+|+|........ .+.+.+|+++++.++|+||+.+..+... .+.
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~---~~~ 413 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD---LDN 413 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE---TTT
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe---CCc
Confidence 345689999999999994 35778999987433211 2346889999999999999944333332 245
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeCCeeEEEeCCCccccc----
Q psy11098 174 DTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGAVLKLIDLGSSVSVS---- 249 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~~~ikl~DFG~a~~~~---- 249 (380)
.||||||+.|++|.+++.. +..++.||+.||.|||++||+||||||+|||++. .+||+|||+|+...
T Consensus 414 ~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~-~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 414 KRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK-DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp TEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS-SEEECCCTTCEECCCHHH
T ss_pred cEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC-eEEEEECccCEECCCccc
Confidence 6999999999999999865 5689999999999999999999999999999999 99999999998764
Q ss_pred ---------ccccCCCcccCCccccC-CCCCCCcccHHHHHHHHHHHHhCCCCC
Q psy11098 250 ---------TVVLPDLEFASPEMLTS-PATAGPSTDMWSLGVLLYILLSGVSPF 293 (380)
Q Consensus 250 ---------~~~~gt~~y~aPE~~~~-~~~~~~~~DiwSlGvil~~lltg~~Pf 293 (380)
....||+.|||||++.. ...|+..+|+||.++-..+-..++-+|
T Consensus 485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 25678999999999975 124566789999998888877766665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7.4e-27 Score=217.79 Aligned_cols=145 Identities=16% Similarity=0.148 Sum_probs=119.3
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC-------------------chHHHHHHHHHHHhhccCCCc
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ-------------------PQQITRAEYNLLSTLMHAHIP 159 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-------------------~~~~~~~E~~il~~l~h~ni~ 159 (380)
...|++.+.||+|+||.||+|.+ .+|+.||+|+++.... ....+.+|+.+++.++ | +
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~ 164 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-L 164 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-S
T ss_pred CeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-C
Confidence 45677889999999999999999 8899999999964321 2345788999999999 4 6
Q ss_pred ceeeecccccCCCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeCCeeEE
Q psy11098 160 TALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGAVLKL 239 (380)
Q Consensus 160 ~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~~~ikl 239 (380)
++..++.. +..++||||+.|++|.+ +. ......++.||+.||.|||++||+||||||+|||++++.+||
T Consensus 165 ~v~~~~~~----~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~~~~vkl 233 (282)
T 1zar_A 165 AVPKVYAW----EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEGIWI 233 (282)
T ss_dssp SSCCEEEE----ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTEEEE
T ss_pred CcCeEEec----cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEECCcEEE
Confidence 66666654 45699999999999987 42 123557999999999999999999999999999999779999
Q ss_pred EeCCCcccccccccCCCcccCCcccc
Q psy11098 240 IDLGSSVSVSTVVLPDLEFASPEMLT 265 (380)
Q Consensus 240 ~DFG~a~~~~~~~~gt~~y~aPE~~~ 265 (380)
+|||+|+. +..++|||++.
T Consensus 234 ~DFG~a~~-------~~~~~a~e~l~ 252 (282)
T 1zar_A 234 IDFPQSVE-------VGEEGWREILE 252 (282)
T ss_dssp CCCTTCEE-------TTSTTHHHHHH
T ss_pred EECCCCeE-------CCCCCHHHHHH
Confidence 99999964 45678999874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=4e-23 Score=189.92 Aligned_cols=137 Identities=19% Similarity=0.226 Sum_probs=109.1
Q ss_pred ceeeeeeecccCCeEEEEEEEcCCCcE--EEEEEecCCCCc-------------------------hHHHHHHHHHHHhh
Q psy11098 101 RYEELERLGNGRFCTVRKARDRGTGQL--VALKQIPRERQP-------------------------QQITRAEYNLLSTL 153 (380)
Q Consensus 101 ~y~~~~~LG~G~fg~V~~~~~~~~~~~--vAvK~~~~~~~~-------------------------~~~~~~E~~il~~l 153 (380)
-|++.+.||+|+||.||+|.+..+|+. ||||+++..... ...+.+|+.++..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 478899999999999999999778989 999997543211 12567899999999
Q ss_pred ccCCC--cceeeecccccCCCceEEEEEecCC-C----CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCcEeecC
Q psy11098 154 MHAHI--PTALALFENAPVPGTDTIVMQLVHG-E----SLIQHLCRQSTITESYICCIIRQLHSALHCLH-SQQIAHKDI 225 (380)
Q Consensus 154 ~h~ni--~~i~~~~~~~~~~~~~~lv~e~~~g-g----~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH-~~~iiHrDl 225 (380)
.|+++ +.++.. +..+|||||+.+ | +|.+.... .++..+..++.||+.||.||| +.||+||||
T Consensus 128 ~~~~i~~p~~~~~-------~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDl 197 (258)
T 1zth_A 128 KEAGVSVPQPYTY-------MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADL 197 (258)
T ss_dssp HHTTCCCCCEEEE-------ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSC
T ss_pred HhCCCCCCeEEEc-------CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCC
Confidence 99864 334332 245999999932 3 67665432 235567899999999999999 999999999
Q ss_pred CCCcEEEeCCeeEEEeCCCcccc
Q psy11098 226 RPENILMNGAVLKLIDLGSSVSV 248 (380)
Q Consensus 226 Kp~NIl~~~~~ikl~DFG~a~~~ 248 (380)
||+|||++. .++|+|||+|...
T Consensus 198 kp~NILl~~-~~~liDFG~a~~~ 219 (258)
T 1zth_A 198 SEYNIMYID-KVYFIDMGQAVTL 219 (258)
T ss_dssp STTSEEESS-SEEECCCTTCEET
T ss_pred CHHHEEEcC-cEEEEECcccccC
Confidence 999999999 9999999999654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.79 E-value=1.9e-19 Score=173.37 Aligned_cols=135 Identities=21% Similarity=0.254 Sum_probs=100.2
Q ss_pred eeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---------------chH--------HHHHHHHHHHhhccCCC
Q psy11098 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---------------PQQ--------ITRAEYNLLSTLMHAHI 158 (380)
Q Consensus 102 y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---------------~~~--------~~~~E~~il~~l~h~ni 158 (380)
|++...||.|+||.||+|.+. +|+.||||+++.... ... ...+|...|..+.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 999999999999999999975 699999999753210 000 12357777888866554
Q ss_pred cceeeecccccCCCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeCC---
Q psy11098 159 PTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGA--- 235 (380)
Q Consensus 159 ~~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~~--- 235 (380)
.. ...+.. ...+|||||+.|++|..+. .......++.||+.+|.+||+.|||||||||.|||++++
T Consensus 176 ~v-p~p~~~----~~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 176 PV-PEPIAQ----SRHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp SC-CCEEEE----ETTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECS
T ss_pred CC-Ceeeec----cCceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCc
Confidence 32 222222 1238999999998885432 223456789999999999999999999999999999643
Q ss_pred --------eeEEEeCCCcccc
Q psy11098 236 --------VLKLIDLGSSVSV 248 (380)
Q Consensus 236 --------~ikl~DFG~a~~~ 248 (380)
.+.||||+.+...
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEET
T ss_pred ccccccccceEEEEeCCcccC
Confidence 2889999987654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.45 E-value=5.9e-13 Score=121.62 Aligned_cols=139 Identities=19% Similarity=0.183 Sum_probs=109.1
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC-CchHHHHHHHHHHHhhc-cCCCcceeeecccccCCCceE
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER-QPQQITRAEYNLLSTLM-HAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~il~~l~-h~ni~~i~~~~~~~~~~~~~~ 175 (380)
....|++...+|.|+.+.||++... ++.+++|+..... .....+.+|+.+++.+. +..+++++.+... .+..|
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~---~~~~~ 86 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH---DGWSN 86 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE---TTEEE
T ss_pred HhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEec---CCceE
Confidence 3457999999999999999999743 6789999986421 22345788999999995 5677788877764 36779
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q psy11098 176 IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHS-------------------------------------- 217 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~-------------------------------------- 217 (380)
+|||++.|.+|.+.+. +......++.++..+|..||+
T Consensus 87 lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 87 LLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 9999999999877531 122344788999999999998
Q ss_pred ---------------------CCcEeecCCCCcEEEeCCe-eEEEeCCCcc
Q psy11098 218 ---------------------QQIAHKDIRPENILMNGAV-LKLIDLGSSV 246 (380)
Q Consensus 218 ---------------------~~iiHrDlKp~NIl~~~~~-ikl~DFG~a~ 246 (380)
..++|+|++|.|||++++. +.|+||+.+.
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 4589999999999998775 5699999763
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.30 E-value=1.9e-11 Score=110.88 Aligned_cols=134 Identities=18% Similarity=0.174 Sum_probs=96.6
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCC--CcceeeecccccCCCceEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAH--IPTALALFENAPVPGTDTI 176 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~n--i~~i~~~~~~~~~~~~~~l 176 (380)
...|.+....+.|..+.||++.. .+|+.+++|+.... ....+.+|..+++.+.+.+ +++++.+... .+..++
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~---~~~~~~ 92 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTE---AGRDWL 92 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC---SSCEEE
T ss_pred cCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccC---CCCCEE
Confidence 34566654445666799999964 45778999998654 2345678999999997654 4556665543 356799
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC-------------------------------------
Q psy11098 177 VMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQ------------------------------------- 219 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~------------------------------------- 219 (380)
|||++.|.+|. . ...+. ..++.+++..|..||+..
T Consensus 93 v~e~i~G~~l~--~---~~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 93 LLGEVPGQDLL--S---SHLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp EEECCSSEETT--T---SCCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred EEEecCCcccC--c---CcCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 99999998883 2 11222 356777888888888643
Q ss_pred ---------------------cEeecCCCCcEEEeCCe-eEEEeCCCcc
Q psy11098 220 ---------------------IAHKDIRPENILMNGAV-LKLIDLGSSV 246 (380)
Q Consensus 220 ---------------------iiHrDlKp~NIl~~~~~-ikl~DFG~a~ 246 (380)
++|+|++|.|||++++. +.|+|||.+.
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 99999999999999775 5699999863
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.26 E-value=2.3e-11 Score=116.41 Aligned_cols=141 Identities=21% Similarity=0.351 Sum_probs=105.7
Q ss_pred eeeeecccCCeEEEEEEEcCCCcEEEEEEec--CCC--CchHHHHHHHHHHHhhcc--CCCcceeeecccccCCCceEEE
Q psy11098 104 ELERLGNGRFCTVRKARDRGTGQLVALKQIP--RER--QPQQITRAEYNLLSTLMH--AHIPTALALFENAPVPGTDTIV 177 (380)
Q Consensus 104 ~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~--~~~--~~~~~~~~E~~il~~l~h--~ni~~i~~~~~~~~~~~~~~lv 177 (380)
..+.|+.|.++.||++... +..+++|+.. ... .....+.+|..+++.|.. ..+++++.++......+..|+|
T Consensus 42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 4578999999999998854 4578899876 332 223567889999999974 5577888777654433567999
Q ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q psy11098 178 MQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHS---------------------------------------- 217 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~---------------------------------------- 217 (380)
||++.|..+.+.. ...+++.+...++.+++.+|..||+
T Consensus 120 me~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (359)
T 3dxp_A 120 MEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM 197 (359)
T ss_dssp EECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred EEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence 9999988774321 2347788889999999999999997
Q ss_pred ------------------CCcEeecCCCCcEEEeCC---eeEEEeCCCcccc
Q psy11098 218 ------------------QQIAHKDIRPENILMNGA---VLKLIDLGSSVSV 248 (380)
Q Consensus 218 ------------------~~iiHrDlKp~NIl~~~~---~ikl~DFG~a~~~ 248 (380)
..++|+|+++.|||++.+ .+.|+||+.+...
T Consensus 198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 369999999999999843 3689999988643
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.15 E-value=4.5e-11 Score=111.73 Aligned_cols=181 Identities=17% Similarity=0.199 Sum_probs=120.4
Q ss_pred eeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhc-cCC--CcceeeecccccCCCceEEEEEec
Q psy11098 105 LERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLM-HAH--IPTALALFENAPVPGTDTIVMQLV 181 (380)
Q Consensus 105 ~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~-h~n--i~~i~~~~~~~~~~~~~~lv~e~~ 181 (380)
.+.++.|....||++. ..+++|+.... .....+.+|.++++.+. +.. ++.++............|+||+++
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568999999999864 45889986432 23456788999999884 333 344444433222122458999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------------
Q psy11098 182 HGESLIQHLCRQSTITESYICCIIRQLHSALHCLHS-------------------------------------------- 217 (380)
Q Consensus 182 ~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~-------------------------------------------- 217 (380)
.|.+|.+... ..++..+...++.+++..|..||+
T Consensus 99 ~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 176 (304)
T 3sg8_A 99 KGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF 176 (304)
T ss_dssp CCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred CCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence 9988865433 347777888888899988888886
Q ss_pred --------------CCcEeecCCCCcEEEeC--C-eeEEEeCCCccccccc--ccCCCcc---cCCccc----cCCCCC-
Q psy11098 218 --------------QQIAHKDIRPENILMNG--A-VLKLIDLGSSVSVSTV--VLPDLEF---ASPEML----TSPATA- 270 (380)
Q Consensus 218 --------------~~iiHrDlKp~NIl~~~--~-~ikl~DFG~a~~~~~~--~~gt~~y---~aPE~~----~~~~~~- 270 (380)
..++|+|++|.|||+++ + .+.|+||+.+...... ......+ ..|+.. ......
T Consensus 177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~ 256 (304)
T 3sg8_A 177 YRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKD 256 (304)
T ss_dssp HHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSC
T ss_pred HHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCC
Confidence 23799999999999986 5 5789999988654310 0000011 122211 110000
Q ss_pred --------CCcccHHHHHHHHHHHHhCCCCC
Q psy11098 271 --------GPSTDMWSLGVLLYILLSGVSPF 293 (380)
Q Consensus 271 --------~~~~DiwSlGvil~~lltg~~Pf 293 (380)
....+.|++|.++|.+.+|..+|
T Consensus 257 ~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 257 IPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 11268999999999999998776
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.76 E-value=8.1e-08 Score=89.75 Aligned_cols=133 Identities=20% Similarity=0.212 Sum_probs=92.8
Q ss_pred eeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccC---CCcceeeecccccCCCceEEEEEec
Q psy11098 105 LERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHA---HIPTALALFENAPVPGTDTIVMQLV 181 (380)
Q Consensus 105 ~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~---ni~~i~~~~~~~~~~~~~~lv~e~~ 181 (380)
.+.++.|....||+. +..+++|+... ......+.+|.++|+.|.+. .++.++.+.. ...+..++|||++
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~--~~~g~~~~v~e~i 95 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS-QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK--RSDGNPFVGYRKV 95 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS-HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE--CTTSCEEEEEECC
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC-chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc--cCCCceEEEEecc
Confidence 456888999999988 45688998532 22345678899999999753 2455555543 1235678999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-------------------------------------------
Q psy11098 182 HGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQ------------------------------------------- 218 (380)
Q Consensus 182 ~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~------------------------------------------- 218 (380)
.|..+.+..- ..++..+...++.++...|..||+.
T Consensus 96 ~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 96 QGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp CSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred CCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 9988866321 2345555555666666666655542
Q ss_pred -----------------CcEeecCCCCcEEEeC----Ce-eEEEeCCCccc
Q psy11098 219 -----------------QIAHKDIRPENILMNG----AV-LKLIDLGSSVS 247 (380)
Q Consensus 219 -----------------~iiHrDlKp~NIl~~~----~~-ikl~DFG~a~~ 247 (380)
.++|+|+++.|||++. +. +.|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3599999999999986 55 58999998754
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.58 E-value=2.6e-07 Score=89.32 Aligned_cols=75 Identities=16% Similarity=0.141 Sum_probs=49.4
Q ss_pred eeeecccCCeEEEEEEEcCCCcEEEEEEecCCC--------CchHHHHHHHHHHHhhcc---CCCcceeeecccccCCCc
Q psy11098 105 LERLGNGRFCTVRKARDRGTGQLVALKQIPRER--------QPQQITRAEYNLLSTLMH---AHIPTALALFENAPVPGT 173 (380)
Q Consensus 105 ~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~--------~~~~~~~~E~~il~~l~h---~ni~~i~~~~~~~~~~~~ 173 (380)
.+.||.|.++.||++....+++.+++|...... ........|.++++.+.. ..++.++.+ . .+.
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~-d----~~~ 109 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS-D----TEM 109 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE-E----TTT
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE-c----CCc
Confidence 568999999999999766567889999864221 123456779999998853 234455433 2 234
Q ss_pred eEEEEEecCCC
Q psy11098 174 DTIVMQLVHGE 184 (380)
Q Consensus 174 ~~lv~e~~~gg 184 (380)
.++|||++.|.
T Consensus 110 ~~lvmE~l~g~ 120 (397)
T 2olc_A 110 AVTVMEDLSHL 120 (397)
T ss_dssp TEEEECCCTTS
T ss_pred cEEEEEeCCCc
Confidence 58999999774
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.58 E-value=8.4e-07 Score=80.75 Aligned_cols=131 Identities=20% Similarity=0.204 Sum_probs=91.9
Q ss_pred eecccCCe-EEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhc-cCCCcceeeecccccCCCceEEEEEecCCC
Q psy11098 107 RLGNGRFC-TVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLM-HAHIPTALALFENAPVPGTDTIVMQLVHGE 184 (380)
Q Consensus 107 ~LG~G~fg-~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~-h~ni~~i~~~~~~~~~~~~~~lv~e~~~gg 184 (380)
.+..|..| .||+......+..+++|+-... ....+.+|..+|+.|. +--+++++.+... .+..++|||++.|.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~---~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRT---PDDAWLLTTAIPGK 105 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEE---TTEEEEEEECCCSE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEE---CCeEEEEEEeeCCc
Confidence 44555555 6999887777788999987533 3455778999999885 3335666666554 36779999999998
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC----------------------------------------------
Q psy11098 185 SLIQHLCRQSTITESYICCIIRQLHSALHCLHSQ---------------------------------------------- 218 (380)
Q Consensus 185 ~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~---------------------------------------------- 218 (380)
++.+..... ......+..++...|..||+.
T Consensus 106 ~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 106 TAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp EHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred cccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 887765432 122334556666666666631
Q ss_pred ------------CcEeecCCCCcEEEeCCe-eEEEeCCCcc
Q psy11098 219 ------------QIAHKDIRPENILMNGAV-LKLIDLGSSV 246 (380)
Q Consensus 219 ------------~iiHrDlKp~NIl~~~~~-ikl~DFG~a~ 246 (380)
.++|+|+.+.|||++++. +-|+||+.+.
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 278999999999999775 5699999874
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.40 E-value=5.6e-07 Score=85.53 Aligned_cols=83 Identities=14% Similarity=0.150 Sum_probs=56.3
Q ss_pred eeeee-cccCCeEEEEEEEc--C----CCcEEEEEEecCCC---C-chHHHHHHHHHHHhhcc---CCCcceeeeccccc
Q psy11098 104 ELERL-GNGRFCTVRKARDR--G----TGQLVALKQIPRER---Q-PQQITRAEYNLLSTLMH---AHIPTALALFENAP 169 (380)
Q Consensus 104 ~~~~L-G~G~fg~V~~~~~~--~----~~~~vAvK~~~~~~---~-~~~~~~~E~~il~~l~h---~ni~~i~~~~~~~~ 169 (380)
..+.| +.|....+|+.... . +++.+++|+..... . ....+.+|..+++.|.. ..+++++.+.....
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~ 103 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD 103 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence 45678 88889999988753 1 15678999875432 1 23457789999998853 35677777655432
Q ss_pred CCCceEEEEEecCCCCH
Q psy11098 170 VPGTDTIVMQLVHGESL 186 (380)
Q Consensus 170 ~~~~~~lv~e~~~gg~L 186 (380)
..+..++|||++.|..+
T Consensus 104 ~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 104 VLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp TTSSCEEEEECCCCBCC
T ss_pred ccCCceEEEEecCCCCh
Confidence 22456899999988654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.22 E-value=1.1e-05 Score=75.53 Aligned_cols=77 Identities=16% Similarity=0.186 Sum_probs=45.4
Q ss_pred eeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccC--CCcceeeeccc---ccCCCceEEEEE
Q psy11098 105 LERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHA--HIPTALALFEN---APVPGTDTIVMQ 179 (380)
Q Consensus 105 ~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~--ni~~i~~~~~~---~~~~~~~~lv~e 179 (380)
.+.|+.|..+.||++... +..+++|+.... ......|..+++.|... .++.++..... ....+..+++|+
T Consensus 37 ~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTD--SGAVCLKRIHRP---EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EEECC----CEEEEEEET--TEEEEEEEECSC---HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeeccccccCcEEEEEeC--CCCEEEEecCCC---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 456766788999999754 335899998652 23445677788777532 34555542111 012356789999
Q ss_pred ecCCCCH
Q psy11098 180 LVHGESL 186 (380)
Q Consensus 180 ~~~gg~L 186 (380)
|+.|..+
T Consensus 112 ~i~G~~~ 118 (346)
T 2q83_A 112 WIEGRPF 118 (346)
T ss_dssp CCCCBCC
T ss_pred eecCccC
Confidence 9988643
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.05 E-value=1.3e-05 Score=77.93 Aligned_cols=74 Identities=14% Similarity=0.100 Sum_probs=47.0
Q ss_pred HHCCcEeecCCCCcEEEeCCeeEEEeCCCcccccc-----cccC--CCcccCCccccCCC--CCCCcccHHHHHHHHHHH
Q psy11098 216 HSQQIAHKDIRPENILMNGAVLKLIDLGSSVSVST-----VVLP--DLEFASPEMLTSPA--TAGPSTDMWSLGVLLYIL 286 (380)
Q Consensus 216 H~~~iiHrDlKp~NIl~~~~~ikl~DFG~a~~~~~-----~~~g--t~~y~aPE~~~~~~--~~~~~~DiwSlGvil~~l 286 (380)
+...++|+|+++.|||++.+.+.|+||+.+..-.. .... ...|++|+...... ......++.++...+|..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDSTQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSCEEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCCeEEecCCCCCcEEEeCCCCEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 45689999999999999876699999998865431 1111 23466666543211 111234555777777777
Q ss_pred HhC
Q psy11098 287 LSG 289 (380)
Q Consensus 287 ltg 289 (380)
+++
T Consensus 310 y~~ 312 (420)
T 2pyw_A 310 FNK 312 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=98.05 E-value=2.2e-05 Score=72.63 Aligned_cols=132 Identities=14% Similarity=0.052 Sum_probs=76.0
Q ss_pred eeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCC-cceeeecccccCCCceEEEEEec-C
Q psy11098 105 LERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHI-PTALALFENAPVPGTDTIVMQLV-H 182 (380)
Q Consensus 105 ~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni-~~i~~~~~~~~~~~~~~lv~e~~-~ 182 (380)
++.|+.|....+|++ +.+++|+........-...+|..+++.+....+ ++++.... +..++++||+ .
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~~-----~~~~~v~e~i~~ 91 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVDP-----ATGVMVTRYIAG 91 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEECT-----TTCCEEEECCTT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEEC-----CCCEEEEeecCC
Confidence 678999999999999 458899886532222223568888888865444 45554322 2347899999 6
Q ss_pred CCCHHH-----------HH----H---hcC-CC----C-HHHHHHHHHH--------------HHHHHHHHH--------
Q psy11098 183 GESLIQ-----------HL----C---RQS-TI----T-ESYICCIIRQ--------------LHSALHCLH-------- 216 (380)
Q Consensus 183 gg~L~~-----------~l----~---~~~-~l----~-e~~~~~i~~q--------------il~al~~lH-------- 216 (380)
|.++.. .+ . ... .+ + ...+..+..+ +...+..+.
T Consensus 92 g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~ 171 (301)
T 3dxq_A 92 AQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPL 171 (301)
T ss_dssp CEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCC
T ss_pred CccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCC
Confidence 654421 01 0 000 01 1 0111111111 111111111
Q ss_pred HCCcEeecCCCCcEEEeCCeeEEEeCCCccc
Q psy11098 217 SQQIAHKDIRPENILMNGAVLKLIDLGSSVS 247 (380)
Q Consensus 217 ~~~iiHrDlKp~NIl~~~~~ikl~DFG~a~~ 247 (380)
...++|+|+.+.|||.+++.+.|+||..+..
T Consensus 172 ~~~l~HgDl~~~Nil~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 172 PLAACHCDPLCENFLDTGERMWIVDWEYSGM 202 (301)
T ss_dssp CCEEECSCCCGGGEEECSSCEEECCCTTCEE
T ss_pred CceeeccCCCcCCEEECCCCEEEEecccccC
Confidence 1248999999999997777899999987753
|
| >1bpv_A Titin, A71, connectin; fibronectin type III; NMR {Homo sapiens} SCOP: b.1.2.1 | Back alignment and structure |
|---|
Probab=98.04 E-value=1.2e-05 Score=63.28 Aligned_cols=71 Identities=24% Similarity=0.391 Sum_probs=55.2
Q ss_pred CCCCCCCCCCCCeeeeecCCCCeeEEeecCCCCCC---cceeeeccccccCCcEEec----CCCCeEEeecCCCCceeeE
Q psy11098 3 SSPLDFNPATQPVINVHPLSESSVELALLTENLSS---IRLCDHESGVWSDARWVIS----PHNGTIQVDDLAPGHTYTF 75 (380)
Q Consensus 3 ~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~~~~~~f 75 (380)
|+||+ |++.|.+.. .+.+++.|+|..+..+| +..|.++.....+..|... .....+.+.+|.+|..|.|
T Consensus 8 ~~~p~--~P~~P~v~~--v~~~sv~L~W~~P~~~gg~~i~~Y~Ve~~~~~~~~w~~~~~~~~~~~~~~v~~L~p~t~Y~f 83 (112)
T 1bpv_A 8 SSPID--PPGKPVPLN--ITRHTVTLKWAKPEYTGGFKITSYIVEKRDLPNGRWLKANFSNILENEFTVSGLTEDAAYEF 83 (112)
T ss_dssp -CCCC--CCCCCEEEE--EETTEEEEECCCCSCCTTCCCSCCEEEEEETTSCCCEECCCSCCCSSEEEECSCCSSCCEEE
T ss_pred CCCCC--CCCCCEEEE--eeCCEEEEEECCCCcCCCCcccEEEEEEEECCCCceEEeecccCccCEEEECCCCCCCEEEE
Confidence 56677 568899988 89999999999877665 5667776655556778762 2356799999999999999
Q ss_pred Ee
Q psy11098 76 CI 77 (380)
Q Consensus 76 ~~ 77 (380)
++
T Consensus 84 rV 85 (112)
T 1bpv_A 84 RV 85 (112)
T ss_dssp EE
T ss_pred EE
Confidence 98
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.90 E-value=0.00015 Score=63.43 Aligned_cols=135 Identities=16% Similarity=0.192 Sum_probs=88.8
Q ss_pred CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecC-CCCcEEEe-CCeeEEEeCCCcccccccccCCCcccC
Q psy11098 184 ESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDI-RPENILMN-GAVLKLIDLGSSVSVSTVVLPDLEFAS 260 (380)
Q Consensus 184 g~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDl-Kp~NIl~~-~~~ikl~DFG~a~~~~~~~~gt~~y~a 260 (380)
-+|.++|.. +.+++|+++|.+++|.+.+|.-+-...--|..| -|..|++. +|.|.+.+ +.+ ......+.|
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s------~~~~~~~~~ 105 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AAD------DAGEPPPVA 105 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-ccc------cccccCCCC
Confidence 478998865 678999999999999999987763211112333 35788886 56766553 111 112345778
Q ss_pred CccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhccc------
Q psy11098 261 PEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNT------ 334 (380)
Q Consensus 261 PE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~------ 334 (380)
||... ...+.+.=|||||+++|..+- |..+...-..+|+++..||..|..-
T Consensus 106 pe~~~--~~~te~~~IysLG~tLY~ALD---------------------ygL~e~eE~eLS~~LE~LL~~Mt~~~~d~~~ 162 (229)
T 2yle_A 106 GKLGY--SQCMETEVIESLGIIIYKALD---------------------YGLKENEERELSPPLEQLIDHMANTVEADGS 162 (229)
T ss_dssp -CCSS--SSSCHHHHHHHHHHHHHHHHT---------------------TTCCTTEEECCCHHHHHHHHHHTTCCC----
T ss_pred hhhcc--ccchHHHHHHHHHHHHHHHhh---------------------cCCCcccchhhCHHHHHHHHHHHhccccccc
Confidence 88764 245668899999999998874 3344444457899999999999755
Q ss_pred -------------------CCCCCCCHHHHHhc
Q psy11098 335 -------------------HADKRPTAGQLLQV 348 (380)
Q Consensus 335 -------------------dP~~Rpt~~e~L~h 348 (380)
.+..|.+.+++|+.
T Consensus 163 ~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~ 195 (229)
T 2yle_A 163 NDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKL 195 (229)
T ss_dssp ----------------CCSCCCCCCSHHHHHHH
T ss_pred ccccccccccccccccccccccCcCCHHHHHHH
Confidence 24688899998854
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.85 E-value=8.1e-05 Score=69.51 Aligned_cols=76 Identities=20% Similarity=0.250 Sum_probs=57.0
Q ss_pred eeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhcc---CCCcceeeecccccCCCceEEEEEe
Q psy11098 104 ELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMH---AHIPTALALFENAPVPGTDTIVMQL 180 (380)
Q Consensus 104 ~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h---~ni~~i~~~~~~~~~~~~~~lv~e~ 180 (380)
-.+.|+.|....+|+... ++..+++|+.... ....+..|...|+.|.. ..+++++..... .+..++|||+
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~---~g~~~lvme~ 112 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNS---QGHSFLLLEA 112 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC---SSEEEEEEEC
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec---CCceEEEEEe
Confidence 457799999999999874 4668889987543 35677889999999853 456666665443 3567999999
Q ss_pred cCCCCH
Q psy11098 181 VHGESL 186 (380)
Q Consensus 181 ~~gg~L 186 (380)
++|..+
T Consensus 113 l~G~~~ 118 (312)
T 3jr1_A 113 LNKSKN 118 (312)
T ss_dssp CCCCCC
T ss_pred ccCCCC
Confidence 988753
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.83 E-value=0.00018 Score=65.98 Aligned_cols=79 Identities=16% Similarity=0.208 Sum_probs=56.9
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC-CchHHHHHHHHHHHhhccC---CCcceeeecccccCCCce
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER-QPQQITRAEYNLLSTLMHA---HIPTALALFENAPVPGTD 174 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~il~~l~h~---ni~~i~~~~~~~~~~~~~ 174 (380)
..+..-.+.+|.|..+.||+... .+|+.|.+|+..... .....+..|...|+.|... -++.++.. +..
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~-------~~~ 85 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW-------DDR 85 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE-------ETT
T ss_pred CCCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec-------cCc
Confidence 34556678899999999999985 468899999875433 3346788999999999533 23444433 223
Q ss_pred EEEEEecCCCC
Q psy11098 175 TIVMQLVHGES 185 (380)
Q Consensus 175 ~lv~e~~~gg~ 185 (380)
++|||++.++.
T Consensus 86 ~lv~e~l~~~~ 96 (288)
T 3f7w_A 86 TLAMEWVDERP 96 (288)
T ss_dssp EEEEECCCCCC
T ss_pred eEEEEeecccC
Confidence 89999997754
|
| >1wfu_A Unnamed protein product; FN3 domain, similar to 1700007B22RIK protein, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Mus musculus} SCOP: b.1.2.1 | Back alignment and structure |
|---|
Probab=97.78 E-value=6.4e-05 Score=59.90 Aligned_cols=65 Identities=18% Similarity=0.173 Sum_probs=50.3
Q ss_pred CCCeeeeecCCCCeeEEeecCCCCCC-------cceeeeccccccCCcEEe--cCCCCeEEeecCCCCceeeEEee
Q psy11098 12 TQPVINVHPLSESSVELALLTENLSS-------IRLCDHESGVWSDARWVI--SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 12 ~~p~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
..|.+.. .+.+|++|+|..+..+| +..|.++........|.. +.....+.+++|.|+..|.|++.
T Consensus 20 ~~p~v~~--vt~~Sv~LsW~~p~~~g~~~g~~~I~~Y~ve~~~~~~~~~~~v~~~~~t~~~v~gL~p~t~Y~frV~ 93 (120)
T 1wfu_A 20 HPPVVGK--VTHHSIELYWDLEQKEKRQGPQEQWLRFSIEEEDPKMHSYGVIYTGYATRHVVEGLEPRTLYKFRLK 93 (120)
T ss_dssp CCCBCCC--EETTEEEEECTTTSCSCCCSCGGGCCEEEEEEECTTTCCEEEEEEESCSEEEEESCCTTCEEEEEEE
T ss_pred CCceece--EECCEEEEEECCCccCCccCCCCceEEEEEEEecCCCCceEEEecCCccEEEECCCCCCCEEEEEEE
Confidence 3456666 78899999999999876 567888843334577876 33456799999999999999983
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.74 E-value=0.00016 Score=67.39 Aligned_cols=137 Identities=18% Similarity=0.138 Sum_probs=80.8
Q ss_pred eeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCC--Ccceeeecccc---cCCCceEEEEEe
Q psy11098 106 ERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAH--IPTALALFENA---PVPGTDTIVMQL 180 (380)
Q Consensus 106 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~n--i~~i~~~~~~~---~~~~~~~lv~e~ 180 (380)
..|+ |....||++.. .+|+.+++|+..........+..|..+++.|.... ++.++.. ... ...+..+++|++
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~-~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAF-NGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCB-TTBSCEEETTEEEEEEEC
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeec-CCcEEEEECCEEEEEEEe
Confidence 4566 88889998764 34667999998754445566778999999886433 3444443 110 113456789999
Q ss_pred cCCCCHH-----------HHH---Hh---cC------CCCHHHH----------------------HHHHHHHHHHHHHH
Q psy11098 181 VHGESLI-----------QHL---CR---QS------TITESYI----------------------CCIIRQLHSALHCL 215 (380)
Q Consensus 181 ~~gg~L~-----------~~l---~~---~~------~l~e~~~----------------------~~i~~qil~al~~l 215 (380)
+.|..+. ..+ .. .. ..+.... ...+.+++..+.-+
T Consensus 109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 188 (328)
T 1zyl_A 109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH 188 (328)
T ss_dssp CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence 9874321 111 00 00 1111110 11112222222221
Q ss_pred ----HHCCcEeecCCCCcEEEeCCeeEEEeCCCcc
Q psy11098 216 ----HSQQIAHKDIRPENILMNGAVLKLIDLGSSV 246 (380)
Q Consensus 216 ----H~~~iiHrDlKp~NIl~~~~~ikl~DFG~a~ 246 (380)
....++|+|+++.|||+++ .+.|+||+.+.
T Consensus 189 ~~~~~~~~l~HgD~~~~Nil~~~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 189 WREDFTVLRLHGDCHAGNILWRD-GPMFVDLDDAR 222 (328)
T ss_dssp CCSCSCCEECCSSCSGGGEEESS-SEEECCCTTCC
T ss_pred hhhcCCeeeeeCCCCcccEeEcC-CCEEEECCCCC
Confidence 2346899999999999985 88999998764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.71 E-value=9.6e-05 Score=70.43 Aligned_cols=74 Identities=14% Similarity=0.180 Sum_probs=45.7
Q ss_pred eeeecccCCeEEEEEEEcC--------CCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCC-cceeeecccccCCCceE
Q psy11098 105 LERLGNGRFCTVRKARDRG--------TGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHI-PTALALFENAPVPGTDT 175 (380)
Q Consensus 105 ~~~LG~G~fg~V~~~~~~~--------~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni-~~i~~~~~~~~~~~~~~ 175 (380)
.+.|+.|....+|++.... .++.+++|+.............|..+++.|...++ ++++.... .+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~~-------~~ 110 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTFN-------GG 110 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEET-------TE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEecC-------Cc
Confidence 4678888889999998653 13678899875432221123678999998865453 45554431 27
Q ss_pred EEEEecCCCC
Q psy11098 176 IVMQLVHGES 185 (380)
Q Consensus 176 lv~e~~~gg~ 185 (380)
+||||+.|..
T Consensus 111 ~v~e~i~G~~ 120 (369)
T 3c5i_A 111 RIEEWLYGDP 120 (369)
T ss_dssp EEEECCCSEE
T ss_pred EEEEEecCCc
Confidence 8999998743
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.70 E-value=0.00013 Score=67.87 Aligned_cols=139 Identities=13% Similarity=0.163 Sum_probs=78.5
Q ss_pred eeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCC--cceeeeccc---ccCCCceEEEEE
Q psy11098 105 LERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHI--PTALALFEN---APVPGTDTIVMQ 179 (380)
Q Consensus 105 ~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni--~~i~~~~~~---~~~~~~~~lv~e 179 (380)
++.|+.|....+|++... +| .+++|+.... .....+..|..+++.|....+ +.++..... ....+..+++|+
T Consensus 27 ~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~ 103 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTT-KD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS 103 (322)
T ss_dssp EEEECC---EEEEEEEES-SC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred eeccCCCcccceEEEEeC-Cc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence 466788888999999754 33 6889988653 123445678999988864433 444432110 011245689999
Q ss_pred ecCCCCHH-----------HH---HHh---cCC------CCHHHHHH---------------HHHHHHHHHHHHHH----
Q psy11098 180 LVHGESLI-----------QH---LCR---QST------ITESYICC---------------IIRQLHSALHCLHS---- 217 (380)
Q Consensus 180 ~~~gg~L~-----------~~---l~~---~~~------l~e~~~~~---------------i~~qil~al~~lH~---- 217 (380)
++.|..+. .. +.. ... .....-.. +...+...+..+++
T Consensus 104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~ 183 (322)
T 2ppq_A 104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK 183 (322)
T ss_dssp CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence 99885431 11 111 100 11100000 00113344555542
Q ss_pred ---CCcEeecCCCCcEEEeCCee-EEEeCCCcc
Q psy11098 218 ---QQIAHKDIRPENILMNGAVL-KLIDLGSSV 246 (380)
Q Consensus 218 ---~~iiHrDlKp~NIl~~~~~i-kl~DFG~a~ 246 (380)
.+++|+|+.+.|||++++.+ .|+||+.+.
T Consensus 184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp SSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 37999999999999997765 799999774
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00061 Score=66.44 Aligned_cols=73 Identities=15% Similarity=0.188 Sum_probs=50.1
Q ss_pred eeeeecccCCeEEEEEEEcC-------CCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCC-cceeeecccccCCCceE
Q psy11098 104 ELERLGNGRFCTVRKARDRG-------TGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHI-PTALALFENAPVPGTDT 175 (380)
Q Consensus 104 ~~~~LG~G~fg~V~~~~~~~-------~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni-~~i~~~~~~~~~~~~~~ 175 (380)
.++.|+.|....||++.... +++.+++|+.... .....+..|..+++.|...++ ++++..+.. .
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~-------g 148 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG-------G 148 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT-------E
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC-------C
Confidence 35678889899999998653 2578999988432 221344579999999865555 555554431 4
Q ss_pred EEEEecCCC
Q psy11098 176 IVMQLVHGE 184 (380)
Q Consensus 176 lv~e~~~gg 184 (380)
+|+||+.|.
T Consensus 149 ~v~e~l~G~ 157 (429)
T 1nw1_A 149 RLEEYIPSR 157 (429)
T ss_dssp EEECCCCEE
T ss_pred EEEEEeCCc
Confidence 899999763
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.50 E-value=0.0003 Score=65.86 Aligned_cols=136 Identities=13% Similarity=0.140 Sum_probs=71.9
Q ss_pred eeeecccCCeE-EEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCC--CcceeeecccccCCCceEEEEEec
Q psy11098 105 LERLGNGRFCT-VRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAH--IPTALALFENAPVPGTDTIVMQLV 181 (380)
Q Consensus 105 ~~~LG~G~fg~-V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~n--i~~i~~~~~~~~~~~~~~lv~e~~ 181 (380)
.+.|+.|+... +|+... .+++.+++|...... ......|+.+++.+.... +++++.+-. . .. +++||++
T Consensus 23 ~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~--~~~~~~e~~~l~~L~~~g~~vP~v~~~d~---~-~g-~ll~e~l 94 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEE--GGDTQPFVDLAQYLRNLDISAPEIYAEEH---A-RG-LLLIEDL 94 (333)
T ss_dssp ECC--------CCEEEEC-TTCCEEEEEECCTTT--TCCSHHHHHHHHHHHHTTCBCCCEEEEET---T-TT-EEEECCC
T ss_pred eeECCCCCCCceEEEEEc-CCCCeEEEEECCCCC--CccccHHHHHHHHHHhCCCCCCceeeecC---C-CC-EEEEeeC
Confidence 35566665554 667653 235677777654322 133456888888886433 455555421 1 12 7899999
Q ss_pred CCCCHHHHHHhc--------------------------CCCCHHHHH-------H-H------------HHHHHHHHHHH
Q psy11098 182 HGESLIQHLCRQ--------------------------STITESYIC-------C-I------------IRQLHSALHCL 215 (380)
Q Consensus 182 ~gg~L~~~l~~~--------------------------~~l~e~~~~-------~-i------------~~qil~al~~l 215 (380)
.+..+.+.+... ..++..... . + ...+...+..+
T Consensus 95 ~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l 174 (333)
T 3csv_A 95 GDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQI 174 (333)
T ss_dssp CSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHH
T ss_pred CCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHH
Confidence 776665443211 012221110 0 0 00111122222
Q ss_pred ------HHCCcEeecCCCCcEEEeC-----CeeEEEeCCCcccc
Q psy11098 216 ------HSQQIAHKDIRPENILMNG-----AVLKLIDLGSSVSV 248 (380)
Q Consensus 216 ------H~~~iiHrDlKp~NIl~~~-----~~ikl~DFG~a~~~ 248 (380)
+...++|+|+.+.|||++. +.+.|+||+.+..-
T Consensus 175 ~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 175 LSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred HHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 2347999999999999975 57899999987543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.36 E-value=0.0011 Score=65.04 Aligned_cols=75 Identities=12% Similarity=0.153 Sum_probs=49.1
Q ss_pred eeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCC-cceeeecccccCCCceEEEEEecC
Q psy11098 104 ELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHI-PTALALFENAPVPGTDTIVMQLVH 182 (380)
Q Consensus 104 ~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni-~~i~~~~~~~~~~~~~~lv~e~~~ 182 (380)
-++.|+.|-...+|++.....+..+++|+........-....|..+++.|...++ ++++..+. . .+||||++
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~----~---G~v~e~I~ 184 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT----N---GRIEEFMD 184 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET----T---EEEEECCC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC----C---eEEEEeeC
Confidence 3567888888999999876545789999885432211112579999999976555 45555542 1 35999998
Q ss_pred CCC
Q psy11098 183 GES 185 (380)
Q Consensus 183 gg~ 185 (380)
|.+
T Consensus 185 G~~ 187 (458)
T 2qg7_A 185 GYA 187 (458)
T ss_dssp SEE
T ss_pred Ccc
Confidence 743
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.34 E-value=0.00074 Score=64.71 Aligned_cols=135 Identities=17% Similarity=0.173 Sum_probs=80.2
Q ss_pred eeeecccCCeEEEEEEEcC-------CCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCC-cceeeecccccCCCceEE
Q psy11098 105 LERLGNGRFCTVRKARDRG-------TGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHI-PTALALFENAPVPGTDTI 176 (380)
Q Consensus 105 ~~~LG~G~fg~V~~~~~~~-------~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni-~~i~~~~~~~~~~~~~~l 176 (380)
.+.|..|....+|++.... +++.|++|+............+|.++++.|...++ ++++..+.. .+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~-------g~ 127 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE-------GR 127 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT-------EE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC-------cc
Confidence 3567778888999998642 35789999874333334555689999998864444 455554432 38
Q ss_pred EEEecCCCCHH--------------HHHHh--c------CCCC--HHHHHHHHHHHHH-------------------HHH
Q psy11098 177 VMQLVHGESLI--------------QHLCR--Q------STIT--ESYICCIIRQLHS-------------------ALH 213 (380)
Q Consensus 177 v~e~~~gg~L~--------------~~l~~--~------~~l~--e~~~~~i~~qil~-------------------al~ 213 (380)
||||++|..|. +.+.+ . .... ...+..+..++.. .+.
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 99999875432 11111 1 1111 3455555554422 233
Q ss_pred HHH----H----CCcEeecCCCCcEEEeC-----CeeEEEeCCCcc
Q psy11098 214 CLH----S----QQIAHKDIRPENILMNG-----AVLKLIDLGSSV 246 (380)
Q Consensus 214 ~lH----~----~~iiHrDlKp~NIl~~~-----~~ikl~DFG~a~ 246 (380)
.|. . ..++|+|+.+.|||++. +.+.|+||..+.
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 332 2 25999999999999975 389999998774
|
| >1x5x_A Fibronectin type-III domain containing protein 3A; structural genomics, KIAA0970, NPPSFA; NMR {Homo sapiens} SCOP: b.1.2.1 | Back alignment and structure |
|---|
Probab=97.33 E-value=0.00097 Score=51.32 Aligned_cols=71 Identities=13% Similarity=0.012 Sum_probs=52.4
Q ss_pred CCCCCCCCCCCeeeeecCCCCeeEEeecCCCCCC---cceeeeccccccC-CcEEe--cCCCCeEEeecCCCCceeeEEe
Q psy11098 4 SPLDFNPATQPVINVHPLSESSVELALLTENLSS---IRLCDHESGVWSD-ARWVI--SPHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 4 ~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~~l~~~~~~~f~~ 77 (380)
.+|+ |++.|.+.. .+.+++.|+|..+..++ +..|.++...... ..|.. ......+.+.+|.++..|.|++
T Consensus 6 ~~P~--~P~~p~~~~--~~~~sv~l~W~~p~~~~~~~i~~Y~v~~~~~~~~~~~~~~~~~~~~~~~v~~L~p~t~Y~frV 81 (109)
T 1x5x_A 6 SGPS--MPASPVLTK--AGITWLSLQWSKPSGTPSDEGISYILEMEEETSGYGFKPKYDGEDLAYTVKNLRRSTKYKFKV 81 (109)
T ss_dssp CCCC--CCCCCEEEE--ECSSEEEEECCCCSSCCSSSSCEEEEEECCSSSSCCCEEEEEESCSEEEEESCCSSCEEEEEE
T ss_pred CCCc--CCCCCEEEE--ccCCEEEEEEcCCCCCCCCcccEEEEEEecCCCCcceEEeEeCCccEEEECCCCCCCEEEEEE
Confidence 4455 456777777 89999999999988775 4667776544333 35653 3346789999999999999998
Q ss_pred e
Q psy11098 78 N 78 (380)
Q Consensus 78 ~ 78 (380)
.
T Consensus 82 ~ 82 (109)
T 1x5x_A 82 I 82 (109)
T ss_dssp E
T ss_pred E
Confidence 3
|
| >2ic2_A CG9211-PA, GH03927P; IHOG, hedgehog, fibronectin type III, protein binding; HET: MSE; 1.30A {Drosophila melanogaster} SCOP: b.1.2.1 | Back alignment and structure |
|---|
Probab=97.26 E-value=0.00026 Score=55.71 Aligned_cols=67 Identities=30% Similarity=0.420 Sum_probs=44.6
Q ss_pred CCCCCeeeeecCCCCeeEEeecCCCCCC--cceeeeccccc-cCCcEEecC---------------CCCeEEeecCCCCc
Q psy11098 10 PATQPVINVHPLSESSVELALLTENLSS--IRLCDHESGVW-SDARWVISP---------------HNGTIQVDDLAPGH 71 (380)
Q Consensus 10 p~~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~-~~~~~~~~~---------------~~~~~~~~~l~~~~ 71 (380)
||+.|.+.. ++.++++|+|..+..+| +..|.++.... .+..|.... ....+.+.+|.|+.
T Consensus 5 pP~~P~v~~--~~~~sv~L~W~~P~~~G~pI~~Y~Ve~r~~~~~~~w~~~~~~~~~~~~~~~~~~~~~~~~~v~~L~p~t 82 (115)
T 2ic2_A 5 PPTPPNVTR--LSDESVMLRWMVPRNDGLPIVIFKVQYRMVGKRKNWQTTNDNIPYGKPKWNSELGKSFTASVTDLKPQH 82 (115)
T ss_dssp CCCCCEEEE--CC---EEEEEEEECCSSCCEEEEEEEEEECC---CCEEEEEEEECCSCSCSSSSEEEEEEEECSCCSSE
T ss_pred CCCcCEeEE--EeCCEEEEEEcCCCCCCCCCceEEEEEEECCCCCCceECcccccccccccccccCceeEEEeCCCCCCC
Confidence 345556776 89999999999988777 56677766544 346787411 12368899999999
Q ss_pred eeeEEee
Q psy11098 72 TYTFCIN 78 (380)
Q Consensus 72 ~~~f~~~ 78 (380)
.|.|++.
T Consensus 83 ~Y~FRV~ 89 (115)
T 2ic2_A 83 TYRFRIL 89 (115)
T ss_dssp EEEEEEE
T ss_pred EEEEEEE
Confidence 9999983
|
| >2db8_A Tripartite motif protein 9, isoform 2; ring finger protein 91, TRIM9, KIAA0282, RNF91, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.20 E-value=0.0011 Score=51.45 Aligned_cols=58 Identities=17% Similarity=0.060 Sum_probs=44.7
Q ss_pred CCCCeeEEeecCCCCCC--cceeeeccccccCCcEEec--CCCCeEEeecCCCCceeeEEee
Q psy11098 21 LSESSVELALLTENLSS--IRLCDHESGVWSDARWVIS--PHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 21 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
.+.+++.|+|..+..++ +..|.++........|... .....+.+.+|.|+..|.|++.
T Consensus 22 ~~~~sv~l~W~~p~~~~~~i~~Y~v~~~~~~~~~~~~~~~~~~~~~~v~~L~p~t~Y~frV~ 83 (110)
T 2db8_A 22 THNNSATLSWKQPPLSTVPADGYILELDDGNGGQFREVYVGKETMCTVDGLHFNSTYNARVK 83 (110)
T ss_dssp CSSSEEEECCBCCTTCCSCCSEEEEEECCSSSSCCEEEEEESCSCEEEECCCSSSCCEEEEE
T ss_pred cCCCEEEEEECCCCCCCCCccEEEEEEEeCCCCceEEEEeCCcCEEEECCCCCCCEEEEEEE
Confidence 46799999999988764 5677776555444678752 3567899999999999999983
|
| >2crz_A Fibronectin type-III domain containing protein 3A; structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: b.1.2.1 | Back alignment and structure |
|---|
Probab=97.14 E-value=0.0015 Score=50.44 Aligned_cols=65 Identities=17% Similarity=0.170 Sum_probs=47.8
Q ss_pred CCCee-eeecCCCCeeEEeecCCCCCC---cceeeeccccccCCcEEe--cCCCCeEEeecCCCCceeeEEee
Q psy11098 12 TQPVI-NVHPLSESSVELALLTENLSS---IRLCDHESGVWSDARWVI--SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 12 ~~p~~-~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
..+.+ .. .+.+++.|+|..+..++ +..|.++.....+..|.. ......+.+.+|.++..|.|++.
T Consensus 13 ~~~~~~~~--~~~~sv~l~W~~P~~~~~~~i~~Y~v~~~~~~~~~~~~~~~~~~~~~~v~~L~p~t~Y~frV~ 83 (110)
T 2crz_A 13 LPPRLQGR--PKAKEIQLRWGPPLVDGGSPISCYSVEMSPIEKDEPREVYQGSEVECTVSSLLPGKTYSFRLR 83 (110)
T ss_dssp CCCEECSC--CCSSEEEEECCCCSCCTTSCCCEEEEEEECTTSCCCEEEEEESCSEEEEESCCTTCEEEECCE
T ss_pred CCceeccc--cCCCEEEEEeCCCCCCCCceeEEEEEEEEeCCCCceEEEEeCCcEEEEECCcCCCCEEEEEEE
Confidence 34444 44 67899999998876654 566777765545567875 33467899999999999999973
|
| >1x5y_A Myosin binding protein C, fast-type; fast MYBP-C, fibronectin type III domain containing protein, cytoskeleton, muscle contraction; NMR {Mus musculus} SCOP: b.1.2.1 | Back alignment and structure |
|---|
Probab=97.14 E-value=0.0012 Score=51.11 Aligned_cols=58 Identities=17% Similarity=0.199 Sum_probs=44.9
Q ss_pred CCCCeeEEeecCCCCCC---cceeeeccccccCCcEEec----CCCCeEEeecCCCCceeeEEee
Q psy11098 21 LSESSVELALLTENLSS---IRLCDHESGVWSDARWVIS----PHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 21 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
.+.+++.|+|..+..++ +..|.++........|... .....+.+.+|.++..|.|++.
T Consensus 20 ~~~~sv~l~W~~p~~~~~~~i~~Y~v~~~~~~~~~w~~~~~~~~~~~~~~v~~L~p~t~Y~frV~ 84 (111)
T 1x5y_A 20 VTDTTTTLKWRPPDRIGAGGIDGYLVEYCLEGSEEWVPANKEPVERCGFTVKDLPTGARILFRVV 84 (111)
T ss_dssp ECSSEEEEEEECCSCCCSSCCCEEEEEEEETTCCCCEESSSSCBSSSEEEEECCCTTCCEEEEEE
T ss_pred ccCCEEEEEECCCCcCCCCcccEEEEEEEECCCCceEEccccCCcccEEEECCCCCCCEEEEEEE
Confidence 78899999999988765 5666666544445678762 2366799999999999999983
|
| >2yuw_A Myosin binding protein C, SLOW type; fibronectin III domain, SLOW- type protein, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0017 Score=50.04 Aligned_cols=63 Identities=6% Similarity=0.142 Sum_probs=47.5
Q ss_pred CeeeeecCCCCeeEEeecCCCCCC---cceeeeccccccCCcEEec----CCCCeEEeecCCCCceeeEEee
Q psy11098 14 PVINVHPLSESSVELALLTENLSS---IRLCDHESGVWSDARWVIS----PHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 14 p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
+.+.. .+.+++.|+|..+..++ +..|.++........|... .....+.+.+|.++..|.|++.
T Consensus 14 l~~~~--~~~~sv~l~W~~p~~~g~~~i~~Y~v~~~~~~~~~w~~~~~~~~~~~~~~v~~L~p~t~Y~frV~ 83 (110)
T 2yuw_A 14 LTVDS--VTDTTVTMRWRPPDHIGAAGLDGYVLEYCFEGTEDWIVANKDLIDKTKFTITGLPTDAKIFVRVK 83 (110)
T ss_dssp EEEEE--ECSSCEEEEEECCSSCCSSCEEEEEEEEEETTCSSEEECCSSCCCSSEEEECSCCTTCEEEEEEE
T ss_pred cEEEe--ccCCeEEEEECCCCCCCCCCccEEEEEEEECCCccceEeccccCccCEEEECCCCCCCEEEEEEE
Confidence 34444 78899999999988764 5667776555455678862 2466799999999999999983
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0042 Score=58.37 Aligned_cols=74 Identities=9% Similarity=0.056 Sum_probs=45.6
Q ss_pred eeec--ccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCC---Ccceeeeccc---ccCCCceEEE
Q psy11098 106 ERLG--NGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAH---IPTALALFEN---APVPGTDTIV 177 (380)
Q Consensus 106 ~~LG--~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~n---i~~i~~~~~~---~~~~~~~~lv 177 (380)
+.+. .|....||++... +| .+++|+...... ..|+.+++.|.... ++..+..... ....+..+++
T Consensus 27 ~~l~~G~g~~N~vy~v~~~-~g-~~vLK~~~~~~~-----~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l 99 (339)
T 3i1a_A 27 QFIQGGADTNAFAYQADSE-SK-SYFIKLKYGYHD-----EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIA 99 (339)
T ss_dssp EEETTTSCSSCEEEEEECS-SC-EEEEEEEECSSC-----CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEE
T ss_pred EEeeccCccccceEEEEeC-CC-CEEEEEecCccc-----hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEE
Confidence 4453 3336789999743 35 899998865432 45778888875433 3444433211 0123567899
Q ss_pred EEecCCCCH
Q psy11098 178 MQLVHGESL 186 (380)
Q Consensus 178 ~e~~~gg~L 186 (380)
|+|+.|..+
T Consensus 100 ~~~i~G~~~ 108 (339)
T 3i1a_A 100 YPFIHAPNG 108 (339)
T ss_dssp EECCCCCBT
T ss_pred EeccCCCcC
Confidence 999988655
|
| >1x4x_A Fibronectin type-III domain containing protein 3A; FN3, immunoglobulin-like beta- sandwich fold, KIAA0970, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: b.1.2.1 | Back alignment and structure |
|---|
Probab=96.94 E-value=0.0028 Score=48.55 Aligned_cols=71 Identities=15% Similarity=0.141 Sum_probs=49.1
Q ss_pred CCCCCCCCCCCCeeeeecCCCCeeEEeecCCCCCC--cceeeeccccccCCcEE--ecCCCCeEEeecCCCCceeeEEee
Q psy11098 3 SSPLDFNPATQPVINVHPLSESSVELALLTENLSS--IRLCDHESGVWSDARWV--ISPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 3 ~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
.+||. ++..+.+.. .+.+++.|+|..+...| +..|.++..... ..|. .......+.+.+|.|+..|.|++.
T Consensus 5 ~~~P~--~P~~~~~~~--~s~~sv~l~W~~p~~~g~~i~~Y~v~~~~~~-~~~~~~~~~~~~~~~v~~L~p~t~Y~frV~ 79 (106)
T 1x4x_A 5 SSGPD--QCKPPQVTC--RSATCAQVNWEVPLSNGTDVTEYRLEWGGVE-GSMQICYCGPGLSYEIKGLSPATTYYCRVQ 79 (106)
T ss_dssp CCSCC--CCCCCCCEE--EETTEEEEECCCCSCSSSCCCEEEEEEESST-TSCCEEEEESCSEEEEESCCSSCEEEEEEE
T ss_pred CCCcC--CCCCCEEEE--cCCCEEEEEEcCCCCCCCcceEEEEEEEcCC-CceEEEEeCCcceEEEcCCCCCCEEEEEEE
Confidence 34555 445666666 78899999999887654 556666553322 2332 234467899999999999999983
|
| >2yux_A Myosin-binding protein C, SLOW-type; fibronectin III domain, structural genomics., NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.91 E-value=0.002 Score=50.59 Aligned_cols=65 Identities=15% Similarity=0.174 Sum_probs=48.5
Q ss_pred CCCeeeeecCCCCeeEEeecCCCCCC---cceeeeccccccCCcEEe---cCCCCeEEeecCCCCceeeEEee
Q psy11098 12 TQPVINVHPLSESSVELALLTENLSS---IRLCDHESGVWSDARWVI---SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 12 ~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
..+.+.. .+.+++.|+|..+..+| +..|.++........|.. ......+.+.+|.|+..|.|++.
T Consensus 22 ~~l~~~~--~~~~sv~l~W~~p~~~gg~~i~~Y~v~~~~~~~~~w~~~~~~~~~~~~~v~~L~p~t~Y~frV~ 92 (120)
T 2yux_A 22 QIVKIED--VWGENVALTWTPPKDDGNAAITGYTIQKADKKSMEWFTVIEHYHRTSATITELVIGNEYYFRVF 92 (120)
T ss_dssp SCEEEEE--EETTEEEEEECCCSCCCSSCCCCCCEEEEETTTCCCEEEESSCCSSCCEECCCCSSEEEEEEEC
T ss_pred CCCEEEE--ecCCEEEEEEcCCCcCCCCCceEEEEEEEECCCCceEEeeecCCcCEEEECCCCCCCEEEEEEE
Confidence 4455555 78899999999988765 556666654444567875 23466789999999999999984
|
| >2crm_A Fibronectin type-III domain containing protein 3A; structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: b.1.2.1 | Back alignment and structure |
|---|
Probab=96.85 E-value=0.0042 Score=48.53 Aligned_cols=66 Identities=18% Similarity=0.262 Sum_probs=48.1
Q ss_pred CCCCeee-eecCCCCeeEEeecCCCCCC---cceeeeccccccC-CcEEe--cCCCCeEEeecCCCCceeeEEee
Q psy11098 11 ATQPVIN-VHPLSESSVELALLTENLSS---IRLCDHESGVWSD-ARWVI--SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 11 ~~~p~~~-~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
+..|.+. . .+.+++.|+|..+..+| +..|.++.....+ ..|.. ......+.+.+|.++..|.|++.
T Consensus 21 P~~~~~~~~--~~~~sv~l~W~~p~~~gg~~i~~Y~v~~~~~~~~~~~~~~~~~~~~~~~v~~L~p~t~Y~frV~ 93 (120)
T 2crm_A 21 PVKPSVKGK--IHSHSFKITWDPPKDNGGATINKYVVEMAEGSNGNKWEMIYSGATREHLCDRLNPGCFYRLRVY 93 (120)
T ss_dssp CCCCEEEEE--EETTEEEEECCCCTTCCSSCCCEEEEEEEESSSSCCCEEEECSSCSEEEECSCCTTSCEEEEEE
T ss_pred CCCCEEeec--cCCCEEEEEECCCCcCCCCeeeEEEEEEccCCCCcCCEEEEeccccEEEECCCCCCCEEEEEEE
Confidence 3445554 4 67899999999988773 5667776544433 57875 33467899999999999999983
|
| >2kbg_A N-CAM 2, neural cell adhesion molecule 2; fibronectin type III module, beta-sheet sandwich, cell membrane, glycoprotein, immunoglobulin domain; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0037 Score=49.06 Aligned_cols=66 Identities=17% Similarity=0.096 Sum_probs=44.6
Q ss_pred CCCeeeeecCCCCeeEEeecCCCCCC---cceeeeccccccCCcEE-e---cCCCCeEEeecCCCCceeeEEee
Q psy11098 12 TQPVINVHPLSESSVELALLTENLSS---IRLCDHESGVWSDARWV-I---SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 12 ~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~-~---~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
+.|.....+.+.+|+.|+|..+ .|| +..+.++-.......|. . +....++.+.+|.|+..|.|++.
T Consensus 10 ~pP~~~~~~~~~~sv~L~W~p~-~dggsPI~~Y~I~yr~~~~~~w~~~~~~~~~~~~~~l~~L~p~t~Y~frV~ 82 (114)
T 2kbg_A 10 SPPSIHGQPSSGKSFKLSITKQ-DDGGAPILEYIVKYRSKDKEDQWLEKKVQGNKDHIILEHLQWTMGYEVQIT 82 (114)
T ss_dssp CSCCEECCBCSTTCEEEEECCC-CCSSSCCSEEEEEEEESSCCSCCEEEEEETTTCCEEECCCCTTCCEEEEEE
T ss_pred cCCcccccccCCCEEEEEEECC-CCCCCcccEEEEEEEeCCCCCcEEeEEcCCCcCEEEEcCCCCCCEEEEEEE
Confidence 3444443336889999999865 444 66666655444334453 2 34567899999999999999983
|
| >1x4z_A Biregional cell adhesion molecule-related/DOWN- regulated oncogenes (CDON)binding...; fibronectin type III, FN3; NMR {Mus musculus} SCOP: b.1.2.1 | Back alignment and structure |
|---|
Probab=96.76 E-value=0.0071 Score=47.32 Aligned_cols=67 Identities=21% Similarity=0.410 Sum_probs=47.4
Q ss_pred CCCCCeeeeecCCCCeeEEeecCCCCCC--cceeeecccccc-CCcEEec-----CCCCeEEeecCCCCceeeEEee
Q psy11098 10 PATQPVINVHPLSESSVELALLTENLSS--IRLCDHESGVWS-DARWVIS-----PHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 10 p~~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~-~~~~~~~-----~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
|+..+.+.. .+.+++.|+|..+...+ +..|.++..... +..|... .....+.+.+|.|+..|.|++.
T Consensus 20 ~P~~~~~~~--~~~~sv~l~W~p~~~~~~~i~~Y~v~~~~~~~~~~w~~~~~~~~~~~~~~~v~~L~p~t~Y~frV~ 94 (121)
T 1x4z_A 20 APDRPTIST--ASETSVYVTWIPRGNGGFPIQSFRVEYKKLKKVGDWILATSAIPPSRLSVEITGLEKGISYKFRVR 94 (121)
T ss_dssp CCCCCEEEE--CCSSEEEEECCCCCCTTSCCCEEEEEEEESSSCCCCEEEEEEECTTCCEEEEESCCTTCEEEEEEE
T ss_pred cCCCCEEEE--ccCCEEEEEEECCCCCCCcceEEEEEEEECCCCCceEEeecccCCCcCEEEECCCCCCCEEEEEEE
Confidence 334566666 88999999999543322 566776654433 4678642 2467899999999999999983
|
| >1wis_A KIAA1514 protein; FNIII domain, sidekick-2, structural genomics, riken structural genomics/proteomics initiative, RSGI, unknown function; NMR {Homo sapiens} SCOP: b.1.2.1 | Back alignment and structure |
|---|
Probab=96.73 E-value=0.0031 Score=49.84 Aligned_cols=63 Identities=24% Similarity=0.330 Sum_probs=45.2
Q ss_pred CeeeeecCCCCeeEEeecCCCCCC--cceeeecccc---ccCCcEEe-c-----CCCCeEEeecCCCCceeeEEee
Q psy11098 14 PVINVHPLSESSVELALLTENLSS--IRLCDHESGV---WSDARWVI-S-----PHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 14 p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~---~~~~~~~~-~-----~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
+.+.. ++.+++.|+|..+...+ +..|.++... .....|.. . .....+.+.+|.|+..|.|++.
T Consensus 24 l~~~~--~~~~sv~l~W~p~~~~~~~i~~Y~v~~~~~~~~~~~~w~~~~~~~~~~~~~~~~v~~L~p~t~Y~frV~ 97 (124)
T 1wis_A 24 LGISN--IGPRSVTLQFRPGYDGKTSISRWLVEAQVGVVGEGEEWLLIHQLSNEPDARSMEVPDLNPFTCYSFRMR 97 (124)
T ss_dssp EEEES--CCSSCEEEEEECCCCCSSCCSEEEEEECBSCCSTTSCCEEEEEEESCTTCSEEEECSCCTTSEECCCCE
T ss_pred CEEEE--ecCCEEEEEEECCCCCCCcccEEEEEEEECCCCCCCCCeEeeeEccCCCceEEEeCCCCCCCEEEEEEE
Confidence 44444 78999999996665433 5667766544 34567864 1 3467899999999999999973
|
| >1x3d_A Fibronectin type-III domain containing protein 3A; structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: b.1.2.1 | Back alignment and structure |
|---|
Probab=96.61 E-value=0.007 Score=47.00 Aligned_cols=65 Identities=14% Similarity=0.140 Sum_probs=47.3
Q ss_pred CCCCeeeeecCCCCeeEEeecCCCCCC--cceeeeccccccC-CcEEe--cCCCCeEEeecCCCCceeeEEe
Q psy11098 11 ATQPVINVHPLSESSVELALLTENLSS--IRLCDHESGVWSD-ARWVI--SPHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 11 ~~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~~l~~~~~~~f~~ 77 (380)
+..+.+.. .+.+++.|+|..+...+ +..|.++...... ..|.. ......+.+.+|.|+..|.|++
T Consensus 21 P~~~~~~~--~~~~sv~l~W~~p~~~~~~i~~Y~v~~~~~~~~~~~~~~~~~~~~~~~v~~L~p~t~Y~frV 90 (118)
T 1x3d_A 21 PNPPRIAN--RTKNSLTLQWKAPSDNGSKIQNFVLEWDEGKGNGEFCQCYMGSQKQFKITKLSPAMGCKFRL 90 (118)
T ss_dssp CCCCEEEE--EETTEEEEECCCCCCCSSCEEEEEEEECTTTSSSCCEEEEEESCSEEEEESCCTTCEEEEEC
T ss_pred CCCcEEec--cCCCEEEEEECCCCCCCCcceEEEEEEecCCCCCCeEEeeccCCcEEEeCCCCCCCEEEEEE
Confidence 34566666 78899999999987444 4666665544333 56764 2345789999999999999997
|
| >1v5j_A KIAA1355 protein, RSGI RUH-008; FN3 domain, human cDNA, structural genomics, riken structural genomics/proteomics initiative, cell adhesion; NMR {Homo sapiens} SCOP: b.1.2.1 | Back alignment and structure |
|---|
Probab=96.56 E-value=0.0038 Score=48.46 Aligned_cols=55 Identities=16% Similarity=0.191 Sum_probs=42.1
Q ss_pred CCCeeEEeecCCCCCC--cceeeeccccccCCcEEe-----cCCCCeEEeecCCCCceeeEEe
Q psy11098 22 SESSVELALLTENLSS--IRLCDHESGVWSDARWVI-----SPHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 22 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~~~~~~f~~ 77 (380)
..+++.|+|..+...+ +..|.++... .+.+|.. ..+...+.+.+|.+|..|.|++
T Consensus 19 ~~~sv~L~W~pP~~~~~~I~gY~vey~~-~~~~W~~~~~~~~~~~t~~~v~~L~pg~~Y~FRV 80 (108)
T 1v5j_A 19 TPRGVLLHWDPPELVPKRLDGYVLEGRQ-GSQGWEVLDPAVAGTETELLVPGLIKDVLYEFRL 80 (108)
T ss_dssp CSSSEEEEEECCSCCSSCCCBEEEEEEE-TTCCCEEEEEEECSSCCEEECCCCCTTSCEECCB
T ss_pred eCCEEEEEECCCCCCCCCCcEEEEEEEe-CCCCcEEeeeecCCCcCEEEeCCCCCCCEEEEEE
Confidence 4578999999997543 6677766544 4567874 2346789999999999999998
|
| >2dmk_A Midline 2 isoform 2; midline defect 2, tripartite motif protein 1, midin-2, ring finger protein 60, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.53 E-value=0.0033 Score=50.06 Aligned_cols=63 Identities=17% Similarity=0.323 Sum_probs=44.8
Q ss_pred CCeeeeecCCCCeeEEeecCCCCCCcceeeecccc-----------ccCCcEEe--cCCCCeEEeecCCCCceeeEEe
Q psy11098 13 QPVINVHPLSESSVELALLTENLSSIRLCDHESGV-----------WSDARWVI--SPHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 13 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~--~~~~~~~~~~~l~~~~~~~f~~ 77 (380)
.+.+.. .+.++++|+|..+..+|+..+.++-.. .....|.. ......+.+.+|.|+..|.|++
T Consensus 22 ~~~~~~--~~~~sv~L~W~~p~~~g~~~Y~~~Y~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~v~gL~p~t~Y~frV 97 (127)
T 2dmk_A 22 REELCT--ASHDTITVHWISDDEFSISSYELQYTIFTGQANFISLYNSVDSWMIVPNIKQNHYTVHGLQSGTRYIFIV 97 (127)
T ss_dssp EEEEEE--EETTEEEEEEECSCCSSEEEEEEEEEEESCCSCHHHHHHTGGGSEEEEEECSSEEEEESCCSSCEEEEEE
T ss_pred CCEEEe--eeCCEEEEEECCCCCCCccceEEEEEEecccccccccccCCCCcEEeecccCCeEEECCCCCCCEEEEEE
Confidence 555666 788999999999998875443332111 11246764 2346789999999999999998
|
| >2yrz_A Integrin beta-4; GP150, CD104 antigen, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.42 E-value=0.017 Score=44.72 Aligned_cols=63 Identities=19% Similarity=0.338 Sum_probs=46.7
Q ss_pred CeeeeecCCCCeeEEeecCCCCCC-cceeeeccccccCCcEEe----cCCCCeEEeecCCCCceeeEEee
Q psy11098 14 PVINVHPLSESSVELALLTENLSS-IRLCDHESGVWSDARWVI----SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 14 p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
..+.. .+.+++.|+|..+...| +..|.++-....+..|.. ......+.+.+|.|+..|.|++.
T Consensus 24 l~~~~--~~~~sv~l~W~~p~~~g~i~~Y~v~~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~ 91 (118)
T 2yrz_A 24 LVFSA--LGPTSLRVSWQEPRCERPLQGYSVEYQLLNGGELHRLNIPNPAQTSVVVEDLLPNHSYVFRVR 91 (118)
T ss_dssp CEECC--CBTTEEEEECCCCCCSSCEEEEEEEEEBSSSCCEEEEEESCTTCCEEEEESCCTTCEEEEEEE
T ss_pred eEEEe--CCCCEEEEEeCCCCCCCCccEEEEEEEECCCCceEEEEcCCCCcCEEEeCCCCCCCEEEEEEE
Confidence 34444 78899999999988775 566776654444456654 13467899999999999999983
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.37 E-value=0.013 Score=56.95 Aligned_cols=74 Identities=12% Similarity=0.172 Sum_probs=48.9
Q ss_pred eeeecccCCeEEEEEEEcCC-------CcEEEEEEecCCCCchHHHHHHHHHHHhhccCCC-cceeeecccccCCCceEE
Q psy11098 105 LERLGNGRFCTVRKARDRGT-------GQLVALKQIPRERQPQQITRAEYNLLSTLMHAHI-PTALALFENAPVPGTDTI 176 (380)
Q Consensus 105 ~~~LG~G~fg~V~~~~~~~~-------~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni-~~i~~~~~~~~~~~~~~l 176 (380)
++.|..|-...+|++..... ++.|++|+........-...+|..+++.+...++ ++++..+. .++
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~-------~~~ 147 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADFP-------EGR 147 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEET-------TEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEcC-------CCE
Confidence 46677788889999987521 5789999875432222223579999998864444 44554322 278
Q ss_pred EEEecCCCC
Q psy11098 177 VMQLVHGES 185 (380)
Q Consensus 177 v~e~~~gg~ 185 (380)
||||++|..
T Consensus 148 I~efI~G~~ 156 (424)
T 3mes_A 148 IEEFIDGEP 156 (424)
T ss_dssp EEECCCSEE
T ss_pred EEEEeCCcc
Confidence 999998855
|
| >2ed8_A Netrin receptor DCC; tumor suppressor protein DCC, colorectal cancer suppressor, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.29 E-value=0.015 Score=44.18 Aligned_cols=58 Identities=9% Similarity=-0.016 Sum_probs=43.4
Q ss_pred CCCCeeEEeecCCCCCC--cceeeeccccccCCcEEe-cCCCCeEEeecCCCCceeeEEee
Q psy11098 21 LSESSVELALLTENLSS--IRLCDHESGVWSDARWVI-SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 21 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
.+.+++.|+|..+...+ +..|.+.-.......|.. ......+.+.+|.|+..|.|++.
T Consensus 19 ~~~~si~l~W~~p~~~~g~i~~Y~v~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~ 79 (106)
T 2ed8_A 19 TSPTSILITWEPPAYANGPVQGYRLFCTEVSTGKEQNIEVDGLSYKLEGLKKFTEYSLRFL 79 (106)
T ss_dssp SSTTEEEEEEECCSSCSSCCCEEEEEEEETTTCCEEEEEECSSCEEEESCCTTCEEEEEEE
T ss_pred cCCCEEEEEECCCCCCCCCeeEEEEEEEECCCCceEEEeCCccEEEECCCCCCCEEEEEEE
Confidence 78899999999886443 566666554444455654 34478899999999999999983
|
| >1wf5_A Sidekick 2 protein; FNIII domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: b.1.2.1 | Back alignment and structure |
|---|
Probab=96.18 E-value=0.015 Score=45.15 Aligned_cols=61 Identities=16% Similarity=0.336 Sum_probs=43.4
Q ss_pred eeeeecCCCCeeEEeecCCCCCC--cceeeeccccccCCcEEe-----cCCCCeEEeecCCCCceeeEEee
Q psy11098 15 VINVHPLSESSVELALLTENLSS--IRLCDHESGVWSDARWVI-----SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 15 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
.+.. .+.+++.|+|..+...+ +..|.++.... +..|.. ......+.+.+|.|+..|.|++.
T Consensus 27 ~~~~--~~~~sv~l~W~~p~~~~~~i~~Y~v~~~~~-~~~~~~~~~~~~~~~~~~~v~~L~p~t~Y~frV~ 94 (121)
T 1wf5_A 27 TLST--VERRAINLTWTKPFDGNSPLIRYILEMSEN-NAPWTVLLASVDPKATSVTVKGLVPARSYQFRLC 94 (121)
T ss_dssp EECS--SSTTEEEEECCCCCCCSSCEEEEEEEEECT-TCCCEEEESSCCTTCCEEEEESCCTTCEEEEEEE
T ss_pred eeEe--ccCCEEEEEEcCCCCCCCcceEEEEEEEcC-CCCceEeEcccCCCccEEEECCcCCCCEEEEEEE
Confidence 4444 78899999999874333 45566665333 367764 22456799999999999999983
|
| >2dju_A Receptor-type tyrosine-protein phosphatase F; LAR protein, leukocyte antigen related, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.15 E-value=0.012 Score=44.47 Aligned_cols=64 Identities=14% Similarity=0.168 Sum_probs=45.2
Q ss_pred CCeeeeecCCCCeeEEeecCCCCCCcceeeecccccc-CCcEEe--cCCCCeEEeecCCCCceeeEEee
Q psy11098 13 QPVINVHPLSESSVELALLTENLSSIRLCDHESGVWS-DARWVI--SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 13 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
...+.. .+.+++.|+|..+....+..|.++-.... +..|.. ......+.+.+|.|+..|.|++.
T Consensus 13 ~~~~~~--~~~~sv~l~W~~~~~~~i~~Y~v~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~ 79 (106)
T 2dju_A 13 DLVVTE--TTATSVTLTWDSGNSEPVTYYGIQYRAAGTEGPFQEVDGVATTRYSIGGLSPFSEYAFRVL 79 (106)
T ss_dssp EEEEEE--EETTEEEEEEECCCSSCCSEEEEEEEETTCCSCCCCBCCCCSSEEEEESCCTTCEEEEEEE
T ss_pred CcEEEe--ccCCEEEEEEcCCCCCCceEEEEEEEECCCCCCeEEccCCCccEEEEeCCCCCcEEEEEEE
Confidence 344444 78899999999886555677776543322 235654 23466799999999999999983
|
| >1uem_A KIAA1568 protein; immunoglobulin-like beta-sandwich fold, fibronectin type III, structural genomics; NMR {Homo sapiens} SCOP: b.1.2.1 | Back alignment and structure |
|---|
Probab=96.08 E-value=0.016 Score=44.78 Aligned_cols=65 Identities=17% Similarity=0.242 Sum_probs=46.1
Q ss_pred CCCeeeeecCCCCeeEEeecCCCCCC--cceeeeccccc-cCCcEEe---cCCCCeEEeecCCCCceeeEEee
Q psy11098 12 TQPVINVHPLSESSVELALLTENLSS--IRLCDHESGVW-SDARWVI---SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 12 ~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~-~~~~~~~---~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
..+.+.. .+.+++.|+|..+...+ +..|.++.... ....|.. ......+.+.+|.|+..|.|++.
T Consensus 20 ~~~~~~~--~~~~sv~l~W~~p~~~~~~i~~Y~v~~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~frV~ 90 (117)
T 1uem_A 20 SKPQVTD--VTKNSVTLSWQPGTPGTLPASAYIIEAFSQSVSNSWQTVANHVKTTLYTVRGLRPNTIYLFMVR 90 (117)
T ss_dssp CCCEEEE--ECSSCEEEECCCCBCSSSCCCEEEEEEEETTTEEEEEEEEEEECSSEEEECSCCTTCEEEEEEE
T ss_pred CCCEEEE--ecCCEEEEEEeCCCCCCcCceEEEEEEEECCCCCceeEcccccCcCEEEECCCCCCCEEEEEEE
Confidence 4455555 78899999999887333 55666654332 2456765 23577899999999999999983
|
| >2edy_A Receptor-type tyrosine-protein phosphatase F; LAR protein, leukocyte antigen related, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.00 E-value=0.02 Score=42.94 Aligned_cols=60 Identities=18% Similarity=0.112 Sum_probs=43.1
Q ss_pred eecCCCCeeEEeecCCC----CCCcceeeeccccccCCcEEe-cCCCCeEEeecCCCCceeeEEe
Q psy11098 18 VHPLSESSVELALLTEN----LSSIRLCDHESGVWSDARWVI-SPHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 18 ~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~~~~~f~~ 77 (380)
....+.+++.|+|..+. ...+..|.+.-.......|.. ......+.+.+|.|+..|.|++
T Consensus 17 ~~~~~~~si~l~W~~p~~~~~~g~i~~Y~i~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V 81 (103)
T 2edy_A 17 VTGLTTSTTELAWDPPVLAERNGRIISYTVVFRDINSQQELQNITTDTRFTLTGLKPDTTYDIKV 81 (103)
T ss_dssp CSSBCSSCEECEEECCCTTSCSSCCCEEEEEEEETTSCCEEEEEESSSCCEECSCCTTCCEEEEC
T ss_pred EEecCCCEEEEEECCCCCcCCCCcEeEEEEEEEECCCCccEEEcCCcceEEEcCCCCCCEEEEEE
Confidence 33378899999999983 223566766544433445655 4456789999999999999997
|
| >2rb8_A Tenascin; beta sheet,loop design, alternative splicing, cell adhesion, coiled coil, EGF-like domain, extracellular matrix, glycoprotein; 1.45A {Homo sapiens} PDB: 2rbl_A 1ten_A | Back alignment and structure |
|---|
Probab=95.93 E-value=0.019 Score=43.74 Aligned_cols=63 Identities=8% Similarity=0.248 Sum_probs=44.1
Q ss_pred CCCeeeeecCCCCeeEEeecCCCCCCcceeeecccccc-CCcEE---ecCCCCeEEeecCCCCceeeEEe
Q psy11098 12 TQPVINVHPLSESSVELALLTENLSSIRLCDHESGVWS-DARWV---ISPHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 12 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~---~~~~~~~~~~~~l~~~~~~~f~~ 77 (380)
..-.+.. .+.+|+.|+|..+. ..+..+.+.-.... +..|. ......++.+.+|.||..|.|++
T Consensus 7 ~~l~v~~--~t~~sv~lsW~~p~-~~i~~Y~v~y~~~~~~~~~~~~~v~~~~~~~~l~~L~p~t~Y~~~V 73 (104)
T 2rb8_A 7 SQIEVKD--VTDTTALITWMPPS-QPVDGFELTYGIKDVPGDRTTIDLTEDENQYSIGNLKPDTEYEVSL 73 (104)
T ss_dssp EEEEEES--CCSSCEEEEEECCS-SCCSEEEEEEEETTCTTCCEEEEEETTCCEEEECSCCTTCEEEEEE
T ss_pred CccEEEE--ecCCeEEEEEcCCC-CccceEEEEEEECcCCCceEEEEcCCCcCEEEeCCCCCCCEEEEEE
Confidence 3445555 88999999998876 44666766432221 23343 24557789999999999999997
|
| >2dn7_A Receptor-type tyrosine-protein phosphatase F; LAR protein, leukocyte antigen related, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: b.1.2.1 | Back alignment and structure |
|---|
Probab=95.93 E-value=0.035 Score=41.96 Aligned_cols=58 Identities=16% Similarity=0.084 Sum_probs=42.9
Q ss_pred CCCCeeEEeecCCCCCC--cceeeeccccccCCcEEe---cCCCCeEEeecCCCCceeeEEee
Q psy11098 21 LSESSVELALLTENLSS--IRLCDHESGVWSDARWVI---SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 21 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
.+.+++.|+|..+...+ +..|.++-.......|.. ......+.+.+|.|+..|.|++.
T Consensus 18 ~~~~sv~l~W~~p~~~~g~i~~Y~v~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~ 80 (107)
T 2dn7_A 18 TAMNTALLQWHPPKELPGELLGYRLQYCRADEARPNTIDFGKDDQHFTVTGLHKGTTYIFRLA 80 (107)
T ss_dssp CSTTEEEEEEECCSSCSSCCCEEEEEEEETTCSSCEEEEEETTCCEEEEECCCTTCEEEEEEE
T ss_pred cCCCEEEEEECCCCCCCCceeEEEEEEEECCCCCCEEEEeCCCccEEEeCCCCCCCEEEEEEE
Confidence 68899999999986433 556666554444455654 34567899999999999999983
|
| >2ed7_A Netrin receptor DCC; tumor suppressor protein DCC, colorectal cancer suppressor, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.91 E-value=0.025 Score=43.69 Aligned_cols=63 Identities=22% Similarity=0.173 Sum_probs=43.3
Q ss_pred CeeeeecCCCCeeEEeecCCCCCC--cceeeeccccccCCcEEe--c--CCCCeEEeecCCCCceeeEEee
Q psy11098 14 PVINVHPLSESSVELALLTENLSS--IRLCDHESGVWSDARWVI--S--PHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 14 p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~--~--~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
..+.. .+.+++.|+|..+...+ +..|.++........|.. . .....+.+.+|.|+..|.|++.
T Consensus 24 l~~~~--~~~~sv~l~W~~p~~~~~~i~~Y~v~~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~ 92 (119)
T 2ed7_A 24 VVPVL--VSSRFVRLSWRPPAEAKGNIQTFTVFFSREGDNRERALNTTQPGSLQLTVGNLKPEAMYTFRVV 92 (119)
T ss_dssp CEEEE--ECSSCEEEECCCCSCCSSCEEEEEEEEEESSCCCCEEEECCCTTCCEEEECSCCSSSEEEECCE
T ss_pred eEEEe--cCCCEEEEEEeCCCCCCCcEEEEEEEEEeCCCCcceeeEeecCCceEEEeCCCCCCCEEEEEEE
Confidence 34444 78899999999886533 556666543333334442 2 3467899999999999999873
|
| >2cui_A Tenascin-X; fibronectin type III domain, extracellular matirx, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: b.1.2.1 | Back alignment and structure |
|---|
Probab=95.87 E-value=0.05 Score=42.24 Aligned_cols=66 Identities=17% Similarity=0.175 Sum_probs=44.6
Q ss_pred CCCCCeeeeecCCCCeeEEeecCCCCCCcceeeeccccccC-----------C-cEEecCCCCeEEeecCCCCceeeEEe
Q psy11098 10 PATQPVINVHPLSESSVELALLTENLSSIRLCDHESGVWSD-----------A-RWVISPHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 10 p~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~-~~~~~~~~~~~~~~~l~~~~~~~f~~ 77 (380)
++..=.+.. .+.+|+.|+|..+. ..+..|.+.-..... . ....+....++.+.+|.||..|.|.+
T Consensus 11 ~p~~L~v~~--~T~~Si~LsW~~p~-g~v~~Y~i~y~~~~~~~~e~~~~~~~~~~~~v~~~~t~~~l~gL~PgT~Y~~~V 87 (112)
T 2cui_A 11 RLSQLSVTD--VTTSSLRLNWEAPP-GAFDSFLLRFGVPSPSTLEPHPRPLLQRELMVPGTRHSAVLRDLRSGTLYSLTL 87 (112)
T ss_dssp CCCCCEEES--CCSSCEEEECCCCT-TSCSEEEEEEECCCCSSSCCCSSCCCCEEEEEETTCCEEEECSCCTTCEEEEEE
T ss_pred CCCceEEEe--ecCCeEEEEECCCC-CCccEEEEEEEeCCCCccccccccCcceEEEcCCCcCEEEeCCCCCCCEEEEEE
Confidence 445556666 88999999999774 335566654322211 1 12234567789999999999999987
Q ss_pred e
Q psy11098 78 N 78 (380)
Q Consensus 78 ~ 78 (380)
.
T Consensus 88 ~ 88 (112)
T 2cui_A 88 Y 88 (112)
T ss_dssp E
T ss_pred E
Confidence 3
|
| >1x5z_A Receptor-type tyrosine-protein phosphatase delta; fibronectin type III domain containing protein, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: b.1.2.1 | Back alignment and structure |
|---|
Probab=95.86 E-value=0.023 Score=43.62 Aligned_cols=59 Identities=17% Similarity=0.138 Sum_probs=44.3
Q ss_pred cCCCCeeEEeecCCCCCCcceeeeccccccCCcEEe--cCCCCeEEeecCCCCceeeEEee
Q psy11098 20 PLSESSVELALLTENLSSIRLCDHESGVWSDARWVI--SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 20 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
..+.+++.|+|..+....+..|.+.-.......|.. ......+.+.+|.|+..|.|++.
T Consensus 28 ~~~~~sv~l~W~~p~~~~i~~Y~v~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~ 88 (115)
T 1x5z_A 28 PESETSILLSWTPPRSDTIANYELVYKDGEHGEEQRITIEPGTSYRLQGLKPNSLYYFRLA 88 (115)
T ss_dssp CSSSSEEEEEEECCSCCCCCEEEECBEESSSCCCBCCEECSSSEEEEECCCTTCEEEECEE
T ss_pred eCCCCEEEEEEcCCCCCCccEEEEEEEeCCCCCceEEecCCCcEEEECCCCCCCeEEEEEE
Confidence 378899999999987655777777654444444532 23467899999999999999873
|
| >1x5g_A Neogenin; RGM binding, fibronectin type III domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: b.1.2.1 | Back alignment and structure |
|---|
Probab=95.85 E-value=0.022 Score=43.82 Aligned_cols=65 Identities=11% Similarity=-0.010 Sum_probs=45.7
Q ss_pred CCCeeeeecCCCCeeEEeecCCCCCC--cceeeeccccccCCcEEe-cCCCCeEEeecCCCCceeeEEee
Q psy11098 12 TQPVINVHPLSESSVELALLTENLSS--IRLCDHESGVWSDARWVI-SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 12 ~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
....+.. .+.+++.|+|..+...+ +..|.+.-.......|.. ......+.+.+|.|+..|.|++.
T Consensus 22 ~~l~~~~--~~~~si~l~W~~p~~~~~~i~~Y~v~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~ 89 (116)
T 1x5g_A 22 PNLRAYA--ASPTSITVTWETPVSGNGEIQNYKLYYMEKGTDKEQDVDVSSHSYTINGLKKYTEYSFRVV 89 (116)
T ss_dssp SSCEEEE--EETTEEEEECCCCSCCSSCCSEEEEEEEETTCCCCCCEEECSSEEEECSCCTTCEEEEEEE
T ss_pred CccEEEe--cCCCEEEEEEeCCCCCCCcccEEEEEEEECCCCccEEEecCCceEEEcCCCCCCEEEEEEE
Confidence 3344444 78899999999886433 566766554444445543 34567899999999999999983
|
| >2djs_A Ephrin type-B receptor 1; tyrosine-protein kinase receptor EPH-2, NET, HEK6, ELK, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: b.1.2.1 | Back alignment and structure |
|---|
Probab=95.75 E-value=0.04 Score=41.81 Aligned_cols=63 Identities=14% Similarity=0.129 Sum_probs=43.2
Q ss_pred CeeeeecCCCCeeEEeecCCCCCC--cceeeeccccccCCcE--E-ecCCCCeEEeecCCCCceeeEEee
Q psy11098 14 PVINVHPLSESSVELALLTENLSS--IRLCDHESGVWSDARW--V-ISPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 14 p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~--~-~~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
..+.. .+.+++.|+|..+...+ +..|.+.-.......| . .......+.+.+|.|+..|.|++.
T Consensus 14 l~~~~--~~~~sv~l~W~~p~~~~g~i~~Y~v~~~~~~~~~~~~~~~~~~~~~~~l~~L~p~t~Y~~~V~ 81 (108)
T 2djs_A 14 MHQVS--ATMRSITLSWPQPEQPNGIILDYEIRYYEKEHNEFNSSMARSQTNTARIDGLRPGMVYVVQVR 81 (108)
T ss_dssp CEEEE--ECSSEEEEECCCCSCCSSCEEEEEEEEEETTSCSTTCEEEEESSSEEEEESCCTTCEEEEEEE
T ss_pred eEEEe--cCCCEEEEEECCCCCCCCeEEEEEEEEEECCCCCcceeEEecCccEEEEcCCCCCCEEEEEEE
Confidence 44444 78899999999886543 4556654433322233 2 234567899999999999999983
|
| >3b83_A Ten-D3; beta sheet, computational redesigned protein, alternative splicing, cell adhesion, coiled coil, EGF-like domain, extracellular matrix; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.71 E-value=0.019 Score=43.29 Aligned_cols=64 Identities=13% Similarity=0.100 Sum_probs=44.0
Q ss_pred CCCeeeeecCCCCeeEEeecCCCCCCcceeeecccccc-CCcEE---ecCCCCeEEeecCCCCceeeEEee
Q psy11098 12 TQPVINVHPLSESSVELALLTENLSSIRLCDHESGVWS-DARWV---ISPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 12 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~---~~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
....+.. .+.+++.|+|..+.. .+..|.++-.... ...|. ......++.+.+|.|+..|.|++.
T Consensus 6 ~~l~~~~--~~~~sv~lsW~pP~~-~i~~Y~v~y~~~~~~~~~~~~~~~~~~t~~~i~~L~p~t~Y~~~V~ 73 (100)
T 3b83_A 6 FNIKVTN--ITLTTAVVTWQPPIL-PIEGILVTFGRKNDPSDETTVDLTSSITSLTLTNLEPNTTYEIRIV 73 (100)
T ss_dssp EEEEEES--CCSSCEEEEEECCSS-CCSEEEEEEEESSCTTTCEEEEECTTEEEEEECSCCTTCEEEEEEE
T ss_pred CccEEEE--ecCCEEEEEEcCCcc-cCCEEEEEEEECCCCCCceEEEECCcceEEEECCCCCCCEEEEEEE
Confidence 3445555 889999999988863 4666766543222 22232 244567899999999999999983
|
| >2dm4_A Sortilin-related receptor; beta-sandwich, sorting protein-related receptor containing LDLR class A repeats, sorla; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.62 E-value=0.035 Score=42.16 Aligned_cols=58 Identities=14% Similarity=0.091 Sum_probs=43.0
Q ss_pred CCCCeeEEeecCCCCCC--cceeeeccccccCCcEEe-cCCCCeEEeecCCCCceeeEEee
Q psy11098 21 LSESSVELALLTENLSS--IRLCDHESGVWSDARWVI-SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 21 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
.+.+++.|+|..+...+ +..|.+.-....+..|.. ......+.+.+|.++..|.|++.
T Consensus 21 ~~~~sv~l~W~~p~~~~g~i~~Y~v~~~~~~~~~~~~~~~~~~~~~l~~L~p~t~Y~~~V~ 81 (108)
T 2dm4_A 21 EAEGVIVGHWAPPIHTHGLIREYIVEYSRSGSKMWASQRAASNFTEIKNLLVNTLYTVRVA 81 (108)
T ss_dssp TCSSCEEEEEECCSCCSSCEEEEEEEEEETTCSCCEEEEESSSEEEECSCCSSCEEEEEEE
T ss_pred cCCCEEEEEEcCCCCCCCcEEEEEEEEEECCCCCeEEecCCccEEEeCCCCCCCEEEEEEE
Confidence 47899999999986333 556666554444556765 34466899999999999999983
|
| >3tes_A Tencon; fibronectin type III domain, FN3, consensus design, de novo; 2.50A {Synthetic} | Back alignment and structure |
|---|
Probab=95.59 E-value=0.028 Score=42.31 Aligned_cols=66 Identities=15% Similarity=0.200 Sum_probs=45.2
Q ss_pred CCCCCeeeeecCCCCeeEEeecCCCCCCcceeeeccccccC-C--cEEe-cCCCCeEEeecCCCCceeeEEee
Q psy11098 10 PATQPVINVHPLSESSVELALLTENLSSIRLCDHESGVWSD-A--RWVI-SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 10 p~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~--~~~~-~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
||..-.+.. .+.+|+.|+|..+. +.+..+.++-..... . .+.. .....++.+.+|.|+..|.|++.
T Consensus 4 ~P~~l~v~~--~t~~Sv~lsW~~p~-~~i~~Y~v~y~~~~~~~~~~~~~~~~~~t~~~l~gL~P~t~Y~~~V~ 73 (98)
T 3tes_A 4 APKNLVVSE--VTEDSLRLSWTAPD-AAFDSFMIQYQESEKVGEAINLTVPGSERSYDLTGLKPGTEYTVSIY 73 (98)
T ss_dssp CCEEEEEES--CCSSCEEEEEECCT-TSCSEEEEEEEETTBCSCCEEEEEETTCSEEEECSCCTTCEEEEEEE
T ss_pred CCCceEEEe--cCCCeEEEEecCCc-CccceEEEEEEECCCCCceEEEEcCCCcCEEEECCCCCCCEEEEEEE
Confidence 334455565 88999999999875 345566654433221 2 2232 45677899999999999999973
|
| >1x5f_A Neogenin; RGM binding, fibronectin type III domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: b.1.2.1 | Back alignment and structure |
|---|
Probab=95.41 E-value=0.04 Score=42.57 Aligned_cols=58 Identities=17% Similarity=0.122 Sum_probs=41.6
Q ss_pred CCCCeeEEeecCCC-CCC--cceeeeccccccCCcEEe----cCCCCeEEeecCCCCceeeEEee
Q psy11098 21 LSESSVELALLTEN-LSS--IRLCDHESGVWSDARWVI----SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 21 ~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
.+.+++.|+|..+. ..+ +..|.++.....+..|.. ......+.+.+|.|+..|.|++.
T Consensus 29 ~~~~sv~l~W~~p~~~~~g~i~~Y~v~~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~ 93 (120)
T 1x5f_A 29 VSTRFIKLTWRTPASDPHGDNLTYSVFYTKEGIARERVENTSHPGEMQVTIQNLMPATVYIFRVM 93 (120)
T ss_dssp ECSSCEEEEEECCSSCSSCCSSEEEEEEEETTCCCCEEEECSSTTCSEEEECSCCTTCEEEEEEE
T ss_pred cCCCEEEEEECCCCCCCCCcEEEEEEEEEECCCCCceEEEeccCCccEEEeCCCCCCCEEEEEEE
Confidence 78889999999886 333 566766554443344443 23367899999999999999983
|
| >1k85_A Chitinase A1; fibronectin type III domain, chitin binding domain, carbohydrase, horizontal gene transfer, hydrolase; NMR {Bacillus circulans} SCOP: b.1.2.1 | Back alignment and structure |
|---|
Probab=95.40 E-value=0.043 Score=40.08 Aligned_cols=58 Identities=17% Similarity=0.205 Sum_probs=41.3
Q ss_pred CeeeeecCCCCeeEEeecCCCCC-CcceeeeccccccCCcEEecCCCCeEEeecCCCCceeeEEe
Q psy11098 14 PVINVHPLSESSVELALLTENLS-SIRLCDHESGVWSDARWVISPHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 14 p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~f~~ 77 (380)
..+.. .+.+++.|+|..+... ++..+.+.. +...+.......+.+.+|.||..|.|++
T Consensus 10 l~~~~--~~~~sv~L~W~~~~~~~~i~~Y~v~~----~~~~~~~~~~~~~~~~~L~~~t~Y~~~V 68 (88)
T 1k85_A 10 LASTA--QTTSSITLSWTASTDNVGVTGYDVYN----GTALATTVTGTTATISGLAADTSYTFTV 68 (88)
T ss_dssp EEEEE--ECSSCEEEEEECCSCCSSEEEEEEEE----SSSEEEEESSSEEEECCCCSSCEEEEEE
T ss_pred cEEEe--ccCCEEEEEECCCCCCCCccEEEEEE----CCEEEeecCCCEEEeCCCCCCCEEEEEE
Confidence 44444 6789999999988743 356666652 2233333446789999999999999997
|
| >3teu_A Fibcon; FN3 domain, fibronectin TPYE III domain, consensus design, S de novo protein; HET: DIO; 1.00A {Synthetic} | Back alignment and structure |
|---|
Probab=95.32 E-value=0.041 Score=41.05 Aligned_cols=64 Identities=13% Similarity=0.211 Sum_probs=44.1
Q ss_pred CCCeeeeecCCCCeeEEeecCCCCCCcceeeeccccccC-CcEEe---cCCCCeEEeecCCCCceeeEEee
Q psy11098 12 TQPVINVHPLSESSVELALLTENLSSIRLCDHESGVWSD-ARWVI---SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 12 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~---~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
....+.. .+.+++.|+|..++ ..+..|.++-..... ..|.. ......+.+.+|.|+..|.|++.
T Consensus 6 ~~l~v~~--~~~~sv~l~W~~p~-~~i~~Y~v~y~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~ 73 (98)
T 3teu_A 6 TDLQVTN--VTDTSITVSWTPPS-ATITGYRITYTPSNGPGEPKELTVPPSSTSVTITGLTPGVEYVVSVY 73 (98)
T ss_dssp EEEEEEE--ECSSCEEEEEECCS-SCCSEEEEEEEETTSCSCCEEEEECTTCSEEEECSCCTTCEEEEEEE
T ss_pred CceEEEE--ecCCEEEEEEeCCC-CcccEEEEEEEECCCCCceEEEEcCCCcCEEEecCCCCCCEEEEEEE
Confidence 3444555 78899999999884 445666665432222 33332 34577899999999999999973
|
| >1x5l_A Ephrin type-A receptor 8; FN3 domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: b.1.2.1 | Back alignment and structure |
|---|
Probab=95.31 E-value=0.053 Score=41.19 Aligned_cols=58 Identities=17% Similarity=0.181 Sum_probs=41.1
Q ss_pred CCCCeeEEeecCCCCCC--cceeeecccccc--CCcEEe-cCCCCeEEeecCCCCceeeEEee
Q psy11098 21 LSESSVELALLTENLSS--IRLCDHESGVWS--DARWVI-SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 21 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~--~~~~~~-~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
.+.+++.|+|..+...+ +..|.++-.... ...|.. ......+.+.+|.|+..|.|++.
T Consensus 22 ~~~~sv~l~W~~p~~~~g~i~~Y~v~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~ 84 (111)
T 1x5l_A 22 AGQTSVSLLWQEPEQPNGIILEYEIKYYEKDKEMQSYSTLKAVTTRATVSGLKPGTRYVFQVR 84 (111)
T ss_dssp BCSSCEEEEECCCSCCCSCCCEEEEEEEESSSCCSSCEEEEESSSEEEECSCCTTCEEEECEE
T ss_pred cCCCEEEEEECCCCCCCCEEEEEEEEEEECCCCceeEEEecCCCCEEEEcCCCCCCEEEEEEE
Confidence 78899999999886543 456665443222 233433 44567899999999999999873
|
| >2edb_A Netrin receptor DCC; tumor suppressor protein DCC, colorectal cancer suppressor, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.19 E-value=0.091 Score=40.64 Aligned_cols=62 Identities=10% Similarity=0.079 Sum_probs=41.7
Q ss_pred CeeeeecCCCCeeEEeecCCCCCC--cceeeeccccccCCcEEe--cCCCCeEEeecCCCCceeeEEee
Q psy11098 14 PVINVHPLSESSVELALLTENLSS--IRLCDHESGVWSDARWVI--SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 14 p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
..+.. .+ +++.|+|..+...+ +..|.+.-.......+.. ......+.+.+|.|+..|.|++.
T Consensus 24 l~~~~--~~-~sv~l~W~~P~~~ng~i~gY~i~y~~~~~~~~~~~~~~~~~~~~l~~L~p~t~Y~~~V~ 89 (116)
T 2edb_A 24 LHVRP--QT-NCIIMSWTPPLNPNIVVRGYIIGYGVGSPYAETVRVDSKQRYYSIERLESSSHYVISLK 89 (116)
T ss_dssp EEEEE--CS-SCEEEEECCCSCTTBCCCEEEEEEEESSTTSEEEEEETTCCEEEECSCCSSSBEEEEEE
T ss_pred eEEEE--CC-CEEEEEEcCCCCCCCceeEEEEEEEeCCCCeEEEEeCCCeeEEEeCCCCCCCEEEEEEE
Confidence 34444 67 99999999886554 556665443211222222 34567899999999999999983
|
| >2cum_A Tenascin-X; hexabrachion-like, fibronectin type III domain, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: b.1.2.1 | Back alignment and structure |
|---|
Probab=95.18 E-value=0.06 Score=40.91 Aligned_cols=62 Identities=8% Similarity=-0.114 Sum_probs=43.3
Q ss_pred CCCeeeeecCCCCeeEEeecCCCCCCcceeeeccccccCCcEEe---cCCCCeEEeecCCCCceeeEEe
Q psy11098 12 TQPVINVHPLSESSVELALLTENLSSIRLCDHESGVWSDARWVI---SPHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 12 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~~~~~~f~~ 77 (380)
..-.+.. ++.+|+.|+|..+. ..+..+.+.-... +..|.. .....++.+.+|.|+..|.|++
T Consensus 12 ~~l~v~~--~~~~sv~lsW~~p~-~~i~~Y~i~y~~~-~~~~~~~~~~~~~ts~~l~~L~p~t~Y~~~V 76 (105)
T 2cum_A 12 RDLEAKE--VTPRTALLTWTEPP-VRPAGYLLSFHTP-GGQTQEILLPGGITSHQLLGLFPSTSYNARL 76 (105)
T ss_dssp EEEEEES--CCSSCEEEEEECCS-SCCSEEEEEEECT-TSCEEEEEECSSCSEEEECSCCTTCEEEEEE
T ss_pred CceEEEe--ccCCEEEEEEcCCC-CccceEEEEEEeC-CCceEEEEECCCccEEEECCCCCCCEEEEEE
Confidence 3344555 88999999998876 3455666543221 234543 3457789999999999999997
|
| >1x5j_A Neogenin; RGM binding, fibronectin type III domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: b.1.2.1 | Back alignment and structure |
|---|
Probab=95.03 E-value=0.076 Score=41.01 Aligned_cols=62 Identities=15% Similarity=0.242 Sum_probs=40.9
Q ss_pred eeeecCCCCeeEEeecCCCCCC------cceeeecccccc--CCcEEe-cCCCCeEEeecCCCCceeeEEe
Q psy11098 16 INVHPLSESSVELALLTENLSS------IRLCDHESGVWS--DARWVI-SPHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 16 ~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~--~~~~~~-~~~~~~~~~~~l~~~~~~~f~~ 77 (380)
+.+..++.+++.|+|..+.... +..|.+.-.... ...+.. ......+.+.+|.|+..|.|.+
T Consensus 15 l~~~~~s~tsi~lsW~~p~~~~~~~~~~~~~Y~v~y~~~~~~~~~~~~~~~~~~~~~i~gL~P~T~Y~f~V 85 (113)
T 1x5j_A 15 VQASILSHDTIRITWADNSLPKHQKITDSRYYTVRWKTNIPANTKYKNANATTLSYLVTGLKPNTLYEFSV 85 (113)
T ss_dssp EEEEEEETTEEEEEEECTTSCSSSCCCSSCEEEEEECBSSSSSCCCEECCBCSSEEEEESCCTTCEECCEE
T ss_pred eEEEEecCCEEEEEecCCCCccccccCcCceEEEEEEECCCCCeEEEEEecCcCEEEeCCCCCCcEEEEEE
Confidence 3444489999999999876543 225555332211 122332 3456789999999999999987
|
| >1x4y_A Biregional cell adhesion molecule-related/DOWN- regulated oncogenes (CDON)binding...; fibronectin type III, FN3; NMR {Mus musculus} SCOP: b.1.2.1 | Back alignment and structure |
|---|
Probab=95.03 E-value=0.083 Score=40.53 Aligned_cols=62 Identities=10% Similarity=0.073 Sum_probs=41.7
Q ss_pred eeecCCCCeeEEeecCCCC----CCcceeeeccccccCC---cEE---ecCCCCeEEeecCCCCceeeEEee
Q psy11098 17 NVHPLSESSVELALLTENL----SSIRLCDHESGVWSDA---RWV---ISPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 17 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~---~~~---~~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
..-.++.+++.|+|..+.. ..+..|.+.-...... .|. .......+.+.+|.|+..|.|++.
T Consensus 16 ~~~~~~~~si~l~W~~p~~~~~~g~i~gY~v~y~~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~ 87 (114)
T 1x4y_A 16 FTDAVNETTIMLKWMYIPASNNNTPIHGFYIYYRPTDSDNDSDYKKDMVEGDRYWHSISHLQPETSYDIKMQ 87 (114)
T ss_dssp EEECSSSSCEEEEEECCCTTSCCCCCCEEEEEECCTTSCSGGGCCCEEEETTCCEEEECSCCTTCEEEEEEE
T ss_pred EEEecCCCEEEEEEeCCCchhcCCccceEEEEEEECCCCCCcceeeEecCCcEeEEEcCCCCCCCEEEEEEE
Confidence 4444899999999998852 2256666554332222 342 233456799999999999999973
|
| >2e7h_A Ephrin type-B receptor 4; FN3 domain, tyrosine- protein kinase receptor HTK, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.99 E-value=0.077 Score=40.35 Aligned_cols=64 Identities=14% Similarity=0.093 Sum_probs=43.3
Q ss_pred CCeeeeecCCCCeeEEeecCCCCCC--cceeeecccccc---CCcEEe-cCCCCeEEeecCCCCceeeEEee
Q psy11098 13 QPVINVHPLSESSVELALLTENLSS--IRLCDHESGVWS---DARWVI-SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 13 ~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~---~~~~~~-~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
...+.. .+.+++.|+|..+...+ +..|.+.-.... ...|.. ......+.+.+|.|+..|.|++.
T Consensus 13 ~l~~~~--~~~~sv~l~W~~p~~~~g~i~~Y~v~~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~ 82 (109)
T 2e7h_A 13 DIRVTR--SSPSSLSLAWAVPRAPSGAVLDYEVKYHEKGAEGPSSVRFLKTSENRAELRGLKRGASYLVQVR 82 (109)
T ss_dssp CCEEEE--EETTEEEEECCCCCCSSSCCCEEEEEEEETTCCSTTTSEEEEESSSEEEEESCCTTSCEEEEEE
T ss_pred ccEEEe--cCCCEEEEEeCCCCCCCCcEeEEEEEEEECCCCCCceeEEEccCCCEEEECCCCCCCeEEEEEE
Confidence 344544 78899999999886443 556665433322 122332 33456899999999999999983
|
| >2dkm_A Collagen alpha-1(XX) chain; FN3 domain, KIAA1510, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.96 E-value=0.11 Score=39.19 Aligned_cols=65 Identities=14% Similarity=0.138 Sum_probs=41.6
Q ss_pred CCCCCeeeeecCCCCeeEEeecCCCCCCcceeeeccccccCC---cEEe-cCCCCeEEeecCCCCceeeEEee
Q psy11098 10 PATQPVINVHPLSESSVELALLTENLSSIRLCDHESGVWSDA---RWVI-SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 10 p~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~-~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
|+..-.+.. .+.+|+.|+|..+.. ...|.+........ .+.. .....++.+.+|.|+..|.|++.
T Consensus 11 ~P~~l~~~~--~~~~sv~lsW~~p~~--~~~Y~v~y~~~~~~~~~~~~~~~~~~~~~~l~~L~p~t~Y~~~V~ 79 (104)
T 2dkm_A 11 PPRALTLAA--VTPRTVHLTWQPSAG--ATHYLVRCSPASPKGEEEEREVQVGRPEVLLDGLEPGRDYEVSVQ 79 (104)
T ss_dssp CCCCCEEEE--ECSSEEEEECCCCSS--CSEEEEEEEESSSCCSSCCEEEEESSSEEEEESCCTTCCEEEEEE
T ss_pred CCceeEEEe--cCCCEEEEEEeCCCC--CCeEEEEEEECCCCCCcceEEEecCCCEEEECCCCCCCEEEEEEE
Confidence 334445555 788999999988753 35565543322222 2222 22233899999999999999973
|
| >2ibg_A CG9211-PA, GH03927P; IHOG, fibronectin type III, protein binding; 2.20A {Drosophila melanogaster} SCOP: b.1.2.1 b.1.2.1 PDB: 2ibb_A | Back alignment and structure |
|---|
Probab=94.88 E-value=0.038 Score=47.31 Aligned_cols=66 Identities=30% Similarity=0.443 Sum_probs=47.7
Q ss_pred CCCCCeeeeecCCCCeeEEeecCCCCCC--cceeeecccccc-CCcEEecC---------------CCCeEEeecCCCCc
Q psy11098 10 PATQPVINVHPLSESSVELALLTENLSS--IRLCDHESGVWS-DARWVISP---------------HNGTIQVDDLAPGH 71 (380)
Q Consensus 10 p~~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~-~~~~~~~~---------------~~~~~~~~~l~~~~ 71 (380)
||+.|.+.. ++.+++.|+|..+..++ +..|.++-.... ...|.... ....+.+.+|.|+.
T Consensus 4 pP~~~~~~~--~~~~sv~l~W~~p~~~~~~i~~Y~v~~~~~~~~~~w~~~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t 81 (214)
T 2ibg_A 4 PPTPPNVTR--LSDESVMLRWMVPRNDGLPIVIFKVQYRMVGKRKNWQTTNDNIPYGKPKWNSELGKSFTASVTDLKPQH 81 (214)
T ss_dssp CCCCCEEEE--EETTEEEEEEEEECCSSCCEEEEEEEEEESSSSCCCEECSCCEECCSSSCSSSSEEEEEEEECSCCTTC
T ss_pred CCCCCEeeE--ecCCEEEEEEECCCCCCCCceEEEEEEEECCCCCcCcccccccCccccccccccCcceeEEecCCcCCC
Confidence 557788877 89999999999887654 556666543322 35676522 23467899999999
Q ss_pred eeeEEe
Q psy11098 72 TYTFCI 77 (380)
Q Consensus 72 ~~~f~~ 77 (380)
.|.|++
T Consensus 82 ~Y~~~V 87 (214)
T 2ibg_A 82 TYRFRI 87 (214)
T ss_dssp EEEEEE
T ss_pred EEEEEE
Confidence 999997
|
| >2ekj_A Collagen alpha-1(XX) chain; KIAA1510, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.86 E-value=0.044 Score=41.59 Aligned_cols=64 Identities=8% Similarity=0.049 Sum_probs=43.6
Q ss_pred CCCeeeeecCCCCeeEEeecCCCCCCcceeeeccccccC-CcEE---ecCCCCeEEeecCCCCceeeEEee
Q psy11098 12 TQPVINVHPLSESSVELALLTENLSSIRLCDHESGVWSD-ARWV---ISPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 12 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~---~~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
..-.+.. .+.+++.|+|..++ ..+..|.++-..... ..|. .......+.+.+|.|+..|.|++.
T Consensus 12 ~~l~v~~--~t~~si~lsW~~p~-g~i~~Y~v~y~~~~~~~~~~~~~v~~~~~~~~l~~L~p~t~Y~~~V~ 79 (105)
T 2ekj_A 12 SNLALAS--ETPDSLQVSWTPPL-GRVLHYWLTYAPASGLGPEKSVSVPGARSHVTLPDLQAATKYRVLVS 79 (105)
T ss_dssp EEEEEEE--EETTEEEEEEECCS-SCCSBBCBBCCCTTSCSCCCCBCCBTTSSEEEECSCCSSCCCBCBBC
T ss_pred CceEEEe--CCCCEEEEEEeCCC-CcceEEEEEEEECCCCCccEEEEeCCCcCEEEeCCCCCCCEEEEEEE
Confidence 3344444 78899999999985 446666664433222 2232 234567899999999999999873
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.84 E-value=0.12 Score=49.46 Aligned_cols=28 Identities=36% Similarity=0.413 Sum_probs=23.5
Q ss_pred cEeecCCCCcEEEe-------CCeeEEEeCCCccc
Q psy11098 220 IAHKDIRPENILMN-------GAVLKLIDLGSSVS 247 (380)
Q Consensus 220 iiHrDlKp~NIl~~-------~~~ikl~DFG~a~~ 247 (380)
++|.|+.+.|||+. ++.+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 67999999999993 24799999998754
|
| >2ede_A Netrin receptor DCC; tumor suppressor protein DCC, colorectal cancer suppressor, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.82 E-value=0.093 Score=39.99 Aligned_cols=57 Identities=19% Similarity=0.119 Sum_probs=40.8
Q ss_pred CCCeeEEeecCCCCCC--cceeeecccccc---CCcEEe---cCCCCeEEeecCCCCceeeEEee
Q psy11098 22 SESSVELALLTENLSS--IRLCDHESGVWS---DARWVI---SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 22 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~---~~~~~~---~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
+.+++.|+|..+...+ +..|.+...... ...|.. ......+.+.+|.|+..|.|++.
T Consensus 23 ~~~sv~l~W~~p~~~~g~i~~Y~v~~~~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~ 87 (114)
T 2ede_A 23 KPRAVIVSWQPPLEANGKITAYILFYTLDKNIPIDDWIMETISGDRLTHQIMDLNLDTMYYFRIQ 87 (114)
T ss_dssp CSSCEEEEEECCSSCSSCCSEEEEEEESCSSSCTTTSEEEEEETTCCEEEECSCCSSCEEEEEEE
T ss_pred CCCEEEEEECCCCCCCCceeEEEEEEEeCCCCCccceEEEEECCCceEEEEcCCCCCCEEEEEEE
Confidence 7799999999886554 556665443321 235553 35577899999999999999983
|
| >2ed9_A Netrin receptor DCC; tumor suppressor protein DCC, colorectal cancer suppressor, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.82 E-value=0.092 Score=40.72 Aligned_cols=58 Identities=16% Similarity=0.167 Sum_probs=42.7
Q ss_pred CCCCeeEEeecCCCCC---C-cceeeeccccccCCcEEe--cCCCCeEEeecCCCCceeeEEee
Q psy11098 21 LSESSVELALLTENLS---S-IRLCDHESGVWSDARWVI--SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 21 ~~~~~~~~~~~~~~~~---~-~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
.+.+++.|+|..+..+ | +..|.+......+..|.. ......+.+.+|.|+..|.|++.
T Consensus 40 ~~~~sv~l~W~~p~~~~~~g~i~~Y~v~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~ 103 (124)
T 2ed9_A 40 VNSRSIKVSWLPPPSGTQNGFITGYKIRHRKTTRRGEMETLEPNNLWYLFTGLEKGSQYSFQVS 103 (124)
T ss_dssp EETTEEEEECBCCCTTTCCSCCCEEEEEEEESSSSCCEEEECSSCSEEEEECCCSSCEEEECEE
T ss_pred cCCCEEEEEEECcCCcCCCcEEeEEEEEEEECCCCcceEEecCCcCEEEEcCCCCCCEEEEEEE
Confidence 7789999999999762 2 566766554444444543 34567899999999999999873
|
| >1uey_A KIAA0343 protein; immunoglobulin-like beta-sandwich fold, NG-CAM related cell adhesion molecule, fibronectin type III domain, structural genomics; NMR {Homo sapiens} SCOP: b.1.2.1 | Back alignment and structure |
|---|
Probab=94.78 E-value=0.063 Score=42.05 Aligned_cols=64 Identities=17% Similarity=0.118 Sum_probs=41.5
Q ss_pred CCeeeeecCCCCeeEEeecCCCCCC--cceeeeccccc--cCCcEEec---CCCCeEEeecCCCCceeeEEee
Q psy11098 13 QPVINVHPLSESSVELALLTENLSS--IRLCDHESGVW--SDARWVIS---PHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 13 ~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~--~~~~~~~~---~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
.+.+.. .+.+++.|+|..+...+ +..|.++.... ....|... ..+....+.+|.|+..|.|++.
T Consensus 22 ~~~~~~--~~~~sv~l~W~p~~~~~~~i~~Y~v~~~~~~~~~~~w~~~~~~~~~~~~~i~~L~p~t~Y~frV~ 92 (127)
T 1uey_A 22 DLELTD--QLDKSVQLSWTPGDDNNSPITKFIIEYEDAMHKPGLWHHQTEVSGTQTTAQLNLSPYVNYSFRVM 92 (127)
T ss_dssp EEEEEC--CSSSCEEEEEECCCCCSSCEEEEEEEEEBTTTCTTCEEEEEEEESSCCEEEECCCTTCEECCEEE
T ss_pred CcEEEE--ccCCEEEEEEECCCCCCCCceEEEEEEEECCCCCCccEEEeeeCCCceEEEecCCCCCEEEEEEE
Confidence 344444 78999999999764333 55666654332 24668641 1122335789999999999983
|
| >2haz_A N-CAM 1, neural cell adhesion molecule 1; fibronectin type III repeat, FN1, beta sandwich; 1.70A {Homo sapiens} SCOP: b.1.2.1 | Back alignment and structure |
|---|
Probab=94.59 E-value=0.057 Score=40.89 Aligned_cols=62 Identities=15% Similarity=0.230 Sum_probs=43.4
Q ss_pred CeeeeecCCCCeeEEeecCCCCCC---cceeeeccccccCCcEE----e-c--CCCCeEEeecCCCCceeeEEee
Q psy11098 14 PVINVHPLSESSVELALLTENLSS---IRLCDHESGVWSDARWV----I-S--PHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 14 p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~----~-~--~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
..+.. .+.+ +.|+|..+..++ +..|.++-.......|. . . .....+.+.+|.|+..|.|++.
T Consensus 13 ~~~~~--~~~~-v~l~W~~P~~~~G~pi~~Y~v~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~rV~ 84 (105)
T 2haz_A 13 DQVEP--YSST-AQVQFDEPEATGGVPILKYKAEWRAVGEEVWHSKWYDAKEASMEGIVTIVGLKPETTYAVRLA 84 (105)
T ss_dssp EEEEE--CSSC-EEEEEECCSCCTTSCCCEEEEEEEETTCCCCEEEEEEHHHHHHHSEEEECSCCTTCEEEEEEE
T ss_pred CEEEE--cCCc-EEEEEcCCcccCCccccEEEEEEEECCCCCCccceEEccccCCccEEEECCCCCCCEEEEEEE
Confidence 44444 6666 999999887665 56777665444445563 2 1 1356799999999999999983
|
| >3t04_D Monobody 7C12; engineered binding protein, antibody mimic, protein-protein SH2 domain, ATP-binding, phosphoprotein; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.47 E-value=0.13 Score=38.81 Aligned_cols=65 Identities=14% Similarity=0.155 Sum_probs=43.3
Q ss_pred CCCeeeeecCCCCeeEEeecCCCC--CCcceeeeccccccC-Cc--EE-ecCCCCeEEeecCCCCceeeEEee
Q psy11098 12 TQPVINVHPLSESSVELALLTENL--SSIRLCDHESGVWSD-AR--WV-ISPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 12 ~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~-~~--~~-~~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
..-.+.. .+.+|+.|+|..+.. ..+..+.+.-..... .. .. ......++.+.+|.|+..|.|++.
T Consensus 12 ~~l~v~~--~t~~Sv~lsW~~p~~~~g~i~~Y~v~y~~~~~~~~~~~~~v~~~~ts~~l~~L~p~t~Y~~~V~ 82 (103)
T 3t04_D 12 TKLEVVD--ATPTSLKISWDAYYSSWQNVKYYRITYGETGGDSPVQEFTVPGYYSTATISGLKPGVDYTITVY 82 (103)
T ss_dssp CSCEEEE--EETTEEEEECTTTTTTSCCCCEEEEEEEETTCSSCCEEEEEETTCCEEEECSCCTTCCEEEEEE
T ss_pred ceeEEEe--cCCCEEEEEccCCCCCCCccceEEEEEEECCCCCccEEEEcCCCcCEEEeCCCCCCCEEEEEEE
Confidence 3344445 788999999998774 335566554332211 11 22 245577899999999999999973
|
| >2e3v_A Neural cell adhesion molecule 1, 140 kDa isoform; NCAM, N-CAM 1, NCAM-120, CD56 antigen, membra protein, glycoprotein, structural genomics, NPPSFA; HET: PGE BTB; 1.95A {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.45 E-value=0.051 Score=42.50 Aligned_cols=62 Identities=15% Similarity=0.246 Sum_probs=43.8
Q ss_pred CeeeeecCCCCeeEEeecCCCCCC---cceeeeccccccCCcEEe-------cCCCCeEEeecCCCCceeeEEee
Q psy11098 14 PVINVHPLSESSVELALLTENLSS---IRLCDHESGVWSDARWVI-------SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 14 p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
..+.. .+.+ +.|+|..+..++ +..|.++........|.. ......+.+.+|.|+..|.|++.
T Consensus 14 ~~~~~--~~~t-v~l~W~~P~~~~G~pI~~Y~v~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~rV~ 85 (122)
T 2e3v_A 14 DQVEP--YSST-AQVQFDEPEATGGVPILKYKAEWRAVGEEVWHSKWYDAKEASMEGIVTIVGLKPETTYAVRLA 85 (122)
T ss_dssp EEEEE--CSSC-EEEEEECCCCC--CCEEEEEEEEEETTCCSCEEEEEEHHHHHTTTEEEECSCCTTCEEEEEEE
T ss_pred cEEEe--cCCc-EEEEECCCCcCCCCcceEEEEEEEECCCCCcccceeeeeecCccceEEeCCCCCCCEEEEEEE
Confidence 34444 6666 999999887665 567777665545566722 13467899999999999999983
|
| >1x5i_A Neogenin; RGM binding, fibronectin type III domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: b.1.2.1 | Back alignment and structure |
|---|
Probab=94.29 E-value=0.12 Score=40.59 Aligned_cols=57 Identities=14% Similarity=0.216 Sum_probs=38.9
Q ss_pred CCCCeeEEeecCCCCCC--cceeeeccccccCC-cEEe-cCCCCeEEeecCCCCceeeEEee
Q psy11098 21 LSESSVELALLTENLSS--IRLCDHESGVWSDA-RWVI-SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 21 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
.+ +++.|+|..+...+ +..|.+.-...... .+.. ......+.+.+|.|+..|.|++.
T Consensus 39 ~~-~sv~l~W~~P~~~~g~i~~Y~v~y~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~ 99 (126)
T 1x5i_A 39 LV-TSIVVSWTPPENQNIVVRGYAIGYGIGSPHAQTIKVDYKQRYYTIENLDPSSHYVITLK 99 (126)
T ss_dssp ET-TEEEEEEECCSCTTBCCCEEEEEECSSCGGGEEEECCTTCCEEEECSCCSSCEECCEEE
T ss_pred cC-CEEEEEEcCCCCCCCCEeEEEEEEEcCCCCceEEEeCCCeeEEEEeCCCCCCEEEEEEE
Confidence 55 89999999987553 55666554321111 1222 34467899999999999999983
|
| >1wfo_A Sidekick 2; FN3, cell adhesion, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: b.1.2.1 | Back alignment and structure |
|---|
Probab=94.28 E-value=0.21 Score=38.99 Aligned_cols=63 Identities=16% Similarity=0.189 Sum_probs=42.7
Q ss_pred CeeeeecCCCCeeEEeecCCCCCC--cceeeeccccccC--CcEE---ecCCCCeEEeecCCCCceeeEEee
Q psy11098 14 PVINVHPLSESSVELALLTENLSS--IRLCDHESGVWSD--ARWV---ISPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 14 p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~--~~~~---~~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
..+.. .+.+++.|+|..+...+ +..|.+.-..... ..|. .......+.+.+|.|+..|.|++.
T Consensus 34 l~~~~--~~~~sv~l~W~~p~~~~g~i~~Y~v~~~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~ 103 (130)
T 1wfo_A 34 ILFPE--VRTTSVRLIWQPPAAPNGIILAYQITHRLNTTTANTATVEVLAPSARQYTATGLKPESVYLFRIT 103 (130)
T ss_dssp CEEEE--ECSSEEEEECCCCSCCCSCCCEEEEEEEESSCCCSCCCEEEECTTCCEEEEESCCSSSEEEEEEE
T ss_pred eEEEe--cCCCEEEEEEcCCCCCCCceEEEEEEEEECCCCCceEEEEEeCCCceEEEEcCCCCCCEEEEEEE
Confidence 34444 78899999999886543 4566654433221 1232 244577899999999999999983
|
| >1j8k_A Fibronectin; EDA, TYPEIII domain, protein binding; NMR {Homo sapiens} SCOP: b.1.2.1 | Back alignment and structure |
|---|
Probab=94.26 E-value=0.14 Score=37.60 Aligned_cols=64 Identities=14% Similarity=0.184 Sum_probs=43.2
Q ss_pred CCCeeeeecCCCCeeEEeecCCCCCCcceeeeccccccCC--cEEe--cCCCCeEEeecCCCCceeeEEee
Q psy11098 12 TQPVINVHPLSESSVELALLTENLSSIRLCDHESGVWSDA--RWVI--SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 12 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~--~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
....+.. .+.+|+.|+|..+. ..+..+.++-...... .|.. ......+.+.+|.||..|.|++.
T Consensus 6 ~~l~~~~--~~~~si~lsW~~p~-~~i~~Y~v~y~~~~~~~~~~~~~~~~~~~~~~l~~L~p~t~Y~~~V~ 73 (94)
T 1j8k_A 6 KGLAFTD--VDVDSIKIAWESPQ-GQVSRYRVTYSSPEDGIHELFPAPDGEEDTAELQGLRPGSEYTVSVV 73 (94)
T ss_dssp CCCEEEE--EETTEEEEECCCCS-SCCSCEEEEEEETTTEEEEECCCCCSSCCEEEECSCCCCSEEEEEEE
T ss_pred CccEEEe--ecCCEEEEEEcCCC-CCcceEEEEEEeCCCCCceEEecCCCCccEEEeCCCCCCCEEEEEEE
Confidence 4455565 78899999998876 4456666543222222 1332 23456899999999999999983
|
| >3qht_C Monobody YSMB-1; fibronectin type III, yeast small ubiquitin-like modifier, S NOVO protein; 2.40A {Artificial gene} | Back alignment and structure |
|---|
Probab=94.14 E-value=0.15 Score=37.94 Aligned_cols=63 Identities=16% Similarity=0.218 Sum_probs=41.9
Q ss_pred CCeeeeecCCCCeeEEeecCCCCCCcceeeeccccccCCc-E---EecCCCCeEEeecCCCCceeeEEee
Q psy11098 13 QPVINVHPLSESSVELALLTENLSSIRLCDHESGVWSDAR-W---VISPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 13 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~---~~~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
.-.+.. .+.+|+.|+|..+. ..+..+.+.-....... + ........+.+.+|.|+..|.|++.
T Consensus 10 ~l~v~~--~t~~Si~lsW~~p~-~~i~~Y~v~y~~~~~~~~~~~~~v~~~~t~~~l~~L~p~t~Y~v~V~ 76 (97)
T 3qht_C 10 KLEVVA--ATPTSLLISWDASS-SSVSYYRITYGETGGNSPVQEFTVPGSSSTATISGLSPGVDYTITVY 76 (97)
T ss_dssp SCEEEE--EETTEEEEECCCCC-SSCCEEEEEEEESSSCSCCEEEEEETTCCEEEECSCCTTCEEEEEEE
T ss_pred ceEEEe--cCCCEEEEEEeCCC-CCCCEEEEEEEECCCCCccEEEEeCCCcCEEEeCCCCCCCEEEEEEE
Confidence 334444 78899999998874 34555655432222221 1 1245577899999999999999873
|
| >3lpw_A A77-A78 domain from titin; intracellular FNIII-tandem, structural protein; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.08 E-value=0.099 Score=43.62 Aligned_cols=57 Identities=23% Similarity=0.283 Sum_probs=43.5
Q ss_pred CCCCeeEEeecCCCCCC---cceeeeccccccCCcEEe---cCCCCeEEeecCCCCceeeEEe
Q psy11098 21 LSESSVELALLTENLSS---IRLCDHESGVWSDARWVI---SPHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 21 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~~~~~~f~~ 77 (380)
.+.+++.|+|..+..++ +..|.++........|.. ......+.+.+|.|+..|.|++
T Consensus 17 ~~~~sv~l~W~~p~~~~~~~i~~Y~v~~~~~~~~~~~~~~~~~~~~~~~~~~L~p~t~Y~~~V 79 (197)
T 3lpw_A 17 VTKTSVTLTWDPPLLDGGSKIKNYIVEKRESTRKAYSTVATNCHKTSWKVDQLQEGCSYYFRV 79 (197)
T ss_dssp ECSSCEEEEEECCSCCTTSCCCEEEEEEEETTCSSCEEEEEEECSSEEEECCCCTTCEEEEEE
T ss_pred ecCCEEEEEEcCCccCCCCcccEEEEEEEECCCCccEEeecCCCccEEEEcCCCCCCEEEEEE
Confidence 78899999999986553 456666654444556664 3467789999999999999987
|
| >3n1f_C Cell adhesion molecule-related/DOWN-regulated BY; binding sites, calcium, cell adhesion molecules, cell cycle cell LINE, conserved sequence; 1.60A {Homo sapiens} SCOP: b.1.2.1 PDB: 3d1m_C 3n1q_C 3n1m_C 3n1g_C 3n1p_C | Back alignment and structure |
|---|
Probab=94.08 E-value=0.31 Score=36.61 Aligned_cols=62 Identities=10% Similarity=0.037 Sum_probs=41.1
Q ss_pred eeecCCCCeeEEeecCCCC---C-CcceeeeccccccC---CcEEe---cCCCCeEEeecCCCCceeeEEee
Q psy11098 17 NVHPLSESSVELALLTENL---S-SIRLCDHESGVWSD---ARWVI---SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 17 ~~~~~~~~~~~~~~~~~~~---~-~~~~~~~~~~~~~~---~~~~~---~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
....++++++.|+|..+.. . .+..+.+.-..... ..|.. ......+.+.+|.|+..|.|++.
T Consensus 12 ~~~~~s~tsi~v~W~~p~~~~~ng~i~gY~v~y~~~~~~~~~~~~~~~v~~~~~~~~l~~L~p~t~Y~v~V~ 83 (102)
T 3n1f_C 12 YTEAVSDTQIMLKWTYIPSSNNNTPIQGFYIYYRPTDSDNDSDYKRDVVEGSKQWHMIGHLQPETSYDIKMQ 83 (102)
T ss_dssp EEEECSSSCEEEEEECCC-----CCCCEEEEEEEETTCCCGGGCEEEEEETTCSEEEECSCCTTCEEEEEEE
T ss_pred EEEEcCCCEEEEEeECCChhhcCCccceEEEEEEECCCCCCCceEEEEEcCCceEEECCCCCCCCEEEEEEE
Confidence 3345899999999998853 2 25566554333222 24542 33456789999999999999873
|
| >2ocf_D Fibronectin; estrogen receptor, LBD, monobody, estradiol, hormone-growth complex; HET: CME EST; 2.95A {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.07 E-value=0.13 Score=40.20 Aligned_cols=57 Identities=16% Similarity=0.231 Sum_probs=40.2
Q ss_pred CCCCeeEEeecCCCCCCcceeeeccccccCC---cEEe-cCCCCeEEeecCCCCceeeEEee
Q psy11098 21 LSESSVELALLTENLSSIRLCDHESGVWSDA---RWVI-SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 21 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~-~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
.+.+|+.|+|..+.. .+..+.+.-...... .+.. ......+.+.+|.||..|.|.+.
T Consensus 40 ~t~~Si~lsW~~p~~-~i~~Y~V~y~~~~~~~~~~~~~v~~~~t~~~l~gL~P~t~Y~~~V~ 100 (121)
T 2ocf_D 40 ATPTSLLISWDAPAV-TVRYYRITYGETGGNSPVQEFTVPGSKSTATISGLKPGVDYTITVY 100 (121)
T ss_dssp ECSSCEEEEEECCSS-CCCEEEEEEEETTTCSCBEEEEEETTCCEEEECCCCTTCEEEEEEE
T ss_pred cCCCEEEEEEcCCCC-CCcEEEEEEEECCCCCccEEEEeCCCcCEEEeCCCCCCCEEEEEEE
Confidence 788999999988763 355666543222221 2332 45577899999999999999973
|
| >1wfn_A Sidekick 2; FN3, cell adhesion, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: b.1.2.1 | Back alignment and structure |
|---|
Probab=94.06 E-value=0.18 Score=38.72 Aligned_cols=63 Identities=11% Similarity=0.087 Sum_probs=41.9
Q ss_pred CeeeeecCCCCeeEEeecCCCCCC--cceeeeccccccCC-cEE---ecCCCCeEEeecCCCCceeeEEee
Q psy11098 14 PVINVHPLSESSVELALLTENLSS--IRLCDHESGVWSDA-RWV---ISPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 14 p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~-~~~---~~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
..+.. .+.+++.|+|..+...+ +..|.+.-...... .|. .......+.+.+|.|+..|.|++.
T Consensus 24 l~~~~--~~~~sv~l~W~~p~~~~g~i~~Y~v~~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~ 92 (119)
T 1wfn_A 24 LSFSE--ILDTSLKVSWQEPGEKNGILTGYRISWEEYNRTNTRVTHYLPNVTLEYRVTGLTALTTYTIEVA 92 (119)
T ss_dssp CEEES--CCSSEEEEECCCCTTCCSCCCEEEEEEEESSCGGGCCCEEECSSCCEEEEESCCTTCEEEEEEE
T ss_pred eEEEE--CCCCEEEEEEcCCCCCCCcEEEEEEEEEECCCCCceEEEEeCCCceEEEEcCCCCCCEEEEEEE
Confidence 34444 78899999999886544 44566543222211 121 234567899999999999999983
|
| >3qwq_B Adnectin; cell surface receptor, tyrosine kinase, glycoprotein, adnect antitumor, drug, engineered binding protein; HET: NAG BMA MAN FUC; 2.75A {Homo sapiens} PDB: 3qwr_D* | Back alignment and structure |
|---|
Probab=93.91 E-value=0.13 Score=39.83 Aligned_cols=57 Identities=16% Similarity=0.182 Sum_probs=39.8
Q ss_pred CCCCeeEEeecCCCCCCcceeeeccccccCC---cEE-ecCCCCeEEeecCCCCceeeEEee
Q psy11098 21 LSESSVELALLTENLSSIRLCDHESGVWSDA---RWV-ISPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 21 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~-~~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
.+.+|+.|+|..+. ..+..|.+.-...... .+. ......++.+.+|.|+..|.|++.
T Consensus 15 ~t~~Sv~lsW~~p~-g~i~~Y~v~y~~~~~~~~~~~~~v~~~~ts~~l~gL~P~T~Y~v~V~ 75 (114)
T 3qwq_B 15 ATPTSLLISWDSGR-GSYQYYRITYGETGGNSPVQEFTVPGPVHTATISGLKPGVDYTITVY 75 (114)
T ss_dssp EETTEEEEEEECCS-CCCSEEEEEEEESSCSSCCEEEEEETTCCEEEECSCCTTCEEEEEEE
T ss_pred cCCCEEEEEEcCCc-CcccEEEEEEEECCCCCccEEEEeCCCcCEEEeCCCCCCCEEEEEEE
Confidence 78899999999875 4455666543222221 222 345677899999999999999873
|
| >3r8q_A Fibronectin; heparin, FNIII, heparin binding, cell adhesion; 2.40A {Homo sapiens} PDB: 1fnh_A | Back alignment and structure |
|---|
Probab=93.82 E-value=0.1 Score=46.86 Aligned_cols=56 Identities=11% Similarity=0.126 Sum_probs=40.4
Q ss_pred CCCCeeEEeecCCCCCCcceeeecccccc-CCcEEe---cCCCCeEEeecCCCCceeeEEe
Q psy11098 21 LSESSVELALLTENLSSIRLCDHESGVWS-DARWVI---SPHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 21 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~---~~~~~~~~~~~l~~~~~~~f~~ 77 (380)
.+.+++.|+|..++ ..+..|.+.-.... +..|.. ......+.+.+|.|+..|.|++
T Consensus 32 ~~~~sv~l~W~~p~-~~~~~Y~v~~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V 91 (290)
T 3r8q_A 32 VTPTSLSAQWTPPN-VQLTGYRVRVTPKEKTGPMKEINLAPDSSSVVVSGLMVATKYEVSV 91 (290)
T ss_dssp ECSSCEEEEEECCS-SCCCEEEEEEEESSSSSCCEEEEECTTCCEEEECSCCSSCEEEEEE
T ss_pred CCCCEEEEEEeCCC-CCeeEEEEEEEeCCCCCceEEEEcCCCccEEEeCCCCCCCEEEEEE
Confidence 88899999999884 34556666432222 234443 3456789999999999999987
|
| >2vkw_A Neural cell adhesion molecule 1,140 kDa isoform; adhesion receptor; 2.3A {Homo sapiens} SCOP: b.1.2.1 b.1.2.1 PDB: 2vkx_A 1lwr_A | Back alignment and structure |
|---|
Probab=93.80 E-value=0.31 Score=41.33 Aligned_cols=61 Identities=11% Similarity=0.158 Sum_probs=42.5
Q ss_pred eeecCCCCeeEEeecCCCCC--CcceeeeccccccCCcEEe----cCCCCeEEeecCCCCceeeEEee
Q psy11098 17 NVHPLSESSVELALLTENLS--SIRLCDHESGVWSDARWVI----SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 17 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
.....+.+++.|+|..+... .+..|.++-.. .+..|.. .....++.+.+|.|+..|.|++.
T Consensus 117 ~~~~~~~~sv~l~W~~p~~~~~~i~~Y~v~~~~-~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~ 183 (209)
T 2vkw_A 117 GQMGEDGNSIKVNLIKQDDGGSPIRHYLVRYRA-LSSEWKPEIRLPSGSDHVMLKSLDWNAEYEVYVV 183 (209)
T ss_dssp EEECTTSSCEEEEEECCCCTTSCCCEEEEEEEE-TTSCCCCCEEECTTCCEEEECSCCTTCEEEEEEE
T ss_pred ccccccCCeEEEEEECcccCCCCCceEEEEEEC-CCCCCceeeecCCCccEEEecCCCCCCEEEEEEE
Confidence 33347889999999998322 25667665433 3445553 23456899999999999999983
|
| >2ibg_A CG9211-PA, GH03927P; IHOG, fibronectin type III, protein binding; 2.20A {Drosophila melanogaster} SCOP: b.1.2.1 b.1.2.1 PDB: 2ibb_A | Back alignment and structure |
|---|
Probab=93.72 E-value=0.12 Score=43.98 Aligned_cols=58 Identities=17% Similarity=0.147 Sum_probs=41.1
Q ss_pred CCCCeeEEeecCCCC---CCcceeeeccccccC-CcEEec----CCCCeEEeecCCCCceeeEEee
Q psy11098 21 LSESSVELALLTENL---SSIRLCDHESGVWSD-ARWVIS----PHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 21 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~-~~~~~~----~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
.+.+++.|+|..+.. ..+..+.+.-..... ..|... .....+.+.+|.|+..|.|++.
T Consensus 127 ~~~~sv~l~W~~p~~~~~~~i~~Y~v~~~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~ 192 (214)
T 2ibg_A 127 YSETAVVLHWSLASDADEHLITGYYAYYRPSSSAGEYFKATIEGAHARSFKIAPLETATMYEFKLQ 192 (214)
T ss_dssp CSSSCEEEEEECCTTCCGGGCCEEEEEEEETTCCSCCEEEEEECTTCCEEEECSCCTTCEEEEEEE
T ss_pred ccCCeEEEEEeCCCccCCCCcceEEEEEEECCCCcceEEeeccCCcceEEEeCCCCCCCEEEEEEE
Confidence 788999999999852 225566665433333 466641 2256899999999999999973
|
| >3lpw_A A77-A78 domain from titin; intracellular FNIII-tandem, structural protein; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.59 E-value=0.22 Score=41.45 Aligned_cols=58 Identities=17% Similarity=0.258 Sum_probs=43.8
Q ss_pred CCCCeeEEeecCCCCCC---cceeeeccccccCCcEEe--cCCCCeEEeecCCCCceeeEEee
Q psy11098 21 LSESSVELALLTENLSS---IRLCDHESGVWSDARWVI--SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 21 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
.+.+++.|+|..+..++ +..+.+.-.......|.. ......+.+.+|.|+..|.|++.
T Consensus 114 ~~~~~v~l~W~~p~~~~~~~i~~Y~v~~~~~~~~~~~~~~~~~~~~~~~~~L~p~t~Y~~~V~ 176 (197)
T 3lpw_A 114 VTRNSVSLSWEKPEHDGGSRILGYIVEMQTKGSDKWATCATVKVTEATITGLIQGEEYSFRVS 176 (197)
T ss_dssp ECSSCEEEEECCCSCCTTSCCCEEEEEEEETTCSCCEEEEEESSSEEEECCCCTTCEEEEEEE
T ss_pred ccCCeEEEEecCCCcCCCCcccEEEEEEEeCCCCceEEeecccccEEEeCCcCCCCEEEEEEE
Confidence 77899999999877653 556666554444556765 34577899999999999999983
|
| >3k2m_C Monobody HA4; engineered binding protein, antibody mimic, protein-protein SH2 domain, ATP-binding, phosphoprotein; 1.75A {Homo sapiens} PDB: 3uyo_D 1ttf_A 1ttg_A 3rzw_A 1fna_A | Back alignment and structure |
|---|
Probab=93.44 E-value=0.19 Score=37.75 Aligned_cols=57 Identities=18% Similarity=0.193 Sum_probs=39.6
Q ss_pred CCCCeeEEeecCCCCC-CcceeeeccccccCC-cEE---ecCCCCeEEeecCCCCceeeEEe
Q psy11098 21 LSESSVELALLTENLS-SIRLCDHESGVWSDA-RWV---ISPHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 21 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~-~~~---~~~~~~~~~~~~l~~~~~~~f~~ 77 (380)
.+.+|+.|+|..+... .+..+.+.-...... .|. ......++.+.+|.||..|.|.+
T Consensus 16 ~t~~Sv~l~W~~p~~~~~i~~Y~v~y~~~~~~~~~~~~~v~~~~t~~~l~~L~p~t~Y~~~V 77 (101)
T 3k2m_C 16 ATPTSLLISWDAPMSSSSVYYYRITYGETGGNSPVQEFTVPYSSSTATISGLSPGVDYTITV 77 (101)
T ss_dssp EETTEEEEEECCCCTTSCCCEEEEEEEETTCSSCCEEEEEETTCCEEEECSCCTTCEEEEEE
T ss_pred cCCCEEEEEecCCCCCCceeeEEEEEEECCCCCccEEEEcCCCccEEEECCCCCCCEEEEEE
Confidence 7889999999987632 355565543322211 222 24567789999999999999987
|
| >2ee3_A Collagen alpha-1(XX) chain; KIAA1510, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.42 E-value=0.25 Score=37.86 Aligned_cols=63 Identities=11% Similarity=0.052 Sum_probs=43.2
Q ss_pred CCCeeeeecCCCCeeEEeecCCCCCCcceeeeccccccCCcE---EecCCCCeEEeecCCCCceeeEEe
Q psy11098 12 TQPVINVHPLSESSVELALLTENLSSIRLCDHESGVWSDARW---VISPHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 12 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~~~~~~f~~ 77 (380)
..=.+.. ++.+|+.|+|..+. ..+..|.+.-....+..+ .......++.+.+|.|+..|.|++
T Consensus 12 ~~l~~~~--vt~tsi~vsW~pp~-~~i~~Y~I~y~~~~~~~~~~~~v~~~~t~~~l~~L~p~T~Y~v~V 77 (108)
T 2ee3_A 12 RHLGFSD--VSHDAARVFWEGAP-RPVRLVRVTYVSSEGGHSGQTEAPGNATSAMLGPLSSSTTYTVRV 77 (108)
T ss_dssp SCEEEES--CCSSCEEEEESCCS-SCCSEEEEEEEETTTCCBCCEEEETTCCEEEECSCCSSCEEEEEE
T ss_pred ceEEEEE--ccCCeEEEEeeCCC-CCccEEEEEEEeCCCCceeEEEcCCCcCEEEcCCCCCCCEEEEEE
Confidence 3445555 89999999998875 446777764322222222 234456789999999999999997
|
| >1x5h_A Neogenin; RGM binding, fibronectin type III domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: b.1.2.1 | Back alignment and structure |
|---|
Probab=93.42 E-value=0.24 Score=38.66 Aligned_cols=58 Identities=16% Similarity=0.075 Sum_probs=40.9
Q ss_pred cCCCCeeEEeecCCCCC---C-cceeeeccccccCCcEEe----cCCCCeEEeecCCCCceeeEEe
Q psy11098 20 PLSESSVELALLTENLS---S-IRLCDHESGVWSDARWVI----SPHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 20 ~~~~~~~~~~~~~~~~~---~-~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~~~~~~f~~ 77 (380)
..+.+++.|+|..+..+ | +..|.+.-.......|.. ......+.+.+|.|+..|.|++
T Consensus 29 ~~~~~sv~l~W~~p~~~~~~g~i~~Y~v~~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V 94 (132)
T 1x5h_A 29 VRNSKSIMIHWQPPAPATQNGQITGYKIRYRKASRKSDVTETLVSGTQLSQLIEGLDRGTEYNFRV 94 (132)
T ss_dssp CCSSSEEEEEEECCCTTTCCSCEEEEBCEEEETTEEEEEECCBCCTTCCEEEEECCCSSCEEEEEC
T ss_pred eCCCCEEEEEEeCCCCcCCCceEeEEEEEEEECCCCCccEEEEeCCCccEEEeCCCCCCCEEEEEE
Confidence 37889999999999752 2 556665543333333432 2346689999999999999987
|
| >2cuh_A Tenascin-X; fibronectin type III domain, extracellular matrix, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: b.1.2.1 | Back alignment and structure |
|---|
Probab=93.41 E-value=0.24 Score=37.98 Aligned_cols=56 Identities=14% Similarity=0.076 Sum_probs=38.6
Q ss_pred CCCCeeEEeecCCCCCCcceeeeccccccC-CcEE-ecCCCCeEEeecCCCCceeeEEe
Q psy11098 21 LSESSVELALLTENLSSIRLCDHESGVWSD-ARWV-ISPHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 21 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~l~~~~~~~f~~ 77 (380)
.+.+++.|+|..+. ..+..|.+.-..... .... .......+.+.+|.|+..|.|++
T Consensus 19 ~t~~sv~lsW~~p~-~~i~~Y~v~y~~~~~~~~~~~v~~~~t~~~l~~L~P~t~Y~~~V 76 (115)
T 2cuh_A 19 LTEGFAVLHWKPPQ-NPVDTYDIQVTAPGAPPLQAETPGSAVDYPLHDLVLHTNYTATV 76 (115)
T ss_dssp CSSSCEEEEEECCS-SCCSEEEEEEECSSSCCEEEEEETTCSEEEECSCCSSSEEEEEE
T ss_pred ccCCeEEEEEECCC-CCccEEEEEEEcCCCCcEEEEECCCccEEEEeCCCCCCEEEEEE
Confidence 78899999998775 345556554222111 1122 24567789999999999999987
|
| >3p4l_A Neogenin; iron homeostasis, hemojuvelin receptor, FNIII domain, fibron type III, cell adhesion; 1.80A {Homo sapiens} PDB: 1x5k_A | Back alignment and structure |
|---|
Probab=93.39 E-value=0.16 Score=43.17 Aligned_cols=58 Identities=17% Similarity=0.242 Sum_probs=39.8
Q ss_pred CCCCeeEEeecCCCC------CCcceeeeccccccCC--cEEe-cCCCCeEEeecCCCCceeeEEee
Q psy11098 21 LSESSVELALLTENL------SSIRLCDHESGVWSDA--RWVI-SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 21 ~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~--~~~~-~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
.+.+++.|+|..+.. ..+..|.++-...... .|.. ......+.+.+|.|+..|.|++.
T Consensus 16 ~~~~si~l~W~~p~~~~~~~~~~i~~Y~v~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~ 82 (211)
T 3p4l_A 16 LSHDTIRITWADNSLPKHQKITDSRYYTVRWKTNIPANTKYKNANATTLSYLVTGLKPNTLYEFSVM 82 (211)
T ss_dssp CSSSCEEEEEECTTSCTTCCCCSSCEEEEEEEECC---CCCEEEEESSSEEEECSCCTTCEEEEEEE
T ss_pred cCCCeEEEEEeCCCCCcccccCCCcEEEEEEEECCCCcceEEEeCCCceEEEecCcCCCCEEEEEEE
Confidence 889999999998653 3355666654332222 2332 34566899999999999999973
|
| >2ee2_A Contactin-1; neural cell surface protein F3, glycoprotein GP135, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.12 E-value=0.42 Score=36.62 Aligned_cols=63 Identities=13% Similarity=0.080 Sum_probs=42.3
Q ss_pred CeeeeecCCCCeeEEeecCCCCCCcceeeeccccccC--CcEEe---cCCCCeEEeecCCCCceeeEEee
Q psy11098 14 PVINVHPLSESSVELALLTENLSSIRLCDHESGVWSD--ARWVI---SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 14 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~---~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
..+.. ++.+++.|+|..+....+..|.+.-....+ ..|.. ......+.+.+|.|+..|.|++.
T Consensus 25 l~~~~--~~~~sv~l~W~~p~~g~i~~Y~v~~~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~ 92 (119)
T 2ee2_A 25 VGVKV--LSSSEISVHWEHVLEKIVESYQIRYWAAHDKEEAANRVQVTSQEYSARLENLLPDTQYFIEVG 92 (119)
T ss_dssp CEEEE--EETTEEEEECCCCSCTTCCEEEEEEEESSSCGGGCEEEEEETTCSEEEECSCCTTCEEEEEEE
T ss_pred EEEEE--ccCCEEEEEecCCCCCccceEEEEEEECCCcccCcEEEEcCCCEeEEEECCCCCCCEEEEEEE
Confidence 34444 788999999999877335566655432221 12221 23456899999999999999983
|
| >2edx_A Protein tyrosine phosphatase, receptor type, F; LAR protein, leukocyte antigen related, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.11 E-value=0.41 Score=37.29 Aligned_cols=61 Identities=8% Similarity=0.107 Sum_probs=40.3
Q ss_pred eecCCCCeeEEeecCC--CCCC--cceeeeccccccCC--cEE-e---cCCCCeEEeecCCCCceeeEEee
Q psy11098 18 VHPLSESSVELALLTE--NLSS--IRLCDHESGVWSDA--RWV-I---SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 18 ~~~~~~~~~~~~~~~~--~~~~--~~~~~~~~~~~~~~--~~~-~---~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
....+.+++.|+|..+ ...+ +..|.+........ .+. . ......+.+.+|.|+..|.|++.
T Consensus 27 ~~~~~~~sv~l~W~~p~~~~~~g~i~~Y~v~~~~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~ 97 (134)
T 2edx_A 27 CVSMGSTTVRVSWVPPPADSRNGVITQYSVAYEAVDGEDRGRHVVDGISREHSSWDLVGLEKWTEYRVWVR 97 (134)
T ss_dssp EECSSSSEEEEEEECCCSTTCSSCEEEEEEEEEESSSSCCCCEEECCCBTTCSEEEEESCCTTCEEEEEEE
T ss_pred EEeCCCCEEEEEecCCCccCCCCceeEEEEEEEECCCCCcccEEEEeeCCCccEEEeCCCCCCCEEEEEEE
Confidence 3347889999999998 3222 55666544322222 222 2 24467899999999999999973
|
| >1x5a_A Ephrin type-A receptor 1; tyrosine-protein kinase receptor, ESK, fibronectin type III (FN3) domain, structural genomics, NPPSFA; NMR {Mus musculus} SCOP: b.1.2.1 | Back alignment and structure |
|---|
Probab=93.06 E-value=0.39 Score=36.36 Aligned_cols=57 Identities=14% Similarity=0.124 Sum_probs=36.8
Q ss_pred CCCCeeEEee--cCCCCCC-cceeeeccccccCCcEEecCCCCeEEeecCCCCceeeEEee
Q psy11098 21 LSESSVELAL--LTENLSS-IRLCDHESGVWSDARWVISPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 21 ~~~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
.+.+++.|+| ..+...+ ...|.+.-... ...+........+.+.+|.|+..|.|++.
T Consensus 21 ~~~~sv~l~W~~~~P~~~ng~~~Y~v~y~~~-~~~~~~~~~~~~~~i~~L~p~t~Y~f~V~ 80 (107)
T 1x5a_A 21 KEPRQLELTWAGSRPRNPGGNLSYELHVLNQ-DEEWHQMVLEPRVLLTKLQPDTTYIVRVR 80 (107)
T ss_dssp EETTEEEEECCCCCSSCCSSCCEEEEEEECS-SCEEEEEESSSEEEEESCCSSCEEEEEEE
T ss_pred cCCCEEEEEECCCCCCCCCCceEEEEEEEeC-CCCceEEEecceEEECCCCCCCEEEEEEE
Confidence 7889999999 7776543 34455543222 11222222233499999999999999984
|
| >2nzi_A Titin; IG-domain, FNIII-domain, transferase; 2.90A {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.01 E-value=0.21 Score=44.86 Aligned_cols=62 Identities=19% Similarity=0.214 Sum_probs=48.8
Q ss_pred CeeeeecCCCCeeEEeecCCCCCC---cceeeeccccccCCcEEe--cCCCCeEEeecCCCCceeeEEe
Q psy11098 14 PVINVHPLSESSVELALLTENLSS---IRLCDHESGVWSDARWVI--SPHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 14 p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~~f~~ 77 (380)
+.+.. .+.+++.|+|..+..+| +..|.++........|.. ...+..+.+.+|.++..|.|++
T Consensus 205 ~~~~~--~~~~~v~l~w~~p~~~g~~~i~~y~v~~~~~~~~~w~~~~~~~~~~~~i~~l~~~~~y~~~~ 271 (305)
T 2nzi_A 205 VKVSD--VSRDSVNLTWTEPASDGGSKITNYIVEKCATTAERWLRVGQARETRYTVINLFGKTSYQFRV 271 (305)
T ss_dssp EEEES--CCSSCEEEEEECCSCCSBSCEEEEEEEEEETTSCCEEEEEEESSSEEEECSCCSSCEEEEEE
T ss_pred ceeee--ccCCEEEEEEcCCccCCCCceeEEEEEEecCCCCccEECccccCceEEecCCCCCCeEEEEE
Confidence 44444 78899999999876665 567888776666788986 2347789999999999999987
|
| >1wk0_A KIAA0970 protein; fibronectin type III domain, structural genomics, riken structural genomics/proteomics initiative, RSGI, unknown function; NMR {Homo sapiens} SCOP: b.1.2.1 | Back alignment and structure |
|---|
Probab=92.98 E-value=0.34 Score=38.99 Aligned_cols=64 Identities=16% Similarity=0.198 Sum_probs=45.2
Q ss_pred CCCeeeeecCCCCeeEEeecCCCCC-C-------c---ceeeecccc-ccCCcEEe--cCCCCeEEeecCCCCceeeEEe
Q psy11098 12 TQPVINVHPLSESSVELALLTENLS-S-------I---RLCDHESGV-WSDARWVI--SPHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 12 ~~p~~~~~~~~~~~~~~~~~~~~~~-~-------~---~~~~~~~~~-~~~~~~~~--~~~~~~~~~~~l~~~~~~~f~~ 77 (380)
..|.+.. ++..|+.|+|..+... + . ..+.+.-.. ..+..+.. .....++.+.+|.|+..|.|++
T Consensus 22 ~~p~v~~--i~s~S~~LsW~~P~~~~~g~~~~~g~~~i~~Yev~~~~k~~~~~~~~~~~g~~ts~~v~~L~P~T~Y~~rV 99 (137)
T 1wk0_A 22 VKPVASD--IQARTVVLTWSPPSSLINGETDESSVPELYGYEVLISSTGKDGKYKSVYVGEETNITLNDLKPAMDYHAKV 99 (137)
T ss_dssp CCCEEES--CCSSCEEEECCCCCCCSTTSSCSSCSCSCCEEEEEECSSCTTSCCEEEEEESCSEEEECSCCTTCEECEEE
T ss_pred CCcEEEE--EccCEEEEEECCCCCccCccccccccCccEEEEEEEEecCCCCceEEEEecCccEEEEcCCCCCCEEEEEE
Confidence 5788888 9999999999998765 2 1 344432111 12334443 3556789999999999999998
|
| >2edd_A Netrin receptor DCC; tumor suppressor protein DCC, colorectal cancer suppressor, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.94 E-value=0.2 Score=39.20 Aligned_cols=59 Identities=15% Similarity=0.264 Sum_probs=38.5
Q ss_pred cCCCCeeEEeecCCCCCC------cceeeecccccc--CCcEEe-cCCCCeEEeecCCCCceeeEEee
Q psy11098 20 PLSESSVELALLTENLSS------IRLCDHESGVWS--DARWVI-SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 20 ~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~--~~~~~~-~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
.++.+++.|+|..+.... +..|.+.-+... ...|.. ......+.+.+|.|+..|.|.+.
T Consensus 29 ~~s~tsi~lsW~~p~~~~~~i~~~~~~Y~v~y~~~~~~~~~~~~~~~~~~~~~v~gL~P~T~Y~f~V~ 96 (123)
T 2edd_A 29 ALTHDAVRVSWADNSVPKNQKTSEVRLYTVRWRTSFSASAKYKSEDTTSLSYTATGLKPNTMYEFSVM 96 (123)
T ss_dssp EEETTEEEEEEECSSSCSSCCCSCCCCEEEEEEETTCTTCCCCCEEESSSEEEEESCCTTCEEEEEEE
T ss_pred EcCCCeEEEEecCCCCCcccccCcCceEEEEEEECCCCCccEEEEeCCceEEEecCCCCCCEEEEEEE
Confidence 378899999999765432 124554322211 123332 33467899999999999999973
|
| >1uc6_A CNTF receptor, ciliary neurotrophic factor receptor alpha; cytokine, leukemia inhibitory factor, cytokine receptor; NMR {Homo sapiens} SCOP: b.1.2.1 | Back alignment and structure |
|---|
Probab=92.82 E-value=0.23 Score=37.81 Aligned_cols=57 Identities=12% Similarity=0.077 Sum_probs=41.4
Q ss_pred CCeeEEeecCCCC----CC-cceeeeccccccCCcEEe--cCCCCeEEeecCCCCceeeEEeec
Q psy11098 23 ESSVELALLTENL----SS-IRLCDHESGVWSDARWVI--SPHNGTIQVDDLAPGHTYTFCINN 79 (380)
Q Consensus 23 ~~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~~f~~~~ 79 (380)
..++.|+|..+.. .+ ...|.+.-....+..|.. .....++.+.+|.||..|.|++..
T Consensus 23 ~~~l~lsW~~P~~w~~~~~~~l~Y~v~y~~~~~~~w~~~~~~~~~~~~l~~L~p~t~Y~~~VRa 86 (109)
T 1uc6_A 23 PRRLEVTWQTPSTWPDPESFPLKFFLRYRPLILDQWQHVELSNGTAHTITDAYAGKEYIIQVAA 86 (109)
T ss_dssp TTCEEEEEECCTTCCCTTTTTBCEEEEEEESSSCCCCCEEESSCSEEEETTCCSSSCEEEEEEC
T ss_pred CCEEEEEECCCCCccCCCcEEEEEEEEEEECCCCCcEEEecccCCEEEEeCCCCCCEEEEEEEE
Confidence 5899999998874 22 556666544444456764 345678999999999999999853
|
| >2gee_A Hypothetical protein; fibronectin, EIIIB, cancer, neovascularization, cell adhesion, protein binding, oncoprotein; 2.01A {Homo sapiens} PDB: 2fnb_A | Back alignment and structure |
|---|
Probab=92.80 E-value=0.22 Score=42.25 Aligned_cols=58 Identities=21% Similarity=0.201 Sum_probs=41.8
Q ss_pred cCCCCeeEEeecCCCCCCcceeeeccccccCCcE-E--e-cCCCCeEEeecCCCCceeeEEe
Q psy11098 20 PLSESSVELALLTENLSSIRLCDHESGVWSDARW-V--I-SPHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 20 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~--~-~~~~~~~~~~~l~~~~~~~f~~ 77 (380)
..+.+++.|+|..+....+..+.+.-....+..+ . . ......+.+.+|.|+..|.|++
T Consensus 33 ~~~~~sv~lsW~~p~~~~i~~Y~v~~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V 94 (203)
T 2gee_A 33 DITDSSIGLRWTPLNSSTIIGYRITVVAAGEGIPIFEDFVDSSVGYYTVTGLEPGIDYDISV 94 (203)
T ss_dssp CCTTTCEEEEEECCSSSSCCEEEEEEEESSSSSCCEEEEEETTCCEEEECSCCTTCEEEEEE
T ss_pred ecCCCEEEEEecCCCCCCccEEEEEEEECCCCCCceeEEcCCCccEEEeCCCCCCCEEEEEE
Confidence 3889999999999885456667665433322222 1 1 3557789999999999999997
|
| >2h41_A Fibronectin; beta sandwich, cell adhesion, structural protein; NMR {Homo sapiens} PDB: 2h45_A | Back alignment and structure |
|---|
Probab=92.78 E-value=0.3 Score=36.55 Aligned_cols=56 Identities=14% Similarity=0.287 Sum_probs=41.3
Q ss_pred CCCCeeEEeecCCCCCCcceeeeccccccC----CcEEecCCCCeEEeecCCCCceeeEEe
Q psy11098 21 LSESSVELALLTENLSSIRLCDHESGVWSD----ARWVISPHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 21 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~~~~~~f~~ 77 (380)
.+.+|+.|+|..+. ..++.|.+.-..... .++..+....++.+.+|.||..|.+.+
T Consensus 17 vt~~S~~lsW~~p~-~~v~~Y~I~y~~~~g~~~~~~~~v~g~~~s~~l~~L~PgT~Y~V~v 76 (95)
T 2h41_A 17 ITASSFVVSWVSAS-DTVSGFRVEYELSEEGDEPQYLDLPSTATSVNIPDLLPGRKYIVNV 76 (95)
T ss_dssp CGGGCEEEECCCSC-TTEEEEEEEEEETTTCCCCEEEEEETTCCEEEECSCCTTCEEEEEE
T ss_pred eCCCeEEEEECCCC-CCccEEEEEEEeCCCCCcceEEECCCCccEEEECCCCCCCEEEEEE
Confidence 78899999998875 446667754333221 134456678889999999999999987
|
| >2ha1_A Fibronectin; beta sandwich, protein-protein complex, rigid BODY docking, cell adhesion, structural protein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.64 E-value=0.33 Score=40.91 Aligned_cols=56 Identities=14% Similarity=0.286 Sum_probs=38.9
Q ss_pred CCCCeeEEeecCCCCCCcceeeeccccccCCcEE----ecCCCCeEEeecCCCCceeeEEe
Q psy11098 21 LSESSVELALLTENLSSIRLCDHESGVWSDARWV----ISPHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 21 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~~~~~~f~~ 77 (380)
.+.+++.|+|..+. +.+..+.+.-.......|. .......+.+.+|.||..|.|++
T Consensus 123 ~~~~sv~l~W~~p~-~~i~~Y~v~~~~~~~~~~~~~~~v~~~~~~~~i~~L~p~t~Y~~~V 182 (201)
T 2ha1_A 123 ITASSFVVSWVSAS-DTVSGFRVEYELSEEGDEPQYLDLPSTATSVNIPDLLPGRKYIVNV 182 (201)
T ss_dssp CCSCCEEEECCCSC-TTEEEEEEEEEETTTCCCCEEEEEETTCCEEEECSCCTTCEEEEEE
T ss_pred cCCCeEEEEEeCCC-CCccEEEEEEEECCCCCceeEEEcCCceeEEEeCCCCCCCEEEEEE
Confidence 67899999998883 3456666543322222232 23456789999999999999987
|
| >1uen_A KIAA0343 protein; immunoglobulin-like beta-sandwich fold, fibronectin type III, NG-CAM related cell adhesion molecule, structural genomics; NMR {Homo sapiens} SCOP: b.1.2.1 | Back alignment and structure |
|---|
Probab=92.28 E-value=0.38 Score=37.04 Aligned_cols=63 Identities=13% Similarity=0.049 Sum_probs=41.1
Q ss_pred CeeeeecCCCCeeEEeecCCCC---CC-cceeeeccccccCCcE---------E--ecCCCCeEEeecCCCCceeeEEee
Q psy11098 14 PVINVHPLSESSVELALLTENL---SS-IRLCDHESGVWSDARW---------V--ISPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 14 p~~~~~~~~~~~~~~~~~~~~~---~~-~~~~~~~~~~~~~~~~---------~--~~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
..+.. ++.+++.|+|..+.. .| +..|.+......+..| . .......+.+.+|.|+..|.|++.
T Consensus 21 l~~~~--~~~~sv~l~W~~p~~~~~~g~i~gY~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~ 98 (125)
T 1uen_A 21 VRVNV--VNSTLAEVHWDPVPLKSIRGHLQGYRIYYWKTQSSSKRNRRHIEKKILTFQGSKTHGMLPGLEPFSHYTLNVR 98 (125)
T ss_dssp CEEEE--EETTEEEEECCCCCHHHHCSCEEEEEEEEEEESCCCCSTTCCCCEEEEEEESSCSEEEEESCCSSCEEEEEEE
T ss_pred eEEEe--cCCcEEEEEEcCCCchhcCceEeEEEEEEEECCCCcccccccccceEEEecCCccEEEeCCCCCCCEEEEEEE
Confidence 34444 788999999998743 22 5556554333222211 1 134567899999999999999973
|
| >2dbj_A Proto-oncogene tyrosine-protein kinase MER precursor; C-MER, receptor tyrosine kinase mertk, FN3 domain, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.25 E-value=0.93 Score=35.01 Aligned_cols=58 Identities=10% Similarity=0.012 Sum_probs=40.1
Q ss_pred CCCCeeEEeecCCC--CCC--cceeeecccccc---CCcEEe--cCCCCeEEeecCCCCceeeEEee
Q psy11098 21 LSESSVELALLTEN--LSS--IRLCDHESGVWS---DARWVI--SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 21 ~~~~~~~~~~~~~~--~~~--~~~~~~~~~~~~---~~~~~~--~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
.+.+++.|+|..+. ..+ +..|.+.-.... ...|.. ......+.+.+|.++..|.|++.
T Consensus 31 ~s~~sv~l~W~pp~~~~~~g~i~~Y~v~~~~~~~~~~~~~~~~~~~~~~~~~l~~L~p~t~Y~~~V~ 97 (124)
T 2dbj_A 31 ESSDNVDIRWMKPPTKQQDGELVGYRISHVWQSAGISKELLEEVGQNGSRARISVQVHNATCTVRIA 97 (124)
T ss_dssp SSSSEEEEEEECCSCCSTTCCEEEEEEEEEEEETTEEEEEEEEEESTTSCEEEECCCSSSEEEECEE
T ss_pred CCCCEEEEEEcCCCcccCCCeEeEEEEEEEECCCCCccceEEEeCCCcceEEecCCCCCCEEEEEEE
Confidence 67899999999983 222 556665532111 145653 34567899999999999999873
|
| >2dlh_A Receptor-type tyrosine-protein phosphatase delta; protein-tyrosine phosphatase delta, R-PTP-delta, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.23 E-value=0.22 Score=38.15 Aligned_cols=59 Identities=14% Similarity=0.168 Sum_probs=41.1
Q ss_pred cCCCCeeEEeecCCCCCC--cceeeecccccc---CCcEEe--cCCCCeEEeecCCCCceeeEEee
Q psy11098 20 PLSESSVELALLTENLSS--IRLCDHESGVWS---DARWVI--SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 20 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~---~~~~~~--~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
.++.+++.|+|..+...+ +..|.+.-.... ...|.. ......+.+.+|.|+..|.|++.
T Consensus 29 ~~~~~sv~l~W~~p~~~~g~i~~Y~v~~~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~ 94 (121)
T 2dlh_A 29 MLSSTTILVQWKEPEEPNGQIQGYRVYYTMDPTQHVNNWMKHNVADSQITTIGNLVPQKTYSVKVL 94 (121)
T ss_dssp CCSSSBCCEEEECCSCCCSCEEEEEEECCSCTTSCTTTSCCCCCSSCSEECCBSCCSSCEEEEEEE
T ss_pred ecCCCEEEEEECCCCCCCCcEeEEEEEEEeCCCCCccccEEEecCCceEEEecCCCCCCEEEEEEE
Confidence 378899999999986543 456665543322 234543 23466788999999999999983
|
| >2gee_A Hypothetical protein; fibronectin, EIIIB, cancer, neovascularization, cell adhesion, protein binding, oncoprotein; 2.01A {Homo sapiens} PDB: 2fnb_A | Back alignment and structure |
|---|
Probab=92.23 E-value=0.22 Score=42.27 Aligned_cols=58 Identities=10% Similarity=0.198 Sum_probs=41.0
Q ss_pred CCCCeeEEeecCCCCCCcceeeecccccc-CCcEEe---cCCCCeEEeecCCCCceeeEEee
Q psy11098 21 LSESSVELALLTENLSSIRLCDHESGVWS-DARWVI---SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 21 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~---~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
.+.+++.|+|..+....+..+.+.-.... ...|.. ......+.+.+|.|+..|.|++.
T Consensus 125 ~~~~sv~l~W~~p~~~~i~~Y~v~~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~ 186 (203)
T 2gee_A 125 IGPDTMRVTWAPPPSIDLTNFLVRYSPVKNEEDVAELSISPSDNAVVLTNLLPGTEYVVSVS 186 (203)
T ss_dssp EETTEEEEEEECCSSCCCSEEEEEEEETTCGGGCEEEEECTTCCEEEECSCCTTCEEEEEEE
T ss_pred cCCCEEEEEEcCCCCCCccEEEEEEEECCCCCccEEEEcCCCcCEEEECCCCCCCEEEEEEE
Confidence 67899999999997545666665433211 122332 34577899999999999999983
|
| >1bqu_A Protein (GP130); cytokine receptor, glycoprotein 130, interleukine 6 R beta subunit, signaling protein; 2.00A {Homo sapiens} SCOP: b.1.2.1 b.1.2.1 PDB: 1pvh_A 1bj8_A | Back alignment and structure |
|---|
Probab=92.19 E-value=0.18 Score=43.01 Aligned_cols=57 Identities=21% Similarity=0.294 Sum_probs=42.8
Q ss_pred CCCeeEEeecCCCCCC--cceeeeccccccCCcEEec------CCCCeEEeecCCCCceeeEEee
Q psy11098 22 SESSVELALLTENLSS--IRLCDHESGVWSDARWVIS------PHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 22 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
+.+++.|+|..+..++ +..|.++-....+..|... .....+.+.+|.|+..|.|++.
T Consensus 118 ~~~sv~l~W~~p~~~~~~i~~Y~v~y~~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~ 182 (215)
T 1bqu_A 118 LSSILKLTWTNPSIKSVIILKYNIQYRTKDASTWSQIPPEDTASTRSSFTVQDLKPFTEYVFRIR 182 (215)
T ss_dssp CCSCEEEEEECCGGGGTSCEEEEEEEEETTCSSCEECCGGGGCSCCSEEEECSCCSSEEEEEEEE
T ss_pred CCceEEEEEeCCCCCCcceEEEEEEEccCCCCCceEeccccccCccceEEeCCCCCCCEEEEEEE
Confidence 6789999999887654 5567766544445678752 2356899999999999999983
|
| >1qr4_A Protein (tenascin); fibronectin type-III, heparin, extracellular matrix, adhesion, fusion protein, structural protein; 2.55A {Gallus gallus} SCOP: b.1.2.1 b.1.2.1 | Back alignment and structure |
|---|
Probab=92.06 E-value=0.44 Score=39.48 Aligned_cols=63 Identities=13% Similarity=0.097 Sum_probs=42.3
Q ss_pred CCeeeeecCCCCeeEEeecCCCCCCcceeeeccccccCCcEE---ecCCCCeEEeecCCCCceeeEEee
Q psy11098 13 QPVINVHPLSESSVELALLTENLSSIRLCDHESGVWSDARWV---ISPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 13 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
...+.. .+.+++.|+|..+. ..+..+.+.-.......+. .......+.+.+|.||..|.|++.
T Consensus 100 ~l~~~~--~~~~sv~l~W~~p~-~~i~~Y~v~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~ 165 (186)
T 1qr4_A 100 GISFSD--ITENSATVSWTPPR-SRVDSYRVSYVPITGGTPNVVTVDGSKTRTKLVKLVPGVDYNVNII 165 (186)
T ss_dssp CEEEES--CCSSCEEEEECCCS-SCCSEEEEEEEETTCCCCEEEEEETTCCEEEECSCCSSCEEEEEEE
T ss_pred ccEEEE--eCCCEEEEEEECCC-CcccEEEEEEEeCCCCCceEEEcCCCcCEEEEcCCCCCCEEEEEEE
Confidence 344444 78899999999876 3355666543222222222 234567899999999999999973
|
| >2ha1_A Fibronectin; beta sandwich, protein-protein complex, rigid BODY docking, cell adhesion, structural protein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.93 E-value=0.31 Score=41.04 Aligned_cols=62 Identities=18% Similarity=0.132 Sum_probs=44.4
Q ss_pred CeeeeecCC--CCeeEEeecCCCCCCcceeeecccccc-CCcEEe---cCCCCeEEeecCCCCceeeEEe
Q psy11098 14 PVINVHPLS--ESSVELALLTENLSSIRLCDHESGVWS-DARWVI---SPHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 14 p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~---~~~~~~~~~~~l~~~~~~~f~~ 77 (380)
..+.. ++ .+++.|+|..+....+..|.++-.... +..|.. ......+.+.+|.|+..|.|++
T Consensus 6 l~v~~--v~~~~~si~l~W~~p~~~~i~~Y~v~~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V 73 (201)
T 2ha1_A 6 VFITE--TPSQPNSHPIQWNAPQPSHISKYILRWRPKNSVGRWKEATIPGHLNSYTIKGLKPGVVYEGQL 73 (201)
T ss_dssp EECCS--CSCCSSCEEEEEECCSSTTCCEEEEEEEETTCSSCCEEEEECTTCCEEEECSCCTTEEEEEEE
T ss_pred EEEEe--cCCCCCEEEEEEeCCCCCCceEEEEEEEECCCCCceEEEecCCCccEEEecCCCCCCEEEEEE
Confidence 34444 44 899999999996556777776543322 345554 3456789999999999999998
|
| >1qr4_A Protein (tenascin); fibronectin type-III, heparin, extracellular matrix, adhesion, fusion protein, structural protein; 2.55A {Gallus gallus} SCOP: b.1.2.1 b.1.2.1 | Back alignment and structure |
|---|
Probab=91.82 E-value=0.42 Score=39.63 Aligned_cols=63 Identities=10% Similarity=0.030 Sum_probs=43.0
Q ss_pred CCCeeeeecCCCCeeEEeecCCCCCCcceeeeccccccCCcEEe---cCCCCeEEeecCCCCceeeEEee
Q psy11098 12 TQPVINVHPLSESSVELALLTENLSSIRLCDHESGVWSDARWVI---SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 12 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
....+.. .+.+++.|+|..+.. .+..+.+.-... +..|.. ......+.+.+|.|+..|.|++.
T Consensus 11 ~~l~~~~--~~~~sv~l~W~~p~~-~i~~Y~v~~~~~-~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~ 76 (186)
T 1qr4_A 11 KDLEVSD--PTETTLSLRWRRPVA-KFDRYRLTYVSP-SGKKNEMEIPVDSTSFILRGLDAGTEYTISLV 76 (186)
T ss_dssp EEEEEES--CCSSEEEEEEECCSS-CCSEEEEEEECT-TCCEEEEEECTTCSEEEEESCCSSCEEEEEEE
T ss_pred CceEEEe--cCCCEEEEEEeCCCC-CccEEEEEEEeC-CCCeeEEECCCCCCEEEECCCCCCCEEEEEEE
Confidence 3344555 888999999998753 455666544322 233332 34467899999999999999983
|
| >1va9_A DOWN syndrome cell adhesion molecule like- protein 1B; FNIII domain, dscaml1 protein, structural genomics; NMR {Homo sapiens} SCOP: b.1.2.1 | Back alignment and structure |
|---|
Probab=91.56 E-value=0.37 Score=36.88 Aligned_cols=59 Identities=15% Similarity=0.156 Sum_probs=39.8
Q ss_pred cCCCCeeEEeecCCCC---CC-cceeeeccccccCCcE---Ee-c----CCCCeEEeecCCCCceeeEEee
Q psy11098 20 PLSESSVELALLTENL---SS-IRLCDHESGVWSDARW---VI-S----PHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 20 ~~~~~~~~~~~~~~~~---~~-~~~~~~~~~~~~~~~~---~~-~----~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
..+.+++.|+|..+.. .| +..|.+.-.......| .. . .....+.+.+|.|+..|.|++.
T Consensus 26 ~~~~~sv~l~W~~p~~~~~~g~i~~Y~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~ 96 (122)
T 1va9_A 26 PVTSQSIQVTWKAPKKELQNGVIRGYQIGYRENSPGSNGQYSIVEMKATGDSEVYTLDNLKKFAQYGVVVQ 96 (122)
T ss_dssp ECSSSEEEEEEECCCSSTTCSCCCEEEEEEEESSTTSCCSCBCCBCCCCSSEEEEEEESCCSSCCEEEEEE
T ss_pred eccCCEEEEEEeCCCCcCCCCcEeEEEEEEEECCCCCCcceEEEEEecCCceeEEEeCCCCCCCEEEEEEE
Confidence 3788999999999975 22 5566665433332323 21 1 1235788999999999999983
|
| >2vkw_A Neural cell adhesion molecule 1,140 kDa isoform; adhesion receptor; 2.3A {Homo sapiens} SCOP: b.1.2.1 b.1.2.1 PDB: 2vkx_A 1lwr_A | Back alignment and structure |
|---|
Probab=91.28 E-value=0.28 Score=41.64 Aligned_cols=62 Identities=15% Similarity=0.203 Sum_probs=43.1
Q ss_pred CCeeeeecCCCCeeEEeecCCCCCC---cceeeeccccccCCcEEecC-------CCCeEEeecCCCCceeeEEe
Q psy11098 13 QPVINVHPLSESSVELALLTENLSS---IRLCDHESGVWSDARWVISP-------HNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 13 ~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~~~~~~f~~ 77 (380)
...+.. .+. ++.|+|..+..++ +..|.++-.......|.... ....+.+.+|.|+..|.|++
T Consensus 14 ~~~~~~--~~~-s~~l~W~~p~~~~g~~i~~Y~v~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V 85 (209)
T 2vkw_A 14 IDQVEP--YSS-TAQVQFDEPEATGGVPILKYKAEWRAVGEEVWHSKWYDAKEASMEGIVTIVGLKPETTYAVRL 85 (209)
T ss_dssp EEEEEE--CSS-CEEEEEECCSCCCSSCCCEEEEEEEESSCCCCEEEEEEHHHHHHHSEEEECCCCTTCEEEEEE
T ss_pred ccEeee--ccC-eEEEEEcCCCcCCCcceeEEEEEEeeCCCCCceEeEeeccCCCccceEEeCCCCCCCeEEEEE
Confidence 344444 555 7899999985332 56677765555556776421 24578999999999999998
|
| >2jll_A NCAM2, neural cell adhesion molecule 2; immunoglobulin domain, immunoglobulin superfamily, transmembrane, phosphoprotein, membrane, glycoprotein; HET: NAG; 2.30A {Homo sapiens} PDB: 2xyc_A* 2jlk_A* 2doc_A | Back alignment and structure |
|---|
Probab=91.26 E-value=0.38 Score=44.80 Aligned_cols=66 Identities=17% Similarity=0.127 Sum_probs=43.5
Q ss_pred CCeeeeecCCCCeeEEeecCCCCCC--cceeeeccccccCCcEEe----cCCCCeEEeecCCCCceeeEEee
Q psy11098 13 QPVINVHPLSESSVELALLTENLSS--IRLCDHESGVWSDARWVI----SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 13 ~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
.|.+...+.+.+++.|+|..+...+ +..|.++-.......|.. ......+.+.+|.|+..|.|++.
T Consensus 296 ~p~~~~~~~~~~~v~l~W~~p~~~~~~i~~Y~v~~~~~~~~~~~~~~~~~~~~~~~~i~~L~~~t~Y~~~V~ 367 (389)
T 2jll_A 296 PPSIHGQPSSGKSFKLSITKQDDGGAPILEYIVKYRSKDKEDQWLEKKVQGNKDHIILEHLQWTMGYEVQIT 367 (389)
T ss_dssp CCCEEEEEETTTEEEEEECCCCCCSSCCCEEEEEEEC-----CCBCCEECTTCCEEEECSCCTTCEEEEEEE
T ss_pred CCccccccCcCCEEEEEEECCCCCCCcccEEEEEEEeCCCCcceeEeeccCCcceEEeCCcCCCCEEEEEEE
Confidence 3445544578899999999776443 566776654444456653 23456789999999999999983
|
| >1i1r_A GP130, interleukin-6 receptor beta chain; cytokine/receptor complex, GP130; 2.40A {Homo sapiens} SCOP: b.1.2.1 b.1.2.1 b.1.2.1 PDB: 1p9m_A | Back alignment and structure |
|---|
Probab=90.99 E-value=0.3 Score=44.22 Aligned_cols=57 Identities=21% Similarity=0.294 Sum_probs=43.2
Q ss_pred CCCeeEEeecCCCCCC--cceeeeccccccCCcEEec------CCCCeEEeecCCCCceeeEEee
Q psy11098 22 SESSVELALLTENLSS--IRLCDHESGVWSDARWVIS------PHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 22 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
+.+++.|+|..+...+ +..|.++-.......|... .....+.+.+|.|+..|.|++.
T Consensus 214 ~~~sv~l~W~~p~~~~~~i~~Y~v~y~~~~~~~w~~~~~~~~~~~~~~~~l~~L~p~t~Y~~rV~ 278 (303)
T 1i1r_A 214 LSSILKLTWTNPSIKSVIILKYNIQYRTKDASTWSQIPPEDTASTRSSFTVQDLKPFTEYVFRIR 278 (303)
T ss_dssp SSSCEEEEEECCGGGGTSCEEEEEEEEETTCSSCEECCGGGGCSCCSEEEECSCCTTCEEEEEEE
T ss_pred CCCEEEEEECCCCCCCcccEEEEEEEEeCCCCCceEEccccCCCceeEEEeCCCCCCCEEEEEEE
Confidence 6789999999887654 5667776544445678752 2356799999999999999983
|
| >1cfb_A Drosophila neuroglian; neural adhesion molecule; HET: NAG; 2.00A {Drosophila melanogaster} SCOP: b.1.2.1 b.1.2.1 | Back alignment and structure |
|---|
Probab=90.96 E-value=0.51 Score=39.76 Aligned_cols=55 Identities=16% Similarity=0.250 Sum_probs=37.5
Q ss_pred CCCeeEEeecCCCCCC--cceeeeccccc-cCCcEEe-----cCCCCeEEeecCCCCceeeEEe
Q psy11098 22 SESSVELALLTENLSS--IRLCDHESGVW-SDARWVI-----SPHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 22 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~-~~~~~~~-----~~~~~~~~~~~l~~~~~~~f~~ 77 (380)
+.+++.|+|..+...+ +..|.++-... .+..|.. +.....+.+ +|.|+..|.|++
T Consensus 17 ~~~sv~l~W~~p~~~~~~i~~Y~v~~~~~~~~~~w~~~~~~~~~~~~~~~~-~L~p~t~Y~~~V 79 (205)
T 1cfb_A 17 QADKAEIHWEQQGDNRSPILHYTIQFNTSFTPASWDAAYEKVPNTDSSFVV-QMSPWANYTFRV 79 (205)
T ss_dssp CSSEEEEEEECCCCTTSCCCEEEEEEEESSSTTCCEEEEEEEETTCSEEEE-ECCSSEEEEEEE
T ss_pred cCCEEEEEEECcccCCCceEEEEEEEecCCCCCCceeeeeccCCCceEEEE-eCCCCCEEEEEE
Confidence 7899999999884332 55666654332 2356742 233456666 999999999997
|
| >2qbw_A PDZ-fibronectin fusion protein; fibronectin PDZ, unknown function; 1.80A {Homo sapiens} PDB: 3ch8_A | Back alignment and structure |
|---|
Probab=90.53 E-value=0.81 Score=38.67 Aligned_cols=57 Identities=14% Similarity=0.221 Sum_probs=38.7
Q ss_pred CCCCeeEEeecCCCCCCcceeeeccccccCCc----EEecCCCCeEEeecCCCCceeeEEee
Q psy11098 21 LSESSVELALLTENLSSIRLCDHESGVWSDAR----WVISPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 21 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
++++|+.|+|..+. ..+..|.+.-....... ........++.+.+|.|+..|.|++.
T Consensus 115 ~t~~si~l~W~~p~-~~i~~Y~v~y~~~~~~~~~~~~~v~~~~t~~~l~gL~p~t~Y~~~V~ 175 (195)
T 2qbw_A 115 ATPTSLLISWDASY-YGVSYYRITYGETGGNSPVQEFTVPYSSSTATISGLKPGVDYTITVY 175 (195)
T ss_dssp EETTEEEEECCCCC-SSCSEEEEEEEETTCCSCCEEEEEETTCSEEEECSCCTTCEEEEEEE
T ss_pred CCCCEEEEEEeCCC-CCccEEEEEEEECCCCCcceEEEeCCCCCEEEeCCCCCCCEEEEEEE
Confidence 78899999998886 33455554322211111 22244567899999999999999973
|
| >3fl7_A Ephrin receptor; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase, glycoprotein; HET: NAG; 2.50A {Homo sapiens} PDB: 2x10_A* 2x11_A 3mx0_A* 3mbw_A* | Back alignment and structure |
|---|
Probab=90.42 E-value=0.67 Score=46.14 Aligned_cols=57 Identities=21% Similarity=0.227 Sum_probs=39.7
Q ss_pred CCCCeeEEeecCCCCCC---cceeeeccccc-----------cCCcEEe---cCCCCeEEeecCCCCceeeEEe
Q psy11098 21 LSESSVELALLTENLSS---IRLCDHESGVW-----------SDARWVI---SPHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 21 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~-----------~~~~~~~---~~~~~~~~~~~l~~~~~~~f~~ 77 (380)
++.+++.|+|..+...+ +..|.+..... ....|.. ......+.+.+|.|+..|.|++
T Consensus 344 vs~tSv~LsW~pP~~~gG~~i~~Y~V~~~~~~~~~~~~~~c~~~~~~~~~~~~~~~ts~tI~gL~P~T~Y~frV 417 (536)
T 3fl7_A 344 GMGAKVELRWTPPQDSGGREDIVYSVTCEQCWPESGECGPCEASVRYSEPPHGLTRTSVTVSDLEPHMNYTFTV 417 (536)
T ss_dssp CCTTSEEEEECCBSCCCSCSCCEEEEEEEEECC-CCCEEECCTTCEESSCSSSBCSSEEEEECCCTTCEEEEEE
T ss_pred ecCCEEEEEEeCCcCCCCCceeEEEEEEEeccCCCCcccccCCCceEEEeecCCccceeEeCCCCCCCEEEEEE
Confidence 78899999999888765 44555543221 1123332 1246689999999999999998
|
| >3mpc_A FN3-like protein; fibronectin, FN(III), unknown function; 1.60A {Clostridium thermocellum} | Back alignment and structure |
|---|
Probab=90.28 E-value=0.55 Score=35.56 Aligned_cols=54 Identities=11% Similarity=0.173 Sum_probs=38.0
Q ss_pred CCCeeEEeecCCCCCCcceeeeccccccCCcEEe--c-CCCCeEEeecCCCCceeeEEe
Q psy11098 22 SESSVELALLTENLSSIRLCDHESGVWSDARWVI--S-PHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~-~~~~~~~~~~l~~~~~~~f~~ 77 (380)
...++.|+|... .+...+.+.....++..|.. . ....++....+.+|.+|.|+|
T Consensus 18 ~~~~v~LsW~~~--~~~~~Y~VyR~~~~~~~~~~i~~~~~~tsy~d~~l~~g~~Y~Y~V 74 (103)
T 3mpc_A 18 SGNTANLTWNAA--PGANSYNVKRSTKSGGPYTTIATNITSTNYTDTGVATGTKYYYVV 74 (103)
T ss_dssp TSCCEEEEEECC--TTCSEEEEEEESSTTCCCEEEEEEECSSEEEETTCCTTCCCEEEE
T ss_pred CCCEEEEEEECC--CCCCEEEEEEecCCCCCcEEEeecCCCCEEEECCCCCCCEEEEEE
Confidence 357999999885 34556666543333445653 2 356788888999999999997
|
| >2w1n_A O-GLCNACASE NAGJ; hexosaminidase, glycoside hydrolase, fibronectin type-III, beta-N-acetylglucosaminidase, cohesin, hydrolase; 1.80A {Clostridium perfringens} | Back alignment and structure |
|---|
Probab=90.10 E-value=1.3 Score=38.48 Aligned_cols=55 Identities=15% Similarity=0.187 Sum_probs=42.1
Q ss_pred ecCCCCeeEEeecCCCCC-CcceeeeccccccCCcEE--ecCCCCeEEeecCCCCceeeEEe
Q psy11098 19 HPLSESSVELALLTENLS-SIRLCDHESGVWSDARWV--ISPHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~~~~~f~~ 77 (380)
.-.+++|++|+|..|... |+..|.+-. +..-. .+....++.+.+|.++..|.|++
T Consensus 160 t~VT~tSVtLsW~aP~~~~GI~gY~ly~----~g~~v~~v~~~~tsyt~~gLk~~TeYsF~V 217 (238)
T 2w1n_A 160 SEINKKNVTVTWTEPETTEGLEGYILYK----DGKKVAEIGKDETSYTFKKLNRHTIYNFKI 217 (238)
T ss_dssp EEECSSCEEEEEECCSCCTTEEEEEEEE----TTEEEEEEETTCCEEEECSCCTTCEEEEEE
T ss_pred EEccCCeEEEEecCCCCCCCceeEEEEe----CCceeEEeeccceEEEecCCCCCCEEEEEE
Confidence 337899999999999984 577777533 23322 24556789999999999999998
|
| >3f7q_A Integrin beta-4, GP150; hemidesmosome, cell adhesion, carcinoma, epidermolysis bullosa, alternative splicing, disease mutation, glycoprotein; HET: 1PE PG4; 1.75A {Homo sapiens} PDB: 3f7r_A 3f7p_C 1qg3_A | Back alignment and structure |
|---|
Probab=90.08 E-value=0.42 Score=41.42 Aligned_cols=61 Identities=10% Similarity=0.133 Sum_probs=41.3
Q ss_pred CeeeeecCCCCeeEEeecCCCCCCcceeeeccccccCCc--EEe-cCCCCeEEeecCCCCceeeEEe
Q psy11098 14 PVINVHPLSESSVELALLTENLSSIRLCDHESGVWSDAR--WVI-SPHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 14 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~-~~~~~~~~~~~l~~~~~~~f~~ 77 (380)
..+.. .+.+++.|+|..++ ..+..|.+.-....+.. +.. ......+.+.+|.|+..|.|++
T Consensus 12 l~~~~--~~~~si~l~W~~p~-g~i~~Y~v~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V 75 (234)
T 3f7q_A 12 PNAKA--AGSRKIHFNWLPPS-GKPMGYRVKYWIQGDSESEAHLLDSKVPSVELTNLYPYCDYEMKV 75 (234)
T ss_dssp EEEEE--CSSSCEEEEEECCS-SCCCEEEEEEEETTSCGGGCEEEEESSSEEEECSCCTTCEEEEEE
T ss_pred eEEEE--cCCCEEEEEEECCC-CccceEEEEEEECCCCccceEEEcCCccEEEECCCCCCCEEEEEE
Confidence 34444 88899999999884 34556665432222221 222 3557789999999999999987
|
| >2dle_A Receptor-type tyrosine-protein phosphatase ETA; protein-tyrosine phosphatase ETA, R-PTP-ETA, HPTP ETA, protein-tyrosine phosphatase receptor type J; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.84 E-value=0.66 Score=35.17 Aligned_cols=57 Identities=11% Similarity=0.024 Sum_probs=38.4
Q ss_pred CCCCeeEEeecCCCCCC--cceeeeccccccCCcEEecCCCCeEEeecCCCCceeeEEee
Q psy11098 21 LSESSVELALLTENLSS--IRLCDHESGVWSDARWVISPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 21 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
.+.+|+.|+|..+.... +..+.+.-... ...+........+.+.+|.||..|.|++.
T Consensus 19 ~t~~Sv~LsW~~p~~~~~~i~~Y~v~~~~~-~~~~~~~~~~t~~~i~gL~PgT~Y~~~V~ 77 (104)
T 2dle_A 19 ISATSLTLIWKVSDNESSSNYTYKIHVAGE-TDSSNLNVSEPRAVIPGLRSSTFYNITVC 77 (104)
T ss_dssp ECSSCEEEEEEESCSTTCCSCEEEEEEECS-SCEEEEEESSSEEECCSCCSSCEEEEEEE
T ss_pred eecCEEEEEEcCCCCCCCceEEEEEEEECC-CCeEEEcCCCCEEEECCCCCCCEEEEEEE
Confidence 67899999998664433 23454422111 12344455678899999999999999873
|
| >1cfb_A Drosophila neuroglian; neural adhesion molecule; HET: NAG; 2.00A {Drosophila melanogaster} SCOP: b.1.2.1 b.1.2.1 | Back alignment and structure |
|---|
Probab=89.51 E-value=1.3 Score=37.19 Aligned_cols=59 Identities=8% Similarity=-0.074 Sum_probs=40.7
Q ss_pred cCCCCeeEEeecCCC--C-CC-cceeeecccccc-CCcEEe----cCCCCeEEeecCCCCceeeEEee
Q psy11098 20 PLSESSVELALLTEN--L-SS-IRLCDHESGVWS-DARWVI----SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 20 ~~~~~~~~~~~~~~~--~-~~-~~~~~~~~~~~~-~~~~~~----~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
..+.+++.|+|..+. . .| +..+.+.-.... ...|.. ......+.+.+|.|+..|.|++.
T Consensus 115 ~~~~~sv~l~W~~p~~~~~ng~i~~Y~v~~~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~ 182 (205)
T 1cfb_A 115 GTEPNNLVISWTPMPEIEHNAPNFHYYVSWKRDIPAAAWENNNIFDWRQNNIVIADQPTFVKYLIKVV 182 (205)
T ss_dssp CSSTTCEEEECCCCCGGGTCSSSCEEEEEEEESSTTCCCEEEEECCTTCCEEEECSCCSSCEEEEEEE
T ss_pred cCCCCeEEEEEECCCccccCCCceEEEEEEEECCCCCCcEEEEecCCCccEEEEcCCCCCcEEEEEEE
Confidence 378899999999876 2 22 556665433222 234764 12467899999999999999983
|
| >3t1w_A Four-domain fibronectin fragment; human fibronectin, FN type-III domain, oncofetal splice VARI extra-domain B, EIIIB, ED-B, angiogenesis, integrin; 2.40A {Homo sapiens} PDB: 4gh7_B | Back alignment and structure |
|---|
Probab=88.99 E-value=1.3 Score=41.12 Aligned_cols=58 Identities=21% Similarity=0.240 Sum_probs=41.5
Q ss_pred cCCCCeeEEeecCCCCCCcceeeeccccccCC-cEE---ecCCCCeEEeecCCCCceeeEEe
Q psy11098 20 PLSESSVELALLTENLSSIRLCDHESGVWSDA-RWV---ISPHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 20 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~---~~~~~~~~~~~~l~~~~~~~f~~ 77 (380)
..+.+++.|+|..+....+..+.+.-...... .|. .......+.+.+|.|+..|.|++
T Consensus 106 ~~~~~si~l~W~~~~~~~i~~Y~v~~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V 167 (375)
T 3t1w_A 106 DITDSSIGLRWTPLNSSTIIGYRITVVAAGEGIPIFEDFVDSSVGYYTVTGLEPGIDYDISV 167 (375)
T ss_dssp CCCSSEEEEECCCCCCTTEEEEEEEEEESSSCCSCEEEEECTTCCEEEEECCCTTCEEEEEE
T ss_pred ecCCCeEEEEEECCCCCCceEEEEEEEECCCCCceeEEEcCCCcceEEEeCCCCCCEEEEEE
Confidence 38889999999988655566776653322222 222 23456789999999999999997
|
| >1fnf_A Fibronectin; RGD, extracellular matrix, cell adhesion protein; 2.00A {Homo sapiens} SCOP: b.1.2.1 b.1.2.1 b.1.2.1 b.1.2.1 PDB: 1mfn_A 2mfn_A 2ck2_A | Back alignment and structure |
|---|
Probab=88.99 E-value=0.62 Score=43.09 Aligned_cols=64 Identities=11% Similarity=0.153 Sum_probs=43.7
Q ss_pred CCCeeeeecCCCC-eeEEeecCCCCCCcceeeeccccccC---CcEEe--cCCCCeEEeecCCCCceeeEEe
Q psy11098 12 TQPVINVHPLSES-SVELALLTENLSSIRLCDHESGVWSD---ARWVI--SPHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 12 ~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~--~~~~~~~~~~~l~~~~~~~f~~ 77 (380)
....+.. .+.+ ++.|+|..+....+..|.++-..... ..|.. ......+.+.+|.|+..|.|++
T Consensus 6 ~~l~~~~--~~~~~sv~l~W~~~~~~~i~~Y~v~~~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V 75 (368)
T 1fnf_A 6 TNLHLEA--NPDTGVLTVSWERSTTPDITGYRITTTPTNGQQGNSLEEVVHADQSSCTFDNLSPGLEYNVSV 75 (368)
T ss_dssp EEEEEEE--CSSSSCEEEEEECCSCSSCCEEEEEEEETTTCSSCCEEEEECTTCCEEECCCCCTTSCEEEEE
T ss_pred cceEEEe--cCCCcEEEEEEeCCCCCCceEEEEEEEECCCCCCceeEEEecCCcCEEEECCCCCCCEEEEEE
Confidence 3444444 6665 69999999875556677765433222 23443 3456789999999999999987
|
| >3f7q_A Integrin beta-4, GP150; hemidesmosome, cell adhesion, carcinoma, epidermolysis bullosa, alternative splicing, disease mutation, glycoprotein; HET: 1PE PG4; 1.75A {Homo sapiens} PDB: 3f7r_A 3f7p_C 1qg3_A | Back alignment and structure |
|---|
Probab=88.78 E-value=1.5 Score=37.84 Aligned_cols=58 Identities=16% Similarity=0.310 Sum_probs=38.7
Q ss_pred CCCCeeEEeecCCCCCC--cceeeeccccccC-----CcEEe----cCCCCeEEeecCCCCceeeEEee
Q psy11098 21 LSESSVELALLTENLSS--IRLCDHESGVWSD-----ARWVI----SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 21 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~-----~~~~~----~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
.+.+++.|+|..+...+ +..|.+.-....+ ..|.. ......+.+.+|.|+..|.|++.
T Consensus 110 ~~~~sv~l~W~~p~~~~g~i~~Y~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~ 178 (234)
T 3f7q_A 110 VSSTVTQLSWAEPAETNGEITAYEVCYGLVNDDNRPIGPMKKVLVDNPKNRMLLIENLRESQPYRYTVK 178 (234)
T ss_dssp CSSSCEEEECCCCSCCSSCCCEEEEEEEEBCTTSCBSSCCEECCCSCTTCCEEEEECCCTTCCEEEEEE
T ss_pred ecCCEEEEEEcCCCCCCCceeEEEEEEEECCCCCCccCcceEEEecCCcceEEEeCCCCCCCeEEEEEE
Confidence 88899999999875533 5555554322221 22332 12345799999999999999983
|
| >3r8q_A Fibronectin; heparin, FNIII, heparin binding, cell adhesion; 2.40A {Homo sapiens} PDB: 1fnh_A | Back alignment and structure |
|---|
Probab=88.56 E-value=0.96 Score=40.31 Aligned_cols=56 Identities=14% Similarity=0.233 Sum_probs=39.8
Q ss_pred CCCCeeEEeecCCCCCCcceeeeccccccCCcE-Ee--cCCCCeEEeecCCCCceeeEEe
Q psy11098 21 LSESSVELALLTENLSSIRLCDHESGVWSDARW-VI--SPHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 21 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~l~~~~~~~f~~ 77 (380)
.+.+++.|+|..+. +.+..+.+.-.......+ .. ......+.+.+|.|+..|.|++
T Consensus 124 ~~~~sv~l~W~~p~-~~~~~Y~v~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V 182 (290)
T 3r8q_A 124 ATETTITISWRTKT-ETITGFQVDAVPANGQTPIQRTIKPDVRSYTITGLQPGTDYKIYL 182 (290)
T ss_dssp ECSSCEEEEEECCS-CCCCEEEEEEEESSSCCCEEEEECTTCSEEEECSCCTTCEEEEEE
T ss_pred cCCCeEEEEEeCCC-CcccEEEEEEEECCCCcceEEecCCCccEEEECCCCCCCEEEEEE
Confidence 78899999999874 335566655433323332 22 3456789999999999999998
|
| >1cd9_B G-CSF-R, protein (G-CSF receptor); class1 cytokine, hematopoietic receptor, signal transduction cytokine; HET: NAG; 2.80A {Mus musculus} SCOP: b.1.2.1 b.1.2.1 PDB: 1pgr_B 1cto_A 1gcf_A | Back alignment and structure |
|---|
Probab=87.63 E-value=0.62 Score=39.61 Aligned_cols=57 Identities=14% Similarity=0.237 Sum_probs=41.8
Q ss_pred CCCeeEEeecCCCCCCc--ceeeeccc-cccCCcEEe----cCCCCeEEeecCCCCceeeEEee
Q psy11098 22 SESSVELALLTENLSSI--RLCDHESG-VWSDARWVI----SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 22 ~~~~~~~~~~~~~~~~~--~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
+.+++.|+|..+...|. ..|.+.-. ...+..|.. ......+.+.+|.|+..|.|++.
T Consensus 127 ~~~~~~l~W~~p~~~~~~~l~Y~v~y~~~~~~~~w~~~~~~~~~~~~~~l~~L~p~t~Y~~~Vr 190 (215)
T 1cd9_B 127 QPGCLWLSWKPWKPSEYMEQECELRYQPQLKGANWTLVFHLPSSKDQFELCGLHQAPVYTLQMR 190 (215)
T ss_dssp CCSCEEEEEECCGGGTTSCEEEEEEEEESSTTCCCEEEEEEESCEEEEEECCCCSCSCEEEEEE
T ss_pred CCCeEEEEEeCCCCCCeEEEEEEEEEccCCCCCCcEEEecccCcceEEEEcCCCCCCEEEEEEE
Confidence 57889999998876552 46777654 444567874 12345788999999999999984
|
| >4go6_B HCF C-terminal chain 1; tandem fibronectin repeat, protein interaction, transcriptio protein binding; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.56 E-value=0.61 Score=40.65 Aligned_cols=25 Identities=16% Similarity=0.004 Sum_probs=19.1
Q ss_pred CCCCeeEEeecCCCCCC--cceeeecc
Q psy11098 21 LSESSVELALLTENLSS--IRLCDHES 45 (380)
Q Consensus 21 ~~~~~~~~~~~~~~~~~--~~~~~~~~ 45 (380)
.+.+++.|+|..|..++ +..|.++.
T Consensus 98 ~~~~sv~l~W~~P~~~~G~i~~Y~v~~ 124 (232)
T 4go6_B 98 KSPDGAHLTWEPPSVTSGKIIEYSVYL 124 (232)
T ss_dssp EETTEEEEEEECCSCCSSCCCEEEEEE
T ss_pred cCCCEEEEEEeCCCCCCCceeeEEEEE
Confidence 67899999999998777 45555543
|
| >1zlg_A Anosmin 1; insulin-like growth factor receptor Cys-rich fold, WHEY acidic protein fold, fibronectin type III fold, hormone- growth factor complex; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.21 E-value=1.1 Score=45.95 Aligned_cols=63 Identities=13% Similarity=0.208 Sum_probs=44.6
Q ss_pred CCCeeeeecCCCCeeEEeecCCCCC---CcceeeeccccccC--------CcEEe--cCCCCeEEeecCCCCceeeEEe
Q psy11098 12 TQPVINVHPLSESSVELALLTENLS---SIRLCDHESGVWSD--------ARWVI--SPHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 12 ~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~--------~~~~~--~~~~~~~~~~~l~~~~~~~f~~ 77 (380)
..+.+.. .+.+++.|+|..+..+ .+. |.++-..... ..|.. ......+.+.+|.|+..|.|++
T Consensus 165 ~~l~v~~--~~~~sv~l~W~pp~~~~~~~i~-Y~V~~r~~~g~~~~~~~~~~w~~v~~~~~~~~~i~~L~P~t~Y~frV 240 (680)
T 1zlg_A 165 KELRFTE--LQSGQLEVKWSSKFNISIEPVI-YVVQRRWNYGIHPSEDDATHWQTVAQTTDERVQLTDIRPSRWYQFRV 240 (680)
T ss_pred ccceEEe--ccCceEEEEEeCCCCCCCCCEE-EEEEEEECCCCCcCccccCceEEEEecCCCeEEeCCCCCCCEEEEEE
Confidence 5566666 7889999999988543 244 6665433211 46875 2345678999999999999997
|
| >1fnf_A Fibronectin; RGD, extracellular matrix, cell adhesion protein; 2.00A {Homo sapiens} SCOP: b.1.2.1 b.1.2.1 b.1.2.1 b.1.2.1 PDB: 1mfn_A 2mfn_A 2ck2_A | Back alignment and structure |
|---|
Probab=86.94 E-value=1.3 Score=40.88 Aligned_cols=60 Identities=10% Similarity=0.177 Sum_probs=42.6
Q ss_pred eecCCCCeeEEeecCCCCCCcceeeeccccccC-CcEEe---cCCCCeEEeecCCCCceeeEEe
Q psy11098 18 VHPLSESSVELALLTENLSSIRLCDHESGVWSD-ARWVI---SPHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 18 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~---~~~~~~~~~~~l~~~~~~~f~~ 77 (380)
....+.+++.|+|..+....+..+.+.-....+ ..|.. ......+.+.+|.|+..|.|++
T Consensus 103 ~~~~~~~si~l~W~~p~~~~~~~Y~v~~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V 166 (368)
T 1fnf_A 103 FTNIGPDTMRVTWAPPPSIDLTNFLVRYSPVKNEEDVAELSISPSDNAVVLTNLLPGTEYVVSV 166 (368)
T ss_dssp EESCCSSCEEEEEECCTTCCCSEEEEEEEETTCTTCCEEEEECTTCCEEEECSCCTTCEEEEEE
T ss_pred EEEcCCCeEEEEeeCCCCCCCcEEEEEEEECCCCCccEEEEcCCCcceEEecCCCCCCEEEEEE
Confidence 334788999999999865456666665433222 34443 3456789999999999999987
|
| >1tdq_A Tenascin-R; extracellular matrix, lecticans, tenascins, protein-protein interactions, C-type lectin domain; 2.60A {Rattus norvegicus} SCOP: b.1.2.1 b.1.2.1 b.1.2.1 | Back alignment and structure |
|---|
Probab=86.58 E-value=1.3 Score=39.12 Aligned_cols=56 Identities=16% Similarity=0.254 Sum_probs=40.2
Q ss_pred CCCCeeEEeecCCCCCCcceeeeccccc-cCCcEEe---cCCCCeEEeecCCCCceeeEEe
Q psy11098 21 LSESSVELALLTENLSSIRLCDHESGVW-SDARWVI---SPHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 21 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~~~~l~~~~~~~f~~ 77 (380)
.+.+++.|+|..+. ..+..+.+.-... .+..|.. ......+.+.+|.|+..|.|++
T Consensus 26 ~~~~sv~l~W~~~~-~~~~~Y~v~~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V 85 (283)
T 1tdq_A 26 VSDTVAFVEWTPPR-AKVDFILLKYGLVGGEGGKTTFRLQPPLSQYSVQALRPGSRYEVSI 85 (283)
T ss_dssp ECSSCEEEEEECCS-SCCSEEEEEEEESSSSCCCEEEEECTTCSEEEECSCCTTCEEEEEE
T ss_pred cCCCeEEEEEECCC-CceeEEEEEEEEecCCCCcEEEEeCCCCCEEEecCCCCCCEEEEEE
Confidence 78899999999887 4455666553211 1233432 4457789999999999999987
|
| >3n06_B PRL-R, prolactin receptor; PH dependence, hematopoietic cytokine, hormone-hormone recep complex; 2.00A {Homo sapiens} PDB: 3mzg_B 3n0p_B 3ncb_B 1bp3_B 3d48_R 3nce_B 3ncc_B 3ncf_B 3ew3_B 3npz_B 1f6f_B 2lfg_A | Back alignment and structure |
|---|
Probab=86.44 E-value=1.5 Score=37.10 Aligned_cols=56 Identities=16% Similarity=0.236 Sum_probs=41.6
Q ss_pred CCeeEEeecCCCCCC------cceeeeccccccCCcEEe--cCCCCeEEeecCCCCceeeEEee
Q psy11098 23 ESSVELALLTENLSS------IRLCDHESGVWSDARWVI--SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 23 ~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
.+++.|+|..+.... ...|.+.-....+..|.. ......+.+.+|.|+..|.|++.
T Consensus 120 ~~~l~l~W~~p~~~~~~~g~~~~~Y~v~y~~~~~~~~~~~~~~~~~~~~l~~L~p~t~Y~v~Vr 183 (210)
T 3n06_B 120 KPYLWIKWSPPTLIDLKTGWFTLLYEIRLKPEKAAEWEIHFAGQQTEFKILSLHPGQKYLVQVR 183 (210)
T ss_dssp CCEEEEEEECCTTCCCTTSSCCEEEEEEEECTTCSSCEEEEEETCSEEEECCCCTTCEEEEEEE
T ss_pred CceEEEEcCCCCCccccCCeEEEEEEEEEecCCCCCCEEEeccCceEEEEeccCCCCEEEEEEE
Confidence 579999999886542 356776655444566765 23467899999999999999984
|
| >3t1w_A Four-domain fibronectin fragment; human fibronectin, FN type-III domain, oncofetal splice VARI extra-domain B, EIIIB, ED-B, angiogenesis, integrin; 2.40A {Homo sapiens} PDB: 4gh7_B | Back alignment and structure |
|---|
Probab=85.87 E-value=1.5 Score=40.47 Aligned_cols=57 Identities=11% Similarity=0.156 Sum_probs=41.5
Q ss_pred CCCC-eeEEeecCCCCCCcceeeeccccccC---CcEEe--cCCCCeEEeecCCCCceeeEEe
Q psy11098 21 LSES-SVELALLTENLSSIRLCDHESGVWSD---ARWVI--SPHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 21 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~--~~~~~~~~~~~l~~~~~~~f~~ 77 (380)
.+.+ ++.|+|..+...++..|.+.-..... ..|.. ......+.+.+|.|+..|.|++
T Consensus 14 ~~~~~sv~l~W~~~~~~~~~~Y~v~~~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V 76 (375)
T 3t1w_A 14 NPDTGVLTVSWERSTTPDITGYRITTTPTNGQQGNSLEEVVHADQSSCTFDNLSPGLEYNVSV 76 (375)
T ss_dssp ETTTTEEEEEEECCSCSSCCEEEEEEEETTCTTSCCEEEEEETTCCEEEECCCCTTCCEEEEE
T ss_pred cCCCeEEEEEEeCCCCCCeeeEEEEEEECCCCCCcceeEEcCCCccEEEEcCCcCCCEEEEEE
Confidence 6778 99999998876566677765433221 23432 4457889999999999999987
|
| >1n26_A IL-6 receptor alpha chain; transmembrane, glycoprotein, immunoglobulin domain, cytokine; HET: NAG BMA MAN NDG; 2.40A {Homo sapiens} SCOP: b.1.1.4 b.1.2.1 b.1.2.1 PDB: 1p9m_C 2arw_A | Back alignment and structure |
|---|
Probab=85.68 E-value=1.4 Score=40.26 Aligned_cols=56 Identities=7% Similarity=-0.050 Sum_probs=41.3
Q ss_pred CCeeEEeecCCCC--CC--cceeeeccccccCCcEEe---cCCCCeEEeecCCCCceeeEEee
Q psy11098 23 ESSVELALLTENL--SS--IRLCDHESGVWSDARWVI---SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 23 ~~~~~~~~~~~~~--~~--~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
.+++.|+|..+.. .+ +..|.++-.......|.. ......+.+.+|.|+..|.|++.
T Consensus 212 ~~sv~lsW~~p~~~~~~~~~~~Y~V~yr~~~~~~W~~~~~~~~~~~~~l~~L~p~t~Y~~rVr 274 (325)
T 1n26_A 212 PRWLSVTWQDPHSWNSSFYRLRFELRYRAERSKTFTTWMVKDLQHHCVIHDAWSGLRHVVQLR 274 (325)
T ss_dssp TTCEEEEEECCTTCCCSSSCEEEEEEEEETTCSCCEEEECGGGCSEEEESSCCTTCCEEEEEE
T ss_pred CCEEEEEECCCCccCCCcEeEEEEEEEEeCCCCCCEEEcccCCceEEEEeCCCCCCeEEEEEE
Confidence 3689999998875 33 466776654444567875 23356889999999999999983
|
| >3l5i_A Interleukin-6 receptor subunit beta; cytokine receptor, fibronectin type III domain, alternative cell membrane, disulfide bond; 1.90A {Homo sapiens} PDB: 3l5j_A | Back alignment and structure |
|---|
Probab=85.40 E-value=2.1 Score=37.93 Aligned_cols=62 Identities=8% Similarity=0.020 Sum_probs=40.1
Q ss_pred eeeeecCCCCeeEEeecCCCC----CCcceeeeccccccCCcEEe---cCCCCeEEeecCCCCceeeEEe
Q psy11098 15 VINVHPLSESSVELALLTENL----SSIRLCDHESGVWSDARWVI---SPHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 15 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~~~~~~f~~ 77 (380)
.+.....+.+++.|+|..+.. ..+..|.+.-.... ..|.. ......+.+.+|.||..|.|++
T Consensus 202 ~~~~~~~~~~sv~l~W~~~~~~~~~g~i~~Y~v~~~~~~-~~~~~~~~~~~~~~~~~~~L~p~t~Y~~~V 270 (290)
T 3l5i_A 202 TVRTKKVGKNEAVLEWDQLPVDVQNGFIRNYTIFYRTII-GNETAVNVDSSHTEYTLSSLTSDTLYMVRM 270 (290)
T ss_dssp CEEEEEECSSCEEEEECCCCHHHHSSCCCEEEEEEEETT-SCCEEEEEETTCSEEEECSCCTTCEEEEEE
T ss_pred eeeEeeccCCEEEEEEcCCChhccCCEEEEEEEEEEeCC-CCeEEEEeCCCceEEEeCCCCCCCEEEEEE
Confidence 333344788999999984421 12455655433222 22322 4556789999999999999998
|
| >1ujt_A KIAA1568 protein; fibronectin type III domain, structural genomics, riken structural genomics/proteomics initiative, RSGI, unknown function; NMR {Homo sapiens} SCOP: b.1.2.1 | Back alignment and structure |
|---|
Probab=85.34 E-value=1.7 Score=33.79 Aligned_cols=58 Identities=17% Similarity=0.236 Sum_probs=40.0
Q ss_pred cCCCCeeEEeecCCCCCC-cceeeecccccc----CCcEEe----cCCCCeEEeecCCCCceeeEEe
Q psy11098 20 PLSESSVELALLTENLSS-IRLCDHESGVWS----DARWVI----SPHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 20 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~----~~~~~~----~~~~~~~~~~~l~~~~~~~f~~ 77 (380)
.++++++.|+|..+...| +..|.+.-+... ...|.. .....++.+.+|.|+..|.|.+
T Consensus 26 a~sstsi~vsW~~~~~~g~i~gY~V~Y~~~~~~~~~~~~~~~~v~~~~~~~~~l~~L~p~T~Y~~~V 92 (120)
T 1ujt_A 26 VLTPTTVQVTWTVDRQPQFIQGYRVMYRQTSGLQATSSWQNLDAKVPTERSAVLVNLKKGVTYEIKV 92 (120)
T ss_dssp CCBTTEEEEEEEESSCCSSCCEEEEEEEESSSSSTTTCCEEEECCCTTCCEEEEESCCSSEEEEEEE
T ss_pred EccCceEEEEEccCCCCCcEeeEEEEEEECCCCCCCCccEEEEecCCCcCEEEECCCCCCCEEEEEE
Confidence 378899999999654444 555654332222 246753 2335689999999999999987
|
| >2b5i_C Cytokine receptor common gamma chain; four-helix bundle, fibronectin domain, cytokine-cytokine REC complex; HET: NAG; 2.30A {Homo sapiens} SCOP: b.1.2.1 b.1.2.1 PDB: 3bpl_C* 3qb7_C* 3qaz_C* | Back alignment and structure |
|---|
Probab=85.29 E-value=2.2 Score=36.04 Aligned_cols=58 Identities=21% Similarity=0.162 Sum_probs=43.3
Q ss_pred CCCCeeEEeecCCCCCCcceeeeccccccCCcEEe--cCCCCeEEeecCCCCceeeEEee
Q psy11098 21 LSESSVELALLTENLSSIRLCDHESGVWSDARWVI--SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 21 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
.+...+.|+|..+.......|.+.-....+..|.. ......+.+.+|.|+..|.|++.
T Consensus 110 ~~~~~l~l~W~~p~~~~~l~yev~y~~~~~~~w~~~~~~~~~~~~l~~l~p~~~Y~vqVR 169 (199)
T 2b5i_C 110 LSESQLELNWNNRFLNHCLEHLVQYRTDWDHSWTEQSVDYRHKFSLPSVDGQKRYTFRVR 169 (199)
T ss_dssp EETTEEEEEEECSSCSTTCEEEEEEEETTCSSCEEEEECSSCEEEECSCCTTSCEEEEEE
T ss_pred CCCCCEEEEECCCCCCCceEEEEEEeecCCcccEEEeccCceEEEecCCCCCcEEEEEEE
Confidence 44579999999997655556776554444557875 34457888999999999999984
|
| >2d9q_B Granulocyte colony-stimulating factor receptor; cytokine, ligand-receptor complex, signaling protein-cytokin; HET: NAG; 2.80A {Homo sapiens} SCOP: b.1.1.3 b.1.2.1 b.1.2.1 | Back alignment and structure |
|---|
Probab=84.80 E-value=0.82 Score=41.47 Aligned_cols=57 Identities=16% Similarity=0.254 Sum_probs=41.7
Q ss_pred CCCeeEEeecCCCCCC--cceeeeccc-cccCCcEEec----CCCCeEEeecCCCCceeeEEee
Q psy11098 22 SESSVELALLTENLSS--IRLCDHESG-VWSDARWVIS----PHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 22 ~~~~~~~~~~~~~~~~--~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
+.+++.|+|..+...| ...|.++-. ...+.+|... .....+.+.+|.|+..|.|++.
T Consensus 221 ~~~~l~l~W~~p~~~~~~~l~Y~v~y~~~~~~~~w~~~~~~~~~~~~~~l~~L~p~t~Y~~rVr 284 (313)
T 2d9q_B 221 QAGCLQLSWEPWQPGLHINQKCELRHKPQRGEASWALVGPLPLEALQYELCGLLPATAYTLQIR 284 (313)
T ss_dssp CCSCEEEEEECCGGGTTSCEEEEEEEEESSSCCCCEEEEEECSCEEEEEECSCCSCCCEEEEEE
T ss_pred CCCeEEEEECCCCCCCceeEEEEEEEccCCCCCCcEEcccccCcceEEEEeCCCCCCeEEEEEE
Confidence 4689999999986544 357777655 3445678751 2245688999999999999984
|
| >1tdq_A Tenascin-R; extracellular matrix, lecticans, tenascins, protein-protein interactions, C-type lectin domain; 2.60A {Rattus norvegicus} SCOP: b.1.2.1 b.1.2.1 b.1.2.1 | Back alignment and structure |
|---|
Probab=84.61 E-value=1.8 Score=38.21 Aligned_cols=58 Identities=14% Similarity=0.224 Sum_probs=40.1
Q ss_pred ecCCCCeeEEeecCCCCCCcceeeeccccccCCcEE--e-cCC---CCeEEeecCCCCceeeEEe
Q psy11098 19 HPLSESSVELALLTENLSSIRLCDHESGVWSDARWV--I-SPH---NGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~-~~~---~~~~~~~~l~~~~~~~f~~ 77 (380)
...+.+++.|+|..+. ..+..+.+.-.......|. . ... ...+.+.+|.|+..|.|++
T Consensus 114 ~~~~~~sv~l~W~~p~-~~i~~Y~v~~~~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V 177 (283)
T 1tdq_A 114 GSRTATSLDLEWDNSE-AEAQEYKVVYSTLAGEQYHEVLVPKGIGPTTKTTLTDLVPGTEYGVGI 177 (283)
T ss_dssp EEECSSCEEEEEECCS-SCCSEEEEEEEETTCCCCEEEEEECCSSSEEEEEECSCCTTCEEEEEE
T ss_pred EecCCCeEEEEecCCC-CCccEEEEEEEeCCCCcceEEECCCCCcccceEEEecCCCCCEEEEEE
Confidence 3378899999999886 3455566544333333442 2 333 5678899999999999997
|
| >1wj3_A KIAA1496 protein; beta sandwich, PANG, structural genomics, riken structural genomics/proteomics initiative, RSGI, neuropeptide; NMR {Homo sapiens} SCOP: b.1.2.1 | Back alignment and structure |
|---|
Probab=83.70 E-value=3.6 Score=31.41 Aligned_cols=56 Identities=11% Similarity=0.053 Sum_probs=34.7
Q ss_pred CCCeeEEeecCCCC----CCcceeeeccccccCCcEEe-cCCCCeEEeecCCCCceeeEEee
Q psy11098 22 SESSVELALLTENL----SSIRLCDHESGVWSDARWVI-SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 22 ~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
+.+++.|+|..+.. .-+..|.+.-.......+.. ......+.+. |.++..|.|++.
T Consensus 30 ~~~si~l~W~~p~~~~~ng~i~gY~v~y~~~~~~~~~~~~~~~~~~~~~-L~~~t~Y~~~V~ 90 (117)
T 1wj3_A 30 TDTKVLLNWEQVKAMENESEVTGYKVFYRTSSQNNVQVLNTNKTSAELV-LPIKEDYIIEVK 90 (117)
T ss_dssp ETTEEEEECCCCCCCSSSCCEEEEEEEEEESSCSSCEEEEESSSEEEEE-CCCSSCEEEEEE
T ss_pred eCCEEEEEEcCCCccccCCceeEEEEEEEECCCCCCeEEeCCCcEEEEE-CCCCCEEEEEEE
Confidence 66899999998843 22555665432222222322 2334567777 888999999873
|
| >3p4l_A Neogenin; iron homeostasis, hemojuvelin receptor, FNIII domain, fibron type III, cell adhesion; 1.80A {Homo sapiens} PDB: 1x5k_A | Back alignment and structure |
|---|
Probab=83.15 E-value=3.2 Score=34.83 Aligned_cols=57 Identities=18% Similarity=0.159 Sum_probs=39.1
Q ss_pred CCCeeEEeecCCCCCC--cceeeeccccccC---CcEEe---cCCCCeEEeecCCCCceeeEEee
Q psy11098 22 SESSVELALLTENLSS--IRLCDHESGVWSD---ARWVI---SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 22 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~---~~~~~---~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
+.+++.|+|..+...+ +..|.+.-..... ..|.. ......+.+.+|.|+..|.|++.
T Consensus 120 s~~sv~l~W~~p~~~~g~i~~Y~v~~~~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~ 184 (211)
T 3p4l_A 120 KPKTIIVNWQPPSEANGKITGYIIYYSTDVNAEIHDWVIEPVVGNRLTHQIQELTLDTPYYFKIQ 184 (211)
T ss_dssp EEEEEEEEEECCTTCCSCCCEEEEEEESCTTSCGGGSEEEEEESSCSEEEECCCCTTCEEEEEEE
T ss_pred CCCEEEEEECCCCCCCCCEEEEEEEEEECCCCCCCceEEEEecCCeeEEEEcCCCCCCEEEEEEE
Confidence 4689999999876433 5566654333222 23442 34577899999999999999973
|
| >3fl7_A Ephrin receptor; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase, glycoprotein; HET: NAG; 2.50A {Homo sapiens} PDB: 2x10_A* 2x11_A 3mx0_A* 3mbw_A* | Back alignment and structure |
|---|
Probab=82.89 E-value=1.8 Score=42.99 Aligned_cols=58 Identities=17% Similarity=0.231 Sum_probs=39.1
Q ss_pred CCCCeeEEeecCCCCCC--cceeeeccccccCC-cEEe-cCCCCeEEeecCCCCceeeEEee
Q psy11098 21 LSESSVELALLTENLSS--IRLCDHESGVWSDA-RWVI-SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 21 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
.+.+++.|+|..+...+ +..|.+.-...... .|.. .....++.+.+|.|+..|.|++.
T Consensus 452 ~s~tSV~LsW~pP~~~ng~I~~Y~V~y~~~~~~~~~~~v~~~~ts~~l~gL~P~T~Y~frVr 513 (536)
T 3fl7_A 452 RSTTSLSVSWSIPPPQQSRVWKYEVTYRKKGDSNSYNVRRTEGFSVTLDDLAPDTTYLVQVQ 513 (536)
T ss_dssp CCC-CCEEEEECCTTTTTTCSEEEEEEEEC--CCCCEEEEESSSEEECCSCCSSCEEEEEEE
T ss_pred ccCCeEEEEEECCcCCCCcccEEEEEEEECCCCceEEEEcCCCCEEEECCCCCCCEEEEEEE
Confidence 78899999999875433 55666544332222 2332 34567899999999999999983
|
| >3l5h_A Interleukin-6 receptor subunit beta; IG-like, FNIII, cell membrane, disulfide bond, glycoprotein, immunoglobulin domain, membrane, phosphoprotein; HET: NAG NDG BMA FUC; 3.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=82.21 E-value=1.7 Score=43.03 Aligned_cols=66 Identities=18% Similarity=0.211 Sum_probs=45.9
Q ss_pred CCCeeeeecCCCCeeEEeecCCCCCC--cceeeeccccccCCcEEec------CCCCeEEeecCCCCceeeEEe
Q psy11098 12 TQPVINVHPLSESSVELALLTENLSS--IRLCDHESGVWSDARWVIS------PHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 12 ~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~~~~~~f~~ 77 (380)
....+.....+.+++.|+|..+...+ +..|.++-....+..|... .....+.+.+|.|+..|.|++
T Consensus 203 ~~~~~~~~~~~~~~v~l~W~~p~~~~~~~~~Y~v~~~~~~~~~w~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V 276 (589)
T 3l5h_A 203 HNLSVINSEELSSILKLTWTNPSIKSVIILKYNIQYRTKDASTWSQIPPEDTASTRSSFTVQDLKPFTEYVFRI 276 (589)
T ss_dssp CSCEEECTTTCTTCEEEECCCCGGGGTSCEEEEEEEEETTCSCCBCCCTTSSCSCCSEEEECSCCSSCCEEEEE
T ss_pred ceEEEEecCCCCCeEEEEeCCCCCCCeeeEEEEEEECCCCCCCcEEEccccCcCceeEEEECCCCCCCEEEEEE
Confidence 34444212267899999999887544 4567766544455678752 234678999999999999998
|
| >2erj_C Cytokine receptor common gamma chain; immune system-cytok complex; HET: NAG FUC BMA; 3.00A {Homo sapiens} SCOP: b.1.2.1 b.1.2.1 | Back alignment and structure |
|---|
Probab=81.13 E-value=3.3 Score=36.51 Aligned_cols=58 Identities=21% Similarity=0.162 Sum_probs=43.2
Q ss_pred CCCCeeEEeecCCCCCCcceeeeccccccCCcEEe--cCCCCeEEeecCCCCceeeEEee
Q psy11098 21 LSESSVELALLTENLSSIRLCDHESGVWSDARWVI--SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 21 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
.+...+.|+|..+.......|.++-....+..|.. ......+.+.+|.|+..|.|++.
T Consensus 148 ~~~~~l~l~W~~P~~~~~L~Yevry~~~~~~~W~~~~~~~~~~~~l~~L~p~~~Y~vqVR 207 (247)
T 2erj_C 148 LSESQLELNWNNRFLNHCLEHLVQYRTDWDHSWTEQSVDYRHKFSLPSVDGQKRYTFRVR 207 (247)
T ss_dssp SSSSCEEEEEECSSCCTTEEEEEEEECSSCSSCEEEEECSSCEEEESCCCTTSCEEEEEE
T ss_pred CCCCcEEEEECCCCCCCcEEEEEEEeeCCCCCCEEEecCCceEEEecCCCCCCEEEEEEE
Confidence 55679999999987555556666554444567875 34467788999999999999984
|
| >1bqu_A Protein (GP130); cytokine receptor, glycoprotein 130, interleukine 6 R beta subunit, signaling protein; 2.00A {Homo sapiens} SCOP: b.1.2.1 b.1.2.1 PDB: 1pvh_A 1bj8_A | Back alignment and structure |
|---|
Probab=80.77 E-value=2.6 Score=35.45 Aligned_cols=57 Identities=5% Similarity=-0.231 Sum_probs=37.8
Q ss_pred CCCCeeEEeecCCCCCC-cceeeeccccccCCcEEe---cCCCCeEEeecC-CCCceeeEEe
Q psy11098 21 LSESSVELALLTENLSS-IRLCDHESGVWSDARWVI---SPHNGTIQVDDL-APGHTYTFCI 77 (380)
Q Consensus 21 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l-~~~~~~~f~~ 77 (380)
.+..++.|+|..+...+ ...|.+.........+.. ......+.+.+| .++..|.|++
T Consensus 19 ~~~~sv~l~W~~p~~~~~~~~Y~v~~~~~~~~~~~~~~~~~~~~~~~i~~L~~~~t~Y~~~V 80 (215)
T 1bqu_A 19 NEGKKMRCEWDGGRETHLETNFTLKSEWATHKFADCKAKRDTPTSCTVDYSTVYFVNIEVWV 80 (215)
T ss_dssp ETTSCCEEEEECCSCCSSCCEEEEEEEETTEECCCEECCSSCTTEEECSSCCCTTSCEEEEE
T ss_pred CCCCcEEEEcCCCCCCCCCceEEEEEEEcCCCccccccccCCcceEEEcCCccccccEEEEE
Confidence 56689999999888765 335555432211111211 223568999999 8999999987
|
| >3mtr_A N-CAM-1, NCAM-1, neural cell adhesion molecule 1; immunoglobulin domain, fibronectin type III repeat, CE adhesion; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=80.46 E-value=3.5 Score=34.60 Aligned_cols=57 Identities=16% Similarity=0.207 Sum_probs=40.2
Q ss_pred CCCCeeEEeecCCCCCC---cceeeeccccccCCcEEecC-------CCCeEEeecCCCCceeeEEe
Q psy11098 21 LSESSVELALLTENLSS---IRLCDHESGVWSDARWVISP-------HNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 21 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~~~~~~f~~ 77 (380)
....++.|+|..+..++ +..|.++-.......|.... .+..+.+.+|.++..|.|++
T Consensus 124 ~~~~~~~l~w~~p~~~~~~pi~~y~v~~~~~~~~~w~~~~~~~~~~~~~~~l~i~~L~~~~~y~~~~ 190 (215)
T 3mtr_A 124 PYSSTAQVQFDEPEATGGVPILKYKAEWRAVGEEVWHSKWYDAKEASMEGIVTIVGLKPETTYAVRL 190 (215)
T ss_dssp EETTEEEEEEECCSCCCSSCEEEEEEEEEETTCCCCEEEEEEHHHHHHHTEEEEECCCTTCEEEEEE
T ss_pred EecceEEEEEecCCccCCCceEEEEEEEEECCCCcccccccccccccccccEEECCCCCCCEEEEEE
Confidence 45688999998776554 44556655444445676421 13789999999999999987
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 380 | ||||
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-60 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-59 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-57 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-57 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-57 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-56 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-56 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-56 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-54 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-54 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 8e-54 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-53 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-50 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-50 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-50 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-50 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-48 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-48 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-47 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-47 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-46 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-46 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-46 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-45 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-45 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-44 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-44 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-43 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-43 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-43 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-42 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-42 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-42 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-41 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-41 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-41 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-41 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-40 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-40 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-40 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-39 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-38 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-38 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-38 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-38 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-37 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-36 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-36 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-35 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-35 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-35 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-34 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-34 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-34 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-33 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-33 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-33 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-32 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-31 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 9e-30 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-29 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 8e-18 |
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 195 bits (496), Expect = 7e-60
Identities = 85/321 (26%), Positives = 137/321 (42%), Gaps = 20/321 (6%)
Query: 73 YTFCINNEYKVLYTVPFETRWQQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQ 132
Y + + +K Y P E + + Y+ E LG G F V + +R TG A K
Sbjct: 1 YDNYVFDIWKQYYPQPVEIK--HDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKF 58
Query: 133 IPRER-QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLC 191
+ ++ R E +S L H + FE+ ++ + + G L + +
Sbjct: 59 VMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED---DNEMVMIYEFMSGGELFEKVA 115
Query: 192 RQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN---GAVLKLIDLGSSVS 247
+ + ++E +RQ+ L +H H D++PENI+ LKLID G +
Sbjct: 116 DEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 175
Query: 248 VST-----VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETR 302
+ V EFA+PE+ G TDMWS+GVL YILLSG+SPF E+++ET
Sbjct: 176 LDPKQSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL 234
Query: 303 AHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASC----SE 358
++ D++ IS ++ I +LL + R T Q L+ W + S+
Sbjct: 235 RNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQ 294
Query: 359 FDTERLLPFSARRKQKFKEIQ 379
+ R K K+
Sbjct: 295 IPSSRYTKIRDSIKTKYDAWP 315
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 4e-59
Identities = 78/294 (26%), Positives = 132/294 (44%), Gaps = 14/294 (4%)
Query: 95 QEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLM 154
+E +E +Y E LG G F V + + + + K + + Q + + E ++L+
Sbjct: 1 KELYE-KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIAR 59
Query: 155 HAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQS-TITESYICCIIRQLHSALH 213
H +I FE+ ++ + + G + + + + + E I + Q+ AL
Sbjct: 60 HRNILHLHESFES---MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQ 116
Query: 214 CLHSQQIAHKDIRPENILM---NGAVLKLIDLGSSVSVSTVVLPDLEFASPEMLTSPA-- 268
LHS I H DIRPENI+ + +K+I+ G + + L F +PE
Sbjct: 117 FLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQ 176
Query: 269 --TAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARE 326
+TDMWSLG L+Y+LLSG++PFL E+ ++ +I A+Y+F E IS+ A +
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD 236
Query: 327 LIGQLLNTHADKRPTAGQLLQVAWFAEAS--CSEFDTERLLPFSARRKQKFKEI 378
+ +LL R TA + LQ W + S L K++
Sbjct: 237 FVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKDL 290
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 187 bits (475), Expect = 1e-57
Identities = 70/277 (25%), Positives = 113/277 (40%), Gaps = 23/277 (8%)
Query: 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP----------QQITRAEY 147
F YE E LG G VR+ + T + A+K I ++ T E
Sbjct: 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 60
Query: 148 NLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQ 207
++L + P + L + +V L+ L +L + T++E I+R
Sbjct: 61 DILRKVSG--HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 118
Query: 208 LHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVS-----TVVLPDLEFASP 261
L + LH I H+D++PENIL++ +KL D G S + V + +P
Sbjct: 119 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAP 178
Query: 262 EMLTSPATA-----GPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQ 316
E++ G DMWS GV++Y LL+G PF + I +Y F +
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 238
Query: 317 CGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAE 353
S ++L+ + L KR TA + L +F +
Sbjct: 239 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 1e-57
Identities = 93/303 (30%), Positives = 154/303 (50%), Gaps = 27/303 (8%)
Query: 91 TRWQQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER-------QPQQIT 143
T ++QE + Y+ E LG+G+F V+K R++ TG A K I + R ++
Sbjct: 1 TVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 60
Query: 144 RAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICC 203
E ++L + H ++ T ++EN ++++LV G L L + ++TE
Sbjct: 61 EREVSILKEIQHPNVITLHEVYEN---KTDVILILELVAGGELFDFLAEKESLTEEEATE 117
Query: 204 IIRQLHSALHCLHSQQIAHKDIRPENILMN-----GAVLKLIDLGSSVSVS-----TVVL 253
++Q+ + ++ LHS QIAH D++PENI++ +K+ID G + + +
Sbjct: 118 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF 177
Query: 254 PDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFP 313
EF +PE++ G DMWS+GV+ YILLSG SPFL ++++ET A++S +Y F
Sbjct: 178 GTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE 236
Query: 314 PEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASCSEFDTERLLPFSARRKQ 373
E + S A++ I +LL KR T LQ W DT++ L SA
Sbjct: 237 DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI-----KPKDTQQALS-SAWSHP 290
Query: 374 KFK 376
+F+
Sbjct: 291 QFE 293
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 187 bits (476), Expect = 2e-57
Identities = 64/295 (21%), Positives = 116/295 (39%), Gaps = 18/295 (6%)
Query: 95 QEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLL 150
++ E + +L +G+G F V ARD ++VA+K++ + Q E L
Sbjct: 10 KDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFL 69
Query: 151 STLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHS 210
L H + + T +VM+ G + + + E I +
Sbjct: 70 QKLRHPNTIQYRGCYLR---EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQ 126
Query: 211 ALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSS--VSVSTVVLPDLEFASPEMLT-- 265
L LHS + H+D++ NIL++ ++KL D GS+ ++ + + + +PE++
Sbjct: 127 GLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAM 186
Query: 266 SPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAR 325
D+WSLG+ L P + + HI+ + P Q GH S R
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES--PALQSGHWSEYFR 244
Query: 326 ELIGQLLNTHADKRPTAGQLLQVAWFAEASCSEFDTERLLPFSARRKQKFKEIQD 380
+ L RPT+ LL+ + E ++ R K +E+ +
Sbjct: 245 NFVDSCLQKIPQDRPTSEVLLKHRFVLR----ERPPTVIMDLIQRTKDAVRELDN 295
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 2e-56
Identities = 74/264 (28%), Positives = 125/264 (47%), Gaps = 17/264 (6%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQITRAEYNLLSTLMHA 156
+E LG G+F V AR++ + ++ALK + + + + R E + S L H
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66
Query: 157 HIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLH 216
+I F + ++++ ++ + L + S E I +L +AL H
Sbjct: 67 NILRLYGYFHD---ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 123
Query: 217 SQQIAHKDIRPENILMNGA-VLKLIDLGSSVSVSTVVLPDL----EFASPEMLTSPATAG 271
S+++ H+DI+PEN+L+ A LK+ D G SV + L ++ PEM+
Sbjct: 124 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEG-RMHD 182
Query: 272 PSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQL 331
D+WSLGVL Y L G PF + +ET IS +++FP ++ AR+LI +L
Sbjct: 183 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRL 238
Query: 332 LNTHADKRPTAGQLLQVAWFAEAS 355
L + +RP ++L+ W S
Sbjct: 239 LKHNPSQRPMLREVLEHPWITANS 262
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 184 bits (467), Expect = 5e-56
Identities = 86/299 (28%), Positives = 137/299 (45%), Gaps = 21/299 (7%)
Query: 93 WQQ-EQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRA--EYNL 149
W+Q E Y+ + LG G F V A D+ T +LVA+K I ++ + E +
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 150 LSTLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLH 209
L + H +I ++E+ G ++MQLV G L + + TE +I Q+
Sbjct: 61 LHKIKHPNIVALDDIYES---GGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVL 117
Query: 210 SALHCLHSQQIAHKDIRPENIL----MNGAVLKLIDLGSSV-----SVSTVVLPDLEFAS 260
A+ LH I H+D++PEN+L + + + D G S SV + + +
Sbjct: 118 DAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVA 177
Query: 261 PEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHI 320
PE+L + D WS+GV+ YILL G PF DE++ + I A+Y F I
Sbjct: 178 PEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDI 236
Query: 321 SVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASCSEFD-----TERLLPFSARRKQK 374
S A++ I L+ +KR T Q LQ W A + + + +E++ A+ K K
Sbjct: 237 SDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNFAKSKWK 295
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 185 bits (470), Expect = 5e-56
Identities = 80/306 (26%), Positives = 138/306 (45%), Gaps = 17/306 (5%)
Query: 87 VPFETRWQQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP-QQITRA 145
VP +Q Y+ LE LG+G F V + ++ TG++ K I + +
Sbjct: 16 VPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKN 75
Query: 146 EYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQS-TITESYICCI 204
E ++++ L H + FE+ ++++ + G L + + ++E+ +
Sbjct: 76 EISIMNQLHHPKLINLHDAFED---KYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINY 132
Query: 205 IRQLHSALHCLHSQQIAHKDIRPENILM---NGAVLKLIDLGSSVSVST-----VVLPDL 256
+RQ L +H I H DI+PENI+ + +K+ID G + ++ V
Sbjct: 133 MRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATA 192
Query: 257 EFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQ 316
EFA+PE++ G TDMW++GVL Y+LLSG+SPF E + ET ++ D+ F +
Sbjct: 193 EFAAPEIV-DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDA 251
Query: 317 CGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFA---EASCSEFDTERLLPFSARRKQ 373
+S A++ I LL KR T L+ W S + R + K+
Sbjct: 252 FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKE 311
Query: 374 KFKEIQ 379
K+ +
Sbjct: 312 KYADWP 317
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 1e-54
Identities = 64/264 (24%), Positives = 117/264 (44%), Gaps = 21/264 (7%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQITRAEYNLLSTLMHA 156
++ + LG G F TV AR+ T + A+K + + E +++S L H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 157 HIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLH 216
F++ + L++++ + + E+ ++ SAL LH
Sbjct: 69 FFVKLYFTFQD---DEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 125
Query: 217 SQQIAHKDIRPENILMNG-AVLKLIDLG--------SSVSVSTVVLPDLEFASPEMLTSP 267
+ I H+D++PENIL+N +++ D G S + + + ++ SPE+LT
Sbjct: 126 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185
Query: 268 ATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAREL 327
+A S+D+W+LG ++Y L++G+ PF +E I +Y FP AR+L
Sbjct: 186 -SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE----KFFPKARDL 240
Query: 328 IGQLLNTHADKRPTAGQLLQVAWF 351
+ +LL A KR ++
Sbjct: 241 VEKLLVLDATKRLGCEEMEGYGPL 264
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 7e-54
Identities = 53/267 (19%), Positives = 106/267 (39%), Gaps = 15/267 (5%)
Query: 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRA--EYNLLSTLMH 155
F ++ ++ LG G + V+ A +R T + VA+K + +R E + L H
Sbjct: 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 62
Query: 156 AHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCL 215
++ + + + + ++ G L + + E QL + + L
Sbjct: 63 ENV---VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 119
Query: 216 HSQQIAHKDIRPENILMNGA-VLKLIDLG--------SSVSVSTVVLPDLEFASPEMLTS 266
H I H+DI+PEN+L++ LK+ D G + + + L + +PE+L
Sbjct: 120 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 267 PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARE 326
D+WS G++L +L+G P+ S+ ++ I
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW-KKIDSAPLA 238
Query: 327 LIGQLLNTHADKRPTAGQLLQVAWFAE 353
L+ ++L + R T + + W+ +
Sbjct: 239 LLHKILVENPSARITIPDIKKDRWYNK 265
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 8e-54
Identities = 72/281 (25%), Positives = 131/281 (46%), Gaps = 18/281 (6%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQ-QITRAEYNLLSTLMHAHIP 159
+Y E++G G TV A D TGQ VA++Q+ ++QP+ ++ E ++ + +I
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 160 TALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQ 219
L + +VM+ + G SL + + E I + R+ AL LHS Q
Sbjct: 81 NYLDSYLV---GDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQ 136
Query: 220 IAHKDIRPENILMNG-AVLKLIDLGSSVSVS------TVVLPDLEFASPEMLTSPATAGP 272
+ H+DI+ +NIL+ +KL D G ++ + ++ + +PE++T GP
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGP 195
Query: 273 STDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLL 332
D+WSLG++ ++ G P+L+E+ I + + + +S R+ + + L
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-ATNGTPELQNPEKLSAIFRDFLNRCL 254
Query: 333 NTHADKRPTAGQLLQVAWFAEASCSEFDTERLLPFSARRKQ 373
+ +KR +A +LLQ + A L P A K+
Sbjct: 255 DMDVEKRGSAKELLQHQFLKIAK----PLSSLTPLIAAAKE 291
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 2e-53
Identities = 61/270 (22%), Positives = 115/270 (42%), Gaps = 17/270 (6%)
Query: 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQ-QITRAEYNLLSTLMHAH 157
E +E + LG+G F V KA+++ T L A K I + + + + E ++L++ H +
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 158 IPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQS-TITESYICCIIRQLHSALHCLH 216
I + L + I+++ G ++ + +TES I + +Q AL+ LH
Sbjct: 71 I---VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH 127
Query: 217 SQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVS------TVVLPDLEFASPEMLTSPAT 269
+I H+D++ NIL +KL D G S + + + +PE++ +
Sbjct: 128 DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 187
Query: 270 A----GPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAR 325
D+WSLG+ L + P + + I+ ++ + S +
Sbjct: 188 KDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPS-RWSSNFK 246
Query: 326 ELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355
+ + + L + D R T QLLQ + S
Sbjct: 247 DFLKKCLEKNVDARWTTSQLLQHPFVTVDS 276
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 1e-50
Identities = 81/298 (27%), Positives = 126/298 (42%), Gaps = 26/298 (8%)
Query: 101 RYEELER-LGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLM-HAHI 158
Y+ + LG G V + ++ T + ALK + Q R E L HI
Sbjct: 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML----QDCPKARREVELHWRASQCPHI 67
Query: 159 PTALALFENAPVPGTDT-IVMQLVHGESLIQHLCRQS--TITESYICCIIRQLHSALHCL 215
+ ++EN IVM+ + G L + + TE I++ + A+ L
Sbjct: 68 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 127
Query: 216 HSQQIAHKDIRPENILM----NGAVLKLIDLGSSVSVST-----VVLPDLEFASPEMLTS 266
HS IAH+D++PEN+L A+LKL D G + ++ + +PE+L
Sbjct: 128 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL-G 186
Query: 267 PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEET----RAHISVADYSFPPEQCGHISV 322
P S DMWSLGV++YILL G PF + I + Y FP + +S
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 246
Query: 323 PARELIGQLLNTHADKRPTAGQLLQVAWFAEAS---CSEFDTERLLPFSARRKQKFKE 377
+ LI LL T +R T + + W +++ + T R+L R + KE
Sbjct: 247 EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKE 304
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 1e-50
Identities = 65/268 (24%), Positives = 117/268 (43%), Gaps = 24/268 (8%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQ---QITRAEYNLLSTLMHAHI 158
YE L +G G + +K R + G+++ K++ + Q+ +E NLL L H +I
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 159 PTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQS----TITESYICCIIRQLHSALHC 214
+ T IVM+ G L + + + + E ++ ++ QL AL
Sbjct: 66 VRYYDRIID-RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 215 LHSQ-----QIAHKDIRPENILMNGA-VLKLIDLGSS------VSVSTVVLPDLEFASPE 262
H + + H+D++P N+ ++G +KL D G + S + + + SPE
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPE 184
Query: 263 MLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISV 322
+ + +D+WSLG LLY L + + PF S++E I + P S
Sbjct: 185 QMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPY---RYSD 240
Query: 323 PARELIGQLLNTHADKRPTAGQLLQVAW 350
E+I ++LN RP+ ++L+
Sbjct: 241 ELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 2e-50
Identities = 59/264 (22%), Positives = 109/264 (41%), Gaps = 16/264 (6%)
Query: 101 RYEELER-LGNGRFCTVRKARDRGTGQLVALKQIPRER---QPQQITRAEYNLLSTLMHA 156
R+ + + +G G F TV K D T VA ++ + +Q + E +L L H
Sbjct: 9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP 68
Query: 157 HIPTALALFENAPVPGTDT-IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCL 215
+I +E+ +V +L+ +L +L R + + RQ+ L L
Sbjct: 69 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFL 128
Query: 216 HSQ--QIAHKDIRPENILMNGA--VLKLIDLGSSV----SVSTVVLPDLEFASPEMLTSP 267
H++ I H+D++ +NI + G +K+ DLG + S + V+ EF +PEM
Sbjct: 129 HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEK 188
Query: 268 ATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAREL 327
S D+++ G+ + + + P+ + V P +E+
Sbjct: 189 YD--ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR-VTSGVKPASFDKVAIPEVKEI 245
Query: 328 IGQLLNTHADKRPTAGQLLQVAWF 351
I + + D+R + LL A+F
Sbjct: 246 IEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 3e-50
Identities = 64/308 (20%), Positives = 111/308 (36%), Gaps = 52/308 (16%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRA--EYNLLSTLMHAHI 158
+E++ LG G V K + +G ++A K I E +P + E +L +I
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 159 PTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQ 218
F + G +I M+ + G SL Q L + I E + + + L L +
Sbjct: 67 VGFYGAFYS---DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 219 Q-IAHKDIRPENILMNGA-VLKLIDLGSSV----SVSTVVLPDLEFASPEMLTSPATAGP 272
I H+D++P NIL+N +KL D G S S++ + + SPE L
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQG-THYSV 182
Query: 273 STDMWSLGVLLYILLSGVSPFLDESEEETRAHI--------------------------- 305
+D+WS+G+ L + G P +E
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGM 242
Query: 306 -------------SVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFA 352
+ + P G S+ ++ + + L + +R QL+ A+
Sbjct: 243 DSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 302
Query: 353 EASCSEFD 360
+ E D
Sbjct: 303 RSDAEEVD 310
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 1e-48
Identities = 62/266 (23%), Positives = 106/266 (39%), Gaps = 21/266 (7%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPR-----ERQPQQITRAEYNLLSTLMH 155
+ + LG G F V A + T Q A+K + + + + + L H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 156 AHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCL 215
+ F+ VM+ ++G L+ H+ S ++ L L
Sbjct: 63 PFLTHMFCTFQT---KENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFL 119
Query: 216 HSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVS------TVVLPDLEFASPEMLTSPA 268
HS+ I ++D++ +NIL++ +K+ D G ++ +PE+L
Sbjct: 120 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG-Q 178
Query: 269 TAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELI 328
S D WS GVLLY +L G SPF + EEE I + + +P + A++L+
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR----WLEKEAKDLL 234
Query: 329 GQLLNTHADKRPTA-GQLLQVAWFAE 353
+L +KR G + Q F E
Sbjct: 235 VKLFVREPEKRLGVRGDIRQHPLFRE 260
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 163 bits (414), Expect = 1e-48
Identities = 65/265 (24%), Positives = 107/265 (40%), Gaps = 16/265 (6%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE--RQPQQITRA--EYNLLSTLMHA 156
RYE E LG G V ARD + VA+K + + R P R E + L H
Sbjct: 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 67
Query: 157 HIPTALALFENA-PVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCL 215
I E P IVM+ V G +L + + +T +I AL+
Sbjct: 68 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 127
Query: 216 HSQQIAHKDIRPENILMN----------GAVLKLIDLGSSVSVSTVVLPDLEFASPEMLT 265
H I H+D++P NI+++ G + D G+SV+ + V+ ++ SPE
Sbjct: 128 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 187
Query: 266 SPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAR 325
+ +D++SLG +LY +L+G PF +S D P + +S
Sbjct: 188 GD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLD 246
Query: 326 ELIGQLLNTHADKRPTAGQLLQVAW 350
++ + L + + R ++
Sbjct: 247 AVVLKALAKNPENRYQTAAEMRADL 271
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 1e-47
Identities = 64/279 (22%), Positives = 105/279 (37%), Gaps = 25/279 (8%)
Query: 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER-------QPQQITRAEYNLL 150
E +Y+ LG+G F +V VA+K + ++R E LL
Sbjct: 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 151 STLMHAHIPTALALFENAPVPGTDTIVMQLVHGES-LIQHLCRQSTITESYICCIIRQLH 209
+ + L + P + ++++ L + + + E Q+
Sbjct: 62 KKVSSGF-SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL 120
Query: 210 SALHCLHSQQIAHKDIRPENILM--NGAVLKLIDLGSSV----SVSTVVLPDLEFASPEM 263
A+ H+ + H+DI+ ENIL+ N LKLID GS +V T ++ PE
Sbjct: 121 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEW 180
Query: 264 LTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVP 323
+ G S +WSLG+LLY ++ G PF + E I F +S
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQ----RVSSE 230
Query: 324 ARELIGQLLNTHADKRPTAGQLLQVAWFAEASCSEFDTE 362
+ LI L RPT ++ W + + E
Sbjct: 231 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 269
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 162 bits (411), Expect = 3e-47
Identities = 58/267 (21%), Positives = 114/267 (42%), Gaps = 15/267 (5%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQITRAEYNLLSTLMHA 156
+ +G G F V R TG++ A+K + ++R Q + + E +LS +
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 157 HIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLH 216
P + + P + ++ L++G L HL + +E+ + ++ L +H
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 124
Query: 217 SQQIAHKDIRPENILMNGA-VLKLIDLGSSVSVS----TVVLPDLEFASPEMLTSPATAG 271
++ + ++D++P NIL++ +++ DLG + S + + +PE+L
Sbjct: 125 NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYD 184
Query: 272 PSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQL 331
S D +SLG +L+ LL G SPF ++ I + E S R L+ L
Sbjct: 185 SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMAVELPDSFSPELRSLLEGL 243
Query: 332 LNTHADKRPT-----AGQLLQVAWFAE 353
L ++R A ++ + +F
Sbjct: 244 LQRDVNRRLGCLGRGAQEVKESPFFRS 270
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 159 bits (403), Expect = 2e-46
Identities = 68/277 (24%), Positives = 121/277 (43%), Gaps = 26/277 (9%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLSTLMHAH 157
++ L LG G F V R R G+ A+K + +E + + T E +LS + H
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 158 IPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHS 217
I F++ ++M + G L L + ++ AL LHS
Sbjct: 66 IIRMWGTFQD---AQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122
Query: 218 QQIAHKDIRPENILMNG-AVLKLIDLGSSVSVS---TVVLPDLEFASPEMLTSPATAGPS 273
+ I ++D++PENIL++ +K+ D G + V + ++ +PE++++ S
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVST-KPYNKS 181
Query: 274 TDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLN 333
D WS G+L+Y +L+G +PF D + +T I A+ FPP + ++L+ +L+
Sbjct: 182 IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP----FFNEDVKDLLSRLIT 237
Query: 334 THADKR-----PTAGQLLQVAWFAEASCSEFDTERLL 365
+R + WF E E+LL
Sbjct: 238 RDLSQRLGNLQNGTEDVKNHPWF-----KEVVWEKLL 269
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 2e-46
Identities = 69/300 (23%), Positives = 116/300 (38%), Gaps = 47/300 (15%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRA---EYNLLSTLMHAH 157
+YE+L ++G G F V KAR R TGQ VALK++ E + + E +L L H +
Sbjct: 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70
Query: 158 IPTALALFENAPVP-----GTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSAL 212
+ + + P G+ +V + T S I +++ L + L
Sbjct: 71 VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL 130
Query: 213 HCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVS----------TVVLPDLEFASP 261
+ +H +I H+D++ N+L+ VLKL D G + + S T + L + P
Sbjct: 131 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 190
Query: 262 EMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHI- 320
E+L GP D+W G ++ + + +E+ A IS S PE ++
Sbjct: 191 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 250
Query: 321 ---------------------------SVPARELIGQLLNTHADKRPTAGQLLQVAWFAE 353
A +LI +LL +R + L +F
Sbjct: 251 NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 3e-46
Identities = 71/288 (24%), Positives = 116/288 (40%), Gaps = 40/288 (13%)
Query: 103 EELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQ------QITRAEYNLLSTLMHA 156
E+L+ LG G+F TV KARD+ T Q+VA+K+I + + + E LL L H
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 157 HIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLH 216
+I + L + ++V + + + +T S+I + L LH
Sbjct: 61 NI---IGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH 117
Query: 217 SQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVS------TVVLPDLEFASPEMLTSPAT 269
I H+D++P N+L++ VLKL D G + S T + + +PE+L
Sbjct: 118 QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARM 177
Query: 270 AGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQC------------ 317
G DMW++G +L LL V +S+ + I + EQ
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 318 ------------GHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAE 353
+LI L + R TA Q L++ +F+
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 1e-45
Identities = 64/330 (19%), Positives = 116/330 (35%), Gaps = 50/330 (15%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRA--EYNLLSTLMHAHI 158
RY L +G G + V A D VA+K+I R E +L H +I
Sbjct: 9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 68
Query: 159 PTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQ 218
+ + + + + + L + ++ +IC + Q+ L +HS
Sbjct: 69 IGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 128
Query: 219 QIAHKDIRPENILMNG-AVLKLIDLGSSVSVS---------TVVLPDLEFASPEMLTSPA 268
+ H+D++P N+L+N LK+ D G + T + + +PE++ +
Sbjct: 129 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 188
Query: 269 TAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQC----------- 317
S D+WS+G +L +LS F + + HI S E
Sbjct: 189 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 248
Query: 318 ----------------GHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAE-------- 353
+ A +L+ ++L + KR Q L + +
Sbjct: 249 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEP 308
Query: 354 --ASCSEFDTE-RLLPFSARRKQKFKEIQD 380
+ +FD E LP ++ F+E
Sbjct: 309 IAEAPFKFDMELDDLPKEKLKELIFEETAR 338
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 6e-45
Identities = 68/338 (20%), Positives = 133/338 (39%), Gaps = 52/338 (15%)
Query: 90 ETRWQQEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQI---TRAE 146
+T W+ Y +L+ +G+G + V A D TG VA+K++ R Q + E
Sbjct: 11 KTAWE---VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRE 67
Query: 147 YNLLSTLMHAHIPTALALFENAPVPGTDT---IVMQLVHGESLIQHLCRQSTITESYICC 203
LL + H ++ L +F T +VM + + L + + E I
Sbjct: 68 LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT--DLGKLMKHEKLGEDRIQF 125
Query: 204 IIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVS---TVVLPDLEFA 259
++ Q+ L +H+ I H+D++P N+ +N LK++D G + T + +
Sbjct: 126 LVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYR 185
Query: 260 SPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCG- 318
+PE++ + + D+WS+G ++ +++G + F + I + P E
Sbjct: 186 APEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245
Query: 319 --------------------------HISVPARELIGQLLNTHADKRPTAGQLLQVAWFA 352
+ S A L+ ++L A++R TAG+ L +F
Sbjct: 246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 305
Query: 353 -------EASCSEFDT---ERLLPFSARRKQKFKEIQD 380
E ++D + ++ +KE+
Sbjct: 306 SLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLS 343
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 3e-44
Identities = 63/267 (23%), Positives = 111/267 (41%), Gaps = 22/267 (8%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLSTLMHAH 157
++ L+ LG G F V R++ TG+ A+K + +E + T E +L H
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 158 IPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHS 217
+ AL VM+ +G L HL R+ TE ++ SAL LHS
Sbjct: 67 L---TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 218 QQIAHKDIRPENILMNG-AVLKLIDLGSSVSVSTVVLPDLEFAS-----PEMLTSPATAG 271
+ + ++DI+ EN++++ +K+ D G + F + G
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYG 183
Query: 272 PSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQL 331
+ D W LGV++Y ++ G PF ++ E I + + FP +S A+ L+ L
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGL 239
Query: 332 LNTHADKRP-----TAGQLLQVAWFAE 353
L +R A ++++ +F
Sbjct: 240 LKKDPKQRLGGGPSDAKEVMEHRFFLS 266
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 151 bits (382), Expect = 7e-44
Identities = 58/288 (20%), Positives = 121/288 (42%), Gaps = 39/288 (13%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQI---TRAEYNLLSTLMHAH 157
+Y LE++G G + V KA++ G+ ALK+I E++ + I T E ++L L H++
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 158 IPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHS 217
I + L++ +V + + + + + + QL + + H
Sbjct: 62 I---VKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 218 QQIAHKDIRPENILMNG-AVLKLIDLGSSVSVST------VVLPDLEFASPEMLTSPATA 270
+++ H+D++P+N+L+N LK+ D G + + + L + +P++L
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 271 GPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQC------------- 317
+ D+WS+G + +++G F SE + I + +
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238
Query: 318 ------------GHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAE 353
+ +L+ ++L ++R TA Q L+ A+F E
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (381), Expect = 1e-43
Identities = 57/264 (21%), Positives = 108/264 (40%), Gaps = 24/264 (9%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRA---EYNLLSTLMHAH 157
+ +R+G+G F TV K + G VA+K + Q +A E +L H +
Sbjct: 9 QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 158 IPTALALFENAPVPGTDTIVMQLVHGESLIQHL-CRQSTITESYICCIIRQLHSALHCLH 216
I + + IV Q G SL HL ++ + I RQ + LH
Sbjct: 66 ILLFMGYSTAPQL----AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121
Query: 217 SQQIAHKDIRPENILMNG-AVLKLIDLG--------SSVSVSTVVLPDLEFASPEMLT-- 265
++ I H+D++ NI ++ +K+ D G S + + + +PE++
Sbjct: 122 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 266 SPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFP--PEQCGHISVP 323
+D+++ G++LY L++G P+ + + + + Y P + +
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA 241
Query: 324 ARELIGQLLNTHADKRPTAGQLLQ 347
+ L+ + L D+RP Q+L
Sbjct: 242 MKRLMAECLKKKRDERPLFPQILA 265
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 2e-43
Identities = 63/289 (21%), Positives = 119/289 (41%), Gaps = 39/289 (13%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRA---EYNLLSTLMHAH 157
+YE+LE++G G + TV KA++R T ++VALK++ + + + + E LL L H +
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 158 IPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHS 217
I + + T+V + + + + + QL L HS
Sbjct: 63 IVRLHDVLHS---DKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 218 QQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------TVVLPDLEFASPEMLTSPATA 270
+ + H+D++P+N+L+N LKL + G + + + + L + P++L
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 271 GPSTDMWSLGVLLYILLSGVSP-FLDESEEETRAHISVADYSFPPEQC------------ 317
S DMWS G + L + P F ++ I + EQ
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239
Query: 318 -------------GHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAE 353
++ R+L+ LL + +R +A + LQ +F++
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 4e-43
Identities = 69/275 (25%), Positives = 116/275 (42%), Gaps = 24/275 (8%)
Query: 101 RYEELERLGNGRFCTVRKARD---RGTGQLVALKQIPRERQPQ-----QITRAEYNLLST 152
+E L+ LG G + V R TG+L A+K + + Q + TR E +L
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 153 LMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSAL 212
+ + + L +++ ++G L HL ++ TE + + ++ AL
Sbjct: 85 IRQSPF--LVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLAL 142
Query: 213 HCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVSTVVLPDLEF--------ASPEM 263
LH I ++DI+ ENIL++ + L D G S A +
Sbjct: 143 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 202
Query: 264 LTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVP 323
+ + D WSLGVL+Y LL+G SPF + E+ ++A IS P +S
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSAL 262
Query: 324 ARELIGQLLNTHADKRP-----TAGQLLQVAWFAE 353
A++LI +LL KR A ++ + +F +
Sbjct: 263 AKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 2e-42
Identities = 57/270 (21%), Positives = 109/270 (40%), Gaps = 23/270 (8%)
Query: 93 WQQEQFE---HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNL 149
W ++++E + +ERLG G+F V G VA+K + + AE NL
Sbjct: 3 WWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQGSMSPDAFLAEANL 61
Query: 150 LSTLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQS--TITESYICCIIRQ 207
+ L H + A+ P+ I+ + + SL+ L S +T + + + Q
Sbjct: 62 MKQLQHQRLVRLYAVVTQEPI----YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 208 LHSALHCLHSQQIAHKDIRPENIL-MNGAVLKLIDLG-------SSVSVSTVVLPDLEFA 259
+ + + + H+D+R NIL + K+ D G + + +++
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT 177
Query: 260 SPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCG 318
+PE + + T +D+WS G+LL +++ G P+ + E ++ P+ C
Sbjct: 178 APEAI-NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC- 235
Query: 319 HISVPARELIGQLLNTHADKRPTAGQLLQV 348
+L+ + RPT L V
Sbjct: 236 --PEELYQLMRLCWKERPEDRPTFDYLRSV 263
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 149 bits (376), Expect = 3e-42
Identities = 60/266 (22%), Positives = 113/266 (42%), Gaps = 21/266 (7%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER--QPQQITRA--EYNLLSTLMHA 156
+++ ++ LG G F V + + +G A+K + +++ + +QI E +L +
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 157 HIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLH 216
+ L + +VM+ V G + HL R +E + Q+ LH
Sbjct: 102 FLVK---LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 217 SQQIAHKDIRPENILMN-GAVLKLIDLGSSVSV---STVVLPDLEFASPEMLTSPATAGP 272
S + ++D++PEN+L++ +++ D G + V + + E +PE++ S
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSK-GYNK 217
Query: 273 STDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLL 332
+ D W+LGVL+Y + +G PF + + I FP H S ++L+ LL
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLL 273
Query: 333 NTHADKR-----PTAGQLLQVAWFAE 353
KR + WFA
Sbjct: 274 QVDLTKRFGNLKNGVNDIKNHKWFAT 299
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 3e-42
Identities = 72/326 (22%), Positives = 133/326 (40%), Gaps = 47/326 (14%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQ---QITRAEYNLLSTLMHAH 157
RY+ L +G+G + +V A D TG VA+K++ R Q + T E LL + H +
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 78
Query: 158 IPTALALFENAPVP--GTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCL 215
+ L +F A D ++ + G + ++ + +T+ ++ +I Q+ L +
Sbjct: 79 VIGLLDVFTPARSLEEFNDVYLVTHLMGAD-LNNIVKCQKLTDDHVQFLIYQILRGLKYI 137
Query: 216 HSQQIAHKDIRPENILMNGA-VLKLIDLGSSVSVS---TVVLPDLEFASPEMLTSPATAG 271
HS I H+D++P N+ +N LK++D G + T + + +PE++ +
Sbjct: 138 HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYN 197
Query: 272 PSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQC-------------- 317
+ D+WS+G ++ LL+G + F + I + E
Sbjct: 198 QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQS 257
Query: 318 -------------GHISVPARELIGQLLNTHADKRPTAGQLLQVAWFA-------EASCS 357
+ A +L+ ++L +DKR TA Q L A+FA E
Sbjct: 258 LTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD 317
Query: 358 EFDT---ERLLPFSARRKQKFKEIQD 380
+D R L + + E+
Sbjct: 318 PYDQSFESRDLLIDEWKSLTYDEVIS 343
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 1e-41
Identities = 63/291 (21%), Positives = 123/291 (42%), Gaps = 39/291 (13%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRA---EYNLLSTLMHAH 157
++++E++G G + V KAR++ TG++VALK+I + + + + E +LL L H +
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 158 IPTALALFENAPVPGTDTIVMQLVHGESL-IQHLCRQSTITESYICCIIRQLHSALHCLH 216
I + L + +V + +H + + I I + QL L H
Sbjct: 63 I---VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 217 SQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVS------TVVLPDLEFASPEMLTSPAT 269
S ++ H+D++P+N+L+N +KL D G + + T + L + +PE+L
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 270 AGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQ------------- 316
+ D+WSLG + +++ + F +SE + I +
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 317 ------------CGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355
+ R L+ Q+L+ +KR +A L +F + +
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 2e-41
Identities = 52/254 (20%), Positives = 102/254 (40%), Gaps = 16/254 (6%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPT 160
+ L+ +G G F V RG VA+K I + Q E ++++ L H+++
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDYRGN--KVAVKCIKNDATAQAFLA-EASVMTQLRHSNLVQ 64
Query: 161 ALALFENAPVPGTDTIVMQLVHGESLIQHLCRQ--STITESYICCIIRQLHSALHCLHSQ 218
L + G IV + + SL+ +L + S + + + A+ L
Sbjct: 65 LLGVIVEEK--GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 122
Query: 219 QIAHKDIRPENILMNGA-VLKLIDLGSSVSVS---TVVLPDLEFASPEMLTSPATAGPST 274
H+D+ N+L++ V K+ D G + S +++ +PE L +
Sbjct: 123 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALRE-KKFSTKS 181
Query: 275 DMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLN 333
D+WS G+LL+ + S G P+ ++ + + + + E++ +
Sbjct: 182 DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV---EKGYKMDAPDGCPPAVYEVMKNCWH 238
Query: 334 THADKRPTAGQLLQ 347
A RP+ QL +
Sbjct: 239 LDAAMRPSFLQLRE 252
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 2e-41
Identities = 66/293 (22%), Positives = 117/293 (39%), Gaps = 41/293 (13%)
Query: 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHI 158
E Y + + +GNG F V +A+ +G+LVA+K++ +++ + E ++ L H +I
Sbjct: 19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---RFKNRELQIMRKLDHCNI 75
Query: 159 PTALALFENAPVPGTDT---IVMQLVHG---ESLIQHLCRQSTITESYICCIIRQLHSAL 212
F ++ + +V+ V + + T+ Y+ + QL +L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 213 HCLHSQQIAHKDIRPENILM--NGAVLKLIDLGSSVSVS-----TVVLPDLEFASPEMLT 265
+HS I H+DI+P+N+L+ + AVLKL D GS+ + + + +PE++
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIF 195
Query: 266 SPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQC-------- 317
S D+WS G +L LL G F +S + I + EQ
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 255
Query: 318 -----------------GHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAE 353
A L +LL R T + ++F E
Sbjct: 256 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 144 bits (365), Expect = 4e-41
Identities = 48/269 (17%), Positives = 89/269 (33%), Gaps = 25/269 (9%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPT 160
RY ++G+G F + D G+ VA+K + + Q+ E + +
Sbjct: 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI-ESKIYKMMQGGVGIP 66
Query: 161 ALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQI 220
+ + +VM+L+ + + + Q+ S + +HS+
Sbjct: 67 TIRWCGAEG--DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNF 124
Query: 221 AHKDIRPENILMN----GAVLKLIDLGSSVSV-------------STVVLPDLEFASPEM 263
H+D++P+N LM G ++ +ID G + + + +AS
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184
Query: 264 LTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHI---SVADYSFPPEQ-CGH 319
D+ SLG +L G P+ R S S P E C
Sbjct: 185 HLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKG 243
Query: 320 ISVPARELIGQLLNTHADKRPTAGQLLQV 348
+ + D +P L Q+
Sbjct: 244 YPSEFATYLNFCRSLRFDDKPDYSYLRQL 272
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 1e-40
Identities = 57/256 (22%), Positives = 103/256 (40%), Gaps = 18/256 (7%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTA 161
L+ LG G+F V+ + R VA+K I + E ++ L H +
Sbjct: 6 LTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQL 64
Query: 162 LALFENAPVPGTDTIVMQLVHGESLIQHLC-RQSTITESYICCIIRQLHSALHCLHSQQI 220
+ I+ + + L+ +L + + + + + A+ L S+Q
Sbjct: 65 YGVCTK---QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF 121
Query: 221 AHKDIRPENILMNG-AVLKLIDLGSSVSV-------STVVLPDLEFASPEMLTSPATAGP 272
H+D+ N L+N V+K+ D G S V S + ++ PE+L +
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKFSS 180
Query: 273 STDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQL 331
+D+W+ GVL++ + S G P+ + ET HI+ + P S ++
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLA---SEKVYTIMYSC 237
Query: 332 LNTHADKRPTAGQLLQ 347
+ AD+RPT LL
Sbjct: 238 WHEKADERPTFKILLS 253
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 143 bits (361), Expect = 1e-40
Identities = 44/272 (16%), Positives = 85/272 (31%), Gaps = 29/272 (10%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHA-HIP 159
Y+ R+G G F + + + Q VA+K PR Q+ R EY L IP
Sbjct: 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQL-RDEYRTYKLLAGCTGIP 64
Query: 160 TALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQ 219
+ + +V+ L+ + + +Q+ + + +H +
Sbjct: 65 NVYYFGQE---GLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121
Query: 220 IAHKDIRPENILMN------GAVLKLIDLGSSVSVS-------------TVVLPDLEFAS 260
+ ++DI+P+N L+ ++ ++D G + + S
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 261 PEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRA---HISVADYSFPPEQ- 316
D+ +LG + L G P+ + I S P +
Sbjct: 182 INTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 240
Query: 317 CGHISVPARELIGQLLNTHADKRPTAGQLLQV 348
C + + N D P L +
Sbjct: 241 CAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 272
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 141 bits (357), Expect = 4e-40
Identities = 44/271 (16%), Positives = 102/271 (37%), Gaps = 18/271 (6%)
Query: 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIP 159
+LG G++ V + + VA+K + + + E ++ + H ++
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 76
Query: 160 TALALFENAPVPGTDTIVMQLVHGESLIQHLCRQS--TITESYICCIIRQLHSALHCLHS 217
L + I+ + + +L+ +L + ++ + + Q+ SA+ L
Sbjct: 77 QLLGVCTR---EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 133
Query: 218 QQIAHKDIRPENILMNGA-VLKLIDLG-------SSVSVSTVVLPDLEFASPEMLTSPAT 269
+ H+D+ N L+ ++K+ D G + + +++ +PE L +
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-AYNK 192
Query: 270 AGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIG 329
+D+W+ GVLL+ + + + + DY + EL+
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPE--GCPEKVYELMR 250
Query: 330 QLLNTHADKRPTAGQLLQV--AWFAEASCSE 358
+ RP+ ++ Q F E+S S+
Sbjct: 251 ACWQWNPSDRPSFAEIHQAFETMFQESSISD 281
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 7e-39
Identities = 63/295 (21%), Positives = 114/295 (38%), Gaps = 40/295 (13%)
Query: 98 FEHRYEELERLGNGRFCTVRKARD-RGTGQLVALKQIPRERQPQQITRA---EYNLLSTL 153
+ +YE + +G G + V KARD + G+ VALK++ + + + + E +L L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 154 MHAHIPTALALFENAPVPGTDT-----IVMQLVHGESL-IQHLCRQSTITESYICCIIRQ 207
P + LF+ V TD +V + V + + + I ++ Q
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 208 LHSALHCLHSQQIAHKDIRPENILMNG------AVLKLIDLGSSVSVSTVVLPDLEFASP 261
L L LHS ++ H+D++P+NIL+ A L + S T V+ L + +P
Sbjct: 125 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184
Query: 262 EMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQC---- 317
E+L ++ D+WS+G + + F S+ + I E
Sbjct: 185 EVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243
Query: 318 -------------------GHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAE 353
I ++L+ + L + KR +A L +F +
Sbjct: 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 1e-38
Identities = 49/259 (18%), Positives = 89/259 (34%), Gaps = 20/259 (7%)
Query: 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIP 159
+LG G F V GT + VA+K + + E ++ L H +
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 160 TALALFENAPVPGTDTIVMQLVHGESL--IQHLCRQSTITESYICCIIRQLHSALHCLHS 217
A+ P+ IV + + SL + + + Q+ S + +
Sbjct: 76 QLYAVVSEEPIY----IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 218 QQIAHKDIRPENILMNG-AVLKLIDLG-------SSVSVSTVVLPDLEFASPEMLTSPAT 269
H+D+R NIL+ V K+ D G + + +++ +PE
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GR 190
Query: 270 AGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELI 328
+D+WS G+LL L + G P+ E + + + +L+
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV---ERGYRMPCPPECPESLHDLM 247
Query: 329 GQLLNTHADKRPTAGQLLQ 347
Q ++RPT L
Sbjct: 248 CQCWRKEPEERPTFEYLQA 266
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (342), Expect = 3e-38
Identities = 49/257 (19%), Positives = 97/257 (37%), Gaps = 18/257 (7%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPT 160
++ +G+G+F V VA+K I ++ E ++ L H +
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 161 ALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTI-TESYICCIIRQLHSALHCLHSQQ 219
+ +V + + L +L Q + + + + + L
Sbjct: 65 LYGVCLE---QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121
Query: 220 IAHKDIRPENILMNGA-VLKLIDLG-------SSVSVSTVVLPDLEFASPEMLTSPATAG 271
+ H+D+ N L+ V+K+ D G + ST +++ASPE+ + +
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRYS 180
Query: 272 PSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQ 330
+D+WS GVL++ + S G P+ + S E IS + P S +++
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLA---STHVYQIMNH 237
Query: 331 LLNTHADKRPTAGQLLQ 347
+ RP +LL+
Sbjct: 238 CWKERPEDRPAFSRLLR 254
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 137 bits (346), Expect = 4e-38
Identities = 61/295 (20%), Positives = 114/295 (38%), Gaps = 48/295 (16%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTL-MHAHIP 159
Y+ + +LG G++ V +A + + V +K + ++ + + E +L L +I
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK--IKREIKILENLRGGPNII 93
Query: 160 TALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQ 219
T + ++ PV T +V + V+ Q T+T+ I + ++ AL HS
Sbjct: 94 TLADIVKD-PVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG 149
Query: 220 IAHKDIRPENILMN--GAVLKLIDLGSSVSVSTVVLPD-----LEFASPEMLTSPATAGP 272
I H+D++P N++++ L+LID G + + F PE+L
Sbjct: 150 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDY 209
Query: 273 STDMWSLGVLLYILLSGVSPFLDESEE--------------ETRAHISVADYSFPP---- 314
S DMWSLG +L ++ PF + + +I + P
Sbjct: 210 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 269
Query: 315 ----------------EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAE 353
E +S A + + +LL R TA + ++ +F
Sbjct: 270 ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 5e-38
Identities = 53/268 (19%), Positives = 103/268 (38%), Gaps = 26/268 (9%)
Query: 98 FEHRYEELE--RLGNGRFCTVRKA--RDRGTGQLVALKQIPRERQPQQITR---AEYNLL 150
+ + LE LG+G F TV+K + + + VA+K + E + AE N++
Sbjct: 3 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 62
Query: 151 STLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHS 210
L + +I + + E + +VM++ L ++L + + + I ++ Q+
Sbjct: 63 QQLDNPYIVRMIGICEA----ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSM 118
Query: 211 ALHCLHSQQIAHKDIRPENILMNGA-VLKLIDLGSS---------VSVSTVVLPDLEFAS 260
+ L H+D+ N+L+ K+ D G S T +++ +
Sbjct: 119 GMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 178
Query: 261 PEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGH 319
PE + +D+WS GVL++ S G P+ E A + + P C
Sbjct: 179 PECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC-- 235
Query: 320 ISVPARELIGQLLNTHADKRPTAGQLLQ 347
+L+ + RP +
Sbjct: 236 -PREMYDLMNLCWTYDVENRPGFAAVEL 262
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 1e-37
Identities = 54/268 (20%), Positives = 100/268 (37%), Gaps = 26/268 (9%)
Query: 99 EHRYEELERLGNGRFCTVRKARDR---GTGQLVALKQIPRER--QPQQITR--AEYNLLS 151
E LE+LG+G F VR+ G VA+K + + QP+ + E N +
Sbjct: 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 66
Query: 152 TLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLC-RQSTITESYICCIIRQLHS 210
+L H ++ + P+ +V +L SL+ L Q + Q+
Sbjct: 67 SLDHRNLIRLYGVVLTPPMK----MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAE 122
Query: 211 ALHCLHSQQIAHKDIRPENILMNGA-VLKLIDLG---------SSVSVSTVVLPDLEFAS 260
+ L S++ H+D+ N+L+ ++K+ D G + + +
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 261 PEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGH 319
PE L + T ++D W GV L+ + + G P++ + + I P +
Sbjct: 183 PESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPE--D 239
Query: 320 ISVPARELIGQLLNTHADKRPTAGQLLQ 347
++ Q + RPT L
Sbjct: 240 CPQDIYNVMVQCWAHKPEDRPTFVALRD 267
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 131 bits (330), Expect = 4e-36
Identities = 51/272 (18%), Positives = 100/272 (36%), Gaps = 24/272 (8%)
Query: 95 QEQFEHRYEELERLGNGRFCTVRKARDRGTGQ---LVALKQIPRERQPQQITR--AEYNL 149
+E + + +G G F V + G+ VA+K + +Q +E ++
Sbjct: 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASI 80
Query: 150 LSTLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQH-LCRQSTITESYICCIIRQL 208
+ H ++ + I+ + + SL T + ++R +
Sbjct: 81 MGQFDHPNVIHLEGVVTK---STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGI 137
Query: 209 HSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS-----TVVLPDLEFASPE 262
+ + L H+D+ NIL+N V K+ D G S + L P
Sbjct: 138 AAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPI 197
Query: 263 MLTSPA-----TAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQ 316
T+P ++D+WS G++++ ++S G P+ D + ++ I DY PP
Sbjct: 198 RWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI-EQDYRLPPPM 256
Query: 317 CGHISVPARELIGQLLNTHADKRPTAGQLLQV 348
+L+ + RP GQ++
Sbjct: 257 --DCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 5e-36
Identities = 46/262 (17%), Positives = 105/262 (40%), Gaps = 23/262 (8%)
Query: 102 YEELERLGNGRFCTVRKARDRGTGQL----VALKQIPRERQPQQITR--AEYNLLSTLMH 155
+++++ LG+G F TV K G+ VA+K++ P+ E +++++ +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 156 AHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCL 215
H+ L + I + G L + I Y+ Q+ ++ L
Sbjct: 71 PHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 216 HSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSV--------STVVLPDLEFASPEMLTS 266
+++ H+D+ N+L+ +K+ D G + + + +++ + E +
Sbjct: 128 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 187
Query: 267 PATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAR 325
+D+WS GV ++ L++ G P+ E + + + P C ++
Sbjct: 188 RI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPIC---TIDVY 243
Query: 326 ELIGQLLNTHADKRPTAGQLLQ 347
++ + AD RP +L+
Sbjct: 244 MIMVKCWMIDADSRPKFRELII 265
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 3e-35
Identities = 54/267 (20%), Positives = 103/267 (38%), Gaps = 27/267 (10%)
Query: 108 LGNGRFCTVRKA--RDRGTGQLVALKQIPRERQPQQITR--AEYNLLSTLMHAHIPTALA 163
LG G F +VR+ R R VA+K + + + E ++ L + +I +
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 164 LFENAPVPGTDTIVMQLVHGESLIQHL-CRQSTITESYICCIIRQLHSALHCLHSQQIAH 222
+ + + +VM++ G L + L ++ I S + ++ Q+ + L + H
Sbjct: 77 VCQAEAL----MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH 132
Query: 223 KDIRPENILMNG-AVLKLIDLG---------SSVSVSTVVLPDLEFASPEMLTSPATAGP 272
+D+ N+L+ K+ D G S + + L++ +PE +
Sbjct: 133 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSS 191
Query: 273 STDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQL 331
+D+WS GV ++ LS G P+ E A I P +C L+
Sbjct: 192 RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC---PPELYALMSDC 248
Query: 332 LNTHADKRPTAGQLLQV---AWFAEAS 355
+ RP + Q +++ AS
Sbjct: 249 WIYKWEDRPDFLTVEQRMRACYYSLAS 275
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 3e-35
Identities = 59/264 (22%), Positives = 96/264 (36%), Gaps = 25/264 (9%)
Query: 100 HRYEELERLGNGRFCTVRKARDRGT---GQLVALKQIPRERQPQQITR--AEYNLLSTLM 154
R E +G G+F V + VA+K + E +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 155 HAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLC-RQSTITESYICCIIRQLHSALH 213
H HI + + PV I+M+L L L R+ ++ + + QL +AL
Sbjct: 67 HPHIVKLIGVITENPVW----IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 122
Query: 214 CLHSQQIAHKDIRPENILMNGA-VLKLIDLGSSVSV--------STVVLPDLEFASPEML 264
L S++ H+DI N+L++ +KL D G S + S LP A +
Sbjct: 123 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 182
Query: 265 TSPATAGPSTDMWSLGVLLY-ILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVP 323
T ++D+W GV ++ IL+ GV PF + I + P C
Sbjct: 183 FRRFT--SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC---PPT 237
Query: 324 ARELIGQLLNTHADKRPTAGQLLQ 347
L+ + +RP +L
Sbjct: 238 LYSLMTKCWAYDPSRRPRFTELKA 261
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 129 bits (324), Expect = 3e-35
Identities = 51/290 (17%), Positives = 105/290 (36%), Gaps = 48/290 (16%)
Query: 100 HRYEELERLGNGRFCTVRKARDRG-----TGQLVALKQIPRERQPQQITR--AEYNLLST 152
+ E + +G G F V +AR G +VA+K + E E L++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 153 LMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQS------------------ 194
+ +I L + ++ + + L + L S
Sbjct: 73 FDNPNIVKLLGVCAV---GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 129
Query: 195 ------TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVS 247
++ + CI RQ+ + + L ++ H+D+ N L+ V+K+ D G S +
Sbjct: 130 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 248 V--------STVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESE 298
+ + + PE + +D+W+ GV+L+ + S G+ P+ +
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 248
Query: 299 EETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQV 348
EE ++ + PE C + L+ + RP+ + ++
Sbjct: 249 EEVIYYVRDGNILACPENC---PLELYNLMRLCWSKLPADRPSFCSIHRI 295
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 2e-34
Identities = 58/276 (21%), Positives = 104/276 (37%), Gaps = 35/276 (12%)
Query: 100 HRYEELERLGNGRFCTVRKARDRGTGQL--VALKQIPRERQPQQI--TRAEYNLLSTLMH 155
+ + + +G G F V KAR + G A+K++ E +L L H
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 156 AHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQ----------------STITES 199
H P + L G + ++ +L+ L + ST++
Sbjct: 70 -H-PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127
Query: 200 YICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSS------VSVSTVV 252
+ + + L +Q H+D+ NIL+ V K+ D G S V +
Sbjct: 128 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR 187
Query: 253 LPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYS 311
LP A + S T ++D+WS GVLL+ ++S G +P+ + E +
Sbjct: 188 LPVRWMAIESLNYSVYT--TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL---PQG 242
Query: 312 FPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQ 347
+ E+ + +L+ Q +RP+ Q+L
Sbjct: 243 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 278
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 7e-34
Identities = 56/314 (17%), Positives = 109/314 (34%), Gaps = 53/314 (16%)
Query: 78 NNEYKVL--YTVPFETRWQQEQFEHRYEELERLGNGRFCTVRKARDRGTGQL-----VAL 130
+NEY + ++ +W E E + LG+G F V A G + VA+
Sbjct: 15 DNEYFYVDFREYEYDLKW--EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAV 72
Query: 131 KQIPRERQPQQITR--AEYNLLSTLM-HAHIPTALALFENAPVPGTDTIVMQLVHGESLI 187
K + + + +E +++ L H +I L G ++ + L+
Sbjct: 73 KMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL---SGPIYLIFEYCCYGDLL 129
Query: 188 QHLCRQ-----------------------STITESYICCIIRQLHSALHCLHSQQIAHKD 224
+L + + +T + C Q+ + L + H+D
Sbjct: 130 NYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 189
Query: 225 IRPENILMN-GAVLKLIDLGSS---------VSVSTVVLPDLEFASPEMLTSPATAGPST 274
+ N+L+ G V+K+ D G + V LP A + T +
Sbjct: 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT--IKS 247
Query: 275 DMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLN 333
D+WS G+LL+ + S GV+P+ + + + + + ++
Sbjct: 248 DVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPF--YATEEIYIIMQSCWA 305
Query: 334 THADKRPTAGQLLQ 347
+ KRP+ L
Sbjct: 306 FDSRKRPSFPNLTS 319
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 8e-34
Identities = 49/270 (18%), Positives = 106/270 (39%), Gaps = 26/270 (9%)
Query: 96 EQFEHRYEELERLGNGRFCTVRKARDR---GTGQLVALKQIPRERQPQQITR--AEYNLL 150
+ E+ +G G F V G A+K + R ++++ E ++
Sbjct: 25 SSLIVHFNEV--IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 82
Query: 151 STLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLC-RQSTITESYICCIIRQLH 209
H ++ + L + + G+ +V+ + L + T + Q+
Sbjct: 83 KDFSHPNVLSLLGICLRSE--GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVA 140
Query: 210 SALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSS----------VSVSTVVLPDLEF 258
+ L S++ H+D+ N +++ +K+ D G + V T +++
Sbjct: 141 KGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 200
Query: 259 ASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQC 317
+ E L + +D+WS GVLL+ L++ G P+ D + + ++ PE C
Sbjct: 201 MALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 259
Query: 318 GHISVPARELIGQLLNTHADKRPTAGQLLQ 347
P E++ + + A+ RP+ +L+
Sbjct: 260 ---PDPLYEVMLKCWHPKAEMRPSFSELVS 286
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 1e-33
Identities = 59/315 (18%), Positives = 108/315 (34%), Gaps = 50/315 (15%)
Query: 70 GHTYTFCINNEYKVLYTVPFETRWQQEQFEHRYEELERLGNGRFCTVRKARDRG-----T 124
G+ Y + + P++ +W E +R + LG G F V +A G
Sbjct: 1 GNNYVYIDPTQL------PYDHKW--EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDA 52
Query: 125 GQLVALKQIPRERQPQQITR--AEYNLLSTLM-HAHIPTALALFENAPVPGTDTIVMQLV 181
VA+K + + +E +LS L H +I L G ++ +
Sbjct: 53 AMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI---GGPTLVITEYC 109
Query: 182 HGESLIQHLCR------------------QSTITESYICCIIRQLHSALHCLHSQQIAHK 223
L+ L R + + + Q+ + L S+ H+
Sbjct: 110 CYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHR 169
Query: 224 DIRPENIL-MNGAVLKLIDLGSSVSV---------STVVLPDLEFASPEMLTSPATAGPS 273
D+ NIL +G + K+ D G + + LP A + T
Sbjct: 170 DLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYT--FE 227
Query: 274 TDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLN 333
+D+WS G+ L+ L S S +++ + + F H +++ +
Sbjct: 228 SDVWSYGIFLWELFSLGSSPYPGMPVDSKFY-KMIKEGFRMLSPEHAPAEMYDIMKTCWD 286
Query: 334 THADKRPTAGQLLQV 348
KRPT Q++Q+
Sbjct: 287 ADPLKRPTFKQIVQL 301
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 2e-33
Identities = 60/343 (17%), Positives = 119/343 (34%), Gaps = 68/343 (19%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQ---QITRAEYNLLSTLMHAH 157
RY+ L+ +G+G V A D + VA+K++ R Q Q + E L+ + H +
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 158 IPTALALFENAPVPGTDT---IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHC 214
I + L +F +VM+L+ + ++ Q+ +
Sbjct: 78 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD---HERMSYLLYQMLCGIKH 134
Query: 215 LHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVS-----TVVLPDLEFASPEMLTSPA 268
LHS I H+D++P NI++ LK++D G + + T + + +PE++
Sbjct: 135 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 194
Query: 269 TAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPE------------- 315
+ D+WS+G ++ ++ F + + + PE
Sbjct: 195 Y-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 253
Query: 316 -------------------------QCGHISVPARELIGQLLNTHADKRPTAGQLLQVAW 350
+ AR+L+ ++L KR + LQ +
Sbjct: 254 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 313
Query: 351 FAEASC-------------SEFDTERLLPFSARRKQKFKEIQD 380
+ D ER ++ +KE+ +
Sbjct: 314 INVWYDPAEVEAPPPQIYDKQLD-EREHTIEEWKELIYKEVMN 355
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 6e-33
Identities = 44/275 (16%), Positives = 95/275 (34%), Gaps = 34/275 (12%)
Query: 100 HRYEELERLGNGRFCTVRKARDRG-----TGQLVALKQIPRERQPQQITR--AEYNLLST 152
+ LG G F V + +G VA+K + ++ E +++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 153 LMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLC----------RQSTITESYIC 202
H+ L + ++M+L+ L +L + + S +
Sbjct: 80 FNCHHVVRLLGVVSQ---GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136
Query: 203 CIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLG--------SSVSVSTVVL 253
+ ++ + L++ + H+D+ N ++ +K+ D G L
Sbjct: 137 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 254 PDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGV-SPFLDESEEETRAHISVADYSF 312
+ + SPE L +D+WS GV+L+ + + P+ S E+ +
Sbjct: 197 LPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD 255
Query: 313 PPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQ 347
P+ C EL+ + RP+ +++
Sbjct: 256 KPDNC---PDMLFELMRMCWQYNPKMRPSFLEIIS 287
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 3e-32
Identities = 44/267 (16%), Positives = 98/267 (36%), Gaps = 25/267 (9%)
Query: 100 HRYEELERLGNGRFCTVRKARDRGTGQ----LVALKQIPRERQPQQITR--AEYNLLSTL 153
+ +G G F V K + + VA+K + +Q E ++
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 154 MHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQS-TITESYICCIIRQLHSAL 212
H +I + I+ + + +L + L + + + ++R + + +
Sbjct: 67 SHHNIIRLEGVISK---YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM 123
Query: 213 HCLHSQQIAHKDIRPENILMNG-AVLKLIDLG---------SSVSVSTVVLPDLEFASPE 262
L + H+D+ NIL+N V K+ D G + ++ + + +PE
Sbjct: 124 KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183
Query: 263 MLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHIS 321
++ S D+WS G++++ +++ G P+ + S E I + F
Sbjct: 184 AISYRKFTSAS-DVWSFGIVMWEVMTYGERPYWELSNHEVMKAI---NDGFRLPTPMDCP 239
Query: 322 VPARELIGQLLNTHADKRPTAGQLLQV 348
+L+ Q +RP ++ +
Sbjct: 240 SAIYQLMMQCWQQERARRPKFADIVSI 266
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 1e-31
Identities = 53/296 (17%), Positives = 106/296 (35%), Gaps = 45/296 (15%)
Query: 88 PFETRWQQEQFEHRYEELERLGNGRFCTVRKARDRGT-------GQLVALKQIPRERQPQ 140
P + RW E R + LG G F V A G VA+K + + +
Sbjct: 3 PEDPRW--ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK 60
Query: 141 QITR--AEYNLLSTLM-HAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHL------- 190
++ +E ++ + H +I L G ++++ +L ++L
Sbjct: 61 DLSDLISEMEMMKMIGKHKNIINLLGACTQ---DGPLYVIVEYASKGNLREYLQARRPPG 117
Query: 191 ---------CRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG------- 234
+ ++ + Q+ + L S++ H+D+ N+L+
Sbjct: 118 LEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIA 177
Query: 235 --AVLKLIDLGSSVSVSTVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVS 291
+ + I +T +++ +PE L +D+WS GVLL+ + + G S
Sbjct: 178 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGS 236
Query: 292 PFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQ 347
P+ EE + P C + ++ + +RPT QL++
Sbjct: 237 PYPGVPVEELFKLLKEGHRMDKPSNC---TNELYMMMRDCWHAVPSQRPTFKQLVE 289
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (295), Expect = 5e-31
Identities = 48/290 (16%), Positives = 95/290 (32%), Gaps = 46/290 (15%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPT 160
E +G GRF V + + G+ VA+K + AE L H +I
Sbjct: 4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 61
Query: 161 ALALFENAPVPGTDT-IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQ- 218
+A T +V SL +L + T+T + + S L LH +
Sbjct: 62 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 219 -------QIAHKDIRPENILMNG-AVLKLIDLG----------SSVSVSTVVLPDLEFAS 260
IAH+D++ +NIL+ + DLG + + + +
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 261 PEMLTSPAT-----AGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHI---------- 305
PE+L + D++++G++ + + S + + +
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240
Query: 306 ---SVADYSFPPEQCGHISVP-----ARELIGQLLNTHADKRPTAGQLLQ 347
V + P +++ + + R TA ++ +
Sbjct: 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 115 bits (288), Expect = 9e-30
Identities = 70/326 (21%), Positives = 112/326 (34%), Gaps = 69/326 (21%)
Query: 101 RYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHA---- 156
RY + +LG G F TV A+D VA+K + ++ + E LL + A
Sbjct: 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTK 73
Query: 157 -------HIPTALALFENAPVPGTDTIVMQLVHG--ESLIQHLCRQSTITESYICCIIRQ 207
HI L F + G +++ V G + I Y+ I +Q
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 208 LHSALHCLHSQQ-IAHKDIRPENILM-------NGAVLKLIDLGSSVSVST---VVLPDL 256
L L +H + I H DI+PEN+LM N +K+ DLG++ +
Sbjct: 134 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193
Query: 257 EFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDES------EEETRAHISVADY 310
E+ SPE+L A G D+WS L++ L++G F + +++ A I
Sbjct: 194 EYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 252
Query: 311 SFPPEQ--------------------------------------CGHISVPARELIGQLL 332
P + + + +L
Sbjct: 253 ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 312
Query: 333 NTHADKRPTAGQLLQVAWFAEASCSE 358
KR AG L+ W + E
Sbjct: 313 QLDPRKRADAGGLVNHPWLKDTLGME 338
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 4e-29
Identities = 57/295 (19%), Positives = 107/295 (36%), Gaps = 42/295 (14%)
Query: 88 PFET-RWQQEQFEHRYEELERLGNGRFCTVRKARDRG-----TGQLVALKQIPRE--RQP 139
P++ +W E R + + LG G F V +A G T + VA+K +
Sbjct: 2 PYDASKW--EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE 59
Query: 140 QQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHL--------- 190
+ +E +L + H L P G ++++ +L +L
Sbjct: 60 HRALMSELKILIHIGHHLNVVNLLGACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVP 118
Query: 191 -------CRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDL 242
+ +T ++ C Q+ + L S++ H+D+ NIL++ V+K+ D
Sbjct: 119 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDF 178
Query: 243 GSS---------VSVSTVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGV-SP 292
G + V LP A + T +D+WS GVLL+ + S SP
Sbjct: 179 GLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT--IQSDVWSFGVLLWEIFSLGASP 236
Query: 293 FLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQ 347
+ +E + + + + + +RPT +L++
Sbjct: 237 YPGVKIDEEFCRRLKEGTRMRAPD--YTTPEMYQTMLDCWHGEPSQRPTFSELVE 289
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 78.7 bits (193), Expect = 8e-18
Identities = 29/202 (14%), Positives = 58/202 (28%), Gaps = 38/202 (18%)
Query: 106 ERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP-------------------QQITRAE 146
+ +G G+ V +K + R E
Sbjct: 6 KLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 147 YNLLSTLMHAHIPTALALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIR 206
+ L L +P A NA ++M+L + ++
Sbjct: 65 FRALQKLQGLAVPKVYAWEGNA-------VLMEL-------IDAKELYRVRVENPDEVLD 110
Query: 207 QLHSALHCLHSQQIAHKDIRPENILMNGAVLKLIDLGSSVSVSTVVLPDLEFASPEMLTS 266
+ + + + I H D+ N+L++ + +ID SV V ++ + +
Sbjct: 111 MILEEVAKFYHRGIVHGDLSQYNVLVSEEGIWIIDFPQSVEVGEEGWREILERDVRNIIT 170
Query: 267 PA--TAGPSTDMWSLGVLLYIL 286
T D+ S + IL
Sbjct: 171 YFSRTYRTEKDINS--AIDRIL 190
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 380 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.47 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.29 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.89 | |
| d1bpva_ | 104 | Type I titin module {Human (Homo sapiens) [TaxId: | 97.84 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.84 | |
| d1x5ya1 | 98 | Myosin binding protein C, fast-type {Mouse (Mus mu | 97.64 | |
| d2crza1 | 97 | Fibronectin type-III domain containing protein 3a, | 97.56 | |
| d1x3da1 | 105 | Fibronectin type-III domain containing protein 3a, | 97.36 | |
| d2fnba_ | 95 | Fibronectin, different Fn3 modules {Human (Homo sa | 97.35 | |
| d1x5xa1 | 96 | Fibronectin type-III domain containing protein 3a, | 97.32 | |
| d1x4xa1 | 93 | Fibronectin type-III domain containing protein 3a, | 97.22 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.17 | |
| d1x4za1 | 108 | Brother of CDO precursor (BOC) {Mouse (Mus musculu | 97.16 | |
| d1wf5a1 | 108 | Sidekick 2 {Human (Homo sapiens) [TaxId: 9606]} | 97.11 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.03 | |
| d1wfua_ | 120 | Fibronectin type 3 and ankyrin repeat domains 1 pr | 97.01 | |
| d2crma1 | 107 | Fibronectin type-III domain containing protein 3a, | 96.95 | |
| d2dn7a1 | 94 | Receptor-type tyrosine-protein phosphatase F, PTPR | 96.76 | |
| d1x5za1 | 102 | Receptor-type tyrosine-protein phosphatase delta, | 96.76 | |
| d2b5ic1 | 95 | Cytokine receptor common gamma chain {Human (Homo | 96.72 | |
| d1uema_ | 117 | KIAA1568 protein {Human (Homo sapiens) [TaxId: 960 | 96.68 | |
| d1fnha2 | 90 | Fibronectin, different Fn3 modules {Human (Homo sa | 96.6 | |
| d1k85a_ | 88 | Fibronectin type III domain from chitinase A1. {Ba | 96.57 | |
| d2cuia1 | 101 | Tenascin-X {Human (Homo sapiens) [TaxId: 9606]} | 96.53 | |
| d1fnha1 | 90 | Fibronectin, different Fn3 modules {Human (Homo sa | 96.52 | |
| d1x5ga1 | 103 | Neogenin {Human (Homo sapiens) [TaxId: 9606]} | 96.5 | |
| d2ic2a1 | 107 | Hedgehog receptor iHog {Fruit fly (Drosophila mela | 96.44 | |
| d2vkwa2 | 93 | Neural cell adhesion molecule 1, NCAM {Human (Homo | 96.4 | |
| d1x5la1 | 98 | Ephrin type-A receptor 8 {Human (Homo sapiens) [Ta | 96.36 | |
| d1fnfa2 | 91 | Fibronectin, different Fn3 modules {Human (Homo sa | 96.31 | |
| d2djsa1 | 95 | Ephrin type-B receptor 1 {Human (Homo sapiens) [Ta | 96.31 | |
| d1wisa1 | 111 | Sidekick 2 {Human (Homo sapiens) [TaxId: 9606]} | 96.12 | |
| d2ibga1 | 95 | Hedgehog receptor iHog {Fruit fly (Drosophila mela | 96.06 | |
| d2haza1 | 101 | Neural cell adhesion molecule 1, NCAM {Human (Homo | 96.03 | |
| d1fnfa1 | 94 | Fibronectin, different Fn3 modules {Human (Homo sa | 96.03 | |
| d1uc6a_ | 109 | Ciliary neurotrophic factor receptor alpha {Human | 96.02 | |
| d1wfna1 | 106 | Sidekick 2 {Human (Homo sapiens) [TaxId: 9606]} | 95.98 | |
| d1n26a3 | 104 | Interleukin-6 receptor alpha chain, domains 2 and | 95.94 | |
| d1x5fa1 | 107 | Neogenin {Human (Homo sapiens) [TaxId: 9606]} | 95.88 | |
| d1fnfa3 | 89 | Fibronectin, different Fn3 modules {Human (Homo sa | 95.85 | |
| d1qr4a2 | 88 | Tenascin {Chicken (Gallus gallus) [TaxId: 9031]} | 95.8 | |
| d1cd9b2 | 106 | Granulocyte colony-stimulating factor (GC-SF) rece | 95.76 | |
| d1fnha3 | 89 | Fibronectin, different Fn3 modules {Human (Homo sa | 95.74 | |
| d1axib2 | 106 | Growth hormone receptor {Human (Homo sapiens) [Tax | 95.73 | |
| d1tena_ | 90 | Tenascin {Human (Homo sapiens) [TaxId: 9606]} | 95.69 | |
| d2cuha1 | 102 | Tenascin-X {Human (Homo sapiens) [TaxId: 9606]} | 95.69 | |
| d2d9qb2 | 105 | Granulocyte colony-stimulating factor (GC-SF) rece | 95.62 | |
| d1wfoa1 | 117 | Sidekick 2 {Human (Homo sapiens) [TaxId: 9606]} | 95.62 | |
| d1qg3a2 | 103 | Integrin beta-4 subunit {Human (Homo sapiens) [Tax | 95.6 | |
| d1qr4a1 | 87 | Tenascin {Chicken (Gallus gallus) [TaxId: 9031]} | 95.6 | |
| d1x5aa1 | 94 | Ephrin type-A receptor 1 {Mouse (Mus musculus) [Ta | 95.49 | |
| d2cuma1 | 93 | Tenascin-X {Human (Homo sapiens) [TaxId: 9606]} | 95.37 | |
| d1qg3a1 | 92 | Integrin beta-4 subunit {Human (Homo sapiens) [Tax | 95.37 | |
| d1j8ka_ | 94 | Fibronectin, different Fn3 modules {Human (Homo sa | 95.37 | |
| d1tdqa3 | 86 | Tenascin {Rat (Rattus norvegicus) [TaxId: 10116]} | 95.3 | |
| d1f6fb2 | 103 | Prolactin receptor {Rat (Rattus norvegicus) [TaxId | 95.29 | |
| d1owwa_ | 93 | Fibronectin, different Fn3 modules {Human (Homo sa | 95.24 | |
| d1bqua1 | 95 | Cytokine receptor gp130 cytokine-binding domains { | 95.14 | |
| d1tdqa1 | 93 | Tenascin {Rat (Rattus norvegicus) [TaxId: 10116]} | 95.09 | |
| d1bqua2 | 115 | Cytokine receptor gp130 cytokine-binding domains { | 95.01 | |
| d1cfba1 | 100 | Neuroglian, two amino proximal Fn3 repeats {Drosop | 94.97 | |
| d1v5ja_ | 108 | KIAA1355 {Human (Homo sapiens) [TaxId: 9606]} | 94.96 | |
| d1x4ya1 | 101 | Brother of CDO precursor (BOC) {Mouse (Mus musculu | 94.92 | |
| d1fnaa_ | 91 | Fibronectin, different Fn3 modules {Human (Homo sa | 94.81 | |
| d1wk0a_ | 137 | Fibronectin type-III domain containing protein 3a, | 94.81 | |
| d1x5ka1 | 111 | Neogenin {Human (Homo sapiens) [TaxId: 9606]} | 94.69 | |
| d1x5ja1 | 100 | Neogenin {Human (Homo sapiens) [TaxId: 9606]} | 94.59 | |
| d1tdqa2 | 92 | Tenascin {Rat (Rattus norvegicus) [TaxId: 10116]} | 94.21 | |
| d1cd9b1 | 107 | Granulocyte colony-stimulating factor (GC-SF) rece | 94.03 | |
| d1erna2 | 105 | Erythropoietin (EPO) receptor {Human (Homo sapiens | 94.02 | |
| d1x5ia1 | 113 | Neogenin {Human (Homo sapiens) [TaxId: 9606]} | 93.96 | |
| d2dtge1 | 102 | Insulin receptor {Human (Homo sapiens) [TaxId: 960 | 93.96 | |
| d3d48r2 | 104 | Prolactin receptor {Human (Homo sapiens) [TaxId: 9 | 93.87 | |
| d1va9a1 | 109 | Down syndrome cell adhesion molecule-like protein | 93.79 | |
| d2b5ib2 | 104 | Interleukin-2 receptor beta chain {Human (Homo sap | 93.63 | |
| d1ueya_ | 127 | KIAA0343 protein {Human (Homo sapiens) [TaxId: 960 | 93.58 | |
| d1iarb2 | 101 | Interleukin-4 receptor alpha chain {Human (Homo sa | 93.44 | |
| d1cfba2 | 105 | Neuroglian, two amino proximal Fn3 repeats {Drosop | 93.29 | |
| d1wfta_ | 123 | Host cell factor 2, HCF-2 {Mouse (Mus musculus) [T | 93.06 | |
| d1x5ha1 | 119 | Neogenin {Human (Homo sapiens) [TaxId: 9606]} | 91.82 | |
| d1wj3a_ | 117 | Contactin 3 (KIAA1496) {Human (Homo sapiens) [TaxI | 91.64 | |
| d1uena_ | 125 | KIAA0343 protein {Human (Homo sapiens) [TaxId: 960 | 91.52 | |
| d1ujta_ | 120 | KIAA1568 protein {Human (Homo sapiens) [TaxId: 960 | 91.32 | |
| d2cspa1 | 117 | Rim binding protein 2 {Human (Homo sapiens) [TaxId | 91.29 | |
| d2gysa4 | 100 | Common beta-chain in the GM-CSF, IL-3 and IL-5 rec | 88.43 | |
| d2gysa2 | 114 | Common beta-chain in the GM-CSF, IL-3 and IL-5 rec | 85.61 | |
| d1fyhb1 | 98 | Interferon-gamma receptor alpha chain {Human (Homo | 82.17 | |
| d2dtge3 | 125 | Insulin receptor {Human (Homo sapiens) [TaxId: 960 | 81.5 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-63 Score=456.80 Aligned_cols=247 Identities=30% Similarity=0.514 Sum_probs=226.2
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC----CCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
++|++.+.||+|+||+||+|+++.+++.||+|++.+. ......+.+|+++++.++||||+++++++... +..|
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~---~~~~ 82 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA---TRVY 82 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS---SEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEEC---CEEE
Confidence 5799999999999999999999999999999998642 33456778899999999999999999998864 6789
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc----c
Q psy11098 176 IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS----T 250 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~----~ 250 (380)
+||||+.||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|.... .
T Consensus 83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 162 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT 162 (263)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCCE
T ss_pred EEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCccc
Confidence 9999999999999999888999999999999999999999999999999999999998 5699999999997664 4
Q ss_pred cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHH
Q psy11098 251 VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQ 330 (380)
Q Consensus 251 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 330 (380)
...||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+...++....+.++. .+|+++++||.+
T Consensus 163 ~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~ 237 (263)
T d2j4za1 163 TLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISR 237 (263)
T ss_dssp ETTEEGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT----TSCHHHHHHHHH
T ss_pred ccCCCCcccCHHHHcC-CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCc----cCCHHHHHHHHH
Confidence 5678999999999998 57889999999999999999999999999999999999888777664 589999999999
Q ss_pred hcccCCCCCCCHHHHHhccccccc
Q psy11098 331 LLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 331 ~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
||++||++|||++|+|+||||+..
T Consensus 238 ~L~~dp~~R~t~~eil~hp~~~~~ 261 (263)
T d2j4za1 238 LLKHNPSQRPMLREVLEHPWITAN 261 (263)
T ss_dssp HTCSSGGGSCCHHHHHTCHHHHHH
T ss_pred HccCCHhHCcCHHHHHcCcCcCCc
Confidence 999999999999999999999764
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-63 Score=470.38 Aligned_cols=256 Identities=30% Similarity=0.491 Sum_probs=220.9
Q ss_pred hhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCCc
Q psy11098 96 EQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGT 173 (380)
Q Consensus 96 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~ 173 (380)
+++.++|++.+.||+|+||+||+|+++.+|+.||||++.+... ....+.+|+.+|+.++||||+++++++... +.
T Consensus 5 edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~---~~ 81 (307)
T d1a06a_ 5 EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESG---GH 81 (307)
T ss_dssp SCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECS---SE
T ss_pred CCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC---CE
Confidence 4678899999999999999999999999999999999975432 335567899999999999999999998764 77
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe----CCeeEEEeCCCccccc
Q psy11098 174 DTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN----GAVLKLIDLGSSVSVS 249 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~----~~~ikl~DFG~a~~~~ 249 (380)
.|||||||.||+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||+. ++.+||+|||+|+...
T Consensus 82 ~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 82 LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred EEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 899999999999999999888999999999999999999999999999999999999994 4589999999997653
Q ss_pred -----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHH
Q psy11098 250 -----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPA 324 (380)
Q Consensus 250 -----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 324 (380)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......++......+|+++
T Consensus 162 ~~~~~~~~~GT~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 240 (307)
T d1a06a_ 162 PGSVLSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA 240 (307)
T ss_dssp -----------CTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHH
T ss_pred CCCeeeeeeeCccccCcHHHcC-CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHH
Confidence 45679999999999988 478999999999999999999999999999999999999998888877778899999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 325 RELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 325 ~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
++||++||++||++|||++|+|+||||+...
T Consensus 241 ~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 271 (307)
T d1a06a_ 241 KDFIRHLMEKDPEKRFTCEQALQHPWIAGDT 271 (307)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHHSTTTTSSC
T ss_pred HHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 9999999999999999999999999998653
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-63 Score=459.20 Aligned_cols=253 Identities=21% Similarity=0.346 Sum_probs=216.3
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
|.++|++.+.||+|+||+||+|+++.+|+.||||+++.... ..+.+.+|+++++.++||||+++++++... +..|
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~---~~~~ 79 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG---NIQY 79 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEET---TEEE
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccC---ceeE
Confidence 46789999999999999999999999999999999975432 345678899999999999999999998874 6789
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-----
Q psy11098 176 IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS----- 249 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~----- 249 (380)
|||||+.||+|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|+...
T Consensus 80 ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 80 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 9999999999999998888999999999999999999999999999999999999998 5699999999997542
Q ss_pred ---ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHH
Q psy11098 250 ---TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARE 326 (380)
Q Consensus 250 ---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 326 (380)
...+||+.|||||++.+...++.++|||||||++|+|++|+.||...+............... ...+..+|+++++
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~~ 238 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-LNPWKKIDSAPLA 238 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT-STTGGGSCHHHHH
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CCccccCCHHHHH
Confidence 456799999999999885556778999999999999999999997765433322222222222 2224568999999
Q ss_pred HHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 327 LIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 327 li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
||++||+.||++|||++|+|+||||++.
T Consensus 239 li~~~L~~dP~~R~t~~eil~hpwf~~~ 266 (271)
T d1nvra_ 239 LLHKILVENPSARITIPDIKKDRWYNKP 266 (271)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence 9999999999999999999999999864
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-62 Score=455.70 Aligned_cols=265 Identities=26% Similarity=0.423 Sum_probs=227.6
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC-CCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEE
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE-RQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
..++|++++.||+|+||+||+|+++.+|+.||||+++.. ....+.+.+|+++++.++||||++++++|... +..||
T Consensus 18 p~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~---~~~~i 94 (293)
T d1yhwa1 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG---DELWV 94 (293)
T ss_dssp TTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET---TEEEE
T ss_pred cccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEEC---CEEEE
Confidence 456899999999999999999999999999999999654 33556788999999999999999999998874 67899
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------
Q psy11098 177 VMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------ 249 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------ 249 (380)
||||+.||+|.+++.+ ..+++.+++.+++||+.||.|||++||+||||||+|||++ ++.+||+|||+|+...
T Consensus 95 vmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 173 (293)
T d1yhwa1 95 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173 (293)
T ss_dssp EEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred EEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccc
Confidence 9999999999998765 4799999999999999999999999999999999999997 5699999999998653
Q ss_pred ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHH
Q psy11098 250 TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIG 329 (380)
Q Consensus 250 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 329 (380)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+..... ........+|+++++||+
T Consensus 174 ~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~~li~ 251 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSAIFRDFLN 251 (293)
T ss_dssp CCCCSCGGGCCHHHHSS-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS-CCCSSGGGSCHHHHHHHH
T ss_pred cccccCCCccChhhhcC-CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC-CCCCCcccCCHHHHHHHH
Confidence 45679999999999988 5788999999999999999999999999887776666554332 112233568999999999
Q ss_pred HhcccCCCCCCCHHHHHhcccccccCCCCCccccccchHHHHH
Q psy11098 330 QLLNTHADKRPTAGQLLQVAWFAEASCSEFDTERLLPFSARRK 372 (380)
Q Consensus 330 ~~L~~dP~~Rpt~~e~L~hpw~~~~~~~~~~~~~~~~~~~~~~ 372 (380)
+||++||++|||++|+|+||||+... ....+.|.+.+-|
T Consensus 252 ~~L~~dP~~R~s~~eil~Hp~~~~~~----~~~~l~p~~~~~~ 290 (293)
T d1yhwa1 252 RCLDMDVEKRGSAKELLQHQFLKIAK----PLSSLTPLIAAAK 290 (293)
T ss_dssp HHTCSSTTTSCCHHHHTTCGGGGGCC----CGGGGHHHHHHHH
T ss_pred HHccCChhHCcCHHHHhcCHhhCCCC----CCCcCCCCCcccc
Confidence 99999999999999999999997542 2333566666544
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-61 Score=454.23 Aligned_cols=257 Identities=33% Similarity=0.574 Sum_probs=233.0
Q ss_pred hhhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC-------chHHHHHHHHHHHhhccCCCcceeeeccc
Q psy11098 95 QEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ-------PQQITRAEYNLLSTLMHAHIPTALALFEN 167 (380)
Q Consensus 95 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-------~~~~~~~E~~il~~l~h~ni~~i~~~~~~ 167 (380)
.+.+.++|++.+.||+|+||+||+|+++.+|+.||||++++... ..+.+.+|+.+|+.++||||++++++|..
T Consensus 5 ~~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 84 (293)
T d1jksa_ 5 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN 84 (293)
T ss_dssp CSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 45578899999999999999999999999999999999964321 24678899999999999999999999876
Q ss_pred ccCCCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-C----eeEEEeC
Q psy11098 168 APVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-A----VLKLIDL 242 (380)
Q Consensus 168 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~----~ikl~DF 242 (380)
. +..|||||||.||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++. + .+||+||
T Consensus 85 ~---~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 85 K---TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp S---SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred C---CEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecch
Confidence 4 678999999999999999998889999999999999999999999999999999999999973 2 5999999
Q ss_pred CCccccc-----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcC
Q psy11098 243 GSSVSVS-----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQC 317 (380)
Q Consensus 243 G~a~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 317 (380)
|+|.... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+...++......++....
T Consensus 162 G~a~~~~~~~~~~~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 240 (293)
T d1jksa_ 162 GLAHKIDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 240 (293)
T ss_dssp TTCEECTTSCBCSCCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred hhhhhcCCCccccccCCCCcccCHHHHcC-CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhc
Confidence 9997653 35678999999999988 57899999999999999999999999999999999999998888887777
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 318 GHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 318 ~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
..+|.++++||++||++||++|||++|+|+||||+...
T Consensus 241 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 278 (293)
T d1jksa_ 241 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 278 (293)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 78999999999999999999999999999999998653
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.4e-61 Score=463.66 Aligned_cols=258 Identities=29% Similarity=0.509 Sum_probs=234.2
Q ss_pred hhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC-chHHHHHHHHHHHhhccCCCcceeeecccccCCCce
Q psy11098 96 EQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ-PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 96 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~ 174 (380)
+.+.++|++.+.||+|+||+||+|+++.+|+.||||++..... ..+.+.+|+++|+.++||||+++++++... +..
T Consensus 22 ~~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~---~~~ 98 (350)
T d1koaa2 22 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD---NEM 98 (350)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEET---TEE
T ss_pred CCCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEEC---CEE
Confidence 3456799999999999999999999999999999999976543 346678899999999999999999998864 788
Q ss_pred EEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe---CCeeEEEeCCCccccc-
Q psy11098 175 TIVMQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN---GAVLKLIDLGSSVSVS- 249 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~---~~~ikl~DFG~a~~~~- 249 (380)
|||||||.||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|+...
T Consensus 99 ~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 99 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp EEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred EEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 999999999999999954 56799999999999999999999999999999999999996 3589999999998764
Q ss_pred ----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHH
Q psy11098 250 ----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAR 325 (380)
Q Consensus 250 ----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 325 (380)
....||+.|||||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+....+.++...+..+|++++
T Consensus 179 ~~~~~~~~gT~~Y~aPEv~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 257 (350)
T d1koaa2 179 KQSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK 257 (350)
T ss_dssp TSCEEEECSCTTTCCHHHHHT-CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHH
T ss_pred ccccceecCcccccCHHHHcC-CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence 35689999999999988 4778999999999999999999999999999999999999998888877788999999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhcccccccCCC
Q psy11098 326 ELIGQLLNTHADKRPTAGQLLQVAWFAEASCS 357 (380)
Q Consensus 326 ~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~~ 357 (380)
+||++||++||++|||++|+|+||||++....
T Consensus 258 ~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~ 289 (350)
T d1koaa2 258 DFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 289 (350)
T ss_dssp HHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCC
T ss_pred HHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence 99999999999999999999999999876543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-62 Score=453.14 Aligned_cols=254 Identities=26% Similarity=0.434 Sum_probs=228.7
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC----CCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
++|++.+.||+|+||+||+|+++.+|+.||||++.+. ....+.+.+|+++++.++||||+++++++... +..|
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~---~~~~ 84 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD---EKLY 84 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS---SEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEEC---CEEE
Confidence 5799999999999999999999999999999999642 33456788999999999999999999998764 6789
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-----
Q psy11098 176 IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS----- 249 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~----- 249 (380)
+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|+.+.
T Consensus 85 ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 85 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 9999999999999999989999999999999999999999999999999999999998 5699999999997653
Q ss_pred ---ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHH
Q psy11098 250 ---TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARE 326 (380)
Q Consensus 250 ---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 326 (380)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+...++....+.++. .+++++++
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~ 239 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE----KFFPKARD 239 (288)
T ss_dssp -----CCCCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCT----TCCHHHHH
T ss_pred cccccccCCccccCceeecc-CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCc----cCCHHHHH
Confidence 34679999999999988 47889999999999999999999999999999999999888877763 58999999
Q ss_pred HHHHhcccCCCCCCCHHH------HHhcccccccCCCCCcc
Q psy11098 327 LIGQLLNTHADKRPTAGQ------LLQVAWFAEASCSEFDT 361 (380)
Q Consensus 327 li~~~L~~dP~~Rpt~~e------~L~hpw~~~~~~~~~~~ 361 (380)
||++||++||++|||++| +++||||+...+..+..
T Consensus 240 li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~~ 280 (288)
T d1uu3a_ 240 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQ 280 (288)
T ss_dssp HHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGG
T ss_pred HHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhhc
Confidence 999999999999999998 58899998876665543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3e-61 Score=453.94 Aligned_cols=256 Identities=23% Similarity=0.338 Sum_probs=225.4
Q ss_pred hhhhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCc----hHHHHHHHHHHHhhccCCCcceeeecccccC
Q psy11098 95 QEQFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP----QQITRAEYNLLSTLMHAHIPTALALFENAPV 170 (380)
Q Consensus 95 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~----~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~ 170 (380)
.++..+.|++++.||+|+||+||+|+++.+|+.||||+++..... .+.+.+|+++|+.++||||+++++++...
T Consensus 10 ~~dp~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-- 87 (309)
T d1u5ra_ 10 KDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-- 87 (309)
T ss_dssp CSCHHHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--
T ss_pred ccCcHHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEEC--
Confidence 345677899999999999999999999999999999999765432 24567899999999999999999998764
Q ss_pred CCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc
Q psy11098 171 PGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS 249 (380)
Q Consensus 171 ~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~ 249 (380)
+..|||||||.||+|..++.....+++.+++.+++||+.||.|||++||+||||||+|||++ ++.+||+|||+|....
T Consensus 88 -~~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (309)
T d1u5ra_ 88 -HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (309)
T ss_dssp -TEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred -CEEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccC
Confidence 67899999999999988888888999999999999999999999999999999999999998 5699999999998664
Q ss_pred --ccccCCCcccCCccccC--CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHH
Q psy11098 250 --TVVLPDLEFASPEMLTS--PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAR 325 (380)
Q Consensus 250 --~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 325 (380)
....||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+.+..+....+........ ....+|++++
T Consensus 167 ~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~s~~~~ 244 (309)
T d1u5ra_ 167 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL--QSGHWSEYFR 244 (309)
T ss_dssp SBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC--SCTTSCHHHH
T ss_pred CCCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC--CCCCCCHHHH
Confidence 56789999999999864 24578899999999999999999999999888887777766554332 2346899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 326 ELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 326 ~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
+||++||++||++|||++|+|+||||.+..
T Consensus 245 ~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~ 274 (309)
T d1u5ra_ 245 NFVDSCLQKIPQDRPTSEVLLKHRFVLRER 274 (309)
T ss_dssp HHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred HHHHHHCcCChhHCcCHHHHHhCHHhcCCC
Confidence 999999999999999999999999998753
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-61 Score=449.52 Aligned_cols=252 Identities=25% Similarity=0.335 Sum_probs=222.5
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC-CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER-QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIV 177 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv 177 (380)
.+.|++++.||+|+||+||+|+++.+|+.||||++.... ...+.+.+|+++|+.++||||+++++++... +..+||
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~---~~~~lv 87 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYE---NNLWIL 87 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEET---TEEEEE
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC---CeEEEE
Confidence 467999999999999999999999999999999997543 3456788999999999999999999998764 678999
Q ss_pred EEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------
Q psy11098 178 MQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------ 249 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------ 249 (380)
|||+.||+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|....
T Consensus 88 mEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~ 167 (288)
T d2jfla1 88 IEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 167 (288)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHH
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCcccc
Confidence 999999999998765 45799999999999999999999999999999999999998 5699999999997653
Q ss_pred ccccCCCcccCCccccC----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHH
Q psy11098 250 TVVLPDLEFASPEMLTS----PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAR 325 (380)
Q Consensus 250 ~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 325 (380)
....||+.|+|||++.. ...++.++|||||||++|+|++|..||.+.+..+...++........ .....+|++++
T Consensus 168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~s~~~~ 246 (288)
T d2jfla1 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTL-AQPSRWSSNFK 246 (288)
T ss_dssp TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCC-SSGGGSCHHHH
T ss_pred cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC-CccccCCHHHH
Confidence 46789999999999852 24678899999999999999999999999888888888776654322 22346899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 326 ELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 326 ~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
+||++||++||++|||++|+|+||||+..
T Consensus 247 ~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 247 DFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred HHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 99999999999999999999999999754
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-61 Score=456.07 Aligned_cols=249 Identities=26% Similarity=0.447 Sum_probs=227.5
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC----CCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
++|++++.||+|+||+||+|+++.+|+.||||++++. ......+.+|+.+|+.++||||++++++|... +.+|
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~---~~~~ 81 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH---DRLC 81 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS---SEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccc---cccc
Confidence 5799999999999999999999999999999999643 33456678899999999999999999999874 6789
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-----
Q psy11098 176 IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS----- 249 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~----- 249 (380)
+||||+.||+|.+++.....++|..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|+...
T Consensus 82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~ 161 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 161 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCcc
Confidence 9999999999999999999999999999999999999999999999999999999998 5799999999998653
Q ss_pred -ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHH
Q psy11098 250 -TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELI 328 (380)
Q Consensus 250 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 328 (380)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..++...+....+.+|. .+|+++++||
T Consensus 162 ~~~~~GT~~Y~aPE~~~~-~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~dli 236 (337)
T d1o6la_ 162 MKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLL 236 (337)
T ss_dssp BCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHH
T ss_pred cccceeCHHHhhhhhccC-CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCc----cCCHHHHHHH
Confidence 35689999999999998 47799999999999999999999999999999999999888877764 5899999999
Q ss_pred HHhcccCCCCCC-----CHHHHHhcccccccCC
Q psy11098 329 GQLLNTHADKRP-----TAGQLLQVAWFAEASC 356 (380)
Q Consensus 329 ~~~L~~dP~~Rp-----t~~e~L~hpw~~~~~~ 356 (380)
++||++||.+|+ +++|+++||||.+..+
T Consensus 237 ~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~ 269 (337)
T d1o6la_ 237 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 269 (337)
T ss_dssp HHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred HhhccCCchhhcccccccHHHHHcCcccccCCH
Confidence 999999999999 4999999999987543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=9.6e-61 Score=458.27 Aligned_cols=254 Identities=29% Similarity=0.525 Sum_probs=232.0
Q ss_pred hhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC-chHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 97 QFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ-PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 97 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
.+.++|++++.||+|+||+||+|+++.+|+.||||+++.... ....+.+|+++|+.++||||++++++|... +.+|
T Consensus 26 ~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~---~~~~ 102 (352)
T d1koba_ 26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK---YEMV 102 (352)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS---SEEE
T ss_pred CcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC---CEEE
Confidence 356789999999999999999999999999999999976543 345678899999999999999999998764 7789
Q ss_pred EEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe---CCeeEEEeCCCccccc--
Q psy11098 176 IVMQLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN---GAVLKLIDLGSSVSVS-- 249 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~---~~~ikl~DFG~a~~~~-- 249 (380)
||||||.||+|.+.+... ..+++.+++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|....
T Consensus 103 ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 103 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred EEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC
Confidence 999999999999988654 4699999999999999999999999999999999999997 4689999999998764
Q ss_pred ---ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHH
Q psy11098 250 ---TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARE 326 (380)
Q Consensus 250 ---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 326 (380)
....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+....+.++...+..+|+++++
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 261 (352)
T d1koba_ 183 EIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD 261 (352)
T ss_dssp SCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHH
T ss_pred CceeeccCcccccCHHHHcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 35688999999999988 57899999999999999999999999999999999999999988888888889999999
Q ss_pred HHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 327 LIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 327 li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
||++||++||++|||++|+|+||||+..
T Consensus 262 li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 262 FIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp HHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred HHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 9999999999999999999999999865
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-61 Score=455.65 Aligned_cols=254 Identities=28% Similarity=0.517 Sum_probs=234.3
Q ss_pred hhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEE
Q psy11098 97 QFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 97 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
++.++|++++.||+|+||+||+|+++.+|+.||||+++........+.+|+++|+.++||||++++++|... +.+||
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~---~~~~l 78 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESM---EELVM 78 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEET---TEEEE
T ss_pred CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC---CEEEE
Confidence 356889999999999999999999999999999999988777777788999999999999999999998864 78899
Q ss_pred EEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC---CeeEEEeCCCccccc---
Q psy11098 177 VMQLVHGESLIQHLCRQS-TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG---AVLKLIDLGSSVSVS--- 249 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~~~-~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~---~~ikl~DFG~a~~~~--- 249 (380)
|||||.||+|.+++...+ .+++.+++.++.||+.||.|||++||+||||||+|||++. ..+||+|||++....
T Consensus 79 vmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 999999999999997654 7999999999999999999999999999999999999973 379999999998664
Q ss_pred --ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHH
Q psy11098 250 --TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAREL 327 (380)
Q Consensus 250 --~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 327 (380)
....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+...++....+.++...+..+|+++++|
T Consensus 159 ~~~~~~~t~~y~ape~~~~-~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 237 (321)
T d1tkia_ 159 NFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237 (321)
T ss_dssp EEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHH
T ss_pred cccccccccccccchhccC-CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHH
Confidence 35578999999999988 578899999999999999999999999999999999999999888887778899999999
Q ss_pred HHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 328 IGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 328 i~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
|++||.+||++|||++|+|+||||++.
T Consensus 238 i~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 238 VDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHccCChhHCcCHHHHhcCHhhccC
Confidence 999999999999999999999999764
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-61 Score=455.81 Aligned_cols=258 Identities=24% Similarity=0.341 Sum_probs=216.1
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
.++|++++.||+|+||+||+|+++.+|+.||+|+++.... ....+.+|+.+|+.++||||++++++|... +.+|+
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~---~~~~i 81 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD---GEISI 81 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECS---SEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC---CEEEE
Confidence 6789999999999999999999999999999999975433 346778899999999999999999999864 67899
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeecCCCCcEEEe-CCeeEEEeCCCccccc----c
Q psy11098 177 VMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHS-QQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS----T 250 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~-~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~----~ 250 (380)
||||+.||+|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++ ++.+||+|||+|+... .
T Consensus 82 VmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~ 161 (322)
T d1s9ja_ 82 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 161 (322)
T ss_dssp EEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC-
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCccc
Confidence 99999999999999988899999999999999999999997 5999999999999998 5699999999998653 5
Q ss_pred cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---c-------------------
Q psy11098 251 VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISV---A------------------- 308 (380)
Q Consensus 251 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~---~------------------- 308 (380)
..+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....... +
T Consensus 162 ~~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (322)
T d1s9ja_ 162 SFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY 240 (322)
T ss_dssp --CCSSCCCCHHHHHC-SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------------
T ss_pred cccCCccccCchHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccccc
Confidence 6789999999999998 5789999999999999999999999977543322111000 0
Q ss_pred ------------------cCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCCCCCc
Q psy11098 309 ------------------DYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASCSEFD 360 (380)
Q Consensus 309 ------------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~~~~~ 360 (380)
....+......+|.+++|||++||+.||++|||++|+|+||||++......+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~~~~d 310 (322)
T d1s9ja_ 241 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVD 310 (322)
T ss_dssp -----CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHHSCCC
T ss_pred ccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCccccc
Confidence 0001111123468999999999999999999999999999999876544333
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.7e-60 Score=448.90 Aligned_cols=257 Identities=26% Similarity=0.472 Sum_probs=231.2
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC----CCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
++|++++.||+|+||+||+|+++.+|+.||||++++. ....+.+.+|+.+++.++||||+++++++... +..|
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~---~~~~ 80 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA---QQIF 80 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS---SEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeC---Ceee
Confidence 5799999999999999999999999999999999642 33456788899999999999999999998764 7889
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc---cc
Q psy11098 176 IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS---TV 251 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~---~~ 251 (380)
+||||+.||+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|+... ..
T Consensus 81 ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~~~ 160 (316)
T d1fota_ 81 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT 160 (316)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCBCC
T ss_pred eEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecccccc
Confidence 9999999999999999999999999999999999999999999999999999999998 5799999999998764 56
Q ss_pred ccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHh
Q psy11098 252 VLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQL 331 (380)
Q Consensus 252 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 331 (380)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+...++..+...++. .+|++++++|++|
T Consensus 161 ~~Gt~~Y~APE~l~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~~ 235 (316)
T d1fota_ 161 LCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP----FFNEDVKDLLSRL 235 (316)
T ss_dssp CCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHHHHHH
T ss_pred ccCcccccCHHHHcC-CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHH
Confidence 789999999999988 47889999999999999999999999999999999999888776654 5899999999999
Q ss_pred cccCCCCCC-----CHHHHHhcccccccCCCCCccccc
Q psy11098 332 LNTHADKRP-----TAGQLLQVAWFAEASCSEFDTERL 364 (380)
Q Consensus 332 L~~dP~~Rp-----t~~e~L~hpw~~~~~~~~~~~~~~ 364 (380)
|.+||.+|+ |++++|+||||++..+..+...++
T Consensus 236 L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~l~~~~~ 273 (316)
T d1fota_ 236 ITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNI 273 (316)
T ss_dssp TCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCS
T ss_pred hhhCHHhccccchhhHHHHHcCcccccCCHHHHHhCCC
Confidence 999999996 999999999999875554433333
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.7e-60 Score=438.62 Aligned_cols=254 Identities=28% Similarity=0.428 Sum_probs=229.5
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCc----------hHHHHHHHHHHHhhc-cCCCcceeeecc
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP----------QQITRAEYNLLSTLM-HAHIPTALALFE 166 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~----------~~~~~~E~~il~~l~-h~ni~~i~~~~~ 166 (380)
|.++|++.+.||+|+||+||+|+++.+|+.||||++++.... .+.+.+|+.+++.++ ||||+++++++.
T Consensus 1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 80 (277)
T d1phka_ 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 80 (277)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence 468999999999999999999999999999999999764321 134678999999997 999999999988
Q ss_pred cccCCCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCc
Q psy11098 167 NAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSS 245 (380)
Q Consensus 167 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a 245 (380)
. .+..||||||+.||+|.+++..++.+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||++
T Consensus 81 ~---~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 81 T---NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp C---SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred c---CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchhe
Confidence 6 478899999999999999999888999999999999999999999999999999999999998 569999999999
Q ss_pred cccc-----ccccCCCcccCCccccC-----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCC
Q psy11098 246 VSVS-----TVVLPDLEFASPEMLTS-----PATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPE 315 (380)
Q Consensus 246 ~~~~-----~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~ 315 (380)
+.+. ....||+.|+|||++.+ ...++.++||||+||++|+|++|..||.+.+..+....+......++.+
T Consensus 158 ~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 237 (277)
T d1phka_ 158 CQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 237 (277)
T ss_dssp EECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred eEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence 8764 45678999999999853 2356889999999999999999999999999999999998888887777
Q ss_pred cCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 316 QCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 316 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
....+|+++++||++||++||++|||++|+|+||||++.
T Consensus 238 ~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 238 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence 777899999999999999999999999999999999763
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-60 Score=439.82 Aligned_cols=248 Identities=25% Similarity=0.422 Sum_probs=210.3
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCc---hHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP---QQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
.++|++++.||+|+||+||+|+++.+|+.||+|++...... .+.+.+|+++++.++||||+++++++... ..+.+|
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR-TNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-----CEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeC-CCCEEE
Confidence 35799999999999999999999999999999999765432 35577899999999999999999987542 235689
Q ss_pred EEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----cEeecCCCCcEEEe-CCeeEEEeCCCc
Q psy11098 176 IVMQLVHGESLIQHLCR----QSTITESYICCIIRQLHSALHCLHSQQ-----IAHKDIRPENILMN-GAVLKLIDLGSS 245 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~----~~~l~e~~~~~i~~qil~al~~lH~~~-----iiHrDlKp~NIl~~-~~~ikl~DFG~a 245 (380)
|||||+.||+|.+++.+ ...+++..++.++.||+.||.|||++| |+||||||+|||++ ++.+||+|||+|
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 99999999999999864 467999999999999999999999876 99999999999998 569999999999
Q ss_pred cccc------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCC
Q psy11098 246 VSVS------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGH 319 (380)
Q Consensus 246 ~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 319 (380)
+... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+....+...+ ..
T Consensus 162 ~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~---~~ 237 (269)
T d2java1 162 RILNHDTSFAKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP---YR 237 (269)
T ss_dssp HHC-----------CCCSCCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCC---TT
T ss_pred eecccCCCccccCCCCcccCCHHHHcC-CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC---cc
Confidence 7653 45688999999999988 47889999999999999999999999999999988888777654322 46
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHhcccc
Q psy11098 320 ISVPARELIGQLLNTHADKRPTAGQLLQVAWF 351 (380)
Q Consensus 320 ~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~ 351 (380)
+|+++++||++||+.||++|||++|+|+|||+
T Consensus 238 ~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 238 YSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred cCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 89999999999999999999999999999996
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-60 Score=435.90 Aligned_cols=247 Identities=22% Similarity=0.299 Sum_probs=212.7
Q ss_pred eeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---chHHHHHHHHHHHhhccCCCcceeeeccccc-CCCceEEE
Q psy11098 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLMHAHIPTALALFENAP-VPGTDTIV 177 (380)
Q Consensus 102 y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~-~~~~~~lv 177 (380)
|+..++||+|+||+||+|+++.+++.||+|++..... ..+.+.+|+++|+.++||||+++++++.... ....+|||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 3667789999999999999999999999999865432 3456788999999999999999999987532 33567999
Q ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeecCCCCcEEEe--CCeeEEEeCCCccccc----
Q psy11098 178 MQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQ--IAHKDIRPENILMN--GAVLKLIDLGSSVSVS---- 249 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~--iiHrDlKp~NIl~~--~~~ikl~DFG~a~~~~---- 249 (380)
|||+.||+|.+++.+...+++..++.++.||+.||.|||++| |+||||||+|||++ ++.+||+|||+|+...
T Consensus 91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~~ 170 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA 170 (270)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTSB
T ss_pred EeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCCcc
Confidence 999999999999998889999999999999999999999998 99999999999996 4689999999997543
Q ss_pred ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhcccCCCCCCcCCCCCHHHHHHH
Q psy11098 250 TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDES-EEETRAHISVADYSFPPEQCGHISVPARELI 328 (380)
Q Consensus 250 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 328 (380)
...+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.. ..+....+..... +.......++++++||
T Consensus 171 ~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~li 246 (270)
T d1t4ha_ 171 KAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--PASFDKVAIPEVKEII 246 (270)
T ss_dssp EESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--CGGGGGCCCHHHHHHH
T ss_pred CCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCC--CcccCccCCHHHHHHH
Confidence 45689999999999976 47899999999999999999999997754 4455555544322 2233346789999999
Q ss_pred HHhcccCCCCCCCHHHHHhccccc
Q psy11098 329 GQLLNTHADKRPTAGQLLQVAWFA 352 (380)
Q Consensus 329 ~~~L~~dP~~Rpt~~e~L~hpw~~ 352 (380)
++||++||++|||++|+|+||||+
T Consensus 247 ~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 247 EGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHccCCHhHCcCHHHHhCCcccC
Confidence 999999999999999999999996
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.2e-60 Score=452.41 Aligned_cols=252 Identities=23% Similarity=0.419 Sum_probs=228.4
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC----CCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
++|++++.||+|+||+||+|+++.+|+.||||++.+. ....+.+.+|+++|+.++||||+++++++... +..+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~---~~~~ 117 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN---SNLY 117 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS---SEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccc---cccc
Confidence 6899999999999999999999999999999999642 23446678899999999999999999988764 6789
Q ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc---cc
Q psy11098 176 IVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS---TV 251 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~---~~ 251 (380)
+||||+.||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|+... ..
T Consensus 118 ~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~~~ 197 (350)
T d1rdqe_ 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT 197 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCBCC
T ss_pred cccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccccccc
Confidence 9999999999999999988999999999999999999999999999999999999998 5799999999998765 45
Q ss_pred ccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHh
Q psy11098 252 VLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQL 331 (380)
Q Consensus 252 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 331 (380)
..||+.|||||++.+ ..++.++|||||||++|+|++|..||.+.+.......+......++. .+++++.+||++|
T Consensus 198 ~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~~ 272 (350)
T d1rdqe_ 198 LCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNL 272 (350)
T ss_dssp CEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TCCHHHHHHHHHH
T ss_pred ccCccccCCHHHHcC-CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCc----cCCHHHHHHHHHH
Confidence 678999999999998 57899999999999999999999999999999999999888766653 5899999999999
Q ss_pred cccCCCCCC-----CHHHHHhcccccccCCCCC
Q psy11098 332 LNTHADKRP-----TAGQLLQVAWFAEASCSEF 359 (380)
Q Consensus 332 L~~dP~~Rp-----t~~e~L~hpw~~~~~~~~~ 359 (380)
|++||.+|+ |++++|+||||+...+..+
T Consensus 273 L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~ 305 (350)
T d1rdqe_ 273 LQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAI 305 (350)
T ss_dssp SCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHH
T ss_pred hhhCHHhccccccccHHHHHcCccccCCCHHHH
Confidence 999999995 9999999999987654433
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-59 Score=437.47 Aligned_cols=251 Identities=28% Similarity=0.366 Sum_probs=213.2
Q ss_pred eeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCc------hHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEE
Q psy11098 104 ELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP------QQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIV 177 (380)
Q Consensus 104 ~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~------~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv 177 (380)
.++.||+|+||+||+|+++.+|+.||||+++..... ...+.+|+++++.++||||+++++++... +..|||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~---~~~~iv 78 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK---SNISLV 78 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT---TCCEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccC---Cceeeh
Confidence 468899999999999999999999999999654321 24577899999999999999999998874 678999
Q ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------c
Q psy11098 178 MQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------T 250 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------~ 250 (380)
|||+.|+.+..++.....+++..++.+++||+.||+|||++||+||||||+|||++ ++.+||+|||+|.... .
T Consensus 79 mE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~ 158 (299)
T d1ua2a_ 79 FDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT 158 (299)
T ss_dssp EECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCC
T ss_pred hhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccccc
Confidence 99998888877776677899999999999999999999999999999999999998 4699999999997653 3
Q ss_pred cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCC---------------
Q psy11098 251 VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPE--------------- 315 (380)
Q Consensus 251 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~--------------- 315 (380)
..+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+.........+
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhc
Confidence 45789999999999876678999999999999999999999999999888877765322111110
Q ss_pred ---------cCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCCC
Q psy11098 316 ---------QCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASCS 357 (380)
Q Consensus 316 ---------~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~~ 357 (380)
....+++++++||++||+.||++|||++|+|+||||++...+
T Consensus 239 ~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p 289 (299)
T d1ua2a_ 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP 289 (299)
T ss_dssp CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred cCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCC
Confidence 123578899999999999999999999999999999876543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-59 Score=439.23 Aligned_cols=252 Identities=26% Similarity=0.393 Sum_probs=223.4
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC----CCchHHHHHHHHHHH-hhccCCCcceeeecccccCCCce
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE----RQPQQITRAEYNLLS-TLMHAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~il~-~l~h~ni~~i~~~~~~~~~~~~~ 174 (380)
++|++.+.||+|+||+||+|+++.+|+.||||++++. ....+.+..|..++. .++||||+++++++... +..
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~---~~~ 78 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK---ENL 78 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS---SEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC---Cce
Confidence 5799999999999999999999999999999999643 233344555666654 68999999999998874 678
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCccccc----
Q psy11098 175 TIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVS---- 249 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~---- 249 (380)
||||||+.||+|.+++.....+++.+++.++.||+.||.|||++||+||||||+|||++. +.+||+|||+|+...
T Consensus 79 yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 79 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 158 (320)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred eEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccc
Confidence 999999999999999999899999999999999999999999999999999999999984 699999999997553
Q ss_pred --ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHH
Q psy11098 250 --TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAREL 327 (380)
Q Consensus 250 --~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 327 (380)
....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..++...+....+.++. .+|+++++|
T Consensus 159 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~----~~s~~~~dl 233 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR----WLEKEAKDL 233 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT----TSCHHHHHH
T ss_pred cccccCCCCCcCCHHHHcC-CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc----cCCHHHHHH
Confidence 45678999999999998 47889999999999999999999999999999999999888766653 589999999
Q ss_pred HHHhcccCCCCCCCHH-HHHhcccccccCCCCC
Q psy11098 328 IGQLLNTHADKRPTAG-QLLQVAWFAEASCSEF 359 (380)
Q Consensus 328 i~~~L~~dP~~Rpt~~-e~L~hpw~~~~~~~~~ 359 (380)
|++||++||++|||+. ++++||||++..+..+
T Consensus 234 i~~~L~~dP~~R~s~~~~l~~hpff~~~~~~~l 266 (320)
T d1xjda_ 234 LVKLFVREPEKRLGVRGDIRQHPLFREINWEEL 266 (320)
T ss_dssp HHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHHH
T ss_pred HHHhcccCCCCCcCHHHHHHhCchhccCCHHHH
Confidence 9999999999999995 8999999987644333
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-59 Score=443.75 Aligned_cols=254 Identities=29% Similarity=0.451 Sum_probs=217.4
Q ss_pred hhhhceeeee-eecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhh-ccCCCcceeeeccccc-CCCc
Q psy11098 97 QFEHRYEELE-RLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTL-MHAHIPTALALFENAP-VPGT 173 (380)
Q Consensus 97 ~~~~~y~~~~-~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~-~~~~ 173 (380)
.+.++|++++ .||+|+||+||+|+++.+++.||||+++. .....+|+.++..+ +||||++++++|+... ....
T Consensus 8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 4567899885 59999999999999999999999999964 34577899987654 8999999999987532 2356
Q ss_pred eEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC----CeeEEEeCCCccc
Q psy11098 174 DTIVMQLVHGESLIQHLCRQ--STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG----AVLKLIDLGSSVS 247 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~----~~ikl~DFG~a~~ 247 (380)
+|||||||.||+|.+++.+. ..+++.+++.+++||+.||+|||++||+||||||+|||+++ +.+||+|||+|+.
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~ 163 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 163 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeee
Confidence 89999999999999999764 46999999999999999999999999999999999999973 3799999999976
Q ss_pred cc-----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHhcccCCCCCCcCC
Q psy11098 248 VS-----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEE----TRAHISVADYSFPPEQCG 318 (380)
Q Consensus 248 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~~ 318 (380)
.. ...+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+ ....+....+.++...+.
T Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~-~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 242 (335)
T d2ozaa1 164 TTSHNSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 242 (335)
T ss_dssp CCCCCCCCCCSCCCSSCCCCCCCG-GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHH
T ss_pred ccCCCccccccCCcccCCcHHHcC-CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccc
Confidence 53 45689999999999988 578899999999999999999999997765433 344555666777766666
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 319 HISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 319 ~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
.+|+++++||++||++||++|||+.|+|+||||++..
T Consensus 243 ~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 279 (335)
T d2ozaa1 243 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 279 (335)
T ss_dssp HSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence 7899999999999999999999999999999998654
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=9.2e-59 Score=446.54 Aligned_cols=253 Identities=23% Similarity=0.375 Sum_probs=212.1
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC----CchHHHHHH---HHHHHhhccCCCcceeeecccccCCC
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER----QPQQITRAE---YNLLSTLMHAHIPTALALFENAPVPG 172 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~E---~~il~~l~h~ni~~i~~~~~~~~~~~ 172 (380)
++|++.+.||+|+||+||+|+++.+|+.||||++.+.. .....+.+| +.+++.+.||||+++++++... +
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~---~ 80 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP---D 80 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS---S
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC---C
Confidence 57999999999999999999999999999999985432 222334444 5556666799999999888764 6
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc--
Q psy11098 173 TDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS-- 249 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~-- 249 (380)
..|+||||+.||+|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|+...
T Consensus 81 ~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 81 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp EEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred EEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 7899999999999999999999999999999999999999999999999999999999998 5799999999998664
Q ss_pred --ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHH
Q psy11098 250 --TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAREL 327 (380)
Q Consensus 250 --~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 327 (380)
...+||+.|+|||++.....++.++|||||||++|+|++|..||.+.+..+..... ......+......+|+++++|
T Consensus 161 ~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~-~~~~~~~~~~~~~~s~~~~~l 239 (364)
T d1omwa3 161 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-RMTLTMAVELPDSFSPELRSL 239 (364)
T ss_dssp CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH-HHSSSCCCCCCSSSCHHHHHH
T ss_pred cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HhcccCCCCCCCCCCHHHHHH
Confidence 45689999999999976567899999999999999999999999875433322211 122222233335689999999
Q ss_pred HHHhcccCCCCCCC-----HHHHHhcccccccCC
Q psy11098 328 IGQLLNTHADKRPT-----AGQLLQVAWFAEASC 356 (380)
Q Consensus 328 i~~~L~~dP~~Rpt-----~~e~L~hpw~~~~~~ 356 (380)
|.+||++||++||| ++|+|+||||++..+
T Consensus 240 i~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~ 273 (364)
T d1omwa3 240 LEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 273 (364)
T ss_dssp HHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCH
T ss_pred HHHHcccCHHHhCCCcccCHHHHHcCccccCCCH
Confidence 99999999999999 799999999987543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-58 Score=426.67 Aligned_cols=244 Identities=25% Similarity=0.398 Sum_probs=212.3
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC-------chHHHHHHHHHHHhhc--cCCCcceeeecccc
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ-------PQQITRAEYNLLSTLM--HAHIPTALALFENA 168 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-------~~~~~~~E~~il~~l~--h~ni~~i~~~~~~~ 168 (380)
+.++|++.+.||+|+||+||+|+++.+|+.||||++.+... ....+.+|+.+++.++ ||||+++++++...
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 46789999999999999999999999999999999964321 1133567999999997 89999999998764
Q ss_pred cCCCceEEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-C-CeeEEEeCCCc
Q psy11098 169 PVPGTDTIVMQLVHG-ESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-G-AVLKLIDLGSS 245 (380)
Q Consensus 169 ~~~~~~~lv~e~~~g-g~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~-~~ikl~DFG~a 245 (380)
+..|+||||+.+ +++.+++.....+++.+++.++.||+.||.|||++||+||||||+|||++ + +.+||+|||+|
T Consensus 82 ---~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 82 ---DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp ---SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred ---CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccc
Confidence 678999999976 68888898888999999999999999999999999999999999999998 3 58999999999
Q ss_pred cccc----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCC
Q psy11098 246 VSVS----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHIS 321 (380)
Q Consensus 246 ~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 321 (380)
.... ....||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+ .+..+...++ ..+|
T Consensus 159 ~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~~~----~~~s 228 (273)
T d1xwsa_ 159 ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFR----QRVS 228 (273)
T ss_dssp EECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCS----SCCC
T ss_pred eecccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccCCC----CCCC
Confidence 7654 456899999999999876566778999999999999999999997642 3444444444 3589
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 322 VPARELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 322 ~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
+++++||++||++||++|||++|+|+||||++.
T Consensus 229 ~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 229 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 999999999999999999999999999999875
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-57 Score=425.60 Aligned_cols=254 Identities=25% Similarity=0.393 Sum_probs=213.4
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
++|++++.||+|+||+||+|+++.+|+.||||+++.... ....+.+|+++++.++||||+++++++... +.+|+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~---~~~~i 78 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE---NKLYL 78 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEET---TEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccc---cceeE
Confidence 589999999999999999999999999999999965432 346678899999999999999999999874 78899
Q ss_pred EEEecCCCCHHHHHH-h-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc----
Q psy11098 177 VMQLVHGESLIQHLC-R-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS---- 249 (380)
Q Consensus 177 v~e~~~gg~L~~~l~-~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~---- 249 (380)
||||+.++ +.+.+. . ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|+...
T Consensus 79 v~e~~~~~-~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~ 157 (298)
T d1gz8a_ 79 VFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 157 (298)
T ss_dssp EEECCSEE-HHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred EEeecCCc-hhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcc
Confidence 99999654 444443 2 45799999999999999999999999999999999999998 5699999999997653
Q ss_pred --ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCC------------
Q psy11098 250 --TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPE------------ 315 (380)
Q Consensus 250 --~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~------------ 315 (380)
....||+.|+|||++.....++.++|||||||++|+|++|+.||.+.+..+...++..........
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccc
Confidence 345789999999998876677899999999999999999999999988877766654321111100
Q ss_pred -------------cCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCCC
Q psy11098 316 -------------QCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASCS 357 (380)
Q Consensus 316 -------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~~ 357 (380)
....+|.++++||++||++||++|||++|+|+||||++...+
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred cccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 123568899999999999999999999999999999887544
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.4e-56 Score=417.66 Aligned_cols=250 Identities=23% Similarity=0.363 Sum_probs=213.4
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
++|++++.||+|+||+||+|+++ +|+.||||+++.... ....+.+|+.+|+.++||||+++++.+... +..++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~---~~~~i 77 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK---KRLVL 77 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS---SCEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccC---CceeE
Confidence 58999999999999999999986 789999999965432 246778899999999999999999888764 67899
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------
Q psy11098 177 VMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------ 249 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------ 249 (380)
+||++.++.+..+....+.+++..++.+++||+.||+|||++||+||||||+|||++ ++.+||+|||+|....
T Consensus 78 ~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 157 (286)
T d1ob3a_ 78 VFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157 (286)
T ss_dssp EEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred EEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcccc
Confidence 999998877777777788899999999999999999999999999999999999998 5699999999987653
Q ss_pred ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCC----------------
Q psy11098 250 TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFP---------------- 313 (380)
Q Consensus 250 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~---------------- 313 (380)
....+++.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+...++........
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T d1ob3a_ 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (286)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccc
Confidence 3446899999999998767789999999999999999999999999888777666542111100
Q ss_pred ---------CCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccc
Q psy11098 314 ---------PEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAE 353 (380)
Q Consensus 314 ---------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~ 353 (380)
......++++++|||++||++||++|||++|+|+||||++
T Consensus 238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 1123457889999999999999999999999999999975
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-56 Score=417.70 Aligned_cols=257 Identities=24% Similarity=0.320 Sum_probs=212.8
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCC-CcEEEEEEecCC---CCchHHHHHHHHHHHhh---ccCCCcceeeeccccc-
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGT-GQLVALKQIPRE---RQPQQITRAEYNLLSTL---MHAHIPTALALFENAP- 169 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~-~~~vAvK~~~~~---~~~~~~~~~E~~il~~l---~h~ni~~i~~~~~~~~- 169 (380)
..++|++++.||+|+||+||+|++..+ ++.||||+++.. ........+|+.+++.| +||||++++++|....
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 357999999999999999999999765 677999998643 22233456788888777 6999999999886432
Q ss_pred -CCCceEEEEEecCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCcc
Q psy11098 170 -VPGTDTIVMQLVHGESLIQHLC-RQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSV 246 (380)
Q Consensus 170 -~~~~~~lv~e~~~gg~L~~~l~-~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~ 246 (380)
.....+++||++.++.+..... ....+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||++.
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence 2346799999998877654443 3467999999999999999999999999999999999999984 799999999987
Q ss_pred ccc-----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCC---------
Q psy11098 247 SVS-----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSF--------- 312 (380)
Q Consensus 247 ~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~--------- 312 (380)
... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.......
T Consensus 165 ~~~~~~~~~~~~gT~~Y~APE~~~~-~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 243 (305)
T d1blxa_ 165 IYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243 (305)
T ss_dssp CCCGGGGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTC
T ss_pred hhcccccCCCcccChhhcCcchhcC-CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccc
Confidence 553 56789999999999988 578999999999999999999999999999888777764321100
Q ss_pred --------------CCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 313 --------------PPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 313 --------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
.......+++++++||++||++||++|||++|+|+||||++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300 (305)
T ss_dssp SSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence 0112346789999999999999999999999999999998753
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-56 Score=419.62 Aligned_cols=257 Identities=26% Similarity=0.358 Sum_probs=215.8
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC---CchHHHHHHHHHHHhhccCCCcceeeeccccc-----C
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER---QPQQITRAEYNLLSTLMHAHIPTALALFENAP-----V 170 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~-----~ 170 (380)
.++|++++.||+|+||+||+|+++.+|+.||||++.... .....+.+|+++|+.++|+|+++++.++.... .
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 579999999999999999999999999999999986442 23456788999999999999999999875532 2
Q ss_pred CCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc
Q psy11098 171 PGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS 249 (380)
Q Consensus 171 ~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~ 249 (380)
.+..++|||++.++.+.........+++..++.+++||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~ 168 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 168 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecc
Confidence 356799999997777666656677899999999999999999999999999999999999998 5699999999996543
Q ss_pred ----------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCC
Q psy11098 250 ----------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGH 319 (380)
Q Consensus 250 ----------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 319 (380)
...+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+....+......++.+....
T Consensus 169 ~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 248 (318)
T d3blha1 169 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248 (318)
T ss_dssp C-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred cccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccc
Confidence 3457899999999998766789999999999999999999999999988888877765544443332211
Q ss_pred ----------------------------CCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 320 ----------------------------ISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 320 ----------------------------~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
.+++++|||++||++||++|||++|+|+||||+...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p 312 (318)
T d3blha1 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 312 (318)
T ss_dssp CCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSS
T ss_pred cchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCC
Confidence 267789999999999999999999999999998653
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2e-56 Score=414.87 Aligned_cols=255 Identities=24% Similarity=0.318 Sum_probs=218.7
Q ss_pred hhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCc----hHHHHHHHHHHHhhccCCCcceeeecccccC-C
Q psy11098 97 QFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP----QQITRAEYNLLSTLMHAHIPTALALFENAPV-P 171 (380)
Q Consensus 97 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~----~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~-~ 171 (380)
.+.++|++.+.||+|+||+||+|+++.+|+.||||++++.... ...+.+|+++++.++||||+++++++..... .
T Consensus 4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~ 83 (277)
T d1o6ya_ 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 83 (277)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSS
T ss_pred CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCC
Confidence 3578999999999999999999999999999999999754332 2457889999999999999999999876532 2
Q ss_pred CceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-
Q psy11098 172 GTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS- 249 (380)
Q Consensus 172 ~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~- 249 (380)
...||||||+.|++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++ ++.++|+|||.+....
T Consensus 84 ~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 84 PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred ceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcc
Confidence 34789999999999999999989999999999999999999999999999999999999998 5689999999876442
Q ss_pred --------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCC
Q psy11098 250 --------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHIS 321 (380)
Q Consensus 250 --------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 321 (380)
...+||+.|+|||++.+ ..++.++|||||||++|+|+||..||.+.+..+...++.......+......+|
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s 242 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 242 (277)
T ss_dssp ---------------TTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCC
T ss_pred ccccccccccccCcccccCHHHHcC-CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCC
Confidence 34578999999999988 478899999999999999999999999999888888887777666666667899
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhccccc
Q psy11098 322 VPARELIGQLLNTHADKRPTAGQLLQVAWFA 352 (380)
Q Consensus 322 ~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~ 352 (380)
+++++||++||++||++||+..+.|.|+|.+
T Consensus 243 ~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 243 ADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 9999999999999999999555555677764
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-55 Score=421.48 Aligned_cols=255 Identities=24% Similarity=0.361 Sum_probs=211.4
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCc---hHHHHHHHHHHHhhccCCCcceeeeccccc---CC
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP---QQITRAEYNLLSTLMHAHIPTALALFENAP---VP 171 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~E~~il~~l~h~ni~~i~~~~~~~~---~~ 171 (380)
+.++|++++.||+|+||+||+|+++.+|+.||||++++.... .+.+.+|+++|+.++||||++++++|.... ..
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 678999999999999999999999999999999999764433 346678999999999999999999987643 22
Q ss_pred CceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc-
Q psy11098 172 GTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS- 249 (380)
Q Consensus 172 ~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~- 249 (380)
..+|+||||+ |.+|...+ +...+++..++.+++||+.||.|||++||+||||||+|||++ ++.+||+|||+|+...
T Consensus 96 ~~~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~ 173 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 173 (346)
T ss_dssp CCCEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ceEEEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC
Confidence 3579999999 77777665 456899999999999999999999999999999999999998 5699999999998775
Q ss_pred --ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCC---------------
Q psy11098 250 --TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSF--------------- 312 (380)
Q Consensus 250 --~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~--------------- 312 (380)
....||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+.......+.......
T Consensus 174 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (346)
T d1cm8a_ 174 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN 253 (346)
T ss_dssp SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHH
T ss_pred ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhh
Confidence 456789999999999876677899999999999999999999999888776655443221111
Q ss_pred --------C----CCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 313 --------P----PEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 313 --------~----~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
. ......+++++++||++||..||++|||++|+|+||||++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 254 YMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 1 11234678999999999999999999999999999999864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-55 Score=411.38 Aligned_cols=242 Identities=17% Similarity=0.247 Sum_probs=209.6
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVM 178 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~ 178 (380)
.++|++.+.||+|+||+||+|+++.+++.||||+++.+....+.+.+|+++|+.++||||+++++++... +..++||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~---~~~~iv~ 92 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE---PPFYIIT 92 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS---SSCEEEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeC---CeeEEEe
Confidence 4689999999999999999999999999999999988777778889999999999999999999988764 6779999
Q ss_pred EecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------
Q psy11098 179 QLVHGESLIQHLCRQ--STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------ 249 (380)
Q Consensus 179 e~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------ 249 (380)
||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|+...
T Consensus 93 E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~ 172 (287)
T d1opja_ 93 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 172 (287)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEE
T ss_pred ecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCcee
Confidence 999999999999754 5789999999999999999999999999999999999998 4699999999998653
Q ss_pred -ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHH
Q psy11098 250 -TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPF-LDESEEETRAHISVADYSFPPEQCGHISVPAREL 327 (380)
Q Consensus 250 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 327 (380)
....||+.|+|||++.+ ..++.++|||||||++|+|++|..|| .+.+..+....+... ... +....+++++++|
T Consensus 173 ~~~~~g~~~y~aPE~~~~-~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~-~~~--~~~~~~~~~l~~l 248 (287)
T d1opja_ 173 HAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRM--ERPEGCPEKVYEL 248 (287)
T ss_dssp ETTEEECGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-CCC--CCCTTCCHHHHHH
T ss_pred eccccccccccChHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC-CCC--CCCccchHHHHHH
Confidence 22346889999999987 47889999999999999999965554 555555555554433 222 2335689999999
Q ss_pred HHHhcccCCCCCCCHHHHHh
Q psy11098 328 IGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 328 i~~~L~~dP~~Rpt~~e~L~ 347 (380)
|.+||+.||++|||++|+++
T Consensus 249 i~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 249 MRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHH
Confidence 99999999999999999976
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-55 Score=406.82 Aligned_cols=246 Identities=20% Similarity=0.303 Sum_probs=213.9
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVM 178 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~ 178 (380)
.++|++.+.||+|+||+||+|+++ +++.||||+++......+.+.+|+++++.++||||+++++++.. +..++||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~~~~iv~ 86 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ----EPIYIIT 86 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS----SSCEEEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc----CCeEEEE
Confidence 478999999999999999999986 57789999998777777889999999999999999999998754 4679999
Q ss_pred EecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCccccc------
Q psy11098 179 QLVHGESLIQHLCRQ--STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVS------ 249 (380)
Q Consensus 179 e~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~------ 249 (380)
||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+++ +.+||+|||+|+...
T Consensus 87 Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~ 166 (272)
T d1qpca_ 87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (272)
T ss_dssp ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred EeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCcccc
Confidence 999999999977543 46999999999999999999999999999999999999985 599999999998653
Q ss_pred -ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHH
Q psy11098 250 -TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPAREL 327 (380)
Q Consensus 250 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 327 (380)
....||+.|+|||++.+ ..++.++|||||||++|||+| |.+||...+..+....+..+.... ....+++++++|
T Consensus 167 ~~~~~gt~~y~APE~~~~-~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~---~p~~~~~~l~~l 242 (272)
T d1qpca_ 167 REGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV---RPDNCPEELYQL 242 (272)
T ss_dssp CTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCTTCCHHHHHH
T ss_pred ccccCCcccccChHHHhC-CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC---CcccChHHHHHH
Confidence 34568899999999987 477899999999999999999 566677777777777776543222 224689999999
Q ss_pred HHHhcccCCCCCCCHHHHHh--cccccc
Q psy11098 328 IGQLLNTHADKRPTAGQLLQ--VAWFAE 353 (380)
Q Consensus 328 i~~~L~~dP~~Rpt~~e~L~--hpw~~~ 353 (380)
|.+||+.||++|||++|+++ |+||..
T Consensus 243 i~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 243 MRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 99999999999999999998 889864
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-55 Score=416.54 Aligned_cols=257 Identities=24% Similarity=0.345 Sum_probs=210.2
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCc--hHHHHHHHHHHHhhccCCCcceeeecccccCC-Cce
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP--QQITRAEYNLLSTLMHAHIPTALALFENAPVP-GTD 174 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~-~~~ 174 (380)
+.++|++++.||+|+||+||+|+++.+|+.||||++.+.... ...+.+|+++|+.++|+||+++++++...... ...
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 457899999999999999999999999999999999754432 34677899999999999999999998764322 223
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc----
Q psy11098 175 TIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS---- 249 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~---- 249 (380)
+++++++.||+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|....
T Consensus 86 ~~l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 164 (345)
T ss_dssp EEEEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred EEEEEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence 4455666699999999654 799999999999999999999999999999999999998 4699999999987542
Q ss_pred -----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCC-------------
Q psy11098 250 -----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYS------------- 311 (380)
Q Consensus 250 -----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~------------- 311 (380)
...+||+.|+|||++.....++.++||||+||++|+|++|..||.+.+..+...........
T Consensus 165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (345)
T d1pmea_ 165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244 (345)
T ss_dssp BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhh
Confidence 34568999999999977667889999999999999999999999888766555443221110
Q ss_pred -------CCC-------CcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 312 -------FPP-------EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 312 -------~~~-------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
.+. ..+..+++++++||++||++||++|||++|+|+||||++..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~ 302 (345)
T d1pmea_ 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302 (345)
T ss_dssp HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred hhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCC
Confidence 010 12346788999999999999999999999999999998643
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-55 Score=416.91 Aligned_cols=252 Identities=25% Similarity=0.368 Sum_probs=209.2
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeeccccc---CCCceEE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAP---VPGTDTI 176 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~---~~~~~~l 176 (380)
-+|+.+++||+|+||+||+|+++.+|+.||||++.++... ..+|+++|+.++|+||++++++|.... ....++|
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS---CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH---HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 3699999999999999999999999999999999765432 346999999999999999999985432 2235689
Q ss_pred EEEecCCCCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CC-eeEEEeCCCccccc--
Q psy11098 177 VMQLVHGESLIQHL---CRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GA-VLKLIDLGSSVSVS-- 249 (380)
Q Consensus 177 v~e~~~gg~L~~~l---~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~-~ikl~DFG~a~~~~-- 249 (380)
||||+.++.+.... .....+++..++.+++||+.||+|||++||+||||||+|||++ ++ .+||+|||++....
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~ 176 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTT
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCC
Confidence 99999665333322 3456799999999999999999999999999999999999998 44 89999999997653
Q ss_pred ---ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc-----------------c
Q psy11098 250 ---TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVA-----------------D 309 (380)
Q Consensus 250 ---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~-----------------~ 309 (380)
....||+.|+|||++.+...++.++|||||||++|+|++|..||...+..+....+... .
T Consensus 177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~ 256 (350)
T d1q5ka_ 177 EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256 (350)
T ss_dssp SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---C
T ss_pred cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhh
Confidence 45678999999999887668899999999999999999999999988877766655321 1
Q ss_pred CCCCC--------CcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 310 YSFPP--------EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 310 ~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
..++. .....+++++++||++||++||++|||+.|+|+||||++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 257 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp CCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred ccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 11111 1123578999999999999999999999999999999875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.1e-54 Score=412.59 Aligned_cols=252 Identities=23% Similarity=0.360 Sum_probs=209.3
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhc-cCCCcceeeecccccCCCceEEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLM-HAHIPTALALFENAPVPGTDTIV 177 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~-h~ni~~i~~~~~~~~~~~~~~lv 177 (380)
.++|++++.||+|+||+||+|+++.+|+.||||+++.. ....+.+|+++|+.+. |+||++++++|.... ....++|
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~-~~~~~~v 110 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPV-SRTPALV 110 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTT-TCSEEEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH--HHHHHHHHHHHHHhccCCCCCcEEEEEEEecC-CCceeEE
Confidence 46899999999999999999999999999999999654 3456788999999996 999999999987532 3578999
Q ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-C-eeEEEeCCCccccc-----c
Q psy11098 178 MQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-A-VLKLIDLGSSVSVS-----T 250 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~-~ikl~DFG~a~~~~-----~ 250 (380)
|||+.+++|.... ..+++..++.+++||+.||.|||++||+||||||+|||++. + .+||+|||+|.... .
T Consensus 111 ~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~ 187 (328)
T d3bqca1 111 FEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN 187 (328)
T ss_dssp EECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCCC
T ss_pred EeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCCccc
Confidence 9999999986653 57999999999999999999999999999999999999983 4 69999999997653 4
Q ss_pred cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhc-------------ccC------
Q psy11098 251 VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEE-ETRAHISV-------------ADY------ 310 (380)
Q Consensus 251 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~-~~~~~i~~-------------~~~------ 310 (380)
...+|+.|+|||++.+...++.++|||||||++|+|++|..||...... +....+.. ...
T Consensus 188 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 267 (328)
T d3bqca1 188 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF 267 (328)
T ss_dssp SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGG
T ss_pred ccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCccc
Confidence 5678999999999888667899999999999999999999999765432 22111110 000
Q ss_pred --------------CCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccCC
Q psy11098 311 --------------SFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEASC 356 (380)
Q Consensus 311 --------------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~~ 356 (380)
.+.......++++++|||++||++||++|||++|+|+||||++..+
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 268 NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327 (328)
T ss_dssp GGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred chhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 0111122347899999999999999999999999999999987643
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-55 Score=406.10 Aligned_cols=243 Identities=23% Similarity=0.344 Sum_probs=202.9
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCC---CchHHHHHHHHHHHhhccCCCcceeeecccccCCCceE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRER---QPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDT 175 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~ 175 (380)
.++|++.+.||+|+||+||+|+.+ ..||||+++... ...+.+.+|+.+++.++||||++++++... +..+
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~----~~~~ 79 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA----PQLA 79 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS----SSCE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec----cEEE
Confidence 467999999999999999999854 359999996442 334677889999999999999999987643 4679
Q ss_pred EEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc----
Q psy11098 176 IVMQLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS---- 249 (380)
Q Consensus 176 lv~e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~---- 249 (380)
+||||+.||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|+...
T Consensus 80 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp EEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 999999999999999654 5699999999999999999999999999999999999998 4699999999997553
Q ss_pred ----ccccCCCcccCCccccCC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCC--CCcCCCCC
Q psy11098 250 ----TVVLPDLEFASPEMLTSP--ATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFP--PEQCGHIS 321 (380)
Q Consensus 250 ----~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~~~s 321 (380)
....||+.|||||++.+. ..++.++|||||||++|||+||+.||.+.+.......+.......+ ......++
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 239 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 239 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCC
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccch
Confidence 346789999999998753 3478899999999999999999999988765544444433333222 22345689
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 322 VPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 322 ~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
+++++||.+||..||++|||++|++++
T Consensus 240 ~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 240 KAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999999999987
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-54 Score=399.99 Aligned_cols=241 Identities=20% Similarity=0.311 Sum_probs=205.4
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEEE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQ 179 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e 179 (380)
++|++.+.||+|+||+||+|+++ +++.||||+++......+.+.+|+++++.++||||+++++++... +..++|||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~---~~~~lv~E 80 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ---APICLVFE 80 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS---SSCEEEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccC---CceEEEEE
Confidence 47999999999999999999986 567899999988777778889999999999999999999998764 66799999
Q ss_pred ecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCccccc-------c
Q psy11098 180 LVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVS-------T 250 (380)
Q Consensus 180 ~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~-------~ 250 (380)
|+.+|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||+++ +.+||+|||+|+... .
T Consensus 81 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~ 160 (263)
T d1sm2a_ 81 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 160 (263)
T ss_dssp CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred ecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceeec
Confidence 99999999988654 56899999999999999999999999999999999999984 689999999997653 2
Q ss_pred cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHH
Q psy11098 251 VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIG 329 (380)
Q Consensus 251 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 329 (380)
...||+.|+|||++.+ ..++.++|||||||++|||+| |.+||...+..+....+..+.....+ ...++++.+||.
T Consensus 161 ~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p---~~~~~~l~~li~ 236 (263)
T d1sm2a_ 161 GTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP---RLASTHVYQIMN 236 (263)
T ss_dssp ----CTTSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCC---TTSCHHHHHHHH
T ss_pred ceecCcccCChHHhcC-CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCc---cccCHHHHHHHH
Confidence 3567999999999988 478899999999999999999 67788888888888887765433222 357899999999
Q ss_pred HhcccCCCCCCCHHHHHhc
Q psy11098 330 QLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 330 ~~L~~dP~~Rpt~~e~L~h 348 (380)
+||+.||++|||++|+|+|
T Consensus 237 ~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 237 HCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHccCCHhHCcCHHHHHHH
Confidence 9999999999999999987
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-55 Score=416.36 Aligned_cols=256 Identities=26% Similarity=0.360 Sum_probs=213.9
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCc---hHHHHHHHHHHHhhccCCCcceeeeccccc--CCCc
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP---QQITRAEYNLLSTLMHAHIPTALALFENAP--VPGT 173 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~E~~il~~l~h~ni~~i~~~~~~~~--~~~~ 173 (380)
.++|++++.||+|+||+||+|+++.+|+.||||++++.... ...+.+|+++|+.++|+|+++++.++.... ....
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 57899999999999999999999999999999999765433 345678999999999999999999886542 1234
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc---
Q psy11098 174 DTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS--- 249 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~--- 249 (380)
.+++|+++.||+|.+++.. ..+++.+++.+++||+.||+|||++||+||||||+|||++ ++.+|++|||+|....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~~ 175 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM 175 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTGGG
T ss_pred eEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCccc
Confidence 4666777889999998854 5799999999999999999999999999999999999998 5699999999987664
Q ss_pred ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCC---------------
Q psy11098 250 TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPP--------------- 314 (380)
Q Consensus 250 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~--------------- 314 (380)
....||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+.......+.........
T Consensus 176 ~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 255 (348)
T d2gfsa1 176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255 (348)
T ss_dssp SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHH
T ss_pred ccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhh
Confidence 45677999999999887667789999999999999999999999998887777666543322211
Q ss_pred ------------CcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhcccccccC
Q psy11098 315 ------------EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEAS 355 (380)
Q Consensus 315 ------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~~ 355 (380)
.....++++++|||++||+.||++|||++|+|+||||++..
T Consensus 256 ~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 256 QSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp TTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 01245789999999999999999999999999999999753
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-55 Score=403.48 Aligned_cols=238 Identities=21% Similarity=0.315 Sum_probs=203.3
Q ss_pred eeecccCCeEEEEEEEc--CCCcEEEEEEecCCCC---chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEEEe
Q psy11098 106 ERLGNGRFCTVRKARDR--GTGQLVALKQIPRERQ---PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQL 180 (380)
Q Consensus 106 ~~LG~G~fg~V~~~~~~--~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e~ 180 (380)
++||+|+||+||+|.++ .+++.||||+++.... ..+.+.+|+++|+.++||||+++++++.. +..+|||||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~----~~~~lvmE~ 88 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA----ESWMLVMEM 88 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES----SSEEEEEEC
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc----CCEEEEEEc
Confidence 46999999999999865 4567899999965432 23567889999999999999999998854 457999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc---------c
Q psy11098 181 VHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS---------T 250 (380)
Q Consensus 181 ~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~---------~ 250 (380)
+++|+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|+... .
T Consensus 89 ~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~ 168 (277)
T d1xbba_ 89 AELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 168 (277)
T ss_dssp CTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred CCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence 99999999999888999999999999999999999999999999999999998 5799999999997542 2
Q ss_pred cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHH
Q psy11098 251 VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIG 329 (380)
Q Consensus 251 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 329 (380)
...||+.|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+....+..+... +....+|+++++||.
T Consensus 169 ~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~---~~p~~~~~~~~~li~ 244 (277)
T d1xbba_ 169 HGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM---GCPAGCPREMYDLMN 244 (277)
T ss_dssp --CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTTCCHHHHHHHH
T ss_pred ccCCCceecCchhhcC-CCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCC---CCCcccCHHHHHHHH
Confidence 3568999999999987 477889999999999999998 99999999888888887765422 122468999999999
Q ss_pred HhcccCCCCCCCHHHH---Hhcccc
Q psy11098 330 QLLNTHADKRPTAGQL---LQVAWF 351 (380)
Q Consensus 330 ~~L~~dP~~Rpt~~e~---L~hpw~ 351 (380)
+||+.||++|||++++ |+|+|+
T Consensus 245 ~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 245 LCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp HHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 9999999999999998 456554
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-54 Score=400.76 Aligned_cols=252 Identities=24% Similarity=0.374 Sum_probs=214.6
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC---chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ---PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~l 176 (380)
++|++++.||+|+||+||+|+++.+++.||||+++.... ....+.+|+.+++.++|+||++++.++... +..++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~---~~~~i 78 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD---KKLTL 78 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECS---SEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccc---cceeE
Confidence 589999999999999999999999999999999965433 346778899999999999999999988774 67799
Q ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------
Q psy11098 177 VMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------ 249 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------ 249 (380)
+++++.|++|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++ ++.+||+|||.|....
T Consensus 79 v~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~ 158 (292)
T d1unla_ 79 VFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp EEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCC
T ss_pred EeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCccc
Confidence 999999999999888888999999999999999999999999999999999999998 5699999999998654
Q ss_pred ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHhcccCC-----------------
Q psy11098 250 TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFL-DESEEETRAHISVADYS----------------- 311 (380)
Q Consensus 250 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~-~~~~~~~~~~i~~~~~~----------------- 311 (380)
....+++.|+|||++.+...++.++|||||||++|+|++|..||. +.+..+....+......
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T d1unla_ 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccc
Confidence 234568889999999886677899999999999999999998864 44555555544321111
Q ss_pred --------CCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 312 --------FPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 312 --------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
........+++++++||++||+.||++|||++|+|+||||++.
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred cccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 1111234578899999999999999999999999999999864
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-55 Score=416.46 Aligned_cols=263 Identities=27% Similarity=0.434 Sum_probs=219.8
Q ss_pred hhceeeeeeecccCCeEEEEEEE---cCCCcEEEEEEecCCC-----CchHHHHHHHHHHHhhcc-CCCcceeeeccccc
Q psy11098 99 EHRYEELERLGNGRFCTVRKARD---RGTGQLVALKQIPRER-----QPQQITRAEYNLLSTLMH-AHIPTALALFENAP 169 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~---~~~~~~vAvK~~~~~~-----~~~~~~~~E~~il~~l~h-~ni~~i~~~~~~~~ 169 (380)
-++|++++.||+|+||+||+|++ +.+|+.||||++++.. ...+.+.+|+++++.++| +||++++.++...
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~- 101 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE- 101 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC-
Confidence 36799999999999999999997 4478999999986432 234567789999999987 7999999888774
Q ss_pred CCCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCcccc
Q psy11098 170 VPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSV 248 (380)
Q Consensus 170 ~~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~ 248 (380)
...+++|||+.||+|.+++.....+.+..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|...
T Consensus 102 --~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 102 --TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp --TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred --CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 67899999999999999999999999999999999999999999999999999999999998 569999999998754
Q ss_pred c-------ccccCCCcccCCccccCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCCCcCCCC
Q psy11098 249 S-------TVVLPDLEFASPEMLTSP-ATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPPEQCGHI 320 (380)
Q Consensus 249 ~-------~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 320 (380)
. ....|++.|+|||.+.+. ..++.++|||||||++|+|++|..||.+.+..+....+..............+
T Consensus 180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 259 (322)
T d1vzoa_ 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 259 (322)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTS
T ss_pred cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccC
Confidence 2 356789999999999763 35678999999999999999999999887655554444444333333334568
Q ss_pred CHHHHHHHHHhcccCCCCCC-----CHHHHHhcccccccCCCCCccccc
Q psy11098 321 SVPARELIGQLLNTHADKRP-----TAGQLLQVAWFAEASCSEFDTERL 364 (380)
Q Consensus 321 s~~~~~li~~~L~~dP~~Rp-----t~~e~L~hpw~~~~~~~~~~~~~~ 364 (380)
|+++++||++||++||++|| |++|+|+||||++.....+...++
T Consensus 260 s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~ 308 (322)
T d1vzoa_ 260 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKV 308 (322)
T ss_dssp CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCS
T ss_pred CHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHhCCC
Confidence 99999999999999999999 589999999998865554444444
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-54 Score=411.08 Aligned_cols=244 Identities=20% Similarity=0.317 Sum_probs=206.9
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCc-----EEEEEEecCC--CCchHHHHHHHHHHHhh-ccCCCcceeeecccccC
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQ-----LVALKQIPRE--RQPQQITRAEYNLLSTL-MHAHIPTALALFENAPV 170 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~-----~vAvK~~~~~--~~~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~~ 170 (380)
.++|++.+.||+|+||+||+|+++.+++ .||+|.+... ......+.+|+.++..+ +||||+++++++...
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~-- 113 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS-- 113 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC--
Confidence 4689999999999999999999887654 6999998643 33445678899999998 899999999998764
Q ss_pred CCceEEEEEecCCCCHHHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCC
Q psy11098 171 PGTDTIVMQLVHGESLIQHLCRQ-----------------------STITESYICCIIRQLHSALHCLHSQQIAHKDIRP 227 (380)
Q Consensus 171 ~~~~~lv~e~~~gg~L~~~l~~~-----------------------~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp 227 (380)
+..|+|||||.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||
T Consensus 114 -~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp 192 (325)
T d1rjba_ 114 -GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 192 (325)
T ss_dssp -SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred -CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCch
Confidence 6789999999999999999653 2489999999999999999999999999999999
Q ss_pred CcEEEe-CCeeEEEeCCCccccc--------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCC
Q psy11098 228 ENILMN-GAVLKLIDLGSSVSVS--------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDES 297 (380)
Q Consensus 228 ~NIl~~-~~~ikl~DFG~a~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~ 297 (380)
+|||++ ++.+||+|||+|+... ....||+.|||||++.+ ..++.++|||||||++|||+| |..||.+.+
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC-CCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 999998 5699999999997553 24457999999999987 478899999999999999998 899998877
Q ss_pred HHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 298 EEETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 298 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
..+...++......++. ...+|+++++||.+||+.||++|||++|+++|
T Consensus 272 ~~~~~~~~~~~~~~~~~--p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 272 VDANFYKLIQNGFKMDQ--PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp CSHHHHHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHhcCCCCCC--CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 66655555555444332 34689999999999999999999999999987
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-54 Score=401.83 Aligned_cols=248 Identities=20% Similarity=0.286 Sum_probs=212.1
Q ss_pred hhceeeeee-ecccCCeEEEEEEEcC--CCcEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCCc
Q psy11098 99 EHRYEELER-LGNGRFCTVRKARDRG--TGQLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGT 173 (380)
Q Consensus 99 ~~~y~~~~~-LG~G~fg~V~~~~~~~--~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~ 173 (380)
.++|.+.+. ||+|+||+||+|.++. ++..||||+++.... ..+.+.+|+++|+.++||||+++++++.. +.
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~----~~ 82 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA----EA 82 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES----SS
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc----Ce
Confidence 356778884 9999999999998764 345799999976543 24567889999999999999999998864 46
Q ss_pred eEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc--
Q psy11098 174 DTIVMQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS-- 249 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~-- 249 (380)
.||||||+.||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|+...
T Consensus 83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence 7999999999999998865 46799999999999999999999999999999999999998 6799999999997653
Q ss_pred -------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCC
Q psy11098 250 -------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHIS 321 (380)
Q Consensus 250 -------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 321 (380)
....||+.|+|||++.+ ..++.++|||||||++|||+| |..||.+.+..+....+..+... +....++
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~---~~p~~~~ 238 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM---ECPPECP 238 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC---CCCTTCC
T ss_pred ccccccccccccCccccChHHHhC-CCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCcCC
Confidence 24567899999999987 478899999999999999998 99999998888888888765432 2224689
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHH---Hhccccccc
Q psy11098 322 VPARELIGQLLNTHADKRPTAGQL---LQVAWFAEA 354 (380)
Q Consensus 322 ~~~~~li~~~L~~dP~~Rpt~~e~---L~hpw~~~~ 354 (380)
+++.+||.+||+.||++|||+.++ |+|+|+.-.
T Consensus 239 ~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~ 274 (285)
T d1u59a_ 239 PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 274 (285)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence 999999999999999999999888 678888543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-54 Score=396.16 Aligned_cols=241 Identities=23% Similarity=0.315 Sum_probs=215.1
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEEE
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQ 179 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e 179 (380)
++|++.+.||+|+||+||+|+++ +++.||||++++.....+.+.+|+.+++.++||||+++++++... +..++|||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~---~~~~iv~E 79 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ---RPIFIITE 79 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCS---SSEEEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeC---CceEEEEE
Confidence 46888999999999999999985 678999999998877788899999999999999999999988753 67899999
Q ss_pred ecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCccccc-------c
Q psy11098 180 LVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVS-------T 250 (380)
Q Consensus 180 ~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~-------~ 250 (380)
|+.+|+|.+++.. ...+++..+..++.||++||.|||++||+||||||+|||+++ +.+||+|||+|+... .
T Consensus 80 y~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 159 (258)
T d1k2pa_ 80 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 159 (258)
T ss_dssp CCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCC
T ss_pred ccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeec
Confidence 9999999998754 567999999999999999999999999999999999999985 699999999997543 2
Q ss_pred cccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHH
Q psy11098 251 VVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIG 329 (380)
Q Consensus 251 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 329 (380)
...||+.|+|||++.+ ..++.++|||||||++|||+| |+.||.+.+..++...+..+..... ....+.++++||+
T Consensus 160 ~~~~t~~y~aPE~~~~-~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~---p~~~~~~l~~li~ 235 (258)
T d1k2pa_ 160 GSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR---PHLASEKVYTIMY 235 (258)
T ss_dssp CSCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC---CTTCCHHHHHHHH
T ss_pred ccCCCCCcCCcHHhcC-CCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCC---cccccHHHHHHHH
Confidence 3567899999999987 467889999999999999998 8999999999999888877543332 2467899999999
Q ss_pred HhcccCCCCCCCHHHHHhc
Q psy11098 330 QLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 330 ~~L~~dP~~Rpt~~e~L~h 348 (380)
+||+.||++|||++++|+|
T Consensus 236 ~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 236 SCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HTTCSSGGGSCCHHHHHHH
T ss_pred HHccCCHhHCcCHHHHHHH
Confidence 9999999999999999987
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.6e-54 Score=402.55 Aligned_cols=243 Identities=19% Similarity=0.306 Sum_probs=201.6
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCc---EEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCCc
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQ---LVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGT 173 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~---~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~ 173 (380)
.++|++.+.||+|+||+||+|+++.+++ .||||.+..... ..+.+.+|+++|+.++||||+++++++... +.
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~---~~ 101 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS---TP 101 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS---SS
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC---CE
Confidence 4679999999999999999999987765 588998865443 335678999999999999999999998654 67
Q ss_pred eEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc--
Q psy11098 174 DTIVMQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS-- 249 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~-- 249 (380)
.++||||+.||+|.+++.. .+.+++.++..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|+...
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCC
Confidence 8999999999999998876 45799999999999999999999999999999999999998 4699999999997653
Q ss_pred ---------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCC
Q psy11098 250 ---------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGH 319 (380)
Q Consensus 250 ---------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 319 (380)
....||+.|+|||++.+ ..++.++|||||||++|||+| |..||.+.+..+....+..... .+ ....
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~-~~--~~~~ 257 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR-LP--PPMD 257 (299)
T ss_dssp --------------CGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-CC--CCTT
T ss_pred CCcceeeecccccCCccccCHHHHhc-CCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CC--CCcc
Confidence 12356899999999988 478889999999999999998 8999999998888888765432 22 2246
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 320 ISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 320 ~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
+++++.+||.+||+.||++|||+.|++++
T Consensus 258 ~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 258 CPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 89999999999999999999999999876
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-53 Score=396.37 Aligned_cols=249 Identities=20% Similarity=0.255 Sum_probs=212.1
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVM 178 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~ 178 (380)
.++|++.+.||+|+||+||+|+++.+ +.||||+++......+.+.+|+.+++.++|+||+++++++.. +..++||
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~----~~~~lv~ 90 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE----EPIYIVT 90 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS----SSCEEEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec----CCeEEEE
Confidence 46899999999999999999998765 579999998777777889999999999999999999998754 4579999
Q ss_pred EecCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc------
Q psy11098 179 QLVHGESLIQHLCR--QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS------ 249 (380)
Q Consensus 179 e~~~gg~L~~~l~~--~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~------ 249 (380)
||+.+|+|..++.. ...+++.++..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|+...
T Consensus 91 Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 170 (285)
T d1fmka3 91 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 170 (285)
T ss_dssp CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred EecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence 99999999998854 45799999999999999999999999999999999999998 4689999999997552
Q ss_pred -ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHH
Q psy11098 250 -TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSG-VSPFLDESEEETRAHISVADYSFPPEQCGHISVPAREL 327 (380)
Q Consensus 250 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 327 (380)
....||+.|+|||++.. ..++.++|||||||++|||++| .+||.+....+....+..... . +....+++++++|
T Consensus 171 ~~~~~gt~~y~aPE~~~~-~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~-~--~~~~~~~~~l~~l 246 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-M--PCPPECPESLHDL 246 (285)
T ss_dssp -----CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-C--CCCTTSCHHHHHH
T ss_pred eccccccccccChHHHhC-CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC-C--CCCcccCHHHHHH
Confidence 33568999999999987 4778899999999999999994 566667777777777765432 2 2235689999999
Q ss_pred HHHhcccCCCCCCCHHHHHh--cccccccCC
Q psy11098 328 IGQLLNTHADKRPTAGQLLQ--VAWFAEASC 356 (380)
Q Consensus 328 i~~~L~~dP~~Rpt~~e~L~--hpw~~~~~~ 356 (380)
|.+||+.||++|||++++++ ++||.....
T Consensus 247 i~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p 277 (285)
T d1fmka3 247 MCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 277 (285)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred HHHHcccCHhHCcCHHHHHHHHhhhhcCCCC
Confidence 99999999999999999988 899976543
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-53 Score=391.82 Aligned_cols=242 Identities=21% Similarity=0.272 Sum_probs=202.2
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCC---cEEEEEEecCCCCc--hHHHHHHHHHHHhhccCCCcceeeecccccCCCc
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTG---QLVALKQIPRERQP--QQITRAEYNLLSTLMHAHIPTALALFENAPVPGT 173 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~---~~vAvK~~~~~~~~--~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~ 173 (380)
.++|++.+.||+|+||+||+|++..++ ..||||.++..... ...+.+|+++++.++||||+++++++.. +.
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~ 81 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE----NP 81 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS----SS
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec----Ce
Confidence 468999999999999999999987653 46899988654433 4567889999999999999999998853 56
Q ss_pred eEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc--
Q psy11098 174 DTIVMQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS-- 249 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~-- 249 (380)
.|+||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|+...
T Consensus 82 ~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 82 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCC
Confidence 7999999999999998765 45799999999999999999999999999999999999998 5799999999997653
Q ss_pred -----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHH
Q psy11098 250 -----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVP 323 (380)
Q Consensus 250 -----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 323 (380)
....||+.|+|||++.+ ..++.++|||||||++|||++ |.+||.+.+..+....+..+... +....+|++
T Consensus 162 ~~~~~~~~~gt~~y~apE~l~~-~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~---~~~~~~~~~ 237 (273)
T d1mp8a_ 162 TYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---PMPPNCPPT 237 (273)
T ss_dssp ---------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---CCCTTCCHH
T ss_pred cceeccceecCcccchhhHhcc-CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCHH
Confidence 34567999999999987 478889999999999999998 89999999888888887765432 223568999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 324 ARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 324 ~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
+++||.+||+.||++|||++|+++|
T Consensus 238 ~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 238 LYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999999976
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-53 Score=404.85 Aligned_cols=252 Identities=23% Similarity=0.324 Sum_probs=201.7
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCc---hHHHHHHHHHHHhhccCCCcceeeeccccc---CCC
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQP---QQITRAEYNLLSTLMHAHIPTALALFENAP---VPG 172 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~E~~il~~l~h~ni~~i~~~~~~~~---~~~ 172 (380)
.++|+++++||+|+||+||+|+++.+|+.||||++.+.... ...+.+|+.+++.++||||++++++|.... ..+
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 47899999999999999999999999999999999765433 345678999999999999999999986542 336
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc--
Q psy11098 173 TDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS-- 249 (380)
Q Consensus 173 ~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~-- 249 (380)
..|+||||+.+ ++.+.+ ...+++..++.+++||+.||.|||++||+||||||+|||++ ++.+|++|||+++...
T Consensus 96 ~~~iv~Ey~~~-~l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~ 172 (355)
T d2b1pa1 96 DVYLVMELMDA-NLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_dssp EEEEEEECCSE-EHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred eeEEEEeccch-HHHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc
Confidence 78999999955 455555 35689999999999999999999999999999999999998 5689999999987654
Q ss_pred ---ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcccCCCCC------------
Q psy11098 250 ---TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHISVADYSFPP------------ 314 (380)
Q Consensus 250 ---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i~~~~~~~~~------------ 314 (380)
...++|+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+.......+.........
T Consensus 173 ~~~~~~~~t~~y~aPE~l~~-~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 251 (355)
T d2b1pa1 173 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251 (355)
T ss_dssp --------CCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHH
T ss_pred cccccccccccccChhhhcC-CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHH
Confidence 45678999999999988 57889999999999999999999999988877665554321111000
Q ss_pred --------------------------CcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhccccccc
Q psy11098 315 --------------------------EQCGHISVPARELIGQLLNTHADKRPTAGQLLQVAWFAEA 354 (380)
Q Consensus 315 --------------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~hpw~~~~ 354 (380)
......+.++++||++||.+||++||||+|+|+||||+..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp HHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred HhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 0011236678999999999999999999999999999863
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-52 Score=394.35 Aligned_cols=242 Identities=19% Similarity=0.288 Sum_probs=204.9
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCc----EEEEEEecCC--CCchHHHHHHHHHHHhhccCCCcceeeecccccCCCc
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQ----LVALKQIPRE--RQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGT 173 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~----~vAvK~~~~~--~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~ 173 (380)
.+|++++.||+|+||+||+|++..+|+ .||+|.++.. ....+.+.+|+++++.++||||+++++++.. +.
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~----~~ 84 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT----ST 84 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES----SS
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec----CC
Confidence 469999999999999999999988876 5888888643 2345678899999999999999999999865 45
Q ss_pred eEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc--
Q psy11098 174 DTIVMQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS-- 249 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~-- 249 (380)
.++++|++.+++|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|+...
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 7899999999999998866 46799999999999999999999999999999999999998 5699999999987652
Q ss_pred ------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCH
Q psy11098 250 ------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISV 322 (380)
Q Consensus 250 ------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 322 (380)
....||+.|+|||++.+ ..++.++|||||||++|||+| |.+||.+.+..+....+..+.... ....+++
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~---~p~~~~~ 240 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP---QPPICTI 240 (317)
T ss_dssp CC--------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCC---CCTTBCH
T ss_pred cccccccccccCccccChHHHhc-CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC---CCcccCH
Confidence 23467999999999988 478999999999999999998 899999888877777776554321 2246799
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhcc
Q psy11098 323 PARELIGQLLNTHADKRPTAGQLLQVA 349 (380)
Q Consensus 323 ~~~~li~~~L~~dP~~Rpt~~e~L~hp 349 (380)
++.+||.+||+.||++|||+.|+++|-
T Consensus 241 ~~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 241 DVYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence 999999999999999999999999883
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=383.77 Aligned_cols=241 Identities=17% Similarity=0.262 Sum_probs=199.9
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCC----cEEEEEEecCCCCc--hHHHHHHHHHHHhhccCCCcceeeecccccCCCc
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTG----QLVALKQIPRERQP--QQITRAEYNLLSTLMHAHIPTALALFENAPVPGT 173 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~----~~vAvK~~~~~~~~--~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~ 173 (380)
+.|++.+.||+|+||+||+|.++.++ ..||||+++..... ...+.+|+++++.++||||+++++++... +.
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~---~~ 83 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY---KP 83 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS---SS
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC---Cc
Confidence 46889999999999999999987655 47999999755443 34577899999999999999999988754 67
Q ss_pred eEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc--
Q psy11098 174 DTIVMQLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS-- 249 (380)
Q Consensus 174 ~~lv~e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~-- 249 (380)
.++||||+.++++.+.+... ..+++.++..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|+...
T Consensus 84 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred eEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 89999999999999988654 6799999999999999999999999999999999999998 4699999999997642
Q ss_pred -------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHhcccCCCCCCcCCCCC
Q psy11098 250 -------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSG-VSPFLDESEEETRAHISVADYSFPPEQCGHIS 321 (380)
Q Consensus 250 -------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 321 (380)
....||+.|+|||++.+ ..++.++|||||||++|||++| .+||.+.+..+....+..+.. . +....++
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~-~--~~~~~~~ 239 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR-L--PTPMDCP 239 (283)
T ss_dssp ----------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-C--CCCTTCB
T ss_pred CccceEeccCCCCccccCHHHHcc-CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCC-C--CCchhhH
Confidence 23467999999999988 4788899999999999999995 555666677777777665432 2 2234689
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHh
Q psy11098 322 VPARELIGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 322 ~~~~~li~~~L~~dP~~Rpt~~e~L~ 347 (380)
.++.+||.+||+.||++|||+.|+++
T Consensus 240 ~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 240 SAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 99999999999999999999999987
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-52 Score=389.34 Aligned_cols=244 Identities=21% Similarity=0.300 Sum_probs=192.1
Q ss_pred hhceeeeeeecccCCeEEEEEEEcC-----CCcEEEEEEecCCCC--chHHHHHHHHHHHhh-ccCCCcceeeecccccC
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRG-----TGQLVALKQIPRERQ--PQQITRAEYNLLSTL-MHAHIPTALALFENAPV 170 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~~ 170 (380)
.++|++.+.||+|+||+||+|++.. +++.||||+++.... ....+.+|..++..+ +|+||+.+..++...
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~-- 89 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-- 89 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST--
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC--
Confidence 4789999999999999999999764 457899999975433 234556677777776 688998888776543
Q ss_pred CCceEEEEEecCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-
Q psy11098 171 PGTDTIVMQLVHGESLIQHLCRQ----------------STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN- 233 (380)
Q Consensus 171 ~~~~~lv~e~~~gg~L~~~l~~~----------------~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~- 233 (380)
.+..++|||||.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 169 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECG
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECC
Confidence 34679999999999999999643 2489999999999999999999999999999999999998
Q ss_pred CCeeEEEeCCCccccc--------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhC-CCCCCCCCHHH-HHH
Q psy11098 234 GAVLKLIDLGSSVSVS--------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSG-VSPFLDESEEE-TRA 303 (380)
Q Consensus 234 ~~~ikl~DFG~a~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg-~~Pf~~~~~~~-~~~ 303 (380)
++.+||+|||+|+... ....||+.|+|||++.+ ..++.++|||||||++|||++| .+||.+....+ ...
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~ 248 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 5699999999997542 34578999999999988 5788999999999999999986 56887765443 333
Q ss_pred HHhcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 304 HISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 304 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
.+..+ ..++ ....+++++++||.+||+.||++|||++|+++|
T Consensus 249 ~~~~~-~~~~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 249 RLKEG-TRMR--APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHT-CCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhcC-CCCC--CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 33333 2222 234689999999999999999999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-52 Score=383.09 Aligned_cols=242 Identities=21% Similarity=0.308 Sum_probs=200.8
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCC-C--cEEEEEEecCCC----CchHHHHHHHHHHHhhccCCCcceeeecccccCC
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGT-G--QLVALKQIPRER----QPQQITRAEYNLLSTLMHAHIPTALALFENAPVP 171 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~-~--~~vAvK~~~~~~----~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~ 171 (380)
.++|++++.||+|+||+||+|++..+ + ..||||++.+.. ...+.+.+|+.+|+.++||||+++++++..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~---- 82 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT---- 82 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee----
Confidence 35799999999999999999987543 3 368999986532 223567889999999999999999998864
Q ss_pred CceEEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc
Q psy11098 172 GTDTIVMQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS 249 (380)
Q Consensus 172 ~~~~lv~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~ 249 (380)
+..++||||+.+|++.+.+.. ...+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++...
T Consensus 83 ~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 83 PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 457999999999999988765 45799999999999999999999999999999999999998 5699999999998653
Q ss_pred ---------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCC
Q psy11098 250 ---------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGH 319 (380)
Q Consensus 250 ---------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 319 (380)
....|+..|+|||++.+ ..++.++|||||||++|||+| |..||.+.+..+....+......++. ...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~ 239 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR--PED 239 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC--CTT
T ss_pred cCCCcceecCccccCcccCCHHHHhC-CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCC--ccc
Confidence 23457889999999988 578889999999999999998 89999999999998888776654433 357
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy11098 320 ISVPARELIGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 320 ~s~~~~~li~~~L~~dP~~Rpt~~e~L~ 347 (380)
+|+++++||.+||..||++|||++|+++
T Consensus 240 ~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 240 CPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 8999999999999999999999999963
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-51 Score=384.56 Aligned_cols=242 Identities=20% Similarity=0.294 Sum_probs=209.1
Q ss_pred hhceeeeeeecccCCeEEEEEEEcC-----CCcEEEEEEecCCCCc--hHHHHHHHHHHHhhccCCCcceeeecccccCC
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRG-----TGQLVALKQIPRERQP--QQITRAEYNLLSTLMHAHIPTALALFENAPVP 171 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vAvK~~~~~~~~--~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~ 171 (380)
.++|++.+.||+|+||+||+|+++. +++.||||+++..... ...+.+|+++++.++|+||+++++++...
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~--- 88 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG--- 88 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS---
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccC---
Confidence 5689999999999999999999763 5678999999755433 45678999999999999999999988764
Q ss_pred CceEEEEEecCCCCHHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCC
Q psy11098 172 GTDTIVMQLVHGESLIQHLCRQS------------------------TITESYICCIIRQLHSALHCLHSQQIAHKDIRP 227 (380)
Q Consensus 172 ~~~~lv~e~~~gg~L~~~l~~~~------------------------~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp 227 (380)
+..+++|||+.+|+|.+++.... .+++..+..++.||+.||+|||++||+||||||
T Consensus 89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp 168 (301)
T d1lufa_ 89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 168 (301)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcc
Confidence 67799999999999999996432 388999999999999999999999999999999
Q ss_pred CcEEEeC-CeeEEEeCCCccccc--------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhC-CCCCCCCC
Q psy11098 228 ENILMNG-AVLKLIDLGSSVSVS--------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSG-VSPFLDES 297 (380)
Q Consensus 228 ~NIl~~~-~~ikl~DFG~a~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg-~~Pf~~~~ 297 (380)
+|||++. +.+||+|||+|+... ....||+.|+|||++.+ ..++.++|||||||++|||++| .+||.+.+
T Consensus 169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc-CCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 9999984 589999999997542 34567899999999988 4788999999999999999998 57899999
Q ss_pred HHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy11098 298 EEETRAHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 298 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~ 347 (380)
..+....+..+.... ....+++++.+||.+||+.||++|||+.|+++
T Consensus 248 ~~e~~~~v~~~~~~~---~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 248 HEEVIYYVRDGNILA---CPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCCCC---CCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999988887665322 23468999999999999999999999999965
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-51 Score=377.26 Aligned_cols=241 Identities=22% Similarity=0.321 Sum_probs=201.3
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVM 178 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~ 178 (380)
.++|++.+.||+|+||.||+|+++ |..||||+++.+. ..+.+.+|+++++.++||||+++++++... .+.+|+||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~--~~~~~lv~ 80 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEE--KGGLYIVT 80 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC----CCEEEE
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEEec--CCcEEEEE
Confidence 357999999999999999999985 6789999997644 345678899999999999999999987542 24579999
Q ss_pred EecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCeeEEEeCCCccccc---ccc
Q psy11098 179 QLVHGESLIQHLCRQ--STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVLKLIDLGSSVSVS---TVV 252 (380)
Q Consensus 179 e~~~gg~L~~~l~~~--~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~~---~~~ 252 (380)
||+.+|+|.+++.+. ..+++..+..++.||+.||.|||+.+|+||||||+|||++ ++.+||+|||+++... ...
T Consensus 81 ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~~~ 160 (262)
T d1byga_ 81 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 160 (262)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred eccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCCCccc
Confidence 999999999999654 3589999999999999999999999999999999999998 5699999999998654 456
Q ss_pred cCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcccCCCCCCcCCCCCHHHHHHHHHh
Q psy11098 253 LPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETRAHISVADYSFPPEQCGHISVPARELIGQL 331 (380)
Q Consensus 253 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 331 (380)
.+|+.|+|||++.+ ..++.++|||||||++|||+| |.+||...+..+....+..+.. .+....+++++++||++|
T Consensus 161 ~~~~~y~aPE~l~~-~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~---~~~~~~~~~~~~~li~~c 236 (262)
T d1byga_ 161 KLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---MDAPDGCPPAVYEVMKNC 236 (262)
T ss_dssp -CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC---CCCCTTCCHHHHHHHHHH
T ss_pred cccccCCChHHHhC-CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC---CCCCccCCHHHHHHHHHH
Confidence 77999999999987 478899999999999999998 7999998888888877765422 122346789999999999
Q ss_pred cccCCCCCCCHHHHHhc
Q psy11098 332 LNTHADKRPTAGQLLQV 348 (380)
Q Consensus 332 L~~dP~~Rpt~~e~L~h 348 (380)
|..||++|||+.+++++
T Consensus 237 l~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 237 WHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred cccCHhHCcCHHHHHHH
Confidence 99999999999999875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-50 Score=380.33 Aligned_cols=242 Identities=21% Similarity=0.307 Sum_probs=203.8
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCC-------cEEEEEEecCCCCc--hHHHHHHHHHHHhh-ccCCCcceeeecccc
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTG-------QLVALKQIPRERQP--QQITRAEYNLLSTL-MHAHIPTALALFENA 168 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~-------~~vAvK~~~~~~~~--~~~~~~E~~il~~l-~h~ni~~i~~~~~~~ 168 (380)
.++|++.+.||+|+||.||+|++..++ ..||||+++.+... ...+.+|...+..+ +||||+++++++...
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 579999999999999999999987654 37999999765543 35667788888888 799999999998764
Q ss_pred cCCCceEEEEEecCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEE
Q psy11098 169 PVPGTDTIVMQLVHGESLIQHLCRQ----------------STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILM 232 (380)
Q Consensus 169 ~~~~~~~lv~e~~~gg~L~~~l~~~----------------~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~ 232 (380)
+..++||||+.+|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 92 ---~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 ---GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 168 (299)
T ss_dssp ---SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred ---CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee
Confidence 6789999999999999999654 358999999999999999999999999999999999999
Q ss_pred e-CCeeEEEeCCCccccc--------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy11098 233 N-GAVLKLIDLGSSVSVS--------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETR 302 (380)
Q Consensus 233 ~-~~~ikl~DFG~a~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~ 302 (380)
+ ++.+||+|||+++... ....+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+..
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~ 247 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcC-CCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHH
Confidence 8 5699999999998653 23567899999999987 578999999999999999998 79999998888888
Q ss_pred HHHhcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy11098 303 AHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 303 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~ 347 (380)
..+..+.. ++ ....+++++++||.+||+.||++|||+.|+|+
T Consensus 248 ~~i~~~~~-~~--~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 248 KLLKEGHR-MD--KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHTTCC-CC--CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCCC-CC--CCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 77765432 22 23468999999999999999999999999986
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-51 Score=384.04 Aligned_cols=242 Identities=22% Similarity=0.303 Sum_probs=205.8
Q ss_pred hceeeeeeecccCCeEEEEEEEcCCCcE--EEEEEecCCC--CchHHHHHHHHHHHhh-ccCCCcceeeecccccCCCce
Q psy11098 100 HRYEELERLGNGRFCTVRKARDRGTGQL--VALKQIPRER--QPQQITRAEYNLLSTL-MHAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 100 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~--vAvK~~~~~~--~~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~~~~~~ 174 (380)
++|++.+.||+|+||+||+|+++.+|.. ||||.++... ...+.+.+|+++|+.+ +||||+++++++... +..
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~---~~~ 86 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR---GYL 86 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET---TEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC---Cee
Confidence 6789999999999999999999988874 6777775432 2345678899999999 799999999998764 678
Q ss_pred EEEEEecCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe-CCee
Q psy11098 175 TIVMQLVHGESLIQHLCRQ----------------STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN-GAVL 237 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~----------------~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~-~~~i 237 (380)
++||||+.||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+
T Consensus 87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCE
T ss_pred EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCce
Confidence 9999999999999999643 5689999999999999999999999999999999999998 4699
Q ss_pred EEEeCCCccccc-----ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHhcccCC
Q psy11098 238 KLIDLGSSVSVS-----TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSG-VSPFLDESEEETRAHISVADYS 311 (380)
Q Consensus 238 kl~DFG~a~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg-~~Pf~~~~~~~~~~~i~~~~~~ 311 (380)
||+|||+|+... ....||+.|+|||.+.+ ..++.++|||||||++|||++| .+||.+.+..+....+..+..
T Consensus 167 kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~- 244 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR- 244 (309)
T ss_dssp EECCTTCEESSCEECCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC-
T ss_pred EEccccccccccccccccceecCCcccchHHhcc-CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC-
Confidence 999999997653 34568999999999987 4788899999999999999996 568988888888888766432
Q ss_pred CCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 312 FPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 312 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
.+....+++++++||.+||+.||++|||++|+|+|
T Consensus 245 --~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 245 --LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp --CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 22234689999999999999999999999999987
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-50 Score=378.80 Aligned_cols=252 Identities=19% Similarity=0.259 Sum_probs=200.8
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEE
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIV 177 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv 177 (380)
+.++|++.+.||+|+||+||+|++..+|+.||||++...... ..+..|+++++.++|+|++..+..+... .+..++|
T Consensus 5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-~~~~~E~~i~~~l~~~~~i~~~~~~~~~--~~~~~iv 81 (299)
T d1ckia_ 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-PQLHIESKIYKMMQGGVGIPTIRWCGAE--GDYNVMV 81 (299)
T ss_dssp ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-CCHHHHHHHHHHSTTSTTCCCEEEEEEE--TTEEEEE
T ss_pred ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-HHHHHHHHHHHHccCCCcccEEEEEEec--CCEEEEE
Confidence 357899999999999999999999999999999998765433 3467899999999888766655544332 4677899
Q ss_pred EEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC----CeeEEEeCCCccccc---
Q psy11098 178 MQLVHGESLIQHLCR-QSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG----AVLKLIDLGSSVSVS--- 249 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~-~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~----~~ikl~DFG~a~~~~--- 249 (380)
|||+ +++|.+.+.. ...+++..+..++.|++.||+|||++||+||||||+|||++. ..+||+|||+|+...
T Consensus 82 me~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 82 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred EEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 9999 6666666644 568999999999999999999999999999999999999852 379999999997652
Q ss_pred ----------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---hcccCCCC-CC
Q psy11098 250 ----------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEEETRAHI---SVADYSFP-PE 315 (380)
Q Consensus 250 ----------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~~~~~~i---~~~~~~~~-~~ 315 (380)
....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+ .......+ ..
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTT-BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHH
T ss_pred cccceeccccCCcCCCccccCHHHHhC-CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhH
Confidence 34579999999999988 47899999999999999999999999876554433322 11211122 22
Q ss_pred cCCCCCHHHHHHHHHhcccCCCCCCCHH---HHHhccccccc
Q psy11098 316 QCGHISVPARELIGQLLNTHADKRPTAG---QLLQVAWFAEA 354 (380)
Q Consensus 316 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~---e~L~hpw~~~~ 354 (380)
....+|+++.+||.+||..||++||+++ ++|+|+|..+.
T Consensus 240 ~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~ 281 (299)
T d1ckia_ 240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281 (299)
T ss_dssp HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcC
Confidence 3457899999999999999999999987 55788877554
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-50 Score=376.84 Aligned_cols=243 Identities=21% Similarity=0.331 Sum_probs=205.7
Q ss_pred hhceeeeeeecccCCeEEEEEEEc-----CCCcEEEEEEecCCCC--chHHHHHHHHHHHhh-ccCCCcceeeecccccC
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDR-----GTGQLVALKQIPRERQ--PQQITRAEYNLLSTL-MHAHIPTALALFENAPV 170 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vAvK~~~~~~~--~~~~~~~E~~il~~l-~h~ni~~i~~~~~~~~~ 170 (380)
.++|++.+.||+|+||+||+|+++ .+++.||||+++.... ....+.+|+.+++.+ +||||+++++++...
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~-- 99 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG-- 99 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC--
Confidence 479999999999999999999864 4667999999976544 334577899999999 699999999998764
Q ss_pred CCceEEEEEecCCCCHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEE
Q psy11098 171 PGTDTIVMQLVHGESLIQHLCRQS------------------TITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILM 232 (380)
Q Consensus 171 ~~~~~lv~e~~~gg~L~~~l~~~~------------------~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~ 232 (380)
+..++||||+.+|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 100 -~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 100 -GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (311)
T ss_dssp -SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred -CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccc
Confidence 56799999999999999996532 58999999999999999999999999999999999999
Q ss_pred e-CCeeEEEeCCCccccc--------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy11098 233 N-GAVLKLIDLGSSVSVS--------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLS-GVSPFLDESEEETR 302 (380)
Q Consensus 233 ~-~~~ikl~DFG~a~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~llt-g~~Pf~~~~~~~~~ 302 (380)
+ ++.+||+|||+++... ...+||+.|+|||++.+ ..++.++|||||||++|+|+| |.+||.+.+..+..
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~ 257 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC-CCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 8 5699999999997653 34567999999999987 578899999999999999998 77777776665555
Q ss_pred HHHhcccCCCCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy11098 303 AHISVADYSFPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 303 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~ 347 (380)
.++........ ....+++++.+||.+||+.||++|||++|+|+
T Consensus 258 ~~~i~~~~~~~--~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 258 YKMIKEGFRML--SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHHTCCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhcCCCCC--CcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 55444433322 22467999999999999999999999999996
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-50 Score=376.90 Aligned_cols=248 Identities=18% Similarity=0.251 Sum_probs=212.3
Q ss_pred hhceeeeeeecccCCeEEEEEEEcC-----CCcEEEEEEecCCCCc--hHHHHHHHHHHHhhccCCCcceeeecccccCC
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRG-----TGQLVALKQIPRERQP--QQITRAEYNLLSTLMHAHIPTALALFENAPVP 171 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vAvK~~~~~~~~--~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~ 171 (380)
.++|++.+.||+|+||+||+|.++. ++..||||+++..... ...+.+|+++++.++|+||+++++++...
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~--- 95 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG--- 95 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS---
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC---
Confidence 4789999999999999999999863 3578999999754433 34578899999999999999999988764
Q ss_pred CceEEEEEecCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEE
Q psy11098 172 GTDTIVMQLVHGESLIQHLCRQ----------STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLI 240 (380)
Q Consensus 172 ~~~~lv~e~~~gg~L~~~l~~~----------~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~ 240 (380)
+..++||||+.+|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++. +.+||+
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEe
Confidence 5679999999999999988542 34789999999999999999999999999999999999985 589999
Q ss_pred eCCCccccc--------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHhcccCC
Q psy11098 241 DLGSSVSVS--------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSG-VSPFLDESEEETRAHISVADYS 311 (380)
Q Consensus 241 DFG~a~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg-~~Pf~~~~~~~~~~~i~~~~~~ 311 (380)
|||+|+... ....||+.|+|||.+.+ ..++.++|||||||++|||+|| ..||.+.+..+....+..+...
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~-~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~ 254 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 254 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCC
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHcc-CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCC
Confidence 999997553 34467999999999988 4778899999999999999997 6889999999988888765532
Q ss_pred CCCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh------cccccc
Q psy11098 312 FPPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQ------VAWFAE 353 (380)
Q Consensus 312 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~------hpw~~~ 353 (380)
.. ...++.++.++|.+||+.||++|||++|+++ +|+|++
T Consensus 255 ~~---p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~ 299 (308)
T d1p4oa_ 255 DK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299 (308)
T ss_dssp CC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred CC---cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcC
Confidence 22 2467899999999999999999999999998 566544
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.5e-48 Score=364.60 Aligned_cols=244 Identities=19% Similarity=0.263 Sum_probs=202.5
Q ss_pred hhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhcc-CCCcceeeecccccCCCceEE
Q psy11098 98 FEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMH-AHIPTALALFENAPVPGTDTI 176 (380)
Q Consensus 98 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h-~ni~~i~~~~~~~~~~~~~~l 176 (380)
+.++|++.+.||+|+||+||+|++..+|+.||||++..... ...+++|+++++.|.| +|+++++.++.. ....++
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~e~~~~~~l~~~~~i~~~~~~~~~---~~~~~~ 78 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-APQLRDEYRTYKLLAGCTGIPNVYYFGQE---GLHNVL 78 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-SCCHHHHHHHHHHTTTCTTCCCEEEEEEE---TTEEEE
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-cHHHHHHHHHHHHhcCCCCCCEEEEEeec---CCccEE
Confidence 46789999999999999999999999999999999865443 3446789999999976 788888888765 367799
Q ss_pred EEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEe------CCeeEEEeCCCccccc
Q psy11098 177 VMQLVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMN------GAVLKLIDLGSSVSVS 249 (380)
Q Consensus 177 v~e~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~------~~~ikl~DFG~a~~~~ 249 (380)
||||+ |++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++ ++.+||+|||+|+...
T Consensus 79 vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 79 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 99999 89999988764 4799999999999999999999999999999999999996 3579999999997542
Q ss_pred -------------ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhcccC-CC
Q psy11098 250 -------------TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDES---EEETRAHISVADY-SF 312 (380)
Q Consensus 250 -------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~---~~~~~~~i~~~~~-~~ 312 (380)
....||+.|||||++.+ ..++.++|||||||++|+|++|..||.+.. ..+....+..... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred cCccccceeecccCceEEchhhcCHHHhcC-CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence 24579999999999988 578999999999999999999999997543 3333333332222 12
Q ss_pred CCCcCCCCCHHHHHHHHHhcccCCCCCCCHHHHHh
Q psy11098 313 PPEQCGHISVPARELIGQLLNTHADKRPTAGQLLQ 347 (380)
Q Consensus 313 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~ 347 (380)
..+.+..+|+++.+++..|+..+|++||+++.+.+
T Consensus 237 ~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 237 LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 22334568999999999999999999999887754
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=366.86 Aligned_cols=238 Identities=18% Similarity=0.248 Sum_probs=194.8
Q ss_pred eeeecccCCeEEEEEEEcCCC---cEEEEEEecCCCC--chHHHHHHHHHHHhhccCCCcceeeecccccCCCceEEEEE
Q psy11098 105 LERLGNGRFCTVRKARDRGTG---QLVALKQIPRERQ--PQQITRAEYNLLSTLMHAHIPTALALFENAPVPGTDTIVMQ 179 (380)
Q Consensus 105 ~~~LG~G~fg~V~~~~~~~~~---~~vAvK~~~~~~~--~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~~~~~~lv~e 179 (380)
.++||+|+||+||+|++..++ ..||||++++... ....+.+|+++|+.++||||+++++++... .+..++|||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~--~~~~~lv~E 109 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS--EGSPLVVLP 109 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET--TTEEEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec--CCceEEEEE
Confidence 478999999999999987643 3689999975433 335688999999999999999999986542 356799999
Q ss_pred ecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeC-CeeEEEeCCCccccc--------
Q psy11098 180 LVHGESLIQHLCRQ-STITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNG-AVLKLIDLGSSVSVS-------- 249 (380)
Q Consensus 180 ~~~gg~L~~~l~~~-~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~-~~ikl~DFG~a~~~~-------- 249 (380)
|+.+|+|.+++... ..+++..+..++.|++.||.|||+.+|+||||||+|||+++ +.+||+|||+++...
T Consensus 110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~ 189 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH 189 (311)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTT
T ss_pred EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccce
Confidence 99999999988754 46788899999999999999999999999999999999985 589999999997643
Q ss_pred --ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcccCCCCCCcCCCCCHHHHH
Q psy11098 250 --TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDE-SEEETRAHISVADYSFPPEQCGHISVPARE 326 (380)
Q Consensus 250 --~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 326 (380)
....||+.|+|||++.+ ..++.++||||||+++|||++|..||... +..+....+..+..... ...+++++.+
T Consensus 190 ~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~---p~~~~~~l~~ 265 (311)
T d1r0pa_ 190 NKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ---PEYCPDPLYE 265 (311)
T ss_dssp CTTCSSCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCC---CTTCCHHHHH
T ss_pred ecccccccccccChHHHhc-CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC---cccCcHHHHH
Confidence 23467899999999987 47789999999999999999977776554 44445555554433222 2457899999
Q ss_pred HHHHhcccCCCCCCCHHHHHhc
Q psy11098 327 LIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 327 li~~~L~~dP~~Rpt~~e~L~h 348 (380)
||.+||..||++|||+.|+++|
T Consensus 266 li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 266 VMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999998
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-48 Score=363.65 Aligned_cols=247 Identities=21% Similarity=0.217 Sum_probs=190.8
Q ss_pred hhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccccC-CCceEEE
Q psy11098 99 EHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENAPV-PGTDTIV 177 (380)
Q Consensus 99 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~~~-~~~~~lv 177 (380)
..+|.+.+.||+|+||+||+|++ +|+.||||+++.+.......+.|+..+..++||||+++++++..... ....++|
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 46789999999999999999986 58899999996554333334445556667899999999998875432 2357899
Q ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------CCcEeecCCCCcEEEe-CCeeEEEeCCCcccc
Q psy11098 178 MQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHS--------QQIAHKDIRPENILMN-GAVLKLIDLGSSVSV 248 (380)
Q Consensus 178 ~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~--------~~iiHrDlKp~NIl~~-~~~ikl~DFG~a~~~ 248 (380)
|||+.+|+|.+++.+. .+++.....++.|++.||.|||+ +||+||||||+|||++ ++.+||+|||++...
T Consensus 80 ~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~ 158 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp EECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred EecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence 9999999999999764 69999999999999999999996 5999999999999997 569999999998755
Q ss_pred c----------ccccCCCcccCCccccCCC-----CCCCcccHHHHHHHHHHHHhCCCCCCCC---------------CH
Q psy11098 249 S----------TVVLPDLEFASPEMLTSPA-----TAGPSTDMWSLGVLLYILLSGVSPFLDE---------------SE 298 (380)
Q Consensus 249 ~----------~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwSlGvil~~lltg~~Pf~~~---------------~~ 298 (380)
. ....||+.|+|||++.+.. .++.++|||||||++|||+||..||... +.
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T d1vjya_ 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH
Confidence 2 3467899999999987632 2456899999999999999998876321 22
Q ss_pred HHHHHHHhcccCC--CCCCc-CCCCCHHHHHHHHHhcccCCCCCCCHHHHHhc
Q psy11098 299 EETRAHISVADYS--FPPEQ-CGHISVPARELIGQLLNTHADKRPTAGQLLQV 348 (380)
Q Consensus 299 ~~~~~~i~~~~~~--~~~~~-~~~~s~~~~~li~~~L~~dP~~Rpt~~e~L~h 348 (380)
......+...... ++... ......++.+|+.+||+.||++|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp HHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 2233332222221 11110 11123458899999999999999999999874
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.7e-47 Score=367.11 Aligned_cols=257 Identities=26% Similarity=0.391 Sum_probs=195.7
Q ss_pred hhhh-hceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhcc-----------CCCcceee
Q psy11098 96 EQFE-HRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMH-----------AHIPTALA 163 (380)
Q Consensus 96 ~~~~-~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h-----------~ni~~i~~ 163 (380)
+.|. .||+++++||+|+||+||+|+++.+|+.||||++++.....+...+|+++++.+.| +||+++++
T Consensus 8 ~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~ 87 (362)
T d1q8ya_ 8 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 87 (362)
T ss_dssp CEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred CCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEE
Confidence 3344 47999999999999999999999999999999998765556677889999988865 56777777
Q ss_pred ecccccCCCceEEEEEecCCCCHHHH-H--HhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeecCCCCcEEEeC-C---
Q psy11098 164 LFENAPVPGTDTIVMQLVHGESLIQH-L--CRQSTITESYICCIIRQLHSALHCLHS-QQIAHKDIRPENILMNG-A--- 235 (380)
Q Consensus 164 ~~~~~~~~~~~~lv~e~~~gg~L~~~-l--~~~~~l~e~~~~~i~~qil~al~~lH~-~~iiHrDlKp~NIl~~~-~--- 235 (380)
++.... ....+++|+++..+..... . .....+++..++.++.||+.||.|||+ .||+||||||+|||++. +
T Consensus 88 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 88 HFNHKG-PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEEEEE-TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred Eeeecc-ccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccc
Confidence 665432 2455667776655433222 2 234679999999999999999999998 89999999999999962 2
Q ss_pred ---eeEEEeCCCccccc---ccccCCCcccCCccccCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCCHH------HHHH
Q psy11098 236 ---VLKLIDLGSSVSVS---TVVLPDLEFASPEMLTSPATAGPSTDMWSLGVLLYILLSGVSPFLDESEE------ETRA 303 (380)
Q Consensus 236 ---~ikl~DFG~a~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~~lltg~~Pf~~~~~~------~~~~ 303 (380)
.+|++|||.|.... ...+||+.|+|||++.+ ..++.++||||+||++++|++|+.||...... +...
T Consensus 167 ~~~~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~ 245 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245 (362)
T ss_dssp TEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred ccceeeEeecccccccccccccccccccccChhhccc-cCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence 58999999997654 56679999999999987 57789999999999999999999999654321 1111
Q ss_pred HHhccc------------------------CCCCC--------------CcCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q psy11098 304 HISVAD------------------------YSFPP--------------EQCGHISVPARELIGQLLNTHADKRPTAGQL 345 (380)
Q Consensus 304 ~i~~~~------------------------~~~~~--------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e~ 345 (380)
...... ..... ......+.+++|||++||++||++|||++|+
T Consensus 246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~ 325 (362)
T d1q8ya_ 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325 (362)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 110000 00000 0012246779999999999999999999999
Q ss_pred Hhccccccc
Q psy11098 346 LQVAWFAEA 354 (380)
Q Consensus 346 L~hpw~~~~ 354 (380)
|+||||++.
T Consensus 326 L~Hp~f~~~ 334 (362)
T d1q8ya_ 326 VNHPWLKDT 334 (362)
T ss_dssp HTCGGGTTC
T ss_pred hcCcccCCC
Confidence 999999965
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=8.9e-28 Score=209.00 Aligned_cols=161 Identities=17% Similarity=0.160 Sum_probs=120.2
Q ss_pred eeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCCCC-------------------chHHHHHHHHHHHhhccCCCccee
Q psy11098 102 YEELERLGNGRFCTVRKARDRGTGQLVALKQIPRERQ-------------------PQQITRAEYNLLSTLMHAHIPTAL 162 (380)
Q Consensus 102 y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-------------------~~~~~~~E~~il~~l~h~ni~~i~ 162 (380)
|.+.++||+|+||+||+|++. +|+.||||+++.... ......+|...+..+.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 457899999999999999975 689999998753211 012234588889999999988776
Q ss_pred eecccccCCCceEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCcEEEeCCeeEEEeC
Q psy11098 163 ALFENAPVPGTDTIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHSQQIAHKDIRPENILMNGAVLKLIDL 242 (380)
Q Consensus 163 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~~~iiHrDlKp~NIl~~~~~ikl~DF 242 (380)
.+.. .+++|||+.+..+. .+++..+..++.|++.||.|||++||+||||||+|||++++.++|+||
T Consensus 81 ~~~~-------~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~~~liDF 146 (191)
T d1zara2 81 AWEG-------NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEGIWIIDF 146 (191)
T ss_dssp EEET-------TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTEEEECCC
T ss_pred EecC-------CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCCEEEEEC
Confidence 5532 28999999876542 245566778999999999999999999999999999999989999999
Q ss_pred CCcccccccccCCCcccCC------ccccCCCCCCCcccHHHHHH
Q psy11098 243 GSSVSVSTVVLPDLEFASP------EMLTSPATAGPSTDMWSLGV 281 (380)
Q Consensus 243 G~a~~~~~~~~gt~~y~aP------E~~~~~~~~~~~~DiwSlGv 281 (380)
|+|........ ..|... +.+. +.++.++|+||+.-
T Consensus 147 G~a~~~~~~~~--~~~l~rd~~~~~~~f~--r~y~~~~d~~s~~~ 187 (191)
T d1zara2 147 PQSVEVGEEGW--REILERDVRNIITYFS--RTYRTEKDINSAID 187 (191)
T ss_dssp TTCEETTSTTH--HHHHHHHHHHHHHHHH--HHHCCCCCHHHHHH
T ss_pred CCcccCCCCCc--HHHHHHHHHHHHHHHc--CCCCCcccHHHHHH
Confidence 99976542211 112211 1121 35678999999754
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.47 E-value=9e-07 Score=77.94 Aligned_cols=140 Identities=19% Similarity=0.218 Sum_probs=92.2
Q ss_pred hhhhceeeeeeecccCCeEEEEEEEcCCCcEEEEEEecCC-CCchHHHHHHHHHHHhhc-cCCCcceeeecccccCCCce
Q psy11098 97 QFEHRYEELERLGNGRFCTVRKARDRGTGQLVALKQIPRE-RQPQQITRAEYNLLSTLM-HAHIPTALALFENAPVPGTD 174 (380)
Q Consensus 97 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~il~~l~-h~ni~~i~~~~~~~~~~~~~ 174 (380)
.+-..|++.+..+.|+.+.||+.. ..++.+++|+.... ........+|...++.+. +--++.++.+... .+..
T Consensus 11 ~~~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~---~~~~ 85 (263)
T d1j7la_ 11 KLIEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH---DGWS 85 (263)
T ss_dssp HHHTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE---TTEE
T ss_pred HhhhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEec---CCce
Confidence 345677777766556667999886 34567888887533 233445677999998885 3345677766554 3667
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------
Q psy11098 175 TIVMQLVHGESLIQHLCRQSTITESYICCIIRQLHSALHCLHS------------------------------------- 217 (380)
Q Consensus 175 ~lv~e~~~gg~L~~~l~~~~~l~e~~~~~i~~qil~al~~lH~------------------------------------- 217 (380)
++||+++.|..+.+..... .. ...++.++...+..||+
T Consensus 86 ~lv~~~l~G~~~~~~~~~~--~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE--QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC--SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred EEEEEeccccccccccccc--cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence 9999999998876543211 11 12233344444444442
Q ss_pred ----------------------CCcEeecCCCCcEEEeCCee-EEEeCCCcc
Q psy11098 218 ----------------------QQIAHKDIRPENILMNGAVL-KLIDLGSSV 246 (380)
Q Consensus 218 ----------------------~~iiHrDlKp~NIl~~~~~i-kl~DFG~a~ 246 (380)
..++|+|+.|.|||++++.+ -|+||+.+.
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 12799999999999998765 599999764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.29 E-value=1.9e-06 Score=80.99 Aligned_cols=77 Identities=17% Similarity=0.176 Sum_probs=48.7
Q ss_pred eeeecccCCeEEEEEEEcCCCcEEEEEEecC------C--CCchHHHHHHHHHHHhhcc---CCCcceeeecccccCCCc
Q psy11098 105 LERLGNGRFCTVRKARDRGTGQLVALKQIPR------E--RQPQQITRAEYNLLSTLMH---AHIPTALALFENAPVPGT 173 (380)
Q Consensus 105 ~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~------~--~~~~~~~~~E~~il~~l~h---~ni~~i~~~~~~~~~~~~ 173 (380)
.+.||.|....||++....+++.+++|.-.. . .........|.+.|+.+.- ..+++++.+ . .+.
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~-d----~~~ 105 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS-D----TEM 105 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE-E----TTT
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE-c----CCC
Confidence 4578999999999999877788999997521 1 1123445668888887742 234555443 2 134
Q ss_pred eEEEEEecCCCCH
Q psy11098 174 DTIVMQLVHGESL 186 (380)
Q Consensus 174 ~~lv~e~~~gg~L 186 (380)
.++|||++.+..+
T Consensus 106 ~~lvmE~L~~~~~ 118 (392)
T d2pula1 106 AVTVMEDLSHLKI 118 (392)
T ss_dssp TEEEECCCTTSEE
T ss_pred CEEEEeccCCccc
Confidence 5899999977554
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.89 E-value=2.3e-05 Score=68.16 Aligned_cols=74 Identities=18% Similarity=0.140 Sum_probs=49.1
Q ss_pred eecccCC-eEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCC--CcceeeecccccCCCceEEEEEecCC
Q psy11098 107 RLGNGRF-CTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAH--IPTALALFENAPVPGTDTIVMQLVHG 183 (380)
Q Consensus 107 ~LG~G~f-g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~n--i~~i~~~~~~~~~~~~~~lv~e~~~g 183 (380)
.+..|.. +.||+.... .+..+++|...... ...+..|...++.|.... +++++.+... .+..++||+++.|
T Consensus 17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~---~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVTE---AGRDWLLLGEVPG 90 (255)
T ss_dssp ECSCTTSSCEEEEEECT-TSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEEC---SSCEEEEEECCSS
T ss_pred EcCCcccCCeEEEEEeC-CCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeeccc---ccceEEEEEeeec
Confidence 4455543 688988753 46678889875443 234677899998886544 3455554333 4677999999988
Q ss_pred CCH
Q psy11098 184 ESL 186 (380)
Q Consensus 184 g~L 186 (380)
.++
T Consensus 91 ~~~ 93 (255)
T d1nd4a_ 91 QDL 93 (255)
T ss_dssp EET
T ss_pred ccc
Confidence 654
|
| >d1bpva_ b.1.2.1 (A:) Type I titin module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Type I titin module species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.84 E-value=2.1e-05 Score=58.68 Aligned_cols=70 Identities=23% Similarity=0.386 Sum_probs=52.4
Q ss_pred CCCCCCCCCCCeeeeecCCCCeeEEeecCCCCCC---cceeeeccccccCCcEEec----CCCCeEEeecCCCCceeeEE
Q psy11098 4 SPLDFNPATQPVINVHPLSESSVELALLTENLSS---IRLCDHESGVWSDARWVIS----PHNGTIQVDDLAPGHTYTFC 76 (380)
Q Consensus 4 ~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~~~~~~f~ 76 (380)
.||+ ||+.|.+.. .+.++|.|+|..+..+| +..+.++........|... .....+.+.+|.|+..|.|+
T Consensus 1 ~Pp~--pP~~p~~~~--~t~~sv~lsW~~P~~~~g~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~fr 76 (104)
T d1bpva_ 1 SPID--PPGKPVPLN--ITRHTVTLKWAKPEYTGGFKITSYIVEKRDLPNGRWLKANFSNILENEFTVSGLTEDAAYEFR 76 (104)
T ss_dssp CCCC--CCCCCEEEE--EETTEEEEECCCCSCCTTCCCSCCEEEEEETTSCCCEECCCSCCCSSEEEECSCCSSCCEEEE
T ss_pred CCCC--CCCCCEEEE--ecCCEEEEEEEeccccCcceEEEEEEEeecccccceeEEEeeccceeEEEEcCCCCCCEEEEE
Confidence 3677 568888887 88999999999887665 4556666555555555541 23567899999999999999
Q ss_pred e
Q psy11098 77 I 77 (380)
Q Consensus 77 ~ 77 (380)
+
T Consensus 77 V 77 (104)
T d1bpva_ 77 V 77 (104)
T ss_dssp E
T ss_pred E
Confidence 8
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.84 E-value=4.9e-05 Score=69.08 Aligned_cols=131 Identities=20% Similarity=0.163 Sum_probs=78.6
Q ss_pred eEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccc----cCCCceEEEEEecCCCCH---
Q psy11098 114 CTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENA----PVPGTDTIVMQLVHGESL--- 186 (380)
Q Consensus 114 g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~----~~~~~~~lv~e~~~gg~L--- 186 (380)
-.||++.. .+|+.|++|+.+........+..|...+..|....++-........ ...+..+.+++++.|..+
T Consensus 36 N~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 47999885 4688899999977766777788899999999765554322221111 123456788999876322
Q ss_pred --H------HHH---Hh---c------CCCCH----------------------HHHHHHHHHHHHHHHHHH----HCCc
Q psy11098 187 --I------QHL---CR---Q------STITE----------------------SYICCIIRQLHSALHCLH----SQQI 220 (380)
Q Consensus 187 --~------~~l---~~---~------~~l~e----------------------~~~~~i~~qil~al~~lH----~~~i 220 (380)
. ..+ .. . ...+. ......+.+++..+.-.- ..++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 0 011 00 0 01111 112223333333332221 2369
Q ss_pred EeecCCCCcEEEeCCeeEEEeCCCcc
Q psy11098 221 AHKDIRPENILMNGAVLKLIDLGSSV 246 (380)
Q Consensus 221 iHrDlKp~NIl~~~~~ikl~DFG~a~ 246 (380)
||+|+.+.|||++++. .++||+.+.
T Consensus 195 iHgDlh~~NvL~~~~~-~~IDFdd~~ 219 (325)
T d1zyla1 195 LHGDCHAGNILWRDGP-MFVDLDDAR 219 (325)
T ss_dssp CCSSCSGGGEEESSSE-EECCCTTCC
T ss_pred ecCCCCcccEEEeCCc-eEEechhcc
Confidence 9999999999998765 489999874
|
| >d1x5ya1 b.1.2.1 (A:8-105) Myosin binding protein C, fast-type {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Myosin binding protein C, fast-type species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.64 E-value=5.4e-05 Score=55.98 Aligned_cols=65 Identities=15% Similarity=0.178 Sum_probs=49.5
Q ss_pred CCCeeeeecCCCCeeEEeecCCCCCC---cceeeeccccccCCcEEec----CCCCeEEeecCCCCceeeEEee
Q psy11098 12 TQPVINVHPLSESSVELALLTENLSS---IRLCDHESGVWSDARWVIS----PHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 12 ~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
..+.+.. .+.+++.|+|..+..+| +..|.++-....+..|... .....+.+.+|.+|..|.|++.
T Consensus 6 ~~~~v~~--~~~~sv~l~W~pP~~~~~~~i~~Y~V~~~~~~~~~~~~~~~~~~~~~~~~v~~L~~~~~Y~frV~ 77 (98)
T d1x5ya1 6 QHLTVED--VTDTTTTLKWRPPDRIGAGGIDGYLVEYCLEGSEEWVPANKEPVERCGFTVKDLPTGARILFRVV 77 (98)
T ss_dssp EEEEEEE--ECSSEEEEEEECCSCCCSSCCCEEEEEEEETTCCCCEESSSSCBSSSEEEEECCCTTCCEEEEEE
T ss_pred cCcEEEE--ccCCEEEEEEECCCcCCCCCceEEEEEEEecCcceeEEeeeecCceeEEEECCCcCCeEEEEEEE
Confidence 4455665 88999999999877664 5667777666666788762 2345799999999999999983
|
| >d2crza1 b.1.2.1 (A:8-104) Fibronectin type-III domain containing protein 3a, FNDC3A (KIAA0970) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Fibronectin type-III domain containing protein 3a, FNDC3A (KIAA0970) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.56 E-value=9.2e-05 Score=54.60 Aligned_cols=58 Identities=17% Similarity=0.160 Sum_probs=45.4
Q ss_pred CCCCeeEEeecCCCCCC---cceeeeccccccCCcEEe--cCCCCeEEeecCCCCceeeEEee
Q psy11098 21 LSESSVELALLTENLSS---IRLCDHESGVWSDARWVI--SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 21 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
.+.+++.|+|..+..+| +..|.++........|.. ......+.+.+|.|+..|.|++.
T Consensus 14 ~~~~sv~l~W~~P~~~gg~~i~~Y~v~~~~~~~~~~~~~~~~~~~~~~v~~L~p~t~Y~frV~ 76 (97)
T d2crza1 14 PKAKEIQLRWGPPLVDGGSPISCYSVEMSPIEKDEPREVYQGSEVECTVSSLLPGKTYSFRLR 76 (97)
T ss_dssp CCSSEEEEECCCCSCCTTSCCCEEEEEEECTTSCCCEEEEEESCSEEEEESCCTTCEEEECCE
T ss_pred eeCCEEEEEEeCCCcCCCCceeEEEEEEEcCcCCceeEeecCCceEEEEcCCCCCEEEEEEEE
Confidence 45689999999887765 567888766666667775 33466799999999999999983
|
| >d1x3da1 b.1.2.1 (A:8-112) Fibronectin type-III domain containing protein 3a, FNDC3A (KIAA0970) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Fibronectin type-III domain containing protein 3a, FNDC3A (KIAA0970) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.36 E-value=0.00043 Score=51.38 Aligned_cols=72 Identities=15% Similarity=0.128 Sum_probs=49.6
Q ss_pred CCCCCCCCCCCCeeeeecCCCCeeEEeecCCCCCC--cceeeeccccccCCc-EEe--cCCCCeEEeecCCCCceeeEEe
Q psy11098 3 SSPLDFNPATQPVINVHPLSESSVELALLTENLSS--IRLCDHESGVWSDAR-WVI--SPHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 3 ~~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~l~~~~~~~f~~ 77 (380)
+.||+ ||..+.+.. .+.+++.|+|..+...+ +..+.++-....... |.. ......+.+.+|.|+..|.|++
T Consensus 8 ~~~P~--~P~~~~~~~--~~~~sv~l~W~pp~~~~~~i~~Y~i~~~~~~~~~~~~~~~~~~~~~~~~~~L~p~t~Y~frV 83 (105)
T d1x3da1 8 SCEPD--IPNPPRIAN--RTKNSLTLQWKAPSDNGSKIQNFVLEWDEGKGNGEFCQCYMGSQKQFKITKLSPAMGCKFRL 83 (105)
T ss_dssp CSCCC--CCCCCEEEE--EETTEEEEECCCCCCCSSCEEEEEEEECTTTSSSCCEEEEEESCSEEEEESCCTTCEEEEEC
T ss_pred CCCCc--CCCCCEEEE--ccCCEEEEEEECCCCCcCccEEEEEEEecCCCcceeEEEecCCccEEEecCCcCCcEEEEEE
Confidence 45565 445666666 88999999999886554 556666544333222 332 2356789999999999999998
Q ss_pred e
Q psy11098 78 N 78 (380)
Q Consensus 78 ~ 78 (380)
.
T Consensus 84 ~ 84 (105)
T d1x3da1 84 S 84 (105)
T ss_dssp C
T ss_pred E
Confidence 3
|
| >d2fnba_ b.1.2.1 (A:) Fibronectin, different Fn3 modules {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Fibronectin, different Fn3 modules species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.35 E-value=0.00041 Score=50.35 Aligned_cols=67 Identities=19% Similarity=0.152 Sum_probs=49.4
Q ss_pred CCCCCeeeeecCCCCeeEEeecCCCCCCcceeeeccccccCCcEEe----cCCCCeEEeecCCCCceeeEEee
Q psy11098 10 PATQPVINVHPLSESSVELALLTENLSSIRLCDHESGVWSDARWVI----SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 10 p~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
||....+.. .+.+++.|+|..+....+..+.++-....+..|.. .....++.+.+|.||..|.|++.
T Consensus 8 ~P~~l~v~~--~t~~si~l~W~~p~~~~i~~Y~v~~~~~~~~~~~~~~~~~~~~t~~~i~~L~p~t~Y~~~V~ 78 (95)
T d2fnba_ 8 QLTDLSFVD--ITDSSIGLRWTPLNSSTIIGYRITVVAAGEGIPIFEDFVDSSVGYYTVTGLEPGIDYDISVI 78 (95)
T ss_dssp CCTTCEEEC--CCSSCEEEECCCCCCSSCCEEEEEEEEETSCCEEEEEECCSSCSEEEECCCCTTSEEEEEEE
T ss_pred cCCCeEEEE--EcCCEEEEEEEecCCceEEeEEEEEEEeeccceEEEEEeCCCCeEEEEecccCCEEEEEEEE
Confidence 445566666 89999999999887666667776654444444443 34567899999999999999983
|
| >d1x5xa1 b.1.2.1 (A:8-103) Fibronectin type-III domain containing protein 3a, FNDC3A (KIAA0970) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Fibronectin type-III domain containing protein 3a, FNDC3A (KIAA0970) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.32 E-value=0.00035 Score=50.63 Aligned_cols=67 Identities=12% Similarity=0.002 Sum_probs=48.0
Q ss_pred CCCCCeeeeecCCCCeeEEeecCCCCCC---cceeeeccccccCCcEEe---cCCCCeEEeecCCCCceeeEEee
Q psy11098 10 PATQPVINVHPLSESSVELALLTENLSS---IRLCDHESGVWSDARWVI---SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 10 p~~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
||..|.+.. .+.+++.|+|..+..++ +.++.+.........|.. ......+.+.+|.++..|.|++.
T Consensus 3 ~P~~~~v~~--~~~~si~l~W~~p~~~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~v~~L~p~t~Y~~rV~ 75 (96)
T d1x5xa1 3 MPASPVLTK--AGITWLSLQWSKPSGTPSDEGISYILEMEEETSGYGFKPKYDGEDLAYTVKNLRRSTKYKFKVI 75 (96)
T ss_dssp CCCCCEEEE--ECSSEEEEECCCCSSCCSSSSCEEEEEECCSSSSCCCEEEEEESCSEEEEESCCSSCEEEEEEE
T ss_pred cCCCCEEEE--ecCCEEEEEEEeecccCcceEeeeEEEeeeccceeeeEEeecCCCCEEEECCCCCCCEEEEEEE
Confidence 345677777 88999999999877665 455555543333344433 34567899999999999999983
|
| >d1x4xa1 b.1.2.1 (A:8-100) Fibronectin type-III domain containing protein 3a, FNDC3A (KIAA0970) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Fibronectin type-III domain containing protein 3a, FNDC3A (KIAA0970) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.22 E-value=0.00042 Score=50.11 Aligned_cols=67 Identities=12% Similarity=0.132 Sum_probs=49.0
Q ss_pred CCCCCeeeeecCCCCeeEEeecCCCCCC--cceeeeccccccCCcEEe-cCCCCeEEeecCCCCceeeEEee
Q psy11098 10 PATQPVINVHPLSESSVELALLTENLSS--IRLCDHESGVWSDARWVI-SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 10 p~~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
|++.|.+.. .+.+++.|+|..+...+ +..|.++-....+..|.. ......+.+.+|.|+..|.|++.
T Consensus 3 ~P~~~~v~~--~s~~si~l~W~~p~~~~~~i~~Y~v~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~ 72 (93)
T d1x4xa1 3 QCKPPQVTC--RSATCAQVNWEVPLSNGTDVTEYRLEWGGVEGSMQICYCGPGLSYEIKGLSPATTYYCRVQ 72 (93)
T ss_dssp CCCCCCCEE--EETTEEEEECCCCSCSSSCCCEEEEEEESSTTSCCEEEEESCSEEEEESCCSSCEEEEEEE
T ss_pred CCCCCEEEE--eCCCeEEEEEEecccCCCeeEEEEEEEccCCCcceEeecCCccEEEEcccceeeEEEEEEE
Confidence 345667777 78899999999877655 455666554444444554 45577899999999999999983
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.17 E-value=0.0012 Score=61.21 Aligned_cols=73 Identities=15% Similarity=0.182 Sum_probs=50.7
Q ss_pred eeeecccCCeEEEEEEEcC-------CCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCC-cceeeecccccCCCceEE
Q psy11098 105 LERLGNGRFCTVRKARDRG-------TGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHI-PTALALFENAPVPGTDTI 176 (380)
Q Consensus 105 ~~~LG~G~fg~V~~~~~~~-------~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni-~~i~~~~~~~~~~~~~~l 176 (380)
++.|+.|-.=.+|++.... ..+.|.+++.-... ......+|..+++.+.-.++ ++++.++.. .+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~-------g~ 118 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-TESHLVAESVIFTLLSERHLGPKLYGIFSG-------GR 118 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT-------EE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC-------ce
Confidence 4678888888999998653 34568888875332 33345679999998865454 466666542 78
Q ss_pred EEEecCCCC
Q psy11098 177 VMQLVHGES 185 (380)
Q Consensus 177 v~e~~~gg~ 185 (380)
|+||+.|..
T Consensus 119 I~efi~g~~ 127 (395)
T d1nw1a_ 119 LEEYIPSRP 127 (395)
T ss_dssp EECCCCEEE
T ss_pred EEEEecccc
Confidence 999998744
|
| >d1x4za1 b.1.2.1 (A:8-115) Brother of CDO precursor (BOC) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Brother of CDO precursor (BOC) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.16 E-value=0.00092 Score=49.90 Aligned_cols=70 Identities=21% Similarity=0.427 Sum_probs=48.5
Q ss_pred CCCCCCCCCCeeeeecCCCCeeEEeecCCCCCC--cceeeecccccc-CCcEEe-----cCCCCeEEeecCCCCceeeEE
Q psy11098 5 PLDFNPATQPVINVHPLSESSVELALLTENLSS--IRLCDHESGVWS-DARWVI-----SPHNGTIQVDDLAPGHTYTFC 76 (380)
Q Consensus 5 ~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~-~~~~~~-----~~~~~~~~~~~l~~~~~~~f~ 76 (380)
||+ ||..|.+.. .+.+++.|+|..+...| +..|.++-.... ...|.. ......+.+.+|.|+..|.|+
T Consensus 10 pP~--~P~~~~v~~--~~~~sv~l~W~p~~~~g~~I~~Y~v~~~~~~~~~~~~~~~~~~~~~~~~~~v~~L~p~t~Y~fr 85 (108)
T d1x4za1 10 PPE--APDRPTIST--ASETSVYVTWIPRGNGGFPIQSFRVEYKKLKKVGDWILATSAIPPSRLSVEITGLEKGISYKFR 85 (108)
T ss_dssp CCC--CCCCCEEEE--CCSSEEEEECCCCCCTTSCCCEEEEEEEESSSCCCCEEEEEEECTTCCEEEEESCCTTCEEEEE
T ss_pred CCc--cCCCCEEEE--ccCCEEEEEEECCCCCCCccEEEEEEEEecCCCCceEEEEEeecCCccEEEECCCCCCCEEEEE
Confidence 455 346677777 89999999997554433 566776543322 345553 234557999999999999999
Q ss_pred ee
Q psy11098 77 IN 78 (380)
Q Consensus 77 ~~ 78 (380)
+.
T Consensus 86 V~ 87 (108)
T d1x4za1 86 VR 87 (108)
T ss_dssp EE
T ss_pred EE
Confidence 83
|
| >d1wf5a1 b.1.2.1 (A:8-115) Sidekick 2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Sidekick 2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.11 E-value=0.0012 Score=49.09 Aligned_cols=67 Identities=16% Similarity=0.248 Sum_probs=44.9
Q ss_pred CCCeeeeecCCCCeeEEeecCCCCCC--cceeeeccccccCCcEEec----CCCCeEEeecCCCCceeeEEee
Q psy11098 12 TQPVINVHPLSESSVELALLTENLSS--IRLCDHESGVWSDARWVIS----PHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 12 ~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
+.|.+..-..+.+++.|+|..+...| +..|.++-.......|... .....+.+++|.||..|.|++.
T Consensus 15 ~~p~~~~~~~~~~sv~l~W~~P~~~~~~I~~Y~v~~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~frV~ 87 (108)
T d1wf5a1 15 EHPVATLSTVERRAINLTWTKPFDGNSPLIRYILEMSENNAPWTVLLASVDPKATSVTVKGLVPARSYQFRLC 87 (108)
T ss_dssp SSCEEEECSSSTTEEEEECCCCCCCSSCEEEEEEEEECTTCCCEEEESSCCTTCCEEEEESCCTTCEEEEEEE
T ss_pred CCCEEEEEeccCCEEEEEEECCCCCCCccEEEEEEEEeccCCceEEeeeecCCccEEEECCCCCCCEEEEEEE
Confidence 45555543478899999999886443 5667665543333323321 2355799999999999999983
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.03 E-value=0.0028 Score=56.44 Aligned_cols=147 Identities=16% Similarity=0.134 Sum_probs=76.8
Q ss_pred hhhhceeee-----eeecccCCeEEEEEEEcCCCcEEEEEEecCCCCchHHHHHHHHHHHhhccCCCcceeeecccc---
Q psy11098 97 QFEHRYEEL-----ERLGNGRFCTVRKARDRGTGQLVALKQIPRERQPQQITRAEYNLLSTLMHAHIPTALALFENA--- 168 (380)
Q Consensus 97 ~~~~~y~~~-----~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~il~~l~h~ni~~i~~~~~~~--- 168 (380)
.+..+|.+. +.|..|---+.|+..... | .+++|++.... ....+..|++++..|...+++-....-...
T Consensus 10 ~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~-g-~yVLri~~~~~-~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~ 86 (316)
T d2ppqa1 10 NFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKRV-EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGEL 86 (316)
T ss_dssp HHHTTBCCCCEEEEEEECC---EEEEEEEESS-C-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCS
T ss_pred HHHHhCCCCCceEeecCCCCcccCeEEEEECC-C-cEEEEEcCCCC-CHHHHHHHHHHHHhhhhccccccccceecCCCc
Confidence 344556542 344566667889987543 4 58999986532 334556688899988765543222211110
Q ss_pred --cCCCceEEEEEecCCCCHH--------------HHHHh---cC------------------------CCCHHHHHHHH
Q psy11098 169 --PVPGTDTIVMQLVHGESLI--------------QHLCR---QS------------------------TITESYICCII 205 (380)
Q Consensus 169 --~~~~~~~lv~e~~~gg~L~--------------~~l~~---~~------------------------~l~e~~~~~i~ 205 (380)
...+....++.++.|.... ..+.. .. ..........+
T Consensus 87 ~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 166 (316)
T d2ppqa1 87 LGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEI 166 (316)
T ss_dssp CEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHH
T ss_pred ceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHH
Confidence 0113345566666553220 00000 00 00011122233
Q ss_pred HHHHHHHHHHH----HCCcEeecCCCCcEEEeCCee-EEEeCCCcc
Q psy11098 206 RQLHSALHCLH----SQQIAHKDIRPENILMNGAVL-KLIDLGSSV 246 (380)
Q Consensus 206 ~qil~al~~lH----~~~iiHrDlKp~NIl~~~~~i-kl~DFG~a~ 246 (380)
..+...+.-.+ ..|+||+|+.++||+++++.+ -|+||+.+.
T Consensus 167 ~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 167 RPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 33333333333 247999999999999997754 799999874
|
| >d1wfua_ b.1.2.1 (A:) Fibronectin type 3 and ankyrin repeat domains 1 protein, FANK1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Fibronectin type 3 and ankyrin repeat domains 1 protein, FANK1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.01 E-value=0.00092 Score=50.76 Aligned_cols=66 Identities=18% Similarity=0.175 Sum_probs=45.7
Q ss_pred CCCCeeeeecCCCCeeEEeecCCCCCC---ccee----eeccccccCCcEEe--cCCCCeEEeecCCCCceeeEEee
Q psy11098 11 ATQPVINVHPLSESSVELALLTENLSS---IRLC----DHESGVWSDARWVI--SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 11 ~~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~----~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
|..|.+.. ++.+++.|+|..+..++ +..+ .++........|.. ......+.+.+|.|+..|.|++.
T Consensus 19 P~~p~v~~--vt~~sv~l~W~~P~~~~g~~i~~y~i~y~~~~~~~~~~~~~~~~~~~~~~~~v~~L~p~t~Y~frV~ 93 (120)
T d1wfua_ 19 PHPPVVGK--VTHHSIELYWDLEQKEKRQGPQEQWLRFSIEEEDPKMHSYGVIYTGYATRHVVEGLEPRTLYKFRLK 93 (120)
T ss_dssp CCCCBCCC--EETTEEEEECTTTSCSCCCSCGGGCCEEEEEEECTTTCCEEEEEEESCSEEEEESCCTTCEEEEEEE
T ss_pred CCCCEEeE--ecCCEEEEEEECCcccCcccccceeeeeeeecccccccceeeeccccccEEeCCCCCCCcEeeEEEE
Confidence 35567776 88899999999877654 2222 22222233456765 33466899999999999999983
|
| >d2crma1 b.1.2.1 (A:8-114) Fibronectin type-III domain containing protein 3a, FNDC3A (KIAA0970) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Fibronectin type-III domain containing protein 3a, FNDC3A (KIAA0970) species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.95 E-value=0.0012 Score=48.82 Aligned_cols=58 Identities=19% Similarity=0.225 Sum_probs=41.6
Q ss_pred CCCCeeEEeecCCCCCC---cceeeecccccc-CCcEEe--cCCCCeEEeecCCCCceeeEEee
Q psy11098 21 LSESSVELALLTENLSS---IRLCDHESGVWS-DARWVI--SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 21 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
++.+++.|+|..|..++ +..+.++..... ...|.. ......+.+.+|.||..|.|++.
T Consensus 23 ~~~~sv~l~W~~P~~~~g~~~~~y~v~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~rV~ 86 (107)
T d2crma1 23 IHSHSFKITWDPPKDNGGATINKYVVEMAEGSNGNKWEMIYSGATREHLCDRLNPGCFYRLRVY 86 (107)
T ss_dssp EETTEEEEECCCCTTCCSSCCCEEEEEEEESSSSCCCEEEECSSCSEEEECSCCTTSCEEEEEE
T ss_pred ecCCEEEEEEEECccCCcceEEEEEEEEEeecCCCcEEEeecCCccEEEEeccCCCCEEEEEEE
Confidence 67799999999877665 445555543333 234444 34467799999999999999983
|
| >d2dn7a1 b.1.2.1 (A:8-101) Receptor-type tyrosine-protein phosphatase F, PTPRF {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Receptor-type tyrosine-protein phosphatase F, PTPRF species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.76 E-value=0.0028 Score=45.48 Aligned_cols=58 Identities=16% Similarity=0.084 Sum_probs=43.6
Q ss_pred CCCCeeEEeecCCCCCC--cceeeeccccccCCcEEe---cCCCCeEEeecCCCCceeeEEee
Q psy11098 21 LSESSVELALLTENLSS--IRLCDHESGVWSDARWVI---SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 21 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
.+.+++.|+|..+..++ +..|.++-.......|.. .....++.+.+|.|+..|.|++.
T Consensus 11 ~~~~sv~l~W~pP~~~~g~i~~Y~i~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~ 73 (94)
T d2dn7a1 11 TAMNTALLQWHPPKELPGELLGYRLQYCRADEARPNTIDFGKDDQHFTVTGLHKGTTYIFRLA 73 (94)
T ss_dssp CSTTEEEEEEECCSSCSSCCCEEEEEEEETTCSSCEEEEEETTCCEEEEECCCTTCEEEEEEE
T ss_pred EeCCEEEEEEeCCCCCCCceEEEEEEEEEcCCCCcEEEEcCCCccEEEEEccCCeeEEEEEEE
Confidence 78899999999887665 556666544444445553 34567899999999999999983
|
| >d1x5za1 b.1.2.1 (A:8-109) Receptor-type tyrosine-protein phosphatase delta, PTPRD {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Receptor-type tyrosine-protein phosphatase delta, PTPRD species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.76 E-value=0.0018 Score=47.49 Aligned_cols=61 Identities=16% Similarity=0.142 Sum_probs=44.5
Q ss_pred eeecCCCCeeEEeecCCCCCCcceeeeccccccCCcEEe--cCCCCeEEeecCCCCceeeEEe
Q psy11098 17 NVHPLSESSVELALLTENLSSIRLCDHESGVWSDARWVI--SPHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 17 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~~f~~ 77 (380)
.....+.+++.|+|..+..+.+..+.+.-.......|.. .....++.+.+|.|+..|.|++
T Consensus 18 ~~~~~~~~si~l~W~~p~~~~i~~Y~i~y~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V 80 (102)
T d1x5za1 18 KAEPESETSILLSWTPPRSDTIANYELVYKDGEHGEEQRITIEPGTSYRLQGLKPNSLYYFRL 80 (102)
T ss_dssp EEECSSSSEEEEEEECCSCCCCCEEEECBEESSSCCCBCCEECSSSEEEEECCCTTCEEEECE
T ss_pred EEEEccCCEEEEEEECCCCCCccceEEEEEeCCCCceEEEEcCCcCEEEECCCCCCCEEEEEE
Confidence 334489999999999987766777776544333333332 3446689999999999999998
|
| >d2b5ic1 b.1.2.1 (C:130-224) Cytokine receptor common gamma chain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Cytokine receptor common gamma chain species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.72 E-value=0.0014 Score=47.54 Aligned_cols=64 Identities=19% Similarity=0.151 Sum_probs=50.3
Q ss_pred CCeeeeecCCCCeeEEeecCCCCCCcceeeeccccccCCcEEe--cCCCCeEEeecCCCCceeeEEee
Q psy11098 13 QPVINVHPLSESSVELALLTENLSSIRLCDHESGVWSDARWVI--SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 13 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
--.+.. ++.+++.|+|..+..+.+..|.++-....+..|.. ......+.+.+|.|+..|.|++.
T Consensus 8 nl~v~~--~~~~~v~l~W~~p~~~~~~~y~v~y~~~~~~~~~~~~~~~~~~~~~~~L~p~t~Y~frVR 73 (95)
T d2b5ic1 8 NLTLHK--LSESQLELNWNNRFLNHCLEHLVQYRTDWDHSWTEQSVDYRHKFSLPSVDGQKRYTFRVR 73 (95)
T ss_dssp EEEEEE--EETTEEEEEEECSSCSTTCEEEEEEEETTCSSCEEEEECSSCEEEECSCCTTSCEEEEEE
T ss_pred CCEEEE--EeCCEEEEEECCCCCceeEEEEEEEEcCCCceeeEeeecccceeEcCCCCCCCEEEEEEE
Confidence 344555 78899999999988877777887766666677776 34466899999999999999984
|
| >d1uema_ b.1.2.1 (A:) KIAA1568 protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: KIAA1568 protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.68 E-value=0.0017 Score=48.97 Aligned_cols=67 Identities=19% Similarity=0.290 Sum_probs=48.1
Q ss_pred CCCCCeeeeecCCCCeeEEeecCCCCCC--cceeeecccccc-CCcEEe---cCCCCeEEeecCCCCceeeEEee
Q psy11098 10 PATQPVINVHPLSESSVELALLTENLSS--IRLCDHESGVWS-DARWVI---SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 10 p~~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~-~~~~~~---~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
||..|.+.. .+.+++.|+|..+...+ +..|.++-.... +..|.. ......+.+.+|.|+..|.|++.
T Consensus 18 pP~~~~v~~--~~~~sv~l~W~p~~~~~~~i~~Y~v~~~~~~~~~~~~~~~~~~~~~~~~v~~L~p~t~Y~frV~ 90 (117)
T d1uema_ 18 PPSKPQVTD--VTKNSVTLSWQPGTPGTLPASAYIIEAFSQSVSNSWQTVANHVKTTLYTVRGLRPNTIYLFMVR 90 (117)
T ss_dssp CCCCCEEEE--ECSSCEEEECCCCBCSSSCCCEEEEEEEETTTEEEEEEEEEEECSSEEEECSCCTTCEEEEEEE
T ss_pred CCCCCEEEE--ccCCEEEEEEECCCcCCCCeEEEEEEEeccCCceeeEEeccccccccceECCCCCCCEEEEEEE
Confidence 446788877 88999999998665433 556666543322 345765 23467899999999999999983
|
| >d1fnha2 b.1.2.1 (A:93-182) Fibronectin, different Fn3 modules {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Fibronectin, different Fn3 modules species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.60 E-value=0.0026 Score=45.41 Aligned_cols=65 Identities=14% Similarity=0.269 Sum_probs=46.6
Q ss_pred CCCCCeeeeecCCCCeeEEeecCCCCCCcceeeeccccccCCcEEe---cCCCCeEEeecCCCCceeeEEe
Q psy11098 10 PATQPVINVHPLSESSVELALLTENLSSIRLCDHESGVWSDARWVI---SPHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 10 p~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~~~~~~f~~ 77 (380)
||....+.. .+.+++.|+|..+. +.+..|.+.-....+..|.. ......+.+.+|.||..|.|++
T Consensus 4 pP~~l~v~~--~~~~si~v~W~~p~-~~~~~Y~i~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V 71 (90)
T d1fnha2 4 PPRRARVTD--ATETTITISWRTKT-ETITGFQVDAVPANGQTPIQRTIKPDVRSYTITGLQPGTDYKIYL 71 (90)
T ss_dssp CCEEEEEEE--ECSSEEEEEEECCS-SCCCCEEEEEEESSSSCCEEEECCTTCSEEEEESCCTTCEEEEEE
T ss_pred cCCCCEEEE--ecCCEEEEEEECCC-CCCceeEEEEEEccCCceEEEecCCCccEEEeCCCCCCcEEEEEE
Confidence 445566766 89999999998765 34556665544433334443 3457789999999999999997
|
| >d1k85a_ b.1.2.1 (A:) Fibronectin type III domain from chitinase A1. {Bacillus circulans [TaxId: 1397]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Fibronectin type III domain from chitinase A1. species: Bacillus circulans [TaxId: 1397]
Probab=96.57 E-value=0.0026 Score=45.38 Aligned_cols=61 Identities=18% Similarity=0.209 Sum_probs=43.1
Q ss_pred CCCeeeeecCCCCeeEEeecCCCCCC-cceeeeccccccCCcEEecCCCCeEEeecCCCCceeeEEee
Q psy11098 12 TQPVINVHPLSESSVELALLTENLSS-IRLCDHESGVWSDARWVISPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 12 ~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
....+.. .+.+++.|+|..+..++ +..+.+.. +..-.....+..+.+.+|.|+..|.|++.
T Consensus 8 ~~l~~~~--~~~~sv~lsW~~p~~~~~i~~Y~i~~----~~~~~~~~~~t~~~~~~L~p~t~Y~~~V~ 69 (88)
T d1k85a_ 8 TNLASTA--QTTSSITLSWTASTDNVGVTGYDVYN----GTALATTVTGTTATISGLAADTSYTFTVK 69 (88)
T ss_dssp EEEEEEE--ECSSCEEEEEECCSCCSSEEEEEEEE----SSSEEEEESSSEEEECCCCSSCEEEEEEE
T ss_pred CCcEEEE--ecCCEEEEEEeCCCCCCCEEEEEEEc----cceEEEecCCCEEEECCCCCCCEEEEEEE
Confidence 3445555 78899999999877654 55555543 12222345567899999999999999983
|
| >d2cuia1 b.1.2.1 (A:6-106) Tenascin-X {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Tenascin-X species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.53 E-value=0.0041 Score=45.17 Aligned_cols=69 Identities=16% Similarity=0.126 Sum_probs=43.4
Q ss_pred CCCCCCCCCCCeeeeecCCCCeeEEeecCCCCCCcceeeecccccc----------CCcEEe--cCCCCeEEeecCCCCc
Q psy11098 4 SPLDFNPATQPVINVHPLSESSVELALLTENLSSIRLCDHESGVWS----------DARWVI--SPHNGTIQVDDLAPGH 71 (380)
Q Consensus 4 ~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~--~~~~~~~~~~~l~~~~ 71 (380)
++|+ ++..-.+.. ++.+++.|+|..+. +.+..+.++-.... ...+.. ......+.+.+|.|+.
T Consensus 2 g~Pp--~~~~l~v~~--~t~~sv~v~W~pp~-~~~~~y~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~L~p~t 76 (101)
T d2cuia1 2 GSRP--RLSQLSVTD--VTTSSLRLNWEAPP-GAFDSFLLRFGVPSPSTLEPHPRPLLQRELMVPGTRHSAVLRDLRSGT 76 (101)
T ss_dssp CCCC--CCCCCEEES--CCSSCEEEECCCCT-TSCSEEEEEEECCCCSSSCCCSSCCCCEEEEEETTCCEEEECSCCTTC
T ss_pred CCcc--CCCCcEEEE--ECCCEEEEEEEecc-ccccceEEEEEecCCCceeeccCCcceeEeecccceeEEEeCCCCcCC
Confidence 4444 445566666 89999999998765 33334443222111 111111 2456688999999999
Q ss_pred eeeEEe
Q psy11098 72 TYTFCI 77 (380)
Q Consensus 72 ~~~f~~ 77 (380)
.|.|++
T Consensus 77 ~Y~~~V 82 (101)
T d2cuia1 77 LYSLTL 82 (101)
T ss_dssp EEEEEE
T ss_pred EEEEEE
Confidence 999998
|
| >d1fnha1 b.1.2.1 (A:3-92) Fibronectin, different Fn3 modules {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Fibronectin, different Fn3 modules species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.52 E-value=0.0037 Score=44.38 Aligned_cols=66 Identities=11% Similarity=0.120 Sum_probs=44.0
Q ss_pred CCCCCeeeeecCCCCeeEEeecCCCCCCcceeeeccccccCC----cEEecCCCCeEEeecCCCCceeeEEee
Q psy11098 10 PATQPVINVHPLSESSVELALLTENLSSIRLCDHESGVWSDA----RWVISPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 10 p~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
||....+.. ++.+|+.|+|..+.... ..+.+.-...... ..........+.+.+|.||..|.|++.
T Consensus 2 pP~~l~~~~--v~~~si~l~W~~p~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~ 71 (90)
T d1fnha1 2 APTDLKFTQ--VTPTSLSAQWTPPNVQL-TGYRVRVTPKEKTGPMKEINLAPDSSSVVVSGLMVATKYEVSVY 71 (90)
T ss_dssp CCEEEEEEE--ECSSCEEEEEECCSSCC-SEEEEEEEESSSCSCCCEEEECTTCCEEEECSCCTTCEEEEEEE
T ss_pred CCCCEEEEE--ecCCEEEEEEEccceec-cceEEEEEeeeCCCceEEEEeCCCCeEEEEecccCceEEEEEEE
Confidence 445666777 89999999999876443 3333322221111 222345577899999999999999983
|
| >d1x5ga1 b.1.2.1 (A:8-110) Neogenin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Neogenin species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.50 E-value=0.0029 Score=46.38 Aligned_cols=62 Identities=11% Similarity=-0.003 Sum_probs=44.5
Q ss_pred CeeeeecCCCCeeEEeecCCCCCC--cceeeeccccccCCcEEe-cCCCCeEEeecCCCCceeeEEe
Q psy11098 14 PVINVHPLSESSVELALLTENLSS--IRLCDHESGVWSDARWVI-SPHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 14 p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~~~~~f~~ 77 (380)
..+.. ++.+++.|+|..+...+ +..|.+.-.......|.. .....++.+.+|.|+..|.|++
T Consensus 17 l~v~~--~s~~si~l~W~~P~~~~g~i~~Y~v~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V 81 (103)
T d1x5ga1 17 LRAYA--ASPTSITVTWETPVSGNGEIQNYKLYYMEKGTDKEQDVDVSSHSYTINGLKKYTEYSFRV 81 (103)
T ss_dssp CEEEE--EETTEEEEECCCCSCCSSCCSEEEEEEEETTCCCCCCEEECSSEEEECSCCTTCEEEEEE
T ss_pred cEEEE--ccCCEEEEEEECCcCCCccEEEEEEEEEeCCCceeEEEeccccEEecCCCCCCCEEEEEE
Confidence 44444 88999999999776554 556666544433444543 4456789999999999999998
|
| >d2ic2a1 b.1.2.1 (A:466-572) Hedgehog receptor iHog {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Hedgehog receptor iHog species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=96.44 E-value=0.0014 Score=48.70 Aligned_cols=66 Identities=30% Similarity=0.438 Sum_probs=42.4
Q ss_pred CCCCCeeeeecCCCCeeEEeecCCCCCC--cceeeeccccc-cCCcEEec---------------CCCCeEEeecCCCCc
Q psy11098 10 PATQPVINVHPLSESSVELALLTENLSS--IRLCDHESGVW-SDARWVIS---------------PHNGTIQVDDLAPGH 71 (380)
Q Consensus 10 p~~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~-~~~~~~~~---------------~~~~~~~~~~l~~~~ 71 (380)
||+.|.+.. ++.++|.|+|..+...| +..|.++-... ....|... .....+.+.+|.|+.
T Consensus 2 PP~~p~v~~--~~~~sv~l~W~~P~~~g~~I~~Y~ie~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t 79 (107)
T d2ic2a1 2 PPTPPNVTR--LSDESVMLRWMVPRNDGLPIVIFKVQYRMVGKRKNWQTTNDNIPYGKPKWNSELGKSFTASVTDLKPQH 79 (107)
T ss_dssp CCCCCEEEE--CC---EEEEEEEECCSSCCEEEEEEEEEECC---CCEEEEEEEECCSCSCSSSSEEEEEEEECSCCSSE
T ss_pred cCcCCEEEE--EECCEEEEEEEeCccccCCceEEEEEEEeccCCCcceEEEeeeeccceeeeecccceeEEEECCCcCCc
Confidence 667888888 89999999999987554 45565543221 12344321 113368899999999
Q ss_pred eeeEEe
Q psy11098 72 TYTFCI 77 (380)
Q Consensus 72 ~~~f~~ 77 (380)
.|.|++
T Consensus 80 ~Y~frV 85 (107)
T d2ic2a1 80 TYRFRI 85 (107)
T ss_dssp EEEEEE
T ss_pred EEEEEE
Confidence 999998
|
| >d2vkwa2 b.1.2.1 (A:601-693) Neural cell adhesion molecule 1, NCAM {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Neural cell adhesion molecule 1, NCAM species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.40 E-value=0.0032 Score=45.22 Aligned_cols=62 Identities=13% Similarity=0.133 Sum_probs=44.4
Q ss_pred CeeeeecCCCCeeEEeecCCCCCC--cceeeeccccccCCcEEe----cCCCCeEEeecCCCCceeeEEee
Q psy11098 14 PVINVHPLSESSVELALLTENLSS--IRLCDHESGVWSDARWVI----SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 14 p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
+.+.. .+.+++.|.|..+...| +..|.++-.... ..|.. ......+.+.+|.|+..|.|++.
T Consensus 7 ~~~~~--~~~~sv~l~W~~p~~~~~~I~~Y~i~~~~~~-~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~ 74 (93)
T d2vkwa2 7 EGQMG--EDGNSIKVNLIKQDDGGSPIRHYLVRYRALS-SEWKPEIRLPSGSDHVMLKSLDWNAEYEVYVV 74 (93)
T ss_dssp EEEEC--TTSSCEEEEEECCCCTTSCCCEEEEEEEETT-SCCCCCEEECTTCCEEEECSCCTTCEEEEEEE
T ss_pred CEeEE--cCCCEEEEEeeCCCCCcCceEEEEEEeeecC-cceeeeeeccCCceEEEEeccccceEEEEEEE
Confidence 44444 88899999999987544 567776654433 33332 34567899999999999999983
|
| >d1x5la1 b.1.2.1 (A:8-105) Ephrin type-A receptor 8 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Ephrin type-A receptor 8 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.36 E-value=0.0034 Score=45.60 Aligned_cols=65 Identities=15% Similarity=0.110 Sum_probs=44.1
Q ss_pred CCCeeeeecCCCCeeEEeecCCCCCC--cceeeeccccccCC---cEEecCCCCeEEeecCCCCceeeEEee
Q psy11098 12 TQPVINVHPLSESSVELALLTENLSS--IRLCDHESGVWSDA---RWVISPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 12 ~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
....+.. .+.+++.|+|..+...+ +..|.+.-....+. .+.....+..+.+.+|.|+..|.|++.
T Consensus 8 ~~~~~~~--~s~~si~v~W~~P~~~~g~i~~Y~v~y~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~ 77 (98)
T d1x5la1 8 VVIRQER--AGQTSVSLLWQEPEQPNGIILEYEIKYYEKDKEMQSYSTLKAVTTRATVSGLKPGTRYVFQVR 77 (98)
T ss_dssp CCEECSC--BCSSCEEEEECCCSCCCSCCCEEEEEEEESSSCCSSCEEEEESSSEEEECSCCTTCEEEECEE
T ss_pred CceEEEe--ccCCEEEEEEECCCCCCCCEEEEEEEeecccccceeeEEecCCceEEEECCCCCCCEEEEEEE
Confidence 3445555 89999999999776543 45666543222222 222345577899999999999999983
|
| >d1fnfa2 b.1.2.1 (A:1236-1326) Fibronectin, different Fn3 modules {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Fibronectin, different Fn3 modules species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.31 E-value=0.004 Score=44.31 Aligned_cols=63 Identities=11% Similarity=0.165 Sum_probs=43.2
Q ss_pred CeeeeecCCCCeeEEeecCCCCCCcceeeeccccccCCcEE---e-cCCCCeEEeecCCCCceeeEEee
Q psy11098 14 PVINVHPLSESSVELALLTENLSSIRLCDHESGVWSDARWV---I-SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 14 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~-~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
-.+.. .+.+++.|+|..+....+..+.++-....+..+. . ......+.+++|.|+..|.|++.
T Consensus 7 l~~~~--~~~~sv~l~W~~p~~~~~~~y~v~y~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~ 73 (91)
T d1fnfa2 7 LRFTN--IGPDTMRVTWAPPPSIDLTNFLVRYSPVKNEEDVAELSISPSDNAVVLTNLLPGTEYVVSVS 73 (91)
T ss_dssp EEEES--CCSSCEEEEEECCTTCCCSEEEEEEEETTCTTCCEEEEECTTCCEEEECSCCTTCEEEEEEE
T ss_pred eEEEE--eCCCEEEEEEEecCCCCcceeEEEEEECCCCccEEEEEeCCCceEEEEeceeCCCEEEEEEE
Confidence 34444 8899999999987655566666544332222222 1 34566899999999999999973
|
| >d2djsa1 b.1.2.1 (A:8-102) Ephrin type-B receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Ephrin type-B receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.31 E-value=0.0035 Score=44.90 Aligned_cols=58 Identities=16% Similarity=0.213 Sum_probs=39.5
Q ss_pred CCCCeeEEeecCCCCCC--cceeeeccccccCCcE--Ee-cCCCCeEEeecCCCCceeeEEee
Q psy11098 21 LSESSVELALLTENLSS--IRLCDHESGVWSDARW--VI-SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 21 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~--~~-~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
.+.+++.|+|..+...+ +..+.+.........| .. ......+.+.+|.|+..|.|++.
T Consensus 12 ~t~~si~l~W~~p~~~~g~i~~Y~v~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~ 74 (95)
T d2djsa1 12 ATMRSITLSWPQPEQPNGIILDYEIRYYEKEHNEFNSSMARSQTNTARIDGLRPGMVYVVQVR 74 (95)
T ss_dssp ECSSEEEEECCCCSCCSSCEEEEEEEEEETTSCSTTCEEEEESSSEEEEESCCTTCEEEEEEE
T ss_pred ecCCEEEEEEEECCCCCcceEEeeeeeeeeccCcceeEeecCCccEEEEeecCCccEEEEEEE
Confidence 88999999999876555 3344443322222222 22 34567899999999999999983
|
| >d1wisa1 b.1.2.1 (A:8-118) Sidekick 2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Sidekick 2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.12 E-value=0.0055 Score=45.23 Aligned_cols=73 Identities=25% Similarity=0.369 Sum_probs=43.5
Q ss_pred CCCCCC-CCCCCeeeeecCCCCeeEEeecCCCCCC--cceeeecccccc---CCcEEe------cCCCCeEEeecCCCCc
Q psy11098 4 SPLDFN-PATQPVINVHPLSESSVELALLTENLSS--IRLCDHESGVWS---DARWVI------SPHNGTIQVDDLAPGH 71 (380)
Q Consensus 4 ~~~~~~-p~~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~---~~~~~~------~~~~~~~~~~~l~~~~ 71 (380)
.||+.| |+..+.+.. .+.+++.|+|..+...+ +..+.++-.... +..|.. ......+.+.+|.|+.
T Consensus 6 ~p~~~P~~P~~~~~~~--~~~~sv~l~W~pp~~~~~~i~~y~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~L~p~t 83 (111)
T d1wisa1 6 VPPELPGPPTNLGISN--IGPRSVTLQFRPGYDGKTSISRWLVEAQVGVVGEGEEWLLIHQLSNEPDARSMEVPDLNPFT 83 (111)
T ss_dssp CCCCCCCCCEEEEEES--CCSSCEEEEEECCCCCSSCCSEEEEEECBSCCSTTSCCEEEEEEESCTTCSEEEECSCCTTS
T ss_pred CCCCCCcCCCCCEEEE--cCCCEEEEEEeCCCCCCCceeEEEEeeeecccCCCcceeeeeeeecccceeEEEeCCCCCCC
Confidence 455531 223344444 78999999998766443 334443322211 222221 2235578899999999
Q ss_pred eeeEEee
Q psy11098 72 TYTFCIN 78 (380)
Q Consensus 72 ~~~f~~~ 78 (380)
.|.|++.
T Consensus 84 ~Y~frV~ 90 (111)
T d1wisa1 84 CYSFRMR 90 (111)
T ss_dssp EECCCCE
T ss_pred EEEEEEE
Confidence 9999983
|
| >d2ibga1 b.1.2.1 (A:573-667) Hedgehog receptor iHog {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Hedgehog receptor iHog species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=96.06 E-value=0.0087 Score=42.87 Aligned_cols=62 Identities=18% Similarity=0.140 Sum_probs=42.8
Q ss_pred CeeeeecCCCCeeEEeecCCCCCC---cceeeecccccc-CCcEEe----cCCCCeEEeecCCCCceeeEEe
Q psy11098 14 PVINVHPLSESSVELALLTENLSS---IRLCDHESGVWS-DARWVI----SPHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 14 p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~-~~~~~~----~~~~~~~~~~~l~~~~~~~f~~ 77 (380)
-.+.. ++.+++.|.|..+...+ +..+.+.-+... +..|.. ......+.+.+|.|+..|.|++
T Consensus 13 ~~v~~--~s~tsv~l~W~~P~~~~~~~i~gY~i~y~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V 82 (95)
T d2ibga1 13 LEIEE--YSETAVVLHWSLASDADEHLITGYYAYYRPSSSAGEYFKATIEGAHARSFKIAPLETATMYEFKL 82 (95)
T ss_dssp CCCBC--CSSSCEEEEEECCTTCCGGGCCEEEEEEEETTCCSCCEEEEEECTTCCEEEECSCCTTCEEEEEE
T ss_pred eEEEE--eCCCEEEEEEEeeeeccCCcccccceeEeeeeecceeeeeeccCCceeEEEEeeccCCeEEEEEE
Confidence 34444 89999999998765554 555665433322 344443 2345679999999999999998
|
| >d2haza1 b.1.2.1 (A:489-589) Neural cell adhesion molecule 1, NCAM {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Neural cell adhesion molecule 1, NCAM species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.03 E-value=0.0049 Score=44.94 Aligned_cols=58 Identities=16% Similarity=0.233 Sum_probs=42.5
Q ss_pred CCCCeeEEeecCCCCCC---cceeeeccccccCCcEEec-------CCCCeEEeecCCCCceeeEEee
Q psy11098 21 LSESSVELALLTENLSS---IRLCDHESGVWSDARWVIS-------PHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 21 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
.+.+++.|.|..|..+| +..|.++-....+..|... .....+.+.+|.|+..|.|++.
T Consensus 13 ~~~~sv~l~W~~P~~~gg~~I~~Y~v~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~frV~ 80 (101)
T d2haza1 13 PYSSTAQVQFDEPEATGGVPILKYKAEWRAVGEEVWHSKWYDAKEASMEGIVTIVGLKPETTYAVRLA 80 (101)
T ss_dssp ECSSCEEEEEECCSCCTTSCCCEEEEEEEETTCCCCEEEEEEHHHHHHHSEEEECSCCTTCEEEEEEE
T ss_pred eeCCEEEEEEeCCCcCccccEEEEEEEEeecCCcceeeeeeeeecccceeEEEecCCCCCeEEEEEEE
Confidence 45689999999987775 5677776555445555531 1245799999999999999983
|
| >d1fnfa1 b.1.2.1 (A:1142-1235) Fibronectin, different Fn3 modules {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Fibronectin, different Fn3 modules species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.03 E-value=0.005 Score=44.36 Aligned_cols=57 Identities=11% Similarity=0.156 Sum_probs=39.2
Q ss_pred CC-CCeeEEeecCCCCCCcceeeeccccccCCcEE-----ecCCCCeEEeecCCCCceeeEEe
Q psy11098 21 LS-ESSVELALLTENLSSIRLCDHESGVWSDARWV-----ISPHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 21 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~l~~~~~~~f~~ 77 (380)
.+ .+++.|+|..+....+..+.+.-....+..|. .......+.+++|.||..|.+++
T Consensus 13 ~~~ts~i~v~W~~p~~~~i~~Y~v~y~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~v~V 75 (94)
T d1fnfa1 13 NPDTGVLTVSWERSTTPDITGYRITTTPTNGQQGNSLEEVVHADQSSCTFDNLSPGLEYNVSV 75 (94)
T ss_dssp CSSSSCEEEEEECCSCSSCCEEEEEEEETTTCSSCCEEEEECTTCCEEECCCCCTTSCEEEEE
T ss_pred ecCCCEEEEEeeCCCCCCeeEEEEEEEEecccCceEEEEEeCCCccEEEECCCCCCCEEEEEE
Confidence 44 45689999988765677777654333222221 13445689999999999999987
|
| >d1uc6a_ b.1.2.1 (A:) Ciliary neurotrophic factor receptor alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Ciliary neurotrophic factor receptor alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.02 E-value=0.0057 Score=45.08 Aligned_cols=68 Identities=12% Similarity=0.063 Sum_probs=45.5
Q ss_pred CCCCeeeeecCCCCeeEEeecCCCCCC-----cceeeeccccccCCcEEe--cCCCCeEEeecCCCCceeeEEee
Q psy11098 11 ATQPVINVHPLSESSVELALLTENLSS-----IRLCDHESGVWSDARWVI--SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 11 ~~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
|.-..+.....+.+++.|+|..+...+ ...|.++.....+..|.. ..+...+.+.+|.++..|.|++.
T Consensus 11 P~~l~v~~~~~~~~~l~l~W~~P~~~~~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~i~~L~~~t~Y~~rVr 85 (109)
T d1uc6a_ 11 PENVVARPVPSNPRRLEVTWQTPSTWPDPESFPLKFFLRYRPLILDQWQHVELSNGTAHTITDAYAGKEYIIQVA 85 (109)
T ss_dssp CEEEEEEECTTCTTCEEEEEECCTTCCCTTTTTBCEEEEEEESSSCCCCCEEESSCSEEEETTCCSSSCEEEEEE
T ss_pred CCCCEEEEEecCCCEEEEEEeCCcccCCCCeeEEEEEEEEeecCCCceEEeccCCceeEEeCCCCCCCEEEEEEE
Confidence 344556553346789999999876443 223444443444556664 34567899999999999999984
|
| >d1wfna1 b.1.2.1 (A:8-113) Sidekick 2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Sidekick 2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.98 E-value=0.012 Score=43.06 Aligned_cols=65 Identities=11% Similarity=0.081 Sum_probs=44.1
Q ss_pred CCCeeeeecCCCCeeEEeecCCCCCC--cceeeeccccccC-CcEE---ecCCCCeEEeecCCCCceeeEEee
Q psy11098 12 TQPVINVHPLSESSVELALLTENLSS--IRLCDHESGVWSD-ARWV---ISPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 12 ~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~-~~~~---~~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
....+.. ++.+++.|+|..+...+ +..+.+.-..... ..|. .......+.+.+|.|+..|.|++.
T Consensus 15 ~~l~~~~--~~~~sv~l~W~~P~~~ng~i~~Y~i~~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~ 85 (106)
T d1wfna1 15 GHLSFSE--ILDTSLKVSWQEPGEKNGILTGYRISWEEYNRTNTRVTHYLPNVTLEYRVTGLTALTTYTIEVA 85 (106)
T ss_dssp SCCEEES--CCSSEEEEECCCCTTCCSCCCEEEEEEEESSCGGGCCCEEECSSCCEEEEESCCTTCEEEEEEE
T ss_pred CCcEEEE--ecCCEEEEEEECCCCCCCcEEeEEEEEEECCCCcceEEEecCCCeeEEEEccCCCCCEEEEEEE
Confidence 4455555 89999999999877654 4556554322221 2222 234456899999999999999983
|
| >d1n26a3 b.1.2.1 (A:196-299) Interleukin-6 receptor alpha chain, domains 2 and 3 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Interleukin-6 receptor alpha chain, domains 2 and 3 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.94 E-value=0.0075 Score=44.04 Aligned_cols=69 Identities=7% Similarity=-0.005 Sum_probs=46.7
Q ss_pred CCCCCeeeeecCCCCeeEEeecCCCC--CC--cceeeeccccccCCcEEe---cCCCCeEEeecCCCCceeeEEee
Q psy11098 10 PATQPVINVHPLSESSVELALLTENL--SS--IRLCDHESGVWSDARWVI---SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 10 p~~~p~~~~~~~~~~~~~~~~~~~~~--~~--~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
||..+.+.....+.+++.|+|..+.. ++ +..|.++-.......|.. ..+...+.+.+|.||..|.|++.
T Consensus 4 pP~~l~v~~~~~~~~~l~v~W~~P~~~~~~~~~~~y~v~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~rVr 79 (104)
T d1n26a3 4 PPANITVTAVARNPRWLSVTWQDPHSWNSSFYRLRFELRYRAERSKTFTTWMVKDLQHHCVIHDAWSGLRHVVQLR 79 (104)
T ss_dssp CCEEEEEEECTTCTTCEEEEEECCTTCCCSSSCEEEEEEEEETTCSCCEEEECGGGCSEEEESSCCTTCCEEEEEE
T ss_pred CCCCCEEEEEecCCCEEEEEEEeeeecCCCceeEEEEEEEeeCCCCceeeeccccceEEEEECCCCCCCEEEEEEE
Confidence 44556777644456789999998753 22 445555444444456664 34466899999999999999983
|
| >d1x5fa1 b.1.2.1 (A:8-114) Neogenin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Neogenin species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.88 E-value=0.012 Score=43.26 Aligned_cols=61 Identities=18% Similarity=0.171 Sum_probs=39.9
Q ss_pred eeeeecCCCCeeEEeecCCCCCC---cceeeeccccccCCcEEe----cCCCCeEEeecCCCCceeeEEe
Q psy11098 15 VINVHPLSESSVELALLTENLSS---IRLCDHESGVWSDARWVI----SPHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 15 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~~~~~~f~~ 77 (380)
.+.. ++.+++.|+|..+..++ +..+.+.-.......|.. ......+.+++|.|+..|.|++
T Consensus 18 ~~~~--~~~~sv~lsW~~P~~~~~~~i~~Y~v~~~~~~~~~~~~~~~~~~~~~~~~~~~L~p~t~Y~~rV 85 (107)
T d1x5fa1 18 VASL--VSTRFIKLTWRTPASDPHGDNLTYSVFYTKEGIARERVENTSHPGEMQVTIQNLMPATVYIFRV 85 (107)
T ss_dssp EEEE--ECSSCEEEEEECCSSCSSCCSSEEEEEEEETTCCCCEEEECSSTTCSEEEECSCCTTCEEEEEE
T ss_pred EEEE--ecCCEEEEEEECCccCCCCceEEEEEEEEeCCCCceEEEEEeCCCccEEEecCCCCCCEEEEEE
Confidence 4444 88999999998765443 334444322222222222 2345689999999999999998
|
| >d1fnfa3 b.1.2.1 (A:1327-1415) Fibronectin, different Fn3 modules {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Fibronectin, different Fn3 modules species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.85 E-value=0.0091 Score=42.17 Aligned_cols=63 Identities=14% Similarity=0.173 Sum_probs=44.5
Q ss_pred CCCeeeeecCCCCeeEEeecCCCCCCcceeeeccccccCCcEE----ecCCCCeEEeecCCCCceeeEEe
Q psy11098 12 TQPVINVHPLSESSVELALLTENLSSIRLCDHESGVWSDARWV----ISPHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 12 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~~~~~~f~~ 77 (380)
..-.+.. ++.+++.|+|..+. +.+..+.++-.......|. .+.....+.+++|.|+..|.|++
T Consensus 5 ~~l~v~~--vt~~sv~l~W~~p~-~~~~~Y~i~~~~~~~~~~~~~~~v~~~~~~~~i~~L~p~t~Y~~~V 71 (89)
T d1fnfa3 5 TGIDFSD--ITANSFTVHWIAPR-ATITGYRIRHHPEHFSGRPREDRVPHSRNSITLTNLTPGTEYVVSI 71 (89)
T ss_dssp EEEEEES--CCSSEEEEEEECCS-SCCSEEEEEEECSCCSSCCEEEEEETTCCEEEEESCCTTCEEEEEE
T ss_pred cCCEEEE--ecCCEEEEEEEeCC-CEEeeEEEEEEECCCCCceEEEEECCCccEEEECCCcccCEEEEEE
Confidence 4455666 89999999999875 3355666544333333332 24567789999999999999997
|
| >d1qr4a2 b.1.2.1 (A:88-175) Tenascin {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Tenascin species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=95.80 E-value=0.016 Score=40.88 Aligned_cols=64 Identities=13% Similarity=0.096 Sum_probs=46.9
Q ss_pred CCCeeeeecCCCCeeEEeecCCCCCCcceeeeccccccCCcEEe---cCCCCeEEeecCCCCceeeEEee
Q psy11098 12 TQPVINVHPLSESSVELALLTENLSSIRLCDHESGVWSDARWVI---SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 12 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
..-.+.. ++.+++.|+|..+. +.+..|.++-....+..|.. ......+.+.+|.||..|.|++.
T Consensus 5 ~~l~v~~--v~~~s~~l~W~~~~-~~~~~Y~i~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~ 71 (88)
T d1qr4a2 5 KGISFSD--ITENSATVSWTPPR-SRVDSYRVSYVPITGGTPNVVTVDGSKTRTKLVKLVPGVDYNVNII 71 (88)
T ss_dssp SCEEEES--CCSSCEEEEECCCS-SCCSEEEEEEEETTCCCCEEEEEETTCCEEEECSCCSSCEEEEEEE
T ss_pred cceEEEE--ecCCEEEEEEEccc-EeeceEEEEEEeccCCceEEEEecCCccEEEECCCCCCCEEEEEEE
Confidence 4567777 89999999998775 34556766544444444443 34567899999999999999983
|
| >d1cd9b2 b.1.2.1 (B:108-213) Granulocyte colony-stimulating factor (GC-SF) receptor {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Granulocyte colony-stimulating factor (GC-SF) receptor species: Mouse (Mus musculus) [TaxId: 10090]
Probab=95.76 E-value=0.0042 Score=45.83 Aligned_cols=58 Identities=14% Similarity=0.201 Sum_probs=42.1
Q ss_pred CCCCeeEEeecCCCCCC--cceeeecccc-ccCCcEEec----CCCCeEEeecCCCCceeeEEee
Q psy11098 21 LSESSVELALLTENLSS--IRLCDHESGV-WSDARWVIS----PHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 21 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
.+++++.|+|..+..++ ...|.++-.. .++..|... .....+.+.+|.|+..|.|++.
T Consensus 19 ~~~~~i~v~W~pp~~~~~~~~~Y~i~y~~~~~~~~w~~v~~~~~~~~~~~l~~L~p~t~Y~frVr 83 (106)
T d1cd9b2 19 HQPGCLWLSWKPWKPSEYMEQECELRYQPQLKGANWTLVFHLPSSKDQFELCGLHQAPVYTLQMR 83 (106)
T ss_dssp -CCSCEEEEEECCGGGTTSCEEEEEEEEESSTTCCCEEEEEEESCEEEEEECCCCSCSCEEEEEE
T ss_pred CCCCEEEEEEcCcccCCccceEEEEEEeeccccccceeeecccCCceEEEEeccCCCeEEEEEEE
Confidence 78899999999877666 4556665433 345667752 3456788999999999999983
|
| >d1fnha3 b.1.2.1 (A:183-271) Fibronectin, different Fn3 modules {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Fibronectin, different Fn3 modules species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.74 E-value=0.012 Score=41.55 Aligned_cols=63 Identities=13% Similarity=0.088 Sum_probs=44.2
Q ss_pred CCeeeeecCCCCeeEEeecCCCCCCcceeeeccccccCCcEEe----cCCCCeEEeecCCCCceeeEEee
Q psy11098 13 QPVINVHPLSESSVELALLTENLSSIRLCDHESGVWSDARWVI----SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 13 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
-..+.. ++.+++.|+|..+. +.+..+.++-....+..|.. ......+.+.+|.||..|.|++.
T Consensus 6 nl~v~~--~~~~s~~l~W~~p~-~~i~~Y~i~~~~~~~~~~~~~~~~~~~~~~~~~~~L~p~t~Y~~~V~ 72 (89)
T d1fnha3 6 NLRFLA--TTPNSLLVSWQPPR-ARITGYIIKYEKPGSPPREVVPRPRPGVTEATITGLEPGTEYTIYVI 72 (89)
T ss_dssp EEEEEE--EETTEEEEEEECCS-SCCSEEEEEEECTTSCCEECTTCCCTTCCEEEEESCCTTCEEEEEEE
T ss_pred CCEEEE--ecCCEEEEEEeCCC-cCCceEEEEEeeccCCccEEEEEcCCCccEEEEEeeeCCCEEEEEEE
Confidence 344444 88899999999875 34566666544444444543 23356799999999999999983
|
| >d1axib2 b.1.2.1 (B:131-236) Growth hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Growth hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.73 E-value=0.0044 Score=45.77 Aligned_cols=57 Identities=7% Similarity=0.158 Sum_probs=42.9
Q ss_pred CCCeeEEeecCCCCCC------cceeeeccccccCCcEEec--CCCCeEEeecCCCCceeeEEee
Q psy11098 22 SESSVELALLTENLSS------IRLCDHESGVWSDARWVIS--PHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 22 ~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
..++|.|+|..|.... ...|.++-....+.+|..- ..+..+.+.+|.+|..|.|++.
T Consensus 19 ~~~~v~vsW~pP~~~~~~~~~~~l~Y~v~y~~~~~~~w~~~~~~~~~~~~i~~L~~~t~Y~frVR 83 (106)
T d1axib2 19 IHADIQVRWEAPRNADIQKGWMVLEYELQYKEVNETKWKMMDPILTTSVPVYSLKVDKEYEVRVR 83 (106)
T ss_dssp SEEEEEEEEECCTTSCTTTTSCCEEEEEEEEETTCSSCEECCCBSSSEEEEEEEETTSCEEEEEE
T ss_pred ccCeEEEEEcCCCccCCCCCeeEEEEEEeeeecCCccceeeeecccceEEECCCCCCCEEEEEEE
Confidence 3568999999886432 3467776655667788862 4467899999999999999984
|
| >d1tena_ b.1.2.1 (A:) Tenascin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Tenascin species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.69 E-value=0.011 Score=41.75 Aligned_cols=66 Identities=9% Similarity=0.199 Sum_probs=45.3
Q ss_pred CCCCCeeeeecCCCCeeEEeecCCCCCCcceeeeccccccCCc---EE-ecCCCCeEEeecCCCCceeeEEee
Q psy11098 10 PATQPVINVHPLSESSVELALLTENLSSIRLCDHESGVWSDAR---WV-ISPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 10 p~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~-~~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
||....+.. .+.+++.|+|..+. +.+..+.+.-....+.. +. ...+...+.+.+|.||..|.|++.
T Consensus 4 ~P~~l~v~~--~s~~s~~l~W~~p~-~~~~~y~v~~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~ 73 (90)
T d1tena_ 4 APSQIEVKD--VTDTTALITWFKPL-AEIDGIELTYGIKDVPGDRTTIDLTEDENQYSIGNLKPDTEYEVSLI 73 (90)
T ss_dssp CCEEEEEES--CCSSCEEEEEECCS-SCCSEEEEEEEETTCTTCCEEEEEETTCCEEEECSCCTTCEEEEEEE
T ss_pred CCCCcEEEE--ecCCEEEEEEEeCc-eEeccEEEEEEEcCCCceeEEEEecCCcceeeEeeecCCCEEEEEEE
Confidence 345566666 89999999998775 33455655433322222 22 245677899999999999999973
|
| >d2cuha1 b.1.2.1 (A:8-109) Tenascin-X {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Tenascin-X species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.69 E-value=0.013 Score=42.48 Aligned_cols=63 Identities=16% Similarity=0.048 Sum_probs=44.8
Q ss_pred CCCeeeeecCCCCeeEEeecCCCCCCcceeeeccccccCCcEEe--cCCCCeEEeecCCCCceeeEEe
Q psy11098 12 TQPVINVHPLSESSVELALLTENLSSIRLCDHESGVWSDARWVI--SPHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 12 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~~f~~ 77 (380)
..-.+.. ++.+++.|+|..+. +.+..|.+.-....+..|.. ......+.+.+|.||..|.|++
T Consensus 5 ~~l~~~~--~t~~si~l~W~~p~-~~i~~Y~v~~~~~~~~~~~~~~~~~~~~~~l~~L~p~t~Y~~~V 69 (102)
T d2cuha1 5 TQLRALN--LTEGFAVLHWKPPQ-NPVDTYDIQVTAPGAPPLQAETPGSAVDYPLHDLVLHTNYTATV 69 (102)
T ss_dssp EEEECCC--CSSSCEEEEEECCS-SCCSEEEEEEECSSSCCEEEEEETTCSEEEECSCCSSSEEEEEE
T ss_pred CccEEEE--eCCCEEEEEEEeee-ccceeeEEEEEeccccceeeeeeeeeeeEEEccEEeeEEEEEEE
Confidence 3344445 89999999998765 33566766543333445554 4456789999999999999997
|
| >d2d9qb2 b.1.2.1 (B:204-308) Granulocyte colony-stimulating factor (GC-SF) receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Granulocyte colony-stimulating factor (GC-SF) receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.62 E-value=0.0053 Score=45.02 Aligned_cols=59 Identities=17% Similarity=0.281 Sum_probs=40.5
Q ss_pred cCCCCeeEEeecCCCCCC--cceeeecccc-ccCCcEEe----cCCCCeEEeecCCCCceeeEEee
Q psy11098 20 PLSESSVELALLTENLSS--IRLCDHESGV-WSDARWVI----SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 20 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~-~~~~~~~~----~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
+.+.+++.|+|..+..++ +..|.+.-.. .++..|.. ......+.+.+|.||..|.|++.
T Consensus 17 ~~~~~~v~l~W~pp~~~~~~~~~y~i~y~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~frVr 82 (105)
T d2d9qb2 17 PPQAGCLQLSWEPWQPGLHINQKCELRHKPQRGEASWALVGPLPLEALQYELCGLLPATAYTLQIR 82 (105)
T ss_dssp --CCSCEEEEEECCGGGTTSCEEEEEEEEESSSCCCCEEEEEECSCEEEEEECSCCSCCCEEEEEE
T ss_pred cCCCCeEEEEEcCCCCCCceeEEEEEEEEecCCccceeeeecccCCcceeEEecccCCeEEEEEEE
Confidence 378899999999876555 5556654432 23456664 22345688999999999999984
|
| >d1wfoa1 b.1.2.1 (A:8-124) Sidekick 2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Sidekick 2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.62 E-value=0.034 Score=41.25 Aligned_cols=63 Identities=19% Similarity=0.195 Sum_probs=41.9
Q ss_pred CeeeeecCCCCeeEEeecCCCCCC--cceeeeccccccC-CcE--Ee--cCCCCeEEeecCCCCceeeEEee
Q psy11098 14 PVINVHPLSESSVELALLTENLSS--IRLCDHESGVWSD-ARW--VI--SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 14 p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~-~~~--~~--~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
..+.. ++.+++.|+|..+..++ +..|.+.-..... ..| .. ......+.+.+|.|+..|.|++.
T Consensus 27 ~~~~~--~~~~sv~v~W~~P~~~~g~i~~Y~i~y~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~ 96 (117)
T d1wfoa1 27 ILFPE--VRTTSVRLIWQPPAAPNGIILAYQITHRLNTTTANTATVEVLAPSARQYTATGLKPESVYLFRIT 96 (117)
T ss_dssp CEEEE--ECSSEEEEECCCCSCCCSCCCEEEEEEEESSCCCSCCCEEEECTTCCEEEEESCCSSSEEEEEEE
T ss_pred cEEEE--ecCCEEEEEEECCCCCCCceEEEeeeeeeccCCCceEeEEecCCceEEEEECCCCCCCEEEEEEE
Confidence 44444 88999999999887665 4555554222111 222 11 34466899999999999999983
|
| >d1qg3a2 b.1.2.1 (A:1218-1320) Integrin beta-4 subunit {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Integrin beta-4 subunit species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.60 E-value=0.023 Score=41.04 Aligned_cols=65 Identities=14% Similarity=0.227 Sum_probs=42.3
Q ss_pred CCCeeeeecCCCCeeEEeecCCCCCC--cceeeec-----cccccCCcEEe----cCCCCeEEeecCCCCceeeEEee
Q psy11098 12 TQPVINVHPLSESSVELALLTENLSS--IRLCDHE-----SGVWSDARWVI----SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 12 ~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~-----~~~~~~~~~~~----~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
.-..+.. ++.+++.|+|..+...+ +..+.+. ........|.. ......+.+.+|.++..|.|++.
T Consensus 7 ~~~~~~~--~~~~sv~v~W~~P~~~~g~i~~Y~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~ 82 (103)
T d1qg3a2 7 GRLAFNV--VSSTVTQLSWAEPAETNGEITAYEVCYGLVNDDNRPIGPMKKVLVDNPKNRMLLIENLRESQPYRYTVK 82 (103)
T ss_dssp CCCEEEE--EETTEEEEECCCCSCCSSCCCEEEEEEEEBCTTSCBCSCCEEEEECCTTCCEEEECCCCTTCCEEEEEE
T ss_pred CCcEEEE--ecCCEEEEEEEECccCCCCceEEEEEeeccccccccccceEEEEecCCCceEEEEeecCCCCEEEEEEE
Confidence 3445555 89999999999877665 3334332 22222333432 12345789999999999999983
|
| >d1qr4a1 b.1.2.1 (A:1-87) Tenascin {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Tenascin species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=95.60 E-value=0.018 Score=40.31 Aligned_cols=62 Identities=11% Similarity=0.071 Sum_probs=43.1
Q ss_pred CeeeeecCCCCeeEEeecCCCCCCcceeeeccccccCCcEEe--cCCCCeEEeecCCCCceeeEEee
Q psy11098 14 PVINVHPLSESSVELALLTENLSSIRLCDHESGVWSDARWVI--SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 14 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
-.+.. .+.+|+.|+|..+. +.+..|.+.-.......+.. +.....+.+.+|.||..|.|++.
T Consensus 6 l~v~~--~t~~sv~v~W~~p~-~~~~~Y~v~~~~~~~~~~~~~~~~~~~~~~~~~L~p~t~Y~v~V~ 69 (87)
T d1qr4a1 6 LEVSD--PTETTLSLRWRRPV-AKFDRYRLTYVSPSGKKNEMEIPVDSTSFILRGLDAGTEYTISLV 69 (87)
T ss_dssp EEEES--CCSSEEEEEEECCS-SCCSEEEEEEECTTCCEEEEEECTTCSEEEEESCCSSCEEEEEEE
T ss_pred cEEEE--ecCCEEEEEEECCC-CCcceeEEEeecCCcceeEEeCCCCcCEEEECCCCcCCEEEEEEE
Confidence 34555 88999999999875 34556665543332222222 45577899999999999999983
|
| >d1x5aa1 b.1.2.1 (A:8-101) Ephrin type-A receptor 1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Ephrin type-A receptor 1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=95.49 E-value=0.021 Score=40.94 Aligned_cols=57 Identities=14% Similarity=0.132 Sum_probs=39.3
Q ss_pred CCCCeeEEeecCCCCCC---cceeeeccccccCCcEEecCCCCeEEeecCCCCceeeEEee
Q psy11098 21 LSESSVELALLTENLSS---IRLCDHESGVWSDARWVISPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 21 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
.+..++.|+|..+...+ +..+.+..... +..|.....+..+.+.+|.|+..|.|++.
T Consensus 14 ~~~~si~vsW~~p~~~~~~~~i~Y~i~~~~~-~~~~~~~~~~t~~~i~~L~p~t~Y~~rV~ 73 (94)
T d1x5aa1 14 KEPRQLELTWAGSRPRNPGGNLSYELHVLNQ-DEEWHQMVLEPRVLLTKLQPDTTYIVRVR 73 (94)
T ss_dssp EETTEEEEECCCCCSSCCSSCCEEEEEEECS-SCEEEEEESSSEEEEESCCSSCEEEEEEE
T ss_pred cCCCEEEEEEecccCCCCCcEEEEEEEEecC-CceEEEeeccCEEEECCCCCCCEEEEEEE
Confidence 67799999998764332 33455443222 34444444577899999999999999983
|
| >d2cuma1 b.1.2.1 (A:7-99) Tenascin-X {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Tenascin-X species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.37 E-value=0.022 Score=40.42 Aligned_cols=64 Identities=9% Similarity=-0.080 Sum_probs=44.1
Q ss_pred CCCeeeeecCCCCeeEEeecCCCCCCcceeeeccccccCCcEEe--cCCCCeEEeecCCCCceeeEEee
Q psy11098 12 TQPVINVHPLSESSVELALLTENLSSIRLCDHESGVWSDARWVI--SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 12 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
....+.. .+.+++.|+|..+. +.+..|.+.-.......+.. .....++.+.+|.||..|.|++.
T Consensus 6 ~~l~~~~--~~~~sv~l~W~~p~-~~~~~Y~v~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~ 71 (93)
T d2cuma1 6 RDLEAKE--VTPRTALLTWTEPP-VRPAGYLLSFHTPGGQTQEILLPGGITSHQLLGLFPSTSYNARLQ 71 (93)
T ss_dssp EEEEEES--CCSSCEEEEEECCS-SCCSEEEEEEECTTSCEEEEEECSSCSEEEECSCCTTCEEEEEEE
T ss_pred CCCEEEE--eCCCEEEEEEEccc-cccccEEEEEEccccccEEEEECCCccEEEEeCccCCCEEEEEEE
Confidence 3344555 88999999998875 34566666543332232322 45567899999999999999973
|
| >d1qg3a1 b.1.2.1 (A:1126-1217) Integrin beta-4 subunit {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Integrin beta-4 subunit species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.37 E-value=0.013 Score=41.49 Aligned_cols=66 Identities=9% Similarity=0.130 Sum_probs=44.5
Q ss_pred CCCCCeeeeecCCCCeeEEeecCCCCCCcceeeeccccccCCc---EEecCCCCeEEeecCCCCceeeEEee
Q psy11098 10 PATQPVINVHPLSESSVELALLTENLSSIRLCDHESGVWSDAR---WVISPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 10 p~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
||..+.+.. ++.+++.|+|..++.. +..+.+.-....... .........+.+.+|.|+..|.|++.
T Consensus 4 aP~n~~~~~--~s~~si~l~W~~p~~~-~~~Y~i~y~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~ 72 (92)
T d1qg3a1 4 APQNPNAKA--AGSRKIHFNWLPPSGK-PMGYRVKYWIQGDSESEAHLLDSKVPSVELTNLYPYCDYEMKVC 72 (92)
T ss_dssp CCEEEEEEE--CSTTCEEEEEECCSSC-CCEEEEEEEETTSCGGGCEEEEESSSEEEECSCCTTCEEEEEEE
T ss_pred cCCCCEEEE--ccCCEEEEEEEecCCC-ccceEEeeeeccccccEEEEecCCccEEEECCCCCCcEEEEEEE
Confidence 335566777 8999999999988644 344554332222221 22244567899999999999999983
|
| >d1j8ka_ b.1.2.1 (A:) Fibronectin, different Fn3 modules {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Fibronectin, different Fn3 modules species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.37 E-value=0.024 Score=40.19 Aligned_cols=65 Identities=14% Similarity=0.133 Sum_probs=43.8
Q ss_pred CCCCeeeeecCCCCeeEEeecCCCCCCcceeeeccccccCCcEE--e--cCCCCeEEeecCCCCceeeEEee
Q psy11098 11 ATQPVINVHPLSESSVELALLTENLSSIRLCDHESGVWSDARWV--I--SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 11 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~--~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
|..-.+.. ++.+|+.|+|..+... +..+.++-....+..+. . ......+.+++|.||..|.|++.
T Consensus 5 P~~l~v~~--vt~~sv~l~W~~p~~~-~~~y~i~~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~ 73 (94)
T d1j8ka_ 5 PKGLAFTD--VDVDSIKIAWESPQGQ-VSRYRVTYSSPEDGIHELFPAPDGEEDTAELQGLRPGSEYTVSVV 73 (94)
T ss_dssp CCCCEEEE--EETTEEEEECCCCSSC-CSCEEEEEEETTTEEEEECCCCCSSCCEEEECSCCCCSEEEEEEE
T ss_pred CCCCEEEE--ecCCEEEEEEeCCCcc-ccceEEEEEeecCCCceEEEecCCCccEEEECCCCCCCEEEEEEE
Confidence 35566666 8899999999887643 44555433222222222 2 34467899999999999999983
|
| >d1tdqa3 b.1.2.1 (A:186-271) Tenascin {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Tenascin species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=95.30 E-value=0.022 Score=39.81 Aligned_cols=65 Identities=18% Similarity=0.223 Sum_probs=45.9
Q ss_pred CCCCeeeeecCCCCeeEEeecCCCCCCcceeeeccccccCCcEEe--cCCCCeEEeecCCCCceeeEEee
Q psy11098 11 ATQPVINVHPLSESSVELALLTENLSSIRLCDHESGVWSDARWVI--SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 11 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
|....+.. .+.+++.|+|..+. +.+..+.++-.......+.. ......+.+.+|.||..|.|++.
T Consensus 4 P~nl~v~~--~~~~s~~l~W~~p~-~~~~~Y~v~~~~~~~~~~~~~~~~~~~~~~~~~L~p~t~Y~v~V~ 70 (86)
T d1tdqa3 4 PRDLMVTA--SSETSISLIWTKAS-GPIDHYRITFTPSSGISSEVTVPRDRTSYTLTDLEPGAEYIISIT 70 (86)
T ss_dssp CEEEEEEE--ECSSCEEEEEECCC-SCCSEEEEEEECSSSCCEEEEEESSCSEEEECCCCTTCCEEEEEE
T ss_pred CCCCEEEE--ecCCEEEEEEeCCC-CCccceEEEEecccccceEEEeCCCccEEEECCCccccEEEEEEE
Confidence 34556666 78999999998875 34556665543333333333 45677899999999999999973
|
| >d1f6fb2 b.1.2.1 (B:101-203) Prolactin receptor {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Prolactin receptor species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=95.29 E-value=0.012 Score=42.64 Aligned_cols=58 Identities=16% Similarity=0.193 Sum_probs=42.4
Q ss_pred CCCCeeEEeecCCCCCC------cceeeeccccccCCcEEe--cCCCCeEEeecCCCCceeeEEee
Q psy11098 21 LSESSVELALLTENLSS------IRLCDHESGVWSDARWVI--SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 21 ~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
.+.+++.|+|..|.... ...|.++........|.. ......+.+.+|.+|..|.|++.
T Consensus 18 ~~~~~v~vsW~pP~~~~~~~~~~~l~Y~v~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~rVr 83 (103)
T d1f6fb2 18 DKKTYLWVKWSPPTITDVKTGWFTMEYEIRLKPEEAEEWEIHFTGHQTQFKVFDLYPGQKYLVQTR 83 (103)
T ss_dssp -CCCCEEEEEECCTTSCTTTTSSCEEEEEEEEESSCSCCEEEEEETCSEEEECCCCTTCEEEEEEE
T ss_pred cCCCEEEEEECCCCcccCCCCcEEEEEEEEEEeCCCcceeeecccceeEEEeCCCCcceEEEEEEE
Confidence 45688999999885421 345666655555677765 34567899999999999999984
|
| >d1owwa_ b.1.2.1 (A:) Fibronectin, different Fn3 modules {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Fibronectin, different Fn3 modules species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.24 E-value=0.019 Score=41.28 Aligned_cols=66 Identities=18% Similarity=0.165 Sum_probs=45.8
Q ss_pred CCCeeeeecCCCCeeEEeecCCCCCCcceeeecccccc-CCcEEe---cCCCCeEEeecCCCCceeeEEe
Q psy11098 12 TQPVINVHPLSESSVELALLTENLSSIRLCDHESGVWS-DARWVI---SPHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 12 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~---~~~~~~~~~~~l~~~~~~~f~~ 77 (380)
..+.+..-+.+.+|+.|+|..|..+.+..+.++-.... ...|.. +.....+.+++|.||..|.|.+
T Consensus 4 ~~~~vt~~~~~~~s~~vsW~~P~~~~i~~Y~i~y~~~~~~~~~~~~~v~~~~~~~~l~gL~P~t~Y~v~v 73 (93)
T d1owwa_ 4 VEVFITETPSQPNSHPIQWNAPQPSHISKYILRWRPKNSVGRWKEATIPGHLNSYTIKGLKPGVVYEGQL 73 (93)
T ss_dssp CEEECCCCSSCTTCEEEEEECCSSSCEEEEEEEEEETTCSSCCEEEEECSSCCEEEECSCCSSEEEEEEE
T ss_pred cccEEEEccCCCCEEEEEeecccccceeEEEEEEeeccccceeeeeccCCCccEEEECCcccCcEEEEEE
Confidence 34556553445589999999987556677776544332 233432 4556789999999999999987
|
| >d1bqua1 b.1.2.1 (A:5-99) Cytokine receptor gp130 cytokine-binding domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Cytokine receptor gp130 cytokine-binding domains species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.14 E-value=0.011 Score=42.32 Aligned_cols=59 Identities=2% Similarity=-0.265 Sum_probs=38.2
Q ss_pred cCCCCeeEEeecCCCCCC-cceeeeccccccCCcE-Eec---CCCCeEEeecCCCCceeeEEee
Q psy11098 20 PLSESSVELALLTENLSS-IRLCDHESGVWSDARW-VIS---PHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 20 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~-~~~---~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
..+.+++.++|..+...+ ...+.+.-.......| ... ..+..+.+.+|.++..|.|++.
T Consensus 14 ~~~~~si~~~W~p~~~~~~~~~y~v~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~~~Y~f~V~ 77 (95)
T d1bqua1 14 VNEGKKMRCEWDGGRETHLETNFTLKSEWATHKFADCKAKRDTPTSCTVDYSTVYFVNIEVWVE 77 (95)
T ss_dssp EETTSCCEEEEECCSCCSSCCEEEEEEEETTEECCCEECCSSCTTEEECSSCCCTTSCEEEEEE
T ss_pred EccCCEEEEEEeCcccCCCceEEEEEEEEcccceeEeecccccceeeeeeeecCCCcEEEEEEE
Confidence 378899999999887665 3345544322222222 221 2244577789999999999983
|
| >d1tdqa1 b.1.2.1 (A:1-93) Tenascin {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Tenascin species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=95.09 E-value=0.032 Score=39.56 Aligned_cols=63 Identities=17% Similarity=0.231 Sum_probs=43.0
Q ss_pred CCCeeeeecCCCCeeEEeecCCCCCCcceeeeccccccCCc---E-EecCCCCeEEeecCCCCceeeEEe
Q psy11098 12 TQPVINVHPLSESSVELALLTENLSSIRLCDHESGVWSDAR---W-VISPHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 12 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~-~~~~~~~~~~~~~l~~~~~~~f~~ 77 (380)
....+.. .+.+++.|+|..+... +..+.+.-....... + ........+.+.+|.||..|.|++
T Consensus 8 ~~l~v~~--v~~~si~v~W~~p~~~-~~~y~i~~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~v~V 74 (93)
T d1tdqa1 8 TQILVRD--VSDTVAFVEWTPPRAK-VDFILLKYGLVGGEGGKTTFRLQPPLSQYSVQALRPGSRYEVSI 74 (93)
T ss_dssp EEEEEEE--ECSSCEEEEEECCSSC-CSEEEEEEEESSSSCCCEEEEECTTCSEEEECSCCTTCEEEEEE
T ss_pred CCCEEEE--eCCCEEEEEEEccccC-CCceEEEEEeccCcceeeEEEeCCCceEEEEeCcccceEEEEEE
Confidence 4455666 8889999999877543 344554433333222 2 224557789999999999999997
|
| >d1bqua2 b.1.2.1 (A:100-214) Cytokine receptor gp130 cytokine-binding domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Cytokine receptor gp130 cytokine-binding domains species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.01 E-value=0.018 Score=42.60 Aligned_cols=66 Identities=18% Similarity=0.211 Sum_probs=44.6
Q ss_pred CCCeeeeecCCCCeeEEeecCCCCCC--cceeeeccccccCCcEEec------CCCCeEEeecCCCCceeeEEe
Q psy11098 12 TQPVINVHPLSESSVELALLTENLSS--IRLCDHESGVWSDARWVIS------PHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 12 ~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~~~~~~f~~ 77 (380)
..+.+...-.+.+++.|+|..+...+ +..|.++-....+..|... .....+.+.+|.++..|.|++
T Consensus 9 ~~~~v~~~~~~~~si~v~W~~p~~~~~~~~~Y~v~y~~~~~~~~~~~~~~~~~~~~~~~~i~~L~~~t~Y~~~V 82 (115)
T d1bqua2 9 HNLSVINSEELSSILKLTWTNPSIKSVIILKYNIQYRTKDASTWSQIPPEDTASTRSSFTVQDLKPFTEYVFRI 82 (115)
T ss_dssp EEEEEECC--CCSCEEEEEECCGGGGTSCEEEEEEEEETTCSSCEECCGGGGCSCCSEEEECSCCSSEEEEEEE
T ss_pred CCCEEEEeccCCCEEEEEEeeccccccceeeeeeeeeeeeeeeeeccccccccccccEEeeCCCccCcEEEEEE
Confidence 44555432356788999998765443 6677776555555555531 234578999999999999998
|
| >d1cfba1 b.1.2.1 (A:610-709) Neuroglian, two amino proximal Fn3 repeats {Drosophila melanogaster [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Neuroglian, two amino proximal Fn3 repeats species: Drosophila melanogaster [TaxId: 7227]
Probab=94.97 E-value=0.032 Score=40.11 Aligned_cols=58 Identities=14% Similarity=0.076 Sum_probs=38.5
Q ss_pred CCCCeeEEeecCCCCCC--cceeeeccccccCCcE-Ee----cCCCCeEEeecCCCCceeeEEee
Q psy11098 21 LSESSVELALLTENLSS--IRLCDHESGVWSDARW-VI----SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 21 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~-~~----~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
.+.+++.|+|..+...+ +..|.++-.......| .. ...+.++.+.+|.|+..|.|++.
T Consensus 16 ~~~~sv~lsW~pp~~~~~~i~~Y~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~p~t~Y~frV~ 80 (100)
T d1cfba1 16 CQADKAEIHWEQQGDNRSPILHYTIQFNTSFTPASWDAAYEKVPNTDSSFVVQMSPWANYTFRVI 80 (100)
T ss_dssp ECSSEEEEEEECCCCTTSCCCEEEEEEEESSSTTCCEEEEEEEETTCSEEEEECCSSEEEEEEEE
T ss_pred EcCCEEEEEEcCCcccccceEEEEEEEecCCCCceeeEEeeecCCceEEEEecCCCCCEEEEEEE
Confidence 45679999998765433 5566665433322222 21 23466788999999999999983
|
| >d1v5ja_ b.1.2.1 (A:) KIAA1355 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: KIAA1355 species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.96 E-value=0.026 Score=41.38 Aligned_cols=56 Identities=16% Similarity=0.148 Sum_probs=39.6
Q ss_pred CCCCeeEEeecCCCCCC--cceeeeccccccCCcEEe-----cCCCCeEEeecCCCCceeeEEe
Q psy11098 21 LSESSVELALLTENLSS--IRLCDHESGVWSDARWVI-----SPHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 21 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~~~~~~f~~ 77 (380)
.+.+++.|+|..+...+ +..+.++-... +..|.. ......+.+.+|.++..|.|++
T Consensus 18 ~t~~si~l~W~pp~~~~~~i~~Y~v~~~~~-~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~rV 80 (108)
T d1v5ja_ 18 RTPRGVLLHWDPPELVPKRLDGYVLEGRQG-SQGWEVLDPAVAGTETELLVPGLIKDVLYEFRL 80 (108)
T ss_dssp ECSSSEEEEEECCSCCSSCCCBEEEEEEET-TCCCEEEEEEECSSCCEEECCCCCTTSCEECCB
T ss_pred EcCCEEEEEEEecccCCCceeEEEEEeeee-eeeeeeccccccceeeeEEEEeccCCcEEEEEE
Confidence 46789999999876554 45566654332 344442 2346679999999999999998
|
| >d1x4ya1 b.1.2.1 (A:8-108) Brother of CDO precursor (BOC) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Brother of CDO precursor (BOC) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=94.92 E-value=0.049 Score=38.98 Aligned_cols=64 Identities=11% Similarity=0.056 Sum_probs=41.2
Q ss_pred CCCeeeeecCCCCeeEEeecCCCCCC----cceeeeccccccC---CcEEe---cCCCCeEEeecCCCCceeeEEe
Q psy11098 12 TQPVINVHPLSESSVELALLTENLSS----IRLCDHESGVWSD---ARWVI---SPHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 12 ~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~---~~~~~---~~~~~~~~~~~l~~~~~~~f~~ 77 (380)
....+.. ++.+++.|+|..+.... +..+.+.-....+ ..|.. ......+.+.+|.|+..|.|++
T Consensus 6 ~~~~~~~--~s~tsi~v~W~~~~~~~~~~~i~~Y~v~y~~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~v 79 (101)
T d1x4ya1 6 YITFTDA--VNETTIMLKWMYIPASNNNTPIHGFYIYYRPTDSDNDSDYKKDMVEGDRYWHSISHLQPETSYDIKM 79 (101)
T ss_dssp EEEEEEC--SSSSCEEEEEECCCTTSCCCCCCEEEEEECCTTSCSGGGCCCEEEETTCCEEEECSCCTTCEEEEEE
T ss_pred cccEEEE--EcCCEEEEEEecCcccccccceEEEEEEeeeccceeeeeeeEEEEcCCeeEEEEcCCCCCCEEEEEE
Confidence 4455555 99999999997543222 4445544322222 22332 3346678999999999999987
|
| >d1fnaa_ b.1.2.1 (A:) Fibronectin, different Fn3 modules {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Fibronectin, different Fn3 modules species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.81 E-value=0.031 Score=39.39 Aligned_cols=56 Identities=18% Similarity=0.254 Sum_probs=40.6
Q ss_pred CCCCeeEEeecCCCCCCcceeeeccccccCCcEE----ecCCCCeEEeecCCCCceeeEEe
Q psy11098 21 LSESSVELALLTENLSSIRLCDHESGVWSDARWV----ISPHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 21 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~~~~~~f~~ 77 (380)
++.+++.|+|..+. +.+..+.++-....+..|. .+.....+.+.+|.||..|.|++
T Consensus 8 ~t~~sv~l~W~~p~-~~~~~Y~v~~~~~~~~~~~~~~~~~~~~t~~~l~~L~p~t~Y~~~V 67 (91)
T d1fnaa_ 8 ATPTSLLISWDAPA-VTVRYYRITYGETGGNSPVQEFTVPGSKSTATISGLKPGVDYTITV 67 (91)
T ss_dssp ECSSCEEEECCCCS-SCCSEEEEEEEETTCCSCCEEEEEETTCCEEEECSCCTTCEEEEEE
T ss_pred eCCCEEEEEEEccc-eEecEEEEEEEcCCCCceeEEEEeCCCccEEEeCCCCCCCEEEEEE
Confidence 78899999998775 3456676654333333222 24567789999999999999998
|
| >d1wk0a_ b.1.2.1 (A:) Fibronectin type-III domain containing protein 3a, FNDC3A (KIAA0970) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Fibronectin type-III domain containing protein 3a, FNDC3A (KIAA0970) species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.81 E-value=0.038 Score=42.20 Aligned_cols=66 Identities=15% Similarity=0.171 Sum_probs=44.5
Q ss_pred CCCCCeeeeecCCCCeeEEeecCCCCCC-----------cceeeeccccc-cCCcEEe--cCCCCeEEeecCCCCceeeE
Q psy11098 10 PATQPVINVHPLSESSVELALLTENLSS-----------IRLCDHESGVW-SDARWVI--SPHNGTIQVDDLAPGHTYTF 75 (380)
Q Consensus 10 p~~~p~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~-~~~~~~~--~~~~~~~~~~~l~~~~~~~f 75 (380)
...+|.+.. ++..|+.|+|..+...+ ...+.+..... .+..|.. ......+.+++|.|+..|.|
T Consensus 20 ~~~~P~V~~--v~~~sv~l~W~~P~~~~~~~~~~~~~~~~~~y~v~~~~~~~~~~~~~~~~~~~~~~~i~~L~P~t~Y~f 97 (137)
T d1wk0a_ 20 NIVKPVASD--IQARTVVLTWSPPSSLINGETDESSVPELYGYEVLISSTGKDGKYKSVYVGEETNITLNDLKPAMDYHA 97 (137)
T ss_dssp CCCCCEEES--CCSSCEEEECCCCCCCSTTSSCSSCSCSCCEEEEEECSSCTTSCCEEEEEESCSEEEECSCCTTCEECE
T ss_pred CCCCCEEEE--eEcCEEEEEEeCcCcCCCceeeccccceEEeeEEEEeeCCCCccEEEEEecCccEEEECCCCCCcEEEE
Confidence 346688888 99999999999876543 11222222111 1234443 33466799999999999999
Q ss_pred Ee
Q psy11098 76 CI 77 (380)
Q Consensus 76 ~~ 77 (380)
++
T Consensus 98 ~V 99 (137)
T d1wk0a_ 98 KV 99 (137)
T ss_dssp EE
T ss_pred EE
Confidence 98
|
| >d1x5ka1 b.1.2.1 (A:8-118) Neogenin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Neogenin species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.69 E-value=0.064 Score=38.87 Aligned_cols=64 Identities=16% Similarity=0.103 Sum_probs=40.7
Q ss_pred eeeeecCCCCeeEEeecCCCCCC--cceeeecccc---ccCCcEEe---cCCCCeEEeecCCCCceeeEEee
Q psy11098 15 VINVHPLSESSVELALLTENLSS--IRLCDHESGV---WSDARWVI---SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 15 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~---~~~~~~~~---~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
.+.....+.+++.|+|..+...+ +..+.+.-.. .....|.. ......+.+.+|.|+..|.|++.
T Consensus 19 ~v~~~~~~~~sv~v~W~~P~~~~g~i~~Y~i~~~~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~ 90 (111)
T d1x5ka1 19 TVVSKEGKPKTIIVNWQPPSEANGKITGYIIYYSTDVNAEIHDWVIEPVVGNRLTHQIQELTLDTPYYFKIQ 90 (111)
T ss_dssp EEEECSSCTTCEEEEEECCSCCSSCCCEEEEEEESCSSSCTTTSEEEEESTTCSEEEECSCCSSSEEEEEEE
T ss_pred EEEEecCCCCEEEEEEEccccCCCceeeeEEeeeecCCCCcceeEEEEeCCCeeEEEECCCCCCCEEEEEEE
Confidence 34443467789999999877655 3334332111 11234443 23455799999999999999983
|
| >d1x5ja1 b.1.2.1 (A:8-107) Neogenin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Neogenin species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.59 E-value=0.031 Score=40.00 Aligned_cols=64 Identities=14% Similarity=0.238 Sum_probs=40.5
Q ss_pred CCCeeeeecCCCCeeEEeecCCCCCC------cceeeeccccc--cCCcEEe-cCCCCeEEeecCCCCceeeEEe
Q psy11098 12 TQPVINVHPLSESSVELALLTENLSS------IRLCDHESGVW--SDARWVI-SPHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 12 ~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~--~~~~~~~-~~~~~~~~~~~l~~~~~~~f~~ 77 (380)
....+.. ++.+++.|+|..+.... ...+.+.-... ....|.. ...+..+.+.+|.|+..|.|++
T Consensus 6 ~~v~~~~--~s~tsi~v~W~~p~~~~~~~~~~~~~y~v~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V 78 (100)
T d1x5ja1 6 VGVQASI--LSHDTIRITWADNSLPKHQKITDSRYYTVRWKTNIPANTKYKNANATTLSYLVTGLKPNTLYEFSV 78 (100)
T ss_dssp EEEEEEE--EETTEEEEEEECTTSCSSSCCCSSCEEEEEECBSSSSSCCCEECCBCSSEEEEESCCTTCEECCEE
T ss_pred cCeEEEE--ecCCEEEEEEcCCccccccceeeEEEEEEEeeecCCCcceeEecCCCccEEEECCCCCCCEEEEEE
Confidence 4445555 99999999998753322 22222322121 2233433 3456789999999999999998
|
| >d1tdqa2 b.1.2.1 (A:94-185) Tenascin {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Tenascin species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=94.21 E-value=0.029 Score=39.42 Aligned_cols=62 Identities=13% Similarity=0.183 Sum_probs=40.3
Q ss_pred CCeeeeecCCCCeeEEeecCCCCCCcceeeeccccccCCcEE---e---cCCCCeEEeecCCCCceeeEEe
Q psy11098 13 QPVINVHPLSESSVELALLTENLSSIRLCDHESGVWSDARWV---I---SPHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 13 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~---~~~~~~~~~~~l~~~~~~~f~~ 77 (380)
...+.. .+.+++.|+|..+... +..+.+.-....+..+. . ......+.+.+|.||..|.|++
T Consensus 6 ~l~v~~--~~~~sv~v~W~~p~~~-~~~y~v~y~~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V 73 (92)
T d1tdqa2 6 NLRVGS--RTATSLDLEWDNSEAE-AQEYKVVYSTLAGEQYHEVLVPKGIGPTTKTTLTDLVPGTEYGVGI 73 (92)
T ss_dssp EEEEEE--ECSSCEEEEEECCSSC-CSEEEEEEEETTCCCCEEEEEECCSSSEEEEEECSCCTTCEEEEEE
T ss_pred CCEEEE--ecCCEEEEEEEecCCc-ccceEEEEEEcCCCcceeeEEEecCCCeeEEEECCccCCCEEEEEE
Confidence 344555 7899999999887643 44555543332222221 1 1223468999999999999998
|
| >d1cd9b1 b.1.2.1 (B:1-107) Granulocyte colony-stimulating factor (GC-SF) receptor {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Granulocyte colony-stimulating factor (GC-SF) receptor species: Mouse (Mus musculus) [TaxId: 10090]
Probab=94.03 E-value=0.043 Score=39.87 Aligned_cols=58 Identities=9% Similarity=-0.039 Sum_probs=34.5
Q ss_pred CCCCeeEEeecCCCCCCc-ceee----eccccccCC--cEEe--c---CCCCeEEeecCCCCceeeEEee
Q psy11098 21 LSESSVELALLTENLSSI-RLCD----HESGVWSDA--RWVI--S---PHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 21 ~~~~~~~~~~~~~~~~~~-~~~~----~~~~~~~~~--~~~~--~---~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
.+..+++++|..+...|. ..+. .+....... .|.. . ..+..+.+.+|.++..|.|++.
T Consensus 17 ~~~~sv~~sW~p~~d~~~~~~y~~~y~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~t~Y~frV~ 86 (107)
T d1cd9b1 17 LTTNSLVCQWEPGPETHLPTSFILKSFRSRADCQYQGDTIPDCVAKKRQNNCSIPRKNLLLYQYMAIWVQ 86 (107)
T ss_dssp TTTTEEEEEEECCSCCSSCCEEEEEEEECCGGGCSCCCEEEEEECCTTCCEEEEEGGGCCTTSCEEEEEE
T ss_pred cCCCEEEEEEcCCCCCCCCcceeEEEEEeecccceeeeeeeeeccccCccccEEEcCCCCcCceEEEEEE
Confidence 788999999987765551 1121 121111111 2221 1 1234677899999999999983
|
| >d1erna2 b.1.2.1 (A:117-221) Erythropoietin (EPO) receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Erythropoietin (EPO) receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.02 E-value=0.064 Score=38.73 Aligned_cols=65 Identities=15% Similarity=0.118 Sum_probs=40.4
Q ss_pred CCCeeeeecC-CCCeeEEeecCCCCCC---cceeeeccccccCCcEE--e--cCCCCeEEeecCCCCceeeEEee
Q psy11098 12 TQPVINVHPL-SESSVELALLTENLSS---IRLCDHESGVWSDARWV--I--SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 12 ~~p~~~~~~~-~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~--~--~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
.-..+.. . +.+.+.++|..+..++ ...|.++-.......|. . ..+...+.+.+|.+|..|.|++.
T Consensus 9 ~nl~v~~--~~~~~~l~v~W~~P~~~~~~~~~~Y~v~y~~~~~~~~~~~~~~~~~~t~~~i~~L~p~t~Y~~rVR 81 (105)
T d1erna2 9 VGLVARL--ADESGHVVLRWLPPPETPMTSHIRYEVDVSAGNGAGSVQRVEILEGRTECVLSNLRGRTRYTFAVR 81 (105)
T ss_dssp EEEEEEE--CCC-CCEEEEEECSSSCSCGGGEEEEEEEEEC-CCCEEEEEEECTTCCEEEECSCCSSCEEEEEEE
T ss_pred CCCEEEE--ecCCCcEEEEeeeccccccceEEEEEEEEecCCCCCceEEEeecCCccEEEEeCCCCCcEEEEEEE
Confidence 4444443 3 3456999999887665 33455554333222222 2 34457899999999999999983
|
| >d1x5ia1 b.1.2.1 (A:8-120) Neogenin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Neogenin species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.96 E-value=0.069 Score=39.20 Aligned_cols=56 Identities=14% Similarity=0.184 Sum_probs=41.3
Q ss_pred CCCeeEEeecCCCCCC--cceeeeccccccCCcEEe--cCCCCeEEeecCCCCceeeEEe
Q psy11098 22 SESSVELALLTENLSS--IRLCDHESGVWSDARWVI--SPHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 22 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~~f~~ 77 (380)
..+++.|.|..+...+ +..|.++-.......|.. ......+.+.+|.++..|.|++
T Consensus 32 ~~~si~v~W~~p~~~~g~i~~Y~i~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V 91 (113)
T d1x5ia1 32 LVTSIVVSWTPPENQNIVVRGYAIGYGIGSPHAQTIKVDYKQRYYTIENLDPSSHYVITL 91 (113)
T ss_dssp ETTEEEEEEECCSCTTBCCCEEEEEECSSCGGGEEEECCTTCCEEEECSCCSSCEECCEE
T ss_pred CCCEEEEEEEccccCCccEEEEEEEeeeccccceeeeeeCCccEEEEeccccCcEEEEEE
Confidence 4589999999877665 566777654444444554 3446679999999999999998
|
| >d2dtge1 b.1.2.1 (E:808-909) Insulin receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Insulin receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.96 E-value=0.014 Score=42.43 Aligned_cols=69 Identities=16% Similarity=0.189 Sum_probs=45.8
Q ss_pred CCCCCCCCCCCeeeeecCCCCeeEEeecCCCCCC--cceeeeccccccCC---cEEe---cCCCCeEEeecCCCCceeeE
Q psy11098 4 SPLDFNPATQPVINVHPLSESSVELALLTENLSS--IRLCDHESGVWSDA---RWVI---SPHNGTIQVDDLAPGHTYTF 75 (380)
Q Consensus 4 ~~~~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~---~~~~---~~~~~~~~~~~l~~~~~~~f 75 (380)
.|||+ ++...+.. ++++++.|+|..|...+ +..|.++-....+. .|.. ......+.+.+|.++ +|.|
T Consensus 3 ~~~d~--P~~v~~~~--~~~~sv~l~W~pP~~~ng~i~~Y~v~y~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~-tY~~ 77 (102)
T d2dtge1 3 KADDI--VGPVTHEI--FENNVVHLMWQEPKEPNGLIVLYEVSYRRYGDEELHLCDTRKHFALERGCRLRGLSPG-NYSV 77 (102)
T ss_dssp CCCCC--CCCCCCCS--SSSSCCCCCCCCCCSCSSCEEEECCCCBSSSBCCCCCCCCSSSCCCTTCCCCCSCCSS-EECC
T ss_pred CCCCC--CCCCEEEE--ECCCEEEEEEEeCCCCcceEEEeeeEEEecCCCCceeeeeeecccceEEEEEecccee-eEEE
Confidence 46774 46667777 89999999999877665 56666654433322 2222 123446888999997 5999
Q ss_pred Ee
Q psy11098 76 CI 77 (380)
Q Consensus 76 ~~ 77 (380)
++
T Consensus 78 rV 79 (102)
T d2dtge1 78 RI 79 (102)
T ss_dssp CC
T ss_pred EE
Confidence 87
|
| >d3d48r2 b.1.2.1 (R:101-204) Prolactin receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Prolactin receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.87 E-value=0.035 Score=39.90 Aligned_cols=58 Identities=16% Similarity=0.204 Sum_probs=35.1
Q ss_pred CCCCeeEEeecCCCCCC------cceeeeccccccCCcEEe--cCCCCeEEeecCCCCceeeEEee
Q psy11098 21 LSESSVELALLTENLSS------IRLCDHESGVWSDARWVI--SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 21 ~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
.+.+++.|+|..+.... ...|.++.....+..|.. ......+.+.+|.++..|.|++.
T Consensus 18 ~~~~~l~v~W~pP~~~~~~~~~~~~~Y~~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~rVr 83 (104)
T d3d48r2 18 DRKPYLWIKWSPPTLIDLKTGWFTLLYEIRLKPEKAAEWEIHFAGQQTEFKILSLHPGQKYLVQVR 83 (104)
T ss_dssp ---CCEEEEEECCTTCCCTTSSCCEEEEEEEEETTCSSCEEEEEETCSEEEECC--CCCEEEEEEE
T ss_pred CCCCeEEEEEeCCccccCCCCcEEEEEeeccccccccceeeeccccccEEEECCCCCCCEEEEEEE
Confidence 46788999999875322 233444433333445544 34466788999999999999984
|
| >d1va9a1 b.1.2.1 (A:8-116) Down syndrome cell adhesion molecule-like protein 1, DSCAML1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Down syndrome cell adhesion molecule-like protein 1, DSCAML1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.79 E-value=0.071 Score=38.51 Aligned_cols=61 Identities=13% Similarity=0.156 Sum_probs=38.3
Q ss_pred eeeeecCCCCeeEEeecCCCCCC----cceeeeccccccC---CcEEe-----cCCCCeEEeecCCCCceeeEEe
Q psy11098 15 VINVHPLSESSVELALLTENLSS----IRLCDHESGVWSD---ARWVI-----SPHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 15 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~---~~~~~-----~~~~~~~~~~~l~~~~~~~f~~ 77 (380)
.+.. ++.+++.|.|..+..+. +..+.+.-..... ..|.. ......+.+.+|.|+..|.|++
T Consensus 16 ~v~~--~~~~si~l~W~~p~~~~~~~~i~~y~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V 88 (109)
T d1va9a1 16 TLQP--VTSQSIQVTWKAPKKELQNGVIRGYQIGYRENSPGSNGQYSIVEMKATGDSEVYTLDNLKKFAQYGVVV 88 (109)
T ss_dssp EEEE--CSSSEEEEEEECCCSSTTCSCCCEEEEEEEESSTTSCCSCBCCBCCCCSSEEEEEEESCCSSCCEEEEE
T ss_pred EEEE--ecCCEEEEEEcCCCCCCCCCcEEEEEEEEeeccccccceeeeeEEecCCCeeEEEECCCCcceEEEEEE
Confidence 3555 89999999998764443 3344443222111 12221 1234578899999999999998
|
| >d2b5ib2 b.1.2.1 (B:104-207) Interleukin-2 receptor beta chain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Interleukin-2 receptor beta chain species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.63 E-value=0.089 Score=37.56 Aligned_cols=67 Identities=10% Similarity=0.087 Sum_probs=43.6
Q ss_pred CCCCCeeeeecCCCCeeEEeecCCCCCC--ccee--eeccccccC--CcEE--e-cCCCCeEEeecCCCCceeeEEee
Q psy11098 10 PATQPVINVHPLSESSVELALLTENLSS--IRLC--DHESGVWSD--ARWV--I-SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 10 p~~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~--~~~~~~~~~--~~~~--~-~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
||....+.. ++.+++.|+|..+..++ ...| .+.-....+ ..+. . ..+...+.+.+|.|+..|.|++.
T Consensus 5 pP~~l~v~~--~~~~s~~l~W~~p~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~rVr 80 (104)
T d2b5ib2 5 APISLQVVH--VETHRCNISWEISQASHYFERHLEFEARTLSPGHTWEEAPLLTLKQKQEWICLETLTPDTQYEFQVR 80 (104)
T ss_dssp CCEEEEEEE--ECSSCEEEEEECCSCCGGGTTCEEEEEEEECTTSCSTTSCCEEECSCCCEEEECSCCTTCEEEEEEE
T ss_pred CCCCcEEEE--EeCCEEEEEEccccccccccceeEEEEEEecccccceeeeEEecCCCcEEEEECCCCCCCEEEEEEE
Confidence 556777777 88999999998887664 2222 232211111 1111 1 33466799999999999999984
|
| >d1ueya_ b.1.2.1 (A:) KIAA0343 protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: KIAA0343 protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.58 E-value=0.046 Score=41.03 Aligned_cols=63 Identities=17% Similarity=0.123 Sum_probs=41.7
Q ss_pred CeeeeecCCCCeeEEeecCCCCCC--cceeeecccc--ccCCcEEe---cCCCCeEEeecCCCCceeeEEee
Q psy11098 14 PVINVHPLSESSVELALLTENLSS--IRLCDHESGV--WSDARWVI---SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 14 p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~--~~~~~~~~---~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
+.+.. .+.+++.|+|..+...+ +..|.++... .....|.. ......+.+.+|.++..|.|++.
T Consensus 23 ~~v~~--~~~~sv~l~W~~p~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~frV~ 92 (127)
T d1ueya_ 23 LELTD--QLDKSVQLSWTPGDDNNSPITKFIIEYEDAMHKPGLWHHQTEVSGTQTTAQLNLSPYVNYSFRVM 92 (127)
T ss_dssp EEEEC--CSSSCEEEEEECCCCCSSCEEEEEEEEEBTTTCTTCEEEEEEEESSCCEEEECCCTTCEECCEEE
T ss_pred cEEEE--ecCCeEEEEEeCCcccccceEeeeeeeccccccceeEEEEeecCCceEEEECCCccCCEEEEEEE
Confidence 34444 89999999998776554 4555543322 12233433 23455788999999999999983
|
| >d1iarb2 b.1.2.1 (B:97-197) Interleukin-4 receptor alpha chain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Interleukin-4 receptor alpha chain species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.44 E-value=0.034 Score=39.87 Aligned_cols=65 Identities=9% Similarity=-0.046 Sum_probs=33.3
Q ss_pred CCCeeeeecCCCCeeEEeecCCCCCC-----cceeeeccccccCCcEEe----cCC--CCeEEeecCCCCceeeEEee
Q psy11098 12 TQPVINVHPLSESSVELALLTENLSS-----IRLCDHESGVWSDARWVI----SPH--NGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 12 ~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~----~~~--~~~~~~~~l~~~~~~~f~~~ 78 (380)
.-..+.. .+.+++.|.|..+...+ ...|.++-....+..|.. ... ...+.+.+|.|+..|.|++.
T Consensus 6 ~~l~v~~--~~~~s~~v~W~~P~~~~~~~~~~~~y~v~y~~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~rVr 81 (101)
T d1iarb2 6 GNLTVHT--NVSDTLLLTWSNPYPPDNYLYNHLTYAVNIWSENDPADFRIYNVTYLEPSLRIAASTLKSGISYRARVR 81 (101)
T ss_dssp EEEEEC------CCEEEEEECSSCTTSTTGGGCEEEEEEEESSSCSCEEEEEECSSCCEEEECC-----CCCEEEEEE
T ss_pred CcCEEEE--EeCCeEEEEEccccCCCCccceeeEEEEeeecccceeeeeeeeeccCccceEEEECCCCCCCEEEEEEE
Confidence 4455655 78899999998776544 223555433333333332 222 23577889999999999984
|
| >d1cfba2 b.1.2.1 (A:710-814) Neuroglian, two amino proximal Fn3 repeats {Drosophila melanogaster [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Neuroglian, two amino proximal Fn3 repeats species: Drosophila melanogaster [TaxId: 7227]
Probab=93.29 E-value=0.17 Score=36.43 Aligned_cols=62 Identities=10% Similarity=-0.079 Sum_probs=40.4
Q ss_pred eeeeecCCCCeeEEeecCCCC--C--Ccceeeeccccc-cCCcEEe----cCCCCeEEeecCCCCceeeEEee
Q psy11098 15 VINVHPLSESSVELALLTENL--S--SIRLCDHESGVW-SDARWVI----SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 15 ~~~~~~~~~~~~~~~~~~~~~--~--~~~~~~~~~~~~-~~~~~~~----~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
.+.. .+.+++.++|..+.. . .+..|.+.-... ++..|.. .....++.+.+|.++..|.|++.
T Consensus 12 ~~~~--~~~~si~v~W~p~~~~~~ng~i~~Y~I~y~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V~ 82 (105)
T d1cfba2 12 VGQG--TEPNNLVISWTPMPEIEHNAPNFHYYVSWKRDIPAAAWENNNIFDWRQNNIVIADQPTFVKYLIKVV 82 (105)
T ss_dssp EEEC--SSTTCEEEECCCCCGGGTCSSSCEEEEEEEESSTTCCCEEEEECCTTCCEEEECSCCSSCEEEEEEE
T ss_pred EEEE--ccCCeEEEEEeCCChhhcCceEEEEEEEeeeeccccceeEEEecCCCccEEEECCCCCCCEEEEEEE
Confidence 4444 888999999975332 1 255666543222 2344543 23356799999999999999983
|
| >d1wfta_ b.1.2.1 (A:) Host cell factor 2, HCF-2 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Host cell factor 2, HCF-2 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=93.06 E-value=0.13 Score=38.20 Aligned_cols=57 Identities=11% Similarity=-0.022 Sum_probs=34.1
Q ss_pred CCCeeEEeecCCCCCC--cceeeeccccccCC-------cEEe-c--CC---------CCeEEeecCCCCceeeEEee
Q psy11098 22 SESSVELALLTENLSS--IRLCDHESGVWSDA-------RWVI-S--PH---------NGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 22 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~-------~~~~-~--~~---------~~~~~~~~l~~~~~~~f~~~ 78 (380)
+.+++.|+|..+..++ +..|.++-...... .|.. . .. ...+.+.+|.|+..|.|+|.
T Consensus 19 ~~~si~l~W~~P~~~~g~i~~Y~v~y~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~frV~ 96 (123)
T d1wfta_ 19 NVDGIHLSWEPPTSPSGNILEYSAYLAIRTAQMQDNPSQLVFMRIYCGLKTSCTVTAGQLANAHIDYTSRPAIVFRIS 96 (123)
T ss_dssp CSSEEEEEEECCSSCCSSCCCEEEEEEECSSCCCSCSCCCEEEEEEEESCSEEEEEHHHHTTCCCBCSSSCEEEEEEE
T ss_pred CCCEEEEEecCchhcCCceEEEEEEEEECCCCCccccceeeeEEEecCCceeEeecCCccEEEEcCCCCCCEEEEEEE
Confidence 5789999999887666 44555442221111 1111 0 01 12345678999999999984
|
| >d1x5ha1 b.1.2.1 (A:8-126) Neogenin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Neogenin species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.82 E-value=0.19 Score=36.97 Aligned_cols=61 Identities=15% Similarity=0.089 Sum_probs=40.0
Q ss_pred eeecCCCCeeEEeecCCCCC---C-cceeeeccccccCCcEEe----cCCCCeEEeecCCCCceeeEEe
Q psy11098 17 NVHPLSESSVELALLTENLS---S-IRLCDHESGVWSDARWVI----SPHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 17 ~~~~~~~~~~~~~~~~~~~~---~-~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~~~~~~f~~ 77 (380)
..-..+.+++.++|..+..+ | +..|.+.-....+..|.. ......+.+.+|.|+..|.|++
T Consensus 19 ~~~~~~~~si~v~W~~p~~~~~ng~i~~Y~v~y~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~~V 87 (119)
T d1x5ha1 19 SLEVRNSKSIMIHWQPPAPATQNGQITGYKIRYRKASRKSDVTETLVSGTQLSQLIEGLDRGTEYNFRV 87 (119)
T ss_dssp EEECCSSSEEEEEEECCCTTTCCSCEEEEBCEEEETTEEEEEECCBCCTTCCEEEEECCCSSCEEEEEC
T ss_pred EEEEecCcEEEEEEEcccccCCCCCEEEEEEEEeecccccceeeeecCCCccEEEeCCCCCCCEEEEEE
Confidence 33348899999999876422 2 445555433322333332 2345678999999999999987
|
| >d1wj3a_ b.1.2.1 (A:) Contactin 3 (KIAA1496) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Contactin 3 (KIAA1496) species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.64 E-value=0.15 Score=37.41 Aligned_cols=57 Identities=14% Similarity=-0.026 Sum_probs=37.9
Q ss_pred CCCCeeEEeecCCCC--C-C-cceeeeccccccCCcEEecCCCCeEEeecCCCCceeeEEe
Q psy11098 21 LSESSVELALLTENL--S-S-IRLCDHESGVWSDARWVISPHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 21 ~~~~~~~~~~~~~~~--~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~f~~ 77 (380)
.+.+++.|.|..+.. . | +..|.+.-.......|.....+..+.+.+|.++..|.|++
T Consensus 29 ~~~~~i~v~W~~~~~~~~~g~i~~Y~v~y~~~~~~~~~~~~~~~~~~~~~L~p~t~Y~~~V 89 (117)
T d1wj3a_ 29 ATDTKVLLNWEQVKAMENESEVTGYKVFYRTSSQNNVQVLNTNKTSAELVLPIKEDYIIEV 89 (117)
T ss_dssp EETTEEEEECCCCCCCSSSCCEEEEEEEEEESSCSSCEEEEESSSEEEEECCCSSCEEEEE
T ss_pred ecCCEEEEEEeecccccCCCceeEEEEEEEecCCCceeeeeceeeEEEeeccCCcEEEEEE
Confidence 677999999986332 2 2 4556654323233445444445667788999999999998
|
| >d1uena_ b.1.2.1 (A:) KIAA0343 protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: KIAA0343 protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.52 E-value=0.15 Score=37.71 Aligned_cols=65 Identities=17% Similarity=0.136 Sum_probs=39.3
Q ss_pred CCCCeeeeecCCCCeeEEeecCCCCCC----cceeeec-----cccccCCc----EEe--cCCCCeEEeecCCCCceeeE
Q psy11098 11 ATQPVINVHPLSESSVELALLTENLSS----IRLCDHE-----SGVWSDAR----WVI--SPHNGTIQVDDLAPGHTYTF 75 (380)
Q Consensus 11 ~~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~-----~~~~~~~~----~~~--~~~~~~~~~~~l~~~~~~~f 75 (380)
|....+.. ++.+++.|+|..+...+ +..+.+. ........ +.. ......+.+.+|.|+..|.|
T Consensus 18 P~~v~v~~--~~~~si~l~W~~p~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~L~p~t~Y~~ 95 (125)
T d1uena_ 18 PGNVRVNV--VNSTLAEVHWDPVPLKSIRGHLQGYRIYYWKTQSSSKRNRRHIEKKILTFQGSKTHGMLPGLEPFSHYTL 95 (125)
T ss_dssp CSSCEEEE--EETTEEEEECCCCCHHHHCSCEEEEEEEEEEESCCCCSTTCCCCEEEEEEESSCSEEEEESCCSSCEEEE
T ss_pred CcccEEEE--ecCCEEEEEEeCccCCCCCcceeeEEeEEEeecCCccceeecccceEEEeCCCccEEEECCCCCCCEEEE
Confidence 34555655 88999999998875432 2222221 11111111 111 23456799999999999999
Q ss_pred Ee
Q psy11098 76 CI 77 (380)
Q Consensus 76 ~~ 77 (380)
++
T Consensus 96 ~V 97 (125)
T d1uena_ 96 NV 97 (125)
T ss_dssp EE
T ss_pred EE
Confidence 98
|
| >d1ujta_ b.1.2.1 (A:) KIAA1568 protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: KIAA1568 protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.32 E-value=0.25 Score=36.59 Aligned_cols=58 Identities=16% Similarity=0.265 Sum_probs=40.3
Q ss_pred CCCCeeEEeecCCCCCC-cceeeeccc----cccCCcEEe----cCCCCeEEeecCCCCceeeEEee
Q psy11098 21 LSESSVELALLTENLSS-IRLCDHESG----VWSDARWVI----SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 21 ~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~----~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
++.+++.|+|..+...+ ++.|.+.-. ...+..|.. .....++.+.+|.|+..|.|++.
T Consensus 27 ~s~tsi~v~W~~p~~~~~i~gY~v~y~~~~~~~~~~~~~~~~v~~~~~~s~~i~~L~p~t~Y~f~V~ 93 (120)
T d1ujta_ 27 LTPTTVQVTWTVDRQPQFIQGYRVMYRQTSGLQATSSWQNLDAKVPTERSAVLVNLKKGVTYEIKVR 93 (120)
T ss_dssp CBTTEEEEEEEESSCCSSCCEEEEEEEESSSSSTTTCCEEEECCCTTCCEEEEESCCSSEEEEEEEE
T ss_pred eCCCeEEEEecCCCCCCcEEEEEEEeeecccCCCCcceEEEEeccCceeEEEECCCCCCCEEEEEEE
Confidence 67899999999875444 445554322 223456764 23456799999999999999983
|
| >d2cspa1 b.1.2.1 (A:8-124) Rim binding protein 2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Rim binding protein 2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.29 E-value=0.023 Score=42.42 Aligned_cols=54 Identities=6% Similarity=0.079 Sum_probs=32.8
Q ss_pred CCCCeeEEeecCCCCCC--------cceeeeccccccCCcEE-e-c--CCCCeEEeecCCCCceeeEEe
Q psy11098 21 LSESSVELALLTENLSS--------IRLCDHESGVWSDARWV-I-S--PHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 21 ~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~-~-~--~~~~~~~~~~l~~~~~~~f~~ 77 (380)
.+..++.++|..+..++ +..|.+... ...+. . . .+...+.+.+|.++..|.|++
T Consensus 23 ~s~~si~vsW~PP~~~~~~~~~~~~i~~Y~v~~~---~~~~~~~~~~~~~~~~~~i~~L~~~t~Y~v~V 88 (117)
T d2cspa1 23 VTPATIRVSWRPPVLTPTGLSNGANVTGYGVYAK---GQRVAEVIFPTADSTAVELVRLRSLEAKGVTV 88 (117)
T ss_dssp SSTTEEEEEEECCCCCTTSCSSSSCEEEEEEESS---SSEEEEECCTTCSEEEEESHHHHHHTCSCBEE
T ss_pred cCCCEEEEEEcCCCccccCcccccceEEEEEEee---cccceeeeeeccceeeeeccCCCCCcEEEEEE
Confidence 45679999998775432 344443321 12222 2 1 223357788999999999987
|
| >d2gysa4 b.1.2.1 (A:317-416) Common beta-chain in the GM-CSF, IL-3 and IL-5 receptors {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Common beta-chain in the GM-CSF, IL-3 and IL-5 receptors species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.43 E-value=0.27 Score=34.73 Aligned_cols=56 Identities=14% Similarity=0.124 Sum_probs=32.6
Q ss_pred CCCeeEEeecCCCCCCc---ceeeeccccccCCcEEe-----cCCCCeEEeecCCCCceeeEEee
Q psy11098 22 SESSVELALLTENLSSI---RLCDHESGVWSDARWVI-----SPHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 22 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
+.+++.|.|..|...+. ..|.++-.... ..|.. ......+.+.+|.||..|.|++.
T Consensus 16 ~~~s~~l~W~~P~~~~~~~~~~Y~v~y~~~~-~~~~~~~~~~~~~~~~~~l~~L~p~t~Y~~rVR 79 (100)
T d2gysa4 16 DGDSYSLRWETMKMRYEHIDHTFEIQYRKDT-ATWKDSKTETLQNAHSMALPALEPSTRYWARVR 79 (100)
T ss_dssp --CCCEEEEEC--------CEEEEEEEECSS-SCSTTSCEEEEESCSEEECCCCCSSCCCEEEEE
T ss_pred CCCEEEEEEecCcccCCccceEEEEEEeecc-cceeceeecccCCceEEEeCCCCCCCeEEEEEE
Confidence 45789999998877653 24555443322 22221 23466899999999999999984
|
| >d2gysa2 b.1.2.1 (A:104-217) Common beta-chain in the GM-CSF, IL-3 and IL-5 receptors {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Common beta-chain in the GM-CSF, IL-3 and IL-5 receptors species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.61 E-value=0.23 Score=36.09 Aligned_cols=65 Identities=15% Similarity=0.065 Sum_probs=37.4
Q ss_pred CCCCeeeeecCCCCeeEEeecCCCCCC--------cceeeeccccccCC--cEEe-c--CCCCeEEeecCCCCceeeEEe
Q psy11098 11 ATQPVINVHPLSESSVELALLTENLSS--------IRLCDHESGVWSDA--RWVI-S--PHNGTIQVDDLAPGHTYTFCI 77 (380)
Q Consensus 11 ~~~p~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~--~~~~-~--~~~~~~~~~~l~~~~~~~f~~ 77 (380)
|....+. .+.+++.|+|..+..++ ...|.++-...... .+.. . .....+.+.+|.|+..|.|++
T Consensus 9 P~nl~v~---~~~~~~~lsW~~P~~~~~~~~~~~~~~~y~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~p~t~Y~~rV 85 (114)
T d2gysa2 9 PRDLQIS---TDQDHFLLTWSVALGSPQSHWLSPGDLEFEVVYKRLQDSWEDAAILLSNTSQATLGPEHLMPSSTYVARV 85 (114)
T ss_dssp CEEEEEE---EETTEEEEEEECCC-----CCSCGGGEEEEEEEEETTSCSTTCEEEEESSSEEEECTTTCCTTCEEEEEE
T ss_pred CCCeEEE---EeCCEEEEECCCCcccccccceeeeEEEEEEEEeccCCceEEEEEeeccCceEEEEeCCCCCCcEEEEEE
Confidence 3444554 46689999999886554 12344433222222 2222 1 223367788999999999998
Q ss_pred e
Q psy11098 78 N 78 (380)
Q Consensus 78 ~ 78 (380)
.
T Consensus 86 R 86 (114)
T d2gysa2 86 R 86 (114)
T ss_dssp E
T ss_pred E
Confidence 4
|
| >d1fyhb1 b.1.2.1 (B:12-109) Interferon-gamma receptor alpha chain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Interferon-gamma receptor alpha chain species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.17 E-value=0.41 Score=33.54 Aligned_cols=57 Identities=9% Similarity=0.056 Sum_probs=34.2
Q ss_pred CCCCeeEEeecCCCCCCcceeeecc--ccccCCcEEec-----CCCCeEEeecCCCCceeeEEee
Q psy11098 21 LSESSVELALLTENLSSIRLCDHES--GVWSDARWVIS-----PHNGTIQVDDLAPGHTYTFCIN 78 (380)
Q Consensus 21 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~-----~~~~~~~~~~l~~~~~~~f~~~ 78 (380)
... ..+|+|..+..+|...+.++. .......|... .....+.++.|.++..|.|++.
T Consensus 12 ~n~-~~~L~W~pP~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~Y~fRV~ 75 (98)
T d1fyhb1 12 YNM-NPIVYWEYQIMPQVPVFTVEVKNYGVKNSEWIDACINISHHYCNISDHVGDPSNSLWVRVK 75 (98)
T ss_dssp BSS-CCEEEEECCCCSSCCEEEEEEEETTCSSSCCEEEEEEESSSEEECGGGCCSTTSCEEEEEE
T ss_pred eCC-cEEEEECCCCCCCCCceeEEEEEeccccceeEEeeeecccceeeeEecccCCCCEEEEEEE
Confidence 443 457999998888854443322 12222333322 1223456788999999999984
|
| >d2dtge3 b.1.2.1 (E:468-592) Insulin receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Immunoglobulin-like beta-sandwich superfamily: Fibronectin type III family: Fibronectin type III domain: Insulin receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.50 E-value=0.93 Score=33.15 Aligned_cols=59 Identities=12% Similarity=0.026 Sum_probs=37.2
Q ss_pred cCCCCeeEEeecCCCCCC---cceeeecccccc--------------CCcEEe-------------cCCCCeEEeecCCC
Q psy11098 20 PLSESSVELALLTENLSS---IRLCDHESGVWS--------------DARWVI-------------SPHNGTIQVDDLAP 69 (380)
Q Consensus 20 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~--------------~~~~~~-------------~~~~~~~~~~~l~~ 69 (380)
..+.++|.|+|..|...+ +..+.+.-...+ ...|.. .....++.+.+|.|
T Consensus 12 ~~sstsv~lsW~pP~~~~~~~i~gY~I~y~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~L~p 91 (125)
T d2dtge3 12 RTSFDKILLRWEPYWPPDFRDLLGFMLFYKEAPYQNVTEFDGQDACGSNSWTVVDIDPPLRSNDPKSQNHPGWLMRGLKP 91 (125)
T ss_dssp EECSSCEEEECCCCCSSSCCCEEEECCCSSSCCTTTCCCCCCCCCSCCCCCCCCCSCCEEEECCCCSSSCCEEEECSCCS
T ss_pred EecCCEEEEEEeCCCccCCCcEEEEEEEEEECCCCceEEEeeccccCCcccceecccCcceeeeecCCccCEEEECCCcc
Confidence 388999999999876433 445544321111 112221 12245688999999
Q ss_pred CceeeEEee
Q psy11098 70 GHTYTFCIN 78 (380)
Q Consensus 70 ~~~~~f~~~ 78 (380)
+..|.|++.
T Consensus 92 ~T~Y~~~V~ 100 (125)
T d2dtge3 92 WTQYAIFVK 100 (125)
T ss_dssp SCBCCBEEE
T ss_pred CCEEEEEEE
Confidence 999999873
|